PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wei, ZY; Li, YJ; Ye, F; Zhang, MJ				Wei, Zhiyi; Li, Youjun; Ye, Fei; Zhang, Mingjie			Structural Basis for the Phosphorylation-regulated Interaction between the Cytoplasmic Tail of Cell Polarity Protein Crumbs and the Actin-binding Protein Moesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA EPITHELIAL-CELLS; ZONULA ADHERENS FORMATION; ERM PROTEINS; APICAL MEMBRANE; FERM DOMAIN; CARGO RECOGNITION; HIPPO PATHWAY; COMPLEX; ORGANIZATION; REVEALS	The type I transmembrane protein crumbs (Crb) plays critical roles in the establishment and maintenance of cell polarities in diverse tissues. As such, mutations of Crb can cause different forms of cancers. The cell intrinsic role of Crb in cell polarity is governed by its conserved, 37-residue cytoplasmic tail (Crb-CT) via binding to moesin and protein associated with Lin7-1 (PALS1). However, the detailed mechanism governing the Crb center dot moesin interaction and the balance of Crb in binding to moesin and PALS1 are not well understood. Here we report the 1.5 angstrom resolution crystal structure of the moesin proin 4.1/ez-rin/radixin/moesin (FERM)center dot Crb-CT complex, revealing that both the canonical FERM binding motif and the postsynaptic density protein-95/Disc large-1/Zonula occludens-1 (PDZ) binding motif of Crb contribute to the Crb center dot moesin interaction. We further demonstrate that phosphorylation of Crb-CT by atypical protein kinase C (aPKC) disrupts the Crb center dot moesin association but has no impact on the Crb center dot PALS1 interaction. The above results indicate that, upon the establishment of the apical-basal polarity in epithelia, apical-localized aPKC can actively prevent the Crb center dot moesin complex formation and thereby shift Crb to form complex with PALS1 at apical junctions. Therefore, Crb may serve as an aPKC-mediated sensor in coordinating contact-dependent cell growth inhibition in epithelial tissues.	[Wei, Zhiyi; Li, Youjun; Ye, Fei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi; Ye, Fei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Sch Sci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi; Ye, Fei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Southern University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/C-4315-2014; Wei, Zhiyi/N-9995-2019	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Zhang, Mingjie/0000-0001-9404-0190	Research Grants Council of Hong Kong [663811, 663812, 664113, AoE/M09/12, T13-607/12R]; Asia Fund for Cancer Research	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Asia Fund for Cancer Research	This work was supported by Research Grants Council of Hong Kong Grants 663811, 663812, 664113, AoE/M09/12, and T13-607/12R and by the Asia Fund for Cancer Research (to M. Z.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; FUNAYAMA N, 1991, J CELL BIOL, V115, P1039, DOI 10.1083/jcb.115.4.1039; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Klose S, 2013, G3-GENES GENOM GENET, V3, P153, DOI 10.1534/g3.112.005074; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Li YJ, 2014, P NATL ACAD SCI USA, V111, P17444, DOI 10.1073/pnas.1416515111; Li YJ, 2014, J BIOL CHEM, V289, P14674, DOI 10.1074/jbc.M114.551184; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Pocha SM, 2013, CURR BIOL, V23, pR289, DOI 10.1016/j.cub.2013.03.001; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; SATO N, 1992, J CELL SCI, V103, P131; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wei ZY, 2011, P NATL ACAD SCI USA, V108, P3572, DOI 10.1073/pnas.1016567108; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WODARZ A, 1993, MECH DEVELOP, V44, P175, DOI 10.1016/0925-4773(93)90066-7; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	60	41	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11384	11392		10.1074/jbc.M115.643791	http://dx.doi.org/10.1074/jbc.M115.643791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792740	Green Published, hybrid			2022-12-26	WOS:000353719400015
J	Muhic, M; Vardjan, N; Chowdhury, HH; Zorec, R; Kreft, M				Muhic, Marko; Vardjan, Nina; Chowdhury, Helena H.; Zorec, Robert; Kreft, Marko			Insulin and Insulin-like Growth Factor 1 (IGF-1) Modulate Cytoplasmic Glucose and Glycogen Levels but Not Glucose Transport across the Membrane in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; CULTURED MOUSE ASTROCYTES; RAT-BRAIN; CEREBROSPINAL-FLUID; FACTOR-I; ALZHEIMERS-DISEASE; WHITE-MATTER; INTRANASAL INSULIN; ENERGY-METABOLISM	Astrocytes contain glycogen, an energy buffer, which can bridge local short term energy requirements in the brain. Glycogen levels reflect a dynamic equilibrium between glycogen synthesis and glycogenolysis. Many factors that include hormones and neuropeptides, such as insulin and insulin-like growth factor 1 (IGF-1) likely modulate glycogen stores in astrocytes, but detailed mechanisms at the cellular level are sparse. We used a glucose nanosensor based on Forster resonance energy transfer to monitor cytosolic glucose concentration with high temporal resolution and a cytochemical approach to determine glycogen stores in single cells. The results show that after glucose depletion, glycogen stores are replenished. Insulin and IGF-1 boost the process of glycogen formation. Although astrocytes appear to express glucose transporter GLUT4, glucose entry across the astrocyte plasma membrane is not affected by insulin. Stimulation of cells with insulin and IGF-1 decreased cytosolic glucose concentration, likely because of elevated glucose utilization for glycogen synthesis.	[Muhic, Marko; Vardjan, Nina; Chowdhury, Helena H.; Zorec, Robert; Kreft, Marko] Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Ljubljana 1000, Slovenia; [Vardjan, Nina; Chowdhury, Helena H.; Zorec, Robert; Kreft, Marko] Celica Biomed, Ljubljana 1000, Slovenia; [Kreft, Marko] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia	University of Ljubljana; University of Ljubljana	Zorec, R (corresponding author), Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Zaloska 4, Ljubljana 1000, Slovenia.	robert.zorec@celica.si; marko.kreft@celica.si	Vardjan, Nina/AAP-1496-2021; Chowdhury, Helena/ADV-0582-2022; Zorec, Robert/AAD-7180-2021	Chowdhury, Helena/0000-0001-8252-573X; Zorec, Robert/0000-0002-7478-3875	Slovenian Research Agency [P3 310, J3 4051, J3 4146]; COST Action [BM1002]; EduGlia Initial Training Network European Union (ITN EU)	Slovenian Research Agency(Slovenian Research Agency - Slovenia); COST Action(European Cooperation in Science and Technology (COST)); EduGlia Initial Training Network European Union (ITN EU)	This work was supported by Grants P3 310, J3 4051, and J3 4146 from the Slovenian Research Agency, COST Action BM1002, and an EduGlia Initial Training Network European Union (ITN EU) grant.	Armstrong CS, 2000, J NEUROSCI RES, V59, P649, DOI 10.1002/(SICI)1097-4547(20000301)59:5<649::AID-JNR8>3.0.CO;2-W; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Banks WA, 2004, EUR J PHARMACOL, V490, P5, DOI 10.1016/j.ejphar.2004.02.040; Banks WA, 1997, PEPTIDES, V18, P1423, DOI 10.1016/S0196-9781(97)00231-3; BASKIN DG, 1987, ANNU REV PHYSIOL, V49, P335, DOI 10.1146/annurev.ph.49.030187.002003; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; BAURA GD, 1993, J CLIN INVEST, V92, P1824, DOI 10.1172/JCI116773; Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378; Bittner C.X., 2010, FRONT NEUROENERGETIC, V2; Blakesley Vicky A., 1996, Cytokine and Growth Factor Reviews, V7, P153, DOI 10.1016/1359-6101(96)00015-9; BRANT AM, 1993, BIOCHEM BIOPH RES CO, V192, P1297, DOI 10.1006/bbrc.1993.1557; Brown AM, 2003, J PHYSIOL-LONDON, V549, P501, DOI 10.1113/jphysiol.2003.042416; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Cheng CL, 2005, WORLD J GASTROENTERO, V11, P1891; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Craft S, 1999, ARCH GEN PSYCHIAT, V56, P1135, DOI 10.1001/archpsyc.56.12.1135; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cruz NF, 2002, J CEREBR BLOOD F MET, V22, P1476, DOI 10.1097/01.WCB.0000034362.37277.C0; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; DiNuzzo M, 2011, BIOESSAYS, V33, P319, DOI 10.1002/bies.201000151; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P1895, DOI 10.1038/jcbfm.2010.151; DRINGEN R, 1993, NEUROSCI LETT, V163, P5, DOI 10.1016/0304-3940(93)90215-7; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; DRINGEN R, 1992, J NEUROCHEM, V58, P511, DOI 10.1111/j.1471-4159.1992.tb09750.x; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Gil-Bea FJ, 2010, J ALZHEIMERS DIS, V22, P405, DOI 10.3233/JAD-2010-100795; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; GOODE N, 1992, J BIOL CHEM, V267, P16878; Hamai M, 1999, J NEUROCHEM, V73, P400, DOI 10.1046/j.1471-4159.1999.0730400.x; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Heni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021594; INOUE N, 1988, J NEUROCHEM, V50, P400, DOI 10.1111/j.1471-4159.1988.tb02926.x; Kacem K, 1998, GLIA, V23, P1; Kern W, 2001, NEUROENDOCRINOLOGY, V74, P270, DOI 10.1159/000054694; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Kong JM, 2002, J NEUROSCI, V22, P5581; KUM W, 1992, GLIA, V6, P264, DOI 10.1002/glia.440060404; Laron Zvi, 2009, Archives of Physiology and Biochemistry, V115, P112, DOI 10.1080/13813450902949012; MAGISTRETTI PJ, 1988, DIABETES METAB, V14, P237; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; McCall AL, 1997, BRAIN RES, V744, P318, DOI 10.1016/S0006-8993(96)01122-5; McEwen BS, 2002, J PSYCHOSOM RES, V53, P883, DOI 10.1016/S0022-3999(02)00307-0; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Ngarmukos C, 2001, BRAIN RES, V900, P1, DOI 10.1016/S0006-8993(01)02184-9; Nijland PG, 2014, GLIA, V62, P1125, DOI 10.1002/glia.22667; OCRANT I, 1988, ENDOCRINOLOGY, V123, P1023, DOI 10.1210/endo-123-2-1023; Pellegri G, 1996, MOL BRAIN RES, V38, P191, DOI 10.1016/0169-328X(95)00305-C; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; PFEIFFER B, 1990, HISTOCHEMISTRY, V94, P73; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Prebil M, 2011, GLIA, V59, P903, DOI 10.1002/glia.21161; Ransom BR, 1997, GLIA, V21, P134; RAYNER DV, 1994, CAN J PHYSIOL PHARM, V72, P476, DOI 10.1139/y94-069; Reagan LP, 2007, CURR OPIN PHARMACOL, V7, P633, DOI 10.1016/j.coph.2007.10.012; RODIN J, 1985, METABOLISM, V34, P826, DOI 10.1016/0026-0495(85)90106-4; ROSENBERG PA, 1985, J NEUROSCI METH, V15, P101, DOI 10.1016/0165-0270(85)90048-2; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; SCHWARTZ MW, 1990, AM J PHYSIOL, V259, pE378, DOI 10.1152/ajpendo.1990.259.3.E378; Shulman RG, 2001, P NATL ACAD SCI USA, V98, P6417, DOI 10.1073/pnas.101129298; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; STEFFENS AB, 1988, AM J PHYSIOL, V255, pR200, DOI 10.1152/ajpregu.1988.255.2.R200; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Swanson RA, 1992, CAN J PHYSIOL PHARM, V70, P138; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Walls AB, 2009, NEUROSCIENCE, V158, P284, DOI 10.1016/j.neuroscience.2008.09.058; WALZ W, 1988, NEUROSCI LETT, V86, P296, DOI 10.1016/0304-3940(88)90499-5; Weindl A, 1981, Adv Biochem Psychopharmacol, V28, P303; Werner Haim, 2008, Archives of Physiology and Biochemistry, V114, P17, DOI [10.1080/13813450801900694, 10.1080/13813450801900694 ]; Wiesinger H, 1997, GLIA, V21, P22, DOI 10.1002/(SICI)1098-1136(199709)21:1<22::AID-GLIA3>3.0.CO;2-3; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323; ZHU SQ, 1990, BRAIN RES, V529, P329, DOI 10.1016/0006-8993(90)90846-4	83	41	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11167	11176		10.1074/jbc.M114.629063	http://dx.doi.org/10.1074/jbc.M114.629063			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25792745	Green Published, hybrid			2022-12-26	WOS:000353404500049
J	Aronoff, JM; Padilla, M; Fu, QJ; Landsberger, DM				Aronoff, Justin M.; Padilla, Monica; Fu, Qian-Jie; Landsberger, David M.			Contralateral Masking in Bilateral Cochlear Implant Patients: A Model of Medial Olivocochlear Function Loss	PLOS ONE			English	Article							EVOKED OTOACOUSTIC EMISSIONS; EXCITATION PATTERNS; SPEECH-PERCEPTION; USERS; SUPPRESSION; RECIPIENTS; HEARING; DISCRIMINATION; STIMULATION; HUMANS	Contralateral masking is the phenomenon where a masker presented to one ear affects the ability to detect a signal in the opposite ear. For normal hearing listeners, contralateral masking results in masking patterns that are both sharper and dramatically smaller in magnitude than ipsilateral masking. The goal of this study was to investigate whether medial olivocochlear (MOC) efferents are needed for the sharpness and relatively small magnitude of the contralateral masking function. To do this, bilateral cochlear implant patients were tested because, by directly stimulating the auditory nerve, cochlear implants circumvent the effects of the MOC efferents. The results indicated that, as with normal hearing listeners, the contralateral masking function was sharper than the ipsilateral masking function. However, although there was a reduction in the magnitude of the contralateral masking function compared to the ipsilateral masking function, it was relatively modest. This is in sharp contrast to the results of normal hearing listeners where the magnitude of the contralateral masking function is greatly reduced. These results suggest that MOC function may not play a large role in the sharpness of the contralateral masking function but may play a considerable role in the magnitude of the contralateral masking function.	[Aronoff, Justin M.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; [Aronoff, Justin M.; Padilla, Monica; Fu, Qian-Jie; Landsberger, David M.] House Res Inst, Commun & Neurosci Div, Los Angeles, CA USA; [Padilla, Monica; Landsberger, David M.] NYU, Dept Otolaryngol, New York, NY 10016 USA; [Fu, Qian-Jie] Univ Calif Los Angeles, Div Head & Neck Surg, Los Angeles, CA 90024 USA	University of Illinois System; University of Illinois Urbana-Champaign; New York University; University of California System; University of California Los Angeles	Aronoff, JM (corresponding author), Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA.	jaronoff@illinois.edu	Aronoff, Justin/AAP-5827-2021	Aronoff, Justin/0000-0001-6623-5273	National Organization for Hearing Research (NOHR); National Institutes of Health (NIH) [T32DC009975, R01-DC12152, R01-DC001526, R01-DC004993, R03-DC010064, R03-DC013380]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012152, R01DC001526, R01DC004993, T32DC009975, R03DC013380] Funding Source: NIH RePORTER	National Organization for Hearing Research (NOHR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Organization for Hearing Research (NOHR) http://nohrfoundation.org/ and by National Institutes of Health (NIH http://www.nidcd.nih.gov/) grants T32DC009975, R01-DC12152, R01-DC001526, R01-DC004993, R03-DC010064, and R03-DC013380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas PJ, 2004, AUDIOL NEURO-OTOL, V9, P203, DOI 10.1159/000078390; Aronoff JM, 2011, EAR HEARING, V32, P468, DOI 10.1097/AUD.0b013e31820dd3f0; Aschendorff A, 2005, OTOL NEUROTOL, V26, P34, DOI 10.1097/00129492-200501000-00007; Busby PA, 2008, EAR HEARING, V29, P853, DOI 10.1097/AUD.0b013e318181a878; Chatterjee M, 1998, J ACOUST SOC AM, V103, P2565, DOI 10.1121/1.422777; Donaldson GS, 2005, J ACOUST SOC AM, V118, P623, DOI 10.1121/1.1937362; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; FAYAD J, 1991, ANN OTO RHINOL LARYN, V100, P807, DOI 10.1177/000348949110001004; Firszt JB, 2007, OTOL NEUROTOL, V28, P629, DOI 10.1097/01.mao.0000281803.36574.bc; Francart T, 2007, J ACOUST SOC AM, V122, P2826, DOI 10.1121/1.2783130; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; James C, 2001, AUDIOL NEURO-OTOL, V6, P87, DOI 10.1159/000046814; Landsberger DM, 2009, HEARING RES, V254, P34, DOI 10.1016/j.heares.2009.04.007; Lin P, 2013, J ACOUST SOC AM, V133, P962, DOI 10.1121/1.4773262; Luo X, 2012, J ACOUST SOC AM, V131, P1325, DOI 10.1121/1.3672708; Luo X, 2010, J ACOUST SOC AM, V128, P1215, DOI 10.1121/1.3474237; Maison S, 2001, PSYCHOPHYSIOLOGY, V38, P35, DOI 10.1017/S0048577201990109; MARSH MA, 1993, AM J OTOL, V14, P386; Mills JH, 1996, J ACOUST SOC AM, V100, P3336, DOI 10.1121/1.416974; Moore JK, 1999, AUDIOL NEURO-OTOL, V4, P311, DOI 10.1159/000013855; Poon BB, 2009, J ACOUST SOC AM, V126, P806, DOI 10.1121/1.3158821; PRASHER D, 1994, BRIT J AUDIOL, V28, P247, DOI 10.3109/03005369409086574; RUGGERO MA, 1992, J NEUROPHYSIOL, V68, P1087, DOI 10.1152/jn.1992.68.4.1087; Saoji AA, 2009, EAR HEARING, V30, P559, DOI 10.1097/AUD.0b013e3181ab2b6f; Schrott-Fischer A, 2007, ACTA OTO-LARYNGOL, V127, P13, DOI 10.1080/00016480600652123; Srinivasan AG, 2013, HEARING RES, V299, P29, DOI 10.1016/j.heares.2013.02.004; vanHoesel RJM, 1997, J ACOUST SOC AM, V102, P495, DOI 10.1121/1.419611; Vermeire K, 2013, HEARING RES, V306, P29, DOI 10.1016/j.heares.2013.09.004; Wilcox RR, 1998, BRIT J MATH STAT PSY, V51, P1, DOI 10.1111/j.2044-8317.1998.tb00659.x; ZWICKER E, 1990, ACUSTICA, V70, P189; ZWISLOCKI JJ, 1968, J ACOUST SOC AM, V43, P1267, DOI 10.1121/1.1910978; ZWISLOCKI JJ, 1972, J ACOUST SOC AM, V52, P644, DOI 10.1121/1.1913154	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121591	10.1371/journal.pone.0121591	http://dx.doi.org/10.1371/journal.pone.0121591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798581	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300273
J	Corovic, S; Markelc, B; Dolinar, M; Cemazar, M; Jarm, T				Corovic, Selma; Markelc, Bostjan; Dolinar, Mitja; Cemazar, Maja; Jarm, Tomaz			Modeling of Microvascular Permeability Changes after Electroporation	PLOS ONE			English	Article							DORSAL WINDOW CHAMBER; VASCULAR-PERMEABILITY; ELECTRIC PULSES; DRUG-DELIVERY; GENE DELIVERY; ELECTROCHEMOTHERAPY; MACROMOLECULES; TRANSPORT; MELANOMA; CANCER	Vascular endothelium selectively controls the transport of plasma contents across the blood vessel wall. The principal objective of our preliminary study was to quantify the electroporation-induced increase in permeability of blood vessel wall for macromolecules, which do not normally extravasate from blood into skin interstitium in homeostatic conditions. Our study combines mathematical modeling (by employing pharmacokinetic and finite element modeling approach) with in vivo measurements (by intravital fluorescence microscopy). Extravasation of fluorescently labeled dextran molecules of two different sizes (70 kDa and 2000 kDa) following the application of electroporation pulses was investigated in order to simulate extravasation of therapeutic macromolecules with molecular weights comparable to molecular weight of particles such as antibodies and plasmid DNA. The increase in blood vessel permeability due to electroporation and corresponding transvascular transport was quantified by calculating the apparent diffusion coefficients for skin microvessel wall (D [mu m(2)/s]) for both molecular sizes. The calculated apparent diffusion coefficients were D = 0.0086 mu m(2)/s and D = 0.0045 mu m(2)/s for 70 kDa and 2000 kDa dextran molecules, respectively. The results of our preliminary study have important implications in development of realistic mathematical models for prediction of extravasation and delivery of large therapeutic molecules to target tissues by means of electroporation.	[Corovic, Selma; Dolinar, Mitja; Jarm, Tomaz] Univ Ljubljana, Lab Biocybernet, Fac Elect Engn, SI-1000 Ljubljana, Slovenia; [Markelc, Bostjan; Cemazar, Maja] Inst Oncol Ljubljana, Dept Expt Oncol, SI-1000 Ljubljana, Slovenia; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, SI-6310 Izola, Slovenia	University of Ljubljana; Institute of Oncology - Slovenia; University of Primorska	Jarm, T (corresponding author), Univ Ljubljana, Lab Biocybernet, Fac Elect Engn, Trzaska Cesta 25, SI-1000 Ljubljana, Slovenia.	tomaz.jarm@fe.uni-lj.si	Markelc, Bostjan/AAC-2968-2022; Cemazar, Maja/K-6182-2013	Markelc, Bostjan/0000-0002-8674-702X; Cemazar, Maja/0000-0002-1418-1928	Slovenian Research Agency [Z2-4312, P3-0003, P2-0249]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	Funding: The work was financed by Slovenian Research Agency through grants Z2-4312, P3-0003 and P2-0249. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Bellard E, 2012, J CONTROL RELEASE, V163, P396, DOI 10.1016/j.jconrel.2012.09.010; Blagus T, 2013, J CONTROL RELEASE, V172, P862, DOI 10.1016/j.jconrel.2013.09.030; Brown EB, 2004, MICROVASC RES, V67, P231, DOI 10.1016/j.mvr.2004.02.001; Cemazar M, 2010, CURR GENE THER, V10, P300, DOI 10.2174/156652310791823425; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chiarella P, 2013, CURR DRUG METAB, V14, P291, DOI 10.2174/1389200211314030004; Cornelissen LH, 2008, SKIN RES TECHNOL, V14, P462, DOI 10.1111/j.1600-0846.2008.00313.x; Corovic S, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-16; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; GAHM T, 1984, RES EXP MED, V184, P1, DOI 10.1007/BF01852217; Gehl J, 2002, BBA-GEN SUBJECTS, V1569, P51, DOI 10.1016/S0304-4165(01)00233-1; Golberg A, 2013, IEEE T BIO-MED ENG, V60, P707, DOI 10.1109/TBME.2013.2238672; Goldberg A, 2014, CHEM ENG COMMUN, V201, P102; Granot Y, 2008, INT J HEAT MASS TRAN, V51, P5610, DOI 10.1016/j.ijheatmasstransfer.2008.04.041; Heller LC, 2010, CURR GENE THER, V10, P312; Jarm T, 2010, EXPERT REV ANTICANC, V10, P729, DOI 10.1586/ERA.10.43; Kanthou C, 2006, MOL CANCER THER, V5, P3145, DOI 10.1158/1535-7163.MCT-06-0410; Kim D, 1993, AM J PHYSIOL, V265, P993; Kotnik T, 2012, IEEE ELECTR INSUL M, V28, P14, DOI 10.1109/MEI.2012.6268438; Larina IV, 2005, ANTICANCER RES, V25, P149; LEY K, 1986, MICROVASC RES, V31, P84, DOI 10.1016/0026-2862(86)90009-9; Lin F, 2011, VACCINE, V29, P6771, DOI 10.1016/j.vaccine.2010.12.057; Mali B, 2013, RADIOL ONCOL, V47, P32, DOI 10.2478/raon-2013-0002; Marcan M, 2014, RADIOL ONCOL, V48, P267, DOI 10.2478/raon-2014-0022; Markelc B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059557; Markelc B, 2012, J MEMBRANE BIOL, V245, P545, DOI 10.1007/s00232-012-9435-5; Marrero B, 2012, BIOMATERIALS, V33, P3036, DOI 10.1016/j.biomaterials.2011.12.049; Matthiessen LW, 2011, ACTA ONCOL, V50, P621, DOI 10.3109/0284186X.2011.573626; Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3; Michel CC, 1996, CARDIOVASC RES, V32, P644, DOI 10.1016/0008-6363(96)00064-8; Miklavcic D, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-29; Mir LM, 2006, EJC SUPPL, V4, P14, DOI 10.1016/j.ejcsup.2006.08.003; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Palmer GM, 2011, NAT PROTOC, V6, P1355, DOI 10.1038/nprot.2011.349; Prijic S, 2012, BIOMATERIALS, V33, P4379, DOI 10.1016/j.biomaterials.2012.02.061; Renkin EM, 1998, MICROCIRCULATION, V5, P139, DOI 10.1038/sj.mn.7300016; RENKIN EM, 1985, J APPL PHYSIOL, V58, P315, DOI 10.1152/jappl.1985.58.2.315; RIPPE B, 1994, PHYSIOL REV, V74, P163, DOI 10.1152/physrev.1994.74.1.163; Sersa G, 2008, BRIT J CANCER, V98, P388, DOI 10.1038/sj.bjc.6604168; Sersa G, 1999, ANTICANCER RES, V19, P4017; Sersa G, 1999, EUR J CANCER, V35, P672, DOI 10.1016/S0959-8049(98)00426-2; Sersa G, 2012, CANCER TREAT REV, V38, P379, DOI 10.1016/j.ctrv.2011.07.006; Spanggaard I, 2013, HUM GENE THER CL DEV, V24, P99, DOI 10.1089/humc.2012.240; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Towhidi L, 2012, RADIOL ONCOL, V46, P119, DOI 10.2478/v10019-012-0014-2; YUAN F, 1993, MICROVASC RES, V45, P269, DOI 10.1006/mvre.1993.1024; Zeng GSL, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-70; Zupanic A, 2008, RADIOL ONCOL, V42, P93, DOI 10.2478/v10019-008-0005-5	53	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121370	10.1371/journal.pone.0121370	http://dx.doi.org/10.1371/journal.pone.0121370			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793292	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900129
J	Heyne, GW; Melberg, CG; Doroodchi, P; Parins, KF; Kietzman, HW; Everson, JL; Ansen-Wilson, LJ; Lipinski, RJ				Heyne, Galen W.; Melberg, Cal G.; Doroodchi, Padydeh; Parins, Kia F.; Kietzman, Henry W.; Everson, Joshua L.; Ansen-Wilson, Lydia J.; Lipinski, Robert J.			Definition of Critical Periods for Hedgehog Pathway Antagonist-Induced Holoprosencephaly, Cleft Lip, and Cleft Palate	PLOS ONE			English	Article							SONIC-HEDGEHOG; FOREBRAIN; DEFECTS; MORPHOGENESIS; EPIDEMIOLOGY; PREVALENCE; EXPRESSION; MUTATIONS; ANOMALIES; GROWTH	The Hedgehog (Hh) signaling pathway mediates multiple spatiotemporally-specific aspects of brain and face development. Genetic and chemical disruptions of the pathway are known to result in an array of structural malformations, including holoprosencephaly (HPE), clefts of the lip with or without cleft palate (CL/P), and clefts of the secondary palate only (CPO). Here, we examined patterns of dysmorphology caused by acute, stage-specific Hh signaling inhibition. Timed-pregnant wildtype C57BL/6J mice were administered a single dose of the potent pathway antagonist vismodegib at discrete time points between gestational day (GD) 7.0 and 10.0, an interval approximately corresponding to the 15th to 24th days of human gestation. The resultant pattern of facial and brain dysmorphology was dependent upon stage of exposure. Insult between GD7.0 and GD8.25 resulted in HPE, with peak incidence following exposure at GD7.5. Unilateral clefts of the lip extending into the primary palate were also observed, with peak incidence following exposure at GD8.875. Insult between GD9.0 and GD10.0 resulted in CPO and forelimb abnormalities. We have previously demonstrated that Hh antagonist-induced cleft lip results from deficiency of the medial nasal process and show here that CPO is associated with reduced growth of the maxillary-derived palatal shelves. By defining the critical periods for the induction of HPE, CL/P, and CPO with fine temporal resolution, these results provide a mechanism by which Hh pathway disruption can result in "non-syndromic" orofacial clefting, or HPE with or without co-occurring clefts. This study also establishes a novel and tractable mouse model of human craniofacial malformations using a single dose of a commercially available and pathwayspecific drug.	[Heyne, Galen W.; Melberg, Cal G.; Doroodchi, Padydeh; Parins, Kia F.; Kietzman, Henry W.; Everson, Joshua L.; Ansen-Wilson, Lydia J.; Lipinski, Robert J.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA; [Everson, Joshua L.; Lipinski, Robert J.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Lipinski, RJ (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA.	rjlipinski@wisc.edu		Lipinski, Robert/0000-0002-1994-4090; Everson, Josh/0000-0002-2887-8574; Colopy, Lydia/0000-0002-8955-117X; Kietzman, Henry/0000-0001-7435-0546	National Institute of Dental and Craniofacial Research/National Institutes of Health [R00DE022101-02]; National Institute of Environmental Health Sciences/National Institutes of Health [T32ES007015-37]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE022101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Environmental Health Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by R00DE022101-02 grants to RJL from the National Institute of Dental and Craniofacial Research/National Institutes of Health and T32ES007015-37 to JLE from the National Institute of Environmental Health Sciences/National Institutes of Health. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2011, MECH DEVELOP, V128, P129, DOI 10.1016/j.mod.2010.11.005; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; DASILVA OG, 1993, AM J ORTHOD DENTOFAC, V104, P269; Dhar Reema Sharma, 2014, J Indian Soc Pedod Prev Dent, V32, P346, DOI 10.4103/0970-4388.140972; DIEWERT VM, 1992, CRIT REV ORAL BIOL M, V4, P111, DOI 10.1177/10454411920040010201; Dunty WC, 2002, DEV NEUROSCI-BASEL, V24, P328, DOI 10.1159/000066748; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Franca MM, 2010, J CLIN ENDOCR METAB, V95, pE384, DOI 10.1210/jc.2010-1050; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Gritli-Linde A, 2008, CURR TOP DEV BIOL, V84, P37, DOI 10.1016/S0070-2153(08)00602-9; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Keaton AA, 2010, AM J MED GENET C, V154C, P170, DOI 10.1002/ajmg.c.30251; Kietzman HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089448; KOTCH LE, 1992, TERATOLOGY, V46, P323, DOI 10.1002/tera.1420460403; Lan Y, 2009, DEVELOPMENT, V136, P1387, DOI 10.1242/dev.028167; Leoncini E, 2008, BIRTH DEFECTS RES A, V82, P585, DOI 10.1002/bdra.20479; Lidral Andrew C, 2008, Semin Orthod, V14, P103, DOI 10.1053/j.sodo.2008.02.002; Lima MC, 2009, CLEFT PALATE-CRAN J, V46, P481, DOI 10.1597/08-018.1; Lipinski RJ, 2008, TOXICOL SCI, V104, P189, DOI 10.1093/toxsci/kfn076; Lipinski RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102603; Lipinski RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043067; Lipinski RJ, 2010, BIRTH DEFECTS RES A, V88, P232, DOI 10.1002/bdra.20656; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Mastroiacovo P, 2011, CLEFT PALATE-CRAN J, V48, P66, DOI 10.1597/09-217; MATSUNAGA E, 1977, TERATOLOGY, V16, P261, DOI 10.1002/tera.1420160304; Milerad J, 1997, PEDIATRICS, V100, P180, DOI 10.1542/peds.100.2.180; Mo R, 1997, DEVELOPMENT, V124, P113; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Orioli IM, 2010, AM J MED GENET C, V154C, P13, DOI 10.1002/ajmg.c.30233; Ribeiro LA, 2005, AM J MED GENET A, V136A, P350, DOI 10.1002/ajmg.a.30627; Richieri-Costa A, 2010, AM J MED GENET C, V154C, P149, DOI 10.1002/ajmg.c.30247; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; SANDHAM A, 1986, CLEFT PALATE J, V23, P206; Sasaki Y, 2007, ARCH ORAL BIOL, V52, P260, DOI 10.1016/j.archoralbio.2006.09.012; Solomon BD, 2012, J MED GENET, V49, P473, DOI 10.1136/jmedgenet-2012-101008; van Straaten HWM, 2001, ANAT EMBRYOL, V203, P225, DOI 10.1007/s004290100169; Vieira AR, 2008, J DENT RES, V87, P119, DOI 10.1177/154405910808700202; Watkins SE, 2014, CLIN PLAST SURG, V41, P149, DOI 10.1016/j.cps.2013.12.003; Wong H, 2011, CLIN CANCER RES, V17, P4682, DOI 10.1158/1078-0432.CCR-11-0975	42	41	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120517	10.1371/journal.pone.0120517	http://dx.doi.org/10.1371/journal.pone.0120517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793997	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900046
J	Park, IU; Wojtal, N; Silverberg, MJ; Bauer, HM; Hurley, LB; Manos, MM				Park, Ina U.; Wojtal, Nicole; Silverberg, Michael J.; Bauer, Heidi M.; Hurley, Leo B.; Manos, M. Michele			Cytology and Human Papillomavirus Co-Test Results Preceding Incident High-Grade Cervical Intraepithelial Neoplasia	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LIQUID-BASED CYTOLOGY; CONVENTIONAL CYTOLOGY; CONSENSUS GUIDELINES; CANCER PRECURSORS; CLINICAL-PRACTICE; WOMEN; METAANALYSIS; MANAGEMENT; RISK	Objective High-risk HPV (hrHPV) and cytology co-testing is utilized for primary cervical cancer screening and for enhanced follow-up of women who are hrHPV-positive, cytology negative. However, data are lacking on the utility of this method to detect pre-cancer or cancer in community-based clinical practice. This study describes cytology and hrHPV results preceding high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, or cervical cancer (i.e., CIN2+) in an integrated health system employing routine co-testing among women aged 30 years and older. Methods We conducted a cross-sectional analysis of adult female members of Kaiser Permanente Northern California (KPNC) with incident CIN2+ between July 2008 and June 2009. The primary outcome was the proportions of cytologic diagnoses and hrHPV co-test results preceding a diagnosis of CIN2+. Cervical cytology and hrHPV testing results were abstracted from electronic medical records. Results Of 1283 CIN2+ cases among adult women, 880 (68.5%) were among women aged 30 years and older and 145/880 (16.5%, 95% CI 14.1-19.1) had only normal cytology during the 12 months prior to diagnosis. Furthermore, 133/880 (15.1%, 95% 12.9-17.7) were preceded by only normal cytology and persistent hrHPV infection (at least 2 positive hrHPV tests) during the 6-36 months preceding CIN2+ diagnosis. Conclusions Incident CIN2+ is frequently preceded by normal cytology and persistent hrHPV infection among women aged 30 years and older; screening strategies that employ HPV testing and cytology may improve the detection of CIN2+ compared with cytology alone.	[Park, Ina U.; Bauer, Heidi M.] Calif Dept Publ Hlth, Ctr Infect Dis, Sexually Transmitted Dis Control Branch, Div Communicable Dis Control, Richmond, CA 94804 USA; [Wojtal, Nicole] Univ Calif Berkeley, Hlth & Med Sci, Berkeley, CA 94720 USA; [Silverberg, Michael J.; Hurley, Leo B.; Manos, M. Michele] Kaiser Permanente No Calif, Div Res, Oakland, CA USA	California Department of Public Health; University of California System; University of California Berkeley; Kaiser Permanente	Park, IU (corresponding author), Calif Dept Publ Hlth, Ctr Infect Dis, Sexually Transmitted Dis Control Branch, Div Communicable Dis Control, Richmond, CA 94804 USA.	ina.park@cdph.ca.gov			Permanente Medical Group; Centers for Disease Control and Prevention (CDC), Supplement to California Emerging Infections Program (CEIP) [5-U01/C1000309-05]; NIAID [K01AI071725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI071725] Funding Source: NIH RePORTER	Permanente Medical Group; Centers for Disease Control and Prevention (CDC), Supplement to California Emerging Infections Program (CEIP); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was jointly supported by The Permanente Medical Group and the Centers for Disease Control and Prevention (CDC), Supplement to California Emerging Infections Program (CEIP) Cooperative Agreement 5-U01/C1000309-05. Dr. Silverberg's time was also supported in part by grant number K01AI071725 from the NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; Gordon N, 2006, KAISER PERMANENTE ME; Kaiser Permanente, FAST FACTS KAIS PERM; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Sawaya GF, 2009, NEW ENGL J MED, V361, P2503, DOI 10.1056/NEJMp0911380; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P1757, DOI 10.1001/jama.2009.1569; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Spence AR, 2007, PREV MED, V45, P93, DOI 10.1016/j.ypmed.2007.06.007; US Food and Drug Administration, 2003, DIG HYBR CAPT 2 HIGH; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P340, DOI 10.1016/j.ajog.2007.07.050; Wright TC, 2007, CLIN OBSTET GYNECOL, V50, P313, DOI 10.1097/GRF.0b013e31804a8285; Zhao CQ, 2013, ARCH PATHOL LAB MED, V137, P942, DOI 10.5858/arpa.2012-0307-OA	31	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118938	10.1371/journal.pone.0118938	http://dx.doi.org/10.1371/journal.pone.0118938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793987	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200048
J	Shao, XY; Guo, Y; Xu, XH; Zheng, YB; Wang, JW; Chen, ZH; Huang, J; Huang, P; Cai, JF; Wang, XJ				Shao, Xiying; Guo, Yong; Xu, Xiaohong; Zheng, Yabing; Wang, Jiwen; Chen, Zhanhong; Huang, Jian; Huang, Ping; Cai, Jufen; Wang, Xiaojia			The CYP19 RS4646 Polymorphism Is Related to the Prognosis of Stage I-II and Operable Stage III Breast Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; AROMATASE GENE; ESTROGEN-LEVELS; REPEAT POLYMORPHISM; VARIANTS; EFFICACY; WOMEN; ASSOCIATION; EXPRESSION; INHIBITOR	Purpose Aromatase, encoded by the CYP19 gene, catalyzes the final step of the conversion of androgens to estrogens. Given the critical role of CYP19 in estrogen synthesis, the potential influence of CYP19 rs4646 polymorphism on breast cancer survival, deserves further study. Methods Genotyping for CYP19 rs4646 variants was performed on 406 Chinese women with stage I-II and operable stage III breast cancer. Associations were evaluated between CYP19 rs4646 genotypes and disease-free survival (DFS). Results In premenopausal patients, women who are homozygous for the minor allele (AA) have a longer DFS compared with those carrying the major allele (CC or AC) (87 months versus 48.7 months; Hazard ratio (HR) = 0.56, 95% CI = 0.318-0.985, P = 0.041). These differences were further demonstrated by a multivariate analysis (HR = 0.456, 95% CI = 0.249-0.836, P = 0.011). Conversely, the same variant (AA) was estimated to be associated with a poorer DFS in postmenopausal women (AA versus AC or CC: 13.7 months versus 56.3 months; HR = 2.758, 95% CI = 1.432-5.313, P = 0.002). Furthermore, the differences were confirmed by the COX proportional hazards model (HR = 2.983, 95% CI = 1.494-5.955, P = 0.002). Conclusions The present study indicates that CYP19 rs4646 polymorphism is related to DFS in early breast cancer and that the prognosis index of the homozygous for the minor allele (AA) may depend on menopause status. The findings are novel, if confirmed, rs4646 genotypes may provide useful information for routine management in breast cancer.	[Shao, Xiying; Zheng, Yabing; Chen, Zhanhong; Huang, Jian; Huang, Ping; Cai, Jufen; Wang, Xiaojia] Zhejiang Chinese Med Univ, Affiliated Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Guo, Yong] Zhejiang Tradit Chinese Med Univ, Affiliated Hosp 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiaohong] Zhejiang Chinese Med Univ, Affiliated Zhejiang Canc Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Wang, Jiwen] Zhejiang Canc Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Cancer Hospital; Zhejiang Chinese Medical University; Zhejiang Cancer Hospital	Wang, XJ (corresponding author), Zhejiang Chinese Med Univ, Affiliated Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China.	wxiaojia0803@163.com			Zhejiang provincial natural science foundation (China) [Y206856, Y2101312]; Zhejiang provincial medical science and technology program (China) [2010QNA006, 2011RCA011]; Zhejiang traditional Chinese medicine science and technology program (China) [2013ZB022, 2014ZB019]; Special fund of Wu Jieping Medical Foundation (China) [320.670010007]	Zhejiang provincial natural science foundation (China)(Natural Science Foundation of Zhejiang Province); Zhejiang provincial medical science and technology program (China); Zhejiang traditional Chinese medicine science and technology program (China); Special fund of Wu Jieping Medical Foundation (China)	Funding: This work was supported by grants from Zhejiang provincial natural science foundation (Y206856, Y2101312, China), Zhejiang provincial medical science and technology program (2010QNA006, 2011RCA011, China), Zhejiang traditional Chinese medicine science and technology program (2013ZB022, 2014ZB019, China), Special fund of Wu Jieping Medical Foundation clinical research (320.670010007, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; Bulun SE, 2003, J STEROID BIOCHEM, V86, P219, DOI 10.1016/S0960-0760(03)00359-5; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chen XW, 2006, HUM MUTAT, V27, P427, DOI 10.1002/humu.20319; Colomer R, 2008, CLIN CANCER RES, V14, P811, DOI 10.1158/1078-0432.CCR-07-1923; de Jong PC, 2001, BREAST, V10, P91, DOI 10.1054/brst.2000.0209; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Fasching PA, 2008, BREAST CANCER RES TR, V112, P89, DOI 10.1007/s10549-007-9822-2; Ferraldeschi R, 2012, BREAST CANCER RES TR, V133, P1191, DOI 10.1007/s10549-012-2010-z; Garcia-Casado Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-36; Gennari L, 2004, J CLIN ENDOCR METAB, V89, P2803, DOI 10.1210/jc.2003-031342; Germain D, 2011, ENDOCRIN METAB CLIN, V40, P473, DOI 10.1016/j.ecl.2011.05.009; Haiman CA, 2000, INT J CANCER, V87, P204, DOI 10.1002/1097-0215(20000715)87:2<204::AID-IJC8>3.3.CO;2-V; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Huang CS, 2008, ONCOLOGIST, V13, P751, DOI 10.1634/theoncologist.2007-0246; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Jin Y, 1996, J CLIN INVEST, V98, P1745, DOI 10.1172/JCI118973; Kristensen VN, 2000, ONCOGENE, V19, P1329, DOI 10.1038/sj.onc.1203425; Kuo SH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/562197; Liu L, 2013, INT J MOL SCI, V14, P18973, DOI 10.3390/ijms140918973; Lonning PE, 1996, BREAST CANCER RES TR, V39, P335, DOI 10.1007/BF01806162; Ma CX, 2005, CANCER RES, V65, P11071, DOI 10.1158/0008-5472.CAN-05-1218; Pedraza AM, 2012, BREAST CANCER RES TR, V134, P1199, DOI 10.1007/s10549-012-2026-4; Miki Y, 2007, CANCER RES, V67, P3945, DOI 10.1158/0008-5472.CAN-06-3105; Park IH, 2011, CANCER CHEMOTH PHARM, V68, P1263, DOI 10.1007/s00280-011-1615-y; Piersma D, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1756; Rock CL, 2008, CANCER EPIDEM BIOMAR, V17, P614, DOI 10.1158/1055-9965.EPI-07-0761; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skorupski P, 2006, AM J OBSTET GYNECOL, V194, P346, DOI 10.1016/j.ajog.2005.07.034; Tworoger SS, 2004, CANCER EPIDEM BIOMAR, V13, P94, DOI 10.1158/1055-9965.EPI-03-0026; Wang LW, 2010, CANCER RES, V70, P319, DOI 10.1158/0008-5472.CAN-09-3224; Xu WH, 2007, AM J EPIDEMIOL, V166, P1420, DOI 10.1093/aje/kwm242; ZHAO Y, 1995, MOL ENDOCRINOL, V9, P340, DOI 10.1210/me.9.3.340	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121535	10.1371/journal.pone.0121535	http://dx.doi.org/10.1371/journal.pone.0121535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793413	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900139
J	Herrero, AB; San Miguel, J; Gutierrez, NC				Herrero, Ana B.; San Miguel, Jess; Gutierrez, Norma C.			Deregulation of DNA Double-Strand Break Repair in Multiple Myeloma: Implications for Genome Stability	PLOS ONE			English	Article							NONHOMOLOGOUS END; HOMOLOGOUS RECOMBINATION; LIGASE-III; HEMATOPOIETIC-CELLS; NHEJ PATHWAYS; HISTONE H2AX; TUMOR-CELLS; COMET ASSAY; INSTABILITY; DAMAGE	Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abnormalities. However, the molecular basis for this genome instability remains unknown. Since both impaired and hyperactive double strand break (DSB) repair pathways can result in DNA rearrangements, we investigated the functionality of DSB repair in MM cells. Repair kinetics of ionizing-radiation (IR)-induced DSBs was similar in MM and normal control lymphoblastoid cell lines, as revealed by the comet assay. However, four out of seven MM cell lines analyzed exhibited a subset of persistent DSBs, marked by gamma-H2AX and Rad51 foci that elicited a prolonged G2/M DNA damage checkpoint activation and hypersensitivity to IR, especially in the presence of checkpoint inhibitors. An analysis of the proteins involved in DSB repair in MM cells revealed upregulation of DNA-PKcs, Artemis and XRCC4, that participate in non-homologous end joining (NHEJ), and Rad51, involved in homologous recombination (HR). Accordingly, activity of both NHEJ and HR were elevated in MM cells compared to controls, as determined by in vivo functional assays. Interestingly, levels of proteins involved in a highly mutagenic, translocation-promoting, alternative NHEJ subpathway (Alt-NHEJ) were also increased in all MM cell lines, with the Alt-NHEJ protein DNA ligase III alpha, also overexpressed in several plasma cell samples isolated from MM patients. Overactivation of the Alt-NHEJ pathway was revealed in MM cells by larger deletions and higher sequence microhomology at repair junctions, which were reduced by chemical inhibition of the pathway. Taken together, our results uncover a deregulated DSB repair in MM that might underlie the characteristic genome instability of the disease, and could be therapeutically exploited.	[Herrero, Ana B.; Gutierrez, Norma C.] Univ Hosp, IBMCC USAL CSIC, IBSAL, Serv Hematol, Salamanca, Spain; [San Miguel, Jess] Univ Navarra Clin, CIMA, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Navarra	Gutierrez, NC (corresponding author), Univ Hosp, IBMCC USAL CSIC, IBSAL, Serv Hematol, Salamanca, Spain.	normagu@usal.es	San-Miguel, Jesús F./V-8977-2018; Herrero, Ana/AAF-1694-2021	San-Miguel, Jesús F./0000-0002-9183-4857; Gutierrez, Norma/0000-0001-5834-9510; Herrero, Ana/0000-0002-1414-6532	Spanish Myeloma Network Program [RD12/0036/0058]; Gerencia Regional de Salud, Junta de Castilla y Leon [GRS 702/A/11]; Asociacion Espanola Contra el Cancer (AECC) [GCB-120981SAN]	Spanish Myeloma Network Program; Gerencia Regional de Salud, Junta de Castilla y Leon(Junta de Castilla y Leon); Asociacion Espanola Contra el Cancer (AECC)	This work was partially supported by the Spanish Myeloma Network Program (RD12/0036/0058), the "Gerencia Regional de Salud, Junta de Castilla y Leon" (GRS 702/A/11) and grant GCB-120981SAN from the "Asociacion Espanola Contra el Cancer (AECC)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Banath JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-4; Bishop AJR, 2001, BBA-REV CANCER, V1471, pM109, DOI 10.1016/S0304-419X(01)00018-X; Busby EC, 2000, CANCER RES, V60, P2108; Cahill D, 2006, FRONT BIOSCI-LANDMRK, V11, P1958, DOI 10.2741/1938; Chakraborty S, 2012, BLOOD, V119, P6187, DOI 10.1182/blood-2011-05-352252; Ching WJ, 2009, ENVIRON MOL MUTAGEN, V50, P697, DOI 10.1002/em.20528; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Francis R, 2007, GENE DEV, V21, P1064, DOI 10.1101/gad.1522807; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; Hahnel PS, 2014, BLOOD, V123, P2355, DOI 10.1182/blood-2013-01-477620; Helleday T, 2010, CARCINOGENESIS, V31, P955, DOI 10.1093/carcin/bgq064; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Klokov D, 2006, RADIOTHER ONCOL, V80, P223, DOI 10.1016/j.radonc.2006.07.026; Kotnis A, 2009, PHILOS T R SOC B, V364, P653, DOI 10.1098/rstb.2008.0196; Kovala AT, 2000, FASEB J, V14, P2486, DOI 10.1096/fj.00-0147com; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Luoto KR, 2010, CANCER RES, V70, P8748, DOI 10.1158/0008-5472.CAN-10-0944; Magin S, 2013, DNA REPAIR, V12, P148, DOI 10.1016/j.dnarep.2012.11.008; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Olive PL, 2011, RADIOTHER ONCOL, V101, P18, DOI 10.1016/j.radonc.2011.05.055; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pierce AJ, 2001, MOL CELL, V8, P1160, DOI 10.1016/S1097-2765(01)00424-5; Qi WQ, 2002, RADIAT RES, V157, P166, DOI 10.1667/0033-7587(2002)157[0166:CITIGP]2.0.CO;2; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Roddam PL, 2010, BRIT J HAEMATOL, V149, P258, DOI 10.1111/j.1365-2141.2010.08088.x; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sarkaria JN, 1998, CANCER RES, V58, P4375; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shammas MA, 2009, BLOOD, V113, P2290, DOI 10.1182/blood-2007-05-089193; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Slupianek A, 2006, DNA REPAIR, V5, P243, DOI 10.1016/j.dnarep.2005.10.005; Tobin LA, 2013, ONCOGENE, V32, P1784, DOI 10.1038/onc.2012.203; Volcic M, 2012, NUCLEIC ACIDS RES, V40, P181, DOI 10.1093/nar/gkr687; Walters DK, 2011, LEUKEMIA, V25, P1344, DOI 10.1038/leu.2011.94; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang X, 2002, CANCER RES, V62, P6031; Willmore E, 2008, CLIN CANCER RES, V14, P3984, DOI 10.1158/1078-0432.CCR-07-5158; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yang C, 2009, MUTAT RES-FUND MOL M, V660, P66, DOI 10.1016/j.mrfmmm.2008.10.019; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021	57	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121581	10.1371/journal.pone.0121581	http://dx.doi.org/10.1371/journal.pone.0121581			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790254	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400197
J	Hsiau, THC; Sukovich, D; Elms, P; Prince, RN; Stritmatter, T; Ruan, P; Curry, B; Anderson, P; Sampson, J; Anderson, JC				Hsiau, Timothy H. -C.; Sukovich, David; Elms, Phillip; Prince, Robin N.; Stritmatter, Tobias; Ruan, Paul; Curry, Bo; Anderson, Paige; Sampson, Jeff; Anderson, J. Christopher			A Method for Multiplex Gene Synthesis Employing Error Correction Based on Expression	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; IN-VIVO; AMPLIFICATION; OPTIMIZATION; STABILITY; SEQUENCES; LIBRARIES; SELECTION; COMPLEX	Our ability to engineer organisms with new biosynthetic pathways and genetic circuits is limited by the availability of protein characterization data and the cost of synthetic DNA. With new tools for reading and writing DNA, there are opportunities for scalable assays that more efficiently and cost effectively mine for biochemical protein characteristics. To that end, we have developed the Multiplex Library Synthesis and Expression Correction (MuLSEC) method for rapid assembly, error correction, and expression characterization of many genes as a pooled library. This methodology enables gene synthesis from microarray-synthesized oligonucleotide pools with a one-pot technique, eliminating the need for robotic liquid handling. Post assembly, the gene library is subjected to an ampicillin based quality control selection, which serves as both an error correction step and a selection for proteins that are properly expressed and folded in E. coli. Next generation sequencing of post selection DNA enables quantitative analysis of gene expression characteristics. We demonstrate the feasibility of this approach by building and testing over 90 genes for empirical evidence of soluble expression. This technique reduces the problem of part characterization to multiplex oligonucleotide synthesis and deep sequencing, two technologies under extensive development with projected cost reduction.	[Hsiau, Timothy H. -C.; Sukovich, David; Elms, Phillip; Prince, Robin N.; Stritmatter, Tobias; Anderson, J. Christopher] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Ruan, Paul] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Curry, Bo; Anderson, Paige; Sampson, Jeff] Agilent Technol, Santa Clara, CA USA; [Anderson, J. Christopher] Univ Calif Berkeley, Synthet Biol Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Agilent Technologies; University of California System; University of California Berkeley	Anderson, JC (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	jcanderson@berkeley.edu		Strittmatter, Tobias/0000-0003-4579-1013	Agilent Technologies via the Synthetic Biology Institute	Agilent Technologies via the Synthetic Biology Institute	Work was supported by funding from Agilent Technologies via the Synthetic Biology Institute. Agilent provided some of the software development. Additional software and wetlab experiments were performed at UC Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2003, BIOCHEMISTRY-US, V42, P9598, DOI 10.1021/bi034550w; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, P7486, DOI 10.1093/nar/gku469; Blakeley BD, 2012, MOL BIOSYST, V8, P2036, DOI 10.1039/c2mb25130b; Borovkov AY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq677; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002387; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Kim H, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks546; Kim I, 2013, MOL CELL PROTEOMICS, V12, P3370, DOI 10.1074/mcp.O113.031708; Kittleson JT, 2012, CURR OPIN CHEM BIOL, V16, P329, DOI 10.1016/j.cbpa.2012.06.009; Kittleson JT, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-10; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Lim HK, 2009, PROTEIN SCI, V18, P2537, DOI 10.1002/pro.262; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Shagin D, 1999, NUCLEIC ACIDS RES, V27, pi; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wan W, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku405; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Xu QK, 2009, P NATL ACAD SCI USA, V106, P2289, DOI 10.1073/pnas.0812506106; Zhou XC, 2004, NUCLEIC ACIDS RES, V32, P5409, DOI 10.1093/nar/gkh879	27	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119927	10.1371/journal.pone.0119927	http://dx.doi.org/10.1371/journal.pone.0119927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790188	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400116
J	Panda, S; Bisht, S; Malakar, D; Mohanty, AK; Kaushik, JK				Panda, Santanu; Bisht, Sonu; Malakar, Dhruba; Mohanty, Ashok K.; Kaushik, Jai K.			In Vitro Culture of Functionally Active Buffalo Hepatocytes Isolated by Using a Simplified Manual Perfusion Method	PLOS ONE			English	Article							BIOARTIFICIAL LIVER; GENE-EXPRESSION; BOVINE HEPATOCYTES; PARENCHYMAL-CELLS; SANDWICH; METABOLISM; WHOLE	Background In farm animals, there is no suitable cell line available to understand liver-specific functions. This has limited our understanding of liver function and metabolism in farm animals. Culturing and maintenance of functionally active hepatocytes is difficult, since they survive no more than few days. Establishing primary culture of hepatocytes can help in studying cellular metabolism, drug toxicity, hepatocyte specific gene function and regulation. Here we provide a simple in vitro method for isolation and short-term culture of functionally active buffalo hepatocytes. Results Buffalo hepatocytes were isolated from caudate lobes by using manual enzymatic perfusion and mechanical disruption of liver tissue. Hepatocyte yield was (5.3 +/- 0.66)x10(7) cells per gram of liver tissue with a viability of 82.3 +/- 3.5%. Freshly isolated hepatocytes were spherical with well contrasted border. After 24 hours of seeding onto fibroblast feeder layer and different extracellular matrices like dry collagen, matrigel and sandwich collagen coated plates, hepatocytes formed confluent monolayer with frequent clusters. Cultured hepatocytes exhibited typical cuboidal and polygonal shape with restored cellular polarity. Cells expressed hepatocyte-specific marker genes or proteins like albumin, hepatocyte nuclear factor 4 alpha, glucose-6-phosphatase, tyrosine aminotransferase, cytochromes, cytokeratin and alpha 1-antitrypsin. Hepatocytes could be immunostained with anti-cytokeratins, anti-albumin and anti alpha 1-antitrypsin antibodies. Abundant lipid droplets were detected in the cytosol of hepatocytes using oil red stain. In vitro cultured hepatocytes could be grown for five days and maintained for up to nine days on buffalo skin fibroblast feeder layer. Cultured hepatocytes were viable for functional studies. Conclusion We developed a convenient and cost effective technique for hepatocytes isolation for short-term culture that exhibited morphological and functional characteristics of active hepatocytes for studying gene expression, regulation, hepatic genomics and proteomics in farm animals.	[Panda, Santanu; Bisht, Sonu; Malakar, Dhruba; Mohanty, Ashok K.; Kaushik, Jai K.] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal 132001, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Kaushik, JK (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal 132001, Haryana, India.	jaikr1@gmail.com		Kaushik, Jai/0000-0002-8872-0066	Indian Council of Agricultural Research	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	The running grant of the division was used for purchasing chemicals and other consumables. SP received Institute fellowship provided by Indian Council of Agricultural Research during initial years of the study.	AIELLO RJ, 1987, COMP BIOCHEM PHYS B, V88, P193, DOI 10.1016/0305-0491(87)90100-3; Allen JW, 2001, HEPATOLOGY, V34, P447, DOI 10.1053/jhep.2001.26753; Baker TK, 2001, CHEM RES TOXICOL, V14, P1218, DOI 10.1021/tx015518a; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi HJ, 2013, J KOREAN SURG SOC, V84, P202, DOI 10.4174/jkss.2013.84.4.202; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Corlu A, 1997, CELL BIOL TOXICOL, V13, P235, DOI 10.1023/A:1007475122321; DIXIT V, 1992, ARTIF ORGANS, V16, P336; DONKIN SS, 1993, J ANIM SCI, V71, P2218, DOI 10.2527/1993.7182218x; DORKO K, 1994, CELL TRANSPLANT, V3, P387, DOI 10.1177/096368979400300505; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; FABRE G, 1988, BIOCHEM PHARMACOL, V37, P4389, DOI 10.1016/0006-2952(88)90622-3; FRASLIN JM, 1985, EMBO J, V4, P2487, DOI 10.1002/j.1460-2075.1985.tb03960.x; Funaki N, 2002, ONCOL REP, V9, P713; Guguen-Guillouzo C, 1986, ISOLATED CULTURED HE, P259; HOWARD RB, 1967, J CELL BIOL, V35, P675, DOI 10.1083/jcb.35.3.675; Hughes RD, 2006, LIVER TRANSPLANT, V12, P713, DOI 10.1002/lt.20732; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; KONO Y, 1995, EXP CELL RES, V221, P478, DOI 10.1006/excr.1995.1399; Krasko A, 2003, CRIT CARE CLIN, V19, P155, DOI 10.1016/S0749-0704(02)00051-9; KURIHARCUCH W, 1989, DIFFERENTIATION, V41, P148, DOI 10.1111/j.1432-0436.1989.tb00742.x; Li Jun, 2005, Hepatobiliary Pancreat Dis Int, V4, P249; Montesissa C, 1996, VET RES COMMUN, V20, P449, DOI 10.1007/BF00419182; OKA M, 1992, BIOSCI BIOTECH BIOCH, V56, P1472, DOI 10.1271/bbb.56.1472; Patterson Jr MK, 1973, TISSUE CULTURE METHO, P406; Puviani AC, 1998, COMP BIOCHEM PHYS A, V121, P99, DOI 10.1016/S1095-6433(98)10109-5; ROZGA J, 1993, HEPATOLOGY, V17, P258, DOI 10.1016/0270-9139(93)90086-3; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SHULL LR, 1987, XENOBIOTICA, V17, P345, DOI 10.3109/00498258709043944; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Spotorno VG, 2006, CYTOTECHNOLOGY, V51, P51, DOI 10.1007/s10616-006-9000-0; Strom SC, 2001, ILTS ELTA LICATE JOI, P62; Talamini MA, 1997, HEPATOLOGY, V25, P167, DOI 10.1053/jhep.1997.v25.pm0008985285; Tchaparian EH, 2011, DRUG METAB DISPOS, V39, P2387, DOI 10.1124/dmd.111.039545; UPRETI GC, 1991, SMALL RUMINANT RES, V4, P175, DOI 10.1016/0921-4488(91)90063-V; Wang YJ, 2004, WORLD J GASTROENTERO, V10, P699, DOI 10.3748/wjg.v10.i5.699; Yin LY, 2011, ARTERIOSCL THROM VAS, V31, P328, DOI 10.1161/ATVBAHA.110.217828	41	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118841	10.1371/journal.pone.0118841	http://dx.doi.org/10.1371/journal.pone.0118841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790478	Green Submitted, gold, Green Published			2022-12-26	WOS:000351425400049
J	Paschou, SA; Ioannidis, D; Vassilatou, E; Mizamtsidi, M; Panagou, M; Lilis, D; Tzavara, I; Vryonidou, A				Paschou, Stavroula A.; Ioannidis, Dimitrios; Vassilatou, Evangeline; Mizamtsidi, Maria; Panagou, Maria; Lilis, Dimitrios; Tzavara, Ioanna; Vryonidou, Andromachi			Birth Weight and Polycystic Ovary Syndrome in Adult Life: Is There a Causal Link?	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; CHILDREN BORN SMALL; INSULIN-RESISTANCE; BODY-SIZE; GESTATIONAL-AGE; SEX-HORMONES; WOMEN; HYPERANDROGENISM; ORIGINS; GROWTH	Objectives Several studies have demonstrated associations of birth weight with metabolic and reproductive abnormalities in adults. The aim of this study was to investigate the birth weight in women with PCOS and its correlation with clinical and biochemical characteristics of the syndrome. Materials and Methods We studied 288 women with PCOS according to the NIH criteria and 166 women with normal cycle and without clinical hyperandrogenism. Birth weight and anthropometric characteristics were recorded, and levels of serum androgens, SHBG, insulin and fasting glucose were measured. Results Birth weight data were available for 243/288 women with PCOS and age- and BMI-matched 101/166 controls. No differences were found (p > 0.05) in birth weight among women with PCOS and normal controls. Birth weight of PCOS women was negatively correlated with DHEAS levels (p = 0.031, r = -0.143) and positively correlated with waist circumference (p < 0.001, r = 0.297) and body mass index (BMI) (p = 0.040, r = 0.132). Birth weight of controls was negatively correlated with SHBG levels (p = 0.021, r = -0.234). Women from both groups were further divided in 6 categories according to birth weight (A. <2.500 gr, B. 2.501-3.000 gr, C. 3.001-3.500 gr, D. 3.501-4.000 gr, E. 4.001-4.500 gr, F. > 4.500 gr). No statistically significant differences were observed in the distribution percentages between PCOS women and controls. (A. 7% vs 7.9%, B. 26.8% vs 20.8%, C. 39.1% vs 48.5%, D. 21.4% vs 20.8%, E. 4.9% vs 2%, F. 0.8% vs 0%), (in all comparisons, p > 0.05). Conclusions Women with PCOS do not differ from controls in birth weight distribution. However, birth weight may contribute to subtypes of the syndrome that are characterized by adrenal hyperandrogenism and central obesity.	[Paschou, Stavroula A.; Mizamtsidi, Maria; Vryonidou, Andromachi] Hellen Red Cross Hosp, Dept Endocrinol & Diabet, Athens, Greece; [Ioannidis, Dimitrios; Panagou, Maria; Lilis, Dimitrios; Tzavara, Ioanna] Amalia Fleming Hosp, Dept Endocrinol & Diabet, Athens, Greece; [Vassilatou, Evangeline] Attikon Univ Hosp, Dept Med 2, Endocrine Unit, Athens, Greece	University Hospital Attikon	Vryonidou, A (corresponding author), Hellen Red Cross Hosp, Dept Endocrinol & Diabet, Athens, Greece.	mahi_vr@hotmail.com	Vassilatou, Evangeline/ABE-2651-2020					Azziz R, 1998, J CLIN ENDOCR METAB, V83, P2317, DOI 10.1210/jc.83.7.2317; Azziz R, 2008, J CLIN ENDOCR METAB, V93, P1579, DOI 10.1210/jc.2008-0477; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Cnattingius S, 2012, INT J OBESITY, V36, P1320, DOI 10.1038/ijo.2011.248; Conway G, 2014, EUR J ENDOCRINOL, V171, pP1, DOI 10.1530/EJE-14-0253; Cresswell JL, 1997, LANCET, V350, P1131, DOI 10.1016/S0140-6736(97)06062-5; Davies MJ, 2012, HUM REPROD, V27, P1475, DOI 10.1093/humrep/des027; de Zegher F, 2009, J CLIN ENDOCR METAB, V94, P3682, DOI 10.1210/jc.2009-1608; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Escobar-Morreale HF, 2007, TRENDS ENDOCRIN MET, V18, P266, DOI 10.1016/j.tem.2007.07.003; Gennarelli G, 1999, J CLIN ENDOCR METAB, V84, P76, DOI 10.1210/jc.84.1.76; Gluckman PD, 2005, BIOL NEONATE, V87, P127, DOI 10.1159/000082311; Goodarzi MO, 2014, J STEROID BIOCH MOL; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; HATCH R, 1981, AM J OBSTET GYNECOL, V140, P815, DOI 10.1016/0002-9378(81)90746-8; Hediger ML, 1998, ARCH PEDIAT ADOL MED, V152, P1225; Ibanez L, 2000, CLIN ENDOCRINOL, V53, P523, DOI 10.1046/j.1365-2265.2000.01133.x; Ibanez L, 1998, J CLIN ENDOCR METAB, V83, P3558, DOI 10.1210/jc.83.10.3558; Jaquet D, 1999, J CLIN ENDOCR METAB, V84, P3945, DOI 10.1210/jc.84.11.3945; Laitinen J, 2003, INT J OBESITY, V27, P710, DOI 10.1038/sj.ijo.0802301; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P789, DOI 10.1210/jc.2009-1849; Markopoulos MC, 2011, J CLIN ENDOCR METAB, V96, P623, DOI 10.1210/jc.2010-0130; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Melo AS, 2010, HUM REPROD, V25, P2124, DOI 10.1093/humrep/deq162; Michelmore K, 2001, CLIN ENDOCRINOL, V55, P439, DOI 10.1046/j.1365-2265.2001.01375.x; Mumm H, 2013, FERTIL STERIL, V99, P777, DOI 10.1016/j.fertnstert.2012.11.004; Opdahl S, 2008, BRIT J CANCER, V99, P201, DOI 10.1038/sj.bjc.6604449; Pandolfi C, 2008, METABOLISM, V57, P999, DOI 10.1016/j.metabol.2008.02.018; Pasquali R, 2012, ANN NY ACAD SCI, V1264, P20, DOI 10.1111/j.1749-6632.2012.06569.x; Puurunen J, 2009, J CLIN ENDOCR METAB, V94, P1973, DOI 10.1210/jc.2008-2583; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Rosner W, 2006, CELL, V124, P455, DOI 10.1016/j.cell.2006.01.026; Ross MG, 2013, CLIN OBSTET GYNECOL, V56, P529, DOI 10.1097/GRF.0b013e318299c39d; Ruder EH, 2011, CANCER CAUSE CONTROL, V22, P611, DOI 10.1007/s10552-011-9734-7; Sir-Petermann T, 2005, HUM REPROD, V20, P2122, DOI 10.1093/humrep/dei009; Tenhola S, 2002, J PEDIATR-US, V141, P477, DOI 10.1067/mpd.2002.126923; Tworoger SS, 2006, CANCER EPIDEM BIOMAR, V15, P2494, DOI 10.1158/1055-9965.EPI-06-0671; Villa J, 2011, CURR DIABETES REP, V11, P179, DOI 10.1007/s11892-011-0189-8; Xita N, 2010, MOL CELL ENDOCRINOL, V316, P60, DOI 10.1016/j.mce.2009.08.025; Xita N, 2010, ANN NY ACAD SCI, V1205, P148, DOI 10.1111/j.1749-6632.2010.05658.x; Zawadski J., 1992, POLYCYSTIC OVARY SYN, P377	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122050	10.1371/journal.pone.0122050	http://dx.doi.org/10.1371/journal.pone.0122050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790331	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400208
J	George, SHL; Milea, A; Sowamber, R; Chehade, R; Tone, A; Shaw, PA				George, S. H. L.; Milea, A.; Sowamber, R.; Chehade, R.; Tone, A.; Shaw, P. A.			Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; INTRAEPITHELIAL CARCINOMA; CANCER; BRCA; SUPPRESSION; EXPRESSION; MUTATIONS; DIAGNOSIS; PATHWAYS; FEATURES	Liver kinase B1 (LKB1) is a tumor suppressor ubiquitously expressed serine/threonine protein kinase involved in energy metabolism and cellular polarity. In microarray experiments that compared normal tubal epithelium with high-grade serous carcinoma (HGSC), we observed a decrease in LKB1 mRNA expression in HGSC. In this study, we demonstrate that loss of cytoplasmic and nuclear LKB1 protein expression is frequently observed in tubal cancer precursor lesions as well as in both sporadic and hereditary HGSCs compared with other ovarian cancer histotypes. Bi-allelic genomic loss of LKB1 in HGSC did not account for the majority of cases with a decrease in protein expression. In vitro, shLKB1-fallopian tube epithelial (FTE) cells underwent premature cellular arrest and in ex vivo FTE culture, LKB1 loss and p53 mutant synergized to disrupt apical to basal polarity and decrease the number of ciliated cells. Overexpression of cyclin E1 allowed for bypass of LKB1-induced cellular arrest, and increased both proliferation and anchorage-independent growth of transformed FTE cells. These data suggest that LKB1 loss early in ovarian serous tumorigenesis has an integral role in tumor promotion by disrupting apical to basal polarity in the presence of mutated p53 in fallopian tube cells.	[George, S. H. L.; Milea, A.; Sowamber, R.; Chehade, R.; Tone, A.; Shaw, P. A.] Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [George, S. H. L.; Milea, A.; Sowamber, R.; Chehade, R.; Shaw, P. A.] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [George, S. H. L.; Milea, A.; Sowamber, R.; Tone, A.; Shaw, P. A.] Univ Hlth Network, Dept Lab Med, Toronto, ON, Canada; [Chehade, R.; Tone, A.; Shaw, P. A.] Univ Toronto, Toronto, ON, Canada; [Shaw, P. A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Shaw, PA (corresponding author), Toronto Gen Hosp, Dept Pathol, Eaton Wing,Room 11-444,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	patricia.shaw@uhn.ca	GEORGE, SOPHIA/AAZ-7443-2020	GEORGE, SOPHIA/0000-0003-1013-1883	CDMRP Ovarian Cancer program [W81WH-0701-0371]; Princess Margaret Cancer Centre Foundation	CDMRP Ovarian Cancer program; Princess Margaret Cancer Centre Foundation(University of Toronto)	We thank the UHN Cancer Biobank Core Laboratory for sample acquisition, the UHN Pathology Research Program for immunohistochemistry, Doug Holmyard at Mount Sinai Hospital for the SEM, as well as the Gynecological Oncologists at the Princess Margaret Cancer Centre. This study was funded by the CDMRP Ovarian Cancer program (W81WH-0701-0371) and the Princess Margaret Cancer Centre Foundation.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Chen EY, 2010, J PATHOL, V222, P110, DOI 10.1002/path.2739; Contreras CM, 2010, DIS MODEL MECH, V3, P181, DOI 10.1242/dmm.004440; George SHL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00005; George SHL, 2012, CLIN CANCER RES, V18, P6199, DOI 10.1158/1078-0432.CCR-12-2155; George SHL, 2011, J PATHOL, V225, P106, DOI 10.1002/path.2927; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Jarboe EA, 2008, HISTOPATHOLOGY, V53, P127, DOI 10.1111/j.1365-2559.2007.02938.x; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Karst AM, 2014, CANCER RES, V74, P1141, DOI 10.1158/0008-5472.CAN-13-2247; Karst AM, 2012, NAT PROTOC, V7, P1755, DOI 10.1038/nprot.2012.097; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Kuhn E, 2012, J PATHOL, V226, P421, DOI 10.1002/path.3023; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Launonen V, 2005, HUM MUTAT, V26, P291, DOI 10.1002/humu.20222; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Matulonis UA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024433; May T, 2010, GYNECOL ONCOL, V117, P9, DOI 10.1016/j.ygyno.2010.01.006; McCarthy A, 2009, J PATHOL, V219, P306, DOI 10.1002/path.2599; Milea A, 2014, MODERN PATHOL, V27, P991, DOI 10.1038/modpathol.2013.218; Morton JP, 2010, GASTROENTEROLOGY, V139, P586, DOI 10.1053/j.gastro.2010.04.055; Ning G, 2013, INT J GYNECOL PATHOL, V32, P345, DOI 10.1097/PGP.0b013e31826feee2; Norquist BM, 2010, CANCER-AM CANCER SOC, V116, P5261, DOI 10.1002/cncr.25439; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Partanen JI, 2009, CELL CYCLE, V8, P716, DOI 10.4161/cc.8.5.7786; Sehdev AS, 2010, MODERN PATHOL, V23, P844, DOI 10.1038/modpathol.2010.60; Shaw PA, 2009, MODERN PATHOL, V22, P1133, DOI 10.1038/modpathol.2009.89; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tanwar PS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002906; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Tone AA, 2008, CLIN CANCER RES, V14, P4067, DOI 10.1158/1078-0432.CCR-07-4959; van Veelen W, 2011, ONCOGENE, V30, P2289, DOI 10.1038/onc.2010.630; Vang R, 2012, INT J GYNECOL PATHOL, V31, P243, DOI 10.1097/PGP.0b013e31823b8831; Visvanathan K, 2011, AM J SURG PATHOL, V35, P1766, DOI 10.1097/PAS.0b013e31822f58bc; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031	39	15	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2016	35	1					59	68		10.1038/onc.2015.62	http://dx.doi.org/10.1038/onc.2015.62			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DA4ZT	25798842				2022-12-26	WOS:000367812400006
J	Armstrong, DL; Eisenstein, M; Zidovetzki, R; Jacob, CO				Armstrong, Don L.; Eisenstein, Miriam; Zidovetzki, Raphael; Jacob, Chaim O.			Systemic Lupus Erythematosus-associated Neutrophil Cytosolic Factor 2 Mutation Affects the Structure of NADPH Oxidase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; CONTROLS PHAGOSOMAL PH; REVISED CRITERIA; PROTEIN; VAV1; CLASSIFICATION; SUSCEPTIBILITY; LYMPHOCYTES; P67(PHOX); ADMIXTURE	In a case-control association study with 3716 North Americans of Hispanic descent and 4867 North Americans of European descent, we show that the associations of rs17849502 (NCF2 His-389 -> Gln) and rs13306575 (NCF2 Arg-395 -> Trp) with systemic lupus erythematosus are independent. We have shown that His-389 -> Gln disrupts the binding of NCF2 to the ZF domain of VAV1, resulting in decreased NADPH oxidase activity. With respect to Arg-395 -> Trp, using protein docking and structure analyses, we provide a model for the involvement of this mutation in the structure and function of the NADPH oxidase complex. This model assigns a central role to Arg-395 in the structure and stability of the quaternary NCF2/NCF4/VAV1/RAC1 NADPH oxidase complex. Arg-395 stabilizes the C-terminal tail of NCF4 and the conformation of NCF2 loop 395-402, which in turn stabilize the evolutionarily conserved interactions of NCF2/NCF4 with the DH domain of VAV1 and RAC1 region 120-137. Our findings are consistent with the high levels of conservation of all of the residues involved in these interactions.	[Armstrong, Don L.; Zidovetzki, Raphael; Jacob, Chaim O.] Univ So Calif, Dept Med, Lupus Genet Grp, Los Angeles, CA 90089 USA; [Zidovetzki, Raphael] Univ Calif Riverside, Cell Biol & Neurosci, Riverside, CA 92521 USA; [Eisenstein, Miriam] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	University of Southern California; University of California System; University of California Riverside; Weizmann Institute of Science	Jacob, CO (corresponding author), Univ So Calif, Dept Med, Lupus Genet Grp, Los Angeles, CA 90089 USA.	jacob@usc.edu		Armstrong, Don/0000-0002-4904-638X	National Institutes of health from NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	National Institutes of health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Systemic Lupus Erythematosus Genetics Consortium (John B. Harley, Marta E Alarcon-Riquelme, Lindsey A. Criswell, Patrick M. Gaffney, Chaim O. Jacob, Robert P. Kimberly, Kathy L. M. Sivils, Betty P. Tsao, Timothy J. Vyse, and Carl D. Langefeld) for their involvement in the collection of samples and genotyping of these variants. We thank Mary C. Dinauer invaluable insights into the function of the NADPH oxidase complex. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of health Grant P41-GM103311 from NIGMS).	Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Baye TM, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-1; Ben-Shimon A, 2010, J MOL BIOL, V402, P259, DOI 10.1016/j.jmb.2010.07.021; Berchanski A, 2004, PROTEINS, V56, P130, DOI 10.1002/prot.20145; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bouaziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028845; Cale CM, 2007, CLIN EXP IMMUNOL, V148, P79, DOI 10.1111/j.1365-2249.2007.03321.x; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; Deng HW, 2001, GENETICS, V159, P1319; Dhillon SS, 2014, GASTROENTEROLOGY, V147, P680, DOI 10.1053/j.gastro.2014.06.005; Doherty E, 2014, ANTIOXID REDOX SIGN, V21, P56, DOI 10.1089/ars.2013.5702; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Katzav S, 2009, INT J BIOCHEM CELL B, V41, P1245, DOI 10.1016/j.biocel.2008.11.006; Kim-Howard X, 2014, HUM MOL GENET, V23, P1656, DOI 10.1093/hmg/ddt532; Kowalsman N, 2009, PROTEINS, V77, P297, DOI 10.1002/prot.22436; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Ming WY, 2007, MOL CELL BIOL, V27, P312, DOI 10.1128/MCB.00985-06; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Paclet MH, 2001, EUR J BIOCHEM, V268, P5197, DOI 10.1046/j.0014-2956.2001.02455.x; Patino PJ, 1999, BLOOD, V94, P2505, DOI 10.1182/blood.V94.7.2505.419k10_2505_2514; Perl A, 2013, NAT REV RHEUMATOL, V9, P674, DOI 10.1038/nrrheum.2013.147; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; R Core Team, 2012, R LANG ENV STAT COMP; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schappi MG, 2008, SEMIN IMMUNOPATHOL, V30, P255, DOI 10.1007/s00281-008-0119-2; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Vyshkina T, 2008, CLIN IMMUNOL, V129, P31, DOI 10.1016/j.clim.2008.07.011; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003	43	22	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12595	12602		10.1074/jbc.M115.639021	http://dx.doi.org/10.1074/jbc.M115.639021			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25795782	Green Published, hybrid			2022-12-26	WOS:000354569000015
J	Carlson, SM; Moore, KE; Sankaran, SM; Reynoird, N; Elias, JE; Gozani, O				Carlson, Scott M.; Moore, Kaitlyn E.; Sankaran, Saumya M.; Reynoird, Nicolas; Elias, Joshua E.; Gozani, Or			A Proteomic Strategy Identifies Lysine Methylation of Splicing Factor snRNP70 by the SETMAR Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Methylation; Mass Spectrometry (MS); Protein Methylation; Proteomics; Substrate Specificity	ENHANCES DNA-REPAIR; CHROMOSOME DECATENATION; MASS-SPECTROMETRY; CELL-CULTURE; AMINO-ACIDS; HISTONE H3; IN-VIVO; PROTEIN; METHYLTRANSFERASES; ENRICHMENT	Background: SETMAR is a lysine methyltransferase (KMT) that contributes to DNA repair, but its biochemical function is not well understood. Results: A novel proteomic strategy identifies splicing factor snRNP70 as a SETMAR substrate. Conclusion: SETMAR is the first KMT identified to target splicing factors. Significance: Proteomics can be harnessed to discover methyltransferase substrates. Lysine methylation may be a new mode of regulation for mRNA splicing. The lysine methyltransferase (KMT) SETMAR is implicated in the response to and repair of DNA damage, but its molecular function is not clear. SETMAR has been associated with dimethylation of histone H3 lysine 36 (H3K36) at sites of DNA damage. However, SETMAR does not methylate H3K36 in vitro. This and the observation that SETMAR is not active on nucleosomes suggest that H3K36 methylation is not a physiologically relevant activity. To identify potential non-histone substrates, we utilized a strategy on the basis of quantitative proteomic analysis of methylated lysine. Our approach identified lysine 130 of the mRNA splicing factor snRNP70 as a SETMAR substrate in vitro, and we show that the enzyme primarily generates monomethylation at this position. Furthermore, we show that SETMAR methylates snRNP70 Lys-130 in cells. Because snRNP70 is a key early regulator of 5 splice site selection, our results suggest a model in which methylation of snRNP70 by SETMAR regulates constitutive and/or alternative splicing. In addition, the proteomic strategy described here is broadly applicable and is a promising route for large-scale mapping of KMT substrates.	[Carlson, Scott M.; Moore, Kaitlyn E.; Sankaran, Saumya M.; Reynoird, Nicolas; Gozani, Or] Stanford Univ, Dept Biol, Sch Med, Stanford, CA 94305 USA; [Moore, Kaitlyn E.; Elias, Joshua E.] Stanford Univ, Sch Med, Dept Chem & Syst, Stanford, CA 94305 USA	Stanford University; Stanford University	Carlson, SM (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.	scottmc@stanford.edu	reynoird, nicolas/M-7568-2017; Reynoird, Nicolas/AAX-4043-2020	reynoird, nicolas/0000-0003-1578-2781; Reynoird, Nicolas/0000-0003-1578-2781; Gozani, Or/0000-0002-1365-4463; Carlson, Scott/0000-0003-1996-0012	National Institute of Health [R01 GM079641]; American Cancer Society Illinois Division [123711-PF-13-093-01-TBE]; National Science Foundation Graduate Research Fellowship [DGE-1147470]; Hubert Shaw and Sandra Lui Stanford Graduate Fellowship; W. M. Keck Foundation; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Illinois Division(American Cancer Society); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Hubert Shaw and Sandra Lui Stanford Graduate Fellowship; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of Health Grants R01 GM079641 (to O. G.).; Supported in part by Postdoctoral Fellowship 123711-PF-13-093-01-TBE from the American Cancer Society Illinois Division. To whom correspondence may be addressed: Dept. of Biology, Stanford University, 371 Serra Mall, Stanford, CA. Tel.: 617-301-0242; E-mail: scottmc@stanford.edu.; Supported by a National Science Foundation Graduate Research Fellowship under Grant DGE-1147470 and by the Hubert Shaw and Sandra Lui Stanford Graduate Fellowship.; Supported by funds from the W. M. Keck Foundation.	Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carlson SM, 2014, J MOL BIOL, V426, P3350, DOI 10.1016/j.jmb.2014.04.024; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hromas R, 2012, ONCOGENE, V31, P4245, DOI 10.1038/onc.2011.586; Hromas R, 2008, DNA REPAIR, V7, P1927, DOI 10.1016/j.dnarep.2008.08.002; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Liu HD, 2013, MOL CELL, V50, P723, DOI 10.1016/j.molcel.2013.04.025; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong Shao-En, 2007, Methods Mol Biol, V359, P37; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Su ZL, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-7; West LE, 2010, J BIOL CHEM, V285, P37725, DOI 10.1074/jbc.M110.139527; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Wray J, 2009, BLOOD, V114, P1852, DOI 10.1182/blood-2008-08-175760; Wray J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005323; Wu ZX, 2015, MOL CELL PROTEOMICS, V14, P329, DOI 10.1074/mcp.M114.044255; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	35	23	25	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12040	12047		10.1074/jbc.M115.641530	http://dx.doi.org/10.1074/jbc.M115.641530			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25795785	Green Published, hybrid			2022-12-26	WOS:000354388600019
J	Oligschlaeger, Y; Miglianico, M; Chanda, D; Scholz, R; Thali, RF; Tuerk, R; Stapleton, DI; Gooley, PR; Neumann, D				Oligschlaeger, Yvonne; Miglianico, Marie; Chanda, Dipanjan; Scholz, Roland; Thali, Ramon F.; Tuerk, Roland; Stapleton, David I.; Gooley, Paul R.; Neumann, Dietbert			The Recruitment of AMP-activated Protein Kinase to Glycogen Is Regulated by Autophosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; CARBOHYDRATE-BINDING; POSTTRANSLATIONAL MODIFICATIONS; SUBCELLULAR-LOCALIZATION; GLUCOSE-UPTAKE; SUBUNIT; PHOSPHORYLATION; SYNTHASE; DOMAIN; SITE	The mammalian AMP-activated protein kinase (AMPK) is an obligatory alpha beta gamma heterotrimeric complex carrying a carbohydrate-binding module (CBM) in the beta-subunit (AMPK beta) capable of attaching AMPK to glycogen. Nonetheless, AMPK localizes at many different cellular compartments, implying the existence of mechanisms that prevent AMPK from glycogen binding. Cell-free carbohydrate binding assays revealed that AMPK autophosphorylation abolished its carbohydrate-binding capacity. X-ray structural data of the CBM displays the central positioning of threonine 148 within the binding pocket. Substitution of Thr-148 for a phospho-mimicking aspartate (T148D) prevents AMPK from binding to carbohydrate. Overexpression of isolated CBM or beta 1-containing AMPK in cellular models revealed that wild type( WT) localizes to glycogen particles, whereas T148D shows a diffuse pattern. Pharmacological AMPK activation and glycogen degradation by glucose deprivation but not forskolin enhanced cellular Thr-148 phosphorylation. Cellular glycogen content was higher if pharmacological AMPK activation was combined with overexpression of T148D mutant relative to WT AMPK. In summary, these data show that glycogen-binding capacity of AMPK beta is regulated by Thr-148 autophosphorylation with likely implications in the regulation of glycogen turnover. The findings further raise the possibility of regulated carbohydrate-binding function in a wider variety of CBM-containing proteins.	[Oligschlaeger, Yvonne; Miglianico, Marie; Chanda, Dipanjan; Neumann, Dietbert] Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Scholz, Roland; Thali, Ramon F.; Tuerk, Roland; Neumann, Dietbert] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Stapleton, David I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Gooley, Paul R.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	Maastricht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Neumann, D (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.	d.neumann@maastrichtuniversity.nl	Scholz, Roland W./AAH-8385-2020; Chanda, Dipanjan/AAU-3996-2021	Scholz, Roland W./0000-0003-2506-3254; Chanda, Dipanjan/0000-0003-0685-187X; Gooley, Paul/0000-0002-0323-449X; Neumann, Dietbert/0000-0002-4316-684X	Netherlands Organization for Scientific Research (NWO) [864.10.007]; Swiss National Science Foundation [3100A-0114137]; EU [LSHM-CT-2004-005272]; Marie Curie fellowship [PIIF-GA-2012-332230];  [ETHIIRA 36/05-3];  [32/05-3]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Marie Curie fellowship(European Commission); ; 	Research in the laboratory of D. N. was supported by the Netherlands Organization for Scientific Research (NWO) (VIDI Grant 864.10.007). This work was also supported by Swiss National Science Foundation Grant 3100A-0114137, EU FP6 Contract LSHM-CT-2004-005272 (EXGENESIS), and Graduate Training Fellowships ETHIIRA 36/05-3 and 32/05-3 (for R. S. and R. F. T.).; Recipient of a Marie Curie fellowship (Grant PIIF-GA-2012-332230).	Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Avila-Castaneda A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00199; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Bieri M, 2012, BIOPHYS J, V102, P305, DOI 10.1016/j.bpj.2011.12.012; Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; Diaz A, 2011, J BIOL CHEM, V286, P18505, DOI 10.1074/jbc.M111.236109; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Han GH, 2010, ELECTROPHORESIS, V31, P1080, DOI 10.1002/elps.200900493; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hegarty BD, 2009, ACTA PHYSIOL, V196, P129, DOI 10.1111/j.1748-1716.2009.01968.x; HIRAGA A, 1986, EUR J BIOCHEM, V161, P763, DOI 10.1111/j.1432-1033.1986.tb10505.x; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Janecek S, 2011, ENZYME MICROB TECH, V49, P429, DOI 10.1016/j.enzmictec.2011.07.002; Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Kim N, 2014, CELL SIGNAL, V26, P1800, DOI 10.1016/j.cellsig.2014.03.023; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Koay A, 2010, FEBS LETT, V584, P3499, DOI 10.1016/j.febslet.2010.07.015; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; MACKINTOSH C, 1988, FEBS LETT, V234, P189, DOI 10.1016/0014-5793(88)81331-0; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; McMahon RJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE640, DOI 10.1152/ajpendo.1996.270.4.E640; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Neumann D, 2007, MOL BIOTECHNOL, V36, P220, DOI 10.1007/s12033-007-0029-x; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Prats C, 2011, EXP PHYSIOL, V96, P385, DOI 10.1113/expphysiol.2010.052860; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Roma-Mateo C, 2011, BIOCHEM J, V439, P265, DOI 10.1042/BJ20110150; Sakoda H, 2005, AM J PHYSIOL-ENDOC M, V289, pE474, DOI 10.1152/ajpendo.00003.2005; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Scholz R, 2009, J BIOL CHEM, V284, P27425, DOI 10.1074/jbc.M109.047670; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Singh PK, 2012, MOL CELL BIOL, V32, P652, DOI 10.1128/MCB.06353-11; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tuerk RD, 2009, ANAL BIOCHEM, V390, P141, DOI 10.1016/j.ab.2009.04.015; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wiatrowski HA, 2004, MOL CELL BIOL, V24, P352, DOI 10.1128/MCB.24.1.352-361.2004; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200	59	34	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11715	11728		10.1074/jbc.M114.633271	http://dx.doi.org/10.1074/jbc.M114.633271			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792737	Green Published, hybrid			2022-12-26	WOS:000353719400044
J	Viegas, EO; Tembe, N; Macovela, E; Goncalves, E; Augusto, O; Ismael, N; Sitoe, N; De Schacht, C; Bhatt, N; Meggi, B; Araujo, C; Sandstrom, E; Biberfeld, G; Nilsson, C; Andersson, S; Jani, I; Osman, N				Viegas, Edna Omar; Tembe, Nelson; Macovela, Eulalia; Goncalves, Emilia; Augusto, Orvalho; Ismael, Nalia; Sitoe, Nadia; De Schacht, Caroline; Bhatt, Nilesh; Meggi, Bindiya; Araujo, Carolina; Sandstrom, Eric; Biberfeld, Gunnel; Nilsson, Charlotta; Andersson, Soren; Jani, Ilesh; Osman, Nafissa			Incidence of HIV and the Prevalence of HIV, Hepatitis B and Syphilis among Youths in Maputo, Mozambique: A Cohort Study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; BLOOD-DONORS; SOUTH-AFRICA; VIRUS; POPULATION; WOMEN; EPIDEMIOLOGY; COMMUNITY; CITY; MEN	Background Prevalence of HIV in Mozambique among individuals aged 15-49 years is 11.5%. The HIV prevalence is higher in women than in men across the country, peaking at ages 25-29 years and 35-39 years, respectively. In this study, we aimed at determining the prevalence and incidence of HIV, prevalence of Hepatitis B (HBV), and prevalence of syphilis in youths. We also characterized a cohort of youths for future participation in phase I/II HIV vaccine trials. Methods The study was conducted at a youth clinic in Maputo Central Hospital from August 2009 to October 2011. Youths of both genders aged 18-24 years (n = 1380) were screened for HIV using a sequential algorithm of two immunochromatographic assays, HBV using an enzyme linked immunosorbant test, and syphilis using a treponemal immunochromatographic strip test. The HIV seronegative participants (n = 1309) were followed-up for 12 months with quarterly study visits. The clinical and behavioral data were collected using structured questionnaires. The HIV seroconversions were confirmed by a molecular assay. Results The study population was female dominant (76.8%). All participants had a formal education, with 44.6% studying for technical or higher education degrees. The mean age at sexual debut was 16.6 years (SD: +/-1.74), with 85.6% reporting more than one sexual partner in life. The screening showed the prevalence of HIV, HBV, and syphilis at 5.1% (95% CI: 3.97-6.31), 12.2% (95% CI 10.5%-14.0%), and 0.36% (95% CI 0.15%-0.84%), respectively. The HIV incidence rate was found to be 1.14/100 person years (95% CI: 0.67-1.92). Retention rates were stable throughout the study being 85.1% at the last visit. Conclusion Incidence of HIV in this cohort of youths in Maputo was relatively low. Also, the prevalence of HIV and syphilis was lower than the national values in this age group. However, the HBV prevalence was higher than in previous reports in the country.	[Viegas, Edna Omar; Tembe, Nelson; Ismael, Nalia; Sitoe, Nadia; Bhatt, Nilesh; Meggi, Bindiya; Jani, Ilesh] Inst Nacl Saude, Maputo, Mozambique; [Viegas, Edna Omar; Tembe, Nelson; Nilsson, Charlotta] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Viegas, Edna Omar; Tembe, Nelson; Macovela, Eulalia; Goncalves, Emilia; Augusto, Orvalho; Araujo, Carolina; Osman, Nafissa] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Macovela, Eulalia; Goncalves, Emilia; Osman, Nafissa] Hosp Cent Maputo, Maputo, Mozambique; [Biberfeld, Gunnel; Nilsson, Charlotta] Publ Hlth Agcy Sweden, Solna, Sweden; [Biberfeld, Gunnel; Nilsson, Charlotta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [De Schacht, Caroline] Elizabeth Glaser Pediat AIDS Fdn, Maputo, Mozambique; [Sandstrom, Eric] Karolinska Inst, Sodersjukhuset, Dept Educ & Clin Res, Stockholm, Sweden; [Andersson, Soren] Univ Orebro, Fac Med & Hlth, Dept Lab Med, SE-70182 Orebro, Sweden	Karolinska Institutet; Eduardo Mondlane University; Public Health Agency of Sweden; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Orebro University	Viegas, EO (corresponding author), Inst Nacl Saude, Maputo, Mozambique.	ednaviegas@gmail.com	Viegas, Elisabete Maria Macedo/C-3138-2012; Augusto, Orvalho/J-8767-2019	Viegas, Elisabete Maria Macedo/0000-0002-1970-2198; Augusto, Orvalho/0000-0002-0005-3968; Jani, Ilesh/0000-0002-6880-6655	Regional HIV/AIDS Team for Africa; Embassy of Sweden, Lusaka - Sweden (Sida) [2150012801]; Embassy of Sweden, Lusaka - Norway (Sida) [2150012801]	Regional HIV/AIDS Team for Africa; Embassy of Sweden, Lusaka - Sweden (Sida); Embassy of Sweden, Lusaka - Norway (Sida)	This study was supported by funding from The Regional HIV/AIDS Team for Africa, Embassy of Sweden, Lusaka jointly funded by Sweden and Norway (Sida contribution number 2150012801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, EP SURV PSYCH ILL KO, P6; Bakari M, 2000, AIDS, V14, P313, DOI 10.1097/00002030-200002180-00014; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Booker CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-249; Braunstein SL, 2009, AIDS REV, V11, P140; Carpenter LM, 2002, J ACQ IMMUN DEF SYND, V29, P174, DOI 10.1097/00042560-200202010-00011; Chege W, 2012, J INFECT DEV COUNTR, V6, P870, DOI 10.3855/jidc.2636; Cunha L, 2007, J MED VIROL, V79, P1832, DOI 10.1002/jmv.21010; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Doody MM, 2003, AM J EPIDEMIOL, V157, P643, DOI 10.1093/aje/kwg033; Dube K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084979; Esparza J, 2001, B WORLD HEALTH ORGAN, V79, P1133; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097547; Ghys PD, 2006, SEX TRANSM INFECT, V82, pI52, DOI 10.1136/sti.2005.016428; Gloyd S, 2007, SEX TRANSM DIS, V34, pS31, DOI 10.1097/01.olq.0000264586.49616.72; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Gudo ES, 2009, TRANSFUSION, V49, P1146, DOI 10.1111/j.1537-2995.2009.02100.x; Hallett TB, 2007, STUD FAMILY PLANN, V38, P1, DOI 10.1111/j.1728-4465.2007.00111.x; HENG BH, 1995, J EPIDEMIOL COMMUN H, V49, P309, DOI 10.1136/jech.49.3.309; Instituto Nacional de Estatistica, 2011, MULH HOM MOC IND SEL, P15; Instituto Nacional de Saude (INS) INdEsI Grupo Tecnico Multisectorial de Combate ao HIV/SIDA (GTM), 2011, VIG EP HIV SEU IMP D, P36; Instituto Nacional de Saude (INS) INdEsI ICF Macro, 2010, INQ NAC PREV RISC CO, P151; Jani IV, 2012, J CLIN MICROBIOL, V50, P1458, DOI 10.1128/JCM.00107-12; Karim QA, 2012, AIDS BEHAV, V16, P1870, DOI 10.1007/s10461-012-0209-y; KARIM SSA, 1989, AM J PUBLIC HEALTH, V79, P893, DOI 10.2105/AJPH.79.7.893; Komas NP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-226; Kumogola Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-553; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; McKellar MS, 2013, AIDS RES HUM RETROV, V29, P121, DOI [10.1089/aid.2012.0064, 10.1089/AID.2012.0064]; Melo J, 2008, TROP MED INT HEALTH, V13, P17, DOI [10.1111/j-1365-3156.2007.01972.x, 10.1111/j.1365-3156.2007.01972.x]; Ministerio da Saude, 2008, GUIAO ESTR OP IMPL U, P24; Ministerio da Saude GTM, 2008, ROND VIG EP HIV 2007, P33; Ministerio da Saude GTM, 2013, ROND VIG EP HIV SIF, P4; Ministry of Health, 2001, INTR DPT HEP B VACC, P2; Negero Asfaw, 2011, BMC Res Notes, V4, P35, DOI 10.1186/1756-0500-4-35; Nel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035278; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Tapko J.B. BT, 2014, STATUS BLOOD SAFETY, P2; Tembe N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097391; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; UNAIDS, 2014, AIDSINFO EP STAT; UNAIDS, COR EP SLID; UNAIDS JUNPoHA, 2013, GLOB REP UNAIDS REP, P2; World Health O, 2009, WKLY EPIDEMIOL REC, V84, P405, DOI DOI 10.1016/J.VACCINE.2009.10.110; World Health Organization, 2012, INV CAS EL MOTH CHIL, P9; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	49	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121452	10.1371/journal.pone.0121452	http://dx.doi.org/10.1371/journal.pone.0121452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798607	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300253
J	Anta, AF; Georgiou, C; Mosteiro, MA; Pareja, D				Anta, Antonio Fernandez; Georgiou, Chryssis; Mosteiro, Miguel A.; Pareja, Daniel			Algorithmic Mechanisms for Reliable Crowdsourcing Computation under Collusion	PLOS ONE			English	Article								We consider a computing system where a master processor assigns a task for execution to worker processors that may collude. We model the workers' decision of whether to comply (compute the task) or not (return a bogus result to save the computation cost) as a game among workers. That is, we assume that workers are rational in a game-theoretic sense. We identify analytically the parameter conditions for a unique Nash Equilibrium where the master obtains the correct result. We also evaluate experimentally mixed equilibria aiming to attain better reliability-profit trade-offs. For a wide range of parameter values that may be used in practice, our simulations show that, in fact, both master and workers are better off using a pure equilibrium where no worker cheats, even under collusion, and even for colluding behaviors that involve deviating from the game.	[Anta, Antonio Fernandez] IMDEA Networks Inst, Madrid, Spain; [Georgiou, Chryssis] Univ Cyprus, Dept Comp Sci, CY-1678 Nicosia, Cyprus; [Mosteiro, Miguel A.; Pareja, Daniel] Kean Univ, Dept Comp Sci, Union, NJ 07083 USA	University of Cyprus	Mosteiro, MA (corresponding author), Kean Univ, Dept Comp Sci, Union, NJ 07083 USA.	mmosteir@kean.edu	Anta, Antonio Fernández/B-4176-2009	Anta, Antonio Fernández/0000-0001-6501-2377; Georgiou, Chryssis/0000-0003-4360-0260	Comunidad de Madrid [S2013/ICE-2894]; Spanish Ministerio de Ciencia e Innovacion / Ministerio de Economia y Competitividad [TEC2011-29688-C02-01]; National Natural Science Foundation of China [61020106002]; University of Cyprus [UCY-ED2014-CG]; National Science Foundation [CCF 1114930]; Kean University	Comunidad de Madrid(Comunidad de Madrid); Spanish Ministerio de Ciencia e Innovacion / Ministerio de Economia y Competitividad; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Cyprus; National Science Foundation(National Science Foundation (NSF)); Kean University	A. Fernandez Anta is partially supported by grants from the Comunidad de Madrid (http://www.madrid.org) (Cloud4BigData-CM, S2013/ICE-2894), the Spanish Ministerio de Ciencia e Innovacion / Ministerio de Economia y Competitividad (http://www.mineco.gob.es)(TEC2011-29688-C02-01), and the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (61020106002). C. Georgiou is partially supported by research funds from the University of Cyprus (http://www.ucy.ac.cy/en/) (UCY-ED2014-CG). M. A. Mosteiro is partially supported by grants from the National Science Foundation (http://www.nsf.gov) (CCF 1114930) and from Kean University (http://www.kean.edu) (UFRI grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Ittai, 2011, SIGACT News, V42, P69, DOI 10.1145/1998037.1998055; Abraham I., 2006, P 25 ANN ACM S PRINC, P53, DOI 10.1145/1146381.1146393; Anderson D.P., 2010, ACM CROSSROADS, V16, P7, DOI [10.1145/1734160.1734164, DOI 10.1145/1734160.1734164]; Anderson DP, 2004, FIFTH IEEE/ACM INTERNATIONAL WORKSHOP ON GRID COMPUTING, PROCEEDINGS, P4, DOI 10.1109/GRID.2004.14; Anta Antonio Fernandez, 2008, 2008 7th IEEE International Symposium on Network Computing and Applications (NCA), P315, DOI 10.1109/NCA.2008.41; Christoforou Evgenia, 2013, Principles of Distributed Systems. 17th International Conference, OPODIS 2013. Proceedings: LNCS 8304, P98, DOI 10.1007/978-3-319-03850-6_8; Christoforou E, 2014, IEEE T COMPUT, V63, P179, DOI 10.1109/TC.2012.186; Christoforou E, 2013, CONCURR COMP-PRACT E, V25, P2363, DOI 10.1002/cpe.3104; Ding S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097762; Ding S, 2014, KNOWL-BASED SYST, V56, P216, DOI 10.1016/j.knosys.2013.11.014; Douceur JR, 2002, LECT NOTES COMPUT SC, V2429, P251, DOI 10.1007/3-540-45748-8_24; Anta AF, 2012, PARALLEL PROCESS LET, V22, DOI 10.1142/S0129626412500028; Golle P, 2001, LECT NOTES COMPUT SC, V2020, P425; Golle P, 2001, 5 INT C FIN CRYPT FC, P289, DOI DOI 10.1007/3-540-46088-8_23; Kondo D., 2002, P INT PAR DISTR PROC, P79; Kondo D, 2007, LECT NOTES COMPUT SC, V4641, P361; Korpela E, 2001, COMPUT SCI ENG, V3, P78, DOI 10.1109/5992.895191; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nisan N, 2007, ALGORITHMIC GAME THEORY, P1, DOI 10.1017/CBO9780511800481; Nisan N, 2001, GAME ECON BEHAV, V35, P166, DOI 10.1006/game.1999.0790; Nisan N, 2006, P 7 ACM C EL COMM EC, P18, DOI DOI 10.1145/1134707.1134710; Osborne MJ., 2003, INTRO GAME THEORY; Sarmenta LFG, 2002, FUTURE GENER COMP SY, V18, P561, DOI 10.1016/S0167-739X(01)00077-2; Shneidman J, 2003, LECT NOTES COMPUT SC, V2735, P139; Silaghi GC, 2009, J GRID COMPUT, V7, P555, DOI 10.1007/s10723-009-9124-5; Staab E, 2009, CCGRID: 2009 9TH IEEE INTERNATIONAL SYMPOSIUM ON CLUSTER COMPUTING AND THE GRID, P412, DOI 10.1109/CCGRID.2009.12; Taufer M., 2005, P 19 IEEE INT PAR DI, p119a, DOI [10.1109/IPDPS.2005.247, DOI 10.1109/IPDPS.2005.247]; Yurkewych M., 2005, P CCS 2005, P280	28	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0116520	10.1371/journal.pone.0116520	http://dx.doi.org/10.1371/journal.pone.0116520			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793524	Green Published, gold			2022-12-26	WOS:000352084200007
J	Delahaye-Sourdeix, M; Oliver, J; Timofeeva, MN; Gaborieau, V; Johansson, M; Chabrier, A; Wozniak, MB; Brenner, DR; Vallee, MP; Anantharaman, D; Lagiou, P; Holcatova, I; Richiardi, L; Kjaerheim, K; Agudo, A; Castellsague, X; Macfarlane, TV; Barzan, L; Canova, C; Thakker, NS; Conway, DI; Znaor, A; Healy, CM; Ahrens, W; Zaridze, D; Szeszenia-Dabrowska, N; Lissowska, J; Fabianova, E; Mates, IN; Bencko, V; Foretova, L; Janout, V; Curado, MP; Koifman, S; Menezes, A; Wunsch-Filho, V; Eluf-Neto, J; Boffetta, P; Garrote, LF; Serraino, D; Lener, M; Jaworowska, E; Lubinski, J; Boccia, S; Rajkumar, T; Samant, TA; Mahimkar, MB; Matsuo, K; Franceschi, S; Byrnes, G; Brennan, P; Mckay, JD				Delahaye-Sourdeix, Manon; Oliver, Javier; Timofeeva, Maria N.; Gaborieau, Valerie; Johansson, Mattias; Chabrier, Amelie; Wozniak, Magdalena B.; Brenner, Darren R.; Vallee, Maxime P.; Anantharaman, Devasena; Lagiou, Pagona; Holcatova, Ivana; Richiardi, Lorenzo; Kjaerheim, Kristina; Agudo, Antonio; Castellsague, Xavier; Macfarlane, Tatiana V.; Barzan, Luigi; Canova, Cristina; Thakker, Nalin S.; Conway, David I.; Znaor, Ariana; Healy, Claire M.; Ahrens, Wolfgang; Zaridze, David; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Fabianova, Eleonora; Mates, Ioan Nicolae; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; Curado, Maria Paula; Koifman, Sergio; Menezes, Ana; Wuensch-Filho, Victor; Eluf-Neto, Jose; Boffetta, Paolo; Fernandez Garrote, Leticia; Serraino, Diego; Lener, Marcin; Jaworowska, Ewa; Lubinski, Jan; Boccia, Stefania; Rajkumar, Thangarajan; Samant, Tanuja A.; Mahimkar, Manoj B.; Matsuo, Keitaro; Franceschi, Silvia; Byrnes, Graham; Brennan, Paul; McKay, James D.			The 12p13.33/RAD52 Locus and Genetic Susceptibility to Squamous Cell Cancers of Upper Aerodigestive Tract	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; HOMOLOGOUS RECOMBINATION; SYNTHETICALLY LETHAL; RAD52 INACTIVATION; RISK; BRCA2; ABERRATIONS; CARCINOMA; PROTEIN; REPAIR	Genetic variants located within the 12p13.33/RAD52 locus have been associated with lung squamous cell carcinoma (LUSC). Here, within 5,947 UADT cancers and 7,789 controls from 9 different studies, we found rs10849605, a common intronic variant in RAD52, to be also associated with upper aerodigestive tract (UADT) squamous cell carcinoma cases (OR = 1.09, 95% CI: 1.04-1.15, p = 6x10(-4)). We additionally identified rs10849605 as a RAD52 cis-eQTL inUADT(p = 1x10(-3)) and LUSC (p = 9x10(-4)) tumours, with the UADT/LUSC risk allele correlated with increased RAD52 expression levels. The 12p13.33 locus, encompassing rs10849605/RAD52, was identified as a significant somatic focal copy number amplification in UADT(n = 374, q-value = 0.075) and LUSC (n = 464, q-value = 0.007) tumors and correlated with higher RAD52 tumor expression levels (p = 6x10(-48) and p = 3x10(-29) in UADT and LUSC, respectively). In combination, these results implicate increased RAD52 expression in both genetic susceptibility and tumorigenesis of UADT and LUSC tumors.	[Delahaye-Sourdeix, Manon; Oliver, Javier; Chabrier, Amelie; Vallee, Maxime P.; McKay, James D.] IARC, Genet Canc Susceptibil Grp GCS, Lyon, France; [Timofeeva, Maria N.; Gaborieau, Valerie; Johansson, Mattias; Wozniak, Magdalena B.; Brenner, Darren R.; Anantharaman, Devasena; Brennan, Paul] IARC, GEP, Lyon, France; [Timofeeva, Maria N.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Timofeeva, Maria N.] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Holcatova, Ivana; Bencko, Vladimir] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague, Czech Republic; [Richiardi, Lorenzo] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy; [Kjaerheim, Kristina] Canc Registry Norway, Oslo, Norway; [Agudo, Antonio; Castellsague, Xavier] IDIBELL Hosp Llobregat, Catalan Inst Oncol ICO, Barcelona, Spain; [Castellsague, Xavier] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Macfarlane, Tatiana V.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Barzan, Luigi] Gen Hosp Pordenone, Pordenone, Italy; [Canova, Cristina] Univ Padua, Dept Environm Med & Publ Hlth, Padua, Italy; [Canova, Cristina] Imperial Coll, Natl Heart & Lung Inst, MRC HPA Ctr Environm & Hlth, Resp Epidemiol & Publ Hlth, London, England; [Thakker, Nalin S.] Univ Manchester, Sch Dent, Manchester, Lancs, England; [Conway, David I.] Univ Glasgow, Sch Dent, Glasgow, Lanark, Scotland; [Znaor, Ariana] Croatian Natl Inst Publ Hlth, Croatian Natl Canc Registry, Zagreb, Croatia; [Healy, Claire M.] Trinity Coll Dublin, Sch Dent Sci, Dublin, Ireland; [Ahrens, Wolfgang] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Ahrens, Wolfgang] Univ Bremen, Fac Math & Comp Sci, D-28359 Bremen, Germany; [Zaridze, David] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Fabianova, Eleonora] Reg Author Publ Hlth, Banska Bystrica, Slovakia; [Mates, Ioan Nicolae] Carol Davila Univ Med & Pharm, St Mary Gen & Esophageal Surg Clin, Bucharest, Romania; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Foretova, Lenka] Masaryk Univ, Brno, Czech Republic; [Janout, Vladimir] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Curado, Maria Paula] IPRI, Ecully, France; [Koifman, Sergio] Fiocruz MS, Natl Sch Publ Hlth, BR-21045900 Rio De Janeiro, Brazil; [Menezes, Ana] Univ Fed Pelotas, Pelotas, Brazil; [Wuensch-Filho, Victor; Eluf-Neto, Jose] Univ Sao Paulo, Sao Paulo, Brazil; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Fernandez Garrote, Leticia] Inst Oncol & Radiobiol, Havana, Cuba; [Serraino, Diego] IRCSS, Ctr Riferimento Oncol, Unit Epidemiol & Biostat, Aviano, Italy; [Lener, Marcin; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Jaworowska, Ewa] Pomeranian Med Univ, Dept Otolaryngol & Laryngol Oncol, Szczecin, Poland; [Boccia, Stefania] Univ Cattolica Sacro Cuore, Fac Med, Sect Hyg, Inst Publ Hlth, Rome, Italy; [Rajkumar, Thangarajan] Canc Inst WIA, Dept Mol Oncol, Madras, Tamil Nadu, India; [Samant, Tanuja A.; Mahimkar, Manoj B.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Canc Res Inst, Navi Mumbai, India; [Matsuo, Keitaro] Kyushu Dent Univ, Div Oral Pathol, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan; [Franceschi, Silvia] IARC, Infect & Canc Epidemiol Grp ICE, Lyon, France; [Byrnes, Graham] IARC, Biostat Grp BST, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); University of Edinburgh; University of Edinburgh; Athens Medical School; National & Kapodistrian University of Athens; Charles University Prague; University of Turin; University of Oslo; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Aberdeen; University of Padua; Imperial College London; University of Manchester; University of Glasgow; Trinity College Dublin; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; Russian Academy of Medical Sciences; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Regional Authority of Public Health Banska Bystrica; Carol Davila University of Medicine & Pharmacy; Masaryk Memorial Cancer Institute; Masaryk University Brno; Palacky University Olomouc; Fundacao Oswaldo Cruz; Universidade Federal de Pelotas; Universidade de Sao Paulo; Icahn School of Medicine at Mount Sinai; IRCCS Aviano (CRO); Pomeranian Medical University; Pomeranian Medical University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Kyushu Dental University; World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC)	Mckay, JD (corresponding author), IARC, Genet Canc Susceptibil Grp GCS, Lyon, France.	gcs@iarc.fr	Lissowska, Jolanta/AAH-3252-2020; Boccia, Stefania/AFN-1666-2022; Jaworowska, Ewa/B-1211-2015; Johansson, Mattias/ABF-3365-2020; RAJKUMAR, THANGARAJAN/AAZ-5663-2020; oliver, javier/A-5338-2009; Boffetta, Paolo/AAI-7767-2021; Boccia, Stefania/AAB-9533-2022; Mates, Ioan Nicolae/E-9255-2017; Agudo, Antonio/J-1805-2016; Bencko, Vladimir/H-8598-2017; Holcatova, Ivana/C-8327-2017; Eluf-Neto, Jose/B-2522-2009; Healy, Claire M/AGL-9755-2022; Menezes, Ana MB/G-7266-2012; Szeszenia-Dabrowska, Neonila/F-7190-2010; Serraino, Diego/J-3915-2018; franceschi, silvia/M-2452-2014; Matsuo, Keitaro/H-6758-2019; Pique, Xavier Castellsagué/N-5795-2014; Janout, Vladimir/M-5133-2014; Curado, Maria Paula/M-6200-2013; Znaor, A/H-6718-2019; richiardi, lorenzo/J-3480-2018; Ahrens, Wolfgang/A-2740-2012	Lissowska, Jolanta/0000-0003-2695-5799; Boccia, Stefania/0000-0002-1864-749X; Jaworowska, Ewa/0000-0001-9050-5042; oliver, javier/0000-0002-8073-4711; Boffetta, Paolo/0000-0002-3811-2791; Boccia, Stefania/0000-0002-1864-749X; Agudo, Antonio/0000-0001-9900-5677; Bencko, Vladimir/0000-0003-1935-2228; Holcatova, Ivana/0000-0002-1366-0337; Eluf-Neto, Jose/0000-0001-7504-2115; Healy, Claire M/0000-0003-0583-6360; Menezes, Ana MB/0000-0002-2996-9427; Serraino, Diego/0000-0003-0565-8920; franceschi, silvia/0000-0003-4181-8071; Matsuo, Keitaro/0000-0003-1761-6314; Pique, Xavier Castellsagué/0000-0002-0802-3595; Curado, Maria Paula/0000-0001-8172-2483; Ioan Nicoale, Mates/0000-0001-7210-0615; Byrnes, Graham/0000-0003-3893-7539; Johansson, Mattias/0000-0002-3116-5081; Kjaerheim, Kristina/0000-0003-0691-3735; Lubinski, Jan/0000-0003-2931-3003; Macfarlane, Tatiana/0000-0002-9392-0812; Rasul, holem/0000-0003-0579-9029; richiardi, lorenzo/0000-0003-0316-9402; Vallee, Maxime/0000-0002-3616-9508; Healy, Claire M/0000-0001-7940-4611; Timofeeva, Maria/0000-0002-2503-4253; CANOVA, CRISTINA/0000-0001-7027-7935; Foretova, Lenka/0000-0003-0494-2620; Conway, David/0000-0001-7762-4063; Ahrens, Wolfgang/0000-0003-3777-570X	US National Institutes of Health [R01 CA092039 05/05S1]; National Institute of Dental and Craniofacial Research [1R03DE020116]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE020116] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for study coordination, genotyping of replication studies and statistical analysis was provided by the US National Institutes of Health (R01 CA092039 05/05S1) and the National Institute of Dental and Craniofacial Research (1R03DE020116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anantharaman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088240; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Delahaye-Sourdeix M, 2015, J NATL CANC IN PRESS; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108; Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391; Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Negri E, 2009, INT J CANCER, V124, P394, DOI 10.1002/ijc.23848; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oze I, 2010, CANCER SCI, V101, P1875, DOI 10.1111/j.1349-7006.2010.01599.x; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scully C, 2000, ORAL ONCOL, V36, P256, DOI 10.1016/S1368-8375(00)00007-5; Shi JX, 2012, CANCER DISCOV, V2, P131, DOI 10.1158/2159-8290.CD-11-0246; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stewart B.W., 2003, WORLD CANC REPORT; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thacker J, 1999, BIOCHIMIE, V81, P77, DOI 10.1016/S0300-9084(99)80041-8; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Yan W, 2011, AM J CANCER RES, V1, P275; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	39	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117639	10.1371/journal.pone.0117639	http://dx.doi.org/10.1371/journal.pone.0117639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793373	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000352084200015
J	Devert, A; Fabre, N; Floris, M; Canard, B; Robaglia, C; Crete, P				Devert, Anthony; Fabre, Nicolas; Floris, Maina; Canard, Bruno; Robaglia, Christophe; Crete, Patrice			Primer-Dependent and Primer-Independent Initiation of Double Stranded RNA Synthesis by Purified Arabidopsis RNA-Dependent RNA Polymerases RDR2 and RDR6	PLOS ONE			English	Article							TRANS-ACTING SIRNAS; AGROBACTERIUM-MEDIATED TRANSFORMATION; DNA METHYLATION; GENE; BIOGENESIS; REQUIRES; REVEALS; PLANTS; SGS3; AMPLIFICATION	Cellular RNA-dependent RNA polymerases (RDRs) are fundamental components of RNA silencing in plants and many other eukaryotes. In Arabidopsis thaliana genetic studies have demonstrated that RDR2 and RDR6 are involved in the synthesis of double stranded RNA (dsRNA) from single stranded RNA (ssRNA) targeted by RNA silencing. The dsRNA is subsequently cleaved by the ribonuclease DICER-like into secondary small interfering RNAs (siRNAs) that reinforce and/or maintain the silenced state of the target RNA. Models of RNA silencing propose that RDRs could use primer-independent and primer-dependent initiation to generate dsRNA from a transcript targeted by primary siRNA or microRNA (miRNA). However, the biochemical activities of RDR proteins are still partly understood. Here, we obtained active recombinant RDR2 and RDR6 in a purified form. We demonstrate that RDR2 and RDR6 have primer-independent and primer-dependent RNA polymerase activities with different efficiencies. We further show that RDR2 and RDR6 can initiate dsRNA synthesis either by elongation of 21- to 24-nucleotides RNAs hybridized to complementary RNA template or by elongation of self-primed RNA template. These findings provide new insights into our understanding of the molecular mechanisms of RNA silencing in plants.	[Devert, Anthony; Fabre, Nicolas; Floris, Maina; Robaglia, Christophe; Crete, Patrice] Aix Marseille Univ, Lab Genet & Biophys Plantes, Marseille, France; [Devert, Anthony; Fabre, Nicolas; Floris, Maina; Robaglia, Christophe; Crete, Patrice] CNRS, UMR Biol Vegetale & Microbiol Environm 7265, Marseille, France; [Devert, Anthony; Fabre, Nicolas; Floris, Maina; Robaglia, Christophe; Crete, Patrice] Commissariat Energie Atom, Dept Sci Vivant, Inst Biol Environm & Biotechnol, Marseille, France; [Canard, Bruno] Aix Marseille Univ, AFMB UMR 7257, Marseille, France; [Canard, Bruno] CNRS, AFMB UMR 7257, Marseille, France	CEA; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Crete, P (corresponding author), Aix Marseille Univ, Lab Genet & Biophys Plantes, Marseille, France.	patrice.crete@univ-amu.fr	Crété, Patrice/A-6400-2015	Canard, Bruno/0000-0003-4924-1991	Agence Nationale de la Recherche [ANR-06-BLAN-0256]; Ecole Doctorale des Sciences de la Vie et de la Sante, Aix-Marseille Universite, Ministere de l'enseignement superieur et de la recherche; Commissariat a l'Energie Atomique, Centre National de la Recherche Scientifique, Aix-Marseille Universite	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ecole Doctorale des Sciences de la Vie et de la Sante, Aix-Marseille Universite, Ministere de l'enseignement superieur et de la recherche; Commissariat a l'Energie Atomique, Centre National de la Recherche Scientifique, Aix-Marseille Universite	This research was supported by a grant from Agence Nationale de la Recherche, ANR-06-BLAN-0256 (to N.F., B.C. and P.C). A.D and M.F were supported by a PhD fellowship from the Ecole Doctorale des Sciences de la Vie et de la Sante, Aix-Marseille Universite, Ministere de l'enseignement superieur et de la recherche. Funding for open access charge: Commissariat a l'Energie Atomique, Centre National de la Recherche Scientifique, Aix-Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bechtold N, 1998, METH MOL B, V82, P259; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Daxinger L, 2009, EMBO J, V28, P48, DOI 10.1038/emboj.2008.260; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Ferrari E, 2008, J BIOL CHEM, V283, P33893, DOI 10.1074/jbc.M803094200; Fukunaga R, 2009, EMBO J, V28, P545, DOI 10.1038/emboj.2009.2; Haag JR, 2012, MOL CELL, V48, P811, DOI 10.1016/j.molcel.2012.09.027; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kumakura N, 2009, FEBS LETT, V583, P1261, DOI 10.1016/j.febslet.2009.03.055; Laurila MRL, 2005, J GEN VIROL, V86, P521, DOI 10.1099/vir.0.80492-0; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Rajeswaran R, 2012, NUCLEIC ACIDS RES, V40, P6241, DOI 10.1093/nar/gks242; Rajeswaran R, 2012, NUCLEIC ACIDS RES, V40, P594, DOI 10.1093/nar/gkr760; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Schwab R, 2010, P NATL ACAD SCI USA, V107, P14945, DOI 10.1073/pnas.1009416107; Simon SA, 2011, CURR OPIN PLANT BIOL, V14, P148, DOI 10.1016/j.pbi.2010.11.007; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Willmann MR, 2011, ARABIDOPSIS BOOK, V9, P1; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zheng Q, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001141; Zheng ZM, 2010, PLANT J, V62, P92, DOI 10.1111/j.1365-313X.2010.04130.x	48	19	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120100	10.1371/journal.pone.0120100	http://dx.doi.org/10.1371/journal.pone.0120100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793874	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200145
J	Korzeniewski, SJ; Allred, E; Logan, JW; Fichorova, RN; Engelke, S; Kuban, KCK; O'Shea, TM; Paneth, N; Holm, M; Dammann, O; Leviton, A				Korzeniewski, Steven J.; Allred, Elizabeth; Logan, J. Wells; Fichorova, Raina N.; Engelke, Stephen; Kuban, Karl C. K.; O'Shea, T. Michael; Paneth, Nigel; Holm, Mari; Dammann, Olaf; Leviton, Alan		ELGAN Study Investigators	Elevated Endogenous Erythropoietin Concentrations Are Associated with Increased Risk of Brain Damage in Extremely Preterm Neonates	PLOS ONE			English	Article							INFLAMMATION-RELATED PROTEINS; GESTATIONAL-AGE; BIRTH-WEIGHT; ANGIOGENESIS; OUTCOMES; INJURY; BLOOD; NEUROPROTECTION; CYTOKINES; CHILDREN	Background We sought to determine, in very preterm infants, whether elevated perinatal erythropoietin (EPO) concentrations are associated with increased risks of indicators of brain damage, and whether this risk differs by the co-occurrence or absence of intermittent or sustained systemic inflammation (ISSI). Methods Protein concentrations were measured in blood collected from 786 infants born before the 28th week of gestation. EPO was measured on postnatal day 14, and 25 inflammation-related proteins were measured weekly during the first 2 postnatal weeks. We defined ISSI as a concentration in the top quartile of each of 25 inflammation-related proteins on two separate days a week apart. Hypererythropoietinemia (hyperEPO) was defined as the highest quartile for gestational age on postnatal day 14. Using logistic regression and multinomial logistic regression models, we compared risks of brain damage among neonates with hyperEPO only, ISSI only, and hyperEPO+ISSI, to those who had neither hyperEPO nor ISSI, adjusting for gestational age. Results Newborns with hyperEPO, regardless of ISSI, were more than twice as likely as those without to have very low (<55) Mental (OR 2.3; 95% CI 1.5-3.5) and/or Psychomotor (OR 2.4; 95% CI 1.6-3.7) Development Indices (MDI, PDI), and microcephaly at age two years (OR 2.4; 95% CI 1.5-3.8). Newborns with both hyperEPO and ISSI had significantly increased risks of ventriculomegaly, hemiparetic cerebral palsy, microcephaly, and MDI and PDI <55 (ORs ranged from 2.2-6.3), but not hypoechoic lesions or other forms of cerebral palsy, relative to newborns with neither hyperEPO nor ISSI. Conclusion hyperEPO, regardless of ISSI, is associated with elevated risks of very low MDI and PDI, and microcephaly, but not with any form of cerebral palsy. Children with both hyperEPO and ISSI are at higher risk than others of very low MDI and PDI, ventriculomegaly, hemiparetic cerebral palsy, and microcephaly.	[Korzeniewski, Steven J.] NICHD, Perinatol Res Branch, NIH, DHHS, Bethesda, MD 20892 USA; [Korzeniewski, Steven J.] NICHD, Perinatol Res Branch, NIH, Detroit, MI USA; [Korzeniewski, Steven J.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Korzeniewski, Steven J.; Paneth, Nigel] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Allred, Elizabeth; Leviton, Alan] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Allred, Elizabeth; Fichorova, Raina N.; Leviton, Alan] Harvard Univ, Sch Med, Boston, MA USA; [Logan, J. Wells] Nationwide Childrens Hosp, Dept Neonatol, Columbus, OH USA; [Fichorova, Raina N.] Brigham & Womens Hosp, Dept Obstet, Boston, MA 02115 USA; [Fichorova, Raina N.] Brigham & Womens Hosp, Dept Gynecol, Boston, MA 02115 USA; [Fichorova, Raina N.] Brigham & Womens Hosp, Dept Reprod Biol, Boston, MA 02115 USA; [Engelke, Stephen] E Carolina Univ, Brody Sch Med, Dept Pediat, Greenville, NC USA; [Kuban, Karl C. K.] Boston Med Ctr, Dept Pediat, Boston, MA USA; [Kuban, Karl C. K.] Boston Univ, Boston, MA 02215 USA; [O'Shea, T. Michael] Wake Forest Univ, Dept Pediat, Winston Salem, NC 27109 USA; [Paneth, Nigel] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [Holm, Mari] Norwegian Univ Sci & Technol, Fac Med, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway; [Holm, Mari; Dammann, Olaf] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Dammann, Olaf] Hannover Med Sch, Neuroepidemiol Unit, Hannover, Germany	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Michigan State University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of North Carolina; East Carolina University; Boston Medical Center; Boston University; Wake Forest University; Michigan State University; Norwegian University of Science & Technology (NTNU); Massachusetts Department of Public Health; Tufts University; Hannover Medical School	Korzeniewski, SJ (corresponding author), NICHD, Perinatol Res Branch, NIH, DHHS, Bethesda, MD 20892 USA.	sKorzeni@med.wayne.edu	Logan, John Wells/I-5715-2019; Korzeniewski, Steven J/U-6481-2017	Korzeniewski, Steven J/0000-0002-8895-6052; Holm, Mari/0000-0003-3968-0851; Fordham, Lynn/0000-0002-0232-0484; Soul, Janet/0000-0001-6998-7753	National Institute of Neurological Disorders and Stroke [5U01NS040069-05, 2R01NS040069-06A2]; National Eye Institute [1-R01-EY021820-01]; National Institute of Child Health and Human Development [5P30HD018655-28]; Wayne State University Perinatal Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS040069] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wayne State University Perinatal Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by The National Institute of Neurological Disorders and Stroke (5U01NS040069-05; 2R01NS040069-06A2), The National Eye Institute (1-R01-EY021820-01), the National Institute of Child Health and Human Development (5P30HD018655-28), and the Wayne State University Perinatal Initiative.	Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; ARNOLD CC, 1991, AM J EPIDEMIOL, V134, P604, DOI 10.1093/oxfordjournals.aje.a116133; Ashley RA, 2002, PEDIATR RES, V51, P472, DOI 10.1203/00006450-200204000-00012; Bayley N, 1993, BAYLEY SCALES INFANT; Bierer R, 2006, PEDIATRICS, V118, pE635, DOI 10.1542/peds.2005-3186; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Byts N, 2009, EXPT TRANSLATIONAL S, V21, P1; CARLINI RG, 1995, KIDNEY INT, V47, P740, DOI 10.1038/ki.1995.113; CDC, 2007, CDC GROWTH CHARTS US; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Contaldo C, 2011, SHOCK, V35, P315, DOI 10.1097/SHK.0b013e3181fd0700; Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Fichorova RN, 2011, MBIO, V2, DOI DOI 10.1128/MBIO.00280-11; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hecht JL, 2011, PEDIATR RES, V69, P68, DOI 10.1203/PDR.0b013e3181fed334; Iwai M, 2007, STROKE, V38, P557; Iwai M, 2010, STROKE, V41, P1032, DOI 10.1161/STROKEAHA.109.570325; Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025; Kuban K, 2007, PEDIATR RADIOL, V37, P1201, DOI 10.1007/s00247-007-0605-z; Kuban KC, 2014, J CHILD NEUROL; Kuban KCK, 2005, J CHILD NEUROL, V20, P829, DOI 10.1177/08830738050200101001; Kumral A, 2007, NEONATOLOGY, V92, P269, DOI 10.1159/000105493; Lee Seung Hun, 2005, Am J Nephrol, V25, P64, DOI 10.1159/000084275; Leviton A, 1999, PEDIATR RES, V46, P566, DOI 10.1203/00006450-199911000-00013; Leviton A, 2013, PEDIATR RES, V73, P362, DOI 10.1038/pr.2012.188; Leviton A, 2011, EARLY HUM DEV, V87, P325, DOI 10.1016/j.earlhumdev.2011.01.043; Leviton A, 2011, J PEDIATR-US, V158, P897, DOI 10.1016/j.jpeds.2010.11.059; Leviton A, 2011, CYTOKINE, V53, P66, DOI 10.1016/j.cyto.2010.09.003; Liu W, 2011, EXP NEUROL, V230, P227, DOI 10.1016/j.expneurol.2011.04.021; Logan JW, 2014, CYTOKINE, V69, P22, DOI 10.1016/j.cyto.2014.04.009; Marti HH, 2000, NEWS PHYSIOL SCI, V15, P225; MASUDA S, 1994, J BIOL CHEM, V269, P19488; McElrath TF, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.010; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; NAGAO M, 1992, BIOCHEM BIOPH RES CO, V188, P888, DOI 10.1016/0006-291X(92)91139-H; Neubauer AP, 2010, ANN NEUROL, V67, P657, DOI 10.1002/ana.21977; O'Shea TM, 2009, EARLY HUM DEV, V85, P719, DOI 10.1016/j.earlhumdev.2009.08.060; O'Shea TM, 2013, BRAIN BEHAV IMMUN, V29, P104, DOI 10.1016/j.bbi.2012.12.012; O'Shea TM, 2012, J PEDIATR-US, V160, P395, DOI 10.1016/j.jpeds.2011.08.069; Ohls RK, 2014, PEDIATRICS, V133, P1023, DOI 10.1542/peds.2013-4307; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; Schultz C, 2008, CLIN EXP IMMUNOL, V154, P187, DOI 10.1111/j.1365-2249.2008.03760.x; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wu YW, 2012, PEDIATRICS, V130, P683, DOI 10.1542/peds.2012-0498; YUDKIN PL, 1987, EARLY HUM DEV, V15, P45, DOI 10.1016/0378-3782(87)90099-5; Zhu CL, 2009, PEDIATRICS, V124, pE218, DOI 10.1542/peds.2008-3553	48	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0115083	10.1371/journal.pone.0115083	http://dx.doi.org/10.1371/journal.pone.0115083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793991	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200003
J	Lee, CT; Kokolus, KM; Leigh, ND; Capitano, M; Hylander, BL; Repasky, EA				Lee, Chen-Ting; Kokolus, Kathleen M.; Leigh, Nicholas D.; Capitano, Maegan; Hylander, Bonnie L.; Repasky, Elizabeth A.			Defining Immunological Impact and Therapeutic Benefit of Mild Heating in a Murine Model of Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; FEBRILE-RANGE TEMPERATURE; LPS-STIMULATED MACROPHAGES; EARLY RHEUMATOID-ARTHRITIS; NECROSIS-FACTOR INHIBITORS; HYPOXIA-INDUCIBLE FACTOR; ALPHA MESSENGER-RNA; FACTOR-KAPPA-B; GENE-EXPRESSION; SYNOVIAL INFLAMMATION	Traditional treatments, including a variety of thermal therapies have been known since ancient times to provide relief from rheumatoid arthritis (RA) symptoms. However, a general absence of information on how heating affects molecular or immunological targets relevant to RA has limited heat treatment (HT) to the category of treatments known as "alternative therapies". In this study, we evaluated the effectiveness of mild HT in a collagen-induced arthritis (CIA) model which has been used in many previous studies to evaluate newer pharmacological approaches for the treatment of RA, and tested whether inflammatory immune activity was altered. We also compared the effect of HT to methotrexate, a well characterized pharmacological treatment for RA. CIA mice were treated with either a single HT for several hours or daily 30 minute HT. Disease progression and macrophage infiltration were evaluated. We found that both HT regimens significantly reduced arthritis disease severity and macrophage infiltration into inflamed joints. Surprisingly, HT was as efficient as methotrexate in controlling disease progression. At the molecular level, HT suppressed TNF-alpha while increasing production of IL-10. We also observed an induction of HSP70 and a reduction in both NF-kappa B and HIF-1 alpha in inflamed tissues. Additionally, using activated macrophages in vitro, we found that HT reduced production of pro-inflammatory cytokines, an effect which is correlated to induction of HSF-1 and HSP70 and inhibition of NF-kappa B and STAT activation. Our findings demonstrate a significant therapeutic benefit of HT in controlling arthritis progression in a clinically relevant mouse model, with an efficacy similar to methotrexate. Mechanistically, HT targets highly relevant anti-inflammatory pathways which strongly support its increased study for use in clinical trials for RA.	[Lee, Chen-Ting; Kokolus, Kathleen M.; Leigh, Nicholas D.; Capitano, Maegan; Hylander, Bonnie L.; Repasky, Elizabeth A.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Repasky, EA (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	elizabeth.repasky@roswellpark.org	Leigh, Nicholas/AAV-6537-2021; Kokolus, Kathleen M./I-8779-2019	Kokolus, Kathleen M./0000-0002-9088-5409; Leigh, Nicholas/0000-0002-6978-6254	National Institutes of Health (NIH) [RO1 CA135368-01A1, NIH CA16056, NIH T32 CA085183]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA135368, T32CA085183] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by National Institutes of Health (NIH) RO1 CA135368-01A1, NIH CA16056, and NIH T32 CA085183. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2003, RHEUMATOL INT, V23, P134, DOI 10.1007/s00296-002-0267-y; Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Capitano ML, 2008, INT J HYPERTHER, V24, P141, DOI 10.1080/02656730701858289; Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Constantin A, 1998, ARTHRITIS RHEUM, V41, P48, DOI 10.1002/1529-0131(199801)41:1<48::AID-ART7>3.0.CO;2-K; Cooper ZA, 2010, CELL STRESS CHAPERON, V15, P665, DOI 10.1007/s12192-010-0179-9; Cooper ZA, 2010, AM J PHYSIOL-CELL PH, V298, pC171, DOI 10.1152/ajpcell.00346.2009; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; ENSOR JE, 1994, AM J PHYSIOL, V266, pC967, DOI 10.1152/ajpcell.1994.266.4.C967; ENSOR JE, 1995, AM J PHYSIOL-CELL PH, V269, pC1140, DOI 10.1152/ajpcell.1995.269.5.C1140; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Gerards AH, 2003, RHEUMATOLOGY, V42, P1189, DOI 10.1093/rheumatology/keg323; Giacomelli R, 2002, CLIN EXP RHEUMATOL, V20, P365; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Hagiwara S, 2007, INFLAMM RES, V56, P297, DOI 10.1007/s00011-007-6161-z; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Kozier B., 2004, FUNDAMENTALS NURSING; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Lin CF, 2008, J CELL BIOCHEM, V105, P746, DOI 10.1002/jcb.21868; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Mariette X, 2011, ANN RHEUM DIS, V70, P1895, DOI 10.1136/ard.2010.149419; McHugh GA, 2007, J CLIN NURS, V16, P168, DOI 10.1111/j.1365-2702.2007.01885.x; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Quattrocchi E, 2001, J IMMUNOL, V166, P5970, DOI 10.4049/jimmunol.166.10.5970; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Rosloniec Edward F, 2001, Curr Protoc Immunol, VChapter 15, DOI [10.1002/0471142735.im1505s89, 10.1002/0471142735.im1505s20]; Schmid KL, 2001, THERMOTHERAPY FOR NE; SCHMIDT KL, 1979, Z RHEUMATOL, V38, P391; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sen A, 2011, CANCER RES, V71, P3872, DOI 10.1158/0008-5472.CAN-10-4482; Shi YZ, 2006, SHOCK, V26, P277, DOI 10.1097/01.shk.0000223134.17877.ad; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Steiner G, 2006, RHEUMATOID ARTHRITIS, P194; Sukenik S, 1997, ISRAEL J MED SCI, V33, P258; Tak PP, 2001, ARTHRITIS RHEUM, V44, P1897, DOI 10.1002/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4; Tas SW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1958; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; TRENTHAM DE, 1982, ARTHRITIS RHEUM, V25, P911, DOI 10.1002/art.1780250801; Verhagen AP, 2003, COCHRANE DB SYST REV, pCD000518; Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279; Whalen JD, 1999, J IMMUNOL, V162, P3625; Wijbrandts CA, 2007, ARTHRITIS RHEUM, V56, P3869, DOI 10.1002/art.22964; Woodrick RS, 2011, NAT REV RHEUMATOL, V7, P639, DOI 10.1038/nrrheum.2011.145; Ye L, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4544; Yildirim N, 2010, J CLIN NURS, V19, P1113, DOI 10.1111/j.1365-2702.2009.03070.x; Zhang HL, 2012, INFLAMMATION, V35, P1558, DOI 10.1007/s10753-012-9471-4	58	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120327	10.1371/journal.pone.0120327	http://dx.doi.org/10.1371/journal.pone.0120327			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793532	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900014
J	Saladie, P; Caceres, I; Huguet, R; Rodriguez-Hidalgo, A; Santander, B; Olle, A; Gabucio, MJ; Martin, P; Marin, J				Saladie, Palmira; Caceres, Isabel; Huguet, Rosa; Rodriguez-Hidalgo, Antonio; Santander, Boris; Olle, Andreu; Joana Gabucio, Ma; Martin, Patricia; Marin, Juan			Experimental Butchering of a Chimpanzee Carcass for Archaeological Purposes	PLOS ONE			English	Article							GRAN DOLINA; OLDUVAI-GORGE; BONE MODIFICATIONS; EARLY PLEISTOCENE; PERCUSSION MARKS; ATAPUERCA BURGOS; MOULA-GUERCY; CUT MARKS; HOMINID; CANNIBALISM	Two archaeological assemblages from the Sierra de Atapuerca sites show evidence of anthropogenic cannibalism. These are the late Early Pleistocene level TD6-2 at Gran Dolina, and the Bronze Age level MIR4 in the Mirador Cave. Despite the chronological distance between these two assemblages, they share the common feature that the human remains exhibit a high frequency of anthropogenic modifications (cut marks, percussion pits and notches and peeling). This frequency could denote special treatment of bodies, or else be the normal result of the butchering process. In order to test these possibilities, we subjected a chimpanzee carcass to a butchering process. The processing was intensive and intended to simulate preparation for consumption. In doing this, we used several simple flakes made from quartzite and chert from quarries in the Sierra de Atapuerca. The skull, long bones, metapodials and phalanges were also fractured in order to remove the brain and bone marrow. As a result, about 40% of the remains showed some kind of human modification. The frequency, distribution and characteristics of these modifications are very similar to those documented on the remains of Homo antecessor from TD6-2. In case of the MIR4 assemblage, the results are similar except in the treatment of skulls. Our results indicate that high frequencies of anthropogenic modifications are common after an intensive butchering process intended to prepare a hominin body for consumption in different contexts (both where there was possible ritual behavior and where this was not the case and the modifications are not the result of special treatment).	[Saladie, Palmira; Caceres, Isabel; Huguet, Rosa; Rodriguez-Hidalgo, Antonio; Santander, Boris; Olle, Andreu; Joana Gabucio, Ma; Martin, Patricia; Marin, Juan] IPHES, Inst Catala Paleoecol Humana & Evolucio Social, Tarragona 43007, Spain; [Saladie, Palmira; Caceres, Isabel; Huguet, Rosa; Rodriguez-Hidalgo, Antonio; Santander, Boris; Olle, Andreu; Joana Gabucio, Ma; Martin, Patricia; Marin, Juan] Univ Rovira & Virgili, Area Prehist, E-43007 Tarragona, Spain; [Saladie, Palmira; Santander, Boris] GQP CG, Grp Quaternario & Prehist Ctr Geociencias Ul & FC, Tomar, Portugal; [Saladie, Palmira; Huguet, Rosa] Museo Ciencias Nat MNCN, Dept Paleobiol, Unit Associated Consejo Super Invest Cient CSIC, Madrid, Spain; [Rodriguez-Hidalgo, Antonio; Marin, Juan] Equipo Primeros Pobladores Extremadura, Caceres, Spain	ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC)	Saladie, P (corresponding author), IPHES, Carrer Marcel Li Domingo S-N,Edifici W3,Campus Se, Tarragona 43007, Spain.	psaladie@iphes.cat	Rodríguez-Hidalgo, Antonio/B-9694-2019; Saladie, Palmira/AAR-7932-2020; Marín, Juan/ABE-1453-2020; Gabucio, Maria Joana/AAH-5586-2019; Cáceres, Isabel/G-2636-2015; Marín, Juan/O-9893-2016; Martín, Patricia/AAH-4903-2019; Rodríguez, Patricia Martín/C-9568-2019; Rodríguez-Hidalgo, Antonio/H-4128-2019; Ollé, Andreu/D-6837-2013; Huguet, Rosa/H-5713-2015; Saladie, Palmira/G-4019-2015	Rodríguez-Hidalgo, Antonio/0000-0002-5449-9287; Marín, Juan/0000-0002-5698-602X; Gabucio, Maria Joana/0000-0002-5061-1825; Cáceres, Isabel/0000-0001-8487-2591; Marín, Juan/0000-0002-5698-602X; Martín, Patricia/0000-0002-8781-7966; Rodríguez, Patricia Martín/0000-0002-8781-7966; Rodríguez-Hidalgo, Antonio/0000-0002-5449-9287; Ollé, Andreu/0000-0002-8643-5536; Saladie, Palmira/0000-0002-1730-8461	Ministry of Economy and Competitiveness (MINECO) of Spain Government [CGL2012-38434-C03-03, HAR2012-32548]; Catalonian Government [SGR2014-899]; Cultural and Tourism Council of Castilla y Leon and Atapuerca Foundation; MINECO [CGL2009-12703-C03-02]; CONICYT-Advanced Human Capital Program (Becas Chile)	Ministry of Economy and Competitiveness (MINECO) of Spain Government; Catalonian Government; Cultural and Tourism Council of Castilla y Leon and Atapuerca Foundation; MINECO(Spanish Government); CONICYT-Advanced Human Capital Program (Becas Chile)	This work was supported by Ministry of Economy and Competitiveness (MINECO) of Spain Government, project no CGL2012-38434-C03-03 and project no HAR2012-32548; and by the Catalonian Government, project no SGR2014-899. Funding for the fieldwork came from Cultural and Tourism Council of Castilla y Leon and Atapuerca Foundation. ARH is beneficiary of a predoctoral research fellowship (FPI) from the MINECO (CGL2009-12703-C03-02). BS is beneficiary of a predoctoral fellowship from CONICYT-Advanced Human Capital Program (Becas Chile 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P., 2003, B NATURAL HIST MUSEU, V58, P59, DOI DOI 10.1017/5096804620300010X; Arsuaga JL, 1997, J HUM EVOL, V33, P109, DOI 10.1006/jhev.1997.0132; Bello SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017026; Bello SM, 2009, J ARCHAEOL SCI, V36, P1869, DOI 10.1016/j.jas.2009.04.014; Berger GW, 2008, J HUM EVOL, V55, P300, DOI 10.1016/j.jhevol.2008.02.012; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; BINFORD LR, 1988, CURR ANTHROPOL, V29, P123, DOI 10.1086/203618; Binford LRB., 1981, ANCIENT MEN MODERN M; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Boulestin B., 1999, BAR INT SERIES, V776; Boulestin B, 2009, ANTIQUITY, V83, P968, DOI 10.1017/S0003598X00099282; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; Caceres I, 2007, AM J PHYS ANTHROPOL, V133, P899, DOI 10.1002/ajpa.20610; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; Carbonell E, 1999, J HUM EVOL, V37, P653, DOI 10.1006/jhev.1999.0336; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carretero JM., 2008, MUNIBE, V59, P67; deCastro JMB, 1997, SCIENCE, V276, P1392; Defleur A, 1999, SCIENCE, V286, P128, DOI 10.1126/science.286.5437.128; Dewbury AG, 2007, J ARCHAEOL SCI, V34, P354, DOI 10.1016/j.jas.2006.05.009; Diez JC, 1999, J HUM EVOL, V37, P623, DOI 10.1006/jhev.1999.0346; Dominguez-Rodrigo M, 2003, EVOL ANTHROPOL, V12, P275, DOI 10.1002/evan.10119; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Dominguez-Rodrigo M, 1999, PALAEOGEOGR PALAEOCL, V149, P373, DOI 10.1016/S0031-0182(98)00213-2; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P884, DOI 10.1016/j.jas.2008.11.007; Egeland CP, 2003, PLAINS ANTHROPOL, V48, P39, DOI 10.1080/2052546.2003.11949279; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; Fernandez-Jalvo Y, 1999, J HUM EVOL, V37, P591, DOI 10.1006/jhev.1999.0324; Fernandez-Jalvo Y, 2011, J HUM EVOL, V60, P117, DOI 10.1016/j.jhevol.2010.08.003; Chacon MG, 2007, BAR INT SER, V1725, P187; Huguet R., 2007, PRIMERAS OCUPACIONES; Lyman RL, 2005, J ARCHAEOL SCI, V32, P1722, DOI 10.1016/j.jas.2005.06.003; LYMAN RL, 1995, J ANTHROPOL ARCHAEOL, V14, P45, DOI 10.1006/jaar.1995.1003; Lyman RL, 2008, CAMB MAN ARCHAEOL, P1, DOI 10.1017/CBO9780511813863; LYMAN RL, 1992, AM ANTIQUITY, V57, P246, DOI 10.2307/280730; Milo RG, 1998, J ARCHAEOL SCI, V25, P99, DOI 10.1006/jasc.1997.0233; Nilssen P.J., 2000, ACTUALISTIC BUTCHERY; Olle A, 2013, QUATERN INT, V295, P138, DOI 10.1016/j.quaint.2011.11.009; Orschiedt J, 2002, SECONDARY BURIAL MAG; Padilla M, 2008, TRANSMISION CULTURAL; Pares JM, 2013, J ARCHAEOL SCI, V40, P4586, DOI 10.1016/j.jas.2013.06.013; PARES JM, 1995, SCIENCE, V269, P830, DOI 10.1126/science.7638599; Pares JM, 1999, J HUM EVOL, V37, P325, DOI 10.1006/jhev.1999.0331; Pickering TR, 2008, J ARCHAEOL SCI, V35, P310, DOI 10.1016/j.jas.2007.03.012; Pickering TR, 2013, J ARCHAEOL SCI, V40, P1295, DOI 10.1016/j.jas.2012.09.025; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Saladie P, 2014, QUATERNARY SCI REV, V93, P47, DOI 10.1016/j.quascirev.2014.04.001; Saladie P, 2013, J ARCHAEOL SCI, V40, P380, DOI 10.1016/j.jas.2012.08.002; Saladie P, 2012, J HUM EVOL, V63, P682, DOI 10.1016/j.jhevol.2012.07.004; Saladie P, 2011, J HUM EVOL, V61, P425, DOI 10.1016/j.jhevol.2011.05.012; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Stiner MC, 2009, P NATL ACAD SCI USA, V106, P13207, DOI 10.1073/pnas.0900564106; Turner C. G., 1983, CARNIVORES HUMAN SCA, P219; Turner CG II, 1999, CANNIBALISM VIOLENCE; Valensi P, 2012, QUATERN INT, V252, P48, DOI 10.1016/j.quaint.2011.07.028; Verges JM., 2002, TRABAJOS PREHIST, V59, P107, DOI [10.3989/tp.2002.v59.i1.213, DOI 10.3989/TP.2002.V59.I1.213]; Verges JM, 2008, ACT 4 C NEOL PEN AL, P418; VILLA P, 1986, SCIENCE, V233, P431, DOI 10.1126/science.233.4762.431; Villa P., 1992, EVOLUTIONARY ANTHR, V1, P93, DOI DOI 10.1002/EVAN.1360010307; White T.D., 1992, PREHISTORIC CANNIBAL	62	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121208	10.1371/journal.pone.0121208	http://dx.doi.org/10.1371/journal.pone.0121208			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CE8HY	25793521	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900113
J	Stax, MJ; Mouser, EEIM; van Montfort, T; Sanders, RW; de Vries, HJC; Dekker, HL; Herrera, C; Speijer, D; Pollakis, G; Paxton, WA				Stax, Martijn J.; Mouser, Emily E. I. M.; van Montfort, Thijs; Sanders, Rogier W.; de Vries, Henry J. C.; Dekker, Henk L.; Herrera, Carolina; Speijer, Dave; Pollakis, Georgios; Paxton, William A.			Colorectal Mucus Binds DC-SIGN and Inhibits HIV-1 Trans-Infection of CD4(+) T-Lymphocytes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SALT-STIMULATED LIPASE; ENVELOPE GLYCOPROTEIN; DENDRITIC CELLS; TRANSMISSION; PROTEIN; LIGAND; GP120	Bodily secretions, including breast milk and semen, contain factors that modulate HIV-1 infection. Since anal intercourse caries one of the highest risks for HIV-1 transmission, our aim was to determine whether colorectal mucus (CM) also contains factors interfering with HIV-1 infection and replication. CM from a number of individuals was collected and tested for the capacity to bind DC-SIGN and inhibit HIV-1 cis- or trans-infection of CD4(+) T-lymphocytes. To this end, a DC-SIGN binding ELISA, a gp140 trimer competition ELISA and HIV-1 capture/transfer assays were utilized. Subsequently we aimed to identify the DC-SIGN binding component through biochemical characterization and mass spectrometry analysis. CM was shown to bind DC-SIGN and competes with HIV-1 gp140 trimer for binding. Pre-incubation of Raji-DC-SIGN cells or immature dendritic cells (iDCs) with CM potently inhibits DC-SIGN mediated trans-infection of CD4(+) T-lymphocytes with CCR5 and CXCR4 using HIV-1 strains, while no effect on direct infection is observed. Preliminary biochemical characterization demonstrates that the component seems to be large (>100kDa), heat and proteinase K resistant, binds in a alpha 1-3 mannose independent manner and is highly variant between individuals. Immunoprecipitation using DC-SIGN-Fc coated agarose beads followed by mass spectrometry indicated lactoferrin (fragments) and its receptor (intelectin-1) as candidates. Using ELISA we showed that lactoferrin levels within CM correlate with DC-SIGN binding capacity. In conclusion, CM can bind the C-type lectin DC-SIGN and block HIV-1 trans-infection of both CCR5 and CXCR4 using HIV-1 strains. Furthermore, our data indicate that lactoferrin is a DC-SIGN binding component of CM. These results indicate that CM has the potential to interfere with pathogen transmission and modulate immune responses at the colorectal mucosa.	[Stax, Martijn J.; Mouser, Emily E. I. M.; van Montfort, Thijs; Sanders, Rogier W.; Pollakis, Georgios; Paxton, William A.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [de Vries, Henry J. C.] Univ Amsterdam, Dept Dermatol, Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Dekker, Henk L.] Univ Amsterdam, Mass Spectrometry Biomacromol, Swammerdam Inst Life Sci, NL-1105 AZ Amsterdam, Netherlands; [Herrera, Carolina] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Infect Dis, London, England; [Speijer, Dave] Univ Amsterdam, Dept Med Biochem, Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Pollakis, Georgios; Paxton, William A.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [de Vries, Henry J. C.] Univ Amsterdam, STI Outpatient Clin, Cluster Infect Dis, Publ Hlth Serv Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University; University of Amsterdam; University of Amsterdam; Imperial College London; University of Amsterdam; University of Liverpool; Public Health Service Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Paxton, WA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands.	w.a.paxton@liverpool.ac.uk	de Vries, Henry/K-5963-2012; Georgios, Pollakis/Y-2341-2019; paxton, william/R-9747-2019; Speijer, Dave/AAE-4613-2019	de Vries, Henry/0000-0001-9784-547X; Speijer, Dave/0000-0002-2340-2753; Paxton, William/0000-0002-2654-5186; Herrera, Carolina/0000-0003-3701-752X; Paxton, William/0000-0001-5200-0801; Pollakis, Georgios/0000-0002-9659-5461	Dutch AIDS fonds grant [2005024]; University of Amsterdam; European Community [41642, 305578]	Dutch AIDS fonds grant; University of Amsterdam; European Community(European Commission)	This work was partly funded through a Dutch AIDS fonds grant (2005024), a SKE grant from the University of Amsterdam (WAP), and two European Community's Seventh Framework Programme Grants [41642 (IDEA) and 305578 (PathCo)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand Kumar BH, 2003, INDIAN J DERMATOL VE, V69, P126; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Buisine MP, 2001, GUT, V49, P544, DOI 10.1136/gut.49.4.544; Carthagena Laetitia, 2011, Open Virol J, V5, P27, DOI 10.2174/1874357901105010027; Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579; Downs JA, 2011, AM J TROP MED HYG, V84, P364, DOI 10.4269/ajtmh.2011.10-0585; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Groot F, 2005, J VIROL, V79, P3009, DOI 10.1128/JVI.79.5.3009-3015.2005; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Herrera C, 2009, ANTIMICROB AGENTS CH, V53, P1797, DOI 10.1128/AAC.01096-08; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Jendrysik MA, 2005, J INFECT DIS, V192, P630, DOI 10.1086/432071; Martellini JA, 2009, FASEB J, V23, P3609, DOI 10.1096/fj.09-131961; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06; NILSSON J, 1990, EUR J BIOCHEM, V192, P543, DOI 10.1111/j.1432-1033.1990.tb19259.x; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sabatte J, 2011, J IMMUNOL, V187, P5299, DOI 10.4049/jimmunol.1101889; Saeland E, 2009, MOL IMMUNOL, V46, P2309, DOI 10.1016/j.molimm.2009.03.025; Stax MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032534; Stax MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017316; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177	29	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122020	10.1371/journal.pone.0122020	http://dx.doi.org/10.1371/journal.pone.0122020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793526	Green Published, gold			2022-12-26	WOS:000352083900167
J	Wojcicki, JM; Young, MB; Perham-Hester, KA; de Schweinitz, P; Gessner, BD				Wojcicki, Janet M.; Young, Margaret B.; Perham-Hester, Katherine A.; de Schweinitz, Peter; Gessner, Bradford D.			Risk Factors for Obesity at Age 3 in Alaskan Children, Including the Role of Beverage Consumption: Results from Alaska PRAMS 2005-2006 and Its Three-Year Follow-Up Survey, CUBS, 2008-2009	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; CHILDHOOD OBESITY; RESPIRATORY-TRACT; WEIGHT-GAIN; OVERWEIGHT; PREGNANCY; ASSOCIATION; WATER; ADOLESCENCE; PREVENTION	Background Prenatal and early life risk factors are associated with childhood obesity. Alaska Native children have one of the highest prevalences of childhood obesity of all US racial/ethnic groups. Methods Using the Pregnancy Risk Assessment Monitoring System (PRAMS) and the follow-up survey at 3 years of age (CUBS), we evaluated health, behavioral, lifestyle and nutritional variables in relation to obesity (95th percentile for body mass index (BMI)) at 3 years of age. Multivariate logistic regression modeling was conducted using Stata 12.0 to evaluate independent risk factors for obesity in non-Native and Alaska Native children. Results We found an obesity prevalence of 24.9% in all Alaskan and 42.2% in Alaska Native 3 year olds. Among Alaska Native children, obesity prevalence was highest in the Northern/Southwest part of the state (51.6%, 95% CI (42.6-60.5)). Independent predictive factors for obesity at age 3 years in Alaska non-Native children were low income (<$10,000 in the year before the child was born (OR 3.94, 95% CI 1.22-17.03) and maternal pre-pregnancy obesity (OR 2.01, 95% CI 1.01-4.01) and longer duration of breastfeeding was protective (OR 0.95, 95% CI 0.91-0.995). Among Alaska Native children, predictive factors were witnessing domestic violence/abuse as a 3 year-old (OR 2.28, 95% CI 1.17-7.60). Among obese Alaska Native children, there was an increased daily consumption of energy dense beverages in the Northern/Southwest region of the state, which may explain higher rates of obesity in this part of the state. Conclusions The high prevalence of obesity in Alaska Native children may be explained by differences in lifestyle patterns and food consumption in certain parts of the state, specifically the Northern/Southwest region, which have higher consumption of energy dense beverages.	[Wojcicki, Janet M.] Univ Calif San Francisco, Dept Pediat GI & Nutr, San Francisco, CA 94143 USA; [Young, Margaret B.; Perham-Hester, Katherine A.] Alaska Div Publ Hlth, Sect Womens Childrens & Family Hlth, Maternal & Child Hlth Epidemiol Unit, Anchorage, AK USA; [de Schweinitz, Peter] Tanana Chiefs Conf, Fairbanks, AK USA; [Gessner, Bradford D.] Agence Med Prevent, Paris, France	University of California System; University of California San Francisco; Agence de Medecine Preventive	Wojcicki, JM (corresponding author), Univ Calif San Francisco, Dept Pediat GI & Nutr, San Francisco, CA 94143 USA.	Wojcicki@gmail.com			National Institutes of Health [NIDDK 080825]; Centers for Disease Control and Prevention [5U01DP003114]; Maternal and Child Health Bureau, Health Resources and Services Administration, Alaska DHHS [B04MC26649]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U01DP003114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007762, K01DK080825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Maternal and Child Health Bureau, Health Resources and Services Administration, Alaska DHHS; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Janet Wojcicki is supported by an National Institutes of Health NIDDK 080825 award. Alaska PRAMS is supported by grant number 5U01DP003114 from the Centers for Disease Control and Prevention. Alaska PRAMS and Alaska CUBS are supported by project B04MC26649 from the Maternal and Child Health Bureau (Title V, Social Security Act), Health Resources and Services Administration, Alaska DHHS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alaska Department of Health and Social Services Obesity Prevention and Control Program, 2013, ALASKA OBESITY FACTS; Anderson SE, 2009, ARCH PEDIAT ADOL MED, V163, P344, DOI 10.1001/archpediatrics.2009.18; Beck LF, 2001, MMWR-MORBID MORTAL W, V51, P1; Boles M, 2012, PREVALENCE OVERWEIGH, V4; Boynton-Jarrett R, 2010, ARCH PEDIAT ADOL MED, V164, P540, DOI 10.1001/archpediatrics.2010.94; Centers for Disease Control and Prevention, 2013, MMWR-MORBID MORTAL W, P426; Cook C, 2010, J MAN MANIP THER, V18, P3, DOI 10.1179/106698110X12595770849362; Demment MM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-417; Dennison BA, 1997, PEDIATRICS, V99, P15; Dubnov-Raz G, 2011, INT J OBESITY, V35, P1295, DOI 10.1038/ijo.2011.130; Eberling S, 2011, RESULTS 2010 2011 SU; Ehrenthal DB, 2013, OBSTET GYNECOL, V121, P115, DOI [10.1097/AOG.0b013e318278f56a, http://10.1097/AOG.0b013e318278f56a]; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fenaughty AM, 2009, CHILDHOOD OBESITY AL; Flores G, 2013, INT J OBESITY, V37, P31, DOI 10.1038/ijo.2012.168; Gessner BD, 2008, J PEDIATR-US, V152, P666, DOI 10.1016/j.jpeds.2007.10.049; Grummer-Strawn LM, 2004, PEDIATRICS, V113, P81; Halpern P., 2007, OBESITY AM INDIAN AL; Hennessy TW, 2008, AM J PUBLIC HEALTH, V98, P2072, DOI 10.2105/AJPH.2007.115618; Heo M, 2011, OBESITY FACTS, V4, P449, DOI 10.1159/000335279; Irigoyen M, 2008, J URBAN HEALTH, V85, P545, DOI 10.1007/s11524-008-9285-8; Jun HJ, 2012, J EPIDEMIOL COMMUN H, V66, P629, DOI 10.1136/jech.2010.110932; Kitsantas P, 2010, EARLY HUM DEV, V86, P563, DOI 10.1016/j.earlhumdev.2010.07.006; LaRowe TL, 2010, J AM DIET ASSOC, V110, P1049, DOI 10.1016/j.jada.2010.04.009; Li Y, 2014, CHILD CARE HLTH DEV; Lindberg SM, 2012, MATERN CHILD HLTH J, V16, P1879, DOI 10.1007/s10995-012-1024-9; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; McFarlane JM, 2003, PEDIATRICS, V112, pE202, DOI 10.1542/peds.112.3.e202; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oken E, 2008, OBSTET GYNECOL, V112, P999, DOI 10.1097/AOG.0b013e31818a5d50; Pak A. W. P., 2005, PREVENTING CHRONIC D, V2, P1; Schiff M, 2014, CHILD ABUSE NEGL; Shulman HB, 2006, PUBLIC HEALTH REP, V121, P74, DOI 10.1177/003335490612100114; Skinner AC, 2013, PUBLIC HLTH REPORTS, V128; Suglia SF, 2012, PEDIATRICS, V129, pE1173, DOI 10.1542/peds.2011-2456; Surkan PJ, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065664; Weden MM, 2013, AM J EPIDEMIOL, V178, P461, DOI 10.1093/aje/kws477; Wojcicki JM, 2012, AM J PUBLIC HEALTH, V102, P1630, DOI 10.2105/AJPH.2012.300719; Wojcicki JM, 2010, NEW ENGL J MED, V362, P1457, DOI 10.1056/NEJMp1001857; Young M. B., 2011, ALASKA MATERNAL CHIL	41	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118711	10.1371/journal.pone.0118711	http://dx.doi.org/10.1371/journal.pone.0118711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793411	Green Submitted, gold, Green Published			2022-12-26	WOS:000352084200033
J	Xue, YJ; Wu, LN; Liu, YN; Ma, YY; Zhang, LJ; Ma, XM; Yang, Y; Chen, JF				Xue, Yijun; Wu, Lina; Liu, Yinan; Ma, Yuanyuan; Zhang, Lijian; Ma, Xuemei; Yang, Yue; Chen, Jinfeng			ENTPD5 Induces Apoptosis in Lung Cancer Cells via Regulating Caspase 3 Expression	PLOS ONE			English	Article							GROWTH-FACTOR; PROGNOSIS; METAANALYSIS; ASSOCIATION; RESISTANCE; CARCINOMA; FAMILY; TUMORS; AKT; P53	This study is to investigate the relationship between ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5) expression and lung cancer clinicopathological factors, and the impact of ENTPD5 on lung cancer cell functions. Lung cancer specimens and matched adjacent normal tissues were obtained from patients without any preoperative radiotherapy or chemotherapy. Knockdown of ETNPD5 expression led to significantly decreased lung cancer cell growth rate, markedly increased apoptosis and the ability to repair, and significantly reduced invasion. Gene chip tests showed that knockdown of ENTPD5 expression caused more Caspase expression. Quantitative real-time polymerase chain reaction showed that the Caspase 3 expression was significantly increased after the knockdown of ENTPD5. In addition, immunohistochemistry showed that the tumor growth marker, proliferating cell nuclear antigen, was significantly reduced in the knockdown model. Tumorigenicity assay and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay showed that the apoptosis of lung cancer cells was increased in the knockdown model. Our results suggest that ENTPD5 affects lung cancer apoptosis via Caspase 3 pathway, and can be potentially used to monitor prognosis or to guide appropriate therapeutic regimens.	[Xue, Yijun; Ma, Xuemei] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100022, Peoples R China; [Wu, Lina] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Cent Lab, Beijing 100142, Peoples R China; [Xue, Yijun; Liu, Yinan; Ma, Yuanyuan; Zhang, Lijian; Yang, Yue; Chen, Jinfeng] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Surg 2, Beijing 100142, Peoples R China	Beijing University of Technology; Peking University; Peking University	Chen, JF (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Surg 2, Beijing 100142, Peoples R China.	chenjinfengdoctor@163.com			Beijing Science New Star Plan [Z11111005450000]; National Natural Science Foundation of China [81101598]	Beijing Science New Star Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Science New Star Plan (No. Z11111005450000) and National Natural Science Foundation of China (No. 81101598).	Alzahouri K, 2006, EUR J CANCER CARE, V15, P348, DOI 10.1111/j.1365-2354.2006.00665.x; Beckenkamp A, 2014, BIOCHEM CELL BIOL, V92, P95, DOI 10.1139/bcb-2013-0051; Blanquez MJ, 2004, INT J ONCOL, V25, P821; Blanquez MJ, 2002, MOL CARCINOGEN, V35, P186, DOI 10.1002/mc.10091; Burke L, 2005, CLIN CANCER RES, V11, P232; Curry NL, 2013, CANCER DISCOV, V3, P908, DOI 10.1158/2159-8290.CD-12-0507; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Galluzzi L, 2012, ONCOGENE, V31, P2805, DOI 10.1038/onc.2011.459; Grote HJ, 2006, CANCER CYTOPATHOL, V108, P129, DOI 10.1002/cncr.21717; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirami Y, 2004, CANCER LETT, V214, P157, DOI 10.1016/j.canlet.2004.04.028; Horeweg N, 2014, EXPERT REV RESP MED, P1; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Kim SJ, 2005, LUNG CANCER, V49, P325, DOI 10.1016/j.lungcan.2005.03.036; Ludovini V, 2004, LUNG CANCER, V46, P77, DOI 10.1016/j.lungcan.2004.03.018; MacCarthy CM, 2013, INT J ONCOL, V43, P1244, DOI 10.3892/ijo.2013.2052; Meert AP, 2002, EUR RESPIR J, V20, P975, DOI 10.1183/09031936.02.00296502; Nakamura H, 2005, CANCER-AM CANCER SOC, V103, P1865, DOI 10.1002/cncr.20957; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Planque C, 2010, CLIN CHEM, V56, P987, DOI 10.1373/clinchem.2009.138917; Regadera J, 2006, INT J ONCOL, V28, P595; Shen Z, 2011, COLD SH Q B, V76, P217, DOI 10.1101/sqb.2011.76.010876; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; Villar J, 2009, CANCER RES, V69, P102, DOI 10.1158/0008-5472.CAN-08-2922; Wu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070839; Yoshino I, 2001, Ann Thorac Cardiovasc Surg, V7, P204; Zadran S, 2012, TUMOR BIOL, V33, P2411, DOI 10.1007/s13277-012-0505-1	27	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120046	10.1371/journal.pone.0120046	http://dx.doi.org/10.1371/journal.pone.0120046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794010	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200138
J	Liu, HP; Cheng, Y; Du, B; Tong, CF; Liang, SL; Han, SY; Zheng, SP; Lin, Y				Liu, Huiping; Cheng, Yu; Du, Bing; Tong, Chaofan; Liang, Shuli; Han, Shuangyan; Zheng, Suiping; Lin, Ying			Overexpression of a Novel Thermostable and Chloride-Tolerant Laccase from Thermus thermophilus SG0.5JP17-16 in Pichia pastoris and Its Application in Synthetic Dye Decolorization	PLOS ONE			English	Article							BIOCHEMICAL-CHARACTERIZATION; BACILLUS-LICHENIFORMIS; MULTICOPPER OXIDASE; PURIFICATION; EXPRESSION; BIODEGRADATION; HYDROCARBONS; EVOLUTION; BACTERIAL; CLONING	Laccases have been used for the decolorization and detoxification of synthetic dyes due to their ability to oxidize a wide variety of dyes with water as the sole byproduct. A putative laccase gene (LacTT) from Thermus thermophilus SG0.5JP17-16 was screened using the genome mining approach, and it was highly expressed in Pichia pastoris, yielding a high laccase activity of 6130 U/L in a 10-L fermentor. The LacTT open reading frame encoded a protein of 466 amino acid residues with four putative Cu-binding regions. The optimal pH of the recombinant LacTT was 4.5, 6.0, 7.5 and 8.0 with 2,2 '-azino-bis(3-ethylbenzothazoline-6-sulfonic acid) (ABTS), syringaldazine (SGZ), guaiacol, and 2,6-dimethoxyphenol (2,6-DMP) as the substrate, respectively. The optimal temperature of LacTT was 90 degrees C with guaiacol as the substrate. LacTT was highly stable at pH 4.0-11.0 and thermostable at 40 degrees C-90 degrees C, confirming that it is a pH-stable and thermostable laccase. Furthermore, LacTT also exhibited high tolerance to halides such as NaCl, NaBr and NaF, and decolorized 100%, 94%, 94% and 73% of Congo Red, Reactive Black B and Reactive Black WNN, and Remazol Brilliant Blue R, respectively. Interestingly, addition of high concentration of NaCl increased the RBBR decolorization efficiency of LacTT. These results suggest that LacTT is a good candidate for industrial applications such as dyestuff processing and degradation of dyes in textile wastewaters.	[Liu, Huiping; Cheng, Yu; Tong, Chaofan; Liang, Shuli; Han, Shuangyan; Zheng, Suiping; Lin, Ying] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Du, Bing] South China Agr Univ, Coll Food Sci & Engn, Guangzhou 510642, Guangdong, Peoples R China	South China University of Technology; South China Agricultural University	Lin, Y (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China.	feylin@scut.edu.cn		Ying, Lin/0000-0001-8686-7868	Natural Science Foundation of Guangdong province [2008A010900002, 2010A010500003]	Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This study was supported by Natural Science Foundation of Guangdong province (2008A010900002 and 2010A010500003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bello M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040700; Camarero S, 2012, APPL ENVIRON MICROB, V78, P1370, DOI 10.1128/AEM.07530-11; Champagne PP, 2013, APPL MICROBIOL BIOT, V97, P6263, DOI 10.1007/s00253-012-4525-y; Damasceno LM, 2012, APPL MICROBIOL BIOT, V93, P31, DOI 10.1007/s00253-011-3654-z; Das N, 2001, J BASIC MICROB, V41, P261, DOI 10.1002/1521-4028(200110)41:5&lt;261::AID-JOBM261&gt;3.0.CO;2-V; Freixo MD, 2008, PROCESS BIOCHEM, V43, P1265, DOI 10.1016/j.procbio.2008.07.013; Dwivedi UN, 2011, J MOL CATAL B-ENZYM, V68, P117, DOI 10.1016/j.molcatb.2010.11.002; Fan B, 2013, J SOIL SEDIMENT, V13, P1232, DOI 10.1007/s11368-013-0705-3; Fang ZM, 2012, BIORESOURCE TECHNOL, V111, P36, DOI 10.1016/j.biortech.2012.01.172; Fang Z, 2011, APPL MICROBIOL BIOT, V89, P1103, DOI 10.1007/s00253-010-2934-3; Forootanfar H, 2011, BIORESOURCE TECHNOL, V102, P1808, DOI 10.1016/j.biortech.2010.09.043; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Hsu CA, 2012, ENVIRON SCI TECHNOL, V46, P5109, DOI 10.1021/es2047014; Kiiskinen LL, 2002, APPL MICROBIOL BIOT, V59, P198, DOI 10.1007/s00253-002-1012-x; Kim H, 2012, APPL BIOCHEM BIOTECH, V166, P159, DOI 10.1007/s12010-011-9412-y; Kittl R, 2012, J BIOTECHNOL, V157, P304, DOI 10.1016/j.jbiotec.2011.11.021; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kumar P, 2007, J HAZARD MATER, V149, P26, DOI 10.1016/j.jhazmat.2007.03.051; Lin-Cereghino J, 2008, YEAST, V25, P293, DOI 10.1002/yea.1587; Lu L, 2013, BIORESOURCE TECHNOL, V134, P81, DOI 10.1016/j.biortech.2013.02.015; Lu L, 2012, BIORESOURCE TECHNOL, V115, P35, DOI 10.1016/j.biortech.2011.07.111; Mate D, 2010, CHEM BIOL, V17, P1030, DOI 10.1016/j.chembiol.2010.07.010; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Mohammadian M, 2010, J IND MICROBIOL BIOT, V37, P863, DOI 10.1007/s10295-010-0734-5; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065633; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Santhanam N, 2011, TRENDS BIOTECHNOL, V29, P480, DOI 10.1016/j.tibtech.2011.04.005; Serrano-Posada H, 2011, ACTA CRYSTALLOGR F, V67, P1595, DOI 10.1107/S174430911103805X; Si J, 2013, BIORESOURCE TECHNOL, V128, P49, DOI 10.1016/j.biortech.2012.10.085; Sun YF, 2012, APPL MICROBIOL BIOT, V96, P1539, DOI 10.1007/s00253-012-4264-0; Wong KS, 2012, BIORESOURCE TECHNOL, V104, P157, DOI 10.1016/j.biortech.2011.10.097; Ye M, 2010, APPL MICROBIOL BIOT, V87, P1023, DOI 10.1007/s00253-010-2507-5; Zhao XL, 2013, PROCESS BIOCHEM, V48, P1317, DOI 10.1016/j.procbio.2013.06.021	39	18	26	13	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119833	10.1371/journal.pone.0119833	http://dx.doi.org/10.1371/journal.pone.0119833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790466	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400109
J	Wolfe, K; Graba-Landry, A; Dworjanyn, SA; Byrne, M				Wolfe, Kennedy; Graba-Landry, Alexia; Dworjanyn, Symon A.; Byrne, Maria			Larval Starvation to Satiation: Influence of Nutrient Regime on the Success of Acanthaster planci	PLOS ONE			English	Article							OF-THORNS STARFISH; GREAT-BARRIER-REEF; FOOD-LIMITED GROWTH; WATER-QUALITY; POPULATION-DYNAMICS; SEA-URCHINS; CORAL COVER; OUTBREAKS; METAMORPHOSIS; LAGOON	High density populations of the crown-of-thorns seastar, Acanthaster planci, are a major contributor to the decline of coral reefs, however the causes behind periodic outbreaks of this species are not understood. The enhanced nutrients hypothesis posits that pulses of enhanced larval food in eutrophic waters facilitate metamorphic success with a flow-on effect for population growth. The larval resilience hypothesis suggests that Acanthaster planci larvae naturally thrive in tropical oligotrophic waters. Both hypotheses remain to be tested empirically. We raised Acanthaster planci larvae in a range of food regimes from starvation (no food) to satiation (excess food). Algal cell concentration and chlorophyll levels were used to reflect phytoplankton conditions in nature for oligotrophic waters (0-100 cells ml(-1); 0-0.01 mu g chl a L-1), natural background levels of nutrients on the Great Barrier Reef (GBR) (1,000-10,000 cells ml(-1); 0.1-1.0 mu g chl a L-1), and enhanced eutrophic conditions following runoff events (100,000 cells ml(-1); 10 mu g chl a L-1). We determine how these food levels affected larval growth and survival, and the metamorphic link between larval experience and juvenile quality (size) in experiments where food ration per larvae was carefully controlled. Phytoplankton levels of 1 mu g chl a L-1, close to background levels for some reefs on the GBR and following flood events, were optimal for larval success. Development was less successful above and below this food treatment. Enhanced larval performance at 1 mu g chl a L-1 provides empirical support for the enhanced nutrients hypothesis, but up to a limit, and emphasizes the need for appropriate mitigation strategies to reduce eutrophication and the consequent risk of Acanthaster planci outbreaks.	[Wolfe, Kennedy; Byrne, Maria] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Graba-Landry, Alexia; Dworjanyn, Symon A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW 2450, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney; Southern Cross University; University of Sydney	Wolfe, K (corresponding author), Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.	kennedywolfe90@gmail.com	Dworjanyn, Symon A/O-5633-2017; Graba-Landry, Alexia/AAF-5862-2020; Byrne, Maria/K-6355-2016	Dworjanyn, Symon A/0000-0002-6690-8033; Graba-Landry, Alexia/0000-0002-1176-2321; Byrne, Maria/0000-0002-8902-9808; Wolfe, Kennedy/0000-0002-9502-6769				ALLISON GW, 1994, MAR BIOL, V118, P255, DOI 10.1007/BF00349792; BABCOCK RC, 1992, AUST J MAR FRESH RES, V43, P525; Baird AH, 2013, CORAL REEFS; BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Brodie J, 2007, MAR FRESHWATER RES, V58, P342, DOI 10.1071/MF06236; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Devlin M, 2001, GBRMPA RES PUBLICATI, V68; Done TJ, 1997, GREAT BARRIER REEF M, V846, P97; Dove SG, 2013, PNAS; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Dworjanyn SA, 2008, AQUACULTURE, V274, P268, DOI 10.1016/j.aquaculture.2007.11.030; Endean R, 1969, REPORT INVESTIGATION; Engelhardt U., 1997, GREAT BARRIER REEF S; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; FENAUX L, 1994, LIMNOL OCEANOGR, V39, P84, DOI 10.4319/lo.1994.39.1.0084; FURNAS MJ, 1986, CONT SHELF RES, V6, P363, DOI 10.1016/0278-4343(86)90078-6; GEORGE SB, 1994, ECHINODERMS THROUGH TIME, P297; George SB, 1996, OCEANOL ACTA, V19, P297; George SB, 1999, J EXP MAR BIOL ECOL, V237, P203, DOI 10.1016/S0022-0981(98)00205-6; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Haynes D, 2001, GREAT BARRIER REEF W; Haynes D, 2007, ENVIRON MANAGE, V40, P993, DOI 10.1007/s00267-007-9009-y; Hock K, 2014, J APPL ECOL; HOEGHGULDBERG O, 1994, MAR BIOL, V120, P55; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JOHNSON CR, 1994, MAR BIOL, V120, P305, DOI 10.1007/BF00349692; Kamya PZ, 2014, GLOBAL CHANGE BIOL, V20, P3365, DOI 10.1111/gcb.12530; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; KEESING JK, 1992, AUST J MAR FRESH RES, V43, P635; Lamare MD, 2001, MAR ECOL PROG SER, V218, P153, DOI 10.3354/meps218153; Lane DJW, 2012, J MAR BIOL ASSOC UK, V92, P803, DOI 10.1017/S0025315411000890; Lourey MJ, 2000, MAR ECOL PROG SER, V196, P179, DOI 10.3354/meps196179; LUCAS JS, 1982, J EXP MAR BIOL ECOL, V65, P173, DOI 10.1016/0022-0981(82)90043-0; Miller BA, 1999, J EXP MAR BIOL ECOL, V235, P67, DOI 10.1016/S0022-0981(98)00164-6; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Nakamura M, 2014, MAR BIOL, V161, P2521, DOI 10.1007/s00227-014-2524-5; Okaji K, 1997, CORAL REEFS, V16, P47, DOI 10.1007/s003380050058; Okaji K, 1996, THESIS; OLSON RR, 1989, ANNU REV ECOL SYST, V20, P225; OLSON RR, 1987, LIMNOL OCEANOGR, V32, P895, DOI 10.4319/lo.1987.32.4.0895; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pace DA, 2007, J EXP MAR BIOL ECOL, V353, P89, DOI 10.1016/j.jembe.2007.09.005; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; PAULAY G, 1985, J EXP MAR BIOL ECOL, V93, P1, DOI 10.1016/0022-0981(85)90145-5; Pechenik JA, 1996, J EXP MAR BIOL ECOL, V199, P137; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; PECHENIK JA, 1993, MAR BIOL, V115, P287, DOI 10.1007/BF00346346; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Quinn GP, 2003, EXPT DESIGN DATA ANA; SAMMARCO PW, 1984, MAR BIOL, V82, P167, DOI 10.1007/BF00394100; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Seymour RM, 1999, MAR ECOL PROG SER, V176, P1, DOI 10.3354/meps176001; STRATHMANN RR, 1992, EVOLUTION, V46, P972, DOI 10.1111/j.1558-5646.1992.tb00613.x; STRATHMANN RR, 1993, BIOL BULL, V185, P232, DOI 10.2307/1542003; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Uthicke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082938; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Vine P, 1973, ATOLL RES BULL, V166; Wallace RB, 2014, ESTUAR COAST SHELF S; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009; Yamaguchi M., 1973, P369; YAMAGUCHI M, 1974, PAC SCI, V28, P123	68	51	52	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122010	10.1371/journal.pone.0122010	http://dx.doi.org/10.1371/journal.pone.0122010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790074	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400205
J	Bagheri-Yarmand, R; Sinha, KM; Gururaj, AE; Ahmed, Z; Rizvi, YQ; Huang, SC; Ladbury, JE; Bogler, O; Williams, MD; Cote, GJ; Gagel, RF				Bagheri-Yarmand, Rozita; Sinha, Krishna M.; Gururaj, Anupama E.; Ahmed, Zamal; Rizvi, Yasmeen Q.; Huang, Su-Chen; Ladbury, John E.; Bogler, Oliver; Williams, Michelle D.; Cote, Gilbert J.; Gagel, Robert F.			A Novel Dual Kinase Function of the RET Proto-oncogene Negatively Regulates Activating Transcription Factor 4-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY-THYROID-CARCINOMA; ENDOPLASMIC-RETICULUM STRESS; RECEPTOR TYROSINE KINASES; BREAST-CANCER CELLS; FACTOR 4 ATF4; ER-STRESS; NEUROTROPHIC FACTOR; UP-REGULATION; BCL-2 FAMILY; LUNG-CANCER	The RET proto-oncogene, a tyrosine kinase receptor, is widely known for its essential role in cell survival. Germ line missense mutations, which give rise to constitutively active oncogenic RET, were found to cause multiple endocrine neoplasia type 2, a dominant inherited cancer syndrome that affects neuroendocrine organs. However, the mechanisms by which RET promotes cell survival and prevents cell death remain elusive. We demonstrate that in addition to cytoplasmic localization, RET is localized in the nucleus and functions as a tyrosine-threonine dual specificity kinase. Knockdown of RET by shRNA in medullary thyroid cancer-derived cells stimulated expression of activating transcription factor 4 (ATF4), a master transcription factor for stress-induced apoptosis, through activation of its target proapoptotic genes NOXA and PUMA. RET knockdown also increased sensitivity to cisplatin-induced apoptosis. We observed that RET physically interacted with and phosphorylated ATF4 at tyrosine and threonine residues. Indeed, RET kinase activity was required to inhibit the ATF4-dependent activation of the NOXA gene because the site-specific substitution mutations that block threonine phosphorylation increased ATF4 stability and activated its targets NOXA and PUMA. Moreover, chromatin immunoprecipitation assays revealed that ATF4 occupancy increased at the NOXA promoter in TT cells treated with tyrosine kinase inhibitors or the ATF4 inducer eeyarestatin as well as in RET-depleted TT cells. Together these findings reveal RET as a novel dual kinase with nuclear localization and provide mechanisms by which RET represses the proapoptotic genes through direct interaction with and phosphorylation-dependent inactivation of ATF4 during the pathogenesis of medullary thyroid cancer.	[Bagheri-Yarmand, Rozita; Sinha, Krishna M.; Rizvi, Yasmeen Q.; Huang, Su-Chen; Cote, Gilbert J.; Gagel, Robert F.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA; [Gururaj, Anupama E.; Bogler, Oliver] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Ahmed, Zamal; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ahmed, Zamal; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Williams, Michelle D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Bagheri-Yarmand, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Unit 1461,1515 Holcombe Blvd, Houston, TX 77030 USA.	ryarmand@mdanderson.org		Williams, Michelle D./0000-0002-9133-7332; Bogler, Oliver/0000-0002-3700-0480; Ladbury, John/0000-0002-6328-7200; Bagheri-Yarmand, Rozita/0000-0001-5139-6381	American Thyroid Association; Kosberg Foundation; National Institutes of Health Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA168505] Funding Source: NIH RePORTER	American Thyroid Association; Kosberg Foundation; National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an American Thyroid Association research grant (to R. B.Y.) and by a Kosberg Foundation grant (to R. F. G.). This work was also supported, in whole or in part, by National Institutes of Health Cancer Center Support Grant CA016672 (to the University of Texas M.D. Anderson Cancer Center).	Ahmed Z, 2013, J CELL BIOL, V200, P493, DOI 10.1083/jcb.201204106; Ahmed Z, 2010, CELL SIGNAL, V22, P23, DOI 10.1016/j.cellsig.2009.08.011; Ampofo E, 2013, BBA-MOL CELL RES, V1833, P439, DOI 10.1016/j.bbamcr.2012.10.025; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Ballerini P, 2012, LEUKEMIA, V26, P2384, DOI 10.1038/leu.2012.109; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; COOLEY LD, 1995, CANCER GENET CYTOGEN, V80, P138, DOI 10.1016/0165-4608(94)00185-E; Diaz-Beya M, 2013, LEUKEMIA, V27, P595, DOI 10.1038/leu.2012.278; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Drosten M, 2004, JNCI-J NATL CANCER I, V96, P1231, DOI 10.1093/jnci/djh226; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Frank CL, 2010, J BIOL CHEM, V285, P33324, DOI 10.1074/jbc.M110.140699; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gattelli A, 2013, EMBO MOL MED, V5, P1335, DOI 10.1002/emmm.201302625; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Kawai K, 2000, CANCER RES, V60, P5254; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Nakajima W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.6; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Nikiforov YE, 1997, CANCER RES, V57, P1690; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohshima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010279; Parthasarathy R, 1999, CANCER RES, V59, P3911; Pike LRG, 2013, BIOCHEM J, V449, P389, DOI 10.1042/BJ20120972; Portella G, 1996, ONCOGENE, V13, P2021; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Richardson DS, 2012, MOL BIOL CELL, V23, P3838, DOI 10.1091/mbc.E12-02-0114; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Velasco JA, 1997, INT J CANCER, V73, P449, DOI 10.1002/(SICI)1097-0215(19971104)73:3<449::AID-IJC21>3.0.CO;2-6; Vitagliano D, 2011, ENDOCR-RELAT CANCER, V18, P1, DOI 10.1677/ERC-09-0292; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zeng Q, 2008, J INT MED RES, V36, P656, DOI 10.1177/147323000803600406; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152; Zhu W, 2010, J CLIN ENDOCR METAB, V95, P439, DOI 10.1210/jc.2009-1485	52	34	35	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11749	11761		10.1074/jbc.M114.619833	http://dx.doi.org/10.1074/jbc.M114.619833			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25795775	hybrid, Green Published			2022-12-26	WOS:000353719400047
J	Lim, SY; Tyan, YS; Chao, YP; Nien, FY; Weng, JC				Lim, Seong Yong; Tyan, Yeu-Sheng; Chao, Yi-Ping; Nien, Fang-Yu; Weng, Jun-Cheng			New Insights into the Developing Rabbit Brain Using Diffusion Tensor Tractography and Generalized q-Sampling MRI	PLOS ONE			English	Article							WHITE-MATTER DEVELOPMENT; CEREBRAL-PALSY; MATURATION; MODEL; COEFFICIENT; CHILDHOOD; CHILDREN; INFANTS	The use of modern neuroimaging methods to characterize the complex anatomy of brain development at different stages reveals an enormous wealth of information in understanding this highly ordered process and provides clues to detect neurological and neurobehavioral disorders that have their origin in early structural and functional cerebral maturation. Non-invasive diffusion tensor magnetic resonance imaging (DTI) is able to distinguish cerebral microscopic structures, especially in the white matter regions. However, DTI is unable to resolve the complicated neural structure, i.e., the fiber crossing that is frequently observed during the maturation process. To overcome this limitation, several methods have been proposed. One such method, generalized q-sampling imaging (GQI), can be applied to a variety of datasets, including the single shell, multi-shell or grid sampling schemes that are believed to be able to resolve the complicated crossing fibers. Rabbits have been widely used for neurodevelopment research because they exhibit human-like timing of perinatal brain white matter maturation. Here, we present a longitudinal study using both DTI and GQI to demonstrate the changes in cerebral maturation of in vivo developing rabbit brains over a period of 40 weeks. Fractional anisotropy (FA) of DTI and generalized fractional anisotropy (GFA) of GQI indices demonstrated that the white matter anisotropy increased with age, with GFA exhibiting an increase in the hippocampus as well. Normalized quantitative anisotropy (NQA) of GQI also revealed an increase in the hippocampus, allowing us to observe the changes in gray matter as well. Regional and whole brain DTI tractography also demonstrated refinement in fiber pathway architecture with maturation. We concluded that DTI and GQI results were able to characterize the white matter anisotropy changes, whereas GQI provided further information about the gray matter hippocampus area. This developing rabbit brain DTI and GQI database could also be used for educational purposes and neuroscience investigations.	[Lim, Seong Yong; Tyan, Yeu-Sheng; Nien, Fang-Yu; Weng, Jun-Cheng] Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan; [Tyan, Yeu-Sheng; Weng, Jun-Cheng] Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung 40201, Taiwan; [Tyan, Yeu-Sheng] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chao, Yi-Ping] Chang Gung Univ, Grad Inst Med Mechatron, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chang Gung University	Weng, JC (corresponding author), Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan.	jcweng@csmu.edu.tw	Chao, Yi-Ping/GOP-0833-2022	Chao, Yi-Ping/0000-0002-1681-5410	Ministry of Science and Technology, Taipei, Taiwan [NSC102-2320-B-040-002, NSC101-2320-B-040-001]; Chung Shan Medical University, Taichung, Taiwan [CSMU-INT-103-08]	Ministry of Science and Technology, Taipei, Taiwan; Chung Shan Medical University, Taichung, Taiwan	This study was supported in part by the research programs NSC102-2320-B-040-002 and NSC101-2320-B-040-001, sponsored by the Ministry of Science and Technology, Taipei, Taiwan, and the intramural research program CSMU-INT-103-08 of the Chung Shan Medical University, Taichung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; BARKOVICH AJ, 1988, RADIOLOGY, V166, P173, DOI 10.1148/radiology.166.1.3336675; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Callaghan PT, 1993, PRINCIPLES NUCL MAGN, P438; D'Arceuil H, 2008, DEV NEUROSCI-BASEL, V30, P262, DOI 10.1159/000110503; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Drobyshevsky A, 2007, J CEREBR BLOOD F MET, V27, P270, DOI 10.1038/sj.jcbfm.9600333; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Fukunaga M, 2010, P NATL ACAD SCI USA, V107, P3834, DOI 10.1073/pnas.0911177107; Glenn OA, 2003, J MAGN RESON IMAGING, V18, P641, DOI 10.1002/jmri.10420; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Huppi PS, 1998, PEDIATR RES, V44, P584; Jin T, 2008, NEUROIMAGE, V41, P801, DOI 10.1016/j.neuroimage.2008.03.014; Khachaturian MH, 2007, MAGN RESON MED, V57, P289, DOI 10.1002/mrm.21090; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Rutherford MA, 2005, PEDIATRICS, V116, P1001, DOI 10.1542/peds.2005-0328; Saadani-Makki F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.090; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Weng JC, 2007, MAGN RESON IMAGING, V25, P78, DOI 10.1016/j.mri.2006.08.018; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126	30	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119932	10.1371/journal.pone.0119932	http://dx.doi.org/10.1371/journal.pone.0119932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798595	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300093
J	Morino, M; Nukina, K; Sakaguchi, H; Maeda, T; Takahara, M; Shiomi, Y; Nishitani, H				Morino, Masayuki; Nukina, Kohei; Sakaguchi, Hiroki; Maeda, Takeshi; Takahara, Michiyo; Shiomi, Yasushi; Nishitani, Hideo			Mitotic UV Irradiation Induces a DNA Replication-Licensing Defect that Potentiates G1 Arrest Response	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; S-PHASE; CDT1 PROTEOLYSIS; DAMAGE RESPONSE; RE-REPLICATION; FISSION YEAST; CELL-CYCLE; PIP BOX; PROTEINS; PCNA	Cdt1 begins to accumulate in M phase and has a key role in establishing replication licensing at the end of mitosis or in early G1 phase. Treatments that damage the DNA of cells, such as UV irradiation, induce Cdt1 degradation through PCNA-dependent CRL4-Cdt2 ubiquitin ligase. How Cdt1 degradation is linked to cell cycle progression, however, remains unclear. In G1 phase, when licensing is established, UV irradiation leads to Cdt1 degradation, but has little effect on the licensing state. In M phase, however, UV irradiation does not induce Cdt1 degradation. When mitotic UV-irradiated cells were released into G1 phase, Cdt1 was degraded before licensing was established. Thus, these cells exhibited both defective licensing and G1 cell cycle arrest. The frequency of G1 arrest increased in cells expressing extra copies of Cdt2, and thus in cells in which Cdt1 degradation was enhanced, whereas the frequency of G1 arrest was reduced in cell expressing an extra copy of Cdt1. The G1 arrest response of cells irradiated in mitosis was important for cell survival by preventing the induction of apoptosis. Based on these observations, we propose that mammalian cells have a DNA replication-licensing checkpoint response to DNA damage induced during mitosis.	[Morino, Masayuki; Nukina, Kohei; Sakaguchi, Hiroki; Maeda, Takeshi; Takahara, Michiyo; Shiomi, Yasushi; Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan	University of Hyogo	Nishitani, H (corresponding author), Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan.	hideon@sci.u-hyogo.ac.jp		Nishitani, Hideo/0000-0001-5907-9380	JSPS KAKENHI [23131512, 25131718, 26291025, 25430171]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by Grant-in-Aid for Scientific Research on Innovative Area (JSPS KAKENHI Grant Number 23131512 and 25131718) and by Grants-in-Aid for Basic Scientific Research (B) (JSPS KAKENHI Number 26291025) to HN, and by Grants-in-Aid for Basic Scientific Research (C) (JSPS KAKENHI Number 25430171) to YS.	Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Araujo SJ, 2000, GENE DEV, V14, P349; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Chandrasekaran S, 2011, MOL CELL BIOL, V31, P4405, DOI 10.1128/MCB.06163-11; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Feng H, 2003, CELL CYCLE, V2, P431, DOI 10.4161/cc.2.5.527; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Havens CG, 2012, J BIOL CHEM; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Ishii T, 2010, J BIOL CHEM, V285, P41993, DOI 10.1074/jbc.M110.161661; Jascur T, 2011, J BIOL CHEM, V286, P29531, DOI 10.1074/jbc.M111.221341; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Lau E, 2009, MOL BIOL CELL, V20, P3953, DOI 10.1091/mbc.E09-01-0022; Liu PJ, 2009, CELL CYCLE, V8, P125, DOI 10.4161/cc.8.1.7528; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Miotto B, 2011, MOL CELL, V44, P62, DOI 10.1016/j.molcel.2011.06.021; Morino M, 2014, METHODS MOL BIOL, V1170, P529, DOI 10.1007/978-1-4939-0888-2_29; Nevis KR, 2009, CELL CYCLE, V8, P1952, DOI 10.4161/cc.8.12.8811; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Peterson SE, 2011, J CELL BIOL, V194, P705, DOI 10.1083/jcb.201103103; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Roukos V, 2011, J CELL SCI, V124, P422, DOI 10.1242/jcs.074229; Sakaguchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046480; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Seo YR, 2002, ONCOGENE, V21, P731, DOI 10.1038/sj.onc.1205129; Shiomi Y, 2012, MOL CELL BIOL, V32, P2279, DOI 10.1128/MCB.06506-11; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Stathopoulou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034621; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120553	10.1371/journal.pone.0120553	http://dx.doi.org/10.1371/journal.pone.0120553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798850	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300154
J	Yune, HY; Chung, SP; Park, YS; Chung, HS; Lee, HS; Lee, JW; Park, JW; You, JS; Park, I; Lee, HS				Yune, Ho Young; Chung, Sung Phil; Park, Yoo Seok; Chung, Hyun Soo; Lee, Hye Sun; Lee, Jong Wook; Park, Jong Woo; You, Je Sung; Park, Incheol; Lee, Hahn Shick			Delta Neutrophil Index as a Promising Prognostic Marker in Out of Hospital Cardiac Arrest	PLOS ONE			English	Article							MORTALITY; CARDIOPULMONARY; RESUSCITATION; DIAGNOSIS	Background The post-resuscitation phase after out-of-hospital cardiac arrest (OHCA) is characterised by a systemic inflammatory response (e.g., severe sepsis), for which the immature granulocyte count is a diagnostic marker. In this study we evaluated the prognostic significance of the delta neutrophil index (DNI), which is the difference in leukocyte subfractions as assessed by an automated blood cell analyser, for early mortality after OHCA. Materials and Methods OHCA records from the emergency department cardiac arrest registry were retrospectively analysed. Patients who survived at least 24 h after return of spontaneous circulation were included in the analysis. We evaluated mortality and cerebral performance category scores at 30 days. Results A total of 83 patients with OHCA were included in the study. Our results showed that DNI >8.4% on day 1 (hazard ratio [HR], 3.227; 95% CI, 1.485-6.967; p = 0.001) and DNI >10.5% on day 2 (HR, 3.292; 95% CI, 1.662-6.519; p<0.001) were associated with increased 30-day mortality in patients with OHCA. Additionally, DNI >8.4% on day 1 (HR, 2.718; 95% CI, 1.508-4.899; p<0.001) and DNI >10.5% on day 2 (HR, 1.709; 95% CI, 1.051-2.778; p = 0.02) were associated with worse neurologic outcomes 30 days after OHCA. Conclusion A higher DNI is a promising prognostic marker for 30-day mortality and neurologic outcomes after OHCA. Our findings indicate that patients with elevated DNI values after OHCA might be closely monitored so that appropriate treatment strategies can be implemented.	[Yune, Ho Young; Chung, Sung Phil; Park, Yoo Seok; Chung, Hyun Soo; You, Je Sung; Park, Incheol; Lee, Hahn Shick] Yonsei Univ, Coll Med, Dept Emergency Med, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Unit, Seoul, South Korea; [Lee, Jong Wook] Jincheon Sungmo Hosp, Dept Lab Med, Jincheon, South Korea; [Park, Jong Woo] Changwon Fatima Hosp, Dept Emergency Med, Chang Won, South Korea; [You, Je Sung] Kangwon Natl Univ, Grad Sch Med, Dept Emergency Med, Chunchon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Kangwon National University	You, JS (corresponding author), Yonsei Univ, Coll Med, Dept Emergency Med, Seoul, South Korea.	youjsmd@yuhs.ac	; Lee, Hye Sun/J-2154-2015; Chung, Sung Phil/F-8344-2016	You, Je Sung/0000-0002-2074-6745; Park, Incheol/0000-0001-7033-766X; Lee, Hye Sun/0000-0001-6328-6948; Chung, Sung Phil/0000-0002-3074-011X; Park, Yoo Seok/0000-0003-1543-4664	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2009391]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2009391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Engel H, 2013, RESUSCITATION, V84, P776, DOI 10.1016/j.resuscitation.2013.01.029; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Ha SO, 2015, SCAND J CLIN LAB INV, V75, P36, DOI 10.3109/00365513.2014.965736; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; Kim HW, 2012, SCAND J INFECT DIS, V44, P475, DOI 10.3109/00365548.2012.657232; Kim J, 2013, RESUSCITATION, V84, P48, DOI 10.1016/j.resuscitation.2012.09.003; Kim J, 2012, RESUSCITATION, V83, P1248, DOI 10.1016/j.resuscitation.2012.01.038; Lim TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086884; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Park BH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-299; Pyo JY, 2013, LUPUS, V22, P1102, DOI 10.1177/0961203313499957; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Seok Y, 2012, SHOCK, V37, P242, DOI 10.1097/SHK.0b013e3182454acf; Vincent JL, 2014, CLIN EXP EMERG MED, V1, P3, DOI 10.15441/ceem.14.005	19	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120677	10.1371/journal.pone.0120677	http://dx.doi.org/10.1371/journal.pone.0120677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798609	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300163
J	Boix, N; Teixido, E; Vila-Cejudo, M; Ortiz, P; Ibanez, E; Llobet, JM; Barenys, M				Boix, Nuria; Teixido, Elisabet; Vila-Cejudo, Marta; Ortiz, Pedro; Ibanez, Elena; Llobet, Juan M.; Barenys, Marta			Triclabendazole Sulfoxide Causes Stage-Dependent Embryolethality in Zebrafish and Mouse In Vitro	PLOS ONE			English	Article							WHOLE-EMBRYO CULTURE; DEVELOPMENTAL TOXICITY; ALBENDAZOLE SULFOXIDE; METABOLITES; DISPOSITION; FLUBENDAZOLE; FASCIOLIASIS; OXFENDAZOLE; KINETICS; FOOD	Background Fascioliasis and paragonimiasis are widespread foodborne trematode diseases, affecting millions of people in more than 75 countries. The treatment of choice for these parasitic diseases is based on triclabendazole, a benzimidazole derivative which has been suggested as a promising drug to treat pregnant women and children. However, at the moment, this drug is not approved for human use in most countries. Its potential adverse effects on embryonic development have been scarcely studied, and it has not been assigned a pregnancy category by the FDA. Thus, to help in the process of risk-benefit decision making upon triclabendazole treatment during pregnancy, a better characterization of its risks during gestation is needed. Methodology The zebrafish embryo test, a preimplantation and a postimplantation rodent whole embryo culture were used to investigate the potential embryotoxicity/teratogenicity of triclabendazole and its first metabolite triclabendazole sulfoxide. Albendazole and albendazole sulfoxide were included as positive controls. Principal Findings Triclabendazole was between 10 and 250 times less potent than albendazole in inducing dysmorphogenic effects in zebrafish or postimplantation rodent embryos, respectively. However, during the preimplantation period, both compounds, triclabendazole and triclabendazole sulfoxide, induced a dose-dependent embryolethal effect after only 24 h of exposure in rodent embryos and zebrafish (lowest observed adverse effect concentrations = 10 mu M). Conclusions/Significance In humans, after ingestion of the recommended doses of triclabendazole to treat fascioliasis and paragonimiasis (10 mg/kg), the main compound found in plasma is triclabendazole sulfoxide (maximum concentration 38.6 mu M), while triclabendazole concentrations are approximately 30 times lower (1.16 mu M). From our results it can be concluded that triclabendazole, at concentrations of the same order of magnitude as the clinically relevant ones, does not entail teratogenic potential in vitro during the organogenesis period, but its first metabolite triclabendazole sulfoxide has a high embryotoxic capacity in vitro during the preimplantation stage.	[Boix, Nuria; Teixido, Elisabet; Llobet, Juan M.; Barenys, Marta] Univ Barcelona, Fac Pharm, Pharmacol & Therapeut Chem Dept, GRET CERETOX INSA UB & Toxicol Unit, Barcelona, Spain; [Teixido, Elisabet] Univ Autonoma Barcelona, Fac Biociencies, Dept Genet Microbiol, Grp Mutagenesi, Bellaterra, Spain; [Vila-Cejudo, Marta; Ibanez, Elena] Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular, Bellaterra, Spain; [Ortiz, Pedro] Univ Nacl Cajamarca, Fac Ciencias Vet, Cajamarca, Peru; [Barenys, Marta] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany	University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Universidad Nacional de Cajamarca; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Barenys, M (corresponding author), Univ Barcelona, Fac Pharm, Pharmacol & Therapeut Chem Dept, GRET CERETOX INSA UB & Toxicol Unit, Barcelona, Spain.	marta.barenys@iuf-duesseldorf.de	Llobet, Juan M/F-7775-2016; Ibáñez, Elena/K-4320-2014; Teixido, Elisabet/P-2823-2015	Ibáñez, Elena/0000-0002-0275-6958; Teixido, Elisabet/0000-0002-0146-876X; Ortiz, Pedro/0000-0001-8846-777X; Vila Cejudo, Marta/0000-0002-3138-2668; Barenys, Marta/0000-0001-5046-9796	University of Barcelona [MCI2011D]; Generalitat de Catalunya [2014 SGR566, 2014 SGR524]; Universitat Autonoma de Barcelona	University of Barcelona; Generalitat de Catalunya(Generalitat de Catalunya); Universitat Autonoma de Barcelona	Funding: Funding for this work was provided by the University of Barcelona, with the International Cooperation and Development project MCI2011D. The Toxicology Unit of the University of Barcelona and the Cellular Biology unit of the Biosciences Faculty of the Universitat Autonoma de Barcelona were financially supported by the Generalitat de Catalunya (2014 SGR566 and 2014 SGR524, respectively). MVC received a predoctoral scholarship from the Universitat Autonoma de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZBUJIDOS ML, 1993, COMP BIOCHEM PHYS C, V106, P805, DOI 10.1016/0742-8413(93)90245-G; Barenys M, 2012, REPROD TOXICOL, V34, P57, DOI 10.1016/j.reprotox.2012.02.001; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Bogan JA, 1988, P 4 C EUR ASS VET PH, P159; Capece BPS, 2003, VET J, V165, P266, DOI 10.1016/S1090-0233(02)00158-2; Carlsson G, 2011, REPROD TOXICOL, V32, P129, DOI 10.1016/j.reprotox.2011.05.015; Ceballos L, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-8; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Cristofol C, 1997, TOXICOL APPL PHARM, V144, P56, DOI 10.1006/taap.1997.8114; de Jong E, 2011, TOXICOL APPL PHARM, V253, P103, DOI 10.1016/j.taap.2011.03.014; DELATOUR P, 1984, J VET PHARMACOL THER, V7, P139, DOI 10.1111/j.1365-2885.1984.tb00890.x; Eckardt K, 2012, REPROD TOXICOL, V34, P378, DOI 10.1016/j.reprotox.2012.05.037; El-Makawy A, 2006, REPROD NUTR DEV, V46, P139, DOI 10.1051/rnd:2006007; El-Tantawy WH, 2007, PHARM WORLD SCI, V29, P190, DOI 10.1007/s11096-006-9069-8; Fairweather I, 2009, J HELMINTHOL, V83, P139, DOI 10.1017/S0022149X09321173; Flick B, 2006, CURR PHARM DESIGN, V12, P1467, DOI 10.2174/138161206776389822; Flick B, 2009, TOXICOL APPL PHARM, V237, P154, DOI 10.1016/j.taap.2009.02.024; HENNESSY DR, 1987, J VET PHARMACOL THER, V10, P64, DOI 10.1111/j.1365-2885.1987.tb00078.x; HOPKINS DR, 1992, AM J TROP MED HYG, V46, P626, DOI 10.4269/ajtmh.1992.46.626; Hurtt ME, 2003, FOOD CHEM TOXICOL, V41, P611, DOI 10.1016/S0278-6915(02)00326-5; Imperiale F, 2011, FOOD ADDIT CONTAM A, V28, P438, DOI 10.1080/19440049.2010.551422; Keiser J, 2005, EXPERT OPIN INV DRUG, V14, P1513, DOI 10.1517/13543784.14.12.1513; KLUG S, 1985, ARCH TOXICOL, V58, P84, DOI 10.1007/BF00348314; Kohler P, 2001, INT J PARASITOL, V31, P336, DOI 10.1016/S0020-7519(01)00131-X; Lecaillon JB, 1998, BRIT J CLIN PHARMACO, V45, P601, DOI 10.1046/j.1365-2125.1998.00725.x; Longo M, 2013, REPROD TOXICOL, V36, P78, DOI 10.1016/j.reprotox.2012.12.004; MANTOVANI A, 1995, REPROD TOXICOL, V9, P265, DOI 10.1016/0890-6238(95)00008-X; Mattsson A, 2012, REPROD TOXICOL, V34, P31, DOI 10.1016/j.reprotox.2012.02.007; Mestorino N, 2008, VET RES COMMUN, V32, P21, DOI 10.1007/s11259-007-9000-3; Ministerio de Salud y Desarrollo Social. Junta revisora de productos farmaceuticos, 2004, MIN SAL DES SOC B; Nagel R., 2002, ALTEX, V19, P37; OFORIADJEI D, 2008, INT J RISK SAF MED, V20, P113, DOI DOI 10.3233/JRS-2008-0440; Organisation of Economic Co-operation and Development, 2013, GUID TEST CHEM TEST; Piersma AH, 2002, INVITTOX PROTOCOL 12; Richard-Lenoble D, 2003, Med Trop (Mars), V63, P491; Stitt AW, 1996, PARASITOL RES, V82, P333, DOI 10.1007/s004360050122; Teixido E, 2013, TOXICOL IN VITRO, V27, P469, DOI 10.1016/j.tiv.2012.07.010; Teruel MT, 2003, VET HUM TOXICOL, V45, P131; WHITTAKER SG, 1991, TOXICOL APPL PHARM, V109, P73, DOI 10.1016/0041-008X(91)90192-H; WHITTAKER SG, 1992, TOXICOL APPL PHARM, V113, P144, DOI 10.1016/0041-008X(92)90019-O; World Health Organization, 1993, TOX EV CERT VET DRUG; World Health Organization, 2006, WHO INF M US TRICL F; World Health Organization, 2011, REP WHO EXP CONS FOO; YOSHIMURA H, 1987, TOXICOLOGY, V43, P283, DOI 10.1016/0300-483X(87)90087-4; Yoshimura H, 2003, REPROD TOXICOL, V17, P377, DOI 10.1016/S0890-6238(03)00033-9	45	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121308	10.1371/journal.pone.0121308	http://dx.doi.org/10.1371/journal.pone.0121308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793498	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900122
J	Burke, SD; Seaward, AVC; Ramshaw, H; Smith, GN; Virani, S; Croy, BA; Lima, PDA				Burke, Suzanne D.; Seaward, Alexandra V. C.; Ramshaw, Heather; Smith, Graeme N.; Virani, Sophia; Croy, Barbara A.; Lima, Patricia D. A.			Homing Receptor Expression Is Deviated on CD56(+) Blood Lymphocytes during Pregnancy in Type 1 Diabetic Women	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; NK CELLS; IL-7; PREECLAMPSIA; CD56(BRIGHT); RECRUITMENT; UTERUS; INFLAMMATION; TROPHOBLASTS; TRAFFICKING	Type 1 Diabetes Mellitus (T1DM) is characterized by an augmented pro-inflammatory immune state. This contributes to the increased risk for gestational complications observed in T1DM mothers. In normal pregnancies, critical immunological changes occur, including the massive recruitment of lymphocytes, particularly CD56(bright) NK cells, into early decidua basalis and a 2(nd) trimester shift towards Type 2 immunity. Decidual CD56bright NK cells arise at least partly from circulating progenitors expressing adhesion molecules SELL and ITGA4 and the chemokine receptors CXCR3 and CXCR4. In vitro studies show that T1DM reduces interactions between blood CD56(+) NK cells and decidual endothelial cells by reducing SELL and ITGA4- based interactions. To address the mechanisms by which specific lymphocyte subsets may be recruited from the circulation during pregnancy and whether these mechanisms are altered in T1DM, flow cytometry was used to examine eight peripheral blood lymphocyte subsets (Type 1 (IL18R1(+)) and Type 2 (IL1RL1(+)) CD56(bright) NK, CD56(dim) NK, NKT and T cells) from control and T1DM women. Blood was collected serially over pregnancy and postpartum, and lymphocytes were compared for expression of homing receptors SELL, ITGA4, CXCR3, and CXCR4. The decline of Type 1/Type 2 immune cells in normal pregnancy was driven by an increase in Type 2 cells that did not occur in T1DM. CD56(bright) NK cells from control women had the highest expression of all four receptors with greatest expression in 2nd trimester. At this time, these receptors were expressed at very low levels by CD56(bright) NK cells from TIDM patients. Type 1/Type 2 NKT cell ratios were not influenced by either pregnancy or TIDM. Our results suggest that T1DM alters immunological balances during pregnancy with its greatest impact on CD56(bright) NK cells. This implicates CD56(bright) NK cells in diabetic pregnancy complications.	[Burke, Suzanne D.; Seaward, Alexandra V. C.; Virani, Sophia; Croy, Barbara A.; Lima, Patricia D. A.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Ramshaw, Heather; Smith, Graeme N.] Queens Univ, Dept Obstet & Gynecol, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Lima, PDA (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	limapda@gmail.com	Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523; Burke, Suzanne/0000-0003-4594-4163	Canadian Institutes for Health Research [CIHR MOP 77519]; Canada Research Chairs Program; Canada Doctoral Fellowship from CIHR	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canada Doctoral Fellowship from CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (CIHR MOP 77519) and the Canada Research Chairs Program (BAC). SDB was supported by a Canada Doctoral Fellowship from CIHR (CIHR: http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2009, J IMMUNOL, V182, P6951, DOI 10.4049/jimmunol.0803340; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Borzychowski AM, 2005, EUR J IMMUNOL, V35, P3054, DOI 10.1002/eji.200425929; Bulmer JN, 2005, MOL IMMUNOL, V42, P511, DOI 10.1016/j.molimm.2004.07.035; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Carlino C, 2008, BLOOD, V111, P3108, DOI 10.1182/blood-2007-08-105965; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Chan WL, 2001, J IMMUNOL, V167, P1238, DOI 10.4049/jimmunol.167.3.1238; Chantakru S, 2003, J IMMUNOL, V171, P4011, DOI 10.4049/jimmunol.171.8.4011; Chantakru S, 2002, J IMMUNOL, V168, P22, DOI 10.4049/jimmunol.168.1.22; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Chen ZL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102293; Cimbro R, 2012, BLOOD, V120, P2610, DOI 10.1182/blood-2012-06-434779; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Frey M, 1998, J IMMUNOL, V161, P400; GISMONDI A, 1991, J IMMUNOL, V146, P384; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Holmes VA, 2013, DIABETES CARE, V36, P3671, DOI 10.2337/dc13-0944; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; Lash GE, 2011, HUM REPROD, V26, P2289, DOI 10.1093/humrep/der198; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Lima PDA, 2014, CELL MOL IMMUNOL, V11, P522, DOI 10.1038/cmi.2014.63; Male V, 2010, J IMMUNOL, V185, P3913, DOI 10.4049/jimmunol.1001637; Michaud A, 2010, J IMMUNOTHER, V33, P382, DOI 10.1097/CJI.0b013e3181cd872d; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; Oboki K, 2011, ALLERGY ASTHMA IMMUN, V3, P81, DOI 10.4168/aair.2011.3.2.81; Peralta CG, 2008, J LEUKOCYTE BIOL, V84, P1065, DOI 10.1189/jlb.0308164; Rahmati M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102286; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4; Rutella S, 2005, J IMMUNOL, V175, P7085, DOI 10.4049/jimmunol.175.11.7085; Saito S, 1999, CLIN EXP IMMUNOL, V117, P550; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Schmitt N, 2003, J VIROL, V77, P5784, DOI 10.1128/JVI.77.10.5784-5793.2003; Seaward AVC, 2011, HUM REPROD, V26, P1675, DOI 10.1093/humrep/der114; Sentman CL, 2004, J IMMUNOL, V173, P6760, DOI 10.4049/jimmunol.173.11.6760; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Srikhajon K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.114975; Taylor R, 2007, BMJ-BRIT MED J, V334, P742, DOI 10.1136/bmj.39154.700417.BE; Tognarelli S, 2014, J IMMUNOL, V192, P3399, DOI 10.4049/jimmunol.1301508; Tokmadzic VS, 2002, AM J REPROD IMMUNOL, V48, P191, DOI 10.1034/j.1600-0897.2002.01132.x; Vacca P, 2011, TRENDS IMMUNOL, V32, P517, DOI 10.1016/j.it.2011.06.013; van den Heuvel MJ, 2008, AM J REPROD IMMUNOL, V59, P90, DOI 10.1111/j.1600-0897.2007.00546.x; van den Heuvel MJ, 2007, AM J REPROD IMMUNOL, V58, P447, DOI 10.1111/j.1600-0897.2007.00529.x; van den Heuvel MJ, 2005, AM J REPROD IMMUNOL, V54, P322, DOI 10.1111/j.1600-0897.2005.00336.x; Vehik K, 2013, CURR DIABETES REP, V13, P642, DOI 10.1007/s11892-013-0406-8; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Vince GS, 1996, J REPROD IMMUNOL, V32, P101, DOI 10.1016/S0165-0378(96)00995-3; Wallace AE, 2013, AM J PATHOL, V183, P1853, DOI 10.1016/j.ajpath.2013.08.023; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438; Williams PJ, 2009, REPRODUCTION, V138, P177, DOI 10.1530/REP-09-0007; Wu X, 2005, J IMMUNOL, V175, P61, DOI 10.4049/jimmunol.175.1.61; Yu Y, 2009, DIABETOLOGIA, V52, P160, DOI 10.1007/s00125-008-1182-x; Zhang JH, 2009, PLACENTA, V30, P968, DOI 10.1016/j.placenta.2009.08.011; Zhang Y, 2007, IMMUNOLOGY, V121, P258, DOI 10.1111/j.1365-2567.2007.02573.x	58	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119526	10.1371/journal.pone.0119526	http://dx.doi.org/10.1371/journal.pone.0119526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793768	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200091
J	Contreras-Ruiz, L; Masli, S				Contreras-Ruiz, Laura; Masli, Sharmila			Immunomodulatory Cross-Talk between Conjunctival Goblet Cells and Dendritic Cells	PLOS ONE			English	Article							TGF-BETA; EPITHELIAL-CELLS; CROHNS-DISEASE; MURINE MODEL; T-CELLS; THROMBOSPONDIN-1; EXPRESSION; PEPTIDE; TEAR; INFLAMMATION	Goblet cells are secretory epithelial cells of mucosal tissues that confer protection from environmental agents or pathogens via expression and secretion of soluble mucins. Loss of these cells is associated with several chronic inflammatory disorders of the mucosa. Although demonstrated to transfer antigens from the luminal surface to stromal cells in the intestinal mucosa, it is not known if goblet cells contribute to the regulation of an immune response. In this study we report that similar to intestinal and respiratory mucosal epithelia, mouse ocular surface epithelia predominantly express the TGF-beta 2 isoform. Specifically, we demonstrate the ability of goblet cells to express TGF-beta 2 and increase it in response to Toll-Like Receptor 4 mediated stimulus in cultures. Goblet cells not only express TGF-beta 2, but are also able to activate it in a thrombospondin-1 (TSP-1) dependent manner via their cell surface receptor CD36. Furthermore, goblet cell derived soluble factors that possibly include TGF-beta 2, alter dendritic cell (DC) phenotype to a tolerogenic type by downregulating DC expression of MHC class II and co-stimulatory molecules CD80, CD86 and CD40. Thus our study demonstrates goblet cells as a cellular source of active TGF-beta 2 in ocular mucosa and implicates their immunomodulatory function in maintaining mucosal immune homeostasis.	[Contreras-Ruiz, Laura; Masli, Sharmila] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA	Boston University	Masli, S (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.	smasli@bu.edu			National Eye Institute Grant [EY015472]; NATIONAL EYE INSTITUTE [R01EY015472] Funding Source: NIH RePORTER	National Eye Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by National Eye Institute Grant EY015472 (https://www.nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Balzar S, 2005, J ALLERGY CLIN IMMUN, V115, P110, DOI 10.1016/j.jaci.2004.09.034; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Contreras-Ruiz L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/636812; Contreras-Ruiz L, 2014, OPHTHALMOLOGY, V121, P1389, DOI 10.1016/j.ophtha.2014.01.033; Contreras-Ruiz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075937; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Egan RM, 2000, J IMMUNOL, V164, P4543, DOI 10.4049/jimmunol.164.9.4543; Ezzie ME, 2011, AM J RESP CELL MOL, V44, P556, DOI 10.1165/rcmb.2009-0019OC; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Gandhi NB, 2013, J LEUKOCYTE BIOL, V94, P1293, DOI 10.1189/jlb.1012524; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; GILBARD JP, 1990, OPHTHALMOLOGY, V97, P308; Gipson IK, 1998, ADV EXP MED BIOL, V438, P221; Benito MJ, 2013, EXP EYE RES, V107, P88, DOI 10.1016/j.exer.2012.11.017; Kasper M, 2002, CLIN EXP ALLERGY, V32, P1251, DOI 10.1046/j.1365-2745.2002.01423.x; Khandelwal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064193; Knop N, 2000, INVEST OPHTH VIS SCI, V41, P1270; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Leonardi A, 2011, CLIN EXP ALLERGY, V41, P52, DOI 10.1111/j.1365-2222.2010.03626.x; Leonardi A, 2006, GRAEF ARCH CLIN EXP, V244, P1240, DOI 10.1007/s00417-006-0285-7; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04; Nakamura T, 2001, INVEST OPHTH VIS SCI, V42, P549; Pflugfelder SC, 2008, CORNEA, V27, P64, DOI 10.1097/ICO.0b013e318158f6dc; Punekar S, 2008, PATHOBIOLOGY, V75, P9, DOI 10.1159/000113790; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; Reinoso R, 2012, MUCOSAL IMMUNOL, V5, P455, DOI 10.1038/mi.2012.27; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Schaumburg CS, 2014, INVEST OPHTHALMOL VI, V55; Siebelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082355; Tesseur I, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-15; Thompson HGR, 2006, AM J PHYSIOL-LUNG C, V291, pL1277, DOI 10.1152/ajplung.00057.2006; TSENG SCG, 1984, OPHTHALMOLOGY, V91, P545; Turpie B, 2009, AM J PATHOL, V175, P1136, DOI 10.2353/ajpath.2009.081058; Wen FQ, 2002, AM J RESP CELL MOL, V26, P484, DOI 10.1165/ajrcmb.26.4.4784; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Yamaguchi Y, 1997, STEM CELLS, V15, P144, DOI 10.1002/stem.150144; Yehualaeshet T, 1999, AM J PATHOL, V155, P841, DOI 10.1016/S0002-9440(10)65183-8	40	57	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120284	10.1371/journal.pone.0120284	http://dx.doi.org/10.1371/journal.pone.0120284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793763	gold, Green Submitted, Green Published			2022-12-26	WOS:000352083900008
J	Grabinski, TM; Kneynsberg, A; Manfredsson, FP; Kanaan, NM				Grabinski, Tessa M.; Kneynsberg, Andrew; Manfredsson, Fredric P.; Kanaan, Nicholas M.			A Method for Combining RNAscope In Situ Hybridization with Immunohistochemistry in Thick Free-Floating Brain Sections and Primary Neuronal Cultures	PLOS ONE			English	Article							SIGNAL AMPLIFICATION; NUCLEIC-ACID; RAT MODEL; SENSITIVITY; MOLECULES; INCREASE; TISSUES	In situ hybridization (ISH) is an extremely useful tool for localizing gene expression and changes in expression to specific cell populations in tissue samples across numerous research fields. Typically, a research group will put forth significant effort to design, generate, validate and then utilize in situ probes in thin or ultrathin paraffin embedded tissue sections. While combining ISH and IHC is an established technique, the combination of RNAscope ISH, a commercially available ISH assay with single transcript sensitivity, and IHC in thick free-floating tissue sections has not been described. Here, we provide a protocol that combines RNAscope ISH with IHC in thick free-floating tissue sections from the brain and allows simultaneous co-localization of genes and proteins in individual cells. This approach works well with a number of ISH probes (e.g. small proline-rich repeat 1a, beta III-tubulin, tau, and beta-actin) and IHC antibody stains (e.g. tyrosine hydroxylase, beta III-tubulin, NeuN, and glial fibrillary acidic protein) in rat brain sections. In addition, we provide examples of combining ISH-IHC dual staining in primary neuron cultures and double-ISH labeling in thick free-floating tissue sections from the brain. Finally, we highlight the ability of RNAscope to detect ectopic DNA in neurons transduced with viral vectors. RNAscope ISH is a commercially available technology that utilizes a branched or "tree" in situ method to obtain ultrasensitive, single transcript detection. Immunohistochemistry is a tried and true method for identifying specific protein in cell populations. The combination of a sensitive and versatile oligonucleotide detection method with an established and versatile protein assay is a significant advancement in studies using free-floating tissue sections.	[Grabinski, Tessa M.; Kneynsberg, Andrew; Manfredsson, Fredric P.; Kanaan, Nicholas M.] Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA	Michigan State University; Michigan State University College of Human Medicine	Kanaan, NM (corresponding author), Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA.	Nicholas.kanaan@hc.msu.edu	Manfredsson, Fredric/GMI-5876-2022; Kanaan, Nicholas M./J-3428-2016	Manfredsson, Fredric/0000-0001-5802-5487; Kanaan, Nicholas M./0000-0002-4362-2593; Kneynsberg, Andrew/0000-0001-7321-9415	National Institutes of Health/National Institute of Neurological Disorders and Stroke [P50 NS058830]; Saint Mary's Doran Foundation Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082730, P50NS058830] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Saint Mary's Doran Foundation Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke funded Morris K. Udall Center for Excellence in Parkinson's disease research (P50 NS058830) at Michigan State University, as well as the Saint Mary's Doran Foundation Research Fund (NMK).	Andras SC, 2001, MOL BIOTECHNOL, V19, P29, DOI 10.1385/MB:19:1:029; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; CACCAMO D, 1989, LAB INVEST, V60, P390; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; GENDELMAN HE, 1985, J VIROL METHODS, V11, P93, DOI 10.1016/0166-0934(85)90033-3; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Jin L, 1997, J CLIN LAB ANAL, V11, P2, DOI 10.1002/(SICI)1098-2825(1997)11:1<2::AID-JCLA2>3.0.CO;2-F; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; KERSTENS HMJ, 1995, J HISTOCHEM CYTOCHEM, V43, P347, DOI 10.1177/43.4.7897179; Komminoth P, 1997, HISTOCHEM CELL BIOL, V108, P325, DOI 10.1007/s004180050173; Kwon S, 2013, BMB REP, V46, P65, DOI 10.5483/BMBRep.2013.46.2.016; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Mabruk MJEMF, 2004, EXPERT REV MOL DIAGN, V4, P653, DOI 10.1586/14737159.4.5.653; Manfredsson FP, 2007, EXP NEUROL, V207, P289, DOI 10.1016/j.expneurol.2007.06.019; Manfredsson FP, 2009, MOL THER, V17, P980, DOI 10.1038/mt.2009.45; Player AN, 2001, J HISTOCHEM CYTOCHEM, V49, P603, DOI 10.1177/002215540104900507; Qian X, 2003, DIAGN MOL PATHOL, V12, P1, DOI 10.1097/00019606-200303000-00001; Ramos-Vara JA, 2014, VET PATHOL, V51, P42, DOI 10.1177/0300985813505879; Speel EJM, 1999, J HISTOCHEM CYTOCHEM, V47, P281, DOI 10.1177/002215549904700302; Spieles-Engemann AL, 2010, NEUROBIOL DIS, V39, P105, DOI 10.1016/j.nbd.2010.03.009; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002	23	67	69	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120120	10.1371/journal.pone.0120120	http://dx.doi.org/10.1371/journal.pone.0120120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794171	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200148
J	Otmakhov, N; Gorbacheva, EV; Regmi, S; Yasuda, R; Hudmon, A; Lisman, J				Otmakhov, Nikolai; Gorbacheva, Elena V.; Regmi, Shaurav; Yasuda, Ryohei; Hudmon, Andy; Lisman, John			Excitotoxic Insult Results in a Long-Lasting Activation of CaMKII alpha and Mitochondrial Damage in Living Hippocampal Neurons	PLOS ONE			English	Article							PROTEIN-KINASE-II; SUBUNIT 2B NR2B; CEREBRAL-ISCHEMIA; TERM POTENTIATION; DENDRITIC SPINES; SELF-ASSOCIATION; PERMEABILITY TRANSITION; SYNAPTIC STRENGTH; SLICE MODEL; CALCIUM	Over-activation of excitatory NMDA receptors and the resulting Ca2+ overload is the main cause of neuronal toxicity during stroke. CaMKII becomes misregulated during such events. Biochemical studies show either a dramatic loss of CaMKII activity or its persistent autonomous activation after stroke, with both of these processes being implicated in cell toxicity. To complement the biochemical data, we monitored CaMKII activation in living hippocampal neurons in slice cultures using high spatial/temporal resolution two-photon imaging of the CaMKII alpha FRET sensor, Camui. CaMKII activation state was estimated by measuring Camui fluorescence lifetime. Short NMDA insult resulted in Camui activation followed by a redistribution of its protein localization: an increase in spines, a decrease in dendritic shafts, and concentration into numerous clusters in the cell soma. Camui activation was either persistent (> 1-3 hours) or transient (similar to 20 min) and, in general, correlated with its protein redistribution. After longer NMDA insult, however, Camui redistribution persisted longer than its activation, suggesting distinct regulation/phases of these processes. Mutational and pharmacological analysis suggested that persistent Camui activation was due to prolonged Ca2+ elevation, with little impact of autonomous states produced by T286 autophosphorylation and/or by C280/M281 oxidation. Cell injury was monitored using expressible mitochondrial marker mito-dsRed. Shortly after Camui activation and clustering, NMDA treatment resulted in mitochondrial swelling, with persistence of the swelling temporarily linked to the persistence of Camui activation. The results suggest that in living neurons excitotoxic insult produces long-lasting Ca2+-dependent active state of CaMKII temporarily linked to cell injury. CaMKII function, however, is to be restricted due to strong clustering. The study provides the first characterization of CaMKII activation dynamics in living neurons during excitotoxic insults.	[Otmakhov, Nikolai; Gorbacheva, Elena V.; Regmi, Shaurav; Lisman, John] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Yasuda, Ryohei] Max Planck Florida Inst, Jupiter, FL 33458 USA; [Hudmon, Andy] Indiana Univ Sch Med, STARK Neurosci Res Inst, Indianapolis, IN 46202 USA	Brandeis University; Max Planck Society; Indiana University System; Indiana University Bloomington	Otmakhov, N (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	otmakhov@brandeis.edu		Yasuda, Ryohei/0000-0001-6263-9297	Ellison Medical Foundation [AG-SS-2358-09]; Angelman Syndrome Foundation; National Institutes of Health [NS078171]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078171] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Angelman Syndrome Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Ellison Medical Foundation, Senior Scholar in Aging, AG-SS-2358-09 (to J.L.) (http://www.ellisonfoundation.org/); Angelman Syndrome Foundation grant (to J.L.) (http://www.angelman.org/research/); and National Institutes of Health Grant NS078171 (to A.H.) (http://health.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bell JR, 2014, CLIN EXP PHARMACOL P, V41, P940, DOI 10.1111/1440-1681.12301; Bickler PE, 2004, NEUROSCIENCE, V127, P673, DOI 10.1016/j.neuroscience.2004.05.035; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; CHURN SB, 1995, J NEUROSCI, V15, P3200; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; Coultrap SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037176; Coultrap SJ, 2011, ACTA PHARMACOL SIN, V32, P861, DOI 10.1038/aps.2011.68; Davies KD, 2007, BRAIN RES, V1158, P39, DOI 10.1016/j.brainres.2007.05.008; Ding JD, 2013, J COMP NEUROL, V521, P3570, DOI 10.1002/cne.23372; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Dosemeci A, 2002, J NEUROCYTOL, V31, P605, DOI 10.1023/A:1025735410738; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, CIRC RES, V109, P729, DOI 10.1161/CIRCRESAHA.111.247148; FONG YL, 1989, J BIOL CHEM, V264, P16759; Fujii H, 2013, CELL REP, V3, P978, DOI 10.1016/j.celrep.2013.03.033; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Greenwood SM, 2007, NEUROPHARMACOLOGY, V53, P891, DOI 10.1016/j.neuropharm.2007.10.003; Gurd JW, 2008, BRAIN RES, V1218, P158, DOI 10.1016/j.brainres.2008.04.040; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; HAJIMOHAMMADREZA I, 1995, J NEUROSCI, V15, P4093; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON SK, 1994, STROKE, V25, P466, DOI 10.1161/01.STR.25.2.466; HIESTAND DM, 1992, J NEUROL SCI, V113, P31, DOI 10.1016/0022-510X(92)90261-I; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Hudmon A, 2001, J NEUROCHEM, V76, P1364, DOI 10.1046/j.1471-4159.2001.00119.x; Kato K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-37; KOLB SJ, 1995, J NEUROCHEM, V64, P2147; Kristensen BW, 2001, BRAIN RES, V917, P21, DOI 10.1016/S0006-8993(01)02900-6; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lemieux M, 2012, J CELL BIOL, V198, P1055, DOI 10.1083/jcb.201202058; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Meng FJ, 2003, BRAIN RES, V967, P161, DOI 10.1016/S0006-8993(02)04267-1; Meng FJ, 2002, NEUROSCI LETT, V333, P59, DOI 10.1016/S0304-3940(02)00961-8; MOLLOY SS, 1991, P NATL ACAD SCI USA, V88, P4756, DOI 10.1073/pnas.88.11.4756; Montero M, 2007, EXP NEUROL, V204, P106, DOI 10.1016/j.expneurol.2006.09.026; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Otmakhov N, 2012, J NEUROSCI METH, V203, P106, DOI 10.1016/j.jneumeth.2011.09.022; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Pivovarova NB, 2004, J NEUROSCI, V24, P5611, DOI 10.1523/JNEUROSCI.0531-04.2004; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Schulman Howard, 2010, Drug Discov Today Dis Mech, V7, pe117, DOI 10.1016/j.ddmec.2010.07.005; Shamloo M, 2000, NEUROSCIENCE, V96, P665, DOI 10.1016/S0306-4522(99)00586-2; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shetty PK, 2008, J BIOL CHEM, V283, P5389, DOI 10.1074/jbc.M708479200; SIMS NR, 1995, METAB BRAIN DIS, V10, P191, DOI 10.1007/BF02081026; Skelding KA, 2012, J CEREBRAL BLOOD FLO; TAFT WC, 1988, BRAIN RES, V447, P159, DOI 10.1016/0006-8993(88)90978-X; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tang KX, 2004, J NEUROCHEM, V91, P429, DOI 10.1111/j.1471-4159.2004.02733.x; Tao-Cheng JH, 2001, NEUROSCIENCE, V106, P69, DOI 10.1016/S0306-4522(01)00262-7; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Vest RS, 2009, FEBS LETT, V583, P3577, DOI 10.1016/j.febslet.2009.10.028; Vinade L, 2003, J NEUROCHEM, V87, P1255, DOI 10.1046/j.1471-4159.2003.02091.x; Wang N, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/827161; WESTGATE SA, 1994, J NEUROCHEM, V63, P2217; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; YAMAMOTO H, 1992, J NEUROCHEM, V58, P1110, DOI 10.1111/j.1471-4159.1992.tb09369.x; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zalewska T, 1996, NEUROREPORT, V7, P637, DOI 10.1097/00001756-199601310-00062; Zhang YL, 1999, J NEUROSCI, V19, P3307; Zhou XJ, 2012, J NEUROCHEM, V122, P295, DOI 10.1111/j.1471-4159.2012.07787.x	76	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120881	10.1371/journal.pone.0120881	http://dx.doi.org/10.1371/journal.pone.0120881			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793533	Green Published, gold			2022-12-26	WOS:000352083900086
J	Rahman, S; Rehman, MT; Singh, LR; Warepam, M; Ahmad, F; Dar, TA				Rahman, Safikur; Rehman, Md Tabish; Singh, Laishram R.; Warepam, Marina; Ahmad, Faizan; Dar, Tanveer Ali			Salt Potentiates Methylamine Counteraction System to Offset the Deleterious Effects of Urea on Protein Stability and Function	PLOS ONE			English	Article							TRIMETHYLAMINE-N-OXIDE; ELASMOBRANCH FISHES; OSMOLYTE; WATER; MECHANISM; LYSOZYME; SOLUTES; STRESS; KIDNEY; CELLS	Cellular methylamines are osmolytes (low molecular weight organic compounds) believed to offset the urea's harmful effects on the stability and function of proteins in mammalian kidney and marine invertebrates. Although urea and methylamines are found at 2: 1 molar ratio in tissues, their opposing effects on protein structure and function have been questioned on several grounds including failure to counteraction or partial counteraction. Here we investigated the possible involvement of cellular salt, NaCl, in ureamethylamine counteraction on protein stability and function. We found that NaCl mediates methylamine counteracting system from no or partial counteraction to complete counteraction of urea's effect on protein stability and function. These conclusions were drawn from the systematic thermodynamic stability and functional activity measurements of lysozyme and RNaseA. Our results revealed that salts might be involved in protein interaction with charged osmolytes and hence in the ureamethylamine counteraction.	[Rahman, Safikur; Rehman, Md Tabish; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Singh, Laishram R.; Warepam, Marina] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Dar, Tanveer Ali] Univ Kashmir, Clin Biochem, Srinagar 190006, Jammu & Kashmir, India	Jamia Millia Islamia; University of Delhi; University of Kashmir	Dar, TA (corresponding author), Univ Kashmir, Clin Biochem, Srinagar 190006, Jammu & Kashmir, India.	tanveerali@kashmiruniversity.ac.in	Rahman, Safikur/K-1264-2019; Dar, Tanveer/F-3738-2019; Rehman, Md Tabish/AAC-8512-2019; Ahmad, Faizan/AGH-4493-2022; REHMAN, TABISH/H-8471-2012	Rahman, Safikur/0000-0002-6282-8706; Dar, Tanveer/0000-0002-1574-9036; Rehman, Md Tabish/0000-0003-2341-900X; Ahmad, Faizan/0000-0001-7021-7502; REHMAN, TABISH/0000-0003-2341-900X	Department of Science and Technology (DST); Council of Scientific and Industrial Research (India)	Department of Science and Technology (DST)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank Department of Science and Technology (DST) and Council of Scientific and Industrial Research (India) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; BECK F, 1984, KIDNEY INT, V25, P397, DOI 10.1038/ki.1984.30; BIGELOW C C, 1960, C R Trav Lab Carlsberg, V31, P305; BULGER RE, 1981, J CELL BIOL, V88, P274, DOI 10.1083/jcb.88.2.274; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; Haque I, 2005, FEBS LETT, V579, P3891, DOI 10.1016/j.febslet.2005.06.005; HAUSSINGER D, 1992, TRENDS PHARMACOL SCI, V13, P371, DOI 10.1016/0165-6147(92)90114-L; LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021; MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V258, P356, DOI 10.1016/0003-9861(87)90355-9; MAUREL P, 1976, J MOL BIOL, V102, P253, DOI 10.1016/S0022-2836(76)80052-6; Muller E, 1998, PFLUG ARCH EUR J PHY, V435, P705, DOI 10.1007/s004240050572; Neuhofer W, 2005, ANNU REV PHYSIOL, V67, P531, DOI 10.1146/annurev.physiol.67.031103.154456; NOZAKI Y, 1963, J BIOL CHEM, V238, P4074; PANG PKT, 1977, AM ZOOL, V17, P365; Perlman D.F., 1988, P253; Prosser, 1973, COMP ANIMAL PHYSL, P966; Prosser C.L., 1961, COMP ANIMAL PHYSL; Scaloni F, 2009, FASEB J, V23, P2360, DOI 10.1096/fj.08-128306; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Singh LR, 2009, J BIOSCIENCES, V34, P321, DOI 10.1007/s12038-009-0036-0; Singh LR, 2007, BBA-PROTEINS PROTEOM, V1774, P1555, DOI 10.1016/j.bbapap.2007.09.006; Singh R, 2005, J BIOL CHEM, V280, P11035, DOI 10.1074/jbc.M410716200; Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Von Hippel PH, 1969, STRUCTURE STABILITY, P417; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; WOLFF SD, 1990, ANNU REV PHYSIOL, V52, P727; Yancey Paul H., 2004, Science Progress, V87, P1, DOI 10.3184/003685004783238599; YANCEY PH, 1980, J EXP ZOOL, V212, P205, DOI 10.1002/jez.1402120207; YANCEY PH, 1988, J COMP PHYSIOL B, V158, P369, DOI 10.1007/BF00695336; YANCEY PH, 1979, BIOCHEM J, V183, P317, DOI 10.1042/bj1830317; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yancey PH, 2003, BIOLOGIST, V50, P126; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zhang Z, 2000, AM J PHYSIOL-RENAL, V278, pF155, DOI 10.1152/ajprenal.2000.278.1.F155	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119597	10.1371/journal.pone.0119597	http://dx.doi.org/10.1371/journal.pone.0119597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793733	Green Submitted, gold, Green Published			2022-12-26	WOS:000352084200099
J	Tschinkel, WR				Tschinkel, Walter R.			Biomantling and Bioturbation by Colonies of the Florida Harvester Ant, Pogonomyrmex badius	PLOS ONE			English	Article							NEST ARCHITECTURE; SOIL; HYMENOPTERA; FORMICIDAE; TRANSPORT; SOCIOGENESIS; SOCIOMETRY; AUSTRALIA; ECOLOGY	In much of the world, soil-nesting ants are among the leading agents of biomantling and bioturbation, depositing excavated soil on the surface or in underground chambers. Colonies of the Florida harvester ant, Pogonomyrmex badius excavate a new nest once a year on average, depositing 0.1 to 12 L (3 L average) of soil on the surface. Repeated surveys of a population of about 400 colonies yielded the frequency of moves (approximately once per year), the distance moved (mean 4 m), and the direction moved (random). The area of the soil disc correlated well with the volume and maximum depth of the nest, as determined by excavation and mapping of chambers. The population-wide frequency distribution of disc areas thus yielded the frequency distribution of nest volumes and maximum depths. For each surveyed colony, the volume of soil excavated from six specified depth ranges and deposited on the surface was estimated. These parameters were used in a simulation to estimate the amount of soil mantled over time by the observed population of P. badius colonies. Spread evenly, P. badius mantling would create a soil layer averaging 0.43 cm thick in a millennium, with 10-15% of the soil deriving from depths greater than 1 m. Biomantling by P. badius is discussed in the context of the ant community of which it is a part, and in relation to literature reports of ant biomantling.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu			National Science Foundation [IOS-1021632]	National Science Foundation(National Science Foundation (NSF))	This work was funded by National Science Foundation grant number IOS-1021632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER FP, 1967, SOIL SCI SOC AM PRO, V31, P425, DOI 10.2136/sssaj1967.03615995003100030036x; Borojevic K, 2011, J ARCHAEOL SCI, V38, P829, DOI 10.1016/j.jas.2010.11.005; BRIESE DT, 1982, INSECT SOC, V29, P375, DOI 10.1007/BF02228765; Cerda A, 2008, J APPL ENTOMOL, V132, P306, DOI 10.1111/j.1439-0418.2008.01267.x; Cole BJ, 1999, SCIENCE, V285, P891, DOI 10.1126/science.285.5429.891; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; DEBRUYN LAL, 1994, AUST J SOIL RES, V32, P555, DOI 10.1071/SR9940555; Dorn RI, 2014, GEOLOGY, V42, P771, DOI 10.1130/G35825.1; Eldridge DJ, 2012, P LINN SOC N S W, V134, pA11; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P323, DOI 10.1071/SR9940323; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Gabet EJ, 2003, ANNU REV EARTH PL SC, V31, P249, DOI 10.1146/annurev.earth.31.100901.141314; Gabet EJ, 2000, EARTH SURF PROC LAND, V25, P1419, DOI 10.1002/1096-9837(200012)25:13&lt;1419::AID-ESP148&gt;3.0.CO;2-1; Halfen AF, 2010, 19 WORLD C SOIL SCI; Halfen AF, 2010, PALAIOS, V25, P703, DOI 10.2110/palo.2010.p10-005r; Hembree DI, 2008, PALAEOGEOGR PALAEOCL, V270, P349, DOI 10.1016/j.palaeo.2008.07.019; Humphreys G.S., 1998, 16 WORLD C SOIL SCI; JOHNSON DL, 1990, SOIL SCI, V149, P84, DOI 10.1097/00010694-199002000-00004; Johnson DL, 2010, 19 WORLD C SOIL SCI; Johnson RA, 2000, SOCIOBIOLOGY, V36, P89; KACZOR SA, 1990, AM MIDL NAT, V123, P100, DOI 10.2307/2425763; Keeler K, 1993, SW NAT, V38, P1229; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; McGlynn TP, 2012, ANNU REV ENTOMOL, V57, P291, DOI 10.1146/annurev-ento-120710-100708; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Moser JC, 2006, ANN ENTOMOL SOC AM, V99, P891, DOI 10.1603/0013-8746(2006)99[891:CEAMOA]2.0.CO;2; Nkem JN, 2000, PEDOBIOLOGIA, V44, P609, DOI 10.1078/S0031-4056(04)70075-X; Persson T, 2007, R06123 SWED NUCL FUE; Phillips JD, 2007, CATENA, V70, P92, DOI 10.1016/j.catena.2006.08.002; PORTER SD, 1988, J RANGE MANAGE, V41, P104, DOI 10.2307/3898942; Richards PJ, 2011, EARTH SURF PROC LAND, V36, P1240, DOI 10.1002/esp.2149; Richards PJ, 2010, EARTH SURF PROC LAND, V35, P856, DOI 10.1002/esp.2007; Richards PJ, 2009, EARTH-SCI REV, V96, P92, DOI 10.1016/j.earscirev.2009.06.004; Rink WJ, 2013, J ARCHAEOL SCI, V40, P2217, DOI 10.1016/j.jas.2012.11.006; Robins R, 2011, ENVIRON ARCHAEOL, V16, P151, DOI 10.1179/174963111X13110803261010; Rodrigues K., 2013, THESIS MCMASTER U FL; Seal JN, 2006, ANN ENTOMOL SOC AM, V99, P673, DOI 10.1603/0013-8746(2006)99[673:CPOTFA]2.0.CO;2; Smith CR, 2007, ECOL ENTOMOL, V32, P105, DOI 10.1111/j.1365-2311.2006.00845.x; Tschinkel WR, 2012, J INSECT SCI, V12, P1, DOI 10.1673/031.012.11401; Tschinkel WR, 1999, ANN ENTOMOL SOC AM, V92, P80, DOI 10.1093/aesa/92.1.80; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.9; Tschinkel WR, 2003, PALAEOGEOGR PALAEOCL, V192, P321, DOI 10.1016/S0031-0182(02)00690-9; Tschinkel WR, 2014, PLOSONE IN PRESS; Whitford WG, 2000, INVERTEBRATES AS WEB-MASTERS IN ECOSYSTEMS, P25, DOI 10.1079/9780851993942.0025; Wilkinson MT, 2009, EARTH-SCI REV, V97, P257, DOI 10.1016/j.earscirev.2009.09.005	47	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120407	10.1371/journal.pone.0120407	http://dx.doi.org/10.1371/journal.pone.0120407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794047	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900028
J	Carozzo, A; Diez, F; Gomez, N; Cabrera, M; Shayo, C; Davio, C; Fernandez, N				Carozzo, Alejandro; Diez, Federico; Gomez, Natalia; Cabrera, Maia; Shayo, Carina; Davio, Carlos; Fernandez, Natalia			Dual Role of cAMP in the Transcriptional Regulation of Multidrug Resistance-Associated Protein 4 (MRP4) in Pancreatic Adenocarcinoma Cell Lines	PLOS ONE			English	Article							SIGNALING MOLECULES; REDUCED GLUTATHIONE; CONFERS RESISTANCE; EFFLUX TRANSPORTER; CYCLIC-NUCLEOTIDES; ABCC4; CANCER; EXPRESSION; DRUGS; EPAC	Cyclic AMP represents one of the most studied signaling molecules and its role in proliferation and differentiation processes has been well established. Intracellular cAMP levels are tightly regulated where the MRP4 transporter plays a major role. In the present study, we sought to establish whether cAMP modulated MRP4 expression in pancreatic adenocarcinoma cell lines. Quantitative PCR and western blot studies showed that cAMP-increasing agents enhanced MRP4 transcripts and protein levels in PANC-1 cells. Reporter luciferase experiments carried out in pancreatic AR42J cells showed that intracellular cAMP up-regulates MRP4 through an Epac2-and Rap1-mediated mechanism whereas extracellular cAMP reduced MRP4 promoter activity by a MEK/ ERK-mediated pathway. Present results show that cAMP regulates MRP4 promoter activity, and further indicate that the balance between intracellular and extracellular cAMP levels determines MRP4 expression.	[Carozzo, Alejandro; Diez, Federico; Gomez, Natalia; Cabrera, Maia; Shayo, Carina; Davio, Carlos; Fernandez, Natalia] Univ Buenos Aires, Fac Farm & Bioquim, Dept Farmacol, Catedra Quim Med,Lab Farmacol Receptores, RA-1113 Buenos Aires, DF, Argentina; [Shayo, Carina] Inst Biol & Med Expt, Lab Patol & Farmacol Mol, RA-1428 Buenos Aires, DF, Argentina; [Carozzo, Alejandro; Diez, Federico; Gomez, Natalia; Cabrera, Maia; Davio, Carlos; Fernandez, Natalia] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fernandez, N (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Farmacol, Catedra Quim Med,Lab Farmacol Receptores, RA-1113 Buenos Aires, DF, Argentina.	natycfernandez@gmail.com			Universidad de Buenos Aires [UBACyT 20020400100601]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2010-1571]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP0344]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Universidad de Buenos Aires (UBACyT 20020400100601), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2010-1571), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP0344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnoli M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143202; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Broderdorf S, 2014, PHARMACOGENET GENOM, V24, P522, DOI 10.1097/FPC.0000000000000084; Burgun C, 2000, FEBS LETT, V484, P189, DOI 10.1016/S0014-5793(00)02153-0; Chen ZS, 2002, CANCER RES, V62, P3144; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Copsel S, 2011, J BIOL CHEM, V286, P6979, DOI 10.1074/jbc.M110.166868; DAVIO CA, 1995, BIOCHEM PHARMACOL, V50, P91, DOI 10.1016/0006-2952(95)00108-C; Dreuw A, 2005, J INVEST DERMATOL, V124, P28, DOI 10.1111/j.0022-202X.2004.23499.x; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gu XS, 2010, DRUG METAB REV, V42, P482, DOI 10.3109/03602531003654915; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; Hofer AM, 2007, PHYSIOLOGY, V22, P320, DOI 10.1152/physiol.00019.2007; Huynh T, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00178; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Lohr M, 2006, NAT CLIN PRACT GASTR, V3, P236, DOI 10.1038/ncpgasthep0469; Montani M, 2013, VIRCHOWS ARCH, V462, P437, DOI 10.1007/s00428-013-1390-8; Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Osycka-Salut C, 2014, MOL HUM REPROD, V20, P89, DOI 10.1093/molehr/gat053; Qian ZL, 2014, GENE CHROMOSOME CANC, V53, P883, DOI 10.1002/gcc.22196; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Ritter CA, 2005, DRUG METAB REV, V37, P253, DOI 10.1081/DMR-200047984; Rius M, 2006, AM J PHYSIOL-GASTR L, V290, pG640, DOI 10.1152/ajpgi.00354.2005; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Rodriguez MR, 2011, GASTROENTEROLOGY, V140, P1292, DOI 10.1053/j.gastro.2010.12.053; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun YL, 2014, CARCINOGENESIS, V35, P1941, DOI 10.1093/carcin/bgu043; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Yu ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085446; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zhang Z, 2012, GENE, V491, P194, DOI 10.1016/j.gene.2011.09.029; Zhao XT, 2014, ONCOTARGETS THER, V7, P343, DOI 10.2147/OTT.S56029	38	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120651	10.1371/journal.pone.0120651	http://dx.doi.org/10.1371/journal.pone.0120651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790437	Green Submitted, gold, Green Published			2022-12-26	WOS:000351425400168
J	Halbach, MV; Stehning, T; Damrath, E; Jendrach, M; Sen, NE; Basak, AN; Auburger, G				Halbach, Melanie Vanessa; Stehning, Tanja; Damrath, Ewa; Jendrach, Marina; Sen, Nesli Ece; Basak, A. Nazli; Auburger, Georg			Both Ubiquitin Ligases FBXW8 and PARK2 Are Sequestrated into Insolubility by ATXN2 PolyQ Expansions, but Only FBXW8 Expression Is Dysregulated	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-2; LENGTH POLYGLUTAMINE EXPANSIONS; F-BOX; INTRANUCLEAR INCLUSIONS; TRINUCLEOTIDE REPEAT; DROSOPHILA HOMOLOG; PROTEIN; SCA2; GENE; RNA	The involvement of the ubiquitin-proteasome system (UPS) in the course of various age-associated neurodegenerative diseases is well established. The single RING finger type E3 ubiquitin-protein ligase PARK2 is mutated in a Parkinson's disease (PD) variant and was found to interact with ATXN2, a protein where polyglutamine expansions cause Spinocerebellar ataxia type 2 (SCA2) or increase the risk for Levodopa-responsive PD and for the motor neuron disease Amyotrophic lateral sclerosis (ALS). We previously reported evidence for a transcriptional induction of the multi-subunit RING finger Skp1/Cul/F-box (SCF) type E3 ubiquitin-protein ligase complex component FBXW8 in global microarray profiling of ATXN2-expansion mouse cerebellum and demonstrated its role for ATXN2 degradation in vitro. Now, we documented co-localization in vitro and co-immunoprecipitations both in vitro and in vivo, which indicate associations of FBXW8 with ATXN2 and PARK2. Both FBXW8 and PARK2 proteins are driven into insolubility by expanded ATXN2. Whereas the FBXW8 transcript upregulation by ATXN2-expansion was confirmed also in qPCR of skin fibroblasts and blood samples of SCA2 patients, a FBXW8 expression dysregulation was not observed in ATXN2-deficient mice, nor was a PARK2 transcript dysregulation observed in any samples. Jointly, all available data suggest that the degradation of wildtype and mutant ATXN2 is dependent on FBXW8, and that ATXN2 accumulation selectively modulates FBXW8 levels, while PARK2 might act indirectly through FBXW8. The effects of ATXN2-expansions on FBXW8 expression in peripheral tissues like blood may become useful for clinical diagnostics.	[Halbach, Melanie Vanessa; Stehning, Tanja; Damrath, Ewa; Jendrach, Marina; Auburger, Georg] Goethe Univ Frankfurt, Dept Neurol, Sch Med, Expt Neurol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Sen, Nesli Ece; Basak, A. Nazli] Bogazici Univ, Dept Genet & Mol Biol, Neurodegenerat Res Lab NDAL, TR-34470 Istanbul, Turkey	Goethe University Frankfurt; Bogazici University	Auburger, G (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Sch Med, Expt Neurol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	auburger@em.uni-frankfurt.de		Rollmann, Ewa/0000-0001-9777-4608	Deutsche Forschungsgemeinschaft [AU96/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft AU96/11-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affaitati A, 2001, GENE, V267, P89, DOI 10.1016/S0378-1119(01)00402-4; Auburger G, 2014, WORLD J DIABETES, V5, P316, DOI 10.4239/wjd.v5.i3.316; Auburger Georg W J, 2012, Handb Clin Neurol, V103, P423, DOI 10.1016/B978-0-444-51892-7.00026-7; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Benbrook D. M., 2012, Experimental Oncology, V34, P286; Boesch SM, 2004, MOVEMENT DISORD, V19, P1320, DOI 10.1002/mds.20159; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Charles P, 2007, NEUROLOGY, V69, P1970, DOI 10.1212/01.wnl.0000269323.21969.db; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Damrath E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002920; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Drost J, 2013, J MOL NEUROSCI, V51, P68, DOI 10.1007/s12031-012-9949-4; Duyckaerts C, 1999, ACTA NEUROPATHOL, V97, P201, DOI 10.1007/s004010050975; Ekholm-Reed S, 2013, MOL CELL BIOL, V33, P3627, DOI 10.1128/MCB.00535-13; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Estrada R, 1999, ACTA NEUROPATHOL, V97, P306, DOI 10.1007/s004010050989; Freund HJ, 2007, MOVEMENT DISORD, V22, P732, DOI 10.1002/mds.21338; Galvao R, 2001, BRAIN RES BULL, V56, P191, DOI 10.1016/S0361-9230(01)00651-7; Gierga K, 2005, ACTA NEUROPATHOLOGIC, P109; Gispert S, 2012, NEUROBIOL DIS, V45, P356, DOI 10.1016/j.nbd.2011.08.021; Gwinn-Hardy K, 2000, NEUROLOGY, V55, P800, DOI 10.1212/WNL.55.6.800; Hallen L, 2011, HUM MOL GENET, V20, P104, DOI 10.1093/hmg/ddq436; HERNANDEZ A, 1995, GENOMICS, V25, P433, DOI 10.1016/0888-7543(95)80043-L; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Huynh DP, 2007, EXP NEUROL, V203, P531, DOI 10.1016/j.expneurol.2006.09.009; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klinkenberg M, 2012, NEUROGENETICS, V13, P9, DOI 10.1007/s10048-011-0303-8; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Lahut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042956; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Lastres-Becker I, 2008, HUM MOL GENET, V17, P1465, DOI 10.1093/hmg/ddn035; Lee T, 2011, HUM MOL GENET, V20, P1697, DOI 10.1093/hmg/ddr045; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Lieberman AP, 2002, HUM MOL GENET, V11, P1967, DOI 10.1093/hmg/11.17.1967; Lim C, 2013, SCIENCE, V340, P875, DOI 10.1126/science.1234785; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lindenberg KS, 2000, BRAIN PATHOL, V10, P385; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Nonis D, 2008, CELL SIGNAL, V20, P1725, DOI 10.1016/j.cellsig.2008.05.018; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Ortega Z, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00077, 10.3389/fnmo1.2014.00077]; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Petroi D, 2012, J BIOL CHEM, V287, P27567, DOI 10.1074/jbc.M112.361865; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ralser M, 2005, J MOL BIOL, V346, P203, DOI 10.1016/j.jmb.2004.11.024; Rub U, 2005, J NEURAL TRANSM, V112, P1523, DOI 10.1007/s00702-005-0287-3; Rub U, 2004, NEUROLOGY, V63, P1258, DOI 10.1212/01.WNL.0000140498.24112.8C; Rub U, 2003, NEUROPATH APPL NEURO, V29, P418, DOI 10.1046/j.1365-2990.2003.00504.x; Rub U, 2003, BRAIN, V126, P2257, DOI 10.1093/brain/awg234; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Satterfield TF, 2002, GENETICS, V162, P1687; Schipper-Krom S, 2014, FEBS LETT, V588, P151, DOI 10.1016/j.febslet.2013.11.023; Schipper-Krom S, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/837015; Scoles DR, 2012, HUM MOL GENET, V21, P5048, DOI 10.1093/hmg/dds349; Scuderi S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/690796; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Sudhakaran IP, 2014, P NATL ACAD SCI USA, V111, pE99, DOI 10.1073/pnas.1309543111; van de Loo S, 2009, EXP NEUROL, V215, P110, DOI 10.1016/j.expneurol.2008.09.020; Velazquez-Perez L, 2014, LANCET NEUROL, V13, P482, DOI 10.1016/S1474-4422(14)70027-4; von Coelln R, 2004, CELL TISSUE RES, V318, P175, DOI 10.1007/s00441-004-0924-4; Yamashita C, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.022; Yang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06410; Zhang Y, 2013, SCIENCE, V340, P879, DOI 10.1126/science.1234746	74	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121089	10.1371/journal.pone.0121089	http://dx.doi.org/10.1371/journal.pone.0121089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790475	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400189
J	Suzuki, M; Tada, A; Kanmani, P; Watanabe, H; Aso, H; Suda, Y; Nochi, T; Miyazawa, K; Yoda, K; He, F; Hosoda, M; Saito, T; Villena, J; Kitazawa, H				Suzuki, Masahiko; Tada, Asuka; Kanmani, Paulraj; Watanabe, Hitoshi; Aso, Hisashi; Suda, Yoshihito; Nochi, Tomonori; Miyazawa, Kenji; Yoda, Kazutoyo; He, Fang; Hosoda, Masataka; Saito, Tadao; Villena, Julio; Kitazawa, Haruki			Advanced Application of Porcine Intramuscular Adipocytes for Evaluating Anti-Adipogenic and Anti-Inflammatory Activities of Immunobiotics	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LACTOBACILLUS-GASSERI TMC0356; TNF-ALPHA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; IMMUNE-RESPONSES; IN-VIVO; EXPRESSION; OBESE; DIFFERENTIATION	We previously established a clonal porcine intramuscular preadipocyte (PIP) line and we were able to establish a protocol to obtain functional mature adipocytes from PIP cells. We hypothesized that both PIP cells and mature adipocytes are likely to be useful in vitro tools for increasing our understanding of immunobiology of adipose tissue, and for the selection and study of immunoregulatory probiotics (immunobiotics) able to modulate adipocytes immune responses. In this study, we investigated the immunobiology of PIP cells and mature adipocytes in relation to their response to TNF-alpha stimulation. In addition, we evaluated the possibility that immunobiotic microorganisms modify adipogenesis and immune functions of porcine adipose tissue through Peyer's patches (PPs) immune-competent cells. We treated the porcine PPs immune cells with different probiotic strains; and we evaluated the effect of conditioned media from probiotic-stimulated immune cells in PIP cells and mature adipocytes. The Lactobacillus GG and L. gasseri TMC0356 showed remarkable effects, and were able to significantly reduce the expression of pro-inflammatory factors and negative regulators (A20, Bcl-3, and MKP-1) in adipocytes challenged with TNF-alpha. The results of this study demonstrated that the evaluation of IL-6, and MCP-1 production, and A20 and Bcl-3 down-regulation in TNF-alpha-challenged adipocytes could function as biomarkers to screen and select potential immunobiotic strains. Taking into consideration that several in vivo and in vitro studies clearly demonstrated the beneficial effects of Lactobacillus GG and L. gasseri TMC0356 in adipose inflammation, the results presented in this work indicate that the PIP cells and porcine adipocytes could be used for the screening and the selection of new immunobiotic strains with the potential to functionally modulate adipose inflammation when orally administered.	[Suzuki, Masahiko; Tada, Asuka; Kanmani, Paulraj; Saito, Tadao; Kitazawa, Haruki] Tohoku Univ, Grad Sch Agr Sci, Food & Feed Immunol Grp, Sendai, Miyagi 9818555, Japan; [Watanabe, Hitoshi; Aso, Hisashi; Nochi, Tomonori] Tohoku Univ, Grad Sch Agr Sci, Cell Biol Lab, Sendai, Miyagi 9818555, Japan; [Villena, Julio] Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Argentina; [Suda, Yoshihito] Miyagi Univ, Dept Food Agr & Environm, Sendai, Miyagi 9820215, Japan; [Miyazawa, Kenji; Yoda, Kazutoyo; He, Fang; Hosoda, Masataka] Takanashi Milk Prod Co Ltd, Tech Res Lab, Yokohama, Kanagawa 2410023, Japan	Tohoku University; Tohoku University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miyagi University	Villena, J (corresponding author), Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Argentina.	jcvillena@cerela.org.ar; haruki@bios.tohoku.ac.jp	Nochi, Tomonori/U-2533-2019	Nochi, Tomonori/0000-0003-1800-6972; Kitazawa, Haruki/0000-0003-4586-5553; Watanabe, Hitoshi/0000-0002-9236-7744; Tada, Asuka/0000-0003-2364-9462	Japanese Society for the Promotion of Science (JSPS) [24380146, 26660216]; Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO), Japan; JSPS Postdoctoral Fellowship for Foreign Researchers [25-03397]; Takanashi Milk Products Co., Ltd.; Grants-in-Aid for Scientific Research [15H04586, 26660217, 26660216] Funding Source: KAKEN	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO), Japan; JSPS Postdoctoral Fellowship for Foreign Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takanashi Milk Products Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (B)(2) (No. 24380146) and Challenging Exploratory Research (No. 26660216) from the Japanese Society for the Promotion of Science (JSPS) to Dr. H. Kitazawa, and the Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO), Japan to Dr. H. Aso. Dr. Paulraj Kanmani was supported by JSPS Postdoctoral Fellowship for Foreign Researchers, Program No. 25-03397. Takanashi Milk Products Co., Ltd., provided support in the form of salaries for authors KM, KY, FH and MH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Batra A, 2007, AM J PATHOL, V170, P1931, DOI 10.2353/ajpath.2007.060699; Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Burcelin R, 2013, DIABETES OBES METAB, V15, P61, DOI 10.1111/dom.12157; Carvalho BM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/986734; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cheung AT, 1998, ENDOCRINOLOGY, V139, P4928, DOI 10.1210/en.139.12.4928; Chi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097675; Constant VA, 2006, DIABETOLOGIA, V49, P1402, DOI 10.1007/s00125-006-0253-0; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dorronsoro A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.494; Harata G, 2009, MICROBIOL IMMUNOL, V53, P475, DOI 10.1111/j.1348-0421.2009.00146.x; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huebner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075703; Jansson JO, 2007, J APPL PHYSIOL, V102, P821, DOI 10.1152/japplphysiol.01353.2006; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kawase M, 2007, MICROBIOL IMMUNOL, V51, P1109, DOI 10.1111/j.1348-0421.2007.tb04006.x; Kawase M, 2006, BIOSCI BIOTECH BIOCH, V70, P3025, DOI 10.1271/bbb.60152; Khazen W, 2007, BIOCHIMIE, V89, P669, DOI 10.1016/j.biochi.2007.01.003; Kim SW, 2013, BIOCHEM BIOPH RES CO, V431, P258, DOI 10.1016/j.bbrc.2012.12.121; Kim S, 2014, BMB REP, V47, P173, DOI 10.5483/BMBRep.2014.47.3.272; Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3; Lo J, 2007, AM J PHYSIOL-ENDOC M, V293, pE102, DOI 10.1152/ajpendo.00089.2007; Maury E, 2009, J CLIN ENDOCR METAB, V94, P1393, DOI 10.1210/jc.2008-2196; Miyazawa K, 2012, MICROBIOL IMMUNOL, V56, P847, DOI 10.1111/j.1348-0421.2012.00512.x; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Nobusue H, 2010, J CELL BIOCHEM, V109, P542, DOI 10.1002/jcb.22431; Oliver E, 2010, P NUTR SOC, V69, P232, DOI 10.1017/S0029665110000042; Park JE, 2014, J SCI FOOD AGR, V94, P2514, DOI 10.1002/jsfa.6588; Poulain-Godefroy O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823486; Prins JB, 1997, DIABETES, V46, P1939, DOI 10.2337/diabetes.46.12.1939; Salva S, 2014, INT IMMUNOPHARMACOL, V22, P209, DOI 10.1016/j.intimp.2014.06.017; Salva S, 2010, INT J FOOD MICROBIOL, V141, P82, DOI 10.1016/j.ijfoodmicro.2010.03.013; Sanosaka M, 2008, COMP BIOCHEM PHYS B, V149, P285, DOI 10.1016/j.cbpb.2007.09.019; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schroeder K, 2009, ARTERIOSCL THROM VAS, V29, P239, DOI 10.1161/ATVBAHA.108.174219; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Shimazu T, 2012, INFECT IMMUN, V80, P276, DOI 10.1128/IAI.05729-11; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Tomosada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059259; Toral M, 2014, CLIN SCI, V127, P33, DOI 10.1042/CS20130339; Tsai YT, 2014, APPL MICROBIOL BIOT, V98, P1, DOI 10.1007/s00253-013-5346-3; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VANDERPOLL T, AM J PHYSL, V261, pE457; Villena J, 2013, IMMUNOBIOTICS IMMUNO, P89; Villena J, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-53; Yoda K, 2012, J APPL MICROBIOL, V113, P155, DOI 10.1111/j.1365-2672.2012.05316.x; Zhang HM, 2009, NUTR METAB CARDIOVAS, V19, P736, DOI 10.1016/j.numecd.2008.12.016; Zhu HJ, 2013, J DIABETES INVEST, V4, P252, DOI 10.1111/jdi.12046	56	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119644	10.1371/journal.pone.0119644	http://dx.doi.org/10.1371/journal.pone.0119644			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789857	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400093
J	Tanaka-Arakawa, MM; Matsui, M; Tanaka, C; Uematsu, A; Uda, S; Miura, K; Sakai, T; Noguchi, K				Tanaka-Arakawa, Megumi M.; Matsui, Mie; Tanaka, Chiaki; Uematsu, Akiko; Uda, Satoshi; Miura, Kayoko; Sakai, Tomoko; Noguchi, Kyo			Developmental Changes in the Corpus Callosum from Infancy to Early Adulthood: A Structural Magnetic Resonance Imaging Study	PLOS ONE			English	Article							LOCALLY WEIGHTED REGRESSION; SEX-DIFFERENCES; WHITE-MATTER; BRAIN-DEVELOPMENT; FIBER COMPOSITION; GENDER; SIZE; ADOLESCENCE; CHILDHOOD; CHILDREN	Previous research has reported on the development trajectory of the corpus callosum morphology. However, there have been only a few studies that have included data on infants. The goal of the present study was to examine the morphology of the corpus callosum in healthy participants of both sexes, from infancy to early adulthood. We sought to characterize normal development of the corpus callosum and possible sex differences in development. We performed a morphometric magnetic resonance imaging (MRI) study of 114 healthy individuals, aged 1 month to 25 years old, measuring the size of the corpus callosum. The corpus callosum was segmented into seven subareas of the rostrum, genu, rostral body, anterior midbody, posterior midbody, isthmus and splenium. Locally weighted regression analysis (LOESS) indicated significant non-linear age-related changes regardless of sex, particularly during the first few years of life. After this increase, curve slopes gradually became flat during adolescence and adulthood in both sexes. Age of local maximum for each subarea of the corpus callosum differed across the sexes. Ratios of total corpus callosum and genu, posterior midbody, as well as splenium to the whole brain were significantly higher in females compared with males. The present results demonstrate that the developmental trajectory of the corpus callosum during early life in healthy individuals is non-linear and dynamic. This pattern resembles that found for the cerebral cortex, further suggesting that this period plays a very important role in neural and functional development. In addition, developmental trajectories and changes in growth do show some sex differences.	[Tanaka-Arakawa, Megumi M.; Matsui, Mie; Uematsu, Akiko; Uda, Satoshi; Miura, Kayoko] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Psychol, Toyama 930, Japan; [Tanaka, Chiaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pediat, Toyama 930, Japan; [Noguchi, Kyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol, Toyama 930, Japan; [Sakai, Tomoko] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan	University of Toyama; University of Toyama; University of Toyama; Keio University	Matsui, M (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Psychol, Toyama 930, Japan.	mmatsui@las.u-toyama.ac.jp		Miura, Kayoko/0000-0001-6012-5583; Noguchi, Kyo/0000-0002-6305-8045; Uematsu, Akiko/0000-0001-6123-4247	Japan Society for the Promotion of Science (JSPS) [20330141, 21243040]; JSPS Asian Core Program	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (B) 20330141 and (A) 21243040 from the Japan Society for the Promotion of Science (JSPS) and JSPS Asian Core Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Achiron R, 2001, ULTRASOUND OBST GYN, V18, P343, DOI 10.1046/j.0960-7692.2001.00512.x; ALLEN LS, 1991, J NEUROSCI, V11, P933; Anderson NG, 2005, AM J NEURORADIOL, V26, P2685; BARKOVICH AJ, 1988, AM J ROENTGENOL, V151, P171, DOI 10.2214/ajr.151.1.171; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chura LR, 2010, PSYCHONEUROENDOCRINO, V35, P122, DOI 10.1016/j.psyneuen.2009.09.009; CLARKE JM, 1994, BEHAV BRAIN RES, V64, P185, DOI 10.1016/0166-4328(94)90131-7; CLARKE S, 1989, J COMP NEUROL, V280, P213, DOI 10.1002/cne.902800205; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; COWELL PE, 1992, DEV BRAIN RES, V66, P187, DOI 10.1016/0165-3806(92)90079-C; Davatzikos C, 1998, CEREB CORTEX, V8, P635, DOI 10.1093/cercor/8.7.635; DELACOSTE MC, 1986, HUM NEUROBIOL, V5, P93; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; DELACOSTEUTAMSING C, 1982, SCIENCE, V216, P1431, DOI 10.1126/science.7089533; Fabri M, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/251308; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Garel C, 2011, AM J NEURORADIOL, V32, P1436, DOI 10.3174/ajnr.A2542; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Giedd JN, 1996, DEV BRAIN RES, V91, P274; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; Gilmore JH, 2007, AM J NEURORADIOL, V28, P1789, DOI 10.3174/ajnr.A0751; HABIB M, 1991, BRAIN COGNITION, V16, P41, DOI 10.1016/0278-2626(91)90084-L; Highley JR, 1999, BRAIN, V122, P99, DOI 10.1093/brain/122.1.99; Hwang SJ, 2004, NEUROREPORT, V15, P1029, DOI 10.1097/00001756-200404290-00019; Jancke L, 1997, CEREB CORTEX, V7, P48, DOI 10.1093/cercor/7.1.48; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kameyama T, 1981, SEISHIN IGAKU, V23, P1271; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Luders E, 2006, NEUROREPORT, V17, P1103, DOI 10.1097/01.wnr.0000227987.77304.cc; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; Miller MB, 2010, NEUROPSYCHOLOGIA, V48, P2215, DOI 10.1016/j.neuropsychologia.2010.02.021; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Piven J, 1997, AM J PSYCHIAT, V154, P1051; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; RAKIC P, 1968, J COMP NEUROL, V132, P45, DOI 10.1002/cne.901320103; RYMAR K, 1984, CORTEX, V20, P441, DOI 10.1016/S0010-9452(84)80013-1; Salat D, 1997, NEUROBIOL AGING, V18, P191, DOI 10.1016/S0197-4580(97)00014-6; Tanaka C, 2012, DEV NEUROSCI-BASEL, V34, P477, DOI 10.1159/000345152; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Uematsu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046970; Venkatasubramanian G, 2007, PSYCHIAT RES-NEUROIM, V156, P209, DOI 10.1016/j.pscychresns.2006.12.010; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; WOODRUFF PWR, 1995, J NEUROL NEUROSUR PS, V58, P457, DOI 10.1136/jnnp.58.4.457	48	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118760	10.1371/journal.pone.0118760	http://dx.doi.org/10.1371/journal.pone.0118760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790124	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400045
J	Aschacher, T; Wolf, B; Enzmann, F; Kienzl, P; Messner, B; Sampl, S; Svoboda, M; Mechtcheriakova, D; Holzmann, K; Bergmann, M				Aschacher, T.; Wolf, B.; Enzmann, F.; Kienzl, P.; Messner, B.; Sampl, S.; Svoboda, M.; Mechtcheriakova, D.; Holzmann, K.; Bergmann, M.			LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines	ONCOGENE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; EMBRYONIC STEM-CELLS; DNA-DAMAGE-RESPONSE; C-MYC; MAMMALIAN TELOMERES; CATALYTIC SUBUNIT; CANCER-CELLS; CHROMOSOME INSTABILITY; L1 RETROTRANSPOSITION; TERMINAL TRANSFERASE	A hallmark of cancer cells is an activated telomere maintenance mechanism, which allows prolonged survival of the malignant cells. In more than 80% of tumours, telomeres are elongated by the enzyme telomerase, which adds de novo telomere repeats to the ends of chromosomes. Cancer cells are also characterized by expression of active LINE-1 elements (L1s, long interspersed nuclear elements-1). L1 elements are abundant retrotransposons in the eukaryotic genome that are primarily known for facilitating aberrant recombination. Using L1-knockdown (KD), we show for the first time that L1 is critical for telomere maintenance in telomerase-positive tumour cells. The reduced length of telomeres in the L1-KD-treated cells correlated with an increased rate of telomere dysfunction foci, a reduced expression of shelterin proteins and an increased rate of anaphase bridges. The decreased telomere length was associated with a decreased telomerase activity and decreased telomerase mRNA level; the latter was increased upon L1 overexpression. L1-KD also led to a decrease in mRNA and protein expression of cMyc and KLF-4, two main transcription factors of telomerase and altered mRNA levels of other stem-cell-associated proteins such as CD44 and hMyb, as well as a corresponding reduced growth of spheroids. The KD of KLF-4 or cMyc decreased the level of L1-ORF1 mRNA, suggesting a specific reciprocal regulation with L1. Thus, our findings contribute to the understanding of L1 as a pathogenicity factor in cancer cells. As L1 is only expressed in pathophysiological conditions, L1 now appears to be target in the rational treatment of telomerase-positive cancer.	[Aschacher, T.; Messner, B.] Med Univ Vienna, Dept Surg, Cardiac Surg Res Labs, A-1090 Vienna, Austria; [Wolf, B.; Enzmann, F.; Kienzl, P.; Bergmann, M.] Med Univ Vienna, Dept Surg, Surg Res Labs, A-1090 Vienna, Austria; [Sampl, S.; Holzmann, K.] Inst Canc Res, Dept Med 1, Vienna, Austria; [Svoboda, M.; Mechtcheriakova, D.] Med Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria; [Mechtcheriakova, D.; Holzmann, K.; Bergmann, M.] Comprehens Canc Ctr Vienna, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Bergmann, M (corresponding author), Med Univ Vienna, Dept Surg, Surg Res Labs, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	michael.bergmann@meduniwien.ac.at	Enzmann, Florian K/U-6884-2019; Messner, Barbara/GLS-8150-2022; Bergmann, Michael/GZK-7700-2022; Holzmann, Klaus/I-4437-2019	Enzmann, Florian K/0000-0002-7200-4145; Messner, Barbara/0000-0001-8331-6497; Holzmann, Klaus/0000-0003-4077-3377; Bergmann, Michael/0000-0001-8529-1166; Kienzl, Philip/0000-0002-0114-6904; Wolf, Brigitte/0000-0003-2120-5614; Mechtcheriakova, Diana/0000-0002-8737-3592	Medical Scientific Fund of the Mayor of Vienna [10091]	Medical Scientific Fund of the Mayor of Vienna	We want to thank Roger Reddel and Bert Vogelstein for providing cell lines, Silvia Bacchetti for adenovirus expressing hTERT, Satoru Kyo for hTERT promoter constructs. Furthermore, we appreciate the critical discussion with members of the Surgical Research Laboratories of the Medical University of Vienna, as well as with Igor Bondarev, Roger Reddel, Berthold Streubl and Wolfgang Kostler. Further, we appreciate the critical reading of the manuscript by Walter Berger and Christine Brostjan. SS and KH were supported by the Medical Scientific Fund of the Mayor of Vienna #10091.	Ahmad K, 1999, GENETICS, V151, P1041; Aoki Y, 2012, GENOME MED, V4, DOI 10.1186/gm402; Aschacher T, 2012, NEOPLASIA, V14, P44, DOI 10.1593/neo.11426; Atsumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023432; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; BLACKBURN EH, 1991, TRENDS BIOCHEM SCI, V16, P378, DOI 10.1016/0968-0004(91)90155-O; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Cesare AJ, 2013, MOL CELL, V51, P141, DOI 10.1016/j.molcel.2013.06.006; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; Choi KH, 2011, NUCLEIC ACIDS RES, V39, P9206, DOI 10.1093/nar/gkr665; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Dai LX, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-18; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2010, COLD SH Q B, V75, P167, DOI 10.1101/sqb.2010.75.017; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; Ergun S, 2004, J BIOL CHEM, V279, P27753, DOI 10.1074/jbc.M312985200; Fang JL, 2009, TOXICOL SCI, V111, P120, DOI 10.1093/toxsci/kfp136; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Grandjenette C, 2014, NEOPLASIA, V16, P511, DOI 10.1016/j.neo.2014.05.009; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Grusch Michael, 2009, V515, P125, DOI 10.1007/978-1-59745-559-6_8; Guiducci C, 2001, EXP CELL RES, V265, P304, DOI 10.1006/excr.2001.5189; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Hao Huang, 2008, J Exp Clin Cancer Res, V27, P27, DOI 10.1186/1756-9966-27-27; Hao LY, 2004, J BIOL CHEM, V279, P45148, DOI 10.1074/jbc.M403924200; Haoudi A, 2004, J BIOMED BIOTECHNOL, P185, DOI 10.1155/S1110724304403131; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hochreiter AE, 2006, CLIN CANCER RES, V12, P3184, DOI 10.1158/1078-0432.CCR-05-2760; Hu XY, 2009, NUCLEOS NUCLEOT NUCL, V28, P1, DOI 10.1080/15257770802581633; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kolosha VO, 2003, J BIOL CHEM, V278, P8112, DOI 10.1074/jbc.M210487200; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Montoya-Durango DE, 2009, MUTAT RES-FUND MOL M, V665, P20, DOI 10.1016/j.mrfmmm.2009.02.011; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Ohka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023332; Oricchio E, 2007, ONCOGENE, V26, P4226, DOI 10.1038/sj.onc.1210214; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qian YQ, 2014, CELL IMMUNOL, V289, P63, DOI 10.1016/j.cellimm.2014.03.009; Rodic N, 2014, AM J PATHOL, V184, P1280, DOI 10.1016/j.ajpath.2014.01.007; Sampl S, 2012, TRANSL ONCOL, V5, P56, DOI 10.1593/tlo.11202; Schneider-Stock R, 2003, J PATHOL, V199, P517, DOI 10.1002/path.1315; Sciamanna E, 2005, ONCOGENE, V24, P3923, DOI 10.1038/sj.onc.1208562; Sciamanna I, 2013, ONCOTARGET, V4, P2271, DOI 10.18632/oncotarget.1403; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Sinibaldi-Vallebona Paola, 2011, Cancers (Basel), V3, P1141, DOI 10.3390/cancers3011141; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takakura M, 1999, CANCER RES, V59, P551; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Vitullo P, 2012, MOL REPROD DEV, V79, P118, DOI 10.1002/mrd.22003; Wallace NA, 2008, GENE, V419, P75, DOI 10.1016/j.gene.2008.04.013; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Wong CW, 2010, STEM CELLS, V28, P1510, DOI 10.1002/stem.477; Xi LH, 2014, NUCLEIC ACIDS RES, V42, P8565, DOI 10.1093/nar/gku560	81	37	39	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2016	35	1					94	104		10.1038/onc.2015.65	http://dx.doi.org/10.1038/onc.2015.65			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DA4ZT	25798839				2022-12-26	WOS:000367812400009
J	Choi, JE; Kwon, JH; Kim, JH; Hur, W; Sung, PS; Choi, SW; Yoon, SK				Choi, Jung Eun; Kwon, Jung Hyun; Kim, Jung-Hee; Hur, Wonhee; Sung, Pil Soo; Choi, Sang Wook; Yoon, Seung Kew			Suppression of Dual Specificity Phosphatase I Expression Inhibits Hepatitis C Virus Replication	PLOS ONE			English	Article							RIBAVIRIN COMBINATION THERAPY; PLUS RIBAVIRIN; UP-REGULATION; INTERFERON; HCV; SOFOSBUVIR; LEDIPASVIR; PREDICT	It was reported that dual specificity phosphatase 1 (DUSP1) is specifically upregulated in the liver of patients with chronic hetpatitis C virus (HCV) infection who do not respond to peginterferon (PegIFN) treatment. Here, we have investigated the role of DUSP1 in HCV replication in hepatoma cells stably expressing the full HCV replicon (FK). DUSP1 was silenced in cells harboring the FK replicon using a lentiviral vector encoding a DUSP1-specific short hairpin RNA (LV-shDUSP1). We demonstrated that knock-down of DUSP1 significantly inhibited HCV RNA and protein expression. Also, DUSP1 silencing enhanced the expression of phosphorylated signal transducer and activator of transcription 1 (phosho-STAT1) and facilitated the translocation of STAT1 into the nucleus. The mRNA expression levels of myxovirus resistance protein A (MxA), 2'-5'-oligoadenylate synthetase 1 (OAS1), ISG15 ubiquitin-like modifier (ISG15), chemokine C-X-C motif ligand 10 (CXCL10), and ubiquitin-specific protease 18 (USP18) were also accelerated by silencing of DUSP1. Furthermore, combined with the IFN treatment, DUSP1 silencing synergistically decreased the levels of HCV RNA. These results suggest that suppression of DUSP1 expression enhances phosphorylation and nuclear translocation of STAT1, resulting in increasing expression of interferon-stimulated genes (ISGs), which synergizes with IFN's antiviral effect against HCV. In conclusion, DUSP1 is involved in the antiviral host defense mechanism against a HCV infection and thus DUSP1 might be a target to treat chronic HCV infection.	[Choi, Jung Eun; Kwon, Jung Hyun; Kim, Jung-Hee; Hur, Wonhee; Choi, Sang Wook; Yoon, Seung Kew] Catholic Univ Korea, Catholic Univ Liver Res Ctr, Seoul, South Korea; [Choi, Jung Eun; Kwon, Jung Hyun; Kim, Jung-Hee; Hur, Wonhee; Choi, Sang Wook; Yoon, Seung Kew] Catholic Univ Korea, WHO Collaborating Ctr Hepatitis, Seoul, South Korea; [Kwon, Jung Hyun] Catholic Univ Korea, Dept Internal Med, Incheon St Marys Hosp, Incheon, South Korea; [Sung, Pil Soo] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea; [Choi, Sang Wook] Catholic Univ Korea, St Paul Hosp, Dept Internal Med, Seoul, South Korea; [Yoon, Seung Kew] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Korea Advanced Institute of Science & Technology (KAIST); Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Yoon, SK (corresponding author), Catholic Univ Korea, Catholic Univ Liver Res Ctr, Seoul, South Korea.	yoonsk@catholic.ac.kr	Sung, Pil Soo/AAD-6344-2021; Sung, Pil Soo/K-2072-2019	Sung, Pil Soo/0000-0002-5780-9607; 	Ministry of Science, ICT and Basic Science Research Program [NRF-2013M3A9C4078136, NRF-2012R1A2A1A01001941]; Future Planning through the National Research Foundation	Ministry of Science, ICT and Basic Science Research Program; Future Planning through the National Research Foundation(National Research Foundation of Korea)	This research was supported by grants of Bio-Synergy Research Project (NRF-2013M3A9C4078136) of the Ministry of Science, ICT and Basic Science Research Program (NRF-2012R1A2A1A01001941) and Future Planning through the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Ajakaiye MA, 2011, BIOCHEM BIOPH RES CO, V409, P406, DOI 10.1016/j.bbrc.2011.05.007; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Choi JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091958; Choi JE, 2011, CANCER LETT, V303, P99, DOI 10.1016/j.canlet.2011.01.015; Duong FHT, 2004, GASTROENTEROLOGY, V126, P263, DOI 10.1053/j.gastro.2003.10.076; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Lawitz E, 2011, ANTIVIR RES, V89, P238, DOI 10.1016/j.antiviral.2011.01.003; Leelawat K, 2010, J CANCER RES CLIN, V136, P1537, DOI 10.1007/s00432-010-0811-1; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Liu DX, 2002, BIOCHEM BIOPH RES CO, V299, P574, DOI 10.1016/S0006-291X(02)02694-3; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022; Zhang YL, 2009, J BIOL CHEM, V284, P30815, DOI 10.1074/jbc.M109.052472	27	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119172	10.1371/journal.pone.0119172	http://dx.doi.org/10.1371/journal.pone.0119172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798824	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300034
J	Dalton, DL; Linden, B; Wimberger, K; Nupen, LJ; Tordiffe, ASW; Taylor, PJ; Madisha, MT; Kotze, A				Dalton, Desire L.; Linden, Birthe; Wimberger, Kirsten; Nupen, Lisa Jane; Tordiffe, Adrian S. W.; Taylor, Peter John; Madisha, M. Thabang; Kotze, Antoinette			New Insights into Samango Monkey Speciation in South Africa	PLOS ONE			English	Article							CERCOPITHECUS-MITIS; MICROSATELLITE MARKERS; PAPIO-HAMADRYAS; LINKAGE MAP; SOFTWARE; DNA; IDENTIFICATION; CONSERVATION; POLYMORPHISMS; INFERENCE	The samango monkey is South Africa's only exclusively forest dwelling primate and represents the southernmost extent of the range of arboreal guenons in Africa. The main threats to South Africa's forests and thus to the samango are linked to increasing land- use pressure and increasing demands for forest resources, resulting in deforestation, degradation and further fragmentation of irreplaceable habitats. The species belongs to the highly polytypic Cercopithecus nictitans group which is sometimes divided into two species C. mitis and C. albogularis. The number of subspecies of C. albogularis is also under debate and is based only on differences in pelage colouration and thus far no genetic research has been undertaken on South African samango monkey populations. In this study we aim to further clarify the number of samango monkey subspecies, as well as their respective distributions in South Africa by combining molecular, morphometric and pelage data. Overall, our study provides the most comprehensive view to date into the taxonomic description of samango monkeys in South Africa. Our data supports the identification of three distinct genetic entities namely; C. a. labiatus, C. a. erythrarchus and C. a. schwarzi and argues for separate conservation management of the distinct genetic entities defined by this study.	[Dalton, Desire L.; Nupen, Lisa Jane; Tordiffe, Adrian S. W.; Madisha, M. Thabang; Kotze, Antoinette] Natl Zool Gardens South Africa, Pretoria, South Africa; [Dalton, Desire L.; Kotze, Antoinette] Univ Orange Free State, Dept Genet, Bloemfontein, South Africa; [Linden, Birthe] Univ Venda, Sch Math & Nat Sci, Dept Zool, Thohoyandou, South Africa; [Linden, Birthe; Taylor, Peter John] Univ Venda, Sch Math & Nat Sci, SARChI Chair Biodivers Value & Change Vhembe Bios, Thohoyandou, South Africa; [Wimberger, Kirsten] Univ Cape Town, Dept Biol Sci, ZA-7700 Rondebosch, South Africa; [Nupen, Lisa Jane] Univ Cape Town, Dept Biol Sci, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Tordiffe, Adrian S. W.] Univ Pretoria, Fac Vet Sci, Dept Compan Anim Clin Studies, ZA-0110 Onderstepoort, South Africa	National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of the Free State; University of Venda; University of Venda; University of Cape Town; University of Cape Town; University of Pretoria	Dalton, DL (corresponding author), Natl Zool Gardens South Africa, Pretoria, South Africa.	desire@nzg.ac.za	Taylor, Peter/E-8655-2011; Taylor, Peter John/N-3172-2019; Tordiffe, Adrian/T-4517-2017	Taylor, Peter/0000-0001-9048-7366; Tordiffe, Adrian/0000-0001-5416-3153; Nupen, Lisa/0000-0003-1030-6057; Dalton, Desire Lee/0000-0001-5975-6425; Madisha, M. Thabang/0000-0002-7295-9283; Wimberger, Kirsten/0000-0002-8420-0987	National Research Foundation (NRF); Department of Science Technology (DST) through the SARChI Chair on Biodiversity Value Change in the Vhembe Biosphere; NRF; National Zoological Gardens of South Africa (NZG); University of Venda; Ezemvelo KZN Wildlife; Novartis South African Veterinary Foundation Wildlife Research Fund; Primate Conservation Inc; Mazda Wildlife Fund [BD06MZGP]	National Research Foundation (NRF); Department of Science Technology (DST) through the SARChI Chair on Biodiversity Value Change in the Vhembe Biosphere(Department of Science & Technology (India)); NRF; National Zoological Gardens of South Africa (NZG); University of Venda; Ezemvelo KZN Wildlife; Novartis South African Veterinary Foundation Wildlife Research Fund; Primate Conservation Inc; Mazda Wildlife Fund	PJT acknowledges funding from the National Research Foundation (NRF) and Department of Science Technology (DST) through the SARChI Chair on Biodiversity Value Change in the Vhembe Biosphere. DLD, AK and ASWT acknowledge NRF and the National Zoological Gardens of South Africa (NZG) for organizational core grant funding of support of research. BL thanks the University of Venda for research funding for field work. ASWT and KW would like to thank Ezemvelo KZN Wildlife for providing funding for the sample collection at those sites. KW would like to thank Novartis South African Veterinary Foundation Wildlife Research Fund (Grant 13/11/2010), and Primate Conservation Inc, for project funding, and Mazda Wildlife Fund for sponsorship of a research vehicle (Number: BD06MZGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; [Anonymous], 1986, BIOINFORMATICS; Avise John C., 2004, P1; Bayes M. K., 2000, Conservation Genetics, V1, P173, DOI 10.1023/A:1026595324974; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Clifford SL, 1999, MOL ECOL, V8, P1556, DOI 10.1046/j.1365-294X.1999.07184.x; CONSTABLE JJ, 1995, NATURE, V373, P393, DOI 10.1038/373393a0; Coote T, 1996, J HERED, V87, P406, DOI 10.1093/oxfordjournals.jhered.a023026; Cotterill FPD, 2014, SYST BIOL, V63, P819, DOI 10.1093/sysbio/syu003; Dandelot P, 1974, MAMMALS AFRICA IDE 3, P1; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ekernas LS, 2007, ANIM BEHAV, V73, P1009, DOI 10.1016/j.anbehav.2006.11.007; Ely JJ, 1998, INT J PRIMATOL, V19, P255, DOI 10.1023/A:1020379531874; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 1992, WINAMOVA VER 1 55 AN; Friedmann Y, 2004, RED DATA BOOK MAMMAL; Gippoliti S, 2013, HYSTRIX ITA IN PRESS; Gippoliti S, 2012, HYSTRIX, V23, P8, DOI 10.4404/hystrix-23.2-8685; Grobler JP, 2006, ECOLOGICAL ENV ANTRO, V2, P12; Groves C.P., 2005, MAMMAL SPECIES WORLD, P111; Groves C.P., 2001, PRIMATE TAXONOMY; Groves CP, 2013, MAMM BIOL, V78, P7, DOI 10.1016/j.mambio.2012.09.009; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hart JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044271; Heller R, 2013, SYST BIOL, V62, P490, DOI 10.1093/sysbio/syt004; HENZI SP, 1987, FOLIA PRIMATOL, V48, P125, DOI 10.1159/000156290; HENZI SP, 1988, INT J PRIMATOL, V9, P479, DOI 10.1007/BF02736221; Hsieh HM, 2001, FORENSIC SCI INT, V122, P7, DOI 10.1016/S0379-0738(01)00403-0; Hudson RR, 1992, MOL BIOL EVOL, V23, P254; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kayser M, 1996, MOL ECOL, V5, P157, DOI 10.1111/j.1365-294X.1996.tb00302.x; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kingdon J, 2013, KINGDON FIELD GUIDE; LAWES MJ, 1990, J BIOGEOGR, V17, P669, DOI 10.2307/2845148; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Morin PA, 1997, AM J PRIMATOL, V42, P199, DOI 10.1002/(SICI)1098-2345(1997)42:3<199::AID-AJP3>3.0.CO;2-S; Morin PA, 1998, GENOMICS, V53, P12, DOI 10.1006/geno.1998.5460; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Napier PH, 1981, CATALOGUE PRIMATES 3; Palumbi S.R, 1991, SIMPLE FOOLS GUIDE P; Park SDE, 2001, EXC MICR TOOLK; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perelygin AA, 1996, CYTOGENET CELL GENET, V75, P207, DOI 10.1159/000134484; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roberts A., 1951, MAMMALS S AFRICA; Rogers J, 2000, GENOMICS, V67, P237, DOI 10.1006/geno.2000.6245; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos C, 2011, FUTURE TRENDS PRIMAT, P9; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruiz-Garcia M, 2007, FOLIA PRIMATOL, V78, P73, DOI 10.1159/000097058; Skinner J.D., 2006, MAMMALS S AFRICAN SU; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEBER JL, 1989, AM J HUM GENET, V44, P388; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; XIONG B, 1991, GENOME, V34, P306, DOI 10.1139/g91-050; Yan Guangmei, 2011, Nat Biotechnol, V29, P1019, DOI 10.1038/nbt.1992; Zachos FE, 2013, NATURE, V494, P35, DOI 10.1038/494035c; Zachos FE, 2013, MAMM BIOL, V78, P1, DOI 10.1016/j.mambio.2012.07.083; Zhang YW, 2001, CONSERV GENET, V2, P391, DOI 10.1023/A:1012594626095	70	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0117003	10.1371/journal.pone.0117003	http://dx.doi.org/10.1371/journal.pone.0117003			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798604	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300003
J	van der Zwaluw, K; de Haan, A; Pluister, GN; Bootsma, HJ; de Neeling, AJ; Schouls, LM				van der Zwaluw, Kim; de Haan, Angela; Pluister, Gerlinde N.; Bootsma, Hester J.; de Neeling, Albert J.; Schouls, Leo M.			The Carbapenem Inactivation Method (CIM), a Simple and Low-Cost Alternative for the Carba NP Test to Assess Phenotypic Carbapenemase Activity in Gram-Negative Rods	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; BETA-LACTAMASE GENE; RAPID DETECTION; MULTIPLEX PCR; KLEBSIELLA-PNEUMONIAE; ENTEROBACTERIACEAE; RESISTANCE; ACINETOBACTER; PSEUDOMONAS	A new phenotypic test, called the Carbapenem Inactivation Method (CIM), was developed to detect carbapenemase activity in Gram-negative rods within eight hours. This method showed high concordance with results obtained by PCR to detect genes coding for the carbapenemases KPC, NDM, OXA-48, VIM, IMP and OXA-23. It allows reliable detection of carbapenemase activity encoded by various genes in species of Enterobacteriaceae (e.g., Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae), but also in non-fermenters Pseudomonas aeruginosa and Acinetobacter baumannii. The CIM was shown to be a cost-effective and highly robust phenotypic screening method that can reliably detect carbapenemase activity.	[van der Zwaluw, Kim; de Haan, Angela; Pluister, Gerlinde N.; Bootsma, Hester J.; de Neeling, Albert J.; Schouls, Leo M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diagnost & Screening IDS, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	van der Zwaluw, K (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diagnost & Screening IDS, Bilthoven, Netherlands.	Kim.van.der.Zwaluw@rivm.nl		de Haan, Angela/0000-0003-1916-1835; de Neeling, Albert Johannes/0000-0001-8578-1990				Anthony RM, 2000, J CLIN MICROBIOL, V38, P781, DOI 10.1128/JCM.38.2.781-788.2000; Burckhardt I, 2011, J CLIN MICROBIOL, V49, P3321, DOI 10.1128/JCM.00287-11; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dortet L, 2014, J CLIN MICROBIOL, V52, P2359, DOI 10.1128/JCM.00594-14; Dortet L, 2014, J MED MICROBIOL, V63, P772, DOI 10.1099/jmm.0.071340-0; Dortet L, 2012, J CLIN MICROBIOL, V50, P3773, DOI 10.1128/JCM.01597-12; El Salabi A, 2013, CRIT REV MICROBIOL, V39, P113, DOI 10.3109/1040841X.2012.691870; Hrabak J, 2011, J CLIN MICROBIOL, V49, P3222, DOI 10.1128/JCM.00984-11; Jacoby GA, 2004, ANTIMICROB AGENTS CH, V48, P3203, DOI 10.1128/AAC.48.8.3203-3206.2004; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031676; Knox J, 2014, J CLIN MICROBIOL, V52, P4075, DOI 10.1128/JCM.02121-14; Lauretti L, 1999, ANTIMICROB AGENTS CH, V43, P1584, DOI 10.1128/AAC.43.7.1584; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Livermore DM, 2001, J ANTIMICROB CHEMOTH, V47, P247, DOI 10.1093/jac/47.3.247; MASUDA G, 1976, J ANTIBIOT, V29, P662, DOI 10.7164/antibiotics.29.662; Miriagou V, 2010, ANTIMICROB AGENTS CH, V54, P4497, DOI 10.1128/AAC.00665-10; Nordmann P, 2014, MED MALADIES INFECT, V44, P51, DOI 10.1016/j.medmal.2013.11.007; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Papagiannitsis CC, 2012, ANTIMICROB AGENTS CH, V56, P4024, DOI 10.1128/AAC.00470-12; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Tijet Nathalie, 2013, Antimicrob Agents Chemother, V57, P4578, DOI 10.1128/AAC.00878-13; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Zhao WH, 2011, CRIT REV MICROBIOL, V37, P214, DOI 10.3109/1040841X.2011.559944	27	233	246	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0123690	10.1371/journal.pone.0123690	http://dx.doi.org/10.1371/journal.pone.0123690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798828	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300344
J	Bernard, MA; Wang, LY; Tachado, SD				Bernard, Mark A.; Wang, Leyu; Tachado, Souvenir D.			DICER-ARGONAUTE2 Complex in Continuous Fluorogenic Assays of RNA Interference Enzymes	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; NUCLEAR EXPORT; PROTEIN; DECAY; RIBONUCLEASE; ARGONAUTE2; CLEAVAGE; KINETICS; EXOSOME	Mechanistic studies of RNA processing in the RNA-Induced Silencing Complex (RISC) have been hindered by lack of methods for continuous monitoring of enzymatic activity. "Quencherless" fluorogenic substrates of RNAi enzymes enable continuous monitoring of enzymatic reactions for detailed kinetics studies. Recombinant RISC enzymes cleave the fluorogenic substrates targeting human thymidylate synthase (TYMS) and hypoxiainducible factor 1-alpha subunit (HIF1A). Using fluorogenic dsRNA DICER substrates and fluorogenic siRNA, DICER+ARGONAUTE2 mixtures exhibit synergistic enzymatic activity relative to either enzyme alone, and addition of TRBP does not enhance the apparent activity. Titration of AGO2 and DICER in enzyme assays suggests that AGO2 and DICER form a functional high-affinity complex in equimolar ratio. DICER and DICER+AGO2 exhibit Michaelis-Menten kinetics with DICER substrates. However, AGO2 cannot process the fluorogenic siRNA without DICER enzyme, suggesting that AGO2 cannot self-load siRNA into its active site. The DICER+AGO2 combination processes the fluorogenic siRNA substrate (K-m=74 nM) with substrate inhibition kinetics (K-i=105 nM), demonstrating experimentally that siRNA binds two different sites that affect Dicing and AGO2-loading reactions in RISC. This result suggests that siRNA (product of DICER) bound in the active site of DICER may undergo direct transfer (as AGO2 substrate) to the active site of AGO2 in the DICER+AGO2 complex. Competitive substrate assays indicate that DICER+AGO2 cleavage of fluorogenic siRNA is specific, since unlabeled siRNA and DICER substrates serve as competing substrates that cause a concentration-dependent decrease in fluorescent rates. Competitive substrate assays of a series of DICER substrates in vitro were correlated with cell-based assays of HIF1A mRNA knockdown (log-log slope=0.29), suggesting that improved DICER substrate designs with 10-fold greater processing by the DICER+AGO2 complex can provide a strong (similar to 2800-fold) improvement in potency for mRNA knockdown. This study laysthe foundation of a systematic biochemical approach to optimize nucleic acid-based therapeutics for Dicing and ARGONAUTE2-loading for improving efficacy.	[Bernard, Mark A.; Wang, Leyu] Pfizer Oligonucleotide Therapeut Unit, Dept Target Biol, Cambridge, MA USA; [Bernard, Mark A.] Pfizer Global Biotherapeut Technol Unit, Dept Prot Biol, Cambridge, MA USA; [Bernard, Mark A.; Tachado, Souvenir D.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Bernard, Mark A.; Tachado, Souvenir D.] Harvard Univ, Sch Med, Boston, MA USA	Pfizer; Pfizer; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Bernard, MA (corresponding author), Omniome Inc, Dept Enzymol, La Jolla, CA 92037 USA.	MarkABernard@hotmail.com		Tachado, Souvenir/0000-0002-8368-6102; Bernard, Mark/0000-0001-7141-2975	Pfizer Inc.; National Institutes of Health [2R56HL092811]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL092811] Funding Source: NIH RePORTER	Pfizer Inc.(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MAB and LW received salary from Pfizer Inc. but are no longer affiliated with Pfizer. This work was supported by the National Institutes of Health grant 2R56HL092811 (to SDT). The National Institutes of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer Oligonucleotide Therapeutics Unit had a role in funding, study design, data collection and analysis, and gave permission to publish the manuscript, but had no role in manuscript preparation. Pfizer Global Biotherapeutics Technology Unit had a role in funding and data collection, but had no role in study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are listed in the authors contributions section.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; DiNitto JP, 2010, BIOTECHNIQUES, V48, P303, DOI 10.2144/000113402; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fritz DT, 2004, CELL BIOCHEM BIOPHYS, V41, P265, DOI 10.1385/CBB:41:2:265; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kurata S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e34; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Li F, 2012, CHEM COMMUN, V48, P12192, DOI 10.1039/c2cc36404b; Lima WF, 2009, J BIOL CHEM, V284, P26017, DOI 10.1074/jbc.M109.010835; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu XK, 2007, ANAL BIOCHEM, V360, P154, DOI 10.1016/j.ab.2006.10.011; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Parniak MA, 2003, ANAL BIOCHEM, V322, P33, DOI 10.1016/j.ab.2003.06.001; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Tani H, 2007, ANAL BIOCHEM, V369, P105, DOI 10.1016/j.ab.2007.06.047; Torimura M, 2001, ANAL SCI, V17, P155, DOI 10.2116/analsci.17.155; Van Dijk EL, 2007, RNA, V13, P1027, DOI 10.1261/rna.575107; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang LY, 2008, PROTEIN EXPRES PURIF, V61, P204, DOI 10.1016/j.pep.2008.05.017; Wasilko D., 2006, BIOPROCESS J, V5, P29, DOI [10.12665/J53.WasilkoLee, DOI 10.12665/J53.WASILKOLEE]; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Werner A, 2012, BIOL CHEM, V393, P187, DOI 10.1515/hsz-2011-0202; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	30	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120614	10.1371/journal.pone.0120614	http://dx.doi.org/10.1371/journal.pone.0120614			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793518	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900059
J	Bogaerts, E; Heindryckx, F; Devisscher, L; Paridaens, A; Vandewynckel, YP; Van den Bussche, A; Verhelst, X; Libbrecht, L; van Grunsven, LA; Geerts, A; Van Vlierberghe, H				Bogaerts, Eliene; Heindryckx, Femke; Devisscher, Lindsey; Paridaens, Annelies; Vandewynckel, Yves-Paul; Van den Bussche, Anja; Verhelst, Xavier; Libbrecht, Louis; van Grunsven, Leo A.; Geerts, Anja; Van Vlierberghe, Hans			Time-Dependent Effect of Hypoxia on Tumor Progression and Liver Progenitor Cell Markers in Primary Liver Tumors	PLOS ONE			English	Article							PLACENTAL GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; CYTOKERATIN-19 EXPRESSION; INDUCIBLE FACTOR; FACTOR-BETA; HEPATOCYTES; INHIBITION; CHOLANGIOCARCINOMA; CHEMORESISTANCE; RESISTANCE	Background & Aims Expression of liver progenitor cell (LPC) characteristics has been proposed as a negative prognostic marker in primary liver tumors. Hypoxia has been linked to activation of the Notch pathway which is responsible for activation and proliferation of LPCs and hypoxia- induced LPC activation has been shown in hepatocellular carcinoma. Our aim was to elucidate the time-dependent effects of hypoxia on the LPC niche in hepatocellular carcinoma which could aid in determining a safe time frame for use of hypoxia inducing therapies. Methods We used dimethyloxaloylglycine to mimic a hypoxic reaction in mice by stabilizing hypoxia-inducible factor 1 alpha at three distinct time points in diethylnitrosamine induced hepatocarcinogenesis. LPC, metastasis and Notch pathway markers were determined by quantitative PCR and (immune) histochemistry (heamatoxillin-eosin, reticulin, Sirius red and cytokeratin 19 staining). Results Activating the hypoxia inducible pathway early in hepatocarcinogenesis resulted in an increased incidence of both cholangioma and hepatocellular lesions, associated with high expression of LPC, metastatic and Notch pathway markers. Adversely, activating the hypoxic response during tumor development resulted in decreased incidence of hepatocellular lesions and increased cholangioma incidence, with an unaltered gene expression profile of LPC-, Notch pathway-and metastatic markers. A hypoxic insult at advanced stages of hepatocarcinogenesis severely increased the expression of LPC characteristics, however without increased expression of actors of the Notch pathway and metastatic markers and minor changes in incidence of hepatocellular and cholangioma lesions. Conclusion Our results indicate that increased hypoxia at the onset of tumor development has detrimental effects on tumor progression; patients with HCC developed in a background of fibrosis/cirrhosis might therefore represent a more difficult treatment group. In contrast, hypoxia during tumor development appears to favor tumor outcome, highlighting the importance of early detection. Finally, hypoxia in advanced stages resulted in increased expression of LPC characteristics indicating poor outcome.	[Bogaerts, Eliene; Devisscher, Lindsey; Paridaens, Annelies; Vandewynckel, Yves-Paul; Van den Bussche, Anja; Verhelst, Xavier; Geerts, Anja; Van Vlierberghe, Hans] Univ Ghent, Gastroenterol & Hepatol, B-9000 Ghent, Belgium; [Heindryckx, Femke] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Libbrecht, Louis] Univ Hosp Ghent, Dept Pathol, Ghent, Belgium; [van Grunsven, Leo A.] Vrije Univ Brussel, Liver Cell Biol Lab, Brussels, Belgium	Ghent University; Uppsala University; Ghent University; Ghent University Hospital; Vrije Universiteit Brussel	Van Vlierberghe, H (corresponding author), Univ Ghent, Gastroenterol & Hepatol, B-9000 Ghent, Belgium.	hans.vanvlierberghe@ugent.be	van Grunsven, Leo/E-5839-2010; Devisscher, Lindsey/AAD-5969-2021; Vandewynckel, Yves-Paul/H-3699-2019; Verhelst, Xavier/ABF-6965-2021	van Grunsven, Leo/0000-0002-0990-7034; Devisscher, Lindsey/0000-0003-4862-9580; Vandewynckel, Yves-Paul/0000-0002-7829-6732; Verhelst, Xavier/0000-0002-2798-5415; geerts, anja/0000-0002-2218-9081; Van Vlierberghe, Hans/0000-0003-0647-9238; Heindryckx, Femke/0000-0002-1987-7676	research foundation Flanders (FWO) project [G033313N]; "Emmanuel van der Schueren" grant by the flemmish league against cancer (VLK); Wenner-Gren Foundation-Sweden; Ghent University [01D20510, B/12531/01]	research foundation Flanders (FWO) project(FWO); "Emmanuel van der Schueren" grant by the flemmish league against cancer (VLK); Wenner-Gren Foundation-Sweden; Ghent University(Ghent University)	This study was supported by the research foundation Flanders (FWO) project (G033313N) and Xavier Verhelst and Hans Van Vlierberghe are clinical investigators for the research foundation Flanders (FWO) (www.FWO.be). Eliene Bogaerts was funded by an "Emmanuel van der Schueren" grant by the flemmish league against cancer (VLK). Femke Heindryckx received funding from the Wenner-Gren Foundation-Sweden. Lindsey Devisscher and Yves-Paul Vandewynckel are supported by a grant of the special research fund (BOF) from Ghent University (01D20510 and B/12531/01) (www.UGent.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogaerts E, 2014, INT J ONCOL, V44, P1015, DOI 10.3892/ijo.2014.2286; Borght SV, 2008, LIVER INT, V28, P1370, DOI 10.1111/j.1478-3231.2008.01889.x; Boulter L, 2012, NAT MED; Choi BY, 2005, J CLIN GASTROENTEROL, V39, P401, DOI 10.1097/01.mcg.0000159226.63037.a2; Copple BL, 2010, LIVER INT, V30, P669, DOI 10.1111/j.1478-3231.2010.02205.x; Devisscher L, 2011, BIOCHEM BIOPH RES CO, V416, P307, DOI 10.1016/j.bbrc.2011.11.031; Ding SJ, 2004, MOL CELL PROTEOMICS, V3, P73, DOI 10.1074/mcp.M300094-MCP200; Durnez A, 2006, HISTOPATHOLOGY, V49, P138, DOI 10.1111/j.1365-2559.2006.02468.x; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Geerts AM, 2008, INT J EXP PATHOL, V89, P251, DOI 10.1111/j.1365-2613.2008.00597.x; Govaere O, 1468, KERATIN 19 KEY ROLE, P1468; Heindryckx F CS, 2012, J HEPATOL UNPUB; Heindryckx F, 2013, J HEPATOL, V58, P319, DOI 10.1016/j.jhep.2012.09.032; Heindryckx F, 2012, EUR J GASTROEN HEPAT, V24, P1020, DOI 10.1097/MEG.0b013e3283554219; Heindryckx F, 2012, J HEPATOL, V57, P61, DOI 10.1016/j.jhep.2012.02.021; Heindryckx F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-219; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lau CK, 2009, CLIN CANCER RES, V15, P3462, DOI 10.1158/1078-0432.CCR-08-2127; Liang YJ, 2013, HEPATOLOGY, V57, P1847, DOI 10.1002/hep.26224; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Michalopoulos GK, 2002, HEPATOLOGY, V36, P278, DOI 10.1053/jhep.2002.34858; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Roskams TA, 2003, SEMIN LIVER DIS, V23, P385; Sapisochin G, 2011, LIVER TRANSPLANT, V17, P934, DOI 10.1002/lt.22307; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Strazzabosco M, 2013, J HEPATOL, V58, P181, DOI 10.1016/j.jhep.2012.08.006; Timme CR, 2013, APOPTOSIS, V18, P1163, DOI 10.1007/s10495-013-0883-x; Uenishi T, 2003, CANCER SCI, V94, P851, DOI 10.1111/j.1349-7006.2003.tb01366.x; Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820; Van Steenkiste C, 2011, HEPATOLOGY, V53, P1629, DOI 10.1002/hep.24238; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Yang W, 2012, J HEPATOL, V57, P613, DOI 10.1016/j.jhep.2012.04.024; Zen C, 2011, LIVER TRANSPLANT, V17, P943, DOI 10.1002/lt.22314; Zhang CC, 2013, STEM CELL TRANSL MED, V2, P233, DOI 10.5966/sctm.2012-0096; Zulehner G, 2010, AM J PATHOL, V176, P472, DOI 10.2353/ajpath.2010.090300	41	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119555	10.1371/journal.pone.0119555	http://dx.doi.org/10.1371/journal.pone.0119555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793288	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200095
J	Christiansen, IK; Sandve, GK; Schmitz, M; Durst, M; Hovig, E				Christiansen, Irene Kraus; Sandve, Geir Kjetil; Schmitz, Martina; Duerst, Matthias; Hovig, Eivind			Transcriptionally Active Regions Are the Preferred Targets for Chromosomal HPV Integration in Cervical Carcinogenesis	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CELLULAR FUSION TRANSCRIPTS; COMMON FRAGILE SITES; GENOMIC HYPERBROWSER; ANOGENITAL LESIONS; VIRAL INTEGRATION; CANCER; GENE; CHROMATIN; DNA	Integration of human papillomavirus (HPV) into the host genome is regarded as a determining event in cervical carcinogenesis. However, the exact mechanism for integration, and the role of integration in stimulating cancer progression, is not fully characterized. Although integration sites are reported to appear randomly distributed over all chromosomes, fragile sites, translocation break points and transcriptionally active regions have all been suggested as being preferred sites for integration. In addition, more recent studies have reported integration events occurring within or surrounding essential cancer-related genes, raising the question whether these may reflect key events in the molecular genesis of HPV induced carcinomas. In a search for possible common denominators of the integration sites, we utilized the chromosomal coordinates of 121 viral-cellular fusion transcripts, and examined for statistical overrepresentation of integration sites with various features of ENCODE chromatin information data, using the Genomic HyperBrowser. We find that integration sites coincide with DNA that is transcriptionally active in mucosal epithelium, as judged by the relationship of integration sites to DNase hypersensitivity and H3K4me3 methylation data. Finding an association between integration and transcription is highly informative with regard to the spatio-temporal characteristics of the integration process. These results suggest that integration is an early event in carcinogenesis, more than a late product of chromosomal instability. If the viral integrations were more likely to occur in destabilized regions of the DNA, a completely random distribution of the integration sites would be expected. As a by-product of integration in actively transcribing DNA, a tendency of integration in or close to genes is likely to be observed. This increases the possibility of viral signals to modulate the expression of these genes, potentially contributing to the progression towards cancer.	[Christiansen, Irene Kraus] Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway; [Sandve, Geir Kjetil; Hovig, Eivind] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Schmitz, Martina; Duerst, Matthias] Jena Univ Hosp, Dept Gynaecol, Jena, Germany; [Hovig, Eivind] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Inst Canc Genet & Informat, Oslo, Norway	University of Oslo; University of Oslo; Friedrich Schiller University of Jena; University of Oslo; University of Oslo	Christiansen, IK (corresponding author), Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway.	irene.kraus.christiansen@ahus.no	Hovig, Eivind/H-2474-2011	Hovig, Eivind/0000-0002-9103-1077; Sandve, Geir Kjetil/0000-0002-4959-1409; Christiansen, Irene Kraus/0000-0001-8850-3304	Norwegian Cancer Society [419936 71220 - PR-2006-0433]	Norwegian Cancer Society(Norwegian Cancer Society)	This work was in part supported by a grant to EH from the Norwegian Cancer Society (Grant #419936 71220 - PR-2006-0433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2014, GENOME RES, V24, P185, DOI 10.1101/gr.164806.113; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Collins SI, 2009, CANCER RES, V69, P3828, DOI 10.1158/0008-5472.CAN-08-3099; DURST M, 1987, P NATL ACAD SCI USA, V84, P1070, DOI 10.1073/pnas.84.4.1070; Gallo G, 2003, J CLIN PATHOL, V56, P532, DOI 10.1136/jcp.56.7.532; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gundersen S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-494; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; IARC, 2012, MONOGRAPHS ON THE EV, V100B; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Kulmala SMA, 2006, J CLIN PATHOL, V59, P513, DOI 10.1136/jcp.2004.024570; Li H, 2013, J CLIN VIROL, V56, P342, DOI 10.1016/j.jcv.2012.12.014; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Ojesina AI, 2013, NATURE, V10; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Reuter S, 1998, EMBO J, V17, P215, DOI 10.1093/emboj/17.1.215; ROSL F, 1993, J GEN VIROL, V74, P791, DOI 10.1099/0022-1317-74-5-791; Sandve GK, 2013, NUCLEIC ACIDS RES, V41, pW133, DOI 10.1093/nar/gkt342; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Thorland EC, 2000, CANCER RES, V60, P5916; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tjalma WA, 2013, INT J CANCER, V132, P854, DOI 10.1002/ijc.27713; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Van Tine B. A., 2001, V106, P381; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; Wentzensen N, 2007, DIS MARKERS, V23, P315, DOI 10.1155/2007/678793; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066693; Yu TX, 2005, CANCER GENET CYTOGEN, V158, P27, DOI 10.1016/j.cancergencyto.2004.08.021; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	37	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119566	10.1371/journal.pone.0119566	http://dx.doi.org/10.1371/journal.pone.0119566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793388	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200096
J	Eterovick, PC; Bar, LFF; Souza, JB; Castro, JFM; Leite, FSF; Alford, RA				Eterovick, Paula C.; Bar, Luis F. F.; Souza, Jorge B.; Castro, Jose F. M.; Leite, Felipe S. F.; Alford, Ross A.			Testing the Relationship between Human Occupancy in the Landscape and Tadpole Developmental Stress	PLOS ONE			English	Article							GLOBAL AMPHIBIAN DECLINES; FLUCTUATING ASYMMETRY; CONSERVATION; ANURA; STABILITY; ECOLOGY; QUALITY; BRAZIL; POPULATIONS; BOKERMANN	Amphibian population declines are widespread; the main causal factors are human related and include habitat fragmentation due to agriculture, mining, fires, and urban development. Brazil is the richest country in species of amphibians, and the Brazilian regions with the greatest amphibian diversity are experiencing relatively high rates of habitat destruction, but there are presently relatively few reports of amphibian declines. It is thus important to develop research methods that will detect deterioration in population health before severe declines occur. We tested the use of measurements of fluctuating asymmetry (FA) taken on amphibian larvae to detect anthropogenic stress. We hypothesized that greater human occupancy in the landscape might result in more stressful conditions for amphibians. We conducted this study at the Espinhaco mountain range in southeastern Brazil, using as a model an endemic species (Bokermannohyla saxicola, Hylidae). We chose two tadpole denticle rows and eye-nostril distance as traits for FA measurement. We measured percent cover of human-altered habitats in the landscape around tadpole sampling points and measured FA levels in sampled tadpoles. We found FA levels to differ among localities but found no relationship between human modification of the landscape and tadpole FA levels. Levels of FA in the traits we examined may not be strongly affected by environmental conditions, or may be affected by local variables that were not captured by our landscape-scale measures. Alternatively, populations may be genetically differentiated, affecting how FA levels respond to stress and obscuring the effects of anthropogenic disturbance.	[Eterovick, Paula C.; Bar, Luis F. F.] Pontificia Univ Catolica Minas Gerais, Programa Pos Grad Zool Vertebrados, Belo Horizonte, MG, Brazil; [Souza, Jorge B.; Castro, Jose F. M.] Pontificia Univ Catolica Minas Gerais, Programa Pos Grad Geog Tratamento Informacao Espa, Belo Horizonte, MG, Brazil; [Leite, Felipe S. F.] Univ Fed Vicosa, Inst Ciencias Biol & Saude, Florestal, MG, Brazil; [Alford, Ross A.] James Cook Univ, Ctr Trop Biodivers & Climate Change, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia	Pontificia Universidade Catolica de Minas Gerais; Pontificia Universidade Catolica de Minas Gerais; Universidade Federal de Vicosa; James Cook University	Eterovick, PC (corresponding author), Pontificia Univ Catolica Minas Gerais, Programa Pos Grad Zool Vertebrados, Belo Horizonte, MG, Brazil.	pceterovick@gmail.com	Leite, Felipe S. F. Sá Fortes/H-9179-2012; Eterovick, Paula Cabral/AGC-1678-2022; Souza, Jorge/ABF-2883-2020; Alford, Ross A/H-1577-2011	Leite, Felipe S. F. Sá Fortes/0000-0003-4561-5634; Eterovick, Paula Cabral/0000-0002-1316-1255; Alford, Ross A/0000-0002-3010-6768; Castro, Jose Flavio Morais/0000-0002-5387-7987	Fundo de Incentivo a Pesquisa (FIP) of the Pontificia Universidade Catolica de Minas Gerais (PUC-Minas) [FIP-2012/7485-2S]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [CRA-765/06]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq [301077/2010-0, 555081/2010-9]	Fundo de Incentivo a Pesquisa (FIP) of the Pontificia Universidade Catolica de Minas Gerais (PUC-Minas); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by Fundo de Incentivo a Pesquisa (FIP) of the Pontificia Universidade Catolica de Minas Gerais (PUC-Minas) (FIP-2012/7485-2S, http://www.pucminas.br). Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (CRA-765/06, http://www.fapemig.br/). Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/). A Research Productivity grant (301077/2010-0) was provided to PCE and a Masters scholarship (555081/2010-9) was provided to LFFB by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford R. A., 1999, DECLINES DISAPPEARAN, P34; Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Alford RA, 1999, TADPOLES, P240; Alford RA, 2007, NATURE, V447, pE3, DOI 10.1038/nature05940; Altig R, 1999, TADPOLES, P295; Alvarez D, 2002, FUNCT ECOL, V16, P640, DOI 10.1046/j.1365-2435.2002.00658.x; Beasley DE, 2013, ECOL INDIC, V30, P218, DOI 10.1016/j.ecolind.2013.02.024; Bebbee TJC., 1996, ECOLOGY CONSERVATION, P214; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; BERTOLUCI J, 1995, FROGLOG, V14, P2; Boorse GC, 2003, INTEGR COMP BIOL, V43, P646, DOI 10.1093/icb/43.5.646; BOYER R, 1995, ENVIRON HEALTH PERSP, V103, P352, DOI 10.2307/3432288; CHENG P., 2009, GEOINFORMATICS, V12, P36; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Dauwe T, 2006, ENVIRON POLLUT, V140, P71, DOI 10.1016/j.envpol.2005.06.024; Delgado-Acevedo J, 2008, CONSERV BIOL, V22, P773, DOI 10.1111/j.1523-1739.2008.00930.x; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Eterovick P.C., 2004, AMPHIBIANS SERRA CIP; Eterovick PC, 2006, HERPETOLOGICA, V62, P365, DOI 10.1655/0018-0831(2006)62[365:DOTWAA]2.0.CO;2; Eterovick Paula C., 2009, South American Journal of Herpetology, V4, P235, DOI 10.2994/057.004.0306; Eterovick PC, 2005, BIOTROPICA, V37, P166, DOI 10.1111/j.1744-7429.2005.00024.x; Eterovick PC, 2001, J HERPETOL, V35, P442, DOI 10.2307/1565962; Leite FSF, 2012, HERPETOLOGICA, V68, P401, DOI 10.1655/HERPETOLOGICA-D-11-00006.1; Gardner T., 2001, Animal Biodiversity and Conservation, V24, P25; Gosner K. L., 1960, Herpetologica, V16, P183; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Guix Juan C., 1998, Herpetological Natural History, V6, P1; Hamer AJ, 2008, BIOL CONSERV, V141, P2432, DOI 10.1016/j.biocon.2008.07.020; Hels T, 2002, ECOGRAPHY, V25, P303, DOI 10.1034/j.1600-0587.2002.250307.x; HEYER WR, 1988, BIOTROPICA, V20, P230, DOI 10.2307/2388238; Hogg ID, 2001, J APPL ECOL, V38, P1326, DOI 10.1046/j.0021-8901.2001.00682.x; Izecksohn E, 2001, ANFIBIOS MUNICIPIO R; Kark S, 2001, HEREDITY, V86, P119, DOI 10.1038/sj/hdy/6888560; Kellner JR, 2003, AM NAT, V161, P931, DOI 10.1086/375177; Kupferberg SJ, 1997, AM ZOOL, V37, P146; Leite F.S.F., 2008, MEGADIVERSIDADE, V4, P158; Leite FSF, 2008, J NAT HIST, V42, P2777, DOI 10.1080/00222930802361022; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lens L, 2002, CONSERV BIOL, V16, P479, DOI 10.1046/j.1523-1739.2002.00516.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lopez P, 2002, BEHAV ECOL SOCIOBIOL, V52, P342, DOI 10.1007/s00265-002-0514-y; Lopez-Romero F, 2012, ECOTOX ENVIRON SAFE, V84, P25, DOI 10.1016/j.ecoenv.2012.06.008; McDonald K, 1999, DECLINES DISAPPEARAN, P14; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; Palmer AR, 1996, BIOSCIENCE, V46, P518, DOI 10.2307/1312930; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Pombal Jose P. Jr., 1995, Boletim do Museu Nacional Rio de Janeiro Zoologia, V363, P1; Pombal JP, 1999, COPEIA, P1014, DOI 10.2307/1447976; Pough FH, 2013, VERTEBRATE ZOOLOGY; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; R Core Team, 2012, R LANG ENV STAT COMP; Rasmuson M, 2002, HEREDITAS, V136, P177, DOI 10.1034/j.1601-5223.2002.1360301.x; de Oliveira FFR, 2009, ACTA OECOL, V35, P727, DOI 10.1016/j.actao.2009.07.004; Richardson JML, 2001, BEHAV ECOL, V12, P51, DOI 10.1093/oxfordjournals.beheco.a000378; SANSEVERINO AM, 2008, OECOLOGIA BRASILIENS, V12, P382, DOI DOI 10.4257/OECO.2008.1203.03; Segalla Magno V., 2014, Herpetologia Brasileira, V3, P37; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Sheehan MJ, 2011, BEHAV ECOL, V22, P1166, DOI 10.1093/beheco/arr101; Siikamaki P, 1998, EVOLUTION, V52, P1285, DOI 10.1111/j.1558-5646.1998.tb02010.x; SILVANO DL, 2005, MEGADIVERSIDADE, V1, P79; Soderman F, 2007, OECOLOGIA, V151, P593, DOI 10.1007/s00442-006-0611-0; Solis R, 2010, BIOL INVASIONS, V12, P1641, DOI 10.1007/s10530-009-9577-2; *SYST SOFTW, 2007, SYST VERS 12; Tavares LHS, 1994, LIMNOLOGIA APLICADA, DOI [10.4137/EBO.S14457, DOI 10.4137/EBO.S14457]; Trokovik N, 2012, BMC EVOL BIOL, V12, P1, DOI [10.1186/1471-2148-12-1, DOI 10.1186/1471-2148-12-1]; Tyc G, 2005, ACTA ASTRONAUT, V56, P213, DOI 10.1016/j.actaastro.2004.09.029; Valkama J, 2001, J APPL ECOL, V38, P665, DOI 10.1046/j.1365-2664.2001.00628.x; Van Poucke E, 2007, POULTRY SCI, V86, P2110, DOI 10.1093/ps/86.10.2110; VANVALEN L, 1962, EVOLUTION, V16, P125; Walker SF, 2008, CURR BIOL, V18, pR853, DOI 10.1016/j.cub.2008.07.033; Wassersug RJ, 2001, COMP BIOCHEM PHYS A, V131, P183, DOI 10.1016/S1095-6433(01)00468-8; WEYGOLDT P, 1989, STUD NEOTROP FAUNA E, V24, P249, DOI 10.1080/01650528909360795; Windig JJ, 2000, J INSECT CONSERV, V4, P253, DOI 10.1023/A:1011332401156; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x; Zachos FE, 2007, HEREDITY, V98, P392, DOI 10.1038/sj.hdy.6800954	78	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120172	10.1371/journal.pone.0120172	http://dx.doi.org/10.1371/journal.pone.0120172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793699	Green Published, Green Accepted, gold			2022-12-26	WOS:000352084200153
J	Gorska-Ciebiada, M; Saryusz-Wolska, M; Borkowska, A; Ciebiada, M; Loba, J				Gorska-Ciebiada, Malgorzata; Saryusz-Wolska, Malgorzata; Borkowska, Anna; Ciebiada, Maciej; Loba, Jerzy			Serum Levels of Inflammatory Markers in Depressed Elderly Patients with Diabetes and Mild Cognitive Impairment	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; LATE-LIFE DEPRESSION; METABOLIC SYNDROME; SYMPTOMS; ASSOCIATION; CYTOKINES; DEMENTIA; ADULTS; RISK	Objective The aim of the study was to determine the serum levels of CRP, IL-6 and TNF-alpha in elderly diabetic patients with depressive syndrome alone or with coexisting mild cognitive impairment (MCI). Methods 276 diabetics elders were screened for depressive symptoms (using Geriatric Depression Scale: GDS-30) and MCI (using the Montreal Cognitive Assessment: MoCA score). Data of HbA1c, blood lipids and inflammatory markers levels were collected. Results In all groups of patients levels of CRP, IL-6 and TNF-alpha were significantly higher as compared to controls. The highest level of inflammatory markers was detected in group with depressive mood and coexisting MCI, however IL-6 level didn't significantly differ as compared to MCI group. We founded correlations between all inflammatory markers in group of patients with depressive mood and in group of subjects with depressive symptoms and coexisting MCI. GDS-30 score was correlated with levels of inflammatory markers in group with depressive mood, and with levels of CRP and TNF-alpha in group with depressive mood and coexisting MCI. In the group with depressive mood and coexisting MCI we founded that MoCA score was negatively correlated with CRP and TNF-alpha levels; and HbA1c level was positively correlated with all inflammatory markers. The univariate logistic regression models revealed that variables which increased the likelihood of having been diagnosed with MCI in depressed patients were: higher levels of HbA1c, CRP, IL-6 and TNF-alpha, previous CVD or stroke, increased number of co-morbidities and microvascular complications, older age, less years of formal education. The multivariable model showed that previous CVD, higher HbA1c and IL-6 levels are significant factors. Conclusions We demonstrated that the presence of depressive syndrome is associated with higher levels of inflammatory markers in elderly patients with diabetes. The presence of MCI in these depressed subjects has additive effect on levels of inflammatory mediators.	[Gorska-Ciebiada, Malgorzata; Saryusz-Wolska, Malgorzata; Borkowska, Anna; Loba, Jerzy] Med Univ Lodz, Dept Internal Med & Diabetol, Lodz, Poland; [Ciebiada, Maciej] Med Univ Lodz, Dept Gen & Oncol Pneumol, Lodz, Poland	Medical University Lodz; Medical University Lodz	Gorska-Ciebiada, M (corresponding author), Med Univ Lodz, Dept Internal Med & Diabetol, Lodz, Poland.	magoca@poczta.onet.pl	Gorska-Ciebiada, Malgorzata Maria/S-9668-2016; Ciebiada, Maciej Ireneusz/S-9324-2016	Gorska-Ciebiada, Malgorzata Maria/0000-0002-0065-4376; Ciebiada, Maciej Ireneusz/0000-0003-3391-264X; Borkowska, Anna/0000-0002-8971-9868	Medical University of Lodz [502-03/8-072-03/502-64-052]	Medical University of Lodz	This work was supported by nonprofit grant of Medical University of Lodz no 502-03/8-072-03/502-64-052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alagiakrishnan K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/186106; Alexopoulos GS, 2006, BIOL PSYCHIAT, V60, P1304, DOI 10.1016/j.biopsych.2006.09.006; Banks WA, 1998, NEUROIMMUNOMODULAT, V5, P36, DOI 10.1159/000026324; Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Camus V, 2004, J AFFECT DISORDERS, V81, P1, DOI 10.1016/j.jad.2003.08.003; Danner M, 2003, PSYCHOSOM MED, V65, P347, DOI 10.1097/01.PSY.0000041542.29808.01; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Dinan TG, 2009, CURR OPIN PSYCHIATR, V22, P32, DOI 10.1097/YCO.0b013e328315a561; Ding J, 2010, DIABETES, V59, P2883, DOI 10.2337/db10-0752; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Doyle TA, 2013, J PSYCHOSOM RES, V75, P419, DOI 10.1016/j.jpsychores.2013.08.006; Elovainio M, 2005, PSYCHOSOM MED, V67, P561, DOI 10.1097/01.psy.0000170340.74035.23; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; Faramawi MF, 2007, AM J CARDIOL, V99, P1610, DOI 10.1016/j.amjcard.2006.12.090; Ferketich AK, 2005, AM HEART J, V150, P132, DOI 10.1016/j.ahj.2004.08.029; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723; Gorska-Ciebiada M, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/179648; Hermida AP, 2012, EXPERT REV NEUROTHER, V12, P1339, DOI [10.1586/ern.12.127, 10.1586/ERN.12.127]; Hidaka S, 2012, INT J GERIATR PSYCH, V27, P271, DOI 10.1002/gps.2715; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Jellinger KA, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00017; Kahl KG, 2006, BIOL PSYCHIAT, V59, P667, DOI 10.1016/j.biopsych.2005.08.001; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Ladwig KH, 2005, EUR HEART J, V26, P2537, DOI 10.1093/eurheartj/ehi456; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P570, DOI 10.1001/archneur.64.4.570; Miller GE, 2005, AM J CARDIOL, V95, P317, DOI 10.1016/j.amjcard.2004.09.026; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pizzi C, 2008, EUR HEART J, V29, P1110, DOI 10.1093/eurheartj/ehn137; Portet F, 2006, J NEUROL NEUROSUR PS, V77, P714, DOI 10.1136/jnnp.2005.085332; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Roberts RO, 2010, ALZ DIS ASSOC DIS, V24, P11, DOI 10.1097/WAD.0b013e3181a4485c; Roberts RO, 2009, ALZHEIMERS DEMENT, V5, P398, DOI 10.1016/j.jalz.2009.01.025; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001; Tiemeier H, 2004, ARCH GEN PSYCHIAT, V61, P369, DOI 10.1001/archpsyc.61.4.369; Tousoulis D, 2013, J AM COLL CARDIOL, V62, P667, DOI 10.1016/j.jacc.2013.03.089; Trollor JN, 2010, DEMENT GERIATR COGN, V30, P569, DOI 10.1159/000322092; Umegaki H, 2011, DEMENT GER COGN D EX, V1, P1, DOI 10.1159/000323188; Whipple MO, 2009, STROKE, V40, P3166, DOI 10.1161/STROKEAHA.109.554519; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	52	44	48	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120433	10.1371/journal.pone.0120433	http://dx.doi.org/10.1371/journal.pone.0120433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793613	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900033
J	Moeller, M; Thonig, A; Pohl, S; Ripoll, C; Zipprich, A				Moeller, Miriam; Thonig, Antje; Pohl, Sabine; Ripoll, Cristina; Zipprich, Alexander			Hepatic Arterial Vasodilation Is Independent of Portal Hypertension in Early Stages of Cirrhosis	PLOS ONE			English	Article							BUFFER RESPONSE; BLOOD-FLOW; CCL4-CIRRHOTIC LIVER; INTRINSIC REGULATION; NITRIC-OXIDE; HYPOXIA; VEIN; RAT; TRANSPLANTATION; HYPERPERFUSION	Introduction The compensatory increase in hepatic arterial flow with a decrease in portal venous flow is known as the hepatic arterial buffer response. In cirrhosis with elevated portal pressure, the vascular resistance of the hepatic artery is decreased. Whether this lower resistance of the hepatic artery is a consequence of portal hypertension or not remains unknown. Study Aim The aim of the study was to investigate the hepatic arterial resistance and response to vasoconstriction in cirrhosis without portal hypertension (normal portal resistance). Methods Cirrhosis was induced by CCl4-inhalation for 8 weeks (8W, normal portal resistance) and for 12-14 weeks (12W, elevated portal resistance). Bivascular liver perfusion was performed at 8W or 12W and dose response curves of methoxamine were obtained in the presence or absence of LNMMA (nitric oxide synthase blocker). Vascular resistances of the hepatic artery (HAR), portal vein (PVR) and sinusoids (SVR) were measured. Western Blot (WB) and Immunohistochemistry (IHC) were done to measure eNOS and HIF 1a expression. Results HAR in both groups of cirrhotic animals (8W and 12W) were lower compared to controls. Dose response curves to methoxamine revealed lower HAR in both cirrhotic models (8W and 12W) regardless the magnitude of portal resistance. LNMMA corrected the dose response curves in cirrhosis (8W and 12W) to control. WB and IHC show increased protein expression of eNOS and HIF1a in 8W and 12W. Conclusion Hepatic arterial resistance is decreased in cirrhosis independent of portal resistance. Vasodilation of the hepatic artery in cirrhosis seems to be influenced by hypoxia rather than increase in portal resistance. Nitric oxide is the main vasodilator.	[Moeller, Miriam; Thonig, Antje; Pohl, Sabine; Ripoll, Cristina; Zipprich, Alexander] Univ Halle Wittenberg, Dept Internal Med 1, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg	Zipprich, A (corresponding author), Univ Halle Wittenberg, Dept Internal Med 1, D-06108 Halle, Germany.	alexander.zipprich@medizin.uni-halle.de	Ripoll, Cristina/AAF-6497-2019	Moller, Miriam/0000-0002-0948-9469				Cejudo-Martin P, 2002, HEPATOLOGY, V36, P1172, DOI 10.1053/jhep.2002.36371; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; Demetris AJ, 2006, AM J SURG PATHOL, V30, P986, DOI 10.1097/00000478-200608000-00009; El-Desoky AEH, 2000, EUR SURG RES, V32, P207, DOI 10.1159/000008766; Fondevila C, 2010, LIVER TRANSPLANT, V16, P364, DOI 10.1002/lt.21989; Gracia-Sancho J, 2011, GUT, V60, P517, DOI 10.1136/gut.2010.220913; Iwakiri Y, 2008, HEPATOLOGY, V47, P1754, DOI 10.1002/hep.22203; James PE, 2002, NITRIC OXIDE-BIOL CH, V6, P18, DOI 10.1006/niox.2001.0383; Kleber G, 1999, GASTROENTEROLOGY, V116, P906, DOI 10.1016/S0016-5085(99)70074-0; LAUTT WW, 1990, GASTROENTEROLOGY, V98, P1024, DOI 10.1016/0016-5085(90)90029-Z; LAUTT WW, 1985, AM J PHYSIOL, V249, pG549, DOI 10.1152/ajpgi.1985.249.5.G549; Lautt WW, 1996, CAN J PHYSIOL PHARM, V74, P223, DOI 10.1139/cjpp-74-3-223; Lautt WW, 1985, AM J PHYSL; Marrone G, 2013, J HEPATOL, V58, P98, DOI 10.1016/j.jhep.2012.08.026; Mucke I, 2000, INT J COLORECTAL DIS, V15, P335, DOI 10.1007/s003840000247; Nagula S, 2006, J HEPATOL, V44, P111, DOI 10.1016/j.jhep.2005.07.036; Richter S, 2000, AM J PHYSIOL-GASTR L, V279, pG454, DOI 10.1152/ajpgi.2000.279.2.G454; Richter S, 2001, ANESTH ANALG, V93, P872, DOI 10.1097/00000539-200110000-00014; Richter S, 2001, J PHYSIOL-LONDON, V531, P193, DOI 10.1111/j.1469-7793.2001.0193j.x; Rosmorduc O, 1999, AM J PATHOL, V155, P1065, DOI 10.1016/S0002-9440(10)65209-1; Smyrniotis V, 2002, TRANSPL INT, V15, P355, DOI 10.1111/j.1432-2277.2002.tb00178.x; Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589; Zipprich A, 2003, HEPATOLOGY, V37, P385, DOI 10.1053/jhep.2003.50065; Zipprich A, 2008, J HEPATOL, V49, P739, DOI 10.1016/j.jhep.2008.06.027; Zipprich A, 2008, AM J PHYSIOL-GASTR L, V295, pG197, DOI 10.1152/ajpgi.00190.2007; Zipprich A, 2007, J CLIN GASTROENTEROL, V41, pS254, DOI 10.1097/MCG.0b013e318150d3b5; Zipprich A, 2010, LIVER INT, V30, P988, DOI 10.1111/j.1478-3231.2010.02278.x	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121229	10.1371/journal.pone.0121229	http://dx.doi.org/10.1371/journal.pone.0121229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793622	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900114
J	Morishita, S; Takahashi, K; Araki, M; Hironaka, Y; Sunami, Y; Edahiro, Y; Tsutsui, M; Ohsaka, A; Tsuneda, S; Komatsu, N				Morishita, Soji; Takahashi, Kochi; Araki, Marito; Hironaka, Yumi; Sunami, Yoshitaka; Edahiro, Yoko; Tsutsui, Miyuki; Ohsaka, Akimichi; Tsuneda, Satoshi; Komatsu, Norio			Melting Curve Analysis after T Allele Enrichment (MelcaTle) as a Highly Sensitive and Reliable Method for Detecting the JAK2V617F Mutation	PLOS ONE			English	Article							PEPTIDE-NUCLEIC-ACID; JAK2 V617F MUTATION; REAL-TIME PCR; CHRONIC MYELOPROLIFERATIVE DISORDERS; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; QUANTIFICATION; DIAGNOSIS; PROBE; NEOPLASMS	Detection of the JAK2V617F mutation is essential for diagnosing patients with classical myeloproliferative neoplasms (MPNs). However, detection of the low-frequency JAK2V617F mutation is a challenging task due to the necessity of discriminating between true-positive and false-positive results. Here, we have developed a highly sensitive and accurate assay for the detection of JAK2V617F and named it melting curve analysis after T allele enrichment (MelcaTle). MelcaTle comprises three steps: 1) two cycles of JAK2V617F allele enrichment by PCR amplification followed by BsaXI digestion, 2) selective amplification of the JAK2V617F allele in the presence of a bridged nucleic acid (BNA) probe, and 3) a melting curve assay using a BODIPY-FL-labeled oligonucleotide. Using this assay, we successfully detected nearly a single copy of the JAK2V617F allele, without false-positive signals, using 10 ng of genomic DNA standard. Furthermore, MelcaTle showed no positive signals in 90 assays screening healthy individuals for JAK2V617F. When applying MelcaTle to 27 patients who were initially classified as JAK2V617F-positive on the basis of allele-specific PCR analysis and were thus suspected as having MPNs, we found that two of the patients were actually JAK2V617F-negative. A more careful clinical data analysis revealed that these two patients had developed transient erythrocytosis of unknown etiology but not polycythemia vera, a subtype of MPNs. These findings indicate that the newly developed MelcaTle assay should markedly improve the diagnosis of JAK2V617F-positive MPNs.	[Morishita, Soji; Araki, Marito; Ohsaka, Akimichi] Juntendo Univ, Grad Sch Med, Dept Transfus Med & Stem Cell Regulat, Tokyo 113, Japan; [Takahashi, Kochi; Tsuneda, Satoshi] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Takahashi, Kochi; Hironaka, Yumi; Sunami, Yoshitaka; Edahiro, Yoko; Tsutsui, Miyuki; Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan	Juntendo University; Waseda University; Juntendo University	Komatsu, N (corresponding author), Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan.	komatsun@juntendo.ac.jp	Araki, Marito/T-4283-2019	Araki, Marito/0000-0002-3502-5000	Japan Society for the Promotion of Science (JSPS) KAKENHI grant [25860416]; Ministry of Health, Labor and Welfare [14700000340]	Japan Society for the Promotion of Science (JSPS) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was funded by Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/e-grants/) KAKENHI grant #25860416 (SM) and by Research on Measures for Intractable Diseases, Health Labor Sciences Research Grant from The Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/english/) project #14700000340 (NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bentin T, 2003, BIOCHEMISTRY-US, V42, P13987, DOI 10.1021/bi0351918; Cankovic M, 2009, AM J CLIN PATHOL, V132, P713, DOI 10.1309/AJCPFHUQZ9AGUEKA; Huijsmans CJJ, 2011, J MOL DIAGN, V13, P558, DOI 10.1016/j.jmoldx.2011.04.002; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jovanovic JV, 2013, LEUKEMIA, V27, P2032, DOI 10.1038/leu.2013.219; KOMATSU N, 1993, BLOOD, V82, P456; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kurata S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e34; Larsen TS, 2007, BRIT J HAEMATOL, V136, P745, DOI 10.1111/j.1365-2141.2007.06497.x; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li J, 2011, CLIN CHEM, V57, P770, DOI 10.1373/clinchem.2010.157784; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; Lippert E, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2014.107656; Lippert E, 2009, HAEMATOL-HEMATOL J, V94, P38, DOI 10.3324/haematol.13486; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Morishita S, 2011, LEUKEMIA RES, V35, P1632, DOI 10.1016/j.leukres.2011.06.016; Murugesan G, 2006, AM J CLIN PATHOL, V125, P625, DOI 10.1309/TK0XL917XK2VLRPQ; Oh JE, 2010, J MOL DIAGN, V12, P418, DOI 10.2353/jmoldx.2010.090146; Poodt J, 2006, HEMATOL ONCOL, V24, P227, DOI 10.1002/hon.800; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Rapado I, 2008, ANN HEMATOL, V87, P741, DOI 10.1007/s00277-008-0512-x; Shepard GC, 2011, INT J LAB HEMATOL, V33, P267, DOI 10.1111/j.1751-553X.2010.01282.x; Tani H, 2009, ANAL CHEM, V81, P5678, DOI 10.1021/ac900414u; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Torigoe H, 2012, J BIOCHEM, V152, P17, DOI 10.1093/jb/mvs049; Zhao AH, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-40	28	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122003	10.1371/journal.pone.0122003	http://dx.doi.org/10.1371/journal.pone.0122003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794279	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900164
J	Deng, Y; Nagachar, N; Fang, L; Luan, X; Catchmark, JM; Tien, M; Kao, TH				Deng, Ying; Nagachar, Nivedita; Fang, Lin; Luan, Xin; Catchmark, Jeffrey M.; Tien, Ming; Kao, Teh-hui			Isolation and Characterization of Two Cellulose Morphology Mutants of Gluconacetobacter hansenii ATCC23769 Producing Cellulose with Lower Crystallinity	PLOS ONE			English	Article							ACETOBACTER-XYLINUM; BACTERIAL CELLULOSE; MICROBIAL CELLULOSE; POLYSACCHARIDES; EXOPOLYSACCHARIDES; BIOSYNTHESIS; STRAIN; ACETAN; NMR	Gluconacetobacter hansenii, a Gram-negative bacterium, produces and secrets highly crystalline cellulose into growth medium, and has long been used as a model system for studying cellulose synthesis in higher plants. Cellulose synthesis involves the formation of beta-1,4 glucan chains via the polymerization of glucose units by a multi-enzyme cellulose synthase complex (CSC). These glucan chains assemble into ordered structures including crystalline microfibrils. AcsA is the catalytic subunit of the cellulose synthase enzymes in the CSC, and AcsC is required for the secretion of cellulose. However, little is known about other proteins required for the assembly of crystalline cellulose. To address this question, we visually examined cellulose pellicles formed in growth media of 763 individual colonies of G. hansenii generated via Tn5 transposon insertion mutagenesis, and identified 85 that produced cellulose with altered morphologies. X-ray diffraction analysis of these 85 mutants identified two that produced cellulose with significantly lower crystallinity than wild type. The gene disrupted in one of these two mutants encoded a lysine decarboxylase and that in the other encoded an alanine racemase. Solid-state NMR analysis revealed that cellulose produced by these two mutants contained increased amounts of non-crystalline cellulose and monosaccharides associated with non-cellulosic polysaccharides as compared to the wild type. Monosaccharide analysis detected higher percentages of galactose and mannose in cellulose produced by both mutants. Field emission scanning electron microscopy showed that cellulose produced by the mutants was unevenly distributed, with some regions appearing to contain deposition of non-cellulosic polysaccharides; however, the width of the ribbon was comparable to that of normal cellulose. As both lysine decarboxylase and alanine racemase are required for the integrity of peptidoglycan, we propose a model for the role of peptidoglycan in the assembly of crystalline cellulose.	[Deng, Ying; Nagachar, Nivedita; Luan, Xin; Tien, Ming; Kao, Teh-hui] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Fang, Lin; Catchmark, Jeffrey M.] Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kao, TH (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	txk3@psu.edu	Dalla Zuanna, Teresa/G-3133-2015		Center for Lignocellulose Structure and Formation; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001090]	Center for Lignocellulose Structure and Formation; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by a grant to JMC, MT and THK from The Center for Lignocellulose Structure and Formation, an Energy Frontier Research Center funded by the U.S. Department of Energy (http://www.energy.gov), Office of Science, Office of Basic Energy Sciences under Award Number DE-SC0001090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Chanzy H., 1982, CARBOHYD POLYM, V2, P229, DOI [DOI 10.1016/0144-8617(82)90021-2, 10.1016/0144-8617(82)90021-2]; Chawla PR, 2009, FOOD TECHNOL BIOTECH, V47, P107; COLQUHOUN IJ, 1995, CARBOHYD RES, V269, P319, DOI 10.1016/0008-6215(94)00367-O; COUSO RO, 1987, J GEN MICROBIOL, V133, P2123; Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035; Deng Y, 2013, J BACTERIOL, V195, P5072, DOI 10.1128/JB.00767-13; Dick-Perez M, 2011, BIOCHEMISTRY-US, V50, P989, DOI 10.1021/bi101795q; Fang L, 2015, CARBOHYD POLYM, V115, P663, DOI 10.1016/j.carbpol.2014.09.028; Fang L, 2014, CELLULOSE, V21, P3965, DOI 10.1007/s10570-014-0443-8; Fenwick KM, 1999, PHYTOCHEMISTRY, V51, P17, DOI 10.1016/S0031-9422(98)00723-7; Gu J, 2012, CARBOHYD POLYM, V88, P547, DOI 10.1016/j.carbpol.2011.12.040; Habibi Y, 2004, CARBOHYD RES, V339, P1119, DOI 10.1016/j.carres.2004.02.005; Haigler CH., 1985, CELLULOSE CHEM ITS A, P30; HALL PE, 1992, PLASMID, V28, P194, DOI 10.1016/0147-619X(92)90051-B; Hantus S, 1997, CARBOHYD RES, V304, P11, DOI 10.1016/S0008-6215(97)00200-0; Harris D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002897; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Iyer PR, 2013, ARCH BIOCHEM BIOPHYS, V529, P92, DOI 10.1016/j.abb.2012.12.002; Iyer PR, 2010, J BACTERIOL, V192, P4256, DOI 10.1128/JB.00588-10; JANSSON PE, 1993, CARBOHYD RES, V245, P303, DOI 10.1016/0008-6215(93)80079-T; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; Newman RH, 2004, CELLULOSE, V11, P23, DOI 10.1023/B:CELL.0000014778.49291.c6; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175; Sluiter A., 2008, LAB ANAL PROCED, V1617, P1; Szxena IM, 1994, J BACTERIOL, V176, P5735; Takatsuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1, DOI 10.1271/bbb.68.1; Tang HR, 2000, SOLID STATE NUCL MAG, V15, P239, DOI 10.1016/S0926-2040(99)00064-8; Thygesen A, 2005, CELLULOSE, V12, P563, DOI 10.1007/s10570-005-9001-8; VALLA S, 1981, CAN J MICROBIOL, V27, P599, DOI 10.1139/m81-091; Vignon MR, 2004, CARBOHYD RES, V339, P123, DOI 10.1016/j.carres.2003.09.023; WHITFIELD C, 1988, CAN J MICROBIOL, V34, P415, DOI 10.1139/m88-073; Whitney SEC, 2006, AM J BOT, V93, P1402, DOI 10.3732/ajb.93.10.1402; Whitney SEC, 1998, CARBOHYD RES, V307, P299, DOI 10.1016/S0008-6215(98)00004-4	37	23	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119504	10.1371/journal.pone.0119504	http://dx.doi.org/10.1371/journal.pone.0119504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790428	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400088
J	Valeri, M; Paccani, SR; Kasendra, M; Nesta, B; Serino, L; Pizza, M; Soriani, M				Valeri, Maria; Paccani, Silvia Rossi; Kasendra, Magdalena; Nesta, Barbara; Serino, Laura; Pizza, Mariagrazia; Soriani, Marco			Pathogenic E-coli Exploits SslE Mucinase Activity to Translocate through the Mucosal Barrier and Get Access to Host Cells	PLOS ONE			English	Article							INTESTINAL EPITHELIAL MONOLAYERS; GEL-FORMING MUCINS; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; BIOFILM FORMATION; GROWTH; SECRETION; MUCUS; EXPRESSION; COLONIZATION	SslE is a zinc-metalloprotease involved in the degradation of mucin substrates and recently proposed as a potential vaccine candidate against pathogenic E. coli. In this paper, by exploiting a human in vitro model of mucus-secreting cells, we demonstrated that bacteria expressing SslE have a metabolic benefit which results in an increased growth rate postulating the importance of this antigen in enhancing E. coli fitness. We also observed that SslE expression facilitates E. coli penetration of the mucus favouring bacteria adhesion to host cells. Moreover, we found that SslE-mediated opening of the mucosae contributed to the activation of pro-inflammatory events. Indeed, intestinal cells infected with SslE-secreting bacteria showed an increased production of IL-8 contributing to neutrophil recruitment. The results presented in this paper conclusively designate SslE as an important colonization factor favouring E. coli access to both metabolic substrates and target cells.	[Valeri, Maria; Paccani, Silvia Rossi; Nesta, Barbara; Serino, Laura; Pizza, Mariagrazia; Soriani, Marco] Novartis Vaccines & Diagnost Srl, Siena, Italy; [Kasendra, Magdalena] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA 02115 USA	Novartis; Harvard University; Boston Children's Hospital; Harvard Medical School	Soriani, M (corresponding author), Novartis Vaccines & Diagnost Srl, Via Fiorentina 1, Siena, Italy.	marco.soriani@novartis.com	Nesta, Barbara/AAL-3753-2020; Kasendra, Magdalena J/L-7259-2016	Kasendra, Magdalena J/0000-0002-6376-2489; SORIANI, Marco/0000-0002-9752-5844	Novartis Vaccines and Diagnostics; Italian "Ministero dell'Istruzione, dell'Universia e della Ricerca" [PON01_00117]; EMIDA ERA-NET "Coordination of European Research on Emerging and Major Infectious Diseases of Livestock" (financed by the European Commission's Seventh Framework Programme) [219235]	Novartis Vaccines and Diagnostics; Italian "Ministero dell'Istruzione, dell'Universia e della Ricerca"; EMIDA ERA-NET "Coordination of European Research on Emerging and Major Infectious Diseases of Livestock" (financed by the European Commission's Seventh Framework Programme)	This work was mainly supported by internal funding from Novartis Vaccines and Diagnostics. However, it was also partly supported by funding under both the grant PON01_00117 from the Italian "Ministero dell'Istruzione, dell'Universia e della Ricerca" and the EMIDA ERA-NET "Coordination of European Research on Emerging and Major Infectious Diseases of Livestock" (financed by the European Commission's Seventh Framework Programme project no. 219235) as part of the project "Combatting colibacillosis-a genomics-based approach." The funder provided support in the form of salaries for authors MV, SRP, BN, LS, MGP, MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The affiliation to the commercial funder of this research study " Novartis Vaccines and Diagnostics S.r.l." does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	A Zisakis, 2007, Int J Biomed Sci, V3, P46; ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983; Alemka A, 2010, INFECT IMMUN, V78, P2812, DOI 10.1128/IAI.01249-09; Baldi DL, 2012, INFECT IMMUN, V80, P2042, DOI 10.1128/IAI.06160-11; Connaris S, 1997, GLYCOCONJUGATE J, V14, P879, DOI 10.1023/A:1018554408558; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dolan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047300; Gouyer V, 2001, BBA-MOL CELL RES, V1539, P71, DOI 10.1016/S0167-4889(01)00092-1; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Hernandes RT, 2013, INFECT IMMUN, V81, P3793, DOI 10.1128/IAI.00620-13; HUET C, 1987, J CELL BIOL, V105, P345, DOI 10.1083/jcb.105.1.345; Kaper JB, 2005, INT J MED MICROBIOL, V295, P355, DOI 10.1016/j.ijmm.2005.06.008; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo QW, 2014, INFECT IMMUN, V82, P509, DOI 10.1128/IAI.01106-13; Madara J L, 1990, Monogr Pathol, P306; MANTLE M, 1993, INFECT IMMUN, V61, P4131, DOI 10.1128/IAI.61.10.4131-4138.1993; MCCORMICK BA, 1988, INFECT IMMUN, V56, P2209, DOI 10.1128/IAI.56.9.2209-2217.1988; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Nesta B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004124; Pastorello I, 2013, MBIO, V4, DOI 10.1128/mBio.00206-13; PRIZONT R, 1991, MICROB PATHOGENESIS, V11, P129, DOI 10.1016/0882-4010(91)90006-V; ROBERTON AM, 1982, APPL ENVIRON MICROB, V43, P325, DOI 10.1128/AEM.43.2.325-330.1982; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Savkovic SD, 1996, INFECT IMMUN, V64, P4480, DOI 10.1128/IAI.64.11.4480-4487.1996; SCHNEIDER DR, 1982, J INFECT DIS, V145, P474, DOI 10.1093/infdis/145.4.474; Silva AJ, 2003, MICROBIOL-SGM, V149, P1883, DOI 10.1099/mic.0.26086-0; Sperandio B, 2013, INFECT IMMUN, V81, P3632, DOI 10.1128/IAI.00551-13; STANLEY RA, 1986, APPL ENVIRON MICROB, V51, P1104, DOI 10.1128/AEM.51.5.1104-1109.1986; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Uehling DT, 1999, WORLD J UROL, V17, P351, DOI 10.1007/s003450050160; Vieira MAM, 2010, INFECT IMMUN, V78, P927, DOI 10.1128/IAI.01115-09; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988	38	39	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0117486	10.1371/journal.pone.0117486	http://dx.doi.org/10.1371/journal.pone.0117486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789808	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400023
J	Perdigao-Henriques, R; Petrocca, F; Altschuler, G; Thomas, MP; Le, MTN; Tan, SM; Hide, W; Lieberman, J				Perdigao-Henriques, R.; Petrocca, F.; Altschuler, G.; Thomas, M. P.; Le, M. T. N.; Tan, S. M.; Hide, W.; Lieberman, J.			miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes	ONCOGENE			English	Article							NEGATIVE BREAST-CANCER; E-CADHERIN; GENE-EXPRESSION; WIDE IDENTIFICATION; COLORECTAL-CANCER; PROGNOSTIC-FACTOR; CELL; FAMILY; TARGETS; PROTEIN	The miR-200 family promotes the epithelial state by suppressing the Zeb1/Zeb2 epithelial gene transcriptional repressors. To identify other miR-200-regulated genes, we isolated mRNAs bound to transfected biotinylated miR-200c in mouse breast cancer cells. In all, 520 mRNAs were significantly enriched in miR-200c binding at least twofold. Putative miR-200-regulated genes included Zeb2, enriched 3.5-fold in the pull down. However, Zeb2 knockdown does not fully recapitulate miR-200c overexpression, suggesting that regulating other miR-200 targets contributes to miR-200's enhancement of epithelial gene expression. Candidate genes were highly enriched for miR-200c seed pairing in their 3'UTR and coding sequence and for genes that were downregulated by miR-200c overexpression. Epidermal growth factor receptor and downstream MAPK signaling pathways were the most enriched pathways. Genes whose products mediate transforming growth factor (TGF)-beta signaling were also significantly overrepresented, and miR-200 counteracted the suppressive effects of TGF-beta and bone morphogenic protein 2 (BMP-2) on epithelial gene expression. miR-200c regulated the 3'UTRs of 12 of 14 putative miR-200c-binding mRNAs tested. The extent of mRNA binding to miR-200c strongly correlated with gene suppression. Twelve targets of miR-200c (Crtap, Fhod1, Smad2, Map3k1, Tob1, Ywhag/14-3-3 gamma, Ywhab/14-3-3 beta, Smad5, Zfp36, Xbp1, Mapk12, Snail1) were experimentally validated by identifying their 3'UTR miR-200 recognition elements. Smad2 and Smad5 form a complex with Zeb2 and Ywhab/14-3-3 beta and Ywhag/14-3-3 gamma form a complex with Snail1. These complexes that repress transcription assemble on epithelial gene promoters. miR-200 overexpression induced RNA polymerase II localization and reduced Zeb2 and Snail1 binding to epithelial gene promoters. Expression of miR-200-resistant Smad5 modestly, but significantly, reduced epithelial gene induction by miR-200. miR-200 expression and Zeb2 knockdown are known to inhibit cell invasion in in vitro assays. Knockdown of each of three novel miR-200 target genes identified here, Smad5, Ywhag and Crtap, also profoundly suppressed cell invasion. Thus, miR-200 suppresses TGF-beta/BMP signaling, promotes epithelial gene expression and suppresses cell invasion by regulating a network of genes.	[Perdigao-Henriques, R.; Petrocca, F.; Thomas, M. P.; Le, M. T. N.; Tan, S. M.; Lieberman, J.] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; [Perdigao-Henriques, R.] Univ Nova Lisboa, ITQB, Anim Cell Technol Unit, P-2780156 Oeiras, Portugal; [Perdigao-Henriques, R.] IBET, Oeiras, Portugal; [Altschuler, G.; Hide, W.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hide, W.] Univ Sheffield, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Lieberman, J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Universidade Nova de Lisboa; Harvard University; Harvard T.H. Chan School of Public Health; University of Sheffield; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Childrens Hosp Boston, Program Cellular & Mol Med, 200 Longwood Ave,Warren Alpert Bldg 255, Boston, MA 02115 USA.	judy.lieberman@childrens.harvard.edu	Hide, Winston Hide/C-7217-2009; Hide, Winston/R-3815-2019; Hide, Winston A/V-2727-2017; Lieberman, Judy/A-2717-2015	Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; LE, Thi Nguyet Minh/0000-0002-6077-1566	Portuguese Ministry of Science and Technology (FCT) [SFRH/BD/37188/2007]	Portuguese Ministry of Science and Technology (FCT)	R Perdigao-Henriques acknowledges the Portuguese Ministry of Science and Technology (FCT) for Ph.D. fellowship SFRH/BD/37188/2007. We thank Alex Amiet and Devin Leake (Dharmacon) for providing the biotinylated miRNAs, Linfeng Huang (Lieberman laboratory) for assistance with ChIP assays and Francisco Navarro (Lieberman laboratory) for helpful suggestions.	Ahmadi H, 2013, GENOMICS, V101, P94, DOI 10.1016/j.ygeno.2012.11.005; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Capobianco V, 2012, J PROTEOME RES, V11, P3358, DOI 10.1021/pr300152z; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen R, 2007, NAT METHODS, V4, P879, DOI 10.1038/nmeth1107-879; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; Dai YM, 2013, NUCLEIC ACID THER, V23, P29, DOI 10.1089/nat.2012.0385; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Feng B, 2012, CANCER-AM CANCER SOC, V118, P3365, DOI 10.1002/cncr.26560; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Garibaldi F, 2012, CELL DEATH DIFFER, V19, P937, DOI 10.1038/cdd.2011.175; Grafel I, 2014, NAT MED, V20, P670, DOI 10.1038/nm.3544; Gravgaard KH, 2012, BREAST CANCER RES TR, V134, P207, DOI 10.1007/s10549-012-1969-9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang H, 2012, J BIOL CHEM, V287, P3976, DOI 10.1074/jbc.M111.303156; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Krishnan K, 2013, RNA, V19, P230, DOI 10.1261/rna.034926.112; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Li J, 2013, CANCER LETT, V329, P84, DOI 10.1016/j.canlet.2012.10.019; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Mishra SK, 2004, J BIOL CHEM, V279, P32709, DOI 10.1074/jbc.M402942200; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Obri A, 2014, NATURE, V505, P648, DOI 10.1038/nature12922; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Pichler M, 2014, BRIT J CANCER, V110, P1614, DOI 10.1038/bjc.2014.51; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shin JO, 2012, HISTOCHEM CELL BIOL, V137, P67, DOI 10.1007/s00418-011-0876-1; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Tan SM, 2014, CELL REP, V8, P1225, DOI 10.1016/j.celrep.2014.07.023; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toiyama Y, 2014, ANN SURG, V259, P735, DOI 10.1097/SLA.0b013e3182a6909d; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Yamazaki D, 2005, GENES CELLS, V10, P381, DOI 10.1111/j.1365-2443.2005.00845.x; Yao CX, 2013, RNA BIOL, V10, P465, DOI 10.4161/rna.24370; Ye F, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-17; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhu W, 2012, CANCER CHEMOTH PHARM, V69, P723, DOI 10.1007/s00280-011-1752-3	79	82	85	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2016	35	2					158	172		10.1038/onc.2015.69	http://dx.doi.org/10.1038/onc.2015.69			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB0JH	25798844	Green Accepted			2022-12-26	WOS:000368193900003
J	Sleire, L; Skeie, BS; Netland, IA; Forde, HE; Dodoo, E; Selheim, F; Leiss, L; Heggdal, JI; Pedersen, PH; Wang, J; Enger, PO				Sleire, L.; Skeie, B. S.; Netland, I. A.; Forde, H. E.; Dodoo, E.; Selheim, F.; Leiss, L.; Heggdal, J. I.; Pedersen, P-H; Wang, J.; Enger, P. O.			Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc(-), leading to glutathione depletion	ONCOGENE			English	Article							FACTOR-KAPPA-B; GLUTAMATE TRANSPORTERS; CELLS; GROWTH; GLIOBLASTOMA; INHIBITION; SULPHASALAZINE; RADIOTHERAPY; TEMOZOLOMIDE; ACTIVATION	Glioblastomas (GBMs) are aggressive brain tumors that always recur after radiotherapy. Cystine, mainly provided by the system X-c(-) antiporter, is a requirement for glioma cell synthesis of glutathione (GSH) which has a critical role in scavenging free radicals, for example, after radiotherapy. Thus, we hypothesized that the X-c(-) inhibitor sulfasalazine (SAS) could potentiate the efficacy of radiotherapy against gliomas. Here, we show that the catalytic subunit of system X-c(,)- xCT, was uniformly expressed in a panel of 30 human GBM biopsies. SAS treatment significantly reduced cystine uptake and GSH levels, whereas it significantly increased the levels of reactive oxygen species (ROS) in glioma cells in vitro. Furthermore, SAS and radiation synergistically increased DNA double-strand breaks and increased glioma cell death, whereas adding the antioxidant N-acetyl-L-cysteine (NAC) reversed cell death. Moreover, SAS and gamma knife radiosurgery (GKRS) synergistically prolonged survival in nude rats harboring human GBM xenografts, compared with controls or either treatment alone. In conclusion, SAS effectively blocks cystine uptake in glioma cells in vitro, leading to GSH depletion and increased ROS levels, DNA damage and cell death. Moreover, it potentiates the anti-tumor efficacy of GKRS in rats with human GBM xenografts, providing a survival benefit. Thus, SAS may have a role as a radiosensitizer to enhance the efficacy of current radiotherapies for glioma patients.	[Sleire, L.; Netland, I. A.; Forde, H. E.; Leiss, L.; Wang, J.; Enger, P. O.] Univ Bergen, Oncomatrix Res Lab, Dept Biomed, N-5020 Bergen, Norway; [Skeie, B. S.; Pedersen, P-H] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway; [Skeie, B. S.; Pedersen, P-H; Enger, P. O.] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway; [Dodoo, E.] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Selheim, F.] Univ Bergen, Prote Unit PROBE, Dept Biomed, N-5020 Bergen, Norway; [Leiss, L.] Haukeland Hosp, Neuro Clin, N-5021 Bergen, Norway; [Heggdal, J. I.] Haukeland Hosp, Dept Oncol & Med Phys, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Enger, PO (corresponding author), Univ Bergen, Oncomatrix Res Lab, Dept Biomed, Jonas Lies Vei 91, N-5020 Bergen, Norway.	per.enger@biomed.uib.no		Skeie, Bente Sandvei/0000-0001-9876-5826				AKSLEN LA, 1988, ANTICANCER RES, V8, P797; ALLALUNISTURNER MJ, 1991, J NEURO-ONCOL, V11, P157, DOI 10.1007/BF02390175; ARCHIBALD YM, 1994, J NEUROSURG, V80, P247, DOI 10.3171/jns.1994.80.2.0247; BANNAI S, 1980, J BIOL CHEM, V255, P2372; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; BUMP EA, 1982, SCIENCE, V217, P544, DOI 10.1126/science.7089580; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; DICK AP, 1964, GUT, V5, P437, DOI 10.1136/gut.5.5.437; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hsieh PC, 2005, NEUROSURGERY, V57, P684, DOI 10.1227/01.NEU.0000175550.96901.A3; KATO S, 1992, NEUROSCIENCE, V48, P903, DOI 10.1016/0306-4522(92)90278-A; Kim JY, 2001, BBA-BIOMEMBRANES, V1512, P335, DOI 10.1016/S0005-2736(01)00338-8; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Narang VS, 2007, CHEMOTHERAPY, V53, P210, DOI 10.1159/000100812; NEUMANN VC, 1984, J ROY SOC MED, V77, P169, DOI 10.1177/014107688407700301; Ogunrinu TA, 2010, J BIOL CHEM, V285, P37716, DOI 10.1074/jbc.M110.161190; Rey M, 1996, NEUROCHIRURGIE, V42, P289; Robe PA, 2004, CLIN CANCER RES, V10, P5595, DOI 10.1158/1078-0432.CCR-03-0392; Robe PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-372; Robert SM, 2014, CELL MOL LIFE SCI, V71, P1839, DOI 10.1007/s00018-013-1521-z; Rothstein JD, 2001, NAT MED, V7, P994, DOI 10.1038/nm0901-994; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; SALCMAN M, 1980, NEUROSURGERY, V7, P435, DOI 10.1227/00006123-198011000-00001; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Skeie BS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/139674; Skeie BS, 2012, WORLD NEUROSURG, V78, P658, DOI 10.1016/j.wneu.2012.03.024; Soffietti R, 2013, J CLIN ONCOL, V31, P65, DOI 10.1200/JCO.2011.41.0639; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takeuchi S, 2014, NEUROL INDIA, V62, P42, DOI 10.4103/0028-3886.128280; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Towner RA, 2013, BBA-MOL BASIS DIS, V1832, P2153, DOI 10.1016/j.bbadis.2013.08.004; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999	40	96	102	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2015	34	49					5951	5959		10.1038/onc.2015.60	http://dx.doi.org/10.1038/onc.2015.60			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RO	25798841				2022-12-26	WOS:000366113500002
J	Andersson, ES; Tynelius, P; Nohr, EA; Sorensen, TIA; Rasmussen, F				Andersson, Elina Scheers; Tynelius, Per; Nohr, Ellen Aagaard; Sorensen, Thorkild I. A.; Rasmussen, Finn			No Association of Maternal Gestational Weight Gain with Offspring Blood Pressure and Hypertension at Age 18 Years in Male Sibling-Pairs: A Prospective Register-Based Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; BIRTH-WEIGHT; PREGNANCY; OBESITY; FAMILY; ADIPOSITY	Background Maternal gestational weight gain (GWG) is associated with birth weight, obesity, and possibly blood pressure (BP) and hypertension in the offspring. These associations may however be confounded by genetic and/or shared environmental factors. In contrast to previous studies based on non-siblings and self-reported data, we investigated whether GWG is associated with offspring BP and hypertension, in a register-based cohort of full brothers while controlling for fixed shared effects. Methods By using Swedish nation-wide record-linkage data, we identified women with at least two male children (full brothers) born 1982-1989. Their BP was obtained from the mandatory military conscription induction tests. We adopted linear and Poisson regression models with robust variance, using generalized estimating equations to analyze associations between GWG and BP, as well as with hypertension, within and between offspring sibling-pairs. Results Complete data on the mothers' GWG and offspring BP was obtained for 9,816 brothers (4,908 brother-pairs). Adjusted regression models showed no significant associations between GWG and SBP (beta = 0.03 mmHg per 1-kg GWG difference, [95% CI -0.08, 0.14], or DBP (beta = -0.03 mmHg per 1-kg GWG difference [95% CI -0.11, 0.05]), or between GWG and offspring's risk of hypertension (relative risk = 1.0 [95% CI 0.99, 1.02], neither within nor between siblings. Conclusions In this large sibling-pair study, we did not find any significant association between GWG and offspring BP or the risk of hypertension at 18y, when taking genetic and environmental factors shared within sibling pairs into account. Further large sibling studies are required to confirm a null association between GWG and other cardiovascular risk factors.	[Andersson, Elina Scheers; Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci Child & Adolescent Publ Hlth E, Stockholm, Sweden; [Nohr, Ellen Aagaard] Univ Southern Denmark, Inst Clin Res, Res Unit Obstet & Gynecol, Odense, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, The Capital Reg, Denmark; [Sorensen, Thorkild I. A.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England	Karolinska Institutet; University of Southern Denmark; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Bristol	Rasmussen, F (corresponding author), Karolinska Inst, Dept Publ Hlth Sci Child & Adolescent Publ Hlth E, Stockholm, Sweden.	finn.rasmussen@ki.se		Rasmussen, Finn/0000-0001-7915-7809	Swedish Research Council for Health, Working Life and Welfare (FORTE) [2010-0671]; Karolinska Institutet Faculty Funds (KID); MRC [MC_UU_12013/1] Funding Source: UKRI	Swedish Research Council for Health, Working Life and Welfare (FORTE); Karolinska Institutet Faculty Funds (KID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a grant from the Swedish Research Council for Health, Working Life and Welfare (FORTE) (http://www.forte.se) (Grant No 2010-0671) and the Karolinska Institutet Faculty Funds (KID) (http://ki.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Beyerlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033205; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Christofaro DGD, 2013, SCAND J MED SCI SPOR, V23, P317, DOI 10.1111/j.1600-0838.2011.01382.x; Clark PM, 1998, OBSTET GYNECOL, V91, P103, DOI 10.1016/S0029-7844(97)00581-4; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Crozier SR, 2010, AM J CLIN NUTR, V91, P1745, DOI 10.3945/ajcn.2009.29128; Dello Russo M, 2013, INT J OBESITY, V37, P914, DOI 10.1038/ijo.2013.35; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2; Gaillard R, 2014, INT J OBES LOND; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; KALLEN B, 1995, EUR J EPIDEMIOL, V11, P601, DOI 10.1007/BF01719316; Laor A, 1997, BRIT MED J, V315, P449, DOI 10.1136/bmj.315.7106.449; Ludwig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001521; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; MACINTYRE S, 1991, LANCET, V338, P869, DOI 10.1016/0140-6736(91)91513-T; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Mann V, 2004, STAT MED, V23, P2745, DOI 10.1002/sim.1853; National Board of Health and Welfare, 2013, PREGN DEL NEWB INF S; Oken E, 2008, OBSTET GYNECOL, V112, P999, DOI 10.1097/AOG.0b013e31818a5d50; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Sridhar SB, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.030; Stuebe AM, 2009, INT J OBESITY, V33, P743, DOI 10.1038/ijo.2009.101; Sykes B, 2000, AM J HUM GENET, V66, P1417, DOI 10.1086/302850; Wen XZ, 2011, PEDIATRICS, V127, pE713, DOI 10.1542/peds.2010-2000; Zilko CEM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.007	31	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121202	10.1371/journal.pone.0121202	http://dx.doi.org/10.1371/journal.pone.0121202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794174	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900110
J	DeFranco, E; Hall, E; Hossain, M; Chen, A; Haynes, EN; Jones, D; Ren, S; Lu, L; Muglia, L				DeFranco, Emily; Hall, Eric; Hossain, Monir; Chen, Aimin; Haynes, Erin N.; Jones, David; Ren, Sheng; Lu, Long; Muglia, Louis			Air Pollution and Stillbirth Risk: Exposure to Airborne Particulate Matter during Pregnancy Is Associated with Fetal Death	PLOS ONE			English	Article							BIRTH-WEIGHT; OUTCOMES; COUNTY	Objective To test the hypothesis that exposure to fine particulate air pollution (PM2.5) is associated with stillbirth. Study Design Geo-spatial population-based cohort study using Ohio birth records (2006-2010) and local measures of PM2.5, recorded by the EPA (2005-2010) via 57 monitoring stations across Ohio. Geographic coordinates of the mother's residence for each birth were linked to the nearest PM2.5 monitoring station and monthly exposure averages calculated. The association between stillbirth and increased PM2.5 levels was estimated, with adjustment for maternal age, race, education level, quantity of prenatal care, smoking, and season of conception. Results There were 349,188 live births and 1,848 stillbirths of non-anomalous singletons (20-42 weeks) with residence <= 10 km of a monitor station in Ohio during the study period. The mean PM2.5 level in Ohio was 13.3 mu g/m(3) [+/- 1.8 SD, IQR(Q1: 12.1, Q3: 14.4, IQR: 2.3)], higher than the current EPA standard of 12 mu g/m(3). High average PM2.5 exposure through pregnancy was not associated with a significant increase in stillbirth risk, adjOR 1.21(95% CI 0.96,1.53), nor was it increased with high exposure in the 1st or 2nd trimester. However, exposure to high levels of PM2.5 in the third trimester of pregnancy was associated with 42% increased stillbirth risk, adjOR 1.42(1.06,1.91). Conclusions Exposure to high levels of fine particulate air pollution in the third trimester of pregnancy is associated with increased stillbirth risk. Although the risk increase associated with high PM2.5 levels is modest, the potential impact on overall stillbirth rates could be robust as all pregnant women are potentially at risk.	[DeFranco, Emily; Hall, Eric; Muglia, Louis] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA; [DeFranco, Emily; Muglia, Louis] Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Cincinnati, OH 45267 USA; [Hossain, Monir; Jones, David] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Chen, Aimin; Haynes, Erin N.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Ren, Sheng] Univ Cincinnati, Dept Math, Cincinnati, OH USA; [Ren, Sheng; Lu, Long] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	DeFranco, E (corresponding author), Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA.	emily.defranco@uc.edu	Hossain, Md/N-5360-2015; Hall, Eric S./F-2814-2015	Hall, Eric S./0000-0002-9477-8619; Chen, Aimin/0000-0001-9713-6438; Haynes, Erin/0000-0001-9110-0477	Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; March of Dimes [22-FY13-543]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, RC4ES019755] Funding Source: NIH RePORTER	Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; March of Dimes(March of Dimes); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA, and March of Dimes Grant 22-FY13-543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2009, OBSTET GYNECOL, V113, P748, DOI DOI 10.1097/AOG.0B013E31819E9EE2; Bobak M, 1999, OCCUP ENVIRON MED, V56, P539, DOI 10.1136/oem.56.8.539; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Dietz PM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.875; Faiz AS, 2013, EPIDEMIOLOGY, V24, P538, DOI 10.1097/EDE.0b013e3182949ce5; Faiz AS, 2012, AM J EPIDEMIOL, V176, P308, DOI 10.1093/aje/kws029; Fell DB, 2004, PAEDIATR PERINAT EP, V18, P408, DOI 10.1111/j.1365-3016.2004.00580.x; Glinianaia SV, 2004, EPIDEMIOLOGY, V15, P36, DOI 10.1097/01.ede.0000101023.41844.ac; Hoek G., 2013, ENV HLTH, V12, P12, DOI DOI 10.1186/1476-069X-12-43; Hwang BF, 2011, ENVIRON HEALTH PERSP, V119, P1345, DOI 10.1289/ehp.1003056; Kloog I, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-40; Landgren O, 1996, ACTA PAEDIATR, V85, P1361, DOI 10.1111/j.1651-2227.1996.tb13926.x; MacDorman MF, 2006, NATL VITAL STAT REPO, V60; Mainolfi MB, 2013, J OCCUP ENVIRON MED, V55, P490, DOI 10.1097/JOM.0b013e31828df013; Padula AM, 2013, AM J EPIDEMIOL, V177, P1074, DOI 10.1093/aje/kws367; Pearce MS, 2010, ENVIRON RES, V110, P118, DOI 10.1016/j.envres.2009.10.003; Pereira LAA, 1998, ENVIRON HEALTH PERSP, V106, P325, DOI 10.2307/3434038; Reichman NE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.026; Rich DQ, 2009, J EPIDEMIOL COMMUN H, V63, P488, DOI 10.1136/jech.2008.082792; United States Environmental Protection Agency website, STAT COUNT EM SUMM A; United States Environmental Protection Agency website. National Ambient Air Quality Standards (NAAQS), NAT AM AIR QUAL STAN; US Department of Health and Human Services Centers for Disease Control and Prevention website, 1997, STAT DEF REP REQ; Vassilev ZP, 2001, AM J IND MED, V40, P255, DOI 10.1002/ajim.1096; Vinikoor-Imler LC, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2011.01245.x; Wilhelm M, 2012, ENVIRON HEALTH PERSP, V120, P132, DOI 10.1289/ehp.1103408; World Health Organization website, COUNTR STILLB RAT PE	26	64	68	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120594	10.1371/journal.pone.0120594	http://dx.doi.org/10.1371/journal.pone.0120594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794052	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900056
J	DesRochers, TM; Kuo, IY; Kimmerling, EP; Ehrlich, BE; Kaplan, DL				DesRochers, Teresa M.; Kuo, Ivana Y.; Kimmerling, Erica P.; Ehrlich, Barbara E.; Kaplan, David L.			The Effects of Mycoplasma Contamination upon the Ability to Form Bioengineered 3D Kidney Cysts	PLOS ONE			English	Article							CULTURED-CELLS; DISEASE; INFECTION; MODELS	Mycoplasma contamination of cell cultures is a pervasive, often undiagnosed and ignored problem in many laboratories that can result in reduced cell proliferation and changes in gene expression. Unless contamination is specifically suspected, it is often undetected in two dimensional (2D) cultures and the resulting effects of mycoplasma contamination are rarely appreciated and can lead to incorrect conclusions. Three dimensional (3D) tissue cultures are increasingly utilized to explore tissue development and phenotype. However, 3D cultures are more complex than 2D cell cultures and require a more controlled cellular environment in order to generate structures necessary to mimic in vivo responses and are often maintained for longer time periods. Changes to the microenvironment are assumed to have a more extreme effect upon the success of 3D tissue cultures than 2D cell cultures, but the effects of mycoplasma have not been studied. To test this hypothesis, we grew 2D cell cultures and 3D tissues from pig kidney epithelial cells (LLC-PK1) that were contaminated withmycoplasma and the same stock of cells after mycoplasma removal. We did not observe an effect of mycoplasma contamination on proliferation in 2D monolayer cell culture. However, cyst formation in 3D tissues was altered, with effects upon the number, size and structure of cysts formed. These data serve to reinforce the necessity of testing cell stocks for mycoplasma contamination.	[DesRochers, Teresa M.; Kimmerling, Erica P.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Kuo, Ivana Y.; Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Kuo, Ivana Y.; Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Tufts University; Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	Barbara.ehrlich@yale.edu; David.kaplan@tufts.edu	/AAX-8408-2021	/0000-0001-9657-9704; DesRochers, Teresa/0000-0003-3819-5491; Kuo, Ivana/0000-0002-9867-2408	NIH [P30 DK090744, R01 DK61747, R01 DK087844, P41 EB002520]; AHA [R10682]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, P30DK090744, R01DK087844, R01DK061747, P30DK034989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants: P30 DK090744, R01 DK61747, and R01 DK087844 (B.E.E.), AHA postdoctoral fellowship R10682 (I.Y.K.), and NIH P41 EB002520 (D.L.K.). Use of the Yale Cell Biology Confocal core (P01 DK57751 and P30 DK34989) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; DesRochers TM, 2014, ADV DRUG DELIVER REV, V69, P67, DOI 10.1016/j.addr.2013.12.002; DesRochers TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059219; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; HAY RJ, 1989, NATURE, V339, P487, DOI 10.1038/339487a0; Hernandez FJ, 2012, NUCLEIC ACID THER, V22, P58, DOI 10.1089/nat.2011.0316; Kuo IY, 2014, P NATL ACAD SCI USA, V111, P14283, DOI 10.1073/pnas.1412323111; Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483; Paddenberg R, 1996, EUR J CELL BIOL, V71, P105; Sammels E, 2010, J BIOL CHEM, V285, P18794, DOI 10.1074/jbc.M109.090662; Subramanian B, 2012, BIOMATERIALS, V33, P8383, DOI 10.1016/j.biomaterials.2012.08.020; Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]; Torrente M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096823; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Uphoff CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/267678; Uphoff CC, 2011, METHODS MOL BIOL, V731, P93, DOI 10.1007/978-1-61779-080-5_8; WAYNER EA, 1984, J IMMUNOL, V132, P2135; Zhao Haitian, 2008, BMC Res Notes, V1, P38, DOI 10.1186/1756-0500-1-38; Zihni C, 2014, J CELL SCI, V127, P3401, DOI 10.1242/jcs.145029	20	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120097	10.1371/journal.pone.0120097	http://dx.doi.org/10.1371/journal.pone.0120097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793639	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200143
J	Jamison, S; Lin, YF; Lin, WS				Jamison, Stephanie; Lin, Yifeng; Lin, Wensheng			Pancreatic Endoplasmic Reticulum Kinase Activation Promotes Medulloblastoma Cell Migration and Invasion through Induction of Vascular Endothelial Growth Factor A	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; SMALL-MOLECULE INHIBITOR; VEGF-RECEPTOR; ER STRESS; PERK; TRANSLATION; HYPOXIA; EXPRESSION; PATHWAY; OLIGODENDROCYTES	Evidence is accumulating that activation of the pancreatic endoplasmic reticulum kinase (PERK) in response to endoplasmic reticulum (ER) stress adapts tumor cells to the tumor microenvironment and enhances tumor angiogenesis by inducing vascular endothelial growth factor A (VEGF-A). Recent studies suggest that VEGF-A can act directly on certain tumor cell types in an autocrine manner, via binding to VEGF receptor 2 (VEGFR2), to promote tumor cell migration and invasion. Although several reports show that PERK activation increases VEGF-A expression in medulloblastoma, the most common solid malignancy of childhood, the role that either PERK or VEGF-A plays in medulloblastoma remains elusive. In this study, we mimicked the moderate enhancement of PERK activity observed in tumor patients using a genetic approach and a pharmacologic approach, and found that moderate activation of PERK signaling facilitated medulloblastoma cell migration and invasion and increased the production of VEGF-A. Moreover, using the VEGFR2 inhibitor SU5416 and the VEGF-A neutralizing antibody to block VEGF-A/VEGFR2 signaling, our results suggested that tumor cell-derived VEGF-A promoted medulloblastoma cell migration and invasion through VEGFR2 signaling, and that both VEGF-A and VEGFR2 were required for the promoting effects of PERK activation on medulloblastoma cell migration and invasion. Thus, these findings suggest that moderate PERK activation promotes medulloblastoma cell migration and invasion through enhancement of VEGF-A/VEGFR2 signaling.	[Jamison, Stephanie; Lin, Yifeng; Lin, Wensheng] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Jamison, Stephanie; Lin, Yifeng; Lin, Wensheng] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN USA; [Jamison, Stephanie; Lin, Yifeng; Lin, Wensheng] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lin, WS (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	linw@umn.edu	Lin, Wensheng/J-2661-2019	Lin, Wensheng/0000-0003-4931-7642	National Institutes of Health [NS073132]; National Multiple Sclerosis Society [TA3026-A-1, RG4813-A-2, RG5239-A-3]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (NS073132) and National Multiple Sclerosis Society (TA3026-A-1, RG4813-A-2, and RG5239-A-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Akino T, 2014, CANCER RES, V74, P3716, DOI 10.1158/0008-5472.CAN-13-3116; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Carmeliet P, 2013, CELL MOL LIFE SCI, V70, P1763, DOI 10.1007/s00018-013-1283-7; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; Davare MA, 2014, BIOCHEM BIOPH RES CO, V450, P555, DOI 10.1016/j.bbrc.2014.06.018; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harding HP, 2012, J BIOL CHEM, V287, P44338, DOI 10.1074/jbc.M112.428987; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Hervey-Jumper SL, 2014, J NEUROSURG-PEDIATR, V14, P121, DOI 10.3171/2014.4.PEDS13244; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Huber AL, 2013, MOL CELL, V49, P1049, DOI 10.1016/j.molcel.2013.01.009; Keles GE, 1995, ONCOL RES, V7, P493; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lin WS, 2008, AM J PATHOL, V173, P1508, DOI 10.2353/ajpath.2008.080449; Lin WS, 2013, J NEUROSCI, V33, P5980, DOI 10.1523/JNEUROSCI.1636-12.2013; Lin WS, 2011, J NEUROSCI RES, V89, P1586, DOI 10.1002/jnr.22693; Lin WS, 2010, J NEUROSCI RES, V88, P2569, DOI 10.1002/jnr.22425; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Lin YF, 2014, J NEUROSCI, V34, P12182, DOI 10.1523/JNEUROSCI.1373-14.2014; Lin YF, 2014, AM J PATHOL, V184, P507, DOI 10.1016/j.ajpath.2013.10.009; Lin YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036408; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martin-Perez R, 2014, CANCER RES, V74, P1766, DOI 10.1158/0008-5472.CAN-13-1747; Mendel DB, 2000, ANTI-CANCER DRUG DES, V15, P29; Mercurio AM, 2004, SEMIN CANCER BIOL, V14, P115, DOI 10.1016/j.semcancer.2003.09.016; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Moreira IS, 2007, ANTI-CANCER AGENT ME, V7, P223; Mujcic H, 2013, CLIN CANCER RES, V19, P6126, DOI 10.1158/1078-0432.CCR-13-0526; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Pereira ER, 2014, J BIOL CHEM, V289, P3352, DOI 10.1074/jbc.M113.507194; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Qi L, 2011, METHOD ENZYMOL, V490, P137, DOI 10.1016/B978-0-12-385114-7.00008-8; Ranganathan AC, 2008, CANCER RES, V68, P3260, DOI 10.1158/0008-5472.CAN-07-6215; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Slongo ML, 2007, NEURO-ONCOLOGY, V9, P384, DOI 10.1215/15228517-2007-032; Smith ER, 2008, CLIN CANCER RES, V14, P2378, DOI 10.1158/1078-0432.CCR-07-1253; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	55	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120252	10.1371/journal.pone.0120252	http://dx.doi.org/10.1371/journal.pone.0120252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794107	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900002
J	Kyle, M; Haande, S; Ostermaier, V; Rohrlack, T				Kyle, Marcia; Haande, Sigrid; Ostermaier, Veronika; Rohrlack, Thomas			The Red Queen Race between Parasitic Chytrids and Their Host, Planktothrix: A Test Using a Time Series Reconstructed from Sediment DNA	PLOS ONE			English	Article							CYANOBACTERIA; LAKE; INFECTIVITY; CHEMOTYPES; DEPTH	Parasitic chytrid fungi (phylum Chytridiomycota) are known to infect specific phytoplankton, including the filamentous cyanobacterium Planktothrix. Subspecies, or chemotypes of Planktothrix can be identified by the presence of characteristic oligopeptides. Some of these oligopeptides can be associated with important health concerns due to their potential for toxin production. However, the relationship between chytrid parasite and Planktothrix host is not clearly understood and more research is needed. To test the parasite - host relationship over time, we used a sediment core extracted from a Norwegian lake known to contain both multiple Planktothrix chemotype hosts and their parasitic chytrid. Sediment DNA of chytrids and Planktothrix was amplified and a 35-year coexistence was found. It is important to understand how these two antagonistic species can coexistence in a lake. Reconstruction of the time series showed that between 1979-1990 at least 2 strains of Planktothrix were present and parasitic pressure exerted by chytrids was low. After this period one chemotype became dominant and yet showed continued low susceptibility to chytrid parasitism. Either environmental conditions or intrinsic characteristics of Planktothrixcould have been responsible for this continued dominance. One possible explanation could be found in the shift of Planktothrix to the metalimnion, an environment that typically consists of low light and decreased temperatures. Planktothrix are capable of growth under these conditions while the chytrid parasites are constrained. Another potential explanation could be due to the differences between cellular oligopeptide variations found between Planktothrix chemotypes. These oligopeptides can function as defense systems against chytrids. Our findings suggest that chytrid driven diversity was not maintained over time, but that the combination of environmental constraints and multiple oligopeptide production to combat chytrids could have allowed one Planktothrix chemotype to have dominance despite chytrid presence.	[Kyle, Marcia; Rohrlack, Thomas] Norwegian Univ Life Sci NMBU, Environm Sci, As, Norway; [Haande, Sigrid; Ostermaier, Veronika] Norwegian Inst Water Res NIVA, Oslo, Norway	Norwegian University of Life Sciences; Norwegian Institute for Water Research (NIVA)	Kyle, M (corresponding author), Norwegian Univ Life Sci NMBU, Environm Sci, As, Norway.	marcia.kyle@nmbu.no			Norwegian Institute for Water research (NIVA); Norwegian University of Life Sciences (UMBU); Short Term Scientific Mission (STSM) of COST action [ES1105]	Norwegian Institute for Water research (NIVA); Norwegian University of Life Sciences (UMBU); Short Term Scientific Mission (STSM) of COST action	This project was funded by internal grants from both Norwegian Institute for Water research (NIVA) and Norwegian University of Life Sciences (UMBU) and a Short Term Scientific Mission (STSM) grant in the framework of COST action ES1105 for VO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boere AC, 2011, GEOBIOLOGY, V9, P377, DOI 10.1111/j.1472-4669.2011.00290.x; BRUNING K, 1991, J PLANKTON RES, V13, P103, DOI 10.1093/plankt/13.1.103; De Bruin A, 2008, J EUKARYOT MICROBIOL, V55, P69, DOI 10.1111/j.1550-7408.2008.00306.x; Dokulil MT, 2012, HYDROBIOLOGIA, V698, P29, DOI 10.1007/s10750-012-1020-5; Garneau ME, 2013, LIMNOL OCEANOGR, V58, P1892, DOI 10.4319/lo.2013.58.5.1892; Gerphagnon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060894; Gsell AS, 2013, THESIS UTRECHT U UTR; Haande S, 2014, 66612014 NIVA; Halstvedt CB, 2007, J PLANKTON RES, V29, P471, DOI 10.1093/plankt/fbm036; Ibelings BW, 2011, FRESHWATER BIOL, V56, P754, DOI 10.1111/j.1365-2427.2010.02565.x; Kyle M, 2014, J PALEOLIMNOL, DOI [10.1007/s10933-014-9807-119, DOI 10.1007/S10933-014-9807-119]; Legnani Elena, 2005, Journal of Limnology, V64, P61; Miki T, 2011, FRESHWATER BIOL, V56, P1173, DOI 10.1111/j.1365-2427.2010.02562.x; R Core Team, 2018, R LANG ENV STAT COMP; Rasconi S, 2012, ENVIRON MICROBIOL, V14, P2151, DOI 10.1111/j.1462-2920.2011.02690.x; Rohrlack T, 2008, LIMNOL OCEANOGR, V53, P1279, DOI 10.4319/lo.2008.53.4.1279; Rohrlack T, 2013, APPL ENVIRON MICROB, V79, P2642, DOI 10.1128/AEM.03499-12; Rudi K, 2005, PREP BIOCHEM BIOTECH, V35, P301, DOI 10.1080/10826060500218131; Sime-Ngando T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00361; Sogge H, 2013, APPL ENVIRON MICROB, V79, P508, DOI 10.1128/AEM.02417-12; Sonstebo JH, 2011, APPL ENVIRON MICROB, V77, P1344, DOI 10.1128/AEM.02153-10; Tooming-Klunderud A, 2013, APPL ENVIRON MICROB, V79, P6803, DOI 10.1128/AEM.01455-13; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Walsby AE, 2004, NEW PHYTOL, V162, P133, DOI 10.1111/j.1469-8137.2004.01020.x; Welker M, 2004, ARCH MICROBIOL, V182, P288, DOI 10.1007/s00203-004-0711-3	25	22	22	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118738	10.1371/journal.pone.0118738	http://dx.doi.org/10.1371/journal.pone.0118738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793898	Green Published, Green Accepted, gold			2022-12-26	WOS:000352084200037
J	Muro, R; Nitta, T; Okada, T; Ideta, H; Tsubata, T; Suzuki, H				Muro, Ryunosuke; Nitta, Takeshi; Okada, Toshiyuki; Ideta, Hitoshi; Tsubata, Takeshi; Suzuki, Harumi			The Ras GTPase-Activating Protein Rasal3 Supports Survival of Naive T Cells	PLOS ONE			English	Article							POSITIVE SELECTION; PATHWAY; PROLIFERATION; MOLECULES	The Ras-mitogen-activated protein kinase (MAPK) pathway is crucial for T cell receptor (TCR) signaling in the development and function of T cells. The significance of various modulators of the Ras-MAPK pathway in T cells, however, remains to be fully understood. Ras-activating protein-like 3 (Rasal3) is an uncharacterized member of the SynGAP family that contains a conserved Ras GTPase-activating protein (GAP) domain, and is predominantly expressed in the T cell lineage. In the current study, we investigated the function and physiological roles of Rasal3. Our results showed that Rasal3 possesses RasGAP activity, but not Rap1GAP activity, and represses TCR-stimulated ERK phosphorylation in a T cell line. In systemic Rasal3-deficient mice, T cell development in the thymus including positive selection, negative selection, and beta-selection was unaffected. However, the number of naive, but not effector memory CD4 and CD8 T cell in the periphery was significantly reduced in Rasal3-deficient mice, and associated with a marked increase in apoptosis of these cells. Indeed, survival of Rasal3 deficient naive CD4 T cells in vivo by adoptive transfer was significantly impaired, whereas IL-7-dependent survival of naive CD4 T cells in vitro was unaltered. Collectively, Rasal3 is required for in vivo survival of peripheral naive T cells, contributing to the maintenance of optimal T cell numbers.	[Muro, Ryunosuke; Nitta, Takeshi; Okada, Toshiyuki; Ideta, Hitoshi; Suzuki, Harumi] Natl Ctr Global Hlth & Med, Dept Pathol & Immunol, Res Inst, Ichikawa, Chiba, Japan; [Muro, Ryunosuke; Tsubata, Takeshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Bunkyo Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Tokyo Medical & Dental University (TMDU)	Suzuki, H (corresponding author), Natl Ctr Global Hlth & Med, Dept Pathol & Immunol, Res Inst, Ichikawa, Chiba, Japan.	hsuzuki@ri.ncgm.go.jp	Suzuki, Harumi/L-1271-2013; Tsubata, Takeshi/AAI-7489-2021	Suzuki, Harumi/0000-0003-3616-9361; Tsubata, Takeshi/0000-0003-0760-1258	National Center for Global Health and Medicine [22303, 25-103]; Grants-in-Aid for Scientific Research [25111516] Funding Source: KAKEN	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant for National Center for Global Health and Medicine (22303, 25-103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Grandjean I, 2003, J EXP MED, V198, P1089, DOI 10.1084/jem.20030963; Kim K, 1998, J IMMUNOL, V160, P5735; King PD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003669; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kortum RL, 2013, TRENDS IMMUNOL, V34, P259, DOI 10.1016/j.it.2013.02.004; Kortum RL, 2012, MOL CELL BIOL, V32, P2748, DOI 10.1128/MCB.00317-12; Kupzig S, 2009, MOL CELL BIOL, V29, P3929, DOI 10.1128/MCB.00427-09; Lapinski PE, 2011, J IMMUNOL, V187, P151, DOI 10.4049/jimmunol.1100178; Li WQ, 2004, J BIOL CHEM, V279, P29160, DOI 10.1074/jbc.M401656200; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Navarro MN, 2011, NAT IMMUNOL, V12, P352, DOI 10.1038/ni.2008; Nitta Takeshi, 2013, Methods Mol Biol, V946, P85, DOI 10.1007/978-1-62703-128-8_6; Oda H, 2009, J IMMUNOL, V182, P957, DOI 10.4049/jimmunol.182.2.957; Oliver JA, 2013, MOL IMMUNOL, V55, P292, DOI 10.1016/j.molimm.2013.03.005; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Saitoh T, 2002, FEBS LETT, V532, P45, DOI 10.1016/S0014-5793(02)03622-0; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119898	10.1371/journal.pone.0119898	http://dx.doi.org/10.1371/journal.pone.0119898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793935	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200128
J	Okada, H; Schittenhelm, RB; Straessle, A; Hafen, E				Okada, Hirokazu; Schittenhelm, Ralf B.; Straessle, Anna; Hafen, Ernst			Multi-Functional Regulation of 4E-BP Gene Expression by the Ccr4-Not Complex	PLOS ONE			English	Article							MESSENGER-RNA DEADENYLATION; POLY(A) TAIL; SACCHAROMYCES-CEREVISIAE; DIFFERENTIALLY AFFECTS; CAF1 PROTEINS; TRANSCRIPTION; DROSOPHILA; TRANSLATION; DEGRADATION; INITIATION	The mechanistic target of rapamycin (mTOR) signaling pathway is highly conserved from yeast to humans. It senses various environmental cues to regulate cellular growth and homeostasis. Deregulation of the pathway has been implicated in many pathological conditions including cancer. Phosphorylation cascades through the pathway have been extensively studied but not much is known about the regulation of gene expression of the pathway components. Here, we report that the mRNA level of eukaryotic translation initiation factor (eIF) subunit 4E-binding protein (4E-BP) gene, one of the key mTOR signaling components, is regulated by the highly conserved Ccr4-Not complex. RNAi knockdown of Not1, a putative scaffold protein of this protein complex, increases the mRNA level of 4E-BP in Drosophila Kc cells. Examination of the gene expression mechanism using reporter swap constructs reveals that Not1 depletion increases reporter mRNAs with the 3'UTR of 4E-BP gene, but decreases the ones with the 4E-BP promoter region, suggesting that Ccr4-Not complex regulates both degradation and transcription of 4E-BP mRNA. These results indicate that the Ccr4-Not complex controls expression of a single gene at multiple levels and adjusts the magnitude of the total effect. Thus, our study reveals a novel regulatory mechanism of a key component of the mTOR signaling pathway at the level of gene expression.	[Okada, Hirokazu; Straessle, Anna; Hafen, Ernst] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Schittenhelm, Ralf B.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia	Swiss Federal Institutes of Technology Domain; ETH Zurich; Monash University	Hafen, E (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	hafen@imsb.biol.ethz.ch		Okada, Hirokazu/0000-0002-1065-2470; Schittenhelm, Ralf/0000-0001-8738-1878	SystemsX.ch [SXRTX0-123851]; Swiss National Science Foundation	SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grant SXRTX0-123851 by SystemsX.ch and the Swiss National Science Foundation (https://www.mysnf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bianchin C, 2005, RNA, V11, P487, DOI 10.1261/rna.7135305; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; COLLART MA, 1993, EMBO J, V12, P177, DOI 10.1002/j.1460-2075.1993.tb05643.x; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Costa-Mattioli M, 2013, NAT NEUROSCI, V16, P1537, DOI 10.1038/nn.3546; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Deluen C, 2002, MOL CELL BIOL, V22, P6735, DOI 10.1128/MCB.22.19.6735-6749.2002; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; GLOOR GB, 1993, GENETICS, V135, P81; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maillet L, 2002, J BIOL CHEM, V277, P2835, DOI 10.1074/jbc.M107979200; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Morris JZ, 2005, DEVELOPMENT, V132, P1165, DOI 10.1242/dev.01672; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; Oberholzer U, 1998, GENE, V207, P61, DOI 10.1016/S0378-1119(97)00605-7; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rendl LM, 2008, RNA, V14, P1328, DOI 10.1261/rna.955508; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649	41	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0113902	10.1371/journal.pone.0113902	http://dx.doi.org/10.1371/journal.pone.0113902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793896	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200002
J	Przybylska, A; Fiedler, Z; Kucharczyk, H; Obrepalska-Steplowska, A				Przybylska, Arnika; Fiedler, Zaneta; Kucharczyk, Halina; Obrepalska-Steplowska, Aleksandra			Detection of the Quarantine Species Thrips palmi by Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							MOLECULAR TECHNIQUES; THYSANOPTERA; IDENTIFICATION; EFFICACY; VECTORS; TABACI; KARNY	Thrips palmi (from the order Thysanoptera) is a serious insect pest of various crops, including vegetables, fruits and ornamental plants, causing significant economic losses. Its presence constitutes a double threat; not only does T. palmi feed on the plants, it is also a vector for several plant viruses. T. palmi originated in Asia, but has spread to North and Central America, Africa, Oceania and the Caribbean in recent decades. This species has been sporadically noted in Europe and is under quarantine regulation in the European Union. For non-specialists its larval stages are indistinguishable morphologically from another widespread and serious insect pest Frankliniella occidentalis (a non-quarantine species in the European Union) as well as other frequently occurring thrips. In this study, we have developed a loop-mediated isothermal amplification protocol to amplify rDNA regions of T. palmi. The results were consistent whether isolated DNA or crushed insects were used as template, indicating that the DNA isolation step could be omitted. The described method is species-specific and sensitive and provides a rapid diagnostic tool to detect T. palmi in the field.	[Przybylska, Arnika; Obrepalska-Steplowska, Aleksandra] Natl Res Inst, Inst Plant Protect, Interdept Lab Mol Biol, Poznan, Poland; [Fiedler, Zaneta] Natl Res Inst, Inst Plant Protect, Dept Biol Control, Poznan, Poland; [Kucharczyk, Halina] Marie Curie Sklodowska Univ, Dept Zool, Lublin, Poland	Maria Curie-Sklodowska University	Obrepalska-Steplowska, A (corresponding author), Natl Res Inst, Inst Plant Protect, Interdept Lab Mol Biol, Poznan, Poland.	olaob@o2.pl	Kucharczyk, Halina/G-6636-2016; Obrepalska-Steplowska, Aleksandra/AAC-5684-2019	Kucharczyk, Halina/0000-0001-5341-1872; Obrepalska-Steplowska, Aleksandra/0000-0002-0314-8110; Przybylska, Arnika/0000-0001-9486-4501	Polish Ministry of Agriculture and Rural Development, the Long-Term Programme of IPP-NRI [2.7]	Polish Ministry of Agriculture and Rural Development, the Long-Term Programme of IPP-NRI	This work was supported by the Polish Ministry of Agriculture and Rural Development, the Long-Term Programme of IPP-NRI, Project 2.7 to AOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATTI JS, 1980, SYST ENTOMOL, V5, P109, DOI 10.1111/j.1365-3113.1980.tb00404.x; BOURNIER JP, 1983, COTON FIBRES TROP, V38, P286; CABI/EPPO, 1997, QUARANTINE PESTS EUR; Fujisawa I, 1988, ANN PHYTOPATHOL SOC, V54, P932; Gombac P, 2014, J PLANT DIS PROTECT, V121, P117, DOI 10.1007/BF03356499; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Helyer NL, 1995, ANN APPL BIOL, V127, P405, DOI 10.1111/j.1744-7348.1995.tb07600.x; IWAKI M, 1984, PLANT DIS, V68, P1006, DOI 10.1094/PD-69-1006; Jeszke A, 2015, PEST MANAG SCI, V71, P243, DOI 10.1002/ps.3788; Kato K., 2000, AGR HORTICULTURE, V75, P103; Kox LFF, 2005, OEPP EPPO B, V35, P141, DOI DOI 10.1111/j.1365-2338.2005.00797.x; Kucharczyk H., 2007, FAUNA POLAND CHARACT; Mehle N, 2012, J PEST SCI, V85, P179, DOI 10.1007/s10340-012-0423-4; Mound L.A., 1998, THYSANOPTERA IDENTIF, V2nd ed., P1; Mound LA, 2005, ZOOTAXA, P1; MURAI T, 2001, P 7 INT S THYS, P19; Nakahara S, 1994, USDA TECHNICAL B, P1822; Nicholas K. B., 1997, PITTSBURGH SUPERCOMP; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nowaczyk K, 2009, J ECON ENTOMOL, V102, P1691, DOI 10.1603/029.102.0437; Obrepalska-Steplowska A, 2008, FOOD ADDIT CONTAM A, V25, P1179, DOI 10.1080/02652030802015689; Palmer J.M., 1992, Bulletin of the British Museum (Natural History) Entomology, V61, P1; Rebijith KB, 2012, ENTOMOL NEWS, V122, P201, DOI 10.3157/021.122.0301; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Sakimura K., 1986, Entomology Circular, Division of Plant Industry, Florida Department of Agriculture and Consumer Services; Sampson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080787; Seal DR, 2013, FLA ENTOMOL, V96, P789, DOI 10.1653/024.096.0312; Strassen R. zur, 1989, Gesunde Pflanzen, V41, P63; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toda S, 2002, B ENTOMOL RES, V92, P359, DOI 10.1079/BER2002177; Trdan S, 2007, J PEST SCI, V80, P217, DOI 10.1007/s10340-007-0174-9; Vierbergen G, 2002, VERSLAGEN MEDEDELING, V219, P49; Vierbergen G. (Bert), 2010, Tijdschrift voor Entomologie, V153, P99; Walsh K, 2005, J APPL ENTOMOL, V129, P272, DOI 10.1111/j.1439-0418.2005.00960.x; Winder L, 2011, METHODS ECOL EVOL, V2, P312, DOI 10.1111/j.2041-210X.2010.00079.x; Yao MC, 2012, J ECON ENTOMOL, V105, P1100, DOI 10.1603/EC11381; Yeh WB, 2014, J ECON ENTOMOL, V107, P1728, DOI 10.1603/EC14027; zur Strassen R., 2003, TIERWELT DEUTSCHLAND, V74	38	26	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122033	10.1371/journal.pone.0122033	http://dx.doi.org/10.1371/journal.pone.0122033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793743	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900169
J	Sharma, PM; Ponnaiya, B; Taveras, M; Shuryak, I; Turner, H; Brenner, DJ				Sharma, Preety M.; Ponnaiya, Brian; Taveras, Maria; Shuryak, Igor; Turner, Helen; Brenner, David J.			High Throughput Measurement of gamma H2AX DSB Repair Kinetics in a Healthy Human Population	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE RESPONSE; IONIZING-RADIATION; HOMOLOGOUS RECOMBINATION; HUMAN-LYMPHOCYTES; CANCER PATIENTS; CELL LINES; AGING MICE; IN-VIVO	The Columbia University RABiT (Rapid Automated Biodosimetry Tool) quantifies DNA damage using fingerstick volumes of blood. One RABiT protocol quantifies the total gamma-H2AX fluorescence per nucleus, a measure of DNA double strand breaks (DSB) by an immunofluorescent assay at a single time point. Using the recently extended RABiT system, that assays the gamma-H2AX repair kinetics at multiple time points, the present small scale study followed its kinetics post irradiation at 0.5 h, 2 h, 4 h, 7 h and 24 h in lymphocytes from 94 healthy adults. The lymphocytes were irradiated ex vivo with 4 Gy gamma rays using an external Cs-137 source. The effect of age, gender, race, ethnicity, alcohol use on the endogenous and post irradiation total gamma-H2AX protein yields at various time points were statistically analyzed. The endogenous gamma-H2AX levels were influenced by age, race and alcohol use within Hispanics. In response to radiation, induction of gamma-H2AX yields at 0.5 h and peak formation at 2 h were independent of age, gender, ethnicity except for race and alcohol use that delayed the peak to 4 h time point. Despite the shift in the peak observed, the gamma-H2AX yields reached close to baseline at 24 h for all groups. Age and race affected the rate of progression of the DSB repair soon after the yields reached maximum. Finally we show a positive correlation between endogenous gamma-H2AX levels with radiation induced gamma-H2AX yields (RIY) (r=0.257, P=0.02) and a negative correlation with residuals (r=-0.521, P=<0.0001). A positive correlation was also observed between RIY and DNA repair rate (r=0.634, P<0.0001). Our findings suggest age, race, ethnicity and alcohol use influence DSB gamma-H2AX repair kinetics as measured by RABiT immunofluorescent assay.	[Sharma, Preety M.; Ponnaiya, Brian; Taveras, Maria; Shuryak, Igor; Turner, Helen; Brenner, David J.] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA	Columbia University	Sharma, PM (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	pms2144@columbia.edu			National Institute of Health [R21 5R21ES019494-02, 5U19AI067773-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019494] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by National Institute of Health R21 5R21ES019494-02 grant and National Institute of Health 5U19AI067773-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Henriquez-Hernandez LA, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-60; Andrievski A, 2009, INT J RADIAT BIOL, V85, P369, DOI 10.1080/09553000902781147; Banath JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-4; Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1; Bhogal N, 2009, INT J RADIAT BIOL, V85, P732, DOI 10.1080/09553000902785791; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Chen Yong, 2009, Shengwu Jiagong Guocheng, V7, P61, DOI 10.3969/j.issn.1762-3678.2009.04.013; Collins AR, 2003, CARCINOGENESIS, V24, P511, DOI 10.1093/carcin/24.3.511; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Dikomey E, 1998, INT J RADIAT BIOL, V73, P269, DOI 10.1080/095530098142365; Djuzenova CS, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-98; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Endt H, 2011, J GERONTOL A-BIOL, V66, P367, DOI 10.1093/gerona/glq197; Fenech M, 2005, CARCINOGENESIS, V26, P991, DOI 10.1093/carcin/bgi042; Firsanov D V, 2011, Tsitologiia, V53, P586; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Garty G, 2010, HEALTH PHYS, V98, P209, DOI 10.1097/HP.0b013e3181ab3cb6; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Hamasaki K, 2007, ENVIRON MOL MUTAGEN, V48, P38, DOI 10.1002/em.20273; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025113; Hudson D, 2011, AGING-US, V3, P609, DOI 10.18632/aging.100340; Ismail IH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1169; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; Kotova N, 2013, CARCINOGENESIS, V34, P325, DOI 10.1093/carcin/bgs340; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lobrich M, 2000, GENE CHROMOSOME CANC, V27, P59; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Marcon F, 2003, MUTAT RES-GEN TOX EN, V541, P1, DOI 10.1016/S1383-5718(03)00171-2; Marcon F, 2013, MUTAGENESIS, V28, P135, DOI 10.1093/mutage/ges062; Martin NT, 2011, RADIOTHER ONCOL, V101, P35, DOI 10.1016/j.radonc.2011.05.065; Martin OA, 2013, DNA REPAIR, V12, P844, DOI 10.1016/j.dnarep.2013.07.002; MAYER PJ, 1991, ANN HUM BIOL, V18, P405, DOI 10.1080/03014469100001702; Mohankumar MN, 2002, MUTAT RES-GEN TOX EN, V520, P179, DOI 10.1016/S1383-5718(02)00201-2; Olive PL, 2004, INT J RADIAT ONCOL, V58, P331, DOI 10.1016/j.ijrobp.2003.09.028; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Roch-Lefevre S, 2010, RADIAT RES, V174, P185, DOI 10.1667/RR1775.1; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Schurman SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045728; Scott D, 1999, INT J RADIAT BIOL, V75, P1, DOI 10.1080/095530099140744; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Turner HC, THE RABIT HIGH THROU; Turner HC, 2014, RADIAT ENVIRON BIOPH, V53, P265, DOI 10.1007/s00411-014-0514-0; Turner HC, 2011, RADIAT RES, V175, P282, DOI 10.1667/RR2125.1; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x	56	50	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121083	10.1371/journal.pone.0121083	http://dx.doi.org/10.1371/journal.pone.0121083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794041	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900101
J	Nica, DV; Filimon, MN; Bordean, DM; Harmanescu, M; Draghici, GA; Dragan, S; Gergen, II				Nica, Dragos V.; Filimon, Marioara Nicoleta; Bordean, Despina-Maria; Harmanescu, Monica; Draghici, George Andrei; Dragan, Simona; Gergen, Iosif I.			Impact of Soil Cadmium on Land Snails: A Two-Stage Exposure Approach under Semi-Field Conditions Using Bioaccumulative and Conchological End-Points of Exposure	PLOS ONE			English	Article							HELIX-ASPERSA SNAILS; CD-METALLOTHIONEIN; GROWTH; SHELL; ACCUMULATION; FIELD; COPPER; ZINC; LEAD; PB	Land snails are highly tolerant to cadmium exposure and are able to accumulate soil cadmium independently of food ingestion. However, little information exists on the kinetics of cadmium retention in terrestrial gastropods exposed to an increase in the soil cadmium content, over time. There is also little knowledge about how exposure to cadmium-polluted soils influences shell growth and architecture. In this context, we examined cadmium accumulation in the hepatopancreas and shell of juvenile Cantareus aspersus exposed to elevating high levels of cadmium in soil. Also, the toxicity of cadmium to snails was assessed using a range of conchological endpoints, including shell height, width, volume, allometry and integrity. Test snails, aged three months, were reared under semi-field conditions, fed an uncontaminated diet and exposed first, for a period of 30 days, to a series of soil cadmium concentrations, and then, for a second period of 30 days, to soils with higher cadmium content. Cadmium showed a dose-dependent accumulation in both the hepatopancreas and shell. The kinetics of cadmium retention in the hepatopancreas of snails previously exposed to cadmium-spiked soils was significantly influenced by a new exposure event. The shell was not a relevant bioaccumulator for soil cadmium. Under the present experimental conditions, only high cadmium exposure significantly affected either the shell growth or snail survival. There was no consistent effect on shell allometry, but the shell integrity, especially in rapidly growing parts, appeared to be affected by high cadmium exposure. Our results attest to the value of hepatopancreas for describing cadmium retention in land snails and to the difficulty of using conchological parameters in field surveys for estimating the environmental hazard of soil cadmium.	[Nica, Dragos V.] Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Anim Sci & Biotechnol, Timisoara, Timis, Romania; [Filimon, Marioara Nicoleta] West Univ Timisoara, Fac Chem Biol Geog, Timisoara, Timis, Romania; [Bordean, Despina-Maria; Draghici, George Andrei; Gergen, Iosif I.] Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Food Proc Technol, Timisoara, Timis, Romania; [Harmanescu, Monica] Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Agr, Timisoara, Timis, Romania; [Dragan, Simona] Victor Babes Univ Med & Pharm, Dept Cardiol, Timisoara, Timis, Romania	Banat University of Agricultural Sciences & Veterinary Medicine; West University of Timisoara; Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; Victor Babes University of Medicine & Pharmacy, Timisoara	Nica, DV (corresponding author), Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Anim Sci & Biotechnol, Timisoara, Timis, Romania.	nicadragos@gmail.com	Harmanescu, Monica/AAQ-4906-2020; Filimon, Marioara Nicoleta/C-1904-2012; Dragan, Simona/AAA-6142-2019; Drăghici, George Andrei/AAA-4084-2019; Bordean, Despina Maria/N-8613-2014; Gergen, Iosif/O-3321-2014	Filimon, Marioara Nicoleta/0000-0002-3392-9858; Drăghici, George Andrei/0000-0002-8042-0966; Bordean, Despina Maria/0000-0002-1647-7992; Gergen, Iosif/0000-0002-8144-1961	project "Post-doctoral School Of Agriculture And Veterinary Medicine" [POSDRU/89/1.5/S/62371]; European Social Fund through Sectorial Operational Programme for the Human Resources Development	project "Post-doctoral School Of Agriculture And Veterinary Medicine"; European Social Fund through Sectorial Operational Programme for the Human Resources Development	The present work was funded by the project "Post-doctoral School Of Agriculture And Veterinary Medicine POSDRU/89/1.5/S/62371", cofinanced by the European Social Fund through the Sectorial Operational Programme for the Human Resources Development 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2006, ENVIRON HEALTH PERSP, V114, P830, DOI 10.1289/ehp.8763; Al-Oud S. S., 2008, Journal of Environmental Science and Technology, V1, P135, DOI 10.3923/jest.2008.135.142; Amune M., 2012, INT J PURE APPL SCI, V13, P42; [Anonymous], 2001, BIOL TERRESTRIAL MOL; Bardos DC, 2005, B MATH BIOL, V67, P529, DOI 10.1016/j.bulm.2004.08.009; BERGER B, 1989, OECOLOGIA, V79, P60, DOI 10.1007/BF00378240; Bordean DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085384; Bura M, 2004, CRESTEREA MELCILOR A; Chabicovsky M, 2004, ENVIRON TOXICOL CHEM, V23, P648, DOI 10.1897/02-617; Coeurdassier M, 2002, ECOTOX ENVIRON SAFE, V53, P425, DOI 10.1016/S0147-6513(02)00004-0; Dallinger R, 2004, ECOTOXICOLOGY, V13, P757, DOI 10.1007/s10646-003-4474-4; Dallinger R., 2001, P489, DOI 10.1079/9780851993188.0489; Dallinger R., 1993, ECOTOXICOLOGY METALS; de Paula SM, 2009, MICRON, V40, P669, DOI 10.1016/j.micron.2009.05.006; De Vaufleury A, 2006, ENVIRON TOXICOL CHEM, V25, P797, DOI 10.1897/04-560R.1; Ebenso IE, 2008, POLLUT RES INDIA, V27, P75; Eeva T, 2010, SCI TOTAL ENVIRON, V408, P4165, DOI 10.1016/j.scitotenv.2010.05.028; Egg M, 2009, MOL ECOL, V18, P2426, DOI 10.1111/j.1365-294X.2009.04191.x; Faroon O., 2012, TOXICOLOGICAL PROFIL; Florkin M, 1994, CHEM ZOOLOGY, VVII; Fritsch C, 2011, ECOTOXICOLOGY, V20, P739, DOI 10.1007/s10646-011-0619-z; Garcia A, 2006, LAB ANIM-UK, V40, P309, DOI 10.1258/002367706777611505; Gheoca Voichita, 2005, Transylvanian Review of Systematical and Ecological Research, V2, P67; Gimbert F, 2008, ENVIRON POLLUT, V152, P736, DOI 10.1016/j.envpol.2007.06.044; Gimbert F, 2008, ECOTOX ENVIRON SAFE, V70, P138, DOI 10.1016/j.ecoenv.2007.05.014; Girnbert F, 2006, ENVIRON INT, V32, P866, DOI 10.1016/j.envint.2006.05.006; Gomot A, 1997, ARCH ENVIRON CON TOX, V33, P209, DOI 10.1007/s002449900245; Gomot A, 1997, ECOTOX ENVIRON SAFE, V38, P85, DOI 10.1006/eesa.1997.1566; Hodl E, 2010, CELL TISSUE RES, V341, P159, DOI 10.1007/s00441-010-0980-x; IRELAND MP, 1991, COMP BIOCHEM PHYS A, V98, P111, DOI 10.1016/0300-9629(91)90587-3; Jatto E.O., 2010, ACAEDMIA ARENA, V2, P32; Jordaens K, 2006, SCI TOTAL ENVIRON, V363, P285, DOI 10.1016/j.scitotenv.2005.12.002; Kano N, 2013, ENG BIOMASS NOW SUST, P101; KEMP P, 1984, P NATL ACAD SCI-BIOL, V81, P811, DOI 10.1073/pnas.81.3.811; Kerney M.P., 1979, FIELD GUIDE LAND SNA; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Laskowski R, 1996, ENVIRON POLLUT, V91, P289, DOI 10.1016/0269-7491(95)00070-4; Locher R, 2000, INVERTEBR REPROD DEV, V38, P53, DOI 10.1080/07924259.2000.9652436; Madejon P, 2013, J SCI FOOD AGR, V93, P2259, DOI 10.1002/jsfa.6035; Madrid L, 2006, J ENVIRON MONITOR, V8, P1158, DOI 10.1039/b607980f; Massaro, 1997, HDB HUMAN TOXICOLOGY, DOI 10.1201/9781439805756; McBride M.B., 1994, ENV CHEM SOILS, P416; Mierzwa Dominika, 2011, Folia Malacologica, V19, P97; Moisa C., 2012, Research Journal of Agricultural Science, V44, P86; Mulvey M, 1996, J MOLLUS STUD, V62, P213, DOI 10.1093/mollus/62.2.213; Nica DV, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-55; Notten MJM, 2006, ENVIRON POLLUT, V139, P296, DOI 10.1016/j.envpol.2005.05.007; Nowakowska A, 2012, POL J ENVIRON STUD, V21, P1369; Pauget B, 2011, J HAZARD MATER, V192, P1804, DOI 10.1016/j.jhazmat.2011.07.016; Pauget B, 2013, ECOL INDIC, V29, P445, DOI 10.1016/j.ecolind.2013.01.012; Rabitsch WB, 1996, B ENVIRON CONTAM TOX, V56, P734, DOI 10.1007/s001289900108; RUSSELL LK, 1981, B ENVIRON CONTAM TOX, V26, P634, DOI 10.1007/BF01622148; Scheifler R, 2003, ENVIRON POLLUT, V122, P343, DOI 10.1016/S0269-7491(02)00333-0; Scheifler R, 2003, ENVIRON SCI TECHNOL, V37, P81, DOI 10.1021/es025677w; Soido C, 2009, BRAZ ARCH BIOL TECHN, V52, P93, DOI 10.1590/S1516-89132009000100012; SUNILA I, 1985, ESTUAR COAST SHELF S, V21, P555, DOI 10.1016/0272-7714(85)90056-3; van Gestel CAM, 2012, ZOOKEYS, P275, DOI 10.3897/zookeys.176.2275; Veltman K, 2008, SCI TOTAL ENVIRON, V406, P413, DOI 10.1016/j.scitotenv.2008.05.049; Wei BG, 2010, MICROCHEM J, V94, P99, DOI 10.1016/j.microc.2009.09.014; WHO/ Europe, 2007, HLTH RISKS HEAV MET; WILLIAMSON P, 1980, OECOLOGIA, V44, P213, DOI 10.1007/BF00572682	61	15	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116397	10.1371/journal.pone.0116397	http://dx.doi.org/10.1371/journal.pone.0116397			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790135	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400015
J	Tominaga, M; Ike, K; Kawai-Noma, S; Saito, K; Umeno, D				Tominaga, Masahiro; Ike, Kohei; Kawai-Noma, Shigeko; Saito, Kyoichi; Umeno, Daisuke			Rapid and Liquid-Based Selection of Genetic Switches Using Nucleoside Kinase Fused with Aminoglycoside Phosphotransferase	PLOS ONE			English	Article							DUAL SELECTION; CHLORAMPHENICOL; CIRCUITS; DESIGN	The evolutionary design of genetic switches and circuits requires iterative rounds of positive (ON-) and negative (OFF-) selection. We previously reported a rapid OFF selection system based on the kinase activity of herpes simplex virus thymidine kinase (hsvTK) on the artificial mutator nucleoside dP. By fusing hsvTK with the kanamycin resistance marker aminoglycoside-(3')-phosphotransferase (APH), we established a novel selector system for genetic switches. Due to the bactericidal nature of kanamycin and nucleoside-based lethal mutagenesis, both positive and negative selection could be completed within several hours. Using this new selector system, we isolated a series of homoserine lactone-inducible genetic switches with different expression efficiencies from libraries of the Vibrio fischeri lux promoter in two days, using only liquid handling.	[Tominaga, Masahiro; Ike, Kohei; Kawai-Noma, Shigeko; Saito, Kyoichi; Umeno, Daisuke] Chiba Univ, Fac Engn, Dept Appl Chem & Biotechnol, Inage Ku, Yayoi Cyo, Chiba, Japan; [Umeno, Daisuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	Chiba University; Japan Science & Technology Agency (JST)	Umeno, D (corresponding author), Chiba Univ, Fac Engn, Dept Appl Chem & Biotechnol, Inage Ku, Yayoi Cyo, Chiba, Japan.	umeno@faculty.chiba-u.jp	Tominaga, Masahiro/GYJ-1256-2022	Tominaga, Masahiro/0000-0001-9691-0428	Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/ Japan Society for Promotion of Science (JSPS) [23108507]; commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan	Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/ Japan Society for Promotion of Science (JSPS); commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan	This work is supported by the Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST), Grant-in-Aid for Scientific Research on Innovative Areas (23108507) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/ Japan Society for Promotion of Science (JSPS), and the commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCM, 2008, J BACTERIOL, V190, P4392, DOI 10.1128/JB.01443-07; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; BROCK TD, 1961, BACTERIOL REV, V25, P32, DOI 10.1128/MMBR.25.1.32-48.1961; Candotti F, 2000, CANCER GENE THER, V7, P574, DOI 10.1038/sj.cgt.7700153; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; DAVIES J, 1978, ANNU REV MICROBIOL, V32, P469, DOI 10.1146/annurev.mi.32.100178.002345; GARRETT ER, 1973, J PHARM SCI-US, V62, P1666, DOI 10.1002/jps.2600621018; Haseltine EL, 2007, ANNU REV BIOPH BIOM, V36, P1, DOI 10.1146/annurev.biophys.36.040306.132600; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Muranaka N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp039; Negishi K, 2002, GENETICS, V161, P1363; Nomura Y, 2007, BIOSYSTEMS, V90, P115, DOI 10.1016/j.biosystems.2006.07.006; Patterson AV, 2003, CURR PHARM DESIGN, V9, P2131, DOI 10.2174/1381612033454117; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schaerli Y, 2013, MOL BIOSYST, V9, P1559, DOI 10.1039/c2mb25483b; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; SCHWARTZ F, 1991, P NATL ACAD SCI USA, V88, P10416, DOI 10.1073/pnas.88.23.10416; SHAW WV, 1983, CRC CR REV BIOCH MOL, V14, P1, DOI 10.3109/10409238309102789; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tashiro Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1070; Topp S, 2008, CHEMBIOCHEM, V9, P210, DOI 10.1002/cbic.200700546; Yokobayashi Yohei, 2005, Natural Computing, V4, P245, DOI 10.1007/s11047-004-7442-x	25	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120243	10.1371/journal.pone.0120243	http://dx.doi.org/10.1371/journal.pone.0120243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790096	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400145
J	Kuzmenkov, AI; Vassilevski, AA; Kudryashova, KS; Nekrasova, OV; Peigneur, S; Tytgat, J; Feofanov, AV; Kirpichnikov, MP; Grishin, EV				Kuzmenkov, Alexey I.; Vassilevski, Alexander A.; Kudryashova, Kseniya S.; Nekrasova, Oksana V.; Peigneur, Steve; Tytgat, Jan; Feofanov, Alexey V.; Kirpichnikov, Mikhail P.; Grishin, Eugene V.			Variability of Potassium Channel Blockers in Mesobuthus eupeus Scorpion Venom with Focus on Kv1.1 AN INTEGRATED TRANSCRIPTOMIC AND PROTEOMIC STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Screening; Fluorescence; Molecular Pharmacology; Neurotoxin; Potassium Channel; Protein Chimera; Protein Drug Interaction; Proteomics; Toxin; Transcriptomics	K+ CHANNELS; BUTHUS-MARTENSI; BINDING-SITES; INNER MOUTH; TOXINS; PEPTIDES; INHIBITOR; POTENT; PURIFICATION; DIVERSITY	Background: Scorpion venoms are an ample source of toxins targeting potassium channels. Results: A comprehensive search for new toxins was performed by combining transcriptomics and peptidomics with a fluorescent test system. Conclusion: We identified five new high affinity potassium channel blockers in the venom of Mesobuthus eupeus. Significance: The proposed integrated approach is of general utility for potassium channel pharmacology. The lesser Asian scorpion Mesobuthus eupeus (Buthidae) is one of the most widely spread and dispersed species of the Mesobuthus genus, and its venom is actively studied. Nevertheless, a considerable amount of active compounds is still under-investigated due to the high complexity of this venom. Here, we report a comprehensive analysis of putative potassium channel toxins (KTxs) from the cDNA library of M. eupeus venom glands, and we compare the deduced KTx structures with peptides purified from the venom. For the transcriptome analysis, we used conventional tools as well as a search for structural motifs characteristic of scorpion venom components in the form of regular expressions. We found 59 candidate KTxs distributed in 30 subfamilies and presenting the cysteine-stabilized / and inhibitor cystine knot types of fold. M. eupeus venom was then separated to individual components by multistage chromatography. A facile fluorescent system based on the expression of the KcsA-Kv1.1 hybrid channels in Escherichia coli and utilization of a labeled scorpion toxin was elaborated and applied to follow Kv1.1 pore binding activity during venom separation. As a result, eight high affinity Kv1.1 channel blockers were identified, including five novel peptides, which extend the panel of potential pharmacologically important Kv1 ligands. Activity of the new peptides against rat Kv1.1 channel was confirmed (IC50 in the range of 1-780 nm) by the two-electrode voltage clamp technique using a standard Xenopus oocyte system. Our integrated approach is of general utility and efficiency to mine natural venoms for KTxs.	[Kuzmenkov, Alexey I.; Vassilevski, Alexander A.; Kudryashova, Kseniya S.; Nekrasova, Oksana V.; Feofanov, Alexey V.; Kirpichnikov, Mikhail P.; Grishin, Eugene V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Kudryashova, Kseniya S.; Feofanov, Alexey V.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119992, Russia; [Peigneur, Steve; Tytgat, Jan] Univ Leuven, Lab Toxicol & Pharmacol, B-3000 Leuven, Belgium	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; KU Leuven	Vassilevski, AA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.	avas@ibch.ru	Kudryashova, Ksenia S/A-9510-2014; Vassilevski, Alexander/S-3824-2016; Kudryashova, Ksenia/AAR-9066-2020; Nekrasova, Oksana/V-1851-2018; Kuzmenkov, Alexey I/M-3293-2017; Feofanov, Alexey V/K-3082-2012	Vassilevski, Alexander/0000-0002-1359-0076; Kudryashova, Ksenia/0000-0002-6937-3193; Nekrasova, Oksana/0000-0002-7216-1618; Feofanov, Alexey V/0000-0002-1596-9506; Kuzmenkov, Alexey/0000-0002-5416-1825; Kirpichnikov, Mikhail/0000-0001-8170-1607; Tytgat, Jan/0000-0003-1778-6022; Peigneur, Steve/0000-0003-0504-5702	Russian Foundation for Basic Research [14-04-32091, 13-04-01857]; Program for Fundamental Research of the Presidium of Russian Academy of Sciences [24]; Moscow State University Program of Development; F.W.O. Vlaanderen [G.0433.12]; KU Leuven [OT/12/081]; Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy [IUAP 7/10]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program for Fundamental Research of the Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Moscow State University Program of Development; F.W.O. Vlaanderen(FWO); KU Leuven(KU Leuven); Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported in part by Russian Foundation for Basic Research Grants 14-04-32091 and 13-04-01857, Program for Fundamental Research of the Presidium of Russian Academy of Sciences No. 24, and by the Moscow State University Program of Development.; Supported by grants G.0433.12 from F.W.O. Vlaanderen, Grant OT/12/081 from KU Leuven, and IUAP 7/10 from the Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy.	Abbas N, 2008, BIOCHEM BIOPH RES CO, V376, P525, DOI 10.1016/j.bbrc.2008.09.033; Abdel-Mottaleb Y, 2008, TOXICON, V51, P1424, DOI 10.1016/j.toxicon.2008.03.027; Abdel-Rahman MA, 2013, TOXICON, V74, P193, DOI 10.1016/j.toxicon.2013.08.064; Almeida DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-362; Andalib P, 2004, BIOPHYS J, V87, P3148, DOI 10.1529/biophysj.104.046664; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beraud E, 2006, ANN NEUROL, V60, P586, DOI 10.1002/ana.21007; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; Chen R, 2012, BIOCHEMISTRY-US, V51, P1976, DOI 10.1021/bi201811j; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; CREST M, 1992, J BIOL CHEM, V267, P1640; Dai L, 2000, BIOCHEM J, V346, P805, DOI 10.1042/0264-6021:3460805; Darbon H., 1999, PERSPECTIVES DRUG DI, V15; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Diego-Garcia E, 2013, TOXICON, V61, P72, DOI 10.1016/j.toxicon.2012.10.010; Eskandari G, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.9666; Filippov AK, 1996, FEBS LETT, V384, P277, DOI 10.1016/0014-5793(96)00333-X; Freudenthaler G, 2002, HISTOCHEM CELL BIOL, V117, P197, DOI 10.1007/s00418-001-0374-y; Gao B, 2013, BIOSCIENCE REP, V33, P513, DOI 10.1042/BSR20130052; Gao B, 2011, COMP BIOCHEM PHYS A, V159, P313, DOI 10.1016/j.cbpa.2011.03.027; Gao B, 2010, BIOCHIMIE, V92, P1847, DOI 10.1016/j.biochi.2010.08.003; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Hayes KC, 2004, CNS DRUG REV, V10, P295; He YW, 2013, J PROTEOMICS, V89, P1, DOI 10.1016/j.jprot.2013.06.007; Helms LMH, 1997, BIOCHEMISTRY-US, V36, P3737, DOI 10.1021/bi962351p; Hille B., 2001, ION CHANNELS EXCITAB, P131; Holaday SK, 2000, ARCH BIOCHEM BIOPHYS, V379, P18, DOI 10.1006/abbi.2000.1858; Jang SH, 2011, J VET SCI, V12, P35, DOI 10.4142/jvs.2011.12.1.35; Jeon WI, 2012, ANTICANCER RES, V32, P5279; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Kharrat R, 1997, FEBS LETT, V406, P284, DOI 10.1016/S0014-5793(97)00285-8; KIRSCH GE, 1993, NEURON, V11, P503, DOI 10.1016/0896-6273(93)90154-J; Korolkova YV, 2001, J BIOL CHEM, V276, P9868, DOI 10.1074/jbc.M005973200; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kudryashova KS, 2013, ANAL BIOANAL CHEM, V405, P2379, DOI 10.1007/s00216-012-6655-6; Legros C, 2000, J BIOL CHEM, V275, P16918, DOI 10.1074/jbc.275.22.16918; Legros C, 2002, BIOCHEMISTRY-US, V41, P15369, DOI 10.1021/bi026264a; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; MARTINS JC, 1990, FEBS LETT, V260, P249, DOI 10.1016/0014-5793(90)80115-Y; Mille BG, 2014, TOXICON, V83, P75, DOI 10.1016/j.toxicon.2014.03.001; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; MOZHAEVA GN, 1979, BIOFIZIKA+, V24, P235; Nekrasova O, 2009, ACTA NATURAE, V1, P91, DOI 10.32607/20758251-2009-1-1-91-95; Nekrasova OV, 2009, J NEUROIMMUNE PHARM, V4, P83, DOI 10.1007/s11481-008-9116-4; Ouadid-Ahidouch H, 2000, BIOCHEM BIOPH RES CO, V278, P272, DOI 10.1006/bbrc.2000.3790; Panyi G, 2006, CURR PHARM DESIGN, V12, P2199, DOI 10.2174/138161206777585120; Peigneur S, 2011, BIOCHEM PHARMACOL, V82, P81, DOI 10.1016/j.bcp.2011.03.023; Quintero-Hernandez V, 2011, TOXICON, V58, P644, DOI 10.1016/j.toxicon.2011.09.015; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; RomiLebrun R, 1997, BIOCHEMISTRY-US, V36, P13473, DOI 10.1021/bi971044w; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saucedo AL, 2012, J BIOL CHEM, V287, P12321, DOI 10.1074/jbc.M111.329607; SHIEH CC, 1994, BIOPHYS J, V67, P2316, DOI 10.1016/S0006-3495(94)80718-0; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Takacs Z, 2009, P NATL ACAD SCI USA, V106, P22211, DOI 10.1073/pnas.0910123106; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terstappen GC, 2010, FUTURE MED CHEM, V2, P715, DOI 10.4155/FMC.10.180; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Varga Z, 2012, MOL PHARMACOL, V82, P372, DOI 10.1124/mol.112.078006; Vassilevski AA, 2008, BIOCHEM J, V411, P687, DOI [10.1042/BJ20071123, 10.1042/bj20071123]; Vassilevski AA, 2010, METHODS MOL BIOL, V615, P87, DOI 10.1007/978-1-60761-535-4_7; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yin SJ, 2008, PEPTIDES, V29, P1514, DOI 10.1016/j.peptides.2008.04.021; Zhu SY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002832; Zhu SY, 2010, BBA-PROTEINS PROTEOM, V1804, P872, DOI 10.1016/j.bbapap.2009.12.017	73	34	43	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12195	12209		10.1074/jbc.M115.637611	http://dx.doi.org/10.1074/jbc.M115.637611			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25792741	Green Published, hybrid			2022-12-26	WOS:000354388600031
J	Owens, GP; Ritchie, A; Rossi, A; Schaller, K; Wemlinger, S; Schumann, H; Shearer, A; Verkman, AS; Bennett, JL				Owens, Gregory P.; Ritchie, Alanna; Rossi, Andrea; Schaller, Kristin; Wemlinger, Scott; Schumann, Hannah; Shearer, Andrew; Verkman, Alan S.; Bennett, Jeffrey L.			Mutagenesis of the Aquaporin 4 Extracellular Domains Defines Restricted Binding Patterns of Pathogenic Neuromyelitis Optica IgG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aquaporin; Autoimmunity; Epitope Mapping; Monoclonal Antibody; Neuroimmunology; Demyelination; Neuromyelitis Optica	MULTIPLE-SCLEROSIS; ORTHOGONAL ARRAYS; WATER CHANNEL; CEREBROSPINAL-FLUID; AUTOANTIBODIES; REVEALS; LESIONS; MARKER; MICE	Background: Patient-derived aquaporin 4 (AQP4)-specific recombinant monoclonal antibodies (rAbs) cause neuromyelitis optica (NMO)-specific nervous system injury in animal models. Results: AQP4-specific rAbs bind human AQP4 based on differential sensitivity to loop A and C mutations. Conclusion: AQP4-specific rAbs derived from NMO patients recognize multiple conformational epitopes within the extracellular domains of human AQP4. Significance: High resolution mapping of AQP4 autoantibody epitopes identifies target regions for potential blocking therapies. Neuromyelitis optica-immunoglobulin G (NMO-IgG) binds to aquaporin-4 (AQP4) water channels in the central nervous system leading to immune-mediated injury. We have previously demonstrated that a high proportion of CSF plasma cells of NMO patients produce antibody to the extracellular domains of the AQP4 protein and that recombinant IgG (rAb) derived from these cells recapitulate pathogenic features of disease. We performed a comprehensive mutational analysis of the three extracellular loops of the M23 isoform of human AQP4 using both serial and single point mutations, and we evaluated the effects on binding of NMO AQP4-reactive rAbs by quantitative immunofluorescence. Whereas all NMO rAbs required conserved loop C ((TP138)-T-137 and Val(150)) and loop E ((HW231)-H-230) amino acids for binding, two broad patterns of NMO-IgG recognition could be distinguished based on differential sensitivity to loop A amino acid changes. Pattern 1 NMO rAbs were insensitive to loop A mutations and could be further discriminated by differential sensitivity to amino acid changes in loop C ((TM149)-T-148 and His(151)) and loop E (Asn(226) and Glu(228)). Alternatively, pattern 2 NMO rAbs showed significantly reduced binding following amino acid changes in loop A ((EKP65)-E-63 and Asp(69)) and loop C (Val(141), His(151), and Leu(154)). Amino acid substitutions at (TP138)-T-137 altered loop C conformation and abolished the binding of all NMO rAbs and NMO-IgG, indicating the global importance of loop C conformation to the recognition of AQP4 by pathogenic NMO Abs. The generation of human NMO rAbs has allowed the first high resolution mapping of extracellular loop amino acids critical for NMO-IgG binding and identified regions of AQP4 extracellular structure that may represent prime targets for drug therapy.	[Owens, Gregory P.; Ritchie, Alanna; Schaller, Kristin; Wemlinger, Scott; Schumann, Hannah; Shearer, Andrew; Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA; [Rossi, Andrea] Max Planck Inst Heart & Lung Res, Dept Dev Genet 3, D-61231 Bad Nauheim, Germany; [Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Max Planck Society; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bennett, JL (corresponding author), Univ Colorado, Sch Med, Dept Neurol, 12700 East 19th Ave,Mail Stop B182, Aurora, CO 80045 USA.	jeffrey.bennett@ucdenver.edu	Regan, Clinton/E-6250-2012	Rossi, Andrea/0000-0001-5863-6448	National Institutes of Health [EY022936, NS072141, EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; Guthy-Jackson Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022936, R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI110503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124, P30DK072517, RC1DK086125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY022936 (to J. L. B.), NS072141 (to G. P. O.), and EY13574, EB00415, DK35124, HL73856, DK86125, and DK72517 (to A. S. V.). This work was also supported by the Guthy-Jackson Foundation (to J. L. B. and A. S. V.). G. P. O., J. L. B., and A. S. V. receive license and royalties for a patent regarding Compositions and Methods for the Treatment of Neuromyelitis Optica.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Iorio R, 2013, J AUTOIMMUN, V40, P21, DOI 10.1016/j.jaut.2012.07.008; Kampylafka EI, 2011, J AUTOIMMUN, V36, P221, DOI 10.1016/j.jaut.2011.01.004; Kowarik MC, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0240-9; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2004, ANN NEUROL, V56, P308, DOI 10.1002/ana.20182; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Owens GP, 2003, J IMMUNOL, V171, P2725, DOI 10.4049/jimmunol.171.5.2725; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; Phuan PW, 2012, J BIOL CHEM, V287, P13829, DOI 10.1074/jbc.M112.344325; Pisani F, 2014, J BIOL CHEM, V289, P30578, DOI 10.1074/jbc.M114.582221; Pisani F, 2011, J BIOL CHEM, V286, P9216, DOI 10.1074/jbc.M110.123000; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Tradtrantip L, 2012, ANN NEUROL, V71, P314, DOI 10.1002/ana.22657; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Wrzos C, 2014, ACTA NEUROPATHOL, V127, P523, DOI 10.1007/s00401-013-1220-8; Yang BX, 1996, J BIOL CHEM, V271, P4577; Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551	22	26	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12123	12134		10.1074/jbc.M115.647149	http://dx.doi.org/10.1074/jbc.M115.647149			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25792738	Green Published, hybrid			2022-12-26	WOS:000354388600026
J	Taulemesse, F; Le Gouis, J; Gouache, D; Gibon, Y; Allard, V				Taulemesse, Francois; Le Gouis, Jacques; Gouache, David; Gibon, Yves; Allard, Vincent			Post-Flowering Nitrate Uptake in Wheat Is Controlled by N Status at Flowering, with a Putative Major Role of Root Nitrate Transporter NRT2.1	PLOS ONE			English	Article							GRAIN PROTEIN-CONCENTRATION; SPRING WHEAT; WINTER-WHEAT; BREAD WHEAT; POSTTRANSLATIONAL REGULATION; FUNCTIONAL-CHARACTERIZATION; NITROGEN REMOBILIZATION; NEGATIVE RELATIONSHIP; ARABIDOPSIS-THALIANA; GLUTAMINE-SYNTHETASE	In bread wheat (Triticum aestivum L.), the simultaneous improvement of both yield and grain protein is difficult because of the strong negative relationship between these two traits. However, some genotypes deviate positively from this relationship and this has been linked to their ability to take up nitrogen (N) during the post-flowering period, regardless of their N status at flowering. The physiological and genetic determinants of post-flowering N uptake relating to N satiety are poorly understood. This study uses semi-hydroponic culture of cv. Recital under controlled conditions to explore these controls. The first objective was to record the effects of contrasting N status at flowering on post-flowering nitrate (NO3-) uptake under nonlimiting NO3- conditions, while following the expression of key genes involved in NO3- uptake and assimilation. We found that post-flowering NO3- uptake was strongly influenced by plant N status at flowering during the first 300-400 degree-days after flowering, overlapping with a probable regulation of nitrate uptake exerted by N demand for growth. The uptake of NO3- correlated well with the expression of the gene TaNRT2.1, coding for a root NO3- transporter, which seems to play a major role in post-flowering NO3- uptake. These results provide a useful knowledge base for future investigation of genetic variability in post-flowering N uptake and may lead to concomitant gains in both grain yield and grain protein in wheat.	[Taulemesse, Francois; Le Gouis, Jacques; Allard, Vincent] INRA, UMR Genet Diversite & Ecophysiol Cereales 1095, Clermont Ferrand, France; [Taulemesse, Francois; Le Gouis, Jacques; Allard, Vincent] Blaise Pascal Univ, UMR Genet Diversite & Ecophysiol Cereales 1095, Aubiere, France; [Taulemesse, Francois; Gouache, David] Arvalis Inst Vegetal, Serv Biotechnol, Boigneville, France; [Gibon, Yves] INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France	INRAE; Universite Clermont Auvergne (UCA); INRAE	Allard, V (corresponding author), INRA, UMR Genet Diversite & Ecophysiol Cereales 1095, Clermont Ferrand, France.	vincent.allard@clermont.inra.fr	Allard, Vincent/B-8806-2009; Gouache, David/AAX-2128-2020	Allard, Vincent/0000-0003-1949-9158; Gibon, Yves/0000-0001-8161-1089	French "Fonds de Soutien a l'Obtention Vegetale" (FSOV); ANRT (Association Nationale de la Recherche et de la Technologie) [CIFRE 878/2011]	French "Fonds de Soutien a l'Obtention Vegetale" (FSOV); ANRT (Association Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR))	Funding: This work was supported by the French "Fonds de Soutien a l'Obtention Vegetale" (FSOV) 2010F project (2011-2013). The authors are also grateful to the ANRT (Association Nationale de la Recherche et de la Technologie) which supports the PhD thesis (CIFRE 878/2011) during which the analyses were conducted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, AZ QUANT PCR; BARLOW EWR, 1983, AUST J PLANT PHYSIOL, V10, P99, DOI 10.1071/PP9830099; Barneix AJ, 2007, J PLANT PHYSIOL, V164, P581, DOI 10.1016/j.jplph.2006.03.009; Bernard SM, 2008, PLANT MOL BIOL, V67, P89, DOI 10.1007/s11103-008-9303-y; Bertheloot J, 2012, EUR J AGRON, V42, P11, DOI 10.1016/j.eja.2012.03.005; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Boisson M, 2005, THEOR APPL GENET, V110, P932, DOI 10.1007/s00122-004-1913-4; Branlard G, 2001, EUPHYTICA, V119, P59, DOI 10.1023/A:1017586220359; Carillo P, 2005, FUNCT PLANT BIOL, V32, P209, DOI 10.1071/FP04184; CASTLE SL, 1987, AUST J PLANT PHYSIOL, V14, P503, DOI 10.1071/PP9870503; CLARKSON DT, 1985, ANNU REV PLANT PHYS, V36, P77, DOI 10.1146/annurev.pp.36.060185.000453; COX MC, 1986, CROP SCI, V26, P737, DOI 10.2135/cropsci1986.0011183X002600040022x; Cross JM, 2006, PLANT PHYSIOL, V142, P1574, DOI 10.1104/pp.106.086629; Feil B., 1997, AGRONOMY, V1, P103; Filleur S, 2001, FEBS LETT, V489, P220, DOI 10.1016/S0014-5793(01)02096-8; Finnemann J, 2000, PLANT J, V24, P171, DOI 10.1046/j.1365-313x.2000.00863.x; Garnett T, 2013, NEW PHYTOL, V198, P82, DOI 10.1111/nph.12166; Glass ADM, 2009, BOTANY, V87, P659, DOI 10.1139/B09-014; Howarth JR, 2008, J EXP BOT, V59, P3675, DOI 10.1093/jxb/ern218; Huang NC, 1999, PLANT CELL, V11, P1381, DOI 10.1105/tpc.11.8.1381; IMSANDE J, 1994, PLANT PHYSIOL, V105, P3, DOI 10.1104/pp.105.1.3; JENNER CF, 1991, AUST J PLANT PHYSIOL, V18, P211, DOI 10.1071/PP9910211; Jeuffroy MH, 2002, J EXP BOT, V53, P809, DOI 10.1093/jexbot/53.370.809; JUSTES E, 1994, ANN BOT-LONDON, V74, P397, DOI 10.1006/anbo.1994.1133; Kaiser WM, 2001, J EXP BOT, V52, P1981, DOI 10.1093/jexbot/52.363.1981; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; KING BJ, 1993, PLANT PHYSIOL, V102, P1279, DOI 10.1104/pp.102.4.1279; KIRKMAN MA, 1979, J SCI FOOD AGR, V30, P653, DOI 10.1002/jsfa.2740300703; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; LEA PJ, 1994, PLANT CELL ENVIRON, V17, P541, DOI 10.1111/j.1365-3040.1994.tb00148.x; Lemaire G., 1997, DIAGNOSIS NITROGEN S, P3, DOI [DOI 10.1007/978-3-642-60684-7, 10.1007/978-3-642-60684-7, DOI 10.1007/978-3-642-60684-7_1]; Lin CM, 2000, PLANT PHYSIOL, V122, P379, DOI 10.1104/pp.122.2.379; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Martre P, 2003, PLANT PHYSIOL, V133, P1959, DOI 10.1104/pp.103.030585; Martre P, 2006, EUR J AGRON, V25, P138, DOI 10.1016/j.eja.2006.04.007; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; MATTSSON M, 1992, J EXP BOT, V43, P25, DOI 10.1093/jxb/43.1.25; Meyer C, 2001, NITRATE REDUCTION SI, P37; Migocka M, 2013, PLANT SOIL, V364, P245, DOI 10.1007/s11104-012-1345-x; Miller AJ, 2007, J EXP BOT, V58, P2297, DOI 10.1093/jxb/erm066; Monaghan JM, 2001, EUPHYTICA, V122, P309, DOI 10.1023/A:1012961703208; Nazoa P, 2003, PLANT MOL BIOL, V52, P689, DOI 10.1023/A:1024899808018; Okamoto M, 2003, PLANT CELL PHYSIOL, V44, P304, DOI 10.1093/pcp/pcg036; Olesen JE, 2002, EUR J AGRON, V16, P279, DOI 10.1016/S1161-0301(01)00134-4; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; OSCARSON P, 1995, PLANT SOIL, V175, P179, DOI 10.1007/BF00011353; Oscarson P, 1996, ANN BOT-LONDON, V78, P479, DOI 10.1006/anbo.1996.0145; Oscarson P, 2000, J EXP BOT, V51, P1921, DOI 10.1093/jexbot/51.352.1921; OSCARSON P, 1995, CROP SCI, V35, P1056, DOI 10.2135/cropsci1995.0011183X003500040023x; Oury FX, 2007, EUPHYTICA, V157, P45, DOI 10.1007/s10681-007-9395-5; Oury FX, 2003, J GENET BREED, P57; PALTA JA, 1994, CROP SCI, V34, P118, DOI 10.2135/cropsci1994.0011183X003400010021x; PALTA JA, 1995, AUST J AGR RES, V46, P519, DOI 10.1071/AR9950519; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015289; Quraishi UM, 2011, PLANT J, V65, P745, DOI 10.1111/j.1365-313X.2010.04461.x; R Core Team, 2012, R LANG ENV STAT COMP; Rothstein SJ, 2007, PLANT CELL, V19, P2695, DOI 10.1105/tpc.107.053074; Sadras VO, 2010, FIELD CROP RES, V118, P297, DOI 10.1016/j.fcr.2010.06.010; Shewry PR, 2007, J CEREAL SCI, V46, P239, DOI 10.1016/j.jcs.2007.06.006; SIDDIQI MY, 1990, PLANT PHYSIOL, V93, P1426, DOI 10.1104/pp.93.4.1426; SIMMONDS NW, 1995, J SCI FOOD AGR, V67, P309, DOI 10.1002/jsfa.2740670306; TALOUIZTE A, 1984, J PLANT PHYSIOL, V116, P113, DOI 10.1016/S0176-1617(84)80068-1; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Triboi E, 2003, J EXP BOT, V54, P1731, DOI 10.1093/jxb/erg183; Triboi E, 2006, EUR J AGRON, V25, P108, DOI 10.1016/j.eja.2006.04.004; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; VANSANFORD DA, 1987, CROP SCI, V27, P295, DOI 10.2135/cropsci1987.0011183X002700020035x; Vidmar JJ, 2000, PLANT PHYSIOL, V123, P307, DOI 10.1104/pp.123.1.307; Wang P, 2011, AGR SCI CHINA, V10, P695, DOI 10.1016/S1671-2927(11)60052-7; Wang RC, 2004, PLANT PHYSIOL, V136, P2512, DOI 10.1104/pp.104.044610; Yin LP, 2007, PLANT SCI, V172, P621, DOI 10.1016/j.plantsci.2006.11.014; Yuan LX, 2007, PLANT PHYSIOL, V143, P732, DOI 10.1104/pp.106.093237	75	57	60	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120291	10.1371/journal.pone.0120291	http://dx.doi.org/10.1371/journal.pone.0120291			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798624	Green Published, gold			2022-12-26	WOS:000351987300123
J	Chakraborty, S; Hu, SY; Wu, SH; Karmenyan, A; Chiou, A				Chakraborty, Sandeep; Hu, Shih-Yang; Wu, Shu-Han; Karmenyan, Artashes; Chiou, Arthur			The Interaction Affinity between Vascular Cell Adhesion Molecule-1 (VCAM-1) and Very Late Antigen-4 (VLA-4) Analyzed by Quantitative FRET	PLOS ONE			English	Article							TRANSENDOTHELIAL MIGRATION; PROTEIN INTERACTIONS; BINDING; INTEGRINS; EXPRESSION; PATHWAYS; DOMAIN-4; RECEPTOR; ICAM-1	Very late antigen-4 (VLA-4), a member of integrin superfamily, interacts with its major counter ligand vascular cell adhesion molecule-1 (VCAM-1) and plays an important role in leukocyte adhesion to vascular endothelium and immunological synapse formation. However, irregular expressions of these proteins may also lead to several autoimmune diseases and metastasis cancer. Thus, quantifying the interaction affinity of the VCAM-1/VLA-4 interaction is of fundamental importance in further understanding the nature of this interaction and drug discovery. In this study, we report an 'in solution' steady state organic fluorophore based quantitative fluorescence resonance energy transfer (FRET) assay to quantify this interaction in terms of the dissociation constant (K-d). We have used, in our FRET assay, the Alexa Fluor 488-VLA-4 conjugate as the donor, and Alexa Fluor 546-VCAM-1 as the acceptor. From the FRET signal analysis, K-d of this interaction was determined to be 41.82 +/- 2.36 nM. To further confirm our estimation, we have employed surface plasmon resonance (SPR) technique to obtain K-d = 39.60 +/- 1.78 nM, which is in good agreement with the result obtained by FRET. This is the first reported work which applies organic fluorophore based 'in solution' simple quantitative FRET assay to obtain the dissociation constant of the VCAM-1/VLA-4 interaction, and is also the first quantification of this interaction. Moreover, the value of K-d can serve as an indicator of abnormal protein-protein interactions; hence, this assay can potentially be further developed into a drug screening platform of VLA-4/VCAM-1 as well as other protein-ligand interactions.	[Chakraborty, Sandeep; Hu, Shih-Yang; Wu, Shu-Han; Chiou, Arthur] Natl Yang Ming Univ, Inst Biophoton, Taipei 11221, Taiwan; [Wu, Shu-Han] Acad Sinica, Res Ctr Appl Sci, Taipei 11529, Taiwan; [Karmenyan, Artashes] Natl Dong Hwa Univ, Dept Phys, Hualien 97401, Taiwan; [Karmenyan, Artashes; Chiou, Arthur] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Dong Hwa University; National Yang Ming Chiao Tung University	Karmenyan, A (corresponding author), Natl Dong Hwa Univ, Dept Phys, Hualien 97401, Taiwan.	artashes@mail.ndhu.edu.tw; aechiou@ym.edu.tw	Karmenyan, Artashes/U-3697-2019		Ministry of Science & Technology, Taiwan, ROC [NSC99-2923-E-010-001-MY3]; Top University Project from Taiwan Ministry of Education, ROC	Ministry of Science & Technology, Taiwan, ROC; Top University Project from Taiwan Ministry of Education, ROC	Funding: SC, SH, SW, AK, and AC were jointly supported by the Ministry of Science & Technology, Taiwan, ROC (Project No. NSC99-2923-E-010-001-MY3), and the Top University Project from Taiwan Ministry of Education, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab W, 2013, J VIROL, V87, P5937, DOI 10.1128/JVI.03522-12; Azab W, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-61; BERGESE SD, 1995, AM J PATHOL, V147, P166; Boozer C, 2006, CURR OPIN BIOTECH, V17, P400, DOI 10.1016/j.copbio.2006.06.012; Chakraborty S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102572; Chen HM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799171; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Clark K, 2000, FEBS LETT, V471, P182, DOI 10.1016/S0014-5793(00)01391-0; CYBULSKY MI, 1991, AM J PATHOL, V138, P815; de Andres Clara, 2012, PLoS One, V7, pe34103, DOI 10.1371/journal.pone.0034103; Ding ZQ, 2001, J LEUKOCYTE BIOL, V69, P458; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; ENGELHARDT B, 2007, PROG INFLAM RES, P117; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; HYDUK SJ, 2007, PROG INFLAM RES, P141; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KILGER G, 1995, J BIOL CHEM, V270, P5979, DOI 10.1074/jbc.270.11.5979; Klemke M, 2007, J CELL PHYSIOL, V212, P368, DOI 10.1002/jcp.21029; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4]; Lichlyter DJ, 2003, BIOSENS BIOELECTRON, V19, P219, DOI 10.1016/S0956-5663(03)00215-X; Liu Yan, 2012, [Frontiers in Biology, 生物学前沿], V7, P57; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Martin SF, 2008, PROTEIN SCI, V17, P777, DOI 10.1110/ps.073369608; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Morimoto C, 1998, CURR TOP MICROBIOL, V231, P1; NORRIS P, 1991, J INVEST DERMATOL, V96, P763, DOI 10.1111/1523-1747.ep12471720; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; OSBORN L, 1992, J EXP MED, V176, P99, DOI 10.1084/jem.176.1.99; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; POLTE T, 1991, DNA CELL BIOL, V10, P349, DOI 10.1089/dna.1991.10.349; Salza R, 2014, BIOCHEM J, V457, P137, DOI 10.1042/BJ20130295; Song Y, 2012, BIOTECHNOL BIOENG, V109, P2875, DOI 10.1002/bit.24564; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; Soto MS, 2013, NEURO-ONCOLOGY, P1; Sun YS, 2013, CYTOM PART A, V83, P780, DOI 10.1002/cyto.a.22321; Takeuchi E, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar593; Vogel Steven S, 2006, Sci STKE, V2006, pre2; VONDERHEIDE RH, 1994, J CELL BIOL, V125, P215, DOI 10.1083/jcb.125.1.215; Waksman G., 2005, PROTEOMICS PROTEIN P; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; Weber C, 1998, J IMMUNOL, V161, P6825; Wu SH, 2014, BIOSENS BIOELECTRON, V56, P159, DOI 10.1016/j.bios.2014.01.008; Zwartz G, 2004, BIOPHYS J, V86, P1243, DOI 10.1016/S0006-3495(04)74198-3	47	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121399	10.1371/journal.pone.0121399	http://dx.doi.org/10.1371/journal.pone.0121399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793408	Green Submitted, gold, Green Published			2022-12-26	WOS:000352083900130
J	Dupont, DM; Thuesen, CK; Botkjaer, KA; Behrens, MA; Dam, K; Sorensen, HP; Pedersen, JS; Ploug, M; Jensen, JK; Andreasen, PA				Dupont, Daniel M.; Thuesen, Cathrine K.; Botkjaer, Kenneth A.; Behrens, Manja A.; Dam, Karen; Sorensen, Hans P.; Pedersen, Jan S.; Ploug, Michael; Jensen, Jan K.; Andreasen, Peter A.			Protein-Binding RNA Aptamers Affect Molecular Interactions Distantly from Their Binding Sites	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; RECEPTOR-RELATED PROTEIN; UROKINASE RECEPTOR; ALPHA(2)-MACROGLOBULIN RECEPTOR; MONOCLONAL-ANTIBODIES; STRUCTURE PREDICTION; SCATTERING; EPITOPE; ENDOCYTOSIS; COMPLEX	Nucleic acid aptamer selection is a powerful strategy for the development of regulatory agents for molecular intervention. Accordingly, aptamers have proven their diligence in the intervention with serine protease activities, which play important roles in physiology and pathophysiology. Nonetheless, there are only a few studies on the molecular basis underlying aptamer-protease interactions and the associated mechanisms of inhibition. In the present study, we use site-directed mutagenesis to delineate the binding sites of two 2 '-fluoropyrimidine RNA aptamers (upanap-12 and upanap-126) with therapeutic potential, both binding to the serine protease urokinase-type plasminogen activator (uPA). We determine the subsequent impact of aptamer binding on the well-established molecular interactions (plasmin, PAI-1, uPAR, and LRP-1A) controlling uPA activities. One of the aptamers (upanap-126) binds to the area around the C-terminal alpha-helix in pro-uPA, while the other aptamer (upanap-12) binds to both the beta-hairpin of the growth factor domain and the kringle domain of uPA. Based on the mapping studies, combined with data from small-angle X-ray scattering analysis, we construct a model for the upanap-12: pro-uPA complex. The results suggest and highlight that the size and shape of an aptamer as well as the domain organization of a multi-domain protein such as uPA, may provide the basis for extensive sterical interference with protein ligand interactions considered distant from the aptamer binding site.	[Dupont, Daniel M.; Thuesen, Cathrine K.; Botkjaer, Kenneth A.; Dam, Karen; Sorensen, Hans P.; Jensen, Jan K.; Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Dupont, Daniel M.; Thuesen, Cathrine K.; Botkjaer, Kenneth A.; Sorensen, Hans P.; Ploug, Michael; Jensen, Jan K.; Andreasen, Peter A.] Aarhus Univ, Danish Chinese Ctr Proteases & Canc, Aarhus, Denmark; [Behrens, Manja A.; Pedersen, Jan S.] Aarhus Univ, INANO Interdisciplinary Nanosci Ctr, Aarhus, Denmark; [Behrens, Manja A.; Sorensen, Hans P.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Ploug, Michael] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Ploug, Michael] Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Behrens, Manja A.] Lund Univ, Dept Chem, Lund, Sweden	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; Lund University	Dupont, DM (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	dmd@mbg.au.dk	Dupont, Daniel M./H-7556-2019; Pedersen, Jan Skov/A-8346-2008	Pedersen, Jan Skov/0000-0002-7768-0206; Ploug, Michael/0000-0003-2215-4265; Dupont, Daniel Miotto/0000-0003-1378-1670	Danish Cancer Society [R40-A1838, R56-A2997-12-S2]; Carlsberg Foundation [2010-01-0819]; Danish National Research Foundation [26-331-6]; Danish Research Agency [272-06-0518]; Novo Nordisk Foundation [R114-A11382]; Novo Nordisk Fonden [NNF13OC0006627] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Carlsberg Foundation(Carlsberg Foundation); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Research Agency; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Danish Cancer Society [R40-A1838 to KAB, R56-A2997-12-S2]; the Carlsberg Foundation [2010-01-0819 to DMD]; the Danish National Research Foundation [26-331-6]; the Danish Research Agency [272-06-0518]; and the Novo Nordisk Foundation [R114-A11382]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Behrens MA, 2012, METHOD ENZYMOL, V511, P191, DOI 10.1016/B978-0-12-396546-2.00031-0; Behrens MA, 2011, J MOL BIOL, V411, P417, DOI 10.1016/j.jmb.2011.05.026; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Botkjaer KA, 2012, MOL CANCER RES, V10, P1532, DOI 10.1158/1541-7786.MCR-12-0349; Carriero MV, 2011, CURR PHARM DESIGN, V17, P1944; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Dupont DM, 2011, CURR MED CHEM, V18, P4139; Dupont DM, 2006, J BIOL CHEM, V281, P36071, DOI 10.1074/jbc.M606851200; Dupont DM, 2010, RNA, V16, P2360, DOI 10.1261/rna.2338210; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; Egelund R, 2001, EUR J BIOCHEM, V268, P673, DOI 10.1046/j.1432-1327.2001.01921.x; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; GLIEMANN J, 1994, ANN NY ACAD SCI, V737, P20, DOI 10.1111/j.1749-6632.1994.tb44299.x; Harbeck N, 2014, CANCER TREAT REV, V40, P434, DOI 10.1016/j.ctrv.2013.09.014; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; JENSEN PH, 1990, CELL REGUL, V1, P1043, DOI 10.1091/mbc.1.13.1043; Jeter ML, 2004, FEBS LETT, V568, P10, DOI 10.1016/j.febslet.2004.04.087; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Long SB, 2008, RNA, V14, P2504, DOI 10.1261/rna.1239308; Magdolen V, 1996, EUR J BIOCHEM, V237, P743, DOI 10.1111/j.1432-1033.1996.0743p.x; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pjura PE, 2000, J MOL BIOL, V300, P235, DOI 10.1006/jmbi.2000.3851; PLOUG M, 1995, BIOCHEMISTRY-US, V34, P12524, DOI 10.1021/bi00039a006; Sharma S, 2008, BIOINFORMATICS, V24, P1951, DOI 10.1093/bioinformatics/btn328; Skeldal S, 2006, FEBS J, V273, P5143, DOI 10.1111/j.1742-4658.2006.05511.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEI Y, 1994, J BIOL CHEM, V269, P32380	42	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119207	10.1371/journal.pone.0119207	http://dx.doi.org/10.1371/journal.pone.0119207			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793507	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200061
J	Ito, S; Nozoye, T; Sasaki, E; Imai, M; Shiwa, Y; Shibata-Hatta, M; Ishige, T; Fukui, K; Ito, K; Nakanishi, H; Nishizawa, NK; Yajima, S; Asami, T				Ito, Shinsaku; Nozoye, Tomoko; Sasaki, Eriko; Imai, Misaki; Shiwa, Yuh; Shibata-Hatta, Mari; Ishige, Taichiro; Fukui, Kosuke; Ito, Ken; Nakanishi, Hiromi; Nishizawa, Naoko K.; Yajima, Shunsuke; Asami, Tadao			Strigolactone Regulates Anthocyanin Accumulation, Acid Phosphatases Production and Plant Growth under Low Phosphate Condition in Arabidopsis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; BUD OUTGROWTH; RESPONSES; INHIBITION; ETHYLENE; ARCHITECTURE; MICRORNA399; DEGRADATION; GERMINATION	Phosphate is an essential macronutrient in plant growth and development; however, the concentration of inorganic phosphate (Pi) in soil is often suboptimal for crop performance. Accordingly, plants have developed physiological strategies to adapt to low Pi availability. Here, we report that typical Pi starvation responses in Arabidopsis are partially dependent on the strigolactone (SL) signaling pathway. SL treatment induced root hair elongation, anthocyanin accumulation, activation of acid phosphatase, and reduced plant weight, which are characteristic responses to phosphate starvation. Furthermore, the expression profile of SL-response genes correlated with the expression of genes induced by Pi starvation. These results suggest a potential overlap between SL signaling and Pi starvation signaling pathways in plants.	[Ito, Shinsaku; Nozoye, Tomoko; Fukui, Kosuke; Nakanishi, Hiromi; Nishizawa, Naoko K.; Asami, Tadao] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Ito, Shinsaku; Ito, Ken; Yajima, Shunsuke] Tokyo Univ Agr, Fac Appl Biosci, Dept Biosci, Setagaya Ku, Tokyo, Japan; [Sasaki, Eriko] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Imai, Misaki; Shiwa, Yuh; Shibata-Hatta, Mari; Ishige, Taichiro] Tokyo Univ Agr, Genome Res Ctr, Setagaya Ku, Tokyo, Japan; [Asami, Tadao] King Abdulaziz Univ, Dept Biochem, Jeddah 21413, Saudi Arabia	University of Tokyo; Tokyo University of Agriculture; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Tokyo University of Agriculture; King Abdulaziz University	Asami, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	asami@pgr1.ch.a.u-tokyo.ac.jp	; Nakanishi, Hiromi/C-6461-2015	Fukui, Kosuke/0000-0002-1955-624X; Nakanishi, Hiromi/0000-0001-5556-5058	Core Research for Evolutional Science and Technology (CREST); Kato Memorial Bioscience Foundation; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1311017]; Grants-in-Aid for Scientific Research [23248011] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Kato Memorial Bioscience Foundation; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Core Research for Evolutional Science and Technology (CREST) (T.A.), the Kato Memorial Bioscience Foundation (S.I.) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017 (S1311017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Ha CV, 2014, P NATL ACAD SCI USA, V111, P851, DOI 10.1073/pnas.1322135111; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Dun EA, 2012, PLANT PHYSIOL, V158, P487, DOI 10.1104/pp.111.186783; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Huang TK, 2013, PLANT CELL, V25, P4044, DOI 10.1105/tpc.113.115998; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Kapulnik Y, 2011, J EXP BOT, V62, P2915, DOI 10.1093/jxb/erq464; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Lei MG, 2011, NEW PHYTOL, V189, P1084, DOI 10.1111/j.1469-8137.2010.03555.x; Lung SC, 2008, PHYTOCHEMISTRY, V69, P365, DOI 10.1016/j.phytochem.2007.06.036; Mayzlish-Gati E, 2012, PLANT PHYSIOL, V160, P1329, DOI 10.1104/pp.112.202358; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Raghothama KG, 2000, CURR OPIN PLANT BIOL, V3, P182, DOI 10.1016/S1369-5266(00)00062-5; Ribot C, 2008, PLANT PHYSIOL, V147, P696, DOI 10.1104/pp.108.119321; Richardson AE, 2001, PLANT J, V25, P641, DOI 10.1046/j.1365-313x.2001.00998.x; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Sasaki E, 2011, PLANT CELL PHYSIOL, V52, P169, DOI 10.1093/pcp/pcq185; Seto Y, 2012, PLANT CELL PHYSIOL, V53, P1843, DOI 10.1093/pcp/pcs142; Stanga JP, 2013, PLANT PHYSIOL, V163, P318, DOI 10.1104/pp.113.221259; Torres-Vera R, 2014, MOL PLANT PATHOL, V15, P211, DOI 10.1111/mpp.12074; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Wang LS, 2012, PLANT CELL PHYSIOL, V53, P1093, DOI 10.1093/pcp/pcs072; Wang Y, 2013, DEV CELL, V27, P681, DOI 10.1016/j.devcel.2013.11.010; Waters MT, 2012, PLANT PHYSIOL, V159, P1073, DOI 10.1104/pp.112.196253; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Zhang YM, 2014, J MANUF PROCESS, V16, P1, DOI 10.1016/j.jmapro.2013.12.004; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878	42	37	41	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119724	10.1371/journal.pone.0119724	http://dx.doi.org/10.1371/journal.pone.0119724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793732	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200108
J	Jiang, Y; Li, CY				Jiang, Yu; Li, Changying			Detection and Discrimination of Cotton Foreign Matter Using Push-Broom Based Hyperspectral Imaging: System Design and Capability	PLOS ONE			English	Article							TRASH	Cotton quality, a major factor determining both cotton profitability and marketability, is affected by not only the overall quantity of but also the type of the foreign matter. Although current commercial instruments can measure the overall amount of the foreign matter, no instrument can differentiate various types of foreign matter. The goal of this study was to develop a hyperspectral imaging system to discriminate major types of foreign matter in cotton lint. A push-broom based hyperspectral imaging system with a custom-built multi-thread software was developed to acquire hyperspectral images of cotton fiber with 15 types of foreign matter commonly found in the U.S. cotton lint. A total of 450 (30 replicates for each foreign matter) foreign matter samples were cut into 1 by 1 cm2 pieces and imaged on the lint surface using reflectance mode in the spectral range from 400-1000 nm. The mean spectra of the foreign matter and lint were extracted from the user-defined region-of-interests in the hyperspectral images. The principal component analysis was performed on the mean spectra to reduce the feature dimension from the original 256 bands to the top 3 principal components. The score plots of the 3 principal components were used to examine clusterization patterns for classifying the foreign matter. These patterns were further validated by statistical tests. The experimental results showed that the mean spectra of all 15 types of cotton foreign matter were different from that of the lint. Nine types of cotton foreign matter formed distinct clusters in the score plots. Additionally, all of them were significantly different from each other at the significance level of 0.05 except brown leaf and bract. The developed hyperspectral imaging system is effective to detect and classify cotton foreign matter on the lint surface and has the potential to be implemented in commercial cotton classing offices.	[Jiang, Yu; Li, Changying] Univ Georgia, Coll Engn, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Li, CY (corresponding author), Univ Georgia, Coll Engn, Athens, GA 30602 USA.	cyli@uga.edu	Jiang, Yu/J-1458-2019	Jiang, Yu/0000-0003-4495-3033	Cotton Incorporated; Georgia Cotton Commission	Cotton Incorporated(Cotton R&D Corp); Georgia Cotton Commission	This research is funded by Cotton Incorporated and Georgia Cotton Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2007, J COTTON SCI, V11, P68; Boundless, 2014, BOUNDL BIOL; Dogan MS, 2004, THESIS TEXAS TECH U; Fortier CA, 2011, TEXT RES J, V81, P230, DOI 10.1177/0040517510383620; Frydrych I, 2002, FIBRES TEXT EAST EUR, V10, P35; Guo JunXian, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P126; Himmelsbach DS, 2006, J AGR FOOD CHEM, V54, P7405, DOI 10.1021/jf052949g; International Trade Centre, 2001, COTT EXP GUID; Lawrence KC, 2003, T ASAE, V46, P513, DOI 10.13031/2013.12940; Pai A, 2004, IEEE T IND APPL, V40, P77, DOI 10.1109/TIA.2003.821647; Qin JW, 2013, J FOOD ENG, V118, P157, DOI 10.1016/j.jfoodeng.2013.04.001; Raven P.H., 1992, BIOL PLANTS; USDA Agricultural Marketing Service, 2005, COTT CLASS; USDA Economic Research Service, 2013, COTT WOOL OV; Xu B, 1999, TEXT RES J, V69, P656, DOI 10.1177/004051759906900906; Xu BG, 1997, TEXT RES J, V67, P881, DOI 10.1177/004051759706701204; Yang WZ, 2011, MATH COMPUT MODEL, V54, P877, DOI 10.1016/j.mcm.2010.11.010; Yang WZ, 2009, COMPUT ELECTRON AGR, V68, P68, DOI 10.1016/j.compag.2009.04.005; Zhang Q, 2013, AGR AUTOMATION FUNDA	19	13	14	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121969	10.1371/journal.pone.0121969	http://dx.doi.org/10.1371/journal.pone.0121969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793990	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900162
J	Maneenil, G; Kemp, MW; Kannan, PS; Kramer, BW; Saito, M; Newnham, JP; Jobe, AH; Kallapur, SG				Maneenil, Gunlawadee; Kemp, Matthew W.; Kannan, Paranthaman Senthamarai; Kramer, Boris W.; Saito, Masatoshi; Newnham, John P.; Jobe, Alan H.; Kallapur, Suhas G.			Oral, Nasal and Pharyngeal Exposure to Lipopolysaccharide Causes a Fetal Inflammatory Response in Sheep	PLOS ONE			English	Article							INTRAAMNIOTIC ENDOTOXIN; LUNG MATURATION; ONSET SEPSIS; RISK-FACTOR; CHORIOAMNIONITIS; BIRTH; PULMONARY	Background A fetal inflammatory response (FIR) in sheep can be induced by intraamniotic or selective exposure of the fetal lung or gut to lipopolysaccharide (LPS). The oral, nasal, and pharyngeal cavities (ONP) contain lymphoid tissue and epithelium that are in contact with the amniotic fluid. The ability of the ONP epithelium and lymphoid tissue to initiate a FIR is unknown. Objective To determine if FIR occurs after selective ONP exposure to LPS in fetal sheep. Methods Using fetal recovery surgery, we isolated ONP from the fetal lung, GI tract, and amniotic fluid by tracheal and esophageal ligation and with an occlusive glove fitted over the snout. LPS (5 mg) or saline was infused with 24 h Alzet pumps secured in the oral cavity (n = 7-8/group). Animals were delivered 1 or 6 days after initiation of the LPS or saline infusions. Results The ONP exposure to LPS had time-dependent systemic inflammatory effects with changes in WBC in cord blood, an increase in posterior mediastinal lymph node weight at 6 days, and pro-inflammatory mRNA responses in the fetal plasma, lung, and liver. Compared to controls, the expression of surfactant protein A mRNA increased 1 and 6 days after ONP exposure to LPS. Conclusion ONP exposure to LPS alone can induce a mild FIR with time-dependent inflammatory responses in remote fetal tissues not directly exposed to LPS.	[Maneenil, Gunlawadee; Kannan, Paranthaman Senthamarai; Jobe, Alan H.; Kallapur, Suhas G.] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45220 USA; [Kemp, Matthew W.; Kramer, Boris W.; Saito, Masatoshi; Newnham, John P.; Jobe, Alan H.; Kallapur, Suhas G.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Netherlands; [Saito, Masatoshi] Tohoku Univ Hosp, Dept Perinatal Med, Sendai, Miyagi, Japan; [Maneenil, Gunlawadee] Prince Songkla Univ, Fac Med, Dept Pediat, Hat Yai, Thailand	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Western Australia; Maastricht University; Tohoku University; Prince of Songkla University	Kallapur, SG (corresponding author), Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45220 USA.	Suhas.kallapur@cchmc.org	Kramer, Boris/AAO-3183-2021; Senthamaraikannan, Paranthaman/H-3992-2018; Maneenil, Gunlawadee/L-1343-2019; Senthamaraikannan, Paranthaman/B-6428-2011	Senthamaraikannan, Paranthaman/0000-0002-3333-3720; Maneenil, Gunlawadee/0000-0002-6332-3216; Senthamaraikannan, Paranthaman/0000-0002-3333-3720; Newnham, John/0000-0001-9983-7457	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD-57869]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057869] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant HD-57869 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to SGK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JM, 1998, OBSTET GYNECOL, V91, P725, DOI 10.1016/S0029-7844(98)00056-8; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Collins JJP, 2010, AM J PHYSIOL-LUNG C, V299, pL852, DOI 10.1152/ajplung.00183.2010; Gisslen T, 2014, INNATE IMMUN-LONDON, V20, P214, DOI 10.1177/1753425913488430; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Hartling L, 2012, ARCH DIS CHILD-FETAL, V97, pF8, DOI 10.1136/adc.2010.210187; Hedenstierna G, 2008, CURR OPIN CRIT CARE, V14, P31, DOI 10.1097/MCC.0b013e3282f2f4b5; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2007, J IMMUNOL, V179, P8491, DOI 10.4049/jimmunol.179.12.8491; Kallapur SG, 2013, J IMMUNOL, V191, P1102, DOI 10.4049/jimmunol.1300270; Kallapur SG, 2011, AM J PHYSIOL-LUNG C, V301, pL285, DOI 10.1152/ajplung.00446.2010; Kemp MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063355; Kemp MW, 2011, REPROD SCI, V18, P1128, DOI 10.1177/1933719111408114; Kemp MW, 2011, REPROD SCI, V18, P88, DOI 10.1177/1933719110380470; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Kramer BW, 2010, AM J OBSTET GYNECOL, V202, DOI [10.1016/j.ajog.2009.11.012, DOI 10.1016/J.AJOG.2009.11.012]; Kuypers E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038257; Moss TJM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.065; Moss TJM, 2002, AM J OBSTET GYNECOL, V187, P1059, DOI 10.1067/mob.2002.126296; Nijland M J, 2001, J Matern Fetal Med, V10, P251, DOI 10.1080/714904334; Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508; Payne MS, 2014, PEDIATR RES, V75, P716, DOI 10.1038/pr.2014.35; Shimoya K, 2000, HUM REPROD, V15, P2234, DOI 10.1093/humrep/15.10.2234; Snyder CC, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.018; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Strunk T, 2012, PEDIATRICS, V129, pE134, DOI 10.1542/peds.2010-3493; Wolfs TGAM, 2014, AM J PHYSIOL-GASTR L, V306, pG382, DOI 10.1152/ajpgi.00260.2013; Wolfs TGAM, 2012, J MATERN-FETAL NEO M, V25, P8, DOI 10.3109/14767058.2012.664447; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837	31	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119281	10.1371/journal.pone.0119281	http://dx.doi.org/10.1371/journal.pone.0119281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793992	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200066
J	Reveles, KR; Juday, TR; Labreche, MJ; Mortensen, EM; Koeller, JM; Seekins, D; Oramasionwu, CU; Bollinger, M; Copeland, LA; Jones, X; Frei, CR				Reveles, Kelly R.; Juday, Timothy R.; Labreche, Matthew J.; Mortensen, Eric M.; Koeller, Jim M.; Seekins, Daniel; Oramasionwu, Christine U.; Bollinger, Mary; Copeland, Laurel A.; Jones, Xavier; Frei, Christopher R.			Comparative Value of Four Measures of Retention in Expert Care in Predicting Clinical Outcomes and Health Care Utilization in HIV Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VETERANS-AFFAIRS; LIFETIME COST; UNITED-STATES; ENGAGEMENT; MORTALITY; ADHERENCE; ASSOCIATION; SERVICES; VISITS	This study compared the ability of four measures of patient retention in HIV expert care to predict clinical outcomes. This retrospective study examined Veterans Health Administration (VHA) beneficiaries with HIV (ICD-9-CM codes 042 or V08) receiving expert care (defined as HIV-1 RNA viral load and CD4 cell count tests occurring within one week of each other) at VHA facilities from October 1, 2006, to September 30, 2008. Patients were >= 18 years old and continuous VHA users for at least 24 months after entry into expert care. Retention measures included: Annual Appointments (>= 2 appointments annually at least 60 days apart), Missed Appointments (missed >= 25% of appointments), Infrequent Appointments (> 6 months without an appointment), and Missed or Infrequent Appointments (missed >= 25% of appointments or > 6 months without an appointment). Multivariable nominal logistic regression models were used to determine associations between retention measures and outcomes. Overall, 8,845 patients met study criteria. At baseline, 64% of patients were virologically suppressed and 37% had a CD4 cell count > 500 cells/mm(3). At 24 months, 82% were virologically suppressed and 46% had a CD4 cell count > 500 cells/mm(3). During follow-up, 13% progressed to AIDS, 48% visited the emergency department (ED), 28% were hospitalized, and 0.3% died. All four retention measures were associated with virologic suppression and antiretroviral therapy initiation at 24 months follow-up. Annual Appointments correlated positively with CD4 cell count > 500 cells/mm(3). Missed Appointments was predictive of all primary and secondary outcomes, including CD4 cell count <= 500 cells/mm(3), progression to AIDS, ED visit, and hospitalization. Missed Appointments was the only measure to predict all primary and secondary outcomes. This finding could be useful to health care providers and public health organizations as they seek ways to optimize the health of HIV patients.	[Reveles, Kelly R.; Koeller, Jim M.; Frei, Christopher R.] Univ Texas Austin, Austin, TX 78712 USA; [Reveles, Kelly R.; Koeller, Jim M.; Frei, Christopher R.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Juday, Timothy R.; Seekins, Daniel] Bristol Myers Squibb Co, Plainsboro, NJ USA; [Labreche, Matthew J.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Mortensen, Eric M.] VA North Texas Hlth Care Syst, Dallas, TX USA; [Mortensen, Eric M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Oramasionwu, Christine U.] Univ N Carolina, Chapel Hill, NC USA; [Bollinger, Mary; Jones, Xavier] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Copeland, Laurel A.] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Copeland, Laurel A.] Scott & White Healthcare, Ctr Appl Hlth Res, Temple, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; Bristol-Myers Squibb; Johns Hopkins University; Johns Hopkins Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Frei, CR (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	freic@uthscsa.edu	Reveles, Kelly/AAI-1575-2021; Frei, Christopher/AAI-1421-2020; Copeland, Laurel A/C-3763-2017; Mortensen, Eric/AAF-2713-2020	Frei, Christopher/0000-0002-0692-4787; Copeland, Laurel A/0000-0002-9478-0209; Mortensen, Eric/0000-0002-3880-5563	Bristol-Myers Squibb Company, Plainsboro, NJ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, TL1TR001119] Funding Source: NIH RePORTER	Bristol-Myers Squibb Company, Plainsboro, NJ(Bristol-Myers Squibb); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Bristol-Myers Squibb Company, Plainsboro, NJ (http://www.bms.com/pages/default.aspx). The funders assisted with the study design and preparation of the manuscript. This work was partially supported with the resources of the Department of Veterans Affairs. The views are those of the authors and do not necessarily reflect the views of the Department of Veterans Affairs.	[Anonymous], 2011, GUID US ANT AG HIV 1, P1; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Braithwaite RS, 2007, AIDS, V21, P1579, DOI 10.1097/QAD.0b013e3281532b31; Centers for Disease Control and Prevention, 2011, HIV SURV REP; Chalker John, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P193, DOI 10.1177/1545109708320687; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Giordano TP, 2003, JAIDS-J ACQ IMM DEF, V32, P399, DOI 10.1097/00126334-200304010-00009; HELLINGER FJ, 1993, JAMA-J AM MED ASSOC, V270, P474, DOI 10.1001/jama.270.4.474; Hellinger FJ, 2010, PHARMACOECONOMICS, V28, P23, DOI 10.2165/11313810-000000000-00000; Horberg MA, 2010, CLIN INFECT DIS, V51, P732, DOI 10.1086/655893; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Kposowa AJ, 2013, INT J INFECT DIS, V17, pE868, DOI 10.1016/j.ijid.2013.02.018; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Lo W, 2002, AIDS CARE, V14, pS45, DOI 10.1080/0954012022014992049984; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Morgan RO, 2005, HEALTH SERV RES, V40, P1573, DOI 10.1111/j.1475-6773.2005.00448.x; Motto JA, 2001, PSYCHIATR SERV, V52, P828, DOI 10.1176/appi.ps.52.6.828; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Panel on opportunistic infections in HIV-infected adults and adolescents, GUID PREV TREATM OPP; Park WB, 2007, J INTERN MED, V261, P268, DOI 10.1111/j.1365-2796.2006.01762.x; Park WB, 2008, INT J STD AIDS, V19, P125, DOI 10.1258/ijsa.2007.007101; Pugh MJV, 2005, EPILEPSIA, V46, P1820, DOI 10.1111/j.1528-1167.2005.00291.x; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shen YJ, 2003, MED CARE RES REV, V60, P253, DOI 10.1177/1077558703060002007; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa	45	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120953	10.1371/journal.pone.0120953	http://dx.doi.org/10.1371/journal.pone.0120953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25794182	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900092
J	Roth, VN; Dittmar, T; Gaupp, R; Gleixner, G				Roth, Vanessa-Nina; Dittmar, Thorsten; Gaupp, Reinhard; Gleixner, Gerd			The Molecular Composition of Dissolved Organic Matter in Forest Soils as a Function of pH and Temperature	PLOS ONE			English	Article							RESOLUTION MASS-SPECTROMETRY; SIZE CLASSES; FAGUS-SYLVATICA; CARBON-CYCLE; FULVIC-ACIDS; DOM; ECOSYSTEM; SPECTRA; MARINE; RIVER	We examined the molecular composition of forest soil water during three different seasons at three different sites, using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI-FT-ICR-MS). We examined oxic soils and tested the hypothesis that pH and season correlate with the molecular composition of dissolved organic matter (DOM). We used molecular formulae and their relative intensity from ESI-FT-ICR-MS for statistical analysis. Applying unconstrained and constrained ordination methods, we observed that pH, dissolved organic carbon (DOC) concentration and season were the main factors correlating with DOM molecular composition. This result is consistent with a previous study where pH was a main driver of the molecular differences between DOM from oxic rivers and anoxic bog systems in the Yenisei River catchment. At a higher pH, the molecular formulae had a lower degree of unsaturation and oxygenation, lower molecular size and a higher abundance of nitrogen-containing compounds. These characteristics suggest a higher abundance of tannin connected to lower pH that possibly inhibited biological decomposition. Higher biological activity at a higher pH might also be related to the higher abundance of nitrogen-containing compounds. Comparing the seasons, we observed a decrease in unsaturation, molecular diversity and the number of nitrogen-containing compounds in the course of the year from March to November. Temperature possibly inhibited biological degradation during winter, which could cause the accumulation of a more diverse compound spectrum until the temperature increased again. Our findings suggest that the molecular composition of DOM in soil pore waters is dynamic and a function of ecosystem activity, pH and temperature.	[Roth, Vanessa-Nina; Gleixner, Gerd] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Res Grp Marine Geochem ICBM, MPI Bridging Grp, D-26111 Oldenburg, Germany; [Gaupp, Reinhard] Univ Jena, Inst Geosci, Jena, Germany	Max Planck Society; Carl von Ossietzky Universitat Oldenburg; Friedrich Schiller University of Jena	Roth, VN (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	vroth@bgc-jena.mpg.de	Dittmar, Thorsten/L-7796-2013; Gleixner, Gerd/O-4215-2019; Gleixner, Gerd/M-8519-2017	Dittmar, Thorsten/0000-0002-3462-0107; Gleixner, Gerd/0000-0002-4616-0953; Gleixner, Gerd/0000-0002-4616-0953	Deutsche Forschungsgemeinschaft [GRK 1257, SFB 1076]; Max Planck Society; foundation "Zwillenberg-Tietz Stiftung"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); foundation "Zwillenberg-Tietz Stiftung"	VNR was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) as part of GRK 1257 Alteration and Element Mobility at the Microbe-Mineral Interface as well as SFB 1076 AquaDiva with support from the Max Planck Society. Since October 2014 Vanessa-Nina Roth also receives funding from the foundation "Zwillenberg-Tietz Stiftung" which is located in Germany and promotes science and research especially in the field of nature conservation. More information can be found at http://www.zwillenberg-tietz-stiftung.de/, unfortunately only in German. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk B, 2011, SOIL BIOL BIOCHEM, V43, P628, DOI 10.1016/j.soilbio.2010.11.034; Amon RMW, 2004, MAR CHEM, V92, P311, DOI 10.1016/j.marchem.2004.06.034; Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Bussotti F, 1998, NEW PHYTOL, V138, P469, DOI 10.1046/j.1469-8137.1998.00121.x; Chanton JP, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003274; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; D'Andrilli J, 2010, ORG GEOCHEM, V41, P791, DOI 10.1016/j.orggeochem.2010.05.009; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Flerus R, 2012, BIOGEOSCIENCES, V9, P1935, DOI 10.5194/bg-9-1935-2012; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; Gleixner G, 1999, RAPID COMMUN MASS SP, V13, P1278, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1278::AID-RCM649>3.0.CO;2-N; Gleixner G, 2002, ORG GEOCHEM, V33, P357, DOI 10.1016/S0146-6380(01)00166-8; Gleixner G, 2009, ECOL STUD-ANAL SYNTH, V207, P231, DOI 10.1007/978-3-540-92706-8_11; Green NW, 2014, MAR CHEM, V161, P14, DOI 10.1016/j.marchem.2014.01.012; Hedges J.I., 2011, BIOGEOCHEMISTRY OF M, P1; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Hernes PJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001421; Hertkorn N, 2007, ANAL BIOANAL CHEM, V389, P1311, DOI 10.1007/s00216-007-1577-4; Herzsprung P, 2012, ENVIRON SCI TECHNOL, V46, P5511, DOI 10.1021/es300345c; Huguet A, 2010, ORG GEOCHEM, V41, P595, DOI 10.1016/j.orggeochem.2010.02.006; Jaffe R, 2012, GEOCHIM COSMOCHIM AC, V94, P95, DOI 10.1016/j.gca.2012.06.031; Kaiser K, 2001, BIOGEOCHEMISTRY, V55, P103, DOI 10.1023/A:1010694032121; Kaiser K, 2012, SOIL BIOL BIOCHEM, V52, P29, DOI 10.1016/j.soilbio.2012.04.002; Kim S, 2006, INT J MASS SPECTROM, V251, P260, DOI 10.1016/j.ijms.2006.02.001; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Kindler R, 2011, GLOBAL CHANGE BIOL, V17, P1167, DOI 10.1111/j.1365-2486.2010.02282.x; Kisand V, 2008, AQUAT MICROB ECOL, V53, P151, DOI 10.3354/ame01240; Knicker H, 1997, EUR J SOIL SCI, V48, P431, DOI 10.1046/j.1365-2389.1997.00093.x; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Koch BP, 2006, RAPID COMMUN MASS SP, V20, P926, DOI 10.1002/rcm.2386; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Kujawinski EB, 2004, MAR CHEM, V92, P23, DOI 10.1016/j.marchem.2004.06.038; Landry C, 2012, ENVIRON SCI TECHNOL, V46, P1700, DOI 10.1021/es203711v; Lechtenfeld OJ, 2013, MAR CHEM, V150, P25, DOI 10.1016/j.marchem.2013.01.006; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Leps J., 2003, MULTIVARIATE ANALYSI; Malik A, 2013, FEMS MICROBIOL ECOL, V86, P139, DOI 10.1111/1574-6941.12182; Malik A, 2012, ENVIRON SCI TECHNOL, V46, P10123, DOI 10.1021/es302467y; MCKNIGHT DM, 1991, LIMNOL OCEANOGR, V36, P998, DOI 10.4319/lo.1991.36.5.0998; Michalzik B, 1999, EUR J SOIL SCI, V50, P579, DOI 10.1046/j.1365-2389.1999.00267.x; Minor EC, 2012, ORG GEOCHEM, V43, P1, DOI 10.1016/j.orggeochem.2011.11.007; Moore PD, 2002, ENVIRON CONSERV, V29, P3, DOI 10.1017/S0376892902000024; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Nebbioso A, 2013, ANAL BIOANAL CHEM, V405, P109, DOI 10.1007/s00216-012-6363-2; Ohno T, 2010, ENVIRON SCI TECHNOL, V44, P8594, DOI 10.1021/es101089t; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Reemtsma T, 2009, J CHROMATOGR A, V1216, P3687, DOI 10.1016/j.chroma.2009.02.033; Riedel T, 2014, ANAL CHEM, V86, P8376, DOI 10.1021/ac501946m; Riedel T, 2012, ENVIRON SCI TECHNOL, V46, P4419, DOI 10.1021/es203901u; Roth VN, 2013, GEOCHIM COSMOCHIM AC, V123, P93, DOI 10.1016/j.gca.2013.09.002; Sachse D, 2009, ORG GEOCHEM, V40, P732, DOI 10.1016/j.orggeochem.2009.02.008; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schulze WX, 2005, OECOLOGIA, V142, P335, DOI 10.1007/s00442-004-1698-9; Seidel M, 2014, GEOCHIM COSMOCHIM AC, V140, P418, DOI 10.1016/j.gca.2014.05.038; Sleighter RL, 2008, MAR CHEM, V110, P140, DOI 10.1016/j.marchem.2008.04.008; Sleighter RL, 2007, J MASS SPECTROM, V42, P559, DOI 10.1002/jms.1221; Sleighter RL, 2010, ENVIRON SCI TECHNOL, V44, P7576, DOI 10.1021/es1002204; Smolander A, 2005, SOIL BIOL BIOCHEM, V37, P1309, DOI 10.1016/j.soilbio.2004.12.002; Smolander A, 2012, PLANT SOIL, V350, P1, DOI 10.1007/s11104-011-0895-7; Soule MCK, 2010, ORG GEOCHEM, V41, P725, DOI 10.1016/j.orggeochem.2010.05.017; Steinbeiss S, 2008, SOIL BIOL BIOCHEM, V40, P2634, DOI 10.1016/j.soilbio.2008.07.007; Stenson AC, 2003, ANAL CHEM, V75, P1275, DOI 10.1021/ac026106p; Strobel BW, 2001, BIOGEOCHEMISTRY, V56, P1, DOI 10.1023/A:1011934929379; Stubbins A, 2010, LIMNOL OCEANOGR, V55, P1467, DOI 10.4319/lo.2010.55.4.1467; Tefs C, 2012, FOREST ECOL MANAG, V263, P131, DOI 10.1016/j.foreco.2011.09.010; Tfaily MM, 2013, GEOCHIM COSMOCHIM AC, V112, P116, DOI 10.1016/j.gca.2013.03.002; Thoss V, 2004, PLANT SOIL, V259, P355, DOI 10.1023/B:PLSO.0000020984.17403.82; Thurman EM., 1985, DEVELOPMENTS IN BIOG, V2	72	58	62	11	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119188	10.1371/journal.pone.0119188	http://dx.doi.org/10.1371/journal.pone.0119188			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793306	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200059
J	Xiao, FH; He, YH; Li, QG; Wu, H; Luo, LH; Kong, QP				Xiao, Fu-Hui; He, Yong-Han; Li, Qi-Gang; Wu, Huan; Luo, Long-Hai; Kong, Qing-Peng			A Genome-Wide Scan Reveals Important Roles of DNA Methylation in Human Longevity by Regulating Age-Related Disease Genes	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HEALTH-STATUS; CENTENARIANS; CANCER; EXPRESSION; CADHERINS	It is recognized that genetic factors contribute to human longevity. Besides the hypothesis of existence of longevity genes, another suggests that a lower frequency of risk alleles decreases the incidence of age-related diseases in the long-lived people. However, the latter finds no support from recent genetic studies. Considering the crucial role of epigenetic modification in gene regulation, we then hypothesize that suppressing disease-related genes in longevity individuals is likely achieved by epigenetic modification, e.g. DNA methylation. To test this hypothesis, we investigated the genome-wide methylation profile in 4 Chinese female centenarians and 4 middle-aged controls using methyl-DNA immunoprecipitation sequencing. 626 differentially methylated regions (DMRs) were observed between both groups. Interestingly, genes with these DMRs were enriched in age-related diseases, including type-2 diabetes, cardiovascular disease, stroke and Alzheimer's disease. This pattern remains rather stable after including methylomes of two white individuals. Further analyses suggest that the observed DMRs likely have functional roles in regulating disease-associated gene expressions, with some genes [e.g. caspase 3 (CASP3)] being down-regulated whereas the others [i.e. interleukin 1 receptor, type 2 (IL1R2)] up-regulated. Therefore, our study suggests that suppressing the disease-related genes via epigenetic modification is an important contributor to human longevity.	[Xiao, Fu-Hui; He, Yong-Han; Li, Qi-Gang; Wu, Huan; Kong, Qing-Peng] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan Province, Peoples R China; [Xiao, Fu-Hui; He, Yong-Han; Li, Qi-Gang; Wu, Huan; Kong, Qing-Peng] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Yunnan Province, Peoples R China; [Xiao, Fu-Hui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Luo, Long-Hai] Beijing Genome Inst Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI)	Luo, LH (corresponding author), Beijing Genome Inst Shenzhen, Shenzhen, Peoples R China.	luolh@genomics.cn; kongqp@mail.kiz.ac.cn	He, Yonghan/P-7271-2014	He, Yonghan/0000-0003-4409-4590; Xiao, Fu-Hui/0000-0001-7478-7801	National Basic Research Program of China [2013CB530802]; National Basic Research Program of Yunnan Province [2011FA024, 2013FB069]; Chinese Academy of Sciences, Natural Science Foundation of China [31123005, 31322029]	National Basic Research Program of China(National Basic Research Program of China); National Basic Research Program of Yunnan Province; Chinese Academy of Sciences, Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program of China (2013CB530802), Yunnan Province (2011FA024, 2013FB069), the Chinese Academy of Sciences, Natural Science Foundation of China (31123005, 31322029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; He YH, 2014, J AM GERIATR SOC, V62, P1402, DOI 10.1111/jgs.12895; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Heyn H, 2013, GENOME RES, V23, P1363, DOI 10.1101/gr.154187.112; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; MAZUREK MF, 1987, NEUROLOGY, V37, P1001, DOI 10.1212/WNL.37.6.1001; MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Pou J, 2011, BBA-MOL CELL BIOL L, V1811, P556, DOI 10.1016/j.bbalip.2011.05.014; Resink TJ, 2009, SWISS MED WKLY, V139, P122, DOI smw-12429; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohn TT, 2009, INT J CLIN EXP PATHO, V2, P108; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Sebastiani P, 2012, PLOS ONE, V7; Selim AJ, 2005, J GERONTOL A-BIOL, V60, P515, DOI 10.1093/gerona/60.4.515; Terry DF, 2004, J AM GERIATR SOC, V52, P2074, DOI 10.1111/j.1532-5415.2004.52561.x; Thinakaran G, 2004, PHARMACOL RES, V50, P411, DOI 10.1016/j.phrs.2003.12.026; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472	39	34	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120388	10.1371/journal.pone.0120388	http://dx.doi.org/10.1371/journal.pone.0120388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793257	Green Submitted, gold, Green Published			2022-12-26	WOS:000352083900021
J	Baek, SH; Choi, SW; Park, SJ; Lee, SH; Chun, HS; Kim, SH				Baek, Seung-hwa; Choi, Sik-Won; Park, Sang-Joon; Lee, Sang-Han; Chun, Hang-Suk; Kim, Seong Hwan			Quinoline Compound KM11073 Enhances BMP-2-Dependent Osteogenic Differentiation of C2C12 Cells via Activation of p38 Signaling and Exhibits In Vivo Bone Forming Activity	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-2; OSTEOBLASTIC DIFFERENTIATION; GENE-EXPRESSION; BMP-2; MOLECULES; INDUCTION; MATRIX; DEFECT; MAPK; SMAD	Recombinant human bone morphogenetic protein (rhBMP)-2 has been approved by the FDA for clinical application, but its use is limited due to high cost and a supra-physiological dose for therapeutic efficacy. Therefore, recent studies have focused on the generation of new therapeutic small molecules to induce bone formation or potentiate the osteogenic activity of BMP-2. Here, we show that [4-(7-chloroquinolin-4-yl) piperazino][1-phenyl-5-(trifluoromethyl)- 1H-pyrazol-4-yl] methanone (KM11073) strongly enhances the BMP-2stimulated induction of alkaline phosphatase (ALP), an early phase biomarker of osteoblast differentiation, in bi-potential mesenchymal progenitor C2C12 cells. The KM11073-mediated ALP induction was inhibited by the BMP antagonist noggin, suggesting that its osteogenic activity occurs via BMP signaling. In addition, a pharmacological inhibition study suggested the involvement of p38 activation in the osteogenic action of KM11073 accompanied by enhanced expression of BMP-2, -6, and -7 mRNA. Furthermore, the in vivo osteogenic activity of KM11073 was confirmed in zebrafish and mouse calvarial bone formation models, suggesting the possibility of its single use for bone formation. In conclusion, the combination of rhBMP-2 with osteogenic small molecules could reduce the use of expensive rhBMP-2, mitigating the undesirable side effects of its supra-physiological dose for therapeutic efficacy. Moreover, due to their inherent physical properties, small molecules could represent the next generation of regenerative medicine.	[Baek, Seung-hwa; Choi, Sik-Won; Kim, Seong Hwan] Korea Res Inst Chem Technol, Pharmacol Res Ctr, Lab Translat Therapeut, Taejon 305600, South Korea; [Baek, Seung-hwa; Lee, Sang-Han] Kyungpook Natl Univ, Dept Food Sci & Biotechnol, Taegu 702701, South Korea; [Park, Sang-Joon] Kyungpook Natl Univ, Coll Vet Med, Dept Histol, Taegu 702701, South Korea; [Chun, Hang-Suk] Korea Inst Toxicol, Dept Predict Toxicol, Alternat Toxicol Methods Res Ctr, Taejon 305600, South Korea	Korea Research Institute of Chemical Technology (KRICT); Kyungpook National University; Kyungpook National University; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT)	Kim, SH (corresponding author), Korea Res Inst Chem Technol, Pharmacol Res Ctr, Lab Translat Therapeut, Taejon 305600, South Korea.	hwan@krict.re.kr		Choi, Sik-Won/0000-0003-1726-2536	Ministry of Knowledge Economy, Republic of Korea [SI-1404]	Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric)	This work was supported by KRICT's project, SI-1404, funded by the Ministry of Knowledge Economy, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Garrett IR, 2007, CURR TOP DEV BIOL, V78, P127, DOI 10.1016/S0070-2153(06)78004-8; Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200; GITELMAN SE, 1995, CELL GROWTH DIFFER, V6, P827; Hassel S, 2003, J BONE JOINT SURG AM, V85A, P44, DOI 10.2106/00004623-200300003-00009; Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7; Ishibashi O, 2010, J CELL PHYSIOL, V222, P465, DOI 10.1002/jcp.21968; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kato S, 2011, MOL CELL BIOCHEM, V349, P97, DOI 10.1007/s11010-010-0664-6; Kawai M, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-62; Kim HJ, 2010, AMINO ACIDS, V39, P1217, DOI 10.1007/s00726-010-0557-8; Kim SN, 2012, AMINO ACIDS, V42, P1455, DOI 10.1007/s00726-011-0901-7; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo KWH, 2012, REGEN MED, V7, P535, DOI [10.2217/RME.12.33, 10.2217/rme.12.33]; MartinezBarbera JP, 1997, GENE, V198, P53, DOI 10.1016/S0378-1119(97)00292-8; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3; Nakamura Y, 2005, J BONE MINER METAB, V23, P426, DOI 10.1007/s00774-005-0624-5; Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864; Nikaido M, 1997, MECH DEVELOP, V61, P75, DOI 10.1016/S0925-4773(96)00625-9; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; Noth U, 2003, EXP CELL RES, V291, P201, DOI 10.1016/S0014-4827(03)00386-0; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rozen S, 2000, Methods Mol Biol, V132, P365; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; Takayama K, 2009, J BONE MINER METAB, V27, P402, DOI 10.1007/s00774-009-0054-x; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Valentin-Opran A, 2002, CLIN ORTHOP RELAT R, P110; Vogelin E, 2005, J BONE JOINT SURG AM, V87A, P1323, DOI 10.2106/JBJS.C.00913; Vrijens K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059045; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White AP, 2007, INT ORTHOP, V31, P735, DOI 10.1007/s00264-007-0422-x; Yamachika E, 2009, J BIOMED MATER RES A, V88A, P599, DOI 10.1002/jbm.a.31833; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; Yeh LCC, 2002, J CELL BIOCHEM, V87, P292, DOI 10.1002/jcb.10315	42	6	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120150	10.1371/journal.pone.0120150	http://dx.doi.org/10.1371/journal.pone.0120150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789987	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400134
J	Dave, J; Millar, M; Maxeiner, H; Freedman, J; Meade, R; Rosmarin, C; Jordan, M; Andrews, N; Holliman, R; Sefton, A				Dave, Jayshree; Millar, Michael; Maxeiner, Horst; Freedman, Joanne; Meade, Rachel; Rosmarin, Caryn; Jordan, Matthew; Andrews, Nick; Holliman, Richard; Sefton, Armine			East London Experience with Enteric Fever 2007-2012	PLOS ONE			English	Article							PUBLIC-HEALTH MANAGEMENT; TYPHOID-FEVER; BURDEN	Purpose The clinical presentation and epidemiology for patients with enteric fever at two hospitals in East London during 2007-2012 is described with the aim to identify preventive opportunities and to reduce the cost of treatment. Methods A retrospective analysis of case notes from patients admitted with enteric fever during 2007 to 2012 with a microbiologically confirmed diagnosis was undertaken. Details on clinical presentation, travel history, demographic data, laboratory parameters, treatment, patient outcome and vaccination status were collected. Results Clinical case notes were available for 98/129 (76%) patients including 69 Salmonella enterica serovar Typhi (S. Typhi) and 29 Salmonella enterica serovar Paratyphi (S. Paratyphi). Thirty-four patients (35%) were discharged from emergency medicine without a diagnosis of enteric fever and then readmitted after positive blood cultures. Seventy-one of the 98 patients (72%) were UK residents who had travelled abroad, 23 (23%) were foreign visitors/new entrants to the UK and four (4%) had not travelled abroad. Enteric fever was not considered in the initial differential diagnosis for 48/98 (49%) cases. The median length of hospital stay was 7 days (range 0-57 days). The total cost of bed days for managing enteric fever was 454,000 pound in the two hospitals (mean 75,666 pound/year). Median time to clinical resolution was five days (range 1-20). Seven of 98 (7%) patients were readmitted with relapsed or continued infection. Six of the 71 (8%) patients had received typhoid vaccination, 34 (48%) patients had not received vaccination, and for 31 cases (44%) vaccination status was unknown. Conclusions Further interventions regarding education and vaccination of travellers and recognition of the condition by emergency medicine clinicians in travellers to South Asia is required.	[Dave, Jayshree; Maxeiner, Horst; Meade, Rachel; Jordan, Matthew; Holliman, Richard] Publ Hlth England, Publ Hlth Lab London, London, England; [Millar, Michael; Rosmarin, Caryn] Barts Hlth NHS Trust, Royal London Hosp, Div Infect, London, England; [Freedman, Joanne] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Travel & Migrant Hlth Sect, London, England; [Andrews, Nick] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Stat Modelling & Econ Dept, London, England; [Sefton, Armine] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunol & Infect Dis, London, England	Public Health England; Barts Health NHS Trust; Royal London Hospital; Public Health England; Public Health England; University of London; Queen Mary University London	Dave, J (corresponding author), Publ Hlth England, Publ Hlth Lab London, London, England.	jayshree.dave@phe.gov.uk		Freedman, Joanne/0000-0002-7840-473X				Addiman S, 2013, PUBLIC HEALTH, V127, P207, DOI 10.1016/j.puhe.2012.12.015; Balasegaram S, 2012, J INFECTION, V65, P197, DOI 10.1016/j.jinf.2012.05.005; Barrett Freja Cecille, 2013, BMC Res Notes, V6, P315, DOI 10.1186/1756-0500-6-315; BEHRENS RH, 1994, BRIT MED J, V309, P918, DOI 10.1136/bmj.309.6959.918; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; GILMAN RH, 1975, LANCET, V1, P1211; Health Protection Agency, 2008, PIL ENH SURV ENT FEV; Health Protection Agency, HPA MIGR HLTH GUID E; Health Protection Agency, 2014, ENH SURV ENT FEV; Health Protection Agency, 2012, TYPH FEV VACC REC; Health Protection Agency Migrant Health, 2011, INF DIS NONUK BORN P; IVANOFF B, 1994, B WORLD HEALTH ORGAN, V72, P957; Mandell GL, 2010, MANDELL DOUGLAS BENN, DOI [10.1056/NEJMoa1304839. Two, DOI 10.1056/NEJMOA1304839]; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Meltzer E, 2005, J TRAVEL MED, V12, P275, DOI 10.2310/7060.2005.12507; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Office for National Statistics. International Passenger Survey, 2012, INT PASS SURV 2012; Organization WH, 2003, BACKGR DOC DIAGN TRE, V15, P460; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; PHE, 2014, ENT FEV TYPH PAR ENG; Public Health England, 2013, TYPH GREEN BOOK; Reddy S, 2011, TRAVEL MED INFECT DI, V9, P206, DOI 10.1016/j.tmaid.2011.03.003; Waddington C, 2014, J INFECTION, V68, P38	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120926	10.1371/journal.pone.0120926	http://dx.doi.org/10.1371/journal.pone.0120926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790017	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400184
J	Kilpatrick, K; Zeng, YM; Hancock, T; Segatori, L				Kilpatrick, Kiri; Zeng, Yimeng; Hancock, Tommy; Segatori, Laura			Genetic and Chemical Activation of TFEB Mediates Clearance of Aggregated alpha-Synuclein	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; PARKINSONS-DISEASE; BETA-CYCLODEXTRINS; IN-VITRO; AUTOPHAGY; DEGRADATION; CHOLESTEROL; NEURODEGENERATION; MACROAUTOPHAGY; DEPLETION	Aggregation of a-synuclein (alpha-syn) is associated with the development of a number of neurodegenerative diseases, including Parkinson's disease (PD). The formation of alpha-syn aggregates results from aberrant accumulation of misfolded alpha-syn and insufficient or impaired activity of the two main intracellular protein degradation systems, namely the ubiquitin-proteasome system and the autophagy-lysosomal pathway. In this study, we investigated the role of transcription factor EB (TFEB), a master regulator of the autophagy-lysosomal pathway, in preventing the accumulation of alpha-syn aggregates in human neuroglioma cells. We found that TFEB overexpression reduces the accumulation of aggregated alpha-syn by inducing autophagic clearance of alpha-syn. Furthermore, we showed that pharmacological activation of TFEB using 2-hydroxypropyl-beta-cyclodextrin promotes autophagic clearance of aggregated alpha-syn. In summary, our findings demonstrate that TFEB modulates autophagic clearance of alpha-syn and suggest that pharmacological activation of TFEB is a promising strategy to enhance the degradation of alpha-syn aggregates.	[Kilpatrick, Kiri; Zeng, Yimeng; Hancock, Tommy; Segatori, Laura] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [Segatori, Laura] Rice Univ, Dept Bioengn, Houston, TX USA; [Segatori, Laura] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University; Rice University; Rice University	Segatori, L (corresponding author), Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA.	segatori@rice.edu			National Science Foundation [CBET-1336053, CBET 1254318]; National Institute of Health [R21 NS084005]; Welch Foundation [C-1824]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084005] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1336053] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by The National Science Foundation (CBET-1336053 and CBET 1254318), the National Institute of Health (R21 NS084005), and the Welch Foundation (C-1824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-On P, 2006, J NEUROCHEMISTRY, V98; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Cheng JL, 2006, BIOCHEM BIOPH RES CO, V351, P246, DOI 10.1016/j.bbrc.2006.10.042; Christian AE, 1997, J LIPID RES, V38, P2264; Cook NP, 2012, J AM CHEM SOC, V134, P20776, DOI 10.1021/ja3100287; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hansen C, 2013, NEUROBIOL DIS, V56, P145, DOI 10.1016/j.nbd.2013.04.017; Huang Y, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-2; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kilpatrick K, 2013, ACS CHEM BIOL, V8, P1460, DOI 10.1021/cb400017h; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Monnaert V, 2004, J PHARMACOL EXP THER, V310, P745, DOI 10.1124/jpet.104.067512; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rajewski RA, 1996, J PHARM SCI, V85, P1142, DOI 10.1021/js960075u; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI [10.1126/scisignal.2002437, DOI 10.1126/SCISIGNAL.2002437]; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P323, DOI 10.1093/jnen/63.4.323; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Song WS, 2014, J BIOL CHEM, V289, P10211, DOI 10.1074/jbc.M113.506246; Song WS, 2013, HUM MOL GENET, V22, P1994, DOI 10.1093/hmg/ddt052; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tsunemi T, 2012, SCIENCE TRANSLATIONA, V4, DOI [10.1126/scitranslmed.3003722, DOI 10.1126/SCITRANSLMED.3003722]; Uversky VN, 2008, CURR PROTEIN PEPT SC, V9, P507, DOI 10.2174/138920308785915218; Varkonyi J, 2003, AM J MED GENET A, V116A, P348, DOI 10.1002/ajmg.a.10028; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wong E, 2010, COLD SPRING HARBOR P, V2, DOI [10.1101/cshperspect.a004390, DOI 10.1101/CSHPERSPECT.A004390]; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	55	94	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120819	10.1371/journal.pone.0120819	http://dx.doi.org/10.1371/journal.pone.0120819			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790376	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400178
J	Kim, S; Ahn, C; Bong, N; Choe, S; Lee, DK				Kim, Sooho; Ahn, Chihoon; Bong, Naeun; Choe, Senyon; Lee, Dong Kun			Biphasic Effects of FGF2 on Adipogenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; FIBROBLAST GROWTH FACTOR-2; CHICK LIMB BUD; ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; ADIPOSE-TISSUE; OSTEOGENIC DIFFERENTIATION; EXPRESSION; KINASE; ACTIVATION	Although stem cells from mice deficient of FGF2 have been reported to display enhanced capacity for adipogenesis, the literature using in vitro cell culture system has so far reported conflicting results on the role of FGF2 in adipogenesis. We here demonstrate that FGF2, depending on concentration, can function as either a positive or negative factor of in vitro adipogenesis by regulating activation of the ERK signaling pathway. FGF2 at concentrations lower than 2 ng/ml enhanced in vitro adipogenesis of human adipose-derived stem cells (hASCs). However, FGF2 at concentrations higher than 10 ng/ml was able to suppress adipogenesis by maintaining sustained phosphorylation of ERK and function as a dominant negative adipogenic factor toward BMP ligands. Expression levels of FGF2 in the fat tissues from high fat diet induced obese C57BL/6 mice were lower than those from normal chow diet mice, indicating that expression levels of FGF2 in the fat tissues might be in reverse correlation with the size of fat tissues. Our observation of concentration dependent biphasic effect as well as dominant negative effect of FGF2 on adipogenesis provides a mechanistic basis to understand roles of FGF2 in adipogenesis and development of fat tissues.	[Kim, Sooho; Bong, Naeun; Lee, Dong Kun] Joint Ctr Biosci, Lab Genome Drug Med, Inchon, South Korea; [Ahn, Chihoon; Choe, Senyon] Joint Ctr Biosci, Lab Synthet Biol, Inchon, South Korea		Lee, DK (corresponding author), Joint Ctr Biosci, Lab Genome Drug Med, Inchon, South Korea.	dklee.jcb@gmail.com			Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs [HI12C0328]; IFEZ, Korea	Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs; IFEZ, Korea	This study was supported by the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs (HI12C0328) and IFEZ, Korea. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Bressan RB, 2014, EXP CELL RES, V327, P37, DOI 10.1016/j.yexcr.2014.05.020; Byun MR, 2014, BONE, V58, P72, DOI 10.1016/j.bone.2013.09.024; Camp HS, 1997, J BIOL CHEM, V272, P10811; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Gabrielsson BG, 2002, OBES RES, V10, P608, DOI 10.1038/oby.2002.83; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kakudo N, 2007, BIOCHEM BIOPH RES CO, V359, P239, DOI 10.1016/j.bbrc.2007.05.070; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; KENGAKU M, 1995, DEVELOPMENT, V121, P3121; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kuo MMC, 2014, BIOMATERIALS, V35, P3172, DOI 10.1016/j.biomaterials.2013.12.063; Lai WT, 2011, STEM CELLS, V29, P1102, DOI 10.1002/stem.661; Lee MJ, 2013, J CELL MOL MED, V17, P1188, DOI 10.1111/jcmm.12098; Neubauer M, 2004, FEBS LETT, V577, P277, DOI 10.1016/j.febslet.2004.10.020; Nikbakht N, 1997, CELL MOL LIFE SCI, V53, P447, DOI 10.1007/s000180050054; Patel NG, 2005, J CLIN ENDOCR METAB, V90, P1226, DOI 10.1210/jc.2004-1309; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; RILEY BB, 1993, DEVELOPMENT, V118, P95; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sakaue H, 2004, J BIOL CHEM, V279, P39951, DOI 10.1074/jbc.M407353200; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008; Xiao LP, 2010, BONE, V47, P360, DOI 10.1016/j.bone.2010.05.021; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006	33	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120073	10.1371/journal.pone.0120073	http://dx.doi.org/10.1371/journal.pone.0120073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790378	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400128
J	Suzuki, N; Mukai, HY; Yamamoto, M				Suzuki, Norio; Mukai, Harumi Y.; Yamamoto, Masayuki			In Vivo Regulation of Erythropoiesis by Chemically Inducible Dimerization of the Erythropoietin Receptor Intracellular Domain	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSGENIC MICE; STRESS ERYTHROPOIESIS; HEMATOPOIETIC-CELLS; GATA-1; PROLIFERATION; DISTINCT; PROGENITORS; ACTIVATION; SIGNALS	Erythropoietin (Epo) and its receptor (EpoR) are required for the regulation of erythropoiesis. Epo binds to the EpoR homodimer on the surface of erythroid progenitors and erythroblasts, and positions the intracellular domains of the homodimer to be in close proximity with each other. This conformational change is sufficient for the initiation of Epo-EpoR signal transduction. Here, we established a system of chemically regulated erythropoiesis in transgenic mice expressing a modified EpoR intracellular domain (amino acids 247-406) in which dimerization is induced using a specific compound (chemical inducer of dimerization, CID). Erythropoiesis is reversibly induced by oral administration of the CID to the transgenic mice. Because transgene expression is limited to hematopoietic cells by the Gata1 gene regulatory region, the effect of the CID is limited to erythropoiesis without adverse effects. Additionally, we show that the 160 amino acid sequence is the minimal essential domain of EpoR for intracellular signaling of chemically inducible erythropoiesis in vivo. We propose that the CID-dependent dimerization system combined with the EpoR intracellular domain and the Gata1 gene regulatory region generates a novel peroral strategy for the treatment of anemia.	[Suzuki, Norio] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Div Interdisciplinary Med Sci,Ctr Oxygen Med, Sendai, Miyagi 980, Japan; [Mukai, Harumi Y.; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Suzuki, N (corresponding author), Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Div Interdisciplinary Med Sci,Ctr Oxygen Med, Sendai, Miyagi 980, Japan.	sunorio@med.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science KAKENHI; Takeda Science Foundation; Inamori Foundation; Grants-in-Aid for Scientific Research [26111002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the platform for Drug Discovery, Informatics, and Structural Life Science from Ministry of Education, Culture, Sports, Science and Technology (NS, MY), and by grants from the Japan Society for the Promotion of Science KAKENHI < http://www.jsps.go.jp > (NS, MY), Takeda Science Foundation < http://www.takeda-sci.or.jp > (NS), and Inamori Foundation < http://www.inamori-f.or.jp > (NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami R, 2000, HUM MOL GENET, V9, P631, DOI 10.1093/hmg/9.4.631; Arumugam PI, 2009, MOL THER, V17, P1929, DOI 10.1038/mt.2009.183; Blau C. Anthony, 2006, V349, P163; Blau CA, 1997, P NATL ACAD SCI USA, V94, P3076, DOI 10.1073/pnas.94.7.3076; BROUDY VC, 1991, BLOOD, V77, P2583, DOI 10.1182/blood.V77.12.2583.2583; Bunn HF, 2007, BLOOD, V109, P868, DOI 10.1182/blood-2006-08-019083; Elliott S, 2008, EXP HEMATOL, V36, P1573, DOI 10.1016/j.exphem.2008.08.003; Flint-Ashtamker G, 2002, FEBS LETT, V518, P189, DOI 10.1016/S0014-5793(02)02691-1; Frank SJ, 2002, ENDOCRINOLOGY, V143, P2, DOI 10.1210/en.143.1.2; Gross AW, 2006, J BIOL CHEM, V281, P2024, DOI 10.1074/jbc.M510493200; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Jelkmann W, 2013, TRANSFUS MED HEMOTH, V40, P302, DOI 10.1159/000356193; Jin LQ, 2000, NAT GENET, V26, P64, DOI 10.1038/79194; Jin LQ, 1998, BLOOD, V91, P890, DOI 10.1182/blood.V91.3.890.890_890_897; Ketteler R, 2002, J BIOL CHEM, V277, P26547, DOI 10.1074/jbc.M202287200; Kim K, 2010, TOHOKU J EXP MED, V220, P127, DOI 10.1620/tjem.220.127; Koury MJ, 2014, BLOOD REV, V28, P49, DOI 10.1016/j.blre.2014.01.002; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Miller CP, 2008, GENE THER, V15, P759, DOI 10.1038/gt.2008.43; Miller CP, 1999, BLOOD, V94, P3381, DOI 10.1182/blood.V94.10.3381.422k25_3381_3387; Miyata T, 2013, KIDNEY INT, V84, P693, DOI 10.1038/ki.2013.74; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Ohmori S, 2012, MOL CELL BIOL, V32, P4742, DOI 10.1128/MCB.00718-12; Ohneda K, 2002, GENES CELLS, V7, P1243, DOI 10.1046/j.1365-2443.2002.00595.x; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Otto KG, 2001, BLOOD, V98, P2077, DOI 10.1182/blood.V98.7.2077; Pelletier S, 2006, MOL CELL BIOL, V26, P8527, DOI 10.1128/MCB.01035-06; Pollock C, 2008, CLIN J AM SOC NEPHRO, V3, P193, DOI 10.2215/CJN.02440607; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Souma T, 2013, J AM SOC NEPHROL, V24, P1599, DOI 10.1681/ASN.2013010030; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Suzuki M, 2006, BLOOD, V108, P726, DOI 10.1182/blood-2005-10-4064; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Suzuki N, 2002, BLOOD, V100, P2279, DOI 10.1182/blood-2002-01-0124; Suzuki N, 2007, METHOD ENZYMOL, V435, P157, DOI 10.1016/S0076-6879(07)35009-X; Suzuki N, 2011, MOL CELL BIOL, V31, P3896, DOI 10.1128/MCB.05463-11; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Wojchowski DM, 2010, CURR OPIN HEMATOL, V17, P169, DOI 10.1097/MOH.0b013e328338008b; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; YOSHIMURA A, 1990, P NATL ACAD SCI USA, V87, P4139, DOI 10.1073/pnas.87.11.4139; Zang HS, 2001, EMBO J, V20, P3156, DOI 10.1093/emboj/20.12.3156; Zeng H, 2001, BLOOD, V98, P328, DOI 10.1182/blood.V98.2.328; Zhou XO, 2014, BLOOD, V123, P3895, DOI 10.1182/blood-2014-01-551671	45	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119442	10.1371/journal.pone.0119442	http://dx.doi.org/10.1371/journal.pone.0119442			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790231	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400086
J	Weng, Y; Chabot, JR; Bernardo, B; Yan, QY; Zhu, YM; Brenner, MB; Vage, C; Logan, A; Calle, R; Talukdar, S				Weng, Yan; Chabot, Jeffrey R.; Bernardo, Barbara; Yan, Qingyun; Zhu, Yimin; Brenner, Martin B.; Vage, Chandra; Logan, Alison; Calle, Roberto; Talukdar, Saswata			Pharmacokinetics (PK), Pharmacodynamics (PD) and Integrated PK/PD Modeling of a Novel Long Acting FGF21 Clinical Candidate PF-05231023 in Diet-Induced Obese and Leptin-Deficient Obese Mice	PLOS ONE			English	Article							INCREASES ENERGY-EXPENDITURE; INSULIN SENSITIVITY; GROWTH; KLOTHO; BIOSYNTHESIS; TISSUES; BRAIN	Pharmacological administration of fibroblast growth factor 21 (FGF21) improves metabolic profile in preclinical species and humans. FGF21 exerts its metabolic effects through formation of beta-klotho (KLB)/FGF receptor 1c FGFR1c complex and subsequent signaling. Data from various in vitro systems demonstrate the intact C-and N-terminus of FGF21 is required for binding with KLB, and interaction with FGFR1c, respectively. However the relative roles of the termini for in vivo pharmacological effects are unclear. Here we report PF-05231023, a long-acting FGF21 analogue which is unique in that the half-life and subcutaneous (SC) bioavailability of the intact C-terminus are significantly different from those of the intact N-terminus (2 vs. 22 hr for half-life and 4 similar to 7 vs. similar to 50% SC bioavailability). Therefore, this molecule serves as a valuable tool to evaluate the relative roles of intact C-terminus vs. N-terminus in in vivo pharmacology studies in preclinical species. We determined the effects of PF-05231023 administration on body weight (BW) loss and glucose reduction during an oral glucose tolerance test (OGTT) following SC and intravenous (IV) administration in diet-induced obese (DIO) and leptin-deficient obese (ob/ob) mice, respectively. Our data show that the intact N-terminus of FGF21 in PF-05231023 appears to be sufficient to drive glucose lowering during OGTT and sustain BW loss in DIOs. Further, PK/PD modeling suggests that while the intact FGF21 C-terminus is not strictly required for glucose lowering during OGTT in ob/ob mice or for BW reduction in DIO mice, the higher potency conferred by intact C-terminus contributes to a rapid initiation of pharmacodynamic effects immediately following dosing. These results provide additional insight into the strategy of developing stabilized versions of FGF21 analogs to harness the full spectrum of its metabolic benefits.	[Weng, Yan; Chabot, Jeffrey R.; Bernardo, Barbara; Yan, Qingyun; Zhu, Yimin; Brenner, Martin B.; Logan, Alison; Calle, Roberto; Talukdar, Saswata] Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis CVMED Res Unit, Cambridge, MA 02139 USA; [Weng, Yan; Chabot, Jeffrey R.; Vage, Chandra] Pfizer Worldwide Res & Dev, Pharmacokinet Dynam & Metab, Cambridge, MA 02139 USA	Pfizer; Pfizer	Talukdar, S (corresponding author), Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis CVMED Res Unit, 610 Main St, Cambridge, MA 02139 USA.	Saswata.Talukdar@pfizer.com	Bernardo, Barbara/N-7101-2019	Calle, Roberto/0000-0001-6577-5657	Pfizer Inc.	Pfizer Inc.(Pfizer)	Pfizer Inc. provided funding for this study. The funder provided support in the form of salaries for all authors listed, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065763; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gimeno RE, 2014, TRENDS ENDOCRINOL ME; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Hager T, 2013, ANAL CHEM, V85, P2731, DOI 10.1021/ac303203y; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Huang J, 2013, J PHARMACOL EXP THER, V346, P270, DOI 10.1124/jpet.113.204420; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kim HW, 2013, ENDOCRINOLOGY, V154, P3366, DOI 10.1210/en.2012-2276; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; Lu M, 2013, J BIOL CHEM, V288, P10722, DOI 10.1074/jbc.M112.443606; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Ming AYK, 2012, J BIOL CHEM, V287, P19997, DOI 10.1074/jbc.M111.325670; Mu J, 2012, DIABETES, V61, P505, DOI 10.2337/db11-0838; Owen BM, 2014, CELL METAB; Reitman ML, 2013, CELL METAB, V18, P307, DOI 10.1016/j.cmet.2013.08.014; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023	38	45	48	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119104	10.1371/journal.pone.0119104	http://dx.doi.org/10.1371/journal.pone.0119104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790234	Green Submitted, gold, Green Published			2022-12-26	WOS:000351425400066
J	Bonvallet, PP; Schultz, MJ; Mitchell, EH; Bain, JL; Culpepper, BK; Thomas, SJ; Bellis, SL				Bonvallet, Paul P.; Schultz, Matthew J.; Mitchell, Elizabeth H.; Bain, Jennifer L.; Culpepper, Bonnie K.; Thomas, Steven J.; Bellis, Susan L.			Microporous Dermal-Mimetic Electrospun Scaffolds Pre-Seeded with Fibroblasts Promote Tissue Regeneration in Full-Thickness Skin Wounds	PLOS ONE			English	Article							IN-VITRO; ENGINEERED SKIN; GRAFT CONTRACTION; NUDE-MICE; NANOFIBERS; MECHANISM; CHITOSAN; VIVO; RECONSTRUCTION; INFILTRATION	Electrospun scaffolds serve as promising substrates for tissue repair due to their nanofibrous architecture and amenability to tailoring of chemical composition. In this study, the regenerative potential of a microporous electrospun scaffold pre-seeded with dermal fibroblasts was evaluated. Previously we reported that a 70% collagen I and 30% poly(epsilon-caprolactone) electrospun scaffold (70:30 col/PCL) containing 160 mu m diameter pores had favorable mechanical properties, supported fibroblast infiltration and subsequent cell-mediated deposition of extracellular matrix (ECM), and promotedmore rapid and effective in vivo skin regeneration when compared to scaffolds lacking micropores. In the current study we tested the hypothesis that the efficacy of the 70:30 col/PCL microporous scaffolds could be further enhanced by seeding scaffolds with dermal fibroblasts prior to implantation into skin wounds. To address this hypothesis, a Fischer 344 (F344) rat syngeneic model was employed. In vitro studies showed that dermal fibroblasts isolated from F344 rat skin were able to adhere and proliferate on 70:30 col/PCL microporous scaffolds, and the cells also filled the 160 mu m pores with native ECM proteins such as collagen I and fibronectin. Additionally, scaffolds seeded with F344 fibroblasts exhibited a low rate of contraction (similar to 14%) over a 21 day time frame. To assess regenerative potential, scaffolds with or without seeded F344 dermal fibroblasts were implanted into full thickness, critical size defects created in F344 hosts. Specifically, we compared:microporous scaffolds containing fibroblasts seeded for 4 days; scaffolds containing fibroblasts seeded for only 1 day; acellularmicroporous scaffolds; and a sham wound (no scaffold). Scaffolds containing fibroblasts seeded for 4 days had the best response of all treatment groups with respect to accelerated wound healing, a more normal-appearing dermal matrix structure, and hair follicle regeneration. Collectively these results suggest thatmicroporous electrospun scaffolds pre-seeded with fibroblasts promote greater wound-healing than acellular scaffolds.	[Bonvallet, Paul P.; Schultz, Matthew J.; Mitchell, Elizabeth H.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35233 USA; [Bain, Jennifer L.] Univ Alabama Birmingham, Dept Periodontol, Birmingham, AL USA; [Culpepper, Bonnie K.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL USA; [Thomas, Steven J.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35233 USA.	jbain@uab.edu		Mowry, Katie/0000-0002-0047-544X	National Institutes of Health [P30 AR050948, GM 008111-25, F31DE021613]; National Institutes of Health, National Center for Advancing Translational Research [TL1TR000167]; Howard Hughes Medical Institute Med into Grad Initiative [56005705]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE021613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Center for Advancing Translational Research; Howard Hughes Medical Institute Med into Grad Initiative(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health, P30 AR050948 (SLB), National Institutes of Health, T32 training grant GM 008111-25 (PPB), National Institutes of Health, National Center for Advancing Translational Research TL1TR000167 (PPB), Howard Hughes Medical Institute Med into Grad Initiative 56005705 (PPB) and the National Institutes of Health F31DE021613 (BKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine R, 2014, RSC ADV, V4, P51528, DOI 10.1039/c4ra07361d; Barker DA, 2013, JAMA OTOLARYNGOL, V139, P914, DOI 10.1001/jamaoto.2013.4119; Berthod F, 2001, MATRIX BIOL, V20, P463, DOI 10.1016/S0945-053X(01)00162-7; Blackstone BN, 2014, TISSUE ENG PT A, V20, P2746, DOI [10.1089/ten.tea.2013.0687, 10.1089/ten.TEA.2013.0687]; Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056; Bonvallet PP, 2014, TISSUE ENG PT A, V20, P2434, DOI [10.1089/ten.tea.2013.0645, 10.1089/ten.TEA.2013.0645]; Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003; Calota D R, 2012, J Med Life, V5, P486; Cedidi C, 2007, EUR J MED RES, V12, P541; Chern PL, 2009, DERMATOL SURG, V35, P891, DOI 10.1111/j.1524-4725.2009.01153.x; Chiu T, 2005, CLIN DERMATOL, V23, P419, DOI 10.1016/j.clindermatol.2004.07.027; Croisier F, 2014, ADV HEALTHC MATER, V3, P2032, DOI 10.1002/adhm.201400380; Deepa R, 2013, J BIOMATER TISS ENG, V3, P261, DOI 10.1166/jbt.2013.1094; Duan HC, 2013, INT J NANOMED, V8, P2077, DOI 10.2147/IJN.S42384; Fang TL, 2014, ANN PLAS SURG, V73, P509, DOI 10.1097/SAP.0b013e3182840883; Gomes SR, 2015, MAT SCI ENG C-MATER, V46, P348, DOI 10.1016/j.msec.2014.10.051; Ham R G, 1980, Methods Cell Biol, V21A, P255, DOI 10.1016/S0091-679X(08)60770-0; Harrison CA, 2008, BURNS, V34, P153, DOI 10.1016/j.burns.2007.08.011; Harrison CA, 2006, TISSUE ENG, V12, P3119, DOI 10.1089/ten.2006.12.3119; Kamel RA, 2013, J AM COLL SURGEONS, V217, P533, DOI 10.1016/j.jamcollsurg.2013.03.027; Kempf M, 2011, BIOMATERIALS, V32, P4782, DOI 10.1016/j.biomaterials.2011.03.023; Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008; Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002; Kuppan P, 2011, BIOMACROMOLECULES, V12, P3156, DOI 10.1021/bm200618w; Lai HJ, 2014, ACTA BIOMATER, V10, P4156, DOI 10.1016/j.actbio.2014.05.001; Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015; Nelson CE, 2014, ADV MATER, V26, P607, DOI 10.1002/adma.201303520; Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058; Pezeshki-Modaress M, 2014, J BIOMED MATER RES A, V102, P3908, DOI 10.1002/jbm.a.35054; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080; Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318; Ravichandran R, 2012, MACROMOL BIOSCI, V12, P286, DOI 10.1002/mabi.201100325; Reddy VJ, 2013, WOUND REPAIR REGEN, V21, P1, DOI 10.1111/j.1524-475X.2012.00861.x; Revi D, 2014, J BIOMED MATER RES A, V102, P3273, DOI 10.1002/jbm.a.35003; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032; Rnjak-Kovacina J, 2011, TISSUE ENG PART B-RE, V17, P365, DOI 10.1089/ten.teb.2011.0235; Stephenson AJ, 2000, BRIT J PLAST SURG, V53, P397, DOI 10.1054/bjps.2000.3335; Suganya S, 2014, INT J BIOL MACROMOL, V68, P135, DOI 10.1016/j.ijbiomac.2014.04.031; Sundaramurthi D, 2014, POLYM REV, V54, P348, DOI 10.1080/15583724.2014.881374; Sundaramurthi D, 2013, J BIOMED NANOTECHNOL, V9, P1383, DOI 10.1166/jbn.2013.1618; Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023; Vaquette C, 2011, ACTA BIOMATER, V7, P2544, DOI 10.1016/j.actbio.2011.02.036; Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006; Yildirimer L, 2012, TRENDS BIOTECHNOL, V30, P638, DOI 10.1016/j.tibtech.2012.08.004; You HJ, 2014, J KOREAN MED SCI, V29, P311, DOI 10.3346/jkms.2014.29.3.311; Zeinali R, 2014, ASAIO J, V60, P106, DOI 10.1097/MAT.0000000000000025; Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128; ZHONG SP, 2012, TISSUE ENG PART B-RE, V18, P77, DOI DOI 10.1089/ten.teb.2011.0390	50	48	50	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122359	10.1371/journal.pone.0122359	http://dx.doi.org/10.1371/journal.pone.0122359			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793720	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900178
J	Chen, H; Ren, CL; Han, CX; Wang, DX; Chen, Y; Fu, DY				Chen, Hui; Ren, Chuanli; Han, Chongxu; Wang, Daxin; Chen, Yong; Fu, Deyuan			Expression and Prognostic Value of miR-486-5p in Patients with Gastric Adenocarcinoma	PLOS ONE			English	Article								MicroRNA (miR)-486-5p expression is often reduced in human cancers. However, its expression in gastric carcinoma and its relation to clinicopathological features and prognosis are unclear. Tissue microarrays were constructed from 84 patients with gastric adenocarcinoma (GC) who were undergoing radical resection. miR-486-5p expression was detected by miRNA-locked nucleic acid in situ hybridization, and its correlations with clinicopathological features and overall survival were analyzed. Bioinformatic studies predict that fibroblast growth factor 9 (FGF9) is a potential target gene of miR-486-5p. miR-486-5p was mainly located in the cytoplasm of GC cells and neighboring normal tissues. Compared with paracancerous normal tissue, miR-486-5p expression was decreased in 63.1%(53/84) of the GC samples, increased in 32.1% (27/84) and unchanged in 4.8% (4/84). FGF9 expression was decreased in 69.0% (58/84) of GC samples and increased in 31.0%(26/84) compared with normal paracancerous tissues using immunohistochemical analysis. Low or unchanged miR-486-5p expression (P = 0.002), tumor stage (P = 0.001), tumor status (P = 0.001), node status (P = 0.001), tumor size (P = 0.004), and depth of tumor invasion (P = 0.013) were significant negative prognostic predictors for overall survival in patients with GC. After stratification according to American Joint Committee on Cancer (AJCC) stage, low/unchanged miR-486-5p expression remained a significant predictor of poor survival in stage II (P = 0.024) and stage III (P = 0.003). Cox regression analysis identified the following predictors of poor prognosis: tumor status (hazard ratio [HR], 7.19; 95% confidence interval [CI], 1.75-29.6; P = 0.006), stage (HR, 2.62; 95% CI, 1.50-4.59; P = 0.001), lymph node metastasis (HR, 2.52; 95% CI, 1.27-4.99; P = 0.008), low/unchanged miR486-5p (HR, 2.47; 95% CI, 1.35-4.52; P = 0.003), high level of FGF9 (HR, 2.41; 95% CI, 1.42-4.09; P = 0.001) and tumor size (HR, 2.50; 95% CI, 1.30-4.82; P = 0.006). Low or unchanged expression of miR-486-5p compared with neighboring normal tissues was associated with a poor prognosis, while high expression was associated with a good prognosis in GC. miR-486-5p may thus be useful for evaluating prognosis and may provide a novel target treatment in patients with GC.	[Chen, Hui] Northern Jiangsu Peoples Hosp, Geriatr Med, Yangzhou, Jiangsu, Peoples R China; [Chen, Hui; Ren, Chuanli; Han, Chongxu; Wang, Daxin; Chen, Yong; Fu, Deyuan] Yangzhou Univ, Clin Med Coll, Yangzhou 225009, Jiangsu, Peoples R China; [Ren, Chuanli; Han, Chongxu; Wang, Daxin] Northern Jiangsu Peoples Hosp, Clin Med Testing Lab, Yangzhou, Jiangsu, Peoples R China; [Chen, Yong] Northern Jiangsu Peoples Hosp, Dept Oncol, Yangzhou, Jiangsu, Peoples R China; [Fu, Deyuan] Northern Jiangsu Peoples Hosp, Breast Oncol Surg, Yangzhou, Jiangsu, Peoples R China; [Ren, Chuanli] Nanjing Med Univ, Minist Educ MOE, Dept Epidemiol & Biostat, Key Lab Modern Toxicol,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Yangzhou University; Nanjing Medical University	Ren, CL (corresponding author), Northern Jiangsu Peoples Hosp, Clin Med Testing Lab, Yangzhou, Jiangsu, Peoples R China.	renchl@163.com			Foundation of the Social Development of Jiangsu Province [BE2012705]; Foundation of China Postdoctoral Studies [M2013541699]; Foundation of Jiangsu Province Postdoctoral Studies [1302149C]; National Nature Science Foundation of China [81172508]; Foundation for Yong Scholar in Yangzhou [YZ2014046]	Foundation of the Social Development of Jiangsu Province; Foundation of China Postdoctoral Studies; Foundation of Jiangsu Province Postdoctoral Studies; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Yong Scholar in Yangzhou	This study was supported by the Foundation of the Social Development of Jiangsu Province (BE2012705), the Foundation of China Postdoctoral Studies (M2013541699), the Foundation of Jiangsu Province Postdoctoral Studies (1302149C), the National Nature Science Foundation of China (81172508) and the Foundation for Yong Scholar in Yangzhou (YZ2014046).	Alexander MS, 2014, J CLIN INVEST, V124, P2651, DOI 10.1172/JCI73579; Bansal A, 2011, AM J GASTROENTEROL, V106, P1055, DOI 10.1038/ajg.2011.37; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Deng M., 2013, PLOS ONE, V8; Ferlay J, 2010, INT J CANC, V127; Goto K, 2013, MOL CLIN ONCOL, V1, P235, DOI 10.3892/mco.2012.46; Hartgrink HH, 2009, LANCET, V374; He C, 2014, INT J CLIN EXP PATHO, V7; Hu Z, 2010, J CLIN ONCOL, V28; Kim Y., 2012, ASIA PACIFIC J TOURI, V2012, P1, DOI DOI 10.1016/J.JECP.2012.03.002; Konishi H, 2012, BR J CANC, V106; Li Y, 2013, ANAL CHEM, V85; Mees ST, 2009, ANN SURG ONCOL, V16; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Oh HK, 2011, CLIN CANC RES, V17; Ohgino K, 2014, LUNG CANCER, V83, DOI [10.1016/j.lungcan.2013.11.002, DOI 10.1016/J.LUNGCAN.2013.11.002]; Peng Y, 2013, P NATL ACAD SCI USA, V110, P15043, DOI 10.1073/pnas.1307107110; Ragusa M, 2010, MOL CANC THER, V9; Rask L, 2014, CELL ONCOL DORDR, V37; Shen J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-374; Small EM, 2010, P NATL ACAD SCI US, V107; Stuelten CH, 2010, CELL CYCLE, V9, P4608, DOI 10.4161/cc.9.23.13928; Tahiri A, 2013, CARCINOGENESIS, V35; Tan X, 2011, CLIN CANC RES, V17; Teishima J, 2012, PROSTATE CANCER P D, V15, DOI [10.1038/pcan.2011.53, DOI 10.1038/PCAN.2011.53]; Turner N, 2010, NAT REV CANCER, V10, DOI [10.1038/nrc2627-c1, DOI 10.1038/NRC2627-C1]; van Kouwenhove M, 2011, NAT REV CANCER, V11, DOI [10.1038/nrc3004-c1, DOI 10.1038/NRC3004-C1]; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang J, 2014, ONCOGENE, V33, DOI [10.1038/onc.2013.69, DOI 10.1038/ONC.2013.69]; Wu ZB, 2014, MOL CELL ENDOCRINOL, V395, DOI [10.1016/j.mce.2014.07.018, DOI 10.1016/J.MCE.2014.07.018]; Xie ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057502; Yu L, 2010, INT J CANC, V127; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang G, 2014, TUMOUR BIOL, V35; Zhu C, 2014, BR J CANC, V110	35	33	34	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119384	10.1371/journal.pone.0119384	http://dx.doi.org/10.1371/journal.pone.0119384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793394	Green Submitted, gold, Green Published			2022-12-26	WOS:000352084200078
J	Ching, B; Woo, JM; Hiong, KC; Boo, MV; Choo, CYL; Wong, WP; Chew, SF; Ip, YK				Ching, Biyun; Woo, Jia M.; Hiong, Kum C.; Boo, Mel V.; Choo, Celine Y. L.; Wong, Wai P.; Chew, Shit F.; Ip, Yuen K.			Na plus /K plus -ATPase alpha-subunit (nka alpha) Isoforms and Their mRNA Expression Levels, Overall Nka alpha Protein Abundance, and Kinetic Properties of Nka in the Skeletal Muscle and Three Electric Organs of the Electric Eel, Electrophorus electricus	PLOS ONE			English	Article							NA,K-ATPASE ALPHA; CYTOCHEMICAL-LOCALIZATION; SODIUM-CHANNEL; ELECTROCYTE; MEMBRANE; ISOZYMES; IDENTIFICATION; NA+,K+-ATPASE; HETEROGENEITY; BINDING	This study aimed to obtain the coding cDNA sequences of Na+/K+-ATPase alpha (nka alpha) isoforms from, and to quantify their mRNA expression in, the skeletal muscle (SM), the main electric organ (EO), the Hunter's EO and the Sach's EO of the electric eel, Electrophorus electricus. Four nkaa isoforms (nka alpha 1c1, nka alpha 1c2, nka alpha 2 and nka alpha 3) were obtained from the SM and the EOs of E. electricus. Based on mRNA expression levels, the major nka alpha expressed in the SM and the three EOs of juvenile and adult E. electricus were nka alpha 1c1 and nka alpha 2, respectively. Molecular characterization of the deduced Nka alpha 1c1 and Nka alpha 2 sequences indicates that they probably have different affinities to Na+ and K+. Western blotting demonstrated that the protein abundance of Nka alpha was barely detectable in the SM, but strongly detected in the main and Hunter's EOs and weakly in the Sach's EO of juvenile and adult E. electricus. These results corroborate the fact that the main EO and Hunter's EO have high densities of Na+ channels and produce high voltage discharges while the Sach's EO produces low voltage discharges. More importantly, there were significant differences in kinetic properties of Nka among the three EOs of juvenile E. electricus. The highest and lowest V-max of Nka were detected in the main EO and the Sach's EO, respectively, with the Hunter's EO having a V-max value intermediate between the two, indicating that the metabolic costs of EO discharge could be the highest in the main EO. Furthermore, the Nka from the main EO had the lowest K-m (or highest affinity) for Na+ and K+ among the three EOs, suggesting that the Nka of the main EO was more effective than those of the other two EOs in maintaining intracellular Na+ and K+ homeostasis and in clearing extracellular K+ after EO discharge.	[Ching, Biyun; Woo, Jia M.; Hiong, Kum C.; Boo, Mel V.; Choo, Celine Y. L.; Wong, Wai P.; Ip, Yuen K.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Ip, Yuen K.] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 119227, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore 637616, Singapore	National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsipyk@nus.edu.sg	Ip, Yuen Kwong/H-8041-2012; Chew, Shit Fun/I-2248-2012	Ip, Yuen Kwong/0000-0001-9124-7911; Chew, Shit Fun/0000-0003-4599-5817; Choo, Celine Yen Ling/0000-0001-9099-6988	 [R-347-000188-232]		The authors received anonymous funding from grant R-347-000188-232 to YKI. The authors are not aware of any competing interests regarding this funder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J. S., 2005, PHYSL FISHES, P431; APERIA A, 1994, FASEB J, V8, P436, DOI 10.1096/fasebj.8.6.8168694; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; BENNETT MVL, 1989, BRAIN RES, V488, P22, DOI 10.1016/0006-8993(89)90689-6; Bennett MVL, 1971, FISH PHYSIOL, P346; Berra TM., 2001, FRESHWATER FISH DIST; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLAUSEN T, 1991, PHYSIOL REV, V71, P733, DOI 10.1152/physrev.1991.71.3.733; Couceiro A, 1953, NEUROBIOLOGIA, V16, P299; ELLISMAN MH, 1982, P NATL ACAD SCI-BIOL, V79, P6707, DOI 10.1073/pnas.79.21.6707; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRITZ LC, 1983, J NEUROSCI, V3, P2300; Gallant JR, 2012, J EXP BIOL, V215, P2479, DOI 10.1242/jeb.063222; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Gotter AL, 1998, COMP BIOCHEM PHYS A, V119, P225, DOI 10.1016/S1095-6433(97)00414-5; GRUNDFEST H, 1960, BIOL BULL, V119, P284; Guynn SR, 2002, J EXP MAR BIOL ECOL, V273, P15, DOI 10.1016/S0022-0981(02)00136-3; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; He SW, 2001, AM J PHYSIOL-REG I, V281, pR917, DOI 10.1152/ajpregu.2001.281.3.R917; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; HORISBERGER JD, 1991, ANNU REV PHYSIOL, V53, P565, DOI 10.1146/annurev.physiol.53.1.565; Ip YK, 2012, AM J PHYSIOL-REG I, V303, pR112, DOI 10.1152/ajpregu.00618.2011; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Jorgensen PL, 2001, BBA-BIOENERGETICS, V1505, P57, DOI 10.1016/S0005-2728(00)00277-2; Kaya S, 1997, ANN NY ACAD SCI, V834, P129, DOI 10.1111/j.1749-6632.1997.tb52238.x; Keynes KD, 1961, BIOELECTROGENESIS, P14; Keynes R, 1957, PHYSL FISHES, VII, P323; KEYNES RD, 1953, J PHYSIOL-LONDON, V119, P315, DOI 10.1113/jphysiol.1953.sp004849; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; Lowe J, 2004, BBA-BIOMEMBRANES, V1661, P40, DOI 10.1016/j.bbamem.2003.11.020; Lucking K, 1996, AM J PHYSIOL-RENAL, V271, pF253, DOI 10.1152/ajprenal.1996.271.2.F253; MACHADO RD, 1976, CELL TISSUE RES, V174, P355, DOI 10.1007/BF00220681; MACHADO RD, 1980, CELL TISSUE RES, V213, P69, DOI 10.1007/BF00236921; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MIDDLETON JP, 1993, J BIOL CHEM, V268, P15958; Moller P., 1995, ELECT FISHES HIST BE; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; NACHMANSOHN D, 1970, SCIENCE, V168, P1059, DOI 10.1126/science.168.3935.1059; NAKAMURA Y, 1965, J GEN PHYSIOL, V49, P321, DOI 10.1085/jgp.49.2.321; Nelson ME, 2011, CURR BIOL, V21, pR528, DOI 10.1016/j.cub.2011.03.045; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Ortega H., 1986, SMITHS CONTR ZOOL, V437, P1, DOI DOI 10.5479/SI.00810282.437; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Peng L, 1997, J NEUROSCI, V17, P3488; Rajarao SJR, 2001, GENOME RES, V11, P1211, DOI 10.1101/gr.186001; Richards JG, 2003, J EXP BIOL, V206, P4475, DOI 10.1242/jeb.00701; Semple JW, 2002, MAR BIOTECHNOL, V4, P512, DOI 10.1007/s10126-002-0031-z; SHENKEL S, 1991, J GEN PHYSIOL, V97, P1013, DOI 10.1085/jgp.97.5.1013; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; SOMLO C, 1977, CELL TISSUE RES, V185, P115, DOI 10.1007/BF00226673; SWEADNER KJ, 1992, CAN J PHYSIOL PHARM, V70, pS255, DOI 10.1139/y92-269; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; SZABO T, 1966, ANAT REC, V155, P103, DOI 10.1002/ar.1091550112; Taguchi K, 2007, NEUROSCI LETT, V413, P42, DOI 10.1016/j.neulet.2006.11.061; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Valasco T, 2003, ELECTROPHORUS ELECTR; Wilson Jonathan Mark, 2007, P359; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xu KY, 2005, BIOCHEM BIOPH RES CO, V338, P1669, DOI 10.1016/j.bbrc.2005.10.067; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201	65	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118352	10.1371/journal.pone.0118352	http://dx.doi.org/10.1371/journal.pone.0118352			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793901	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200020
J	Haddeland, PJ; Junge, C; Serbezov, D; Vollestad, LA				Haddeland, Peter Jorgen; Junge, Claudia; Serbezov, Dimitar; Vollestad, Leif Asbjorn			Genetic Parentage Analysis Confirms a Polygynandrous Breeding System in the European Grayling (Thymallus thymallus)	PLOS ONE			English	Article							INDIVIDUAL REPRODUCTIVE SUCCESS; TROUT SALMO-TRUTTA; EARLY-LIFE-HISTORY; BROWN TROUT; CROSS-AMPLIFICATION; MICROSATELLITE LOCI; WATER TEMPERATURE; SEXUAL SELECTION; BODY-SIZE; POPULATION	Knowing the breeding system of a species is important in order to understand individual variation in reproductive success. Large variation in reproductive success and thus reproductive skew strongly impacts on the effective number of breeders and thus the long-term effective population size (N-e). Fishes, in particular species belonging to the salmonid family, exhibit a wide diversity of breeding systems. In general, however, breeding systems are rarely studied in detail in the wild. Here we examine the breeding system of the spring-spawning European grayling Thymallus thymallus from a small Norwegian stream using parentage assignment based on the genotyping of 19 polymorphic microsatellite loci. In total 895 individual grayling fry and 154 mature grayling (57 females and 97 males) were genotyped. A total of 466 offspring were assigned a father, a mother, or a parent pair with a confidence of 90% or higher. Successfully reproducing males had on average 11.9 +/- 13.3 (SD) offspring with on average 2.1 +/- 1.2 partners, whereas successful females had on average 9.5 +/- 12.8 offspring and 2.3 +/- 1.5 partners. Parents with more partners also produced more offspring. Thus the grayling breeding system within this small stream revealed a polygynandrous breeding system, similar to what has been observed for many other salmonid fish species. The present study thus unambiguously corroborates a polygynadrous breeding system in the European grayling. This knowledge is critical for managing populations of this species, which has suffered significant local population declines throughout its range over the last several decades.	[Haddeland, Peter Jorgen; Junge, Claudia; Serbezov, Dimitar; Vollestad, Leif Asbjorn] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Haddeland, Peter Jorgen] Norwegian Inst Publ Hlth, Dept Genet Kinship & Ident, N-0403 Oslo, Norway; [Junge, Claudia] Univ Adelaide, Sch Biol Sci, Southern Seas Ecol Labs, Adelaide, SA 5005, Australia; [Serbezov, Dimitar] Natl Agcy Fisheries & Aquaculture, Sofia 1606, Bulgaria	University of Oslo; Norwegian Institute of Public Health (NIPH); University of Adelaide	Vollestad, LA (corresponding author), Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, POB 1066, N-0316 Oslo, Norway.	avollest@ibv.uio.no	Vøllestad, Leif Asbjørn/H-7305-2019	Vøllestad, Leif Asbjørn/0000-0002-9389-7982	Norwegian Research Council [177728]; Marie Curie EST program	Norwegian Research Council(Research Council of NorwayEuropean Commission); Marie Curie EST program(European Commission)	This study was financially supported by the Norwegian Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906; project no 177728 to LAV) and the Marie Curie EST program (http://cordis.europa.eu/mariecurie-actions/est/home.html) under the 6th framework (to CJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Andersson Malte, 1994; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; BARDONNET A, 1993, J FISH BIOL, V43, P755; Barson N, 2006, EVOLUTION, V63, P549; Bentzen P, 2001, J HERED, V92, P127, DOI 10.1093/jhered/92.2.127; Blanchfield PJ, 2003, MOL ECOL, V12, P2417, DOI 10.1046/j.1365-294X.2003.01917.x; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Coleman SW, 2011, BIOL J LINN SOC, V103, P735, DOI 10.1111/j.1095-8312.2011.01673.x; Crow JF, 1988, GENETICS, V10, P783; Darchambeau F, 1997, J FISH BIOL, V51, P1066, DOI 10.1111/j.1095-8649.1997.tb01545.x; Dickerson BR, 2005, ECOLOGY, V86, P347, DOI 10.1890/03-625; Diggs MD, 2008, MOL ECOL RESOUR, V8, P828, DOI 10.1111/j.1755-0998.2007.02081.x; ELLIOTT JM, 1987, ARCH HYDROBIOL, V109, P257; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FABRICIUS ERIC, 1955, REPT INST FRESHWATER RES DROTTNINGHOLM, V36, P75; Fleming IA, 1998, CAN J FISH AQUAT SCI, V55, P59, DOI 10.1139/cjfas-55-S1-59; Fleming IA, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P264; Fleming IA, 1996, REV FISH BIOL FISHER, V6, P379, DOI 10.1007/BF00164323; Garant D, 2001, J HERED, V92, P137, DOI 10.1093/jhered/92.2.137; Gregersen F, 2008, ECOL FRESHW FISH, V17, P110, DOI 10.1111/j.1600-0633.2007.00264.x; Gregersen F, 2006, ECOL FRESHW FISH, V15, P237, DOI 10.1111/j.1600-0633.2006.00129.x; Grimardias D, 2012, ECOL FRESHW FISH, V21, P495, DOI 10.1111/j.1600-0633.2012.00572.x; GROSS MR, 1991, ECOLOGY, V72, P1180, DOI 10.2307/1941091; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Haugen TO, 2000, J EVOLUTION BIOL, V13, P897, DOI 10.1046/j.1420-9101.2000.00242.x; HUMPESCH UH, 1985, ARCH HYDROBIOL, V104, P129; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Junge C, 2011, HEREDITY, V106, P460, DOI 10.1038/hdy.2010.160; Junge C, 2010, CONSERV GENET RESOUR, V2, P219, DOI 10.1007/s12686-009-9147-z; Junge C, 2011, THESIS U OSLO OSLO; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kavanagh KD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-350; Lahnsteiner F, 2012, FISH PHYSIOL BIOCHEM, V38, P455, DOI 10.1007/s10695-011-9526-8; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mateescu RG, 2005, J HERED, V96, P847, DOI 10.1093/jhered/esi109; Meraner A, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013046; Morrissey MB, 2009, MOL ECOL, V18, P4330, DOI 10.1111/j.1365-294X.2009.04318.x; Mylonas CC, 2005, AQUACULTURE, V246, P467, DOI 10.1016/j.aquaculture.2005.02.046; NORTHCOTE TG, 1995, REV FISH BIOL FISHER, V5, P141; Olsen JB, 1998, MOL ECOL, V7, P1087; Ovidio M, 2004, FOLIA ZOOL, V53, P87; Papakostas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5071; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Poncin P, 1996, J FISH BIOL, V48, P802, DOI 10.1006/jfbi.1995.9998; SAS Institute Inc, 2010, US JMP 9; Seamons TR, 2004, CAN J FISH AQUAT SCI, V61, P193, DOI 10.1139/F03-158; Serbezov D, 2012, EVOL APPL, V5, P607, DOI 10.1111/j.1752-4571.2012.00239.x; Serbezov D, 2010, MOL ECOL, V19, P3193, DOI 10.1111/j.1365-294X.2010.04744.x; Susnik S, 2000, J ANIM SCI, V78, P488; Susnik S, 1999, MOL ECOL, V8, P1756, DOI 10.1046/j.1365-294x.1999.00723-2.x; Susnik S, 1999, ANIM GENET, V30, P478, DOI 10.1046/j.1365-2052.1999.00498-18.x; Thomassen G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-360; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P295; Wedekind C, 2013, CONSERV BIOL, V27, P229, DOI 10.1111/j.1523-1739.2012.01909.x	57	8	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122032	10.1371/journal.pone.0122032	http://dx.doi.org/10.1371/journal.pone.0122032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793629	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900168
J	Jia, HH; Wang, C; Wang, F; Liu, SC; Li, GL; Guo, XQ				Jia, Haihong; Wang, Chen; Wang, Fang; Liu, Shuchang; Li, Guilin; Guo, Xingqi			GhWRKY68 Reduces Resistance to Salt and Drought in Transgenic Nicotiana benthamiana	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; ABIOTIC STRESS RESPONSES; ABSCISIC-ACID; SUPEROXIDE-DISMUTASE; SIGNAL-TRANSDUCTION; DISEASE RESISTANCE; OXIDATIVE STRESS; OSMOTIC-STRESS; DNA-BINDING; TOLERANCE	The WRKY transcription factors modulate numerous physiological processes, including plant growth, development and responses to various environmental stresses. Currently, our understanding of the functions of the majority of the WRKY family members and their possible roles in signalling crosstalk is limited. In particular, very few WRKYs have been identified and characterised from an economically important crop, cotton. In this study, we characterised a novel group IIc WRKY gene, GhWRKY68, which is induced by different abiotic stresses and multiple defence-related signalling molecules. The beta-glucuronidase activity driven by the GhWRKY68 promoter was enhanced after exposure to drought, salt, abscisic acid (ABA) and H2O2. The overexpression of GhWRKY68 in Nicotiana benthamiana reduced resistance to drought and salt and affected several physiological indices. GhWRKY68 may mediate salt and drought responses by modulating ABA content and enhancing the transcript levels of ABA-responsive genes. GhWRKY68-overexpressing plants exhibited reduced tolerance to oxidative stress after drought and salt stress treatments, which correlated with the accumulation of reactive oxygen species (ROS), reduced enzyme activities, elevated malondialdehyde (MDA) content and altered ROS-related gene expression. These results indicate that GhWRKY68 is a transcription factor that responds to drought and salt stresses by regulating ABA signalling and modulating cellular ROS.	[Jia, Haihong; Wang, Chen; Wang, Fang; Liu, Shuchang; Li, Guilin; Guo, Xingqi] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Guo, XQ (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	xqguo@sdau.edu.cn			National Natural Science Foundation of China [31171837, 31471424]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported with two fundings from the National Natural Science Foundation of China (Grant no. 31171837; 31471424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AR, 2007, PLANT PHYSIOL, V143, P1720, DOI 10.1104/pp.106.094771; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Baumann K, 1999, PLANT CELL, V11, P323, DOI 10.1105/tpc.11.3.323; Ben Rejeb K, 2014, PLANT PHYSIOL BIOCH, V80, P278, DOI 10.1016/j.plaphy.2014.04.007; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Bhattacharjee S, 2005, CURR SCI INDIA, V89, P1113; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen ZZ, 2006, MOL CELL BIOL, V26, P6902, DOI 10.1128/MCB.00433-06; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dang FF, 2013, PLANT CELL ENVIRON, V36, P757, DOI 10.1111/pce.12011; Ding ZJ, 2014, PLANT J, V79, P810, DOI 10.1111/tpj.12597; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Gao S, 2008, PLANT SOIL ENVIRON, V54, P374, DOI 10.17221/410-PSE; Jia HH, 2014, J INSECT PHYSIOL, V60, P68, DOI 10.1016/j.jinsphys.2013.11.004; Jiang YJ, 2012, MOL PLANT, V5, P1375, DOI 10.1093/mp/sss080; Kishor PBK, 2014, PLANT CELL ENVIRON, V37, P300, DOI 10.1111/pce.12157; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x; Leshem Y, 2010, J EXP BOT, V61, P2615, DOI 10.1093/jxb/erq099; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Liu QL, 2014, PLANT MOL BIOL REP, V32, P282, DOI 10.1007/s11105-013-0639-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 2012, J PLANT PHYSIOL, V169, P1192, DOI 10.1016/j.jplph.2012.03.019; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Olivella C, 1998, BIOL PLANTARUM, V41, P613, DOI 10.1023/A:1001860920706; Park CY, 2005, FEBS LETT, V579, P1545, DOI 10.1016/j.febslet.2005.01.057; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Shan DP, 2007, NEW PHYTOL, V176, P70, DOI 10.1111/j.1469-8137.2007.02160.x; Shi J, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-22; Shi J, 2010, PLANT MOL BIOL, V74, P1, DOI 10.1007/s11103-010-9661-0; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; SINGH NK, 1989, PLANT PHYSIOL, V90, P1096, DOI 10.1104/pp.90.3.1096; Smith CW, 1999, COTTON ORIGIN HISTOR; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Urao T, 1996, PLANT J, V10, P1145, DOI 10.1046/j.1365-313X.1996.10061145.x; Wang LN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-103; Wang YN, 2013, MOL PLANT PATHOL, V14, P131, DOI 10.1111/j.1364-3703.2012.00836.x; Wang Z, 2014, MOL PLANT PATHOL, V15, P677, DOI 10.1111/mpp.12123; Wei KF, 2012, DNA RES, V19, P153, DOI 10.1093/dnares/dsr048; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Yan HR, 2014, PLANT CELL PHYSIOL, V55, P2060, DOI 10.1093/pcp/pcu133; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Yu FF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-144; Zhang L, 2012, J EXP BOT, V63, P3935, DOI 10.1093/jxb/ers086; Zhang LA, 2011, FEBS J, V278, P1367, DOI 10.1111/j.1742-4658.2011.08056.x; Zhang X, 2004, PLANT PHYSIOL, V136, P4150, DOI 10.1104/pp.104.046573; Zhang X, 2011, PLANT MOL BIOL, V75, P365, DOI 10.1007/s11103-011-9732-x; Zhao L, 2012, PHYTOCHEM ANALYSIS, V23, P647, DOI 10.1002/pca.2368; Zheng Hui-Qiong, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P189; Zheng L, 2013, PLANT MOL BIOL, V82, P303, DOI 10.1007/s11103-013-0063-y; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	74	68	86	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120646	10.1371/journal.pone.0120646	http://dx.doi.org/10.1371/journal.pone.0120646			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793865	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900062
J	Kume, S; Yamato, M; Tamura, Y; Jin, GH; Nakano, M; Miyashige, Y; Eguchi, A; Ogata, Y; Goda, N; Iwai, K; Yamano, E; Watanabe, Y; Soga, T; Kataoka, Y				Kume, Satoshi; Yamato, Masanori; Tamura, Yasuhisa; Jin, Guanghua; Nakano, Masayuki; Miyashige, Yukiharu; Eguchi, Asami; Ogata, Yoshiyuki; Goda, Nobuhito; Iwai, Kazuhiro; Yamano, Emi; Watanabe, Yasuyoshi; Soga, Tomoyoshi; Kataoka, Yosky			Potential Biomarkers of Fatigue Identified by Plasma Metabolome Analysis in Rats	PLOS ONE			English	Article							ANIMAL-MODEL; PROTEIN; LIVER; ACID	In the present study, prior to the establishment of a method for the clinical diagnosis of chronic fatigue in humans, we validated the utility of plasma metabolomic analysis in a rat model of fatigue using capillary electrophoresis-mass spectrometry (CE-MS). In order to obtain a fatigued animal group, rats were placed in a cage filled with water to a height of 2.2 cm for 5 days. A food-restricted group, in which rats were limited to 10 g/d of food (around 50% of the control group), was also assessed. The food-restricted group exhibited weight reduction similar to that of the fatigued group. CE-MS measurements were performed to evaluate the profile of food intake-dependent metabolic changes, as well as the profile in fatigue loading, resulting in the identification of 48 metabolites in plasma. Multivariate analyses using hierarchical clustering and principal component analysis revealed that the plasma metabolome in the fatigued group showed clear differences from those in the control and food-restricted groups. In the fatigued group, we found distinctive changes in metabolites related to branched-chain amino acid metabolism, urea cycle, and proline metabolism. Specifically, the fatigued group exhibited significant increases in valine, leucine, isoleucine, and 2-oxoisopentanoate, and significant decreases in citrulline and hydroxyproline compared with the control and food-restricted groups. Plasma levels of total nitric oxide were increased in the fatigued group, indicating systemic oxidative stress. Further, plasma metabolites involved in the citrate cycle, such as cis-aconitate and isocitrate, were reduced in the fatigued group. The levels of ATP were significantly decreased in the liver and skeletal muscle, indicative of a deterioration in energy metabolism in these organs. Thus, this comprehensive metabolic analysis furthered our understanding of the pathophysiology of fatigue, and identified potential diagnostic biomarkers based on fatigue pathophysiology.	[Kume, Satoshi; Yamato, Masanori; Tamura, Yasuhisa; Jin, Guanghua; Nakano, Masayuki; Miyashige, Yukiharu; Eguchi, Asami; Kataoka, Yosky] RIKEN Ctr Life Sci Technol, Div Biofunct Dynam Imaging, Cellular Funct Imaging Team, Kobe, Hyogo, Japan; [Nakano, Masayuki; Yamano, Emi; Watanabe, Yasuyoshi; Kataoka, Yosky] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan; [Ogata, Yoshiyuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan; [Goda, Nobuhito] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Iwai, Kazuhiro] Kyoto Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Kyoto, Japan; [Watanabe, Yasuyoshi] RIKEN Ctr Life Sci Technol, Pathophysiol & Hlth Sci Team, Kobe, Hyogo, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	RIKEN; Osaka Metropolitan University; Osaka Metropolitan University; Waseda University; Kyoto University; RIKEN; Keio University	Kataoka, Y (corresponding author), RIKEN Ctr Life Sci Technol, Div Biofunct Dynam Imaging, Cellular Funct Imaging Team, Kobe, Hyogo, Japan.	kataokay@riken.jp	IWAI, KAZUHIRO/GSN-7385-2022; Goda, Nobuhito/W-2468-2019; Yamano, Emi/AAL-6201-2020; Soga, Tomoyoshi/B-8105-2014; Kume, Satoshi/C-4160-2017	Yamano, Emi/0000-0003-3907-5360; Soga, Tomoyoshi/0000-0001-9502-2509; Iwai, Kazuhiro/0000-0001-5620-5951; Kume, Satoshi/0000-0001-7481-2843; Goda, Nobuhito/0000-0003-0295-4257	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST); JSPS KAKENHI [25882051]; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government [25460399]	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST), by a Grant-in-Aid for Research Activity Start-up to SK (JSPS KAKENHI Grant Number 25882051), and by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government to YK (JSPS KAKENHI Grant Number 25460399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BLOMSTRAND E, 1991, EUR J APPL PHYSIOL, V63, P83, DOI 10.1007/BF00235174; Bulau P, 2007, AM J PHYSIOL-LUNG C, V292, pL18, DOI 10.1152/ajplung.00076.2006; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Chida J, 2012, ANAL CHIM ACTA, V727, P8, DOI 10.1016/j.aca.2012.03.022; Edoardo Gaude FC, 2013, CURRENT METABOLOMICS, V1, P180; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Hussein SZ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/109636; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jin GH, 2009, NUTRITION, V25, P597, DOI 10.1016/j.nut.2008.11.021; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; LEHMANN M, 1995, INT J SPORTS MED, V16, P155, DOI 10.1055/s-2007-972984; Lentner C., 1981, GEIGY SCI TABLES, V1; Lubec B, 1997, FREE RADICAL BIO MED, V22, P355, DOI 10.1016/S0891-5849(96)00386-3; Maekawa K, 2013, J MOL CELL CARDIOL, V59, P76, DOI 10.1016/j.yjmcc.2013.02.008; Matsui T, 2012, J PHYSIOL-LONDON, V590, P607, DOI 10.1113/jphysiol.2011.217919; Mizuno K, 2007, J NEURAL TRANSM, V114, P555, DOI 10.1007/s00702-006-0608-1; MORI M, 1981, J BIOL CHEM, V256, P4127; Ogawa T, 2005, J NEUROCHEM, V95, P1156, DOI 10.1111/j.1471-4159.2005.03436.x; Ogawa T, 2009, J NEUROCHEM, V109, P1389, DOI 10.1111/j.1471-4159.2009.06057.x; Rohn H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-139; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Takeuchi K, 2013, J PROTEOME RES, V12, P1399, DOI 10.1021/pr3010452; Tanaka M, 2003, NEUROSCI LETT, V352, P159, DOI 10.1016/j.neulet.2003.08.051; Tanaka M, 2008, NUTRITION, V24, P599, DOI 10.1016/j.nut.2008.03.001; Team RC, 2014, R LANG ENV STAT COMP; Villas-Boas SG, 2005, MASS SPECTROM REV, V24, P613, DOI 10.1002/mas.20032; WALKER EA, 1993, J GEN INTERN MED, V8, P436, DOI 10.1007/BF02599621; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yasui M, 2014, GLIA	39	35	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120106	10.1371/journal.pone.0120106	http://dx.doi.org/10.1371/journal.pone.0120106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793974	Green Submitted, gold, Green Published			2022-12-26	WOS:000352084200146
J	Leclere, L; Fransolet, M; Cote, F; Cambier, P; Arnould, T; Van Cutsem, P; Michiels, C				Leclere, Lionel; Fransolet, Maude; Cote, Francois; Cambier, Pierre; Arnould, Thierry; Van Cutsem, Pierre; Michiels, Carine			Heat-Modified Citrus Pectin Induces Apoptosis-Like Cell Death and Autophagy in HepG2 and A549 Cancer Cells	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; PROTEASOMAL DEGRADATION; CLEAVAGE; INHIBITION; CASPASE-3; BIOSYNTHESIS; METASTASIS; ACTIVATION; RESISTANCE; ETOPOSIDE	Cancer is still one of the leading causes of death worldwide, and finding new treatments remains a major challenge. Previous studies showed that modified forms of pectin, a complex polysaccharide present in the primary plant cell wall, possess anticancer properties. Nevertheless, the mechanism of action of modified pectin and the pathways involved are unclear. Here, we show that citrus pectin modified by heat treatment induced cell death in HepG2 and A549 cells. The induced cell death differs from classical apoptosis because no DNA cleavage was observed. In addition, Z-VAD-fmk, a pan-caspase inhibitor, did not influence the observed cell death in HepG2 cells but appeared to be partly protective in A549 cells, indicating that heat-modified citrus pectin might induce caspase-independent cell death. An increase in the abundance of the phosphatidylethanolamine-conjugated Light Chain 3 (LC3) protein and a decrease in p62 protein abundance were observed in both cell types when incubated in the presence of heat-modified citrus pectin. These results indicate the activation of autophagy. To our knowledge, this is the first time that autophagy has been revealed in cells incubated in the presence of a modified form of pectin. This autophagy activation appears to be protective, at least for A549 cells, because its inhibition with 3-methyladenine increased the observed modified pectin-induced cytotoxicity. This study confirms the potential of modified pectin to improve chemotherapeutic cancer treatments.	[Leclere, Lionel; Fransolet, Maude; Cote, Francois; Arnould, Thierry; Michiels, Carine] Univ Namur, Lab Biochem & Cellular Biol URBC, NARILIS, B-5000 Namur, Belgium; [Cambier, Pierre; Van Cutsem, Pierre] Univ Namur, Lab Plant Cellular Biol URBV, B-5000 Namur, Belgium	University of Namur; University of Namur	Michiels, C (corresponding author), Univ Namur, Lab Biochem & Cellular Biol URBC, NARILIS, 61 Rue Bruxelles, B-5000 Namur, Belgium.	carine.michiels@unamur.be		Van Cutsem, Pierre/0000-0001-9456-2802	FRIA fellowship (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Brussels, Belgium)	FRIA fellowship (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS)	L. Leclere was the recipient of a FRIA fellowship (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Benbrook D. M., 2012, Experimental Oncology, V34, P286; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; CHEN JW, 1988, J BIOL CHEM, V263, P8754; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cosse JPJ, 2009, NEOPLASIA, V11, P976, DOI 10.1593/neo.09632; de Bruin EC, 2003, CELL DEATH DIFFER, V10, P1204, DOI 10.1038/sj.cdd.4401296; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Hajji N, 2008, ONCOGENE, V27, P3134, DOI 10.1038/sj.onc.1210976; Han SB, 2006, CANCER LETT, V243, P264, DOI 10.1016/j.canlet.2005.11.040; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; HARRIS AS, 1988, J NEUROSCI, V8, P2640; Hazra B, 2012, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00094; Huang Zhi-liang, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1358; Jackson CL, 2007, GLYCOBIOLOGY, V17, P805, DOI 10.1093/glycob/cwm054; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Laussmann MA, 2011, CELL DEATH DIFFER, V18, P1584, DOI 10.1038/cdd.2011.27; Leclere L, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00128; Liu HY, 2008, WORLD J GASTROENTERO, V14, P7386, DOI 10.3748/wjg.14.7386; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Qiu JH, 2000, J NEUROSCI, V20, P259, DOI 10.1523/JNEUROSCI.20-01-00259.2000; Rommelaere G, 2012, INT J BIOCHEM CELL B, V44, P139, DOI 10.1016/j.biocel.2011.10.009; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Vayssade M, 2010, PHYTOTHER RES, V24, P982, DOI 10.1002/ptr.3040; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yan J, 2010, INTEGR CANCER THER, V9, P197, DOI 10.1177/1534735410369672; Zeng RX, 2014, CELL BIOL INT	40	36	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0115831	10.1371/journal.pone.0115831	http://dx.doi.org/10.1371/journal.pone.0115831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794149	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200004
J	Santibanez, M; Aguirre, E; Belda, S; Aragones, N; Saez, J; Rodriguez, JC; Galiana, A; Sola-Vera, J; Ruiz-Garcia, M; Paz-Zulueta, M; Sarabia-Lavin, R; Brotons, A; Lopez-Girona, E; Perez, E; Sillero, C; Royo, G				Santibanez, Miguel; Aguirre, Estefania; Belda, Sofa; Aragones, Nuria; Saez, Jesus; Rodriguez, Juan Carlos; Galiana, Antonio; Sola-Vera, Javier; Ruiz-Garcia, Montserrat; Paz-Zulueta, Maria; Sarabia-Lavin, Raquel; Brotons, Alicia; Lopez-Girona, Elena; Perez, Estefana; Sillero, Carlos; Royo, Gloria			Relationship between Tobacco, cagA and vacA i1 Virulence Factors and Bacterial Load in Patients Infected by Helicobacter pylori	PLOS ONE			English	Article							VACUOLATING CYTOTOXIN ALLELES; GASTRIC-CANCER; INTESTINAL METAPLASIA; INTERMEDIATE REGION; SMOKING; RISK; ASSOCIATION; STRAINS; ULCER; RECOMBINATION	Background and Aim Several biological and epidemiological studies support a relationship between smoking and Helicobacter pylori (H. pylori) to increase the risk of pathology. However, there have been few studies on the potential synergistic association between specific cagA and vacA virulence factors and smoking in patients infected by Helicobacter pylori. We studied the relationship between smoking and cagA, vacA i1 virulence factors and bacterial load in H. pylori infected patients. Methods Biopsies of the gastric corpus and antrum from 155 consecutive patients in whom there was clinical suspicion of infection by H. pylori were processed. In 106 patients H. pylori infection was detected. Molecular methods were used to quantify the number of microorganisms and presence of cagA and vacA i1 genes. A standardized questionnaire was used to obtain patients' clinical data and lifestyle variables, including tobacco and alcohol consumption. Adjusted Odds Ratios (ORadjusted) were estimated by unconditional logistic regression. Results cagA was significantly associated with active-smoking at endoscope: ORadjusted 4.52. Evidence of association was found for vacA i1 (ORadjusted 3.15). Bacterial load was higher in active-smokers, although these differences did not yield statistical significance (median of 262.2 versus 79.4 copies of H. pylori per cell). Conclusions The association between smoking and a higher risk of being infected by a virulent bacterial population and with higher bacterial load, support a complex interaction between H. pylori infection and environmental factors.	[Santibanez, Miguel] Univ Cantabria, Dept Salud Publ, E-39005 Santander, Spain; [Santibanez, Miguel] IDIVAL Inst Invest Marques de Valdecilla, Santander, Spain; [Aguirre, Estefania; Belda, Sofa; Galiana, Antonio; Ruiz-Garcia, Montserrat; Lopez-Girona, Elena; Royo, Gloria] Microbiol S Elche Univ Gen Hosp, Elche, Alicante, Spain; [Aragones, Nuria] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Aragones, Nuria] ISCIII, Natl Ctr Epidemiol, Environm & Canc Epidemiol Unit, Madrid, Spain; [Saez, Jesus; Sola-Vera, Javier; Brotons, Alicia; Perez, Estefana; Sillero, Carlos] Digest Med S Elche Univ Gen Hosp, Elche, Alicante, Spain; [Rodriguez, Juan Carlos] Microbiol S Alicante Univ Gen Hosp, Alicante, Spain; [Rodriguez, Juan Carlos; Royo, Gloria] Miguel Hernandez Univ, Elche, Spain; [Paz-Zulueta, Maria; Sarabia-Lavin, Raquel] Univ Cantabria, Dept Enfermeria, E-39005 Santander, Spain	Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universidad de Cantabria	Santibanez, M (corresponding author), Univ Cantabria, Dept Salud Publ, E-39005 Santander, Spain.	santibanezm@unican.es	Lopez-Girona, Elena/V-2790-2019; Aragones, Nuria/O-5962-2015; Santibanez, Miguel/L-3323-2017	Lopez-Girona, Elena/0000-0003-0376-6135; Aragones, Nuria/0000-0003-0983-2156; Santibanez, Miguel/0000-0003-2634-615X; Sarabia-Lavin, Raquel/0000-0003-3679-4327; Galiana, Antonio/0000-0002-1134-1914; RODRIGUEZ DIAZ, JUAN CARLOS/0000-0001-8007-5739; Brotons, Alicia/0000-0003-3017-1671	Fundacion Bienvenida Navarro-Luciano Tripodi; Generalitat Valenciana Proyectos [precompetitivos/2008/317]; Fundacion para el fomento de la Investigacion del Hospital General Universitario de Elche	Fundacion Bienvenida Navarro-Luciano Tripodi; Generalitat Valenciana Proyectos; Fundacion para el fomento de la Investigacion del Hospital General Universitario de Elche	This work was supported by the collaboration of the Fundacion Bienvenida Navarro-Luciano Tripodi (research grants 2009); the Generalitat Valenciana Proyectos precompetitivos/2008/317 and Fundacion para el fomento de la Investigacion del Hospital General Universitario de Elche 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argent RH, 2008, J MED MICROBIOL, V57, P145, DOI 10.1099/jmm.0.47465-0; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atherton JC, 1999, J CLIN MICROBIOL, V37, P2979, DOI 10.1128/JCM.37.9.2979-2982.1999; Belda S, 2012, CLIN MICROBIOL INFEC, V18, pE251, DOI 10.1111/j.1469-0691.2012.03884.x; Belda Sofia, 2012, Diagn Microbiol Infect Dis, V74, P248, DOI 10.1016/j.diagmicrobio.2012.07.007; Brenner H, 2002, INT J CANCER, V98, P446, DOI 10.1002/ijc.10201; Cellini L, 2006, SCAND J GASTROENTERO, V41, P280, DOI 10.1080/00365520510024223; Cellini L, 2003, LETT APPL MICROBIOL, V36, P222, DOI 10.1046/j.1472-765X.2003.01295.x; Chung C, 2010, J CLIN MICROBIOL, V48, P690, DOI 10.1128/JCM.01815-09; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; DRUMM B, 1990, NEW ENGL J MED, V322, P359, DOI 10.1056/NEJM199002083220603; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Gonzalez CA, 2003, INT J CANCER, V107, P629, DOI 10.1002/ijc.11426; Jang S, 2010, J CLIN MICROBIOL, V48, P559, DOI 10.1128/JCM.01501-09; Jarosz M, 2000, EUR J CANCER PREV, V9, P423, DOI 10.1097/00008469-200012000-00008; Jones KR, 2011, J CLIN MICROBIOL, V49, P101, DOI 10.1128/JCM.01782-10; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kivi M, 2005, EPIDEMIOL INFECT, V133, P645, DOI 10.1017/S0950268805003900; Lai YC, 2003, WORLD J GASTROENTERO, V9, P1537, DOI 10.3748/wjg.v9.i7.1537; Letley DP, 2003, J BIOL CHEM, V278, P26734, DOI 10.1074/jbc.M304071200; Machida-Montani Ai, 2004, Gastric Cancer, V7, P46, DOI 10.1007/s10120-004-0268-5; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Pandey A, 2014, WORLD J GASTROENTERO, V20, P6860, DOI 10.3748/wjg.v20.i22.6860; Peleteiro B, 2007, CANCER EPIDEM BIOMAR, V16, P322, DOI 10.1158/1055-9965.EPI-06-0885; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Rhead JL, 2007, GASTROENTEROLOGY, V133, P926, DOI 10.1053/j.gastro.2007.06.056; Roesler BM, 2014, CLIN MED INSIGHTS-GA, V7, P9, DOI 10.4137/CGast.S13760; Russo A, 2001, AM J GASTROENTEROL, V96, P1402, DOI 10.1111/j.1572-0241.2001.03773.x; Saez J, 2012, J CLIN MICROBIOL, V50, P3233, DOI 10.1128/JCM.01205-12; Siman JH, 2001, SCAND J GASTROENTERO, V36, P208, DOI 10.1080/003655201750065988; SOBALA GM, 1993, J CLIN PATHOL, V46, P235, DOI 10.1136/jcp.46.3.235; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Tredaniel J, 1997, INT J CANCER, V72, P565, DOI 10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O; van Doorn LJ, 1999, GASTROENTEROLOGY, V116, P823, DOI 10.1016/S0016-5085(99)70065-X; Vannini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098416; Wang XQ, 2011, WORLD J GASTROENTERO, V17, P3330, DOI 10.3748/wjg.v17.i28.3330; Yamazaki S, 2005, J CLIN MICROBIOL, V43, P3906, DOI 10.1128/JCM.43.8.3906-3916.2005; Yeh JM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001451	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120444	10.1371/journal.pone.0120444	http://dx.doi.org/10.1371/journal.pone.0120444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794002	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900037
J	Singer, HS; Mascaro-Blanco, A; Alvarez, K; Morris-Berry, C; Kawikova, I; Ben-Pazi, H; Thompson, CB; Ali, SF; Kaplan, EL; Cunningham, MW				Singer, Harvey S.; Mascaro-Blanco, Adda; Alvarez, Kathy; Morris-Berry, Christina; Kawikova, Ivana; Ben-Pazi, Hilla; Thompson, Carol B.; Ali, Syed F.; Kaplan, Edward L.; Cunningham, Madeleine W.			Neuronal Antibody Biomarkers for Sydenham's Chorea Identify a New Group of Children with Chronic Recurrent Episodic Acute Exacerbations of Tic and Obsessive Compulsive Symptoms Following a Streptococcal Infection	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; TOURETTE SYNDROME; DIFFERENTIATE PANDAS; SERUM AUTOANTIBODIES; MOVEMENT; RECEPTOR; HYPOTHESIS; BEHAVIOR; TUBULIN; MIMICRY	Several autoantibodies (anti-dopamine 1 (D1R) and 2 (D2R) receptors, anti-tubulin, anti-lysoganglioside-GM1) and antibody-mediated activation of calcium calmodulin dependent protein kinase II (CaMKII) signaling activity are elevated in children with Sydenham's chorea (SC). Recognizing proposed clinical and autoimmune similarities between SC and PAN-DAS (pediatric autoimmune neuropsychiatric disorder associated with a streptococcal infection), we sought to identify serial biomarker changes in a slightly different population. Antineuronal antibodies were measured in eight children (mean 11.3 years) with chronic, dramatic, recurrent tics and obsessive-compulsive disorder (OCD) associated with a group A beta-hemolytic streptococcal (GABHS) respiratory tract infection, but differing because they lacked choreiform movements. Longitudinal serum samples in most subjects included two pre-exacerbation samples, Exac), one midst Exac (abrupt recurrence of tic/OCD; temporally association with a GABHS infection in six of eight subjects), and two post-Exac. Controls included four groups of unaffected children (n = 70; mean 10.8 years) obtained at four different institutions and published controls. Clinical exacerbations were not associated with a significant rise in antineuronal antibody titers. CaMKII activation was increased at the GABHS exacerbation point in 5/6 subjects, exceeded combined and published control's 95th percentile at least once in 7/8 subjects, and median values were elevated at each time point. Anti-tubulin and anti-D2R titers did not differ from published or combined control group's 95th percentile or median values. Differences in anti-lysoganglioside-GM1 and anti-D1R titers were dependent on the selected control. Variances in antibody titers and CaMKII activation were identified among the institutional control groups. Based on comparisons to published studies, results identify two groups of PANDAS: 1) a cohort, represented by this study, which lacks choreiform movements and elevated antibodies against D2R; 2) the originally reported group with choreiform movements and elevated anti-D2R antibodies, similar to SC. Increased antibody mediated CaMKII activation was found in both groups and requires further study as a potential biomarker.	[Singer, Harvey S.; Morris-Berry, Christina; Ali, Syed F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Singer, Harvey S.; Morris-Berry, Christina; Ali, Syed F.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Mascaro-Blanco, Adda; Alvarez, Kathy; Cunningham, Madeleine W.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol, Oklahoma City, OK USA; [Mascaro-Blanco, Adda; Alvarez, Kathy; Cunningham, Madeleine W.] Univ Oklahoma, Hlth Sci Ctr, Dept Immunol, Oklahoma City, OK USA; [Kawikova, Ivana] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Ben-Pazi, Hilla] Shaare Zedek Med Ctr, Neuropediat Unit, Jerusalem, Israel; [Thompson, Carol B.] Johns Hopkins Bloomberg Sch Publ Hlth, Biostat Ctr, Baltimore, MD USA; [Kaplan, Edward L.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA	Johns Hopkins University; Johns Hopkins University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Yale University; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities	Singer, HS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	hsinger@jhmi.edu	kawikova, ivana/GXG-1819-2022	Ali, Syed Faizan/0000-0002-0329-0635; benpazi, hilla/0000-0002-8039-4761	National Institutes of Health [HL35280]; Oklahoma Center for the Advancement of Science and Technology; National Center for Research Resources of the National Institutes of Health [UL1T000424]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes [UL1T000424]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035280, R37HL035280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS) of the National Institutes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support included funding from National Institutes of Health grant # HL35280 (MWC) and the Oklahoma Center for the Advancement of Science and Technology. Statistical support, in part, was from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health, Grant # UL1T000424. Molecular Labs provided support in the form of a portion of salaries for some authors [MWC, AMB, KA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Pazi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073516; Brilot F, 2011, NEUROLOGY, V76, P1508, DOI 10.1212/WNL.0b013e3182181090; Brimberg L, 2012, NEUROPSYCHOPHARMACOL, V37, P2076, DOI 10.1038/npp.2012.56; Cardoso F, 2011, SYDENHAMS CHOREA HDB, P221, DOI [10.1016/B978-0-444-52014-2.00014-8, DOI 10.1016/B978-0-444-52014-2.00014-8]; Church AJ, 2003, J NEUROL NEUROSUR PS, V74, P602, DOI 10.1136/jnnp.74.5.602; Cox CJ, 2013, J IMMUNOL, V191, P5524, DOI 10.4049/jimmunol.1102592; Dale RC, 2006, J NEUROIMMUNOL, V172, P187, DOI 10.1016/j.jneuroim.2005.10.014; Dale RC, 2012, BRAIN, V135, P3453, DOI 10.1093/brain/aws256; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Galvin JE, 2000, J CLIN INVEST, V106, P217, DOI 10.1172/JCI7132; Gause C, 2009, J NEUROIMMUNOL, V214, P118, DOI 10.1016/j.jneuroim.2009.06.015; Huerta PT, 2006, P NATL ACAD SCI USA, V103, P678, DOI 10.1073/pnas.0510055103; Johnson DR., 1996, LAB DIAGNOSIS GROUP; Johnson DR, 2010, CLIN INFECT DIS, V50, P481, DOI 10.1086/650167; Kaplan EL, 1998, PEDIATRICS, V101, P86, DOI 10.1542/peds.101.1.86; Kirvan CA, 2006, AUTOIMMUNITY, V39, P21, DOI 10.1080/08916930500484757; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; Kirvan CA, 2007, J IMMUNOL, V178, P7412, DOI 10.4049/jimmunol.178.11.7412; Kirvan CA, 2006, J NEUROIMMUNOL, V179, P173, DOI 10.1016/j.jneuroim.2006.06.017; Klug JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045323; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kurlan R, 1998, NEUROLOGY, V50, P1530, DOI 10.1212/WNL.50.6.1530; Kurlan R, 2004, PEDIATRICS, V113, P883, DOI 10.1542/peds.113.4.883; Kurlan R, 2004, MOVEMENT DISORD, V19, P371, DOI 10.1002/mds.20107; Kurlan R, 2008, PEDIATRICS, V121, P1188, DOI 10.1542/peds.2007-2657; Leckman JF, 2011, J AM ACAD CHILD PSY, V50, P108, DOI 10.1016/j.jaac.2010.10.011; Lin HQ, 2010, BIOL PSYCHIAT, V67, P684, DOI 10.1016/j.biopsych.2009.08.020; Lotan D, 2014, BRAIN BEHAV IMMUN, V38, P249, DOI 10.1016/j.bbi.2014.02.009; Luo F, 2004, PEDIATRICS, V113, pE578, DOI 10.1542/peds.113.6.e578; Macerollo A, 2013, TREMOR OTHER HYPERK, V3; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martino D, 2009, MOVEMENT DISORD, V24, P1267, DOI 10.1002/mds.22504; Mohammad SS, 2013, NEUROPEDIATRICS, V44, P336, DOI 10.1055/s-0033-1358603; Morris CM, 2009, J NEUROL SCI, V276, P45, DOI 10.1016/j.jns.2008.08.032; Morris-Berry CM, 2013, J NEUROIMMUNOL, V264, P106, DOI 10.1016/j.jneuroim.2013.09.010; Padmanabhan S, 2008, EUR J NEUROSCI, V28, P2017, DOI 10.1111/j.1460-9568.2008.06496.x; Pavone P, 2004, PEDIATR NEUROL, V30, P107, DOI 10.1016/S0887-8994(03)00413-2; Shet A, 2002, PEDIATR INFECT DIS J, V21, P420, DOI 10.1097/00006454-200205000-00014; Singer HS, 2008, PEDIATRICS, V121, P1198, DOI 10.1542/peds.2007-2658; Singer HS, 2012, J PEDIATR-US, V160, P725, DOI 10.1016/j.jpeds.2011.11.040; Singer Harvey S, 2011, Handb Clin Neurol, V100, P641, DOI 10.1016/B978-0-444-52014-2.00046-X; Singer HS, 2005, NEUROLOGY, V65, P1701, DOI 10.1212/01.wnl.0000183223.69946.f1; Singer HS, 2003, J PSYCHOSOM RES, V55, P31, DOI 10.1016/S0022-3999(02)00582-2; Spearman C, 1907, AM J PSYCHOL, V18, P161, DOI 10.2307/1412408; Swedo S., 2012, PEDIAT THERAPEUTICS, V2, P1, DOI [DOI 10.4172/2161-0665.1000113, 10.4172/2161-0665.1000113]; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; WAXHAM MN, 1993, BRAIN RES, V609, P1; Yaddanapudi K, 2010, MOL PSYCHIATR, V15, P712, DOI 10.1038/mp.2009.77; Zaccaro D, 2013, VACCINE, V31, P2756, DOI 10.1016/j.vaccine.2013.03.065	50	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120499	10.1371/journal.pone.0120499	http://dx.doi.org/10.1371/journal.pone.0120499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793715	gold, Green Submitted, Green Published			2022-12-26	WOS:000352083900043
J	Chen, LX; Ma, SM; Zhang, P; Fan, ZC; Xiong, M; Cheng, GQ; Yang, Y; Qiu, ZL; Zhou, WH; Li, J				Chen, Long-Xia; Ma, Si-Min; Zhang, Peng; Fan, Zi Chuan; Xiong, Man; Cheng, Guo-Qiang; Yang, Yi; Qiu, Zi-Long; Zhou, Wen-Hao; Li, Jin			Neuroprotective Effects of Oligodendrocyte Progenitor Cell Transplantation in Premature Rat Brain following Hypoxic-Ischemic Injury	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; PERIVENTRICULAR LEUKOMALACIA; CEREBRAL-ISCHEMIA; NEONATAL BRAIN; BDNF PROTECTS; MODEL; REMYELINATION; DEMYELINATION	Periventricular leukomalacia (PVL) is a common ischemic brain injury in premature infants for which there is no effective treatment. The objective of this study was to determine whether transplanted mouse oligodendrocyte progenitor cells (OPCs) have neuroprotective effects in a rat model of PVL. Hypoxia-ischemia (HI) was induced in 3-day-old rat pups by left carotid artery ligation, followed by exposure to 6% oxygen for 2.5 h. Animals were assigned to OPC transplantation or sham control groups and injected with OPCs or PBS, respectively, and sacrificed up to 6 weeks later for immunohistochemical analysis to investigate the survival and differentiation of transplanted OPCs. Apoptosis was evaluated by double immunolabeling of brain sections for caspase-3 and neuronal nuclei (NeuN), while proliferation was assessed using a combination of anti-Nestin and -bromodeoxyuridine antibodies. The expression of brain-derived neurotrophic factor (BDNF) and Bcl-2 was examined 7 days after OPC transplantation. The Morris water maze was used to test spatial learning and memory. The results showed that transplanted OPCs survived and formed a myelin sheath, and stimulated BDNF and Bcl-2 expression and the proliferation of neural stem cells (NSC), while inhibiting HI-induced neuronal apoptosis relative to control animals. Moreover, deficits in spatial learning and memory resulting from HI were improved by OPC transplantation. These results demonstrate an important neuroprotective role for OPCs that can potentially be exploited in cell-based therapeutic approaches to minimize HI-induced brain injury.	[Ma, Si-Min; Cheng, Guo-Qiang; Zhou, Wen-Hao] Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 201102, Peoples R China; [Chen, Long-Xia; Fan, Zi Chuan] Fudan Univ, Childrens Hosp, Key Lab Birth Defect, Shanghai 201102, Peoples R China; [Chen, Long-Xia; Ma, Si-Min; Zhang, Peng; Xiong, Man; Yang, Yi; Zhou, Wen-Hao] Fudan Univ, Childrens Hosp, Key Lab Neonatal Dis, Minist Hlth, Shanghai 201102, Peoples R China; [Qiu, Zi-Long] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Li, Jin] Fudan Univ, Inst Biomed Sci, Shanghai 201102, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Zhou, WH (corresponding author), Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 201102, Peoples R China.	zwhchfu@126.com; lijina_74@163.com	wenhao, zhou/AAA-1505-2020		National Natural Science Foundation of China [30901615]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NO. 30901615).	Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Bambakidis NC, 2004, SPINE J OFFICIAL J N, V4; Blumenthal I, 2004, EUR J PEDIATR, V163, P435, DOI 10.1007/s00431-004-1477-y; Borlongan CV, 2011, PEDIATR RES, V70, P3, DOI 10.1203/PDR.0b013e31821d0d00; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Chen CP, 2007, STEM CELL REV, V3, P280, DOI 10.1007/s12015-007-9006-9; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Du ZW, 2006, MOL CELL NEUROSCI, V33, P371, DOI 10.1016/j.mcn.2006.08.007; Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489; Fang CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066748; Franklin RJM, 1996, EXP NEUROL, V137, P263, DOI 10.1006/exnr.1996.0025; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Kondo Yoichi, 2009, V549, P175, DOI 10.1007/978-1-60327-931-4_12; Lee HD, 2010, EXP MECH, V50, P661, DOI 10.1007/s11340-009-9245-6; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mothe AJ, 2008, EXP NEUROL, V213, P176, DOI 10.1016/j.expneurol.2008.05.024; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Obenaus A, 2011, ANN NEUROL, V69, P282, DOI 10.1002/ana.22168; OLeary MT, 1997, J NEUROSCI RES, V48, P159, DOI 10.1002/(SICI)1097-4547(19970415)48:2<159::AID-JNR8>3.0.CO;2-B; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P351, DOI 10.1089/scd.2009.0049; Rosenkranz K, 2012, CELL TISSUE RES, V348, P429, DOI 10.1007/s00441-012-1401-0; SCHULTHEISS TE, 1995, INT J RADIAT ONCOL, V31, P1093, DOI 10.1016/0360-3016(94)00655-5; Seo JH, 2013, J CLIN INVEST, V123, P782, DOI 10.1172/JCI65863; Sheldon RA, 1996, BIOL NEONATE, V69, P327; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057534; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tirotta E, 2010, J NEUROIMMUNOL, V224, P101, DOI 10.1016/j.jneuroim.2010.05.013; Tuzun F, 2012, NEUROSCI LETT, V520, P6, DOI 10.1016/j.neulet.2012.04.076; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang XL, 2013, BRAIN RES, V1518, P26, DOI 10.1016/j.brainres.2013.04.038; Webber DJ, 2009, AM J PATHOL, V175, P2332, DOI 10.2353/ajpath.2009.090051; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Xia GZ, 2010, J PERINAT MED, V38, P215, DOI 10.1515/jpm.2010.021; Xiong M, 2008, NEUROBIOL DIS, V32, P433, DOI 10.1016/j.nbd.2008.08.007; Zhang P, 2009, ACTA ANAESTH SCAND, V53, P1184, DOI 10.1111/j.1399-6576.2009.02024.x; Zheng T, 2013, METHODS MOL BIOL, V1059, P147, DOI 10.1007/978-1-62703-574-3_13; Zhu LH, 2014, BRAIN RES	48	25	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0115997	10.1371/journal.pone.0115997	http://dx.doi.org/10.1371/journal.pone.0115997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790286	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400007
J	Manosalva, C; Mena, J; Velasquez, Z; Colenso, CK; Brauchi, S; Burgos, RA; Hidalgo, MA				Manosalva, Carolina; Mena, Jaqueline; Velasquez, Zahady; Colenso, Charlotte K.; Brauchi, Sebastian; Burgos, Rafael A.; Hidalgo, Maria A.			Cloning, Identification and Functional Characterization of Bovine Free Fatty Acid Receptor-1 (FFAR1/GPR40) in Neutrophils	PLOS ONE			English	Article							INTRACELLULAR CALCIUM MOBILIZATION; INSULIN-SECRETION; SUPEROXIDE-PRODUCTION; MAPK PHOSPHORYLATION; PHOSPHOLIPASE-C; GRANULE RELEASE; OLEIC-ACID; GPR40; ACTIVATION; AGONIST	Long chain fatty acids (LCFAs), which are ligands for the G-protein coupled receptor FFAR1 (GPR40), are increased in cow plasma after parturition, a period in which they are highly susceptible to infectious diseases. This study identified and analyzed the functional role of the FFAR1 receptor in bovine neutrophils, the first line of host defense against infectious agents. We cloned the putative FFAR1 receptor from bovine neutrophils and analyzed the sequence to construct a homology model. Our results revealed that the sequence of bovine FFAR1 shares 84% identity with human FFAR1 and 31% with human FFAR3/GPR41. Therefore, we constructed a homology model of bovine FFAR1 using human as the template. Expression of the bovine FFAR1 receptor in Chinese hamster ovary (CHO)-K1 cells increased the levels of intracellular calcium induced by the LCFAs, oleic acid (OA) and linoleic acid (LA); no increase in calcium mobilization was observed in the presence of the short chain fatty acid propionic acid. Additionally, the synthetic agonist GW9508 increased intracellular calcium in CHO-K1/bFFAR1 cells. OA and LA increased intracellular calcium in bovine neutrophils. Furthermore, GW1100 (antagonist of FFAR1) and U73122 (phospholipase C (PLC) inhibitor) reduced FFAR1 ligand-induced intracellular calcium in CHO-K1/bFFAR1 cells and neutrophils. Additionally, inhibition of FFAR1, PLC and PKC reduced the FFAR1 ligand-induced release of matrix metalloproteinase (MMP)-9 granules and reactive oxygen species (ROS) production. Thus, we identified the bovine FFAR1 receptor and demonstrate a functional role for this receptor in neutrophils activated with oleic or linoleic acid.	[Manosalva, Carolina; Mena, Jaqueline; Velasquez, Zahady; Burgos, Rafael A.; Hidalgo, Maria A.] Univ Austral Chile, Fac Vet Sci, Inst Pharmacol, Mol Pharmacol Lab, Valdivia, Chile; [Mena, Jaqueline] Univ Narino, Dept Biol, Pasto, Colombia; [Colenso, Charlotte K.; Brauchi, Sebastian] Univ Austral Chile, Fac Med, Inst Physiol, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Hidalgo, MA (corresponding author), Univ Austral Chile, Fac Vet Sci, Inst Pharmacol, Mol Pharmacol Lab, Valdivia, Chile.	mahidalgo@uach.cl	Brauchi, Sebastian E/A-2395-2008	Brauchi, Sebastian E/0000-0002-8494-9912; Mena Huertas, Sandra Jaqueline/0000-0002-3991-7671	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11100413]; Direccion de Investigacion y Desarrollo (DID)-UACH [S-2014-23]; scholarship Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [21100559, 24121495]; Mecesup Program [AUS1203]; scholarship Mecesup [AUS0704, DID-UACH D-201302]; FONDECYT [3140233]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion y Desarrollo (DID)-UACH; scholarship Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Mecesup Program; scholarship Mecesup; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by the following grants: Grant Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) No. 11100413 and Direccion de Investigacion y Desarrollo (DID)-UACH S-2014-23. CM is a Ph.D. student supported by scholarship Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) No. 21100559 and 24121495, and Mecesup Program AUS1203. JM is a Ph.D. student supported by scholarship Mecesup No. AUS0704 and DID-UACH D-201302. CKC is supported by Grant FONDECYT No. 3140233. MAH and SB Laboratories are part of CISNe-UACh, and SB Laboratory is part of the UACh Program in Cellular Dynamics and Microscopy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram A, 2011, ARCH IMMUNOL THER EX, V59, P79, DOI 10.1007/s00005-011-0112-7; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; BOYER JL, 1992, J BIOL CHEM, V267, P25451; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; Carretta MD, 2013, J DAIRY SCI, V96, P2507, DOI 10.3168/jds.2012-6111; Carrillo C, 2011, CELL PHYSIOL BIOCHEM, V28, P329, DOI 10.1159/000331749; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Conejeros I, 2012, RES VET SCI, V92, P103, DOI 10.1016/j.rvsc.2010.10.005; Contreras GA, 2010, J DAIRY SCI, V93, P2508, DOI 10.3168/jds.2009-2876; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; De Lima TM, 2007, CLIN SCI, V113, P65, DOI 10.1042/CS20070006; Doupnik CA, 2004, METHOD ENZYMOL, V389, P131; Ehrenfeld P, 2009, J LEUKOCYTE BIOL, V86, P1179, DOI 10.1189/jlb.0109012; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; Graciano MF, 2013, ISLETS, V5, P139, DOI 10.4161/isl.25459; Graciano MFR, 2011, J CELL PHYSIOL, V226, P1110, DOI 10.1002/jcp.22432; Hardy S, 2005, J BIOL CHEM, V280, P13285, DOI 10.1074/jbc.M410922200; HARDY SJ, 1994, J NEUROCHEM, V62, P1546; Harfi I, 2004, J IMMUNOL, V173, P4154, DOI 10.4049/jimmunol.173.6.4154; Hatanaka E, 2006, FREE RADICAL BIO MED, V41, P1124, DOI 10.1016/j.freeradbiomed.2006.06.014; Hidalgo MA, 2004, BRIT J PHARMACOL, V141, P311, DOI 10.1038/sj.bjp.0705590; Hidalgo MA, 2011, BIOCHEM BIOPH RES CO, V409, P280, DOI 10.1016/j.bbrc.2011.04.144; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Lacetera N, 2004, J DAIRY SCI, V87, P1012, DOI 10.3168/jds.S0022-0302(04)73246-4; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li XM, 1999, VET IMMUNOL IMMUNOP, V67, P247, DOI 10.1016/S0165-2427(98)00228-1; Mena J, 2013, VET IMMUNOL IMMUNOP, V151, P275, DOI 10.1016/j.vetimm.2012.11.017; Morgan NG, 2009, BIOCHEM PHARMACOL, V78, P1419, DOI 10.1016/j.bcp.2009.07.020; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ou HY, 2013, AM J PHYSIOL-ENDOC M, V304, pE668, DOI 10.1152/ajpendo.00419.2012; PARK DG, 1993, J BIOL CHEM, V268, P4573; Scalia D, 2006, J DAIRY SCI, V89, P147, DOI 10.3168/jds.S0022-0302(06)72078-1; Siemsen DW, 2014, METHODS MOL BIOL, V1124, P19, DOI 10.1007/978-1-62703-845-4_3; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soto-Guzman A, 2010, CLIN EXP METASTAS, V27, P505, DOI 10.1007/s10585-010-9340-1; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Suh HN, 2008, AM J PHYSIOL-CELL PH, V295, pC1518, DOI 10.1152/ajpcell.00368.2008; Wauquier F, 2013, J BIOL CHEM, V288, P6542, DOI 10.1074/jbc.M112.429084; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yaqoob P, 2007, BRIT J NUTR, V98, pS41, DOI 10.1017/S0007114507832995; Yonezawa T, 2004, BIOCHEM BIOPH RES CO, V314, P805, DOI 10.1016/j.bbrc.2003.12.175; Yonezawa T, 2008, BIOCHEM BIOPH RES CO, V367, P729, DOI 10.1016/j.bbrc.2007.12.190	50	21	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119715	10.1371/journal.pone.0119715	http://dx.doi.org/10.1371/journal.pone.0119715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790461	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400099
J	Pacholewska, A; Drogemuller, M; Klukowska-Rotzler, J; Lanz, S; Hamza, E; Dermitzakis, ET; Marti, E; Gerber, V; Leeb, T; Jagannathan, V				Pacholewska, Alicja; Droegemueller, Michaela; Klukowska-Roetzler, Jolanta; Lanz, Simone; Hamza, Eman; Dermitzakis, Emmanouil T.; Marti, Eliane; Gerber, Vincent; Leeb, Tosso; Jagannathan, Vidhya			The Transcriptome of Equine Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							RNA-SEQ; SEQUENCE; EXPRESSION; GENE; HORSES; ANNOTATION; GENERATION; ALIGNMENT; GENOMES; HEAVES	Complete transcriptomic data at high resolution are available only for a few model organisms with medical importance. The gene structures of non-model organisms are mostly computationally predicted based on comparative genomics with other species. As a result, more than half of the horse gene models are known only by projection. Experimental data supporting these gene models are scarce. Moreover, most of the annotated equine genes are single-transcript genes. Utilizing RNA sequencing (RNA-seq) the experimental validation of predicted transcriptomes has become accessible at reasonable costs. To improve the horse genome annotation we performed RNA-seq on 561 samples of peripheral blood mononuclear cells (PBMCs) derived from 85 Warmblood horses. The mapped sequencing reads were used to build a new transcriptome assembly. The new assembly revealed many alternative isoforms associated to known genes or to those predicted by the Ensembl and/or Gnomon pipelines. We also identified 7,531 transcripts not associated with any horse gene annotated in public databases. Of these, 3,280 transcripts did not have a homologous match to any sequence deposited in the NCBI EST database suggesting horse specificity. The unknown transcripts were categorized as coding and noncoding based on predicted coding potential scores. Among them 230 transcripts had high coding potential score, at least 2 exons, and an open reading frame of at least 300 nt. We experimentally validated 9 new equine coding transcripts using RT-PCR and Sanger sequencing. Our results provide valuable detailed information on many transcripts yet to be annotated in the horse genome.	[Pacholewska, Alicja; Klukowska-Roetzler, Jolanta; Lanz, Simone; Gerber, Vincent] Univ Bern & Agroscope, Vetsuisse Fac, Swiss Inst Equine Med, Bern, Switzerland; [Pacholewska, Alicja; Droegemueller, Michaela; Klukowska-Roetzler, Jolanta; Leeb, Tosso; Jagannathan, Vidhya] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Klukowska-Roetzler, Jolanta] Univ Hosp Bern, Dept Pediat, Div Pediat Hematol Oncol, CH-3010 Bern, Switzerland; [Hamza, Eman; Marti, Eliane] Univ Bern, Dept Clin Res & Vet Publ Hlth, Clin Immunol Grp, Bern, Switzerland; [Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, Inst Genet & Genom Geneva, Geneva, Switzerland	Swiss Federal Research Station Agroscope; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Geneva; Swiss Institute of Bioinformatics	Pacholewska, A (corresponding author), Univ Bern & Agroscope, Vetsuisse Fac, Swiss Inst Equine Med, Bern, Switzerland.	alicja.pacholewska@vetsuisse.unibe.ch	Pacholewska, Alicja/A-3267-2015; Leeb, Tosso/G-3187-2014; Jagannathan, Vidhya/P-1055-2019	Pacholewska, Alicja/0000-0002-4888-4883; Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Hamza, Eman/0000-0001-9798-842X	Swiss National Science Foundation [310030-138295, 310000-116803/1]; Swiss Institute of Equine Medicine Research	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Institute of Equine Medicine Research	The presented study was funded by Swiss National Science Foundation (www.snf.ch): grant No. 310030-138295 and 310000-116803/1; and Swiss Institute of Equine Medicine Research (ismequine.ch). VG and EM have received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bellone RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078280; Bryant CE, 2007, VET IMMUNOL IMMUNOP, V116, P182, DOI 10.1016/j.vetimm.2007.01.013; Capomaccio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083504; Coleman SJ, 2010, ANIM GENET, V41, P121, DOI 10.1111/j.1365-2052.2010.02118.x; Coleman SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070125; CROWTHER D, 1969, J EXP MED, V129, P849, DOI 10.1084/jem.129.5.849; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Das PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056535; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamza E, 2007, INT ARCH ALLERGY IMM, V144, P325, DOI 10.1159/000106459; Iqbal K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113928; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lanz S, 2013, VET IMMUNOL IMMUNOP, V155, P229, DOI 10.1016/j.vetimm.2013.07.005; Lavoie JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029440; Leclere M, 2011, RESPIROLOGY, V16, P1027, DOI 10.1111/j.1440-1843.2011.02033.x; Leise B.S., 2014, EQUINE VET J; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MAGNO M, 1990, EUR RESPIR J, V3, pS557; Magno M, 1990, EUR RESPIR J, V12, p562S; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; McGivney BA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-398; MCLAUGHLIN RF, 1983, AM REV RESPIR DIS, V128, pS57; McWilliam HEG, 2010, INT J PARASITOL, V40, P265, DOI 10.1016/j.ijpara.2009.08.004; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Moreton J, 2014, PEERJ, V2, DOI 10.7717/peerj.382; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-473; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pirie RS, 2002, EQUINE VET J, V34, P332, DOI 10.2746/042516402776249092; Pruitt K., 2002, NCBI HDB, P1; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Schulz MH, BIOINFORMATICS; Serteyn D, 2010, J ORTHOP RES, V28, P965, DOI 10.1002/jor.21089; Souvorov A., 2010, GNOMON NCBI EUKARYOT, P1; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weikard R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-789; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xie Y., 2014, BIOINFORMATICS; Zhang ZF, 2013, GENOME MED, V5, DOI 10.1186/gm437	53	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122011	10.1371/journal.pone.0122011	http://dx.doi.org/10.1371/journal.pone.0122011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790166	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400206
J	Peeters, SCT; van de Ven, V; Gronenschild, EHBM; Patel, AX; Habets, P; Goebel, R; van Os, J; Marcelis, M				Peeters, Sanne C. T.; van de Ven, Vincent; Gronenschild, Ed H. B. M.; Patel, Ameera X.; Habets, Petra; Goebel, Rainer; van Os, Jim; Marcelis, Machteld		Genetic Risk Outcome Phychosis	Default Mode Network Connectivity as a Function of Familial and Environmental Risk for Psychotic Disorder	PLOS ONE			English	Article							NEGATIVE-SYNDROME-SCALE; RESTING-STATE NETWORKS; SPECTRUM DISORDER; SOCIAL COGNITION; SCHIZOPHRENIA; BRAIN; FMRI; STRESS; SELF; ACTIVATION	Background Research suggests that altered interregional connectivity in specific networks, such as the default mode network (DMN), is associated with cognitive and psychotic symptoms in schizophrenia. In addition, frontal and limbic connectivity alterations have been associated with trauma, drug use and urban upbringing, though these environmental exposures have never been examined in relation to DMN functional connectivity in psychotic disorder. Methods Resting-state functional MRI scans were obtained from 73 patients with psychotic disorder, 83 non-psychotic siblings of patients with psychotic disorder and 72 healthy controls. Posterior cingulate cortex (PCC) seed-based correlation analysis was used to estimate functional connectivity within the DMN. DMN functional connectivity was examined in relation to group (familial risk), group x environmental exposure (to cannabis, developmental trauma and urbanicity) and symptomatology. Results There was a significant association between group and PCC connectivity with the inferior parietal lobule (IPL), the precuneus (PCu) and the medial prefrontal cortex (MPFC). Compared to controls, patients and siblings had increased PCC connectivity with the IPL, PCu and MPFC. In the IPL and PCu, the functional connectivity of siblings was intermediate to that of controls and patients. No significant associations were found between DMN connectivity and (subclinical) psychotic/cognitive symptoms. In addition, there were no significant interactions between group and environmental exposures in the model of PCC functional connectivity. Discussion Increased functional connectivity in individuals with (increased risk for) psychotic disorder may reflect trait-related network alterations. The within-network "connectivity at rest" intermediate phenotype was not associated with (subclinical) psychotic or cognitive symptoms. The association between familial risk and DMN connectivity was not conditional on environmental exposure.	[Peeters, Sanne C. T.; Gronenschild, Ed H. B. M.; Habets, Petra; van Os, Jim; Marcelis, Machteld] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol,EURON, NL-6200 MD Maastricht, Netherlands; [van de Ven, Vincent; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; [Patel, Ameera X.] Univ Cambridge, Dept Psychiat, Behav & Clin Neurosci Inst, Cambridge, England; [van Os, Jim] Univ London, Kings Coll London, Inst Psychiat, Kings Hlth Partners,Dept Psychosis, London SW3 6LX, England; [Marcelis, Machteld] Inst Mental Hlth Care Eindhoven GGzE, Eindhoven, Netherlands	Maastricht University; Maastricht University; University of Cambridge; University of London; King's College London	Marcelis, M (corresponding author), Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol,EURON, NL-6200 MD Maastricht, Netherlands.	M.Marcelis@maastrichtuniversity.nl	van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Lang, Steven/AAE-8102-2021; Myin-Germeys, Inez/L-5106-2014; van Os, Jim/V-8884-2019; van de Ven, Vincent/D-3003-2009; Peeters, Sanne/AAA-9523-2021; Habets, Petra/AAZ-1258-2021	Lang, Steven/0000-0003-1669-9146; van Os, Jim/0000-0002-7245-1586; van de Ven, Vincent/0000-0001-8735-3711; Habets, Petra/0000-0001-9184-517X; Bruggeman, Richard/0000-0002-3238-8471; Marcelis, Machteld/0000-0003-0045-9244; Patel, Ameera/0000-0002-4157-2705; Goebel, Rainer/0000-0003-1780-2467; Myin-Germeys, Inez/0000-0002-3731-4930; Peeters, Sanne/0000-0002-3004-4261	Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]); European Community's Seventh Framework Programme [HEALTH-F2-2009-241909]	Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.])(Netherlands Organization for Scientific Research (NWO)); European Community's Seventh Framework Programme	This work was sponsored by the Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]) and the European Community's Seventh Framework Programme under Grant Agreement No. HEALTH-F2-2009-241909 (European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Anticevic A, 2013, SCHIZOPHRENIA BULL, V39, P168, DOI 10.1093/schbul/sbr107; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Beer JS, 2007, TRENDS COGN SCI, V11, P187, DOI 10.1016/j.tics.2007.02.004; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Central Bureau of Statistics, 1993, BEV GEM NED; Chang X, 2014, BRAIN RES, V1562, P87, DOI 10.1016/j.brainres.2014.03.024; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Ding X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059331; Dodell-Feder D, 2014, SCHIZOPHR RES, V156, P87, DOI 10.1016/j.schres.2014.03.031; Duncan NW, 2013, J PSYCHIATR NEUROSCI, V38, P84, DOI 10.1503/jpn.120059; Esposito F, 2009, ARCH ITAL BIOL, V147, P11; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Geoffroy Pierre Alexis, 2013, Front Psychiatry, V4, P136, DOI 10.3389/fpsyt.2013.00136; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P670, DOI 10.1093/schbul/sbn045; Guo WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091102; Guo WB, 2014, EUR NEUROPSYCHOPHARM, V24, P545, DOI 10.1016/j.euroneuro.2014.01.004; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hills, 1993, STAT MODELS EPIDEMIO; Jang JH, 2011, SCHIZOPHR RES, V127, P58, DOI 10.1016/j.schres.2010.12.022; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jo HJ, 2013, J APPL MATH, DOI 10.1155/2013/935154; Karbasforoushan H, 2012, CURR TOP MED CHEM, V12, P2404, DOI 10.2174/156802612805289863; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Khadka S, 2013, BIOL PSYCHIAT, V74, P458, DOI 10.1016/j.biopsych.2013.04.024; Kindler J, 2013, SCHIZOPHR B; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lindner M, 2008, NEUROIMAGE, V40, P963, DOI 10.1016/j.neuroimage.2007.12.022; Liu HH, 2012, SCHIZOPHRENIA BULL, V38, P285, DOI 10.1093/schbul/sbq074; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Meda SA, 2014, P NATL ACAD SCI USA, V111, pE2066, DOI 10.1073/pnas.1313093111; Metzak PD, 2012, SCHIZOPHRENIA BULL, V38, P803, DOI 10.1093/schbul/sbq154; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Orliac F, 2013, SCHIZOPHR RES, V148, P74, DOI 10.1016/j.schres.2013.05.007; Patel AX, 2014, NEUROIMAGE, V95, P287, DOI 10.1016/j.neuroimage.2014.03.012; Pujol J, 2014, J PSYCHIATR RES, V51, P68, DOI 10.1016/j.jpsychires.2013.12.008; Repovs G, 2011, BIOL PSYCHIAT, V69, P967, DOI 10.1016/j.biopsych.2010.11.009; Roberts GMP, 2010, NEUROIMAGE, V52, P429, DOI 10.1016/j.neuroimage.2010.04.192; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schlosser R, 2003, NEUROIMAGE, V19, P751, DOI 10.1016/S1053-8119(03)00106-X; Schurhoff F, 2003, AM J PSYCHIAT, V160, P1313, DOI 10.1176/appi.ajp.160.7.1313; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shim G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-58; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sinha R, 2004, ANN NY ACAD SCI, V1032, P254, DOI 10.1196/annals.1314.032; Sripada RK, 2014, NEUROPSYCHOPHARMACOL, V39, P2244, DOI 10.1038/npp.2014.75; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stephan KE, 2001, PSYCHOL MED, V31, P1065, DOI 10.1017/S0033291701004330; Tang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071061; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; Tomasi D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010815; van Buuren M, 2012, SCHIZOPHR RES, V142, P237, DOI 10.1016/j.schres.2012.09.017; van de Ven V., 2012, NEUROSCIENCE HALLUCI, P393; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Volkow ND, 2008, PSYCHIAT RES-NEUROIM, V162, P205, DOI 10.1016/j.pscychresns.2007.04.010; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482; Wechsler D., 1997, WECHSLER ADULT INTEL; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Wible CG, 2009, BRAIN IMAGING BEHAV, V3, P85, DOI 10.1007/s11682-008-9052-1; Williamson PC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00184; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; World Health Organization, 1990, COMP INT DIAGN INT C; Wotruba D., 2013, SCHIZOPHR B	93	24	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120030	10.1371/journal.pone.0120030	http://dx.doi.org/10.1371/journal.pone.0120030			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25790002	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400124
J	Wang, XY; Liu, CL; Li, SD; Xu, Y; Chen, P; Liu, Y; Ding, Q; Wahafu, W; Hong, BF; Yang, MH				Wang, XiYou; Liu, CuiLong; Li, ShaoDan; Xu, Yong; Chen, Ping; Liu, Yi; Ding, Qiang; Wahafu, Wasilijiang; Hong, BaoFa; Yang, MingHui			Hypoxia Precondition Promotes Adipose-Derived Mesenchymal Stem Cells Based Repair of Diabetic Erectile Dysfunction via Augmenting Angiogenesis and Neuroprotection	PLOS ONE			English	Article							MARROW STROMAL CELLS; ISCHEMIC RAT-BRAIN; BONE-MARROW; IN-VITRO; INFARCTED MYOCARDIUM; GENE-THERAPY; TRANSPLANTATION; SURVIVAL; DIFFERENTIATION; IMPROVES	The aim of the present study was to examine whether hypoxia preconditioning could improve therapeutic effects of adipose derived mesenchymal stem cells (AMSCs) for diabetes induced erectile dysfunction (DED). AMSCs were pretreated with normoxia (20% O-2, N-AMSCs) or sub-lethal hypoxia (1% O-2, H-AMSCs). The hypoxia exposure up-regulated the expression of several angiogenesis and neuroprotection related cytokines in AMSCs, including vascular endothelial growth factor (VEGF) and its receptor FIK-1, angiotensin (Ang-1), basic fibroblast growth factor (bFGF), brain-derived neurotrophic factor (BDNF), glial cell-derived neurotrophic factor (GDNF), stromal derived factor-1 (SDF-1) and its CXC chemokine receptor 4 (CXCR4). DED rats were induced via intraperitoneal injection of streptozotocin (60 mg/kg) and were randomly divided into three groups-Saline group: intracavernous injection with phosphate buffer saline; N-AMSCs group: N-AMSCs injection; H-AMSCs group: H-AMSCs injection. Ten rats without any treatment were used as normal control. Four weeks after injection, the mean arterial pressure (MAP) and intracavernosal pressure (ICP) were measured. The contents of endothelial, smooth muscle, dorsal nerve in cavernoursal tissue were assessed. Compared with N-AMSCs and saline, intracavernosum injection of H-AMSCs significantly raised ICP and ICP/MAP (p<0.05). Immunofluorescent staining analysis demonstrated that improved erectile function by MSCs was significantly associated with increased expression of endothelial markers (CD31 and vWF) (p<0.01) and smooth muscle markers (alpha-SMA) (p<0.01). Meanwhile, the expression of nNOS was also significantly higher in rats receiving H-AMSCs injection than those receiving N-AMSCs or saline injection. The results suggested that hypoxic preconditioning of MSCs was an effective approach to enhance their therapeutic effect for DED, which may be due to their augmented angiogenesis and neuroprotection.	[Wang, XiYou; Li, ShaoDan; Liu, Yi; Yang, MingHui] Chinese Peoples Liberat Army Gen Hosp, Dept Tradit Chinese Med, Beijing 100853, Peoples R China; [Liu, CuiLong] PLA Navy Gen Hosp, Dept Urol, Beijing 100048, Peoples R China; [Xu, Yong; Chen, Ping; Ding, Qiang; Wahafu, Wasilijiang; Hong, BaoFa] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Sixth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital	Yang, MH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Tradit Chinese Med, 28 Fuxing Rd, Beijing 100853, Peoples R China.	yangminghuipla@126.com			China postdoctoral science foundation [2013M532197]	China postdoctoral science foundation(China Postdoctoral Science Foundation)	The work was supported by China postdoctoral science foundation (2013M532197). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Aytac IA, 1999, BJU INT, V84, P50; Bivalacqua TJ, 2005, J SEX MED, V2, P187, DOI 10.1111/j.1743-6109.2005.20228_1.x; Bivalacqua TJ, 2007, AM J PHYSIOL-HEART C, V292, pH1278, DOI 10.1152/ajpheart.00685.2006; Brant WO, 2007, ENDOCRIN METAB CLIN, V36, P465, DOI 10.1016/j.ecl.2007.02.001; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chang W, 2013, J VET SCI, V14, P69, DOI 10.4142/jvs.2013.14.1.69; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; de Tejada IS, 2005, J SEX MED, V2, P26, DOI 10.1111/j.1743-6109.2005.20103.x; Drela K, 2014, CYTOTHERAPY; Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Fall PA, 2009, EUR UROL, V56, P716, DOI 10.1016/j.eururo.2008.09.059; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Gao XD, 2014, MOL CELL ENDOCRINOL, V388, P41, DOI 10.1016/j.mce.2014.03.004; HEATON JPW, 1991, J UROLOGY, V145, P1099, DOI 10.1016/S0022-5347(17)38543-9; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang YP, 2011, J SEX MED, V8, P840, DOI 10.1111/j.1743-6109.2010.02141.x; Kim Ju-Yeon, 2012, World J Stem Cells, V4, P110, DOI 10.4252/wjsc.v4.i11.110; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lee RH, 2011, J CELL BIOCHEM, V112, P3073, DOI 10.1002/jcb.23250; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Li TS, 2002, AM J PHYSIOL-HEART C, V283, pH468, DOI 10.1152/ajpheart.00261.2002; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Lin CS, 2008, ASIAN J ANDROL, V10, P171, DOI 10.1111/j.1745-7262.2008.00389.x; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Liu LQ, 2013, CELL BIOL INT, V37, P551, DOI 10.1002/cbin.10097; Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044; Long T, 2012, J SEX MED, V9, P1801, DOI 10.1111/j.1743-6109.2012.02739.x; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; Malgieri A, 2010, INT J CLIN EXP MED, V3, P248; MCCULLOCH DK, 1980, DIABETOLOGIA, V18, P279; Morizono K, 2003, HUM GENE THER, V14, P59, DOI 10.1089/10430340360464714; Ni L, 2014, SPINE J; Park JH, 2012, DIABETES RES CLIN PR, V98, P465, DOI 10.1016/j.diabres.2012.09.034; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Portalska KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046842; Qiu XF, 2012, J SEX MED, V9, P1834, DOI 10.1111/j.1743-6109.2012.02753.x; Qiu XF, 2011, J ANDROL, V33, P37, DOI 10.2164/jandrol.110.012666; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; Saigal CS, 2006, ARCH INTERN MED, V166, P207, DOI 10.1001/archinte.166.2.207; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Stuckey BGA, 2003, DIABETES CARE, V26, P279, DOI 10.2337/diacare.26.2.279; Sun DC, 2014, J CELL MOL MED, V18, P434, DOI 10.1111/jcmm.12157; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Thorve VS, 2011, J DIABETES COMPLICAT, V25, P129, DOI 10.1016/j.jdiacomp.2010.03.003; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Yang R, 2009, J SEX MED, V6, P696, DOI 10.1111/j.1743-6109.2008.01054.x; Young A, 2010, J NEUROSCI RES, V88, P3222, DOI 10.1002/jnr.22499; Zhang ZC, 2014, CHINESE MED J-PEKING, V127, P314, DOI 10.3760/cma.j.issn.0366-6999.20130584	57	56	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118951	10.1371/journal.pone.0118951	http://dx.doi.org/10.1371/journal.pone.0118951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790284	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400057
J	Zefferman, EP				Zefferman, Emily P.			Experimental Tests of Priority Effects and Light Availability on Relative Performance of Myriophyllum spicatum and Elodea nuttallii Propagules in Artificial Stream Channels	PLOS ONE			English	Article							FRESH-WATER MACROPHYTES; EURASIAN WATERMILFOIL; HYDRILLA-VERTICILLATA; COMPETITION; INVASION; GROWTH; SUCCESS; REHABILITATION; ESTABLISHMENT; ECOSYSTEMS	Submersed macrophytes have important ecological functions in many streams, but fostering growth of beneficial native species while suppressing weedy invasives may be challenging. Two approaches commonly used in management of terrestrial plant communities may be useful in this context: (1) altering resource availability and (2) establishing desirable species before weeds can invade (priority effects). However, these approaches are rarely used in aquatic systems, despite widespread need for sustainable solutions to aquatic weed problems. In artificial stream channels in California, USA, I conducted experiments with asexual propagules of non-native invasive Myriophyllum spicatum (Eurasian watermilfoil) and native Elodea nuttallii (western waterweed) to address the questions: (1) How does light availability affect relative performance of the two species?; (2) Does planting the native earlier than the invasive decrease survival or growth rate of the invasive?; and (3) Do light level and priority effects interact? The relative performance between E. nuttallii and M. spicatum had an interesting and unexpected pattern: M. spicatum had higher growth rates than E. nuttallii in the zero and medium shade levels, but had similar performance in the low and high shade levels. This pattern is most likely the result of E. nutallii's sensitivity to both very low and very high light, and M. spicatum's sensitivity to very low light only. Native priority did not significantly affect growth rate or survival of M. spicatum, possibly because of unexpectedly poor growth of the E. nuttallii planted early. This study suggests that altering light levels could be effective in reducing growth of an invasive macrophyte, and for changing the competitive balance between a native and a non-native species in the establishment phase. Further investigations into the use of priority effects and resource alteration for submersed macrophyte management are warranted, given their mixed results in other (limited) studies.	[Zefferman, Emily P.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Zefferman, Emily P.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Zefferman, EP (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	epeffer@ucdavis.edu			University of California Davis Plant Sciences Graduate Fellowship; Henry A. Jastro Research Fellowship; Ben A. Madson Scholarship	University of California Davis Plant Sciences Graduate Fellowship; Henry A. Jastro Research Fellowship; Ben A. Madson Scholarship	Research funding and personal support were provided by the University of California Davis Plant Sciences Graduate Fellowship, the Henry A. Jastro Research Fellowship, and the Ben A. Madson Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN SG, 1979, CAN J PLANT SCI, V59, P201, DOI 10.4141/cjps79-028; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Anderson L., 2011, ENCY BIOL INVASIONS, P248; Angelstein S, 2009, FUND APPL LIMNOL, V175, P49, DOI 10.1127/1863-9135/2009/0175-0049; Angelstein S, 2009, PLANT ECOL, V202, P91, DOI 10.1007/s11258-008-9500-4; BARKO JW, 1982, CAN J BOT, V60, P877, DOI 10.1139/b82-113; Boylen CW, 1999, HYDROBIOLOGIA, V415, P207, DOI 10.1023/A:1003804612998; CANFIELD DE, 1988, CAN J FISH AQUAT SCI, V45, P1467, DOI 10.1139/f88-171; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; Chadwell TB, 2008, J APPL ECOL, V45, P515, DOI 10.1111/j.1365-2664.2007.01384.x; Cheruvelil KS, 2001, J AQUAT PLANT MANAGE, V39, P67; Daehler CC, 2003, ANNU REV ECOL EVOL S, P83; DAWSON FH, 1979, INT REV GES HYDROBIO, V64, P437, DOI 10.1002/iroh.19790640402; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Funk JL, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot026; Hussner A, 2010, AQUAT BOT, V93, P17, DOI 10.1016/j.aquabot.2010.02.003; Kardol P, 2013, OIKOS, V122, P84, DOI 10.1111/j.1600-0706.2012.20546.x; KEAST A, 1984, CAN J ZOOL, V62, P1289, DOI 10.1139/z84-186; Lacoul P, 2006, ENVIRON REV, V14, P89, DOI 10.1139/a06-001; Larned ST, 2006, RESTOR ECOL, V14, P429, DOI 10.1111/j.1526-100X.2006.00151.x; MADSEN JD, 1991, J AQUAT PLANT MANAGE, V29, P94; Mjelde M, 2012, ANN LIMNOL-INT J LIM, V48, P225, DOI 10.1051/limn/2012016; Mony C, 2007, AQUAT BOT, V86, P236, DOI 10.1016/j.aquabot.2006.11.007; Moore JE, 2012, J VEG SCI, V23, P647, DOI 10.1111/j.1654-1103.2012.01388.x; NEWMAN RM, 1991, J N AM BENTHOL SOC, V10, P89, DOI 10.2307/1467571; Northwest Hydraulic Consultants, 2008, SPEC ID SEAS BIOM FL; Peffer E., 2013, AQUATIC VEGETATION A; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Reinhart KO, 2006, ECOL APPL, V16, P1821, DOI 10.1890/1051-0761(2006)016[1821:ITQEIS]2.0.CO;2; Rejmankova Eliska, 2011, Journal of Ecology and Field Biology, V34, P333, DOI 10.5141/JEFB.2011.044; Riis T, 2009, AQUAT ECOL, V43, P935, DOI 10.1007/s10452-008-9213-8; SANDJENSEN K, 1991, J ECOL, V79, P749, DOI 10.2307/2260665; Schultz R, HYDROBIOLOGIA, V684, P1; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; SMITH CS, 1990, J AQUAT PLANT MANAGE, V28, P55; Su Wen-Hua, 2004, Acta Hydrobiologica Sinica, V28, P391; Suren AM, 2009, RESTOR ECOL, V17, P873, DOI 10.1111/j.1526-100X.2008.00446.x; Tukey JW, 1962, ANN MATH STAT, V33, P17; Van TK, 1999, AQUAT BOT, V62, P225, DOI 10.1016/S0304-3770(98)00100-4; Vaughn KJ, ECOL APPL IN PRESS; Weaver MJ, 1997, CAN J FISH AQUAT SCI, V54, P2277, DOI 10.1139/cjfas-54-10-2277; Wilson SJ, 2009, CAN J FISH AQUAT SCI, V66, P18, DOI 10.1139/F08-187; Young TP, 2001, ECOL RESTOR, V19, P5, DOI [10.3368/er.19.1.5, DOI 10.3368/ER.19.1.5]; Zefferman E, 2014, HYDROBIOLOGIA, V734, P159, DOI 10.1007/s10750-014-1877-6	45	8	8	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120248	10.1371/journal.pone.0120248	http://dx.doi.org/10.1371/journal.pone.0120248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790180	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400146
J	Zhang, YR; Hu, G; Zhang, L; Mayo, R; Chen, LW				Zhang, Yurong; Hu, Gang; Zhang, Lu; Mayo, Rachel; Chen, Liwei			A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; RISK SCORE; GLYCATED HEMOGLOBIN; PLASMA-GLUCOSE; TYPE-2; MELLITUS; HBA(1C); POPULATION; PREVALENCE; NIDDM	Objective The study aim was to evaluate the performance of a novel simultaneous testing model, based on the Finnish Diabetes Risk Score (FINDRISC) and HbA1c, in detecting undiagnosed diabetes and pre-diabetes in Americans. Research Design and Methods This cross-sectional analysis included 3,886 men and women (>= 20 years) without known diabetes from the U.S. National Health and Nutrition Examination Survey (NHANES) 2005-2010. The FINDRISC was developed based on eight variables (age, BMI, waist circumference, use of antihypertensive drug, history of high blood glucose, family history of diabetes, daily physical activity and fruit & vegetable intake). The sensitivity, specificity, and the receiver operating characteristic (ROC) curve of the testing model were calculated for undiagnosed diabetes and pre-diabetes, determined by oral glucose tolerance test (OGTT). Results The prevalence of undiagnosed diabetes was 7.0% and 43.1% for pre-diabetes (27.7% for isolated impaired fasting glucose (IFG), 5.1% for impaired glucose tolerance (IGT), and 10.3% for having both IFG and IGT). The sensitivity and specificity of using the HbA1c alone was 24.2% and 99.6% for diabetes (cutoff of >= 6.5%), and 35.2% and 86.4% for prediabetes (cutoff of >= 5.7%). The sensitivity and specificity of using the FINDRISC alone (cutoff of >= 9) was 79.1% and 48.6% for diabetes and 60.2% and 61.4% for pre-diabetes. Using the simultaneous testing model with a combination of FINDRISC and HbA1c improved the sensitivity to 84.2% for diabetes and 74.2% for pre-diabetes. The specificity for the simultaneous testing model was 48.4% of diabetes and 53.0% for pre-diabetes. Conclusions This simultaneous testing model is a practical and valid tool in diabetes screening in the general U.S. population.	[Zhang, Yurong] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Xian 710049, Shaanxi, Peoples R China; [Hu, Gang] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Zhang, Lu] Louisiana State Univ, Program Epidemiol, Sch Publ Hlth, Hlth Sci Ctr, New Orleans, LA USA; [Mayo, Rachel; Chen, Liwei] Clemson Univ, Dept Publ Hlth Sci, Clemson, SC 29634 USA	Xi'an Jiaotong University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Clemson University	Chen, LW (corresponding author), Clemson Univ, Dept Publ Hlth Sci, Clemson, SC 29634 USA.	liweic@clemson.edu	Hu, Gang/V-7947-2019; Hu, Gang/N-1971-2017	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017	Clemson University (US); Natural Science Foundation of Shaanxi Province [2014JM4107]; Basic Research Foundation of Xi'an Jiaotong University [08143002]	Clemson University (US); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Basic Research Foundation of Xi'an Jiaotong University	This work was partially supported by Clemson University (US), the Natural Science Foundation of Shaanxi Province (China: No. 2014JM4107), and the Basic Research Foundation of Xi'an Jiaotong University (China: No. 08143002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS11; [Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS4, DOI 10.2337/dc10-S004; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353; Buell C, 2007, DIABETES CARE, V30, P2233, DOI 10.2337/dc07-0585; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Colagiuri S, 2004, DIABETES CARE, V27, P367, DOI 10.2337/diacare.27.2.367; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Ealovega MW, 2004, DIABETES CARE, V27, P9, DOI 10.2337/diacare.27.1.9; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Garca-Alcala H, 2012, DIABET METAB SYND OB, V5, P403, DOI 10.2147/DMSO.S35545; Goldstein David E, 2003, Diabetes Care, V26 Suppl 1, pS106; Haas L, 2013, DIABETES CARE, V36, pS100, DOI [10.2337/dc13-S100, 10.2337/dc13-S004]; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; HARRIS MI, 1993, DIABETES CARE, V16, P642, DOI 10.2337/diacare.16.4.642; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Hellgren MI, 2012, DIABETIC MED, V29, P1501, DOI 10.1111/j.1464-5491.2012.03664.x; Home P, 2006, DIABETIC MED, V23, P579; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; Mannucci E, 2003, ACTA DIABETOL, V40, P181, DOI 10.1007/s00592-003-0109-8; Nakagami T, 2007, DIABETES RES CLIN PR, V76, P251, DOI 10.1016/j.diabres.2006.09.015; Pottie K, 2012, CAN MED ASSOC J, V184, P1687, DOI 10.1503/cmaj.120732; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Saydah SH, 2002, DIABETES CARE, V25, P1940, DOI 10.2337/diacare.25.11.1940; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Soriguer F, 2012, MED CLIN-BARCELONA, V138, P371, DOI 10.1016/j.medcli.2011.05.025; Tankova T, 2011, DIABETES RES CLIN PR, V92, P46, DOI 10.1016/j.diabres.2010.12.020; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Winkler G, 2013, MED SCI MONITOR, V19, P67, DOI 10.12659/MSM.883747; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097865	43	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120382	10.1371/journal.pone.0120382	http://dx.doi.org/10.1371/journal.pone.0120382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790106	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400155
J	Belinsky, KL; Nemes, CE; Schmidt, KA				Belinsky, Kara L.; Nemes, Claire E.; Schmidt, Kenneth A.			Two Novel Vocalizations Are Used by Veeries (Catharus fuscescens) during Agonistic Interactions	PLOS ONE			English	Article							PAIRING SUCCESS; VOCAL SIGNALS; SOFT SONG; CALLS; RESPONSES; PLAYBACK; ATTACK; WRENS	Avian vocalizations are common examples of the complex signals used by animals to negotiate during agonistic interactions. In this study, we used two playback experiments to identify agonistic signals in a songbird species with several acoustically complex songs and calls, the veery. In the first experiment, we compared veery singing behavior in response to simulated territorial intrusions including playback of three variations of veery song: 1) song alone as a control, 2) songs with added whisper calls, and 3) songs with introductory notes removed. In the second experiment, we used multimodal stimuli including songs, whisper calls and songs with introductory notes removed, along with a robotic veery mount. Focal males readily responded to all of the playback stimuli, approached the speaker and/or robotic mount, and vocalized. Male veeries gave more whisper calls, and sang more songs without the introductory note in response to all types of playback. However, veeries responded similarly to all types of stimuli presented, and they failed to physically attack the robotic mount. These results indicate that rival veeries use two different types of novel vocalizations: whisper calls and songs lacking the introductory note as agonistic signals, but do not allow us to discern the specific functions of these two vocalizations.	[Belinsky, Kara L.] State Univ New York New Paltz, Dept Biol, New Paltz, NY 12561 USA; [Nemes, Claire E.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Schmidt, Kenneth A.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	State University of New York (SUNY) System; SUNY New Paltz; Ball State University; Texas Tech University System; Texas Tech University	Belinsky, KL (corresponding author), State Univ New York New Paltz, Dept Biol, New Paltz, NY 12561 USA.	belinskk@newpaltz.edu			National Science Foundation CAREER grant [DEB 0746985]	National Science Foundation CAREER grant(National Science Foundation (NSF))	National Science Foundation CAREER grant DEB 0746985 to K.A.S. (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2012, ANIM BEHAV, V83, pE1, DOI 10.1016/j.anbehav.2011.11.029; Akcay C, 2011, ANIM BEHAV, V82, P377, DOI 10.1016/j.anbehav.2011.05.016; Anderson RC, 2012, ANIM BEHAV, V83, P1443, DOI 10.1016/j.anbehav.2012.03.016; Anderson RC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1267, DOI 10.1007/s00265-007-0357-7; Baker TM, 2012, ANIM BEHAV, V84, P965, DOI 10.1016/j.anbehav.2012.07.022; Ballentine B, 2008, ANIM BEHAV, V75, P693, DOI 10.1016/j.anbehav.2007.07.025; Barnett CA, 2014, J FIELD ORNITHOL, V85, P56, DOI 10.1111/jofo.12049; Beecher MD, 2000, ANIM BEHAV, V59, P21, DOI 10.1006/anbe.1999.1276; Beecher MD, 1996, ANIM BEHAV, V51, P917, DOI 10.1006/anbe.1996.0095; Benedict L, 2012, ANIM BEHAV, V84, P1463, DOI 10.1016/j.anbehav.2012.09.017; BORROR DONALD J., 1964, OHIO J SCI, V64, P195; Bradbury Jack W., 1998, pi; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; DAVIES NB, 1978, NATURE, V274, P683, DOI 10.1038/274683a0; DILGER W. C., 1956, AUK, V73, P313; Foote JR, 2008, BEHAV ECOL, V19, P1192, DOI 10.1093/beheco/arn087; Geberzahn N, 2014, BEHAV ECOL SOCIOBIOL, V68, P1, DOI 10.1007/s00265-013-1616-4; Goodale E, 2008, BEHAV ECOL, V19, P887, DOI 10.1093/beheco/arn045; Griesser M, 2008, CURR BIOL, V18, P69, DOI 10.1016/j.cub.2007.11.069; Hof D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1553; Hof D, 2010, ANIM BEHAV, V80, P821, DOI 10.1016/j.anbehav.2010.07.017; Ishizuka Toru, 2008, Ornithological Science, V7, P157, DOI 10.2326/1347-0558-7.2.157; Kondo N, 2009, JPN PSYCHOL RES, V51, P197, DOI 10.1111/j.1468-5884.2009.00399.x; MAC NALLY RC, 1986, ETHOLOGY, V71, P125; Mennill DJ, 2004, ANIM BEHAV, V67, P441, DOI 10.1016/j.anbehav.2003.04.010; Naguib M, 2010, ANIM BEHAV, V80, pE11, DOI 10.1016/j.anbehav.2010.06.001; SAMUEL DE, 1972, BIRD BANDING, V43, P118, DOI 10.2307/4511856; Schmidt R, 2008, BEHAV ECOL, V19, P635, DOI 10.1093/beheco/arn021; Schmidt R, 2006, ANIM BEHAV, V72, P1355, DOI 10.1016/j.anbehav.2006.03.022; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Searcy WA, 2006, BEHAV ECOL SOCIOBIOL, V60, P234, DOI 10.1007/s00265-006-0161-9; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Templeton CN, 2012, BEHAV ECOL SOCIOBIOL, V66, P1503, DOI 10.1007/s00265-012-1405-5; Vehrencamp SL, 2007, BEHAV ECOL, V18, P849, DOI 10.1093/beheco/arm054; WEARY DM, 1986, ETHOLOGY, V72, P199; Xia CW, 2013, ETHOLOGY, V119, P653, DOI 10.1111/eth.12104	36	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120933	10.1371/journal.pone.0120933	http://dx.doi.org/10.1371/journal.pone.0120933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798825	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300194
J	Hirst, CS; Foong, JPP; Stamp, LA; Fegan, E; Dent, S; Cooper, EC; Lomax, AE; Anderson, CR; Bornstein, JC; Young, HM; McKeown, SJ				Hirst, Caroline S.; Foong, Jaime P. P.; Stamp, Lincon A.; Fegan, Emily; Dent, Stephan; Cooper, Edward C.; Lomax, Alan E.; Anderson, Colin R.; Bornstein, Joel C.; Young, Heather M.; McKeown, Sonja J.			Ion Channel Expression in the Developing Enteric Nervous System	PLOS ONE			English	Article							NEURAL CREST CELLS; GATED POTASSIUM CHANNELS; NEURITE OUTGROWTH; MYENTERIC NEURONS; SMALL-INTESTINE; VAGUS NERVES; MIGRATION; DIFFERENTIATION; BEHAVIOR; PROLIFERATION	The enteric nervous system arises from neural crest-derived cells (ENCCs) that migrate caudally along the embryonic gut. The expression of ion channels by ENCCs in embryonic mice was investigated using a PCR-based array, RT-PCR and immunohistochemistry. Many ion channels, including chloride, calcium, potassium and sodium channels were already expressed by ENCCs at E11.5. There was an increase in the expression of numerous ion channel genes between E11.5 and E14.5, which coincides with ENCC migration and the first extension of neurites by enteric neurons. Previous studies have shown that a variety of ion channels regulates neurite extension and migration of many cell types. Pharmacological inhibition of a range of chloride or calcium channels had no effect on ENCC migration in cultured explants or neuritogenesis in vitro. The non-selective potassium channel inhibitors, TEA and 4-AP, retarded ENCC migration and neuritogenesis, but only at concentrations that also resulted in cell death. In summary, a large range of ion channels is expressed while ENCCs are colonizing the gut, but we found no evidence that ENCC migration or neuritogenesis requires chloride, calcium or potassium channel activity. Many of the ion channels are likely to be involved in the development of electrical excitability of enteric neurons.	[Hirst, Caroline S.; Foong, Jaime P. P.; Stamp, Lincon A.; Fegan, Emily; Dent, Stephan; Anderson, Colin R.; Young, Heather M.; McKeown, Sonja J.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia; [Foong, Jaime P. P.; Bornstein, Joel C.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Cooper, Edward C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lomax, Alan E.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Lomax, Alan E.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	University of Melbourne; University of Melbourne; Baylor College of Medicine; Queens University - Canada; Queens University - Canada	Young, HM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.	h.young@unimelb.edu.au	Bornstein, Joel/I-3322-2019; Cooper, Edward/X-6659-2019; Young, Heather/A-2652-2013	Bornstein, Joel/0000-0002-7518-7717; Cooper, Edward/0000-0003-3672-8442; Young, Heather/0000-0002-0457-8710; McKeown, Sonja/0000-0002-7318-116X; Stamp, Lincon/0000-0002-8925-7894; Lomax, Alan/0000-0003-4743-9929	National Health and Medical Research Council of Australia [1047953, 1002506]; Australian Research Council [DP130101596]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Health and Medical Research Council of Australia Project grant #1047953 to HY and SMcK, Australian Research Council grant #DP130101596 to JB and HY and National Health and Medical Research Council of Australia Senior Research Fellowship #1002506 to HY, http://www.nhmrc.gov.au/, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RB, 2006, GASTROENTEROLOGY, V130, P1221, DOI 10.1053/j.gastro.2006.01.002; Anderson RB, 2010, INT J DEV BIOL, V54, P63, DOI 10.1387/ijdb.082667ra; BAETGE G, 1989, DEV BIOL, V132, P189, DOI 10.1016/0012-1606(89)90217-0; BAETGE G, 1990, DEVELOPMENT, V110, P689; Barlow AJ, 2008, DEVELOPMENT, V135, P1681, DOI 10.1242/dev.017418; Bartoo AC, 2005, J COMP NEUROL, V486, P117, DOI 10.1002/cne.20541; Becchetti A, 2010, ADV EXP MED BIOL, V674, P107; Bergner AJ, 2014, J COMP NEUROL, V522, P514, DOI 10.1002/cne.23423; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Chen M, 2013, MOL NEUROBIOL, V48, P794, DOI 10.1007/s12035-013-8467-x; Cooper EC, 2011, SEMIN CELL DEV BIOL, V22, P185, DOI 10.1016/j.semcdb.2010.10.001; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Cuddapah VA, 2013, CELL CALCIUM, V53, P187, DOI 10.1016/j.ceca.2012.11.013; Cuddapah VA, 2013, J NEUROSCI, V33, P1427, DOI 10.1523/JNEUROSCI.3980-12.2013; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; D'Alessandro G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.279; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; Druckenbrod NR, 2007, DEV DYNAM, V236, P84, DOI 10.1002/dvdy.20974; Druckenbrod NR, 2009, DEVELOPMENT, V136, P3195, DOI 10.1242/dev.031302; Erickson CS, 2014, NEUROGASTROENT MOTIL, V26, P874, DOI 10.1111/nmo.12343; Foong JPP, 2012, J PHYSIOL-LONDON, V590, P2375, DOI 10.1113/jphysiol.2011.225938; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Gisser JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074311; Gu C, 2011, PROG NEUROBIOL, V94, P115, DOI 10.1016/j.pneurobio.2011.04.009; Habela CW, 2009, J NEUROPHYSIOL, V101, P750, DOI 10.1152/jn.90840.2008; Hao MM, 2010, NEUROGASTROENT MOTIL, V22, pe127, DOI 10.1111/j.1365-2982.2009.01462.x; Hao MM, 2009, DEV NEUROBIOL, V69, P22, DOI 10.1002/dneu.20683; Hao MM, 2013, DEV BIOL, V382, P365, DOI 10.1016/j.ydbio.2012.12.006; Hao MM, 2012, J NEUROSCI, V32, P10949, DOI 10.1523/JNEUROSCI.1426-12.2012; Hao MM, 2011, J NEUROSCI, V31, P15352, DOI 10.1523/JNEUROSCI.3053-11.2011; Hao MM, 2009, J CELL MOL MED, V13, P1193, DOI 10.1111/j.1582-4934.2009.00813.x; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Hearn CJ, 1999, DEV DYNAM, V214, P239, DOI 10.1002/(SICI)1097-0177(199903)214:3<239::AID-AJA7>3.0.CO;2-O; Hilaire C, 1996, NEUROSCIENCE, V75, P1219, DOI 10.1016/0306-4522(96)00347-8; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Huang CY, 2012, J COMP NEUROL, V520, P3650, DOI 10.1002/cne.23119; Huang L, 2014, J BIOL CHEM, V289, P2217, DOI 10.1074/jbc.M113.515932; Hur J, 2013, NEUROSCIENCE, V253, P389, DOI 10.1016/j.neuroscience.2013.09.003; KAPUR RP, 1992, DEVELOPMENT, V116, P167; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Lake JI, 2013, AM J PHYSIOL-GASTR L, V305, pG1, DOI 10.1152/ajpgi.00452.2012; Laranjeira C, 2009, AUTON NEUROSCI-BASIC, V151, P61, DOI 10.1016/j.autneu.2009.09.001; Lui VCH, 2010, ANTICANCER RES, V30, P4515; McFarlane S, 2000, J NEUROSCI, V20, P1020, DOI 10.1523/JNEUROSCI.20-03-01020.2000; McFerrin MB, 2006, NEURON GLIA BIOL, V2, P39, DOI 10.1017/S1740925X06000044; Mire E, 2012, NAT NEUROSCI, V15, P1134, DOI 10.1038/nn.3160; MORAN D, 1991, AM J ANAT, V192, P14, DOI 10.1002/aja.1001920103; Nishiyama C, 2012, NAT NEUROSCI, V15, P1211, DOI 10.1038/nn.3184; Obermayr F, 2013, NAT REV GASTRO HEPAT, V10, P43, DOI 10.1038/nrgastro.2012.234; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Park KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1411, DOI 10.1152/ajpcell.00447.2005; Pollock NS, 2002, J COMP NEUROL, V452, P381, DOI 10.1002/cne.10401; Sann SB, 2008, J NEUROSCI, V28, P2366, DOI 10.1523/JNEUROSCI.3828-07.2008; Sasselli V, 2013, J CLIN INVEST, V123, P1763, DOI 10.1172/JCI66759; Sato Y, 2008, DEV BIOL, V320, P185, DOI 10.1016/j.ydbio.2008.05.524; Schmidt EM, 2011, BIOCHEM BIOPH RES CO, V415, P54, DOI 10.1016/j.bbrc.2011.10.009; Schwab A, 2008, PHYSIOLOGY, V23, P212, DOI 10.1152/physiol.00003.2008; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Stewart AL, 2007, DEV BIOL, V307, P92, DOI 10.1016/j.ydbio.2007.04.024; Stock C, 2013, COMPR PHYSIOL, V3, P59, DOI 10.1002/cphy.c110056; Sun JL, 2012, J PHYSIOL-LONDON, V590, P3953, DOI 10.1113/jphysiol.2012.235820; Turner KL, 2013, CEREB CORTEX; Ubels JL, 2010, EXP EYE RES, V90, P216, DOI 10.1016/j.exer.2009.10.005; Vohra BPS, 2006, DEV BIOL, V298, P259, DOI 10.1016/j.ydbio.2006.06.033; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu QL, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0050-z; YNTEMA CL, 1954, J COMP NEUROL, V101, P515, DOI 10.1002/cne.901010212; Young HM, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-23; Young HM, 1998, DEV BIOL, V202, P67, DOI 10.1006/dbio.1998.8987; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448; Young HM, 2002, J NEUROSCI, V22, P6005; Yu PC, 2011, CELL MOL LIFE SCI, V68, P3815, DOI 10.1007/s00018-011-0755-x	74	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0123436	10.1371/journal.pone.0123436	http://dx.doi.org/10.1371/journal.pone.0123436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798587	Green Published, gold			2022-12-26	WOS:000351987300343
J	Takizawa, Y; Nakata, R; Fukuhara, K; Yamashita, H; Kubodera, H; Inoue, H				Takizawa, Yoshie; Nakata, Rieko; Fukuhara, Kiyoshi; Yamashita, Hiroshi; Kubodera, Hideo; Inoue, Hiroyasu			The 4 '-Hydroxyl Group of Resveratrol Is Functionally Important for Direct Activation of PPAR alpha	PLOS ONE			English	Article							CYCLOOXYGENASE-2 EXPRESSION; BINDING; SIRTUINS; LIGAND; J(2)	Long-term moderate consumption of red wine is associated with a reduced risk of developing lifestyle-related diseases such as cardiovascular disease and cancer. Therefore, resveratrol, a constituent of grapes and various other plants, has attracted substantial interest. This study focused on one molecular target of resveratrol, the peroxisome proliferator activated receptor alpha (PPAR alpha). Our previous study in mice showed that resveratrol-mediated protection of the brain against stroke requires activation of PPARa; however, the molecular mechanisms involved in this process remain unknown. Here, we evaluated the chemical basis of the resveratrol-mediated activation of PPARa by performing a docking mode simulation and examining the structure-activity relationships of various polyphenols. The results of experiments using the crystal structure of the PPARa ligand-binding domain and an analysis of the activation of PPARa by a resveratrol analog 4-phenylazophenol (4-PAP) in vivo indicate that the 4'-hydroxyl group of resveratrol is critical for the direct activation of PPAR alpha. Activation of PPARa by 5 mu M resveratrol was enhanced by rolipram, an inhibitor of phosphodiesterase (PDE) and forskolin, an activator of adenylate cyclase. We also found that resveratrol has a higher PDE inhibitory activity (IC50 = 19 mu M) than resveratrol analogs trans-4-hydroxystilbene and 4-PAP (IC50 = 27-28 mu M), both of which has only 4'-hydroxyl group, indicating that this 4'-hydroxyl group of resveratrol is not sufficient for the inhibition of PDE. This result is consistent with that 10 mu M resveratrol has a higher agonistic activity of PPARa than these analogs, suggesting that there is a feedforward activation loop of PPARa by resveratrol, which may be involved in the long-term effects of resveratrol in vivo.	[Takizawa, Yoshie; Nakata, Rieko; Inoue, Hiroyasu] Nara Womens Univ, Dept Food Sci & Nutr, Nara 630, Japan; [Fukuhara, Kiyoshi] Showa Univ, Sch Pharm, Tokyo, Japan; [Yamashita, Hiroshi; Kubodera, Hideo] Mitsubishi Tanabe Pharma Corp, Med Chem Res Labs, Kanagawa, Japan	Nara Womens University; Showa University; Mitsubishi Tanabe Pharma Corporation	Inoue, H (corresponding author), Nara Womens Univ, Dept Food Sci & Nutr, Nara 630, Japan.	inoue@cc.nara-wu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [19300250, 24300217]; Iijima Memorial Foundations for the Promotion of Food Science and Technology; Uehara Memorial Foundation of Nutrition; Japan Food Chemical Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Iijima Memorial Foundations for the Promotion of Food Science and Technology; Uehara Memorial Foundation of Nutrition(Uehara Memorial Foundation); Japan Food Chemical Research Foundation(Japan Food Chemical Research Foundation)	This work was supported by Grants-in-Aid for Scientific Research (Nos. 19300250 and 24300217 to H.I. and R.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Iijima Memorial Foundations for the Promotion of Food Science and Technology; Uehara Memorial Foundation of Nutrition; and the Japan Food Chemical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Calleri E, 2014, CHEMBIOCHEM, V15, P1154, DOI 10.1002/cbic.201300754; Corton JC, 2004, J BIOL CHEM, V279, P46204, DOI 10.1074/jbc.M406739200; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Inoue H, 2000, J BIOL CHEM, V275, P28028; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; Inoue H, 2002, ARTERIOSCL THROM VAS, V22, P1415, DOI 10.1161/01.ATV.0000028816.13582.13; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kleppisch Thomas, 2009, V191, P71, DOI 10.1007/978-3-540-68964-5_5; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; LANGCAKE P, 1976, PHYSIOL PLANT PATHOL, V9, P77, DOI 10.1016/0048-4059(76)90077-1; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875; THAKKAR K, 1993, J MED CHEM, V36, P2950, DOI 10.1021/jm00072a015; Tsukamoto T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-46; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Zhao P, 2013, BBA-PROTEINS PROTEOM, V1834, P2089, DOI 10.1016/j.bbapap.2013.07.004	30	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120865	10.1371/journal.pone.0120865	http://dx.doi.org/10.1371/journal.pone.0120865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798826	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300184
J	Adel, A; Abatih, E; Speybroeck, N; Soukehal, A; Bouguedour, R; Boughalem, K; Bouhbal, A; Djerbal, M; Saegerman, C; Berkvens, D				Adel, Amel; Abatih, Emmanuel; Speybroeck, Niko; Soukehal, Abdelkrim; Bouguedour, Rachid; Boughalem, Karim; Bouhbal, Abdelmalek; Djerbal, Mouloud; Saegerman, Claude; Berkvens, Dirk			Estimation of Canine Leishmania Infection Prevalence in Six Cities of the Algerian Littoral Zone Using a Bayesian Approach	PLOS ONE			English	Article							DIRECT AGGLUTINATION-TEST; VISCERAL LEISHMANIASIS; DIAGNOSTIC-TESTS; CONDITIONAL DEPENDENCE; INFANTUM INFECTION; DISEASE PREVALENCE; DOGS; FOCUS; SERODIAGNOSIS; TRANSMISSION	A large-scale study on canine Leishmania infection (CanL) was conducted in six localities along a west-east transect in the Algerian littoral zone (Tlemcen, Mostaganem, Tipaza, Boumerdes, Bejaia, Jijel) and covering two sampling periods. In total 2,184 dogs were tested with an indirect fluorescent antibody test (IFAT) and a direct agglutination test (DAT). Combined multiple-testing and several statistical methods were compared to estimate the CanL true prevalence and tests characteristics (sensitivity and specificity). The Bayesian full model showed the best fit and yielded prevalence estimates between 11% (Mostaganem, first period) and 38% (Bejaia, second period). Sensitivity of IFAT varied (in function of locality) between 86% and 88% while its specificity varied between 65% and 87%. DAT was less sensitive than IFAT but showed a higher specificity (between 80% and 95% in function of locality or/and season). A general increasing trend of the CanL prevalence was noted from west to east. A concordance between the present results and the incidence of human cases of visceral leishmaniasis was observed, where also a maximum was recorded for Bejaia. The results of the present study highlight the dangers when using IFAT as a gold standard.	[Adel, Amel] Univ Saad Dahlab, Inst Vet Sci, Blida, Algeria; [Adel, Amel; Abatih, Emmanuel; Berkvens, Dirk] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Adel, Amel; Saegerman, Claude] Univ Liege, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, Fundamental & Appl Res Animals & Hlth FARAH, Fac Vet Med, B-4000 Sart Tilman Par Liege, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, IRSS FSP, B-1200 Brussels, Belgium; [Soukehal, Abdelkrim] Univ Hosp Beni Messous, Algiers, Algeria; [Bouguedour, Rachid] OIE Sub Reg Representat North Africa, Tunis, Tunisia; [Boughalem, Karim; Bouhbal, Abdelmalek] Minist Agr & Dev Rural, Direct Serv Vet, Algiers 16000, Algeria; [Djerbal, Mouloud] Reg Vet Lab Draa Ben Kheda, Tizi Ouzou, Algeria	Universite Saad Dahlab de Blida; Institute of Tropical Medicine (ITM); University of Liege; Universite Catholique Louvain	Berkvens, D (corresponding author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.	dberkvens@itg.be		Saegerman, Claude/0000-0001-9087-7436; Speybroeck, Niko/0000-0003-3322-3502	Belgian Directorate-General for Development Co-operation	Belgian Directorate-General for Development Co-operation	This work was supported by Belgian Directorate-General for Development Co-operation: scholarship AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; ABRANCHES P, 1983, ANN PARASIT HUM COMP, V58, P307, DOI 10.1051/parasite/1983584307; Acedo-Sanchez C, 1998, VET PARASITOL, V75, P1, DOI 10.1016/S0304-4017(97)00196-9; Addadi K., 1976, Bulletin de la Societe de Pathologie Exotique, V69, P68; Adel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099207; Adel A, 2010, VET PARASITOL, V172, P204, DOI 10.1016/j.vetpar.2010.05.009; ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879; Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Ballart C, 2013, PREV VET MED, V109, P116, DOI 10.1016/j.prevetmed.2012.09.003; BELAZZOUG S, 1985, ANN SOC BELG MED TR, V65, P329; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Bertrand P, 2005, J CLIN EPIDEMIOL, V58, P688, DOI 10.1016/j.jclinepi.2004.10.021; Boelaert M, 1999, EPIDEMIOL INFECT, V123, P499, DOI 10.1017/S0950268899003040; Chaouch M, 2013, VET PARASITOL, V198, P78, DOI 10.1016/j.vetpar.2013.07.038; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Collins J, 2014, STAT MED, V33, P4141, DOI 10.1002/sim.6218; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Dendukuri N, 2009, STAT MED, V28, P441, DOI 10.1002/sim.3470; Diouani M F, 2008, Arch Inst Pasteur Tunis, V85, P55; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; ELHARITH A, 1989, J CLIN MICROBIOL, V27, P2252, DOI 10.1128/JCM.27.10.2252-2257.1989; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Ertabaklar H, 2005, ACTA TROP, V93, P239, DOI 10.1016/j.actatropica.2005.01.002; Fernandez-Bellon H, 2008, VET PARASITOL, V155, P32, DOI 10.1016/j.vetpar.2008.04.009; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; Gomes AHS, 2008, EXP PARASITOL, V119, P319, DOI 10.1016/j.exppara.2008.02.014; Graham P, 1998, J CLIN EPIDEMIOL, V51, P763, DOI 10.1016/S0895-4356(98)00048-1; HARRAT Z, 1992, B SOC PATHOL EXOT, V85, P296; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Iniesta L, 2002, CLIN DIAGN LAB IMMUN, V9, P1137, DOI 10.1128/CDLI.9.5.1137-1141.2002; IZRI MA, 1990, ANN PARASIT HUM COMP, V65, P151; KILLICKKENDRICK R, 1995, T ROY SOC TROP MED H, V89, P477, DOI 10.1016/0035-9203(95)90072-1; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Lesaffre E, 2007, VET PARASITOL, V148, P58, DOI 10.1016/j.vetpar.2007.05.010; Maia C, 2008, VET PARASITOL, V158, P274, DOI 10.1016/j.vetpar.2008.07.028; MANCIANTI F, 1988, AM J VET RES, V49, P1409; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Morillas F, 1996, PARASITOL RES, V82, P569, DOI 10.1007/s004360050164; Nejjar R, 1998, PARASITE, V5, P325, DOI 10.1051/parasite/1998054325; NEOGY AB, 1992, AM J TROP MED HYG, V47, P772, DOI 10.4269/ajtmh.1992.47.772; Ntais P, 2013, AM J TROP MED HYG, V89, P906, DOI 10.4269/ajtmh.13-0070; OIE, 2014, LEISHM; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; Rami M, 2003, PARASITE, V10, P79, DOI 10.1051/parasite/2003101p77; Rodriguez-Cortes A, 2013, VET PARASITOL, V191, P363, DOI 10.1016/j.vetpar.2012.09.009; Rodriguez-Cortes A, 2010, AM J TROP MED HYG, V82, P251, DOI 10.4269/ajtmh.2010.09-0366; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Scalone A, 2002, VET PARASITOL, V104, P275, DOI 10.1016/S0304-4017(01)00643-4; Schallig HDFH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-100; Sousa S, 2011, ACTA TROP, V120, P82, DOI 10.1016/j.actatropica.2011.06.003; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Vercammen F, 1996, VET REC, V139, P264, DOI 10.1136/vr.139.11.264-a; Zaffaroni E, 1999, VET PARASITOL, V81, P11, DOI 10.1016/S0304-4017(98)00237-4; Zoghlami Z, 2014, INTERACTION CANINE H	55	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117313	10.1371/journal.pone.0117313	http://dx.doi.org/10.1371/journal.pone.0117313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793942	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200011
J	Chapman, C; Henry, M; Bishop-Lilly, KA; Awosika, J; Briska, A; Ptashkin, RN; Wagner, T; Rajanna, C; Tsang, H; Johnson, SL; Mokashi, VP; Chain, PSG; Sozhamannan, S				Chapman, Carol; Henry, Matthew; Bishop-Lilly, Kimberly A.; Awosika, Joy; Briska, Adam; Ptashkin, Ryan N.; Wagner, Trevor; Rajanna, Chythanya; Tsang, Hsinyi; Johnson, Shannon L.; Mokashi, Vishwesh P.; Chain, Patrick S. G.; Sozhamannan, Shanmuga			Scanning the Landscape of Genome Architecture of Non-O1 and Non-O139 Vibrio cholerae by Whole Genome Mapping Reveals Extensive Population Genetic Diversity	PLOS ONE			English	Article							STRAINS; EPIDEMIC; EMERGENCE	Historically, cholera outbreaks have been linked to V. cholerae O1 serogroup strains or its derivatives of the O37 and O139 serogroups. A genomic study on the 2010 Haiti cholera outbreak strains highlighted the putative role of non O1/non-O139 V. cholerae in causing cholera and the lack of genomic sequences of such strains from around the world. Here we address these gaps by scanning a global collection of V. cholerae strains as a first step towards understanding the population genetic diversity and epidemic potential of non O1/non-O139 strains. Whole Genome Mapping (Optical Mapping) based bar coding produces a high resolution, ordered restriction map, depicting a complete view of the unique chromosomal architecture of an organism. To assess the genomic diversity of non-O1/non-O139 V. cholerae, we applied a Whole Genome Mapping strategy on a well-defined and geographically and temporally diverse strain collection, the Sakazaki serogroup type strains. Whole Genome Map data on 91 of the 206 serogroup type strains support the hypothesis that V. cholerae has an unprecedented genetic and genomic structural diversity. Interestingly, we discovered chromosomal fusions in two unusual strains that possess a single chromosome instead of the two chromosomes usually found in V. cholerae. We also found pervasive chromosomal rearrangements such as duplications and indels in many strains. The majority of Vibrio genome sequences currently in public databases are unfinished draft sequences. The Whole Genome Mapping approach presented here enables rapid screening of large strain collections to capture genomic complexities that would not have been otherwise revealed by unfinished draft genome sequencing and thus aids in assembling and finishing draft sequences of complex genomes. Furthermore, Whole Genome Mapping allows for prediction of novel V. cholerae non-O1/non-O139 strains that may have the potential to cause future cholera outbreaks.	[Chapman, Carol; Henry, Matthew; Bishop-Lilly, Kimberly A.; Awosika, Joy; Tsang, Hsinyi; Sozhamannan, Shanmuga] Henry M Jackson Fdn, Bethesda, MD USA; [Chapman, Carol; Henry, Matthew; Bishop-Lilly, Kimberly A.; Awosika, Joy; Tsang, Hsinyi; Mokashi, Vishwesh P.; Sozhamannan, Shanmuga] Naval Med Res Ctr Frederick, Ft Detrick, MD USA; [Briska, Adam; Ptashkin, Ryan N.; Wagner, Trevor] OpGen Inc, Gaithersburg, MD USA; [Rajanna, Chythanya] Univ Florida, Gainesville, FL USA; [Johnson, Shannon L.; Chain, Patrick S. G.] Los Alamos Natl Lab, Biosci Div, Genome Sci, Los Alamos, NM USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Naval Medical Research Center (NMRC); State University System of Florida; University of Florida; United States Department of Energy (DOE); Los Alamos National Laboratory	Sozhamannan, S (corresponding author), GoldBelt Raven LLC, Frederick, MD 21701 USA.	Shanmuga.Sozhamannan.ctr@mail.mil	Johnson, Shannon Lyn/H-2799-2019; Chain, Patrick/O-4140-2019; Sozhamannan, Shanmuga/AAN-7809-2020; Sozhamannan, Shanmuga/AGF-2410-2022	Johnson, Shannon Lyn/0000-0002-3972-9208; Chain, Patrick/0000-0003-3949-3634; Sozhamannan, Shanmuga/0000-0002-6762-7874; 	Defense Threat Reduction Agency [TMTI_IB06RSQ002]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported under contract TMTI_IB06RSQ002 through the Defense Threat Reduction Agency to SS. Additional support was provided by OpGen, Inc for data collection, analyses and interpretation of data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bik EM, 1996, J CLIN MICROBIOL, V34, P1453, DOI 10.1128/JCM.34.6.1453-1461.1996; Center for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V59, P1473; Chen Q, 2006, MICROBIOL-SGM, V152, P1041, DOI 10.1099/mic.0.28648-0; DAVIS BR, 1981, J CLIN MICROBIOL, V14, P631, DOI 10.1128/JCM.14.6.631-639.1981; Frerichs RR, 2012, P NATL ACAD SCI USA, V109, pE3208, DOI 10.1073/pnas.1211512109; Hasan NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI 10.1073/pnas.1207359109; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; Li MR, 2003, APPL ENVIRON MICROB, V69, P1728, DOI 10.1128/AEM.69.3.1728-1738.2003; Li MR, 2002, INFECT IMMUN, V70, P2441, DOI 10.1128/IAI.70.5.2441-2453.2002; Mekalanos JJ, 2012, P NATL ACAD SCI USA, V109, pE3206, DOI 10.1073/pnas.1212443109; MYERS EW, 1992, B MATH BIOL, V54, P599, DOI 10.1016/S0092-8240(05)80078-3; Octavia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065342; Pengsuk C, 2011, J MICROBIOL METH, V87, P224, DOI 10.1016/j.mimet.2011.07.022; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pritchard JK, 2000, GENETICS, V155, P945; RAMAMURTHY T, 1993, LANCET, V341, P703, DOI 10.1016/0140-6736(93)90480-5; Reams AB, 2012, GENETICS, V192, P397, DOI 10.1534/genetics.112.142570; Schwan WR, 2010, MICROBIOL-SGM, V156, P2124, DOI 10.1099/mic.0.033977-0; SHIMADA T, 1994, CURR MICROBIOL, V28, P175, DOI 10.1007/BF01571061; TRUCKSIS M, 1991, J BACTERIOL, V173, P5854, DOI 10.1128/jb.173.18.5854-5860.1991; Trucksis M, 1998, P NATL ACAD SCI USA, V95, P14464, DOI 10.1073/pnas.95.24.14464; Val ME, 2014, MOL MICROBIOL, V91, P665, DOI 10.1111/mmi.12483; Val ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002472; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; WATERMAN MS, 1984, NUCLEIC ACIDS RES, V12, P237, DOI 10.1093/nar/12.1Part1.237	25	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120311	10.1371/journal.pone.0120311	http://dx.doi.org/10.1371/journal.pone.0120311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794000	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900010
J	Huang, WJ; Zhou, GY; Liu, JX; Zhang, DQ; Liu, SZ; Chu, GW; Fang, X				Huang, Wenjuan; Zhou, Guoyi; Liu, Juxiu; Zhang, Deqiang; Liu, Shizhong; Chu, Guowei; Fang, Xiong			Mineral Elements of Subtropical Tree Seedlings in Response to Elevated Carbon Dioxide and Nitrogen Addition	PLOS ONE			English	Article							FOREST ECOSYSTEMS; ATMOSPHERIC CO2; CLIMATE-CHANGE; SOIL; PLANT; DEPOSITION; PHOSPHORUS; DYNAMICS; AVAILABILITY; METAANALYSIS	Mineral elements in plants have been strongly affected by increased atmospheric carbon dioxide (CO2) concentrations and nitrogen (N) deposition due to human activities. However, such understanding is largely limited to N and phosphorus in grassland. Using open-top chambers, we examined the concentrations of potassium (K), calcium (Ca), magnesium (Mg), aluminum (Al), copper (Cu) and manganese (Mn) in the leaves and roots of the seedlings of five subtropical tree species in response to elevated CO2 (ca. 700 mu mol CO2 mol(-1)) and N addition (100 kg N ha(-1) yr(-1)) from 2005 to 2009. These mineral elements in the roots responded more strongly to elevated CO2 and N addition than those in the leaves. Elevated CO2 did not consistently decrease the concentrations of plant mineral elements, with increases in K, Al, Cu and Mn in some tree species. N addition decreased K and had no influence on Cu in the five tree species. Given the shifts in plant mineral elements, Schima superba and Castanopsis hystrix were less responsive to elevated CO2 and N addition alone, respectively. Our results indicate that plant stoichiometry would be altered by increasing CO2 and N deposition, and K would likely become a limiting nutrient under increasing N deposition in subtropics.	[Huang, Wenjuan; Zhou, Guoyi; Liu, Juxiu; Zhang, Deqiang; Liu, Shizhong; Chu, Guowei; Fang, Xiong] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou 510650, Guangdong, Peoples R China; [Fang, Xiong] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, JX (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Xingke Rd 723, Guangzhou 510650, Guangdong, Peoples R China.	ljxiu@scbg.ac.cn	Huang, Wendy/X-1221-2018		National Natural Science Foundation of China [31370530]; Science and Technology Innovation Project of Guangdong Province Forestry [2012KJCX019-02]; South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Project of Guangdong Province Forestry; South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund	This study was jointly funded by the National Natural Science Foundation of China (Grant No. 31370530), Science and Technology Innovation Project of Guangdong Province Forestry (Grant No. 2012KJCX019-02), and South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund.	Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Andrews JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P149, DOI 10.1029/2000GB001278; Bowman WD, 2008, NAT GEOSCI, V1, P767, DOI 10.1038/ngeo339; Buol S.W., 2003, SOIL GENESIS CLASSIF; Bytnerowicz A, 2007, ENVIRON POLLUT, V147, P438, DOI 10.1016/j.envpol.2006.08.028; Cakmak I, 2005, J PLANT NUTR SOIL SC, V168, P521, DOI 10.1002/jpln.200420485; Cernusak LA, 2013, FUNCT PLANT BIOL, V40, P531, DOI 10.1071/FP12309; Deng Q, 2010, BIOGEOSCIENCES, V7, P315, DOI 10.5194/bg-7-315-2010; Duval BD, 2012, PLANT ECOL, V213, P505, DOI 10.1007/s11258-011-9998-8; Elvir JA, 2006, FOREST ECOL MANAG, V221, P207, DOI 10.1016/j.foreco.2005.09.022; Garrish V, 2010, J EXP BOT, V61, P3735, DOI 10.1093/jxb/erq183; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Hofmockel KS, 2011, GLOBAL CHANGE BIOL, V17, P3338, DOI 10.1111/j.1365-2486.2011.02465.x; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Johnson DW, 2004, BIOGEOCHEMISTRY, V69, P379, DOI 10.1023/B:BIOG.0000031054.19158.7c; Johnson DW, 2003, ECOL APPL, V13, P1388, DOI 10.1890/02-5139; Likens GE, 1998, BIOGEOCHEMISTRY, V41, P89, DOI 10.1023/A:1005984620681; Liu JX, 2008, BIOGEOSCIENCES, V5, P1783, DOI 10.5194/bg-5-1783-2008; Liu JX, 2014, J GEOPHYS RES-BIOGEO, V119, P676, DOI 10.1002/2013JG002343; Liu JX, 2013, GLOBAL CHANGE BIOL, V19, P208, DOI 10.1111/gcb.12022; Liu JX, 2011, ECOSYSTEMS, V14, P683, DOI 10.1007/s10021-011-9438-6; Loladze I, 2002, TRENDS ECOL EVOL, V17, P457, DOI 10.1016/S0169-5347(02)02587-9; Lucas RW, 2011, FOREST ECOL MANAG, V262, P95, DOI 10.1016/j.foreco.2011.03.018; Marinari S, 2007, ENVIRON POLLUT, V147, P507, DOI 10.1016/j.envpol.2006.08.041; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Natali SM, 2009, ECOSYSTEMS, V12, P715, DOI 10.1007/s10021-009-9251-7; Niklaus PA, 1998, OECOLOGIA, V117, P201, DOI 10.1007/s004420050649; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Santiago LS, 2012, J ECOL, V100, P309, DOI 10.1111/j.1365-2745.2011.01904.x; Schreeg LA, 2014, ECOLOGY, V95, P2062, DOI 10.1890/13-1671.1; Taub DR, 2008, J INTEGR PLANT BIOL, V50, P1365, DOI 10.1111/j.1744-7909.2008.00754.x; Tripler CE, 2006, ECOL LETT, V9, P451, DOI 10.1111/j.1461-0248.2006.00891.x; Turner BL, 2013, SOIL SCI SOC AM J, V77, P1357, DOI 10.2136/sssaj2012.0128; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Watmough SA, 2003, ECOSYSTEMS, V6, P675, DOI 10.1007/s10021-002-0164-y; WOODIN S, 1992, NEW PHYTOL, V122, P635; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xu ZH, 2009, J SOIL SEDIMENT, V9, P83, DOI 10.1007/s11368-009-0060-6; Yan JH, 2014, GLOBAL CHANGE BIOL, V20, P2230, DOI 10.1111/gcb.12501; Zhang J.S., 2006, PLANT PHYSIOL, P88; Zhao Liang, 2011, Yingyong Shengtai Xuebao, V22, P1949	45	5	6	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120190	10.1371/journal.pone.0120190	http://dx.doi.org/10.1371/journal.pone.0120190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794046	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200157
J	Lim, CC; Teo, BW; Tai, ES; Lim, SC; Chan, CM; Sethi, S; Wong, TY; Sabanayagam, C				Lim, Cynthia Ciwei; Teo, Boon Wee; Tai, E. Shyong; Lim, Su Chi; Chan, Choong Meng; Sethi, Sunil; Wong, Tien Y.; Sabanayagam, Charumathi			Elevated Serum Leptin, Adiponectin and Leptin to Adiponectin Ratio Is Associated with Chronic Kidney Disease in Asian Adults	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; TYPE-2 DIABETIC-PATIENTS; LEPTIN/ADIPONECTIN RATIO; INSULIN-RESISTANCE; RENAL-FUNCTION; CARDIOVASCULAR EVENTS; INDEPENDENT PREDICTOR; PLASMA ADIPONECTIN; WEIGHT; EPIDEMIOLOGY	Background Adiponectin and leptin, two of the key cytokines secreted by adipocytes, have been shown to be associated with cardiovascular disease. However, the association of these adipocytokines with chronic kidney disease (CKD) is not clear. We examined the association of serum adiponectin, leptin levels and leptin to adiponectin ratio (LAR) with CKD in a population- based sample of Asian adults. Methods We conducted a case-control study (450 CKD cases and 920 controls matched for age, sex and ethnicity) involving Chinese and Indian adults aged 40-80 years who participated in the Singapore Epidemiology of Eye Diseases Study (2007-2011). CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73m(2) from serum creatinine. Serum adiponectin and leptin levels were measured using commercially available ELISA. Odds ratio of CKD associated with elevated adiponectin and leptin levels were estimated using logistic regression models adjusted for age, gender, ethnicity, education, smoking, body mass index, diabetes, blood pressure, total and HDL cholesterol. Results CKD cases had higher levels of leptin (mean [SD] 9.7 [11.5] vs. 16.9 [20.2] ng/mL, p<0.0001) and adiponectin (10.4 [7.4] vs. 9.2 [4.2], p = 0.001) compared to controls. In multi-variable models, compared to those in the lowest quartile, the OR (95% confidence interval) of CKD among those in the highest quartile were: 6.46 (3.84, 10.88), 1.94 (1.32-2.85) and 2.88 (1.78-4.64) for leptin, adiponectin and LAR. Similar associations were also observed when adiponectin and leptin were analyzed as continuous variables. This positive association of serum adiponectin, leptin and LAR with CKD was consistently present in subgroups of gender, ethnicity, diabetes, hypertension and overweight status (all P-interaction >0.1). Conclusions Higher levels of serum adiponectin, leptin and LAR were positively associated with CKD independent of traditional risk factors in this Asian population.	[Lim, Cynthia Ciwei; Chan, Choong Meng] Singapore Gen Hosp, Dept Renal Med, Singapore, Singapore; [Teo, Boon Wee; Tai, E. Shyong] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Med, Singapore 117548, Singapore; [Lim, Su Chi] Khoo Teck Puat Hosp, Ctr Diabet, Singapore, Singapore; [Sethi, Sunil] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117548, Singapore; [Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore, Singapore; [Wong, Tien Y.; Sabanayagam, Charumathi] Natl Univ Singapore, Ophthalmol & Visual Sci Acad Clin Program, Duke NUS Grad Med Sch, Singapore 117548, Singapore; [Wong, Tien Y.; Sabanayagam, Charumathi] Singapore Eye Res Inst, Singapore, Singapore	Singapore General Hospital; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore National Eye Center	Sabanayagam, C (corresponding author), Natl Univ Singapore, Ophthalmol & Visual Sci Acad Clin Program, Duke NUS Grad Med Sch, Singapore 117548, Singapore.	charumathi.sabanayagam@seri.com.sg	Wong, Tien Yin/AAC-9724-2020; Sabanayagam, Charumathi/C-1294-2011	Wong, Tien Yin/0000-0002-8448-1264; Sabanayagam, Charumathi/0000-0002-4042-4719; Tai, E Shyong/0000-0003-2929-8966	Singapore Ministry of Health's National Medical Research Council (NMRC) [NMRC/TA/0008/2012, NMRC/STaR/0003/2008]	Singapore Ministry of Health's National Medical Research Council (NMRC)	This work was supported by the Singapore Ministry of Health's National Medical Research Council (NMRC) under its Talent Development Scheme NMRC/TA/0008/2012 (CS), NMRC/STaR/0003/2008 (TYW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker B, 2005, J AM SOC NEPHROL, V16, P1091, DOI 10.1681/ASN.2004090742; Cantarin MPM, 2013, KIDNEY INT, V83, P487, DOI 10.1038/ki.2012.421; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; de Almeida AR, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-25; Donoso MA, 2013, HORM RES PAEDIAT, V80, P363, DOI 10.1159/000356046; Doumatey AP, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/730920; Fruehwald-Schultes B, 1999, METABOLISM, V48, P1290, DOI 10.1016/S0026-0495(99)90270-6; Galletti F, 2008, J CLIN ENDOCR METAB, V93, P3922, DOI 10.1210/jc.2008-1280; Guebre-Egziabher F, 2005, NEPHROL DIAL TRANSPL, V20, P129, DOI 10.1093/ndt/gfh568; Hall JI, 2011, ANN CLIN BIOCHEM, V48, P327, DOI 10.1258/acb.2011.010199; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Inoue M, 2005, METABOLISM, V54, P281, DOI 10.1016/j.metabol.2004.09.006; Iseki K, 2013, CLIN EXP NEPHROL, V17, P372, DOI 10.1007/s10157-012-0718-z; Kappelle PJWH, 2012, EUR J INTERN MED, V23, P755, DOI 10.1016/j.ejim.2012.06.013; Kollerits B, 2007, KIDNEY INT, V71, P1279, DOI 10.1038/sj.ki.5002191; Komaba H, 2006, AM J NEPHROL, V26, P476, DOI 10.1159/000096870; Lastra G, 2006, ADV CHRONIC KIDNEY D, V13, P365, DOI 10.1053/j.ackd.2006.07.011; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Lee MPS, 2005, INT J OBESITY, V29, P1395, DOI 10.1038/sj.ijo.0803031; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li PKT, 2011, NEPHROLOGY, V16, P633, DOI 10.1111/j.1440-1797.2011.01503.x; Liao YC, 2013, BIOMARKERS, V18, P44, DOI 10.3109/1354750X.2012.730550; Lim CC, 2015, EUR J PREV CARDIOL, V22, P1018, DOI 10.1177/2047487314536873; Looker HC, 2004, J CLIN ENDOCR METAB, V89, P4010, DOI 10.1210/jc.2003-031916; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Menon V, 2004, CLIN NEPHROL, V61, P163; Mills KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076902; Mohan V, 2005, METABOLISM, V54, P476, DOI 10.1016/j.metabol.2004.10.016; Nanayakkara PWB, 2009, CLIN NEPHROL, V72, P21; Nerpin E, 2008, DIABETES CARE, V31, P1550, DOI 10.2337/dc08-0369; Norata GD, 2010, NUTR METAB CARDIOVAS, V20, P56, DOI 10.1016/j.numecd.2009.01.011; Norata GD, 2007, STROKE, V38, P2844, DOI 10.1161/STROKEAHA.107.485540; Nordfors L, 1998, KIDNEY INT, V54, P1267, DOI 10.1046/j.1523-1755.1998.00088.x; Park JT, 2013, PERITON DIALYSIS INT, V33, P67, DOI 10.3747/pdi.2011.00066; Risch L, 2007, CLIN CHIM ACTA, V376, P108, DOI 10.1016/j.cca.2006.07.026; Saraheimo M, 2005, DIABETES CARE, V28, P1410, DOI 10.2337/diacare.28.6.1410; Sarnak MJ, 2002, KIDNEY INT, V62, P2208, DOI 10.1046/j.1523-1755.2002.00677.x; Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488; Schalkwijk CG, 2006, J CLIN ENDOCR METAB, V91, P129, DOI 10.1210/jc.2005-1117; Shand BI, 2003, DIABETES OBES METAB, V5, P349, DOI 10.1046/j.1463-1326.2003.00279.x; Shankar A, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/269532; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Stepien M, 2013, MED SCI MONITOR, V19, P1063, DOI 10.12659/MSM.889390; Teo BW, 2012, AM J KIDNEY DIS, V60, P500, DOI 10.1053/j.ajkd.2012.05.008; Tsuboi A, 2013, J ATHEROSCLER THROMB, V20, P568, DOI 10.5551/jat.17426; Wannamethee SG, 2007, ATHEROSCLEROSIS, V191, P418, DOI 10.1016/j.atherosclerosis.2006.04.012; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Yaturu S, 2007, CYTOKINE, V37, P1, DOI 10.1016/j.cyto.2007.02.003; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	51	63	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122009	10.1371/journal.pone.0122009	http://dx.doi.org/10.1371/journal.pone.0122009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793395	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900166
J	Sasaki, K; Hayashi, K; Lee, JB; Kurosaki, F; Hayashi, T				Sasaki, Kohei; Hayashi, Kyoko; Lee, Jung-Bum; Kurosaki, Fumiya; Hayashi, Toshimitsu			Characterization of a Novel Mutation in NS1 Protein of Influenza A Virus Induced by a Chemical Substance for the Attenuation of Pathogenicity	PLOS ONE			English	Article							PI3K/AKT SIGNALING PATHWAY; MDCK CELLS; ACTIVATION; INFECTION; EXPRESSION; APOPTOSIS; RNA	It is generally accepted that live attenuated influenza vaccine (LAIV) has the potential for use as a vaccination against flu. In this study, we demonstrated the nature of an influenza A virus (IAV) mutant induced by treating the IAV with a stable furan derivative, (1R,2R)-1-(5'-methylfur-3'-yl) propane-1,2,3-triol (MFPT), which had been isolated from Streptomyces sp. strain FV60 with the objective of it being an LAIV candidate. The resulting MFPT-resistant (MFPTr) IAVs possessed attenuated pathogenicity in vitro and in vivo when compared with that of the parent virus (H1N1 subtype, NWS strain). Sequencing analysis revealed that a novel mutation, C490U in ns gene (P164S in NS1), was detected in all MFPTr virus clones tested. Therefore, NS1 might be a main target of MFPT, and it was suggested that the P164S mutation contributed to the attenuated pathogenicity of the mutants. Although the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is one of the targets of NS1, the MFPTr virus suppressed the phosphorylation of Akt when compared with the wild-type (WT) virus. It was suggested that this might lead to the subsequent inhibition of the cleavage of PARP-1 and caspase-3, which is important for the progression of apoptosis. At the same time, nucleoprotein (NP) was found to be retained in the nuclei in MFPTr virus-infected cells while nuclear export of NP was detected in WT virus-infected cells. In addition, the expression levels of interferon-beta transcripts were significantly decreased in MFPTr virus-infected cells. From these results it can be shown that the mutation, NS1(P164S), might be one of the key residues to control NS1 function concerning the induction of apoptosis. In conclusion, MFPT induced favorable mutation in the ns gene for the attenuation of IAV, and therefore might provide the novel methodology for preparing LAIVs.	[Sasaki, Kohei; Lee, Jung-Bum; Kurosaki, Fumiya] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan; [Hayashi, Kyoko; Hayashi, Toshimitsu] Chubu Univ, Res Inst Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	University of Toyama; Chubu University	Lee, JB (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan.	lee@pha.u-toyama.ac.jp		Lee, Jung-Bum/0000-0002-8732-7457	Japan Society for the Promotion of Science (JSPS) [25460206]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	KH and JL received a Grant-in-Aid for Scientific Research (C, No. 25460206) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hayashi K, 2000, J ANTIMICROB CHEMOTH, V46, P181, DOI 10.1093/jac/46.2.181; Heynisch B, 2010, VACCINE, V28, P8210, DOI 10.1016/j.vaccine.2010.07.076; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Jackson D, 2010, VIROLOGY, V396, P94, DOI 10.1016/j.virol.2009.10.004; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li CJ, 2014, TRENDS BIOTECHNOL, V32, P147, DOI 10.1016/j.tibtech.2014.01.001; Lindsay SM, 2012, J VIROL METHODS, V179, P351, DOI 10.1016/j.jviromet.2011.11.022; Lui XY, 2010, J GEN VIROL, V91, P1439, DOI 10.1099/vir.0.018465-0; McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seitz C, 2010, J GEN VIROL, V91, P1754, DOI 10.1099/vir.0.020370-0; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Tran AT, 2013, J VIROL, V87, P1049, DOI 10.1128/JVI.02017-12; WHO, 2009, SEQ PRIM PROT; World Health Organization, 2014, INF PREV CONTR EP PA; World Health Organization, 2013, COMPREHENSIVE CERVIC; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279	30	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121205	10.1371/journal.pone.0121205	http://dx.doi.org/10.1371/journal.pone.0121205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793397	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900112
J	Warfield, KL; Dye, JM; Wells, JB; Unfer, RC; Holtsberg, FW; Shulenin, S; Vu, H; Swenson, DL; Bavari, S; Aman, MJ				Warfield, Kelly L.; Dye, John M.; Wells, Jay B.; Unfer, Robert C.; Holtsberg, Frederick W.; Shulenin, Sergey; Vu, Hong; Swenson, Dana L.; Bavari, Sina; Aman, M. Javad			Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles	PLOS ONE			English	Article							MARBURG VIRUSES; INSECT CELLS; GUINEA-PIGS; INFECTION; VACCINE; CHALLENGE; ANTIBODIES; IMMUNIZATION; RESPONSES; MUCOSAL	Filoviruses cause hemorrhagic fever resulting in significant morbidity and mortality in humans. Several vaccine platforms that include multiple virus-vectored approaches and virus-like particles (VLPs) have shown efficacy in nonhuman primates. Previous studies have shown protection of cynomolgus macaques against homologous infection for Ebola virus (EBOV) and Marburg virus (MARV) following a three-dose vaccine regimen of EBOV or MARV VLPs, as well as heterologous protection against Ravn Virus (RAVV) following vaccination with MARV VLPs. The objectives of the current studies were to determine the minimum number of vaccine doses required for protection (using EBOV as the test system) and then demonstrate protection against Sudan virus (SUDV) and Tai Forest virus (TAFV). Using the EBOV nonhuman primate model, we show that one or two doses of VLP vaccine can confer protection from lethal infection. VLPs containing the SUDV glycoprotein, nucleoprotein and VP40 matrix protein provide complete protection against lethal SUDV infection in macaques. Finally, we demonstrate protective efficacy mediated by EBOV, but not SUDV, VLPs against TAFV; this is the first demonstration of complete cross-filovirus protection using a single component heterologous vaccine within the Ebolavirus genus. Along with our previous results, this observation provides strong evidence that it will be possible to develop and administer a broad-spectrum VLP-based vaccine that will protect against multiple filoviruses by combining only three EBOV, SUDV and MARV components.	[Warfield, Kelly L.; Unfer, Robert C.; Holtsberg, Frederick W.; Shulenin, Sergey; Vu, Hong; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD USA; [Dye, John M.; Wells, Jay B.; Swenson, Dana L.; Bavari, Sina] US Army Med Res Inst Infect Dis, Ft Detrick, MD USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Warfield, KL (corresponding author), Unither Virol LLC, Silver Spring, MD 20910 USA.	kwarfield@unithervirology.com	Bavari, Sina/L-3642-2019	Bavari, Sina/0000-0001-8424-5635; Dye, John/0000-0002-0883-5016	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200800055C]; Defense Threat Reduction Agency JSTO-CBD; Medical Research and Material Command; Integrated Biotherapeutics	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; Defense Threat Reduction Agency JSTO-CBD(United States Department of DefenseDefense Threat Reduction Agency); Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Integrated Biotherapeutics	This project has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200800055C to MJA (IBT) and support from the Defense Threat Reduction Agency JSTO-CBD and the Medical Research and Material Command to JMD and SB (USAMRIID). Integrated Biotherapeutics provided support in the form of salaries for authors KLW, RCU, FWH, SS, HV, and MJA but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allaranga Yokouide, 2010, East Afr J Public Health, V7, P30; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500; Boisgerault Florence, 2002, Expert Rev Vaccines, V1, P101, DOI 10.1586/14760584.1.1.101; Buonaguro L, 2010, CURR HIV RES, V8, P299, DOI 10.2174/157016210791208659; Conner ME, 1996, J INFECT DIS, V174, pS88, DOI 10.1093/infdis/174.Supplement_1.S88; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Estes MK, 1997, ADV EXP MED BIOL, V412, P387; Falzarano D, 2011, J INFECT DIS, V204, pS1082, DOI 10.1093/infdis/jir350; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Herbert AS, 2013, J VIROL, V87, P4952, DOI 10.1128/JVI.03361-12; Johnson JE, 2000, CURR OPIN STRUC BIOL, V10, P229, DOI 10.1016/S0959-440X(00)00073-7; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kallstrom G, 2005, J VIROL METHODS, V127, P1, DOI 10.1016/j.jviromet.2005.02.015; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; MOE JB, 1981, J CLIN MICROBIOL, V13, P791, DOI 10.1128/JCM.13.4.791-793.1981; Naslund J, 2009, VIROLOGY, V385, P409, DOI 10.1016/j.virol.2008.12.012; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Pratt WD, 2010, CLIN VACCINE IMMUNOL, V17, P572, DOI 10.1128/CVI.00467-09; Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605; Qiu XG, 2013, J VIROL, V87, P7754, DOI 10.1128/JVI.00173-13; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sun YL, 2009, VIROLOGY, V383, P12, DOI 10.1016/j.virol.2008.09.020; Swenson DL, 2008, EXPERT REV VACCINES, V7, P417, DOI 10.1586/14760584.7.4.417; Swenson DL, 2005, VACCINE, V23, P3033, DOI 10.1016/j.vaccine.2004.11.070; Swenson DL, 2004, FEMS IMMUNOL MED MIC, V40, P27, DOI 10.1016/S0928-8244(03)00273-6; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Warfield KL, 2007, J INFECT DIS, V196, pS421, DOI 10.1086/520612; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2014, P NATL ACAD SCI USA, V111, P8873, DOI 10.1073/pnas.1316902111; Warfield KL, 2011, J INFECT DIS, V204, pS1053, DOI 10.1093/infdis/jir346; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Warfield KL, 2004, VACCINE, V22, P3495, DOI 10.1016/j.vaccine.2004.01.063; Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100; Warfield KL, 2006, PLOS PATHOGENS, V2; Ye L, 2006, VIROLOGY, V351, P260, DOI 10.1016/j.virol.2006.03.021	42	45	48	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118881	10.1371/journal.pone.0118881	http://dx.doi.org/10.1371/journal.pone.0118881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793502	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200043
J	Xu, JS; Menon, SN; Singh, R; Garnier, NB; Sinha, S; Pumir, A				Xu, Jinshan; Menon, Shakti N.; Singh, Rajeev; Garnier, Nicolas B.; Sinha, Sitabhra; Pumir, Alain			The Role of Cellular Coupling in the Spontaneous Generation of Electrical Activity in Uterine Tissue	PLOS ONE			English	Article							CAJAL-LIKE CELLS; SMOOTH-MUSCLE; INTERSTITIAL-CELLS; GAP-JUNCTIONS; RAT UTERUS; MYOCYTES; FIBROBLASTS; PROPAGATION; CALCIUM; CONTRACTIONS	The spontaneous emergence of contraction-inducing electrical activity in the uterus at the beginning of labor remains poorly understood, partly due to the seemingly contradictory observation that isolated uterine cells are not spontaneously active. It is known, however, that the expression of gap junctions increases dramatically in the approach to parturition, by more than one order of magnitude, which results in a significant increase in inter-cellular electrical coupling. In this paper, we build upon previous studies of the activity of electrically excitable smooth muscle cells (myocytes) and investigate the mechanism through which the coupling of these cells to electrically passive cells results in the generation of spontaneous activity in the uterus. Using a recently developed, realistic model of uterine muscle cell dynamics, we investigate a system consisting of a myocyte coupled to passive cells. We then extend our analysis to a simple two-dimensional lattice model of the tissue, with each myocyte being coupled to its neighbors, as well as to a random number of passive cells. We observe that different dynamical regimes can be observed over a range of gap junction conductances: at low coupling strength, corresponding to values measured long before delivery, the activity is confined to cell clusters, while the activity for high coupling, compatible with values measured shortly before delivery, may spread across the entire tissue. Additionally, we find that the system supports the spontaneous generation of spiral wave activity. Our results are both qualitatively and quantitatively consistent with observations from in vitro experiments. In particular, we demonstrate that the increase in inter-cellular electrical coupling observed experimentally strongly facilitates the appearance of spontaneous action potentials that may eventually lead to parturition.	[Xu, Jinshan] Zhejiang Univ Technol, Coll Comp Sci, Hangzhou, Zhejiang, Peoples R China; [Menon, Shakti N.; Singh, Rajeev; Sinha, Sitabhra] Inst Math Sci, Madras 600113, Tamil Nadu, India; [Garnier, Nicolas B.; Pumir, Alain] Ecole Normale Super Lyon, Phys Lab, F-69007 Lyon, France; [Pumir, Alain] Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany	Zhejiang University of Technology; Institute of Mathematical Sciences (IMSc) India; Ecole Normale Superieure de Lyon (ENS de LYON); Max Planck Society	Pumir, A (corresponding author), Ecole Normale Super Lyon, Phys Lab, F-69007 Lyon, France.	alain.pumir@ens-lyon.fr	Pumir, Alain/AAH-6566-2020; Garnier, Nicolas B/H-4439-2012; Singh, Rajeev/F-8854-2019	Garnier, Nicolas B/0000-0002-1094-7201; Singh, Rajeev/0000-0002-0768-6549; Menon, Shakti/0000-0001-5307-2153; Sinha, Sitabhra/0000-0002-3004-1079	Chinese National Science Foundation [11405145]; Institute of Mathematical Sciences in Chennai; Ecole Normale Superieure de Lyon; CNRS; Humboldt foundation; JoriSS exchange program from ENS Lyon; Indo-French Center for Applied Mathematics program	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Institute of Mathematical Sciences in Chennai; Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); CNRS(Centre National de la Recherche Scientifique (CNRS)); Humboldt foundation(Alexander von Humboldt Foundation); JoriSS exchange program from ENS Lyon; Indo-French Center for Applied Mathematics program(French National Research Agency (ANR))	JX is supported by the Chinese National Science Foundation (11405145). RS, SNM and SS received funding from their institution, the Institute of Mathematical Sciences in Chennai. NBG and AP received funding from their institution, the Ecole Normale Superieure de Lyon and CNRS. AP received support from the Humboldt foundation. Computer time on the "Annapurna" supercomputer was provided by the Institute for Mathematical Science in Chennai. Collaborative work was funded by the JoriSS exchange program from ENS Lyon, and by the Indo-French Center for Applied Mathematics program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGTSSON B, 1984, AM J PHYSIOL, V246, pC216, DOI 10.1152/ajpcell.1984.246.3.C216; Bub G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.058101; Burdyga T, 2007, ANN NY ACAD SCI, V1101, P85, DOI 10.1196/annals.1389.002; Bursztyn L, 2007, ANN NY ACAD SCI, V1101, P110, DOI 10.1196/annals.1389.025; Chen W, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/18001; Chilton L, 2007, J PHYSIOL-LONDON, V583, P225, DOI 10.1113/jphysiol.2007.135038; CSAPO IA, 1963, J PHYSIOL-LONDON, V165, P575, DOI 10.1113/jphysiol.1963.sp007081; Doring B, 2006, J CELL SCI, V119, P1715, DOI 10.1242/jcs.02892; Duquette RA, 2005, BIOL REPROD, V72, P276, DOI 10.1095/biolreprod.104.033506; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Guckenheimer J, 2013, APPL MATH SCI, V42; Jacquemet V, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011908; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; Kiseleva I, 1998, J MOL CELL CARDIOL, V30, P1083, DOI 10.1006/jmcc.1998.0673; Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096; KOHL P, 1994, EXP PHYSIOL, V79, P943, DOI 10.1113/expphysiol.1994.sp003819; Kryukov AK, 2008, CHAOS, V18, DOI 10.1063/1.2956985; Lammers WJEP, 2008, AM J PHYSIOL-REG I, V294, pR919, DOI 10.1152/ajpregu.00704.2007; Lammers WJEP, 2013, REPROD SCI, V20, P182, DOI 10.1177/1933719112446082; Lammers WJEP, 1997, PFLUG ARCH EUR J PHY, V433, P287; Lammers WJEP, 1999, PFLUG ARCH EUR J PHY, V437, P363, DOI 10.1007/s004240050790; LANDA JF, 1959, AM J PHYSIOL, V196, P905, DOI 10.1152/ajplegacy.1959.196.4.905; Loch-Caruso Rita K, 2003, Reprod Biol Endocrinol, V1, P62, DOI 10.1186/1477-7827-1-62; Maggio CD, 2012, B MATH BIOL, V74, P143, DOI 10.1007/s11538-011-9681-1; Majumder R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045040; Malmstrom E, 2007, MOL HUM REPROD, V13, P333, DOI 10.1093/molehr/gal117; Martin JA, 2009, TECHNICAL REPORT; Mathews TJ, 2012, NATL VITAL STAT REPO, V60; McHale N, 2006, J PHYSIOL-LONDON, V570, P23, DOI 10.1113/jphysiol.2005.098376; MILLER SM, 1989, AM J PHYSIOL, V256, pC130, DOI 10.1152/ajpcell.1989.256.1.C130; Miyoshi H, 1996, BIOPHYS J, V71, P1324, DOI 10.1016/S0006-3495(96)79332-3; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Parkington HC, 1999, AM J OBSTET GYNECOL, V181, P1445, DOI 10.1016/S0002-9378(99)70390-X; Pervolaraki Eleftheria, 2012, Information Processing in Cells and Tissues. Proceedings of the 9th International Conference, IPCAT 2012, P162, DOI 10.1007/978-3-642-28792-3_21; Popescu LM, 2010, J CELL MOL MED, V14, P729, DOI 10.1111/j.1582-4934.2010.01059.x; Popescu LM, 2007, ANN NY ACAD SCI, V1101, P139, DOI 10.1196/annals.1389.022; Popescu LM, 2005, J CELL MOL MED, V9, P479, DOI 10.1111/j.1582-4934.2005.tb00376.x; Pumir A, 2005, BIOPHYS J, V89, P2332, DOI 10.1529/biophysj.105.061820; Rihana S, 2009, MED BIOL ENG COMPUT, V47, P665, DOI 10.1007/s11517-009-0433-4; Sergeant GP, 2000, J PHYSIOL-LONDON, V526, P359, DOI 10.1111/j.1469-7793.2000.t01-2-00359.x; Singh R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.068102; Takemura M, 2005, MOL HUM REPROD, V11, P659, DOI 10.1093/molehr/gah229; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Tsai ML, 1998, TOXICOL APPL PHARM, V152, P18, DOI 10.1006/taap.1998.8516; Valiunas V, 2004, J PHYSIOL-LONDON, V555, P617, DOI 10.1113/jphysiol.2003.058719; Wang CT, 2002, TOXICOL APPL PHARM, V182, P136, DOI 10.1006/taap.2002.9411; Wang SY, 1998, J GEN PHYSIOL, V112, P737, DOI 10.1085/jgp.112.6.737; Weber CR, 2001, J GEN PHYSIOL, V117, P119, DOI 10.1085/jgp.117.2.119; Wray S, 2001, EXP PHYSIOL, V86, P239, DOI 10.1113/eph8602114; Xu JS, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/093046; Yoshino M, 1997, J GEN PHYSIOL, V110, P565, DOI 10.1085/jgp.110.5.565; Young RC, 2007, ANN NY ACAD SCI, V1101, P72, DOI 10.1196/annals.1389.038	52	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118443	10.1371/journal.pone.0118443	http://dx.doi.org/10.1371/journal.pone.0118443			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793276	gold, Green Submitted, Green Published			2022-12-26	WOS:000352084200023
J	Cruz-Mora, J; Perez-Valdespino, A; Gupta, S; Withange, N; Kuwana, R; Takamatsu, H; Christie, G; Setlow, P				Cruz-Mora, Jose; Perez-Valdespino, Abigail; Gupta, Srishti; Withange, Nilumi; Kuwana, Ritsuko; Takamatsu, Hiromu; Christie, Graham; Setlow, Peter			The GerW Protein Is Not Involved in the Germination of Spores of Bacillus Species	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; INNER MEMBRANE; SUBTILIS; LOCALIZATION; DORMANT	Germination of dormant spores of Bacillus species is initiated when nutrient germinants bind to germinant receptors in spores' inner membrane and this interaction triggers the release of dipicolinic acid and cations from the spore core and their replacement by water. Bacillus subtilis spores contain three functional germinant receptors encoded by the gerA, gerB, and gerK operons. The GerA germinant receptor alone triggers germination with L-valine or L-alanine, and the GerB and GerK germinant receptors together trigger germination with a mixture of L-asparagine, D-glucose, D-fructose and KCl (AGFK). Recently, it was reported that the B. subtilis gerW gene is expressed only during sporulation in developing spores, and that GerW is essential for L-alanine germination of B. subtilis spores but not for germination with AGFK. However, we now find that loss of the B. subtilis gerW gene had no significant effects on: i) rates of spore germination with L-alanine; ii) spores' levels of germination proteins including GerA germinant receptor subunits; iii) AGFK germination; iv) spore germination by germinant receptor-independent pathways; and v) outgrowth of germinated spores. Studies in Bacillus megaterium did find that gerW was expressed in the developing spore during sporulation, and in a temperature-dependent manner. However, disruption of gerW again had no effect on the germination of B. megaterium spores, whether germination was triggered via germinant receptor-dependent or germinant receptor-independent pathways.	[Cruz-Mora, Jose; Perez-Valdespino, Abigail; Setlow, Peter] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06032 USA; [Gupta, Srishti; Withange, Nilumi; Christie, Graham] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Kuwana, Ritsuko; Takamatsu, Hiromu] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 57301, Japan	University of Connecticut; University of Cambridge; Setsunan University	Setlow, P (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06032 USA.	setlow@nso2.uchc.edu		PEREZ VALDESPINO, ABIGAIL/0000-0002-2885-592X	Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory; U.S. Army Research Office [W911F-09-1-0286]; Army Research Office [W911NF-12-1-0325]; Gonville and Caius College, University of Cambridge	Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory; U.S. Army Research Office; Army Research Office; Gonville and Caius College, University of Cambridge	This work was supported by a Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory and the U.S. Army Research Office under contract number W911F-09-1-0286 (PS/YQL), and by a grant from the Army Research Office under contract number W911NF-12-1-0325. SG was the recipient of an R.A. Fisher Bursary Award from Gonville and Caius College, University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert ER, 2005, NAT REV MICROBIOL, V3, P214, DOI 10.1038/nrmicro1096; Butzin XY, 2012, J BACTERIOL, V194, P5749, DOI 10.1128/JB.01276-12; Christie G, 2008, J BACTERIOL, V190, P2014, DOI 10.1128/JB.01687-07; Christie G, 2008, J BACTERIOL, V190, P8009, DOI 10.1128/JB.01073-08; Fisher N, 2005, J BACTERIOL, V187, P8055, DOI 10.1128/JB.187.23.8055-8062.2005; Ghosh S, 2012, J BACTERIOL, V194, P2221, DOI 10.1128/JB.00151-12; Griffiths KK, 2011, MOL MICROBIOL, V81, P1061, DOI 10.1111/j.1365-2958.2011.07753.x; Gupta S, 2013, J BACTERIOL, V195, P3045, DOI 10.1128/JB.00325-13; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Kobayashi K, 2008, MICROBIOL-SGM, V154, P54, DOI 10.1099/mic.0.2007/011783-0; Korza G, 2013, J BACTERIOL, V195, P1484, DOI 10.1128/JB.02262-12; Kuwana R, 2002, MICROBIOL-SGM, V148, P3971, DOI 10.1099/00221287-148-12-3971; Kuwana R, 2013, J BIOCHEM, V154, P409, DOI 10.1093/jb/mvt072; Mongkolthanaruk W, 2011, J BACTERIOL, V193, P2268, DOI 10.1128/JB.01398-10; Mongkolthanaruk W, 2009, MICROBIOL-SGM, V155, P1146, DOI 10.1099/mic.0.023853-0; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Paidhungat M, 2000, J BACTERIOL, V182, P5505, DOI 10.1128/JB.182.19.5505-5512.2000; Paredes-Sabja D, 2011, TRENDS MICROBIOL, V19, P85, DOI 10.1016/j.tim.2010.10.004; Pelczar PL, 2008, J BACTERIOL, V190, P5635, DOI 10.1128/JB.00670-08; Ramirez-Peralta A, 2013, J BACTERIOL, V195, P3009, DOI 10.1128/JB.00257-13; Ramirez-Peralta A, 2012, J BACTERIOL, V194, P3417, DOI 10.1128/JB.00504-12; Ramirez-Peralta A, 2012, APPL ENVIRON MICROB, V78, P2689, DOI 10.1128/AEM.07908-11; Ross C, 2010, CURR ISSUES MOL BIOL, V12, P147; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P, 2013, J APPL MICROBIOL, V115, P1251, DOI 10.1111/jam.12343; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Vepachedu VR, 2005, J BACTERIOL, V187, P5677, DOI 10.1128/JB.187.16.5677-5682.2005; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; WITTCHEN KD, 1995, APPL MICROBIOL BIOT, V42, P871, DOI 10.1007/s002530050345; Yi X, 2011, APPL ENVIRON MICROB, V77, P5536, DOI 10.1128/AEM.00577-11; Yi XA, 2010, J BACTERIOL, V192, P3424, DOI 10.1128/JB.00326-10	31	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119125	10.1371/journal.pone.0119125	http://dx.doi.org/10.1371/journal.pone.0119125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790435	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400068
J	de Frutos, A; Navarro, T; Pueyo, Y; Alados, CL				de Frutos, Angel; Navarro, Teresa; Pueyo, Yolanda; Alados, Concepcion L.			Inferring Resilience to Fragmentation-Induced Changes in Plant Communities in a Semi-Arid Mediterranean Ecosystem	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY INDEXES; LAND-USE INTENSIFICATION; RESPONSE DIVERSITY; SPATIAL-PATTERNS; HABITAT FRAGMENTATION; SELF-ORGANIZATION; DISPERSAL; TRAITS; BIODIVERSITY; REDUNDANCY	Predicting the capacity of ecosystems to absorb impacts from disturbance events (resilience), including land-use intensification and landscape fragmentation, is challenging in the face of global change. Little is known about the impacts of fragmentation on ecosystem functioning from a multi-dimensional perspective (multiple traits). This study used 58 500-m linear transects to quantify changes in the functional composition and resilience of vascular plant communities in response to an increase in landscape fragmentation in 18 natural scrubland fragments embedded within a matrix of abandoned crop fields in Cabo de Gata-Nijar Natural Park, Almeria, Spain. Changes in functional community composition were measured using functional diversity indices (functional richness and functional dispersion) that were based on 12 plant traits. Resilience was evaluated using the functional redundancy and response diversity from the perspective of plant dispersal, which is important, particularly, in fragmented landscapes. Scrubland fragmentation was measured using the Integral Index of Connectivity (IIC). The functional richness of the plant communities was higher in the most fragmented scrubland. Conversely, the functional dispersion (i.e., spread) of trait values among species in the functional trait space was lower at the most fragmented sites; consequently, the ecological tolerance of the vegetation to scrubland fragmentation decreased. Classifying the plant species into four functional groups indicated that fragmentation favoured an increase in functional redundancy in the 'short basal annual forbs and perennial forbs' group, most of which are species adapted to degraded soils. An assessment based on the traits associated with plant dispersal indicated that the resilience of 'woody plants', an important component in the Mediterranean scrubland, and habitat fragmentation were negatively correlated; however, the correlation was positive in the 'short basal annual forbs and perennial forbs' and the 'grasses' groups.	[de Frutos, Angel] CSIC, Pyrenean Inst Ecol, Jaca, Huesca, Spain; [Pueyo, Yolanda; Alados, Concepcion L.] CSIC, Pyrenean Inst Ecol, Zaragoza, Spain; [Navarro, Teresa] Univ Malaga, Dept Biol Vegetal, E-29071 Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Universidad de Malaga	de Frutos, A (corresponding author), CSIC, Pyrenean Inst Ecol, Jaca, Huesca, Spain.	adefrutost@gmail.com	Navarro, Teresa/AAE-8157-2019; Pueyo, Yolanda/I-4248-2015; Alados, Concepción L/K-8085-2014	Pueyo, Yolanda/0000-0001-6970-7790; Alados, Concepción L/0000-0002-6227-861X; de Frutos, Angel/0000-0002-5250-9488; Navarro del Aguila, Maria Teresa/0000-0002-8410-1954	JAE-DOC from the Spanish Research Council (CSIC); Fondo Social Europeo; Spanish Ministry of Economy and Competitiveness [CGL2011-27259, CGL2012-37508]	JAE-DOC from the Spanish Research Council (CSIC); Fondo Social Europeo(European Social Fund (ESF)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	AF was financed by a JAE-DOC postdoctoral contract from the Spanish Research Council (CSIC) (http://www.csic.es/web/guest/home) and Fondo Social Europeo (http://ec.europa.eu/esf/home.jsp?langId=en). The authors acknowledge financial support from the Spanish Ministry of Economy and Competitiveness (research project: CGL2011-27259 and CGL2012-37508). This funder had a role in study design, data collection and analysis.	Alados CL, 2009, ECOL COMPLEX, V6, P197, DOI 10.1016/j.ecocom.2008.10.015; Alados CL, 2006, BIOL J LINN SOC, V87, P103, DOI 10.1111/j.1095-8312.2006.00559.x; Alados CL, 2004, ECOL MODEL, V180, P523, DOI 10.1016/j.ecolmodel.2003.10.034; Alados CL, 2004, LANDSCAPE ECOL, V19, P543; Alados CL, 2003, ECOL MODEL, V163, P1, DOI 10.1016/S0304-3800(02)00294-6; Alados CL, 2010, BIOL J LINN SOC, V100, P935, DOI 10.1111/j.1095-8312.2010.01465.x; Arthaud F, 2012, AQUAT SCI, V74, P471, DOI 10.1007/s00027-011-0241-4; Atkinson B. W., 1981, MESO SCALE ATMOSPHER; Azorin-Molina C, 2009, ATMOSFERA, V22, P33; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; BARROSO FG, 1995, J ARID ENVIRON, V31, P205, DOI 10.1006/jare.1995.0061; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baudena M, 2013, THEOR ECOL-NETH, V6, P131, DOI 10.1007/s12080-012-0165-1; Belda A, 2011, SPAN J AGRIC RES, V9, P1197, DOI [10.5424/http://dx.doi.org/10.5424/sjar/20110904-470-10, 10.5424/sjar/20110904-470-10]; BOJA, 2008, B OFICIAL JUNTA ANDA, V59, P114; Butterfield BJ, 2013, J ECOL, V101, P9, DOI 10.1111/1365-2745.12013; Carranza ML, 2012, PLANT ECOL DIVERS, V5, P541, DOI 10.1080/17550874.2012.740509; Castroviejo S., 1986, FLORA IBERICA, V1; Chapin III F.S., 2001, GLOBAL BIODIVERSITY; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chillo V, 2011, ECOSYSTEMS, V14, P1168, DOI 10.1007/s10021-011-9475-1; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; de Frutos A, 2007, ECOL MODEL, V200, P33, DOI 10.1016/j.ecolmodel.2006.07.007; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; HAASE P, 1995, J ARID ENVIRON, V31, P55, DOI 10.1006/jare.1995.0048; Hanski I, 2011, AMBIO, V40, P248, DOI 10.1007/s13280-011-0147-3; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; INE, 2009, CENS POBL VIV 2009; Katovai E, 2012, BIOL CONSERV, V145, P214, DOI 10.1016/j.biocon.2011.11.008; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Komac B, 2015, APPL VEG SCI, V18, P75, DOI 10.1111/avsc.12119; Laliberte E., 2011, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Legendre P., 2012, NUMERICAL ECOLOGY; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; Maestre FT, 2005, ACTA OECOL, V27, P161, DOI 10.1016/j.actao.2004.11.003; Maru YT, 2010, 201004 CSIRO SUST EC; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navarro T, 2009, J ARID ENVIRON, V73, P103, DOI 10.1016/j.jaridenv.2008.09.009; Navarro T, 2009, CANDOLLEA, V64, P69; Pakeman RJ, 2011, J ECOL, V99, P1143, DOI 10.1111/j.1365-2745.2011.01853.x; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; Peinado M., 1992, VEGETATION SE SPAIN; Pillar VD, 2013, J VEG SCI, V24, P963, DOI 10.1111/jvs.12047; Pinheiro J, 2020, R PACKAGE VERSION 31; Pueyo Y, 2009, RESTOR ECOL, V17, P908, DOI 10.1111/j.1526-100X.2008.00474.x; Pugnaire FI, 2000, ANN BOT-LONDON, V86, P807, DOI 10.1006/anbo.2000.1240; R Core Team, 2021, R LANGUAGE ENV STAT; Realpe-Gomez J, 2013, ECOL COMPLEX, V15, P97, DOI 10.1016/j.ecocom.2013.04.002; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Saiz H, 2011, ECOL COMPLEX, V8, P184, DOI 10.1016/j.ecocom.2011.02.001; Saiz H, 2011, ECOL RES, V26, P595, DOI 10.1007/s11284-011-0818-3; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Schoning C, 2004, J ARID ENVIRON, V56, P43, DOI 10.1016/S0140-1963(03)00024-7; SILBERBAUERGOTTSBERGER I, 1984, PLANT SYST EVOL, V147, P1, DOI 10.1007/BF00984577; SORIANO A, 1994, VEGETATIO, V111, P127, DOI 10.1007/BF00040332; Standish RJ, 2014, BIOL CONSERV, V177, P43, DOI 10.1016/j.biocon.2014.06.008; Suarez F., 2010, ALONDRA RICOTI CHERS; Trombulak SC, 2004, CONSERV BIOL, V18, P1180, DOI 10.1111/j.1523-1739.2004.01851.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Walker B. H., 1992, Conservation Biology, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Zuur Alain F., 2009, P1	89	10	10	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118837	10.1371/journal.pone.0118837	http://dx.doi.org/10.1371/journal.pone.0118837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790432	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400048
J	Lunghi, B; De Cunto, G; Cavarra, E; Fineschi, S; Bartalesi, B; Lungarella, G; Lucattelli, M				Lunghi, Benedetta; De Cunto, Giovanna; Cavarra, Eleonora; Fineschi, Silvia; Bartalesi, Barbara; Lungarella, Giuseppe; Lucattelli, Monica			Smoking p66Shc Knocked Out Mice Develop Respiratory Bronchiolitis with Fibrosis but Not Emphysema	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKE; OXIDATIVE STRESS; LIFE-SPAN; SIGNALING PATHWAY; REDOX REGULATION; APOPTOSIS; MACROPHAGES; EXPRESSION; PROTEINS	The adaptor protein p66Shc regulates intracellular oxidant levels through the modulation of a forkhead-related transcription factor (FOXO3a). The genetic ablation of p66(Shc) (p66(Shc-/-)) renders mice resistant to oxidative stress and p53-dependent apoptosis. We investigated whether p66(Shc) ablation in mice modifies lung cellular and molecular responses to cigarette smoke (CS) exposure. No differences between wild type (WT) and p66(Shc-/-) mice were observed in terms of inflammation and oxidant burden after acute CS exposure; however, p66(Shc) ablation modifies specific features of chronic inflammation induced by repeated exposure to CS. Unlike WT mice, p66(Shc-/-) mice did not develop emphysema, showing protection toward oxidative damage to DNA and apoptosis as revealed by a trivial 8-hydroxyguanosine staining and faint TUNEL and caspase-3 positivity on alveolar epithelial cells. Unexpectedly, CS exposure in p66(Shc-/-) mice resulted in respiratory bronchiolitis with fibrosis in surrounded alveoli. Respiratory bronchiolitis was characterized by peribronchiolar infiltrates of lymphocytes and histiocytes, accumulation of ageing pigmented macrophages within and around bronchioles, and peribronchiolar fibrosis. The blockage of apoptosis interferes with the macrophage "clearance" from alveolar spaces, favouring the accumulation of aging macrophages into alveoli and the progressive accumulation of iron pigment in long-lived senescent cells. The presence of areas of interstitial and alveolar fibrosis in peripheral parenchyma often accompanied the bronchiolar changes. Macrophages from smoking p66(Shc-/-) mice elaborate M2 cytokines (i.e., IL-4 and IL-13) and enzymes (i.e., chitinase and arginase I), which can promote TGF-beta expression, collagen deposition, and fibrosis in the surrounding areas. We demonstrate here that resistance to oxidative stress and p53-dependent apoptosis can modify tissue responses to CS caused by chronic inflammation without influencing early inflammatory response to CS exposure.	[Lunghi, Benedetta; De Cunto, Giovanna; Cavarra, Eleonora; Fineschi, Silvia; Bartalesi, Barbara; Lungarella, Giuseppe; Lucattelli, Monica] Univ Siena, Dept Life Sci, Expt Pathol Sect, Via Laterina 8, I-53100 Siena, Italy	University of Siena	Lucattelli, M (corresponding author), Univ Siena, Dept Life Sci, Expt Pathol Sect, Via Laterina 8, I-53100 Siena, Italy.	monica.lucattelli@unisi.it		De Cunto, Giovanna/0000-0002-3869-4621; CAVARRA, ELEONORA/0000-0002-4600-0546; LUNGARELLA, Giuseppe/0000-0002-3796-7317	Ministero dell'Istruzione, Universita e Ricerca, Rome, Italy [2004067923]	Ministero dell'Istruzione, Universita e Ricerca, Rome, Italy(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from the Ministero dell'Istruzione, Universita e Ricerca, Rome, Italy (grant no. 2004067923) to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; [Anonymous], 1996, Am J Respir Crit Care Med, V153, P861; Aoshiba K, 2001, AM J PHYSIOL-LUNG C, V281, pL1392, DOI 10.1152/ajplung.2001.281.6.L1392; Atzori L, 2009, AM J RESP CELL MOL, V41, P680, DOI 10.1165/rcmb.2007-0386OC; Bartalesi B, 2005, EUR RESPIR J, V25, P15, DOI 10.1183/09031936.04.00067204; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/769214, DOI 10.1155/2013/769214]; CAMPBELL H, 1952, NATURE, V170, P117, DOI 10.1038/170117a0; Cardini S, 2012, AM J RESP CELL MOL, V47, P332, DOI 10.1165/rcmb.2012-0036OC; Cavarra E, 2001, AM J RESP CRIT CARE, V164, P886, DOI 10.1164/ajrccm.164.5.2010032; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Cocci F, 2002, INT J BIOCHEM CELL B, V34, P594, DOI 10.1016/S1357-2725(02)00015-8; EIDELMAN DH, 1990, LUNG, V168, P159, DOI 10.1007/BF02719687; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Frankenberger M, 2004, CLIN EXP IMMUNOL, V138, P507, DOI 10.1111/j.1365-2249.2004.02637.x; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Graiani G, 2005, HYPERTENSION, V46, P433, DOI 10.1161/01.HYP.0000174986.73346.ba; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Hiemstra Pieter S, 2013, Ann Am Thorac Soc, V10 Suppl, pS180, DOI 10.1513/AnnalsATS.201305-123AW; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Hwang JW, 2011, J IMMUNOL, V187, P987, DOI 10.4049/jimmunol.1001861; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Koch OR, 2008, LAB INVEST, V88, P750, DOI 10.1038/labinvest.2008.44; Lee MK, 2014, AM J PHYSIOL-LUNG C, V306, pL316, DOI 10.1152/ajplung.00062.2013; MacNee W, 1999, AM J RESP CRIT CARE, V160, pS58, DOI 10.1164/ajrccm.160.supplement_1.15; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; MYERS JL, 1987, AM REV RESPIR DIS, V135, P880, DOI 10.1164/arrd.1987.135.4.880; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Pastukh VM, 2011, INT J CHRONIC OBSTR, V6, P209, DOI 10.2147/COPD.S15922; Pellegrini M, 2005, APOPTOSIS, V10, P13, DOI 10.1007/s10495-005-6057-8; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Ramsey JJ, 2014, J GERONTOL A-BIOL, V69, P1177, DOI 10.1093/gerona/glt198; Reddy Taryn L, 2013, Ann Am Thorac Soc, V10, P590, DOI 10.1513/AnnalsATS.201304-088OC; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Teramoto S, 2005, CHEST, V127, P1079, DOI 10.1378/chest.127.3.1079; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P765; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Tuder Rubin M, 2012, Proc Am Thorac Soc, V9, P62, DOI 10.1513/pats.201201-012MS; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Yu Q, 2000, GENE DEV, V14, P163; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F	53	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119797	10.1371/journal.pone.0119797	http://dx.doi.org/10.1371/journal.pone.0119797			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790295	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400107
J	Szymkowiak, J; Kuczynski, L				Szymkowiak, Jakub; Kuczynski, Lechoslaw			Predation-Related Costs and Benefits of Conspecific Attraction in Songbirds-An Agent-Based Approach	PLOS ONE			English	Article							WARBLER PHYLLOSCOPUS-SIBILATRIX; SOCIAL INFORMATION USE; HABITAT SELECTION; PUBLIC INFORMATION; NEST PREDATION; ECOLOGICAL TRAPS; PRIMEVAL FOREST; ANIMAL BEHAVIOR; DENSITY; BIRDS	Songbirds that follow a conspecific attraction strategy in the habitat selection process prefer to settle in habitat patches already occupied by other individuals. This largely affects the patterns of their spatio-temporal distribution and leads to clustered breeding. Although making informed settlement decisions is expected to be beneficial for individuals, such territory clusters may potentially provide additional fitness benefits (e.g., through the dilution effect) or costs (e.g., possibly facilitating nest localization if predators respond functionally to prey distribution). Thus, we hypothesized that the fitness consequences of following a conspecific attraction strategy may largely depend on the composition of the predator community. We developed an agent-based model in which we simulated the settling behavior of birds that use a conspecific attraction strategy and breed in a multi-predator landscape with predators that exhibited different foraging strategies. Moreover, we investigated whether Bayesian updating of prior settlement decisions according to the perceived predation risk may improve the fitness of birds that rely on conspecific cues. Our results provide evidence that the fitness consequences of conspecific attraction are predation-related. We found that in landscapes dominated by predators able to respond functionally to prey distribution, clustered breeding led to fitness costs. However, this cost could be reduced if birds performed Bayesian updating of prior settlement decisions and perceived nesting with too many neighbors as a threat. Our results did not support the hypothesis that in landscapes dominated by incidental predators, clustered breeding as a byproduct of conspecific attraction provides fitness benefits through the dilution effect. We suggest that this may be due to the spatial scale of songbirds' aggregative behavior. In general, we provide evidence that when considering the fitness consequences of conspecific attraction for songbirds, one should expect a trade-off between the benefits of making informed decisions and the costs of clustering.	[Szymkowiak, Jakub; Kuczynski, Lechoslaw] Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Avian Biol & Ecol, Poznan, Poland	Adam Mickiewicz University	Szymkowiak, J (corresponding author), Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Avian Biol & Ecol, Poznan, Poland.	jszym@amu.edu.pl	Kuczyński, Lechosław/E-5525-2011; Szymkowiak, Jakub/D-6669-2016	Kuczyński, Lechosław/0000-0003-3498-5445; Szymkowiak, Jakub/0000-0002-4595-1876	National Science Centre in Poland [2012/07/N/NZ8/00129]	National Science Centre in Poland(National Science Centre, Poland)	This work was supported by the National Science Centre in Poland (grant number 2012/07/N/NZ8/00129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2006, AUK, V123, P301, DOI 10.1642/0004-8038(2006)123[301:AHMMCA]2.0.CO;2; Ahlering MA, 2010, CONDOR, V112, P252, DOI 10.1525/cond.2010.090239; ALATALO RV, 1982, BIRD BEHAV, V4, P42, DOI 10.3727/015613882791560576; Andren H., 1991, ANIM BEHAV, V41, P1063; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Bayard TS, 2012, WETLANDS, V32, P521, DOI 10.1007/s13157-012-0287-7; BEEHLER BM, 1988, AM NAT, V131, P203, DOI 10.1086/284786; Betts MG, 2008, ECOGRAPHY, V31, P592, DOI 10.1111/j.0906-7590.2008.05490.x; CLARK KL, 1979, BEHAV ECOL SOCIOBIOL, V5, P359, DOI 10.1007/BF00292524; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Diong CH, 1982, THESIS U HAWAII MANO; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; Forsman JT, 2007, BEHAV ECOL, V18, P888, DOI 10.1093/beheco/arm048; Fuller R.J., 2012, BIRDS HABITAT RELATI; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; Gilroy JJ, 2010, IBIS, V152, P90, DOI 10.1111/j.1474-919X.2009.00988.x; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Glutz von Blotzheim U., 1991, HDB VOGEL MITTELEURO; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hahn BA, 2007, ANIM CONSERV, V10, P436, DOI 10.1111/j.1469-1795.2007.00128.x; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Ioannou CC, 2008, ANIM BEHAV, V75, P1383, DOI 10.1016/j.anbehav.2007.09.012; Kery M., 2010, INTRO WINBUGS ECOLOG; KRAUSE J, 1995, ANIM BEHAV, V50, P465, DOI 10.1006/anbe.1995.0260; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Mallord JW, 2012, BIRD STUDY, V59, P286, DOI 10.1080/00063657.2012.669359; MCNAMARA J, 1980, J THEOR BIOL, V85, P673, DOI 10.1016/0022-5193(80)90265-9; McNamara JM, 2006, OIKOS, V112, P243, DOI 10.1111/j.0030-1299.2006.14228.x; Monkkonen Mikko, 2002, Ornithological Science, V1, P41, DOI 10.2326/osj.1.41; Morosinotto C, 2010, J ANIM ECOL, V79, P327, DOI 10.1111/j.1365-2656.2009.01638.x; NetLogo Wilensky U., 1999, NETLOGO; Nocera JJ, 2006, P ROY SOC B-BIOL SCI, V273, P349, DOI 10.1098/rspb.2005.3318; Phillips ML, 2004, J MAMMAL, V85, P187, DOI 10.1644/1545-1542(2004)085&lt;0187:AOPMIP&gt;2.0.CO;2; Plummer M., 2003, DSC 2003 WORKING PAP, DOI 10.1002/ana.1067; R Development Core Team, 2013, LANG ENV STAT COMP; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Rieucau G, 2011, PHILOS T R SOC B, V366, P949, DOI 10.1098/rstb.2010.0325; Ringelman KM, 2014, OIKOS, V123, P239, DOI 10.1111/j.1600-0706.2013.00851.x; Ringelman KM, 2014, ECOL MODEL, V272, P141, DOI 10.1016/j.ecolmodel.2013.09.028; Ringelman KM, 2012, OECOLOGIA, V169, P695, DOI 10.1007/s00442-011-2228-1; Schmidt KA, 1999, OIKOS, V87, P65, DOI 10.2307/3546997; Schmidt KA, 2010, OIKOS, V119, P304, DOI 10.1111/j.1600-0706.2009.17573.x; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Seymour AS, 2004, ECOL MODEL, V175, P101, DOI 10.1016/j.ecolmodel.2003.10.012; Sridhar H, 2009, ANIM BEHAV, V78, P337, DOI 10.1016/j.anbehav.2009.05.008; STAMPS JA, 1991, BEHAV ECOL SOCIOBIOL, V28, P29; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Su Y., 2014, R2JAGS PACKAGE RUNNI; Szymkowiak J., 2013, SPRINGER SCI REV, V1, P115, DOI DOI 10.1007/s40362-013-0012-9; Thomson RL, 2006, ECOGRAPHY, V29, P507; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Valone TJ, 2006, OIKOS, V112, P252; Ward MP, 2004, CONSERV BIOL, V18, P519, DOI 10.1111/j.1523-1739.2004.00494.x; WESOLOWSKI T, 1985, ORNIS SCAND, V16, P49, DOI 10.2307/3676575; Wesolowski T, 2009, ACTA ORNITHOL, V44, P69, DOI 10.3161/000164509X464902; Wesolowski T, 2009, BIRD STUDY, V56, P26, DOI 10.1080/00063650802681540	60	5	5	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119132	10.1371/journal.pone.0119132	http://dx.doi.org/10.1371/journal.pone.0119132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790479	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400069
J	Hill, J; Kayentao, K; Achieng, F; Diarra, S; Dellicour, S; Diawara, SI; Hamel, MJ; Ouma, P; Desai, M; Doumbo, OK; ter Kuile, FO; Webster, J				Hill, Jenny; Kayentao, Kassoum; Achieng, Florence; Diarra, Samba; Dellicour, Stephanie; Diawara, Sory I.; Hamel, Mary J.; Ouma, Peter; Desai, Meghna; Doumbo, Ogobara K.; ter Kuile, Feiko O.; Webster, Jayne			Access and Use of Interventions to Prevent and Treat Malaria among Pregnant Women in Kenya and Mali: A Qualitative Study	PLOS ONE			English	Article							ANTENATAL CARE; BIRTH-WEIGHT; AFRICA; METAANALYSIS; BURDEN	Background Coverage of malaria in pregnancy interventions in sub-Saharan Africa is suboptimal. We undertook a systematic examination of the operational, socio-economic and cultural constraints to pregnant women's access to intermittent preventive treatment (IPTp), long-lasting insecticide-treated nets (LLINs) and case management in Kenya and Mali to provide empirical evidence for strategies to improve coverage. Methods Focus group discussions (FGDs) were held as part of a programme of research to explore the delivery, access and use of interventions to control malaria in pregnancy. FGDs were held with four sub-groups: non-pregnant women of child bearing age (aged 15-49 years), pregnant women or mothers of children aged <1 year, adolescent women, and men. Content analysis was used to develop themes and sub-themes from the data. Results Women and men's perceptions of the benefits of antenatal care were generally positive; motivation among women consisted of maintaining a healthy pregnancy, disease prevention in mother and foetus, checking the position of the baby in preparation for delivery, and ensuring admission to a facility in case of complications. Barriers to accessing care related to the quality of the health provider-client interaction, perceived health provider skills and malpractice, drug availability, and cost of services. Pregnant women perceived themselves and their babies at particular risk from malaria, and valued diagnosis and treatment from a health professional, but cost of treatment at health facilities drove women to use herbal \remedies or drugs bought from shops. Women lacked information on the safety, efficacy and side effects of antimalarial use in pregnancy. Conclusion Women in these settings appreciated the benefits of antenatal care and yet health services in both countries are losing women to follow-up due to factors that can be improved with greater political will. Antenatal services need to be patient-centred, free-of-charge or highly affordable and accountable to the women they serve.	[Hill, Jenny; Dellicour, Stephanie; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Kayentao, Kassoum; Diarra, Samba; Diawara, Sory I.; Doumbo, Ogobara K.] Univ Sci Tech & Technol, Malaria Res & Training Ctr, Bamako, Mali; [Achieng, Florence; Ouma, Peter] Ctr Global Hlth Res, Kenya Med Res Inst, Kisumu, Kenya; [Hamel, Mary J.; Desai, Meghna] Ctr Dis Control & Prevent, Atlanta, GA USA; [Webster, Jayne] Ctr Dis Control & Prevent, Atlanta, Kenya; [Webster, Jayne] London Sch Trop Med & Hyg, Dis Control Dept, London, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Science & Technology of Bamako; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine	Hill, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	j.hill@liv.ac.uk	Kuile, Feiko ter/ABD-6681-2020; Hill, Jenny/C-3839-2017	Kuile, Feiko ter/0000-0003-3663-5617; Hill, Jenny/0000-0003-1588-485X; Webster, Jayne/0000-0002-0498-8883	Malaria in Pregnancy (MiP) Consortium through Bill & Melinda Gates Foundation	Malaria in Pregnancy (MiP) Consortium through Bill & Melinda Gates Foundation	This work was supported by the Malaria in Pregnancy (MiP) Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, STRATEGIC FRAMEWORK; [Anonymous], WHO TECHN REP SER; Cellule de Planification et de Statistique Ministere de la Sante Direction Nationale de la Statistique et de I'Informatique Ministere de I'Economie dlledC Bamako Mali, 2007, ENQ DEM SANT MAL 200; Dellicour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080551; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Diala C, 2012, BARRIERS UPTAKE MALA; Division of Malaria Control MoH Republic of Kenya, 2001, NAR MAL STRAT 2001 2; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; Famanta Aminata, 2011, Sante, V21, P3, DOI 10.1684/san.2011.0234; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Garner P, 2009, DRUGS PREVENTING MAL; Gies S, 2009, AM J TROP MED HYG, V80, P460, DOI 10.4269/ajtmh.2009.80.460; Hill J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092102; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Hill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064913; Iliyasu Z, 2012, PATHOG GLOB HEALTH, V106, P323, DOI 10.1179/2047773212Y.0000000037; Kenya Ministry of Health and Sanitation Health MoP, 2010, NAT GUID DIAGN TREAT; [Kenya National Bureau of Statistics ICF Macro], 2003, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Maiga Abderrahmane Sideye, 2010, Mali Med, V25, P41; Mathole T, 2004, MIDWIFERY, V20, P122, DOI 10.1016/j.midw.2003.10.003; MENACA A, 2013, MALARIA J, V12, DOI DOI 10.1186/1475-2875-12-; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Pell C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-427; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Programme National de Lutte Contre le Paludisme Mlnistere de al Sante Organisation Mondiale de la Sante, 2006, POL NAT LUTT CONTR P; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Stangeland T, 2011, J ETHNOPHARMACOL, V137, P154, DOI 10.1016/j.jep.2011.05.002; van Eijk AM, 2013, LANCET INFECT DIS, V13, P1029, DOI 10.1016/S1473-3099(13)70199-3; Walker PGT, 2014, LANCET GLOB HEALTH, V2, pE460, DOI 10.1016/S2214-109X(14)70256-6; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065437; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067520; WHO, 2006, INT MAN PREGN CHILDB; World Health Organisation, 2007, EV BUS STRAT HLTH SY; World Health Organization, 2007, INT MAN PREGN CHILDB	37	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119848	10.1371/journal.pone.0119848	http://dx.doi.org/10.1371/journal.pone.0119848			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798847	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300084
J	Ortega-Andrade, HM; Prieto-Torres, DA; Gomez-Lora, I; Lizcano, DJ				Mauricio Ortega-Andrade, H.; Prieto-Torres, David A.; Gomez-Lora, Ignacio; Lizcano, Diego J.			Ecological and Geographical Analysis of the Distribution of the Mountain Tapir (Tapirus pinchaque) in Ecuador: Importance of Protected Areas in Future Scenarios of Global Warming	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; CONSERVATION PRIORITIES; POPULATION-SIZE; EXTINCTION RISK; RANGE; DEFORESTATION; BIODIVERSITY; MODELS; UNCERTAINTY	In Ecuador, Tapirus pinchaque is considered to be critically endangered. Although the species has been registered in several localities, its geographic distribution remains unclear, and the effects of climate change and current land uses on this species are largely unknown. We modeled the ecological niche of T. pinchaque using MaxEnt, in order to assess its potential adaptation to present and future climate change scenarios. We evaluated the effects of habitat loss due by current land use, the ecosystem availability and importance of Ecuadorian System of Protected Areas into the models. The model of environmental suitability estimated an extent of occurrence for species of 21,729 km(2) in all of Ecuador, mainly occurring along the corridor of the eastern Ecuadorian Andes. A total of 10 Andean ecosystems encompassed similar to 98% of the area defined by the model, with herbaceous paramo, northeastern Andean montane evergreen forest and northeastern Andes upper montane evergreen forest being the most representative. When considering the effect of habitat loss, a significant reduction in model area (similar to 17%) occurred, and the effect of climate change represented a net reduction up to 37.86%. However, the synergistic effect of both climate change and habitat loss, given current land use practices, could represent a greater risk in the short-term, leading to a net reduction of 19.90 to 44.65% in T. pinchaque's potential distribution. Even under such a scenarios, several Protected Areas harbor a portion (similar to 36 to 48%) of the potential distribution defined by the models. However, the central and southern populations are highly threatened by habitat loss and climate change. Based on these results and due to the restricted home range of T. pinchaque, its preference for upland forests and paramos, and its small estimated population size in the Andes, we suggest to maintaining its current status as Critically Endangered in Ecuador.	[Mauricio Ortega-Andrade, H.; Prieto-Torres, David A.] Inst Ecol, Dept Evolut Biol, Lab Biogeog, AC, Xalapa 91070, Veracruz, Mexico; [Mauricio Ortega-Andrade, H.] Fdn EcoCiencia, Programa Conservac Especies Amenazadas Extinc Ecu, Quito, Ecuador; [Mauricio Ortega-Andrade, H.] Museo Ecuatoriano Ciencias Nat, Secc Vertebrados, Div Herpetol, Quito, Ecuador; [Prieto-Torres, David A.] Univ Zulia, Ctr Modelado Cient, Eje BioCiencias, Maracaibo 4011, Venezuela; [Gomez-Lora, Ignacio] UIMP, Consejo Super Invest Cient Espana SCIC, Areas Trop & Conservac, Biodiversidad, Madrid, Spain; [Gomez-Lora, Ignacio] Fdn EcoCiencia, Proyecto Conservac Tapir Andino Tapirus Pinchaqua, Quito, Ecuador; [Gomez-Lora, Ignacio] Univ Autonoma Madrid, Fdn Fernando Gonzalez Bernaldez, Espacios Nat Protegidos, Madrid, Spain; [Lizcano, Diego J.] Univ Laica Eloy Alfaro Manabi, Dept Cent Invest, Manta, Ecuador	Instituto de Ecologia - Mexico; Autonomous University of Madrid; Universidad Laica Eloy Alfaro De Manabi	Prieto-Torres, DA (corresponding author), Inst Ecol, Dept Evolut Biol, Lab Biogeog, AC, Carretera Antigua Coatepec 351, Xalapa 91070, Veracruz, Mexico.	dprieto@cmc.org.ve	Prieto-Torres, David A./N-1157-2017; Andrade, H. Mauricio Ortega/G-8245-2016; Lizcano, Diego J./E-6893-2011	Prieto-Torres, David A./0000-0002-0493-5941; Andrade, H. Mauricio Ortega/0000-0001-9464-3688; Lizcano, Diego J./0000-0002-9648-0576	EcoFondo-Ecuador, Programa para la Conservacion de Especies y Ecosistemas Amenazados de Extincion en Ecuador; Fundacion Ecociencia, Fundacion Zoologica del Ecuador; UICN/SSC Tapir Specialist Group-Ecuador; Idea Wild	EcoFondo-Ecuador, Programa para la Conservacion de Especies y Ecosistemas Amenazados de Extincion en Ecuador; Fundacion Ecociencia, Fundacion Zoologica del Ecuador; UICN/SSC Tapir Specialist Group-Ecuador; Idea Wild	This project received financial support by EcoFondo-Ecuador, Programa para la Conservacion de Especies y Ecosistemas Amenazados de Extincion en Ecuador sponsored by Fundacion Ecociencia, Fundacion Zoologica del Ecuador and the UICN/SSC Tapir Specialist Group-Ecuador. Additional field equipment were provided by a grant from Idea Wild.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Bassler C, 2010, ECOL INDIC, V10, P341, DOI 10.1016/j.ecolind.2009.06.014; BARVE N, 2008, TOOL PARTIAL ROC VER; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Bedia J, 2013, GLOBAL PLANET CHANGE, V107, P1, DOI 10.1016/j.gloplacha.2013.04.005; BROMLEY R, 1981, SINGAPORE J TROP GEO, V2, P15, DOI 10.1111/j.1467-9493.1981.tb00114.x; Castellanos P Armando X., 2013, Tapir Conservation, V22, P20; Castellanos P Armando X., 2013, Tapir Conservation, V22, P9; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; CITES, 2013, CONV INT TRAD END SP; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; Crawley M.J., 2007, R BOOK; Cuesta-Camacho F, 2007, ANALISIS VACIOS AREA, P83; de Grammont PC, 2006, CONSERV BIOL, V20, P14, DOI 10.1111/j.1523-1739.2006.00352.x; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; Diaz AG, 2008, TAPIRUS PINCHAQUE IU; DODSON CH, 1991, ANN MO BOT GARD, V78, P273, DOI 10.2307/2399563; Downer CC, 2001, J ZOOL, V254, P279, DOI 10.1017/S0952836901000796; Downer CC, 2003, LYONIA, V4, P31; Downer Craig C., 1997, P10; Downer Craig C., 1996, Oryx, V30, P45; Dudley N, 2006, TECHNICAL SERIE, V24; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2010, ARCMAP 10 0; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V16, P3215, DOI 10.1111/j.1365-2486.2010.02197.x; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2001, CAT CRIT LISTA ROJ U; *IUCN, 2012, PROT PLAN LAT IN HAR; IUCN, 2013, IUCN RED LIST THREAT; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Lees AC, 2006, BIOL CONSERV, V133, P198, DOI 10.1016/j.biocon.2006.06.005; Lessmann J, 2014, ECOL EVOL, V4, P2410, DOI 10.1002/ece3.1102; Lizcano DJ, 2002, J BIOGEOGR, V29, P7, DOI 10.1046/j.1365-2699.2002.00654.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; MacLaren C, 2014, AGROFOREST SYST, V88, P369, DOI 10.1007/s10457-014-9690-9; Ministerio del Ambiente de Ecuador-MAE, 2013, SIST CLAS EC EC CONT; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Morrone JJ, 2002, PROYECTO RED IBEROAM, V2, P267; Mota-Vargas C, 2012, J NAT CONSERV, V20, P10, DOI 10.1016/j.jnc.2011.07.002; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P359, DOI 10.1177/194008290800100405; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ortega-Andrade H Mauricio, 2013, PLoS One, V8, pe81837, DOI 10.1371/journal.pone.0081837; Padilla Miguel, 2010, Mammalian Species, P166, DOI 10.1644/863.1; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1998, IBIS, V140, P288, DOI 10.1111/j.1474-919X.1998.tb04391.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Rojas-Soto OR, 2008, J FIELD ORNITHOL, V79, P245, DOI 10.1111/j.1557-9263.2008.00170.x; Romero D, 2014, J BIOGEOGR, V41, P111, DOI 10.1111/jbi.12189; Roulin X, 1829, ANN SCI NAT ZOOL, V17, P26; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Rull V, 2006, GLOBAL CHANGE BIOL, V12, P1, DOI 10.1111/j.1365-2486.2005.001080.x; SCHAUENBERG P, 1969, Revue Suisse de Zoologie, V76, P211; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockman AK, 2006, DIVERS DISTRIB, V12, P81, DOI 10.1111/j.1366-9516.2006.00225.x; Tapia A, 2011, ESTRATEGIS NACL CONS; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Tirira D., 2011, LIBRO ROJO MAMIFEROS; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, DOI 10.1007/S10584-011-0148-Z]	83	23	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121137	10.1371/journal.pone.0121137	http://dx.doi.org/10.1371/journal.pone.0121137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798851	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300214
J	Deng, XH; Xu, ZM				Deng, Xiaohong; Xu, Zhongmin			Green Auctions and Reduction of Information Rents in Payments for Environmental Services: An Experimental Investigation in Sunan County, Northwestern China	PLOS ONE			English	Article							CONSERVATION CONTRACTS; OPPORTUNITY COSTS; LAND VALUES	Reducing information rents is an important task for government agencies wishing to purchase maximal environmental services with limited budgets. This paper reports on several green auction options for reducing information rents and improving the performance of the "Grain for Green" Payments for environmental services (PES) program implemented in northwestern China. In r experimental auctions and investigations, door-to-door interviews were conducted and bidding envelopes and survey questionnaires were used to determine the offers and the foregone profits of the participants. Three scenarios are analyzed in this paper: a uniform price auction, a discriminatory price auction, and an opportunity-cost system. The results show that compared to the uniform price auction system, the other auction systems can increase the cost-effectiveness of conservation contracting. Competitive bidding can reveal true opportunity costs and can reduce information rents extracted from the government by farmers using private information. The demographics and average bids of these auction types were also analyzed. "Perfect information" in the opportunity-cost offer system has the best performance but is very hard to implement in reality. The results of this research show that the auction is a valuable tool for purchasing conservation contracts in northwestern China, but that in the future, the performance of these auctions should be studied with relaxed model assumptions.	[Deng, Xiaohong; Xu, Zhongmin] Chinese Acad Sci, Key Lab Ecohydrol Inland River Basin, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Deng, XH (corresponding author), Chinese Acad Sci, Key Lab Ecohydrol Inland River Basin, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China.	dengxiaohong2528@163.com			National Natural Science Foundation of China [41401645, 91125019, 40971291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was financed by the National Natural Science Foundation of China (Nos. 41401645, 91125019 and 40971291).	Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; [Anonymous], 2002, PAYMENTS ENV SERVICE; Bennett MT, 2008, ECOL ECON, V65, P699, DOI 10.1016/j.ecolecon.2007.09.017; Bolton P., 2005, CONTRACT THEORY; Bryan BA, 2011, ECOL INDIC, V11, P199, DOI 10.1016/j.ecolind.2009.02.005; Connor JD, 2008, AUST J AGR RESOUR EC, V52, P303, DOI 10.1111/j.1467-8489.2007.00417.x; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Hartshorn G., 2005, EVALUATION WORLD BAN; LataczLohmann U, 1997, AM J AGR ECON, V79, P407, DOI 10.2307/1244139; Liu YS, 2010, J GEOGR SCI, V20, P876, DOI 10.1007/s11442-010-0817-2; MCAFEE RP, 1987, J ECON LIT, V25, P699; MYERSON RB, 1981, MATH OPER RES, V6, P58, DOI 10.1287/moor.6.1.58; Naidoo R, 2006, CONSERV BIOL, V20, P490, DOI 10.1111/j.1523-1739.2006.00304.x; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; Pagiola S., 2007, PAYMENTS ENV SERVICE; RILEY JG, 1981, AM ECON REV, V71, P381; SHOEMAKER R, 1989, LAND ECON, V65, P131, DOI 10.2307/3146787; Sinden JA, 2004, J ENVIRON MANAGE, V70, P351, DOI 10.1016/j.jenvman.2003.12.013; Stoneham G, 2003, AUST J AGR RESOUR EC, V47, P477, DOI 10.1111/j.1467-8489.2003.t01-1-00224.x; Tietenberg T., 2006, ENV NATURAL RESOURCE; Uchida E, 2009, AM J AGR ECON, V91, P70, DOI 10.1111/j.1467-8276.2008.01184.x; VICKREY W, 1961, J FINANC, V16, P8, DOI 10.2307/2977633; Vukina T, 2006, DO FARMERS VALUE ENV; Westphal MI, 2007, LANDSCAPE URBAN PLAN, V81, P56, DOI 10.1016/j.landurbplan.2006.10.015	25	4	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118978	10.1371/journal.pone.0118978	http://dx.doi.org/10.1371/journal.pone.0118978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793263	gold, Green Submitted, Green Published			2022-12-26	WOS:000352084200050
J	Herting, MM; Gautam, P; Spielberg, JM; Dahl, RE; Sowell, ER				Herting, Megan M.; Gautam, Prapti; Spielberg, Jeffrey M.; Dahl, Ronald E.; Sowell, Elizabeth R.			A Longitudinal Study: Changes in Cortical Thickness and Surface Area during Pubertal Maturation	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; BRAIN-DEVELOPMENT; PREFRONTAL CORTEX; STEROID-HORMONES; SEX-DIFFERENCES; VOLUME CHANGES; GRAY-MATTER; ADOLESCENCE; TESTOSTERONE; CELLS	Sex hormones have been shown to contribute to the organization and function of the brain during puberty and adolescence. Moreover, it has been suggested that distinct hormone changes in girls versus boys may contribute to the emergence of sex differences in internalizing and externalizing behavior during adolescence. In the current longitudinal study, the influence of within-subject changes in puberty (physical and hormonal) on cortical thickness and surface area was examined across a 2-year span, while controlling for age. Greater increases in Tanner Stage predicted less superior frontal thinning and decreases in precuneus surface area in both sexes. Significant Tanner Stage and sex interactions were also seen, with less right superior temporal thinning in girls but not boys, as well as greater decreases in the right bank of the superior temporal sulcus surface area in boys compared to girls. In addition, within-subject changes in testosterone over the 2-year follow-up period were found to relate to decreases in middle superior frontal surface area in boys, but increases in surface area in girls. Lastly, larger increases in estradiol in girls predicted greater middle temporal lobe thinning. These results show that within-subject physical and hormonal markers of puberty relate to region and sex-specific changes in cortical development across adolescence.	[Herting, Megan M.; Gautam, Prapti; Sowell, Elizabeth R.] Childrens Hosp Los Angeles, Keck Sch Med USC, Dept Pediat, Los Angeles, CA 90027 USA; [Spielberg, Jeffrey M.] VA Boston Hlth Care Syst, Neuroimaging Res Vet Ctr, Boston, MA USA; [Dahl, Ronald E.] Univ Calif Berkeley, Inst Human Dev, Berkeley, CA 94720 USA	Children's Hospital Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of California System; University of California Berkeley	Herting, MM (corresponding author), Childrens Hosp Los Angeles, Keck Sch Med USC, Dept Pediat, Los Angeles, CA 90027 USA.	mherting@chla.usc.edu; esowell@chla.usc.edu	Dahl, Ronald/AAW-8714-2021; Spielberg, Jeffrey/D-1402-2014	Spielberg, Jeffrey/0000-0001-8348-7157; dahl, ronald/0000-0002-1794-7132	National Institute of Drug Abuse Grant [R01 DA018910]; National Institute of Mental Health Grant [R01 MH087563]; National Institute of Child Development Health Grant [F32 HD078084]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018910] Funding Source: NIH RePORTER	National Institute of Drug Abuse Grant; National Institute of Mental Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Development Health Grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse Grant R01 DA018910 awarded to Dr. Dahl. Support for this research was also provided by the National Institute of Mental Health Grant R01 MH087563 awarded to Dr. Sowell and the National Institute of Child Development Health Grant F32 HD078084 awarded to Dr. Herting. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; APTER D, 1980, CLIN ENDOCRINOL, V12, P107, DOI 10.1111/j.1365-2265.1980.tb02125.x; APTER D, 1978, J CLIN ENDOCR METAB, V47, P944, DOI 10.1210/jcem-47-5-944; Bennett NC, 2010, INT J BIOCHEM CELL B, V42, P813, DOI 10.1016/j.biocel.2009.11.013; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Bramen JE, 2011, CEREB CORTEX, V21, P636, DOI 10.1093/cercor/bhq137; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Giedd JN, 2006, MOL CELL ENDOCRINOL, V254, P154, DOI 10.1016/j.mce.2006.04.016; Gonzalez M, 2007, J COMP NEUROL, V503, P790, DOI 10.1002/cne.21419; Herman-Giddens ME, 2012, PEDIATRICS, V130, pE1058, DOI 10.1542/peds.2011-3291; Herting MM, 2014, HUM BRAIN MAPP, V35, P5633, DOI 10.1002/hbm.22575; JUNGTESTAS I, 1992, J STEROID BIOCHEM, V41, P621, DOI 10.1016/0960-0760(92)90394-X; Juraska JM, 2013, HORM BEHAV, V64, P203, DOI 10.1016/j.yhbeh.2013.05.010; Juraska JM, 2004, ANN NY ACAD SCI, V1021, P431, DOI 10.1196/annals.1308.058; KOLB B, 1991, J NEUROENDOCRINOL, V3, P95, DOI 10.1111/j.1365-2826.1991.tb00245.x; Koolschijn PCMP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083929; Kreipe RE, 1992, TXB ADOLESCENT MED, P44; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Marin-Husstege M, 2004, DEV NEUROSCI-BASEL, V26, P245, DOI 10.1159/000082141; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; MARSHALL WA, 1968, ANNU REV MED, V19, P283, DOI 10.1146/annurev.me.19.020168.001435; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; MUNOZCUETO JA, 1990, BRAIN RES, V515, P64; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Nottelmann ED, 1990, ADOLESCENCE PUBERTY, P88; Nunez JL, 2003, J NEUROBIOL, V56, P293, DOI 10.1002/neu.10236; Nunez JL, 2000, DEV BRAIN RES, V125, P83, DOI 10.1016/S0165-3806(00)00126-7; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Peper JS, 2011, NEUROSCIENCE, V191, P28, DOI 10.1016/j.neuroscience.2011.02.014; Peper JS, 2008, PSYCHONEUROENDOCRINO, V33, P909, DOI 10.1016/j.psyneuen.2008.03.017; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Raznahan A, 2010, P NATL ACAD SCI USA, V107, P16988, DOI 10.1073/pnas.1006025107; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spielberg J. M., 2014, SOCIAL COGNITIVE AFF; Spielberg JM, 2014, DEV COGN NEUROS-NETH, V8, P86, DOI 10.1016/j.dcn.2014.01.004; STEWART J, 1994, BRAIN RES, V654, P149, DOI 10.1016/0006-8993(94)91581-4; Sun SMS, 2002, PEDIATRICS, V110, P911, DOI 10.1542/peds.110.5.911; TRELOAR AE, 1967, INT J FERTIL, V12, P77; Nguyen TV, 2013, J NEUROSCI, V33, P10840, DOI 10.1523/JNEUROSCI.5747-12.2013; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; Winkler AM, 2012, NEUROIMAGE, V61, P1428, DOI 10.1016/j.neuroimage.2012.03.026; Worthman CM, 1997, AM J PHYS ANTHROPOL, V104, P1	50	78	79	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119774	10.1371/journal.pone.0119774	http://dx.doi.org/10.1371/journal.pone.0119774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793383	Green Published, gold			2022-12-26	WOS:000352084200114
J	Lee, SC; Hsu, JS; Li, CC; Chen, KM; Liu, CT				Lee, Shih-Chieh; Hsu, Jie-Sheng; Li, Chien-Chun; Chen, Ke-Ming; Liu, Cheng-Tzu			Protective Effect of Leaf Essential Oil from Cinnamomum osmophloeum Kanehira on Endotoxin-Induced Intestinal Injury in Mice Associated with Suppressed Local Expression of Molecules in the Signaling Pathways of TLR4 and NLRP3	PLOS ONE			English	Article							NF-KAPPA-B; NEUTROPHIL INFILTRATION; DIFFERENT PROVENANCES; GARLIC OIL; SEPSIS; ACTIVATION; INTERLEUKIN-18; INFLAMMASOME; RECOGNITION; DAMAGE	Endotoxin is a potent microbial mediator implicated in sepsis. We investigated the anti-inflammatory effect of leaf essential oil from Cinnamomum osmophloeum Kanehira (CO) of the linalool chemotype on endotoxin-injected mice. Mice were administered CO or vehicle by gavage before endotoxin injection and were killed 12 h after injection. Neither growth nor the organ weight or tissue weight to body weight ratio was affected by CO treatment. CO significantly lowered peripheral levels of tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-18, interferon-gamma, and nitric oxide and inhibited the expression of toll-like receptor 4 (TLR4), myeloid differentiation primary response gene (88), myeloid differentiation factor 2, apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC), caspase-1, and Nod-like receptor family, pyrin domain containing 3 (NLRP3). CO also inhibited the activation of nuclear factor-kappa B, inhibited the activity of caspase-1 in small intestine, and ameliorated intestinal edema. Our data provide strong evidence for a protective effect of CO of the linalool chemotype in the endotoxin-induced systemic inflammatory response in close association with suppression of the TLR4 and NLRP3 signaling pathways in intestine.	[Lee, Shih-Chieh] Da Yeh Univ, Dept BioInd Technol, Dacun, Changhua, Taiwan; [Hsu, Jie-Sheng; Li, Chien-Chun; Liu, Cheng-Tzu] Chung Shan Med Univ, Sch Nutr, Taichung, Taiwan; [Chen, Ke-Ming] Chung Shan Med Univ, Dept Parasitol, Taichung, Taiwan; [Liu, Cheng-Tzu] Chung Shan Med Univ Hosp, Dept Nutr, Taichung 40201, Taiwan	Da Yeh University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Liu, CT (corresponding author), Chung Shan Med Univ, Sch Nutr, 110,Sec 1,Chien Kuo N Rd, Taichung, Taiwan.	ctl@csmu.edu.tw	Li, Chien-Chun/AAI-6536-2020		Ministry of Science and Technology, Taiwan, ROC [NSC 101-2313-B-040 -008 -MY3]	Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the Ministry of Science and Technology, Taiwan, ROC (NSC 101-2313-B-040 -008 -MY3). The website of the funder is http://www.most.gov.tw/mp.aspx. This funding was provided to CTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arndt PG, 2000, AM J RESP CELL MOL, V22, P708, DOI 10.1165/ajrcmb.22.6.3832; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Chao LK, 2005, J AGR FOOD CHEM, V53, P7274, DOI 10.1021/jf051151u; Chao LK, 2008, FOOD CHEM TOXICOL, V46, P220, DOI 10.1016/j.fct.2007.07.016; Cheng SS, 2006, BIORESOURCE TECHNOL, V97, P306, DOI 10.1016/j.biortech.2005.02.030; Chiang YH, 2006, TOXICOL APPL PHARM, V213, P46, DOI 10.1016/j.taap.2005.08.008; DEITCH EA, 1991, CRIT CARE MED, V19, P785, DOI 10.1097/00003246-199106000-00010; Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751; Faggioni R, 2001, J IMMUNOL, V167, P5913, DOI 10.4049/jimmunol.167.10.5913; Ganz M, 2011, WORLD J GASTROENTERO, V17, P4772, DOI 10.3748/wjg.v17.i43.4772; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Huo MX, 2013, J SURG RES, V180, pE47, DOI 10.1016/j.jss.2012.10.050; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kuo CH, 2011, J AGR FOOD CHEM, V59, P7717, DOI 10.1021/jf201185v; Lee SC, 2013, J AGR FOOD CHEM, V61, P4905, DOI 10.1021/jf401039z; Lee SH, 2012, FOOD CHEM TOXICOL, V50, P567, DOI 10.1016/j.fct.2011.11.027; Lewis DH, 2012, J VET INTERN MED, V26, P457, DOI 10.1111/j.1939-1676.2012.00905.x; Lin SSC, 2011, PHYTOTHER RES, V25, P1511, DOI 10.1002/ptr.3419; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Matsuda N, 2006, J PHARMACOL SCI, V101, P189, DOI 10.1254/jphs.CRJ06010X; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; Murugan R, 2014, NEPHROL DIAL TRANSPL, V29, P1854, DOI 10.1093/ndt/gfu051; Oberholzer A, 2001, SHOCK, V16, P411, DOI 10.1097/00024382-200116060-00001; Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Raeburn CD, 2002, AM J PHYSIOL-HEART C, V283, pH650, DOI 10.1152/ajpheart.00043.2002; Rhee SH, 2011, J NEUROGASTROENTEROL, V17, P28, DOI 10.5056/jnm.2011.17.1.28; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tsutsui H, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/641865; Tung YT, 2011, J AGR FOOD CHEM, V59, P8117, DOI 10.1021/jf2018935; Tung YT, 2010, PHARM BIOL, V48, P1130, DOI 10.3109/13880200903527728; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Zhang HJ, 2011, AM J PHYSIOL-RENAL, V301, pF171, DOI 10.1152/ajprenal.00339.2010; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	42	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120700	10.1371/journal.pone.0120700	http://dx.doi.org/10.1371/journal.pone.0120700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794175	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900065
J	Robertson, HE; Lapraz, F; Rhodes, AC; Telford, MJ				Robertson, Helen E.; Lapraz, Francois; Rhodes, Adelaide C.; Telford, Maximilian J.			The Complete Mitochondrial Genome of the Geophilomorph Centipede Strigamia maritima	PLOS ONE			English	Article							GENE ORDER REARRANGEMENT; TRANSFER-RNAS; ARTHROPOD PHYLOGENY; EMBRYONIC-DEVELOPMENT; SEGMENT FORMATION; MYRIAPODA; SEQUENCES; EVOLUTION; CHILOPODA; INSIGHTS	Strigamia maritima (Myriapoda; Chilopoda) is a species from the soil-living order of geophilomorph centipedes. The Geophilomorpha is the most speciose order of centipedes with over a 1000 species described. They are notable for their large number of appendage bearing segments and are being used as a laboratory model to study the embryological process of segmentation within the myriapods. Using a scaffold derived from the recently published genome of Strigamia maritima that contained multiple mitochondrial protein-coding genes, here we report the complete mitochondrial genome of Strigamia, the first from any geophilomorph centipede. The mitochondrial genome of S. maritima is a circular molecule of 14,938 base pairs, within which we could identify the typical mitochondrial genome complement of 13 protein-coding genes and 2 ribosomal RNA genes. Sequences resembling 16 of the 22 transfer RNA genes typical of metazoan mitochondrial genomes could be identified, many of which have clear deviations from the standard 'cloverleaf' secondary structures of tRNA. Phylogenetic trees derived from the concatenated alignment of protein-coding genes of S. maritima and > 50 other metazoans were unable to resolve the Myriapoda as monophyletic, but did support a monophyletic group of chilopods: Strigamia was resolved as the sister group of the scolopendromorph Scolopocryptos sp. and these two (Geophilomorpha and Scolopendromorpha), along with the Lithobiomorpha, formed a monophyletic group the Pleurostigmomorpha. Gene order within the S. maritima mitochondrial genome is unique compared to any other arthropod or metazoan mitochondrial genome to which it has been compared. The highly unusual organisation of the mitochondrial genome of Strigamia maritima is in striking contrast with the conservatively evolving nuclear genome: sampling of more members of this order of centipedes will be required to see whether this unusual organization is typical of the Geophilomorpha or results from a more recent reorganisation in the lineage leading to Strigamia.	[Robertson, Helen E.; Lapraz, Francois; Telford, Maximilian J.] UCL, Dept Genet Evolut & Environm, London, England; [Rhodes, Adelaide C.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	University of London; University College London; Oregon State University	Telford, MJ (corresponding author), UCL, Dept Genet Evolut & Environm, Darwin Bldg,Gower St, London, England.	m.telford@ucl.ac.uk	Lapraz, Francois/W-4948-2017	Lapraz, Francois/0000-0001-9209-2018; Rhodes, Adelaide/0000-0002-1714-1972	ERC [ERC-2012-AdG 322790-XENOTURBELLA]; Biotechnology and Biological Sciences Research Council [BBS/B/0675X]; Royal Society Wolfson Research Merit Award	ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Wolfson Research Merit Award(Royal Society of London)	Funding: H.E.R. is supported by the ERC (ERC-2012-AdG 322790-XENOTURBELLA), F.L. is supported by the Biotechnology and Biological Sciences Research Council (BBS/B/0675X), and M.J. T. is supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur W, 2005, BIOESSAYS, V27, P653, DOI 10.1002/bies.20234; Barber Anthony D., 2009, Soil Organisms, V81, P735; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; BOORE JL, 1995, NATURE, V376, P163, DOI 10.1038/376163a0; Brena C, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-112; Brena C, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-22; Brena C, 2012, DEV BIOL, V363, P290, DOI 10.1016/j.ydbio.2011.11.006; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chipman AD, 2006, DEV BIOL, V290, P337, DOI 10.1016/j.ydbio.2005.11.029; Chipman AD, 2004, CURR BIOL, V14, P1250, DOI 10.1016/j.cub.2004.07.026; Chipman AD, 2004, EVOL DEV, V6, P78, DOI 10.1111/j.1525-142X.2004.04016.x; Chipman AD, 2008, DEV BIOL, V319, P160, DOI 10.1016/j.ydbio.2008.02.038; Chipman AD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002005; Dong Y, 2012, GENE, V505, P57, DOI 10.1016/j.gene.2012.05.049; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgecombe GD, 2004, J ZOOL SYST EVOL RES, V42, P89, DOI 10.1111/j.1439-0469.2004.00245.x; Edgecombe GD, 2007, ZOOTAXA, P327, DOI 10.11646/zootaxa.1668.1.17; Edgecombe GD, 2007, ANNU REV ENTOMOL, V52, P151, DOI 10.1146/annurev.ento.52.110405.091326; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; GABRIEL W, 1993, EVOLUTION, V47, P1744, DOI 10.1111/j.1558-5646.1993.tb01266.x; Gai YH, 2006, ZOOL SCI, V23, P1101, DOI 10.2108/zsj.23.1101; Gai YH, 2008, MOL PHYLOGENET EVOL, V49, P574, DOI 10.1016/j.ympev.2008.08.010; Gai YH, 2014, MITOCHONDR DNA, V25, P192, DOI 10.3109/19401736.2013.792073; Green J, 2013, DEV BIOL, V382, P235, DOI 10.1016/j.ydbio.2013.06.017; Green JE, 2014, DEV BIOL, V392, P419, DOI 10.1016/j.ydbio.2014.06.003; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hunnekuhl VS, 2014, DEV BIOL; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Kettle C, 2003, EVOL DEV, V5, P198, DOI 10.1046/j.1525-142X.2003.03027.x; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Lewis J. G. E., 1961, Proceedings of the Zoological Society of London, V137, P221; Loesel R, 2002, ARTHROPOD STRUCT DEV, V31, P77, DOI 10.1016/S1467-8039(02)00017-8; Macey JR, 1997, MOL BIOL EVOL, V14, P30, DOI 10.1093/oxfordjournals.molbev.a025699; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Masta SE, 2004, MOL BIOL EVOL, V21, P893, DOI 10.1093/molbev/msh096; Miyazawa H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04127; MORITZ C, 1987, P NATL ACAD SCI USA, V84, P7183, DOI 10.1073/pnas.84.20.7183; Negrisolo E, 2004, J MOL EVOL, V58, P413, DOI 10.1007/s00239-003-2563-x; Negrisolo E, 2004, MOL BIOL EVOL, V21, P770, DOI 10.1093/molbev/msh078; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Podsiadlowski L, 2007, MOL PHYLOGENET EVOL, V45, P251, DOI 10.1016/j.ympev.2007.07.017; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Rehm P, 2014, MOL PHYLOGENET EVOL, V77, P25, DOI 10.1016/j.ympev.2014.04.007; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shear WA, 2010, ARTHROPOD STRUCT DEV, V39, P174, DOI 10.1016/j.asd.2009.11.002; STANTON DJ, 1994, GENETICS, V137, P233; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vedel V, 2010, EVOL DEV, V12, P347, DOI 10.1111/j.1525-142X.2010.00421.x; Woo HJ, 2007, MOL CELLS, V23, P182	62	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121369	10.1371/journal.pone.0121369	http://dx.doi.org/10.1371/journal.pone.0121369			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794168	Green Published, gold			2022-12-26	WOS:000352083900128
J	Ruiz, MJ; Hupe, JM				Ruiz, Mathieu J.; Hupe, Jean-Michel			Assessment of the Hemispheric Lateralization of Grapheme-Color Synesthesia with Stroop-Type Tests	PLOS ONE			English	Article							VENTRAL STREAM; SYNAESTHESIA; SPEECH; FORM; HALF; REPRESENTATIONS; ORGANIZATION; ACTIVATION; NUMBERS; MODELS	Grapheme-color synesthesia, the idiosyncratic, arbitrary association of colors to letters or numbers, develops in childhood once reading is mastered. Because language processing is strongly left-lateralized in most individuals, we hypothesized that grapheme-color synesthesia could be left-lateralized as well. We used synesthetic versions of the Stroop test with colored letters and numbers presented either in the right or the left visual field of thirty-four synesthetes. Interference by synesthetic colors was stronger for stimuli in the right hemifield (first experiment, color naming task). Synesthetes were also faster in the right hemifield when naming the synesthetic color of graphemes (second experiment). Overall, the lateralization effect was 7 ms (the 95% confidence interval was [1.5 12] ms), a delay compatible with an additional callosal transfer for stimuli presented in the left hemifield. Though weak, this effect suggests that the association of synesthetic colors to graphemes may be preferentially processed in the left hemisphere. We speculate that this left-lateralization could be a landmark of synesthetic grapheme-color associations, if not found for color associations learnt by non-synesthete adults.	[Ruiz, Mathieu J.] Grenoble Inst Neurosci, INSERM, U836, F-38000 Grenoble, France; [Ruiz, Mathieu J.] Univ Grenoble Alpes, F-38000 Grenoble, France; [Ruiz, Mathieu J.; Hupe, Jean-Michel] Univ Toulouse, Ctr Rech Cerveau & Cognit, F-31300 Toulouse, France; [Ruiz, Mathieu J.; Hupe, Jean-Michel] CNRS, F-31300 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Hupe, JM (corresponding author), Univ Toulouse, Ctr Rech Cerveau & Cognit, F-31300 Toulouse, France.	jean-michel.hupe@cerco.ups-tlse.fr			Agence Nationale de la Recherche [ANR-11-BSH2-010]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche [ANR-11-BSH2-010] to JMH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher JE, 2006, CORTEX, V42, P137, DOI 10.1016/S0010-9452(08)70337-X; BASHORE TR, 1982, CORTEX, V18, P245, DOI 10.1016/S0010-9452(82)80006-3; Belanger HG, 2002, BRAIN LANG, V83, P384, DOI 10.1016/S0093-934X(02)00508-4; Bor D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07089; Brang D, 2009, NEUROCASE, V16, P1; Brown TL, 1998, BRAIN LANG, V63, P122, DOI 10.1006/brln.1997.1940; Chiou R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00105; Chun CA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00776; Colizoli O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039799; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Coulson M, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00026; Cumming G., 2013, UNDERSTANDING NEW ST; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; Eagleman DM, 2007, J NEUROSCI METH, V159, P139, DOI 10.1016/j.jneumeth.2006.07.012; Edquist J, 2006, CORTEX, V42, P222, DOI 10.1016/S0010-9452(08)70347-2; Flournoy T, 1893, PHENOMENES SYNOPSIE; FRANZON M, 1987, CORTEX, V23, P615, DOI 10.1016/S0010-9452(87)80052-7; Hupe JM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00103; Hupe JM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00018; Hupe JM, 2012, CEREB CORTEX, V22, P1622, DOI 10.1093/cercor/bhr236; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Josse G, 2004, BRAIN RES REV, V44, P1, DOI 10.1016/j.brainresrev.2003.10.001; Levy J, 2008, NEUROIMAGE, V43, P581, DOI 10.1016/j.neuroimage.2008.08.008; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; Neufeld J, 2012, NEUROPSYCHOLOGIA, V50, P85, DOI 10.1016/j.neuropsychologia.2011.11.001; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Price GR, 2011, NEUROIMAGE, V57, P1205, DOI 10.1016/j.neuroimage.2011.05.035; Price MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00689; Price MC, 2013, CORTEX, V49, P1165, DOI 10.1016/j.cortex.2012.10.013; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x; Rich AN, 2013, COGN NEUROPSYCHOL, V30, P110, DOI 10.1080/02643294.2013.805686; Rothen N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00109; Rothen N, 2013, CONSCIOUS COGN, V22, P1047, DOI 10.1016/j.concog.2013.07.005; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; SATZ P, 1979, SCIENCE, V203, P1131, DOI 10.1126/science.424744; Shum J, 2013, J NEUROSCI, V33, P6709, DOI 10.1523/JNEUROSCI.4558-12.2013; Simner J, 2006, PERCEPTION, V35, P1024, DOI 10.1068/p5469; Simner J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00603; Simner J, 2009, BRAIN, V132, P57, DOI 10.1093/brain/awn292; Starrfelt R, 2011, NEUROPSYCHOLOGIA, V49, P2283, DOI 10.1016/j.neuropsychologia.2011.04.028; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suarez de Mendoza F, 1890, AUDITION COLOREE ETU; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Turkeltaub PE, 2008, ANN NY ACAD SCI, V1145, P13, DOI 10.1196/annals.1416.026; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Ward J, 2007, CONSCIOUS COGN, V16, P913, DOI 10.1016/j.concog.2006.09.012; Witthoft N, 2006, CORTEX, V42, P175, DOI 10.1016/S0010-9452(08)70342-3; Witthoft N, 2013, PSYCHOL SCI, V24, P258, DOI 10.1177/0956797612452573	54	5	5	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119377	10.1371/journal.pone.0119377	http://dx.doi.org/10.1371/journal.pone.0119377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793307	Green Submitted, gold, Green Published			2022-12-26	WOS:000352084200077
J	Simon, E; Guerrero, I				Simon, Eleanor; Guerrero, Isabel			The Transcription Factor Optomotor-Blind Antagonizes Drosophila Haltere Growth by Repressing Decapentaplegic and Hedgehog Targets	PLOS ONE			English	Article							HOX GENE ULTRABITHORAX; BITHORAX COMPLEX; WING DEVELOPMENT; DNA-BINDING; DPP; EXPRESSION; PROTEIN; BRINKER; MORPHOGENESIS; IDENTIFICATION	Drosophila, decapentaplegic, which codes for a secreted signaling molecule, is activated by the Hedgehog signaling pathway at the anteroposterior compartment border of the two dorsal primordia; the wing and the haltere imaginal discs. In the wing disc, Decapentaplegic and Hedgehog signaling targets are implicated in cell proliferation and cell survival. However, most of their known targets in the wing disc are not expressed in the haltere disc due to their repression by the Hox gene Ultrabithorax. The T-box gene optomotor-blind escapes this repression in the haltere disc, and therefore is expressed in both the haltere and wing discs. Optomotor-blind is a major player during wing development and its function has been intensely investigated in this tissue, however, its role in haltere development has not been reported so far. Here we show that Optomotor-blind function in the haltere disc differs from that in the wing disc. Unlike its role in the wing, Optomotor-blind does not prevent apoptosis in the haltere but rather limits growth by repressing several Decapentaplegic and Hedgehog targets involved both in wing proliferation and in modulating the spread of morphogens similar to Ultrabithorax function but without disturbing Ultrabithorax expression.	[Simon, Eleanor] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; Univ Autonoma Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Simon, E (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	esimon@cbm.csic.es; iguerrero@cbm.csic.es	Guerrero, Isabel/K-2518-2014	Guerrero, Isabel/0000-0001-6761-1218	Spanish Ministry of Economy and Commutativity [BFU2011-25987, CDS 2007-00008]; Initial Training Networks (ITN) - Marie Curie Actions (ITN) [238186]; Fundacion Ramon Areces	Spanish Ministry of Economy and Commutativity; Initial Training Networks (ITN) - Marie Curie Actions (ITN); Fundacion Ramon Areces	Funding: This work was supported by grants Biologia Fundamental (BFU2011-25987) and Consolider Program (CDS 2007-00008) from the Spanish Ministry of Economy and Commutativity (http://www.mineco.gob.es), by Initial Training Networks (ITN) - Marie Curie Actions (ITN 238186) (http://ec.europa.eu/research/mariecurieactions/about-mca/actions/itn/indexen.htm) and by an institutional grant to Centro Biologia Molecular "Severo Ochoa" from the Fundacion Ramon Areces (http://fundacionareces.es/fundacionareces). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434; Burke R, 1996, DEVELOPMENT, V122, P2261; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737; de Navas L, 2006, MECH DEVELOP, V123, P860, DOI 10.1016/j.mod.2006.07.010; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; de Navas LF, 2011, DEVELOPMENT, V138, P107, DOI 10.1242/dev.051409; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Galant R, 2002, DEVELOPMENT, V129, P3115; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1963, AM ZOOL, V3, P33; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Makhijani K, 2007, DEV BIOL, V302, P243, DOI 10.1016/j.ydbio.2006.09.029; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Pavlopoulos A, 2011, P NATL ACAD SCI USA, V108, P2855, DOI 10.1073/pnas.1015077108; PFLUGFELDER GO, 1990, GENETICS, V126, P91; PFLUGFELDER GO, 1992, BIOCHEM BIOPH RES CO, V186, P918, DOI 10.1016/0006-291X(92)90833-7; Reim I, 2003, DEVELOPMENT, V130, P3187, DOI 10.1242/dev.00548; Rodriguez DD, 2004, DEV BIOL, V268, P481, DOI 10.1016/j.ydbio.2004.01.005; Sanchez J, 2011, BIOCHEM J, V438, P437, DOI 10.1042/BJ20110229; Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Sui LY, 2012, DEVELOPMENT, V139, P2773, DOI 10.1242/dev.079384; SUN YH, 1995, GENETICS, V141, P1075; Szuperak M, 2011, DEVELOPMENT, V138, P715, DOI 10.1242/dev.059477; Umemori M, 2007, DEV BIOL, V308, P68, DOI 10.1016/j.ydbio.2007.05.007; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; WAGNERBERNHOLZ JT, 1991, GENE DEV, V5, P2467, DOI 10.1101/gad.5.12b.2467; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; Zecca M, 2007, DEVELOPMENT, V134, P3001, DOI 10.1242/dev.006411; Zhang XB, 2013, DEVELOPMENT, V140, P2917, DOI 10.1242/dev.094300	45	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121239	10.1371/journal.pone.0121239	http://dx.doi.org/10.1371/journal.pone.0121239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793870	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900116
J	Slama, D; Haouas, N; Mezhoud, H; Babba, H; Chaker, E				Slama, Darine; Haouas, Najoua; Mezhoud, Habib; Babba, Hamouda; Chaker, Emna			Blood Meal Analysis of Culicoides (Diptera: Ceratopogonidae) in Central Tunisia	PLOS ONE			English	Article							BITING MIDGES DIPTERA; BLUETONGUE VIRUS; SPECIES COMPOSITION; IDENTIFICATION; MOSQUITO; HOSTS; LATREILLE; VECTORS; ABUNDANCE; EPIDEMIC	To evaluate the host preferences of Culicoidesspecies (Diptera: Ceratopogonidae) in Central Tunisia, we identified the source of blood meals of field collected specimens by sequencing of the cytochrome b (cyt b) mitochondrial locus and Prepronociceptine single copy nuclear gene. The study includes the most common and abundant livestock associated species of biting midges in Tunisia: C. imicola, C. jumineri, C. newsteadi, C. paolae, C. cataneii, C. circumscriptus, C. kingi, C. pseudojumineri, C. submaritimus, C. langeroni, C. jumineri varand some unidentified C. species. Analysis of cyt b PCR products from 182 field collected blood-engorged females' midges revealed that 92% of them fed solely on mammalian species, 1.6% on birds, 2.4% on insects and 0.8% on reptiles. The blast results identified the blood origin of biting midges to the species level with exact or nearly exact matches (>= 98%). The results confirm the presence of several Culicoides species, including proven vectors in Central Tunisia. Blood meal analyses show that these species will indeed feed on bigger mammals, thereby highlighting the risk that these viruses will be able to spread in Tunisia.	[Slama, Darine; Haouas, Najoua; Mezhoud, Habib; Babba, Hamouda; Chaker, Emna] Univ Monastir, Dept Clin Biol B, Lab Parasitol Mycol Med & Mol, Monastir, Tunisia; [Babba, Hamouda] Lab Matern & Neonatol Ctr Monastir, Monastir, Tunisia	Universite de Monastir	Chaker, E (corresponding author), Univ Monastir, Dept Clin Biol B, Lab Parasitol Mycol Med & Mol, Monastir, Tunisia.	emna.chaker@gmail.com	Haouas, Najoua/AAV-7118-2021	, Najoua/0000-0001-8853-352X	Tunisian Ministry of Scientific Research, Technology and Competences Development	Tunisian Ministry of Scientific Research, Technology and Competences Development	This work was supported by finances from the Tunisian Ministry of Scientific Research, Technology and Competences Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bartsch S, 2009, PARASITOL RES, V105, P373, DOI 10.1007/s00436-009-1408-y; Ben Fredj S, 2003, REV ELEV MED VET PAY, V56, P121, DOI DOI 10.19182/REMVT.9852; BENNETT GORDON F., 1960, CANADIAN JOUR ZOOL, V38, P377, DOI 10.1139/z60-042; BISHOP AL, 1995, AUST VET J, V72, P198, DOI 10.1111/j.1751-0813.1995.tb03515.x; Boakye DA, 1999, MED VET ENTOMOL, V13, P282, DOI 10.1046/j.1365-2915.1999.00193.x; Borkent Art, 2005, P113; Braverman Y, 1996, VET MICROBIOL, V51, P19, DOI 10.1016/0378-1135(96)00009-0; BRAVERMAN Y, 1977, RHOD J AGR RES, V15, P101; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvo JH, 2012, B ENTOMOL RES, V102, P692, DOI 10.1017/S0007485312000284; Carpenter S, 2013, ANTIVIR RES, V100, P102, DOI 10.1016/j.antiviral.2013.07.020; Chaker E, 2005, PARASITE, V12, P359, DOI 10.1051/parasite/2005124359; Chaker E, 1981, THESIS; De Liberato C, 2005, VET REC, V156, P301, DOI 10.1136/vr.156.10.301; Delecolle JC, 1985, THESIS; Felippe-Bauer ML, 2008, ENTOMOL NEWS, V119, P185, DOI 10.3157/0013-872X(2008)119[185:CPDCII]2.0.CO;2; Foxi C, 2010, MED VET ENTOMOL, V24, P199, DOI 10.1111/j.1365-2915.2010.00861.x; Garros C, 2011, INFECT GENET EVOL, V11, P1103, DOI 10.1016/j.meegid.2011.04.002; Garvin MC, 2003, J WILDLIFE DIS, V39, P170, DOI 10.7589/0090-3558-39.1.170; Haouas N, 2007, AM J TROP MED HYG, V77, P1054, DOI 10.4269/ajtmh.2007.77.1054; HARRIS P, 1969, SCIENCE, V164, P184, DOI 10.1126/science.164.3876.184; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; HENDRY G, 1988, Scottish Forestry, V42, P113; Hendry G, 2011, BELL AND BAIN; HENRY LG, 1975, ANN ENTOMOL SOC AM, V68, P321, DOI 10.1093/aesa/68.2.321; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Humair PF, 2007, J MED ENTOMOL, V44, P869, DOI 10.1603/0022-2585(2007)44[869:MIOBSI]2.0.CO;2; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KREMER M, 1974, MOSQ NEWS, V34, P471; Lah Ernieenor Faraliana Che, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P223, DOI 10.1016/S2221-1691(12)60046-X; Lassen SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-143; Lassen SB, 2011, PARASITOL RES, V108, P823, DOI 10.1007/s00436-010-2123-4; LeDuc J. W., 1989, The arboviruses: epidemiology and ecology. Volume IV., P1; Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124; LEPRINCE DJ, 1989, J AM MOSQUITO CONTR, V5, P100; LINLEY JR, 1983, J MED ENTOMOL, V20, P347, DOI 10.1093/jmedent/20.4.347; LINLEY JR, 1971, J ECON ENTOMOL, V64, P264, DOI 10.1093/jee/64.1.264; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Ma YJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-326; Martinez-de la Puente J, 2009, PARASITOLOGY, V136, P1033, DOI 10.1017/S0031182009006374; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Mehlhorn H, 2009, PARASITOL RES, V105, P313, DOI 10.1007/s00436-009-1416-y; Meiswinkel R, 2008, PREV VET MED, V87, P55, DOI 10.1016/j.prevetmed.2008.06.005; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Meiswinkel R., 2004, Infectious diseases of livestock, Volume One, P93; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS., 1996, VET B, V66, P1; MEZENEV NP, 1990, PARAZITOLOGIYA+, V24, P28; Mollereau C, 1996, P NATL ACAD SCI USA, V93, P8666, DOI 10.1073/pnas.93.16.8666; Mukabana WR, 2002, TRENDS PARASITOL, V18, P505, DOI 10.1016/S1471-4922(02)02364-4; Mullens BA, 2004, VETER ITAL SER, V40, P160; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; Nielsen SA, 2010, PARASITOL RES, V106, P1197, DOI 10.1007/s00436-010-1791-4; Ninio C, 2011, PARASITOL RES, V108, P657, DOI 10.1007/s00436-010-2110-9; Oura CAL, 2011, EPIDEMIOL INFECT, V139, P1396, DOI 10.1017/S0950268810002396; Parson W, 2000, INT J LEGAL MED, V114, P23, DOI 10.1007/s004140000134; Sghaier S, 2009, REV ELEV MED VET PAY, V62, P2; Sherlock IA, 1964, MEM I OSWALDO CRUZ, V63, P27; Slama D, 2014, PARASITOL RES, V113, P2435, DOI 10.1007/s00436-014-3873-1; Thiry E, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327; Townzen JS, 2008, MED VET ENTOMOL, V22, P386, DOI 10.1111/j.1365-2915.2008.00760.x; van Sittert SJ, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.948; Videvall E, 2013, MED VET ENTOMOL, V27, P104, DOI 10.1111/j.1365-2915.2012.01038.x; WIRTH WW, 1971, ANN ENTOMOL SOC AM, V64, P15, DOI 10.1093/aesa/64.1.15	66	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120528	10.1371/journal.pone.0120528	http://dx.doi.org/10.1371/journal.pone.0120528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793285	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900048
J	Wendt, A; Stephenson, R; Young, M; Webb-Girard, A; Hogue, C; Ramakrishnan, U; Martorell, R				Wendt, Amanda; Stephenson, Rob; Young, Melissa; Webb-Girard, Amy; Hogue, Carol; Ramakrishnan, Usha; Martorell, Reynaldo			Individual and Facility-Level Determinants of Iron and Folic Acid Receipt and Adequate Consumption among Pregnant Women in Rural Bihar, India	PLOS ONE			English	Article							REPRODUCTIVE HEALTH OUTCOMES; CONTEXTUAL INFLUENCES; EARLY MARRIAGE; ANEMIA; CARE; SUPPLEMENTATION; DEFICIENCY; PRADESH	Background In Bihar, India, high maternal anemia prevalence and low iron and folic acid supplement (IFA) receipt and consumption have continued over time despite universal IFA distribution and counseling during pregnancy. Purpose To examine individual and facility-level determinants of IFA receipt and consumption among pregnant women in rural Bihar, India. Methods Using District Level Household Survey (2007-08) data, multilevel modeling was conducted to examine the determinants of two outcomes: IFA receipt (any IFA receipt vs. none) and IFA consumption (>= 90 days vs. <90 days). Individual-level and facility-level factors were included. Factor analysis was utilized to construct antenatal care (ANC) quality and health sub-center (HSC) capacity variables. Results Overall, 37% of women received any IFA during their last pregnancy. Of those, 24% consumed IFA for 90 or more days. Women were more likely to receive any IFA when they received additional ANC services and counseling, and attended ANC earlier and more frequently. Significant interactions were found between ANC quality factors (odds ratio (OR): 0.37, 95% confidence interval (CI): 0.25, 0.56) and between ANC services and ANC timing and frequency (OR: 0.68, 95% CI: 0.56, 0.82). No HSC factors were significantly associated with IFA receipt. Women were more likely to consume IFA for >= 90 days if they attended at least 4 ANC check-ups and received more ANC services. IFA supply at the HSC (OR: 1.37, 95% CI: 1.04, 1.82) was also significantly associated with IFA consumption. Conclusions Our findings indicate that individual and ANC factors (timing, frequency, and quality) play a key role in facilitating IFA receipt and consumption. Although HSC capacity factors were not found to influence our outcomes, significant variation at the facility level indicates unmeasured factors that could be important to address in future interventions.	[Wendt, Amanda; Webb-Girard, Amy; Ramakrishnan, Usha; Martorell, Reynaldo] Emory Univ, Div Biol & Biomed Sci, Nutr & Hlth Sci, Atlanta, GA 30322 USA; [Wendt, Amanda] Heidelberg Univ, Inst Publ Hlth, Epidemiol & Biostat Unit, Heidelberg, Germany; [Stephenson, Rob; Young, Melissa; Webb-Girard, Amy; Ramakrishnan, Usha; Martorell, Reynaldo] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Hogue, Carol] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Emory University; Ruprecht Karls University Heidelberg; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Wendt, A (corresponding author), Emory Univ, Div Biol & Biomed Sci, Nutr & Hlth Sci, Atlanta, GA 30322 USA.	awendt@alum.emory.edu	Webb Girard, Amy/J-7999-2013; Ramakrishnan, Usha/L-8921-2016; Martorell, Reynaldo/I-2539-2012	Wendt, Amanda/0000-0001-6019-1900	Bill & Melinda Gates Foundation [0000011951]; CARE-India (Cooperative for Assistance and Relief Everywhere); Integrated Family Health Initiative in Bihar, India; T-32 Reproductive, Perinatal, Pediatric Predoctoral National Institute of Health [2T32HD052460]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052460] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); CARE-India (Cooperative for Assistance and Relief Everywhere); Integrated Family Health Initiative in Bihar, India; T-32 Reproductive, Perinatal, Pediatric Predoctoral National Institute of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding support was provided by a Bill & Melinda Gates Foundation grant (#0000011951) through a subcontract with CARE-India (Cooperative for Assistance and Relief Everywhere) and the Integrated Family Health Initiative in Bihar, India. (www.careindia.org; RM), and T-32 Reproductive, Perinatal, Pediatric Predoctoral National Institute of Health Grant # 2T32HD052460. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL D K, 1988, Indian Pediatrics, V25, P319; Aikawa R, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-144; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 2010, GUID ANT CAR SKILL A; [Anonymous], 2007, RAM P 7 11 1 AN NUTR, P268; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Barroso F, 2011, EUR J OBSTET GYN R B, V159, P99, DOI 10.1016/j.ejogrb.2011.07.041; Barua A, 2001, REPROD HEALTH MATTER, V9, P53, DOI 10.1016/S0968-8080(01)90008-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Delaney KP, 2013, COLLINEARITY MACRO S; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X; Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X; Godha D, 2013, J ADOLESCENT HEALTH, V52, P552, DOI 10.1016/j.jadohealth.2013.01.021; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Haverkate M, 2014, J EPIDEMIOL COMMUN H, V68, P116, DOI 10.1136/jech-2012-202336; Hazarika I, 2011, MATERN CHILD HLTH J, V15, P1381, DOI 10.1007/s10995-010-0687-3; International Institute for Population Sciences (IIPS), FACILITY SURVEY UNDE; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S, DOI [10.1371/journal.pone.0071584, DOI 10.1371/JOURNAL.PONE.0071584]; International Institute for Population Sciences (IIPS), KEY IND BIH NFHS 3; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; International institute for Population Sciences (IIPS) Ministry of Health & Family Welfare, FAC SURV REPR CHILD; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; Kapil U, 1996, HLTH POPULATION PERS, V19, P19; Kwon HJ, 2013, ASIA PACIFIC J PUBLI; Lacerte P, 2011, ASIA-PAC J PUBLIC HE, V23, P315, DOI 10.1177/1010539511403133; Malagi Usha, 2006, Journal of Human Ecology, V20, P279; Masters SH, 2013, SOC SCI MED, V93, P147, DOI 10.1016/j.socscimed.2013.06.012; Ministry of Health and Family Welfare, 2013, GUID CONTR IR DEF AN; Ministry of Health & Family Welfare, 2005, CHILD HLTH PROGR IND; Ministry of Health & Family Welfare Government of India, 2012, IND PUBL HLTH STAND; Ministry of Health & Family Welfare Government of India, 2007, NAT RUR HLTH MISS; National Rural Health Mission Ministry of Health & Family Welfare Government of India, 2007, MONTHL VILL HLTH NUT; Nayar KR, 2007, INDIAN J MED RES, V126, P355; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Pasricha SR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-617; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4; Rani M, 2008, INT J QUAL HEALTH C, V20, P62, DOI 10.1093/intqhc/mzm052; Roy M. P., 2013, National Journal of Community Medicine, V4, P386; Sabarwal S, 2012, PAEDIATR PERINAT EP, V26, P77, DOI 10.1111/j.1365-3016.2011.01227.x; Santhya KG, 2011, CURR OPIN OBSTET GYN, V23, P334, DOI 10.1097/GCO.0b013e32834a93d2; Santhya KG, 2010, INT PERSPECT SEX R H, V36, P132, DOI 10.1363/ipsrh.36.132.10; Santhya KG, 2008, EARLY MARRIAGE SEXUA; Seck BC, 2008, PUBLIC HEALTH NUTR, V11, P596, DOI 10.1017/S1368980007000924; Singh Manish K, 2010, Indian J Community Med, V35, P414, DOI 10.4103/0970-0218.69272; Singh PK, 2013, HLTH POLICY PLANNING; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; State Health Society National Rural Health Mission Government of Bihar, 2011, CONS REV NRHM STAT P; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Stephenson R, 2002, STUD FAMILY PLANN, V33, P309, DOI 10.1111/j.1728-4465.2002.00309.x; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Sugathan KS, 2001, PROMOTING I DELIVERI; UNICEF, 2010, COV EV SURV BIH FACT; Vijayaraghavan K, 1990, Indian J Pediatr, V57, P183, DOI 10.1007/BF02722084; Villar J., 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000934; Vogel JP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-19; Worku AG, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-20; World Health Organization, 2008, WORLDWIDE PREVALENCE, DOI [10.1017/S1368980008002401, DOI 10.1017/S1368980008002401]; World Health Organization, 2002, WHO ANT CAR RAND TRI; Yip R, 2002, J NUTR, V132, p859S, DOI 10.1093/jn/132.4.859S	64	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120404	10.1371/journal.pone.0120404	http://dx.doi.org/10.1371/journal.pone.0120404			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793866	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900026
J	Zhang, X; Lei, DS; Zhang, L; Rames, M; Zhang, SL				Zhang, Xing; Lei, Dongsheng; Zhang, Lei; Rames, Matthew; Zhang, Shengli			A Model of Lipid-Free Apolipoprotein A-I Revealed by Iterative Molecular Dynamics Simulation	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; RESONANCE ENERGY-TRANSFER; COMPUTATIONAL-EXPERIMENTAL-APPROACH; STRUCTURAL ORGANIZATION; APOA-I; SECONDARY STRUCTURE; FLUORESCENCE PROBE; DOMAIN-STRUCTURE; STABILITY; CONFORMATION	Apolipoprotein A-I (apo A-I), the major protein component of high-density lipoprotein, has been proven inversely correlated to cardiovascular risk in past decades. The lipid-free state of apo A-I is the initial stage which binds to lipids forming high-density lipoprotein. Molecular models of lipid-free apo A-I have been reported by methods like X-ray crystallography and chemical cross-linking/mass spectrometry (CCL/MS). Through structural analysis we found that those current models had limited consistency with other experimental results, such as those from hydrogen exchange with mass spectrometry. Through molecular dynamics simulations, we also found those models could not reach a stable equilibrium state. Therefore, by integrating various experimental results, we proposed a new structural model for lipidfree apo A-I, which contains a bundled four-helix N-terminal domain (1-192) that forms a variable hydrophobic groove and a mobile short hairpin C-terminal domain (193-243). This model exhibits an equilibrium state through molecular dynamics simulation and is consistent with most of the experimental results known from CCL/MS on lysine pairs, fluorescence resonance energy transfer and hydrogen exchange. This solution-state lipid-free apo A-I model may elucidate the possible conformational transitions of apo A-I binding with lipids in high-density lipoprotein formation.	[Zhang, Xing; Lei, Dongsheng; Zhang, Shengli] Xi An Jiao Tong Univ, Dept Appl Phys, Xian 710049, Shaanxi, Peoples R China; [Zhang, Xing; Lei, Dongsheng; Zhang, Lei; Rames, Matthew] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Mol Foundry, Berkeley, CA 94720 USA	Xi'an Jiaotong University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, SL (corresponding author), Xi An Jiao Tong Univ, Dept Appl Phys, Xian 710049, Shaanxi, Peoples R China.	zhangsl@mail.xjtu.edu.cn	Lei, Dongsheng/AAH-4177-2020; Zhang, Lei/G-6427-2012; Lei, Dongsheng/K-3485-2012	Zhang, Lei/0000-0002-4880-824X; Lei, Dongsheng/0000-0003-1640-0693	National Nature Science Foundation of China [11374237]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by National Nature Science Foundation of China (No. 11374237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agree AKB, 2002, BBA-PROTEIN STRUCT M, V1594, P286, DOI 10.1016/S0167-4838(01)00317-X; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Beckstead JA, 2005, BIOCHEMISTRY-US, V44, P4591, DOI 10.1021/bi0477135; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Borhani DW, 1999, ACTA CRYSTALLOGR D, V55, P1578, DOI 10.1107/S0907444999008914; Brouillette CG, 2005, BIOCHEMISTRY-US, V44, P16413, DOI 10.1021/bi051018v; Catte A, 2008, BIOPHYS J, V94, P3361; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davidson WS, 2005, CURR OPIN LIPIDOL, V16, P295, DOI 10.1097/01.mol.0000169349.38321.ad; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Deng XD, 2012, STRUCTURE, V20, P767, DOI 10.1016/j.str.2012.02.020; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frank PG, 2000, J LIPID RES, V41, P853; Gogonea V, 2010, BIOCHEMISTRY-US, V49, P7323, DOI 10.1021/bi100588a; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Gursky O, 2012, BIOCHEMISTRY; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones MK, 2010, J BIOL CHEM, V285, P41161, DOI 10.1074/jbc.M110.187799; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Lagerstedt JO, 2012, BIOCH BIOPHYSICA ACT; Li HH, 2000, J BIOL CHEM, V275, P37048, DOI 10.1074/jbc.M005336200; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/00041433-200304000-00006; Miyazaki O, 2014, J LIPID RES, V55, P214, DOI 10.1194/jlr.M041038; Okon M, 2002, FEBS LETT, V517, P139, DOI 10.1016/S0014-5793(02)02600-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P945, DOI 10.1021/bi9713512; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002; SEGREST JP, 1992, J LIPID RES, V33, P141; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shih AY, 2008, BIOPHYS J, V94, pL87, DOI 10.1529/biophysj.108.131581; Shih AY, 2007, J STRUCT BIOL, V157, P579, DOI 10.1016/j.jsb.2006.08.006; Shih AY, 2009, J R SOC INTERFACE, V6, P863, DOI 10.1098/rsif.2009.0173; Silva RAGD, 2008, ARTERIOSCL THROM VAS, V28, pE64; Silva RAGD, 2008, ANN MED, V40, P5, DOI 10.1080/07853890701687201; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Tricerri MA, 2000, BIOCHEMISTRY-US, V39, P14682, DOI 10.1021/bi0014251; Tricerri MA, 2001, BIOCHEMISTRY-US, V40, P5065, DOI 10.1021/bi002815q; Vaughan AM, 2009, J LIPID RES, V50, P285, DOI 10.1194/jlr.M800366-JLR200; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537	61	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120233	10.1371/journal.pone.0120233	http://dx.doi.org/10.1371/journal.pone.0120233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793886	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200164
J	Zhou, WB; Karcher, D; Fischer, A; Maximova, E; Walther, D; Bock, R				Zhou, Wenbin; Karcher, Daniel; Fischer, Axel; Maximova, Eugenia; Walther, Dirk; Bock, Ralph			Multiple RNA Processing Defects and Impaired Chloroplast Function in Plants Deficient in the Organellar Protein-Only RNase P Enzyme	PLOS ONE			English	Article							PHOTOSYSTEM-I; ARABIDOPSIS-THALIANA; MESSENGER-RNA; TOBACCO; RECONSTITUTION; IDENTIFICATION; MITOCHONDRIA; NUCLEOTIDE; EXPRESSION; NUCLEUS	Transfer RNA (tRNA) precursors undergo endoribonucleolytic processing of their 5' and 3' ends. 5' cleavage of the precursor transcript is performed by ribonuclease P (RNase P). While in most organisms RNase P is a ribonucleoprotein that harbors a catalytically active RNA component, human mitochondria and the chloroplasts (plastids) and mitochondria of seed plants possess protein-only RNase P enzymes (PRORPs). The plant organellar PRORP (PRORP1) has been characterized to some extent in vitro and by transient gene silencing, but the molecular, phenotypic and physiological consequences of its down-regulation in stable transgenic plants have not been assessed. Here we have addressed the function of the dually targeted organellar PRORP enzyme in vivo by generating stably transformed Arabidopsis plants in which expression of the PRORP1 gene was suppressed by RNA interference (RNAi). PRORP1 knock-down lines show defects in photosynthesis, while mitochondrial respiration is not appreciably affected. In both plastids and mitochondria, the effects of PRORP1 knock-down on the processing of individual tRNA species are highly variable. The drastic reduction in the levels of mature plastid tRNA-Phe(GAA) and tRNA-Arg (ACG) suggests that these two tRNA species limit plastid gene expression in the PRORP1 mutants and, hence, are causally responsible for the mutant phenotype.	[Zhou, Wenbin; Karcher, Daniel; Fischer, Axel; Maximova, Eugenia; Walther, Dirk; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany	Max Planck Society	Bock, R (corresponding author), Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany.	rbock@mpimp-golm.mpg.de	Bock, Ralph/B-4352-2009	Bock, Ralph/0000-0001-7502-6940; Walther, Dirk/0000-0002-5755-9265; Zhou, Wenbin/0000-0001-5911-1686; Karcher, Daniel/0000-0001-6393-7376; Fischer, Axel/0000-0001-6130-6984	Deutsche Forschungsgemeinschaft [FOR 804, BO 1482/15-2]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (FOR 804, BO 1482/15-2) to RB and by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Albus CA, 2010, PLANT CELL, V22, P2838, DOI 10.1105/tpc.110.073908; Alkatib S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003076; ALTMAN S, 1995, BIO-TECHNOL, V13, P327, DOI 10.1038/nbt0495-327; BARKAN A, 1993, PLANT CELL, V5, P389, DOI 10.1105/tpc.5.4.389; Baum M, 1996, J MOL BIOL, V257, P43, DOI 10.1006/jmbi.1996.0145; Beeckman T, 2000, BIOTECH HISTOCHEM, V75, P23, DOI 10.3109/10520290009047981; BURGIN AB, 1990, EMBO J, V9, P4111, DOI 10.1002/j.1460-2075.1990.tb07633.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cognat V, 2013, NUCLEIC ACIDS RES, V41, pD273, DOI 10.1093/nar/gks935; Delannoy E, 2009, PLANT CELL, V21, P2058, DOI 10.1105/tpc.109.066654; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Fleischmann TT, 2011, PLANT CELL, V23, P3137, DOI 10.1105/tpc.111.088906; Forner J, 2007, NUCLEIC ACIDS RES, V35, P3676, DOI 10.1093/nar/gkm270; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Gobert A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2358; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Gutmann B, 2012, GENE DEV, V26, P1022, DOI 10.1101/gad.189514.112; Hausler RE, 2009, PLANT PHYSIOL, V149, P515, DOI 10.1104/pp.108.128124; Hager M, 2002, J BIOL CHEM, V277, P14031, DOI 10.1074/jbc.M112053200; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Hricova A, 2006, PLANT PHYSIOL, V141, P942, DOI 10.1104/pp.106.080069; Karcher D, 2009, RNA, V15, P1251, DOI 10.1261/rna.1600609; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; KIRSEBOM LA, 1995, MOL MICROBIOL, V17, P411, DOI 10.1111/j.1365-2958.1995.mmi_17030411.x; KIRSEBOM LA, 1994, EMBO J, V13, P4870, DOI 10.1002/j.1460-2075.1994.tb06814.x; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Krech K, 2012, PLANT PHYSIOL, V159, P579, DOI 10.1104/pp.112.196642; Kubo T, 2007, PHYSIOL PLANTARUM, V129, P6, DOI 10.1111/j.1399-3054.2006.00768.x; Li D, 2007, BIOCHIMIE, V89, P1528, DOI 10.1016/j.biochi.2007.08.004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann A, 2006, J BIOL CHEM, V281, P40461, DOI 10.1074/jbc.M609412200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pascual A, 1999, FEBS LETT, V442, P7, DOI 10.1016/S0014-5793(98)01621-4; Phizicky EM, 2010, FEBS LETT, V584, P265, DOI 10.1016/j.febslet.2009.11.049; Preuten T, 2010, PLANT J, V64, P948, DOI 10.1111/j.1365-313X.2010.04389.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Randau L, 2008, NATURE, V453, P120, DOI 10.1038/nature06833; Reardon EM, 1995, PLANT MOL BIOL REP, V13, P320, DOI 10.1007/BF02669185; Schottler MA, 2007, J BIOL CHEM, V282, P976, DOI 10.1074/jbc.M606436200; Sugita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108962; Tiller N, 2012, PLANT J, V69, P302, DOI 10.1111/j.1365-313X.2011.04791.x; Walter M, 2010, PLANT J, V64, P851, DOI 10.1111/j.1365-313X.2010.04377.x; WANG MJ, 1988, EMBO J, V7, P1567, DOI 10.1002/j.1460-2075.1988.tb02981.x; WITTIG B, 1978, NUCLEIC ACIDS RES, V5, P1165, DOI 10.1093/nar/5.4.1165; Wycliffe P, 2005, PLANT J, V44, P1, DOI 10.1111/j.1365-313X.2005.02482.x; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; Zhou WB, 2013, NUCLEIC ACIDS RES, V41, P3362, DOI 10.1093/nar/gkt013	54	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120533	10.1371/journal.pone.0120533	http://dx.doi.org/10.1371/journal.pone.0120533			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793367	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900049
J	Chen, S; Fleischer, SJ; Saunders, MC; Thomas, MB				Chen, Shi; Fleischer, Shelby J.; Saunders, Michael C.; Thomas, Matthew B.			The Influence of Diurnal Temperature Variation on Degree-Day Accumulation and Insect Life History	PLOS ONE			English	Article							BERRY MOTH LEPIDOPTERA; CLIMATE-CHANGE; VIRUS TRANSMISSION; GRAPE; RANGE; MODEL; VARIABILITY; ECTOTHERMS; EVOLUTION; VOLTINISM	Ectotherms, such as insects, experience non-constant temperatures in nature. Daily mean temperatures can be derived from the daily maximum and minimum temperatures. However, the converse is not true and environments with the same mean temperature can exhibit very different diurnal temperate ranges. Here we apply a degree-day model for development of the grape berry moth (Paralobesia viteana, a significant vineyard pest in the northeastern USA) to investigate how different diurnal temperature range conditions can influence degree-day accumulation and, hence, insect life history. We first consider changes in diurnal temperature range independent of changes in mean temperatures. We then investigate grape berry moth life history under potential climate change conditions, increasing mean temperature via variable patterns of change to diurnal temperature range. We predict that diurnal temperature range change can substantially alter insect life history. Altering diurnal temperature range independent of the mean temperature can affect development rate and voltinism, with the magnitude of the effects dependent on whether changes occur to the daily minimum temperature (Tmin), daily maximum temperature (Tmax), or both. Allowing for an increase in mean temperature produces more marked effects on life history but, again, the patterns and magnitude depend on the nature of the change to diurnal temperature range together with the starting conditions in the local environment. The study highlights the importance of characterizing the influence of diurnal temperature range in addition to mean temperature alone.	[Chen, Shi] N Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Chen, Shi] Natl Inst Math & Biol Synth, Knoxville, TN USA; [Fleischer, Shelby J.; Saunders, Michael C.; Thomas, Matthew B.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA	University of North Carolina; North Carolina State University; University of Tennessee System; University of Tennessee Knoxville; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Chen, S (corresponding author), N Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	schen31@ncsu.edu	Fleischer, Shelby/AAD-6663-2020; Fleischer, Shelby/AAN-1392-2020					Allen J, 2011, ENVIRON ENTOMOL, V5, P388; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Bozinovic F, 2011, PHYSIOL BIOCHEM ZOOL, V84, P543, DOI 10.1086/662551; Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824; Chen S, 2013, VECTOR-BORNE ZOONOT, V13, P489, DOI 10.1089/vbz.2012.1094; Chen S, 2011, ENVIRON ENTOMOL, V40, P505, DOI 10.1603/EN10099; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Folguera G, 2011, COMP BIOCHEM PHYS A, V159, P242, DOI 10.1016/j.cbpa.2011.03.002; Folguera G, 2009, COMP BIOCHEM PHYS A, V154, P389, DOI 10.1016/j.cbpa.2009.07.008; FORSYTHE WC, 1995, ECOL MODEL, V80, P87, DOI 10.1016/0304-3800(94)00034-F; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hong G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036108; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Letcher M, 2009, CLIMATE CHANGE OBSER; LIU SS, 1995, ANN ENTOMOL SOC AM, V88, P107, DOI 10.1093/aesa/88.2.107; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lowry WP, 1989, FUNDAMENTALS BIOMETE; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Nagarkatti S, 2001, ENVIRON ENTOMOL, V30, P540, DOI 10.1603/0046-225X-30.3.540; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Pennsylvania Department of Environmental Protection, 2009, PENNS FIN CLIM CHANG; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ribeiro PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032083; Shein KA, 2013, B AM METEOROL SOC, V94, P393, DOI 10.1175/BAMS-D-11-00013.1; Sternberg ED, 2014, TRENDS PARASITOL, V30, P115, DOI 10.1016/j.pt.2013.12.010; TAYLOR F, 1981, AM NAT, V117, P1, DOI 10.1086/283683; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Tobin PC, 2008, GLOBAL CHANGE BIOL, V14, P951, DOI 10.1111/j.1365-2486.2008.01561.x; Tobin PC, 2003, ENVIRON ENTOMOL, V32, P340, DOI 10.1603/0046-225X-32.2.340; Tobin PC, 2002, ENVIRON ENTOMOL, V31, P708, DOI 10.1603/0046-225X-31.4.708; Tobin PC, 2001, ENVIRON ENTOMOL, V30, P692, DOI 10.1603/0046-225X-30.4.692; Travis DJ, 2004, J CLIMATE, V17, P1123, DOI 10.1175/1520-0442(2004)017<1123:RVIUDT>2.0.CO;2; Travis DJ, 2002, NATURE, V418, P601, DOI 10.1038/418601a; Union of Concerned Scientists, 2011, CLIM CHANG US NE CLI; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Virginia Office of Inspector General, 2013, REV VAS PROGR ADDR C; WIESE AM, 1987, WEED SCI, V35, P177; Wild M., 2007, GEOPHYS RES LETT, V34	43	14	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120772	10.1371/journal.pone.0120772	http://dx.doi.org/10.1371/journal.pone.0120772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790195	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400176
J	Field, D; Gaudin, N; Lyons, F; O'Connor, PM; Cotter, PD; Hill, C; Ross, RP				Field, Des; Gaudin, Noemie; Lyons, Francy; O'Connor, Paula M.; Cotter, Paul D.; Hill, Colin; Ross, R. Paul			A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius	PLOS ONE			English	Article							ANTIMICROBIAL CATIONIC PEPTIDES; IN-VITRO ACTIVITIES; METHICILLIN-RESISTANT; ENHANCED ACTIVITY; AUREUS BIOFILMS; LANTIBIOTICS; COMBINATION; COWS; BIOSYNTHESIS; BACTERIOCINS	Antibiotic resistance and the shortage of novel antimicrobials are among the biggest challenges facing society. One of the major factors contributing to resistance is the use of frontline clinical antibiotics in veterinary practice. In order to properly manage dwindling antibiotic resources, we must identify antimicrobials that are specifically targeted to veterinary applications. Nisin is a member of the lantibiotic family of antimicrobial peptides that exhibit potent antibacterial activity against many gram-positive bacteria, including human and animal pathogens such as Staphylococcus, Bacillus, Listeria, and Clostridium. Although not currently used in human medicine, nisin is already employed commercially as an anti-mastitis product in the veterinary field. Recently we have used bioengineering strategies to enhance the activity of nisin against several high profile targets, including multi-drug resistant clinical pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) and also against staphylococci and streptococci associated with bovine mastitis. However, newly emerging pathogens such as methicillin resistant Staphylococcus pseudintermedius (MRSP) pose a significant threat in terms of veterinary health and as a reservoir for antibiotic resistance determinants. In this study we created a nisin derivative with enhanced antimicrobial activity against S. pseudintermedius. In addition, the novel nisin derivative exhibits an enhanced ability to impair biofilm formation and to reduce the density of established biofilms. The activities of this peptide represent a significant improvement over that of the wild-type nisin peptide and merit further investigation with a view to their use to treat S. pseudintermedius infections.	[Field, Des; Gaudin, Noemie; Lyons, Francy; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [O'Connor, Paula M.; Cotter, Paul D.; Ross, R. Paul] Teagasc Food Res Ctr, Fermoy, Cork, Ireland; [Cotter, Paul D.; Hill, Colin; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	University College Cork; Teagasc; University College Cork	Field, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland.	des.field@ucc.ie; c.hill@ucc.ie	Hill, Colin/A-5611-2012; Ross, Paul/A-7584-2015; Field, Des/AAU-6785-2021; Cotter, Paul/AAX-5449-2021; Cotter, Paul/B-7781-2008; STANTON, CATHERINE/A-9549-2015	Hill, Colin/0000-0002-8527-1445; Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; Cotter, Paul/0000-0002-5465-9068; STANTON, CATHERINE/0000-0002-6724-7011; Field, Des/0000-0003-4425-5817; O'Connor, Paula M./0000-0001-6462-2077	Irish Government under the National Development Plan, through Science Foundation Ireland Investigator [10/IN. 1/B3027]	Irish Government under the National Development Plan, through Science Foundation Ireland Investigator(Science Foundation Ireland)	This work was supported by the Irish Government under the National Development Plan, through Science Foundation Ireland Investigator awards (10/IN. 1/B3027 (http://www.sfi.ie). DF would like to acknowledge receipt of a Society for Applied Microbiology (http://www.sfam.org.uk) Students into Work Grant for FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard AN, 2009, CHEM BIOL, V16, P490, DOI 10.1016/j.chembiol.2009.03.011; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 1999, BBA-BIOMEMBRANES, V1462, P223, DOI 10.1016/S0005-2736(99)00208-4; Cao LT, 2007, J DAIRY SCI, V90, P3980, DOI 10.3168/jds.2007-0153; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Corbin A, 2011, ANTIMICROB AGENTS CH, V55, P3338, DOI 10.1128/AAC.00206-11; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Davison WM, 2010, ANTIMICROB AGENTS CH, V54, P2920, DOI 10.1128/AAC.01734-09; Delves-Broughton J, 2005, FOOD AUST, V57, P525; DiCicco M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-225; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dosler S, 2013, PEPTIDES, V49, P53, DOI 10.1016/j.peptides.2013.08.008; Dosler S, 2011, CHEMOTHERAPY, V57, P511, DOI 10.1159/000335598; Field D, 2008, MOL MICROBIOL, V69, P218, DOI 10.1111/j.1365-2958.2008.06279.x; Field D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046884; Field D, 2010, MICROB BIOTECHNOL, V3, P473, DOI 10.1111/j.1751-7915.2010.00184.x; Fitzgerald JR, 1997, EPIDEMIOL INFECT, V119, P261, DOI 10.1017/S0950268897007802; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Frank LA, 2009, P N AM VET DERMATOLO, V20, P219; Healy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079563; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Islam MR, 2009, MOL MICROBIOL, V72, P1438, DOI 10.1111/j.1365-2958.2009.06733.x; Jain A, 2009, J MICROBIOL METH, V76, P88, DOI 10.1016/j.mimet.2008.09.017; Kelly D, 2012, LETT APPL MICROBIOL, V54, P286, DOI 10.1111/j.1472-765X.2012.03205.x; Kuipers OP, 1996, ANTON LEEUW INT J G, V69, P161, DOI 10.1007/BF00399421; Loeffler A, 2007, VET DERMATOL, V18, P412, DOI 10.1111/j.1365-3164.2007.00635.x; Mataraci E, 2012, ANTIMICROB AGENTS CH, V56, P6366, DOI 10.1128/AAC.01180-12; Molloy EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058530; Murayama N, 2013, VET DERMATOL, V24, P126, DOI 10.1111/j.1365-3164.2012.01103.x; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Okuda K, 2013, ANTIMICROB AGENTS CH, V57, P5572, DOI 10.1128/AAC.00888-13; Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x; Perin LM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-36; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Piper Clare, 2009, Curr Drug Discov Technol, V6, P1; Rankin SC, 2007, VET DERMATOL, V18, P175; Rink R, 2007, APPL ENVIRON MICROB, V73, P5809, DOI 10.1128/AEM.01104-07; ROLLEMA HS, 1995, APPL ENVIRON MICROB, V61, P2873, DOI 10.1128/AEM.61.8.2873-2878.1995; Rouse S, 2012, MICROB BIOTECHNOL, V5, P501, DOI 10.1111/j.1751-7915.2011.00324.x; Ruscher C, 2009, VET MICROBIOL, V136, P197, DOI 10.1016/j.vetmic.2008.10.023; SAHL HG, 1995, EUR J BIOCHEM, V230, P827, DOI 10.1111/j.1432-1033.1995.tb20627.x; SEARS PM, 1992, J DAIRY SCI, V75, P3185, DOI 10.3168/jds.S0022-0302(92)78083-7; Singh A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-93; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Vazquez-Sanchez D, 2014, FOOD CONTROL, V39, P8, DOI 10.1016/j.foodcont.2013.09.029; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Wirawan RE, 2006, APPL ENVIRON MICROB, V72, P1148, DOI 10.1128/AEM.72.2.1148-1156.2006; Wu JQ, 2007, ANTIMICROB AGENTS CH, V51, P3131, DOI 10.1128/AAC.00629-07; Yoo JH, 2010, J MICROBIOL BIOTECHN, V20, P798, DOI 10.4014/jmb.0910.10044; Yoon JW, 2010, J MICROBIOL BIOTECHN, V20, P1764, DOI 10.4014/jmb.1001.01011; Yuan J, 2004, APPL MICROBIOL BIOT, V64, P806, DOI 10.1007/s00253-004-1599-1	54	56	59	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119684	10.1371/journal.pone.0119684	http://dx.doi.org/10.1371/journal.pone.0119684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789988	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400094
J	Hagy, HM; Kaminski, RM				Hagy, Heath M.; Kaminski, Richard M.			Determination of Foraging Thresholds and Effects of Application on Energetic Carrying Capacity for Waterfowl	PLOS ONE			English	Article							MOIST-SOIL WETLANDS; FUNCTIONAL-RESPONSE; WOOD DUCKS; PATCH USE; FOOD USE; MODELS; DEPLETION; DENSITY; SWANS; ABUNDANCE	Energetic carrying capacity of habitats for wildlife is a fundamental concept used to better understand population ecology and prioritize conservation efforts. However, carrying capacity can be difficult to estimate accurately and simplified models often depend on many assumptions and few estimated parameters. We demonstrate the complex nature of parameterizing energetic carrying capacity models and use an experimental approach to describe a necessary parameter, a foraging threshold (i.e., density of food at which animals no longer can efficiently forage and acquire energy), for a guild of migratory birds. We created foraging patches with different fixed prey densities and monitored the numerical and behavioral responses of waterfowl (Anatidae) and depletion of foods during winter. Dabbling ducks (Anatini) fed extensively in plots and all initial densities of supplemented seed were rapidly reduced to 10 kg/ha and other natural seeds and tubers combined to 170 kg/ha, despite different starting densities. However, ducks did not abandon or stop foraging in wetlands when seed reduction ceased approximately two weeks into the winter-long experiment nor did they consistently distribute according to ideal-free predictions during this period. Dabbling duck use of experimental plots was not related to initial seed density, and residual seed and tuber densities varied among plant taxa and wetlands but not plots. Herein, we reached several conclusions: 1) foraging effort and numerical responses of dabbling ducks in winter were likely influenced by factors other than total food densities (e.g., predation risk, opportunity costs, forager condition), 2) foraging thresholds may vary among foraging locations, and 3) the numerical response of dabbling ducks may be an inconsistent predictor of habitat quality relative to seed and tuber density. We describe implications on habitat conservation objectives of using different foraging thresholds in energetic carrying capacity models and suggest scientists reevaluate assumptions of these models used to guide habitat conservation.	[Hagy, Heath M.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Forbes Biol Stn,Bellrose Waterfowl Res Ctr, Havana, IL 62644 USA; [Kaminski, Richard M.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA	Illinois Natural History Survey; University of Illinois System; Mississippi State University	Hagy, HM (corresponding author), Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Forbes Biol Stn,Bellrose Waterfowl Res Ctr, Havana, IL 62644 USA.	hhagy@illinois.edu			Mississippi Department of Wildlife, Fisheries, and Parks; Forest and Wildlife Research Center at Mississippi State University; Ducks Unlimited	Mississippi Department of Wildlife, Fisheries, and Parks; Forest and Wildlife Research Center at Mississippi State University; Ducks Unlimited	The authors' research was supported financially by the Mississippi Department of Wildlife, Fisheries, and Parks (http://www.mdwfp.com/); The Forest and Wildlife Research Center at Mississippi State University (http://fwrc.msstate.edu/); and Ducks Unlimited (http://www.ducks.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hunt Melissa M., 2007, P105; Castillo-Guerrero JA, 2009, WATERBIRDS, V32, P400, DOI 10.1675/063.032.0304; Amano T, 2004, J APPL ECOL, V41, P675, DOI 10.1111/j.0021-8901.2004.00923.x; Amano T, 2006, ETHOLOGY, V112, P544, DOI 10.1111/j.1439-0310.2006.01196.x; Anderson JT, 1999, WILDLIFE SOC B, V27, P281; [Anonymous], 2006, SAS MIXED MODELS; ARENGO F, 1995, CONDOR, V97, P325, DOI 10.2307/1369018; Arzel C, 2007, BEHAV PROCESS, V75, P66, DOI 10.1016/j.beproc.2007.01.001; BALDASSARRE GA, 1984, J WILDLIFE MANAGE, V48, P63, DOI 10.2307/3808453; Ballard BM, 2004, J WILDLIFE MANAGE, V68, P371, DOI 10.2193/0022-541X(2004)068[0371:DANONP]2.0.CO;2; Barras SC, 1996, J WILDLIFE MANAGE, V60, P592, DOI 10.2307/3802077; Bellrose F, 1980, DUCKS GEESE SWANS N; BERNSTEIN C, 1988, J ANIM ECOL, V57, P1007, DOI 10.2307/5108; Brasher MG, 2010, THESIS OHIO STATE U; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; BROWN JS, 1989, AM NAT, V133, P168, DOI 10.1086/284908; Callicutt JT, 2011, J FISH WILDL MANAG, V2, P29, DOI 10.3996/102010-JFWM-038; CARACO T, 1980, ECOLOGY, V61, P119, DOI 10.2307/1937162; Central Valley Joint Venture Implementation Plan (CVJV), 2006, CENTR VALL JOINT VEN; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Combs DL, 1996, J WILDLIFE MANAGE, V60, P603, DOI 10.2307/3802078; Cramer DM, 2012, J WILDLIFE MANAGE, V76, P214, DOI 10.1002/jwmg.252; CRESSWELL W, 1994, J ANIM ECOL, V63, P589, DOI 10.2307/5225; DELNICKI D, 1986, J WILDLIFE MANAGE, V50, P43, DOI 10.2307/3801486; Dobbs RC, 2007, J FIELD ORNITHOL, V78, P133, DOI 10.1111/j.1557-9263.2007.00096.x; Ehrle B, 1995, WILDLIFE SOC B, V23, P774; Fleming K.S., 2010, THESIS MISSISSIPPI S THESIS MISSISSIPPI S; Fretwell S.D., 1970, ACTA BIOTHEOR, V19, P16, DOI DOI 10.1007/BF01601953; Fritz H, 2001, OIKOS, V93, P488, DOI 10.1034/j.1600-0706.2001.930314.x; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; Goss-Custard JD, 2002, BIOL CONSERV, V105, P27, DOI 10.1016/S0006-3207(01)00175-6; Goss-Custard JD, 2003, J APPL ECOL, V40, P176, DOI 10.1046/j.1365-2664.2003.00785.x; Gray MJ, 2013, WETLAND TECHNIQUES, P121; Greer AK, 2007, J WILDLIFE MANAGE, V71, P1561, DOI 10.2193/2006-376; Greer DM, 2009, J WILDLIFE MANAGE, V73, P1125, DOI 10.2193/2008-250; Guillemain M, 2001, J AVIAN BIOL, V32, P345, DOI 10.1111/j.0908-8857.2001.320409.x; Gurd DB, 2006, ZOOLOGY, V109, P120, DOI 10.1016/j.zool.2005.10.002; Hagy H. M., 2011, P ANN C SE ASS FISH, V65, P56; Hagy Heath M., 2014, Wildfowl, P436; Hagy HM, 2012, WILDLIFE SOC B, V36, P512, DOI 10.1002/wsb.165; Hagy HM, 2012, J WILDLIFE MANAGE, V76, P1053, DOI 10.1002/jwmg.325; Hagy HM, 2011, J WILDLIFE MANAGE, V75, P959, DOI 10.1002/jwmg.115; Inger R, 2006, J APPL ECOL, V43, P1022, DOI 10.1111/j.1365-2664.2006.01207.x; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Kahler BM, 2012, UPPER MISSISSIPPI RI; Kaminski RM, 2003, J WILDLIFE MANAGE, V67, P542, DOI 10.2307/3802712; KAMINSKI RM, 1981, AUK, V98, P115; Kirk M, 2008, OECOLOGIA, V155, P859, DOI 10.1007/s00442-007-0947-0; Klaassen RHG, 2007, J ANIM ECOL, V76, P20, DOI 10.1111/j.1365-2656.2006.01184.x; Kotler BP, 2007, ISR J ECOL EVOL, V53, P237, DOI 10.1560/IJEE.53.3.237; Kross J, 2008, J WILDLIFE MANAGE, V72, P707, DOI 10.2193/2007-100; Loesch C. R., 1994, LOWER MISSISSIPPI VA; Lovvorn JR, 1996, ECOLOGY, V77, P435, DOI 10.2307/2265620; LOVVORN JR, 1994, J ANIM ECOL, V63, P11, DOI 10.2307/5578; LOVVORN JR, 1989, J APPL ECOL, V26, P113, DOI 10.2307/2403655; LOVVORN JR, 1994, HYDROBIOLOGIA, V279, P223, DOI 10.1007/BF00027856; Lyons JE, 2005, CONDOR, V107, P41, DOI 10.1650/7462; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Miller MR, 2006, CONDOR, V108, P166, DOI 10.1650/0010-5422(2006)108[0166:TARBRM]2.0.CO;2; Moon JA, 2008, P ANN C SE ASS FISH, V62, P32; Morris DW, 2007, ECOLOGY, V88, P597, DOI 10.1890/06-0389; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Naylor L.W., 2002, THESIS U CALIFORNIA; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nolet BA, 2006, OIKOS, V112, P353, DOI 10.1111/j.0030-1299.2006.13463.x; Nolet BA, 2002, J ANIM ECOL, V71, P979, DOI 10.1046/j.1365-2656.2002.00662.x; Nolet BA, 2001, ECOLOGY, V82, P1655, DOI 10.1890/0012-9658(2001)082[1655:SVITDB]2.0.CO;2; Nolet BA, 2009, OIKOS, V118, P431, DOI 10.1111/j.1600-0706.2008.16857.x; Percival SM, 1998, J APPL ECOL, V35, P57, DOI 10.1046/j.1365-2664.1998.00273.x; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Reinecke K.J., 1989, P203; Richman SE, 2009, J ANIM ECOL, V78, P1033, DOI 10.1111/j.1365-2656.2009.01556.x; Richman SE, 2004, ECOL APPL, V14, P1217, DOI 10.1890/03-5032; SAS Institute Inc., 2008, SAS 9 3 ENH LOGG FAC; Smith RV, 2011, 201137 IL NAT HIST S; Soulliere G. J., 2007, UPPER MISSISSIPPI RI; Sponberg AF, 2005, ECOLOGY, V86, P2127, DOI 10.1890/04-1335; van Gils JA, 2007, AM NAT, V169, P609, DOI 10.1086/513114; van Gils JA, 2003, AM NAT, V161, P777, DOI 10.1086/374205; van Gils JA, 2004, OIKOS, V104, P197, DOI 10.1111/j.0030-1299.2003.12214.x; VanderMeer J, 1997, J ANIM ECOL, V66, P846; VANEERDEN MR, 1997, PATCHWORK PATCH USE, P165; West AD, 2005, BIOL CONSERV, V123, P211, DOI 10.1016/j.biocon.2004.11.010; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Ydenberg Ronald C., 2007, P1; Zar J.H., 2009, BIOSTATISTICAL ANAL	86	27	27	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118349	10.1371/journal.pone.0118349	http://dx.doi.org/10.1371/journal.pone.0118349			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790255	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400027
J	Shibayama, J; Yuzyuk, TN; Cox, J; Makaju, A; Miller, M; Lichter, J; Li, H; Leavy, JD; Franklin, S; Zaitsev, AV				Shibayama, Junko; Yuzyuk, Tatiana N.; Cox, James; Makaju, Aman; Miller, Mickey; Lichter, Justin; Li, Hui; Leavy, Jane D.; Franklin, Sarah; Zaitsev, Alexey V.			Metabolic Remodeling in Moderate Synchronous versus Dyssynchronous Pacing-Induced Heart Failure: Integrated Metabolomics and Proteomics Study	PLOS ONE			English	Article							FATTY-ACID OXIDATION; CARDIAC RESYNCHRONIZATION THERAPY; FAILING HUMAN HEART; IDIOPATHIC DILATED CARDIOMYOPATHY; PROTEIN EXPRESSION; GENE-EXPRESSION; DOWN-REGULATION; MITOCHONDRIAL-FUNCTION; PRESSURE-OVERLOAD; ENERGY-METABOLISM	Heart failure (HF) is accompanied by complex alterations in myocardial energy metabolism. Up to 40% of HF patients have dyssynchronous ventricular contraction, which is an independent indicator of mortality. We hypothesized that electromechanical dyssynchrony significantly affects metabolic remodeling in the course of HF. We used a canine model of tachypacing-induced HF. Animals were paced at 200 bpm for 6 weeks either in the right atrium (synchronous HF, SHF) or in the right ventricle (dyssynchronous HF, DHF). We collected biopsies from left ventricular apex and performed comprehensive metabolic pathway analysis using multi-platform metabolomics (GC/MS; MS/MS; HPLC) and LC-MS/MS labelfree proteomics. We found important differences in metabolic remodeling between SHF and DHF. As compared to Control, ATP, phosphocreatine (PCr), creatine, and PCr/ATP (prognostic indicator of mortality in HF patients) were all significantly reduced in DHF, but not SHF. In addition, the myocardial levels of carnitine (mitochondrial fatty acid carrier) and fatty acids (12:0, 14:0) were significantly reduced in DHF, but not SHF. Carnitine parmitoyltransferase I, a key regulatory enzyme of fatty acid beta-oxidation, was significantly upregulated in SHF but was not different in DHF, as compared to Control. Both SHF and DHF exhibited a reduction, but to a different degree, in creatine and the intermediates of glycolysis and the TCA cycle. In contrast to this, the enzymes of creatine kinase shuttle were upregulated, and the enzymes of glycolysis and the TCA cycle were predominantly upregulated or unchanged in both SHF and DHF. These data suggest a systemic mismatch between substrate supply and demand in pacing-induced HF. The energy deficit observed in DHF, but not in SHF, may be associated with a critical decrease in fatty acid delivery to the beta-oxidation pipeline, primarily due to a reduction in myocardial carnitine content.	[Shibayama, Junko; Makaju, Aman; Miller, Mickey; Lichter, Justin; Li, Hui; Franklin, Sarah; Zaitsev, Alexey V.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Shibayama, Junko; Leavy, Jane D.; Franklin, Sarah] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Yuzyuk, Tatiana N.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Yuzyuk, Tatiana N.] ARUP Labs, Salt Lake City, UT USA; [Cox, James] Univ Utah, Metabol Core Res Facil, Salt Lake City, UT USA; [Cox, James; Franklin, Sarah] Univ Utah, Dept Biochem, Salt Lake City, UT USA; [Lichter, Justin; Zaitsev, Alexey V.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Zaitsev, AV (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA.	zaitsev@cvrti.utah.edu	li, hui/A-3135-2017	Cox, James/0000-0002-5977-2350; Zaitsev, Artem/0000-0002-2314-0482	United States National Institutes of Health NRSA fellowship [F32HL097576]; United States National Institutes of Health [R01HL103877, R01HL094464, R00HL107674]; Nora Eccles Treadwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL107674, F32HL097576, R01HL094464, R01HL103877, R00HL107674] Funding Source: NIH RePORTER	United States National Institutes of Health NRSA fellowship; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nora Eccles Treadwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the United States National Institutes of Health NRSA fellowship F32HL097576 (JS), the United States National Institutes of Health Grants R01HL103877 (AVZ), R01HL094464 (FBS), R00HL107674 ( SF), and Nora Eccles Treadwell Foundation research grant (AVZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetti G, 2010, CIRC-CARDIOVASC GENE, V3, P78, DOI 10.1161/CIRCGENETICS.109.871236; Aiba T, 2009, CIRCULATION, V119, P1220, DOI 10.1161/CIRCULATIONAHA.108.794834; Ardehali H, 2012, EUR J HEART FAIL, V14, P120, DOI 10.1093/eurjhf/hfr173; ARMSTRONG PW, 1986, CIRCULATION, V74, P1075, DOI 10.1161/01.CIR.74.5.1075; Barth AS, 2011, CIRC-CARDIOVASC GENE, V4, P475, DOI 10.1161/CIRCGENETICS.110.957571; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; Birner C, 2012, J CARD FAIL, V18, P660, DOI 10.1016/j.cardfail.2012.06.418; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Calmettes G, 2013, J GEN PHYSIOL, V142, P425, DOI 10.1085/jgp.201310968; Cha YM, 2006, AM J PHYSIOL-HEART C, V290, pH1686, DOI 10.1152/ajpheart.00384.2005; Chakir K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001909; Chakir K, 2009, CIRCULATION, V119, P1231, DOI 10.1161/CIRCULATIONAHA.108.774752; Chandler MP, 2004, AM J PHYSIOL-HEART C, V287, pH1538, DOI 10.1152/ajpheart.00281.2004; Cieniewski-Bernard C, 2008, J PROTEOME RES, V7, P5004, DOI 10.1021/pr800409u; Cordero-Reyes AM, 2014, J MOL CELL CARDIOL, V68, P98, DOI 10.1016/j.yjmcc.2013.12.029; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Doenst T, 2010, CARDIOVASC RES, V86, P461, DOI 10.1093/cvr/cvp414; El-Aroussy W, 2000, MOL CELL BIOCHEM, V213, P37, DOI 10.1023/A:1007142919941; Fueger PT, 2005, J PHYSIOL-LONDON, V566, P533, DOI 10.1113/jphysiol.2005.085043; Gao Z, 2008, PHYSIOL GENOMICS, V35, P222, DOI 10.1152/physiolgenomics.00100.2007; Garcia-Rua V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037505; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Gibala MJ, 2000, ACTA PHYSIOL SCAND, V168, P657, DOI 10.1046/j.1365-201x.2000.00717.x; Grube M, 2011, AM J PATHOL, V178, P2547, DOI 10.1016/j.ajpath.2011.02.020; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Ingwall JS, 2006, CURR HYPERTENS REP, V8, P457, DOI 10.1007/s11906-006-0023-x; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Johannsson E, 2001, CIRCULATION, V104, P729, DOI 10.1161/hc3201.092286; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Karbowska J, 2003, CELL MOL BIOL LETT, V8, P49; Kodde IF, 2007, COMP BIOCHEM PHYS A, V146, P26, DOI 10.1016/j.cbpa.2006.09.014; Lei B, 2004, J MOL CELL CARDIOL, V36, P567, DOI 10.1016/j.yjmcc.2004.02.004; Lichter JG, 2014, J MOL CELL CARDIOL, V72, P186, DOI 10.1016/j.yjmcc.2014.03.012; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Marin-Garcia J, 2001, CARDIOVASC RES, V52, P103, DOI 10.1016/S0008-6363(01)00368-6; Martin MA, 2000, BBA-MOL BASIS DIS, V1502, P330, DOI 10.1016/S0925-4439(00)00061-2; MONTGOMERY C, 1992, J APPL PHYSIOL, V73, P2363, DOI 10.1152/jappl.1992.73.6.2363; Morgan EE, 2006, EUR J HEART FAIL, V8, P687, DOI 10.1016/j.ejheart.2006.01.005; Neglia D, 2007, AM J PHYSIOL-HEART C, V293, pH3270, DOI 10.1152/ajpheart.00887.2007; Neubauer S, 1997, CIRCULATION, V96, P2190; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Pak PH, 1997, J AM COLL CARDIOL, V30, P576, DOI 10.1016/S0735-1097(97)00193-9; Pieske B, 2002, CIRCULATION, V106, P447, DOI 10.1161/01.CIR.0000023042.50192.F4; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; RICHTER PH, 1980, BIOPHYS CHEM, V12, P285, DOI 10.1016/0301-4622(80)80006-8; Rosiers CD, 2011, CARDIOVASC RES, V90, P210, DOI 10.1093/cvr/cvr055; Sachse FB, 2012, CIRC RES, V110, P588, DOI 10.1161/CIRCRESAHA.111.257428; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Schupp M, 2006, EUR J HEART FAIL, V8, P290, DOI 10.1016/j.ejheart.2005.09.003; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Shen WQ, 1999, CIRCULATION, V100, P2113, DOI 10.1161/01.CIR.100.20.2113; Shibayama J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057821; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Southworth R, 2007, AM J PHYSIOL-HEART C, V292, pH378, DOI 10.1152/ajpheart.00664.2006; Spragg DD, 2003, CIRCULATION, V108, P929, DOI 10.1161/01.CIR.0000088782.99568.CA; Ueland T, 2013, INT J CARDIOL, V167, P1892, DOI 10.1016/j.ijcard.2012.04.150; Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Weisiger RA, 2002, MOL CELL BIOCHEM, V239, P35, DOI 10.1023/A:1020550405578; WILLIAMS RE, 1994, CIRC RES, V75, P615, DOI 10.1161/01.RES.75.4.615; WILSON JR, 1987, CIRCULATION, V75, P857, DOI 10.1161/01.CIR.75.4.857; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yazaki Y, 1999, HEART, V81, P153, DOI 10.1136/hrt.81.2.153	70	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118974	10.1371/journal.pone.0118974	http://dx.doi.org/10.1371/journal.pone.0118974			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790351	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400058
J	Wang, X; Wang, ZW; Sidhu, PS; Desai, UR; Zhou, QB				Wang, Xing; Wang, Zhiwei; Sidhu, Preetpal Singh; Desai, Umesh R.; Zhou, Qibing			6-Hydroxyflavone and Derivatives Exhibit Potent Anti-Inflammatory Activity among Mono-, Di- and Polyhydroxylated Flavones in Kidney Mesangial Cells	PLOS ONE			English	Article							INHIBITORS; INFLAMMATION; APOPTOSIS; PATHWAY; AGENT	Inflammatory responses by kidney mesangial cells play a critical role in the glomerulonephritis. The anti-inflammatory potential of nineteen mono-, di- and polyhydroxylated flavones including fisetin, quercetin, morin, tricetin, gossypetin, apigenin and myricetin were investigated on rat mesangial cells with lipopolysaccharide (LPS) as the inflammatory stimuli. 6-Hydroxyflavone and 40,6-dihydroxyflavone exhibited high activity with IC50 in the range of 2.0 mu M, a much better inhibition potential in comparison to the well-studied polyhydroxylated flavones. Interestingly, the anti-inflammatory activity was not due to direct quenching of NO radicals. Investigation on derivatives with methylation, acetylation or sulfation of 6-hydroxyl group revealed that 6-methoxyflavone was the most potent with an IC50 of 192 nM. Mechanistic study indicated that the anti-inflammatory activity of 6-methoxyflavone arose via the inhibition of LPS-induced downstream inducible NO synthase in mesangial cells. The identification of 6-hydroxyflavone and 6-methoxyflavone with potent anti-inflammatory activity in kidney mesangial cells provides a new flavone scaffold and direction to develop naturally derived products for potential nephritis prevention and treatment.	[Wang, Xing; Wang, Zhiwei; Zhou, Qibing] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Nanomed & Biopharmaceut, Wuhan 430074, Hubei, Peoples R China; [Sidhu, Preetpal Singh; Desai, Umesh R.; Zhou, Qibing] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Sidhu, Preetpal Singh; Desai, Umesh R.; Zhou, Qibing] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA USA	Huazhong University of Science & Technology; Virginia Commonwealth University; Virginia Commonwealth University	Zhou, QB (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Nanomed & Biopharmaceut, Wuhan 430074, Hubei, Peoples R China.	qibingzhou@hust.edu.cn	Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597	National Basic Research Program of China [2011CB933100]; National Heart Lung and Blood Institute, USA [HL090586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090586] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Heart Lung and Blood Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Basic Research Program of China (2011CB933100 to QZ) and National Heart Lung and Blood Institute, USA (HL090586 to URD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Amrutha K, 2014, BIOORG MED CHEM LETT, V24, P4735, DOI 10.1016/j.bmcl.2014.07.093; Domitrovic R, 2013, TOXICOLOGY, V310, P115, DOI 10.1016/j.tox.2013.05.015; Geraets L, 2009, BIOCHEM BIOPH RES CO, V382, P598, DOI 10.1016/j.bbrc.2009.03.071; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; Khan A, 2013, INT J RADIAT BIOL, V89, P965, DOI 10.3109/09553002.2013.811310; Lee IT, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-33; Liu CM, 2012, BBA-GEN SUBJECTS, V1820, P1693, DOI 10.1016/j.bbagen.2012.06.011; Liu M, 2001, J MED CHEM, V44, P4443, DOI 10.1021/jm0101747; NATOLI M, 1990, TETRAHEDRON LETT, V31, P7371, DOI 10.1016/S0040-4039(00)88570-6; Ozcan F, 2012, CLIN EXP MED, V12, P265, DOI 10.1007/s10238-011-0167-0; Pandurangan N, 2011, BIOORG MED CHEM LETT, V21, P5328, DOI 10.1016/j.bmcl.2011.07.008; Patel A, 2010, PHARMACOGN RES, V2, P152, DOI 10.4103/0974-8490.65509; Shui HA, 2007, RHEUMATOLOGY, V46, P1277, DOI 10.1093/rheumatology/kem136; Si DY, 2009, DRUG METAB DISPOS, V37, P629, DOI 10.1124/dmd.108.023416; Singh M, 2014, EUR J MED CHEM, V84, P206, DOI 10.1016/j.ejmech.2014.07.013; Tran TA, 2014, ARCH BIOCHEM BIOPHYS, V562, P92, DOI 10.1016/j.abb.2014.08.001; Verghese J, 2009, BIOORG MED CHEM LETT, V19, P4126, DOI 10.1016/j.bmcl.2009.06.013; Xie CH, 2012, J NUTR BIOCHEM, V23, P1184, DOI 10.1016/j.jnutbio.2011.06.013; Zhou QB, 2006, CHEM RES TOXICOL, V19, P1415, DOI 10.1021/tx0601307; Zhou SF, 2009, CURR MED CHEM, V16, P3480, DOI 10.2174/092986709789057635	21	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116409	10.1371/journal.pone.0116409	http://dx.doi.org/10.1371/journal.pone.0116409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790236	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400016
J	Williams, MR; Walter, W				Williams, Matthew R.; Walter, Wayne			Development of a Prototype Over-Actuated Biomimetic Prosthetic Hand	PLOS ONE			English	Article							UPPER-LIMB PROSTHESIS; GRIP FORCE; DESIGN	The loss of a hand can greatly affect quality of life. A prosthetic device that can mimic normal hand function is very important to physical and mental recuperation after hand amputation, but the currently available prosthetics do not fully meet the needs of the amputee community. Most prosthetic hands are not dexterous enough to grasp a variety of shaped objects, and those that are tend to be heavy, leading to discomfort while wearing the device. In order to attempt to better simulate human hand function, a dexterous hand was developed that uses an over-actuated mechanism to form grasp shape using intrinsic joint mounted motors in addition to a finger tendon to produce large flexion force for a tight grip. This novel actuation method allows the hand to use small actuators for grip shape formation, and the tendon to produce high grip strength. The hand was capable of producing fingertip flexion force suitable for most activities of daily living. In addition, it was able to produce a range of grasp shapes with natural, independent finger motion, and appearance similar to that of a human hand. The hand also had a mass distribution more similar to a natural forearm and hand compared to contemporary prosthetics due to the more proximal location of the heavier components of the system. This paper describes the design of the hand and controller, as well as the test results.	[Williams, Matthew R.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland Funct Elect Stimulat Ctr, Cleveland, OH 44106 USA; [Walter, Wayne] Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Rochester Institute of Technology	Williams, MR (corresponding author), Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland Funct Elect Stimulat Ctr, Cleveland, OH 44106 USA.	mwilliams@FEScenter.org			Kate Gleason Foundation	Kate Gleason Foundation	Funding from Kate Gleason Foundation endowed chair funds. Wayne Walter (last author) was the Kate Gleason endowed chair at the time the work was done and assisted in data analysis and manuscript preparation. The funding foundation was not directly involved in the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TOUCH BIONICS; Armiger RS, 2013, J HOPKINS APL TECH D, V31, P345; Atkins DJ., 1996, J PROSTHET ORTHOT, V8, P2, DOI DOI 10.1097/00008526-199600810-00003; Behrend C, 2011, J HAND SURG-AM, V36A, P1711, DOI 10.1016/j.jhsa.2011.07.024; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Blackwell JR, 1999, APPL ERGON, V30, P401, DOI 10.1016/S0003-6870(98)00055-6; Branemark R, 2001, J REHABIL RES DEV, V38, P175; Butterfass J, 1998, IEEE INT CONF ROBOT, P2081; Caffaz A, 1998, IEEE INT CONF ROBOT, P2075, DOI 10.1109/ROBOT.1998.680623; Carrozza MC, 2006, BIOL CYBERN, V95, P629, DOI 10.1007/s00422-006-0124-2; Carrozza MC, 2002, IEEE-ASME T MECH, V7, P108, DOI 10.1109/TMECH.2002.1011247; Controzzi M, 2010, IEEE ENG MED BIO, P499, DOI 10.1109/IEMBS.2010.5627148; CROSBY CA, 1994, J HAND SURG-AM, V19A, P665, DOI 10.1016/0363-5023(94)90280-1; Greiner TM, 1991, HAND ANTHROPOMERY US; Guinnessy P, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2364231; Harvey Zach T, 2012, J Surg Orthop Adv, V21, P58; Jacobsen S. C., 1986, Proceedings 1986 IEEE International Conference on Robotics and Automation (Cat. No.86CH2282-2), P1520; Johannes MS, 2011, J HOPKINS APL TECH D, V30, P207; Kang NV, 2010, J HAND SURG-AM, V35A, P1130, DOI 10.1016/j.jhsa.2010.03.037; Kong YK, 2005, INT J IND ERGONOM, V35, P495, DOI 10.1016/j.ergon.2004.11.003; Kyberd PJ, 1998, ROBOTICA, V16, P531, DOI 10.1017/S0263574798000691; Leitkam ST, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026255; Light C. M., 2002, Journal of Medical Engineering and Technology, V26, P139, DOI 10.1080/03091900210142459; Light CM, 2000, MED ENG PHYS, V22, P679, DOI 10.1016/S1350-4533(01)00017-0; Lin LR, 1998, J MECH DESIGN, V120, P282, DOI 10.1115/1.2826970; Lord M, 1997, ORTHOPEDIC PROSTHETI; Lovchik CS, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P907, DOI 10.1109/ROBOT.1999.772420; Man-Systems Integration Standards, 1995, NASASTD3000; Massa B, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P3374, DOI 10.1109/ROBOT.2002.1014232; McFarland LV, 2010, J REHABIL RES DEV, V47, P299, DOI 10.1682/JRRD.2009.03.0027; MINGRINO A, 1994, IROS '94 - INTELLIGENT ROBOTS AND SYSTEMS: ADVANCED ROBOTIC SYSTEMS AND THE REAL WORLD, VOLS 1-3, P1803, DOI 10.1109/IROS.1994.407614; Pasquina PF, 2006, ARCH PHYS MED REHAB, V87, pS34, DOI 10.1016/j.apmr.2005.11.026; Pellerin C., 1991, Industrial Robot, V18, P25, DOI 10.1108/eb004571; Pons JL, 2004, AUTON ROBOT, V16, P143, DOI 10.1023/B:AURO.0000016862.38337.f1; Pylatiuk C, 2004, P ANN INT IEEE EMBS, V26, P4260; Pylatiuk C, 2004, ARTIF ORGANS, V28, P980, DOI 10.1111/j.1525-1594.2004.00014.x; Ravitz AD, 2013, J HOPKINS APL TECH D, V31, P366; Resnik L, 2014, PROSTHET ORTHOT INT, V38, P492, DOI 10.1177/0309364613506913; Resnik L, 2014, PROSTHET ORTHOT INT, V38, P456, DOI 10.1177/0309364613506914; Resnik L, 2012, ARCH PHYS MED REHAB, V93, P710, DOI 10.1016/j.apmr.2011.11.010; Schultz AE, 2011, PM&R, V3, P55, DOI 10.1016/j.pmrj.2010.06.016; Schulz S, 2005, ROBOTICA, V23, P293, DOI 10.1017/S0263574704001316; Schulz S, 2001, IEEE INT CONF ROBOT, P2437, DOI 10.1109/ROBOT.2001.932988; Smurr LM, 2008, J HAND THER, V21, P160, DOI 10.1197/j.jht.2007.09.006; Tan D, SCI TRANSL IN PRESS; Tennent DJ, 2014, INJURY, V45, P965, DOI 10.1016/j.injury.2014.02.009; Yang JZ, 2004, MECH MACH THEORY, V39, P555, DOI 10.1016/j.mechmachtheory.2004.01.002; Zhao DW, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-3, P878, DOI 10.1109/ROBIO.2006.340336; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	49	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118817	10.1371/journal.pone.0118817	http://dx.doi.org/10.1371/journal.pone.0118817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790306	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400047
J	Zhao, JN; Liu, Y; Li, HC				Zhao, Jiang-nan; Liu, Yao; Li, Huai-chen			Aspiration-Related Acute Respiratory Distress Syndrome in Acute Stroke Patient	PLOS ONE			English	Article							MEDICAL COMPLICATIONS; RISK-FACTORS; PNEUMONIA; MORTALITY; PREDICTORS; MULTICENTER; DEFINITION; OUTCOMES; COHORT	Background Aspiration of oral or gastric contents into the larynx and lower respiratory tract is a common problem in acute stroke patients, which significantly increases the incidence of acute respiratory distress syndrome (ARDS). However, little is known about the clinical characteristics of aspiration-related ARDS in acute stroke patients. Methods Over 17-month period a retrospective cohort study was done on 1495 consecutive patients with acute stroke. The data including demographic characteristics, clinical manifestations, laboratory examinations, chest imaging, and hospital discharge status were collected to analysis. Results Aspiration-related ARDS was diagnosed in 54 patients (3.6%). The most common presenting symptom was tachypnea (respiratory rate >= 25 breaths/min) in 50 cases. Computed tomography (CT) images usually demonstrated diffuse ground-glass opacities (GGOs) and inhomogeneous patchy consolidations involving the low lobes. Age, NIHSS score, GCS score, dysphagia, dysarthria, hemoglobin concentration, serum aspertate aminotransferase (AST), serum albumin, serum sodium, and admission glucose level were independently associated with aspiration-related ARDS (odds ratio (OR) 1.05, 95% confidence interval (CI) (1.04-1.07); OR 2.87, (2.68-3.63); OR 4.21, (3.57-5.09); OR 2.18, (1.23-3.86); OR 1.67, (1.31-2.14); OR 2.31, (1.11-4.84); OR 1.68, (1.01-2.80); OR 2.15, (1.19-3.90); OR 1.92, (1.10-3.36) and OR 1.14, (1.06-1.21) respectively). Conclusions Aspiration-related ARDS frequently occurs in acute stroke patient with impairment consciousness. It is advisable that performing chest CT timely may identify disease early and prompt treatment to rescue patients.	[Zhao, Jiang-nan; Liu, Yao; Li, Huai-chen] Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250021, Shandong, Peoples R China	Shandong University	Li, HC (corresponding author), Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250021, Shandong, Peoples R China.	zjn911016@126.com			Science and technology development plan of Shandong Province [2009GG10002054]	Science and technology development plan of Shandong Province	Funding provided by Science and technology development plan of Shandong Province (Number: 2009GG10002054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JR, 2011, NEUROHOSPITALIST, V1, P85, DOI 10.1177/1941875210395775; Bakowitz M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-54; Bamet Berris, 1965, CAN MED ASSOC J, P92; Chumbler NR, 2010, NEUROEPIDEMIOLOGY, V34, P193, DOI 10.1159/000289350; Fanelli V, 2013, J THORAC DIS, V5, P326, DOI 10.3978/j.issn.2072-1439.2013.04.05; Gattinoni L, 2001, AM J RESP CRIT CARE, V164, P1701, DOI 10.1164/ajrccm.164.9.2103121; Gattinoni L, 1986, J Thorac Imaging, V1, P25, DOI 10.1097/00005382-198607000-00005; Grysiewicz RA, 2008, NEUROL CLIN, V26, P871, DOI 10.1016/j.ncl.2008.07.003; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; Jansson C, 2008, ALIMENT PHARM THER, V27, P58, DOI 10.1111/j.1365-2036.2007.03537.x; Ji RJ, 2013, STROKE, V44, P3436, DOI 10.1161/STROKEAHA.113.001931; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Lanspa MJ, 2013, J HOSP MED, V8, P83, DOI 10.1002/jhm.1996; Lee A, 2014, CHEST, V146, P899, DOI 10.1378/chest.13-3028; Levitt JE, 2012, CRIT CARE, V16, DOI 10.1186/cc11144; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Paul E, 2001, NEW ENGL J MED, V344, P9; Prather AD, 2014, J THORAC IMAG, V29, P304, DOI 10.1097/RTI.0000000000000092; Raghavendran K, 2011, CRIT CARE MED, V39, P818, DOI 10.1097/CCM.0b013e31820a856b; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Routly JJ, 2003, CRIT CARE MED, V31, pS285, DOI 10.1097/01.CCM.0000057905.74813.BC; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Sheu CC, 2010, CHEST, V138, P559, DOI 10.1378/chest.09-2933; Spratt N, 2003, J CLIN NEUROSCI, V10, P665, DOI 10.1016/j.jocn.2002.12.001; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wilson RD, 2012, J STROKE CEREBROVASC, V21, P61, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.002; Yende S, 2010, THORAX, V65, P870, DOI 10.1136/thx.2010.136317	31	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118682	10.1371/journal.pone.0118682	http://dx.doi.org/10.1371/journal.pone.0118682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790377	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400038
J	Londino, JD; Lazrak, A; Noah, JW; Aggarwal, S; Bali, V; Woodworth, BA; Bebok, Z; Matalon, S				Londino, James David; Lazrak, Ahmed; Noah, James W.; Aggarwal, Saurabh; Bali, Vedrana; Woodworth, Bradford A.; Bebok, Zsuzsanna; Matalon, Sadis			Influenza virus M2 targets cystic fibrosis transmembrane conductance regulator for lysosomal degradation during viral infection	FASEB JOURNAL			English	Article						DsiRNA; patch clamp; NHBE cells; short circuit current; amantadine	ION-CHANNEL ACTIVITY; LIQUID INTERFACE CULTURES; UNFOLDED PROTEIN RESPONSE; A VIRUS; MESSENGER-RNA; SELECTIVE PERTURBATION; MATRIX PROTEIN-2; CFTR EXPRESSION; CELL-SURFACE; MEMBRANE	We sought to determine the mechanisms by which influenza infection of human epithelial cells decreases cystic fibrosis transmembrane conductance regulator (CFTR) expression and function. We infected human bronchial epithelial (NHBE) cells and murine nasal epithelial (MNE) cells with various strains of influenza A virus. Influenza infection significantly reduced CFTR short circuit currents (I-sc) and protein levels at 8 hours postinfection. We then infected CFTR expressing human embryonic kidney (HEK)-293 cells (HEK-293 CFTRwt) with influenza virus encoding a green fluorescent protein (GFP) tag and performed whole-cell and cell-attached patch clamp recordings. Forskolin-stimulated, GlyH-101-sensitive CFTR conductances, and CFTR open probabilities were reduced by 80% in GFP-positive cells; Western blots also showed significant reduction in total and plasma membrane CFTR levels. Knockdown of the influenza matrix protein 2 (M2) with siRNA, or inhibition of its activity by amantadine, prevented the decrease in CFTR expression and function. Lysosome inhibition (bafilomycin-A1), but not proteasome inhibition (lactacystin), prevented the reduction in CFTR levels. Western blots of immunoprecipitated CFTR from influenza-infected cells, treated with BafA1, and probed with antibodies against lysine 63-linked (K-63) or lysine 48-linked (K-48) polyubiquitin chains supported lysosomal targeting. These results highlight CFTR damage, leading to early degradation as an important contributing factor to influenza infection-associated ion transport defects.	[Londino, James David; Lazrak, Ahmed; Aggarwal, Saurabh; Matalon, Sadis] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol, Birmingham, AL 35294 USA; [Londino, James David; Lazrak, Ahmed; Noah, James W.; Aggarwal, Saurabh; Bebok, Zsuzsanna; Matalon, Sadis] Univ Alabama Birmingham, Sch Med, Pulm Injury & Repair Ctr, Birmingham, AL 35294 USA; [Londino, James David; Bali, Vedrana; Bebok, Zsuzsanna; Matalon, Sadis] Univ Alabama Birmingham, Sch Med, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Noah, James W.] So Res Inst, Birmingham, AL 35255 USA; [Woodworth, Bradford A.] Univ Alabama Birmingham, Sch Med, Dept Surg, Div Otolaryngol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Matalon, S (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Anesthesiol, 901 19th St South,BMRII 242, Birmingham, AL 35294 USA.	sadis@uab.edu	Londino, James/GXH-2306-2022; Londino, James/GXH-4404-2022	Londino, James/0000-0001-7647-6927; , Vedrana/0000-0002-8881-8717; Lazrak, Ahmed/0000-0002-4127-1937	U.S. National Institutes of Health; National Heart, Lung, and Blood Institute [HL031197, HL076587]; National Institute of Environmental Health Sciences [5U01ES015676]; National Institute of Diabetes and Digestive and Kidney Diseases [DK60065]; Cystic Fibrosis Foundation [Bebok14PO]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076587, R01HL031197, R37HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, R01DK060065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015676] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Adolfo Garcia-Sastre for providing the GFP-tagged NS1 influenza virus, John Riordan, Ph.D., University of North Carolina-Chapel Hill, and the Cystic Fibrosis Foundation Therapeutics for providing anti-CFTR antibody 596, and Dr. Ji-Bin Peng for providing cRNA encoding TRPV5. Sequencing was performed by the Heflin Center Genomics Core Facility, University of Alabama Birmingham. Funding provided by the U.S. National Institutes of Health, HL031197 and HL076587 (National Heart, Lung, and Blood Institute), 5U01ES015676 (National Institute of Environmental Health Sciences), DK60065 (National Institute of Diabetes and Digestive and Kidney Diseases), and Bebok14PO (Cystic Fibrosis Foundation).	Aeffner F, 2013, J INFECT DIS, V208, P780, DOI 10.1093/infdis/jit251; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Bartoszewski R, 2011, METHOD ENZYMOL, V491, P3, DOI 10.1016/B978-0-12-385928-0.00001-8; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Chen L, 2009, AM J RESP CELL MOL, V40, P588, DOI 10.1165/rcmb.2008-0034OC; Collawn JF, 2012, AM J PHYSIOL-LUNG C, V302, pL1141, DOI 10.1152/ajplung.00036.2012; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gerlach RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078912; Gould NS, 2012, FREE RADICAL BIO MED, V52, P1201, DOI 10.1016/j.freeradbiomed.2012.01.001; Henkel JR, 1998, MOL BIOL CELL, V9, P2477, DOI 10.1091/mbc.9.9.2477; Henkel JR, 1999, J BIOL CHEM, V274, P9854, DOI 10.1074/jbc.274.14.9854; Hunter MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011598; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; Kim SJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00201; Kim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072981; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Lazrak A, 2003, AM J PHYSIOL-LUNG C, V285, pL443, DOI 10.1152/ajplung.00412.2002; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590; Lee S, 2014, MOL CELL BIOL, V34, P2554, DOI 10.1128/MCB.01042-13; LeSimple P, 2010, J PHYSIOL-LONDON, V588, P1195, DOI 10.1113/jphysiol.2009.182246; Londino JD, 2013, P NATL ACAD SCI USA, V110, P10055, DOI 10.1073/pnas.1307480110; Londino JD, 2013, AM J PHYSIOL-LUNG C, V304, pL582, DOI 10.1152/ajplung.00314.2012; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Marceau F, 2012, TOXICOL APPL PHARM, V259, P1, DOI 10.1016/j.taap.2011.12.004; McCown M, 2003, VIROLOGY, V313, P514, DOI 10.1016/S0042-6822(03)00341-6; McCullers JA, 2004, J INFECT DIS, V190, P519, DOI 10.1086/421525; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Renk H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078583; Sakaguchi T, 1996, J CELL BIOL, V133, P733, DOI 10.1083/jcb.133.4.733; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sui HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005671; TAKEUCHI K, 1994, J VIROL, V68, P911, DOI 10.1128/JVI.68.2.911-919.1994; Tradtrantip L, 2009, J MED CHEM, V52, P6447, DOI 10.1021/jm9009873; Tripathi S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.89; VALCARCEL J, 1991, J GEN VIROL, V72, P1301, DOI 10.1099/0022-1317-72-6-1301; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Waugh T, 2013, BIOCHEM BIOPH RES CO, V438, P581, DOI 10.1016/j.bbrc.2013.08.012; Woodworth BA, 2007, AM J RHINOL, V21, P533, DOI 10.2500/ajr.2007.21.3068; Xu WL, 2006, J INTERF CYTOK RES, V26, P609, DOI 10.1089/jir.2006.26.609; YOSHIMURA A, 1984, J VIROL, V51, P497, DOI 10.1128/JVI.51.2.497-504.1984	54	30	31	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2712	2725		10.1096/fj.14-268755	http://dx.doi.org/10.1096/fj.14-268755			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25795456	Green Published			2022-12-26	WOS:000356859100004
J	Barcelo, F; Cerda, JJ; Gutierrez, A; Jimenez-Marco, T; Duran, MA; Novo, A; Ros, T; Sampol, A; Portugal, J				Barcelo, Francisca; Cerda, Joan J.; Gutierrez, Antonio; Jimenez-Marco, Teresa; Antonia Duran, M.; Novo, Andres; Ros, Teresa; Sampol, Antonia; Portugal, Jose			Characterization of Monoclonal Gammopathy of Undetermined Significance by Calorimetric Analysis of Blood Serum Proteome	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; MULTIPLE-MYELOMA; SIGNIFICANCE MGUS; PLASMA PROTEOME; COLORECTAL-CANCER; PATHOGENESIS; PREVALENCE; PROFILES; MARKERS	Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant proliferative disorder that may progress to multiple myeloma, a malignant plasma cell neoplasia. We evaluated differential scanning calorimetry (DSC) as an experimental tool for differentiating serum samples of MGUS patients from healthy individuals. DSC thermograms can be used for monitoring changes in the serum proteome associated with MGUS. MGUS patients showed great variability in serum thermogram characteristics, which depended on the IgG, IgA or IgM iso-types and/or the. or. light chains. Thermogram feature parameters distinguished patients with MGUS from healthy people. Serum samples, named as non-MGUS, were also collected from patients with subjacent immunological pathologies who were discarded of having MGUS through serum immunofixation. They were used to verify the sensitivity of DSC for discriminating MGUS from related blood dyscrasias. Only some DSC thermogram feature parameters differentiated, to a lesser extent, between MGUS and non-MGUS individuals. We contemplate DSC as a tool for early diagnosis and monitoring of MGUS.	[Barcelo, Francisca] Univ Islas Baleares, Grp Invest Clin & Translac, Inst Univ Invest Ciencias Salud, Palma De Mallorca, Spain; [Cerda, Joan J.] Univ Islas Baleares, Consejo Super Invest Cient, Inst Fis Interdisciplinar & Sistemas Complejos, Palma De Mallorca, Spain; [Gutierrez, Antonio; Antonia Duran, M.; Novo, Andres; Ros, Teresa] Hosp Univ Son Espases, Biol Clin Hematol, Palma De Mallorca, Spain; [Jimenez-Marco, Teresa] Univ Islas Baleares, Fdn Banco Sangre & Tejidos Islas Baleares, Palma De Mallorca, Spain; [Jimenez-Marco, Teresa] Univ Islas Baleares, Inst Univ Invest Ciencias Salud, Palma De Mallorca, Spain; [Sampol, Antonia] Hosp Univ Son Espases, Inst Invest Sanitaria Palma, Serv Hematol & Hemoterapia, Palma De Mallorca, Spain; [Portugal, Jose] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain	Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Hospital Universitari Son Espases; Fundacio Banc Sang Teixits de les Illes Balears; Universitat de les Illes Balears; Universitat de les Illes Balears; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Barcelo, F (corresponding author), Univ Islas Baleares, Grp Invest Clin & Translac, Inst Univ Invest Ciencias Salud, Palma De Mallorca, Spain.	francisca.barcelo@uib.es	Portugal, José/K-4504-2014; Barceló, Francisca/K-5288-2014; Cerdà, Joan Josep/M-1910-2018; Cerdà, Joan Josep/H-1306-2013	Portugal, José/0000-0002-1923-9666; Barceló, Francisca/0000-0002-9158-099X; Cerdà, Joan Josep/0000-0003-1132-5989; Cerdà, Joan Josep/0000-0003-1132-5989; Jimenez-Marco, Teresa/0000-0001-9631-6541	Spanish Ministry of Science and Innovation [BFU2010-15518]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	BFU2010-15518 from the Spanish Ministry of Science and Innovation.	Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Attaelmannan M, 2000, CLIN CHEM, V46, P1230; Blade J, 2008, LEUKEMIA, V22, P1651, DOI 10.1038/leu.2008.203; Engwegen JYMN, 2008, PROTEOM CLIN APPL, V2, P936, DOI 10.1002/prca.200780068; Garbett NC, 2008, BIOPHYS J, V94, P1377, DOI 10.1529/biophysj.107.119453; Garbett NC, 2007, CLIN CHEM, V53, P2012, DOI 10.1373/clinchem.2007.091165; Garbett NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084710; Garbett NC, 2013, BBA-GEN SUBJECTS, V1830, P4675, DOI 10.1016/j.bbagen.2013.05.007; Garbett NC, 2009, EXP MOL PATHOL, V86, P186, DOI 10.1016/j.yexmp.2008.12.001; Gutierrez NC, 2007, CLIN TRANSL ONCOL, V9, P618, DOI 10.1007/s12094-007-0114-4; Korde N, 2011, BLOOD, V117, P5573, DOI 10.1182/blood-2011-01-270140; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Kyle RA, 2006, BRIT J HAEMATOL, V134, P573, DOI 10.1111/j.1365-2141.2006.06235.x; Landgren O, 2014, LEUKEMIA, V28, P1537, DOI [10.1038/leu.2014.34, 10.1038/1eu.2014.34]; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Lopez-Corral L, 2014, HAEMATOLOGICA, V99, P1365, DOI 10.3324/haematol.2013.087809; Mangiacavalli S, 2013, EUR J HAEMATOL, V91, P356, DOI 10.1111/ejh.12172; Michnik A, 2010, J THERM ANAL CALORIM, V102, P57, DOI 10.1007/s10973-009-0602-6; Michnik A, 2010, J THERM ANAL CALORIM, V101, P513, DOI 10.1007/s10973-010-0826-5; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Palladino C, 2014, TRANSL MED UNISA, V8, P12; Roeker LE, 2013, LEUKEMIA, V27, P1391, DOI 10.1038/leu.2013.34; Scudla V, 2011, NEOPLASMA, V58, P499, DOI 10.4149/neo_2011_06_499; Stein W., 2012, SAGE MATH SOFTWARE V; Todinova S, 2014, ANAL CHEM, V86, P12355, DOI 10.1021/ac503677d; Todinova S, 2012, BBA-GEN SUBJECTS, V1820, P1879, DOI 10.1016/j.bbagen.2012.08.001; Todinova S, 2011, ANAL CHEM, V83, P7992, DOI 10.1021/ac202055m; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	28	18	18	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120316	10.1371/journal.pone.0120316	http://dx.doi.org/10.1371/journal.pone.0120316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794164	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900011
J	Chan, CW; Sakihama, N; Tachibana, SI; Idris, ZM; Lum, JK; Tanabe, K; Kaneko, A				Chan, Chim W.; Sakihama, Naoko; Tachibana, Shin-Ichiro; Idris, Zulkarnain Md; Lum, J. Koji; Tanabe, Kazuyuki; Kaneko, Akira			Plasmodium vivax and Plasmodium falciparum at the Crossroads of Exchange among Islands in Vanuatu: Implications for Malaria Elimination Strategies	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; ANOPHELES-FARAUTI-S.S.; GENETIC DIVERSITY; POPULATION-STRUCTURE; AMA1 GENES; RECOMBINATION; EPIDEMIOLOGY; SETTLEMENT; EVOLUTION; PATTERNS	Understanding the transmission and movement of Plasmodium parasites is crucial for malaria elimination and prevention of resurgence. Located at the limit of malaria transmission in the Pacific, Vanuatu is an ideal candidate for elimination programs due to low endemicity and the isolated nature of its island setting. We analyzed the variation in the merozoite surface protein 1 (msp1) and the circumsporozoite protein (csp) of P. falciparum and P. vivax populations to examine the patterns of gene flow and population structures among seven sites on five islands in Vanuatu. Genetic diversity was in general higher in P. vivax than P. falciparum from the same site. In P. vivax, high genetic diversity was likely maintained by greater extent of gene flow among sites and among islands. Consistent with the different patterns of gene flow, the proportion of genetic variance found among islands was substantially higher in P. falciparum (28.81-31.23%) than in P. vivax (-0.53-3.99%). Our data suggest that the current island-by-island malaria elimination strategy in Vanuatu, while adequate for P. falciparum elimination, might need to be complemented with more centrally integrated measures to control P. vivax movement across islands.	[Chan, Chim W.; Idris, Zulkarnain Md; Kaneko, Akira] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Isl Malaria Grp, Stockholm, Sweden; [Sakihama, Naoko; Tachibana, Shin-Ichiro; Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Lab Malariol, Osaka, Japan; [Lum, J. Koji] SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY USA; [Lum, J. Koji] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Lum, J. Koji] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA; [Kaneko, Akira] Osaka City Univ, Grad Sch Med, Dept Parasitol, Osaka 558, Japan; [Kaneko, Akira] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan	Karolinska Institutet; Osaka University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Osaka Metropolitan University; Nagasaki University	Chan, CW (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Isl Malaria Grp, Stockholm, Sweden.	chim.chan@ki.se	Idris, Zulkarnain Md/V-6615-2018	Chan, Chim/0000-0002-4039-2649	Swedish Research Council [523-2009-3233, 348-2012-6346, 348-2013-6311]; Japan Society for the Promotion of Science (JSPS); B. Asia-Africa Science Platforms; JSPS KAKENHI [24390141, 26257504]; Health Labour Sciences Research Grant; Research on Global Health issues; Nagasaki University Institute of Tropical Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); B. Asia-Africa Science Platforms; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Research on Global Health issues; Nagasaki University Institute of Tropical Medicine	Financial support for this study was provided to AK by the Swedish Research Council (www.vr.se, grant numbers 523-2009-3233, 348-2012-6346, and 348-2013-6311), the Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/english/) Core-to-Core Program, B. Asia-Africa Science Platforms, JSPS KAKENHI (grant numbers 24390141 and 26257504), Health Labour Sciences Research Grant, Research on Global Health issues, and Nagasaki University Institute of Tropical Medicine collaborative research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2013, NAT MED, V19, P150, DOI 10.1038/nm.3077; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Arnott A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-233; Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Asia Pacific Malaria Elimination Network, 2013, COUNTR BRIEF EL MAL; Atkins C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-218; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Buckley HR, 2005, BIOARCHAEOLOGY SE AS, P309; CLARK JT, 1993, AM ANTHROPOL, V95, P612, DOI 10.1525/aa.1993.95.3.02a00040; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Galinski MR, 2013, ADV PARASIT, V81, P1, DOI 10.1016/B978-0-12-407826-0.00001-1; Gray KA, 2013, SOLOMON ISLANDS MALA, V12, P429, DOI DOI 10.1186/1475-2875-12-429; Groube L. M., 1993, COMMUNITY CULTURE PE, P164; HEDRICK JD, 1971, J POLYNESIAN SOC, V80, P5; Huffman Kirk, 1996, ARTS OF VANUATU, P182; Imwong M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-20; Kaneko A, 1998, ACTA TROP, V70, P285, DOI 10.1016/S0001-706X(98)00035-7; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Kaneko A, 2014, INFECT IMMUN, V82, P243, DOI 10.1128/IAI.00931-13; KERR PJ, 1994, MOL BIOCHEM PARASIT, V66, P241, DOI 10.1016/0166-6851(94)90151-1; Kim JR, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-71; Lum JK, 2007, ACTA TROP, V103, P102, DOI 10.1016/j.actatropica.2007.05.012; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Murhandarwati EEH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-130; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Nei M., 1987, MOL EVOLUTIONARY GEN; Ord RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003366; Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029; Pacheco MA, 2007, INFECT GENET EVOL, V7, P180, DOI 10.1016/j.meegid.2006.08.002; Parobek CM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002796; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Putaporntip C, 2002, P NATL ACAD SCI USA, V99, P16348, DOI 10.1073/pnas.252348999; Reiff DM, 2007, J MED ENTOMOL, V44, P601, DOI 10.1603/0022-2585(2007)44[601:PSAGFO]2.0.CO;2; Sakihama N, 2001, EXP PARASITOL, V97, P50, DOI 10.1006/expr.2000.4591; Sakihama N, 2001, GENE, V279, P41, DOI 10.1016/S0378-1119(01)00748-X; Sheppard PJ, 2006, J POLYNESIAN SOC, V115, P47; Tanabe K, 2004, SCIENCE, V303, P493, DOI 10.1126/science.1092077; Tanabe K, 2007, MOL BIOCHEM PARASIT, V156, P74, DOI 10.1016/j.molbiopara.2007.07.002	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119475	10.1371/journal.pone.0119475	http://dx.doi.org/10.1371/journal.pone.0119475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793260	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200086
J	Ferdous, J; Li, Y; Reid, N; Langridge, P; Shi, BJ; Tricker, PJ				Ferdous, Jannatul; Li, Yuan; Reid, Nicolas; Langridge, Peter; Shi, Bu-Jun; Tricker, Penny J.			Identification of Reference Genes for Quantitative Expression Analysis of MicroRNAs and mRNAs in Barley under Various Stress Conditions	PLOS ONE			English	Article							RT-PCR NORMALIZATION; REAL-TIME PCR; DROUGHT-RESPONSIVE MICRORNAS; GENOME-WIDE IDENTIFICATION; POLYMERASE-CHAIN-REACTION; SUPEROXIDE-DISMUTASE; HOUSEKEEPING GENES; OXIDATIVE STRESS; BETA-ACTIN; BIOCHEMICAL RESPONSES	For accurate and reliable gene expression analysis using quantitative real-time reverse transcription PCR (qPCR), the selection of appropriate reference genes as an internal control for normalization is crucial. We hypothesized that non-coding, small nucleolar RNAs (snoRNAs) would be stably expressed in different barley varieties and under different experimental treatments, in different tissues and at different developmental stages of plant growth and therefore might prove to be suitable reference genes for expression analysis of both microRNAs (miRNAs) and mRNAs. In this study, we examined the expression stability of ten candidate reference genes in six barley genotypes under five experimental stresses, drought, fungal infection, boron toxicity, nutrient deficiency and salinity. We compared four commonly used housekeeping genes; Actin (ACT), alpha-Tubulin (a-TUB), Glycolytic glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ADP-ribosylation factor 1-like protein (ADP), four snoRNAs; (U18, U61, snoR14 and snoR23) and two microRNAs (miR168, miR159) as candidate reference genes. We found that ADP, snoR14 and snoR23 were ranked as the best of these candidates across diverse samples. For accurate and reliable gene expression analysis using quantitative real-time reverse transcription PCR (qPCR), the selection of appropriate reference genes as an internal control for normalization is crucial. We hypothesized that non-coding, small nucleolar RNAs (snoRNAs) would be stably expressed in different barley varieties and under different experimental treatments, in different tissues and at different developmental stages of plant growth and therefore might prove to be suitable reference genes for expression analysis of both microRNAs (miRNAs) and mRNAs. In this study, we examined the expression stability of ten candidate reference genes in six barley genotypes under five experimental stresses, drought, fungal infection, boron toxicity, nutrient deficiency and salinity. We compared four commonly used housekeeping genes; Actin (ACT), alpha-Tubulin (a-TUB), Glycolytic glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ADP-ribosylation factor 1-like protein (ADP), four snoRNAs; (U18, U61, snoR14 and snoR23) and two microRNAs (miR168, miR159) as candidate reference genes. We found that ADP, snoR14 and snoR23 were ranked as the best of these candidates across diverse samples. Additionally, we found that miR168 was a suitable reference gene for expression analysis in barley. Finally, we validated the performance of our stable and unstable candidate reference genes for both mRNA and miRNA qPCR data normalization under different stress conditions and demonstrated the superiority of the stable candidates. Our data demonstrate the suitability of barley snoRNAs and miRNAs as potential reference genes for miRNA and mRNA qPCR data normalization under different stress treatments.	[Ferdous, Jannatul; Li, Yuan; Reid, Nicolas; Langridge, Peter; Shi, Bu-Jun; Tricker, Penny J.] Univ Adelaide, Australian Ctr Plant Funct Genom, Urrbrae, SA 5064, Australia	University of Adelaide	Shi, BJ (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, Urrbrae, SA 5064, Australia.	bujun.shi@adelaide.edu.au	Langridge, Peter/G-5864-2010; Tricker, Penny/A-8213-2015	Langridge, Peter/0000-0001-9494-400X; Tricker, Penny/0000-0002-1626-3556	Australian Centre for Plant Functional Genomics	Australian Centre for Plant Functional Genomics	Funded by the Australian Centre for Plant Functional Genomics.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Brattelid T, 2011, PHYSIOL GENOMICS, V43, P604, DOI 10.1152/physiolgenomics.00131.2010; Brosius J, 2005, TRENDS GENET, V21, P287, DOI 10.1016/j.tig.2005.02.014; BURKE JJ, 1985, PLANT PHYSIOL, V79, P415, DOI 10.1104/pp.79.2.415; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cervilla LM, 2007, ANN BOT-LONDON, V100, P747, DOI 10.1093/aob/mcm156; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chu YJ, 2012, NUCLEIC ACID THER, V22, P271, DOI 10.1089/nat.2012.0367; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Genc Y, 2007, PLANT CELL ENVIRON, V30, P1486, DOI 10.1111/j.1365-3040.2007.01726.x; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hackenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042030; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Huang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093724; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Lascano HR, 2001, AUST J PLANT PHYSIOL, V28, P1095, DOI 10.1071/PP01061; Lei YB, 2006, PHYSIOL PLANTARUM, V127, P182, DOI 10.1111/j.1399-3054.2006.00638.x; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Li QQ, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-22; Lin YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095445; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Ma SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003840; Matouskova P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086033; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MCKERSIE BD, 1993, PLANT PHYSIOL, V103, P1155, DOI 10.1104/pp.103.4.1155; McKersie BD, 1996, PLANT PHYSIOL, V111, P1177, DOI 10.1104/pp.111.4.1177; Meng Y, 2009, PLANT PHYSIOL, V149, P271, DOI 10.1104/pp.108.129031; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Olbrich M, 2008, Z NATURFORSCH C, V63, P574; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinheiro HA, 2004, PLANT SCI, V167, P1307, DOI 10.1016/j.plantsci.2004.06.027; Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rapacz M, 2012, ACTA PHYSIOL PLANT, V34, P1723, DOI 10.1007/s11738-012-0967-1; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rueda-Martinez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097449; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Shen JQ, 2010, MOL GENET GENOMICS, V284, P477, DOI 10.1007/s00438-010-0581-0; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Tian XR, 2007, RUSS J PLANT PHYSL+, V54, P676, DOI 10.1134/S1021443707050160; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Tripathy BC, 2012, PLANT SIGNAL BEHAV, V7, P1621, DOI 10.4161/psb.22455; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang FZ, 2005, J PLANT PHYSIOL, V162, P465, DOI 10.1016/j.jplph.2004.09.009; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	74	44	46	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118503	10.1371/journal.pone.0118503	http://dx.doi.org/10.1371/journal.pone.0118503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793505	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200025
J	Harper, AR; Wiechmann, AF; Moiseyev, G; Ma, JX; Summers, JA				Harper, Angelica R.; Wiechmann, Allan F.; Moiseyev, Gennadiy; Ma, Jian-Xing; Summers, Jody A.			Identification of Active Retinaldehyde Dehydrogenase Isoforms in the Postnatal Human Eye	PLOS ONE			English	Article							RETINOIC ACID SYNTHESIS; INDUCED MYOPIA; GUINEA-PIG; GROWTH; SCLERA; PURIFICATION; MAINTENANCE; VISION; SYSTEM; TISSUE	Background/Objectives Retinaldehyde dehydrogenase 2 (RALDH2) has been implicated in regulating all-trans-retinoic acid (atRA) synthesis in response to visual signals in animal models of myopia. To explore the potential role of retinaldehyde dehydrogenase (RALDH) enzymes and atRA in human postnatal ocular growth, RALDH activity, along with the distribution of RALDH1, RALDH2, and RALDH3 in the postnatal eye was determined. Methodology Retina, retinal pigment epithelium (RPE), choroid, and sclera were isolated from donor human eyes. RALDH catalytic activity was measured in tissue homogenates using an in vitro atRA synthesis assay together with HPLC quantification of synthesized atRA. Homogenates were compared by western blotting for RALDH1, RALDH2, and RALDH3 protein. Immunohistochemistry was used to determine RALDH1 and RALDH2 localization in posterior fundal layers of the human eye. Principal Findings In the postnatal human eye, RALDH catalytic activity was detected in the choroid (6.84 +/- 1.20 pmol/hr/ug), RPE (5.46 +/- 1.18 pmol/hr/ug), and retina (4.21 +/- 1.55 pmol/hr/ug), indicating the presence of active RALDH enzymes in these tissues. RALDH2 was most abundant in the choroid and RPE, in moderate abundance in the retina, and in relatively low abundance in sclera. RALDH1 was most abundant in the choroid, in moderate abundance in the sclera, and substantially reduced in the retina and RPE. RALDH3 was undetectable in human ocular fundal tissues. In the choroid, RALDH1 and RALDH2 localized to slender cells in the stroma, some of which were closely associated with blood vessels. Conclusions/Significance Results of this study demonstrated that: 1) Catalytically active RALDH is present in postnatal human retina, RPE, and choroid, 2) RALDH1 and RALDH2 isoforms are present in these ocular tissues, and 3) RALDH1 and RALDH2 are relatively abundant in the choroid and/or RPE. Taken together, these results suggest that RALDH1 and 2 may play a role in the regulation of postnatal ocular growth in humans through the synthesis of atRA.	[Harper, Angelica R.; Wiechmann, Allan F.; Summers, Jody A.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA; [Moiseyev, Gennadiy; Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Harper, AR (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA.	angelica-harper@ouhsc.edu			National Eye Institute [EY09391, EY012231]; NATIONAL EYE INSTITUTE [R01EY009391, R01EY012231] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute EY09391 (JAS) and National Eye Institute EY012231 (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amory JK, 2014, FERTIL STERIL, V101, P960, DOI 10.1016/j.fertnstert.2013.12.053; Bitzer M, 2000, EXP EYE RES, V70, P97, DOI 10.1006/exer.1999.0762; Chen Y, 2013, PROG RETIN EYE RES, V33, P28, DOI 10.1016/j.preteyeres.2012.10.001; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Collop AH, 2006, DEV BIOL, V291, P96, DOI 10.1016/j.ydbio.2005.12.018; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Duester G, 2009, CHEM-BIOL INTERACT, V178, P178, DOI 10.1016/j.cbi.2008.09.004; EICHELE G, 1987, J CELL BIOL, V105, P1917, DOI 10.1083/jcb.105.4.1917; Farjo KM, 2011, DEVELOPMENTAL BIOLOG; Graham C, 1996, J BIOL CHEM, V271, P15623, DOI 10.1074/jbc.271.26.15623; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kawakami Y, 2013, CELL REP, V3, P1337, DOI 10.1016/j.celrep.2013.05.010; KING G, 1993, BIOCHEM MOL BIOL INT, V31, P49; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; Lassen N, 2008, SEMIN CELL DEV BIOL, V19, P100, DOI 10.1016/j.semcdb.2007.10.004; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mao JF, 2012, INT J OPHTHALMOL-CHI, V5, P670, DOI 10.3980/j.issn.2222-3959.2012.06.04; Marmorstein AD, 2002, INVEST OPHTH VIS SCI, V43, P2435; McCaffery P, 1996, P NATL ACAD SCI USA, V93, P12570, DOI 10.1073/pnas.93.22.12570; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Napoli JL, 2011, BIOCH BIOPHYS ACTA; NICOTRA CMA, 1994, MOL CELL BIOCHEM, V132, P45, DOI 10.1007/BF00925674; NORTON TT, 1995, VISION RES, V35, P1271, DOI 10.1016/0042-6989(94)00243-F; RABIN J, 1981, INVEST OPHTH VIS SCI, V20, P561; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; RADA JA, 1991, DEV BIOL, V147, P303, DOI 10.1016/0012-1606(91)90288-E; Saari JC, RETINOIDS BIOL CHEM, P351; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Summers JA, 2013, EXP EYE RES, V114, P120, DOI 10.1016/j.exer.2013.03.008; Troilo D, 2006, INVEST OPHTH VIS SCI, V47, P1768, DOI 10.1167/iovs.05-0298; Wagner E, 2002, CEREB CORTEX, V12, P1244, DOI 10.1093/cercor/12.12.1244; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Zhang DQ, 2001, MOL VIS, V7, P247; Zhang DQ, 2000, P NATL ACAD SCI USA, V97, P14754, DOI 10.1073/pnas.010325897	41	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122008	10.1371/journal.pone.0122008	http://dx.doi.org/10.1371/journal.pone.0122008			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793304	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900165
J	Jung, SW; Thamphiwatana, S; Zhang, LF; Obonyo, M				Jung, Sung Woo; Thamphiwatana, Soracha; Zhang, Liangfang; Obonyo, Marygorret			Mechanism of Antibacterial Activity of Liposomal Linolenic Acid against Helicobacter pylori	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PROPIONIBACTERIUM-ACNES; STAPHYLOCOCCUS-AUREUS; LAURIC ACIDS; INFECTION; MONOGLYCERIDES; MEMBRANE	Helicobacter pylori infects approximately half of the world population and is a major cause of gastritis, peptic ulcer, and gastric cancer. Moreover, this bacterium has quickly developed resistance to all major antibiotics. Recently, we developed a novel liposomal linolenic acid (LipoLLA) formulation, which showed potent bactericidal activity against several clinical isolated antibiotic-resistant strains of H. pylori including both the spiral and coccoid form. In addition, LipoLLA had superior in vivo efficacy compared to the standard triple therapy. Our data showed that LipoLLA associated with H. pylori cell membrane. Therefore, in this study, we investigated the possible antibacterial mechanism of LipoLLA against H. pylori. The antibacterial activity of LipoLLA (C18:3) was compared to that of liposomal stearic acid (LipoSA, C18: 0) and oleic acid (LipoOA, C18: 1). LipoLLA showed the most potent bactericidal effect and completely killed H. pylori within 5 min. The permeability of the outer membrane of H. pylori increased when treated with LipoOA and LipoLLA. Moreover, by detecting released adenosine triphosphate (ATP) from bacteria, we found that bacterial plasma membrane of H. pylori treated with LipoLLA exhibited significantly higher permeability than those treated with LipoOA, resulting in bacteria cell death. Furthermore, LipoLLA caused structural changes in the bacterial membrane within 5 min affecting membrane integrity and leading to leakage of cytoplasmic contents, observed by both transmission electron microscopy (TEM) and scanning electron microscopy (SEM). Our findings showing rapid bactericidal effect of LipoLLA suggest it is a very promising new, effective anti-H. pylori agent.	[Jung, Sung Woo; Obonyo, Marygorret] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Jung, Sung Woo] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea; [Thamphiwatana, Soracha; Zhang, Liangfang] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Korea University; Korea University Medicine (KU Medicine); University of California System; University of California San Diego	Zhang, LF (corresponding author), Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.	zhang@ucsd.edu; mobonyo@ucsd.edu	Thamphiwatana, Soracha D./B-5338-2017	Thamphiwatana, Soracha D./0000-0003-3664-9488	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK095168]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095168] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (http://www.niddk.nih.gov/Pages/default.aspx) under Award Number R01DK095168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JC, 2013, J APPL MICROBIOL, V114, P982, DOI 10.1111/jam.12129; Chiu HC, 2007, HELICOBACTER, V12, P74; Correia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035072; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Duggan AE, 1997, BRIT J NUTR, V78, P515, DOI 10.1079/BJN19970171; GEIS G, 1990, J CLIN MICROBIOL, V28, P930, DOI 10.1128/JCM.28.5.930-932.1990; HAZELL SL, 1990, J CLIN MICROBIOL, V28, P1060, DOI 10.1128/JCM.28.5.1060-1061.1990; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; Huang CM, 2011, BIOMATERIALS, V32, P214, DOI 10.1016/j.biomaterials.2010.08.076; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; KHULUSI S, 1995, J MED MICROBIOL, V42, P276, DOI 10.1099/00222615-42-4-276; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Megraud F, 2004, GUT, V53, P1374, DOI 10.1136/gut.2003.022111; O'Connor A, 2013, HELICOBACTER, V18, P58, DOI 10.1111/hel.12075; Obonyo M, 2007, INFECT IMMUN, V75, P2408, DOI 10.1128/IAI.01794-06; Obonyo M, 2012, MOL PHARMACEUT, V9, P2677, DOI 10.1021/mp300243w; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Petschow BW, 1996, ANTIMICROB AGENTS CH, V40, P302, DOI 10.1128/AAC.40.2.302; Pornpattananangkul D, 2013, ADV HEALTHC MATER, V2, P1322, DOI 10.1002/adhm.201300002; SHEU CW, 1973, J BACTERIOL, V115, P869, DOI 10.1128/JB.115.3.869-875.1973; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun CQ, 2003, FEMS IMMUNOL MED MIC, V36, P9, DOI 10.1016/S0928-8244(03)00008-7; Thamphiwatana S, 2014, PNAS IN PRESS; Thamphiwatana S, 2013, LANGMUIR, V29, P12228, DOI 10.1021/la402695c; THOMPSON L, 1994, GUT, V35, P1557, DOI 10.1136/gut.35.11.1557; TRAUBLE H, 1973, BIOCHIM BIOPHYS ACTA, V307, P491, DOI 10.1016/0005-2736(73)90296-4; Yang DR, 2009, BIOMATERIALS, V30, P6035, DOI 10.1016/j.biomaterials.2009.07.033	29	39	40	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0116519	10.1371/journal.pone.0116519	http://dx.doi.org/10.1371/journal.pone.0116519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793403	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200006
J	Kobal, M; Bertoncelj, I; Pirotti, F; Dakskobler, I; Kutnar, L				Kobal, Milan; Bertoncelj, Irena; Pirotti, Francesco; Dakskobler, Igor; Kutnar, Lado			Using Lidar Data to Analyse Sinkhole Characteristics Relevant for Understory Vegetation under Forest Cover-Case Study of a High Karst Area in the Dinaric Mountains	PLOS ONE			English	Article							LASER SCANNER DATA; EBRO RIVER; MORPHOMETRIC-ANALYSIS; EVAPORITE KARST; AIRBORNE LIDAR; CLIMATE; DOLINE; TOPOGRAPHY; SUBSIDENCE; LANDSCAPE	In this article, we investigate the potential for detection and characterization of sinkholes under dense forest cover by using airborne laser scanning data. Laser pulse returns from the ground provide important data for the estimation of digital elevation model (DEM), which can be used for further processing. The main objectives of this study were to map and determine the geomorphometric characteristics of a large number of sinkholes and to investigate the correlations between geomorphology and vegetation in areas with such characteristics. The selected study area has very low anthropogenic influences and is particularly suitable for studying undisturbed karst sinkholes. The information extracted from this study regarding the shapes and depths of sinkholes show significant directionality for both orientation of sinkholes and their distribution over the area. Furthermore, significant differences in vegetation diversity and composition occur inside and outside the sinkholes, which indicates their presence has important ecological impacts.	[Kobal, Milan; Dakskobler, Igor; Kutnar, Lado] Univ Ljubljana, Dept Forestry & Renewable Forest Resources, Biotech Fac, Ljubljana, Slovenia; [Bertoncelj, Irena] Natl Inst Biol, Dept Freshwater & Terr Ecosyst Res, Ljubljana, Slovenia; [Pirotti, Francesco] Univ Padua, Interdept Res Ctr Geomat, Dept Land Environm Agr & Forestry, Padua, Italy; [Dakskobler, Igor] Slovenian Acad Sci & Arts, Jovan Hadzi Inst Biol, Res Ctr, Ljubljana, Slovenia	University of Ljubljana; National Institute of Biology - Slovenia; University of Padua; Slovenian Academy of Sciences & Arts (SASA)	Kobal, M (corresponding author), Univ Ljubljana, Dept Forestry & Renewable Forest Resources, Biotech Fac, Ljubljana, Slovenia.	milan.kobal@bf.uni-lj.si	Pirotti, Francesco/C-4906-2018	Pirotti, Francesco/0000-0002-4796-6406; Kutnar, Lado/0000-0001-9785-1263	Slovenian Research Agency; Man-For C. BD. [LIFE 09 ENV/IT/000078]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Man-For C. BD.	This work was supported by the Slovenian Research Agency (http://www.arrs.gov.si/sl/), a doctoral study grant from Milan Kobal and by a research Grant from the Man-For C. BD. (LIFE 09 ENV/IT/000078). Lidar data was acquired by the Slovenia Forestry Institute projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti G, 2013, IFOREST, V6, P156, DOI 10.3832/ifor0876-006; Angel JC, 2004, J CAVE KARST STUD, V66, P9; [Anonymous], 2014, HEXAGON BINNING OVER; ar J., 2001, ACTA CARSOLOGICA, V30, P239; Axelsson P., 2000, INT ARCH PHOTOGRAMM, V33, P110, DOI DOI 10.1016/J.ISPRSJPRS.2005.10.005; Bahtijarevic A, 1996, MORPHOMETRIC ANAL NO; Basso A, 2013, ENVIRON EARTH SCI, V70, P2545, DOI 10.1007/s12665-013-2297-z; Batori Z, 2014, INT J SPELEOL, V43, P15, DOI 10.5038/1827-806X.43.1.2; Batori Z, 2012, J CAVE KARST STUD, V74, P127, DOI 10.4311/2011LSC0216; Batori Z, 2011, ACTA BOT CROAT, V70, P147, DOI 10.2478/v10184-010-0018-1; Bell R, 2009, GEOPH RES ABSTR, P11; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G, V3; Bremer M, 2012, GEOMORPHOLOGY, V138, P49, DOI 10.1016/j.geomorph.2011.08.024; Burrough P., 1998, PRINCIPLES GEOGRAPHI; Castaneda C, 2009, EARTH SURF PROC LAND, V34, P1562, DOI 10.1002/esp.1848; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dakskobler I., 2008, Zbornik Gozdarstva in Lesarstva, P3; de Carvalho OA, 2014, REMOTE SENS-BASEL, V6, P330, DOI 10.3390/rs6010330; Denizman C, 2003, J CAVE KARST STUD, V65, P29; Doctor D.H., 2013, P 13 MULTIDISCIPLINA, P449, DOI DOI 10.5038/9780979542275.1156; European Commission, 2007, EUR 27 BRUSS BE; Filin S, 2011, NAT HAZARDS, V58, P1135, DOI 10.1007/s11069-011-9718-7; Galve JP, 2009, GEOMORPHOLOGY, V108, P145, DOI 10.1016/j.geomorph.2008.12.018; Gams I, 2003, KRAS SLOVENIJI PROST; Gams I, 1974, KRAS ZGODOVINSKI NAR; Gao Y, 2005, ENVIRON GEOL, V47, P1083, DOI 10.1007/s00254-005-1241-2; Giraudoux P., 2013, PGIRMESS DATA ANAL E; Gutierrez F, 2014, EARTH-SCI REV, V138, P61, DOI 10.1016/j.earscirev.2014.08.002; Gutierrez-Santolalla F, 2005, ENVIRON GEOL, V48, P370, DOI 10.1007/s00254-005-1281-7; Habic P, 1986, ACTA CARSOLOGICA, V14, P39; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hofle B, 2011, Z GEOMORPHOL, V55, P1, DOI 10.1127/0372-8854/2011/0055S2-0043; Hofton MA, 2002, J GEODYN, V34, P491, DOI 10.1016/S0264-3707(02)00046-7; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; KEMMERLY PR, 1976, GEOL SOC AM BULL, V87, P42, DOI 10.1130/0016-7606(1976)87<42:DDCITC>2.0.CO;2; Kobal M, 2015, FOREST ECOL MANAG, V337, P77, DOI 10.1016/j.foreco.2014.10.017; Kobler A, 2007, REMOTE SENS ENVIRON, V108, P9, DOI 10.1016/j.rse.2006.10.013; Kunaver J., 1983, GEOGRAFSKI ZBORNIK, V22, P197; Kutnar L, 2011, SUMAR LIST, V135, P113; Laurin GV, 2014, ISPRS J PHOTOGRAMM, V89, P49, DOI 10.1016/j.isprsjprs.2014.01.001; LAVALLE P, 1967, ANN ASSOC AM GEOGR, V57, P49, DOI 10.1111/j.1467-8306.1967.tb00590.x; Mallet C, 2009, ISPRS J PHOTOGRAMM, V64, P1, DOI 10.1016/j.isprsjprs.2008.09.007; Meng XL, 2010, REMOTE SENS-BASEL, V2, P833, DOI 10.3390/rs2030833; Nagel TA, 2015, CAN J FOREST RES, V45, P266, DOI 10.1139/cjfr-2014-0249; Nagel TA, 2014, ECOL APPL, V24, P663, DOI 10.1890/13-0632.1; Newby PRT, 2012, PHOTOGRAMM REC, V27, P360, DOI 10.1111/j.1477-9730.2012.00693.x; Obu J, 2013, GEOD VESTN, V57, P260, DOI 10.15292/geodetski-vestnik.2013.02.260-270; Ogden AE, 1988, P C ENV PROBL KARST; Oksanen J., VEGAN INTRO ORDINATI; Ozkan K, 2010, J ENVIRON BIOL, V31, P51; Passalacqua P, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010958; Pebesma E.J., 2005, R NEWS; Pirotti F, 2011, IFOREST, V4, P100, DOI 10.3832/ifor0562-004; Pirotti F, 2013, APPL GEOMAT, V5, P311, DOI 10.1007/s12518-013-0119-3; Pirotti F, 2013, EUR J REMOTE SENS, V46, P66, DOI 10.5721/EuJRS20134605; Pirotti F, 2010, FORESTS, V1, P194, DOI 10.3390/f1040194; Podobnikar T, 2009, ENVIRON GEOL, V58, P257, DOI 10.1007/s00254-008-1607-3; PUNCER I, 1974, Fragmenta Floristica et Geobotanica, V20, P41; R Core Team, 2018, R LANG ENV STAT COMP; Rahimi M., 2013, P 13 MULT C SINKH EN, P469; SCHUMM SA, 1956, GEOL SOC AM BULL, V67, P597, DOI 10.1130/0016-7606(1956)67[597:EODSAS]2.0.CO;2; Seale LD, 2008, ENVIRON GEOL, V54, P995, DOI 10.1007/s00254-007-0890-8; Shamos M.I., 1978, THESIS YALE U; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sofia G, 2013, EARTH SURF PROC LAND, V38, P1116, DOI 10.1002/esp.3363; Surina B, 2014, SUMAR LIST, V138, P259; Surina Bostjan, 2013, Hacquetia, V12, P11, DOI [10.2478/HACQ-2013-0002, 10.2478/hacq-2013-0002]; Sustersic F, 1994, ACTA CARSOLOGICA, V23, P123; Telbisz T, 2009, HRVAT GEORGR GLAS, V71, P5; Ticci M, GEOM 2011 C P, P7; Varhola A, 2013, J HYDROL, V487, P70, DOI 10.1016/j.jhydrol.2013.02.032; Vilhar U, 2005, EUR J FOREST RES, V124, P165, DOI 10.1007/s10342-005-0067-5; Vilhar U, 2012, EUR J FOREST RES, V131, P1381, DOI 10.1007/s10342-012-0605-x; Vilhar U, 2010, EUR J FOREST RES, V129, P729, DOI 10.1007/s10342-010-0379-y; Weishampel JF, 2011, J CAVE KARST STUD, V73, P187, DOI 10.4311/2010EX0179R1; Williams P., 1971, Z GEOMORPHOL, V15, P40; WILLIAMS PW, 1972, GEOL SOC AM BULL, V83, P761, DOI 10.1130/0016-7606(1972)83[761:MAOPKI]2.0.CO;2; Witze A, 2013, NATURE, V504, P196, DOI 10.1038/504196a	80	55	56	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122070	10.1371/journal.pone.0122070	http://dx.doi.org/10.1371/journal.pone.0122070			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793871	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900170
J	Lv, Q; Luo, FL; Zhao, XY; Liu, Y; Hu, GB; Sun, CD; Li, X; Chen, KS				Lv, Qiang; Luo, Fenglei; Zhao, Xiaoyong; Liu, Yu; Hu, Guibing; Sun, Chongde; Li, Xian; Chen, Kunsong			Identification of Proanthocyanidins from Litchi (Litchi chinensis Sonn.) Pulp by LC-ESI-Q-TOF-MS and Their Antioxidant Activity	PLOS ONE			English	Article							POLYMERIC PROCYANIDINS; PHENOLIC-COMPOUNDS; OLIGOMERIC PROANTHOCYANIDINS; MASS-SPECTROMETRY; GRAPE; FLAVONOIDS; APPLE; FOODS; COMPONENTS; PRODUCTS	Content of total proanthocyanidins as well as total phenolics, flavonoids, antioxidant activities were evaluated for litchi (Litchi chinensis Sonn.) pulp of 32 cultivars. One cultivar, Hemaoli, showed the highest total proanthocyanidins and total phenolics, and DPPH or ABTS radical scavenging activities. ESI-MS and NMR analysis of the Hemaoli pulp crude extracts (HPCE) showed that procyandins composed of (epi) catechin unites with degree of polymerization (DP) of 2-6 were dominant proanthocyanidins in HPCE. After the HPCE was fractionated by a Sephadex LH-20 column, 32 procyanidins were identified by LC-ESI-Q-TOF-MS in litchi pulp for the first time. Quantification of individual procyanidin in HPCE indicated that epicatechin, procyanidin B2, procyanidin C1 and A-type procyanidin trimer were the main procyanidins. The radical scavenging activities of different fractions of HPCE as well as six procyanidins standards were evaluated by both DPPH and ABTS assays. HPCE fractions showed similar antioxidant activities with those of Vc and six individual procyanidins, the IC50 of which ranged from 1.88 +/- 0.01 to 2.82 +/- 0.10 mu g/ml for DPPH assay, and from 1.52 +/- 0.17 to 2.71 +/- 0.15 mu g/ml for ABTS assay. Such results indicate that litchi cultivars rich in proanthocyanidins are good resources of dietary antioxidants and have the potential to contribute to human health.	[Lv, Qiang; Luo, Fenglei; Zhao, Xiaoyong; Sun, Chongde; Li, Xian; Chen, Kunsong] Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Yu] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Guibing] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China	Zhejiang University; Zhejiang University; South China Agricultural University	Li, X (corresponding author), Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	xianli@zju.edu.cn		zhao, xiaoyong/0000-0002-7606-900X; Li, Xian/0000-0002-9526-9031	National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [2012BAD33B08]; Program for New Century Excellent Talents in University of Ministry of Education of China	National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China(Ministry of Science and Technology, China); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Project of Scientific and Technical Supporting Programs Funded by the Ministry of Science & Technology of China (2012BAD33B08) and the Program for New Century Excellent Talents in University of Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis-Goretta L, 2008, J NUTR BIOCHEM, V19, P797, DOI 10.1016/j.jnutbio.2007.10.004; Amarowicz R, 2010, FOOD CHEM, V121, P705, DOI 10.1016/j.foodchem.2010.01.009; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Bak MJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/409321; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; de Freitas VAP, 1998, PHYTOCHEMISTRY, V49, P1435, DOI 10.1016/S0031-9422(98)00107-1; Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503; Es-Safi NE, 2006, J AGR FOOD CHEM, V54, P6969, DOI 10.1021/jf061090f; Flamini R, 2003, MASS SPECTROM REV, V22, P218, DOI 10.1002/mas.10052; Fu C, 2007, J AGR FOOD CHEM, V55, P7689, DOI 10.1021/jf071166n; Gabetta B, 2000, FITOTERAPIA, V71, P162, DOI 10.1016/S0367-326X(99)00161-6; Gu LW, 2004, J NUTR, V134, P613, DOI 10.1093/jn/134.3.613; Gu LW, 2003, J AGR FOOD CHEM, V51, P7513, DOI 10.1021/jf034815d; Gu LW, 2002, J AGR FOOD CHEM, V50, P4852, DOI 10.1021/jf020214v; Guyot S, 1998, J AGR FOOD CHEM, V46, P1698, DOI 10.1021/jf970832p; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b; Jerez M, 2009, RAPID COMMUN MASS SP, V23, P4013, DOI 10.1002/rcm.4342; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jiao LH, 2013, FOOD CHEM TOXICOL, V56, P398, DOI 10.1016/j.fct.2013.02.049; Le Roux E, 1998, PHYTOCHEMISTRY, V48, P1251, DOI 10.1016/S0031-9422(97)01070-4; Li SY, 2012, FOOD CHEM, V135, P31, DOI 10.1016/j.foodchem.2012.04.039; Lin LZ, 2014, J AGR FOOD CHEM, V62, P9387, DOI 10.1021/jf501011y; Lv Q, 2014, J FUNCT FOODS, V7, P621, DOI 10.1016/j.jff.2013.12.023; Muchuweti M, 2005, J SCI FOOD AGR, V85, P1647, DOI 10.1002/jsfa.2163; OhnishiKameyama M, 1997, RAPID COMMUN MASS SP, V11, P31, DOI 10.1002/(SICI)1097-0231(19970115)11:1<31::AID-RCM784>3.0.CO;2-T; Ou KQ, 2014, J FUNCT FOODS, V7, P43, DOI 10.1016/j.jff.2013.08.004; Payne MJ, 2010, J AOAC INT, V93, P89; Pesca MS, 2013, J NAT PROD, V76, P29, DOI 10.1021/np300614u; PORTER LJ, 1994, FLAVONOIDS ADV RES 1, P23; Prasad KN, 2009, FOOD CHEM, V116, P1, DOI 10.1016/j.foodchem.2009.01.079; Prior RL, 2005, PHYTOCHEMISTRY, V66, P2264, DOI 10.1016/j.phytochem.2005.03.025; Prior RL, 2001, J AGR FOOD CHEM, V49, P1270, DOI 10.1021/jf001211q; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Gonzalez-Centeno MR, 2012, J AGR FOOD CHEM, V60, P11850, DOI 10.1021/jf303047k; Schieber A, 2001, J CHROMATOGR A, V910, P265, DOI 10.1016/S0021-9673(00)01217-6; Xu XY, 2010, J AGR FOOD CHEM, V58, P11667, DOI 10.1021/jf1033202; Yang DJ, 2012, FOOD CHEM TOXICOL, V50, P3056, DOI 10.1016/j.fct.2012.06.011; Zhao MM, 2006, FOOD CHEM, V98, P539, DOI 10.1016/j.foodchem.2005.06.028; Zhou HC, 2011, FOOD RES INT, V44, P613, DOI 10.1016/j.foodres.2010.12.016	43	61	64	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120480	10.1371/journal.pone.0120480	http://dx.doi.org/10.1371/journal.pone.0120480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793378	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900040
J	Qu, XQ; Proll, M; Neuhoff, C; Zhang, R; Cinar, MU; Hossain, MM; Tesfaye, D; Grosse-Brinkhaus, C; Salilew-Wondim, D; Tholen, E; Looft, C; Holker, M; Schellander, K; Uddin, MJ				Qu, Xueqi; Proell, Maren; Neuhoff, Christiane; Zhang, Rui; Cinar, Mehmet Ulas; Hossain, Md. Munir; Tesfaye, Dawit; Grosse-Brinkhaus, Christine; Salilew-Wondim, Dessie; Tholen, Ernst; Looft, Christian; Hoelker, Michael; Schellander, Karl; Uddin, Muhammad Jasim			Sulforaphane Epigenetically Regulates Innate Immune Responses of Porcine Monocyte-Derived Dendritic Cells Induced with Lipopolysaccharide	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; PROINFLAMMATORY GENE-EXPRESSION; BLOOD MONONUCLEAR-CELLS; HISTONE DEACETYLASES; TNF-ALPHA; INFLAMMATORY RESPONSES; MEDIATED ACTIVATION; CYTOKINE PRODUCTION	Histone acetylation, regulated by histone deacetylases (HDACs) is a key epigenetic mechanism controlling gene expressions. Although dendritic cells (DCs) are playing pivotal roles in host immune responses, the effect of epigenetic modulation of DCs immune responses remains unknown. Sulforaphane (SFN) as a HDAC inhibitor has anti-inflammatory properties, which is used to investigate the epigenetic regulation of LPS-induced immune gene and HDAC family gene expressions in porcine monocyte-derived dendritic cells (moDCs). SFN was found to inhibit the lipopolysaccharide LPS induced HDAC6, HDAC10 and DNA methyltransferase (DNMT3a) gene expression, whereas up-regulated the expression of DNMT1 gene. Additionally, SFN was observed to inhibit the global HDAC activity, and suppressed moDCs differentiation from immature to mature DCs through down-regulating the CD40, CD80 and CD86 expression and led further to enhanced phagocytosis of moDCs. The SFN pre-treated of moDCs directly altered the LPS-induced TLR4 and MD2 gene expression and dynamically regulated the TLR4-induced activity of transcription factor NF-kappa B and TBP. SFN showed a protective role in LPS induced cell apoptosis through suppressing the IRF6 and TGF-beta 1 production. SFN impaired the pro-inflammatory cytokine TNF-alpha and IL-1 beta secretion into the cell culture supernatants that were induced in moDCs by LPS stimulation, whereas SFN increased the cellular-resident TNF-alpha accumulation. This study demonstrates that through the epigenetic mechanism the HDAC inhibitor SFN could modulate the LPS induced innate immune responses of porcine moDCs.	[Qu, Xueqi; Proell, Maren; Neuhoff, Christiane; Zhang, Rui; Cinar, Mehmet Ulas; Hossain, Md. Munir; Tesfaye, Dawit; Grosse-Brinkhaus, Christine; Salilew-Wondim, Dessie; Tholen, Ernst; Looft, Christian; Hoelker, Michael; Schellander, Karl; Uddin, Muhammad Jasim] Univ Bonn, Inst Anim Sci, D-53115 Bonn, Germany; [Cinar, Mehmet Ulas] Erciyes Univ, Dept Anim Sci, Fac Agr, TR-38039 Kayseri, Turkey; [Hossain, Md. Munir] Bangladesh Agr Univ, Fac Anim Husb, Dept Anim Breeding & Genet, Mymensingh 2202, Bangladesh	University of Bonn; Erciyes University; Bangladesh Agricultural University (BAU)	Uddin, MJ (corresponding author), Univ Bonn, Inst Anim Sci, Endenicher Allee 15, D-53115 Bonn, Germany.	judd@itw.uni-bonn.de	Hossain, Munir/C-6692-2008; Uddin, Muhammad Jasim/N-3866-2013; Große-Brinkhaus, Christine/AAF-6712-2020; Uddin, Muhammad Jasim/P-8497-2019	Große-Brinkhaus, Christine/0000-0002-6190-4463; Uddin, Muhammad Jasim/0000-0002-6732-5534; Wondim, Dr. Dessie Salilew/0000-0002-8756-0865; Uddin, Dr. Md. Jashim/0000-0002-3243-3455; Hossain, Dr Md Munir/0000-0002-8595-7578	China Scholarship Council	China Scholarship Council(China Scholarship Council)	We thank Ludger Buschen for animal husbandry; Birgit Koch-Fabritius and Helga Brodesser for technical assistance; Elmar Endl, Andreas Dolf and Peter Wurst for flow cytometry analysis (Institutes of Molecular Medicine and Experimental Immunology, University of Bonn); Nicole Kramer for phagocytosis measurement (Life and Medical Science (LIMES) Institute, Program Unit Chemical Biology and Medicinal Chemistry, University of Bonn); Huitao Fan and Mohammad Ariful Islam for sample collection. We would like to extend acknowledgment to China Scholarship Council for supporting Xueqi Qu.	Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Apostolaki M, 2010, CURR DIR AUTOIMMUN, V11, P1, DOI 10.1159/000289195; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baumann A, 2014, J IMMUNOL, V193, P364, DOI 10.4049/jimmunol.1303219; Berghe W.V., 2006, BIOCHEM PHARMACOL, V72, P1114, DOI DOI 10.1016/j.bcp.2006.07.012; Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Dearman RJ, 2009, IMMUNOLOGY, V126, P475, DOI 10.1111/j.1365-2567.2008.02922.x; Do DP, 2010, INT J PHARMACEUT, V386, P114, DOI 10.1016/j.ijpharm.2009.11.009; Facci MR, 2010, IMMUNOLOGY, V129, P396, DOI 10.1111/j.1365-2567.2009.03192.x; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Fan HT, 2012, EPIGENETICS-US, V7, P1379, DOI 10.4161/epi.22609; de Oliveira JMPF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092980; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Hu N, 2012, GENE DEV, V26, P2380, DOI 10.1101/gad.198747.112; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Inoue A, 2012, ARTHRITIS RHEUM-US, V64, P3877, DOI 10.1002/art.34666; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Joyee AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083463; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Konwinski RR, 2004, TOXICOL LETT, V153, P343, DOI 10.1016/j.toxlet.2004.06.006; Koo JE, 2013, BIOCHEM BIOPH RES CO, V434, P600, DOI 10.1016/j.bbrc.2013.03.123; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Kushwah R, 2009, J IMMUNOL, V183, P7104, DOI 10.4049/jimmunol.0900824; Lam HC, 2013, J CLIN INVEST, V123, P5212, DOI 10.1172/JCI69636; Li CJ, 2009, FUNCT INTEGR GENOMIC, V9, P335, DOI 10.1007/s10142-009-0116-0; Liu H, 2013, P NATL ACAD SCI USA, V110, P19065, DOI 10.1073/pnas.1318247110; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Misaki K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3339; Moon DO, 2009, CANCER LETT, V274, P132, DOI 10.1016/j.canlet.2008.09.013; Moore TA, 2005, CLIN INFECT DIS, V41, pS213, DOI 10.1086/430126; Moore TA, 2003, INFECT IMMUN, V71, P4891, DOI 10.1128/IAI.71.9.4891-4900.2003; Mukherjee R, 2012, CELL PHYSIOL BIOCHEM, V29, P617, DOI 10.1159/000338515; Mussa T, 2013, VET IMMUNOL IMMUNOP, V154, P25, DOI 10.1016/j.vetimm.2013.04.004; Mussa T, 2011, VIROLOGY, V420, P125, DOI 10.1016/j.virol.2011.09.001; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Myzak MC, 2007, EXP BIOL MED, V232, P227; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Park JH, 2008, BIOCHEM BIOPH RES CO, V368, P318, DOI 10.1016/j.bbrc.2008.01.056; Pham NA, 2004, MOL CANCER THER, V3, P1239; Popadin K, 2013, AM J HUM GENET, V93, P1015, DOI 10.1016/j.ajhg.2013.10.022; Provenzano MJ, 2007, HEARING RES, V233, P1, DOI 10.1016/j.heares.2007.07.002; Qu XQ, 2015, INNATE IMMUN-LONDON, V21, P242, DOI 10.1177/1753425914526266; Raymond CR, 2005, VET IMMUNOL IMMUNOP, V107, P235, DOI 10.1016/j.vetimm.2005.05.008; Ren Y, 2008, J IMMUNOL, V180, P4978, DOI 10.4049/jimmunol.180.7.4978; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruud Tom E, 2007, Surg Infect (Larchmt), V8, P495, DOI 10.1089/sur.2006.083; SAHLIN S, 1983, J IMMUNOL METHODS, V60, P115, DOI 10.1016/0022-1759(83)90340-X; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Seki T, 2012, NAT PROTOC, V7, P718, DOI 10.1038/nprot.2012.015; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Silva-Campa E, 2010, VIROLOGY, V396, P264, DOI 10.1016/j.virol.2009.10.024; Uddin MJ, 2012, VET IMMUNOL IMMUNOP, V147, P211, DOI 10.1016/j.vetimm.2012.04.020; Vincent IE, 2003, J VIROL, V77, P13288, DOI 10.1128/JVI.77.24.13288-13300.2003; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Wellmer A, 2001, INFECT IMMUN, V69, P6881, DOI 10.1128/IAI.69.11.6881-6886.2001; Yamaguchi Y, 1997, STEM CELLS, V15, P144, DOI 10.1002/stem.150144; Youn HS, 2010, J IMMUNOL, V184, P411, DOI 10.4049/jimmunol.0803988; ZDS, 2003, RICHTL FUER STAT MAS; Zhang Y, 1999, BLOOD, V93, P1208, DOI 10.1182/blood.V93.4.1208.404k05_1208_1220; Zhu HQ, 2010, J BIOL CHEM, V285, P9429, DOI 10.1074/jbc.M109.071274	73	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121574	10.1371/journal.pone.0121574	http://dx.doi.org/10.1371/journal.pone.0121574			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793534	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900140
J	Torstensson, T; Butler, S; Lindgren, A; Peterson, M; Eriksson, M; Kristiansson, P				Torstensson, Thomas; Butler, Stephen; Lindgren, Anne; Peterson, Magnus; Eriksson, Margaretha; Kristiansson, Per			Referred Pain Patterns Provoked on Intra-Pelvic Structures among Women with and without Chronic Pelvic Pain: A Descriptive Study	PLOS ONE			English	Article							LOW-BACK-PAIN; MUSCLE PAIN; GIRDLE PAIN; PREGNANCY; RELIABILITY; HEALTH; PREVALENCE; INJECTIONS; DIAGNOSIS; SPINE	Objectives To describe referred pain patterns provoked from intra-pelvic structures in women with chronic pelvic pain (CPP) persisting after childbirth with the purpose to improve diagnostics and give implications for treatment. Materials and Methods In this descriptive and comparative study 36 parous women with CPP were recruited from a physiotherapy department waiting list and by advertisements in newspapers. A control group of 29 parous women without CPP was consecutively assessed for eligibility from a midwifery surgery. Inclusion criterion for CPP was: moderate pain in the sacral region persisting at least six months after childbirth confirmed by pelvic pain provocation tests. Exclusion criteria in groups with and without CPP were: persistent back or pelvic pain with onset prior to pregnancy, previous back surgery and positive neurological signs. Pain was provoked by palpation of 13 predetermined intra-pelvic anatomical landmarks. The referred pain distribution was expressed in pain drawings and described in pain maps and calculated referred pain areas. Results Pain provoked by palpation of the posterior intra-pelvic landmarks was mostly referred to the sacral region and pain provoked by palpation of the ischial and pubic bones was mostly referred to the groin and pubic regions, with or without pain referred down the ipsilateral leg. The average pain distribution area provoked by palpation of all 13 anatomical landmarks was 30.3 mm(2) (19.2 to 53.7) in women with CPP as compared to 3.2 mm(2) (1.0 to 5.1) in women without CPP, p< 0.0001. Conclusions Referred pain patterns provoked from intra-pelvic landmarks in women with CPP are consistent with sclerotomal sensory innervation. Magnification of referred pain patterns indicates allodynia and central sensitization. The results suggest that pain mapping can be used to evaluate and confirm the pain experience among women with CPP and contribute to diagnosis.	[Torstensson, Thomas; Butler, Stephen; Lindgren, Anne; Peterson, Magnus; Eriksson, Margaretha; Kristiansson, Per] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Torstensson, Thomas; Lindgren, Anne] Sundsvall Hosp, Dept Physiotherapy, Sundsvall, Sweden; [Butler, Stephen; Peterson, Magnus] Univ Uppsala Hosp, Pain Ctr, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital	Torstensson, T (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	thomas.torstensson@pubcare.uu.se			Vasternorrland County Council; Medical Faculty, Uppsala University	Vasternorrland County Council; Medical Faculty, Uppsala University	This study was supported by grants from the Vasternorrland County Council and Medical Faculty, Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2000, EUR SPINE J, V9, P161, DOI 10.1007/s005860050228; Albert H, 2001, ACTA OBSTET GYN SCAN, V80, P505, DOI 10.1034/j.1600-0412.2001.080006505.x; Arendt-Nielsen L, 2001, CLIN J PAIN, V17, P11, DOI 10.1097/00002508-200103000-00003; Berkley KJ, 2005, PHYSIOL BEHAV, V86, P272, DOI 10.1016/j.physbeh.2005.08.013; Bonica JJ, 1990, MANAGEMENT PAIN, P133; Brown PB, 1997, SOMATOSENS MOT RES, V14, P93, DOI 10.1080/08990229771097; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Dalpiaz O, 2008, BJU INT, V102, P1061, DOI 10.1111/j.1464-410X.2008.07771.x; Dejerine J, 1914, PARIS, V1-2, P1; FAST A, 1987, SPINE, V12, P368, DOI 10.1097/00007632-198705000-00011; Fung B K, 1993, Zhonghua Yi Xue Za Zhi (Taipei), V51, P103; GILLETTE RG, 1993, PAIN, V54, P85, DOI 10.1016/0304-3959(93)90103-V; GravenNielsen T, 1997, PAIN, V69, P111, DOI 10.1016/S0304-3959(96)03243-5; Gutke A, 2006, SPINE, V31, pE149, DOI 10.1097/01.brs.0000201259.63363.e1; Inman VT, 1944, J NERV MENT DIS, V99, P660, DOI 10.1097/00005053-194405000-00023; Ivanusic JJ, 2007, CLIN ANAT, V20, P956, DOI 10.1002/ca.20555; Kang YS, 2000, DIS COLON RECTUM, V43, P1288, DOI 10.1007/BF02237438; Kellgren JH, 1938, BRIT MED J, V1, P325, DOI 10.1136/bmj.1.4023.325; Koninckx PR, 1997, HUM REPROD, V12, P1785, DOI 10.1093/humrep/12.8.1785; Kristiansson P, 1996, SPINE, V21, P702, DOI 10.1097/00007632-199603150-00008; Langford CF, 2007, NEUROUROL URODYNAM, V26, P59, DOI 10.1002/nau.20393; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Latthe P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-177; Mathias SD, 1996, OBSTET GYNECOL, V87, P321, DOI 10.1016/0029-7844(95)00458-0; Merskey H., 1994, PAIN S3, V3, pS1; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Midttun A, 1986, MODERN MANUAL THERAP, P815; Mousavi SJ, 2007, SPINE, V32, pE100, DOI 10.1097/01.brs.0000254123.26649.6e; SALEN BA, 1994, J CLIN EPIDEMIOL, V47, P1423, DOI 10.1016/0895-4356(94)90086-8; SIMONS DG, 1983, POSTGRAD MED, V73, P99, DOI 10.1080/00325481.1983.11697758; Simons DG, 1983, POSTGRAD MED, V73, P73; Southerst D, 2013, J MANIP PHYSIOL THER, V36, P450, DOI 10.1016/j.jmpt.2013.05.021; Srinivasan Arun K, 2007, Curr Pain Headache Rep, V11, P359, DOI 10.1007/s11916-007-0218-0; Swanton A, 2006, BJOG-INT J OBSTET GY, V113, P792, DOI 10.1111/j.1471-0528.2006.00976.x; Takahashi Y, 2003, SPINE, V28, P871, DOI 10.1097/00007632-200305010-00007; Takahashi Y, 2010, J PAIN, V11, P652, DOI 10.1016/j.jpain.2009.10.007; Torstensson T, 2009, SPINE, V34, P2254, DOI 10.1097/BRS.0b013e3181b07eac; Tu FF, 2008, CLIN J PAIN, V24, P45, DOI 10.1097/AJP.0b013e318156db13; van der Windt DAWM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007431.pub2; Vleeming A, 2008, EUR SPINE J, V17, P794, DOI 10.1007/s00586-008-0602-4; Warren JW, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.003; Zondervan K, 2000, BEST PRACT RES CL OB, V14, P403, DOI 10.1053/beog.1999.0083	42	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119542	10.1371/journal.pone.0119542	http://dx.doi.org/10.1371/journal.pone.0119542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793999	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200093
J	van der Linden, MH; Seslija, L; Schneider, P; Driessen, EMC; Castro, PG; Stumpel, DJPM; van Roon, E; de Boer, J; Williams, O; Pieters, R; Stam, RW				van der Linden, Marieke H.; Seslija, Lidija; Schneider, Pauline; Driessen, Emma M. C.; Castro, Patricia Garrido; Stumpel, Dominique J. P. M.; van Roon, Eddy; de Boer, Jasper; Williams, Owen; Pieters, Rob; Stam, Ronald W.			Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ETS-RELATED GENE; CANCER; EXPRESSION; ERG; PROLIFERATION; ACTIVATION; DIFFERENTIATION; CLASSIFICATION; RECEPTOR	Introduction MLL-rearranged acute lymphoblastic leukemia (ALL) in infants (< 1 year) is characterized by high relapse rates and a dismal prognosis. To facilitate the discovery of novel therapeutic targets, we here searched for genes directly influenced by the repression of various MLL fusions. Methods For this, we performed gene expression profiling after siRNA-mediated repression of MLL-AF4, MLL-ENL, and AF4-MLL in MLL-rearranged ALL cell line models. The obtained results were compared with various already established gene signatures including those consisting of known MLL-AF4 target genes, or those associated with primary MLL-rearranged infant ALL samples. Results Genes that were down-regulated in response to the repression of MLL-AF4 and MLL-ENL appeared characteristically expressed in primary MLL-rearranged infant ALL samples, and often represented known MLL-AF4 targets genes. Genes that were up-regulated in response to the repression of MLL-AF4 and MLL-ENL often represented genes typically silenced by promoter hypermethylation in MLL-rearranged infant ALL. Genes that were affected in response to the repression of AF4-MLL showed significant enrichment in gene expression profiles associated with AF4-MLL expressing t(4;11)+ infant ALL patient samples. Conclusion We conclude that the here identified genes readily responsive to the loss of MLL fusion expression potentially represent attractive therapeutic targets and may provide additional insights in MLL-rearranged acute leukemias.	[van der Linden, Marieke H.; Seslija, Lidija; Schneider, Pauline; Driessen, Emma M. C.; Castro, Patricia Garrido; Stumpel, Dominique J. P. M.; van Roon, Eddy; Pieters, Rob; Stam, Ronald W.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [de Boer, Jasper; Williams, Owen] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London, England; [de Boer, Jasper; Williams, Owen] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Pieters, Rob] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Stam, RW (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands.	r.stam@erasmusmc.nl	Stam, Ronald/AAE-7033-2022; de Boer, Jasper/B-5067-2013	de Boer, Jasper/0000-0002-3220-8776; williams, owen/0000-0002-1760-6880; Schneider, Pauline/0000-0003-0162-9436	KIKA (Stichting Kinderen Kankervrij) [18]; KWF Kankerbestrijding (Dutch Cancer Society); Great Ormond Street Hospital Childrens Charity [V1305] Funding Source: researchfish	KIKA (Stichting Kinderen Kankervrij); KWF Kankerbestrijding (Dutch Cancer Society); Great Ormond Street Hospital Childrens Charity	This research was funded by KIKA (Stichting Kinderen Kankervrij, project no. 18), and RWS was financially supported by KWF Kankerbestrijding (Dutch Cancer Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Drexler HG, 2004, LEUKEMIA, V18, P227, DOI 10.1038/sj.leu.2403236; Duong MT, 2013, CANCER RES, V73, P5556, DOI 10.1158/0008-5472.CAN-13-0013; Gaussmann A, 2007, ONCOGENE, V26, P3352, DOI 10.1038/sj.onc.1210125; Goldberg L, 2013, BLOOD, V122, P2694, DOI 10.1182/blood-2013-01-477133; Greaves MF, 1996, LEUKEMIA, V10, P372; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Heidenreich O, 2003, BLOOD, V101, P3157, DOI 10.1182/blood-2002-05-1589; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Iizuka M, 2013, CANCER SCI, V104, P1647, DOI 10.1111/cas.12303; Jansen MWJC, 2007, LEUKEMIA, V21, P633, DOI 10.1038/sj.leu.2404578; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Kumar AR, 2011, LEUKEMIA RES, V35, P305, DOI 10.1016/j.leukres.2010.08.011; Lyu JH, 2014, J CELLULAR BIOCH; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Marcucci G, 2007, J CLIN ONCOL, V25, P3337, DOI 10.1200/JCO.2007.10.8720; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; MORISAKI T, 1985, AM J HEMATOL, V19, P37, DOI 10.1002/ajh.2830190106; Niu Y, 2014, APMIS ACTA PATH 0925; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; POCOCK CFE, 1995, BRIT J HAEMATOL, V90, P855, DOI 10.1111/j.1365-2141.1995.tb05207.x; Schafer E, 2010, BLOOD, V115, P4798, DOI 10.1182/blood-2009-09-243634; Schwable J, 2005, BLOOD, V105, P2107, DOI 10.1182/blood-2004-03-0940; Stam RW, 2010, BLOOD, V115, P2835, DOI 10.1182/blood-2009-07-233049; STONG RC, 1985, BLOOD, V65, P21, DOI 10.1182/blood.V65.1.21.21; Stumpel DJPM, 2009, BLOOD, V114, P5490, DOI 10.1182/blood-2009-06-227660; Susila A, 2010, CELL CYCLE, V9, P179, DOI 10.4161/cc.9.1.10406; Thomas M, 2005, BLOOD, V106, P3559, DOI 10.1182/blood-2005-03-1283; Thoms JAI, 2011, BLOOD, V117, P7079, DOI 10.1182/blood-2010-12-317990; van der Linden MH, 2014, CELL CYCLE, V13, P834, DOI 10.4161/cc.27757; Wilkinson AC, 2013, CELL REP, V3, P116, DOI 10.1016/j.celrep.2012.12.016; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Ying L, 2014, FEBS J          1016; Zhang L, 2014, CANCER BIOTHER RADIO, V29, P77, DOI 10.1089/cbr.2013.1502; Zhang YM, 2014, J MANUF PROCESS, V16, P1, DOI 10.1016/j.jmapro.2013.12.004	39	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120326	10.1371/journal.pone.0120326	http://dx.doi.org/10.1371/journal.pone.0120326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793396	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900013
J	Yang, FQ; Zhang, HM; Chen, SJ; Yan, Y; Zheng, JH				Yang, Feng-qiang; Zhang, Hai-ming; Chen, Shao-Jun; Yan, Yang; Zheng, Jun-hua			MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1	PLOS ONE			English	Article							UP-REGULATION; CANCER; MICRORNA; PROLIFERATION; DIAGNOSTICS; EXPRESSION; SURVIVAL; STAGE	Background Some microRNAs (miRNAs) are abnormally expressed in cancer and contribute to tumorigenesis. In the present study, we investigated the role of miR-506 in clear cell renal cell carcinoma (ccRCC). Methods miR-506 expression was detected in renal cancer cell lines 786-O, ACHN, Caki-1, and Caki-2 and ccRCC specimens by quantitative real-time-PCR. We assessed the association of miR-506 expression with pathology and prognosis in ccRCC patients. We over-expressed and knocked-down miR-506 expression in two renal cancer cell lines, 786-O and ACHN, and assessed the impact on cell proliferation, migration and invasion. A luciferase reporter assay was conducted to confirm the target gene of miR-506 in renal cancer cell lines. Results miR-506 was significantly down-regulated in renal cancer cell lines and ccRCC specimens. Low miR-506 expression in ccRCC specimens was associated with an advanced clinical stage and poor prognosis. miR-506 expression was an independent prognostic marker of overall ccRCC patient survival in a multivariate analysis. Over-expression of miR-506 in renal cancer cells decreased cell growth and metastasis, In contrast, down-regulation of miR-506 expression promoted renal cancer cell growth and metastasis. FLOT1, a potential target gene of miR-506, was inversely correlated with miR-506 expression in ccRCC tissues. Consistent with the effect of miR-506, knockdown of FLOT1 by siRNA inhibited cell malignant behaviors. Rescue of FLOT1 expression partially restored the effects of miR-506. Conclusions miR-506 exerts its anti-cancer function by directly targeting FLOT1 in renal cancer, indicating a potential novel therapeutic role in renal cancer treatment.	[Yang, Feng-qiang; Zhang, Hai-ming; Chen, Shao-Jun; Yan, Yang; Zheng, Jun-hua] Tongji Univ, Dept Urol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University	Zheng, JH (corresponding author), Tongji Univ, Dept Urol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	junhuazheng07@gmail.com	Wei, Li/AAE-9938-2020; wei, li/GSD-3630-2022		National Natural Science Foundation of China [81270831]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81270831) (http://npd.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064273; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cindolo L, 2005, CANCER-AM CANCER SOC, V104, P1362, DOI 10.1002/cncr.21331; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Garzon R, 2012, CURR OPIN ONCOL, V24, P655, DOI 10.1097/CCO.0b013e328358522c; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Jiang Z, 2008, CLIN CANCER RES, V14, P5579, DOI 10.1158/1078-0432.CCR-08-0504; Karakiewicz PI, 2007, J CLIN ONCOL, V25, P1316, DOI 10.1200/JCO.2006.06.1218; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Li H, 2014, TUMOR BIOL, V35, P3311, DOI 10.1007/s13277-013-1434-3; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Liu G, 2014, J PATHOL, V233, P308, DOI 10.1002/path.4348; Miyamoto H, 2010, PATHOL INT, V60, P1, DOI 10.1111/j.1440-1827.2009.02477.x; Patil S, 2010, CANCER-AM CANCER SOC, V116, P347, DOI 10.1002/cncr.24713; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Rufino-Palomares EE, 2014, MICRORNAS MED, P223; Wen S, 2014, ONCOGENE; Xiong P, 2013, NEOPLASMA, V60, P395, DOI 10.4149/neo_2013_051; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908; Zhao Y, 2011, TOXICOL LETT, V205, P320, DOI 10.1016/j.toxlet.2011.06.022	24	51	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120258	10.1371/journal.pone.0120258	http://dx.doi.org/10.1371/journal.pone.0120258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793370	Green Published, gold			2022-12-26	WOS:000352083900004
J	Huber, B; Schellenbacher, C; Jindra, C; Fink, D; Shafti-Keramat, S; Kirnbauer, R				Huber, Bettina; Schellenbacher, Christina; Jindra, Christoph; Fink, Dieter; Shafti-Keramat, Saeed; Kirnbauer, Reinhard			A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; INVASIVE CERVICAL-CANCER; NEUTRALIZING EPITOPE; ADENOSQUAMOUS CARCINOMA; UTERINE CERVIX; HPV-TYPE; ADENOCARCINOMA; L2; L1; EFFICACY	Persistent infection with oncogenic human papillomaviruses (HPV) types causes all cervical and a subset of other anogenital and oropharyngeal carcinomas. Four high-risk (hr) mucosal types HPV16, 18, 45, or 59 cause almost all cervical adenocarcinomas (AC), a subset of cervical cancer (CxC). Although the incidence of cervical squamous cell carcinoma (SCC) has dramatically decreased following introduction of Papanicolaou (PAP) screening, the proportion of AC has relatively increased. Cervical SCC arise mainly from the ectocervix, whereas AC originate primarily from the endocervical canal, which is less accessible to obtain viable PAP smears. Licensed (bivalent and quadrivalent) HPV vaccines comprise virus-like particles (VLP) of the most important hr HPV16 and 18, self-assembled from the major capsid protein L1. Due to mainly type-restricted efficacy, both vaccines do not target 13 additional hr mucosal types causing 30% of CxC. The papillomavirus genus alpha species 7 (alpha 7) includes a group of hr types of which HPV18, 45, 59 are proportionally overrepresented in cervical AC and only partially (HPV18) targeted by current vaccines. To target these types, we generated a chimeric vaccine antigen that consists of a cross-neutralizing epitope (homologue of HPV16 RG1) of the L2 minor capsid protein of HPV45 genetically inserted into a surface loop of HPV18 L1 VLP (18L1-45RG1). Vaccination of NZW rabbits with 18L1-45RG1 VLP plus alum-MPL adjuvant induced high-titer neutralizing antibodies against homologous HPV18, that cross-neutralized non-cognate hr a7 types HPV39, 45, 68, but not HPV59, and low risk HPV70 in vitro, and induced a robust L1-specific cellular immune response. Passive immunization protected mice against experimental vaginal challenge with pseudovirions of HPV18, 39, 45 and 68, but not HPV59 or the distantly related a9 type HPV16. 18L1-45RG1 VLP might be combined with our previously described 16L116RG1 VLP to develop a second generation bivalent vaccine with extended spectrum against hr HPV.	[Huber, Bettina; Schellenbacher, Christina; Jindra, Christoph; Shafti-Keramat, Saeed; Kirnbauer, Reinhard] Med Univ Vienna MUW, LVO, DIAID, Dept Dermatol, Vienna, Austria; [Fink, Dieter] Vet Univ Vienna, Dept Biomed Sci, Inst Lab Anim Sci, A-1030 Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna	Kirnbauer, R (corresponding author), Med Univ Vienna MUW, LVO, DIAID, Dept Dermatol, Vienna, Austria.	reinhard.kirnbauer@meduniwien.ac.at		Shafti-Keramat, Saeed/0000-0002-4180-8853; Huber, Bettina/0000-0002-8086-7848	Vienna Science and Technology Fund [LS11-006]	Vienna Science and Technology Fund	This research was supported by a grant to RK from the Vienna Science and Technology Fund (www.wwtf.at) (Life Science Call 2011) (LS11-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Andersson S, 2001, EUR J CANCER, V37, P246, DOI 10.1016/S0959-8049(00)00376-2; Baalbergen A, 2013, GYNECOL ONCOL, V128, P530, DOI 10.1016/j.ygyno.2012.12.013; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck Christopher B, 2007, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2601s37; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Costa S, 2007, GYNECOL ONCOL, V106, P170, DOI 10.1016/j.ygyno.2007.03.016; Dabic MM, 2008, ACTA OBSTET GYN SCAN, V87, P366, DOI 10.1080/00016340801936560; Day PM, 2012, CLIN VACCINE IMMUNOL, V19, P1075, DOI 10.1128/CVI.00139-12; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gambhira R, 2007, J VIROL, V81, P11585, DOI 10.1128/JVI.01577-07; Gaukroger JM, 1996, J GEN VIROL, V77, P1577, DOI 10.1099/0022-1317-77-7-1577; HAGENSEE ME, 1993, J VIROL, V67, P315, DOI 10.1128/JVI.67.1.315-322.1993; Jagu S, 2010, VACCINE, V28, P4478, DOI 10.1016/j.vaccine.2010.04.039; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kawana K, 1998, VIROLOGY, V245, P353, DOI 10.1006/viro.1998.9168; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kirnbauer R, 2009, HAUTARZT, V60, P878, DOI 10.1007/s00105-009-1803-4; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kondo K, 2008, J MED VIROL, V80, P841, DOI 10.1002/jmv.21124; Liu SL, 2001, CAN MED ASSOC J, V164, P1151; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; McGrath M, 2013, ARCH VIROL, V158, P2079, DOI 10.1007/s00705-013-1713-8; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Pineo CB, 2013, PLANT BIOTECHNOL J, V11, P964, DOI 10.1111/pbi.12089; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Rizk RZ, 2008, J GEN VIROL, V89, P117, DOI 10.1099/vir.0.83145-0; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Sasieni P, 2001, LANCET, V357, P1490, DOI 10.1016/S0140-6736(00)04646-8; Schellenbacher C, 2013, J INVEST DERMATOL, V133, P2706, DOI 10.1038/jid.2013.253; Seitz H, 2013, CLIN VACCINE IMMUNOL, V20, P1061, DOI 10.1128/CVI.00195-13; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Smith HO, 2000, GYNECOL ONCOL, V78, P97, DOI 10.1006/gyno.2000.5826; Tumban E, 2013, VACCINE, V31, P4647, DOI 10.1016/j.vaccine.2013.07.052; Varsani A, 2003, J VIROL, V77, P8386, DOI 10.1128/JVI.77.15.8386-8393.2003; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510	49	21	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120152	10.1371/journal.pone.0120152	http://dx.doi.org/10.1371/journal.pone.0120152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790098	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400135
J	Kowalsky, CA; Klesmith, JR; Stapleton, JA; Kelly, V; Reichkitzer, N; Whitehead, TA				Kowalsky, Caitlin A.; Klesmith, Justin R.; Stapleton, James A.; Kelly, Vince; Reichkitzer, Nolan; Whitehead, Timothy A.			High-Resolution Sequence-Function Mapping of Full-Length Proteins	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; SATURATION MUTAGENESIS; POLYPEPTIDE LIBRARIES; IN-VITRO; AFFINITY; ANTIBODIES; PHAGE; SITE; OPTIMIZATION; SPECIFICITY	Comprehensive sequence-function mapping involves detailing the fitness contribution of every possible single mutation to a gene by comparing the abundance of each library variant before and after selection for the phenotype of interest. Deep sequencing of library DNA allows frequency reconstruction for tens of thousands of variants in a single experiment, yet short read lengths of current sequencers makes it challenging to probe genes encoding full-length proteins. Here we extend the scope of sequence-function maps to entire protein sequences with a modular, universal sequence tiling method. We demonstrate the approach with both growth-based selections and FACS screening, offer parameters and best practices that simplify design of experiments, and present analytical solutions to normalize data across independent selections. Using this protocol, sequence-function maps covering full sequences can be obtained in four to six weeks. Best practices introduced in this manuscript are fully compatible with, and complementary to, other recently published sequence-function mapping protocols.	[Kowalsky, Caitlin A.; Stapleton, James A.; Kelly, Vince; Reichkitzer, Nolan; Whitehead, Timothy A.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Klesmith, Justin R.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Whitehead, TA (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.	taw@msu.edu		Whitehead, Timothy/0000-0003-3177-1361; Klesmith, Justin/0000-0003-2908-9355	National Science Foundation as a CAREER grant [CBET-1254238]; National Institutes of Health (NIH) NRSA Fellowship; Div Of Chem, Bioeng, Env, & Transp Sys [1254238] Funding Source: National Science Foundation	National Science Foundation as a CAREER grant; National Institutes of Health (NIH) NRSA Fellowship; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study was supported by the National Science Foundation (www.nsf.gov) as a CAREER grant to TAW (Award #CBET-1254238). JAS was supported by a National Institutes of Health (NIH) NRSA Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff EA, 2012, PROTEIN SCI, V21, P717, DOI 10.1002/pro.2059; Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Bienick MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109105; Boder ET, 1998, BIOTECHNOL PROGR, V14, P55, DOI 10.1021/bp970144q; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chubiz LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047959; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dai JH, 2009, WORLD J MICROB BIOT, V25, P1589, DOI 10.1007/s11274-009-0048-9; Firnberg E, 2014, MOL BIOL EVOL; Firnberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052031; Fowler DM, 2014, NAT PROTOC, V9, P2267, DOI 10.1038/nprot.2014.153; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldsmith M, 2007, PROTEIN ENG DES SEL, V20, P315, DOI 10.1093/protein/gzm026; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hietpas R, 2012, NAT PROTOC, V7, P1382, DOI 10.1038/nprot.2012.069; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; Hogrefe HH, 2002, BIOTECHNIQUES, V33, P1158, DOI 10.2144/02335pf01; Jain PC, 2014, ANAL BIOCHEM, V449, P90, DOI 10.1016/j.ab.2013.12.002; Lee E., 2012, 2012 IEEE 28 S MASS, P1; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Lofblom J, 2005, FEMS MICROBIOL LETT, V248, P189, DOI 10.1016/j.femsle.2005.05.040; Matochko WL, 2012, METHODS, V58, P47, DOI 10.1016/j.ymeth.2012.07.006; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Michener JK, 2012, METAB ENG, V14, P306, DOI 10.1016/j.ymben.2012.04.004; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Rajpal A, 2005, P NATL ACAD SCI USA, V102, P8466, DOI 10.1073/pnas.0503543102; Roscoe BP, 2013, J MOL BIOL, V425, P1363, DOI 10.1016/j.jmb.2013.01.032; Sambrook J., 2001, MOL CLONING LAB MANU; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Tang SY, 2008, J AM CHEM SOC, V130, P5267, DOI 10.1021/ja7109053; Thomas A., 1991, METHOD ENZYMOL, V204, P125; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Tripathi A, 2014, CURR OPIN STRUC BIOL, V24, P63, DOI 10.1016/j.sbi.2013.12.001; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214	49	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118193	10.1371/journal.pone.0118193	http://dx.doi.org/10.1371/journal.pone.0118193			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790064	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400025
J	Li, BJ; Shao, DY; Luo, YG; Wang, P; Liu, CH; Zhang, XY; Cui, RJ				Li, Bingjin; Shao, Dongyuan; Luo, Yungang; Wang, Pu; Liu, Changhong; Zhang, Xingyi; Cui, Ranji			Role of 5-HT3 Receptor on Food Intake in Fed and Fasted Mice	PLOS ONE			English	Article							MEDIATED APPETITE SUPPRESSION; HYPOTHALAMIC NEUROPEPTIDE-Y; SOLITARY TRACT NUCLEUS; C-FOS EXPRESSION; CATECHOLAMINE NEURONS; INDUCED SATIETY; RATS; ACTIVATION; SEROTONIN; RELEASE	Background Many studies have shown that 5-hydroxytryptamine (5-HT) receptor subtypes are involved in the regulation of feeding behavior. However, the relative contribution of 5-HT3 receptor remains unclear. The present study was aimed to investigate the role of 5-HT3 receptor in control of feeding behavior in fed and fasted mice. Methodology/Principal Findings Food intake and expression of c-Fos, tyrosine hydroxylase (TH), proopiomelanocortin ( POMC) and 5-HT in the brain were examined after acute treatment with 5-HT3 receptor agonist SR-57227 alone or in combination with 5-HT3 receptor antagonist ondansetron. Food intake was significantly inhibited within 3 h after acute treatment with SR 57227 in fasted mice but not fed mice, and this inhibition was blocked by ondansetron. Immunohistochemical study revealed that fasting-induced c-Fos expression was further enhanced by SR 57227 in the brainstem and the hypothalamus, and this enhancement was also blocked by ondansetron. Furthermore, the fasting-induced downregulation of POMC expression in the hypothalamus and the TH expression in the brain stem was blocked by SR 57227 in the fasted mice, and this effect of SR 57227 was also antagonized by ondansetron. Conclusion/Significance Taken together, our findings suggest that the effect of SR 57227 on the control of feeding behavior in fasted mice may be, at least partially, related to the c-Fos expression in hypothalamus and brain stem, as well as POMC system in the hypothalamus and the TH system in the brain stem.	[Li, Bingjin; Luo, Yungang; Zhang, Xingyi; Cui, Ranji] Jilin Univ, Hosp 2, Jilin Prov Key Lab Mol & Chem Genet, Changchun 130024, Peoples R China; [Shao, Dongyuan; Wang, Pu; Liu, Changhong] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun 130024, Peoples R China	Jilin University; Northeast Normal University - China	Cui, RJ (corresponding author), Jilin Univ, Hosp 2, Jilin Prov Key Lab Mol & Chem Genet, Changchun 130024, Peoples R China.	cuiranji@hotmail.com	cui, ranji/AAV-6234-2021		Natural Science Foundation of China [31171123, 31300850, 81328011]; Program for New Century Excellent Talents in University [NCET-13-0715]; Jilin Provincial Department of Human Resources and Social Security Project [[2012]39]; Jilin Science and Technology Agency funding [20110726]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jilin Provincial Department of Human Resources and Social Security Project; Jilin Science and Technology Agency funding	This work was supported by Natural Science Foundation of China (31171123; 31300850; 81328011). The project was supported by Program for New Century Excellent Talents in University (NCET-13-0715); Jilin Provincial Department of Human Resources and Social Security Project ([2012]39); Jilin Science and Technology Agency funding (20110726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript" in the first page of manuscript.	Batterham RL, 2007, NATURE, V450, P106, DOI 10.1038/nature06212; Becskei C, 2008, BRAIN BEHAV IMMUN, V22, P56, DOI 10.1016/j.bbi.2007.06.002; Bedford FK, 1996, HORM RES, V45, P19, DOI 10.1159/000184822; BLUNDELL JE, 1992, AM J CLIN NUTR, V55, P155, DOI 10.1093/ajcn/55.1.155s; Burton-Freeman B, 1999, AM J PHYSIOL-REG I, V276, pR429, DOI 10.1152/ajpregu.1999.276.2.R429; Cui RJ, 2012, J NEUROSCI, V32, P16530, DOI 10.1523/JNEUROSCI.1372-12.2012; Cui RJ, 2011, J NEUROSCI, V31, P3484, DOI 10.1523/JNEUROSCI.3187-10.2011; Daughters RS, 2001, PEPTIDES, V22, P1331, DOI 10.1016/S0196-9781(01)00460-0; DEBOER SF, 1989, PHYSIOL BEHAV, V45, P989, DOI 10.1016/0031-9384(89)90226-6; Depot M, 1999, NEUROPSYCHOPHARMACOL, V20, P177, DOI 10.1016/S0893-133X(98)00074-8; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fetissov SO, 2000, NEUROSCIENCE, V101, P657, DOI 10.1016/S0306-4522(00)00374-2; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; FRIEDMAN E, 1973, LIFE SCI, V12, P317, DOI 10.1016/0024-3205(73)90415-3; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gholipour T, 2010, SEIZURE-EUR J EPILEP, V19, P17, DOI 10.1016/j.seizure.2009.10.006; Hagemann LF, 1998, PHYSIOL BEHAV, V64, P645, DOI 10.1016/S0031-9384(98)00121-8; Hayes MR, 2005, PEPTIDES, V26, P2322, DOI 10.1016/j.peptides.2005.03.045; Hedge S S, 1994, J Pharmacol Exp Ther, V271, P741; Hsieh YS, 2007, BEHAV NEUROSCI, V121, P933, DOI 10.1037/0735-7044.121.5.933; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Janssen P, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01655.x; Kazuyoshi K, 1994, J NEUROPHYSIOL, V71, P1935; Kuo DY, 2012, NEUROPHARMACOLOGY, V63, P842, DOI 10.1016/j.neuropharm.2012.06.018; Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003; Li BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093158; Li BJ, 2014, PROG NEURO-PSYCHOPH, V48, P199, DOI 10.1016/j.pnpbp.2013.08.015; Li BJ, 2013, J BIOCHEM MOL TOXIC, V27, P486, DOI 10.1002/jbt.21510; Li YL, 2009, BRAIN RES, V1268, P181, DOI 10.1016/j.brainres.2009.02.075; Liu L, 2012, J PHARMACOL SCI, V120, P280, DOI 10.1254/jphs.12163FP; Lopez JF, 1997, ANN NY ACAD SCI, V836, P106, DOI 10.1111/j.1749-6632.1997.tb52357.x; Maniscalco JW, 2013, PHYSIOL BEHAV, V121, P35, DOI 10.1016/j.physbeh.2013.01.012; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; Mazda T, 2004, AM J PHYSIOL-GASTR L, V287, pG228, DOI 10.1152/ajpgi.00373.2003; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P4551, DOI 10.1210/en.140.10.4551; Moscarello JM, 2009, BEHAV BRAIN RES, V197, P9, DOI 10.1016/j.bbr.2008.07.025; Roerig B, 1992, J NEUROSCI, V17, P199; Ronde P, 1997, CELL CALCIUM, V22, P357, DOI 10.1016/S0143-4160(97)90020-8; Savastano DM, 2005, AM J PHYSIOL-REG I, V288, pR1499, DOI 10.1152/ajpregu.00745.2004; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Simansky KJ, 1996, BEHAV BRAIN RES, V73, P37, DOI 10.1016/0166-4328(96)00066-6; STACHOWIAK M, 1978, ACTA NEUROBIOL EXP, V38, P157; Sugimoto Y, 1996, EUR J PHARMACOL, V316, P15, DOI 10.1016/S0014-2999(96)00660-7; SUGITA S, 1992, NEURON, V8, P199, DOI 10.1016/0896-6273(92)90121-S; Teubner BJW, 2013, AM J PHYSIOL-REG I, V305, pR323, DOI 10.1152/ajpregu.00097.2013; van Hooft JA, 2000, TRENDS NEUROSCI, V23, P605, DOI 10.1016/S0166-2236(00)01662-3; VANDERHOEK GA, 1994, NEUROPHARMACOLOGY, V33, P805, DOI 10.1016/0028-3908(94)90120-1; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yakel JL, 2000, HANDB EXP PHARM, V147, P541	50	15	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121473	10.1371/journal.pone.0121473	http://dx.doi.org/10.1371/journal.pone.0121473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789930	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400194
J	Tan, AL; Virk, RK; Tambyah, PA; Inoue, M; Lim, EAS; Chan, KW; Chelvi, CS; Ooi, ST; Chua, C; Tan, BH				Tan, Aidan Lyanzhiang; Virk, Ramandeep Kaur; Tambyah, Paul Anantharajah; Inoue, Masafumi; Lim, Elizabeth Ai-Sim; Chan, Ka-Wei; Chelvi, C. Senthamarai; Ooi, Say-Tat; Chua, Catherine; Tan, Boon-Huan			Surveillance and Clinical Characterization of Influenza in a University Cohort in Singapore	PLOS ONE			English	Article							VIRUS; INFECTION; ILLNESS	Background Southeast Asia is a potential locus for the emergence of novel influenza strains. However, information on influenza within the region is limited. Objectives This study was to determine the proportion of influenza-like illness (ILI) caused by influenza A and B viruses in a university cohort in Singapore, identify important distinctive clinical features of influenza infection and potential factors associated with influenza infection compared with other causes of ILI. Methodology A surveillance study was conducted from 2007 to 2009, at the University Health and Wellness Centre, National University of Singapore (NUS). Basic demographic information and nasopharyngeal swabs were collected from consenting students and staff with ILI, with Influenza A and B identified by both culture and molecular methods. Results Proportions of influenza A and B virus infections in subjects with ILI were 153/500 (30.6%) and 11/500 (2.2%) respectively. The predominant subtype was A/H1N1, including both the seasonal strain (20/153) and the pandemic strain (72/153). The clinical symptom of fever was more common in subjects with laboratory confirmed influenza than other ILIs. On-campus hostel residence and being a student (compared with staff) were associated with increased risk of laboratory confirmed influenza A/H1N1 2009 infection. Conclusions This study provides a baseline prevalence of influenza infection within young adults in Singapore in a university setting. Potential risk factors, such as hostel residence, were identified, allowing for more targeted infection control measures in the event of a future influenza pandemic.	[Tan, Aidan Lyanzhiang; Virk, Ramandeep Kaur; Tambyah, Paul Anantharajah; Chelvi, C. Senthamarai] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Inoue, Masafumi] Agcy Sci Technol & Res, Singapore, Singapore; [Lim, Elizabeth Ai-Sim; Chan, Ka-Wei; Tan, Boon-Huan] DSO Natl Labs, Detect & Diagnost Lab, Singapore, Singapore; [Ooi, Say-Tat] Khoo Teck Puat Hosp, Dept Gen Med, Singapore, Singapore; [Chua, Catherine] Natl Univ Singapore, Univ Hlth Ctr, Singapore 117548, Singapore; [Tan, Boon-Huan] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); National University of Singapore; National University of Singapore	Tan, AL (corresponding author), Natl Univ Singapore, Dept Med, Singapore 117548, Singapore.	hi.aidan@gmail.com	Tan, Aidan/R-6346-2019; Tan, Boon Huan/ABB-8381-2021	Tan, Aidan/0000-0003-4081-2209; Tan, Boon Huan/0000-0002-4976-7988	Infectious Diseases Research Fund; NUS-MINDEF JPP grant; Ministry of Defence, Singapore; Biomedical Research Council, Singapore's Agency for Science, Technology and Research (A*STAR)	Infectious Diseases Research Fund; NUS-MINDEF JPP grant; Ministry of Defence, Singapore(Ministry of Defence, Singapore); Biomedical Research Council, Singapore's Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	Funding and support for the work at NUS was by the Infectious Diseases Research Fund and NUS-MINDEF JPP grant. Funding for the work at the DSO National Laboratories was by the Ministry of Defence, Singapore. Funding for the work at the Institute of Molecular and Cell Biology (IMCB) was supported by the Biomedical Research Council, which is part of Singapore's Agency for Science, Technology and Research (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera JF, 2003, EUR J EPIDEMIOL, V18, P751, DOI 10.1023/A:1025337616327; Campbell DS, 1997, J OCCUPATIONAL ENV M, V39; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; DORAISINGHAM S, 1988, B WORLD HEALTH ORGAN, V66, P57; Dwyer DE, 2006, MED J AUSTRALIA, V185, pS48; Eggers M, 2012, EUR J CLIN MICROBIOL, V31, P1257, DOI 10.1007/s10096-011-1437-1; Falcao IM, 1998, J EPIDEMIOL COMMUN H, V52, p39S; Gavin P.J., 2004, CLIN APPL IMMUNOL RE, V4, P151, DOI DOI 10.1016/S1529-1049(03)00064-3; Govaert TM, 1998, FAM PRACT, V15, P15; JOHNSON N, 1991, BRIT MED J, V302, P763, DOI 10.1136/bmj.302.6779.763; Kadri Z N, 1970, Singapore Med J, V11, P30; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; Manuguerra J.C, 2000, Euro Surveill, V5, P63; Mullins J, 2011, J AM COLL HEALTH, V59, P246, DOI 10.1080/07448481.2010.502197; Ng TP, 2002, ANN ACAD MED SINGAP, V31, P182; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Pelletier L, 1999, Can Commun Dis Rep, V25, P185; Seah SGK, 2010, J CLIN VIROL, V47, P289, DOI 10.1016/j.jcv.2009.12.011; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Thomson J, 2000, COMMUNICABLE DIS INT, V24, P145; Virk RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088345	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119485	10.1371/journal.pone.0119485	http://dx.doi.org/10.1371/journal.pone.0119485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790305	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400087
J	Zhou, ZL; Su, YF; Campbell, B; Zhou, ZY; Gao, JM; Yu, Q; Chen, JH; Pan, YS				Zhou, Zhongliang; Su, Yanfang; Campbell, Benjamin; Zhou, Zhiying; Gao, Jianmin; Yu, Qiang; Chen, Jiuhao; Pan, Yishan			The Financial Impact of the 'Zero-Markup Policy for Essential Drugs' on Patients in County Hospitals in Western Rural China	PLOS ONE			English	Article							ESSENTIAL MEDICINES; HEALTH-CARE	Objective With a quasi-experimental design, this study aims to assess whether the Zero-markup Policy for Essential Drugs (ZPED) reduces the medical expense for patients at county hospitals, the major healthcare provider in rural China. Methods Data from Ningshan county hospital and Zhenping county hospital, China, include 2014 outpatient records and 9239 inpatient records. Quantitative methods are employed to evaluate ZPED. Both hospital-data difference-in-differences and individual-data regressions are applied to analyze the data from inpatient and outpatient departments. Results In absolute terms, the total expense per visit reduced by 19.02 CNY (3.12 USD) for outpatient services and 399.6 CNY (65.60 USD) for inpatient services. In relative terms, the expense per visit was reduced by 11% for both outpatient and inpatient services. Due to the reduction of inpatient expense, the estimated reduction of outpatient visits is 2% among the general population and 3.39% among users of outpatient services. The drug expense per visit dropped by 27.20 CNY (4.47 USD) for outpatient services and 278.7 CNY (45.75 USD) for inpatient services. The proportion of drug expense out of total expense per visit dropped by 11.73 percentage points in outpatient visits and by 3.92 percentage points in inpatient visits. Conclusion Implementation of ZPED is a benefit for patients in both absolute and relative terms. The absolute monetary reduction of the per-visit inpatient expense is 20 times of that in outpatient care. According to cross-price elasticity, the substitution between inpatient and outpatient due to the change in inpatient price is small. Furthermore, given that the relative reductions are the same for outpatient and inpatient visits, according to relative thinking theory, the incentive to utilize outpatient or inpatient care attributed to ZPED is equivalent, regardless of the 20-times price difference in absolute terms.	[Zhou, Zhongliang; Gao, Jianmin] Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian 710049, Peoples R China; [Su, Yanfang] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Campbell, Benjamin] Bryn Mawr Coll, Bryn Mawr, PA USA; [Zhou, Zhiying] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Xian 710049, Peoples R China; [Yu, Qiang] Ankang Municipal Dev & Reform Commiss, Ankang, Peoples R China; [Chen, Jiuhao] Ningshan Cty Hosp, Ankang, Shaanxi, Peoples R China; [Pan, Yishan] Zhenping Cty Hosp, Ankang, Shaanxi, Peoples R China	Xi'an Jiaotong University; Harvard University; Harvard T.H. Chan School of Public Health; Bryn Mawr College; Xi'an Jiaotong University	Su, YF (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	yanfangsu@mail.harvard.edu	Pan, Yi/AAJ-2341-2021	Su, Yanfang/0000-0001-7557-8518	National Natural Science Fund of China [71203177]; Shaanxi Social Science Fund [12Q036]; China Medical Board (CMB)	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Shaanxi Social Science Fund; China Medical Board (CMB)	This study was funded by National Natural Science Fund of China (Serial number: 71203177), Shaanxi Social Science Fund (Serial number: 12Q036) and China Medical Board (CMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Azar O.H., 2007, J SOCIO-ECON, V36, P1, DOI [10.1016/j.socec.2005.12.014, DOI 10.1016/J.SOCEC.2005.12.014]; Center for Health Statistics and Information National Health and Family Planning Commission, 2009, AN REP NAT HLTH SERV; Chen M, 2013, CHINESE HLTH RESOURC, V16, P93; Chen YBB, 2013, CHINESE J HLTH POLIC, V6, P34; Craig SR, 2009, SOC SCI MED, V69, P1681, DOI 10.1016/j.socscimed.2009.08.024; Eggleston K, 2012, MILKEN I REV; Geest Sjaak van der, 1996, ANNU REV ANTHROPOL, V25, P153; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; He P, 2011, CHINESE J HLTH POLIC, V4, P11; Hogerzeil HV, 2004, BRIT MED J, V329, P1169, DOI 10.1136/bmj.329.7475.1169; Hu J, 2007, CHIN J PREVCONTRCHRO, V15, P189; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; Lee J.W., 2000, FRAMEWORK R D EVALUA; Li L, 2008, CHINESE HLTH EC, V27, P41; Ministry of Health, 2011, STAT B CHIN HLTH SER; Nichter M., 2008, GLOBAL HLTH WHY CULT; Petryna A., 2006, GLOBAL PHARM ETHICS; Potter W, 2009, HLTH CARE IND VS HLT; Ratanawijitrasin S, 2001, SOC SCI MED, V53, P831, DOI 10.1016/S0277-9536(00)00390-7; Shen R, 2013, CHINESE HOSP, V17, P62; [石亚丽 Shi Yali], 2013, [中国药房, China Pharmacy], V24, P300; Song Y, 2012, CHINESE HLTH SERVICE, V8, P586; Song Yan, 2014, J Pharm Policy Pract, V7, P12, DOI 10.1186/2052-3211-7-12; Sun Q, 2012, CHINESE HLTH EC, V31, P65, DOI [10.1016/j.clnu.2011.08.009, DOI 10.1016/J.CLNU.2011.08.009]; Sussmuth-Dyckerhoff C., 2010, HLTH INT, V10, P55; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wang H, 2012, CHINESE J HLTH POLIC, V5, P30; Wang J, 2013, CHINA PHARM, V23, P2982, DOI DOI 10.6039/J.ISSN.1001-0408.2012.32.03; WHO, 1988, DEV IMPL NAT DRUG PO; Whyte S., 2003, SOCIAL LIVES MED; Wooldridge J., 2005, INTRO ECONOMETRICS M, V3; Yang LP, 2013, HEALTH POLICY PLANN, V28, P750, DOI 10.1093/heapol/czs116; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066; [周忠良 Zhou Zhongliang], 2013, [中国卫生政策研究, Chinese Journal of Health Policy], V6, P25; Zhou ZL, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-34; Zhou ZL, 2011, HEALTH POLICY, V103, P255, DOI 10.1016/j.healthpol.2011.09.005; Zhou ZL, 2015, J ASIAN PUBLIC POLIC	38	25	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121630	10.1371/journal.pone.0121630	http://dx.doi.org/10.1371/journal.pone.0121630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25790443	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400199
J	Choi, JA; Jung, YS; Kim, JY; Kim, HM; Lim, IK				Choi, J-A; Jung, Y. S.; Kim, J. Y.; Kim, H. M.; Lim, I. K.			Inhibition of breast cancer invasion by TIS21(/BTG2/Pc3)-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes	ONCOGENE			English	Article							DIAPHANOUS-RELATED FORMINS; CELL-MIGRATION; INVADOPODIA FORMATION; TRANSCRIPTION FACTOR; TUMOR PROGRESSION; BTG2 EXPRESSION; DOWN-REGULATION; AKT ISOFORMS; PROTEIN; ACTIVATION	The mammalian homolog of Drosophila diaphanous (mDia), actin nucleator, has been known to participate in the process of invasion and metastasis of cancer cells via regulating a number of actin-related biological processes. We have previously reported that tumor suppressor TIS21(/BTG2/Pc3) (TIS21) inhibits invadopodia formation by downregulating reactive oxygen species (ROS) in MDA-MB-231 cells. We herein report that TIS21(/BTG2/Pc3) downregulates diaphanous-related formin (DRF) expression via reducing NADPH oxidase 4 (Nox4)-derived ROS generation by Akt1 activation and subsequently impairs invasion activity of the highly invasive breast cancer cells. Knockdown of Akt1 by RNA interference recovered the TIS21(/BTG2/Pc3)-inhibited F-actin remodeling and ROS generation by recovering Nox4 expression. Furthermore, Sp1-mediated Nox4 transcription was downregulated by TIS21(/BTG2/Pc3)-Akt1 signals, leading to the inhibition of cancer cell invasion via F-actin remodeling by mDia genes. To our best knowledge, this is the first study to show that TIS21(/BTG2/Pc3)-Akt1 inhibited Sp1-Nox4-ROS cascade, subsequently reducing invasion activity via inhibition of mDia family genes.	[Choi, J-A; Lim, I. K.] Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443380, South Korea; [Choi, J-A; Lim, I. K.] Ajou Univ, Grad Sch Med, Dept Biomed Sci, Suwon 443380, South Korea; [Jung, Y. S.; Kim, J. Y.] Ajou Univ, Sch Med, Dept Surg, Suwon 443380, South Korea; [Kim, H. M.] Ajou Univ, Dept Energy Syst Res, Suwon 443380, South Korea	Ajou University; Ajou University; Ajou University; Ajou University	Lim, IK (corresponding author), Ajou Univ, Sch Med, Dept Biochem & Mol Biol, San 5, Suwon 443380, South Korea.	iklim@ajou.ac.kr	Jung, Yongsik/ABH-9311-2020	Jung, Yongsik/0000-0002-2011-1459	Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A121725]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [131280]	Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	Authors greatly appreciate Professor Young-Joon Chwae for his kind help in lucigenin-enhanced chemiluminescence assay, excellent advice for statistical analysis by Professor Seung-Soo Sheen, technical help for two-photon fluorescence microscopy by Cheol Ho Heo and careful reading of this manuscript by Professor Woon Ki Paik at Ajou University School of Medicine. This work was supported by a grant of the Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A121725) and a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (131280).	Arboleda MJ, 2003, CANCER RES, V63, P196; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Buganim Y, 2010, CANCER RES, V70, P2274, DOI 10.1158/0008-5472.CAN-09-2661; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Choi JA, 2013, J CANCER RES CLIN, V139, P1657, DOI 10.1007/s00432-013-1484-3; Choi JA, 2010, CARCINOGENESIS, V31, P543, DOI 10.1093/carcin/bgp203; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Coppola V, 2013, ONCOGENE, V32, P1843, DOI 10.1038/onc.2012.194; Devanand P, 2014, FEBS J, V281, P5581, DOI 10.1111/febs.13099; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Grabinski N, 2011, CELL SIGNAL, V23, P1952, DOI 10.1016/j.cellsig.2011.07.003; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Hong JW, 2005, J BIOL CHEM, V280, P21256, DOI 10.1074/jbc.M500318200; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Imran M, 2013, CELL SIGNAL, V25, P2400, DOI 10.1016/j.cellsig.2013.07.015; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Katsuyama M, 2011, FEBS J, V278, P964, DOI 10.1111/j.1742-4658.2011.08018.x; Kawakubo H, 2004, ONCOGENE, V23, P8310, DOI 10.1038/sj.onc.1208008; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Kim BC, 2008, STEM CELLS, V26, P2339, DOI 10.1634/stemcells.2008-0327; Kim EY, 2010, FREE RADICAL BIO MED, V49, P1072, DOI 10.1016/j.freeradbiomed.2010.06.023; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; LIM IK, 1995, J CANCER RES CLIN, V121, P279, DOI 10.1007/BF01209594; Lim IK, 1998, MOL CARCINOGEN, V23, P25, DOI 10.1002/(SICI)1098-2744(199809)23:1<25::AID-MC4>3.0.CO;2-G; Lim SK, 2012, CLIN EXP METASTAS, V29, P901, DOI 10.1007/s10585-012-9479-z; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Matheny RW, 2010, CELL DEATH DIFFER, V17, P677, DOI 10.1038/cdd.2009.150; Melamed J, 2002, TISSUE CELL, V34, P28, DOI 10.1054/tice.2001.0220; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Park TJ, 2008, HEPATOLOGY, V47, P1533, DOI 10.1002/hep.22212; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Saji M, 2011, ONCOGENE, V30, P4307, DOI 10.1038/onc.2011.136; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Solomon H, 2012, J CELL SCI, V125, P3144, DOI 10.1242/jcs.099663; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Sundaramoorthy S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-69; Takahashi F, 2011, ONCOGENE, V30, P3084, DOI 10.1038/onc.2011.24; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Xing H, 2007, ONCOL REP, V17, P117; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhang L, 2008, FREE RADICAL BIO MED, V45, P679, DOI 10.1016/j.freeradbiomed.2008.05.019	70	33	34	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2016	35	1					83	93		10.1038/onc.2015.64	http://dx.doi.org/10.1038/onc.2015.64			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DA4ZT	25798836				2022-12-26	WOS:000367812400008
J	Ma, N; Shan, YL; Liao, BJ; Kong, GY; Wang, C; Huang, K; Zhang, H; Cai, XJ; Chen, SB; Pei, DQ; Chen, NS; Pan, GJ				Ma, Ning; Shan, Yongli; Liao, Baojian; Kong, Guanyi; Wang, Cheng; Huang, Ke; Zhang, Hui; Cai, Xiujuan; Chen, Shubin; Pei, Duanqing; Chen, Nansheng; Pan, Guangjin			Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in -Thalassemia Induced Pluripotent Stem Cells (iPSCs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Therapy; Genomic Instability; Genomics; Induced Pluripotent Stem Cell (iPS Cell) (iPSC); Reprogramming	COPY NUMBER; MUTATIONS; CLONES; SKIN	Background: Genome alterations need to be investigated before clinical application of iPS cells. Results: Reprogramming and gene targeting can generate substantial but different genomic variations. Conclusion: Stringent genomic monitoring and selection are needed both at the time of iPSC derivation and after gene targeting. Significance: This study examined the genome instability during iPSC generation and subsequent gene correction and revealed different genome alterations at each step. The generation of personalized induced pluripotent stem cells (iPSCs) followed by targeted genome editing provides an opportunity for developing customized effective cellular therapies for genetic disorders. However, it is critical to ascertain whether edited iPSCs harbor unfavorable genomic variations before their clinical application. To examine the mutation status of the edited iPSC genome and trace the origin of possible mutations at different steps, we have generated virus-free iPSCs from amniotic cells carrying homozygous point mutations in -hemoglobin gene (HBB) that cause severe -thalassemia (-Thal), corrected the mutations in both HBB alleles by zinc finger nuclease-aided gene targeting, and obtained the final HBB gene-corrected iPSCs by excising the exogenous drug resistance gene with Cre recombinase. Through comparative genomic hybridization and whole-exome sequencing, we uncovered seven copy number variations, five small insertions/deletions, and 64 single nucleotide variations (SNVs) in -Thal iPSCs before the gene targeting step and found a single small copy number variation, 19 insertions/deletions, and 340 single nucleotide variations in the final gene-corrected -Thal iPSCs. Our data revealed that substantial but different genomic variations occurred at factor-induced somatic cell reprogramming and zinc finger nuclease-aided gene targeting steps, suggesting that stringent genomic monitoring and selection are needed both at the time of iPSC derivation and after gene targeting.	[Ma, Ning; Shan, Yongli; Liao, Baojian; Huang, Ke; Zhang, Hui; Cai, Xiujuan; Chen, Shubin; Pei, Duanqing; Pan, Guangjin] Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Peoples R China; [Kong, Guanyi; Wang, Cheng] Wuhan Frasergen Bioinformat Co Ltd, Wuhan 430075, Peoples R China; [Chen, Nansheng] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Simon Fraser University	Chen, NS (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	chenn@sfu.ca; pan_guangjin@gibh.ac.cn	Liao, Baojian/AAI-6286-2021	Pan, Guangjin/0000-0002-2378-7198	National Basic Research Program of China; 973 Program of China [2012CB966503]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01020202]; National Scientific and Technological Major Special Project on Major New Drug Innovation [2011ZX09102-010]; National Natural Science Foundation of China [31200970]; "Hundred Talents Program" of the Chinese Academy of Sciences; "Youth Innovation Promotion Association of the Chinese Academy of Sciences"; "Pearl River Nova program"; Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN/328095-2014]; International Science and Technology Cooperation Program of China [2014DFA30180]	National Basic Research Program of China(National Basic Research Program of China); 973 Program of China(National Basic Research Program of China); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Scientific and Technological Major Special Project on Major New Drug Innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Hundred Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); "Youth Innovation Promotion Association of the Chinese Academy of Sciences"; "Pearl River Nova program"; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); International Science and Technology Cooperation Program of China	This work was supported by the National Basic Research Program of China, 973 Program of China (Grant 2012CB966503), "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant XDA01020202), National Scientific and Technological Major Special Project on Major New Drug Innovation (Grant 2011ZX09102-010), National Natural Science Foundation of China (Grant 31200970), "Hundred Talents Program" of the Chinese Academy of Sciences (to G. P.), "Youth Innovation Promotion Association of the Chinese Academy of Sciences," "Pearl River Nova program" (to B. L.), Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant (RGPIN/328095-2014, to N. C.), and International Science and Technology Cooperation Program of China (Grant 2014DFA30180).	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Chen YL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-79; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Martin A, 2013, PEDIATR CLIN N AM, V60, P1383, DOI 10.1016/j.pcl.2013.08.008; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Olivieri NF, 1999, NEW ENGL J MED, V341, P99, DOI 10.1056/NEJM199907083410207; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Tsai SQ, 2014, CELL STEM CELL, V15, P3, DOI 10.1016/j.stem.2014.06.017; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang YX, 2012, CELL RES, V22, P637, DOI 10.1038/cr.2012.23; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573	25	22	22	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12079	12089		10.1074/jbc.M114.624999	http://dx.doi.org/10.1074/jbc.M114.624999			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25795783	hybrid, Green Published			2022-12-26	WOS:000354388600023
J	Benito-Calvo, A; Carvalho, S; Arroyo, A; Matsuzawa, T; de la Torre, I				Benito-Calvo, Alfonso; Carvalho, Susana; Arroyo, Adrian; Matsuzawa, Tetsuro; de la Torre, Ignacio			First GIS Analysis of Modern Stone Tools Used by Wild Chimpanzees (Pan troglodytes verus) in Bossou, Guinea, West Africa	PLOS ONE			English	Article							NUT CRACKING; APES VIEW; OLDOWAN; SITE; ARCHAEOLOGY; TECHNOLOGY; HOMINIDS; ECOLOGY; ORIGINS	Stone tool use by wild chimpanzees of West Africa offers a unique opportunity to explore the evolutionary roots of technology during human evolution. However, detailed analyses of chimpanzee stone artifacts are still lacking, thus precluding a comparison with the earliest archaeological record. This paper presents the first systematic study of stone tools used by wild chimpanzees to crack open nuts in Bossou (Guinea-Conakry), and applies pioneering analytical techniques to such artifacts. Automatic morphometric GIS classification enabled to create maps of use wear over the stone tools (anvils, hammers, and hammers/anvils), which were blind tested with GIS spatial analysis of damage patterns identified visually. Our analysis shows that chimpanzee stone tool use wear can be systematized and specific damage patterns discerned, allowing to discriminate between active and passive pounders in lithic assemblages. In summary, our results demonstrate the heuristic potential of combined suites of GIS techniques for the analysis of battered artifacts, and have enabled creating a referential framework of analysis in which wild chimpanzee battered tools can for the first time be directly compared to the early archaeological record.	[Benito-Calvo, Alfonso] CENIEH, Lab Digital Mapping & Anal 3D, Burgos, Spain; [Carvalho, Susana] George Washington Univ, Ctr Adv Study Human Paleobiol, Washington, DC USA; [Carvalho, Susana] Univ Algarve, Interdisciplinary Ctr Archaeol & Evolut Human Beh, Faro, Portugal; [Arroyo, Adrian; de la Torre, Ignacio] UCL, Inst Archaeol, London, England; [Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Sect Language & Intelligence, Kyoto 6068501, Japan	Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); George Washington University; Universidade do Algarve; University of London; University College London; Kyoto University	Benito-Calvo, A (corresponding author), CENIEH, Lab Digital Mapping & Anal 3D, Burgos, Spain.	alfonso.benito@cenieh.es; scarvalho@email.gwu.edu	Benito-Calvo, Alfonso/G-3897-2015; Matsuzawa, Tetsuro/ABE-9654-2021; Arroyo, Adrian/I-1522-2019	Benito-Calvo, Alfonso/0000-0002-6363-1753; Matsuzawa, Tetsuro/0000-0002-8147-2725; Arroyo, Adrian/0000-0002-5850-0847; de la Torre, Ignacio/0000-0002-1805-634X; Carvalho, Susana/0000-0003-4542-3720	Leverhulme Trust [IN-052]; MEXT [20002001, 24000001]; JSPS-U04-PWS; FCT-Portugal [SFRH/BD/36169/2007]; Wenner-Gren Foundation for Anthropological Research	Leverhulme Trust(Leverhulme Trust); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS-U04-PWS; FCT-Portugal(Portuguese Foundation for Science and Technology); Wenner-Gren Foundation for Anthropological Research	Funding: Funding by the Leverhulme Trust (IN-052) is gratefully acknowledged. The research in Guinea was supported by a MEXT grant #20002001 and #24000001, JSPS-U04-PWS to TM, FCT-Portugal (SFRH/BD/36169/2007), and a Dissertation Fieldwork Grant from the Wenner-Gren Foundation for Anthropological Research to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman K., 1975, OCCASIONAL PAPERS AN, V4; Benito-Calvo A, 2009, EARTH SURF PROC LAND, V34, P1433, DOI 10.1002/esp.1840; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Biro D, 2010, MIND CHIMPANZEE ECOL, P128; Boesch C, 2012, COMP CHIMPANZEE HUMA; BOESCH C, 2000, BEHAV ECOLOGY EVOLUT; Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Caruana MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113856; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2012, STONE TOOLS AND FOSSIL BONES: DEBATES IN THE ARCHAEOLOGY OF HUMAN ORIGINS, P201; Carvalho S, 2012, CURR BIOL, V22, pR180, DOI 10.1016/j.cub.2012.01.052; Carvalho S, 2009, ANIM COGN, V12, pS103, DOI 10.1007/s10071-009-0271-7; De Beaune S, 1989, GALLIA PREHISTOIRE, V31, P27, DOI DOI 10.3406/GALIP.1989.2264; de Beaune SA, 1997, GALTS UTILISES PALEO; de Beaune SA, 2000, ARCHAEOLOGIE GESTE B; de Heinzelin J, 1999, SCIENCE, V284, P625; de la Torre I, 2013, J ARCHAEOL SCI, V40, P313, DOI 10.1016/j.jas.2012.08.007; de la Torre I, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P45; Dikau R., 1989, 3 DIMENSIONAL APPL G, V1st, P51, DOI 10.1201/9781003069454-5; Dubreuil L, 2014, J ARCHAEOL SCI, V48, P139, DOI 10.1016/j.jas.2013.06.023; Foley R, 2009, PHILOS T R SOC B, V364, P3267, DOI 10.1098/rstb.2009.0136; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Haslam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072872; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hengl T, 2009, DEV SOIL SCI, V33, P1; Hobson R., 2019, SPATIAL ANAL GEOMORP, P221; Iwahashi J, 2007, GEOMORPHOLOGY, V86, P409, DOI 10.1016/j.geomorph.2006.09.012; Jones P.R., 1994, OLDUVAI GORGE, P254; JOULIAN F, 1996, MODELLING EARLY HUMA, P173; KLINKENBERG B, 1992, GEOMORPHOLOGY, V5, P5, DOI 10.1016/0169-555X(92)90055-S; Koops K, 2013, ANIM BEHAV, V85, P175, DOI 10.1016/j.anbehav.2012.10.022; KORTLANDT A, 1986, J HUM EVOL, V15, P77, DOI 10.1016/S0047-2484(86)80068-9; Lovejoy CO, 2010, SCIENCE, V327, P410, DOI 10.1126/science.327.5964.410-b; Matsuzawa T, 2011, PRIMATOL MONOGR, P1, DOI 10.1007/978-4-431-53921-6; Matsuzawa Tetsuro, 1994, P351; McGrew WC, 2010, PHILOS T R SOC B, V365, P3267, DOI 10.1098/rstb.2010.0067; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mcgrew WC, 2014, LITHIC TECHNOL, V39, P113, DOI 10.1179/0197726114Z.00000000037; McGrew WC, 2010, SCIENCE, V328, P579, DOI 10.1126/science.1187921; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Mercader J, 2002, SCIENCE, V296, P1452, DOI 10.1126/science.1070268; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Miliaresis GC, 2009, CAN J REMOTE SENS, V35, P385, DOI 10.5589/m09-027; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Gilabert XR, 2012, J ARCHAEOL SCI, V39, P1587, DOI 10.1016/j.jas.2011.12.017; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Schick KD, 1999, J ARCHAEOL SCI, V26, P821, DOI 10.1006/jasc.1998.0350; Smith MW, 2014, EARTH-SCI REV, V136, P202, DOI 10.1016/j.earscirev.2014.05.016; Stemp WJ, 2013, SCANNING, V35, P28, DOI 10.1002/sca.21032; Stewart FA, 2011, J HUM EVOL, V61, P388, DOI 10.1016/j.jhevol.2011.05.005; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; SUGIYAMA Y, 1981, Primates, V22, P435, DOI 10.1007/BF02381236; Toth N, 2009, ANNU REV ANTHROPOL, V38, P289, DOI 10.1146/annurev-anthro-091908-164521; Visalberghi E, 2008, AM J PRIMATOL, V70, P884, DOI 10.1002/ajp.20578; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wieczorek M, 2014, GEOMORPHOLOGY, V206, P133, DOI 10.1016/j.geomorph.2013.10.005; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; WRIGHT KI, 1994, AM ANTIQUITY, V59, P238, DOI 10.2307/281929; WYNN T, 1989, MAN, V24, P383, DOI 10.2307/2802697; Wynn T, 2011, EVOL ANTHROPOL, V20, P181, DOI 10.1002/evan.20323; Yamakoshi G, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P537	63	41	42	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121613	10.1371/journal.pone.0121613	http://dx.doi.org/10.1371/journal.pone.0121613			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793642	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900141
J	Chen, JY; Tibroni, N; Sauter, D; Galaski, J; Miura, T; Alter, G; Mueller, B; Haller, C; Walker, BD; Kirchhoff, F; Brumme, ZL; Ueno, T; Fackler, OT				Chen, Jingyan; Tibroni, Nadine; Sauter, Daniel; Galaski, Johanna; Miura, Toshiyuki; Alter, Galit; Mueller, Birthe; Haller, Claudia; Walker, Bruce D.; Kirchhoff, Frank; Brumme, Zabrina L.; Ueno, Takamasa; Fackler, Oliver T.			Modest Attenuation of HIV-1 Vpu Alleles Derived from Elite Controller Plasma	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NK CELL-FUNCTION; PARTICLE RELEASE; TETHERIN ANTAGONISM; BETA-TRCP; HLA-C; RESTRICTION; PROTEIN; DEGRADATION; EXPRESSION	In the absence of antiretroviral therapy, infection with human immunodeficiency virus type 1 (HIV-1) can typically not be controlled by the infected host and results in the development of acquired immunodeficiency. In rare cases, however, patients spontaneously control HIV-1 replication. Mechanisms by which such elite controllers (ECs) achieve control of HIV-1 replication include particularly efficient immune responses as well as reduced fitness of the specific virus strains. To address whether polymorphisms in the accessory HIV-1 protein Vpu are associated with EC status we functionally analyzed a panel of plasma-derived vpu alleles from 15 EC and 16 chronic progressor (CP) patients. Antagonism of the HIV particle release restriction by the intrinsic immunity factor CD317/tetherin was well conserved among EC and CP Vpu alleles, underscoring the selective advantage of this Vpu function in HIV-1 infected individuals. In contrast, interference with CD317/tetherin induced NF-kappa B activation was little conserved in both groups. EC Vpus more frequently displayed reduced ability to downregulate cell surface levels of CD4 and MHC class I (MHC-I) molecules as well as of the NK cell ligand NTB-A. Polymorphisms potentially associated with high affinity interactions of the inhibitory killer immunoglobulin-like receptor (KIR) KIR2DL2 were significantly enriched among EC Vpus but did not account for these functional differences. Together these results suggest that in a subgroup of EC patients, some Vpu functions are modestly reduced, possibly as a result of host selection.	[Chen, Jingyan; Tibroni, Nadine; Galaski, Johanna; Mueller, Birthe; Haller, Claudia; Fackler, Oliver T.] Univ Heidelberg Hosp, Integrat Virol, Dept Infect Dis, Heidelberg, Germany; [Chen, Jingyan; Tibroni, Nadine; Galaski, Johanna; Mueller, Birthe; Haller, Claudia; Fackler, Oliver T.] Heidelberg Univ, German Ctr Infect Res, Heidelberg, Germany; [Sauter, Daniel; Kirchhoff, Frank] Univ Ulm, Inst Mol Virol, Med Ctr, D-89069 Ulm, Germany; [Miura, Toshiyuki] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Alter, Galit; Walker, Bruce D.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Alter, Galit; Walker, Bruce D.] Harvard Univ, Boston, MA USA; [Walker, Bruce D.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Brumme, Zabrina L.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Ueno, Takamasa] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Ueno, Takamasa] Kumamoto Univ, Int Res Ctr Med Sci IRCMS, Kumamoto 860, Japan	Ruprecht Karls University Heidelberg; German Center for Infection Research; Ruprecht Karls University Heidelberg; Ulm University; Nagasaki University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; Kumamoto University; Kumamoto University	Fackler, OT (corresponding author), Univ Heidelberg Hosp, Integrat Virol, Dept Infect Dis, INF 324, Heidelberg, Germany.	oliver.fackler@med.uni-heidelberg.de	Kirchhoff, Frank/O-8367-2018; Ueno, Takamasa/AAW-9491-2020; Ueno, Takamasa/F-5788-2013	Kirchhoff, Frank/0000-0002-7052-2360; Ueno, Takamasa/0000-0003-4852-4236; Ueno, Takamasa/0000-0003-4852-4236; Brumme, Zabrina/0000-0002-8157-1037; Fackler, Oliver Till/0000-0003-2982-4209	German Center for Infection Research [8.2 TTU HIV]; German Center for Infection Research (MD student fellowship); Deutsche Forschungsgemeinschaft; Ministry of Education, Science, Sports, and Culture of Japan; Ministry of Health, Labor, and Welfare of Japan	German Center for Infection Research; German Center for Infection Research (MD student fellowship); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the German Center for Infection Research (project 8.2 TTU HIV to OTF and MD student fellowship to JG), the Deutsche Forschungsgemeinschaft (grants to OTF, DS and FK) and grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan and the Ministry of Health, Labor, and Welfare of Japan (to TU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2002, AIDS, V16, P1071, DOI 10.1097/00002030-200205030-00015; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Alvarez RA, 2014, J VIROL, V88, P6031, DOI 10.1128/JVI.00449-14; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Arias JF, 2014, P NATL ACAD SCI USA, V111, P6425, DOI 10.1073/pnas.1321507111; Bolduan S, 2013, VIROLOGY, V440, P190, DOI 10.1016/j.virol.2013.02.021; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Cerboni C, 2007, J GEN VIROL, V88, P242, DOI 10.1099/vir.0.82125-0; CRISE B, 1990, J VIROL, V64, P5585, DOI 10.1128/JVI.64.11.5585-5593.1990; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Estrabaud E, 2007, PLOS PATHOG, V3, P995, DOI 10.1371/journal.ppat.0030104; Fadda L, 2011, ADV EXP MED BIOL, V780, P27, DOI 10.1007/978-1-4419-5632-3_3; Fausther-Bovendo H, 2009, AIDS, V23, P1077, DOI 10.1097/QAD.0b013e32832cb26b; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Fritz JV, 2012, VIROLOGY, V424, P33, DOI 10.1016/j.virol.2011.12.008; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatziioannou T, 2014, SCIENCE, V344, P1401, DOI 10.1126/science.1250761; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hotter D, 2013, J VIROL, V87, P7160, DOI 10.1128/JVI.00526-13; Jafari M, 2014, J VIROL, V88, P5062, DOI 10.1128/JVI.03472-13; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Kerkau T, 1997, J EXP MED, V185, P1295, DOI 10.1084/jem.185.7.1295; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kluge SF, 2014, CELL HOST MICROBE, V16, P639, DOI 10.1016/j.chom.2014.10.002; Kueck T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002609; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Lobritz MA, 2011, CURR OPIN HIV AIDS, V6, P214, DOI 10.1097/COH.0b013e3283454cf5; Majumder B, 2008, J VIROL, V82, P7189, DOI 10.1128/JVI.01979-07; McNatt MW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003299; Medina-Ramirez M, 2011, J VIROL, V85, P5804, DOI 10.1128/JVI.02482-10; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Mwimanzi P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-1; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Pickering S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003895; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rollason R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075680; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sauter D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-85; Sauter D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003093; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Tervo HM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-9; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Thorn M, 2007, APMIS, V115, P757, DOI 10.1111/j.1600-0463.2007.apm_595.x; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Venkatesh S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003483; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; Walker BD, 2007, TOP HIV MED, V15, P134; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wren LH, 2013, IMMUNOLOGY, V138, P116, DOI 10.1111/imm.12016; Zhai S, 2008, CURR HIV RES, V6, P335, DOI 10.2174/157016208785132473	66	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120434	10.1371/journal.pone.0120434	http://dx.doi.org/10.1371/journal.pone.0120434			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793728	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900034
J	Kuley, R; Smith, HE; Frangoulidis, D; Smits, MA; Roest, HIJ; Bossers, A				Kuley, Runa; Smith, Hilde E.; Frangoulidis, Dimitrios; Smits, Mari A.; Roest, Hendrik I. Jan; Bossers, Alex			Cell-Free Propagation of Coxiella burnetii Does Not Affect Its Relative Virulence	PLOS ONE			English	Article							REAL-TIME PCR; Q-FEVER; ETHIDIUM MONOAZIDE; PHASE-II; PROPIDIUM MONOAZIDE; DEAD CELLS; T-CELLS; LIPOPOLYSACCHARIDE; INFECTION; STRAINS	Q fever is caused by the obligate intracellular bacterium Coxiella burnetii. In vitro growth of the bacterium is usually limited to viable eukaryotic host cells imposing experimental constraints for molecular studies, such as the identification and characterisation of major virulence factors. Studies of pathogenicity may benefit from the recent development of an extracellular growth medium for C. burnetii. However, it is crucial to investigate the consistency of the virulence phenotype of strains propagated by the two fundamentally different culturing systems. In the present study, we assessed the viability of C. burnetii and the lipopolysaccaride (LPS) encoding region of the bacteria in both culture systems as indirect but key parameters to the infection potential of C. burnetii. Propidium monoazide (PMA) treatment-based real-time PCR was used for enumeration of viable C. burnetii which were validated by fluorescent infectious focus forming unit counting assays. Furthermore, RNA isolated from C. burnetiipropagated in both the culture systems was examined for LPS-related gene expression. All thus far known LPS-related genes were found to be expressed in early passages in both culturing systems indicating the presence of predominantly the phase I form of C. burnetii. Finally, we used immune-competent mice to provide direct evidence, that the relative virulence of different C. burnetii strains is essentially the same for both axenic and cell-based methods of propagation.	[Kuley, Runa; Smith, Hilde E.; Smits, Mari A.; Bossers, Alex] Wageningen UR, Cent Vet Inst, Dept Infect Biol, Lelystad, Netherlands; [Roest, Hendrik I. Jan] Wageningen UR, Cent Vet Inst, Dept Bacteriol, Lelystad, Netherlands; [Roest, Hendrik I. Jan] Wageningen UR, Cent Vet Inst, TSEs, Lelystad, Netherlands; [Kuley, Runa; Smits, Mari A.] Wageningen Univ, Host Microbe Interact, NL-6700 AP Wageningen, Netherlands; [Frangoulidis, Dimitrios] Bundeswehr Inst Microbiol, Munich, Germany	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Bundeswehr Institute of Microbiology (IMB)	Bossers, A (corresponding author), Wageningen UR, Cent Vet Inst, Dept Infect Biol, Lelystad, Netherlands.	alex.bossers@wur.nl	smits, mari/J-4892-2013; Bossers, Alex/AAA-6025-2021; Bossers, Alex/F-7757-2019	smits, mari/0000-0002-3493-291X; Bossers, Alex/0000-0002-6586-717X; Bossers, Alex/0000-0002-6586-717X	Dutch Ministry of Economic Affairs [01-002-005.05]; Netherlands Organisation for Health Research and Development [205520009]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Funding: This work was supported by the Dutch Ministry of Economic Affairs [01-002-005.05] http://www.government.nl/ministries/ez and The Netherlands Organisation for Health Research and Development [205520009] http://www.zonmw.nl/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Yanez MA, 2011, J MICROBIOL METH, V85, P124, DOI 10.1016/j.mimet.2011.02.004; AMANO KI, 1984, J BACTERIOL, V160, P982, DOI 10.1128/JB.160.3.982-988.1984; Andoh M, 2007, INFECT IMMUN, V75, P3245, DOI 10.1128/IAI.01767-06; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; BACA OG, 1980, CAN J MICROBIOL, V26, P819, DOI 10.1139/m80-141; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Beare PA, 2012, APPL ENVIRON MICROB, V78, P4580, DOI 10.1128/AEM.00881-12; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Beare PA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00097; Beare PA, 2009, J BACTERIOL, V191, P1369, DOI 10.1128/JB.01580-08; Bouvery NA, 2003, VET RES, V34, P423, DOI 10.1051/vetres:2003017; Brennan RE, 2003, J CLIN MICROBIOL, V41, P1869, DOI 10.1128/JCM.41.5.1869-1874.2003; BUZONIGATEL D, 1983, ANN INST PASTEUR MIC, VA134, P91, DOI 10.1016/0769-2609(83)90107-2; Cawthorn DM, 2008, J APPL MICROBIOL, V105, P1178, DOI 10.1111/j.1365-2672.2008.03851.x; Denison AM, 2007, FEMS MICROBIOL LETT, V267, P102, DOI 10.1111/j.1574-6968.2006.00544.x; Enserink M, 2010, SCIENCE, V327, P266, DOI [10.1126/science.327.5963.266-a, 10.1126/science.327.5963.266-b]; Hoover TA, 2002, INFECT IMMUN, V70, P6726, DOI 10.1128/IAI.70.12.6726-2733.2002; Howe D, 2002, INFECT IMMUN, V70, P5140, DOI 10.1128/IAI.70.9.5140-5147.2002; Kampschreur LM, 2013, EPIDEMIOL INFECT, V141, P847, DOI 10.1017/S0950268812001203; KAZAR J, 1993, ACTA VIROL, V37, P437; Kersh GJ, 2011, VECTOR-BORNE ZOONOT, V11, P1433, DOI 10.1089/vbz.2011.0670; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leroy Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015321; LUKACOVA M, 1993, FEMS MICROBIOL LETT, V113, P285, DOI 10.1111/j.1574-6968.1993.tb06528.x; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mayer H, 1988, Adv Exp Med Biol, V228, P577; Mazokopakis Elias E., 2010, Infectious Disorders - Drug Targets, V10, P27; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Mori M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067622; Narasaki CT, 2012, ADV EXP MED BIOL, V984, P65, DOI 10.1007/978-94-007-4315-1_4; Nocker A, 2006, APPL ENVIRON MICROB, V72, P1997, DOI 10.1128/AEM.72.3.1997-2004.2006; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Nogva HK, 2003, BIOTECHNIQUES, V34, P804, DOI 10.2144/03344rr02; Omsland A, 2011, APPL ENVIRON MICROB, V77, P3720, DOI 10.1128/AEM.02826-10; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Pan Y, 2007, APPL ENVIRON MICROB, V73, P8028, DOI 10.1128/AEM.01198-07; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Read AJ, 2010, INFECT IMMUN, V78, P3019, DOI 10.1128/IAI.00101-10; Rodolakis A., 2010, INT Q FEV C BRED NET; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; Russell-Lodrigue KE, 2009, INFECT IMMUN, V77, P5640, DOI 10.1128/IAI.00851-09; SCHRAMEK S, 1982, INFECT IMMUN, V38, P53, DOI 10.1128/IAI.38.1.53-57.1982; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Stein A, 2005, INFECT IMMUN, V73, P2469, DOI 10.1128/IAI.73.4.2469-2477.2005; STOKER MGP, 1956, CAN J MICROBIOL, V2, P310, DOI 10.1139/m56-036; Tang F, 2013, GENOMICS, V101, P336, DOI 10.1016/j.ygeno.2013.04.005; van der Hoek W, 2010, EURO SURVEILL, P15; Wagner AO, 2008, APPL ENVIRON MICROB, V74, P2537, DOI 10.1128/AEM.02288-07; Zhang GQ, 2003, ANN NY ACAD SCI, V990, P510, DOI 10.1111/j.1749-6632.2003.tb07420.x	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121661	10.1371/journal.pone.0121661	http://dx.doi.org/10.1371/journal.pone.0121661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793981	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900144
J	Matarazzo, SA				Matarazzo, Stacey A.			Trabecular Architecture of the Manual Elements Reflects Locomotor Patterns in Primates	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; BONE-STRUCTURE; FEMORAL-HEAD; APPARENT DENSITY; SUBCHONDRAL BONE; KNUCKLE-WALKING; CANCELLOUS BONE; BIOMECHANICS; HAND; ADAPTATION	The morphology of trabecular bone has proven sensitive to loading patterns in the long bones and metacarpal heads of primates. It is expected that we should also see differences in the manual digits of primates that practice different methods of locomotion. Primate proximal and middle phalanges are load-bearing elements that are held in different postures and experience different mechanical strains during suspension, quadrupedalism, and knuckle walking. Micro CT scans of the middle phalanx, proximal phalanx and the metacarpal head of the third ray were used to examine the pattern of trabecular orientation in Pan, Gorilla, Pongo, Hylobates and Macaca. Several zones, i.e., the proximal ends of both phalanges and the metacarpal heads, were capable of distinguishing between knuckle-walking, quadrupedal, and suspensory primates. Orientation and shape seem to be the primary distinguishing factors but differences in bone volume, isotropy index, and degree of anisotropy were seen across included taxa. Suspensory primates show primarily proximodistal alignment in all zones, and quadrupeds more palmar-dorsal orientation in several zones. Knuckle walkers are characterized by having proximodistal alignment in the proximal ends of the phalanges and a palmar-dorsal alignment in the distal ends and metacarpal heads. These structural differences may be used to infer locmotor propensities of extinct primate taxa.	Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Matarazzo, SA (corresponding author), Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA.	smataraz@anthro.umass.edu			Wenner Gren Foundation dissertation grant; LSB Foundation dissertation grant	Wenner Gren Foundation dissertation grant; LSB Foundation dissertation grant	SM attained the following grants in support of this research: the Wenner Gren Foundation dissertation grant (http://www.wennergren.org) and the LSB Foundation dissertation grant (www.leakeyfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak MM, 2011, BONE, V49, P1141, DOI 10.1016/j.bone.2011.08.020; Bertram JEA, 2001, AM J PHYS ANTHROPOL, V115, P319, DOI 10.1002/ajpa.1088; Carlson KJ, 2006, J ANAT, V208, P659, DOI 10.1111/j.1469-7580.2006.00555.x; Chang YH, 2000, AM J PHYS ANTHROPOL, V113, P201, DOI 10.1002/1096-8644(200010)113:2<201::AID-AJPA5>3.3.CO;2-J; Chirchir H, 2010, AM J PHYS ANTHROPOL, P81; DeSilva JM, 2012, J HUM EVOL, V63, P536, DOI 10.1016/j.jhevol.2012.06.006; Fajardo RJ, 2002, AM J PHYS ANTHROPOL, V118, P1, DOI 10.1002/ajpa.10086; Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089; Fox JC, 2001, J THEOR BIOL, V212, P211, DOI 10.1006/jtbi.2001.2371; Jacobs CR, 2000, J REHABIL RES DEV, V37, P209; Jungers W. L., 1994, AM J PHYS ANTHR S, V18, P117; Jungers WL, 2001, ADV PRIMATO, P371; Jungers WL, 1997, P NATL ACAD SCI USA, V94, P11998, DOI 10.1073/pnas.94.22.11998; Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307; Ketcham RA, 2005, J STRUCT GEOL, V27, P1217, DOI 10.1016/j.jsg.2005.02.006; Ketcham RA, 2004, J MICROSC-OXFORD, V213, P158, DOI 10.1111/j.1365-2818.2004.01277.x; Kivell TL, 2011, J ANAT, V218, P209, DOI 10.1111/j.1469-7580.2010.01314.x; Lazenby RA, 2011, AM J PHYS ANTHROPOL, V144, P215, DOI 10.1002/ajpa.21390; MacLatchy L, 2002, J HUM EVOL, V43, P89, DOI 10.1006/jhev.2002.0559; Marchi D, 2005, J HUM EVOL, V49, P743, DOI 10.1016/j.jhevol.2005.08.002; Matarazzo SA, 2011, AM J PHYS ANTHROPOL, V144, P208; Matarazzo S, 2013, AM J PHYS ANTHROPOL, V152, P44, DOI 10.1002/ajpa.22325; Mittra E, 2005, J BIOMECH, V38, P1229, DOI 10.1016/j.jbiomech.2004.06.007; Patel BA, 2007, J HUM EVOL, V52, P130, DOI 10.1016/j.jhevol.2006.08.007; Patel BA, 2010, J HUM EVOL, V58, P320, DOI 10.1016/j.jhevol.2010.01.001; Polk JD, 2008, ANAT REC, V291, P293, DOI 10.1002/ar.20653; Polk JD, 2010, INT J PRIMATOL, V31, P275, DOI 10.1007/s10764-010-9401-y; Pontzer H, 2006, J EXP BIOL, V209, P57, DOI 10.1242/jeb.01971; Richmond BG, 1998, THESIS STATE U NEW Y; Richmond BG, 2007, J HUM EVOL, V53, P678, DOI 10.1016/j.jhevol.2007.05.011; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ryan TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041037; Ryan TM, 2010, ANAT REC, V293, P719, DOI 10.1002/ar.21139; Ryan TM, 2005, AM J PHYS ANTHROPOL, V126, P82, DOI 10.1002/ajpa.10414; Ryan TM, 2002, J HUM EVOL, V43, P1, DOI 10.1006/jhev.2002.0552; Scherf H, 2013, J HUM EVOL, V65, P29, DOI 10.1016/j.jhevol.2013.03.008; Scherf H, 2009, AM J PHYS ANTHROPOL, V140, P39, DOI 10.1002/ajpa.21033; Schilling AM, 2014, J MORPHOL, V275, P572, DOI 10.1002/jmor.20238; Shaw CN, 2012, AM J PHYS ANTHROPOL, V147, P187, DOI 10.1002/ajpa.21635; Tsegai ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078781; Usherwood JR, 2003, AM J PHYS ANTHROPOL, V120, P364, DOI 10.1002/ajpa.10133; Waarsing J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P310; Zeininger A, 2011, J HUM EVOL, V60, P703, DOI 10.1016/j.jhevol.2011.01.002	43	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120436	10.1371/journal.pone.0120436	http://dx.doi.org/10.1371/journal.pone.0120436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793781	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900035
J	Oh, K; Matsumoto, T; Yamagami, A; Ogawa, A; Yamada, K; Suzuki, R; Sawada, T; Fujioka, S; Yoshizawa, Y; Nakano, T				Oh, Keimei; Matsumoto, Tadashi; Yamagami, Ayumi; Ogawa, Atushi; Yamada, Kazuhiro; Suzuki, Ryuichiro; Sawada, Takayuki; Fujioka, Shozo; Yoshizawa, Yuko; Nakano, Takeshi			YCZ-18 Is a New Brassinosteroid Biosynthesis Inhibitor	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CYTOCHROME-P450 MONOOXYGENASE; POTENT INHIBITORS; CELL ELONGATION; LEAF SENESCENCE; HIGH-EFFICIENCY; C-6 OXIDATION; MUTANT; PATHWAY; PROTEIN	Plant hormone brassinosteroids (BRs) are a group of polyhydroxylated steroids that play critical roles in regulating broad aspects of plant growth and development. The structural diversity of BRs is generated by the action of several groups of P450s. Brassinazole is a specific inhibitor of C-22 hydroxylase (CYP90B1) in BR biosynthesis, and the application use of brassinazole has emerged as an effective way of complementing BR-deficient mutants to elucidate the functions of BRs. In this article, we report a new triazole-type BR biosynthesis inhibitor, YCZ-18. Quantitative analysis the endogenous levels of BRs in Arabidopsis indicated that YCZ-18 significantly decreased the BR contents in plant tissues. Assessment of the binding affinity of YCZ-18 to purified recombinant CYP90D1 indicated that YCZ-18 induced a typical type II binding spectrum with a K-d value of approximately 0.79 mu M. Analysis of the mechanisms underlying the dwarf phenotype associated with YCZ-18 treatment of Arabidopsis indicated that the chemically induced dwarf phenotype was caused by a failure of cell elongation. Moreover, dissecting the effect of YCZ-18 on the induction or down regulation of genes responsive to BRs indicated that YCZ-18 regulated the expression of genes responsible for BRs deficiency in Arabidopsis. These findings indicate that YCZ-18 is a potent BR biosynthesis inhibitor and has a new target site, C23-hydroxylation in BR biosynthesis. Application of YCZ-18 will be a good starting point for further elucidation of the detailed mechanism of BR biosynthesis and its regulation.	[Oh, Keimei; Matsumoto, Tadashi; Yamada, Kazuhiro; Yoshizawa, Yuko] Akita Prefectural Univ, Fac Bioresource Sci, Dept Biotechnol, Akita, Japan; [Yamagami, Ayumi; Fujioka, Shozo; Nakano, Takeshi] RIKEN, Antibiot Lab, Wako, Saitama, Japan; [Ogawa, Atushi; Suzuki, Ryuichiro] Akita Prefectural Univ, Fac Bioresource Sci, Dept Bioprod, Akita, Japan; [Sawada, Takayuki] Akita Prefectural Univ, Fac Bioresource Sci, Biotechnol Res Ctr, Akita, Japan; [Fujioka, Shozo; Nakano, Takeshi] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama, Japan; [Nakano, Takeshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Akita Prefectural University; RIKEN; Akita Prefectural University; Akita Prefectural University; RIKEN; Japan Science & Technology Agency (JST)	Oh, K (corresponding author), Akita Prefectural Univ, Fac Bioresource Sci, Dept Biotechnol, Akita, Japan.	jmwang@akita-pu.ac.jp	Yamagami, Ayumi/C-7602-2017; Nakano, Takeshi/E-9171-2013	Nakano, Takeshi/0000-0002-3188-7770	Akita Prefectural University; CREST, Japan Science and Technology Agency	Akita Prefectural University; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported in part by funding from the Akita Prefectural University President's Research Project to KO and the CREST, Japan Science and Technology Agency to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 1999, TRENDS PLANT SCI, V4, P348, DOI 10.1016/S1360-1385(99)01456-9; Asami T, 2001, J BIOL CHEM, V276, P25687, DOI 10.1074/jbc.M103524200; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Bishop GJ, 1999, P NATL ACAD SCI USA, V96, P1761, DOI 10.1073/pnas.96.4.1761; Blackwell HE, 2003, PLANT PHYSIOL, V133, P448, DOI 10.1104/pp.103.031138; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Castle J, 2005, PLANT MOL BIOL, V57, P129, DOI 10.1007/s11103-004-6851-7; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; CHORY J, 1991, PLANT CELL, V3, P445, DOI 10.1105/tpc.3.5.445; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Fujioka S, 2002, PLANT PHYSIOL, V130, P930, DOI 10.1104/pp.008722; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Kim GT, 2005, PLANT J, V41, P710, DOI 10.1111/j.1365-313X.2004.02330.x; Kim GT, 1998, GENE DEV, V12, P2381, DOI 10.1101/gad.12.15.2381; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KREBBERS E, 1988, PLANT MOL BIOL, V11, P745, DOI 10.1007/BF00019515; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; Kusaba M, 2013, PHOTOSYNTH RES, V117, P221, DOI 10.1007/s11120-013-9862-x; LEUTWILER LS, 1986, NUCLEIC ACIDS RES, V14, P4051, DOI 10.1093/nar/14.10.4051; Nomura T, 1997, PLANT PHYSIOL, V113, P31, DOI 10.1104/pp.113.1.31; Oh K, 2006, FEBS LETT, V580, P5791, DOI 10.1016/j.febslet.2006.09.044; Oh K, 2013, BIOORG MED CHEM LETT, V23, P6915, DOI 10.1016/j.bmcl.2013.09.056; Oh K, 2012, BIOORG MED CHEM LETT, V22, P1625, DOI 10.1016/j.bmcl.2011.12.120; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Ohnishi T, 2012, J BIOL CHEM, V287, P31551, DOI 10.1074/jbc.M112.392720; ROGERSON TD, 1977, BIOCHEM PHARMACOL, V26, P1039, DOI 10.1016/0006-2952(77)90241-6; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sakamoto T, 2012, AM J PLANT SCI, V3, P1699, DOI DOI 10.4236/AJPS.2012.312208; Sakurai A, 1997, BIOSCI BIOTECH BIOCH, V61, P757, DOI 10.1271/bbb.61.757; Sasse JM, 2003, J PLANT GROWTH REGUL, V22, P276, DOI 10.1007/s00344-003-0062-3; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sekimata K, 2008, BIOSCI BIOTECH BIOCH, V72, P7, DOI 10.1271/bbb.70141; Shen H, 2012, MOL PLANT, V5, P750, DOI 10.1093/mp/sss029; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; TESTA B, 1981, DRUG METAB REV, V12, P1, DOI 10.3109/03602538109011082; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Vriet C, 2012, PLANT CELL, V24, P842, DOI 10.1105/tpc.111.094912; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; Yamada K, 2013, BIOORGAN MED CHEM, V21, P2451, DOI 10.1016/j.bmc.2013.03.006; Yamada K, 2012, MOLECULES, V17, P4460, DOI 10.3390/molecules17044460; Yamagami A, 2009, BIOSCI BIOTECH BIOCH, V73, P415, DOI 10.1271/bbb.80752	53	11	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120812	10.1371/journal.pone.0120812	http://dx.doi.org/10.1371/journal.pone.0120812			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793645	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900078
J	Nakane, S; Higuchi, O; Koga, M; Kanda, T; Murata, K; Suzuki, T; Kurono, H; Kunimoto, M; Kaida, K; Mukaino, A; Sakai, W; Maeda, Y; Matsuo, H				Nakane, Shunya; Higuchi, Osamu; Koga, Michiaki; Kanda, Takashi; Murata, Kenya; Suzuki, Takashi; Kurono, Hiroko; Kunimoto, Masanari; Kaida, Ken-ichi; Mukaino, Akihiro; Sakai, Waka; Maeda, Yasuhiro; Matsuo, Hidenori			Clinical Features of Autoimmune Autonomic Ganglionopathy and the Detection of Subunit-Specific Autoantibodies to the Ganglionic Acetylcholine Receptor in Japanese Patients	PLOS ONE			English	Article							MYASTHENIA-GRAVIS; RHEUMATOID-ARTHRITIS; PARKINSONS-DISEASE; GAUSSIA LUCIFERASE; SJOGRENS-SYNDROME; NEUROPATHY; ANTIBODIES; SYSTEM; INVOLVEMENT; DYSFUNCTION	Autoimmune autonomic ganglionopathy (AAG) is a rare acquired channelopathy that is characterized by pandysautonomia, in which autoantibodies to ganglionic nicotinic acetylcholine receptors (gAChR) may play a central role. Radioimmunoprecipitation (RIP) assays have been used for the sensitive detection of autoantibodies to gAChR in the serum of patients with AAG. Here, we developed luciferase immunoprecipitation systems (LIPS) to diagnose AAG based on IgGs to both the alpha 3 and beta 4 gAChR subunits in patient serum. We reviewed the serological and clinical data of 50 Japanese patients who were diagnosed with AAG. With the LIPS testing, we detected anti-alpha 3 and -beta 4 gAChR antibodies in 48% (24/ 50) of the patients. A gradual mode of onset was more common in the seropositive group than in the seronegative group. Patients with AAG frequently have orthostatic hypotension and upper and lower gastrointestinal tract symptoms, with or without anti-gAChR. The occurrence of autonomic symptoms was not significantly different between the seropositive and seronegative group, with the exception of achalasia in three patients from the seropositive group. In addition, we found a significant overrepresentation of autoimmune diseases in the seropositive group and endocrinological abnormalities as an occasional complication of AAG. Our results demonstrated that the LIPS assay was a useful novel tool for detecting autoantibodies against gAChR in patients with AAG.	[Nakane, Shunya; Higuchi, Osamu] Nagasaki Kawatana Med Ctr, Dept Clin Res, Nagasaki, Japan; [Nakane, Shunya; Sakai, Waka; Maeda, Yasuhiro; Matsuo, Hidenori] Nagasaki Kawatana Med Ctr, Dept Neurol, Nagasaki, Japan; [Koga, Michiaki; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Yamaguchi, Japan; [Murata, Kenya] Wakayama Med Univ, Dept Neurol, Wakayama, Japan; [Suzuki, Takashi] Joetsu Gen Hosp, Dept Neurol, Niigata, Japan; [Kurono, Hiroko; Kunimoto, Masanari] Saiseikai Kanagawa Prefecture Hosp, Dept Neurol, Yokohama, Kanagawa, Japan; [Kaida, Ken-ichi] Natl Def Med Coll, Dept Internal Med 3, Div Neurol, Saitama, Japan; [Mukaino, Akihiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Neurol, Nagasaki 852, Japan	Yamaguchi University; Wakayama Medical University; National Defense Medical College - Japan; Nagasaki University	Nakane, S (corresponding author), Nagasaki Kawatana Med Ctr, Dept Clin Res, Nagasaki, Japan.	nakaneshunya@gmail.com	Nakane, Shunya/AAF-3715-2022; Koga, Michiaki/L-4825-2019; Nakane, Shunya/AFB-9194-2022	Koga, Michiaki/0000-0002-1356-955X; 	Neuroimmunological Disease Research Committee; Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [25461305]	Neuroimmunological Disease Research Committee; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Neuroimmunological Disease Research Committee and the Ministry of Health, Labour and Welfare, Japan. This work was also supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan in the form of a Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant Number 25461305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral TN, 2013, SEMIN ARTHRITIS RHEU, V43, P335, DOI 10.1016/j.semarthrit.2013.05.002; Baker SK, 2009, AUTON NEUROSCI-BASIC, V146, P29, DOI 10.1016/j.autneu.2008.10.016; Balestra B, 2000, J NEUROIMMUNOL, V102, P89, DOI 10.1016/S0165-5728(99)00145-9; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Burbelo PD, 2010, CLIN VACCINE IMMUNOL, V17, P904, DOI 10.1128/CVI.00476-09; Ching KH, 2011, NEUROMUSCULAR DISORD, V21, P204, DOI 10.1016/j.nmd.2010.12.003; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Druschky A, 2000, J NEUROL SCI, V175, P3, DOI 10.1016/S0022-510X(00)00279-3; Fukuda Mitsumasa, 1995, No To Hattatsu, V27, P41; Gibbons CH, 2008, ARCH NEUROL-CHICAGO, V65, P213, DOI 10.1001/archneurol.2007.60; Goto H, 2000, J NEUROL NEUROSUR PS, V69, P135, DOI 10.1136/jnnp.69.1.135; Hayashi M, 2009, AUTON NEUROSCI-BASIC, V146, P26, DOI 10.1016/j.autneu.2008.12.013; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Imrich R, 2009, CLIN AUTON RES, V19, P259, DOI 10.1007/s10286-009-0012-7; Inoue Y, 1989, Rinsho Shinkeigaku, V29, P1265; Iodice V, 2009, NEUROLOGY, V72, P2002, DOI 10.1212/WNL.0b013e3181a92b52; Iodice V, 2009, AUTON NEUROSCI-BASIC, V146, P22, DOI 10.1016/j.autneu.2008.11.001; Kim SB, 2011, ANAL CHEM, V83, P8732, DOI 10.1021/ac2021882; Kimpinski K, 2009, NEUROLOGY, V73, P1501, DOI 10.1212/WNL.0b013e3181bf995f; Kobayashi S, 2013, J NEUROIMMUNOL, V257, P102, DOI 10.1016/j.jneuroim.2012.12.010; Kondo T, 2009, AUTON NEUROSCI-BASIC, V146, P33, DOI 10.1016/j.autneu.2008.12.002; Lennon VA, 2003, J CLIN INVEST, V111, P907, DOI 10.1172/JCI200317429; Manganelli F, 2011, ARCH NEUROL-CHICAGO, V68, P504, DOI 10.1001/archneurol.2011.60; Matsui M, 1983, Rinsho Shinkeigaku, V23, P526; Mori K, 2005, BRAIN, V128, P2518, DOI 10.1093/brain/awh605; Nishihara H., 2015, CLIN EXP NEUROIMMUNO, V6, P191, DOI 10.1111/cen3.12137; Pavlakis PP, 2011, J NEUROL NEUROSUR PS, V82, P798, DOI 10.1136/jnnp.2010.222109; Peltier AC, 2010, MUSCLE NERVE, V41, P416, DOI 10.1002/mus.21528; Philip NS, 2010, PSYCHOPHARMACOLOGY, V212, P1, DOI 10.1007/s00213-010-1932-6; Ramos-Remus C, 2012, CLIN RHEUMATOL, V31, P1, DOI 10.1007/s10067-011-1841-z; Reuter M, 2012, NEUROREPORT, V23, P717, DOI 10.1097/WNR.0b013e32835671ba; Sandroni P, 2004, ARCH NEUROL-CHICAGO, V61, P44, DOI 10.1001/archneur.61.1.44; Sandroni P, 2009, AUTON NEUROSCI-BASIC, V146, P13, DOI 10.1016/j.autneu.2008.10.022; Skok MV, 1999, NEUROSCIENCE, V93, P1427, DOI 10.1016/S0306-4522(99)00160-8; Spiegel J, 2007, MOVEMENT DISORD, V22, P1004, DOI 10.1002/mds.21499; Stacher G, 2000, J RHEUMATOL, V27, P692; Stojanovich L, 2007, LUPUS, V16, P181, DOI 10.1177/0961203306076223; Streifler Jonathan Y, 2014, Handb Clin Neurol, V119, P463, DOI 10.1016/B978-0-7020-4086-3.00030-8; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Ustinova J, 2014, J IMMUNOL METHODS, V405, P67, DOI 10.1016/j.jim.2014.01.009; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Vernino S, 1998, NEUROLOGY, V50, P1806, DOI 10.1212/WNL.50.6.1806; Vernino S, 2000, NEW ENGL J MED, V343, P847, DOI 10.1056/NEJM200009213431204; Vernino S, 2004, J NEUROSCI, V24, P7037, DOI 10.1523/JNEUROSCI.1485-04.2004; Vernino S, 2003, J NEUROPHYSIOL, V90, P2053, DOI 10.1152/jn.00408.2003; Vernino S, 2001, AUTON NEUROSCI-BASIC, V88, P187, DOI 10.1016/S1566-0702(01)00239-9; Vernino S, 2008, J NEUROIMMUNOL, V197, P63, DOI 10.1016/j.jneuroim.2008.03.017; Vernino S, 2008, NEUROLOGY, V70, P1926, DOI 10.1212/01.wnl.0000312280.44805.5d; Vernino S, 2009, AUTON NEUROSCI-BASIC, V146, P3, DOI 10.1016/j.autneu.2008.09.005; Wang Z, 2007, NEUROLOGY, V68, P1917, DOI 10.1212/01.wnl.0000263185.30294.61; Wang ZB, 2010, EXP NEUROL, V222, P114, DOI 10.1016/j.expneurol.2009.12.016; Watson R, 2005, NEUROLOGY, V65, P1802, DOI 10.1212/01.wnl.0000191566.86977.04; WIELAND DM, 1981, J NUCL MED, V22, P22; Winston N, 2010, CURR OPIN NEUROL, V23, P514, DOI 10.1097/WCO.0b013e32833d4c7f	54	52	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118312	10.1371/journal.pone.0118312	http://dx.doi.org/10.1371/journal.pone.0118312			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790156	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400026
J	Robijn, S; Vervaet, BA; D'Haese, PC; Verhulst, A				Robijn, Stef; Vervaet, Benjamin A.; D'Haese, Patrick C.; Verhulst, Anja			Evaluation of Intestinal Phosphate Binding to Improve the Safety Profile of Oral Sodium Phosphate Bowel Cleansing	PLOS ONE			English	Article							PLUS BISACODYL TABLETS; RENAL-FAILURE; PARATHYROID-HORMONE; LAVAGE SOLUTION; COLONOSCOPY; NEPHROPATHY; NEPHROCALCINOSIS; TRIAL; ABSORPTION; EFFICACY	Prior to colonoscopy, bowel cleansing is performed for which frequently oral sodium phosphate (OSP) is used. OSP results in significant hyperphosphatemia and cases of acute kidney injury (AKI) referred to as acute phosphate nephropathy (APN; characterized by nephrocalcinosis) are reported after OSP use, which led to a US-FDA warning. To improve the safety profile of OSP, it was evaluated whether the side-effects of OSP could be prevented with intestinal phosphate binders. Hereto a Wistar rat model of APN was developed. OSP administration (2 times 1.2 g phosphate by gavage) with a 12h time interval induced bowel cleansing (severe diarrhea) and significant hyperphosphatemia (21.79 +/- 5.07 mg/dl 6h after the second OSP dose versus 8.44 +/- 0.97 mg/dl at baseline). Concomitantly, serum PTH levels increased fivefold and FGF-23 levels showed a threefold increase, while serum calcium levels significantly decreased from 11.29 +/- 0.53 mg/dl at baseline to 8.68 +/- 0.79 mg/dl after OSP. OSP administration induced weaker NaPi-2a staining along the apical proximal tubular membrane. APN was induced: serum creatinine increased (1.5 times baseline) and nephrocalcinosis developed (increased renal calcium and phosphate content and calcium phosphate deposits on Von Kossa stained kidney sections). Intestinal phosphate binding (lanthanum carbonate or aluminum hydroxide) was not able to attenuate the OSP induced side-effects. In conclusion, a clinically relevant rat model of APN was developed. Animals showed increased serum phosphate levels similar to those reported in humans and developed APN. No evidence was found for an improved safety profile of OSP by using intestinal phosphate binders.	[Robijn, Stef; Vervaet, Benjamin A.; D'Haese, Patrick C.; Verhulst, Anja] Univ Antwerp, Lab Pathophysiol, B-2020 Antwerp, Belgium	University of Antwerp	D'Haese, PC (corresponding author), Univ Antwerp, Lab Pathophysiol, B-2020 Antwerp, Belgium.	patrick.dhaese@uantwerpen.be	Vervaet, Benjamin/AAU-4679-2020; D'Haese, Patrick C/C-9599-2019	Vervaet, Benjamin/0000-0002-8589-5469	Agency for Innovation by Science and Technology in Flanders; FWO [G.0583.09]	Agency for Innovation by Science and Technology in Flanders; FWO(FWO)	SR was funded by a PhD grant of the Agency for Innovation by Science and Technology in Flanders (http://www.iwt.be/). AV is a postdoctoral fellow of the Fund for Scientific Research Flanders (http://www.fwo.be/). This research was funded by FWO research grant G.0583.09.	Aasebo W, 2007, NEPHROL DIAL TRANSPL, V22, P920, DOI 10.1093/ndt/gfl694; Bacic D, 2006, KIDNEY INT, V69, P495, DOI 10.1038/sj.ki.5000148; Becaria A, 2002, TOXICOL IND HEALTH, V18, P309, DOI 10.1191/0748233702th157oa; Behets GJ, 2004, CURR OPIN NEPHROL HY, V13, P403, DOI 10.1097/01.mnh.0000133973.86816.e9; Belsey J, 2007, ALIMENT PHARM THER, V25, P373, DOI 10.1111/j.1365-2036.2006.03212.x; Bourquin Vincent, 2011, Rev Med Suisse, V7, P2227; Caswell M, 2007, J POPUL THER CLIN PH, V14, pE260; Connor A, 2012, GUT, V61, P1525, DOI 10.1136/gutjnl-2011-300861; Desmeules S, 2003, NEW ENGL J MED, V349, P1006, DOI 10.1056/NEJM200309043491020; DiPalma JA, 1996, DIGEST DIS SCI, V41, P749, DOI 10.1007/BF02213131; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Eto N, 2006, DRUG METAB PHARMACOK, V21, P217, DOI 10.2133/dmpk.21.217; Giral H, 2009, AM J PHYSIOL-RENAL, V297, pF1466, DOI 10.1152/ajprenal.00279.2009; Gonlusen G, 2006, ARCH PATHOL LAB MED, V130, P101; Gracia-Iguacel C, 2013, J BONE MINER METAB, V31, P703, DOI 10.1007/s00774-013-0435-z; Han SH, 2010, CLIN NEPHROL, V74, P159; Hassan C, 2013, ENDOSCOPY, V45, P142, DOI 10.1055/s-0032-1326186; Heher EC, 2008, CLIN J AM SOC NEPHRO, V3, P1494, DOI 10.2215/CJN.02040408; Hurst FP, 2009, CURR OPIN NEPHROL HY, V18, P513, DOI 10.1097/MNH.0b013e32833096af; Hutchison AJ, 2009, KIDNEY INT, V75, P906, DOI 10.1038/ki.2009.60; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Isakova T, 2010, KIDNEY INT, V78, P947, DOI 10.1038/ki.2010.281; Johanson JF, 2007, AM J GASTROENTEROL, V102, P2238, DOI 10.1111/j.1572-0241.2007.01363.x; Korsten MA, 2010, DIGEST DIS SCI, V55, P2021, DOI 10.1007/s10620-009-1013-z; Landreneau Stephen W, 2013, Curr Gastroenterol Rep, V15, P341, DOI 10.1007/s11894-013-0341-5; Lichtenstein GR, 2007, ALIMENT PHARM THER, V26, P1361, DOI 10.1111/j.1365-2036.2007.03496.x; Lien YHH, 2008, NAT CLIN PRACT NEPHR, V4, P606, DOI 10.1038/ncpneph0939; Lochy S, 2013, INT J NEPHROL RENOV, V6, P61, DOI 10.2147/IJNRD.S41428; Mackey AC, 2009, AM J GASTROENTEROL, V104, P1903, DOI 10.1038/ajg.2009.342; Manfro RC, 2009, TRANSPLANTATION, V87, P618, DOI 10.1097/TP.0b013e318196a59c; Markowitz GS, 2009, KIDNEY INT, V76, P1027, DOI 10.1038/ki.2009.308; Markowitz GS, 2005, J AM SOC NEPHROL, V16, P3389, DOI 10.1681/ASN.2005050496; Markowitz GS, 2005, NEPHROL DIAL TRANSPL, V20, P850, DOI 10.1093/ndt/gfh718; Markowitz GS, 2004, HUM PATHOL, V35, P675, DOI 10.1016/j.humpath.2003.12.005; Marks J, 2013, CURR OPIN NEPHROL HY, V22, P481, DOI 10.1097/MNH.0b013e3283621310; Palmadottir VK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013484; Patel V, 2007, HUM PATHOL, V38, P193, DOI 10.1016/j.humpath.2006.10.008; Patel V, 2009, AM J GASTROENTEROL, V104, P953, DOI 10.1038/ajg.2008.124; Pelham RW, 2010, AM J GASTROENTEROL, V105, P476, DOI 10.1038/ajg.2009.571; Rex DK, 2007, ANN PHARMACOTHER, V41, P1466, DOI 10.1345/aph.1K206; Rex DK, 2006, AM J GASTROENTEROL, V101, P2594, DOI 10.1111/j.1572-0241.2006.00776.x; Rex DK, 2009, CAN J GASTROENTEROL, V23, P210, DOI 10.1155/2009/417296; Rocuts AK, 2009, KIDNEY INT, V75, P987, DOI 10.1038/ki.2008.293; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Rostom A, 2006, GASTROINTEST ENDOSC, V64, P544, DOI 10.1016/j.gie.2005.09.030; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF395, DOI 10.1152/ajprenal.00100.2006; Slee TM, 2008, NETH J MED, V66, P438; Tan JJY, 2006, COLORECTAL DIS, V8, P247, DOI 10.1111/j.1463-1318.2006.00970.x; VANNER SJ, 1990, AM J GASTROENTEROL, V85, P422	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116590	10.1371/journal.pone.0116590	http://dx.doi.org/10.1371/journal.pone.0116590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790436	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400018
J	Tornqvist, R; Jarsjo, J; Thorslund, J; Rao, PSC; Basu, NB; Destouni, G				Tornqvist, Rebecka; Jarsjo, Jerker; Thorslund, Josefin; Rao, P. Suresh C.; Basu, Nandita B.; Destouni, Georgia			Mechanisms of Basin-Scale Nitrogen Load Reductions under Intensified Irrigated Agriculture	PLOS ONE			English	Article							RIVER-BASIN; AMU-DARYA; RIO-GRANDE; ARAL SEA; WATER; NUTRIENT; EXPORT; TRANSPORT; QUALITY; UZBEKISTAN	Irrigated agriculture can modify the cycling and transport of nitrogen (N), due to associated water diversions, water losses, and changes in transport flow-paths. We investigate dominant processes behind observed long-term changes in dissolved inorganic nitrogen (DIN) concentrations and loads of the extensive (465,000 km(2)) semi-arid Amu Darya River basin (ADRB) in Central Asia. We specifically considered a 40-year period (1960-2000) of large irrigation expansion, reduced river water flows, increased fertilizer application and net increase of N input into the soil-water system. Results showed that observed decreases in riverine DIN concentration near the Aral Sea outlet of ADRB primarily were due to increased recirculation of irrigation water, which extends the flow-path lengths and enhances N attenuation. The observed DIN concentrations matched a developed analytical relation between concentration attenuation and recirculation ratio, showing that a fourfold increase in basin-scale recirculation can increase DIN attenuation from 85 to 99%. Such effects have previously only been observed at small scales, in laboratory experiments and at individual agricultural plots. These results imply that increased recirculation can have contributed to observed increases in N attenuation in agriculturally dominated drainage basins in different parts of the world. Additionally, it can be important for basin scale attenuation of other pollutants, including phosphorous, metals and organic matter. A six-fold lower DIN export from ADRB during the period 1981-2000, compared to the period 1960-1980, was due to the combined result of drastic river flow reduction of almost 70%, and decreased DIN concentrations at the basin outlet. Several arid and semi-arid regions around the world are projected to undergo similar reductions in discharge as the ADRB due to climate change and agricultural intensification, and may therefore undergo comparable shifts in DIN export as shown here for the ADRB. For example, projected future increases of irrigation water withdrawals between 2005 and 2050 may decrease the DIN export from arid world regions by 40%.	[Tornqvist, Rebecka; Jarsjo, Jerker; Thorslund, Josefin; Destouni, Georgia] Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden; [Tornqvist, Rebecka; Jarsjo, Jerker; Thorslund, Josefin; Destouni, Georgia] Stockholm Univ, Bolin Ctr Climate Res, S-10691 Stockholm, Sweden; [Rao, P. Suresh C.] Purdue Univ, Sch Civil Engn, W Lafayette, IN 47907 USA; [Rao, P. Suresh C.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Basu, Nandita B.] Univ Waterloo, Dept Civil & Environm Engn & Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	Stockholm University; Stockholm University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Waterloo	Tornqvist, R (corresponding author), Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden.	rebecka.tornqvist@natgeo.su.se	Destouni, Georgia/M-9662-2016; Srinivasa Rao, Prof. P/ABG-1688-2021; Destouni, Georgia/AAS-5375-2020	Destouni, Georgia/0000-0001-9408-4425; Srinivasa Rao, Prof. P/0000-0003-1379-4906; Destouni, Georgia/0000-0001-9408-4425	Swedish International Development Cooperation Agency (SIDA); Linnaeus grant from the Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)	Swedish International Development Cooperation Agency (SIDA); Linnaeus grant from the Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas)	The authors gratefully acknowledge financial support from the Swedish International Development Cooperation Agency (SIDA, www.sida.se). The work has been carried out within the Bolin Centre for Climate Research, which is supported by a Linnaeus grant from the Swedish Research Council (VR, www.vr.se) and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas, www.formas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, WAT SUST WORLD LTD S, P247; Asarin A.E., 2010, ARAL SEA ENV, P101; Awan UK, 2011, IRRIG DRAIN, V60, P600, DOI 10.1002/ird.612; Basu NB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045168; Beek TAD, 2011, PHYS CHEM EARTH, V36, P684, DOI 10.1016/j.pce.2011.03.004; Bouraoui F, 2011, SCI TOTAL ENVIRON, V409, P4899, DOI 10.1016/j.scitotenv.2011.08.015; Bouwman AF, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003576; Bouwman AF, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002314; Brown JB, 2011, J AM WATER RESOUR AS, V47, P1034, DOI 10.1111/j.1752-1688.2011.00584.x; Bruinsma J., 2009, FEED WORLD 2050, P24; Caraco NF, 1999, AMBIO, V28, P167; Caraco NF, 2001, MAR FRESHWATER RES, V52, P119, DOI 10.1071/MF00083; Causape J, 2006, ENVIRON MONIT ASSESS, V117, P451, DOI 10.1007/s10661-006-0763-8; Crosa G, 2006, ENVIRON SCI POLLUT R, V13, P37, DOI 10.1065/espr2006.01.007; Darracq A, 2010, ENVIRON FLUID MECH, V10, P103, DOI 10.1007/s10652-009-9147-2; de Wit MJM, 2001, HYDROL PROCESS, V15, P743, DOI 10.1002/hyp.175; Destouni G, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044153; Djumaniyazova Y, 2010, FIELD CROP RES, V116, P239, DOI 10.1016/j.fcr.2010.01.001; Dumont E, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002488; Eriksson H, 2007, BIOGEOCHEMISTRY, V85, P153, DOI 10.1007/s10533-007-9126-y; FAO, 2003, FERT US CROP UZB; FAO, 2003, FAO WAT REP; Feng YW, 2004, AGR WATER MANAGE, V68, P47, DOI 10.1016/j.agwat.2004.02.012; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galloway J., 2010, Livestock in a changing landscape, Volume 1: drivers, consequences and responses, P83; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Garcia-Garizabal I, 2010, J HYDROL, V385, P36, DOI 10.1016/j.jhydrol.2010.02.002; Glantz M., 1999, CREEPING ENV PROBLEM; Global Water Partnership GWP, 2013, NAT STAK CONS WAT SU; Gordon LJ, 2008, TRENDS ECOL EVOL, V23, P211, DOI 10.1016/j.tree.2007.11.011; Hama T, 2012, IRRIGATION WATER MAN; Hitomi T, 2006, WATER SCI TECHNOL, V53, P101, DOI 10.2166/wst.2006.043; Holmes RM, 2000, WATER RESOUR RES, V36, P2309, DOI 10.1029/2000WR900099; Holmes RM, 2001, MAR CHEM, V75, P219, DOI 10.1016/S0304-4203(01)00038-X; Howarth RW, 2008, HARMFUL ALGAE, V8, P14, DOI 10.1016/j.hal.2008.08.015; Howden NJK, 2013, ANN ASSOC AM GEOGR, V103, P397, DOI 10.1080/00045608.2013.754672; IMF, 2008, REP UZB POV RED STRA; Jarsjo J, 2012, HYDROL EARTH SYST SC, V16, P1335, DOI 10.5194/hess-16-1335-2012; Kienzler KM, 2011, AGR SYST, V104, P411, DOI 10.1016/j.agsy.2011.01.005; Kienzler KM, 2010, THESIS RHEINISCHEN F; Kubota H, 1979, T JPN SOC IRRIG DRAI, V84, P22; Langbein WB, 1949, 52 US GEOL SURV US D, P52; Lassaletta L, 2012, BIOGEOSCIENCES, V9, P57, DOI 10.5194/bg-9-57-2012; Lassaletta L, 2009, SCI TOTAL ENVIRON, V407, P6034, DOI 10.1016/j.scitotenv.2009.08.002; Lohrenz SE, 2008, CONT SHELF RES, V28, P1466, DOI 10.1016/j.csr.2007.06.019; Ludwig W, 2009, PROG OCEANOGR, V80, P199, DOI 10.1016/j.pocean.2009.02.001; Luo PP, 2011, J ENVIRON MONITOR, V13, P2819, DOI 10.1039/c1em10339c; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Nasrulin A, 2002, J PROB MECH, V4, P38; Nezlin NP, 2004, J MARINE SYST, V47, P67, DOI 10.1016/j.jmarsys.2003.12.009; Oberhansli H, 2009, J MARINE SYST, V76, P310, DOI 10.1016/j.jmarsys.2008.03.019; Oelsner GP, 2007, J AM WATER RESOUR AS, V43, P850, DOI 10.1111/j.1752-1688.2007.00071.x; Olsson O, 2008, NATO SCI PEACE SECUR, P277, DOI 10.1007/978-1-4020-8960-2_20; Ongley ED, 1996, CROP EVAPOTRANSPIRAT, V55, P37; Passell HD, 2005, SCI TOTAL ENVIRON, V345, P239, DOI 10.1016/j.scitotenv.2004.11.010; Persson K, 2011, HYDROL EARTH SYST SC, V15, P3195, DOI 10.5194/hess-15-3195-2011; Rakhmatullaev S, 2010, ENVIRON EARTH SCI, V59, P1183, DOI 10.1007/s12665-009-0107-4; Roll G, 2004, REG WORKSH EUR CENTR; Saiko TA, 2000, APPL GEOGR, V20, P349, DOI 10.1016/S0143-6228(00)00014-X; Scheer C, 2009, PLANT SOIL, V314, P273, DOI 10.1007/s11104-008-9728-8; Scheer C, 2008, SOIL BIOL BIOCHEM, V40, P290, DOI 10.1016/j.soilbio.2007.08.007; Schepers J.S., 2008, NITROGEN AGR SYSTEMS; Schluter M, 2013, GLOBAL PLANET CHANGE, V110, P114, DOI 10.1016/j.gloplacha.2013.05.007; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Seitzinger SP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI [10.1029/2010GB003851, 10.1029/2009GB003587]; Seitzinger SP, 2002, ESTUARIES, V25, P640, DOI 10.1007/BF02804897; Shanafield M, 2010, BIOGEOCHEMISTRY, V101, P357, DOI 10.1007/s10533-010-9509-3; Shibuo Y, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031465; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Sobota DJ, 2009, BIOGEOCHEMISTRY, V94, P43, DOI 10.1007/s10533-009-9307-y; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Takeda I, 1997, WATER RES, V31, P2685, DOI 10.1016/S0043-1354(97)00117-6; Tao Y, 2010, ESTUAR COAST SHELF S, V86, P345, DOI 10.1016/j.ecss.2009.05.014; Taylor WA., 2000, CHANGE POINT ANAL PO; Thompson SE, 2011, WATER RESOUR RES, V47, DOI [10.1029/2010WR009605, 10.1029/2010WR009998]; Thorslund J, 2012, J ENVIRON MONITOR, V14, P2780, DOI 10.1039/c2em30643c; Tornqvist R, 2012, WATER RESOUR MANAG, V26, P949, DOI 10.1007/s11269-011-9819-9; Tornqvist R, 2011, SUSTAINABLE AGRICULTURAL DEVELOPMENT: RECENT APPROACHES IN RESOURCES MANAGEMENT AND ENVIRONMENTALLY-BALANCED PRODUCTION ENHANCEMENT, P157, DOI 10.1007/978-94-007-0519-7_11; Tornqvist R, 2011, ENVIRON INT, V37, P435, DOI 10.1016/j.envint.2010.11.006; TURC L., 1954, Annales Agronomiques, V5, P491; United States Environmental Protection Agency USEPA, 2005, 510R04002 USEPA; Urynowicz MA, 2007, J ENVIRON ENG, V133, P464, DOI 10.1061/(ASCE)0733-9372(2007)133:5(464); van Kessel C, 2009, J ENVIRON QUAL, V38, P393, DOI 10.2134/jeq2008.0277; Vanni MJ, 2001, BIOGEOCHEMISTRY, V54, P85, DOI 10.1023/A:1010681229460; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; Weng LP, 2002, ENVIRON SCI TECHNOL, V36, P4804, DOI 10.1021/es0200084; Who, 2011, GUID DRINK WAT QUAL, Vfourth, DOI DOI 10.1016/S1462-0758(00)00006-6; Yasin JA, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003568; Zhulidov AV, 2003, WATER QUALITY MONITO	91	23	23	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120015	10.1371/journal.pone.0120015	http://dx.doi.org/10.1371/journal.pone.0120015			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789866	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400123
J	Kundu, ST; Byers, LA; Peng, DH; Roybal, JD; Diao, L; Wang, J; Tong, P; Creighton, CJ; Gibbons, DL				Kundu, S. T.; Byers, L. A.; Peng, D. H.; Roybal, J. D.; Diao, L.; Wang, J.; Tong, P.; Creighton, C. J.; Gibbons, D. L.			The miR-200 family and the miR-183 similar to 96 similar to 182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; TRANSCRIPTIONAL REPRESSOR; DOWN-REGULATION; CELL-SURVIVAL; FEEDBACK LOOP; BOX PROTEINS; MICRORNAS; ZEB1; EMT	Metastatic lung cancer is one of the most lethal forms of cancer and molecular pathways driving metastasis are still not clearly elucidated. Metastatic cancer cells undergo an epithelial-mesenchymal transition (EMT) where they lose their epithelial properties and acquire a migratory and invasive phenotype. Here we identify that the expression of microRNAs from the miR-200 family and the miR-183 similar to 96 similar to 182 cluster are significantly co-repressed in non-small cell lung cancer cell lines and primary tumors from multiple TCGA dataset with high EMT scores. Ectopic expression of the miR-183 similar to 96 similar to 182 cluster inhibited cancer cell migration and invasion, whereas its expression was tightly modulated by miR-200. We identified Foxf2 as a common, novel and direct target of both these microRNA families. Foxf2 expression tightly correlates with the transcription factor Zeb1 and is elevated in mesenchymal-like metastatic lung cancer cells. Foxf2 expression induced robust EMT, migration, invasion and metastasis in lung cancer cells, whereas Foxf2 inhibition significantly repressed these phenotypes. We also demonstrated that Foxf2 transcriptionally represses E-cadherin and miR-200, independent of Zeb1, to form a double-negative feedback loop. We, therefore, identified a novel mechanism whereby the miR-200 family and the miR-183 similar to 96 similar to 182 cluster inhibit lung cancer invasion and metastasis by targeting Foxf2.	[Kundu, S. T.; Byers, L. A.; Peng, D. H.; Roybal, J. D.; Gibbons, D. L.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Diao, L.; Wang, J.; Tong, P.; Creighton, C. J.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Creighton, C. J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Med, Houston, TX 77030 USA; [Gibbons, D. L.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Gibbons, DL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd,Unit 432,Room FC9-2038, Houston, TX 77030 USA.	dlgibbon@mdanderson.org		Peng, David/0000-0003-0511-1888; Kundu, Samrat/0000-0002-0117-6986	NCI [K08 CA151661, CA125123]; MD Anderson Cancer Center Physician Scientist Award; Rexanna's Foundation for Fighting Lung Cancer; CDMRP Lung Cancer Research Program [W81XWH-12-10294]; CPRIT Graduate Scholar Training Grant [RP140106]; Lung SPORE [P50 CA070907]; Cancer Center Support Grant [CCSG CA016672]; Mary K. Chapman Foundation; CPRIT [RP120713]; Jeane F. Shelby Scholarship Fund; NATIONAL CANCER INSTITUTE [P30CA125123, K08CA151651, P30CA016672, P50CA070907] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MD Anderson Cancer Center Physician Scientist Award; Rexanna's Foundation for Fighting Lung Cancer; CDMRP Lung Cancer Research Program; CPRIT Graduate Scholar Training Grant; Lung SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Mary K. Chapman Foundation; CPRIT; Jeane F. Shelby Scholarship Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr J. Larner (University of Virginia Health System, VA) for the kind gift of the pTRIPZ-GFP vector. We thank Dr G. Goodall (University of Adelaide, Australia) for the kind gift of the miR-200 promoter reporter construct. 16 This work was supported by NCI K08 CA151661 (DLG), an MD Anderson Cancer Center Physician Scientist Award (DLG), Rexanna's Foundation for Fighting Lung Cancer (DLG), a CDMRP Lung Cancer Research Program award W81XWH-12-10294 (DLG and STK). DP was supported by a CPRIT Graduate Scholar Training Grant (RP140106). LD, JW, PT are supported by Lung SPORE (P50 CA070907), Cancer Center Support Grant (CCSG CA016672) and Mary K. Chapman Foundation. CJC was supported by CPRIT grant RP120713 and NCI grant CA125123. DLG and LAB are R. Lee Clark Fellows of the University of Texas MD Anderson Cancer Center, supported by the Jeane F. Shelby Scholarship Fund. We would like to thank members of the Gibbons lab for the assistance and critical reading of the manuscript.	Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Ahn YH, 2012, J CLIN INVEST, V122, P3170, DOI 10.1172/JCI63608; Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Browne G, 2010, CELL CYCLE, V9, P886, DOI 10.4161/cc.9.5.10839; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Feng Xiangling, 2014, Cancer Lett, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Huynh C, 2011, ONCOGENE, V30, P1481, DOI 10.1038/onc.2010.523; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Knouf EC, 2012, NUCLEIC ACIDS RES, V40, P499, DOI 10.1093/nar/gkr731; Kong PZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061591; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lei R, 2014, ONCOGENE, V33, P1287, DOI 10.1038/onc.2013.65; Li GR, 2010, J BIOL CHEM, V285, P5461, DOI 10.1074/jbc.M109.037127; Li XL, 2014, MOL CELL BIOL, V34, P533, DOI 10.1128/MCB.01043-13; Liu XG, 2012, MED ONCOL, V29, P618, DOI 10.1007/s12032-011-9923-y; Lo PK, 2013, EXP MOL PATHOL, V94, P262, DOI 10.1016/j.yexmp.2012.10.014; Lowery AJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-502; Mizuguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032449; Nik AM, 2013, GASTROENTEROLOGY, V144, P1001, DOI 10.1053/j.gastro.2013.01.045; Nilsson J, 2010, CANCER RES, V70, P2020, DOI 10.1158/0008-5472.CAN-09-1677; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Pacurari M, 2013, INT J ONCOL, V43, P548, DOI 10.3892/ijo.2013.1963; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pieraccioli M, 2013, CELL CYCLE, V12, P2309, DOI 10.4161/cc.25405; Roy SS, 2014, ONCOGENE, V33, P3707, DOI 10.1038/onc.2013.332; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Sun YH, 2010, BIOCHEM BIOPH RES CO, V396, P501, DOI 10.1016/j.bbrc.2010.04.127; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Wang T, 2003, DEV BIOL, V259, P83, DOI 10.1016/S0012-1606(03)00176-3; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xia LM, 2013, HEPATOLOGY, V57, P610, DOI 10.1002/hep.26029; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579; Zhao HE, 2012, INT J MOL MED, V30, P1013, DOI 10.3892/ijmm.2012.1111; Zheng H, 2014, ONCOGENE, V33, P1755, DOI 10.1038/onc.2013.128; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493; Zhu JF, 2012, AM J PATHOL, V180, P2440, DOI 10.1016/j.ajpath.2012.02.023	76	92	97	0	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2016	35	2					173	186		10.1038/onc.2015.71	http://dx.doi.org/10.1038/onc.2015.71			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB0JH	25798833	Green Accepted			2022-12-26	WOS:000368193900004
J	Estill, J; Salazar-Vizcaya, L; Blaser, N; Egger, M; Keiser, O				Estill, Janne; Salazar-Vizcaya, Luisa; Blaser, Nello; Egger, Matthias; Keiser, Olivia			The Cost-Effectiveness of Monitoring Strategies for Antiretroviral Therapy of HIV Infected Patients in Resource-Limited Settings: Software Tool	PLOS ONE			English	Article							CD4 CELL COUNT; VIRAL LOAD; SOUTHERN AFRICA; TRANSMISSION; ADHERENCE; PROGRAMS; OUTCOMES; MALAWI; COHORT; ADULTS	Background The cost-effectiveness of routine viral load (VL) monitoring of HIV-infected patients on anti-retroviral therapy (ART) depends on various factors that differ between settings and across time. Low-cost point-of-care (POC) tests for VL are in development and may make routine VL monitoring affordable in resource-limited settings. We developed a software tool to study the cost-effectiveness of switching to second-line ART with different monitoring strategies, and focused on POC-VL monitoring. Methods We used a mathematical model to simulate cohorts of patients from start of ART until death. We modeled 13 strategies (no 2nd-line, clinical, CD4 (with or without targeted VL), POC-VL, and laboratory-based VL monitoring, with different frequencies). We included a scenario with identical failure rates across strategies, and one in which routine VL monitoring reduces the risk of failure. We compared lifetime costs and averted disability-adjusted life-years (DALYs). We calculated incremental cost-effectiveness ratios (ICER). We developed an Excel tool to update the results of the model for varying unit costs and cohort characteristics, and conducted several sensitivity analyses varying the input costs. Results Introducing 2nd-line ART had an ICER of US$1651-1766/DALY averted. Compared with clinical monitoring, the ICER of CD4 monitoring was US$1896-US$5488/DALY averted and VL monitoring US$951-US$5813/DALY averted. We found no difference between POC- and laboratory-based VL monitoring, except for the highest measurement frequency (every 6 months), where laboratory-based testing was more effective. Targeted VL monitoring was on the cost-effectiveness frontier only if the difference between 1st- and 2nd-line costs remained large, and if we assumed that routine VL monitoring does not prevent failure. Conclusion Compared with the less expensive strategies, the cost-effectiveness of routine VL monitoring essentially depends on the cost of 2nd-line ART. Our Excel tool is useful for determining optimal monitoring strategies for specific settings, with specific sex-and age-distributions and unit costs.	[Estill, Janne; Salazar-Vizcaya, Luisa; Blaser, Nello; Egger, Matthias; Keiser, Olivia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Egger, Matthias] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa	University of Bern; University of Cape Town	Estill, J (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	janne.estill@ispm.unibe.ch	Blaser, Nello/V-1028-2019	Blaser, Nello/0000-0001-9489-1657; Keiser, Olivia/0000-0001-8191-2789; Egger, Matthias/0000-0001-7462-5132; Salazar-Vizcaya, Luisa/0000-0003-0527-0141	UNITAID; National Institutes of Health (NIH) [U01AI069924]; Swiss National Science Foundation [32333B_131629, PDFMP3_137106]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	UNITAID; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	UNITAID, www.unitaid.eu; National Institutes of Health (NIH), grant U01AI069924; Swiss National Science Foundation, grants 32333B_131629 and PDFMP3_137106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2011, ASSA2008 MOD; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Blaser N, 2014, J STAT SOFT IN PRESS; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Braithwaite RS, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-38; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Estill J, 2014, JAIDS-J ACQ IMM DEF, V65, pE179, DOI 10.1097/QAI.0000000000000075; Estill J, 2013, AIDS, V27, P1483, DOI 10.1097/QAD.0b013e328360a4e5; Estill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057611; Estill J, 2012, AIDS, V26, P1403, DOI 10.1097/QAD.0b013e3283536988; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Hamers RL, 2012, AIDS, V26, P1663, DOI 10.1097/QAD.0b013e3283560678; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; International Monetary Fund, 2014, WORLD ECONOMIC AND F; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Joint United Nations Programme on HIV/AIDS (UNAIDS) and Medecines Sans Frontieres (MSF), 2012, SPEED SCAL UP STRAT; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Keebler D, 2014, LANCET GLOB HEALTH, V2, pE35, DOI 10.1016/S2214-109X(13)70048-2; Kimmel AD, 2010, JAIDS-J ACQ IMM DEF, V54, P258, DOI 10.1097/QAI.0b013e3181d0db97; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Orrell C, 2007, ANTIVIR THER, V12, P83; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Rousseau C, 2012, HIV POINT CARE VIRAL; Salazar Vizcaya L, 2014, GEMS GEN MULTISTATE; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; UNITAID, 2013, HIV AIDS DIAGN TECHN; Vijayaraghavan A, 2007, JAIDS-J ACQ IMM DEF, V46, P91; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Walensky RP, 2010, CLIN INFECT DIS, V51, P85, DOI 10.1086/653119; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; World Health Organization, 2004, GLOB BURD DIS 2004 U; World Health Organization, 2001, MACR HLTH INV HLTH E; Zoufaly A, 2014, J ANTIMICRO IN PRESS	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119299	10.1371/journal.pone.0119299	http://dx.doi.org/10.1371/journal.pone.0119299			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793531	Green Published			2022-12-26	WOS:000352084200070
J	Lautenschlager, I; Frerichs, I; Dombrowsky, H; Sarau, J; Goldmann, T; Zitta, K; Albrecht, M; Weiler, N; Uhlig, S				Lautenschlaeger, Ingmar; Frerichs, Inez; Dombrowsky, Heike; Sarau, Juergen; Goldmann, Torsten; Zitta, Karina; Albrecht, Martin; Weiler, Norbert; Uhlig, Stefan			Quinidine, but Not Eicosanoid Antagonists or Dexamethasone, Protect the Gut from Platelet Activating Factor-Induced Vasoconstriction, Edema and Paralysis	PLOS ONE			English	Article							CHEEK POUCH MICROCIRCULATION; INFLAMMATORY-BOWEL-DISEASE; RAT MESENTERIC-ARTERY; NITRIC-OXIDE SYNTHASE; SMALL-INTESTINE; RECEPTOR ANTAGONIST; REPERFUSION INJURY; NECROTIZING ENTEROCOLITIS; MUCOSAL PERMEABILITY; PULMONARY-EDEMA	Intestinal circulatory disturbances, atony, edema and swelling are of great clinical relevance, but the relatedmechanisms and possible therapeutic options are poorly characterized, in part because of the difficulties to comprehensively analyze these conditions. To overcome these limitations we have developed a model of the isolated perfused rat small intestine where all of these symptoms can be studied simultaneously. Here we used this model to study the role of eicosanoids, steroids and quinidine in platelet-activating factor (PAF)-induced intestinal disorders. A vascular bolus of PAF (0.5 nmol) triggered release of thromboxane and peptidoleukotrienes into the vascular bed (peak concentration 35 nM and 0.8 nM) and reproduced all symptoms of intestinal failure: mesenteric vasoconstriction, translocation of fluid and macromolecules from the vasculature to the lumen and lymphatics, intestinal edema formation, loss of intestinal peristalsis and decreased galactose uptake. All effects of PAF were abolished by the PAF-receptor antagonist ABT491 (2.5 mu M). The COX and LOX inhibitors ASA and AA861 (500 mu M, 10 mu M) did not exhibit barrier-protective effects and the eicosanoid antagonists SQ29548 and MK571 (10 mu M, each) only moderately attenuated the loss of vascular fluid, the redistribution to the lumen and the transfer of FITC dextran to the lumen. The steroid dexamethasone (10 mu M) showed no barrier-protective properties and failed to prevent edema formation. Quinidine (100 mu M) inhibited the increase in arterial pressure, stabilized all the intestinal barriers, and reduced lymph production and the transfer of FITC dextran to the lymph. While quinidine by itself reduced peristalsis, it also obviated paralysis, preserved intestinal functions and prevented edema formation. We conclude that quinidine exerts multiple protective effects against vasoconstriction, edema formation and paralysis in the intestine. The therapeutic use of quinidine for intestinal ailments deserves further study.	[Lautenschlaeger, Ingmar; Frerichs, Inez; Zitta, Karina; Albrecht, Martin; Weiler, Norbert] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Lautenschlaeger, Ingmar; Dombrowsky, Heike; Sarau, Juergen] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Barrier Integr, Borstel, Germany; [Sarau, Juergen] Leibniz Ctr Med & Biosci, Div Mucosal Immunol & Diagnost, Res Ctr Borstel, Borstel, Germany; [Goldmann, Torsten] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Clin & Expt Pathol, Borstel, Germany; [Uhlig, Stefan] Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany	University of Kiel; Schleswig Holstein University Hospital; Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel; RWTH Aachen University	Lautenschlager, I (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.	ingmar.lautenschlaeger@uksh.de	Goldmann, Torsten/E-5906-2010; Uhlig, Stefan/A-7290-2014; Frerichs, I./AAT-3685-2021; Albrecht, Martin/AAW-9303-2021	Goldmann, Torsten/0000-0002-1621-560X; Uhlig, Stefan/0000-0003-2332-1280; Frerichs, I./0000-0002-7712-6539; Albrecht, Martin/0000-0003-2580-768X				Adamson RH, 2003, AM J PHYSIOL-HEART C, V285, pH406, DOI 10.1152/ajpheart.00021.2003; [Anonymous], 2009, EUR RESP J; Arumugam TV, 2003, BRIT J PHARMACOL, V140, P71, DOI 10.1038/sj.bjp.0705402; BARNATAN MF, 1995, J SURG RES, V58, P38, DOI 10.1006/jsre.1995.1007; Ben-Zvi I, 2012, CLIN REV ALLERG IMMU, V42, P145, DOI 10.1007/s12016-010-8243-x; BOUGHTONSMITH NK, 1993, BRIT J PHARMACOL, V110, P1189, DOI 10.1111/j.1476-5381.1993.tb13940.x; Buchholz BM, 2010, NEUROGASTROENT MOTIL, V22, P232, DOI 10.1111/j.1365-2982.2009.01464.x; Charous BL, 1998, J ALLERGY CLIN IMMUN, V102, P198, DOI 10.1016/S0091-6749(98)70086-7; CHASIN M, 1978, BIOCHEM PHARMACOL, V27, P2065, DOI 10.1016/0006-2952(78)90070-9; CHIBA Y, 1990, N-S ARCH PHARMACOL, V341, P68; Claing A, 2002, BRIT J PHARMACOL, V135, P433, DOI 10.1038/sj.bjp.0704441; CLAING A, 1994, BRIT J PHARMACOL, V112, P1202, DOI 10.1111/j.1476-5381.1994.tb13211.x; DILLON PK, 1988, CIRC RES, V62, P732, DOI 10.1161/01.RES.62.4.732; DILLON PK, 1988, CIRC RES, V62, P722, DOI 10.1161/01.RES.62.4.722; Dombrowsky H, 2011, J NUTR, V141, P1635, DOI 10.3945/jn.111.143016; Ewer AK, 2004, GUT, V53, P207, DOI 10.1136/gut.2003.024521; Falk S, 1999, AM J RESP CRIT CARE, V160, P1734, DOI 10.1164/ajrccm.160.5.9902033; FERGUSON MK, 1988, J SURG RES, V44, P172, DOI 10.1016/0022-4804(88)90046-7; Gantner F, 1995, EUR J PHARMACOL, V294, P353, DOI 10.1016/0014-2999(95)00724-5; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Goggel R, 2002, AM J RESP CRIT CARE, V166, P657, DOI 10.1164/rccm.20011.0710C; GOLDENBERG MM, 1984, PROSTAGLANDINS, V28, P271, DOI 10.1016/0090-6980(84)90062-5; HSUEH W, 1986, J CLIN INVEST, V78, P108, DOI 10.1172/JCI112538; Huston M, 2006, J EMERG MED, V31, P395, DOI 10.1016/j.jemermed.2006.07.018; Inama G, 2010, J CARDIOVASC MED, V11, P143, DOI 10.2459/JCM.0b013e3283313525; INOUE H, 1993, BRIT J PHARMACOL, V110, P1614, DOI 10.1111/j.1476-5381.1993.tb14009.x; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Karres I, 1998, AM J PHYSIOL-REG I, V274, pR1058, DOI 10.1152/ajpregu.1998.274.4.R1058; Katsanos KH, 2012, J CROHNS COLITIS, V6, P735, DOI 10.1016/j.crohns.2012.03.005; KING JN, 1990, J VET PHARMACOL THER, V13, P333, DOI 10.1111/j.1365-2885.1990.tb00786.x; KOBAYASH.S, 1968, JPN J PHARMACOL, V18, P80, DOI 10.1254/jjp.18.80; Kosior DA, 2009, CARDIOL J, V16, P521; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Lautenschlager I, 2010, AM J PHYSIOL-GASTR L, V298, pG304, DOI 10.1152/ajpgi.00313.2009; LEVY S, 1994, J CARDIOVASC ELECTR, V5, P635, DOI 10.1111/j.1540-8167.1994.tb01304.x; Malagon I, 2005, J THORAC CARDIOV SUR, V130, P265, DOI 10.1016/j.jtcvs.2005.02.047; Million M, 1997, EUR J PHARMACOL, V334, P67, DOI 10.1016/S0014-2999(97)01142-4; MION F, 1994, GUT, V35, P490, DOI 10.1136/gut.35.4.490; Misra UK, 1997, J CELL BIOCHEM, V64, P225, DOI 10.1002/(SICI)1097-4644(199702)64:2<225::AID-JCB6>3.0.CO;2-Z; Muguruma K, 1997, ADV EXP MED BIOL, V407, P379; Nagar J, 2014, INT IMMUNOPHARMACOL, V21, P328, DOI 10.1016/j.intimp.2014.05.005; Oketani K, 2001, EUR J PHARMACOL, V427, P159, DOI 10.1016/S0014-2999(01)01234-1; PELLON MI, 1994, BRIT J PHARMACOL, V112, P1101, DOI 10.1111/j.1476-5381.1994.tb13197.x; Picado C, 2006, CURR ALLERGY ASTHM R, V6, P198, DOI 10.1007/s11882-006-0035-2; PONS L, 1989, LIFE SCI, V45, P533, DOI 10.1016/0024-3205(89)90104-5; Qu XW, 2005, CRIT CARE MED, V33, P1050, DOI 10.1097/01.CCM.0000162908.14887.36; Santos FA, 1998, J PHARM PHARMACOL, V50, P225, DOI 10.1111/j.2042-7158.1998.tb06180.x; Souza DG, 2003, BRIT J PHARMACOL, V139, P733, DOI 10.1038/sj.bjp.0705296; STAHL GL, 1987, BLOOD VESSELS, V24, P24; Szabo A, 1997, SHOCK, V8, P284, DOI 10.1097/00024382-199710000-00008; Szczeklik A, 2003, J ALLERGY CLIN IMMUN, V111, P913, DOI 10.1067/mai.2003.1487; TABUCHI Y, 1995, EUR J PHARMACOL, V273, P281, DOI 10.1016/0014-2999(94)00739-T; Tan XD, 2000, BRIT J PHARMACOL, V129, P1522, DOI 10.1038/sj.bjp.0702939; Uhlig S, 2005, PHARMACOL REP, V57, P206; Uhlig S, 1996, MOL MED, V2, P373, DOI 10.1007/BF03401635; UHLIG S, 1994, J APPL PHYSIOL, V77, P262, DOI 10.1152/jappl.1994.77.1.262; Valeski JE, 2003, MICROCIRCULATION, V10, P411, DOI 10.1038/sj.mn.7800202; VANRENTERGHEM C, 1995, J NEUROCHEM, V65, P1274; Victorino GP, 2004, J TRAUMA, V56, P379, DOI 10.1097/01.TA.0000042156.89779.6C; VINARDELL MP, 1987, COMP BIOCHEM PHYS A, V86, P617, DOI 10.1016/0300-9629(87)90611-6; Viskin S, 2013, J AM COLL CARDIOL, V61, P2383, DOI 10.1016/j.jacc.2013.02.077; WALLACE JL, 1988, DIGEST DIS SCI, V33, P225, DOI 10.1007/BF01535737; WALLACE JL, 1988, EUR J PHARMACOL, V151, P43, DOI 10.1016/0014-2999(88)90690-5; YARWOOD H, 1993, BRIT J PHARMACOL, V108, P959, DOI 10.1111/j.1476-5381.1993.tb13492.x; Yost CC, 2010, BIOCHIMIE, V92, P692, DOI 10.1016/j.biochi.2010.02.011; Zhou H, 2004, INT IMMUNOPHARMACOL, V4, P223, DOI 10.1016/j.intimp.2003.12.006	66	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120802	10.1371/journal.pone.0120802	http://dx.doi.org/10.1371/journal.pone.0120802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793535	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900077
J	Shih, CH; Chen, HY; Lee, HC; Tsai, HJ				Shih, Chen-Han; Chen, Hsiao-Yin; Lee, Hung-Chieh; Tsai, Huai-Jen			Purple Chromoprotein Gene Serves as a New Selection Marker for Transgenesis of the Microalga Nannochloropsis oculata	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII CHLOROPLAST; SITE-SPECIFIC RECOMBINATION; DOMINANT SELECTABLE MARKER; NUCLEAR TRANSFORMATION; REPORTER GENE; HEAT-SHOCK; PLANTS; EXPRESSION; EXCISION; REMOVAL	Among the methods used to screen transgenic microalgae, antibiotics selection has raised environmental and food safety concerns, while the observation of fluorescence proteins could be influenced by the endogenous fluorescence of host chloroplasts. As an alternative, this study isolated the purple chromoprotein (CP) from Stichodacyla haddoni (shCP). A plasmid in which shCP cDNA is driven by a heat-inducible promoter was linearized and electroporated into 2.5x10(8) protoplasts of Nannochloropsis oculata. Following regeneration and cultivation on an f/2 medium plate for two weeks, we observed 26 colonies that displayed a slightly dark green coloration. After individually subculturing and performing five hours of heat shock at 42 degrees C, a dark brown color was mosaically displayed in five of these colonies, indicating that both untransformed and transformed cells were mixed together in each colony. To obtain a uniform expression of shCP throughout the whole colony, we continuously isolated each transformed cell that exhibited brown coloration and subcultured it on a fresh plate, resulting in the generation of five transgenic lines of N. oculata which stably harbored the shCP gene for at least 22 months, as confirmed by PCR detection and observation by the naked eye. As shown by Western blot, exogenous shCP protein was expressed in these transgenic microalgae. Since shCP protein is biodegradable and originates from a marine organism, both environmental and food safety concerns have been eliminated, making this novel shCP reporter gene a simple, but effective and ecologically safe, marker for screening and isolating transgenic microalgae.	[Shih, Chen-Han; Chen, Hsiao-Yin; Lee, Hung-Chieh; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Lee, Hung-Chieh; Tsai, Huai-Jen] MacKay Med Coll, Inst Biomed Sci, New Taipei City, Taiwan	National Taiwan University; Mackay Medical College	Tsai, HJ (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	hjtsai@ntu.edu.tw			National Science Council, Taiwan [NSC 103-2313-B-002 -048 -MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan, under grant NSC 103-2313-B-002 -048 -MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt FCT, 2000, United States of America Patent Number, Patent No. 6027900; Apt KE, 1999, J PHYCOL, V35, P215, DOI 10.1046/j.1529-8817.1999.3520215.x; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Atkins TW, 1998, BIOMATERIALS, V19, P61, DOI 10.1016/S0142-9612(97)00156-7; Bhattacharya Anjanabha, 2012, Methods Mol Biol, V877, P401, DOI 10.1007/978-1-61779-818-4_29; Chen HC, 2013, PLANT BIOTECHNOL J, V11, P818, DOI 10.1111/pbi.12073; Chen Y, 2001, CURR GENET, V39, P365, DOI 10.1007/s002940100205; Chiang CY, 2014, MAR BIOTECHNOL, V16, P436, DOI 10.1007/s10126-014-9563-2; Coll JM, 2006, SPAN J AGRIC RES, V4, P316; Coppoolse ER, 2003, PLANT MOL BIOL, V51, P263, DOI 10.1023/A:1021174726070; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; Dawson HN, 1997, CURR MICROBIOL, V35, P356, DOI 10.1007/s002849900268; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; Duerr EO, 1998, J MAR BIOTECHNOL, V6, P65; FERNANDEZ E, 1989, P NATL ACAD SCI USA, V86, P6449, DOI 10.1073/pnas.86.17.6449; Fischer N, 1996, MOL GEN GENET, V251, P373, DOI 10.1007/s004380050179; Franklin S, 2002, PLANT J, V30, P733, DOI 10.1046/j.1365-313X.2002.01319.x; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3., 10.1007/978-1-4615-8714-9_3]; HALL LM, 1993, GENE, V124, P75, DOI 10.1016/0378-1119(93)90763-S; Hare PD, 2002, NAT BIOTECHNOL, V20, P575, DOI 10.1038/nbt0602-575; Heifetz PB, 2000, BIOCHIMIE, V82, P655, DOI 10.1016/S0300-9084(00)00608-8; Heitzer M, 2007, ADV EXP MED BIOL, V616, P46; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Klaus SMJ, 2004, NAT BIOTECHNOL, V22, P225, DOI 10.1038/nbt933; KROPAT J, 1995, MOL GEN GENET, V248, P727, DOI 10.1007/BF02191713; Kropat J, 1997, P NATL ACAD SCI USA, V94, P14168, DOI 10.1073/pnas.94.25.14168; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Lauersen KJ, 2013, J BIOTECHNOL, V167, P101, DOI 10.1016/j.jbiotec.2012.10.010; Lavens P, 1996, FAO FISHERIES TECHNI; Li SS, 2009, FISH SHELLFISH IMMUN, V26, P316, DOI 10.1016/j.fsi.2008.07.004; Lim FY, 2012, METHOD ENZYMOL, V517, P303, DOI 10.1016/B978-0-12-404634-4.00015-2; Mats B, 2002, BR PHYCOL J, V2, P401; Mayfield SP, 2004, PLANT J, V37, P449, DOI 10.1046/j.1365-313X.2003.01965.x; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; NELSON JAE, 1994, MOL CELL BIOL, V14, P4011, DOI 10.1128/MCB.14.6.4011; ONOUCHI H, 1995, MOL GEN GENET, V247, P653, DOI 10.1007/BF00290396; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Rochaix JD, 1997, TRENDS PLANT SCI, V2, P419, DOI 10.1016/S1360-1385(97)90025-X; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x; Scutt CP, 2002, BIOCHIMIE, V84, P1119, DOI 10.1016/S0300-9084(02)00021-4; Shields RJ, 2012, J ANIM SCI, V21, P23; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Sreekala C, 2005, PLANT CELL REP, V24, P86, DOI 10.1007/s00299-004-0909-5; Srivastava V, 1999, P NATL ACAD SCI USA, V96, P11117, DOI 10.1073/pnas.96.20.11117; Stevens DR, 1996, MOL GEN GENET, V251, P23; SUKENIK A, 1991, AQUACULTURE, V97, P61, DOI 10.1016/0044-8486(91)90279-G; Trautwein EA, 2001, EUR J LIPID SCI TECH, V103, P45, DOI 10.1002/1438-9312(200101)103:1<45::AID-EJLT45>3.0.CO;2-9; Upadhyaya CP, 2010, BOT STUD, V51, P277; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Wang HH, 2009, J GENET GENOMICS, V36, P387, DOI 10.1016/S1673-8527(08)60128-9; Woo HJ, 2009, TRANSGENIC RES, V18, P455, DOI 10.1007/s11248-008-9236-x; Yamaguchi K., 1997, J APPL PHYCOL, V8, P487; Yau YY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-36; Zhang W, 2003, THEOR APPL GENET, V107, P1157, DOI 10.1007/s00122-003-1368-z; Zuo JR, 2001, NAT BIOTECHNOL, V19, P157, DOI 10.1038/84428	56	11	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120780	10.1371/journal.pone.0120780	http://dx.doi.org/10.1371/journal.pone.0120780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793255	gold, Green Submitted, Green Published			2022-12-26	WOS:000352083900075
J	Bakke, SS; Feng, YZ; Nikolic, N; Kase, ET; Moro, C; Stensrud, C; Damlien, L; Ludahl, MO; Sandbu, R; Solheim, BM; Rustan, AC; Hjelmesaeth, J; Thoresen, GH; Aas, V				Bakke, Siril S.; Feng, Yuan Z.; Nikolic, Natasa; Kase, Eili T.; Moro, Cedric; Stensrud, Camilla; Damlien, Lisbeth; Ludahl, Marianne O.; Sandbu, Rune; Solheim, Brita Marie; Rustan, Arild C.; Hjelmesaeth, Joran; Thoresen, G. Hege; Aas, Vigdis			Myotubes from Severely Obese Type 2 Diabetic Subjects Accumulate Less Lipids and Show Higher Lipolytic Rate than Myotubes from Severely Obese Non-Diabetic Subjects	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; FATTY-ACID OXIDATION; HORMONE-SENSITIVE LIPASE; INSULIN-RESISTANCE; MITOCHONDRIAL-FUNCTION; EXPRESSION; MEN; TRIACYLGLYCEROL; DIACYLGLYCEROL; MYOCYTES	About 80% of patients with type 2 diabetes are classified as overweight. However, only about 1/3 of severely obese subjects have type 2 diabetes. This indicates that several severely obese individuals may possess certain characteristics that protect them against type 2 diabetes. We therefore hypothesized that this apparent paradox could be related to fundamental differences in skeletal muscle lipid handling. Energy metabolism and metabolic flexibility were examined in human myotubes derived from severely obese subjects without (BMI 44 +/- 7 kg/m(2)) and with type 2 diabetes (BMI 43 +/- 6 kg/m(2)). Lower insulin sensitivity was observed in myotubes from severely obese subjects with type 2 diabetes. Lipolysis rate was higher, and oleic acid accumulation, triacylglycerol content, and fatty acid adaptability were lower in myotubes from severely obese subjects with type 2 diabetes compared to severely obese non-diabetic subjects. There were no differences in lipid distribution and mRNA and protein expression of the lipases HSL and ATGL, the lipase cofactor CGI-58, or the lipid droplet proteins PLIN2 and PLIN3. Glucose and oleic acid oxidation were also similar in cells from the two groups. In conclusion, myotubes established from severely obese donors with established type 2 diabetes had lower ability for lipid accumulation and higher lipolysis rate than myotubes from severely obese donors without diabetes. This indicates that a difference in intramyocellular lipid turnover might be fundamental in evolving type 2 diabetes.	[Bakke, Siril S.; Feng, Yuan Z.; Nikolic, Natasa; Kase, Eili T.; Stensrud, Camilla; Damlien, Lisbeth; Rustan, Arild C.; Thoresen, G. Hege] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Moro, Cedric] Univ Toulouse, Inst Metab & Cardiovasc Dis, INSERM, Unite Mixte Rech 1048,Obes Res Lab, Toulouse, France; [Ludahl, Marianne O.; Aas, Vigdis] Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth, Oslo, Norway; [Sandbu, Rune; Solheim, Brita Marie; Hjelmesaeth, Joran] Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway; [Hjelmesaeth, Joran; Thoresen, G. Hege] Univ Oslo, Fac Med, Inst Clin Med, Dept Pharmacol, Oslo, Norway; [Hjelmesaeth, Joran; Thoresen, G. Hege] Oslo Univ Hosp, Oslo, Norway	University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo	Aas, V (corresponding author), Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth, Oslo, Norway.	vigdis.aas@hioa.no	, Natasa/X-3265-2019; Moro, Cedric/N-5754-2017	, Natasa/0000-0001-9614-9050; Moro, Cedric/0000-0003-4294-0597	Norwegian Research Council, Oslo and Akershus University College of Applied Sciences; National Research Agency [ANR-12-JSV1-0010-01]; Societe Francophone du Diabete	Norwegian Research Council, Oslo and Akershus University College of Applied Sciences; National Research Agency(French National Research Agency (ANR)); Societe Francophone du Diabete	This work was supported by grants from Norwegian Research Council, Oslo and Akershus University College of Applied Sciences. The authors would also thank NBS (Norwegian biochemical society) and Diabetesforbundet for their contributions. CM is supported by grants from the National Research Agency ANR-12-JSV1-0010-01 and Societe Francophone du Diabete. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas V, 2006, J LIPID RES, V47, P366, DOI 10.1194/jlr.M500300-JLR200; Badin PM, 2013, TRENDS ENDOCRIN MET, V24, P607, DOI 10.1016/j.tem.2013.08.001; Badin PM, 2011, DIABETES, V60, P1734, DOI 10.2337/db10-1364; Bakke SS, 2012, BBA-MOL CELL BIOL L, V1821, P1323, DOI 10.1016/j.bbalip.2012.07.001; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Bell JA, 2010, J CLIN ENDOCR METAB, V95, P3400, DOI 10.1210/jc.2009-1596; Bergman BC, 2012, DIABETOLOGIA, V55, P1140, DOI 10.1007/s00125-011-2419-7; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bikman BT, 2010, AM J PHYSIOL-REG I, V298, pR1692, DOI 10.1152/ajpregu.00190.2009; Boyle KE, 2012, INT J OBESITY, V36, P1025, DOI 10.1038/ijo.2011.201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucci M, 2011, AM J PHYSIOL-ENDOC M, V301, pE105, DOI 10.1152/ajpendo.00680.2010; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Consitt LA, 2010, DIABETES, V59, P1407, DOI 10.2337/db09-1704; Corpeleijn E, 2008, OBESITY, V16, P1025, DOI 10.1038/oby.2008.24; Corpeleijn E, 2010, AM J PHYSIOL-ENDOC M, V299, pE14, DOI 10.1152/ajpendo.00187.2010; Dela F, 2013, INT J BIOCHEM CELL B, V45, P11, DOI 10.1016/j.biocel.2012.09.019; Galgani JE, 2013, J CLIN ENDOCR METAB, V98, pE646, DOI 10.1210/jc.2012-3111; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Gaster M, 2011, BIOCHEM BIOPH RES CO, V404, P1023, DOI 10.1016/j.bbrc.2010.12.102; Gjelstad IMF, 2012, ARCH PHYSIOL BIOCHEM, V118, P22, DOI 10.3109/13813455.2011.630009; Hessvik NP, 2010, J LIPID RES, V51, P2090, DOI 10.1194/jlr.M003319; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Hofso D, 2010, OBES SURG, V20, P302, DOI 10.1007/s11695-009-0022-5; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Holm C, 2000, METH MOL B, V155, P97; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Jocken JWE, 2008, DIABETES, V57, P1834, DOI 10.2337/db07-0857; Jocken JWE, 2010, J CLIN ENDOCR METAB, V95, P5449, DOI 10.1210/jc.2010-0776; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Kitzmann M, 2011, BBA-MOL BASIS DIS, V1812, P423, DOI 10.1016/j.bbadis.2010.12.007; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Lanza IR, 2009, AM J CLIN NUTR, V89, p467S, DOI 10.3945/ajcn.2008.26717D; Moro C, 2008, AM J PHYSIOL-ENDOC M, V294, pE203, DOI 10.1152/ajpendo.00624.2007; Phielix E, 2011, GERONTOLOGY, V57, P387, DOI 10.1159/000317691; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Sparks LM, 2014, DIABETES, V63, P1583, DOI 10.2337/db13-1123; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Timmers S, 2012, P NATL ACAD SCI USA, V109, P11711, DOI 10.1073/pnas.1206868109; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; van Loon LJC, 2004, AM J PHYSIOL-ENDOC M, V287, pE558, DOI 10.1152/ajpendo.00464.2003; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; Wensaas AJ, 2009, DIABETES, V58, P527, DOI 10.2337/db08-1043	49	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119556	10.1371/journal.pone.0119556	http://dx.doi.org/10.1371/journal.pone.0119556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790476	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400089
J	Crew, JD; Galvin, JJ; Landsberger, DM; Fu, QJ				Crew, Joseph D.; Galvin, John J., III; Landsberger, David M.; Fu, Qian-Jie			Contributions of Electric and Acoustic Hearing to Bimodal Speech and Music Perception	PLOS ONE			English	Article							MELODIC CONTOUR IDENTIFICATION; COCHLEAR IMPLANT USERS; COMPETING INSTRUMENT; OPPOSITE EARS; RECOGNITION; STIMULATION; AID; RECIPIENTS; BENEFIT; NOISE	Cochlear implant (CI) users have difficulty understanding speech in noisy listening conditions and perceiving music. Aided residual acoustic hearing in the contralateral ear can mitigate these limitations. The present study examined contributions of electric and acoustic hearing to speech understanding in noise and melodic pitch perception. Data was collected with the CI only, the hearing aid (HA) only, and both devices together (CI+HA). Speech reception thresholds (SRTs) were adaptively measured for simple sentences in speech babble. Melodic contour identification (MCI) was measured with and without a masker instrument; the fundamental frequency of the masker was varied to be overlapping or non-overlapping with the target contour. Results showed that the CI contributes primarily to bimodal speech perception and that the HA contributes primarily to bimodal melodic pitch perception. In general, CI+HA performance was slightly improved relative to the better ear alone (CI-only) for SRTs but not for MCI, with some subjects experiencing a decrease in bimodal MCI performance relative to the better ear alone (HA-only). Individual performance was highly variable, and the contribution of either device to bimodal perception was both subject-and task-dependent. The results suggest that individualized mapping of CIs and HAs may further improve bimodal speech and music perception.	[Crew, Joseph D.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Galvin, John J., III; Fu, Qian-Jie] Univ Calif Los Angeles, Dept Head & Neck Surg, Los Angeles, CA USA; [Landsberger, David M.] NYU, Sch Med, Dept Otolaryngol, New York, NY USA	University of Southern California; University of California System; University of California Los Angeles; New York University	Crew, JD (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	jcrew@usc.edu			University of Southern California Provost Fellowship; University of Southern California Hearing and Communication Neuroscience Program; National Institutes of Health: National Institute on Deafness and Communication Disorders [R01-DC004993]; Paul Veneklasen Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009975, R01DC004993] Funding Source: NIH RePORTER	University of Southern California Provost Fellowship; University of Southern California Hearing and Communication Neuroscience Program; National Institutes of Health: National Institute on Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Paul Veneklasen Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the University of Southern California Provost Fellowship, the University of Southern California Hearing and Communication Neuroscience Program, National Institutes of Health: National Institute on Deafness and Communication Disorders R01-DC004993, and by the Paul Veneklasen Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong M, 1997, AM J OTOL, V18, pS140; Brown CA, 2009, EAR HEARING, V30, P489, DOI 10.1097/AUD.0b013e3181ab2b87; Chan JCY, 2008, INT J AUDIOL, V47, P296, DOI 10.1080/14992020802075407; Dillon MT, 2014, J AM ACAD AUDIOL, V25, P133, DOI 10.3766/jaaa.25.2.2; Dorman MF, 2008, AUDIOL NEURO-OTOL, V13, P105, DOI 10.1159/000111782; Dorman MF, 2010, INT J AUDIOL, V49, P912, DOI 10.3109/14992027.2010.509113; El Fata F, 2009, AUDIOL NEURO-OTOL, V14, P14, DOI 10.1159/000206491; Galvin JJ, 2008, J ACOUST SOC AM, V124, pEL189, DOI 10.1121/1.2961171; Galvin JJ, 2007, EAR HEARING, V28, P302, DOI 10.1097/01.aud.0000261689.35445.20; Galvin John J. III, 2012, Seminars in Hearing, V33, P399, DOI 10.1055/s-0032-1329227; Galvin JJ, 2011, J ACOUST SOC AM, V129, pEL39, DOI 10.1121/1.3531708; Galvin JJ, 2009, ANN NY ACAD SCI, V1169, P518, DOI 10.1111/j.1749-6632.2009.04551.x; Galvin JJ, 2009, J ACOUST SOC AM, V125, pEL98, DOI 10.1121/1.3062148; Gfeller K, 2005, EAR HEARING, V26, P237, DOI 10.1097/00003446-200506000-00001; Gfeller K, 2000, J Am Acad Audiol, V11, P390; Gfeller K, 2007, EAR HEARING, V28, P412, DOI 10.1097/AUD.0b013e3180479318; Gfeller K, 2012, ANN OTO RHINOL LARYN, V121, P782, DOI 10.1177/000348941212101203; Gfeller K, 2012, J MUSIC THER, V49, P68, DOI 10.1093/jmt/49.1.68; Gfeller Kate E, 2006, Audiol Neurootol, V11 Suppl 1, P12, DOI 10.1159/000095608; Gifford RH, 2007, J SPEECH LANG HEAR R, V50, P835, DOI 10.1044/1092-4388(2007/058); Kong YY, 2012, EAR HEARING, V33, P645, DOI 10.1097/AUD.0b013e318252caae; Kong YY, 2011, J SPEECH LANG HEAR R, V54, P959, DOI 10.1044/1092-4388(2010/10-0197); Kong YY, 2005, J ACOUST SOC AM, V117, P1351, DOI 10.1121/1.1857526; Limb CJ, 2012, OTOLARYNG CLIN N AM, V45, P129, DOI 10.1016/j.otc.2011.08.021; Looi V, 2008, EAR HEARING, V29, P1; Looi V, 2007, EAR HEARING, V28, p59S, DOI 10.1097/AUD.0b013e31803150cb; Looi V, 2011, INT J PEDIATR OTORHI, V75, P472, DOI 10.1016/j.ijporl.2010.12.023; Macherey O, 2013, EAR HEARING, V34, P426, DOI 10.1097/AUD.0b013e31827535f8; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; Mok M, 2006, J SPEECH LANG HEAR R, V49, P338, DOI 10.1044/1092-4388(2006/027); Mok M, 2010, AUDIOL NEURO-OTOL, V15, P44, DOI 10.1159/000219487; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Turner CW, 2004, J ACOUST SOC AM, V115, P1729, DOI 10.1121/1.1687425; Tyler RS, 2002, EAR HEARING, V23, P98, DOI 10.1097/00003446-200204000-00003; Yoon YS, 2012, J SPEECH LANG HEAR R, V55, P105, DOI 10.1044/1092-4388(2011/10-0325); Zhang T, 2013, EAR HEARING, V34, P133, DOI 10.1097/AUD.0b013e31826709af; Zhang T, 2010, EAR HEARING, V31, P195, DOI 10.1097/AUD.0b013e3181c4758d; Zhu MM, 2011, J ACOUST SOC AM, V130, P3562, DOI 10.1121/1.3658474	38	39	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120279	10.1371/journal.pone.0120279	http://dx.doi.org/10.1371/journal.pone.0120279			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25790349	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400148
J	Ferrin, G; Rodriguez-Peralvarez, M; Aguilar-Melero, P; Ranchal, I; Llamoza, C; Linares, CI; Gonzalez-Rubio, S; Muntane, J; Briceno, J; Lopez-Cillero, P; Montero-Alvarez, JL; de la Mata, M				Ferrin, Gustavo; Rodriguez-Peralvarez, Manuel; Aguilar-Melero, Patricia; Ranchal, Isidora; Llamoza, Camilo; Linares, Clara I.; Gonzalez-Rubio, Sandra; Muntane, Jordi; Briceno, Javier; Lopez-Cillero, Pedro; Luis Montero-Alvarez, Jose; de la Mata, Manuel			Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; LIVER-DISEASE; SERUM IMMUNOGLOBULINS; ANAPHYLATOXIN C5A; COMPLEMENT; FIBRINOGEN; CANCER; VIRUS; DYSFIBRINOGENEMIA; CARBOXYPEPTIDASE	Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers in the world, with limited options for treatment unless timely diagnosed. Chronic hepatitis C virus (HCV) infection and persistent heavy alcohol consumption are independent risk factors for HCC development, which may induce a specific protein expression pattern different from those caused separately. The aim of the study was to identify protein biomarkers for the detection of HCC in HCV-infected alcoholic patients with cirrhosis in order to improve survival. We compared protein expression profiles of plasma samples from 52 HCV-infected alcoholic patients with and without HCC, using 2-D DIGE coupled with MALDI-TOF/TOF mass spectrometry. The 2-D DIGE results were analyzed statistically using Decyder software, and verified by western-blot and ELISA. In plasma samples from HCV-infected alcoholic patients, we found significantly differential expression profiles of carboxypeptidase-N, ceruloplasmin (CP), complement component 4a (C4a), fibrinogen-alpha (FGA), immunoglobulin mu chain C region, serum albumin, and serum paraoxonase/arylesterase 1 (PON1). Deregulation of plasma/serum levels of the identified proteins was associated to HCV, ethanol consumption, and/or HCC progression. In the validation through ELISA, C4a serum concentration was increased in HCC patients (2.4 +/- 1 ng/mg vs 1.8 +/- 0.6 ng/mg; p = 0.029), being the only independent predictor of HCC in the multivariate analysis (OR = 2.15; p = 0.015), with an AUROC = 0.70. The combination of C4a, FGA, CP and PON1 improved slightly the predictive ability of C4a alone (AUROC 0.81). In conclusion, we identified proteins related to acute-phase response, oxidative stress, or immune response, whose differential expression in plasma may be attributed to the presence of HCC. Among them, C4a, and its combination with CP, FGA and PON1, could be considered as potentially reliable biomarkers for the detection of HCC in HCV-infected alcoholic patients.	[Ferrin, Gustavo; Rodriguez-Peralvarez, Manuel; Aguilar-Melero, Patricia; Ranchal, Isidora; Linares, Clara I.; Gonzalez-Rubio, Sandra; Muntane, Jordi; Briceno, Javier; Lopez-Cillero, Pedro; Luis Montero-Alvarez, Jose; de la Mata, Manuel] Reina Sofia Univ Hosp, Maimonides Inst Biomed Res Cordoba IMBIC, Cordoba, Spain; [Ferrin, Gustavo; Rodriguez-Peralvarez, Manuel; Ranchal, Isidora; Muntane, Jordi; Briceno, Javier; Lopez-Cillero, Pedro; Luis Montero-Alvarez, Jose; de la Mata, Manuel] Digest & Liver Dis CIBERehd, Biomed Res Ctr Network, Cordoba, Spain; [Rodriguez-Peralvarez, Manuel; Llamoza, Camilo; Briceno, Javier; Lopez-Cillero, Pedro; Luis Montero-Alvarez, Jose; de la Mata, Manuel] Reina Sofia Univ Hosp, Hepatol & Liver Transplantat Unit, Cordoba, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Ferrin, G (corresponding author), Reina Sofia Univ Hosp, Maimonides Inst Biomed Res Cordoba IMBIC, Cordoba, Spain.	gusfesa@gmail.com	Rodríguez-Perálvarez, Manuel/AAO-8616-2021; Rodríguez-perálvarez, Manuel/AGR-2409-2022; aguilar, patricia/L-6986-2014	Rodríguez-perálvarez, Manuel/0000-0002-1795-2919; aguilar, patricia/0000-0003-1396-5445; Linares, Clara Isabel/0000-0002-7621-5089; Ferrin, Gustavo/0000-0002-5744-3289; Ranchal, Isidora/0000-0001-7870-7768; Lopez Cillero, Pedro/0000-0002-2568-6438	Instituto de Salud Carlos III [FIS 07/0157]; Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas(CIBEREHD)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas(CIBEREHD)	This study was supported by grants to MDLM from the Instituto de Salud Carlos III (FIS 07/0157; http://www.isciii.es/), and to GF from the Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas(CIBEREHD; https://www.ciberehd.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2011, J VIROL, V85, P4157, DOI 10.1128/JVI.02449-10; Beneduce L, 2005, CANCER-AM CANCER SOC, V103, P2558, DOI 10.1002/cncr.21106; Biro L, 2000, IMMUNOL LETT, V72, P69, DOI 10.1016/S0165-2478(00)00183-8; Chang ML, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-51; CHANG WY, 1988, CANCER-AM CANCER SOC, V62, P227, DOI 10.1002/1097-0142(19880715)62:2<227::AID-CNCR2820620202>3.0.CO;2-D; ENTWISTLE RA, 1988, BIOCHEMISTRY-US, V27, P507, DOI 10.1021/bi00401a073; ERDOS EG, 1965, CLIN CHIM ACTA, V11, P39, DOI 10.1016/0009-8981(65)90087-2; Feng JT, 2005, PROTEOMICS, V5, P4581, DOI 10.1002/pmic.200401309; Ferrin G, 2014, LIVER INT, V34, P438, DOI 10.1111/liv.12277; Fye HKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068381; Garige M, 2010, METABOLISM, V59, P1372, DOI 10.1016/j.metabol.2009.12.025; Gonzalez-Quintela A, 2003, HEPATO-GASTROENTEROL, V50, P2121; GRALNICK HR, 1978, NEW ENGL J MED, V299, P221, DOI 10.1056/NEJM197808032990503; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; GUTTERIDGE JMC, 1985, CHEM-BIOL INTERACT, V56, P113, DOI 10.1016/0009-2797(85)90043-2; Kang XN, 2010, J CANCER RES CLIN, V136, P1151, DOI 10.1007/s00432-010-0762-6; Kanmura S, 2010, J GASTROENTEROL, V45, P459, DOI 10.1007/s00535-009-0160-5; Kim H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101422; Kolev M, 2011, ARCH IMMUNOL THER EX, V59, P407, DOI 10.1007/s00005-011-0146-x; Lakshman R, 2010, GENES NUTR, V5, P111, DOI 10.1007/s12263-009-0161-2; LANE DA, 1977, BRIT J HAEMATOL, V35, P301, DOI 10.1111/j.1365-2141.1977.tb00586.x; Liang Cynthia, 2012, Methods Mol Biol, V854, P181, DOI 10.1007/978-1-61779-573-2_13; LIPPI G, 1992, ITAL J GASTROENTEROL, V24, P383; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; LORENTZ K, 1979, CLIN CHEM, V25, P1714; LUZZATTO G, 1990, SEMIN ONCOL, V17, P147; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; MARTIN DM, 1984, LIVER, V4, P214; Matthews KW, 2004, MOL IMMUNOL, V40, P785, DOI 10.1016/j.molimm.2003.10.002; Mazumdar B, 2013, J VIROL, V87, P7902, DOI [10.1128/JVI.00917-13, 10.1128/JVI.00174-13]; Mazumdar B, 2012, J VIROL, V86, P2221, DOI 10.1128/JVI.06577-11; McKillop IH, 2009, SEMIN LIVER DIS, V29, P222, DOI 10.1055/s-0029-1214377; Na Keun, 2012, Methods Mol Biol, V854, P223, DOI 10.1007/978-1-61779-573-2_16; Nitta H, 2014, ONCOL REP, V32, P1715, DOI 10.3892/or.2014.3341; Nitta H, 2013, CLIN CANCER RES, V19, P2004, DOI 10.1158/1078-0432.CCR-12-1204; Precourt LP, 2011, ATHEROSCLEROSIS, V214, P20, DOI 10.1016/j.atherosclerosis.2010.08.076; Qin XB, 2006, CELL MOL IMMUNOL, V3, P333; Schiff ER, 2003, ALCOHOL RES HEALTH, V27, P232; SCHWEISFURTH H, 1985, CLIN BIOCHEM, V18, P242, DOI 10.1016/S0009-9120(85)80049-7; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; Siu L, 2009, SEMIN LIVER DIS, V29, P188, DOI 10.1055/s-0029-1214374; VERHAEGEN H, 1976, CANCER, V38, P1608, DOI 10.1002/1097-0142(197610)38:4<1608::AID-CNCR2820380427>3.0.CO;2-6; Vollmers HP, 2009, NEW BIOTECHNOL, V25, P294, DOI 10.1016/j.nbt.2009.03.016; Yang MH, 2007, ANAL BIOANAL CHEM, V388, P637, DOI 10.1007/s00216-007-1263-6; YUKI N, 1995, HEPATOLOGY, V22, P402, DOI 10.1002/hep.1840220205; Zhu WL, 2009, ANTICANCER RES, V29, P2531	47	24	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118527	10.1371/journal.pone.0118527	http://dx.doi.org/10.1371/journal.pone.0118527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789864	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400033
J	Karlsen, M; Hansen, T; Nordal, HH; Brun, JG; Jonsson, R; Appel, S				Karlsen, Marie; Hansen, Torbjorn; Nordal, Hilde H.; Brun, Johan G.; Jonsson, Roland; Appel, Silke			Expression of Toll-Like Receptor-7 and-9 in B Cell Subsets from Patients with Primary Sjogren's Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; BLOOD MONONUCLEAR-CELLS; CLASSIFICATION CRITERIA; AUTOANTIBODY PRODUCTION; SALIVARY-GLANDS; UP-REGULATION; DOUBLE-BLIND; ACTIVATION; TLR9; RITUXIMAB	Introduction Sjogren's syndrome (SS) is a rheumatic autoimmune disease characterized by inflammation of exocrine glands. As autoantibodies are present in a majority of patients, B cells have been suggested to play an important role in onset and development of the disease. Toll-like receptors (TLRs) are pattern recognition receptors triggering innate immune responses. Since an increased expression of TLRs has been detected in other rheumatic diseases the purpose of this study was to explore TLRs in B cells of SS patients. Methods The expression of TLR-7 and -9 in B cell subsets of 25 patients with primary SS (pSS) and 25 healthy controls was analysed in peripheral blood using flow cytometry and real time quantitative PCR. Results We detected similar levels of CD19(+) B cells in pSS patients and healthy controls. An increased number of naive B cells, as well as fewer pre-switched memory B cells were found in pSS patients. No significant differences were observed in TLR-7 and -9 expression in B cells between pSS patients and healthy controls. Conclusion This study shows that pSS patients have an alteration in the B cell subpopulation composition compared to controls, with less pre-switched memory B cells and more naive B cells. We did not detect any significant disparities in TLR-7 and -9 expression between the two groups.	[Karlsen, Marie; Nordal, Hilde H.; Jonsson, Roland; Appel, Silke] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway; [Hansen, Torbjorn; Brun, Johan G.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Hansen, Torbjorn] Haukeland Hosp, Dept Immunol & Transfus Med, N-5021 Bergen, Norway; [Nordal, Hilde H.; Brun, Johan G.; Jonsson, Roland] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Appel, S (corresponding author), Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway.	Silke.Appel@k2.uib.no		Appel, Silke/0000-0002-2199-2315	Bergen Research Foundation; Broegelmann Foundation	Bergen Research Foundation; Broegelmann Foundation	This work was funded by Bergen Research Foundation and Broegelmann Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Bohnhorst JO, 2001, SCAND J IMMUNOL, V54, P421, DOI 10.1046/j.1365-3083.2001.00989.x; Capolunghi F, 2010, RHEUMATOLOGY, V49, P2281, DOI 10.1093/rheumatology/keq226; Carubbi F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4359; Chauhan SK, 2013, J CLIN IMMUNOL, V33, P954, DOI 10.1007/s10875-013-9887-0; Cognasse F, 2008, IMMUNOLOGY, V125, P430, DOI 10.1111/j.1365-2567.2008.02844.x; Dass S, 2008, ANN RHEUM DIS, V67, P1541, DOI 10.1136/ard.2007.083865; Devauchelle-Pensec V, 2014, ANN INTERN MED, V160, P233, DOI 10.7326/M13-1085; Eaton-Bassiri A, 2004, INFECT IMMUN, V72, P7202, DOI 10.1128/IAI.72.12.7202-7211.2004; Emamian ES, 2009, GENES IMMUN, V10, P285, DOI 10.1038/gene.2009.20; Goransson LG, 2011, SCAND J RHEUMATOL, V40, P221, DOI 10.3109/03009742.2010.536164; Guerrier T, 2014, J AUTOIMMUN, V51, P23, DOI 10.1016/j.jaut.2014.02.005; Hajas A, 2013, HUM IMMUNOL, V74, P833, DOI 10.1016/j.humimm.2013.04.007; Hamza N, 2012, ANN RHEUM DIS, V71, P1881, DOI 10.1136/annrheumdis-2011-201189; Hansen A, 2002, ARTHRITIS RHEUM-US, V46, P2160, DOI 10.1002/art.10445; Hwang SH, 2012, J IMMUNOL, V189, P5786, DOI 10.4049/jimmunol.1202195; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jonsson R, 2013, JAMA-J AM MED ASSOC, V310, P1854, DOI 10.1001/jama.2013.278448; Jonsson R, 2011, IMMUNOL LETT, V141, P1, DOI 10.1016/j.imlet.2011.06.007; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; LUBECK MD, 1985, J IMMUNOL, V135, P1299; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; McKelvey KJ, 2011, J AUTOIMMUN, V36, P76, DOI 10.1016/j.jaut.2010.11.001; Meijer JM, 2010, ARTHRITIS RHEUM-US, V62, P960, DOI 10.1002/art.27314; Meyer-Bahlburg A, 2008, AUTOIMMUN REV, V7, P313, DOI 10.1016/j.autrev.2007.11.027; Mignogna MD, 2005, J ORAL PATHOL MED, V34, P1, DOI 10.1111/j.1600-0714.2004.00264.x; Moura RA, 2010, RHEUMATOLOGY, V49, P1082, DOI 10.1093/rheumatology/keq029; Poe J C, 2001, Int Rev Immunol, V20, P739, DOI 10.3109/08830180109045588; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wong CK, 2010, CLIN EXP IMMUNOL, V159, P11, DOI 10.1111/j.1365-2249.2009.04036.x; Youinou P, 2010, ARTHRITIS RHEUM-US, V62, P2605, DOI 10.1002/art.27564; Zheng LY, 2010, ORAL SURG ORAL MED O, V109, P844, DOI 10.1016/j.tripleo.2010.01.006; Zheng LY, 2009, ORAL SURG ORAL MED O, V107, pE12, DOI 10.1016/j.tripleo.2008.09.015	39	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120383	10.1371/journal.pone.0120383	http://dx.doi.org/10.1371/journal.pone.0120383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790192	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400156
J	Krone, CL; Wyllie, AL; van Beek, J; Rots, NY; Oja, AE; Chu, MLJN; Bruin, JP; Bogaert, D; Sanders, EAM; Trzcinski, K				Krone, Cassandra L.; Wyllie, Anne L.; van Beek, Josine; Rots, Nynke Y.; Oja, Anna E.; Chu, Mei Ling J. N.; Bruin, Jacob P.; Bogaert, Debby; Sanders, Elisabeth A. M.; Trzcinski, Krzysztof			Carriage of Streptococcus pneumoniae in Aged Adults with Influenza-Like-Illness	PLOS ONE			English	Article							PNEUMOCOCCAL CARRIAGE; PCR; CHILDREN; SEROTYPE; DISEASE; COLONIZATION; COINFECTION	Incidence of pneumococcal disease is disproportionally high in infants and elderly. Nasopharyngeal colonisation by Streptococcus pneumoniae is considered a prerequisite for disease but unlike in children, carriage in elderly is rarely detected. Here, we tested for S. pneumoniae in nasopharyngeal and saliva samples collected from community-dwelling elderly with influenza-like-illness (ILI). Trans-nasal nasopharyngeal, trans-oral nasopharyngeal and saliva samples (n = 270 per sample type) were collected during winter/spring 2011/2012 from 135 persons aged 60-89 at onset of ILI and 7-9 weeks later following recovery. After samples were tested for pneumococci by conventional culture, all plate growth was collected. DNA extracted from plate harvests was tested by quantitative-PCRs (qPCR) specific for S. pneumoniae and serotypes included in the 13-valent pneumococcal conjugated vaccine (PCV13). Pneumococci were cultured from 14 of 135 (10%) elderly with none of the sampled niches showing superiority in carriage detection. With 76/270 (28%) saliva, 31/270 (11%) trans-oral and 13/270 (5%) trans-nasal samples positive by qPCR, saliva was superior to nasopharyngeal swabs (p<0.001) in qPCR-based carriage detection. Overall, from all methods used in the study, 65 of 135 (48%) elderly carried pneumococci at least once and 26 (19%) at both study time points. The difference between carriage prevalence at ILI (n = 49 or 36%) versus recovery (n = 42 or 31%) was not significant (p = 0.38). At least 23 of 91 (25%) carriage events in 19 of 65 (29%) carriers were associated with PCV13-serotypes. We detected a large reservoir of pneumococci in saliva of elderly, with PCV13-serotype distribution closely resembling the contemporary carriage of serotypes reported in the Netherlands for PCV-vaccinated infants.	[Krone, Cassandra L.; Wyllie, Anne L.; Oja, Anna E.; Chu, Mei Ling J. N.; Bogaert, Debby; Sanders, Elisabeth A. M.; Trzcinski, Krzysztof] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Paediat Immunol & Infect Dis, Utrecht, Netherlands; [van Beek, Josine; Rots, Nynke Y.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [Bruin, Jacob P.] Reg Publ Hlth Lab, Haarlem, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Netherlands National Institute for Public Health & the Environment	Trzcinski, K (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Paediat Immunol & Infect Dis, Utrecht, Netherlands.	K.Trzcinski@umcutrecht.nl	Trzcinski, Krzysztof/I-8840-2019	Trzcinski, Krzysztof/0000-0002-5433-8846; Bogaert, Debby/0000-0003-2651-7000; Wyllie, Anne/0000-0001-6015-0279	Pfizer	Pfizer(Pfizer)	A research grant from Pfizer to EAMS and KT provided support that contributed to salaries for CLK and ALW, but Pfizer did not have any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aliberti S, 2014, CLIN MICROBIOL INFEC, V20, P52, DOI 10.1111/1469-0691.12518; Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; Ansaldi F, 2013, HUM VACCINES, V9, P1, DOI [10.4161/hv.23606, DOI 10.4161/HV.23606]; Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Carvalho MDG, 2013, PEERJ, V1, DOI 10.7717/peerj.97; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; de Waroux OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086136; Dhoubhadel BG, 2014, J MED MICROBIOL, V63, P528, DOI 10.1099/jmm.0.071464-0; Flamaing J, 2010, J AM GERIATR SOC, V58, P396, DOI 10.1111/j.1532-5415.2009.02700.x; Hamaluba M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000335; Heffron R, 1979, PNEUMOCOCCUS CARRIER, P342; Janssens JP, 2004, LANCET INFECT DIS, V4, P112, DOI 10.1016/S1473-3099(04)00931-4; Krone CL, 2014, LANCET RESP MED, V2, P141, DOI 10.1016/S2213-2600(13)70165-6; Mackenzie G M, 1941, Trans Am Clin Climatol Assoc, V57, P88; Magomani V, 2014, J CLIN MICROBIOL, V52, P3271, DOI 10.1128/JCM.01061-14; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; Mina MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01040-13; Mina MJ, 2014, LANCET RESP MED, V2, P750, DOI 10.1016/S2213-2600(14)70131-6; Palmu AA, 2012, SCAND J INFECT DIS, V44, P433, DOI 10.3109/00365548.2011.652162; Park IH, 2015, CLIN VACCINE IMMUNOL; Pel J.Z.S., 1965, HUISARTS WETENSCHAP, V86, P321; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Ridda I, 2010, VACCINE, V28, P3902, DOI 10.1016/j.vaccine.2010.03.073; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Trzcinski K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060520; van den Bergh MR, 2013, CLIN INFECT DIS, V56, pE30, DOI 10.1093/cid/cis922; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Versalovic J, 2011, MANUAL CLIN MICROBIO; WEBSTER LESLIE T., 1931, JOUR EXP MED, V53, P535, DOI 10.1084/jem.53.4.535; Weinberger DM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001776; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; White B, 1938, BIOL PNEUMOCOCCUS, P230; White B, 1938, BIOLOGY PNEUMOCOCCUS, P30; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Wyllie AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102045	42	49	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119875	10.1371/journal.pone.0119875	http://dx.doi.org/10.1371/journal.pone.0119875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789854	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400113
J	Matos, I; Machado, MP; Schartl, M; Coelho, MM				Matos, I.; Machado, M. P.; Schartl, M.; Coelho, M. M.			Gene Expression Dosage Regulation in an Allopolyploid Fish	PLOS ONE			English	Article							SQUALIUS-ALBURNOIDES; RNA-SEQ; BALANCE HYPOTHESIS; HYBRID; EVOLUTION; GENOME; COMPLEX; PLOIDY; GROWTH; SIZE	How allopolyploids are able not only to cope but profit from their condition is a question that remains elusive, but is of great importance within the context of successful allopolyploid evolution. One outstanding example of successful allopolyploidy is the endemic Iberian cyprinid Squalius alburnoides. Previously, based on the evaluation of a few genes, it was reported that the transcription levels between diploid and triploid S. alburnoides were similar. If this phenomenon occurs on a full genomic scale, a wide functional "diploidization'' could be related to the success of these polyploids. We generated RNA-seq data from whole juvenile fish and from adult livers, to perform the first comparative quantitative transcriptomic analysis between diploid and triploid individuals of a vertebrate allopolyploid. Together with an assay to estimate relative expression per cell, it was possible to infer the relative sizes of transcriptomes. This showed that diploid and triploid S. alburnoides hybrids have similar liver transcriptome sizes. This in turn made it valid to directly compare the S. alburnoides RNA-seq transcript data sets and obtain a profile of dosage responses across the S. alburnoides transcriptome. We found that 64% of transcripts in juveniles' samples and 44% in liver samples differed less than twofold between diploid and triploid hybrids (similar expression). Yet, respectively 29% and 15% of transcripts presented accurate dosage compensation (PAA/PA expression ratio of 1 instead of 1.5). Therefore, an exact functional diploidization of the triploid genome does not occur, but a significant down regulation of gene expression in triploids was observed. However, for those genes with similar expression levels between diploids and triploids, expression is not globally strictly proportional to gene dosage nor is it set to a perfect diploid level. This quantitative expression flexibility may be a strong contributor to overcome the genomic shock, and be an immediate evolutionary advantage of allopolyploids.	[Matos, I.; Machado, M. P.; Coelho, M. M.] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, P-1749016 Lisbon, Portugal; [Matos, I.; Machado, M. P.; Schartl, M.] Univ Wurzburg, Physiol Chem, D-97070 Wurzburg, Germany; [Schartl, M.] Univ Clin Wurzburg, Ctr Comprehens Canc, D-97074 Wurzburg, Germany	Universidade de Lisboa; University of Wurzburg; University of Wurzburg	Coelho, MM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, P-1749016 Lisbon, Portugal.	mmcoelho@fc.ul.pt	Coelho, Maria M/B-8672-2009; Machado, Miguel/F-6846-2015	Coelho, Maria M/0000-0003-3288-1693; Machado, Miguel/0000-0002-1786-8522; Schartl, Manfred/0000-0001-9882-5948	Fundacao para a Ciencia e Tecnologia [PTDC/BIA-BIC/110277/2009, SFRH/BD/61217/2009, SFRH/BD/73335/2010]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funding for this study was provided by Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/index.phtml.pt): [Project PTDC/BIA-BIC/110277/2009 to MC, PhD grant SFRH/BD/61217/2009 to IM and PhD grant SFRH/BD/73335/2010 to MPM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Auger DL, 2005, GENETICS, V169, P389, DOI 10.1534/genetics.104.032987; Beyea MM, 2005, FISH PHYSIOL BIOCHEM, V31, P303, DOI 10.1007/s10695-005-1552-y; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Birchler JA, 2010, PLANT CELL, V22, P2105, DOI 10.1105/tpc.110.076133; Chang PL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r125; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Coate JE, 2010, GENOME BIOL EVOL, V2, P534, DOI 10.1093/gbe/evq038; Collares-Pereira MJ, 2013, CYTOGENET GENOME RES, V140, P97, DOI 10.1159/000351729; Crespo-Lopez ME, 2006, ZOOLOGY, V109, P277, DOI 10.1016/j.zool.2006.03.008; Cunha C, 2009, J EVOLUTION BIOL, V22, P718, DOI 10.1111/j.1420-9101.2009.01695.x; Feldman M, 2012, J EXP BOT, V63, P5045, DOI 10.1093/jxb/ers192; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Gao ZX, 2007, COMP BIOCHEM PHYS A, V147, P1001, DOI 10.1016/j.cbpa.2007.03.006; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hedgecock D, 2007, P NATL ACAD SCI USA, V104, P2313, DOI 10.1073/pnas.0610880104; Hotz H, 1999, P NATL ACAD SCI USA, V96, P2171, DOI 10.1073/pnas.96.5.2171; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inacio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041158; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Lampert KP, 2008, PHILOS T R SOC B, V363, P2901, DOI 10.1098/rstb.2008.0040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Mable BK, 2013, HEREDITY, V110, P95, DOI 10.1038/hdy.2012.105; Mable BK, 2011, J ZOOL, V284, P151, DOI 10.1111/j.1469-7998.2011.00829.x; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Miller M, 2012, G3-GENES GENOM GENET, V2, P505, DOI 10.1534/g3.112.002162; Morgado-Santos M, 2010, J FISH BIOL, V76, P1228, DOI 10.1111/j.1095-8649.2010.02591.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pala I, 2008, CURR BIOL, V18, P1344, DOI 10.1016/j.cub.2008.07.096; Pala I, 2010, P ROY SOC B-BIOL SCI, V277, P3519, DOI 10.1098/rspb.2010.1071; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pittman K, 2013, REV AQUACULT, V5, pS224, DOI 10.1111/raq.12034; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ribeiro F, 2003, ARCH HYDROBIOL, V156, P471, DOI 10.1127/0003-9136/2003/0156-0471; Ritz CM, 2011, BMC PLANT BIOL, V23, P11; Schwarz EM, 2012, P NATL ACAD SCI USA, V109, P16246, DOI 10.1073/pnas.1203045109; SMALL SA, 1987, J EXP ZOOL, V241, P339, DOI 10.1002/jez.1402410309; Sousa-Santos C, 2005, DNA SEQUENCE, V16, P462, DOI 10.1080/10425170500356065; Stock M, 2002, NAT GENET, V30, P325, DOI 10.1038/ng839; Stupar RM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-33; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Vogel C, 2013, SCIENCE, V342, P1052, DOI 10.1126/science.1247833; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu CY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000523; Xu Y, 2012, PLANT BIOLOGY, V14, P734, DOI 10.1111/j.1438-8677.2011.00553.x	58	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116309	10.1371/journal.pone.0116309	http://dx.doi.org/10.1371/journal.pone.0116309			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789776	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400012
J	Uppu, DSSM; Manjunath, GB; Yarlagadda, V; Kaviyil, JE; Ravikumar, R; Paramanandham, K; Shome, BR; Haldar, J				Uppu, Divakara S. S. M.; Manjunath, Goutham B.; Yarlagadda, Venkateswarlu; Kaviyil, Jyothi E.; Ravikumar, Raju; Paramanandham, Krishnamoorthy; Shome, Bibek R.; Haldar, Jayanta			Membrane-Active Macromolecules Resensitize NDM-1 Gram-Negative Clinical Isolates to Tetracycline Antibiotics	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACINETOBACTER-BAUMANNII; KLEBSIELLA-PNEUMONIAE; RESISTANCE; BACTERIA; POLYMERS; MECHANISMS; DESIGN; AGENTS	Gram-negative 'superbugs' such as New Delhi metallo-beta-lactamase-1 (bla(NDM-1)) producing pathogens have become world's major public health threats. Development of molecular strategies that can rehabilitate the 'old antibiotics' and halt the antibiotic resistance is a promising approach to target them. We report membrane-active macromolecules (MAMs) that restore the antibacterial efficacy (enhancement by >80-1250 fold) of tetracycline antibiotics towards blaNDM-1 Klebsiella pneumonia and blaNDM-1 Escherichia coli clinical isolates. Organismic studies showed that bacteria had an increased and faster uptake of tetracycline in the presence of MAMs which is attributed to the mechanism of re-sensitization. Moreover, bacteria did not develop resistance to MAMs and MAMs stalled the development of bacterial resistance to tetracycline. MAMs displayed membrane-active properties such as dissipation of membrane potential and membrane-permeabilization that enabled higher uptake of tetracycline in bacteria. In-vivo toxicity studies displayed good safety profiles and preliminary in-vivo antibacterial efficacy studies showed that mice treated with MAMs in combination with antibiotics had significantly decreased bacterial burden compared to the untreated mice. This report of re-instating the efficacy of the antibiotics towards blaNDM-1 pathogens using membrane-active molecules advocates their potential for synergistic co-delivery of antibiotics to combat Gram-negative superbugs.	[Uppu, Divakara S. S. M.; Manjunath, Goutham B.; Yarlagadda, Venkateswarlu; Haldar, Jayanta] JNCASR, Chem Biol & Med Chem Lab, New Chem Unit, Bangalore 560064, Karnataka, India; [Kaviyil, Jyothi E.; Ravikumar, Raju] NIMHANS, Dept Neuromicrobiol, Bangalore 560029, Karnataka, India; [Paramanandham, Krishnamoorthy; Shome, Bibek R.] NIVEDI, Bengaluru 560024, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); National Institute of Mental Health & Neurosciences - India; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Veterinary Epidemiology & Disease Informatics	Haldar, J (corresponding author), JNCASR, Chem Biol & Med Chem Lab, New Chem Unit, Bangalore 560064, Karnataka, India.	jayanta@jncasr.ac.in	Uppu, Divakara SSM/U-1848-2019	Uppu, Divakara SSM/0000-0002-7271-9538; PARAMANANDHAM, KRISHNAMOORTHY/0000-0001-7495-1333; Shome, Bibek/0000-0003-4741-7076; Yarlagadda, Venkateswarlu/0000-0001-7476-0078	Department of Science and Technology (DST), Govt. of India [SR/S2/RJN-43/2009]	Department of Science and Technology (DST), Govt. of India(Department of Science & Technology (India))	This work was supported by the grant "Ramanujan fellowship" [SR/S2/RJN-43/2009] from the Department of Science and Technology (DST), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin C, 2012, ANTIMICROB AGENTS CH, V56, P3432, DOI 10.1128/AAC.00230-12; Choi S, 2009, P NATL ACAD SCI USA, V106, P6968, DOI 10.1073/pnas.0811818106; Clinical Laboratory Standards Institute, M100 S22, V32, pM100; Deng M, 2014, ANTIMICROB AGENTS CH, V58, P297, DOI 10.1128/AAC.01727-13; DOCKTER ME, 1978, P NATL ACAD SCI USA, V75, P1319, DOI 10.1073/pnas.75.3.1319; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Goldberg K, 2013, FASEB J, V27, P3818, DOI 10.1096/fj.13-227942; Harris TL, 2014, ACS CHEM BIOL, V9, P122, DOI 10.1021/cb400490k; KASHKET ER, 1985, ANNU REV MICROBIOL, V39, P219, DOI 10.1146/annurev.mi.39.100185.001251; King AM, 2014, NATURE, V510, P503, DOI 10.1038/nature13445; LIPNICK RL, 1995, FOOD CHEM TOXICOL, V33, P223, DOI 10.1016/0278-6915(94)00136-C; Liu RH, 2014, J AM CHEM SOC, V136, P4410, DOI 10.1021/ja500367u; Manchanda V, 2011, INDIAN J MED MICROBI, V29, P249, DOI 10.4103/0255-0857.83907; Ng VWL, 2013, ADV MATER, V25, P6730, DOI 10.1002/adma.201302952; Niu YH, 2012, J MED CHEM, V55, P4003, DOI 10.1021/jm300274p; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pena-Miller R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001540; Pieri C, 2014, J MED CHEM, V57, P4263, DOI 10.1021/jm500194e; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Sakoulas G, 2014, ANTIMICROB AGENTS CH, V58, P1494, DOI 10.1128/AAC.02274-13; Sgolastra F, 2013, ACCOUNTS CHEM RES, V46, P2977, DOI 10.1021/ar400066v; Takahashi H, 2013, MACROMOL BIOSCI, V13, P1285, DOI 10.1002/mabi.201300126; Taylor PL, 2012, ACS CHEM BIOL, V7, P1547, DOI 10.1021/cb300269g; Uppu DSSM, 2013, CHEM COMMUN, V49, P9389, DOI 10.1039/c3cc43751e; Velkov T, 2014, ACS CHEM BIOL, V9, P1172, DOI 10.1021/cb500080r; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; World Health Organization, 2014, ANT RES GLOB REP SUR; Worthington RJ, 2012, ACS MED CHEM LETT, V3, P357, DOI 10.1021/ml200290p; YAMAGUCHI A, 1991, ANTIMICROB AGENTS CH, V35, P53, DOI 10.1128/AAC.35.1.53; Yarlagadda V, 2014, J MED CHEM, V57, P4558, DOI 10.1021/jm500270w; Zhang JY, 2014, J AM CHEM SOC, V136, P4873, DOI 10.1021/ja5011338	32	24	25	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119422	10.1371/journal.pone.0119422	http://dx.doi.org/10.1371/journal.pone.0119422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789871	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400083
J	Philippou, A; Minozzo, FC; Spinazzola, JM; Smith, LR; Lei, HQ; Rassier, DE; Barton, ER				Philippou, Anastassios; Minozzo, Fabio C.; Spinazzola, Janelle M.; Smith, Lucas R.; Lei, Hanqin; Rassier, Dilson E.; Barton, Elisabeth R.			Masticatory muscles of mouse do not undergo atrophy in space	FASEB JOURNAL			English	Article						atrogenes; microgravity; muscle adaptations	MURINE SKELETAL-MUSCLE; THIN FILAMENT DENSITY; SOLEUS MUSCLE; MYOSTATIN INHIBITION; DIAPHRAGM MUSCLES; UBIQUITIN LIGASES; GENE-EXPRESSION; LIMB MUSCLE; FIBER SIZE; SPACEFLIGHT	Muscle loading is important for maintaining muscle mass; when load is removed, atrophy is inevitable. However, in clinical situations such as critical care myopathy, masticatory muscles do not lose mass. Thus, their properties may be harnessed to preserve mass. We compared masticatory and appendicular muscles responses to microgravity, using mice aboard the space shuttle Space Transportation System-135. Age- and sex-matched controls remained on the ground. After 13 days of space flight, 1 masseter (MA) and tibialis anterior (TA) were frozen rapidly for biochemical and functional measurements, and the contralateral MA was processed for morphologic measurements. Flight TA muscles exhibited 20 +/- 3% decreased muscle mass, 2-fold decreased phosphorylated (P)-Akt, and 4- to 12-fold increased atrogene expression. In contrast, MAs had no significant change in mass but a 3-fold increase in P-focal adhesion kinase, 1.5-fold increase in P-Akt, and 50-90% lower atrogene expression compared with limb muscles, which were unaltered in microgravity. Myofibril force measurements revealed that microgravity caused a 3-fold decrease in specific force and maximal shortening velocity in TA muscles. It is surprising that myofibril-specific force from both control and flight MAs were similar to flight TA muscles, yet power was compromised by 40% following flight. Continued loading in microgravity prevents atrophy, but masticatory muscles have a different set point that mimics disuse atrophy in the appendicular muscle.	[Philippou, Anastassios] Univ Athens, Sch Med, Dept Physiol, Goudi, Greece; [Philippou, Anastassios; Spinazzola, Janelle M.; Smith, Lucas R.; Lei, Hanqin; Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Minozzo, Fabio C.; Rassier, Dilson E.] McGill Univ, Dept Kinesiol, Montreal, PQ, Canada; [Spinazzola, Janelle M.; Smith, Lucas R.; Barton, Elisabeth R.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Lei, Hanqin; Barton, Elisabeth R.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	National & Kapodistrian University of Athens; University of Pennsylvania; McGill University; University of Pennsylvania; State University System of Florida; University of Florida	Barton, ER (corresponding author), Univ Florida, 1864 Stadium Rd,124 Florida Gym, Gainesville, FL 32611 USA.	erbarton@ufl.edu	Smith, Lucas R/S-2157-2018; Philippou, Anastassios/H-2748-2019	Smith, Lucas R/0000-0002-7610-4231; Philippou, Anastassios/0000-0003-0047-3003	NASA Space Biology Grant [NNX09AH44G]; U.S. National Institutes of Health [R052646]; Canadian Institutes for Health Research; Natural Science and Engineering Research Council of Canada; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	NASA Space Biology Grant; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors gratefully acknowledge NASA for allowing access to the animals of the CBTM-3 payload of the STS-135 shuttle mission and for providing technical support and equipment in the Space Life Sciences Laboratory in Kennedy Space Center. The study was supported, in part, by NASA Space Biology Grant NNX09AH44G (to E.R.B.), U.S. National Institutes of Health Grant R052646 (to E.R.B.), the Canadian Institutes for Health Research (to D.E.R.), and the Natural Science and Engineering Research Council of Canada (to D.E.R.).	Aare S, 2011, PHYSIOL GENOMICS, V43, P1334, DOI 10.1152/physiolgenomics.00116.2011; Akkad H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092622; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Barton ER, 2010, J BIOL CHEM, V285, P17263, DOI 10.1074/jbc.M109.063990; Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Carson JA, 2001, FASEB J, V15, P207, DOI 10.1096/fj.01-0544fje; Carson JA, 2000, J APPL PHYSIOL, V88, P337, DOI 10.1152/jappl.2000.88.1.337; Daniels DW, 2008, ARCH ORAL BIOL, V53, P187, DOI 10.1016/j.archoralbio.2007.09.006; Dapp C, 2004, PHYSIOL GENOMICS, V20, P97, DOI 10.1152/physiolgenomics.00100.2004; Desplanches D, 1990, Physiologist, V33, pS84; Evans M, 2008, PHYSIOL GENOMICS, V35, P86, DOI 10.1152/physiolgenomics.00232.2007; Fan YY, 2013, J MOL HISTOL, V44, P75, DOI 10.1007/s10735-012-9445-8; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Fitts RH, 2000, AM J PHYSIOL-REG I, V279, pR1546, DOI 10.1152/ajpregu.2000.279.5.R1546; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Harada H, 2002, CONNECT TISSUE RES, V43, P201, DOI 10.1080/030082002900000989; Harrison BC, 2003, J APPL PHYSIOL, V95, P2462, DOI 10.1152/japplphysiol.00603.2003; Howard J., 2001, MECH MOTOR PROTEINS; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Klimek MEB, 2010, BIOCHEM BIOPH RES CO, V391, P1548, DOI 10.1016/j.bbrc.2009.12.123; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; MacDonald EM, 2014, DIS MODEL MECH, V7, P471, DOI 10.1242/dmm.014126; MARTIN TP, 1988, CELL TISSUE RES, V254, P251; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Monemi M, 1999, ACTA PHYSIOL SCAND, V167, P339; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Murphy KT, 2011, J APPL PHYSIOL, V110, P1065, DOI 10.1152/japplphysiol.01183.2010; Norman H, 2006, ACTA ANAESTH SCAND, V50, P1058, DOI 10.1111/j.1399-6576.2006.01105.x; Ochala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020558; Ohira Y, 2002, ADV SPACE RES, V30, P777, DOI 10.1016/S0273-1177(02)00395-2; OHIRA Y, 1992, J APPL PHYSIOL, V73, pS51, DOI 10.1152/jappl.1992.73.2.S51; Pardo PS, 2011, J BIOL CHEM, V286, P2559, DOI 10.1074/jbc.M110.149153; Ribeiro PAB, 2013, INT J CARDIOL, V168, P3564, DOI 10.1016/j.ijcard.2013.05.069; Riley DA, 2005, AM J PHYSIOL-CELL PH, V288, pC360, DOI 10.1152/ajpcell.00386.2004; Riley DA, 2000, J APPL PHYSIOL, V88, P567, DOI 10.1152/jappl.2000.88.2.567; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Schuenke MD, 2009, EUR J APPL PHYSIOL, V106, P885, DOI 10.1007/s00421-009-1091-9; Skorokhod A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-265; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Ulanova A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/104735; Urushiyama T, 2004, CELL TISSUE RES, V315, P97, DOI 10.1007/s00441-003-0787-0; Yoshida T, 1998, J BIOL CHEM, V273, P1583, DOI 10.1074/jbc.273.3.1583; Yu LM, 2003, EXP CELL RES, V289, P162, DOI 10.1016/S0014-4827(03)00252-0	52	15	15	4	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2769	2779		10.1096/fj.14-267336	http://dx.doi.org/10.1096/fj.14-267336			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25795455	Green Published			2022-12-26	WOS:000356859100009
J	Gong, Z; Schwieters, CD; Tang, C				Gong, Zhou; Schwieters, Charles D.; Tang, Chun			Conjoined Use of EM and NMR in RNA Structure Refinement	PLOS ONE			English	Article							SPECTROSCOPY; DYNAMICS; RIBOSOME; ELEMENT	More than 40% of the RNA structures have been determined using nuclear magnetic resonance (NMR) technique. NMR mainly provides local structural information of protons and works most effectively on relatively small biomacromolecules. Hence structural characterization of large RNAs can be difficult for NMR alone. Electron microscopy (EM) provides global shape information of macromolecules at nanometer resolution, which should be complementary to NMR for RNA structure determination. Here we developed a new energy term in Xplor-NIH against the density map obtained by EM. We conjointly used NMR and map restraints for the structure refinement of three RNA systems-U2/U6 small-nuclear RNA, genome-packing motif (psi(CD)) 2 from Moloney murine leukemia virus, and ribosome-binding element from turnip crinkle virus. In all three systems, we showed that the incorporation of a map restraint, either experimental or generated from known PDB structure, greatly improves structural precision and accuracy. Importantly, our method does not rely on an initial model assembled from RNA duplexes, and allows full torsional freedom for each nucleotide in the torsion angle simulated annealing refinement. As increasing number of macromolecules can be characterized by both NMR and EM, the marriage between the two techniques would enable better characterization of RNA three-dimensional structures.	[Gong, Zhou; Tang, Chun] Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom Mol Phys, Natl Magnet Resonance Ctr Wuhan,Wuhan Inst Phys &, Wuhan 430071, Hubei Province, Peoples R China; [Schwieters, Charles D.] NIH, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA	Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Tang, C (corresponding author), Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom Mol Phys, Natl Magnet Resonance Ctr Wuhan,Wuhan Inst Phys &, Wuhan 430071, Hubei Province, Peoples R China.	tanglab@wipm.ac.cn	Tang, Chun/P-4060-2019	Tang, Chun/0000-0001-6477-6500	Chinese Ministry of Science and Technology [2013CB910200]; National Natural Sciences Foundation of China [31400735, 31225007, 31170728]; International Early Career Scientist program from the Howard Hughes Medical Institute; NIH CIT Intramural Research Program; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); International Early Career Scientist program from the Howard Hughes Medical Institute; NIH CIT Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT))	C.T. is supported by grants from the Chinese Ministry of Science and Technology (2013CB910200) and the National Natural Sciences Foundation of China (31400735, 31225007, and 31170728), and supported in part by the International Early Career Scientist program from the Howard Hughes Medical Institute. C.D.S. is supported by the NIH CIT Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NJ, 2010, J AM CHEM SOC, V132, P16352, DOI 10.1021/ja107492b; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Burke JE, 2012, RNA, V18, P673, DOI 10.1261/rna.031138.111; Cao S, 2010, RNA, V16, P538, DOI 10.1261/rna.1800210; Clore GM, 2003, J AM CHEM SOC, V125, P1518, DOI 10.1021/ja028383j; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Gagnon MG, 2014, SCIENCE, V345, P684, DOI 10.1126/science.1253525; Gajda MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078007; Grishaev A, 2008, J BIOMOL NMR, V42, P99, DOI 10.1007/s10858-008-9267-x; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hershkovitz E, 2003, NUCLEIC ACIDS RES, V31, P6249, DOI 10.1093/nar/gkg835; Liu JJ, 2014, NAT STRUCT MOL BIOL, V21, P95, DOI 10.1038/nsmb.2736; Lu K, 2010, J BIOMOL NMR, V46, P113, DOI 10.1007/s10858-009-9375-2; Mainz A, 2013, ANGEW CHEM INT EDIT, V52, P8746, DOI 10.1002/anie.201301215; Miracco EJ, 2014, CURR OPIN STRUC BIOL, V24, P115, DOI 10.1016/j.sbi.2014.01.008; Miyazaki Y, 2010, J MOL BIOL, V404, P751, DOI 10.1016/j.jmb.2010.09.009; Mustoe AM, 2014, ANNU REV BIOCHEM, V83, P441, DOI 10.1146/annurev-biochem-060713-035524; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2014, PROG NUCL MAG RES SP, V80, P1, DOI 10.1016/j.pnmrs.2014.03.001; Scott Lincoln G., 2008, V452, P29, DOI 10.1007/978-1-60327-159-2_2; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tolbert BS, 2010, J BIOMOL NMR, V47, P205, DOI 10.1007/s10858-010-9424-x; van Ingen H, 2014, J MAGN RESON, V241, P103, DOI 10.1016/j.jmr.2013.10.021; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791; Zuo XB, 2010, P NATL ACAD SCI USA, V107, P1385, DOI 10.1073/pnas.0908140107	31	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120445	10.1371/journal.pone.0120445	http://dx.doi.org/10.1371/journal.pone.0120445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798848	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300144
J	Moro, MF; Silva, IA; de Araujo, FS; Lughadha, EN; Meagher, TR; Martins, FR				Moro, Marcelo Freire; Silva, Igor Aurelio; de Araujo, Francisca Soares; Lughadha, Eimear Nic; Meagher, Thomas R.; Martins, Fernando Roberto			The Role of Edaphic Environment and Climate in Structuring Phylogenetic Pattern in Seasonally Dry Tropical Plant Communities	PLOS ONE			English	Article							NICHE CONSERVATISM; SPATIAL-ANALYSIS; EVOLUTION; CAATINGA; ECOLOGY; DIVERSITY; LIFE; OVERDISPERSION; BIODIVERSITY	Seasonally dry tropical plant formations (SDTF) are likely to exhibit phylogenetic clustering owing to niche conservatism driven by a strong environmental filter (water stress), but heterogeneous edaphic environments and life histories may result in heterogeneity in degree of phylogenetic clustering. We investigated phylogenetic patterns across ecological gradients related to water availability (edaphic environment and climate) in the Caatinga, a SDTF in Brazil. Caatinga is characterized by semiarid climate and three distinct edaphic environments - sedimentary, crystalline, and inselberg - representing a decreasing gradient in soil water availability. We used two measures of phylogenetic diversity: Net Relatedness Index based on the entire phylogeny among species present in a site, reflecting long-term diversification; and Nearest Taxon Index based on the tips of the phylogeny, reflecting more recent diversification. We also evaluated woody species in contrast to herbaceous species. The main climatic variable influencing phylogenetic pattern was precipitation in the driest quarter, particularly for herbaceous species, suggesting that environmental filtering related to minimal periods of precipitation is an important driver of Caatinga biodiversity, as one might expect for a SDTF. Woody species tended to show phylogenetic clustering whereas herbaceous species tended towards phylogenetic overdispersion. We also found phylogenetic clustering in two edaphic environments (sedimentary and crystalline) in contrast to phylogenetic overdispersion in the third (inselberg). We conclude that while niche conservatism is evident in phylogenetic clustering in the Caatinga, this is not a universal pattern likely due to heterogeneity in the degree of realized environmental filtering across edaphic environments. Thus, SDTF, in spite of a strong shared environmental filter, are potentially heterogeneous in phylogenetic structuring. Our results support the need for scientifically informed conservation strategies in the Caatinga and other SDTF regions that have not previously been prioritized for conservation in order to take into account this heterogeneity.	[Moro, Marcelo Freire; Silva, Igor Aurelio; Martins, Fernando Roberto] State Univ Campinas UNICAMP, Dept Biol Vegetal, BR-13083970 Sao Paulo, Brazil; [de Araujo, Francisca Soares] Univ Fed Ceara, Dept Biol, Ctr Ciencias, BR-60455760 Fortaleza, Ceara, Brazil; [Lughadha, Eimear Nic] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Meagher, Thomas R.] Univ St Andrews, Sch Biol, St Andrews KY16 9TH, Fife, Scotland	Universidade Estadual de Campinas; Universidade Federal do Ceara; Royal Botanic Gardens, Kew; University of St Andrews	Moro, MF (corresponding author), State Univ Campinas UNICAMP, Dept Biol Vegetal, Bloco M, BR-13083970 Sao Paulo, Brazil.	bio_moro@yahoo.com.br	Martins, Fernando R./F-5652-2012; Araújo, Francisca Soares/H-9371-2012; Moro, Marcelo F/J-9882-2012; Nic Lughadha, Eimear/N-4560-2014; Moro, Marcelo Freire/U-7997-2019	Martins, Fernando R./0000-0002-3068-7099; Araújo, Francisca Soares/0000-0003-4661-6137; Moro, Marcelo F/0000-0003-4527-346X; Nic Lughadha, Eimear/0000-0002-8806-4345; 	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Fapesp) [2013/15280-9]	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was made possible through the kind financial support of the Sao Paulo Research Foundation - http://fapesp.br/en (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Fapesp 2013/15280-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N., 2003, DOMINIOS NATUREZA BR, P159, DOI DOI 10.1016/J.SCITOTENV.2014.12.090; Ab'Saber A.N., 1974, GEOMORFOLOGIA, V43, P1; ArauCjo F.S., 1998, REV BRASILEIRA BOT, V21, P105, DOI [10.1590/S0100-84041998000200001, DOI 10.1590/S0100-84041998000200001]; Araújo Francisca Soares, 2008, Rodriguésia, V59, P659, DOI 10.1590/2175-7860200859403; Araújo Francisca Soares de, 2011, Rodriguésia, V62, P341, DOI 10.1590/2175-7860201162210; Barbosa HA, 2006, J ARID ENVIRON, V67, P288, DOI 10.1016/j.jaridenv.2006.02.022; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Castelletti C. H. M., 2003, ECOLOGIA CONSERVACAO, P719; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cooper N, 2008, P ROY SOC B-BIOL SCI, V275, P2031, DOI 10.1098/rspb.2008.0420; Costa K. C., 2009, Revista Brasileira de Ciencias Agrarias (Agraria), V4, P48; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; da Costa RC, 2007, J ARID ENVIRON, V68, P237, DOI 10.1016/j.jaridenv.2006.06.003; de Araujo F S, 1999, Rev Bras Biol, V59, P663, DOI 10.1590/S0034-71081999000400015; de Queiroz L.P, 2009, LEGUMINOSAS CAATINGA; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Franca Flavio, 2005, Hoehnea, V32, P93; Gomes Ana Paula de Souza, 2006, Acta Bot. Bras., V20, P37; Gomes Polyhanna, 2010, Braz. J. Bot., V33, P661, DOI 10.1590/S0100-84042010000400014; Gotelli NJ, 2004, PRIMER ECOLOGICAL ST, P429; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P, 2012, NUMERICAL ECOLOGY, P990; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; Mendes MRDA, 2010, CHECK LIST, V6, P39, DOI [10.15528/2176-4158/rcpa.v12n2p138-141, DOI 10.15528/2176-4158/RCPA.V12N2P138-141, DOI 10.15560/6.1.039]; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Moro MF, 2014, PHYTOTAXA, V160, P1; Moro MF, 2013, THESIS STATE U CAMPI; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; Niklas K.J., 1997, EVOLUTIONARY BIOL PL; Oliveira AT, 2013, S AFR J BOT, V89, P42, DOI 10.1016/j.sajb.2013.06.010; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; de Queiroz LP, 2006, SYST ASSOC SPEC VOL, P121; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pennington RT, 2006, SYST ASSOC SPEC VOL, P1; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; Porto P. A. F., 2008, Caatinga, V21, P214; R Development Core Team, 2012, R LANG ENV STAT COMP; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; RAUNKIAER C., 1934; Rodal M. J. N., 2005, ANALISE VARIACOES BI, P139; Sampaio Everardo V. S. B., 1995, P35, DOI 10.1017/CBO9780511753398.003; Santos RM, 2012, ECOL EVOL, V2, P409, DOI 10.1002/ece3.91; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Velloso A.L., 2002, ECORREGIOES PROPOSTA; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	60	46	49	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119166	10.1371/journal.pone.0119166	http://dx.doi.org/10.1371/journal.pone.0119166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798584	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300033
J	Oikawa, N; Matsubara, T; Fukuda, R; Yasumori, H; Hatsuta, H; Murayama, S; Sato, T; Suzuki, A; Yanagisawa, K				Oikawa, Naoto; Matsubara, Teruhiko; Fukuda, Ryoto; Yasumori, Hanaki; Hatsuta, Hiroyuki; Murayama, Shigeo; Sato, Toshinori; Suzuki, Akemi; Yanagisawa, Katsuhiko			Imbalance in Fatty-Acid-Chain Length of Gangliosides Triggers Alzheimer Amyloid Deposition in the Precuneus	PLOS ONE			English	Article							GM1 GANGLIOSIDE; BETA-PROTEIN; BRAIN GANGLIOSIDES; NEURITIC TERMINALS; BASE COMPOSITION; DISEASE; DEMENTIA; DENSITY; SPHINGOLIPIDS; ACCUMULATION	Amyloid deposition, a crucial event of Alzheimer's disease (AD), emerges in distinct brain regions. A key question is what triggers the assembly of the monomeric amyloid beta-protein (A beta) into fibrils in the regions. On the basis of our previous findings that gangliosides facilitate the initiation of A beta assembly at presynaptic neuritic terminals, we investigated how lipids, including gangliosides, cholesterol and sphingomyelin, extracted from synaptic plasma membranes (SPMs) isolated from autopsy brains were involved in the A beta assembly. We focused on two regions of the cerebral cortex; precuneus and calcarine cortex, one of the most vulnerable and one of the most resistant regions to amyloid deposition, respectively. Here, we show that lipids extracted from SPMs isolated from the amyloid-bearing precuneus, but neither the amyloid-free precuneus nor the calcarine cortex, markedly accelerate the A beta assembly in vitro. Through liquid chromatography-mass spectrometry of the lipids, we identified an increase in the ratio of the level of GD1b-ganglioside containing C20:0 fatty acid to that containing C18:0 as a cause of the enhanced A beta assembly in the precuneus. Our results suggest that the local glycolipid environment play a critical role in the initiation of Alzheimer amyloid deposition.	[Oikawa, Naoto; Yanagisawa, Katsuhiko] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Drug Discovery, Obu, Aichi, Japan; [Matsubara, Teruhiko; Fukuda, Ryoto; Yasumori, Hanaki; Sato, Toshinori] Keio Univ, Dept Biosci & Informat, Fujisawa, Kanagawa, Japan; [Hatsuta, Hiroyuki; Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan; [Suzuki, Akemi] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan; [Yanagisawa, Katsuhiko] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Alzheimers Dis Res, Obu, Aichi, Japan	National Center for Geriatrics & Gerontology; Keio University; Tokyo Metropolitan Institute of Gerontology; Tokai University; National Center for Geriatrics & Gerontology	Yanagisawa, K (corresponding author), Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Drug Discovery, Obu, Aichi, Japan.	katuhiko@ncgg.go.jp		Sato, Toshinori/0000-0002-4429-6101	Research Funding of the Longevity Sciences from the National Center for Geriatrics and Gerontology [25-19]; Strategic Research Program for Brain Sciences by the Ministry of Education, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23241075] Funding Source: KAKEN	Research Funding of the Longevity Sciences from the National Center for Geriatrics and Gerontology; Strategic Research Program for Brain Sciences by the Ministry of Education, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Research Funding of the Longevity Sciences (25-19) from the National Center for Geriatrics and Gerontology and the Strategic Research Program for Brain Sciences by the Ministry of Education, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, J NEUROPATH EXP NEUR, V69, P737, DOI 10.1097/NEN.0b013e3181e5ae5c; ANDO S, 1984, J NEUROSCI RES, V12, P205, DOI 10.1002/jnr.490120208; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Bernardo A, 2009, NEUROBIOL AGING, V30, P1777, DOI 10.1016/j.neurobiolaging.2007.12.022; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; CRINO PB, 1989, ARCH NEUROL-CHICAGO, V46, P398, DOI 10.1001/archneur.1989.00520400054019; de Chaves EP, 2010, FEBS LETT, V584, P1748, DOI 10.1016/j.febslet.2009.12.010; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; FOLCH J, 1957, J BIOL CHEM, V226, P497; Greenshields KN, 2009, J CLIN INVEST, V119, P595, DOI 10.1172/JCI37338; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Iijima K, 2009, J COLLOID INTERF SCI, V337, P369, DOI 10.1016/j.jcis.2009.05.032; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; Ikonomovic MD, 2011, NEUROLOGY, V77, P39, DOI 10.1212/WNL.0b013e3182231419; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Kirkwood CM, 2013, J NEUROPATH EXP NEUR, V72, P791, DOI 10.1097/NEN.0b013e31829ecc89; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; KRACUN I, 1990, J HIRNFORSCH, V31, P789; KRACUN I, 1991, International Journal of Developmental Biology, V35, P289; KRACUN I, 1984, J NEUROCHEM, V43, P979, DOI 10.1111/j.1471-4159.1984.tb12833.x; MANSSON JE, 1978, J NEUROCHEM, V30, P273, DOI 10.1111/j.1471-4159.1978.tb07064.x; MASSERINI M, 1986, BIOCHEMISTRY-US, V25, P1043, DOI 10.1021/bi00353a014; MASSERINI M, 1989, BIOCHEMISTRY-US, V28, P5029, DOI 10.1021/bi00438a019; Matsubara T, 2013, LANGMUIR, V29, P2258, DOI 10.1021/la3038999; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Mauri L, 2012, GLYCOBIOLOGY, V22, P352, DOI 10.1093/glycob/cwr139; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Moyano AL, 2012, GLYCOBIOLOGY, V22, P1768, DOI 10.1093/glycob/cws117; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nagafuku M, 2012, P NATL ACAD SCI USA, V109, pE336, DOI 10.1073/pnas.1114965109; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Oikawa N, 2014, J NEUROSCI RES, V92, P641, DOI 10.1002/jnr.23341; Oikawa N, 2012, NEUROSCI LETT, V525, P49, DOI 10.1016/j.neulet.2012.07.027; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; ROSENBERG A, 1966, J LIPID RES, V7, P122; ROUSER G, 1972, J NEUROCHEM, V19, P2697, DOI 10.1111/j.1471-4159.1972.tb01329.x; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Walter J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-34; Yamamoto N, 2007, BBA-BIOMEMBRANES, V1768, P1128, DOI 10.1016/j.bbamem.2007.01.009; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; Yuyama K, 2010, NEUROSCI LETT, V481, P168, DOI 10.1016/j.neulet.2010.06.080	54	27	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121356	10.1371/journal.pone.0121356	http://dx.doi.org/10.1371/journal.pone.0121356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798597	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300243
J	Atzema, CL; Khan, S; Lu, H; Allard, YE; Russell, SJ; Gravelle, MR; Klein-Geltink, J; Austin, PC				Atzema, Clare L.; Khan, Saba; Lu, Hong; Allard, Yvon E.; Russell, Storm J.; Gravelle, Mario R.; Klein-Geltink, Julie; Austin, Peter C.			Cardiovascular Disease Rates, Outcomes, and Quality of Care in Ontario Metis: A Population-Based Cohort Study	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; RISK; INDICATORS; DISCHARGE; CANADA	Background The burden of cardiovascular disease in the Metis, Canada's fastest growing Aboriginal group, is not well studied. We determined rates of five cardiovascular diseases and associated outcomes in Ontario Metis, compared to the general Ontario population. Methods Metis persons were identified using the Metis Nation of Ontario Citizenship Registry. Metis citizens aged 20-105 were linked to Ontario health databases for the period of April 2006 to March 2011. Age-and sex-standardized prevalence and incidence of acute coronary syndromes (ACS), congestive heart failure (CHF), cerebrovascular disease (stroke), atrial fibrillation, and hypertension were compared between the Metis and the general population. Secondary outcome measures included one-year hospitalizations and mortality following the incident cardiovascular diagnosis, as well as quality-of-care measures. Results There were 12,550 eligible Metis persons and 10,144,002 in the general population. The adjusted prevalence of each disease was higher (p< 0.05) among the Metis compared to the general population: ACS 5.3% vs. 3.0%; CHF 5.1% vs. 3.9%; stroke 1.4% vs. 1.1%; atrial fibrillation 2.1% vs. 1.4%; hypertension 34.9% vs. 29.8%. Incident ACS, stroke, and atrial fibrillation were also higher (p< 0.05) among the Metis: ACS 2.4% vs. 1.5%; stroke 0.8% vs. 0.6%; atrial fibrillation 0.6% vs. 0.3%. One-year all-cause and cardiovascular-related mortality were not significantly different. Hospitalizations were higher for Metis persons with CHF (OR 1.93; 95% CI 1.34-2.78) and hypertension (OR 2.27; 95% CI 1.88-2.74). Metis with CHF made more emergency department (ED) visits in the year after diagnosis compared to non-Metis with CHF, while Metis aged (3)65 with ACS were more likely to be on beta-blockers following diagnosis. Conclusions The burden of cardiovascular disease was markedly higher in the Metis compared to the general population: prevalence rates for five cardiovascular conditions were 25% to 77% higher. Metis persons with CHF had more frequent hospitalizations and ED visits following their diagnosis.	[Atzema, Clare L.; Khan, Saba; Lu, Hong; Klein-Geltink, Julie; Austin, Peter C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Atzema, Clare L.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Atzema, Clare L.] Univ Toronto, Toronto, ON, Canada; [Allard, Yvon E.; Russell, Storm J.; Gravelle, Mario R.] Metis Nation Ontario, Ottawa, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Atzema, CL (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	clare.atzema@ices.on.ca		Austin, Peter/0000-0003-3337-233X; Atzema, Clare/0000-0002-7236-5522	Public Health Agency of Canada; Department of Emergency Services at Sunnybrook Health Sciences; Department of Medicine, University of Toronto; Sunnybrook Research Institute; Heart and Stroke Foundation of Ontario	Public Health Agency of Canada; Department of Emergency Services at Sunnybrook Health Sciences; Department of Medicine, University of Toronto(University of Toronto); Sunnybrook Research Institute(University of Toronto); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	The project was funded by a grant from the Public Health Agency of Canada. Dr. Atzema was supported by the Practice Plan of the Department of Emergency Services at Sunnybrook Health Sciences, the Department of Medicine, University of Toronto, and the Sunnybrook Research Institute. Dr. Austin was supported by a Career Investigator award from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2001, LANCET, V358, P1147, DOI 10.1016/S0140-6736(01)06255-9; Anderson JL, 2013, CIRCULATION, V127, P1916, DOI 10.1161/CIR.0b013e318290826d; Atzema CL, 2013, AM HEART J, V165, P939, DOI 10.1016/j.ahj.2013.02.026; Atzema CL, 2013, ANN EMERG MED, V61, P539, DOI 10.1016/j.annemergmed.2012.12.022; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Canadian Institute for Health Information, 2013, HOSP CAR HEART ATT 1; Chan B., 2005, SUPPLY UTILIZATION G; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Evans M, 2012, INT J CRIT INDIG STU, V5, P54, DOI DOI 10.5204/ijcis.v5i1.94; Findlay Leanne C, 2011, Health Rep, V22, P47; First Nations Education Steering Committee, 2008, 1 NAT IN MET PUBL DI; Iezonni LI, 1997, RISK ADJUSTMENT MEAS; Iron K, 2008, LIVING DYING ONTARIO; Kumar MB, 2012, CAN J PUBLIC HEALTH, V103, P23, DOI 10.1007/BF03404064; Lee D, 2003, PROF ENG, V16, P19; Lee DS, 2010, CIRCULATION, V122, P1806, DOI 10.1161/CIRCULATIONAHA.110.940262; Lindsay P, 2002, ACAD EMERG MED, V9, P1131, DOI 10.1197/aemj.9.11.1131; Martens P., 2010, PROFILE METIS HLTH S; Public Health Agency of Canada Canadian Institute for Health Information Canadian Stroke Network Heart and Stroke Foundation of Canada Statistics Canada, 2009, TRACK HEART DIS STRO; Ralph-Campbell K, 2009, INT J CIRCUMPOL HEAL, V68, P433; Reading C. L., 2009, HLTH INEQUALITIES SO; Roshanafshar, 2013, SELECT HLTH INDICATO; Shah BR, 2011, DIABETES CARE, V34, P2555, DOI 10.2337/dc11-0945; Statistics Canada, 2011, 10 LEAD CAUS DEATH; Statistics Canada, 2006, POST COD CONV FIL PC; Statistics Canada, 2013, AB PEOPL CAN 1 NAT P; Statistics Canada, 2010, AB STAT GLANC; Tjepkema Michael, 2011, Health Rep, V22, P25; Tran CTT, 2003, CAN J CARDIOL, V19, P38; Tu Karen, 2007, Open Med, V1, pe18; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Young TK, 2012, HEART LUNG CIRC, V21, P618, DOI 10.1016/j.hlc.2012.05.009; Young TK, 2003, BMJ-BRIT MED J, V327, P419, DOI 10.1136/bmj.327.7412.419	33	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121779	10.1371/journal.pone.0121779	http://dx.doi.org/10.1371/journal.pone.0121779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793978	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900153
J	Dai, Y; Wang, XT; Tang, JX; Zhao, S; Xing, YT; Dai, JR; Jin, XL; Zhu, YC				Dai, Yang; Wang, Xiaoting; Tang, Jianxia; Zhao, Song; Xing, Yuntian; Dai, Jianrong; Jin, Xiaolin; Zhu, Yinchang			Enhancement of Protective Efficacy through Adenoviral Vectored Vaccine Priming and Protein Boosting Strategy Encoding Triosephosphate Isomerase (SjTPI) against Schistosoma japonicum in Mice	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; IMMUNE-RESPONSES; C57BL/6 MICE; IGG AVIDITY; INFECTION; SYSTEM; IMMUNOGENICITY; VACCINATIONS; IMMUNIZATION; PRAZIQUANTEL	Background Schistosomiasis japonica is a zoonotic parasitic disease; developing transmission blocking veterinary vaccines are urgently needed for the prevention and control of schistosomiasis in China. Heterologous prime-boost strategy, a novel vaccination approach, is more effective in enhancing vaccine efficacy against multiple pathogens. In the present study, we established a novel heterologous prime-boost vaccination strategy, the rAdV-SjTPI. opt intramuscular priming and rSjTPI subcutaneous boosting strategy, and evaluated its protective efficacy against Schistosoma japonicum in mice. Methodology/Principal Findings Adenoviral vectored vaccine (rAdV-SjTPI. opt) and recombinant protein vaccine (rSjTPI) were prepared and used in different combinations as vaccines in a mouse model. The specific immune responses and protective efficacies were evaluated. Furthermore, the longevity of protective efficacy was also determined. Results showed that the rAdV-SjTPI. opt priming-rSjTPI boosting strategy elicited higher levels of specific IgG responses and broad-spectrum specific cellular immune responses. The protective efficacy could reach up to nearly 70% and 50% of protection could be observed at 10 weeks after the last immunization in mice. Conclusions/Significance The rAdV-SjTPI. opt intramuscular priming-rSjTPI subcutaneous boosting vaccination strategy is a novel, highly efficient, and stable approach to developing vaccines against Schistosoma japonicum infections in China.	[Dai, Yang; Wang, Xiaoting; Tang, Jianxia; Zhao, Song; Xing, Yuntian; Dai, Jianrong; Jin, Xiaolin; Zhu, Yinchang] Minist Hlth, Key Lab Parasit Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China; [Dai, Yang; Wang, Xiaoting; Tang, Jianxia; Zhao, Song; Xing, Yuntian; Dai, Jianrong; Jin, Xiaolin; Zhu, Yinchang] Jiangsu Inst Parasit Dis, Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi, Jiangsu, Peoples R China; [Wang, Xiaoting] Soochow Univ, Coll Med, Inst Med Biotechnol, Jiangsu Stem Cell Key Lab, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Dai, Y (corresponding author), Minist Hlth, Key Lab Parasit Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China.	jipddy@hotmail.com	Wang, Xiaoting/AAI-3159-2020; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Natural Science Foundation of China [81000748, 81000749]; Jiangsu Provincial Nature Science Foundation [BK2010152]; Jiangsu Province's Outstanding Medical Academic Leader Program [LJ2011032]; Jiangsu Province's Key Medical Center Program [201108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Nature Science Foundation; Jiangsu Province's Outstanding Medical Academic Leader Program; Jiangsu Province's Key Medical Center Program	This work was supported by the National Natural Science Foundation of China (Nos. 81000748 and 81000749), the Jiangsu Provincial Nature Science Foundation (BK2010152), Jiangsu Province's Outstanding Medical Academic Leader Program (LJ2011032) and Jiangsu Province's Key Medical Center Program (No. 201108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba Raul, 2012, Methods Mol Biol, V891, P55, DOI 10.1007/978-1-61779-873-3_4; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P21; Betts G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050447; Bigaillon C, 2010, J VIROL METHODS, V164, P127, DOI 10.1016/j.jviromet.2009.11.028; Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Chmielewska AM, 2014, J VIROL, V88, P5502, DOI 10.1128/JVI.03574-13; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Dai Y, 2014, VACCINE, V32, P771, DOI 10.1016/j.vaccine.2013.12.059; Dai Y, 2009, CLIN VACCINE IMMUNOL, V16, P1796, DOI 10.1128/CVI.00231-09; Deisseroth A, 2013, CANCER GENE THER, V20, P65, DOI 10.1038/cgt.2012.87; Fiorino F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00128; Gray DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005900; Gryseels B, 2012, INFECT DIS CLIN N AM, V26, P383, DOI 10.1016/j.idc.2012.03.004; Hewitson JP, 2005, PARASITE IMMUNOL, V27, P271, DOI 10.1111/j.1365-3024.2005.00764.x; Hong XC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002122; Hu Y, 2007, EXP PARASITOL, V115, P379, DOI 10.1016/j.exppara.2006.09.022; Lawrence TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067123; Li Shi-Zhu, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P557; Lin DD, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-103; Liu JM, 2013, VET PARASITOL, V198, P219, DOI 10.1016/j.vetpar.2013.08.020; Liu JM, 2004, PARASITE IMMUNOL, V26, P351, DOI 10.1111/j.0141-9838.2004.00720.x; Liu R, 2013, PARASITOL RES, V112, P1483, DOI 10.1007/s00436-013-3295-5; LIU SX, 1995, VACCINE, V13, P603, DOI 10.1016/0264-410X(94)00045-O; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; McWilliam HEG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002460; Meng M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-494; Pajuaba ACAM, 2010, CLIN VACCINE IMMUNOL, V17, P588, DOI 10.1128/CVI.00444-09; Radosevic K, 2009, EXPERT REV VACCINES, V8, P577, DOI 10.1586/ERV.09.14; Ranasinghe C, 2009, EXPERT REV VACCINES, V8, P1171, DOI 10.1586/ERV.09.86; Rentian F, 2000, CHINESE JOURNAL OF G, V19, P174; Saljoughian N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002174; Seto EYW, 2011, AM J TROP MED HYG, V85, P74, DOI 10.4269/ajtmh.2011.10-0542; Teixeira LH, 2014, INFECT IMMUN, V82, P793, DOI 10.1128/IAI.01410-13; Tian F, 2011, PLOS ONE, V5; Trunova GV, 2011, B EXP BIOL MED+, V151, P99, DOI 10.1007/s10517-011-1268-1; Wang W, 2012, PARASITOL RES, V111, P1871, DOI 10.1007/s00436-012-3151-z; Wang YF, 2014, NORD J BOT, V32, P185, DOI 10.1111/j.1756-1051.2013.00200.x; Wen XY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001399; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Wu W, 2013, PARASITOL RES, V112, P909, DOI 10.1007/s00436-013-3303-9; Yang GJ, 2014, LANCET INFECT DIS, V14, P881, DOI 10.1016/S1473-3099(14)70727-3; Yu Chuanxin, 1999, Chinese Journal of Zoonoses, V15, P31; Zhu YC, 2004, VACCINE, V23, P78, DOI 10.1016/j.vaccine.2004.04.031; Zhu Yinchang, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P518; Zhu YC, 2010, VACCINE, V28, P5347, DOI 10.1016/j.vaccine.2010.05.017; Zhu Yingchang, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P697	47	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120792	10.1371/journal.pone.0120792	http://dx.doi.org/10.1371/journal.pone.0120792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793406	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900076
J	Lambert, SL; Aslam, S; Stillman, E; MacPhail, M; Nelson, C; Ro, B; Sweetwood, R; Lei, YM; Woo, JC; Tang, RS				Lambert, Stacie L.; Aslam, Shahin; Stillman, Elizabeth; MacPhail, Mia; Nelson, Christine; Ro, Bodrey; Sweetwood, Rosemary; Lei, Yuk Man; Woo, Jennifer C.; Tang, Roderick S.			A Novel Respiratory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective T(H)1-Type Humoral and Cellular Immunity In Rodent Models	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; CD8(+) T-LYMPHOCYTES; RECEPTOR 4 AGONIST; FUSION PROTEIN; BALB/C MICE; PULMONARY EOSINOPHILIA; IN-VIVO; INFECTION; CELLS; RESPONSES	Background Illness associated with Respiratory Syncytial Virus (RSV) remains an unmet medical need in both full-term infants and older adults. The fusion glycoprotein (F) of RSV, which plays a key role in RSV infection and is a target of neutralizing antibodies, is an attractive vaccine target for inducing RSV-specific immunity. Methodology and Principal Findings BALB/c mice and cotton rats, two well-characterized rodent models of RSV infection, were used to evaluate the immunogenicity of intramuscularly administered RSV vaccine candidates consisting of purified soluble F (sF) protein formulated with TLR4 agonist glucopyranosyl lipid A (GLA), stable emulsion (SE), GLA-SE, or alum adjuvants. Protection from RSV challenge, serum RSV neutralizing responses, and anti-F IgG responses were induced by all of the tested adjuvanted RSV sF vaccine formulations. However, only RSV sF + GLA-SE induced robust F-specific T(H)1-biased humoral and cellular responses. In mice, these F-specific cellular responses include both CD4 and CD8 T cells, with F-specific polyfunctional CD8 T cells that traffic to the mouse lung following RSV challenge. This RSV sF + GLA- SE vaccine formulation can also induce robust RSV neutralizing titers and prime IFN gamma-producing T cell responses in Sprague Dawley rats. Conclusions/Significance These studies indicate that a protein subunit vaccine consisting of RSV sF + GLA-SE can induce robust neutralizing antibody and T cell responses to RSV, enhancing viral clearance via a T(H)1 immune-mediated mechanism. This vaccine may benefit older populations at risk for RSV disease.	[Lambert, Stacie L.; Aslam, Shahin; Stillman, Elizabeth; MacPhail, Mia; Nelson, Christine; Ro, Bodrey; Sweetwood, Rosemary; Lei, Yuk Man; Woo, Jennifer C.; Tang, Roderick S.] MedImmune, Dept Res, Mountain View, CA 94043 USA	AstraZeneca; Medimmune	Lambert, SL (corresponding author), MedImmune, Dept Res, Mountain View, CA 94043 USA.	lamberts@medimmune.com		Tang, Roderick/0000-0003-0018-4869	MedImmune	MedImmune(AstraZenecaMedimmune)	This work was fully funded by MedImmune, which employed all authors at the time this work was generated and reviewed and authorized the manuscript. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Behzad H, 2012, J INFECT DIS, V205, P466, DOI 10.1093/infdis/jir769; Bernstein DI, 2012, PEDIATR INFECT DIS J, V31, P109, DOI 10.1097/INF.0b013e31823386f1; Cherukuri A, 2013, CLIN VACCINE IMMUNOL, V20, P239, DOI 10.1128/CVI.00580-12; Cherukuri A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-21; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Cusi Maria Grazia, 2010, Immun Ageing, V7, P14, DOI 10.1186/1742-4933-7-14; Cyr SL, 2007, VACCINE, V25, P5378, DOI 10.1016/j.vaccine.2007.05.004; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Durand V, 2009, VACCINE, V27, P1912, DOI 10.1016/j.vaccine.2009.01.109; Falsey AR, 1996, VACCINE, V14, P1214, DOI 10.1016/S0264-410X(96)00030-8; Falsey AR, 1999, J MED VIROL, V59, P221, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;221::AID-JMV16&gt;3.0.CO;2-H; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Fries L, 2013, ICAAC 2013 DEN; Garg R, 2014, J GEN VIROL, V95, P1043, DOI 10.1099/vir.0.062570-0; Garlapati S, VACCINE; GRAHAM BS, 1993, PEDIATR RES, V34, P167, DOI 10.1203/00006450-199308000-00013; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hancock GE, 2001, VACCINE, V19, P4874, DOI 10.1016/S0264-410X(01)00228-6; Huang K, 2010, VIRUS GENES, V40, P212, DOI 10.1007/s11262-010-0449-8; Hurwitz JL, 2011, EXPERT REV VACCINES, V10, P1415, DOI [10.1586/erv.11.120, 10.1586/ERV.11.120]; Hussell T, 1997, EUR J IMMUNOL, V27, P3341, DOI 10.1002/eji.1830271233; Johnson TR, 2008, J LEUKOCYTE BIOL, V84, P748, DOI 10.1189/jlb.0907621; Krilov LR, 2002, EXPERT OPIN BIOL TH, V2, P763, DOI 10.1517/14712598.2.7.763; Kumar R, 2008, EXPERT REV VACCINES, V7, P467, DOI 10.1586/14760584.7.4.467; Lambert SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051618; Langley JM, 2009, VACCINE, V27, P5913, DOI 10.1016/j.vaccine.2009.07.038; Lasarte JJ, 2007, J IMMUNOL, V178, P748, DOI 10.4049/jimmunol.178.2.748; Lee FEH, 2004, ANTIVIR RES, V63, P191, DOI 10.1016/j.antiviral.2004.04.005; Lee S, 2014, J IMMUNOL, V192, P293, DOI 10.4049/jimmunol.1300453; Liu XM, 2007, KIDNEY INT, V71, P388, DOI 10.1038/sj.ki.5002030; Lumsden JM, 2011, INFECT IMMUN, V79, P3492, DOI 10.1128/IAI.05257-11; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; Maher CF, 2004, MICROBES INFECT, V6, P1049, DOI 10.1016/j.micinf.2004.07.001; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Matthews SP, 2005, J VIROL, V79, P2050, DOI 10.1128/JVI.79.4.2050-2057.2005; Mbawuike IN, 1996, CELL IMMUNOL, V173, P64, DOI 10.1006/cimm.1996.0252; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; MUNOZ JL, 1991, J VIROL, V65, P4494; Neuzil KM, 1997, VACCINE, V15, P525, DOI 10.1016/S0264-410X(97)00218-1; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Olson MR, 2008, EXPERT REV VACCINES, V7, P1239, DOI 10.1586/14760584.7.8.1239; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Power UF, 1997, VIROLOGY, V230, P155, DOI 10.1006/viro.1997.8465; PRINCE GA, 1985, VIRUS RES, V3, P193, DOI 10.1016/0168-1702(85)90045-0; Ramanathan S, 2008, ARCH IMMUNOL THER EX, V56, P311, DOI 10.1007/s00005-008-0033-2; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tang RS, 2004, J VIROL, V78, P11198, DOI 10.1128/JVI.78.20.11198-11207.2004; Walsh Edward E., 2012, Infectious Disorders - Drug Targets, V12, P98; Walsh EE, 2004, J INFECT DIS, V189, P233, DOI 10.1086/380907	59	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119509	10.1371/journal.pone.0119509	http://dx.doi.org/10.1371/journal.pone.0119509			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793508	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200088
J	Salem, M; Paneru, B; Al-Tobasei, R; Abdouni, F; Thorgaard, GH; Rexroad, CE; Yao, JB				Salem, Mohamed; Paneru, Bam; Al-Tobasei, Rafet; Abdouni, Fatima; Thorgaard, Gary H.; Rexroad, Caird E.; Yao, Jianbo			Transcriptome Assembly, Gene Annotation and Tissue Gene Expression Atlas of the Rainbow Trout	PLOS ONE			English	Article							3 ABUNDANCE CLASSES; RNA-SEQ DATA; ONCORHYNCHUS-MYKISS; MESSENGER-RNA; GENOME DUPLICATION; ATLANTIC SALMON; INTEGRATED MAP; FISH GENOMES; SKIN MUCUS; GENERATION	Efforts to obtain a comprehensive genome sequence for rainbow trout are ongoing and will be complemented by transcriptome information that will enhance genome assembly and annotation. Previously, transcriptome reference sequences were reported using data from different sources. Although the previous work added a great wealth of sequences, a complete and well-annotated transcriptome is still needed. In addition, gene expression in different tissues was not completely addressed in the previous studies. In this study, non-normalized cDNA libraries were sequenced from 13 different tissues of a single doubled haploid rainbow trout from the same source used for the rainbow trout genome sequence. A total of similar to 1.167 billion paired-end reads were de novo assembled using the Trinity RNA-Seq assembler yielding 474,524 contigs > 500 base-pairs. Of them, 287,593 had homologies to the NCBI non-redundant protein database. The longest contig of each cluster was selected as a reference, yielding 44,990 representative contigs. A total of 4,146 contigs (9.2%), including 710 full-length sequences, did not match any mRNA sequences in the current rainbow trout genome reference. Mapping reads to the reference genome identified an additional 11,843 transcripts not annotated in the genome. A digital gene expression atlas revealed 7,678 housekeeping and 4,021 tissue-specific genes. Expression of about 16,000-32,000 genes (35-71% of the identified genes) accounted for basic and specialized functions of each tissue. White muscle and stomach had the least complex transcriptomes, with high percentages of their total mRNA contributed by a small number of genes. Brain, testis and intestine, in contrast, had complex transcriptomes, with a large numbers of genes involved in their expression patterns. This study provides comprehensive de novo transcriptome information that is suitable for functional and comparative genomics studies in rainbow trout, including annotation of the genome.	[Salem, Mohamed; Paneru, Bam; Al-Tobasei, Rafet; Abdouni, Fatima] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA; [Thorgaard, Gary H.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Thorgaard, Gary H.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Rexroad, Caird E.] USDA ARS, Natl Ctr Cool & Cold Water Aquaculture, Leetown, WV 25430 USA; [Yao, Jianbo] W Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA	Middle Tennessee State University; Washington State University; Washington State University; United States Department of Agriculture (USDA); West Virginia University	Salem, M (corresponding author), Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA.	Mohamed.salem@mtsu.edu	Salem, Mohamed/AGB-2739-2022	Salem, Mohamed/0000-0003-2142-6716; Paneru, Bam/0000-0001-6589-8446; Al-Tobasei, Rafet/0000-0002-0578-0734	United States Department of Agriculture, Agriculture and Food Research [58-1930-0-059]; United States Department of Agriculture, National Institute of Food and Agriculture [2014-67015-21602]	United States Department of Agriculture, Agriculture and Food Research; United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Funding: This study was supported by a cooperative agreement grant No. 58-1930-0-059 from the United States Department of Agriculture, Agriculture and Food Research (JY); and a competitive grant No. 2014-67015-21602 from the United States Department of Agriculture, National Institute of Food and Agriculture (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00348; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; ALLENDORF FW, 1984, TETRAPLOIDY EVOLUTIO, P1; Altschmied J, 2002, GENETICS, V161, P259; [Anonymous], 2014, MOL ECOL RESOUR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AXEL R, 1976, CELL, V7, P247, DOI 10.1016/0092-8674(76)90024-6; BAILEY GS, 1978, P NATL ACAD SCI USA, V75, P5575, DOI 10.1073/pnas.75.11.5575; Bamps Sophie, 2008, Briefings in Functional Genomics & Proteomics, V7, P175, DOI 10.1093/bfgp/eln013; Behenke RJ, 1992, AM FISHERIES SOC MON; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Chikina MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000417; Christensen KA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-325; Conn PJJP, ANNUAL REVIEW OF PHA, V37, P205; Davidson WS, 2012, MOL ECOL, V21, P219, DOI 10.1111/j.1365-294X.2011.05387.x; Devisetty UK, 2014, G3-GENES GENOM GENET, V4, P2065, DOI 10.1534/g3.114.012526; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Fox SE, 2014, MAR GENOM, V15, P13, DOI 10.1016/j.margen.2013.12.001; Genet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-314; Giaquinto PC, 2008, BIOL RES, V41, P33, DOI [10.4067/S0716-97602008000100005, /S0716-97602008000100005]; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; HASTIE ND, 1976, CELL, V9, P761, DOI 10.1016/0092-8674(76)90139-2; Henrich T, 2005, BIOINFORMATICS, V21, P3195, DOI 10.1093/bioinformatics/bti478; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Lamp K, 2001, CYTOGENET CELL GENET, V92, P116, DOI 10.1159/000056880; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee AP, 2011, MOL BIOL EVOL, V28, P1205, DOI 10.1093/molbev/msq304; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu S, 2015, MAR BIOTECHNOL NY; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; Lu JG, 2010, MOL GENET GENOMICS, V283, P531, DOI 10.1007/s00438-010-0538-3; Marancik D, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00453; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; MCLAREN BA, 1947, FED PROC, V6, P413; Miller M, 2011, RAPID ACCURATE SEQUE; Miller M, 2013, RAINBOW TROUT GENOME; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Palti Y, 2004, ANIM GENET, V35, P130, DOI 10.1111/j.1365-2052.2004.01112.x; Palti Y, 2011, MAR BIOTECHNOL NY; Palti Y, 2013, SINGLE NUCL POLYM SN; Palti Y, 2011, GENERATION HIGH DENS; Palti Y, 2010, PRODUCTION DRAFT REF; Palti Y, 2014, MOL ECOL RESOUR, V14, P588, DOI 10.1111/1755-0998.12204; Palti Y, 2012, MAR BIOTECHNOL, V14, P343, DOI 10.1007/s10126-011-9418-z; Palti Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-180; Palti Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-462; Papanastasiou AD, 2007, MOL IMMUNOL, V44, P1300, DOI 10.1016/j.molimm.2006.05.014; Patel M, 2006, AQUAT TOXICOL, V80, P362, DOI 10.1016/j.aquatox.2006.09.012; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Rexroad CE, 2003, CYTOGENET GENOME RES, V102, P347, DOI 10.1159/000075773; Robison BD, 1999, AQUACULTURE, V173, P131, DOI 10.1016/S0044-8486(98)00481-5; Ryynanen HJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-192; Salem M, 2008, J FISH BIOL, V72, P2187, DOI 10.1111/j.1095-8649.2008.01860.x; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Salgado LR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-236; Sanchez CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-626; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; SCHEERER PD, 1991, J EXP ZOOL, V260, P382, DOI 10.1002/jez.1402600312; SCHEERER PD, 1986, AQUACULTURE, V57, P289, DOI 10.1016/0044-8486(86)90207-3; Shin SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043762; Smith CT, 2005, MOL ECOL, V14, P4193, DOI 10.1111/j.1365-294X.2005.02731.x; Speare DJ, 1998, CONTEMP TOP LAB ANIM, V37, P55; Spooren WPJM, 2001, TRENDS PHARMACOL SCI, V22, P331, DOI 10.1016/S0165-6147(00)01694-1; Steinke D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-20; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki Y, 2003, COMP BIOCHEM PHYS B, V136, P723, DOI 10.1016/S1096-4959(03)00178-7; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsutsui S, 2003, J BIOL CHEM, V278, P20882, DOI 10.1074/jbc.M301038200; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Watson J. D., 1987, MOL BIOL GENE; Welsh PG, 2008, ECOTOX ENVIRON SAFE, V69, P199, DOI 10.1016/j.ecoenv.2007.04.003; Williams DE, 2012, COMP BIOCHEM PHYS C, V155, P121, DOI 10.1016/j.cbpc.2011.05.013; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Young WP, 1996, J HERED, V87, P77, DOI 10.1093/oxfordjournals.jhered.a022960; Yu WP, 2003, TRENDS GENET, V19, P180, DOI 10.1016/S0168-9525(03)00048-9; Zhang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06780; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	94	37	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121778	10.1371/journal.pone.0121778	http://dx.doi.org/10.1371/journal.pone.0121778			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793877	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900152
J	van der Horst-Schrivers, ANA; Sluiter, WJ; Kobold, ACM; Wolffenbuttel, BHR; Plukker, JTM; Bisschop, PH; de Klerk, JM; Al Younis, I; Lips, P; Smit, JW; Brouwers, AH; Links, TP				van der Horst-Schrivers, Anouk N. A.; Sluiter, Wim J.; Kobold, Anneke C. Muller; Wolffenbuttel, Bruce H. R.; Plukker, John T. M.; Bisschop, Peter H.; de Klerk, John M.; Al Younis, Imad; Lips, Paul; Smit, Jan W.; Brouwers, Adrienne H.; Links, Thera P.			Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success-An Observational Study	PLOS ONE			English	Article							LOW-DOSE RADIOIODINE; QUALITY-OF-LIFE; RADIOACTIVE IODINE; HORMONE WITHDRAWAL; HUMAN THYROTROPIN; FOLLOW-UP; I-131; CARCINOMA; RHTSH; MANAGEMENT	Introduction Patients with differentiated thyroid cancer (DTC) are treated with (near)-total thyroidectomy followed by remnant ablation. Optimal radioiodine-131 (I-131) uptake is achieved by withholding thyroid hormone (THW), pretreatment with recombinant human Thyrotropin Stimulating Hormone (rhTSH) is an alternative. Six randomized trials have been published comparing THW and rhTSH, however comparison is difficult because an uniform definition of ablation success is lacking. Using a strict definition, we performed an observational study aiming to determine the efficacy of rhTSH as preparation for remnant ablation. Patients and Methods Adult DTC patients with, tumor stage T1b to T3, Nx, N0 and N1, M0 were included in a prospective multicenter observational study with a fully sequential design, using a stopping rule. All patients received remnant ablation with I-131 using rhTSH. Ablation success was defined as no visible uptake in the original thyroid bed on a rhTSH stimulated 150 MBq I-131 whole body scan (WBS) 9 months after remnant ablation, or no visible uptake in the original thyroid bed on a post therapeutic WBS when a second high dose was necessary. Results After interim analysis of the first 8 patients, the failure rate was estimated to be 69% (90% confidence interval (CI) 20-86%) and the inclusion of new patients had to be stopped. Final analysis resulted in an ablation success in 11 out of 17 patients (65%, 95% CI 38-86%). Conclusion According to this study, the efficacy of rhTSH in the preparation of I-131 ablation therapy is inferior, when using a strict definition of ablation success. The current lack of agreement as to the definition of successful remnant ablation, makes comparison between different ablation strategies difficult. Our results point to the need for an international consensus on the definition of ablation success, not only in routine patient's care but also for scientific reasons.	[van der Horst-Schrivers, Anouk N. A.; Sluiter, Wim J.; Wolffenbuttel, Bruce H. R.; Links, Thera P.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Kobold, Anneke C. Muller] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Plukker, John T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [Bisschop, Peter H.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol, NL-1105 AZ Amsterdam, Netherlands; [de Klerk, John M.] Meander Med Ctr Amersfoort, Dept Nucl Med, Amersfoort, Netherlands; [Al Younis, Imad] Leiden Univ, Med Ctr, Dept Nucl Med & Mol Imaging, Leiden, Netherlands; [Lips, Paul] Vrije Univ Amsterdam Med Ctr, Dept Internal Med Endocrinol, Amsterdam, Netherlands; [Smit, Jan W.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Brouwers, Adrienne H.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Meander Medisch Centrum; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; University of Groningen	Links, TP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.	t.p.links@umcg.nl	Smit, J.W.A./H-8091-2014; Muller Kobold, Anna/HHC-2189-2022	Smit, J.W.A./0000-0003-1052-9314; Brouwers, Adrienne/0000-0003-2698-1516; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921	Genzyme Corporation	Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	This work was supported by the Genzyme Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson JK, 2005, BRIT J CLIN PHARMACO, V59, P491, DOI 10.1111/j.1365-2125.2005.02435.x; Association of Comprehensive Cancer Centres (ACCC), CANCER CLINICAL PRAC; Cailleux AF, 2000, J CLIN ENDOCR METAB, V85, P175, DOI 10.1210/jc.85.1.175; Chianelli M, 2009, EUR J ENDOCRINOL, V160, P431, DOI 10.1530/EJE-08-0669; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; de Klerk JMH, 2000, NUCL MED COMMUN, V21, P529, DOI 10.1097/00006231-200006000-00005; Hackshaw A, 2007, J CLIN ENDOCR METAB, V92, P28, DOI 10.1210/jc.2006-1345; Hanscheid H, 2006, J NUCL MED, V47, P648; Haugen BR, 1999, J CLIN ENDOCR METAB, V84, P3877, DOI 10.1210/jc.84.11.3877; Haymart MR, 2013, J CLIN ENDOCR METAB, V98, P2001, DOI 10.1210/jc.2012-3355; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jonklaas J, 2006, THYROID, V16, P1229, DOI 10.1089/thy.2006.16.1229; Lee J, 2010, THYROID, V20, P173, DOI 10.1089/thy.2009.0187; Links TP, 2012, NAT REV ENDOCRINOL, V8, P514, DOI 10.1038/nrendo.2012.113; Luster M, 2008, EUR J NUCL MED MOL I, V35, P1941, DOI 10.1007/s00259-008-0883-1; Maenpaa HO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001885; Mallick U, 2012, CLIN ONCOL-UK, V24, P159, DOI 10.1016/j.clon.2012.01.001; Mallick U, 2012, NEW ENGL J MED, V366, P1674, DOI 10.1056/NEJMoa1109589; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Pacini F, 2006, J CLIN ENDOCR METAB, V91, P926, DOI 10.1210/jc.2005-1651; Pacini F, 2002, J CLIN ENDOCR METAB, V87, P1499, DOI 10.1210/jc.87.4.1499; Pacini F, 2002, J CLIN ENDOCR METAB, V87, P4063, DOI 10.1210/jc.2001-011918; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Phan HTT, 2008, EUR J ENDOCRINOL, V158, P77, DOI 10.1530/EJE-07-0399; Sacks W, 2010, THYROID, V20, P1235, DOI 10.1089/thy.2009.0455; Sawka AM, 2004, J CLIN ENDOCR METAB, V89, P3668, DOI 10.1210/jc.2003-031167; Schlumberger M, 2007, J CLIN ENDOCR METAB, V92, P2487, DOI 10.1210/jc.2006-0723; Schlumberger M, 2012, NEW ENGL J MED, V366, P1663, DOI 10.1056/NEJMoa1108586; Schvartz C, 2012, J CLIN ENDOCR METAB, V97, P1526, DOI 10.1210/jc.2011-2512; SWEENEY DC, 1995, ENDOCRIN METAB CLIN, V24, P803, DOI 10.1016/S0889-8529(18)30022-7; Taieb D, 2009, CLIN ENDOCRINOL, V71, P115, DOI 10.1111/j.1365-2265.2008.03424.x; Van der Zee AGJ, 2008, J CLIN ONCOL, V26, P884, DOI 10.1200/JCO.2007.14.0566; Verkooijen RBT, 2008, EUR J ENDOCRINOL, V159, P301, DOI 10.1530/EJE-08-0062; Westbury C, 2000, THYROID, V10, P171, DOI 10.1089/thy.2000.10.171; Zanotti-Fregonara P, 2010, EUR J NUCL MED MOL I, V37, P2264, DOI 10.1007/s00259-010-1608-9	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120184	10.1371/journal.pone.0120184	http://dx.doi.org/10.1371/journal.pone.0120184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793762	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200154
J	Vu, TH; Le Lamer, AC; Lalli, C; Boustie, J; Samson, M; Devehat, FL; Le Seyec, J				Vu, Thi Huyen; Le Lamer, Anne-Cecile; Lalli, Claudia; Boustie, Joel; Samson, Michel; Devehat, Franoise Lohezic-Le; Le Seyec, Jacques			Depsides: Lichen Metabolites Active against Hepatitis C Virus	PLOS ONE			English	Article							IN-VITRO; ENTRY; REPLICATION; CONSTITUENTS; DERIVATIVES; INHIBITORS	A thorough phytochemical study of Stereocaulon evolutum was conducted, for the isolation of structurally related atranorin derivatives. Indeed, pilot experiments suggested that atranorin (1), the main metabolite of this lichen, would interfere with the lifecycle of hepatitis C virus (HCV). Eight compounds, including one reported for the first time (2), were isolated and characterized. Two analogs (5, 6) were also synthesized, to enlarge the panel of atra-norin-related structures. Most of these compounds were active against HCV, with a half-maximal inhibitory concentration of about 10 to 70 mu M, with depsides more potent than monoaromatic phenols. The most effective inhibitors (1, 5 and 6) were then added at different steps of the HCV lifecycle. Interestingly, atranorin (1), bearing an aldehyde function at C-3, inhibited only viral entry, whereas the synthetic compounds 5 and 6, bearing a hydroxymethyl and a methyl function, respectively, at C-3 interfered with viral replication.	[Vu, Thi Huyen; Le Lamer, Anne-Cecile; Lalli, Claudia; Boustie, Joel; Devehat, Franoise Lohezic-Le] CNRS, ISCR, UMR 6226, Rennes, France; [Vu, Thi Huyen; Le Lamer, Anne-Cecile; Lalli, Claudia; Boustie, Joel; Samson, Michel; Devehat, Franoise Lohezic-Le; Le Seyec, Jacques] Univ Rennes 1, Rennes, France; [Le Lamer, Anne-Cecile] Univ Toulouse 3, F-31062 Toulouse, France; [Samson, Michel; Le Seyec, Jacques] INSERM, IRSET, UMR 1085, Rennes, France; [Samson, Michel; Le Seyec, Jacques] Federat Rech BioSit Rennes, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rennes; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Devehat, FL (corresponding author), CNRS, ISCR, UMR 6226, Rennes, France.	francoise.le-devehat@univ-rennes1.fr; jacques.leseyec@univ-rennes1.fr	Le Seyec, Jacques/GLU-3933-2022; Le Seyec, Jacques/J-5680-2015; Samson, Michel/F-8356-2013	Le Seyec, Jacques/0000-0002-1118-3311; 	Biology and Health Federative Research Structure of Rennes (Biosit) [UMS CNRS 3480 / US INSERM 018]; Comite Grand-Ouest de la Ligue contre le Cancer; "Institute National de la Sante Et de la Recherche Medicale" (INSERM); Universite de Rennes 1; "Centre National de Recherche Scientifique" (CNRS); Vietnamese Government (Ministry of Education and Training) [322]	Biology and Health Federative Research Structure of Rennes (Biosit); Comite Grand-Ouest de la Ligue contre le Cancer; "Institute National de la Sante Et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Rennes 1; "Centre National de Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Vietnamese Government (Ministry of Education and Training)	This research was supported by the Biology and Health Federative Research Structure of Rennes (Biosit, UMS CNRS 3480 / US INSERM 018), by the Comite Grand-Ouest de la Ligue contre le Cancer, by the "Institute National de la Sante Et de la Recherche Medicale" (INSERM), by the "Universite de Rennes 1" and by the "Centre National de Recherche Scientifique" (CNRS). THV. is supported by a scholarship from the Vietnamese Government (Project 322, Ministry of Education and Training). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NAT MED, V20, P319, DOI 10.1038/nm.3538; Atalay F, 2011, TURK J CHEM, V35, P647, DOI 10.3906/kim-1008-847; Bhat R, 2014, BIOORG MED CHEM LETT, V24, P4162, DOI 10.1016/j.bmcl.2014.07.051; Bo L, 1990, ACT BOT YUNN, V12, P447; Boustie J, 2005, PLANT GENET RESOUR, V3, P273, DOI DOI 10.1079/PGR200572; Bugni TS, 2009, FITOTERAPIA, V80, P270, DOI 10.1016/j.fitote.2009.03.003; Bush CO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065273; Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107767; CULBERSON CF, 1978, EXP MYCOL, V2, P245, DOI 10.1016/S0147-5975(78)80018-8; deLemos AS, 2014, TRENDS MOL MED, V20, P315, DOI 10.1016/j.molmed.2014.02.002; ELIX JA, 1987, AUST J CHEM, V40, P1581, DOI 10.1071/CH9871581; Francoise LD, 2014, ADV BOT RES, V71, P467, DOI 10.1016/B978-0-12-408062-1.00016-0; GOLLAPUDI SR, 1994, J NAT PROD, V57, P934, DOI 10.1021/np50109a009; GONZALEZ AG, 1992, Z NATURFORSCH C, V47, P503; Hattori M, 2013, CAN CHEM T, V1, P116; Huneck S, 1996, IDENTIFICATION LICHE; Ingolfsdottir K, 1996, PHYTOMEDICINE, V2, P243, DOI 10.1016/S0944-7113(96)80049-3; Jiang B, 2001, FITOTERAPIA, V72, P832, DOI 10.1016/S0367-326X(01)00287-8; Jiang Bei, 2002, Acta Botanica Yunnanica, V24, P525; Kumar S, 1999, J NAT PROD, V62, P817, DOI 10.1021/np9803777; Lai DW, 2013, PLANTA MED, V79, P1440, DOI 10.1055/s-0033-1350711; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; MATSUMOTO T, 1982, J AM OIL CHEM SOC, V59, P521, DOI 10.1007/BF02636314; Neyts J, 2006, ANTIVIR RES, V71, P363, DOI 10.1016/j.antiviral.2006.06.006; Parrot D, 2013, PHYTOCHEMISTRY, V89, P114, DOI 10.1016/j.phytochem.2013.02.002; Paulson MS, 2009, ANTIVIR RES, V83, P135, DOI 10.1016/j.antiviral.2009.04.003; PULGARIN C, 1985, HELV CHIM ACTA, V68, P1948, DOI 10.1002/hlca.19850680720; Shibata C, 2014, VIROLOGY, V462, P42, DOI 10.1016/j.virol.2014.05.024; Siqueira RS, 2010, Z NATURFORSCH C, V65, P551; Stocker-Worgotter E, 2008, NAT PROD REP, V25, P188, DOI 10.1039/b606983p; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Uprichard SL, 2015, GUT, V64, P690, DOI 10.1136/gutjnl-2014-308396; Zambare VP, 2012, PHARM BIOL, V50, P778, DOI 10.3109/13880209.2011.633089; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong ZJ, 2013, EUR J MED CHEM, V69, P32, DOI 10.1016/j.ejmech.2013.07.053; Zofou D, 2012, PARASITOL RES, V110, P539, DOI 10.1007/s00436-011-2519-9	40	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120405	10.1371/journal.pone.0120405	http://dx.doi.org/10.1371/journal.pone.0120405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793970	gold, Green Submitted, Green Published			2022-12-26	WOS:000352083900027
J	Weiterer, S; Uhle, F; Lichtenstern, C; Siegler, BH; Bhuju, S; Jarek, M; Bartkuhn, M; Weigand, MA				Weiterer, Sebastian; Uhle, Florian; Lichtenstern, Christoph; Siegler, Benedikt H.; Bhuju, Sabin; Jarek, Michael; Bartkuhn, Marek; Weigand, Markus A.			Sepsis Induces Specific Changes in Histone Modification Patterns in Human Monocytes	PLOS ONE			English	Article							GENE-EXPRESSION; IMMUNOSUPPRESSION; EPIDEMIOLOGY; INJURY	Background Sepsis is a global burden and the primary cause of death in intensive care units worldwide. The pathophysiological changes induced by the host's systemic inflammatory response to infection are not yet fully understood. During sepsis, the immune system is confronted with a variety of factors, which are integrated within the individual cells and result in changes of their basal state of responsiveness. Epigenetic mechanisms like histone modifications are known to participate in the control of immune reactions, but so far the situation during sepsis is unknown. Methods and Findings In a pilot approach, we performed combined chromatin immunoprecipitation followed by high-throughput sequencing to assess the genome-wide distribution of the chromatin modifications histone 3 lysine 4 and 27 trimethylation and lysine 9 acetylation in monocytes isolated from healthy donors (n = 4) and patients with sepsis (n = 2). Despite different underlying causes for sepsis, a comparison over promoter regions shows a high correlation between the patients for all chromatin marks. These findings hold true also when comparing patients to healthy controls. Despite the global similarity, differential analysis reveals a set of distinct promoters with significant enrichment or depletion of histone marks. Further analysis of overrepresented GO terms show an enrichment of genes involved in immune function. To the most prominent ones belong different members of the HLA family located within the MHC cluster together with the gene coding for the major regulator of this locus-CIITA. Conclusions We are able to show for the first time that sepsis in humans induces selective and precise changes of chromatin modifications in distinct promoter regions of immunologically relevant genes, shedding light on basal regulatory mechanisms that might be contributing to the functional changes occurring in monocytes.	[Weiterer, Sebastian; Uhle, Florian; Lichtenstern, Christoph; Siegler, Benedikt H.; Weigand, Markus A.] Univ Heidelberg Hosp, Dept Anaesthesiol, Heidelberg, Germany; [Weiterer, Sebastian; Weigand, Markus A.] German Ctr Infect Res DZIF, Giessen, Germany; [Bhuju, Sabin; Jarek, Michael] Helmholtz Ctr Infect Res, Genome Analyt, Braunschweig, Germany; [Bartkuhn, Marek] Univ Giessen, Inst Genet, D-35390 Giessen, Germany	Ruprecht Karls University Heidelberg; German Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Justus Liebig University Giessen	Weiterer, S (corresponding author), Univ Heidelberg Hosp, Dept Anaesthesiol, Heidelberg, Germany.	Sebastian.Weiterer@med.uni-Heidelberg.de	Uhle, Florian/Q-6191-2019	Bartkuhn, Marek/0000-0001-6872-9082	German Centre for Infection Research (DZIF); Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	German Centre for Infection Research (DZIF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	Funding: This work was supported by the German Centre for Infection Research (DZIF). The authors acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bo LL, 2011, CRIT CARE, V15, DOI 10.1186/cc10031; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Cajander S, 2013, CRIT CARE, V17, DOI 10.1186/cc13046; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Hall MW, 2011, INTENS CARE MED, V37, P525, DOI 10.1007/s00134-010-2088-x; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lyn-Kew K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011145; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Thompson CM, 2014, CRIT CARE MED, V42, P1397, DOI 10.1097/CCM.0000000000000218; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Weiterer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094164; Zhang L, 2009, HEPATOL RES, V39, P931, DOI 10.1111/j.1872-034X.2009.00521.x	31	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121748	10.1371/journal.pone.0121748	http://dx.doi.org/10.1371/journal.pone.0121748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793379	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900148
J	Gonzalez-Delgado, M; Gomez-Dantes, H; Fernandez-Nino, JA; Robles, E; Borja, VH; Aguilar, M				Gonzalez-Delgado, Mery; Gomez-Dantes, Hector; Alfredo Fernandez-Nino, Julian; Robles, Eduardo; Borja, Victor H.; Aguilar, Miriam			Factors Associated with Fatal Occupational Accidents among Mexican Workers: A National Analysis	PLOS ONE			English	Article							INJURY MORTALITY; UNITED-STATES; REGISTRATION; INDUSTRY; SAFETY; BURDEN; HEALTH; SECTOR; COSTS; RATES	Objective To identify the factors associated with fatal occupational injuries in Mexico in 2012 among workers affiliated with the Mexican Social Security Institute. Methods Analysis of secondary data using information from the National Occupational Risk Information System, with the consequence of the occupational injury (fatal versus non-fatal) as the response variable. The analysis included 406,222 non-fatal and 1,140 fatal injuries from 2012. The factors associated with the lethality of the injury were identified using a logistic regression model with the Firth approach. Results Being male (OR=5.86; CI95%: 4.22-8.14), age (OR=1.04; CI95%: 1.03-1.06), employed in the position for 1 to 10 years (versus less than 1 year) (OR=1.37; CI95%: 1.15-1.63), working as a facilities or machine operator or assembler (OR: 3.28; CI95%: 2.12-5.07) and being a worker without qualifications (OR=1.96; CI95%: 1.18-3.24) (versus an office worker) were associated with fatality in the event of an injury. Additionally, companies classified as maximum risk (OR=1.90; CI95%: 1.38-2.62), workplace conditions (OR=7.15; CI95%: 3.63-14.10) and factors related to the work environment (OR=9.18; CI95%: 4.36-19.33) were identified as risk factors for fatality in the event of an occupational injury. Conclusions Fatality in the event of an occupational injury is associated with factors related to sociodemographics (age, sex and occupation), the work environment and workplace conditions. Worker protection policies should be created for groups with a higher risk of fatal occupational injuries in Mexico.	[Gonzalez-Delgado, Mery] Escuela Salud Publ Mexico, Cuernavaca, Morelos, Mexico; [Gomez-Dantes, Hector] Inst Nacl Salud Publ, Ctr Invest Sistemas Salud, Cuernavaca, Morelos, Mexico; [Alfredo Fernandez-Nino, Julian] Inst Nacl Salud Publ, Ctr Informac Decisiones Salud Publ CENIDSP, Cuernavaca, Morelos, Mexico; [Robles, Eduardo; Aguilar, Miriam] Inst Mexicano Seguro Social, Coordinac Salud El Trabajo, Mexico City, DF, Mexico; [Borja, Victor H.] Inst Mexicano Seguro Social, Unidad Atenc Primaria Salud, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Fernandez-Nino, JA (corresponding author), Inst Nacl Salud Publ, Ctr Informac Decisiones Salud Publ CENIDSP, Cuernavaca, Morelos, Mexico.	julian.fernandez@insp.mx	Fernández-Niño, Julián Alfredo/AHE-6038-2022	Fernández-Niño, Julián Alfredo/0000-0002-8948-8481				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akerstedt T, 2002, J SLEEP RES, V11, P69, DOI 10.1046/j.1365-2869.2002.00287.x; Alli BO, 2008, PRINCIPIOS FUNDAMENT; [Anonymous], 2014, CIUO88; Armengou LM, 2006, GEST PRACTICA RIESGO, V28, P42, DOI [10.1016/j.ijpharm.2009.05.017, DOI 10.1016/J.IJPHARM.2009.05.017]; Benavides FG, 2003, AM J IND MED, V44, P385, DOI 10.1002/ajim.10290; Biddle EA, 2013, J SAFETY RES, V44, P7, DOI 10.1016/j.jsr.2012.09.005; Carcoba A, 1999, WHOSE COST WHO BENEF; Carlos S., 2009, CIENC TRAB, V11, P32; Castillo D N, 1997, Inj Prev, V3, P277, DOI 10.1136/ip.3.4.277; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P317; Chaparro P, 1999, REV SALUD PUBLICA, V1, P274; Colak B, 2004, IND HEALTH, V42, P424, DOI 10.2486/indhealth.42.424; Dudarev AA, 2013, INT J CIRCUMPOL HEAL, V72, DOI 10.3402/ijch.v72i0.20458; Dumrak J, 2013, CONSTR ECON BUILD, V13, P32, DOI 10.5130/AJCEB.v13i4.3620; Estados Unidos Mexicanos, 2002, REGL LAY SEG SOC MAT, P1; Farrow A, 2012, OCCUP MED-OXFORD, V62, P4, DOI 10.1093/occmed/kqr148; Feitosa Ana Isabela Ramos, 2014, Rev. bras. saúde ocup., V39, P75, DOI 10.1590/0303-7657000072212; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Garduño María de los Ángeles, 2008, Salud de los Trabajadores, V16, P5; Ghai D., 2003, REV INT TRABAJO, V122, P125, DOI [10.1111/j.1564-913X.2003.tb00171.x, DOI 10.1111/J.1564-913X.2003.TB00171.X]; Gobierno de Espana Ministerio de empleo y seguridad social Instituto nacional de seguridad e higiene en el trabajo, 2010, AGR COOP DEP PLANN D, P5; GuemezSandoval JC, 1996, SALUD PUBLICA MEXICO, V38, P110; Gyekye SA, 2010, INT J PSYCHOL, V45, P405, DOI 10.1080/00207594.2010.501337; Hamalainen P, 2006, SAFETY SCI, V44, P137, DOI 10.1016/j.ssci.2005.08.017; Hard David L, 2006, J Agromedicine, V11, P57, DOI 10.1300/J096v11n02_09; Herbert R, 2000, AM J PUBLIC HEALTH, V90, P541, DOI 10.2105/AJPH.90.4.541; INEGI, MEX CIFR; Instituto Mexicano del seguro social, 2012, MEM EST 2012 DAT INT; Instituto Nacional de Estadistica Geografia e Informatica, 1995, CLAS ACT EC ENC NAC, P1; International Labour Office, 2013, PROGR SAF HLTH WORK; Janicak CA, 2013, OPEN J SAF SCI TECHN, V3, P1, DOI [10.4236/ojsst.2013.31001, DOI 10.4236/OJSST.2013.31001]; Konstantinidis A, 2011, AM SURGEON, V77, P702; Laflamme L, 2001, EUR J PUBLIC HEALTH, V11, P309, DOI 10.1093/eurpub/11.3.309; Laneko Segurtasun eta Osasunerako Euskal Erakundea Instituto Vasco de Seguridad y salud labor- ales., 2012, ASIAN PACIFIC NEWSLE; Leigh JP, 2001, PUBLIC HEALTH REP, V116, P235, DOI 10.1093/phr/116.3.235; Loomis D, 2003, INJ PREV, V9, P9, DOI 10.1136/ip.9.1.9; Mora AM, 2011, INT J OCCUP ENV HEAL, V17, P243; Mehrdad R, 2013, INT J OCCUP ENV MED, V4, P205; Mehrdad R, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.10359; Moradinazar M, 2013, IRAN RED CRESCENT ME, V15, DOI 10.5812/ircmj.8011; Nguyen Thi Hong Tu, 2008, Asian-Pacific Newsletter on Occupational Health and Safety, V15, P7; Nishikitani M, 2008, SAFETY SCI, V46, P1078, DOI 10.1016/j.ssci.2007.06.017; ONUSIDA, 2013, SIDA CIFR GIN; Organizacion Internacional del Trabajo, 2003, SEG CIFR SUG CULT GL, P13; Pérez Martínez Patricia, 2008, Med. segur. trab., V54, P45, DOI 10.4321/s0465-546x2008000300005; Betzabé Pérez-Manriquez Gabriela, 2012, Med. segur. trab., V58, P13, DOI 10.4321/s0465-546x2012000100003; Perttula P, 2012, INT J OCCUP SAF ERGO, V18, P541, DOI 10.1080/10803548.2012.11076958; Pratt SG, 2013, MMWR-MORBID MORTAL W, V62, P653; Reddy R, 2013, OCCUP MED-OXFORD, V63, P284, DOI 10.1093/occmed/kqt024; Richardson DB, 2004, AM J PUBLIC HEALTH, V94, P1756, DOI 10.2105/AJPH.94.10.1756; Rubiales-Gutierrez E, 2010, SALUD PUBLICA MEXICO, V52, P199, DOI 10.1590/s0036-36342010000300003; Rydlewska-Liszkowska Izabela, 2006, Medycyna Pracy, V57, P317; Salim C, 2014, OCCUP ENVIRON MED, V71, pA79, DOI [10.1136/oemed-2014-102362.247, DOI 10.1136/OEMED-2014-102362.247]; Salinas-Tovar JS, 2004, SALUD PUBLICA MEXICO, V46, P204, DOI 10.1590/S0036-36342004000300009; Sanchez-Roman FR, 2006, INT J OCCUP ENV HEAL, V12, P346, DOI 10.1179/oeh.2006.12.4.346; Santana VS, 2009, REV SAUDE PUBL, V43, P750, DOI 10.1590/S0034-89102009005000061; Sarmiento-Salinas Rodrigo, 2004, Gac Med Mex, V140, P593; Secretaria del Trabajo y Prevision Social [Secretary of Labor and Social Prevision], 2014, EST ACC ENF TRAB 201; Smith CK, 2014, ACCIDENT ANAL PREV, V65, P63, DOI 10.1016/j.aap.2013.12.012; Sotelo-Suárez Nidia R, 2012, Rev. salud pública, V14, P32; Stout NA, 1996, AM J PUBLIC HEALTH, V86, P73, DOI 10.2105/AJPH.86.1.73; Takala J, 2014, J OCCUP ENVIRON HYG, V11, P326, DOI 10.1080/15459624.2013.863131; The PLoS Medicine, 2007, PLOS MED, pe221; The word Bank, 2014, DATABASE; Velazquez Y, 2013, SEGUR SALUD TRAB, V71, P20; Villanueva V, 2011, ACCIDENT ANAL PREV, V43, P123, DOI 10.1016/j.aap.2010.08.001; Xia ZL, 2000, J OCCUP ENVIRON MED, V42, P917, DOI 10.1097/00043764-200009000-00014; Zakaria NH., 2012, BUS MANAGE REV, V2, P75	69	12	13	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121490	10.1371/journal.pone.0121490	http://dx.doi.org/10.1371/journal.pone.0121490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25790063	gold, Green Published			2022-12-26	WOS:000351425400195
J	Rouaud, A; Hanon, O; Boureau, AS; Chapelet, GG; de Decker, L				Rouaud, Agnes; Hanon, Olivier; Boureau, Anne-Sophie; Chapelet, Guillaume Gilles; de Decker, Laure			Comorbidities against Quality Control of VKA Therapy in Non-Valvular Atrial Fibrillation: A French National Cross-Sectional Study	PLOS ONE			English	Article							ORAL ANTICOAGULATION CONTROL; LONG-TERM; PATIENT CHARACTERISTICS; ANTITHROMBOTIC THERAPY; RISK-FACTOR; WARFARIN; PREDICTORS; CONSEQUENCES; POLYMORPHISM; METAANALYSIS	Background Given the prevalence of non-valvular atrial fibrillation in the geriatric population, thromboembolic prevention by means of vitamin K antagonists (VKA) is one of the most frequent daily concerns of practitioners. The effectiveness and safety of treatment with VKA correlates directly with maximizing the time in therapeutic range, with an International Normalized Ratio (INR) of 2.0-3.0. The older population concentrates many of factors known to influence INR rate, particularly concomitant medications and concurrent medical conditions, also defined as comorbidities. Objective Determine whether a high burden on comorbidities, defined by a Charlson Comorbidity Index (CCI) of 3 or greater, is associated a lower quality of INR control. Study-Design Cross-sectional study. Settings French geriatric care units nationwide. Participants 2164 patients aged 80 and over and treated with vitamin K antagonists. Measurements Comorbidities were assessed using the Charlson Comorbidity Index (CCI). The recorded data included age, sex, falls, kidney failure, hemorrhagic event, VKA treatment duration, and the number and type of concomitant medications. Quality of INR control, defined as time in therapeutic range (TTR), was assessed using the Rosendaal method. Results 487 patients were identified the low-quality control of INR group. On multivariate logistic regression analysis, low-quality control of INR was independently associated with a CCI >= 3 (OR = 1.487; 95% CI [1.15; 1.91]). The other variables associated with low-quality control of INR were: hemorrhagic event (OR = 3.151; 95% CI [1.64; 6.07]), hospitalization (OR = 1.614, 95% CI [1.21; 2.14]). Conclusion An elevated CCI score (>= 3) was associated with low-quality control of INR in elderly patients treated with VKA. Further research is needed to corroborate this finding.	[Rouaud, Agnes; Boureau, Anne-Sophie; Chapelet, Guillaume Gilles; de Decker, Laure] Nantes Univ Hosp, Dept Geriatr, EA 1156 12, Nantes, France; [Hanon, Olivier] Publ Hosp Paris, Broca Hosp, Dept Geriatr, Paris, France	Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Universite Paris Cite	Rouaud, A (corresponding author), Nantes Univ Hosp, Dept Geriatr, EA 1156 12, Nantes, France.	Agnes.ROUAUD@chu-nantes.fr	Hanon, Olivier/GWR-0220-2022	Hanon, Olivier/0000-0002-4697-122X; boureau, annesophie/0000-0002-2224-2014	French Society of Geriatrics and Gerontology (SFGG)	French Society of Geriatrics and Gerontology (SFGG)	None of the authors have any relevant financial interest in this manuscript. Funding was provided by The French Society of Geriatrics and Gerontology (SFGG), http://www.sfgg.fr/. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; [Anonymous], 2009, ASS CAR SEN MULT DRO; [Anonymous], 2003, BIOL MON VKA THER ST; Atrial Fibrillation, 2007, ATR FIBR 2007; Baker WL, 2009, J MANAGE CARE PHARM, V15, P244, DOI 10.18553/jmcp.2009.15.3.244; Cavallari LH, 2009, J THROMB THROMBOLYS, V27, P430, DOI 10.1007/s11239-008-0236-8; Charlemagne A, 2011, ARCH CARDIOVASC DIS, V104, P115, DOI 10.1016/j.acvd.2010.11.012; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chatap G, 2008, THERAPIE, V63, P393, DOI 10.2515/therapie:2008058; Chute J P, 1997, Endocr Pract, V3, P77; Currie CJ, 2005, CURR MED RES OPIN, V21, P1905, DOI 10.1185/030079905X75050; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Costa GLD, 2012, CLIN THER, V34, P1511, DOI 10.1016/j.clinthera.2012.06.002; de Decker L, 2013, J AM GERIATR SOC, V61, P1224, DOI 10.1111/jgs.12345; Dias A, 2014, AGING CLIN EXP RES; Extermann M, 1998, J CLIN ONCOL, V16, P1582, DOI 10.1200/JCO.1998.16.4.1582; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Kaatz S, 2008, J THROMB THROMBOLYS, V25, P61, DOI 10.1007/s11239-007-0106-9; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Khreizat HS, 2012, DRUG AGING, V29, P307, DOI 10.2165/11599060-000000000-00000; Kleinow ME, 2011, J MANAGE CARE PHARM, V17, P523, DOI 10.18553/jmcp.2011.17.7.523; Menzin J, 2012, THROMB HAEMOSTASIS, V107, P662, DOI 10.1160/TH11-09-0646; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; Newschaffer CJ, 1997, J CLIN EPIDEMIOL, V50, P725, DOI 10.1016/S0895-4356(97)00050-4; Palareti G, 2005, J THROMB HAEMOST, V3, P955, DOI 10.1111/j.1538-7836.2005.01330.x; Penning-van Beest FJA, 2001, THROMB HAEMOSTASIS, V86, P569, DOI 10.1055/s-0037-1616088; Phillips Katherine W, 2008, Expert Rev Cardiovasc Ther, V6, P57, DOI 10.1586/14779072.6.1.57; Plichart M, 2013, DRUG AGING, V30, P1019, DOI 10.1007/s40266-013-0127-3; Rose AJ, 2010, J THROMB HAEMOST, V8, P2182, DOI 10.1111/j.1538-7836.2010.03996.x; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Self TH, 2006, CURR MED RES OPIN, V22, P2089, DOI 10.1185/030079906X132479; Tomita H, 2013, THROMB RES, V132, P537, DOI 10.1016/j.thromres.2013.09.003; van Walraven C, 2007, THROMB RES, V119, P705, DOI 10.1016/j.thromres.2006.05.017; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239; Witt DM, 2010, J THROMB HAEMOST, V8, P744, DOI 10.1111/j.1538-7836.2010.03756.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	42	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119043	10.1371/journal.pone.0119043	http://dx.doi.org/10.1371/journal.pone.0119043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789771	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400062
J	Liu, D; Yang, Z; Wang, T; Yang, Z; Chen, H; Hu, Y; Hu, C; Guo, L; Deng, Q; Liu, Y; Yu, M; Shi, M; Du, N; Guo, N				Liu, D.; Yang, Z.; Wang, T.; Yang, Z.; Chen, H.; Hu, Y.; Hu, C.; Guo, L.; Deng, Q.; Liu, Y.; Yu, M.; Shi, M.; Du, N.; Guo, N.			beta 2-AR signaling controls trastuzumab resistance-dependent pathway	ONCOGENE			English	Article							METASTATIC BREAST-CANCER; BETA-BLOCKERS; KINASE ACTIVATION; STAT3 ACTIVATION; SRC ACTIVATION; UP-REGULATION; STRESS; PTEN; THERAPY; MIR-21	Currently, trastuzumab resistance is a major clinical problem in the treatment of Her2-overexpressing breast cancer. The underlying molecular mechanisms are not fully understood. Our previous study demonstrates that beta 2-adrenergic receptor (beta 2-AR) and Her2 comprise a positive feedback loop in human breast cancer cells and that crosstalk between Her2 and beta 2-AR affects the bio-behaviors of breast cancer cells, suggesting that the beta 2-AR activation may be involved in trastuzumab resistance. In this study, we show that the expression of beta 2-AR, which mediates most catecholamine-induced effects, negatively correlates with trastuzumab response in the patients with Her2-overexpressing breast cancer. Catecholamines potently antagonize the anti-proliferative effects of trastuzumab both in vitro and in vivo. Catecholamine stimulation upregulates the expression of miR-21 and MUC-1 by activating Her2 and STAT3, leading to deficiency of phosphatase and tensin homolog and activation of phosphatidylinositol-3-kinase (PI3K) and Akt. Through inhibition of miR-199a/b-3p, catecholamines induce the mammalian target of rapamycin (mTOR) activation. Thus, trastuzumab resistance-dependent PI3K/Akt/mTOR pathway is controlled by catecholamine-induced beta 2-AR activation. The data indicate that beta 2-AR is a reliable molecular marker for prediction of response probability to trastuzumab-based therapy in breast cancer. We also demonstrate that beta-blocker propranolol not only enhances the antitumor activities of trastuzumab but also re-sensitizes the resistant cells to trastuzumab. Our retrospective study shows that concurrent treatment of a-blocker and trastuzumab significantly improved progression-free survival and overall survival in the patients with Her2-overexpressing metastatic breast cancer, implicating the possibility for combination therapy with trastuzumab plus a-blocker in Her2-overexpressing breast cancer.	[Liu, D.; Yang, Z.; Chen, H.; Hu, Y.; Guo, L.; Deng, Q.; Liu, Y.; Yu, M.; Shi, M.; Guo, N.] Inst Basic Med Sci, Dept Pathophysiol, Beijing 100850, Peoples R China; [Wang, T.] Peoples Liberat Army, Hosp 307, Dept Oncol, Beijing, Peoples R China; [Yang, Z.] Beijing Haiyan Pharmaceut Co Ltd, Yangtze River Pharmaceut Grp, Beijing, Peoples R China; [Hu, C.] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Du, N.] Peoples Liberat Army, Gen Hosp, Affiliated Hosp 1, Dept Oncol, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Chinese People's Liberation Army General Hospital	Shi, M (corresponding author), Inst Basic Med Sci, Dept Pathophysiol, Taiping Rd 27, Beijing 100850, Peoples R China.	sm200@sohu.com; dunan05@aliyun.com; ningguo@nic.bmi.ac.cn			National Basic Research Program of China (973 program) [2010CB911904]; National Key Technologies R&D Program for New Drugs [2013ZX09102056]; National High-Tech Research and Development Plan (863 program) [2014AA020604]; National Natural Science Foundation of China [31370825, 81402562, 81272232]; Beijing Natural Science Foundation [7122124, 7132163]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Key Technologies R&D Program for New Drugs(National Key Technology R&D Program); National High-Tech Research and Development Plan (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work is supported by National Basic Research Program of China (973 program, no. 2010CB911904), National Key Technologies R&D Program for New Drugs (2013ZX09102056), the National High-Tech Research and Development Plan (863 program, no. 2014AA020604), National Natural Science Foundation of China (no. 31370825, 81402562 and 81272232) and Beijing Natural Science Foundation (no. 7122124 and 7132163).	Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Antonova L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2836; Armaiz-Pena GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2413; Arnould L, 2007, CLIN CANCER RES, V13, P6404, DOI 10.1158/1078-0432.CCR-06-3022; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bhola NE, 2011, CLIN CANCER RES, V17, P4996, DOI 10.1158/1078-0432.CCR-10-3406; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Carbajal L, 2011, MOL ENDOCRINOL, V25, P1055, DOI 10.1210/me.2010-0410; Cardwell CR, 2013, INT J EPIDEMIOL, V42, P1852, DOI 10.1093/ije/dyt196; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Dominici LS, 2010, CANCER-AM CANCER SOC, V116, P2884, DOI 10.1002/cncr.25152; Esteva FJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1836; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Ganz PA, 2011, J CLIN ONCOL, V29, P2612, DOI 10.1200/JCO.2011.35.8820; Garcia-Garcia C, 2012, CLIN CANCER RES, V18, P2603, DOI 10.1158/1078-0432.CCR-11-2750; Garcia-Recio S, 2013, CANCER RES, V73, P6424, DOI 10.1158/0008-5472.CAN-12-4573; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Gu L, 2009, CLIN CANCER RES, V15, P7196, DOI 10.1158/1078-0432.CCR-09-0585; Haghikia A, 2011, EUR HEART J, V32, P1287, DOI 10.1093/eurheartj/ehq369; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Kuzumaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044368; Lamkin DM, 2011, BRAIN BEHAV IMMUN, V25, P555, DOI 10.1016/j.bbi.2010.12.010; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Liang K, 2010, CANCER CELL, V18, P423, DOI 10.1016/j.ccr.2010.10.025; Lutgendorf SK, 2008, J CLIN ONCOL, V26, P4820, DOI 10.1200/JCO.2007.14.1978; Lutgendorf SK, 2010, J CLIN ONCOL, V28, P4094, DOI 10.1200/JCO.2009.26.9357; Lutgendorf SK, 2009, BRAIN BEHAV IMMUN, V23, P176, DOI 10.1016/j.bbi.2008.04.155; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Morrow PK, 2011, J CLIN ONCOL, V29, P3126, DOI 10.1200/JCO.2010.32.2321; Mukohara T, 2011, CANCER SCI, V102, P1, DOI 10.1111/j.1349-7006.2010.01711.x; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Park BH, 2007, CANCER CELL, V12, P297, DOI 10.1016/j.ccr.2007.10.004; Powe DG, 2011, NAT REV CLIN ONCOL, V8, P511, DOI 10.1038/nrclinonc.2011.123; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; Shi M, 2013, CANCER METAST REV, V32, P603, DOI 10.1007/s10555-013-9440-x; Shi M, 2013, INT J CARDIOL, V167, P1570, DOI 10.1016/j.ijcard.2012.04.093; Shi M, 2011, BREAST CANCER RES TR, V125, P351, DOI 10.1007/s10549-010-0822-2; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Smith C, 1999, CARDIOVASC DRUG THER, V13, P123, DOI 10.1023/A:1007784109255; Sorensen GV, 2013, J CLIN ONCOL, V31, P2265, DOI 10.1200/JCO.2012.43.9190; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Stern HM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3001539; Waller A, 2012, CURR ONCOL, V19, pE53, DOI 10.3747/co.19.882; Woo JK, 2012, ONCOGENE, V31, P2187, DOI 10.1038/onc.2011.410; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Yao MY, 2011, LUNG, V189, P453, DOI 10.1007/s00408-011-9327-y; Yuan GG, 2008, CELL SIGNAL, V20, P1284, DOI 10.1016/j.cellsig.2008.02.017; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	63	39	42	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2016	35	1					47	58		10.1038/onc.2015.58	http://dx.doi.org/10.1038/onc.2015.58			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DA4ZT	25798840				2022-12-26	WOS:000367812400005
J	Ahmad, T; Sundar, IK; Lerner, CA; Gerloff, J; Tormos, AM; Yao, HW; Rahman, I				Ahmad, Tanveer; Sundar, Isaac K.; Lerner, Chad A.; Gerloff, Janice; Tormos, Ana M.; Yao, Hongwei; Rahman, Irfan			Impaired mitophagy leads to cigarette smoke stress-induced cellular senescence: implications for chronic obstructive pulmonary disease	FASEB JOURNAL			English	Article						Parkin; Pink1; reactive oxygen species; perinuclear mitochondrial clustering; DNA damage	MITOCHONDRIAL DYSFUNCTION; OXIDATIVE DAMAGE; SIRT1 PROTECTS; DNA-DAMAGE; PARKIN; PINK1; CELLS; PROMOTES; ROS; FRAGMENTATION	Cigarette smoke (CS)-induced cellular senescence is involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). The molecular mechanism by which CS induces cellular senescence is unknown. Here, we show that CS stress (exposure of primary lung cells to CS extract 0.2-0.75% with a halfmaximal inhibitory concentration of similar to 0.5%) led to impaired mitophagy and perinuclear accumulation of damaged mitochondria associated with cellular senescence in both human lung fibroblasts and small airway epithelial cells (SAECs). Impaired mitophagy was attributed to reduced Parkin translocation to damaged mitochondria, which was due to CS-induced cytoplasmic p53 accumulation and its interaction with Parkin. Impaired Parkin translocation to damaged mitochondria was also observed in mouse lungs with emphysema (6 months CS exposure, 100 mg TPM/m(3)) as well as in lungs of chronic smokers and patients with COPD. Primary SAECs from patients with COPD also exhibited impaired mitophagy and increased cellular senescence via suborganellar signaling. Mitochondria-targeted antioxidant (Mito-Tempo) restored impaired mitophagy, decreased mitochondrial mass accumulation, and delayed cellular senescence in Parkin-overexpressing cells. In conclusion, defective mitophagy leads to CS stress-induced lung cellular senescence, and restoring mitophagy delays cellular senescence, which provides a promising therapeutic intervention in chronic airway diseases.	[Ahmad, Tanveer; Sundar, Isaac K.; Lerner, Chad A.; Gerloff, Janice; Tormos, Ana M.; Yao, Hongwei; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA	University of Rochester	Yao, HW (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	hongwei_yao@urmc.rochester.edu; irfan_rahman@urmc.rochester.edu	Sundar, Isaac K/F-8764-2012; Yao, Hongwei/G-6444-2010	Sundar, Isaac K/0000-0001-6742-3460; Ahmad, Tanveer/0000-0002-8384-5273; Yao, Hongwei/0000-0003-0948-0111	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [2R01HL085613, 1R01HL092842]; American Lung Association [RG-266456-N, RG-305393]; NIH National Institute of Environmental Health Sciences [P30-ES01247]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092842, R01HL085613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association; NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Christian Sell for providing the WI-38 cells expressing microtubule-associated protein light-chain 3-green fluorescent protein. They also thank Dr. Thomas L. Schwarz from the Department of Neuroscience, Harvard Medical School (Boston, MA, USA), for providing the yellow fluorescent protein-Parkin, mCherry-Parkin, and FLAG-Pink1 constructs. The authors thank the late Dr. Vuokko L. Kinnula for providing the human tissue samples from smokers and patients with chronic obstructive pulmonary disease, which were previously used in our published studies. This study was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants 2R01HL085613 and 1R01HL092842 (to I.R.), American Lung Association Grants RG-266456-N (to H.Y.) and RG-305393 (to I.K.S.), and NIH National Institute of Environmental Health Sciences Grant P30-ES01247. T.A. contributed to the experiment design, data analysis, and manuscript writing. T.A., I.K.S., C.L., J.G., H.Y., and A.M.T. performed the experiments. H.Y. analyzed the data and participated in manuscript writing/editing. I.R. contributed significantly to the experimental design and manuscript writing/editing. The authors declare no conflicts of interest.	Ahmad T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.213; Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Aravamudan B, 2014, AM J PHYSIOL-LUNG C, V306, pL840, DOI 10.1152/ajplung.00155.2013; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Ballweg K, 2014, AM J PHYSIOL-LUNG C, V307, pL895, DOI 10.1152/ajplung.00180.2014; Bernhardt D, 2015, SCI REP-UK, V5, DOI 10.1038/srep07885; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463; Dagouassat M, 2013, AM J RESP CRIT CARE, V187, P703, DOI 10.1164/rccm.201208-1361OC; Davis CHO, 2014, AUTOPHAGY, V10, P2383, DOI 10.4161/15548627.2014.981920; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guo LL, 2012, BBA-MOL BASIS DIS, V1822, P852, DOI 10.1016/j.bbadis.2012.02.004; Hackett TL, 2014, AM J RESP CELL MOL, V51, P830, DOI 10.1165/rcmb.2013-0369OC; Haque ME, 2012, J BIOL CHEM, V287, P23162, DOI 10.1074/jbc.M112.346437; Hara H, 2013, AM J PHYSIOL-LUNG C, V305, pL737, DOI 10.1152/ajplung.00146.2013; Hara H, 2012, AM J RESP CELL MOL, V46, P306, DOI 10.1165/rcmb.2011-0214OC; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Jia LH, 2007, INVEST OPHTH VIS SCI, V48, P339, DOI 10.1167/iovs.06-0248; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Morse D, 2014, ANNU REV PHYSIOL, V76, P493, DOI 10.1146/annurev-physiol-021113-170411; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Narendra DP, 2013, HUM MOL GENET, V22, P2572, DOI 10.1093/hmg/ddt106; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Nyunoya T, 2014, AM J RESP CELL MOL, V50, P471, DOI 10.1165/rcmb.2013-0348TR; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Nyunoya T, 2009, AM J RESP CRIT CARE, V179, P279, DOI 10.1164/rccm.200802-320OC; Osellame LD, 2013, AUTOPHAGY, V9, P1633, DOI 10.4161/auto.25878; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11; Samara KD, 2011, PULM MED, V2011, DOI 10.1155/2011/461439; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Tao RD, 2014, ANTIOXID REDOX SIGN, V20, P1646, DOI 10.1089/ars.2013.5482; Trainor C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043326; Vigneron A, 2010, AGING-US, V2, P471, DOI 10.18632/aging.100189; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wu J, 2013, CLIN CANCER RES, V19, P721, DOI 10.1158/1078-0432.CCR-12-2529; Wu JF, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-21; Yamano K, 2014, ELIFE, V3, DOI 10.7554/eLife.01612; Yao HW, 2014, AM J PHYSIOL-LUNG C, V306, pL816, DOI 10.1152/ajplung.00323.2013; Yao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080007; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2010, J BIOL CHEM, V285, P5405, DOI 10.1074/jbc.M109.041418; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	60	152	154	5	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2912	2929		10.1096/fj.14-268276	http://dx.doi.org/10.1096/fj.14-268276			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25792665	Green Published			2022-12-26	WOS:000356859100021
J	Juarez, JF; Liu, HX; Zamarro, MT; McMahon, S; Liu, HT; Naismith, JH; Eberlein, C; Boll, M; Carmona, M; Diaz, E				Juarez, Javier F.; Liu, Huixiang; Zamarro, Maria T.; McMahon, Stephen; Liu, Huanting; Naismith, James H.; Eberlein, Christian; Boll, Matthias; Carmona, Manuel; Diaz, Eduardo			Unraveling the Specific Regulation of the Central Pathway for Anaerobic Degradation of 3-Methylbenzoate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Transcription; Gene Expression; Microbiology; Protein-DNA Interaction; Transcription Regulation; 3-Methylbenzoate; Azoarcus; Anaerobic Degradation	AROMATIC-COMPOUNDS; TRANSCRIPTIONAL REGULATOR; ESCHERICHIA-COLI; TETR FAMILY; COENZYME-A; M-XYLENE; RHODOPSEUDOMONAS-PALUSTRIS; BENZOATE METABOLISM; TOLUENE METABOLISM; CATABOLIC GENES	Background: The specific transcriptional regulation of the mbd pathway for anaerobic 3-methylbenzoate degradation is unknown. Results: The MbdR/3-methylbenzoyl-CoA couple controls the induction of the mbd genes. Conclusion: MbdR is the regulator of the mbd pathway in Azoarcus sp. CIB. Significance: This work highlights the importance of the regulatory systems in the evolution and adaptation of bacteria to the anaerobic degradation of aromatic compounds. The mbd cluster encodes the anaerobic degradation of 3-methylbenzoate in the -proteobacterium Azoarcus sp. CIB. The specific transcriptional regulation circuit that controls the expression of the mbd genes was investigated. The P-O, P-B1, and P-3R promoters responsible for the expression of the mbd genes, their cognate MbdR transcriptional repressor, as well as the MbdR operator regions (ATACN(10)GTAT) have been characterized. The three-dimensional structure of MbdR has been solved revealing a conformation similar to that of other TetR family transcriptional regulators. The first intermediate of the catabolic pathway, i.e. 3-methylbenzoyl-CoA, was shown to act as the inducer molecule. An additional MbdR-dependent promoter, P-A, which contributes to the expression of the CoA ligase that activates 3-methylbenzoate to 3-methylbenzoyl-CoA, was shown to be necessary for an efficient induction of the mbd genes. Our results suggest that the mbd cluster recruited a regulatory system based on the MbdR regulator and its target promoters to evolve a distinct central catabolic pathway that is only expressed for the anaerobic degradation of aromatic compounds that generate 3-methylbenzoyl-CoA as the central metabolite. All these results highlight the importance of the regulatory systems in the evolution and adaptation of bacteria to the anaerobic degradation of aromatic compounds.	[Juarez, Javier F.; Zamarro, Maria T.; Carmona, Manuel; Diaz, Eduardo] CSIC, Dept Environm Biol, Ctr Invest Biol, Madrid 28040, Spain; [Liu, Huixiang; McMahon, Stephen; Liu, Huanting; Naismith, James H.] Univ St Andrews, St Andrews KY16 9ST, Scotland; [Eberlein, Christian; Boll, Matthias] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of St Andrews; University of Freiburg	Diaz, E (corresponding author), CSIC, Dept Environm Biol, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	ediaz@cib.csic.es	Naismith, James Henderson/H-3408-2012; Naismith, James Henderson/AAB-8614-2020; Eberlein, Christian/AAL-8874-2021; Diaz, Eduardo/F-8605-2016	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Diaz, Eduardo/0000-0002-9731-6524; Fernandez Juarez, Javier/0000-0002-1958-9906; Carmona, Manuel/0000-0002-1591-7618	Ministry of Economy and Competitiveness of Spain [BIO2009-10438, BIO2012-39501, CSD2007-00005]; European Union [311815]; Biotechnology and Biological Sciences Research Council; Wellcome Trust; Comunidad Autonoma de Madrid; Biotechnology and Biological Sciences Research Council [BB/K015508/1] Funding Source: researchfish; BBSRC [BB/K015508/1] Funding Source: UKRI	Ministry of Economy and Competitiveness of Spain(Spanish Government); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Comunidad Autonoma de Madrid(Comunidad de Madrid); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Ministry of Economy and Competitiveness of Spain Grants BIO2009-10438, BIO2012-39501, and CSD2007-00005 and European Union FP7 Grant 311815. Crystallography was supported by a Biotechnology and Biological Sciences Research Council grant and a Wellcome Trust award.; Supported by a predoctoral fellowship from the Comunidad Autonoma de Madrid. Present address: Dept. of Genetics, Harvard Medical School, 77 Louis Pasteur Ave., Boston, MA 02155.	Achong GR, 2001, J BACTERIOL, V183, P6763, DOI 10.1128/JB.183.23.6763-6770.2001; Agari Y, 2012, J BACTERIOL, V194, P4630, DOI 10.1128/JB.00668-12; Agari Y, 2011, MICROBIOL-SGM, V157, P1589, DOI 10.1099/mic.0.048017-0; Valderrama JA, 2014, J BIOL CHEM, V289, P1892, DOI 10.1074/jbc.M113.517714; Valderrama JA, 2012, J BIOL CHEM, V287, P10494, DOI 10.1074/jbc.M111.309005; Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Boll M, 2014, ENVIRON MICROBIOL, V16, P612, DOI 10.1111/1462-2920.12328; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Calisti C, 2008, APPL MICROBIOL BIOT, V80, P475, DOI 10.1007/s00253-008-1557-4; Carmona M, 1996, J MOL BIOL, V261, P348, DOI 10.1006/jmbi.1996.0468; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen DW, 2014, APPL ENVIRON MICROB, V80, P4051, DOI 10.1128/AEM.01146-14; Coschigano PW, 2004, FEMS MICROBIOL LETT, V231, P261, DOI 10.1016/S0378-1097(04)00005-9; Coschigano PW, 1997, APPL ENVIRON MICROB, V63, P652, DOI 10.1128/AEM.63.2.652-660.1997; de Lorenzo Victor, 2011, Bioeng Bugs, V2, P3, DOI 10.4161/bbug.2.1.13388; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Diaz E, 2013, CURR OPIN BIOTECH, V24, P431, DOI 10.1016/j.copbio.2012.10.010; Durante-Rodriguez G, 2006, J BACTERIOL, V188, P2343, DOI 10.1128/JB.188.7.2343-2354.2006; Durante-Rodriguez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057518; Durante-Rodriguez G, 2010, J BIOL CHEM, V285, P35694, DOI 10.1074/jbc.M110.143503; Egland PG, 1999, J BACTERIOL, V181, P2102, DOI 10.1128/JB.181.7.2102-2109.1999; Egland PG, 2000, J BACTERIOL, V182, P100, DOI 10.1128/JB.182.1.100-106.2000; FERNANDEZ S, 1995, MOL MICROBIOL, V16, P205, DOI 10.1111/j.1365-2958.1995.tb02293.x; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Fujihashi M, 2014, PROTEINS, V82, P1301, DOI 10.1002/prot.24496; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; GROSS GG, 1966, Z NATURFORSCH PT B, VB 21, P683; Herrmann S, 2009, ENV MICROBIOL REP, V1, P535, DOI 10.1111/j.1758-2229.2009.00076.x; Hirakawa H, 2012, J BACTERIOL, V194, P1960, DOI 10.1128/JB.06817-11; Juarez JF, 2013, ENVIRON MICROBIOL, V15, P148, DOI 10.1111/j.1462-2920.2012.02818.x; Juarez JF, 2010, APPL ENVIRON MICROB, V76, P383, DOI 10.1128/AEM.02255-09; Kasai D, 2012, FEMS MICROBIOL LETT, V332, P68, DOI 10.1111/j.1574-6968.2012.02576.x; Krieger CJ, 1999, J BACTERIOL, V181, P6403, DOI 10.1128/JB.181.20.6403-6410.1999; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Leuthner B, 1998, FEMS MICROBIOL LETT, V166, P35, DOI 10.1111/j.1574-6968.1998.tb13180.x; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; Marschall C, 1998, J MOL BIOL, V276, P339, DOI 10.1006/jmbi.1997.1533; Maxam A M, 1980, Methods Enzymol, V65, P499; Meckenstock RU, 2011, CURR OPIN BIOTECH, V22, P406, DOI 10.1016/j.copbio.2011.02.009; Morasch B, 2004, ARCH MICROBIOL, V181, P407, DOI 10.1007/s00203-004-0672-6; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Parke D, 2003, APPL ENVIRON MICROB, V69, P5398, DOI 10.1128/AEM.69.9.5398-5409.2003; Peres CM, 2006, J BACTERIOL, V188, P8662, DOI 10.1128/JB.01312-06; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Philipp B, 2012, ENV MICROBIOL REP, V4, P469, DOI 10.1111/j.1758-2229.2011.00304.x; Rabus R, 2014, APPL MICROBIOL BIOT, V98, P3371, DOI 10.1007/s00253-013-5466-9; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rieger PG, 2002, J BIOTECHNOL, V94, P101, DOI 10.1016/S0168-1656(01)00422-9; Sakamoto K, 2011, J BACTERIOL, V193, P4388, DOI 10.1128/JB.05203-11; Sambrook J., 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueki T, 2011, APPL ENVIRON MICROB, V77, P7058, DOI 10.1128/AEM.05516-11; Vilchez-Vargas R, 2010, ENVIRON MICROBIOL, V12, P3089, DOI 10.1111/j.1462-2920.2010.02340.x; Willems AR, 2008, J MOL BIOL, V376, P1377, DOI 10.1016/j.jmb.2007.12.061; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062	71	7	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12165	12183		10.1074/jbc.M115.637074	http://dx.doi.org/10.1074/jbc.M115.637074			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25795774	Green Published, hybrid			2022-12-26	WOS:000354388600029
J	Sidahmed, HMA; Hashim, NM; Abdulla, MA; Ali, HM; Mohan, S; Abdelwahab, SI; Taha, MME; Fai, LM; Vadivelu, J				Sidahmed, Heyam Mohamed Ali; Hashim, Najihah Mohd; Abdulla, Mahmood Ameen; Ali, Hapipah Mohd; Mohan, Syam; Abdelwahab, Siddig Ibrahim; Taha, Manal Mohamed Elhassan; Fai, Loke Mun; Vadivelu, Jamuna			Antisecretory, Gastroprotective, Antioxidant and Anti-Helicobcter Pylori Activity of Zerumbone from Zingiber Zerumbet (L.) Smith	PLOS ONE			English	Article							INDUCED GASTRIC-LESIONS; HELICOBACTER-PYLORI; LIPID-PEROXIDATION; MUCOSAL INJURY; ETHANOL; ULCER; EXTRACT; DISEASE; PLANT; CYTOPROTECTION	Background Zingiber zerumbet Smith is a perennial herb, broadly distributed in many tropical areas. In Malaysia, it's locally known among the Malay people as "lempoyang" and its rhizomes, particularly, is widely used in traditional medicine for the treatment of peptic ulcer disease beyond other gastric disorders. Aim of the study The aim of the current study is to evaluate the gastroprotective effect of zerumbone, the main bioactive compound of Zingiber zerumbet rhizome, against ethanol-induced gastric ulcer model in rats. Materials and Methods Rats were pre-treated with zerumbone and subsequently exposed to acute gastric ulcer induced by absolute ethanol administration. Following treatment, gastric juice acidity, ulcer index, mucus content, histological analysis (HE and PAS), immunohistochemical localization for HSP-70, prostaglandin E2 synthesis (PGE2), non-protein sulfhydryl gastric content (NP-SH), reduced glutathione level (GSH), and malondialdehyde level (MDA) were evaluated in ethanol-induced ulcer in vivo. Ferric reducing antioxidant power assay (FRAP) and anti-H. pylori activity were investigated in vitro. Results The results showed that the intragastric administration of zerumbone protected the gastric mucosa from the aggressive effect of ethanol-induced gastric ulcer, coincided with reduced submucosal edema and leukocyte infiltration. This observed gastroprotective effect of zerumbone was accompanied with a significant (p < 0.05) effect of the compound to restore the lowered NP-SH and GSH levels, and to reduce the elevated MDA level into the gastric homogenate. Moreover, the compound induced HSP-70 up-regulation into the gastric tissue. Furthermore, zerumbone significantly (p < 0.05) enhanced mucus production, showed intense PAS stain and maintained PG content near to the normal level. The compound exhibited antisecretory activity and an interesting minimum inhibitory concentration (MIC) against H. pylori strain. Conclusion The results of the present study revealed that zerumbone promotes ulcer protection, which might be attributed to the maintenance of mucus integrity, antioxidant activity, and HSP-70 induction. Zerumbone also exhibited antibacterial action against H. pylori.	[Sidahmed, Heyam Mohamed Ali; Hashim, Najihah Mohd] Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur, Malaysia; [Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Fac Sci, Kuala, Lumpur, Malaysia; [Mohan, Syam; Abdelwahab, Siddig Ibrahim; Taha, Manal Mohamed Elhassan] Jazan Univ, Med Res Ctr, Jazan, Saudi Arabia; [Fai, Loke Mun; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Jazan University; Universiti Malaya	Sidahmed, HMA (corresponding author), Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur, Malaysia.	Diamondhm@hotmail.com	Abdelwahab, Siddig I/E-8929-2010; Mohan, Syam/A-1231-2011; Loke, Mun Fai/B-1060-2011; Hashim, Najihah Mohd/J-5508-2015; VADIVELU, JAMUNARANI S/B-8696-2010; TAHA, MANAL M/C-5968-2011	Abdelwahab, Siddig I/0000-0002-6145-4466; Loke, Mun Fai/0000-0002-3554-5313; Hashim, Najihah Mohd/0000-0003-1133-7998; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; sidahmed, heyam/0000-0003-2466-6248; Taha, Manal/0000-0003-0166-8929	University of Malaya [PG151-2012B]; Ministry of Higher Education Malaysia under High Impact Research grant (UM-MOHE) [UM.C/625/1/HIR/MOHE/SC/09]	University of Malaya(Universiti Malaya); Ministry of Higher Education Malaysia under High Impact Research grant (UM-MOHE)	The authors would like to express their extreme thankfulness and gratefulness to University of Malaya (PG151-2012B) and the Ministry of Higher Education Malaysia under High Impact Research grant (UM-MOHE UM.C/625/1/HIR/MOHE/SC/09) for providing financial funds to perform this work. Also, the authors would like to express their utmost gratitude and appreciation to the late Prof. Datuk Dr. A. Hamid A. Hadi for his help and support throughout this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2013, J ETHNOPHARMACOL, V148, P277, DOI 10.1016/j.jep.2013.04.027; Abdelwahab SI, 2011, J ETHNOPHARMACOL, V137, P963, DOI 10.1016/j.jep.2011.07.010; Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Andreo MA, 2006, J ETHNOPHARMACOL, V107, P431, DOI 10.1016/j.jep.2006.04.001; Aruoma OI, 2010, TOXICOLOGY, V278, P6, DOI 10.1016/j.tox.2010.09.006; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Behmer O.A., 1976, MANUAL TECNICAS HIST, V1st; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Choi JI, 2010, CHEM-BIOL INTERACT, V183, P249, DOI 10.1016/j.cbi.2009.09.015; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; CROSS CE, 1984, LANCET, V1, P1328; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Sanchez-Mendoza ME, 2010, FITOTERAPIA, V81, P66, DOI 10.1016/j.fitote.2009.07.009; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Faridah QZ, 2011, AFR J BIOTECHNOL, V10, P9303; Palacios-Espinosa JF, 2014, J ETHNOPHARMACOL, V151, P990, DOI 10.1016/j.jep.2013.12.012; Goel R. K., 2002, Indian Journal of Pharmacology, V34, P100; Gomes RD, 2009, J ETHNOPHARMACOL, V121, P466, DOI 10.1016/j.jep.2008.11.013; Gourine N, 2010, IND CROP PROD, V31, P203, DOI 10.1016/j.indcrop.2009.10.003; Grotto D, 2009, QUIM NOVA, V32, P169, DOI 10.1590/S0100-40422009000100032; Guo JS, 2002, TOXICOL APPL PHARM, V183, P41, DOI 10.1006/taap.2002.9457; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ibrahim MY, 2010, AFR J BIOTECHNOL, V9, P4442; Jain KS, 2007, BIOORGAN MED CHEM, V15, P1181, DOI 10.1016/j.bmc.2006.07.068; Jainu M, 2006, CHEM-BIOL INTERACT, V161, P262, DOI 10.1016/j.cbi.2006.04.011; Jorgensen JH, 2007, CLIN INFECT DIS, V44, P280, DOI 10.1086/510431; Klopell FC, 2007, Z NATURFORSCH C, V62, P537; Konturek JW, 1998, AM J GASTROENTEROL, V93, P2385, DOI 10.1016/S0002-9270(98)00573-5; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; La Casa C, 2000, J ETHNOPHARMACOL, V71, P45, DOI 10.1016/S0378-8741(99)00174-9; LAINE L, 1988, GASTROENTEROLOGY, V94, P1254, DOI 10.1016/0016-5085(88)90661-0; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Lee JS, 2005, MUTAT RES-FUND MOL M, V579, P214, DOI 10.1016/j.mrfmmm.2005.03.027; LOGUERCIO C, 1993, GUT, V34, P161, DOI 10.1136/gut.34.2.161; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Mathew A, 1998, ANN NY ACAD SCI, V851, P99, DOI 10.1111/j.1749-6632.1998.tb08982.x; Mejia Alex, 2009, Expert Rev Clin Pharmacol, V2, P295, DOI 10.1586/ecp.09.8; Mizushima T, 2014, CURR OPIN PHARMACOL, V19, pR1, DOI 10.1016/j.coph.2014.10.006; Moraes TDM, 2008, J ETHNOPHARMACOL, V120, P161, DOI 10.1016/j.jep.2008.08.001; NASH J, 1994, DRUGS, V47, P862, DOI 10.2165/00003495-199447060-00002; Odashima M, 2002, DIGEST DIS SCI, V47, P2799, DOI 10.1023/A:1021029927386; Okabe S, 2005, BIOL PHARM BULL, V28, P1321, DOI 10.1248/bpb.28.1321; PIHAN G, 1986, GASTROENTEROLOGY, V91, P1415, DOI 10.1016/0016-5085(86)90195-2; Potrich FB, 2010, J ETHNOPHARMACOL, V130, P85, DOI 10.1016/j.jep.2010.04.014; Prakash R.O., 2011, INT J RES AYURVEDA P, V2, P1; ROBERT A, 1985, GASTROENTEROLOGY, V88, P328, DOI 10.1016/S0016-5085(85)80187-6; Rodrigues PD, 2010, J ETHNOPHARMACOL, V127, P725, DOI 10.1016/j.jep.2009.11.031; Romano M, 2008, J CLIN PATHOL, V61, P1112, DOI 10.1136/jcp.2008.060392; Santin JR, 2010, J ETHNOPHARMACOL, V130, P334, DOI 10.1016/j.jep.2010.05.014; Sasaki M, 2007, J CLIN BIOCHEM NUTR, V40, P1, DOI 10.3164/jcbn.40.1; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shakirin FH, 2010, J FOOD COMPOS ANAL, V23, P777, DOI 10.1016/j.jfca.2010.04.008; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; Shine VJ, 2009, J ETHNOPHARMACOL, V125, P350, DOI 10.1016/j.jep.2009.04.039; Sidahmed HMA, 2013, PHYTOMEDICINE, V20, P834, DOI 10.1016/j.phymed.2013.03.002; Sidahmed HMA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/450840; Sidahmed HMA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-183; Sri Nurestri A. M., 2005, Malaysian Journal of Science, V24, P49; SZABO S, 1978, AM J PATHOL, V93, P273; SZABO S, 1985, GASTROENTEROLOGY, V88, P228, DOI 10.1016/S0016-5085(85)80176-1; Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030; Tan PV, 2002, J ETHNOPHARMACOL, V82, P69, DOI 10.1016/S0378-8741(02)00142-3; Vimala S, 1999, BRIT J CANCER, V80, P110, DOI 10.1038/sj.bjc.6690329; Wahab A, 2009, J BIOMEDICINE BIOTEC, V2009; Whittle BJR, 2003, FUND CLIN PHARMACOL, V17, P301, DOI 10.1046/j.1472-8206.2003.00135.x; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038; Yob N, 2011, EVIDENCE BASED COMPL, V2011	68	63	67	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121060	10.1371/journal.pone.0121060	http://dx.doi.org/10.1371/journal.pone.0121060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798602	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300203
J	Cazares-Dominguez, V; Cruz-Cordova, A; Ochoa, SA; Escalona, G; Arellano-Galindo, J; Rodriguez-Leviz, A; Hernandez-Castro, R; Lopez-Villegas, EO; Xicohtencatl-Cortes, J				Cazares-Dominguez, Vicenta; Cruz-Cordova, Ariadnna; Ochoa, Sara A.; Escalona, Gerardo; Arellano-Galindo, Jose; Rodriguez-Leviz, Alejandra; Hernandez-Castro, Rigoberto; Lopez-Villegas, Edgar O.; Xicohtencatl-Cortes, Juan			Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening	PLOS ONE			English	Article							CHROMOSOME MEC TYPE; REGULATOR AGR GROUP; REDUCED SUSCEPTIBILITY; INHIBITORY CONCENTRATION; BACTERICIDAL ACTIVITIES; CLINICAL-FEATURES; GROUP-II; GENE; INTERMEDIATE; STRAINS	Methicillin-resistant Staphylococcus aureus (MRSA) is an important opportunistic pathogen that causes both healthcare-and community-acquired infections. An increase in the incidence of these infections may lead to a substantial change in the rate of vancomycin usage. Incidence of reduced susceptibility to vancomycin has been increasing worldwide for the last few years, conferring different levels of resistance to vancomycin as well as producing changes in the cell wall structure. The aim of the present study was to determine the effect of vancomycin on cell wall thickening in clinical isolates of vancomycin-tolerant (VT) MRSA obtained from pediatric patients. From a collection of 100 MRSA clinical isolates from pediatric patients, 12% (12/100) were characterized as VT-MRSA, and from them, 41.66% (5/ 12) exhibited the heterogeneous vancomycin-intermediate S. aureus (hVISA) phenotype. Multiplex-PCR assays revealed 66.66% (8/12), 25% (3/12), and 8.33% (1/12) of the VT-MRSA isolates were associated with agr group II, I, and III polymorphisms, respectively; the II-mec gene was amplified from 83.3%(10/12) of the isolates, and the mecIVa gene was amplified from 16.66% (2/12) of the isolates. Pulsed field electrophoresis (PFGE) fingerprint analysis showed 62% similarity among the VT-MRSA isolates. Thin transverse sections analyzed by transmission electron microscopy (TEM) revealed an average increase of 24 nm (105.55%) in the cell wall thickness of VT-MRSA compared with untreated VT-MRSA isolates. In summary, these data revealed that the thickened cell walls of VT-MRSA clinical isolates with agr type II and SCCmec group II polymorphisms are associated with an adaptive resistance to vancomycin.	[Cazares-Dominguez, Vicenta; Cruz-Cordova, Ariadnna; Ochoa, Sara A.; Escalona, Gerardo; Xicohtencatl-Cortes, Juan] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Bacteriol Intestinal, Mexico City, DF, Mexico; [Arellano-Galindo, Jose] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Mexico City, DF, Mexico; [Rodriguez-Leviz, Alejandra] Hosp Infantil Mexico Dr Federico Gomez, Lab Patol, Mexico City, DF, Mexico; [Hernandez-Castro, Rigoberto] Hosp Gen Dr Manuel Gea Gonzalez, Dept Ecol Agentes Patogenos, Mexico City, DF, Mexico; [Lopez-Villegas, Edgar O.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Lab Cent Microscopia, Mexico City, DF, Mexico	Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Instituto Politecnico Nacional - Mexico	Xicohtencatl-Cortes, J (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Bacteriol Intestinal, Dr Marquez 162, Mexico City, DF, Mexico.	juanxico@yahoo.com	Córdova, Ariadnna Cruz/AAF-9654-2021; Xicohtencatl-Cortes, Juan/ABD-5463-2020	Lopez Villegas, Edgar Oliver/0000-0002-9995-2145	Children Hospital of Mexico "Federico Gomez" [HIM/2010/016]; CONACYT [133451]; Fondo Sectorial de Investigacion en Salud y Seguridad Social, FOSSIS-CONACYT [2012-01-182651]	Children Hospital of Mexico "Federico Gomez"; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondo Sectorial de Investigacion en Salud y Seguridad Social, FOSSIS-CONACYT	This work was partially supported through a federal grant (HIM/2010/016) from the Children Hospital of Mexico "Federico Gomez" and through additional grants from CONACYT (133451) and the Fondo Sectorial de Investigacion en Salud y Seguridad Social, FOSSIS-CONACYT 2012-01-182651. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoyo TA, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-17; Aiken AM, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-22; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; Bae IG, 2009, J INFECT DIS, V200, P1355, DOI 10.1086/606027; Bardiau M, 2013, LETT APPL MICROBIOL, V57, P181, DOI 10.1111/lam.12099; Bibalan MH, 2014, J CLIN DIAGN RES, V8, pDC07, DOI [10.7860/JCDR/2014/9713.5088, DOI 10.7860/JCDR/2014/9713.5088]; Biedenbacha DJ, 2007, INT J ANTIMICROB AG, V30, P143, DOI 10.1016/j.ijantimicag.2007.03.015; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Clinical and Laboratory Standards Institute, 2013, PERF STAND ANT SUSC; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Deresinski S, 2009, J INFECT DIS, V199, P605, DOI 10.1086/596630; Fong RKC, 2009, EUR J CLIN MICROBIOL, V28, P983, DOI 10.1007/s10096-009-0741-5; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Fukutsuji K, 2013, MED MOL MORPHOL, V46, P70, DOI 10.1007/s00795-013-0009-0; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P315, DOI 10.1093/jac/42.3.315; Hill-Cawthorne GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101419; Holmes RL, 2008, ANTIMICROB AGENTS CH, V52, P757, DOI 10.1128/AAC.00945-07; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Hyo Y, 2013, MED MOL MORPHOL, V46, P217, DOI 10.1007/s00795-013-0027-y; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Jones RN, 2008, CLIN MICROBIOL INFEC, V14, P3, DOI 10.1111/j.1469-0691.2008.01923.x; May J, 1998, J ANTIMICROB CHEMOTH, V42, P189, DOI 10.1093/jac/42.2.189; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Borbon-Esquer EM, 2014, SCAND J INFECT DIS, V46, P523, DOI 10.3109/00365548.2014.912349; Moise-Broder PA, 2004, CLIN INFECT DIS, V38, P1700, DOI 10.1086/421092; Norazah Ahmad, 2012, Med J Malaysia, V67, P269; Pitz AM, 2011, J CLIN MICROBIOL, V49, P269, DOI 10.1128/JCM.00914-10; Reipert A, 2003, ANTIMICROB AGENTS CH, V47, P568, DOI 10.1128/AAC.47.2.568-576.2003; Rose WE, 2007, J ANTIMICROB CHEMOTH, V59, P1190, DOI 10.1093/jac/dkm091; Rose WE, 2012, ANTIMICROB AGENTS CH, V56, P4422, DOI 10.1128/AAC.00676-12; Sader HS, 2009, J ANTIMICROB CHEMOTH, V64, P1024, DOI 10.1093/jac/dkp319; Safdar A, 2006, CANCER-AM CANCER SOC, V106, P1815, DOI 10.1002/cncr.21801; Sakoulas G, 2003, J INFECT DIS, V187, P929, DOI 10.1086/368128; Sakoulas G, 2006, J ANTIMICROB CHEMOTH, V57, P699, DOI 10.1093/jac/dkl030; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; Stojanov M, 2014, EUR J CLIN MICROBIOL, V33, P1967, DOI 10.1007/s10096-014-2169-9; Sujatha S, 2012, INTERDIS CIP PERSPEC; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; Tiwari HK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-156; Traczewski MM, 2009, ANTIMICROB AGENTS CH, V53, P1735, DOI 10.1128/AAC.01022-08; Tsuji BT, 2007, ANTIMICROB AGENTS CH, V51, P1089, DOI 10.1128/AAC.00671-06; Vindel A, 2009, J CLIN MICROBIOL, V47, P1620, DOI 10.1128/JCM.01579-08; Ward PB, 2001, MED J AUSTRALIA, V175, P480, DOI 10.5694/j.1326-5377.2001.tb143681.x; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399; Zhang KY, 2009, ANTIMICROB AGENTS CH, V53, P531, DOI 10.1128/AAC.01118-08; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	51	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118791	10.1371/journal.pone.0118791	http://dx.doi.org/10.1371/journal.pone.0118791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793280	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200041
J	Fernandes, RK; Bachiega, TF; Rodrigues, DR; Golim, MD; Dias-Melicio, LA; Balderramas, HD; Kaneno, R; Soares, AMVC				Fernandes, Reginaldo K.; Bachiega, Tatiana F.; Rodrigues, Daniela R.; Golim, Marjorie de A.; Dias-Melicio, Luciane A.; Balderramas, Helanderson de A.; Kaneno, Ramon; Soares, Angela M. V. C.			Paracoccidioides brasiliensis Interferes on Dendritic Cells Maturation by Inhibiting PGE(2) Production	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ANTIGEN-PRESENTING FUNCTION; REGULATORY T-CELLS; PROSTAGLANDIN E-2; IMMUNE-RESPONSES; HUMAN MONOCYTES; INTERLEUKIN-12 PRODUCTION; ADAPTIVE IMMUNITY; DOWN-REGULATION; RESISTANT MICE	Paracoccidioidomycosis (PCM) is a systemic mycosis, endemic in most Latin American countries, especially in Brazil, whose etiologic agent is the thermodimorphic fungus of the genus Paracoccidioides, comprising cryptic species of Paracoccidioides brasiliensis, S1, PS2, PS3 and Paracoccidioides lutzii. The mechanisms involved in the initial interaction of the fungus with cells of the innate immune response, as dendritic cells (DCs), deserve to be studied. Prostaglandins (PGs) are eicosanoids that play an important role in modulating functions of immune cells including DCs. Here we found that human immature DCs derived from the differentiation of monocytes cultured with GM-CSF and IL-4 release substantial concentrations of PGE2, which, however, were significantly inhibited after challenge with P. brasiliensis. In vitro blocking of pattern recognition receptors (PRRs) by monoclonal antibodies showed the involvement of mannose receptor (MR) in PGE2 inhibition by the fungus. In addition, phenotyping assays showed that after challenge with the fungus, DCs do not change their phenotype of immature cells to mature ones, as well as do not produce IL-12 p70 or adequate concentrations of TNF-alpha. Assays using exogenous PGE2 confirmed an association between PGE2 inhibition and failure of cells to phenotypically mature in response to P. brasiliensis. We conclude that a P. brasiliensis evasion mechanism exists associated to a dysregulation on DC maturation. These findings may provide novel information for the understanding of the complex interplay between the host and this fungus.	[Fernandes, Reginaldo K.; Bachiega, Tatiana F.; Rodrigues, Daniela R.; Balderramas, Helanderson de A.; Kaneno, Ramon; Soares, Angela M. V. C.] Sao Paulo State Univ, UNESP, Biosci Inst, Dept Microbiol & Immunol, Sao Paulo, Brazil; [Golim, Marjorie de A.] Sao Paulo State Univ, UNESP, Hemoctr, Flow Cytometry Lab, Sao Paulo, Brazil; [Dias-Melicio, Luciane A.] Sao Paulo State Univ, UNESP, Botucatu Med Sch, Dept Pathol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Fernandes, RK (corresponding author), Sao Paulo State Univ, UNESP, Biosci Inst, Dept Microbiol & Immunol, Sao Paulo, Brazil.	regiskeller@msn.com; acsoares@ibb.unesp.br	Dias-Melicio, Luciane A/I-5788-2014; Fernandes, Reginaldo Keller/H-3180-2017; Kaneno, Ramon/H-3088-2012	Dias-Melicio, Luciane A/0000-0001-9254-2074; Fernandes, Reginaldo Keller/0000-0001-7069-9628; Kaneno, Ramon/0000-0002-4292-3298; de Assis Golim, Marjorie/0000-0002-4824-9441	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), http://www.fapesp.br/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth A, 2001, J VIROL, V75, P6183, DOI 10.1128/JVI.75.13.6183-6192.2001; Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Almeida SR, 2001, BRAZ J MED BIOL RES, V34, P529, DOI 10.1590/S0100-879X2001000400014; Anjos AR, 2002, MED MYCOL, V40, P377, DOI 10.1080/714031128; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BANKHURST AD, 1982, J CLIN LAB IMMUNOL, V7, P85; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Benard G, 2008, MYCOPATHOLOGIA, V165, P209, DOI 10.1007/s11046-007-9065-0; BETZ M, 1991, J IMMUNOL, V146, P108; Bordon AP, 2007, MICROBES INFECT, V9, P744, DOI 10.1016/j.micinf.2007.02.019; Bordon-Graciani AP, 2012, MED MYCOL, V50, P726, DOI 10.3109/13693786.2012.676740; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Bueno SM, 2012, IMMUNOLOGY, V137, P28, DOI 10.1111/j.1365-2567.2012.03614.x; Calich Vera L. G., 1994, Ciencia e Cultura (Sao Paulo), V46, P455; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; Calvi SA, 2003, MICROBES INFECT, V5, P107, DOI 10.1016/S1286-4579(02)00078-3; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; de Almeida SR, 1998, CELL IMMUNOL, V190, P68, DOI 10.1006/cimm.1998.1388; de Castro LF, 2013, J INFECTION, V67, P470, DOI 10.1016/j.jinf.2013.07.019; Dias-Melicio LA, 2011, INFLAMM RES, V60, P167; Donini M, 2007, EUR J IMMUNOL, V37, P1194, DOI 10.1002/eji.200636532; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Ferreira KS, 2007, J INFECT DIS, V196, P1108, DOI 10.1086/521369; Ferreira KS, 2004, IMMUNOL LETT, V94, P107, DOI 10.1016/j.imlet.2004.04.005; Fornazim MC, 2008, 33 C BRAZ SOC IMM, V1, P1; Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; GOTO T, 1983, J IMMUNOL, V130, P1350; Hanekom WA, 2003, J INFECT DIS, V188, P257, DOI 10.1086/376451; Harizi H, 2005, TISSUE ANTIGENS, V65, P507, DOI 10.1111/j.1399-0039.2005.00394.x; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hashimoto K, 2002, INFECT IMMUN, V70, P5167, DOI 10.1128/IAI.70.9.5167-5176.2002; Hedi H, 2004, CELL IMMUNOL, V228, P99, DOI 10.1016/j.cellimm.2004.04.003; Huston SM, 2013, J IMMUNOL, V191, P249, DOI 10.4049/jimmunol.1202707; Joshi PC, 2001, J IMMUNOL, V166, P885, DOI 10.4049/jimmunol.166.2.885; Kalinski P, 1998, J IMMUNOL, V161, P2804; Kalinski P, 1997, J IMMUNOL, V159, P28; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kashino SS, 2000, J INTERF CYTOK RES, V20, P89, DOI 10.1089/107999000312766; Kolenko V, 1999, BLOOD, V93, P2308, DOI 10.1182/blood.V93.7.2308.407k16_2308_2318; KRAAN TCTMV, 1995, J EXP MED, V181, P775, DOI 10.1084/jem.181.2.775; Livonesi MC, 2008, MED MYCOL, V46, P637, DOI 10.1080/13693780801982762; Luft T, 2002, BLOOD, V100, P1362, DOI 10.1182/blood-2001-12-0360; Ma XJ, 2001, ADV IMMUNOL, V79, P55; Madan-Lala R, 2014, J IMMUNOL, V192, P4263, DOI 10.4049/jimmunol.1303185; Mamomi RL, 2005, CYTOKINE, V32, P20, DOI 10.1016/j.cyto.2005.07.006; Mamoni RL, 2002, MED MYCOL, V40, P153, DOI 10.1080/714031098; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; O'Shea JJ, 2002, NAT IMMUNOL, V3, P506, DOI 10.1038/ni0602-506; Oliveira SJ, 2002, MICROBES INFECT, V4, P139, DOI 10.1016/S1286-4579(01)01521-0; Pina A, 2013, INFECT IMMUN, V81, P1064, DOI 10.1128/IAI.00736-12; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; Rieser C, 1997, J EXP MED, V186, P1603, DOI 10.1084/jem.186.9.1603; RINCON M, 1988, EUR J IMMUNOL, V18, P1791, DOI 10.1002/eji.1830181121; Ritter U, 2003, J LEUKOCYTE BIOL, V74, P216, DOI 10.1189/jlb.1202587; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; San-Blas G, 1993, Arch Med Res, V24, P267; Sato PK, 2011, SCAND J IMMUNOL, V74, P609, DOI 10.1111/j.1365-3083.2011.02614.x; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017; SILVA CL, 1994, MICROBIOL-SGM, V140, P1189, DOI 10.1099/13500872-140-5-1189; SMITH RJ, 1977, J PHARMACOL EXP THER, V200, P647; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; Soares AMVC, 2001, IMMUNOLOGY, V102, P480, DOI 10.1046/j.1365-2567.2001.01179.x; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tavares AH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001459; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Tercarioli GR, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-92; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; Van Overtvelt L, 1999, INFECT IMMUN, V67, P4033, DOI 10.1128/IAI.67.8.4033-4040.1999; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006; Vassiliou E, 2003, CELL IMMUNOL, V223, P120, DOI 10.1016/S0008-8749(03)00158-8; WALKER C, 1983, J IMMUNOL, V130, P1770; Walker W, 2004, IMMUNOLOGY, V111, P298, DOI 10.1111/j.1365-2567.2004.01810.x; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005; Wu CY, 1998, J IMMUNOL, V161, P2723; Zanoni I, 2010, J MOL MED, V88, P873, DOI 10.1007/s00109-010-0638-x; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	88	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120948	10.1371/journal.pone.0120948	http://dx.doi.org/10.1371/journal.pone.0120948			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793979	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900090
J	Gomez-Anson, B; Roman, E; de Bobadilla, RF; Pires-Encuentra, P; Diaz-Manera, J; Nunez, F; Martinez-Horta, S; Vives-Gilabert, Y; Pagonabarraga, J; Kulisevsky, J; Cordoba, J; Guarner, C; Soriano, G				Gomez-Anson, Beatriz; Roman, Eva; Fernandez de Bobadilla, Ramon; Pires-Encuentra, Patricia; Diaz-Manera, Jordi; Nunez, Fidel; Martinez-Horta, Saul; Vives-Gilabert, Yolanda; Pagonabarraga, Javier; Kulisevsky, Jaume; Cordoba, Juan; Guarner, Carlos; Soriano, German			Alterations in Cerebral White Matter and Neuropsychology in Patients with Cirrhosis and Falls	PLOS ONE			English	Article							MINIMAL HEPATIC-ENCEPHALOPATHY; QUALITY-OF-LIFE; PARKINSONS-DISEASE; MAGNETIC-RESONANCE; RATING-SCALE; PERIPHERAL NEUROPATHY; CLINICAL-SIGNIFICANCE; OLDER-PEOPLE; BRAIN; RISK	Background & Aim Falls are frequent in patients with cirrhosis but underlying mechanisms are unknown. The aim was to determine the neuropsychological, neurological and brain alterations using magnetic resonance-diffusion tensor imaging (MR-DTI) in cirrhotic patients with falls. Patients and methods Twelve patients with cirrhosis and falls in the previous year were compared to 9 cirrhotic patients without falls. A comprehensive neuropsychological and neurological evaluation of variables that may predispose to falls included: the Mini-Mental State Examination, Psychometric Hepatic Encephalopathy Score (PHES), Parkinson's Disease-Cognitive Rating Scale, specific tests to explore various cognitive domains, Unified Parkinson's Disease Rating Scale to evaluate parkinsonism, scales for ataxia and muscular strength, and electro-neurography. High-field MR (3T) including DTI and structural sequences was performed in all patients. Results The main neuropsychological findings were impairment in PHES (p = 0.03), Parkinson's Disease-Cognitive Rating Scale (p = 0.04) and in executive (p<0.05) and visuospatial-visuoconstructive functions (p<0.05) in patients with falls compared to those without. There were no statistical differences between the two groups in the neurological evaluation or in the visual assessment of MRI. MR-DTI showed alterations in white matter integrity in patients with falls compared to those without falls (p<0.05), with local maxima in the superior longitudinal fasciculus and corticospinal tract. These alterations were independent of PHES as a covariate and correlated with executive dysfunction (p<0.05). Conclusions With the limitation of the small sample size, our results suggest that patients with cirrhosis and falls present alterations in brain white matter tracts related to executive dysfunction. These alterations are independent of PHES impairment.	[Gomez-Anson, Beatriz; Nunez, Fidel] Hosp Santa Creu & Sant Pau, Dept Radiol, Neuroradiol Unit, Barcelona, Spain; [Roman, Eva; Guarner, Carlos; Soriano, German] Hosp Santa Creu & Sant Pau, Dept Gastroenterol, Barcelona, Spain; [Fernandez de Bobadilla, Ramon; Martinez-Horta, Saul; Pagonabarraga, Javier; Kulisevsky, Jaume] Hosp Santa Creu & Sant Pau, Movement Disorders Unit, Dept Neurol, Barcelona, Spain; [Diaz-Manera, Jordi] Hosp Santa Creu & Sant Pau, Dept Neurol, Neuromuscular Disorders Unit, Barcelona, Spain; [Gomez-Anson, Beatriz; Roman, Eva; Fernandez de Bobadilla, Ramon; Martinez-Horta, Saul; Kulisevsky, Jaume; Guarner, Carlos; Soriano, German] Hosp Santa Creu & Sant Pau, Inst Recerca IIB St Pau, Barcelona, Spain; [Roman, Eva] Hosp Santa Creu & Sant Pau, Escola Univ Infermeria EUI St Pau, Barcelona, Spain; [Cordoba, Juan] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain; [Vives-Gilabert, Yolanda] Univ Autonoma Barcelona, PIC, Bellaterra, Cerdanyola Del, Spain; [Vives-Gilabert, Yolanda] Univ Autonoma Barcelona, IFAE, Bellaterra, Cerdanyola Del, Spain; [Roman, Eva; Diaz-Manera, Jordi; Vives-Gilabert, Yolanda; Pagonabarraga, Javier; Kulisevsky, Jaume; Cordoba, Juan; Guarner, Carlos; Soriano, German] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Roman, Eva; Cordoba, Juan; Guarner, Carlos; Soriano, German] CIBEREHD, Barcelona, Spain; [Diaz-Manera, Jordi] CIBERER, Valencia, Spain; [Pagonabarraga, Javier; Kulisevsky, Jaume] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Pires-Encuentra, Patricia] CR, INNDACYT, Sant Feliu de Llobregat, Spain	Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBERNED	Soriano, G (corresponding author), Hosp Santa Creu & Sant Pau, Dept Gastroenterol, Barcelona, Spain.	gsoriano@santpau.cat	martinez-horta, saul/ABA-4265-2020; Vives-Gilabert, Yolanda/ABB-7461-2021; Kulisevsky, Jaime/AEW-0433-2022; Roman, Eva/P-2377-2016	Kulisevsky, Jaime/0000-0003-4870-1431; Martinez-Horta, Saul/0000-0003-0125-7249; Fernandez-Bobadilla, Ramon/0000-0002-5045-732X; Diaz-Manera, Jordi/0000-0003-2941-7988; Guarner, Carlos/0000-0001-5957-9481; Vives-Gilabert, Yolanda/0000-0002-3744-5893; Soriano, German/0000-0002-9267-6811; Roman, Eva/0000-0001-9084-8555	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain [PI10/01028]; Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain	JC was supported by Grant PI10/01028 from the Instituto de Salud Carlos III (www.isciii.es), Ministerio de Economia y Competitividad, Madrid, Spain. CIBEREHD and CIBERNED are supported by Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alonso J, 2014, SEMIN ULTRASOUND CT, V35, P136, DOI 10.1053/j.sult.2013.09.008; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; Bajaj JS, 2009, HEPATOLOGY, V50, P1175, DOI 10.1002/hep.23128; Butterworth RF, 2012, NAT REV GASTRO HEPAT, V9, P197, DOI 10.1038/nrgastro.2012.22; Chavarria L, 2011, AM J NEURORADIOL, V32, P1510, DOI 10.3174/ajnr.A2533; Chen HJ, 2012, J NEUROL SCI, V321, P65, DOI 10.1016/j.jns.2012.07.056; Cohen SM, 2005, J ARTHROPLASTY, V20, P460, DOI 10.1016/j.arth.2004.05.004; Cordoba J, 2003, HEPATOLOGY, V38, P1026, DOI 10.1053/jhep.2003.50406; Cordoba J, 2003, J HEPATOL, V39, P231, DOI 10.1016/S0168-8278(03)00189-2; DeMott TK, 2007, AM J PHYS MED REHAB, V86, P125, DOI 10.1097/PHM.0b013e31802ee1d1; Dhiman RK, 2010, DIGEST DIS SCI, V55, P2381, DOI 10.1007/s10620-010-1249-7; Eggers C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046813; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; JOHN J, 1984, INT J REHABIL RES, V7, P173, DOI 10.1097/00004356-198406000-00005; Jover R, 2005, J HEPATOL, V42, P659, DOI 10.1016/j.jhep.2004.12.030; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Martin K, 2009, DEMENT GERIATR COGN, V27, P451, DOI 10.1159/000216840; Matsusue E, 2005, AM J NEURORADIOL, V26, P347; Mellion M, 2011, MUSCLE NERVE, V43, P309, DOI 10.1002/mus.21946; Mirelman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040297; Nagano-Saito A, 2004, NEUROIMAGE, V22, P553, DOI 10.1016/j.neuroimage.2004.01.030; Ortiz M, 2005, J HEPATOL, V42, pS45, DOI 10.1016/j.jhep.2004.11.028; Pagonabarraga J, 2008, MOVEMENT DISORD, V23, P998, DOI 10.1002/mds.22007; Peeters G, 2009, BEST PRACT RES CL RH, V23, P797, DOI 10.1016/j.berh.2009.09.004; Perez-Iglesias R, 2010, AM J PSYCHIAT, V167, P451, DOI 10.1176/appi.ajp.2009.09050716; Prosperini L, 2010, MULT SCLER J, V16, P491, DOI 10.1177/1352458509359923; Roman E, 2013, EUR J GASTROEN HEPAT, V25, P77, DOI 10.1097/MEG.0b013e3283589f49; Gomez MR, 2006, MED CLIN-BARCELONA, V127, P246, DOI 10.1157/13091264; Sasson E, 2012, BRAIN STRUCT FUNCT, V217, P503, DOI 10.1007/s00429-011-0344-7; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soriano G, 2012, HEPATOLOGY, V55, P1922, DOI 10.1002/hep.25554; Spahr L, 2000, GASTROENTEROLOGY, V119, P774, DOI 10.1053/gast.2000.17857; Srikanth V, 2009, STROKE, V40, P175, DOI 10.1161/STROKEAHA.108.524355; Stebbins GT, 1998, MOVEMENT DISORD, V13, P633, DOI 10.1002/mds.870130404; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Tsai CF, 2013, J HEPATOL, V58, P706, DOI 10.1016/j.jhep.2012.12.001; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038; Yarnall A, 2011, MOVEMENT DISORD, V26, P2496, DOI 10.1002/mds.23932; Zhang JY, 2014, DIABETES, V63, P3596, DOI 10.2337/db14-0342; Zheng JJJ, 2012, J GERONTOL A-BIOL, V67, P1085, DOI 10.1093/gerona/gls063	46	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118930	10.1371/journal.pone.0118930	http://dx.doi.org/10.1371/journal.pone.0118930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793766	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200046
J	Kim, JY; Shin, E; Kim, JW; Lee, HS; Lee, DW; Kim, SH; Lee, JO; Kim, YJ; Kim, JH; Bang, SM; Ahn, SH; Park, DJ; Lee, JS; Lee, JS; Kim, HH; Lee, KW				Kim, Ji-Yeon; Shin, Eun; Kim, Jin Won; Lee, Hye Seung; Lee, Dae-Won; Kim, Se-Hyun; Lee, Jeong-Ok; Kim, Yu Jung; Kim, Jee Hyun; Bang, Soo-Mee; Ahn, Sang-Hoon; Park, Do Joong; Lee, Jong Seok; Lee, Ju-Seog; Kim, Hyung-Ho; Lee, Keun-Wook			Impact of Intratumoral Expression Levels of Fluoropyrimidine-Metabolizing Enzymes on Treatment Outcomes of Adjuvant S-1 Therapy in Gastric Cancer	PLOS ONE			English	Article							MESSENGER-RNA LEVEL; DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY; THYMIDYLATE SYNTHASE; 5-FLUOROURACIL; CHEMOTHERAPY; CAPECITABINE; CHEMOSENSITIVITY; IMMUNOREACTIVITY; SENSITIVITY; DOCETAXEL	We analyzed the expression levels of fluoropyrimidine-metabolizing enzymes (thymidylate synthase [TS], dihydropyrimidine dehydrogenase [DPD], thymidine phosphorylase [TP] and orotate phosphoribosyltransferase [OPRT]) to identify potential biomarkers related to treatment outcomes in gastric cancer (GC) patients receiving adjuvant S-1 chemotherapy. In this study, 184 patients who received curative gastrectomy (D2 lymph node dissection) and adjuvant S-1 were included. Immunohistochemistry and quantitative reverse transcription polymerase chain reaction were performed to measure the protein and mRNA levels of TS, DPD, TP, and OPRT in tumor tissue. In univariate analysis, low intratumoral DPD protein expression was related to poorer 5-year disease-free survival (DFS; 78% vs. 88%; P = 0.068). Low intratumoral DPD mRNA expression (1st [lowest] quartile) was also related to poorer DFS (69% vs. 90%; P < 0.001) compared to high intratumoral DPD expression (2nd to 4th quartiles). In multivariate analyses, low intratumoral DPD protein or mRNA expression was related to worse DFS (P < 0.05), irrespective of other clinical variables. TS, TP, and OPRT expression levels were not related to treatment outcomes. Severe non-hematologic toxicities (grade >= 3) had a trend towards more frequent development in patients with low intratumoral DPD mRNA expression (29% vs. 16%; P = 0.068). In conclusion, GC patients with high intratumoral DPD expression did not have inferior outcome following adjuvant S-1 therapy compared with those with low DPD expression. Instead, low intratumoral DPD expression was related to poor DFS.	[Kim, Ji-Yeon; Kim, Jin Won; Lee, Dae-Won; Kim, Se-Hyun; Lee, Jeong-Ok; Kim, Yu Jung; Kim, Jee Hyun; Bang, Soo-Mee; Lee, Jong Seok; Lee, Keun-Wook] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Shin, Eun; Lee, Hye Seung] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Pathol, Songnam, South Korea; [Ahn, Sang-Hoon; Park, Do Joong; Kim, Hyung-Ho] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Surg, Songnam, South Korea; [Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Texas System; UTMD Anderson Cancer Center	Lee, KW (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Songnam, South Korea.	hmodoctor@snubh.org	Kim, Hyung-Ho/AAG-3720-2019; Kim, Hyung Ho/J-5451-2012; Lee, Hye Seung/G-6419-2011; Lee, Ju-Seog/X-1786-2018; SANG-HOON, AHN/AAV-2600-2020; LEE, Daewon/GWZ-8418-2022	Kim, Hyung-Ho/0000-0002-8916-0048; Lee, Hye Seung/0000-0002-1667-7986; Lee, Ju-Seog/0000-0002-5666-9753; SANG-HOON, AHN/0000-0001-8827-3625; 	Seoul National University Bundang Hospital [02-2014-019]; Jeil Pharmaceutical Company (Seoul, Korea)	Seoul National University Bundang Hospital; Jeil Pharmaceutical Company (Seoul, Korea)	This study was partially supported by research grants from the Seoul National University Bundang Hospital Research Fund (02-2014-019) and Jeil Pharmaceutical Company (Seoul, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; BECK A, 1994, EUR J CANCER, V30A, P1517, DOI 10.1016/0959-8049(94)00216-R; Bertino EM, 2013, LUNG CANCER, V79, P27, DOI 10.1016/j.lungcan.2012.09.013; Choi IS, 2011, MED ONCOL, V28, P991, DOI 10.1007/s12032-010-9590-4; Cui YH, 2013, CANCER CHEMOTH PHARM, V71, P145, DOI 10.1007/s00280-012-1991-y; Ferlay J, 2012, GLOBOCAN 2012 ESTIMA; Fujiwara H, 2003, EUR J CANCER, V39, P2387, DOI 10.1016/S0959-8049(03)00513-6; Fujiwara H, 2002, JPN J CANCER RES, V93, P1342, DOI 10.1111/j.1349-7006.2002.tb01243.x; Fukuda H, 2006, CANCER INVEST, V24, P235, DOI 10.1080/07357900600632082; Ichikawa W, 2006, INT J CANCER, V119, P1927, DOI 10.1002/ijc.22080; Ide H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-420; Ishikawa Y, 1999, CLIN CANCER RES, V5, P883; Ishikawa Y, 2000, JPN J CANCER RES, V91, P105, DOI 10.1111/j.1349-7006.2000.tb00866.x; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Jeong JH, 2012, CANCER CHEMOTH PHARM, V70, P523, DOI 10.1007/s00280-012-1935-6; Kim J., 2014, J ELECT MAT, V2014, P1, DOI DOI 10.1167/14.7.1.[; Kim N, 2012, ANN ONCOL, V23, P2065, DOI 10.1093/annonc/mds106; Kim SJ, 2013, CANCER SCI, V104, P116, DOI 10.1111/cas.12044; Kim Yeul Hong, 2005, Cancer Res Treat, V37, P79, DOI 10.4143/crt.2005.37.2.79; Koizumi W, 2008, ANTI-CANCER DRUG, V19, P819, DOI 10.1097/CAD.0b013e3283094b5d; Kondo N, 2011, J SURG ONCOL, V104, P146, DOI 10.1002/jso.21955; Kuramochi H, 2008, CANCER CHEMOTH PHARM, V63, P85, DOI 10.1007/s00280-008-0714-x; Miyamoto S, 2000, INT J ONCOL, V17, P653; Oeda M, 2006, ONCOL REP, V16, P1165; Sasako M, 2014, GASTRIC CANC; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Shimizu T, 2005, ANTICANCER RES, V25, P2997; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Takabayashi A, 2000, INT J ONCOL, V17, P889; Takiuchi Hiroya, 2007, Gastrointest Cancer Res, V1, P171; Terashima Masanori, 2003, Gastric Cancer, V6 Suppl 1, P71, DOI 10.1007/s10120-003-0221-z; Toriumi F, 2004, ANTICANCER RES, V24, P2455	32	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120324	10.1371/journal.pone.0120324	http://dx.doi.org/10.1371/journal.pone.0120324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793299	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900012
J	Makai, S; Li, X; Hussain, J; Cui, CJ; Wang, YS; Chen, MJ; Yang, ZW; Ma, C; Guo, AY; Zhou, YH; Chang, JL; Yang, GX; He, GY				Makai, Szabolcs; Li, Xiao; Hussain, Javeed; Cui, Cuiju; Wang, Yuesheng; Chen, Mingjie; Yang, Zhaowan; Ma, Chuang; Guo, An-Yuan; Zhou, Yanhong; Chang, Junli; Yang, Guangxiao; He, Guangyuan			A Census of Nuclear Cyanobacterial Recruits in the Plant Kingdom	PLOS ONE			English	Article							GENE-TRANSFER; PROTEIN IMPORT; CHLOROPLAST DEVELOPMENT; GENOMES; EVOLUTION; MITOCHONDRIA; EUKARYOTES; ALIGNMENT; PLASTIDS; ORIGIN	The plastids and mitochondria of the eukaryotic cell are of endosymbiotic origin. These events occurred similar to 2 billion years ago and produced significant changes in the genomes of the host and the endosymbiont. Previous studies demonstrated that the invasion of land affected plastids and mitochondria differently and that the paths of mitochondrial integration differed between animals and plants. Other studies examined the reasons why a set of proteins remained encoded in the organelles and were not transferred to the nuclear genome. However, our understanding of the functional relations of the transferred genes is insufficient. In this paper, we report a high-throughput phylogenetic analysis to identify genes of cyanobacterial origin for plants of different levels of complexity: Arabidopsis thaliana, Chlamydomonas reinhardtii, Physcomitrella patens, Populus trichocarpa, Selaginella moellen-dorffii, Sorghum bicolor, Oryza sativa, and Ostreococcus tauri. Thus, a census of cyanobacterial gene recruits and a study of their function are presented to better understand the functional aspects of plastid symbiogenesis. From algae to angiosperms, the GO terms demonstrated a gradual expansion over functionally related genes in the nuclear genome, beginning with genes related to thylakoids and photosynthesis, followed by genes involved in metabolism, and finally with regulation-related genes, primarily in angiosperms. The results demonstrate that DNA is supplied to the nuclear genome on a permanent basis with no regard to function, and only what is needed is kept, which thereby expands on the GO space along the related genes.	[Makai, Szabolcs; Li, Xiao; Hussain, Javeed; Cui, Cuiju; Wang, Yuesheng; Chen, Mingjie; Chang, Junli; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol, Genet Engn Int Cooperat Base Chinese Minist Sci &, Key Lab Mol Biophys, Chinese Minist Educ,Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Yang, Zhaowan; Ma, Chuang; Guo, An-Yuan; Zhou, Yanhong] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Makai, Szabolcs] Hungarian Acad Sci, Bioinformat Lab, Appl Genom Dept, Agr Inst,Ctr Agr Res, H-2462 Martonvasar, Hungary	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Chang, JL (corresponding author), Huazhong Univ Sci & Technol, Genet Engn Int Cooperat Base Chinese Minist Sci &, Key Lab Mol Biophys, Chinese Minist Educ,Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	cjl@hust.edu.cn; ygx@hust.edu.cn; hegy@hust.edu.cn			National Science and Technology Major Project of China [2013ZX08002004-007, 2014ZX08010004-004]; International Collaboration Project of the Chinese Ministry of Science and Technology; Innovative Foundation of Huazhong University of Science and Technology [2014QN124]	National Science and Technology Major Project of China; International Collaboration Project of the Chinese Ministry of Science and Technology; Innovative Foundation of Huazhong University of Science and Technology	This work was supported by the grants from the National Science and Technology Major Project of China (2013ZX08002004-007; 2014ZX08010004-004), the International Collaboration Project of the Chinese Ministry of Science and Technology, and the Innovative Foundation of Huazhong University of Science and Technology (2014QN124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JF, 1993, J THEOR BIOL, V165, P609, DOI 10.1006/jtbi.1993.1210; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balzer M, 2005, INFOVIS 05: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION, PROCEEDINGS, P49, DOI 10.1109/INFVIS.2005.1532128; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Barbrook AC, 2006, TRENDS PLANT SCI, V11, P101, DOI 10.1016/j.tplants.2005.12.004; Bock R, 2008, BIOESSAYS, V30, P556, DOI 10.1002/bies.20761; Cavalier-Smith T, 2009, INT J BIOCHEM CELL B, V41, P307, DOI 10.1016/j.biocel.2008.10.002; Cavalier-Smith T, 2013, ANNU REV ECOL EVOL S, V44, P145, DOI 10.1146/annurev-ecolsys-110411-160320; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de la Cruz J, 2003, GENE, V321, P47, DOI 10.1016/S0378-1119(03)00831-X; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esseiva AC, 2004, J BIOL CHEM, V279, P42363, DOI 10.1074/jbc.M404519200; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Gross J, 2009, TRENDS PLANT SCI, V14, P13, DOI 10.1016/j.tplants.2008.10.003; Hirakawa Y, 2009, P NATL ACAD SCI USA, V106, P12820, DOI 10.1073/pnas.0902578106; Jackson-Constan D, 2001, BBA-MOL CELL RES, V1541, P102, DOI 10.1016/S0167-4889(01)00148-3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; KIM MY, 1993, PLANT MOL BIOL, V22, P447, DOI 10.1007/BF00015975; Lane Nick, 2011, Genome Biol Evol, V3, P372, DOI 10.1093/gbe/evr003; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lister DL, 2003, GENE, V316, P33, DOI 10.1016/S0378-1119(03)00754-6; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Oldenburg DJ, 2004, J MOL BIOL, V344, P1311, DOI 10.1016/j.jmb.2004.10.001; Palmer JD, 1997, SCIENCE, V275, P790, DOI 10.1126/science.275.5301.790; Pennisi E, 2011, SCIENCE, V332, P1372, DOI 10.1126/science.332.6036.1372; Reyes-Prieto A, 2006, CURR BIOL, V16, P2320, DOI 10.1016/j.cub.2006.09.063; Richly E, 2004, MOL BIOL EVOL, V21, P1972, DOI 10.1093/molbev/msh210; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; Rosenblad MA, 2004, PLANT CELL PHYSIOL, V45, P1633, DOI 10.1093/pcp/pch185; Sanchez H, 1996, EMBO J, V15, P2138, DOI 10.1002/j.1460-2075.1996.tb00567.x; Sheiner L, 2013, BBA-MOL CELL RES, V1833, P352, DOI 10.1016/j.bbamcr.2012.05.030; Stork S, 2013, PROTOPLASMA, V250, P1013, DOI 10.1007/s00709-013-0498-7; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; VONHEIJNE G, 1986, FEBS LETT, V198, P1, DOI 10.1016/0014-5793(86)81172-3; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Westphal S, 2001, FEBS LETT, V506, P257, DOI 10.1016/S0014-5793(01)02931-3; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Yamauchi A, 2005, GENETICS, V171, P1387, DOI 10.1534/genetics.104.036350; Yizhak K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.11; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	48	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120527	10.1371/journal.pone.0120527	http://dx.doi.org/10.1371/journal.pone.0120527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794152	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900047
J	Martin-Guerrero, I; Gutierrez-Camino, A; Lopez-Lopez, E; Bilbao-Aldaiturriaga, N; Pombar-Gomez, M; Ardanaz, M; Garcia-Orad, A				Martin-Guerrero, Idoia; Gutierrez-Camino, Angela; Lopez-Lopez, Elixabet; Bilbao-Aldaiturriaga, Nerea; Pombar-Gomez, Maria; Ardanaz, Maite; Garcia-Orad, Africa			Genetic Variants in MiRNA Processing Genes and Pre-MiRNAs Are Associated with the Risk of Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MICRORNA TARGET SITES; LUNG-CANCER; LINKING POLYMORPHISMS; FOLLICULAR LYMPHOMA; CELL-PROLIFERATION; POLYMIRTS DATABASE; COMMON VARIATION; COMPLEX TRAITS; BREAST-CANCER	Genome wide association studies (GWAS) have identified several low-penetrance susceptibility alleles in chronic lymphocytic leukemia (CLL). Nevertheless, these studies scarcely study regions that are implicated in non-coding molecules such as microRNAs (miRNAs). Abnormalities in miRNAs, as altered expression patterns and mutations, have been described in CLL, suggesting their implication in the development of the disease. Genetic variations in miRNAs can affect levels of miRNA expression if present in pre-miRNAs and in miRNA biogenesis genes or alter miRNA function if present in both target mRNA and miRNA sequences. Therefore, the present study aimed to evaluate whether polymorphisms in pre-miRNAs, and/or miRNA processing genes contribute to predisposition for CLL. A total of 91 SNPs in 107 CLL patients and 350 cancer-free controls were successfully analyzed using TaqMan Open Array technology. We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206). These findings suggest that polymorphisms in genes involved in miRNAs biogenesis pathway as well as in pre-miRNAs contribute to the risk of CLL. Large-scale studies are needed to validate the current findings.	[Martin-Guerrero, Idoia; Gutierrez-Camino, Angela; Lopez-Lopez, Elixabet; Bilbao-Aldaiturriaga, Nerea; Pombar-Gomez, Maria; Garcia-Orad, Africa] Univ Basque Country, UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Fac Med & Odontol, Bilbao, Spain; [Ardanaz, Maite] Hosp Txagorritxu, Vitoria, Spain; [Garcia-Orad, Africa] Univ Basque Country, BioCruces Hlth Res Inst, E-48940 Leioa, Spain	University of Basque Country; University Hospital of Araba; University of Basque Country	Garcia-Orad, A (corresponding author), Univ Basque Country, UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Fac Med & Odontol, Bilbao, Spain.	africa.garciaorad@ehu.es	López-López, Elixabet/T-4607-2019; Gutierrez-Camino, Angela/AAM-2032-2020; Martin-Guerrero, Idoia/AAF-3446-2020	Gutierrez-Camino, Angela/0000-0002-8679-6868; Martin-Guerrero, Idoia/0000-0002-0098-1908; Lopez-Lopez, Elixabet/0000-0002-5309-3031; Garcia.Orad, Africa/0000-0002-5575-3080	Basque Government [IT661-13]; UPV/EHU [UFI11/35]; Saiotek [S-PE13UN079]; RTICC [RD12/0036/0060, RD12/0036/0036]; Basque Government through the grant "Programa de Formacion de Personal Investigador no doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco"; Basque Government through the grant "Programa Posdoctoral, de Perfeccionamiento de Personal Investigador Doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco"	Basque Government(Basque Government); UPV/EHU; Saiotek; RTICC(Instituto de Salud Carlos III); Basque Government through the grant "Programa de Formacion de Personal Investigador no doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco"(Basque Government); Basque Government through the grant "Programa Posdoctoral, de Perfeccionamiento de Personal Investigador Doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco"(Basque Government)	This work was supported by the Basque Government (IT661-13), UPV/EHU (UFI11/35), Saiotek (S-PE13UN079) and RTICC (RD12/0036/0060, RD12/0036/0036). AGC was supported by a predoctoral grant from the Basque Government through the grant "Programa de Formacion de Personal Investigador no doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco". ELL was supported by a postdoctoral grant from the Basque Government through the grant "Programa Posdoctoral, de Perfeccionamiento de Personal Investigador Doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Brisbin AG, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-156; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Crowther-Swanepoel D, 2010, BRIT J HAEMATOL, V150, P473, DOI 10.1111/j.1365-2141.2010.08270.x; Crowther-Swanepoel D, 2010, HUM MOL GENET, V19, P1840, DOI 10.1093/hmg/ddq044; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5; Facchetti F., 2008, WHO CLASSIFICATION T, V4th ed; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Goldin LR, 2010, CURR OPIN HEMATOL, V17, P350, DOI 10.1097/MOH.0b013e328338cd99; Goldin LR, 2009, HAEMATOL-HEMATOL J, V94, P647, DOI 10.3324/haematol.2008.003632; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Holt R, 2010, EUR J HUM GENET, V18, P1013, DOI 10.1038/ejhg.2010.69; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047454; Kminkova J, 2014, CARCINOGENESIS; Ma HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047544; Martin-Guerrero I, 2011, GENE CHROMOSOME CANC, V50, P887, DOI 10.1002/gcc.20912; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Phua SLC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025689; Rotunno M, 2010, BRIT J CANCER, V103, P1870, DOI 10.1038/sj.bjc.6605976; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Slager SL, 2012, BLOOD, V120, P843, DOI 10.1182/blood-2012-03-413591; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Slager SL, 2010, CANCER EPIDEM BIOMAR, V19, P1098, DOI 10.1158/1055-9965.EPI-09-1217; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Wang F, 2012, MOL BIOL REP, V39, P269, DOI 10.1007/s11033-011-0735-0; Wojcik SE, 2010, CARCINOGENESIS, V31, P208, DOI 10.1093/carcin/bgp209; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Zhang XF, 2010, CARCINOGENESIS, V31, P2118, DOI 10.1093/carcin/bgq177; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	55	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118905	10.1371/journal.pone.0118905	http://dx.doi.org/10.1371/journal.pone.0118905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793711	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200045
J	Melillo, P; Izzo, R; Orrico, A; Scala, P; Attanasio, M; Mirra, M; De Luca, N; Pecchia, L				Melillo, Paolo; Izzo, Raffaele; Orrico, Ada; Scala, Paolo; Attanasio, Marcella; Mirra, Marco; De Luca, Nicola; Pecchia, Leandro			Automatic Prediction of Cardiovascular and Cerebrovascular Events Using Heart Rate Variability Analysis	PLOS ONE			English	Article							RECURRENCE QUANTIFICATION ANALYSIS; INTIMA-MEDIA THICKNESS; TARGET ORGAN DAMAGE; FEATURE-SELECTION; VASCULAR EVENTS; MORTALITY; ENTROPY; RISK; ASSOCIATION; FEATURES	Background There is consensus that Heart Rate Variability is associated with the risk of vascular events. However, Heart Rate Variability predictive value for vascular events is not completely clear. The aim of this study is to develop novel predictive models based on data-mining algorithms to provide an automatic risk stratification tool for hypertensive patients. Methods A database of 139 Holter recordings with clinical data of hypertensive patients followed up for at least 12 months were collected ad hoc. Subjects who experienced a vascular event (i.e., myocardial infarction, stroke, syncopal event) were considered as high-risk subjects. Several data-mining algorithms (such as support vector machine, tree-based classifier, artificial neural network) were used to develop automatic classifiers and their accuracy was tested by assessing the receiver-operator characteristics curve. Moreover, we tested the echographic parameters, which have been showed as powerful predictors of future vascular events. Results The best predictive model was based on random forest and enabled to identify high-risk hypertensive patients with sensitivity and specificity rates of 71.4% and 87.8%, respectively. The Heart Rate Variability based classifier showed higher predictive values than the conventional echographic parameters, which are considered as significant cardiovascular risk factors. Conclusions Combination of Heart Rate Variability measures, analyzed with data-mining algorithm, could be a reliable tool for identifying hypertensive patients at high risk to develop future vascular events.	[Melillo, Paolo; Orrico, Ada; Attanasio, Marcella] Univ Naples 2, Multidisciplinary Dept Med Surg & Dent Sci, Naples, Italy; [Melillo, Paolo; Orrico, Ada; Scala, Paolo; Attanasio, Marcella] Italian Minist Educ, Sci Res, SHARE Project, Rome, Italy; [Melillo, Paolo; Orrico, Ada; Scala, Paolo; Attanasio, Marcella] Univ Rome, Rome, Italy; [Izzo, Raffaele; Mirra, Marco; De Luca, Nicola] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Pecchia, Leandro] Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England	Universita della Campania Vanvitelli; Sapienza University Rome; University of Naples Federico II; University of Warwick	Melillo, P (corresponding author), Univ Naples 2, Multidisciplinary Dept Med Surg & Dent Sci, Naples, Italy.	paolomelillo85@gmail.com; nideluca@unina.it	Melillo, Paolo/H-4067-2011; Pecchia, Leandro/P-6344-2015; Pecchia, Leandro/AAF-7325-2019; Izzo, Raffaele/G-4892-2011	Melillo, Paolo/0000-0002-6519-0293; Pecchia, Leandro/0000-0002-7900-5415; Pecchia, Leandro/0000-0002-7900-5415; Izzo, Raffaele/0000-0002-0308-2836; DE LUCA, Nicola/0000-0002-9606-6586	NOP for Research and Competitiveness for the Convergence Regions (Calabria, Campania, Puglia and Sicilia [PON04a3_00139]	NOP for Research and Competitiveness for the Convergence Regions (Calabria, Campania, Puglia and Sicilia	The current study was supported by "the 2007-2013 NOP for Research and Competitiveness for the Convergence Regions (Calabria, Campania, Puglia and Sicilia)" with code PON04a3_00139-Project Smart Health and Artificial Intelligence for Risk Estimation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binici Z, 2011, STROKE, V42, P3196, DOI 10.1161/STROKEAHA.110.607697; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Camm AJ, 1996, EUR HEART J, V17, P354; Carvajal R, 2005, COMPUT METH PROG BIO, V78, P133, DOI 10.1016/j.cmpb.2005.01.004; Clifford GD, 2005, IEEE T BIO-MED ENG, V52, P630, DOI 10.1109/TBME.2005.844028; De Luca N, 2005, J HYPERTENS, V23, P1417, DOI 10.1097/01.hjh.0000173526.65555.55; de Simone G, 2010, HYPERTENSION, V56, P99, DOI 10.1161/HYPERTENSIONAHA.110.150128; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Ebrahimzadeh E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081896; Fuster V, 1999, CIRCULATION, V99, P1132, DOI 10.1161/01.CIR.99.9.1132; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hall MA, 1997, FEATURE SUBSET SELEC; Hillebrand S, 2013, EUROPACE, V15, P742, DOI 10.1093/europace/eus341; Isler Y, 2007, COMPUT BIOL MED, V37, P1502, DOI 10.1016/j.compbiomed.2007.01.012; Izzo R, 2013, EUR HEART J, V34, P3419, DOI 10.1093/eurheartj/eht281; Jovic A, 2011, ARTIF INTELL MED, V51, P175, DOI 10.1016/j.artmed.2010.09.005; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liu H, 1995, 2012 IEEE 24 INT C T; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Maldonado S, 2011, INFORM SCIENCES, V181, P115, DOI 10.1016/j.ins.2010.08.047; Melillo Paolo, 2014, Ambient Assisted Living and Daily Activities. 6th International Work-Conference, IWAAL 2014. Proceedings: LNCS 8868, P155, DOI 10.1007/978-3-319-13105-4_24; Melillo P, 2013, FOCUS NONLINEAR ANAL; Melillo P., 2013, WORLD C MED PHYS BIO, V39, P477, DOI [10.1007/978-3-642-29305-4_126, DOI 10.1007/978-3-642-29305-4_126]; Melillo P, 2013, IEEE J BIOMED HEALTH, V17, P727, DOI 10.1109/JBHI.2013.2244902; Melillo P, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-105; Melillo P, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-96; Melillo P, 2011, MED BIOL ENG COMPUT, V49, P67, DOI 10.1007/s11517-010-0728-5; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nagai K, 2013, ATHEROSCLEROSIS, V231, P365, DOI 10.1016/j.atherosclerosis.2013.09.028; Pecchia L, 2011, IEEE T BIO-MED ENG, V58, P800, DOI 10.1109/TBME.2010.2092776; Pecchia L, 2011, IEEE T INF TECHNOL B, V15, P40, DOI 10.1109/TITB.2010.2091647; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Ramirez-Villegas JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017060; Ramshur J., 2010, DESIGN EVALUATION AN; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; Sajadieh A, 2003, AM J CARDIOL, V92, P234, DOI 10.1016/S0002-9149(03)00548-4; Schillaci G, 2000, HYPERTENSION, V35, P580, DOI 10.1161/01.HYP.35.2.580; Singh A, 2011, ENG MED BIOL SOC EMB; Song T, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-59; Trulla LL, 1996, PHYS LETT A, V223, P255, DOI 10.1016/S0375-9601(96)00741-4; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Xiao J, 2007, TESTING STATIONARITY; Zbilut JP, 2002, MED ENG PHYS, V24, P53, DOI 10.1016/S1350-4533(01)00112-6; Zong W, 2003, COMPUTERS CARDIOLOGY	51	101	104	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118504	10.1371/journal.pone.0118504	http://dx.doi.org/10.1371/journal.pone.0118504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793605	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200026
J	O'Rourke, SM; Sutthent, R; Phung, P; Mesa, KA; Frigon, NL; To, B; Horthongkham, N; Limoli, K; Wrin, T; Berman, PW				O'Rourke, Sara M.; Sutthent, Ruengpung; Pham Phung; Mesa, Kathryn A.; Frigon, Normand L.; To, Briana; Horthongkham, Navin; Limoli, Kay; Wrin, Terri; Berman, Phillip W.			Glycans Flanking the Hypervariable Connecting Peptide between the A and B Strands of the V1/V2 Domain of HIV-1 gp120 Confer Resistance to Antibodies That Neutralize CRF01_AE Viruses	PLOS ONE			English	Article							ANTIRETROVIRAL-DRUG-RESISTANCE; GLYCOSYLATION SITES; SOLUBLE CD4; V2 DOMAIN; TYPE-1; POTENT; BROAD; SENSITIVITY; VACCINE; INFECTION	Understanding the molecular determinants of sensitivity and resistance to neutralizing antibodies is critical for the development of vaccines designed to prevent HIV infection. In this study, we used a genetic approach to characterize naturally occurring polymorphisms in the HIV envelope protein that conferred neutralization sensitivity or resistance. Libraries of closely related envelope genes, derived from virus quasi-species, were constructed from individuals infected with CRF01_AE viruses. The libraries were screened with plasma containing broadly neutralizing antibodies, and neutralization sensitive and resistant variants were selected for sequence analysis. In vitro mutagenesis allowed us to identify single amino acid changes in three individuals that conferred resistance to neutralization by these antibodies. All three mutations created N-linked glycosylation sites (two at N136 and one at N149) proximal to the hypervariable connecting peptide between the C-terminus of the A strand and the N-terminus of the B strand in the four-stranded V1/V2 domain beta-sheet structure. Although N136 has previously been implicated in the binding of broadly neutralizing monoclonal antibodies, this glycosylation site appears to inhibit the binding of neutralizing antibodies in plasma from HIV-1 infected subjects. Previous studies have reported that the length of the V1/V2 domain in transmitted founder viruses is shorter and possesses fewer glycosylation sites compared to viruses isolated from chronic infections. Our results suggest that vaccine immunogens based on recombinant envelope proteins from clade CRF01_AE viruses might be improved by inclusion of envelope proteins that lack these glycosylation sites. This strategy might improve the efficacy of the vaccines used in the partially successful RV144 HIV vaccine trial, where the two CRF01_AE immunogens (derived from the A244 and TH023 isolates) both possessed glycosylation sites at N136 and N149.	[O'Rourke, Sara M.; Mesa, Kathryn A.; Frigon, Normand L.; To, Briana; Berman, Phillip W.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Sutthent, Ruengpung; Horthongkham, Navin] Mahidol Univ, Siriraj Hosp, Natl HIV Repository & Bioinformat Ctr Thailand, Dept Microbiol,Fac Med, Bangkok 10700, Thailand; [Pham Phung; Limoli, Kay; Wrin, Terri] Monogram Biosci, San Francisco, CA USA; [Berman, Phillip W.] Gladstone Inst Virol & Immunol, San Francisco, CA USA	University of California System; University of California Santa Cruz; Mahidol University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Berman, PW (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	pwb@soe.ucsc.edu	Horthongkham, Navin/AAZ-7963-2021		National Institute on Drug Abuse [R01DA026801-01A1]; University of California; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026801] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); University of California(University of California System); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by award number R01DA026801-01A1 from the National Institute on Drug Abuse and by funding from the University of California. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHKENAZI A, 1991, P NATL ACAD SCI USA, V88, P7056, DOI 10.1073/pnas.88.16.7056; Berman PW, 1999, VIROLOGY, V265, P1, DOI 10.1006/viro.1999.0031; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; Binley J, 2009, CURR OPIN HIV AIDS, V4, P364, DOI 10.1097/COH.0b013e32832e06fe; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Morales JF, 2014, J BIOL CHEM, V289, P20526, DOI 10.1074/jbc.M114.554089; O'Rourke SM, 2012, J VIROL, V86, P12105, DOI 10.1128/JVI.01352-12; O'Rourke SM, 2010, J VIROL, V84, P11200, DOI 10.1128/JVI.00790-10; O'Rourke SM, 2009, J VIROL, V83, P7728, DOI 10.1128/JVI.00688-09; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perez-Losada M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016902; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; Schweighardt B, 2010, JAIDS-J ACQ IMM DEF, V53, P36, DOI 10.1097/QAI.0b013e3181c4b885; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Spearman P, 2011, J INFECT DIS, V203, P1165, DOI 10.1093/infdis/jiq175; Srivastava IK, 2003, J VIROL, V77, P2310, DOI 10.1128/JVI.77.4.2310-2320.2003; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Toma J, 2011, J VIROL, V85, P3872, DOI 10.1128/JVI.02237-10; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Utachee P, 2010, J VIROL, V84, P4311, DOI 10.1128/JVI.02619-09; Utachee P, 2009, MICROBES INFECT, V11, P334, DOI 10.1016/j.micinf.2008.12.008; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; Vartanian JP, 2002, J GEN VIROL, V83, P801, DOI 10.1099/0022-1317-83-4-801; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zwick MB, 2007, CURR HIV RES, V5, P608, DOI 10.2174/157016207782418443	68	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119608	10.1371/journal.pone.0119608	http://dx.doi.org/10.1371/journal.pone.0119608			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793890	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200100
J	Patki, G; Salvi, A; Liu, HS; Atrooz, F; Alkadhi, I; Kelly, M; Salim, S				Patki, Gaurav; Salvi, Ankita; Liu, Hesong; Atrooz, Fatin; Alkadhi, Isam; Kelly, Matthew; Salim, Samina			Tempol Treatment Reduces Anxiety-Like Behaviors Induced by Multiple Anxiogenic Drugs in Rats	PLOS ONE			English	Article							PERMEABLE RADICAL SCAVENGER; OXIDATIVE STRESS; MEMORY IMPAIRMENT; C-FOS; RGS2; CAFFEINE; INFLAMMATION; MODEL; BRAIN; DEPRESSION	We have published that pharmacological induction of oxidative stress (OS) causes anxiety-like behavior in rats. Using animal models, we also have established that psychological stress induces OS and leads to anxiety-like behaviors. All evidence points towards the causal role of OS in anxiety-like behaviors. To fully ascertain the role of OS in anxiety-like behaviors, it is reasonable to test whether the pro-anxiety effects of anxiogenic drugs caffeine or N-methyl-beta-carboline-3-carboxamide (FG-7142) can be mitigated using agents that minimize OS. In this study, osmotic pumps were either filled with antioxidant tempol or saline. The pumps were attached to the catheter leading to the brain cannula and inserted into the subcutaneous pocket in the back pocket of the rat. Continuous i.c.v. infusion of saline or tempol in the lateral ventricle of the brain (4.3mmol/day) was maintained for 1 week. Rats were intraperitoneally injected either with saline or an anxiogenic drug one at a time. Two hours later all groups were subjected to behavioral assessments. Anxiety-like behavior tests (open-field, light-dark and elevated plus maze) suggested that tempol prevented anxiogenic drug-induced anxiety-like behavior in rats. Furthermore, anxiogenic drug-induced increase in stress examined via plasma corticosterone and increased oxidative stress levels assessed via plasma 8-isoprostane were prevented with tempol treatment. Protein carbonylation assay also suggested preventive effect of tempol in the prefrontal cortex brain region of rats. Antioxidant protein expression and pro-inflammatory cytokine levels indicate compromised antioxidant defense as well as an imbalance of inflammatory response.	[Patki, Gaurav; Salvi, Ankita; Liu, Hesong; Atrooz, Fatin; Alkadhi, Isam; Kelly, Matthew; Salim, Samina] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Coll Pharm, Houston, TX 77204 USA	University of Houston System; University of Houston	Salim, S (corresponding author), Univ Houston, Dept Pharmacol & Pharmaceut Sci, Coll Pharm, Houston, TX 77204 USA.	ssalim@uh.edu	Liu, Hesong/ABC-2805-2021	Liu, Hesong/0000-0003-3768-1463; Atrooz, Fatin/0000-0002-1358-7926	NIMH [1R15MH093918-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH093918] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a NIMH 1R15MH093918-01A1 grant awarded to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JK, 2005, NEUROSCIENCE, V133, P983, DOI 10.1016/j.neuroscience.2005.03.025; Allam F, 2013, J NUTR, V143, P835, DOI 10.3945/jn.113.174649; BALDWIN HA, 1989, PHARMACOL BIOCHEM BE, V32, P181, DOI 10.1016/0091-3057(89)90230-X; BALDWIN HA, 1989, EUR J PHARMACOL, V159, P211, DOI 10.1016/0014-2999(89)90709-7; Banday AA, 2005, DIABETES, V54, P2219, DOI 10.2337/diabetes.54.7.2219; Banday AA, 2011, AM J PHYSIOL-RENAL, V301, pF364, DOI 10.1152/ajprenal.00121.2011; Bert B, 2002, NEUROBIOL LEARN MEM, V78, P11, DOI 10.1006/nlme.2001.4040; Bhattacharya SK, 1997, J PSYCHOPHARMACOL, V11, P219, DOI 10.1177/026988119701100304; Chakraborty S, 2009, INDIAN J CLIN BIOCHE, V24, P194, DOI 10.1007/s12291-009-0035-9; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Cui H, 2008, NEUROPSYCHOPHARMACOL, V33, P1537, DOI 10.1038/sj.npp.1301557; Di Paola R, 2005, J CLIN PERIODONTOL, V32, P1062, DOI 10.1111/j.1600-051X.2005.00818.x; El Yacoubi M, 2000, PSYCHOPHARMACOLOGY, V148, P153; FILE SE, 1984, ARCH INT PHARMACOD T, V271, P198; Flint J, 2003, SEMIN CELL DEV BIOL, V14, P37, DOI 10.1016/S1084-9521(02)00170-2; Hale MW, 2010, PROG NEURO-PSYCHOPH, V34, P1285, DOI 10.1016/j.pnpbp.2010.07.012; Haleagrahara N, 2009, EUR J PHARMACOL, V621, P46, DOI 10.1016/j.ejphar.2009.08.030; Heo K, 2006, CELL SIGNAL, V18, P2182, DOI 10.1016/j.cellsig.2006.05.006; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Kawabata K, 2010, J NUTR BIOCHEM, V21, P374, DOI 10.1016/j.jnutbio.2009.01.008; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Kurumaji A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-43; Leker RR, 2002, EXP NEUROL, V176, P355, DOI 10.1006/exnr.2002.7910; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Nguyen CH, 2012, BIOCHEM BIOPH RES CO, V426, P129, DOI 10.1016/j.bbrc.2012.08.050; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; Okimoto N, 2012, BRAIN RES, V1453, P26, DOI 10.1016/j.brainres.2012.03.012; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Otter MH, 1997, METHOD FIND EXP CLIN, V19, P683; Patki G, 2013, BRAIN RES, VS0006-8993; Patki G, 2013, BRAIN RES, V1539, P73, DOI 10.1016/j.brainres.2013.09.033; Patki G, 2014, PHYSIOL BEHAV, V130, P135, DOI 10.1016/j.physbeh.2014.04.011; Patki G, 2014, PHYSIOL BEHAV, V130, P47, DOI 10.1016/j.physbeh.2014.03.016; Patki G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074522; Paxinos GaW C, 1986, RAT BRAIN STEREOTAXI; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Salim S., 2011, AM J INTEGR MED, V1, P11; Salim S, 2012, ADV PROTEIN CHEM STR, V88, P1, DOI 10.1016/B978-0-12-398314-5.00001-5; Salim S, 2011, BRAIN RES, V1404, P63, DOI 10.1016/j.brainres.2011.06.024; Salim S, 2011, FEBS LETT, V585, P1375, DOI 10.1016/j.febslet.2011.04.023; Salim S, 2010, BEHAV BRAIN RES, V208, P545, DOI 10.1016/j.bbr.2009.12.039; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Smoller JW, 2008, ARCH GEN PSYCHIAT, V65, P298, DOI 10.1001/archgenpsychiatry.2007.48; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Vollert C, 2011, BEHAV BRAIN RES, V224, P233, DOI 10.1016/j.bbr.2011.05.010; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yeung M, 2013, NEUROPHARMACOLOGY, V75, P47, DOI 10.1016/j.neuropharm.2013.06.027	50	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117498	10.1371/journal.pone.0117498	http://dx.doi.org/10.1371/journal.pone.0117498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793256	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200014
J	Trojsi, F; Caiazzo, G; Corbo, D; Piccirillo, G; Cristillo, V; Femiano, C; Ferrantino, T; Cirillo, M; Monsurro, MR; Esposito, F; Tedeschi, G				Trojsi, Francesca; Caiazzo, Giuseppina; Corbo, Daniele; Piccirillo, Giovanni; Cristillo, Viviana; Femiano, Cinzia; Ferrantino, Teresa; Cirillo, Mario; Monsurro, Maria Rosaria; Esposito, Fabrizio; Tedeschi, Gioacchino			Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT EXPANSION; VOXEL-BASED MORPHOMETRY; MOTOR-NEURON DEGENERATION; WHITE-MATTER; WHOLE-BRAIN; COGNITIVE IMPAIRMENT; PROBABILISTIC ATLAS; SPORADIC ALS; PATHOLOGY; C9ORF72	Neurodegenerative process in amyotrophic lateral sclerosis (ALS) has been proven to involve several cortical and subcortical brain regions within and beyond motor areas. However, how ALS pathology spreads progressively during disease evolution is still unknown. In this cross-sectional study we investigated 54 ALS patients, divided into 3 subsets according to the clinical stage, and 18 age and sex-matched healthy controls, by using tract-based spatial statistics (TBSS) diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) analyses. We aimed to identify white (WM) and gray matter (GM) patterns of disease distinctive of each clinical stage, corresponding to specific clinical milestones. ALS cases in stage 2A (i.e., at diagnosis) were characterized by GM and WM impairment of left motor and premotor cortices and brainstem at ponto-mesenchephalic junction. ALS patients in clinical stage 2B (with impairment of two functional regions) exhibited decreased fractional anisotropy (FA) (p<0.001, uncorrected) and increased mean (MD) and radial diffusivity (RD) (p<0.001, uncorrected) in the left cerebellar hemisphere and brainstem precerebellar nuclei, as well as in motor areas, while GM atrophy (p<0.001, uncorrected) was detected only in the left inferior frontal gyrus and right cuneus. Finally, ALS patients in stage 3 (with impairment of three functional regions) exhibited decreased FA and increased MD and RD (p<0.05, corrected) within WM underneath bilateral pre and postcentral gyri, corpus callosum midbody, long associative tracts and midbrain, while no significant clusters of GM atrophy were observed. Our findings reinforce the hypothesis that the neurodegenerative process propagates along the axonal pathways and develops beyond motor areas from early stages, involving progressively several frontotemporal regions and their afferents and efferents, while the detection of GM atrophy in earlier stages and its disappearance in later stages may be the result of reactive gliosis.	[Trojsi, Francesca; Caiazzo, Giuseppina; Piccirillo, Giovanni; Cristillo, Viviana; Femiano, Cinzia; Ferrantino, Teresa; Cirillo, Mario; Monsurro, Maria Rosaria; Tedeschi, Gioacchino] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy; [Trojsi, Francesca; Caiazzo, Giuseppina; Cirillo, Mario; Monsurro, Maria Rosaria; Esposito, Fabrizio; Tedeschi, Gioacchino] Univ Naples 2, MRI Res Ctr SUN FISM, I-80138 Naples, Italy; [Corbo, Daniele] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Esposito, Fabrizio] Univ Salerno, Dept Med & Surg, I-84081 Baronissi, Salerno, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Parma; University of Salerno	Tedeschi, G (corresponding author), Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy.	gioacchino.tedeschi@unina2.it	Corbo, Daniele/J-7589-2018; Trojsi, Francesca/AHD-9665-2022; Esposito, Fabrizio/M-8555-2015	Corbo, Daniele/0000-0001-5078-6636; Esposito, Fabrizio/0000-0002-5099-9786; Trojsi, Francesca/0000-0002-3790-8018; CIRILLO, MARIO/0000-0001-5350-7700				Abrahams S, 2005, NEUROLOGY, V64, P1222, DOI 10.1212/01.WNL.0000156519.41681.27; Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; Agosta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042816; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Beaufils E, 2012, AMYOTROPH LATERAL SC, V13, P84, DOI 10.3109/17482968.2011.580848; Bede P, 2013, J NEUROL NEUROSUR PS, V84, P766, DOI 10.1136/jnnp-2012-302674; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; Chio A, 2012, EUR J NEUROL, V19, P551, DOI 10.1111/j.1468-1331.2011.03540.x; Chio A, 2012, BRAIN, V135, P784, DOI 10.1093/brain/awr366; Chio A, 2011, J NEUROL NEUROSUR PS, V82, P740, DOI 10.1136/jnnp.2010.235952; Cirillo M, 2012, AM J NEURORADIOL, V33, P1102, DOI 10.3174/ajnr.A2918; Cistaro A, 2012, EUR J NUCL MED MOL I, V39, P251, DOI 10.1007/s00259-011-1979-6; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; d'Ambrosio A, 2014, AM J NEURORADIOL, V35, P304, DOI 10.3174/ajnr.A3753; Donaghy C, 2011, J NEUROL NEUROSUR PS, V82, P110, DOI 10.1136/jnnp.2010.212407; Eisen A, 2001, MUSCLE NERVE, V24, P564, DOI 10.1002/mus.1042; Eisen A, 2009, MUSCLE NERVE, V40, P297, DOI 10.1002/mus.21404; Fekete T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085190; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Gordon PH, 2010, J NEUROL, V257, P1713, DOI 10.1007/s00415-010-5609-1; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grossman M, 2008, NEUROLOGY, V71, P1396, DOI 10.1212/01.wnl.0000319701.50168.8c; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Kassubek J, 2014, BRAIN, V137, P1733, DOI 10.1093/brain/awu090; Kassubek J, 2012, THER ADV NEUROL DISO, V5, P119, DOI 10.1177/1756285612437562; Keil C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-141; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kwan JY, 2013, NEUROIMAGE-CLIN, V2, P151, DOI 10.1016/j.nicl.2012.12.003; Libon DJ, 2012, NEUROPSYCHOLOGY, V26, P422, DOI 10.1037/a0028668; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mackenzie IRA, 2014, ACTA NEUROPATHOL, V127, P347, DOI 10.1007/s00401-013-1232-4; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Menke RAL, 2014, BRAIN, V137, P2546, DOI 10.1093/brain/awu162; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mioshi E, 2013, NEUROLOGY, V80, P1117, DOI 10.1212/WNL.0b013e31828869da; Ozawa T, 2004, BRAIN, V127, P2657, DOI 10.1093/brain/awh303; Pettit LD, 2013, BRAIN, V136, P3290, DOI 10.1093/brain/awt243; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Prell T, 2013, CLIN NEUROL NEUROSUR, V115, P1281, DOI 10.1016/j.clineuro.2012.11.031; Ravits J, 2007, NEUROLOGY, V68, P1571, DOI 10.1212/01.wnl.0000260965.20021.47; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Roche JC, 2012, BRAIN, V135, P847, DOI 10.1093/brain/awr351; Rosenbohm A, 2014, J NEUROL, V261, P283, DOI 10.1007/s00415-013-7185-7; Sarro L, 2011, AM J NEURORADIOL, V32, P1866, DOI 10.3174/ajnr.A2658; Schuster C, 2014, NEUROBIOL AGING, V35, P240, DOI 10.1016/j.neurobiolaging.2013.07.020; Senda J, 2011, AMYOTROPH LATERAL SC, V12, P59, DOI 10.3109/17482968.2010.517850; Sharma R, 2011, ARCH NEUROL-CHICAGO, V68, P857, DOI 10.1001/archneurol.2011.130; Simone IL, 2010, J NEUROL SCI, V288, P106, DOI 10.1016/j.jns.2009.09.023; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tessitore A, 2006, BRAIN RES BULL, V69, P489, DOI 10.1016/j.brainresbull.2006.01.013; Thomas M, 2013, BRAIN, V136, P1345, DOI 10.1093/brain/awt030; Tsermentseli S, 2012, CORTEX, V48, P166, DOI 10.1016/j.cortex.2011.02.004; Tsujimoto M, 2011, J NEUROL SCI, V307, P34, DOI 10.1016/j.jns.2011.05.025; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Verstraete E, 2012, J NEUROL NEUROSUR PS, V83, P383, DOI 10.1136/jnnp-2011-300909; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Zhang JQ, 2014, J NEUROL, V261, P412, DOI 10.1007/s00415-013-7215-5	76	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119045	10.1371/journal.pone.0119045	http://dx.doi.org/10.1371/journal.pone.0119045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793718	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200054
J	Capra, GF; Ganga, A; Buondonno, A; Grilli, E; Gaviano, C; Vacca, S				Capra, Gian Franco; Ganga, Antonio; Buondonno, Andrea; Grilli, Eleonora; Gaviano, Carla; Vacca, Sergio			Ethnopedology in the Study of Toponyms Connected to the Indigenous Knowledge on Soil Resource	PLOS ONE			English	Article							GENES	In taking an integrated ethnopedological approach, this study aims to investigate the meaning of the distribution of the toponyms used in traditional and recent cartography of Sardinia (southern Italy). It is particularly, but not only, focused on those related to soil resources. Sardinia is particularly interesting in this respect, as its unique history, geography, and linguistic position makes it one of the Italian and Mediterranean regions with the greatest number of toponyms. This research investigated the toponyms belonging to an important subregion of Sardinia, called Ogliastra (central-eastern Sardinia). The research was conducted through the following integrated approach: i) toponymy research and collection from different sources; ii) database creation and translation of toponyms from the Sardinian language (SL); iii) categorization of toponyms; and iv) graphical, statistical, and cartographic data processing. Distribution and diversity of toponyms were assessed using the compiled database, coupled with a geographical information system (GIS). Of around 7700 toponyms collected, 79% had already been reported in SL, while just 21% were in Italian. Of the toponyms in SL, 77% are of known meaning and 54% of these toponyms were characterized by a meaning directly and/or indirectly connected to specific environmental features. On the whole, morphology would appear to be the primary environmental factor able to explain the complex, articulated presence, distribution, and typology of the investigated toponyms. A least squares regression analysis of pedodiversity vs. topodiversity shows a very closed distribution, with an impressive high correlation index (R-2 = 0.824). The principal factor analysis (PFA) shows that such a connection may be morphologically based, thereby confirming that pedodiversity and topodiversity are strongly linked each other. Overall, the research shows that an integrated ethnopedological approach, combining indigenous and scientific knowledge may be of great interest in order to mitigate the impressive phenomena of the indigenous knowledge lost.	[Capra, Gian Franco; Ganga, Antonio; Vacca, Sergio] Univ Sassari, Dipartimento Architettura Design & Urbanist, Nuoro, Italy; [Buondonno, Andrea] Univ Naples 2, Dipartimento Architettura & Disegno Ind Luigi Van, Abazia San Lorenzo Septimum, Aversa, Caserta, Italy; [Grilli, Eleonora] Univ Naples 2, Dipartimento Sci & Tecnol Ambientali, Biol & Farmaceut, Caserta, Italy; [Gaviano, Carla] Univ Cagliari, Dipartimento Sci Chim & Geol, Cagliari, Italy	University of Sassari; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Cagliari	Capra, GF (corresponding author), Univ Sassari, Dipartimento Architettura Design & Urbanist, Via Colombo 1, Nuoro, Italy.	pedolnu@uniss.it	Ganga, Antonio/AAP-9161-2020; Eleonora, Grilli/AAO-2495-2020; grilli, eleonora/ABE-3364-2020	Eleonora, Grilli/0000-0003-0803-315X; 				Agnesi V, 1990, REND SEM FS U CAGLIA, V60, P233; Ardau F, 1999, BALANCED MANAGEMENT, P87; Aru A., 1991, NOTA ILLUSTRATIVA CA; Barrera-Bassols N, 2003, GEODERMA, V111, P171, DOI 10.1016/S0016-7061(02)00263-X; Barrera-Bassols N, 1998, P 16 INT C SOIL SCI; Blasco Ferrer E., 2010, PALEOSARDO RADICI LI; Blasco Ferrer Eduardo, 1994, ELLO ELLUS GRAMMATIC; Cabboi N, 2005, REND SEM FS U CAGLIA, V75, P173; Caramelli D, 2007, HUM GENET, V122, P327, DOI 10.1007/s00439-007-0403-6; Caria MC, 2013, PLANT BIOSYST; Carmignani L., 2001, GEOLOGIA SARDEGNA NO, V60; Casagrande D, 2012, ENCY EARTH EOE; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Corda F, 1994, GRAMMATICA MODERNA S; De Waele J, 1998, ATT 18 CONV NAZ SPEL, P139; De Waele J., 2005, QUATERNARIO, V18, P211; Dedola S, 2012, TOPONOMASTICA SARDEG; Elerie H, 2010, CULTURAL LANDSCAPE & HERITAGE PARADOX: PROTECTION AND DEVELOPMENT OF THE DUTCH ARCHAEOLOGICAL-HISTORICAL LANDSCAPE AND ITS EUROPEAN DIMENSION, P83; FRAKE CO, 1962, AM ANTHROPOL, V64, P53, DOI 10.1525/aa.1962.64.1.02a00060; Fraumene C, 2003, HUM GENET, V114, P1, DOI 10.1007/s00439-003-1008-3; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Ilies DC, 2009, GEO J TOUR GEOSITES, V3, P78; Kadmon N, 2000, TOPONYMY LORE LAWS L; Lupinu G, 2007, LINGUE SARDI RICERCA; Marini A., 1977, RENDICONTI SEMINARIO, V47, P192; Mensching G., 2000, P C MULT MULT MIN LA; Minasny B, 2010, GEODERMA, V155, P132, DOI 10.1016/j.geoderma.2009.04.024; Paulis G, 1997, NAZIONE OPERAIA CULT, P7; Paulis Giulio., 1987, NOMI LUOGO SARDEGNA; Pittau M., 1984, LESSICO ETRUSCO LATI; Pittau M, 2011, TOPONIMI SARDEGNA SI; Pittau Massimo., 2013, NUOVO VOCABOLARIO LI; Pugliatti M, 2007, THESIS U BERGEN; Regione Autonoma della Sardegna, 2007, PIAN REG FOR ALL 1 S; Salminen T, 1993, UNESCO RED BOOK ENDA; Sanna G, 2004, SARDOA GRAMMATA DIO; Siderius W, 2003, GEODERMA, V111, P521, DOI 10.1016/S0016-7061(02)00280-X; Sistema Informativo Territoriale della Regione Autonoma della Sardegna, 2012, SARD GEOP RIC TOP; SOIL SURVEY STAFF, 2014, KEYS SOIL TAXONOMY, V12th; Sotgiu S, 2004, NEUROBIOL DIS, V17, P131, DOI 10.1016/j.nbd.2004.07.015; Spano Giovanni, 1872, VOCABOLARIO SARDO GE; Tagliavini Carlo, 1982, ORIGINI LINGUE NEOLA; Tetti V, 2001, NOMI LUOGO QUARTA DI; Toledo V., 1992, ETNOECOLOGICA, V1, P5; Toledo VM, 2000, ETHNOPEDOLOGY WORLDW, V77, P1; UNESCO, 1996, NUESTR DIV CREAT INF; Virdis M, 2009, P C NUM LOG MON LUOG; VONA G, 1997, INT J ANTHR, V12, P71, DOI DOI 10.1007/BF02447890; WAGNER Max Leopold, 1997, LINGUA SARDA STORIA; Wagner ML, 1964, DIZIONARIO ETIMOLOGI, V1-3; Winklerprins AMGA, 1999, SOC NATUR RESOUR, V12, P151, DOI 10.1080/089419299279812; Zanetti D, 2012, J NEUROLINGUIST, V25, P642, DOI 10.1016/j.jneuroling.2011.11.003	54	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120240	10.1371/journal.pone.0120240	http://dx.doi.org/10.1371/journal.pone.0120240			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789985	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400144
J	Hanold, LE; Oruganty, K; Ton, NT; Beedle, AM; Kannan, N; Kennedy, EJ				Hanold, Laura E.; Oruganty, Krishnadev; Ton, Norman T.; Beedle, Aaron M.; Kannan, Natarajan; Kennedy, Eileen J.			Inhibiting EGFR Dimerization Using Triazolyl-Bridged Dimerization Arm Mimics	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CLICK CHEMISTRY; RECEPTOR ACTIVATION; PEPTIDE; CYCLIZATION; ENDOCYTOSIS; ANTAGONIST; MIGRATION; INSIGHTS; SURFACE	The epidermal growth factor receptor (EGFR) is overexpressed in multiple carcinomas and is the focus of a variety of targeted therapies. Here we report the design of peptide-based compounds that mimic the EGFR dimerization arm and inhibit allosteric activation of EGFR. These peptides are modified to contain a triazolyl bridge between the peptide strands to constrain the EGFR dimerization arm beta-loop. In this study, we demonstrate that these peptides have significantly improved proteolytic stability over the non-modified peptide sequence, and their inhibitory effects are dependent on the number of the methylene units and orientation of the introduced triazolyl bridge. We identified a peptide, EDA2, which downregulates receptor phosphorylation and dimerization and reduces cell viability. This is the first example of a biologically active triazolyl-bridged peptide targeting the EGFR dimerization interface that effectively downregulates EGFR activation.	[Hanold, Laura E.; Ton, Norman T.; Beedle, Aaron M.; Kennedy, Eileen J.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Oruganty, Krishnadev; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kennedy, EJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	ekennedy@uga.edu	Oruganty, KrishnaDev/N-9465-2017; Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015	Oruganty, KrishnaDev/0000-0003-0866-6862; Beedle, Aaron M/0000-0002-1019-3235; Kennedy, Eileen/0000-0001-5610-1677	National Institutes of Health [1K22CA154600]; NATIONAL CANCER INSTITUTE [K22CA154600, R03CA188439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by 1K22CA154600 (EJK), National Institutes of Health, (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aileron Therapeutics, 2000, SAF STUD ALRN 6924 P; Angell Y, 2008, J AM CHEM SOC, V130, P556, DOI 10.1021/ja074717z; Angelo NG, 2005, J AM CHEM SOC, V127, P17134, DOI 10.1021/ja056406z; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bock VD, 2006, ORG LETT, V8, P919, DOI 10.1021/ol053095o; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Case D. A., 2012, AMBER 13; Ceresa BP, 2013, INT J MOL SCI, V14, P72, DOI 10.3390/ijms14010072; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Goncalves V, 2007, BIOORG MED CHEM LETT, V17, P5590, DOI 10.1016/j.bmcl.2007.07.087; Holland-Nell K, 2011, ANGEW CHEM INT EDIT, V50, P5204, DOI 10.1002/anie.201005846; Izetti P, 2014, INVEST NEW DRUG, V32, P783, DOI 10.1007/s10637-014-0090-9; Jagasia R, 2009, J ORG CHEM, V74, P2964, DOI 10.1021/jo802097m; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kulczar C, 2015, DRUG DELIV, P405; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Li HY, 2013, MOLECULES, V18, P9797, DOI 10.3390/molecules18089797; Mizuguchi T, 2012, BIOORGAN MED CHEM, V20, P5730, DOI 10.1016/j.bmc.2012.08.013; Mizuguchi T, 2009, BIOORG MED CHEM LETT, V19, P3279, DOI 10.1016/j.bmcl.2009.04.080; Nyffeler PT, 2002, J AM CHEM SOC, V124, P10773, DOI 10.1021/ja0264605; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Oh K, 2006, CHEM COMMUN, P3069, DOI 10.1039/b606185k; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sawyer TK, 2009, CHEM BIOL DRUG DES, V73, P3, DOI 10.1111/j.1747-0285.2008.00744.x; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Staberg M, 2013, CELL ONCOL, V36, P201, DOI 10.1007/s13402-013-0128-6; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wojtkowiak JW, 2011, MOL PHARMACEUT, V8, P2032, DOI 10.1021/mp200292c; Wolfson W, 2009, CHEM BIOL, V16, P910, DOI 10.1016/j.chembiol.2009.09.008; Xu RD, 2010, CELL ONCOL, V32, P259, DOI 10.3233/CLO-2010-0515; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	41	32	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118796	10.1371/journal.pone.0118796	http://dx.doi.org/10.1371/journal.pone.0118796			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790232	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400046
J	Moller, MS; Vester-Christensen, MB; Jensen, JM; Abou Hachem, M; Henriksen, A; Svensson, B				Moller, Marie S.; Vester-Christensen, Malene B.; Jensen, Johanne M.; Abou Hachem, Maher; Henriksen, Anette; Svensson, Birte			Crystal Structure of Barley Limit Dextrinase-Limit Dextrinase Inhibitor (LD-LDI) Complex Reveals Insights into Mechanism and Diversity of Cereal Type Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARCH-DEBRANCHING ENZYME; ALPHA-AMYLASE INHIBITOR; BIFUNCTIONAL INHIBITOR; WHEAT KERNEL; RAGI SEEDS; GENE; PURIFICATION; EXPRESSION; BINDING; SEQUENCE	Molecular details underlying regulation of starch mobilization in cereal seed endosperm remain unknown despite the paramount role of this process in plant growth. The structure of the complex between the starch debranching enzyme barley limit dextrinase (LD), hydrolyzing alpha-1,6-glucosidic linkages, and its endogenous inhibitor (LDI) was solved at 2.7 angstrom. The structure reveals an entirely new and unexpected binding mode of LDI as compared with previously solved complex structures of related cereal type family inhibitors (CTIs) bound to glycoside hydrolases but is structurally analogous to binding of dual specificity CTIs to proteases. Site-directed mutagenesis establishes that a hydrophobic cluster flanked by ionic interactions in the protein-protein interface is vital for the picomolar affinity of LDI to LD as assessed by analysis of binding by using surface plasmon resonance and also supported by LDI inhibition of the enzyme activity. A phylogenetic analysis identified four LDI-like proteins in cereals among the 45 sequences from monocot databases that could be classified as unique CTI sequences. The unprecedented binding mechanism shown here for LDI has likely evolved in cereals from a need for effective inhibition of debranching enzymes having characteristic open active site architecture. The findings give a mechanistic rationale for the potency of LD activity regulation and provide a molecular understanding of the debranching events associated with optimal starch mobilization and utilization during germination. This study unveils a hitherto not recognized structural basis for the features endowing diversity to CTIs.	[Moller, Marie S.; Vester-Christensen, Malene B.; Jensen, Johanne M.; Abou Hachem, Maher; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, Enzyme & Prot Chem, DK-2800 Lyngby, Denmark; [Moller, Marie S.; Vester-Christensen, Malene B.; Jensen, Johanne M.; Henriksen, Anette] Carlsberg Lab, Prot Chem Grp, DK-1799 Copenhagen V, Denmark	Technical University of Denmark	Henriksen, A (corresponding author), Novo Nordisk AS, Dept Prot Biophys & Formulat, Global Res Unit, Novo Nordisk Pk, DK-2760 Malov, Denmark.	athx@novonordisk.com; bis@bio.dtu.dk	Abou Hachem, Maher/M-4772-2019; Møller, Marie Sofie/AAH-2568-2021; Møller, Marie Sofie/GRE-9135-2022	Abou Hachem, Maher/0000-0001-8250-1842; Møller, Marie Sofie/0000-0001-9017-3367; Svensson, Birte/0000-0002-2993-8196; Henriksen, Anette/0000-0003-4051-5079	Carlsberg Foundation; Danish Council for Independent Research, Natural Sciences; Technical University of Denmark; Oticon Foundation	Carlsberg Foundation(Carlsberg Foundation); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Technical University of Denmark; Oticon Foundation	This work was supported by the Carlsberg Foundation, the Danish Council for Independent Research, Natural Sciences, Technical University of Denmark Ph.D. stipends (to M. B. V.- C. and M. S. M.), and an Oticon Foundation M.Sc. scholarship (to J. M. J.).	Behnke CA, 1998, BIOCHEMISTRY-US, V37, P15277, DOI 10.1021/bi9812266; Burton RA, 1999, PLANT PHYSIOL, V119, P859, DOI 10.1104/pp.119.3.859; Carbonero P, 1999, SEED PROTEINS, P617; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; DUNN G, 1975, CARBOHYD RES, V39, P283, DOI 10.1016/S0008-6215(00)86138-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finnie C, 2011, PROTEOMICS, V11, P1595, DOI 10.1002/pmic.201000656; Fujita N, 2009, J EXP BOT, V60, P1009, DOI 10.1093/jxb/ern349; Gilding EK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2450; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gourinath S, 2000, ACTA CRYSTALLOGR D, V56, P287, DOI 10.1107/S0907444999016601; Jensen JM, 2011, PROTEIN EXPRES PURIF, V79, P217, DOI 10.1016/j.pep.2011.04.009; Jose-Estanyol M, 2004, PLANT PHYSIOL BIOCH, V42, P355, DOI 10.1016/j.plaphy.2004.03.009; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristensen M, 1999, BBA-PROTEIN STRUCT M, V1431, P538, DOI 10.1016/S0167-4838(99)00077-1; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LI B, 1992, PLANT PHYSIOL, V98, P1277, DOI 10.1104/pp.98.4.1277; Li QF, 2009, PLANT PHYSIOL BIOCH, V47, P351, DOI 10.1016/j.plaphy.2009.02.001; LONGSTAFF MA, 1993, PLANT PHYSIOL, V101, P881, DOI 10.1104/pp.101.3.881; LUDWIG I, 1984, PLANT PHYSIOL, V74, P856, DOI 10.1104/pp.74.4.856; MacGregor A. W., 1995, P EUR BREW CONV C BR, P185; MacGregor AW, 2003, J CEREAL SCI, V37, P357, DOI 10.1006/jcrs.2002.0500; MACGREGOR AW, 1994, J CEREAL SCI, V20, P33, DOI 10.1006/jcrs.1994.1042; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Moller MS, 2015, J MOL BIOL, V427, P1263, DOI 10.1016/j.jmb.2014.12.019; Moller MS, 2012, ACTA CRYSTALLOGR F, V68, P1008, DOI 10.1107/S1744309112031004; Morinaga K, 1997, PHYSIOL PLANTARUM, V101, P519, DOI 10.1111/j.1399-3054.1997.tb01032.x; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Oda Y, 1997, BIOCHEMISTRY-US, V36, P13503, DOI 10.1021/bi971307m; Oneda H, 2004, J BIOCHEM, V135, P421, DOI 10.1093/jb/mvh050; Ostergaard O, 2004, PROTEOMICS, V4, P2437, DOI 10.1002/pmic.200300753; Payan F, 2004, BBA-PROTEINS PROTEOM, V1696, P171, DOI 10.1016/j.bbapap.2003.10.012; Repellin A, 2008, J CEREAL SCI, V47, P302, DOI 10.1016/j.jcs.2007.04.015; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schroeder SW, 1998, J AM SOC BREW CHEM, V56, P32; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Stahl Y, 2007, PLANT SCI, V172, P452, DOI 10.1016/j.plantsci.2006.10.008; Stahl Y, 2004, PLANT J, V39, P599, DOI 10.1111/j.1365-313X.2004.02159.x; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Strobl S, 1998, STRUCTURE, V6, P911, DOI 10.1016/S0969-2126(98)00092-6; STROBL S, 1995, BIOCHEMISTRY-US, V34, P8281, DOI 10.1021/bi00026a009; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Svensson B, 2004, BBA-PROTEINS PROTEOM, V1696, P145, DOI 10.1016/j.bbapap.2003.07.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; Vester-Christensen MB, 2010, J MOL BIOL, V403, P739, DOI 10.1016/j.jmb.2010.09.031; Vester-Christensen MB, 2010, PROTEIN EXPRES PURIF, V69, P112, DOI 10.1016/j.pep.2009.08.016; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YAMADA J, 1981, AGR BIOL CHEM TOKYO, V45, P1013, DOI 10.1080/00021369.1981.10864644; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhu ZP, 1998, PLANT PHYSIOL, V118, P581, DOI 10.1104/pp.118.2.581	54	15	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12614	12629		10.1074/jbc.M115.642777	http://dx.doi.org/10.1074/jbc.M115.642777			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25792743	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000354569000017
J	Peterson, DA; Planer, JD; Guruge, JL; Xue, L; Downey-Virgin, W; Goodman, AL; Seedorf, H; Gordon, JI				Peterson, Daniel A.; Planer, Joseph D.; Guruge, Janaki L.; Xue, Lai; Downey-Virgin, Whitt; Goodman, Andrew L.; Seedorf, Henning; Gordon, Jeffrey I.			Characterizing the Interactions between a Naturally Primed Immunoglobulin A and Its Conserved Bacteroides thetaiotaomicron Species-specific Epitope in Gnotobiotic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GUT; SYMBIOTIC BACTERIA; IN-VIVO; RESPONSES; CELLS; HOST; MICROBIOME; DIVERSITY; ANTIBODY; DEFENSE	The adaptive immune response to the human gut microbiota consists of a complex repertoire of antibodies interacting with a broad range of taxa. Fusing intestinal lamina propria lymphocytes from mice monocolonized with Bacteroides thetaiotaomicron to a myeloma fusion partner allowed us to recover hybridomas that captured naturally primed, antigen-specific antibody responses representing multiple isotypes, including IgA. One of these hybridomas, 260.8, produced a monoclonal antibody that recognizes an epitope specific for B. thetaiotaomicron isolates in a large panel of hospital-and community-acquired Bacteroides. Whole genome transposon mutagenesis revealed a 19-gene locus, involved in LPS O-antigen polysaccharide synthesis and conserved among multiple B. thetaiotaomicron isolates, that is required for 260.8 epitope expression. Mutants in this locus exhibited marked fitness defects in vitro during growth in rich medium and in gnotobiotic mice colonized with defined communities of human gut symbionts. Expression of the 260.8 epitope was sustained during 10 months of daily passage in vitro and during 14 months of monocolonization of gnotobiotic wild-type, Rag1(-/-), or Myd88(-/-) mice. Comparison of gnotobiotic Rag1(-/-) mice with and without subcutaneous 260.8 hybridomas disclosed that this IgA did not affect B. thetaiotaomicron population density or suppress 260.8 epitope production but did affect bacterial gene expression in ways emblematic of a diminished host innate immune response. Our study illustrates an approach for (i) generating diagnostic antibodies, (ii) characterizing IgA responses along a continuum of specificity/degeneracy that defines the IgA repertoire to gut symbionts, and (iii) identifying immunogenic epitopes that affect competitiveness and help maintain host-microbe mutualism.	[Peterson, Daniel A.; Planer, Joseph D.; Guruge, Janaki L.; Xue, Lai; Downey-Virgin, Whitt; Goodman, Andrew L.; Seedorf, Henning; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Peterson, Daniel A.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA	Washington University (WUSTL); Johns Hopkins University	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, 4444 Forest Pk Ave, St Louis, MO 63108 USA.	jgordon@wustl.edu	Regan, Clinton/E-6250-2012; Seedorf, Henning/AAW-6023-2020	Seedorf, Henning/0000-0002-5763-0236	National Institutes of Health [DK30292, DK078669, K08-AI07660902, GM007200]; Washington University Medical Scientist Training Program; National Science Foundation [EF-0333284]; Crohn's and Colitis Association of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, R37DK030292, R01DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Medical Scientist Training Program; National Science Foundation(National Science Foundation (NSF)); Crohn's and Colitis Association of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK30292, DK078669, K08-AI07660902, and GM007200, a Washington University Medical Scientist Training Program grant (to J. P.). This work was also supported by National Science Foundation Grant EF-0333284 and the Crohn's and Colitis Association of America. J. I. G is co-founder of Matatu, Inc., a company characterizing the role of diet-by-microbiota interactions in animal health.	Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; GALFRE G, 1979, NATURE, V277, P131, DOI 10.1038/277131a0; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Mirpuri J, 2014, GUT MICROBES, V5, P28, DOI 10.4161/gmic.26489; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Salyers AA, 2000, METHODS, V20, P35, DOI 10.1006/meth.1999.0903; Shimoda M, 1999, IMMUNOLOGY, V97, P9, DOI 10.1046/j.1365-2567.1999.00755.x; SHOEMAKER NB, 1986, J BACTERIOL, V165, P929, DOI 10.1128/jb.165.3.929-936.1986; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Simmon KE, 2008, J CLIN MICROBIOL, V46, P1596, DOI 10.1128/JCM.02469-07; Snydman DR, 2007, ANTIMICROB AGENTS CH, V51, P1649, DOI 10.1128/AAC.01435-06; Sommer F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085254; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stoel M, 2005, J IMMUNOL, V174, P1046, DOI 10.4049/jimmunol.174.2.1046; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5388, DOI 10.1073/pnas.1121627109; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5382, DOI 10.1073/pnas.1121631109	44	39	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12630	12649		10.1074/jbc.M114.633800	http://dx.doi.org/10.1074/jbc.M114.633800			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25795776	hybrid, Green Published			2022-12-26	WOS:000354569000018
J	Muramatsu, R; Kuroda, M; Matoba, K; Lin, HY; Takahashi, C; Koyama, Y; Yamashita, T				Muramatsu, Rieko; Kuroda, Mariko; Matoba, Ken; Lin, Hsiaoyun; Takahashi, Chisato; Koyama, Yoshihisa; Yamashita, Toshihide			Prostacyclin Prevents Pericyte Loss and Demyelination Induced by Lysophosphatidylcholine in the Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; SPINAL-CORD DEMYELINATION; NEURONAL DAMAGE; CELLS; REMYELINATION; RECRUITMENT; DISRUPTION; INTEGRITY; RECOVERY; DISEASE	Pericytes play pivotal roles in physiological and pathophysiological conditions in the central nervous system. As pericytes prevent vascular leakage, they can halt neuronal damage stemming from a compromised blood-brain barrier. Therefore, pericytes may be a good target for the treatment of neurodegenerative disorders, although evidence is lacking. In this study, we show that prostacyclin attenuates lysophosphatidylcholine (LPC)-mediated vascular dysfunction through pericyte protection in the adult mouse spinal cord. LPC decreased the number of pericytes in an in vitro blood-brain barrier model, and this decrease was prevented by iloprost treatment, a prostacyclin analog. Intrathecal administration of iloprost attenuated vascular barrier disruption after LPC injection in the mouse spinal cord. Furthermore, iloprost treatment diminished demyelination and motor function deficits in mice injected with LPC. These results support the notion that prostacyclin acts on pericytes to maintain vascular barrier integrity.	[Muramatsu, Rieko; Kuroda, Mariko; Matoba, Ken; Lin, Hsiaoyun; Takahashi, Chisato; Koyama, Yoshihisa; Yamashita, Toshihide] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Muramatsu, Rieko; Kuroda, Mariko; Matoba, Ken; Lin, Hsiaoyun; Takahashi, Chisato; Koyama, Yoshihisa; Yamashita, Toshihide] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Muramatsu, Rieko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Muramatsu, R (corresponding author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	muramatsu@molneu.med.osaka-u.ac.jp; yamashita@molneu.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018	Ministry of Health, Labour and Welfare; Japan Society for the Promotion of Science [25221309]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid from the Ministry of Health, Labour and Welfare (to R. M.) and Grant-in-aid for Scientific Research (S) 25221309 from Japan Society for the Promotion of Science (to T. Y.).	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311; Cui YL, 1999, BIOCHEM BIOPH RES CO, V265, P301, DOI 10.1006/bbrc.1999.1671; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Fortin D, 2012, CURR CANCER DRUG TAR, V12, P247, DOI 10.2174/156800912799277511; Garbuzova-Davis S., 2014, FRONT CELL NEUROSCI, V8, P21; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Hsieh CC, 2000, ATHEROSCLEROSIS, V151, P481, DOI 10.1016/S0021-9150(00)00453-6; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Jeffery ND, 1997, BRAIN, V120, P27, DOI 10.1093/brain/120.1.27; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Mozafari S, 2010, BRAIN RES, V1351, P50, DOI 10.1016/j.brainres.2010.07.026; Muramatsu R, 2012, NAT MED, V18, P1658, DOI 10.1038/nm.2943; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Ousman SS, 2001, J NEUROSCI, V21, P4649, DOI 10.1523/JNEUROSCI.21-13-04649.2001; Qiao J, 2006, AM J PHYSIOL-LUNG C, V291, pL91, DOI 10.1152/ajplung.00508.2005; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Takahashi C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.335; Takamatsu H, 2002, BRAIN RES, V925, P176, DOI 10.1016/S0006-8993(01)03280-2; TERAWAKI T, 1988, EUR J PHARMACOL, V152, P63, DOI 10.1016/0014-2999(88)90836-9; Tigges U, 2012, MICROVASC RES, V84, P74, DOI 10.1016/j.mvr.2012.03.008; Vane J. R., 1995, AM J CARDIOL, V75, p3A; Winkler EA, 2012, J CEREBR BLOOD F MET, V32, P1841, DOI 10.1038/jcbfm.2012.113; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946	36	36	36	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11515	11525		10.1074/jbc.M114.587253	http://dx.doi.org/10.1074/jbc.M114.587253			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25795781	hybrid, Green Published			2022-12-26	WOS:000353719400027
J	Corthals, A; Martin, A; Warsi, OM; Woller-Skar, M; Lancaster, W; Russell, A; Davalos, LM				Corthals, Angelique; Martin, Alynn; Warsi, Omar M.; Woller-Skar, Megan; Lancaster, Winston; Russell, Amy; Davalos, Liliana M.			From the Field to the Lab: Best Practices for Field Preservation of Bat Specimens for Molecular Analyses	PLOS ONE			English	Article							PCR-AMPLIFICATION; DNA; TISSUES; DIVERSIFICATION; STORAGE; HABITS	Studies in molecular ecology depend on field-collected samples for genetic information, and the tissue sampled and preservation conditions strongly affect the quality of the DNA obtained. DNA yields from different tissue types have seldom been compared, and the relative performance of storage media has never been directly tested, even though these media may influence DNA degradation under field conditions. We analyzed DNA yield from buccal swabs and wing punches harvested from live bats using nucleic acid quantification as well as quantitative PCR for a single-copy nuclear locus. We also compared DNA yields from wing tissue preserved in three media: ethanol, NaCl-saturated dimethyl sulfoxide (DMSO), and silica desiccant. Wing punches yielded more total DNA than did buccal swabs, and wing tissues preserved in silica beads yielded significantly more total and nuclear DNA than those preserved in DMSO or ethanol. These results show that tissue type and preservation media strongly influence the quantity of DNA obtained from non-lethal genetic samples, and based on these effects we provide recommendations for field collection of tissues for genetic analyses.	[Corthals, Angelique] CUNY John Jay Coll Criminal Justice, Dept Sci, New York, NY 10019 USA; [Corthals, Angelique] SUNY Stony Brook, Sch Med, Dept Pathol, Stony Brook, NY 11794 USA; [Martin, Alynn; Woller-Skar, Megan; Russell, Amy] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Warsi, Omar M.; Davalos, Liliana M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Lancaster, Winston] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA; [Davalos, Liliana M.] Sch Marine & Atmospher Sci, Consortium Interdisciplinary Environm Res, Stony Brook, NY USA	City University of New York (CUNY) System; John Jay College of Criminal Justice (CUNY); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Grand Valley State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; California State University System; California State University Sacramento	Corthals, A (corresponding author), CUNY John Jay Coll Criminal Justice, Dept Sci, New York, NY 10019 USA.	acorthals@jjay.cuny.edu	Russell, Amy L/B-2222-2010	Davalos, Liliana/0000-0002-4327-7697; Warsi, Omar/0000-0003-3175-1184; Corthals, Angelique/0000-0002-5610-2992	Direct For Biological Sciences [1442142, 1442314] Funding Source: National Science Foundation; Division Of Environmental Biology [1442278] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Atmadja Djaja Surya, 1995, Kobe Journal of Medical Sciences, V41, P197; Baker RJ, 1984, COLLECTIONS FROZEN T, P35; Bates D. M., 2010, LME4 MIXED EFFECTS M; BENFORD G, 1992, P NATL ACAD SCI USA, V89, P11098, DOI 10.1073/pnas.89.22.11098; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Boston ESM, 2012, ACTA CHIROPTEROL, V14, P45, DOI 10.3161/150811012X654259; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Corthals A, 2005, SYST BIOL, P54; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dessauer HC, 1984, COLLECTIONS FROZEN T, P3; Dumont ER, 2012, P ROY SOC B-BIOL SCI, V279, P1797, DOI 10.1098/rspb.2011.2005; ENGSTROM M. D., 1999, MANAGING MODERN HERB, P315; Faure PA, 2009, J MAMMAL, V90, P1148, DOI 10.1644/08-MAMM-A-332.1; Flanders J, 2009, MOL ECOL, V18, P306, DOI 10.1111/j.1365-294X.2008.04021.x; Florian M.-L., 1990, Collection Forum, V6, P1; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; Gebel T, 1999, MUTAT RES-GEN TOX EN, V444, P405, DOI 10.1016/S1383-5718(99)00111-4; Gelman A, 2005, ANN STAT, V33, P1, DOI 10.1214/009053604000001048; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hanner R, 2005, MOL PHYLOGENET EVOL, V34, P452, DOI 10.1016/j.ympev.2004.10.008; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Kataoka T, 2009, J CLIN BIOCHEM NUTR, V45, P219, DOI 10.3164/jcbn.09-06; Kilpatrick CW, 2002, BIOCHEM GENET, V40, P53, DOI 10.1023/A:1014541222816; Kitchen RR, 2010, METHODS, V50, P231, DOI 10.1016/j.ymeth.2010.01.025; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Longmire Jonathan L., 1997, Occasional Papers the Museum Texas Tech University, V163, P1; Loureiro J, 2006, ANN BOT-LONDON, V98, P679, DOI 10.1093/aob/mcl141; Michaud CL, 2011, J FORENSIC SCI, V56, P846, DOI 10.1111/j.1556-4029.2011.01771.x; Miller-Butterworth CM, 2014, J HERED, V105, P354, DOI 10.1093/jhered/esu012; Muscarella RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017704; Phillips CD, 2012, MOL ECOL, V21, P2617, DOI 10.1111/j.1365-294X.2012.05568.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Racey PA, 2013, ZOONOSES PUBLIC HLTH, V60, P58, DOI 10.1111/j.1863-2378.2012.01533.x; Rojas D, 2011, MOL ECOL, V20, P2217, DOI 10.1111/j.1365-294X.2011.05082.x; Russell AL, 2005, MOL ECOL, V14, P2207, DOI 10.1111/j.1365-294X.2005.02552.x; Russell AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-88; Sahdev S, 2007, MOL CELL PROBE, V21, P303, DOI 10.1016/j.mcp.2007.03.004; SAVOLAINEN V, 2006, DNA TISSUE BANKING B; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sheldon F., 1997, GLOBAL GENETIC RESOU, P151; Thermo Fisher Scientific, 2008, NANODROP 1000 SPECTR, P1; Vazquez-Dominguez E, 2013, ACTA CHIROPTEROL, V15, P411, DOI 10.3161/150811013X679035; Velazco PM, 2013, MOL PHYLOGENET EVOL, V68, P683, DOI 10.1016/j.ympev.2013.04.016; WORTHINGTON WILMER J. M., 1996, BAT RES NEWS, V37, P1; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	46	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118994	10.1371/journal.pone.0118994	http://dx.doi.org/10.1371/journal.pone.0118994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798819	Green Published, gold			2022-12-26	WOS:000351987300024
J	Hallam, GP; Webb, TL; Sheeran, P; Miles, E; Wilkinson, ID; Hunter, MD; Barker, AT; Woodruff, PWR; Totterdell, P; Lindquist, KA; Farrow, TFD				Hallam, Glyn P.; Webb, Thomas L.; Sheeran, Paschal; Miles, Eleanor; Wilkinson, Iain D.; Hunter, Michael D.; Barker, Anthony T.; Woodruff, Peter W. R.; Totterdell, Peter; Lindquist, Kristen A.; Farrow, Tom F. D.			The Neural Correlates of Emotion Regulation by Implementation Intentions	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; PROSPECTIVE MEMORY; SKIN-CONDUCTANCE; FUNCTIONAL CONNECTIVITY; GOAL ACHIEVEMENT; FRONTAL-CORTEX; AMYGDALA; METAANALYSIS; VOLUNTARY; RESPONSES	Several studies have investigated the neural basis of effortful emotion regulation (ER) but the neural basis of automatic ER has been less comprehensively explored. The present study investigated the neural basis of automatic ER supported by 'implementation intentions'. 40 healthy participants underwent fMRI while viewing emotion-eliciting images and used either a previously-taught effortful ER strategy, in the form of a goal intention (e.g., try to take a detached perspective), or a more automatic ER strategy, in the form of an implementation intention (e.g., "If I see something disgusting, then I will think these are just pixels on the screen!"), to regulate their emotional response. Whereas goal intention ER strategies were associated with activation of brain areas previously reported to be involved in effortful ER (including dorsolateral prefrontal cortex), ER strategies based on an implementation intention strategy were associated with activation of right inferior frontal gyrus and ventro-parietal cortex, which may reflect the attentional control processes automatically captured by the cue for action contained within the implementation intention. Goal intentions were also associated with less effective modulation of left amygdala, supporting the increased efficacy of ER under implementation intention instructions, which showed coupling of orbitofrontal cortex and amygdala. The findings support previous behavioural studies in suggesting that forming an implementation intention enables people to enact goal-directed responses with less effort and more efficiency.	[Hallam, Glyn P.; Hunter, Michael D.; Woodruff, Peter W. R.; Farrow, Tom F. D.] Univ Sheffield, SCANLab Sheffield Cognit & Neuroimaging Lab, Acad Clin Psychiat, Dept Neurosci,Longley Ctr,Northern Gen Hosp, Sheffield, S Yorkshire, England; [Webb, Thomas L.; Miles, Eleanor; Totterdell, Peter] Univ Sheffield, Dept Psychol, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Sheeran, Paschal; Lindquist, Kristen A.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Wilkinson, Iain D.] Univ Sheffield, Royal Hallamshire Hosp, Acad Unit Radiol, Sheffield S10 2JF, S Yorkshire, England; [Barker, Anthony T.] Univ Sheffield, Royal Hallamshire Hosp, Dept Med Phys & Clin Engn, Sheffield S10 2JF, S Yorkshire, England; [Farrow, Tom F. D.] Univ Sheffield, Royal Hallamshire Hosp, Dept Neurosci, Acad Clin Neurol, Sheffield S10 2JF, S Yorkshire, England; [Hallam, Glyn P.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Miles, Eleanor] Univ Sussex, Sch Psychol, Falmer, E Sussex, England	Northern General Hospital; University of Sheffield; University of Sheffield; University of North Carolina; University of North Carolina Chapel Hill; University of Sheffield; University of Sheffield; University of Sheffield; University of York - UK; University of Sussex	Hallam, GP (corresponding author), Univ Sheffield, SCANLab Sheffield Cognit & Neuroimaging Lab, Acad Clin Psychiat, Dept Neurosci,Longley Ctr,Northern Gen Hosp, Norwood Grange Dr, Sheffield, S Yorkshire, England.	glyn.hallam@york.ac.uk	Sheeran, Paschal/Y-3370-2019; Webb, Thomas/E-8946-2010; Lindquist, Kristen/AAA-4580-2021; Farrow, Tom/B-5003-2009	Webb, Thomas/0000-0001-9320-0068; Lindquist, Kristen/0000-0002-5368-9302; Wilkinson, Iain/0000-0003-2703-6890; Hallam, Glyn Paul/0000-0002-8956-9054; Miles, Eleanor/0000-0002-8375-4638; Totterdell, Peter/0000-0002-5335-2611; Farrow, Tom/0000-0001-5096-6370	Economic and Social Research Council (ESRC) [RES-060-25-0044]; Economic and Social Research Council [ES/F037449/1] Funding Source: researchfish; ESRC [ES/F037449/1] Funding Source: UKRI	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council (ESRC; grant number RES-060-25-0044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 1999, EUR J SOC PSYCHOL, V29, P971, DOI 10.1002/(SICI)1099-0992(199912)29:8<971::AID-EJSP963>3.3.CO;2-1; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; Benedek M, 2010, PSYCHOPHYSIOLOGY, V47, P647, DOI 10.1111/j.1469-8986.2009.00972.x; Berkman ET, 2009, NEUROIMAGE, V47, P705, DOI 10.1016/j.neuroimage.2009.04.084; Brett M., 2002, NEUROIMAGE, V16, P497; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buhle J. T., 2013, CEREB CORTEX, DOI [10.1093/cercor/bht154, DOI 10.1093/CERC0R/BHT154]; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; Cabeza R, 2012, TRENDS COGN SCI, V16, P338, DOI 10.1016/j.tics.2012.04.008; Caseras X, 2007, BIOL PSYCHIAT, V62, P464, DOI 10.1016/j.biopsych.2006.10.030; Dahm T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026351; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Dolcos F, 2006, NEUROREPORT, V17, P1591, DOI 10.1097/01.wnr.0000236860.24081.be; Driscoll D, 2009, INT J PSYCHOPHYSIOL, V72, P61, DOI 10.1016/j.ijpsycho.2008.03.012; Durnez J, 2014, NEUROIMAGE, V84, P45, DOI 10.1016/j.neuroimage.2013.07.072; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Eisenberg N, 2000, J PERS SOC PSYCHOL, V78, P136, DOI 10.1037//0022-3514.66.4.776; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Farrow TFD, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00349; FRITH CD, 1983, BIOL PSYCHOL, V17, P27, DOI 10.1016/0301-0511(83)90064-9; Fulwiler CE, 2012, NEUROREPORT, V23, P606, DOI 10.1097/WNR.0b013e3283551cfc; Gallo IS, 2009, J PERS SOC PSYCHOL, V96, P11, DOI 10.1037/a0013460; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gilbert SJ, 2007, SOC COGN AFFECT NEUR, V2, P217, DOI 10.1093/scan/nsm014; Gilbert SJ, 2006, CEREB CORTEX, V16, P1783, DOI 10.1093/cercor/bhj113; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Gilbert SJ, 2006, J EXP PSYCHOL HUMAN, V32, P45, DOI 10.1037/0096-1523.32.1.45; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Glascher J, 2003, J NEUROSCI, V23, P10274; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; Gollwitzer P M, 1998, Pers Soc Psychol Rev, V2, P124, DOI 10.1207/s15327957pspr0202_5; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Gross JJ, 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hasenkamp W, 2012, NEUROIMAGE, V59, P750, DOI 10.1016/j.neuroimage.2011.07.008; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Markowitsch HJ, 1998, BEHAV NEUROL, V11, P233; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McDaniel MA, 2010, MEM COGNITION, V38, P221, DOI 10.3758/MC.38.2.221; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Muhlberger A, 2008, EMOTION, V8, P192, DOI 10.1037/1528-3542.8.2.192; Nili U, 2010, NEURON, V66, P949, DOI 10.1016/j.neuron.2010.06.009; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; Olatunji BO, 2007, PSYCHOL ASSESSMENT, V19, P281, DOI 10.1037/1040-3590.19.3.281; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parks-Stamm EJ, 2007, SOC COGNITION, V25, P248, DOI 10.1521/soco.2007.25.2.248; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Richards JM, 1999, PERS SOC PSYCHOL B, V25, P1033, DOI 10.1177/01461672992511010; Rummel J, 2012, MEMORY, V20, P803, DOI 10.1080/09658211.2012.707214; Schaefer SM, 2002, J COGNITIVE NEUROSCI, V14, P913, DOI 10.1162/089892902760191135; Serences JT, 2004, NEUROIMAGE, V21, P1690, DOI 10.1016/j.neuroimage.2003.12.021; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Shastri A, 2001, J MAGN RESON IMAGING, V14, P187, DOI 10.1002/jmri.1171; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shenhav A, 2013, COGN AFFECT BEHAV NE, V13, P46, DOI 10.3758/s13415-012-0128-4; Spence SA, 2008, NEUROIMAGE, V40, P1411, DOI 10.1016/j.neuroimage.2008.01.035; Talairach J., 1988, COPLANAR STEREOTAXIC; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; van Reekum CM, 2011, SOC COGN AFFECT NEUR, V6, P177, DOI 10.1093/scan/nsq031; Vanderhasselt MA, 2006, EXP BRAIN RES, V169, P279, DOI 10.1007/s00221-005-0344-z; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Webb TL, 2008, BRIT J SOC PSYCHOL, V47, P373, DOI 10.1348/014466607X267010; Webb TL, 2007, J EXP SOC PSYCHOL, V43, P295, DOI 10.1016/j.jesp.2006.02.001; Webb TL, 2012, EUR REV SOC PSYCHOL, V23, P143, DOI 10.1080/10463283.2012.718134; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; Webb TL, 2004, EUR J SOC PSYCHOL, V34, P407, DOI 10.1002/ejsp.205; Williams LM, 2000, NEUROREPORT, V11, P3011, DOI 10.1097/00001756-200009110-00037	98	41	42	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119500	10.1371/journal.pone.0119500	http://dx.doi.org/10.1371/journal.pone.0119500			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798822	Green Accepted, gold, Green Published			2022-12-26	WOS:000351987300054
J	Kepp, KP				Kepp, Kasper P.			Genotype-Property Patient-Phenotype Relations Suggest that Proteome Exhaustion Can Cause Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							HUMAN SUPEROXIDE-DISMUTASE; WILD-TYPE; MUTANT SOD1; STABILITY CHANGES; HEXANUCLEOTIDE REPEAT; DISEASE PROGRESSION; MOUSE MODEL; MUTATIONS; ALS; AGGREGATION	Late-onset neurodegenerative diseases remain poorly understood as search continues for the perceived pathogenic protein species. Previously, variants in Superoxide Dismutase 1 (SOD1) causing Amyotrophic Lateral Sclerosis (ALS) were found to destabilize and reduce net charge, suggesting a pathogenic aggregation mechanism. This paper reports analysis of compiled patient data and experimental and computed protein properties for variants of human SOD1, a major risk factor of ALS. Both stability and reduced net charge correlate significantly with disease, with larger significance than previously observed. Using two independent methods and two data sets, a probability < 3% (t-statistical test) is found that ALS-causing mutations share average stability with all possible 2907 SOD1 mutations. Most importantly, un-weighted patient survival times correlate strongly with the misfolded/unfolded protein copy number, expressed as an exponential function of the experimental stabilities (R-2 = 0.31, p = 0.002), and this phenotype is further aggravated by charge (R-2 = 0.51, p = 1.8 x 10-5). This finding suggests that disease relates to the copy number of misfolded proteins. Exhaustion of motor neurons due to expensive protein turnover of misfolded protein copies is consistent with the data but can further explain e. g. the expression-dependence of SOD1 pathogenicity, the lack of identification of a molecular toxic mode, elevated SOD1 mRNA levels in sporadic ALS, bioenergetic effects and increased resting energy expenditure in ALS patients, genetic risk factors affecting RNA metabolism, and recent findings that a SOD1 mutant becomes toxic when proteasome activity is recovered after washout of a proteasome inhibitor. Proteome exhaustion is also consistent with energy-producing mitochondria accumulating at the neuromuscular junctions where ALS often initiates. If true, this exhaustion mechanism implies a complete change of focus in treatment of ALS towards actively nursing the energy state and protein turnover of the motor neurons.	Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark	Kepp, KP (corresponding author), Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark.	kpj@kemi.dtu.dk	Kepp, Kasper P./AAA-4626-2021; Kepp, Kasper Planeta/G-1748-2013	Kepp, Kasper P./0000-0002-6754-7348; Kepp, Kasper Planeta/0000-0002-6754-7348				Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Bourassa MW, 2012, METALLOMICS, V4, P721, DOI 10.1039/c2mt20052j; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Brown JA, 2012, AMYOTROPH LATERAL SC, V13, P217, DOI 10.3109/17482968.2011.643899; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bystrom R, 2010, J BIOL CHEM, V285, P19544, DOI 10.1074/jbc.M109.086074; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2004, BIOINFORMATICS, V20, P63, DOI 10.1093/bioinformatics/bth928; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conte A, 2012, J NEUROL NEUROSUR PS, V83, P1201, DOI 10.1136/jnnp-2012-302897; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; Dangoumau A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.07.012; de Carvalho M, 2011, CURR OPIN NEUROL, V24, P497, DOI 10.1097/WCO.0b013e32834916a9; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Fukada K, 2001, EUR J NEUROSCI, V14, P2032, DOI 10.1046/j.0953-816x.2001.01828.x; Gagliardi S, 2010, NEUROBIOL DIS, V39, P198, DOI 10.1016/j.nbd.2010.04.008; Genton L, 2011, CLIN NUTR, V30, P553, DOI 10.1016/j.clnu.2011.06.004; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Heise K, 2003, COMP BIOCHEM PHYS C, V134, P79, DOI 10.1016/S1532-0456(02)00212-0; Ip P, 2011, J MOL BIOL, V409, P839, DOI 10.1016/j.jmb.2011.04.027; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kepp KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090504; Kepp KP, 2014, J PHYS CHEM B, V118, P1799, DOI 10.1021/jp4119138; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kitamura A, 2014, GENES CELLS, V19, P209, DOI 10.1111/gtc.12125; Kuzma-Kozakiewicz M, 2013, AMYOTROPH LAT SCL FR, V14, P608, DOI 10.3109/21678421.2013.812119; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Le Masson G, 2014, NEURON, V83, P975, DOI 10.1016/j.neuron.2014.07.001; Leinartaite L, 2010, J AM CHEM SOC, V132, P13495, DOI 10.1021/ja1057136; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Magrane J, 2012, J NEUROSCI, V32, P229, DOI 10.1523/JNEUROSCI.1233-11.2012; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Milani P, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/458427; Nishida Y, 2011, MONATSH CHEM, V142, P375, DOI 10.1007/s00706-010-0444-8; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Pfister T, 2013, AMYOTROPH LAT SCL FR, V14, P273, DOI 10.3109/21678421.2012.754044; Pratt AJ, 2012, DEGENER NEUROL NEURO, V2, P1, DOI 10.2147/DNND.S19803; Proctor EA, 2011, J MOL BIOL, V408, P555, DOI 10.1016/j.jmb.2011.03.004; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Redler RL, 2012, PROG MOL BIOL TRANSL, V107, P215, DOI 10.1016/B978-0-12-385883-2.00002-3; Redler RL, 2011, BIOCHEMISTRY-US, V50, P7057, DOI 10.1021/bi200614y; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Richardson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068256; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Roberts BR, 2014, J NEUROSCI, V34, P8021, DOI 10.1523/JNEUROSCI.4196-13.2014; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sabatelli M, 2013, CLIN GENET, V83, P408, DOI 10.1111/cge.12117; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Somalinga BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035818; Somalinga BR, 2011, J BIOMOL SCREEN, V16, P974, DOI 10.1177/1087057111418505; Soon CPW, 2011, J BIOL CHEM, V286, P44035, DOI 10.1074/jbc.M111.274407; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tortelli R, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.027; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Wang ZJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.08.024	84	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118649	10.1371/journal.pone.0118649	http://dx.doi.org/10.1371/journal.pone.0118649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798606	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300013
J	Mweresa, CK; Otieno, B; Omusula, P; Weldegergis, BT; Verhulst, NO; Dicke, M; van Loon, JJA; Takken, W; Mukabana, WR				Mweresa, Collins K.; Otieno, Bruno; Omusula, Philemon; Weldegergis, Berhane T.; Verhulst, Niels O.; Dicke, Marcel; van Loon, Joop J. A.; Takken, Willem; Mukabana, Wolfgang R.			Understanding the Long-Lasting Attraction of Malaria Mosquitoes to Odor Baits	PLOS ONE			English	Article							SENSU-STRICTO DIPTERA; ANOPHELES-GAMBIAE; HUMAN PATHOGEN; HUMAN SWEAT; IDENTIFICATION; VOLATILES; BEHAVIOR; TRAPS/TARGETS; CULICIDAE; RESPONSES	The use of odor baits for surveillance and control of malaria mosquitoes requires robust dispensing tools. In this study, the residual activity of a synthetic mosquito attractant blend dispensed from nylon or low density polyethylene (LDPE) sachets was evaluated at weekly intervals for one year without re-impregnation. The potential role of bacteria in modulating the attraction of mosquitoes to odor-treated nylon that had been used repeatedly over the one year study period, without re-impregnation, was also investigated. Significantly higher proportions of female Anopheles gambiae sensu stricto mosquitoes were consistently attracted to treated nylon strips than the other treatments, up to one year post-treatment. Additional volatile organic compounds and various bacterial populations were found on the treated nylon strips after one year of repeated use. The most abundant bacteria were Bacillus thuringiensis and Acinetobacter baumannii. Autoclaving of treated nylon strips prior to exposure had no effect on trap collections of laboratory-reared female An. Gambiae (P = 0.17) or wild female An. Gambiae sensu lato (P = 0.26) and Mansonia spp. (P = 0.17) mosquitoes. Trap catches of wild female An. Funestus (P < 0.001) and other anophelines (P < 0.007) were higher when treated strips had been autoclaved prior to deployment as opposed to when the treated nylon strips were not autoclaved. By contrast, wild female Culex mosquitoes were more strongly attracted to non-autoclaved compared to autoclaved treated nylon strips (P < 0.042). This study demonstrates the feasibility of using odor baits for sampling and surveillance of malaria as well as other mosquito vectors over prolonged periods of time. Preliminary evidence points towards the potential role of bacteria in sustaining prolonged use of nylon material for dispensing synthetic attractant odorants for host-seeking malaria and other mosquito vectors but further investigations are required.	[Mweresa, Collins K.; Otieno, Bruno; Omusula, Philemon; Mukabana, Wolfgang R.] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Mweresa, Collins K.; Weldegergis, Berhane T.; Verhulst, Niels O.; Dicke, Marcel; van Loon, Joop J. A.; Takken, Willem] Univ Wageningen & Res Ctr, Entomol Lab, Eh Wageningen, Netherlands; [Mukabana, Wolfgang R.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); Wageningen University & Research; University of Nairobi	Mweresa, CK (corresponding author), Int Ctr Insect Physiol & Ecol, POB 30772 GPO, Nairobi, Kenya.	collins.mweresa@yahoo.com	Verhulst, Niels/AAH-4288-2019; Dicke, Marcel/B-2300-2010; van Loon, Joop J.A./B-3744-2009	Dicke, Marcel/0000-0001-8565-8896; van Loon, Joop J.A./0000-0002-4260-0501; Verhulst, Niels/0000-0002-1106-9711; Weldegergis, Berhane T./0000-0001-8838-7876	Foundation of the National institutes of Health (FNIH) through the Grand Challenges in Global Health initiative (GCGH) [121]	Foundation of the National institutes of Health (FNIH) through the Grand Challenges in Global Health initiative (GCGH)	This work was supported by the Foundation of the National institutes of Health (FNIH) through the Grand Challenges in Global Health initiative (GCGH#121); URL - www.fnih.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748; CHANDLER JA, 1975, J MED ENTOMOL, V12, P504, DOI 10.1093/jmedent/12.5.504; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cork A, 2004, PHEROMONE MANUAL; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Drancourt M, 1997, INT J SYST BACTERIOL, V47, P160, DOI 10.1099/00207713-47-1-160; Gillies M. T., 1987, A supplement to the Anophelinae of Africa south of the Sahara (Afrotropical Region).; Greenwood Brian, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS2, DOI 10.1016/j.trstmh.2008.10.027; Imbahale SS, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-130; James A G, 2004, Int J Cosmet Sci, V26, P149, DOI 10.1111/j.1467-2494.2004.00214.x; James AG, 2004, WORLD J MICROB BIOT, V20, P787, DOI 10.1007/s11274-004-5843-8; Jawara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019676; Jawara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008167; Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2; Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2; Kline DL, 1998, J VECTOR ECOL, V23, P171; Logan J. G., 2008, Outlooks on Pest Management, V19, P280, DOI 10.1564/19dec14; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; LOUWS FJ, 1994, APPL ENVIRON MICROB, V60, P2286, DOI 10.1128/AEM.60.7.2286-2295.1994; Meijerink J, 2000, J CHEM ECOL, V26, P1367, DOI 10.1023/A:1005475422978; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Mihok S, 2007, MED VET ENTOMOL, V21, P70, DOI 10.1111/j.1365-2915.2007.00665.x; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Mukabana WR, 2012, PARASITE VECTOR, V50, P123; Okumu F, 2010, MED ENTOMOL, V47, P8; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; Pickett JA, 2010, J CHEM ECOL, V36, P113, DOI 10.1007/s10886-010-9739-9; Qiu YT, 2004, MED VET ENTOMOL, V18, P429, DOI 10.1111/j.0269-283X.2004.00534.x; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Smallegange RC, 2012, PHYSIOL ENTOMOL, V37, P60, DOI 10.1111/j.1365-3032.2011.00827.x; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smallegange RC, 2010, ECOL CONT VECTOR-BOR, V2, P143; SMITH T, 1995, J AM MOSQUITO CONTR, V11, P377; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Torr SJ, 1997, B ENTOMOL RES, V87, P299, DOI 10.1017/S0007485300037251; Verhulst NO, 2011, ENTOMOL EXP APPL, V139, P170, DOI 10.1111/j.1570-7458.2011.01119.x; Verhulst NO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-28; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Verhulst NO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-302; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wood AP, 2010, HDB HYDROCARBON LIPI, DOI [10.1007/978-3-540-77587-4_243, DOI 10.1007/978-3-540-77587-4_243]; World Health Organization, 1975, WHO MAN PRACT ENT 2	49	11	11	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121533	10.1371/journal.pone.0121533	http://dx.doi.org/10.1371/journal.pone.0121533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798818	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300264
J	Chen, YC; Tsai, PJ; Huang, YB; Wu, PC				Chen, Yi-Cheng; Tsai, Pi-Ju; Huang, Yaw-Bin; Wu, Pao-Chu			Optimization and Validation of High-Performance Chromatographic Condition for Simultaneous Determination of Adapalene and Benzoyl Peroxide by Response Surface Methodology	PLOS ONE			English	Article							MILD ACNE-VULGARIS; RANDOMIZED-TRIAL; TRETINOIN GEL; EFFICACY; SAFETY; TOLERABILITY; FORMULATION; HPLC; ACID	The aim of this study was to develop a simple and reliable high-performance chromatographic (HPLC) method for simultaneous analysis of adapalene and benzoyl peroxide in pharmaceutical formulation by response surface methodology (RSM). An optimized mobile phase composed of acetonitrile, tetrahydrofuran and water containing 0.1% acetic acid at a ratio of 25: 50: 25 by volume was successfully predicted by using RSM. An isocratic separation was achieved by using the condition. Furthermore, the analytical method was validated in terms of specificity, linearity, accuracy and precision in a range of 80% to 120% of the expected concentration. Finally, the method was successfully applied to the analysis of a commercial product.	[Chen, Yi-Cheng; Huang, Yaw-Bin; Wu, Pao-Chu] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Tsai, Pi-Ju] I Shou Univ, Dept Business Adm, Kaohsiung, Taiwan	Kaohsiung Medical University; I Shou University	Wu, PC (corresponding author), Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan.	pachwu@kmu.edu.tw		Huang, Yaw-Bin/0000-0002-6024-0108	National Science Council of Taiwan [NSC 93-2320-B-037-050]; Standard Chem & Pharm Co., LTD.	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Standard Chem & Pharm Co., LTD.	This work was supported by grant from the National Science Council of Taiwan (NSC 93-2320-B-037-050) and Standard Chem & Pharm Co., LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2008, J AOAC INT, V91, P1025; [Anonymous], 2011, US PHARM USP 34 NAT; Babaeinejad SH, 2013, J DRUGS DERMATOL, V12, P1033; Babaeinejad SH, 2013, J DRUGS DERMATOL, V12, P790; Berson Diane, 2013, J Clin Aesthet Dermatol, V6, P32; Convention TUSP, 2013, US PHARM USP 36 NAT; Cunliffe WJ, 1997, J AM ACAD DERMATOL, V36, pS126, DOI 10.1016/S0190-9622(97)70056-2; FDA Food and Drug Administration, FDA GUID IND BIOAN M; Fu Lisa W, 2011, Skin Therapy Lett, V16, P3; Ghodsi SZ, 2009, J INVEST DERMATOL, V129, P2136, DOI 10.1038/jid.2009.47; Goreshi R, 2012, J DRUGS DERMATOL, V11, P1422; ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: Q2(R1), 1994, ICH INT C HARM TECHN; Lewis GA., 1999, PHARM EXPT DESIGN; Leyden JJ, 2003, J AM ACAD DERMATOL, V49, pS200, DOI 10.1067/S0190-9622(03)01154-X; LEYDEN JJ, 1995, J AM ACAD DERMATOL, V32, pS15, DOI 10.1016/0190-9622(95)90416-6; Magin Parker, 2006, Can Fam Physician, V52, P978; Malzert-Freon A, 2010, J PHARM SCI-US, V99, P4603, DOI 10.1002/jps.22177; Martin B, 1998, BRIT J DERMATOL, V139, P8; Martins LA, 2011, J CHROMATOGR SCI, V49, P796, DOI 10.1093/chrsci/49.10.796; Mu GF, 2012, J SCI FOOD AGR, V92, P960, DOI 10.1002/jsfa.4677; Shalita A, 1996, J AM ACAD DERMATOL, V34, P482, DOI 10.1016/S0190-9622(96)90443-0; Strauss JS, 2007, J AM ACAD DERMATOL, V56, P651, DOI 10.1016/j.jaad.2006.08.048; Tan JP, 2009, WOR BANK WORK PAPER, P1; Thakur Naresh Kumar, 2012, Sci Pharm, V80, P1045, DOI 10.3797/scipharm.1206-09; Tsai PJ, 2013, THESCIENTIFICWORLDJO, V2013, DOI [10.1155/2013/856967, DOI 10.1155/2013/856967]	25	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120171	10.1371/journal.pone.0120171	http://dx.doi.org/10.1371/journal.pone.0120171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793581	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200152
J	Closson, EF; Mimiaga, MJ; Sherman, SG; Tangmunkongvorakul, A; Friedman, RK; Limbada, M; Moore, AT; Srithanaviboonchai, K; Alves, CA; Roberts, S; Oldenburg, CE; Elharrar, V; Mayer, KH; Safren, SA				Closson, Elizabeth F.; Mimiaga, Matthew J.; Sherman, Susan G.; Tangmunkongvorakul, Arunrat; Friedman, Ruth K.; Limbada, Mohammed; Moore, Ayana T.; Srithanaviboonchai, Kriengkrai; Alves, Carla A.; Roberts, Sarah; Oldenburg, Catherine E.; Elharrar, Vanessa; Mayer, Kenneth H.; Safren, Steven A.		HPTN063 Study Team	Intimacy versus Isolation: A Qualitative Study of Sexual Practices among Sexually Active HIV-Infected Patients in HIV Care in Brazil, Thailand, and Zambia	PLOS ONE			English	Article							POSITIVE MEN; ANTIRETROVIRAL THERAPY; TRANSMISSION RISK; PREVENTION; BEHAVIOR; WOMEN; PARTNERS; PEOPLE; DISCLOSURE; SEROSTATUS	The success of global treatment as prevention (TasP) efforts for individuals living with HIV/AIDS (PLWHA) is dependent on successful implementation, and therefore the appropriate contribution of social and behavioral science to these efforts. Understanding the psychosocial context of condomless sex among PLWHA could shed light on effective points of intervention. HPTN 063 was an observational mixed-methods study of sexually active, in-care PLWHA in Thailand, Zambia, and Brazil as a foundation for integrating secondary HIV prevention into HIV treatment. From 2010-2012, 80 qualitative interviews were conducted with PLWHA receiving HIV care and reported recent sexual risk. Thirty men who have sex with women (MSW) and 30 women who have sex with men (WSM) participated in equal numbers across the sites. Thailand and Brazil also enrolled 20 biologically-born men who have sex with men (MSM). Part of the interview focused on the impact of HIV on sexual practices and relationships. Interviews were recorded, transcribed, translated into English and examined using qualitative descriptive analysis. The mean age was 25 (SD = 3.2). There were numerous similarities in experiences and attitudes between MSM, MSW and WSM across the three settings. Participants had a high degree of HIV transmission risk awareness and practiced some protective sexual behaviors such as reduced sexual activity, increased use of condoms, and external ejaculation. Themes related to risk behavior can be categorized according to struggles for intimacy and fears of isolation, including: fear of infecting a sex partner, guilt about sex, sexual communication difficulty, HIV-stigma, and worry about sexual partnerships. Emphasizing sexual health, intimacy and protective practices as components of nonjudgmental sex-positive secondary HIV prevention interventions is recommended. For in-care PLWHA, this approach has the potential to support TasP. The overlap of themes across groups and countries indicates that similar intervention content may be effective for a range of settings.	[Closson, Elizabeth F.; Mimiaga, Matthew J.; Oldenburg, Catherine E.; Mayer, Kenneth H.; Safren, Steven A.] Fenway Hlth, Fenway Inst, Boston, MA 02215 USA; [Mimiaga, Matthew J.; Safren, Steven A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Mimiaga, Matthew J.; Oldenburg, Catherine E.; Mayer, Kenneth H.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sherman, Susan G.] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; [Tangmunkongvorakul, Arunrat; Srithanaviboonchai, Kriengkrai] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Friedman, Ruth K.; Alves, Carla A.] Fundacao Oswaldo Cruz Fiocruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Limbada, Mohammed; Roberts, Sarah] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Moore, Ayana T.] FHI360, Durham, NC USA; [Srithanaviboonchai, Kriengkrai] Chiang Mai Univ, Fac Med, Chiang Mai 50000, Thailand; [Elharrar, Vanessa] NIAID, Bethesda, MD 20892 USA; [Mayer, Kenneth H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Fenway Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Chiang Mai University; Fundacao Oswaldo Cruz; Chiang Mai University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mimiaga, MJ (corresponding author), Fenway Hlth, Fenway Inst, Boston, MA 02215 USA.	mmimiaga@mgh.harvard.edu	., ksrithan/AAO-2228-2020; Roberts, Sarah/AAG-2768-2020	., ksrithan/0000-0002-1683-4259; Roberts, Sarah/0000-0002-3318-9781; limbada, mohammed/0000-0002-3736-1462	Division of AIDS, National Institute of Allergy and Infectious Disease (NIAID); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH) of the U.S. National Institutes of Health (NIH), U.S. Department of Health and Human Services [UM1 AI068619, UM1 AI068617, UM1 AI068613]; NIAID [T32AI007535]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069412, UM1AI068619, T32AI007535, UM1AI068617, U01AI069412, UM1AI068613, UM1AI069476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH083620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Disease (NIAID); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH) of the U.S. National Institutes of Health (NIH), U.S. Department of Health and Human Services; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study HPTN 063 was funded by the Division of AIDS, National Institute of Allergy and Infectious Disease (NIAID); National Institute on Drug Abuse (NIDA); and the National Institute of Mental Health (NIMH) of the U.S. National Institutes of Health (NIH), U.S. Department of Health and Human Services, under Cooperative Agreements #UM1 AI068619, UM1 AI068617, and UM1 AI068613. CEO is supported by a NIAID T32 NRSA grant (T32AI007535; PI: Seage). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH) or The HIV Prevention Trials Network (HPTN).	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; Alvarez-Uria G., 2013, Interdisciplinary Perspectives on Infectious Diseases, V2013, P384805, DOI 10.1155/2013/384805; Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303013006008; Bravo P, 2010, AIDS REV, V12, P76; Brown Jennifer L, 2011, Curr HIV/AIDS Rep, V8, P269, DOI 10.1007/s11904-011-0092-6; Chaiyamahapurk Sakchai, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P278, DOI 10.1177/1545109710373831; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Clum G, 2009, AIDS CARE, V21, P1455, DOI 10.1080/09540120902883069; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cusick L., 2000, Culture, Health & Sexuality, V2, P473, DOI 10.1080/13691050050174468; De Rosa CJ, 1998, HEALTH PSYCHOL, V17, P224, DOI 10.1037/0278-6133.17.3.224; Doyal L, 2005, SOC SCI MED, V60, P1729, DOI 10.1016/j.socscimed.2004.08.041; Du P, 2015, J PUBLIC HEALTH MAN, V21, pE1, DOI 10.1097/PHH.0000000000000038; Edwards-Jackson N, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-38; El-Bassel N, 2010, JAIDS-J ACQ IMM DEF, V55, pS98, DOI 10.1097/QAI.0b013e3181fbf407; Erickson E., 1950, CHILDHOOD SOC; Flowers P, 2006, PSYCHOL HEALTH, V21, P109, DOI 10.1080/14768320500286286; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Goggin K, 1998, PSYCHOSOM MED, V60, P11, DOI 10.1097/00006842-199801000-00003; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Gorbach PM, 2006, JAIDS-J ACQ IMM DEF, V42, P80, DOI 10.1097/01.qai.0000196665.78497.f1; Guimaraes MDC, 2008, AIDS BEHAV, V12, P741, DOI 10.1007/s10461-008-9407-z; Harzke AJ, 2004, AIDS CARE, V16, P458, DOI 10.1080/09540120410001683394; Horton KL, 2013, ADV NURS SCI, V36, P42, DOI 10.1097/ANS.0b013e3182807813; Joint United Nations Programme on HIV/AIDS, 2013, UNAIDS REP GLOB AIDS; Jones DL, 2005, J URBAN HEALTH, V82, pIV92, DOI 10.1093/jurban/jti111; Kalichman SC, 2000, CLIN PSYCHOL-SCI PR, V7, P32, DOI 10.1093/clipsy/7.1.32; Kalichman SC, 2013, HIV TREATMENT PREVEN; Kerrigan D, 2006, SOC SCI MED, V62, P2386, DOI 10.1016/j.socscimed.2005.10.037; Kirshenbaum SB, 2004, PERSPECT SEX REPRO H, V36, P106, DOI 10.1111/j.1931-2393.2004.tb00198.x; Marks G, 1999, AIDS, V13, P297, DOI [10.1097/00002030-199902250-00001, 10.1080/088395199117432]; O'Cleirigh C, 2013, AIDS BEHAV, V17, P1764, DOI 10.1007/s10461-013-0462-8; Pence BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082974; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; Redd AD, 2013, LANCET INFECT DIS, V13, P622, DOI 10.1016/S1473-3099(13)70066-5; Reynolds HW, 2013, AIDS CARE, V25, P592, DOI 10.1080/09540121.2012.726340; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Siedner MJ, 2014, AIDS, V28, P267, DOI 10.1097/QAD.0000000000000136; Siegel K, 2006, ARCH SEX BEHAV, V35, P437, DOI 10.1007/s10508-006-9043-5; Silverman D., 2013, DOING QUALITATIVE RE; Tunthanathip P, 2009, SEX TRANSM INFECT, V85, P36, DOI 10.1136/sti.2008.032532; Vamos S, 2013, AIDS CARE, V25, P1102, DOI 10.1080/09540121.2012.749339; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS12, DOI 10.1097/QAI.0b013e31829202a2	43	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120957	10.1371/journal.pone.0120957	http://dx.doi.org/10.1371/journal.pone.0120957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25793283	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900093
J	Fumel, B; Froment, P; Holzenberger, M; Livera, G; Monget, P; Fouchecourt, S				Fumel, Betty; Froment, Pascal; Holzenberger, Martin; Livera, Gabriel; Monget, Philippe; Fouchecourt, Sophie			Expression of Dominant-Negative Thyroid Hormone Receptor Alpha1 in Leydig and Sertoli Cells Demonstrates No Additional Defect Compared with Expression in Sertoli Cells Only	PLOS ONE			English	Article							NEONATAL-HYPOTHYROIDISM; SPERM PRODUCTION; ADULT TESTIS; RAT TESTIS; IN-VITRO; IGF-I; MICE; AROMATASE; STEROIDOGENESIS; INCREASE	Background In the testis, thyroid hormone (T3) regulates the number of gametes produced through its action on Sertoli cell proliferation. However, the role of T3 in the regulation of steroidogenesis is still controversial. Methods The TR alpha(AMI) knock-in allele allows the generation of transgenic mice expressing a dominant- negative TR alpha 1 (thyroid receptor alpha 1) isoform restricted to specific target cells after Cre-loxP recombination. Here, we introduced this mutant allele in both Sertoli and Leydig cells using a novel aromatase-iCre (ARO-iCre) line that expresses Cre recombinase under control of the human Cyp19(IIa)/aromatase promoter. Findings We showed that loxP recombination induced by this ARO-iCre isrestricted to male and female gonads, and is effective in Sertoli and Leydig cells, but not in germ cells. We compared this model with the previous introduction of TRaAMI specifically in Sertoli cells in order to investigate T3 regulation of steroidogenesis. We demonstrated that TR alpha(AMI)-ARO males exhibited increased testis weight, increased sperm reserve in adulthood correlated to an increased proliferative index at P3 in vivo, and a loss of T3-response in vitro. Nevertheless, TR alpha(AMI)-ARO males showed normal fertility. This phenotype is similar to TR alpha(AMI)-SC males. Importantly, plasma testosterone and luteinizing hormone levels, as well as mRNA levels of steroidogenesis enzymes StAR, Cyp11a1 and Cyp17a1 were not affected in TR alpha(AMI)-ARO. Conclusions/Significance We concluded that the presence of a mutant TR alpha(AMI) allele in both Leydig and Sertoli cells does not accentuate the phenotype in comparison with its presence in Sertoli cells only. This suggests that direct T3 regulation of steroidogenesis through TR alpha 1 is moderate in Leydig cells, and that Sertoli cells are the main target of T3 action in the testis.	[Fumel, Betty; Froment, Pascal; Monget, Philippe; Fouchecourt, Sophie] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Fumel, Betty; Froment, Pascal; Monget, Philippe; Fouchecourt, Sophie] CNRS, Physiol Reprod & Comportements UMR7247, F-37380 Nouzilly, France; [Fumel, Betty; Froment, Pascal; Monget, Philippe; Fouchecourt, Sophie] Univ Tours, F-37041 Tours, France; [Fumel, Betty; Froment, Pascal; Monget, Philippe; Fouchecourt, Sophie] IFCE, F-37380 Nouzilly, France; [Holzenberger, Martin] INSERM, F-75012 Paris, France; [Holzenberger, Martin] UPMC, Univ Paris 04, UMRS 938, Hop St Antoine, F-75012 Paris, France; [Livera, Gabriel] Univ Paris 11, Univ Paris Diderot, Sorbonne Paris Cite, Lab Dev Gonades,INSERM U967,CEA DSV iRCM SCSR LDG, F-92265 Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Fouchecourt, S (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	sophie.fouchecourt@tours.inra.fr	Holzenberger, Martin/N-9732-2018; LIVERA, Gabriel/F-5740-2019	LIVERA, Gabriel/0000-0001-8436-4730; Holzenberger, Martin/0000-0003-4869-725X; Fouchecourt, Sophie/0000-0001-6923-6220; Froment, Pascal/0000-0002-7388-9598	TimeOfLife2, Agence Nationale pour la Recherche; Region Centre, France; Institut National Recherche Agronomique; Institut National de la Sante et de la Recherche Medicale; Universite Paris Diderot, Sorbonne Paris Cite	TimeOfLife2, Agence Nationale pour la Recherche(French National Research Agency (ANR)); Region Centre, France(Region Centre-Val de Loire); Institut National Recherche Agronomique; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Diderot, Sorbonne Paris Cite	This work was supported by grant: TimeOfLife2, Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr)-SF; Region Centre, France-BF (fellowship); Institut National Recherche Agronomique-PF, PM, SF; Institut National de la Sante et de la Recherche Medicale-MH GL; Universite Paris Diderot, Sorbonne Paris Cite-GL.	ANTONY FF, 1995, J ENDOCRINOL, V144, P293, DOI 10.1677/joe.0.1440293; Ariyaratne HBS, 2000, BIOL REPROD, V63, P1115, DOI 10.1095/biolreprod63.4.1115; Ariyaratne HBS, 2000, BIOL REPROD, V62, P680, DOI 10.1095/biolreprod62.3.680; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; Cadoret A, 2005, INT J CANCER, V114, P668, DOI 10.1002/ijc.20805; Chatonnet F, 2014, MOL REPROD DEV, V81, P1159, DOI 10.1002/mrd.22437; Choksi NY, 2003, BIRTH DEFECTS RES B, V68, P479, DOI 10.1002/bdrb.10045; COOKE PS, 1991, ANN NY ACAD SCI, V637, P122, DOI 10.1111/j.1749-6632.1991.tb27305.x; COOKE PS, 1991, ENDOCRINOLOGY, V129, P237, DOI 10.1210/endo-129-1-237; Donnelly P, 2000, CLIN ENDOCRINOL, V52, P197, DOI 10.1046/j.1365-2265.2000.00918.x; Fauquier T, 2011, DEV BIOL, V356, P350, DOI 10.1016/j.ydbio.2011.05.657; Fumel B, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098418; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; HARDY MP, 1993, ENDOCRINOLOGY, V132, P2417, DOI 10.1210/en.132.6.2417; Hinshelwood MM, 2000, ENDOCRINOLOGY, V141, P2050, DOI 10.1210/en.141.6.2050; Holsberger DR, 2005, CELL TISSUE RES, V322, P133, DOI 10.1007/s00441-005-1082-z; Holsberger DR, 2005, BIOL REPROD, V73, P396, DOI 10.1095/biolreprod.105.041426; Holzenberger M, 2000, ENDOCRINOLOGY, V141, P2557, DOI 10.1210/en.141.7.2557; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; JANNINI EA, 1995, ENDOCR REV, V16, P443, DOI 10.1210/er.16.4.443; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; JOYCE KL, 1993, J ANDROL, V14, P448; KIRBY JD, 1992, ENDOCRINOLOGY, V131, P559, DOI 10.1210/en.131.2.559; Kumar A, 2007, ANDROLOGIA, V39, P253, DOI 10.1111/j.1439-0272.2007.00798.x; Kumar Anand, 2014, Indian J Endocrinol Metab, V18, P23, DOI 10.4103/2230-8210.126523; Leneuve P, 2001, BIOTECHNIQUES, V31, P1156, DOI 10.2144/01315rr05; Levallet J, 1998, BIOL REPROD, V58, P919, DOI 10.1095/biolreprod58.4.919; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; Manna PR, 1999, J BIOL CHEM, V274, P5909, DOI 10.1074/jbc.274.9.5909; Maran RRM, 2000, ENDOCR RES, V26, P411, DOI 10.3109/07435800009066177; Maran RRM, 2003, ARCH ANDROLOGY, V49, P375, DOI 10.1080/01485010390204968; Maran RRM, 2001, ENDOCR RES, V27, P119, DOI 10.1081/ERC-100107175; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; Mendis-Handagama SMLC, 2004, HISTOL HISTOPATHOL, V19, P985, DOI 10.14670/HH-19.985; O'Hara L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084541; PALMERO S, 1995, J ENDOCRINOL, V145, P355, DOI 10.1677/joe.0.1450355; PALMERO S, 1990, MOL CELL ENDOCRINOL, V68, P61, DOI 10.1016/0303-7207(90)90170-D; PAPADOPOULOS V, 1986, J STEROID BIOCHEM, V24, P1211, DOI 10.1016/0022-4731(86)90385-7; Picou F, 2014, MOL ENDOCRINOL, V28, P429, DOI 10.1210/me.2013-1414; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TAGAMI T, 1990, ENDOCRINOLOGY, V127, P1727, DOI 10.1210/endo-127-4-1727; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; TSAIMORRIS CH, 1985, ENDOCRINOLOGY, V116, P38, DOI 10.1210/endo-116-1-38; Valenti S, 1997, INT J ANDROL, V20, P279, DOI 10.1046/j.1365-2605.1997.00071.x; Vandormael-Pournin S, 2015, CELL DEATH DIFFER, V22, P108, DOI 10.1038/cdd.2014.122; VANHAASTER LH, 1993, ENDOCRINOLOGY, V133, P755, DOI 10.1210/en.133.2.755; Velazquez EM, 1997, ARCH ANDROLOGY, V38, P85, DOI 10.3109/01485019708988535; Wagner MS, 2008, J ENDOCRINOL, V199, P351, DOI 10.1677/JOE-08-0218; Wu XF, 2007, J CELL PHYSIOL, V213, P429, DOI 10.1002/jcp.21231; Wu XF, 2012, ENDOCRINOLOGY, V153, P4929, DOI 10.1210/en.2012-1168; Wu XF, 2010, REPRODUCTION, V140, P113, DOI 10.1530/REP-09-0349; Xu QQ, 2007, ENDOCRINE, V32, P96, DOI 10.1007/s12020-007-9015-0	56	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119392	10.1371/journal.pone.0119392	http://dx.doi.org/10.1371/journal.pone.0119392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793522	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200079
J	Laudy, AE; Osinska, P; Namyslowska, A; Zajac, O; Tyski, S				Laudy, Agnieszka E.; Osinska, Paula; Namyslowska, Alicja; Zajac, Olga; Tyski, Stefan			Modification of the Susceptibility of Gram-Negative Rods Producing ES beta LS to beta-Lactams by the Efflux Phenomenon	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA PAO1; ANTIBIOTIC-RESISTANCE; KLEBSIELLA-PNEUMONIAE; PUMPS; ENTEROBACTERIACEAE; IDENTIFICATION; INHIBITORS; STRAINS; REGULON; OPRM	The production of beta-lactamases is the most important mechanism of Gram-negative rod resistance to beta-lactams. Resistance to ceftazidime and cefepime in clinical isolates of Enterobacteriaceae (especially ES beta L-positive E. coli and K. pneumoniae) and P. aeruginosa is life-threatening. However, all strains of the above mentioned species possess chromosomally encoded RND efflux pump systems in addition to beta-lactamase production. The main goal of this study was to assess the role of efflux pump systems in cefepime and/or ceftazidime resistant phenotypes of ES beta L-positive clinical strains of Enterobacteriaceae and P. aeruginosa. The influence of the efflux pump inhibitor PA beta N on the minimum inhibitory concentration (MIC) values of tested cephalosporins was species-dependent. Generally, a significant reduction (at least four-fold) of beta-lactam MICs was observed in the presence of PA beta N only in the case of P. aeruginosa clinical isolates as well as the ES beta L-producing transformant PAO1161 Delta ampC. The usage of this agent resulted in the restoration of susceptibility to cefepime and/or ceftazidime in the majority of the P. aeruginosa ES beta L-positive strains with low and moderate resistance to the above cephalosporins. Moreover, an outer membrane permeabilizing effect in the presence of PA beta N was identified. Strain-dependent beta-lactamase leakage upon PA beta N or beta-lactam treatment was demonstrated. The most important observation was the restoration of susceptibility of P. aeruginosa WUM226 to cefepime (MIC decrease from 32 to 4 mg/L) and ceftazidime (MIC decrease from 128 to 4 mg/L) in the presence of PA beta N, which occurred despite an almost complete lack of beta-lactamase leakage from bacterial cells. In conclusion, these data indicate that RND efflux pumps can modify the susceptibility to beta-lactams in Gram-negative rods producing ES beta Ls. However, this phenomenon occurs only in P. aeruginosa strains and was not observed among E. coli and K. pneumoniae strains, representing the Enterobacteriaceae family.	[Laudy, Agnieszka E.; Osinska, Paula; Namyslowska, Alicja; Zajac, Olga; Tyski, Stefan] Med Univ Warsaw, Dept Pharmaceut Microbiol, Warsaw, Poland; [Tyski, Stefan] Natl Med Inst, Dept Antibiot & Microbiol, Warsaw, Poland	Medical University of Warsaw; National Medicines Institute Lekow (NIL)	Laudy, AE (corresponding author), Med Univ Warsaw, Dept Pharmaceut Microbiol, Warsaw, Poland.	alaudy@wp.pl	Tyski, Stefan/W-5271-2018; Laudy, Agnieszka/M-4930-2018; Laudy, Agnieszka/AAC-1000-2022	Tyski, Stefan/0000-0003-3352-038X; Laudy, Agnieszka/0000-0002-5989-4462; Zajac, Olga/0000-0001-6137-0978	Medical University of Warsaw	Medical University of Warsaw	The authors received funding for this work from Medical University of Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Bialek-Davenet S, 2011, ANTIMICROB AGENTS CH, V55, P2795, DOI 10.1128/AAC.00156-11; Cabot G, 2011, ANTIMICROB AGENTS CH, V55, P1906, DOI 10.1128/AAC.01645-10; Clinical and Laboratory Standards Institute, 2012, M7A9 CLIN LAB STAND, V11th; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Drieux L, 2008, CLIN MICROBIOL INFEC, V14, P90, DOI 10.1111/j.1469-0691.2007.01846.x; Hocquet D, 2006, ANTIMICROB AGENTS CH, V50, P1347, DOI 10.1128/AAC.50.4.1347-1351.2006; Irani VR, 1997, BIOTECHNIQUES, V22, P54, DOI 10.2144/97221bm09; Kargar M, 2014, INDIAN J PATHOL MICR, V57, P244, DOI 10.4103/0377-4929.134688; Kim YJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-161; Kong KF, 2005, ANTIMICROB AGENTS CH, V49, P4567, DOI 10.1128/AAC.49.11.4567-4575.2005; Lamers RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060666; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018547; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Picao RC, 2009, ANTIMICROB AGENTS CH, V53, P2225, DOI 10.1128/AAC.01602-08; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poole K, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P349, DOI 10.1007/978-1-4614-1400-1_10; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Qing Y, 2014, J MED MICROBIOL, V63, P386, DOI 10.1099/jmm.0.069427-0; Renau TE, 1999, J MED CHEM, V42, P4928, DOI 10.1021/jm9904598; Rodriguez-Martinez JM, 2009, ANTIMICROB AGENTS CH, V53, P4783, DOI 10.1128/AAC.00574-09; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Srinivasan VB, 2013, ANTIMICROB AGENTS CH, V57, P4449, DOI 10.1128/AAC.02284-12; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Vatcheva-Dobrevska R, 2013, MICROB DRUG RESIST, V19, P355, DOI 10.1089/mdr.2013.0004; Viedma E, 2009, ANTIMICROB AGENTS CH, V53, P4930, DOI 10.1128/AAC.00900-09; Weldhagen GF, 2003, ANTIMICROB AGENTS CH, V47, P2385, DOI 10.1128/AAC.47.8.2385-2392.2003; Yasufuku T, 2011, J CLIN MICROBIOL, V49, P189, DOI 10.1128/JCM.00827-10	33	15	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119997	10.1371/journal.pone.0119997	http://dx.doi.org/10.1371/journal.pone.0119997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793625	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200134
J	Leander, M; Bass, C; Marchetti, K; Maynard, BF; Wulff, JP; Ons, S; Nichols, R				Leander, Megan; Bass, Chloe; Marchetti, Kathryn; Maynard, Benjamin F.; Wulff, Juan Pedro; Ons, Sheila; Nichols, Ruthann			Cardiac Contractility Structure-Activity Relationship and Ligand-Receptor Interactions; the Discovery Of Unique and Novel Molecular Switches in Myosuppressin Signaling	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; RHODNIUS-PROLIXUS; CHAGAS-DISEASE; ACTIVATION; NEUROPEPTIDE; RHODOPSIN; MODELS; ANTAGONIST; PEPTIDES; ACCURACY	Peptidergic signaling regulates cardiac contractility; thus, identifying molecular switches, ligand-receptor contacts, and antagonists aids in exploring the underlying mechanisms to influence health. Myosuppressin (MS), a decapeptide, diminishes cardiac contractility and gut motility. Myosuppressin binds to G protein-coupled receptor (GPCR) proteins. Two Drosophila melanogaster myosuppressin receptors (DrmMS-Rs) exist; however, no mechanism underlying MS-R activation is reported. We predicted DrmMS-Rs contained molecular switches that resembled those of Rhodopsin. Additionally, we believed DrmMS-DrmMS-R1 and DrmMS-DrmMS-R2 interactions would reflect our structure-activity relationship (SAR) data. We hypothesized agonist-and antagonist-receptor contacts would differ from one another depending on activity. Lastly, we expected our study to apply to other species; we tested this hypothesis in Rhodnius prolixus, the Chagas disease vector. Searching DrmMS-Rs for molecular switches led to the discovery of a unique ionic lock and a novel 3-6 lock, as well as transmission and tyrosine toggle switches. The DrmMS-DrmMS-R1 and DrmMS-DrmMS-R2 contacts suggested tissue-specific signaling existed, which was in line with our SAR data. We identified R. prolixus (Rhp) MS-R and discovered it, too, contained the unique myosuppressin ionic lock and novel 3-6 lock found in DrmMS-Rs as well as transmission and tyrosine toggle switches. Further, these motifs were present in red flour beetle, common water flea, honey bee, domestic silkworm, and termite MS-Rs. RhpMS and DrmMS decreased R. prolixus cardiac contractility dose dependently with EC50 values of 140 nM and 50 nM. Based on ligand-receptor contacts, we designed RhpMS analogs believed to be an active core and antagonist; testing on heart confirmed these predictions. The active core docking mimicked RhpMS, however, the antagonist did not. Together, these data were consistent with the unique ionic lock, novel 3-6 lock, transmission switch, and tyrosine toggle switch being involved in mechanisms underlying TM movement and MS-R activation, and the ability of MS agonists and antagonists to influence physiology.	[Leander, Megan; Marchetti, Kathryn; Maynard, Benjamin F.; Nichols, Ruthann] Univ Michigan, Dept Chem, Undergrad Biochem Program, Ann Arbor, MI 48109 USA; [Leander, Megan; Bass, Chloe; Marchetti, Kathryn; Maynard, Benjamin F.; Nichols, Ruthann] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Bass, Chloe] Univ Michigan, Dept Chem, Undergrad Chem Program, Ann Arbor, MI 48109 USA; [Wulff, Juan Pedro; Ons, Sheila] Univ Nacl La Plata, Fac Ciencias Exactas, Lab Genet & Genom Func, Ctr Reg Estudios Genom, RA-1459 Buenos Aires, DF, Argentina	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National University of La Plata	Nichols, R (corresponding author), Univ Michigan, Dept Chem, Undergrad Biochem Program, Ann Arbor, MI 48109 USA.	nicholsr@umich.edu	Ons, Sheila/ABI-2195-2020		NIH [R21HL093627]; University of Michigan Medical Innovation Center; University of Michigan Cardiovascular Center Innovative Grant; Albert Euclid Hinsdale Award; Seyhan N. Ege-WISE Award; Honors Summer Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Medical Innovation Center; University of Michigan Cardiovascular Center Innovative Grant; Albert Euclid Hinsdale Award; Seyhan N. Ege-WISE Award; Honors Summer Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a NIH grant R21HL093627, Concept to Commercialization Funding from the University of Michigan Medical Innovation Center, and a University of Michigan Cardiovascular Center Innovative Grant to Ruthann Nichols. Megan Leander received an Albert Euclid Hinsdale Award, Chloe Bass received the Seyhan N. Ege-WISE Award, Kathryn Marchetti received an Honors Summer Fellowship, and Ben Maynard received an Albert Euclid Hinsdale Award to support their research in the Nichols' lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bass C, 2014, PEPTIDES, V53, P278, DOI 10.1016/j.peptides.2013.06.009; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Dickerson M, 2012, PEPTIDES, V36, P272, DOI 10.1016/j.peptides.2012.05.002; Egerod K, 2003, P NATL ACAD SCI USA, V100, P9808, DOI 10.1073/pnas.1632197100; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P329, DOI 10.1016/0742-8413(86)90202-1; Jaakola V-P, 2008, SCIENCE, V330, P1091; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; Lee D, 2012, J EXP BIOL, V215, P2088, DOI 10.1242/jeb.067447; Maynard BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075502; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; NICHOLS R, 1992, J MOL NEUROSCI, V3, P213, DOI 10.1007/BF03380141; Nichols R, 2003, ANNU REV ENTOMOL, V48, P485, DOI 10.1146/annurev.ento.48.091801.112525; Ons S, 2011, INSECT MOL BIOL, V20, P29, DOI 10.1111/j.1365-2583.2010.01050.x; Ons S, 2009, PROTEOMICS, V9, P788, DOI 10.1002/pmic.200800499; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; ROBB S, 1994, J EXP BIOL, V197, P437; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024	30	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120492	10.1371/journal.pone.0120492	http://dx.doi.org/10.1371/journal.pone.0120492			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793503	Green Published, gold			2022-12-26	WOS:000352083900041
J	Moenninghoff, C; Kraff, O; Maderwald, S; Umutlu, L; Theysohn, JM; Ringelstein, A; Wrede, KH; Deuschl, C; Altmeppen, J; Ladd, ME; Forsting, M; Quick, HH; Schlamann, M				Moenninghoff, Christoph; Kraff, Oliver; Maderwald, Stefan; Umutlu, Lale; Theysohn, Jens M.; Ringelstein, Adrian; Wrede, Karsten H.; Deuschl, Cornelius; Altmeppen, Jan; Ladd, Mark E.; Forsting, Michael; Quick, Harald H.; Schlamann, Marc			Diffuse Axonal Injury at Ultra-High Field MRI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; CEREBRAL MICROBLEEDS; INTRACEREBRAL HEMORRHAGE; WHITE-MATTER; PROGNOSTIC VALUE; 1.5 TESLA; 7 T; LESIONS; DEMENTIA	Objective Diffuse axonal injury (DAI) is a specific type of traumatic brain injury caused by shearing forces leading to widespread tearing of axons and small vessels. Traumatic microbleeds (TMBs) are regarded as a radiological marker for DAI. This study aims to compare DAIassociated TMBs at 3 Tesla (T) and 7 T susceptibility weighted imaging (SWI) to evaluate possible diagnostic benefits of ultra-high field (UHF) MRI. Material and Methods 10 study participants (4 male, 6 female, age range 20-74 years) with known DAI were included. All MR exams were performed with a 3 T MR system (Magnetom Skyra) and a 7 T MR research system (Magnetom 7 T, Siemens AG, Healthcare Sector, Erlangen, Germany) each in combination with a 32-channel-receive coil. The average time interval between trauma and imaging was 22 months. Location and count of TMBs were independently evaluated by two neuroradiologists on 3 T and 7 T SWI images with similar and additionally increased spatial resolution at 7 T. Inter-and intraobserver reliability was assessed using the interclass correlation coefficient (ICC). Count and diameter of TMB were evaluated with Wilcoxon signed rank test. Results Susceptibility weighted imaging revealed a total of 485 TMBs (range 1-190, median 25) at 3 T, 584 TMBs (plus 20%, range 1-262, median 30.5) at 7 T with similar spatial resolution, and 684 TMBs (plus 41%, range 1-288, median 39.5) at 7 T with 10-times higher spatial resolution. Hemorrhagic DAI appeared significantly larger at 7 T compared to 3 T (p = 0.005). Inter-and intraobserver correlation regarding the counted TMB was high and almost equal 3 T and 7 T. Conclusion 7 T SWI improves the depiction of small hemorrhagic DAI compared to 3 T and may be supplementary to lower field strengths for diagnostic in inconclusive or medicolegal cases.	[Moenninghoff, Christoph; Kraff, Oliver; Maderwald, Stefan; Umutlu, Lale; Theysohn, Jens M.; Ringelstein, Adrian; Deuschl, Cornelius; Altmeppen, Jan; Forsting, Michael; Schlamann, Marc] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Moenninghoff, Christoph; Kraff, Oliver; Maderwald, Stefan; Umutlu, Lale; Theysohn, Jens M.; Wrede, Karsten H.; Deuschl, Cornelius; Ladd, Mark E.; Forsting, Michael; Quick, Harald H.; Schlamann, Marc] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Wrede, Karsten H.] Univ Hosp Essen, Dept Neurosurg, Essen, Germany; [Ladd, Mark E.] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany; [Quick, Harald H.] Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany; [Schlamann, Marc] Univ Hosp Giessen, Inst Neuroradiol, Giessen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University Hospital of Giessen & Marburg	Moenninghoff, C (corresponding author), Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	christoph.moenninghoff@uk-essen.de	Wrede, Karsten/AAZ-2154-2020; Kraff, Oliver/AAE-2238-2020; Maderwald, Stefan/B-4241-2011	Wrede, Karsten/0000-0001-7076-3503; Kraff, Oliver/0000-0002-6006-8934; Ladd, Mark/0000-0002-4128-9440				ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akter M, 2007, ACAD RADIOL, V14, P1011, DOI 10.1016/j.acra.2007.05.013; Allkemper T, 2004, EUR RADIOL, V14, P1000, DOI 10.1007/s00330-004-2241-4; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Conijn MMA, 2011, AM J NEURORADIOL, V32, P1043, DOI 10.3174/ajnr.A2450; Deistung A, 2006, Z MED PHYS, V16, P261, DOI 10.1078/0939-3889-00324; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hilal S, 2014, ALZ DIS ASSOC DIS, V28, P106, DOI 10.1097/WAD.0000000000000015; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Lupo JM, 2012, INT J RADIAT ONCOL, V82, pE493, DOI 10.1016/j.ijrobp.2011.05.046; Lupo Janine M, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P747; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MONACO EA, 2013, NEUROSURGERY, V72, DOI DOI 10.1227/01.NEU; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Reichenbach JR, 1997, JMRI-J MAGN RESON IM, V7, P266, DOI 10.1002/jmri.1880070203; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Schilling S, 2013, NEUROLOGY, V81, P292, DOI 10.1212/WNL.0b013e31829bfda4; Schlamann M, 2010, ACAD RADIOL, V17, P3, DOI 10.1016/j.acra.2009.10.001; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Soria G, 2011, ANAT REC, V294, P1035, DOI 10.1002/ar.21383; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Tatsumi S, 2008, AJNR Am J Neuroradiol, V29, pe13, DOI 10.3174/ajnr.A0908; Theysohn JM, 2011, J MAGN RESON IMAGING, V33, P782, DOI 10.1002/jmri.22513; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Vernooij MW, 2009, ARCH NEUROL-CHICAGO, V66, P714, DOI 10.1001/archneurol.2009.42; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; Wargo CJ, 2013, MAGN RESON IMAGING, V31, P810, DOI 10.1016/j.mri.2013.01.013; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107	47	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122329	10.1371/journal.pone.0122329	http://dx.doi.org/10.1371/journal.pone.0122329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793614	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900177
J	Nachtigall, PG; Dias, MC; Carvalho, RF; Martins, C; Pinhal, D				Nachtigall, Pedro G.; Dias, Marcos C.; Carvalho, Robson F.; Martins, Cesar; Pinhal, Danillo			MicroRNA-499 Expression Distinctively Correlates to Target Genes sox6 and rod1 Profiles to Resolve the Skeletal Muscle Phenotype in Nile Tilapia	PLOS ONE			English	Article							INTRONIC MICRORNA; FIBER TYPES; DIFFERENTIATION; CELL; EVOLUTION; IDENTIFICATION; ROBUSTNESS; REPRESSION; ROLES; WHITE	A class of small non-coding RNAs, the microRNAs (miRNAs), has been shown to be essential for the regulation of specific cell pathways, including skeletal muscle development, maintenance and homeostasis in vertebrates. However, the relative contribution of miRNAs for determining the red and white muscle cell phenotypes is far from being fully comprehended. To better characterize the role of miRNA in skeletal muscle cell biology, we investigated muscle-specific miRNA (myomiR) signatures in Nile tilapia fish. Quantitative (RT-PCR) and spatial (FISH) expression analyses revealed a highly differential expression (forty-four-fold) of miR-499 in red skeletal muscle compared to white skeletal muscle, whereas the remaining known myomiRs were equally expressed in both muscle cell types. Detailed examination of the miR-499 targets through bioinformatics led us to the sox6 and rod1 genes, which had low expression in red muscle cells according to RT-qPCR, FISH, and protein immunofluorescence profiling experiments. Interestingly, we verified that the high expression of miR-499 perfectly correlates with a low expression of sox6 and rod1 target genes, as verified by a distinctive predominance of mRNA destabilization and protein translational decay to these genes, respectively. Through a genome-wide comparative analysis of SOX6 and ROD1 protein domains and through an in silico gene regulatory network, we also demonstrate that both proteins are essentially similar in vertebrate genomes, suggesting their gene regulatory network may also be widely conserved. Overall, our data shed light on the potential regulation of targets by miR-499 associated with the slow-twitch muscle fiber type phenotype. Additionally the results provide novel insights into the evolutionary dynamics of miRNA and target genes enrolled in a putative constrained molecular pathway in the skeletal muscle cells of vertebrates.	[Nachtigall, Pedro G.; Pinhal, Danillo] Sao Paulo State Univ UNESP, Inst Biosci, Dept Genet, BR-18618970 Sao Paulo, Brazil; [Dias, Marcos C.; Carvalho, Robson F.; Martins, Cesar] Sao Paulo State Univ UNESP, Inst Biosci, Dept Morphol, BR-18618970 Sao Paulo, Brazil; [Dias, Marcos C.] Fed Univ Mato Grosso UFMT, Hlth Sci Inst, BR-78550000 Sinop, Mato Grosso, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul	Pinhal, D (corresponding author), Sao Paulo State Univ UNESP, Inst Biosci, Dept Genet, BR-18618970 Sao Paulo, Brazil.	dlpinhal@ibb.unesp.br	Pinhal, Danillo/C-5983-2012; Carvalho, Robson Francisco/AAE-4134-2020; Carvalho, Robson Francisco/E-1161-2012; Martins, Cesar/A-2594-2008; Nachtigall, Pedro Gabriel/M-5424-2017	Pinhal, Danillo/0000-0003-1075-0182; Carvalho, Robson Francisco/0000-0002-4901-7714; Carvalho, Robson Francisco/0000-0002-4901-7714; Martins, Cesar/0000-0003-3534-974X; Nachtigall, Pedro Gabriel/0000-0002-3196-0173; Correa Dias, Marcos/0000-0003-3342-3395	Sao Paulo Research Foundation (FAPESP) [2011/06465-0, 2012/15589-7]; CAPES; FAPESP [2013/06864-7]; CNPq	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the Sao Paulo Research Foundation (FAPESP) grants to CM (2011/06465-0) and DP (2012/15589-7). PGN received master's scholarship from CAPES, and a PhD scholarship from FAPESP (2013/06864-7). MCD was supported by post-doctoral fellowships from CNPq and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CI, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-59; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bhuiyan SS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-142; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chu WY, 2013, CURR MOL MED, V13, P1397, DOI 10.2174/15665240113139990059; Cohen-Barak O, 2003, NUCLEIC ACIDS RES, V31, P5941, DOI 10.1093/nar/gkg807; DRIEDZIC WR, 1976, AM J PHYSIOL, V230, P579, DOI 10.1152/ajplegacy.1976.230.3.579; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Gagan J, 2012, CUR OP IN PHAR, V12, P1; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hagiwara N, 2007, DEV DYNAM, V236, P2062, DOI 10.1002/dvdy.21223; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Ketley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065170; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; McCarthy JJ, 2011, EXERC SPORT SCI REV, V39, P150, DOI 10.1097/JES.0b013e31821c01e1; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Nakajima RT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-198; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pase L, 2011, METHOD CELL BIOL, V104, P353, DOI 10.1016/B978-0-12-374814-0.00020-3; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sadvakassova G, 2009, J CELL PHYSIOL, V220, P672, DOI 10.1002/jcp.21817; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stadler M, 2012, GENOME RES, V22, P2418, DOI 10.1101/gr.136515.111; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tani S, 2013, EVOL DEV, V15, P293, DOI 10.1111/ede.12039; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Wang XG, 2011, DEVELOPMENT, V138, P4399, DOI 10.1242/dev.070516; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yamamoto H, 1999, MOL CELL BIOL, V19, P3829	49	29	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119804	10.1371/journal.pone.0119804	http://dx.doi.org/10.1371/journal.pone.0119804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793727	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200117
J	Nakahara, J; Takechi, K; Myouga, F; Moriyama, Y; Sato, H; Takio, S; Takano, H				Nakahara, Jin; Takechi, Katsuaki; Myouga, Fumiyoshi; Moriyama, Yasuko; Sato, Hiroshi; Takio, Susumu; Takano, Hiroyoshi			Bending of Protonema Cells in a Plastid Glycolate/Glycerate Transporter Knockout Line of Physcomitrella patens	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; CHLOROPLAST DIVISION; MOSS; PHOTORESPIRATION; ENVELOPE; REVEALS; PROTEIN; GENE; DEATH; ACID	Arabidopsis LrgB (synonym PLGG1) is a plastid glycolate/glycerate transporter associated with recycling of 2-phosphoglycolate generated via the oxygenase activity of ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO). We isolated two homologous genes (PpLrgB1 and B2) from the moss Physcomitrella patens. Phylogenetic tree analysis showed that PpLrgB1 was monophyletic with LrgB proteins of land plants, whereas PpLrgB2 was divergent from the green plant lineage. Experiments with PpLrgB-GFP fusion proteins suggested that both PpLrgB1 and B2 proteins were located in chloroplasts. We generated PpLrgB single (Delta B1 and Delta B2) and double (Delta B1/Delta B2)-knockout lines using gene targeting of P. patens. The Delta B1 plants showed decreases in growth and photosynthetic activity, and their protonema cells were bent and accumulated glycolate. However, because Delta B2 and Delta B1/Delta B2 plants showed no obvious phenotypic change relative to the wild-type or Delta B1 plants, respectively, the function of PpLrgB2 remains unclear. Arabidopsis LrgB could complement the Delta B1 phenotype, suggesting that the function of PpLrgB1 is the same as that of AtLrgB. When Delta B1 was grown under high-CO2 conditions, all novel phenotypes were suppressed. Moreover, protonema cells of wild-type plants exhibited a bending phenotype when cultured on media containing glycolate or glycerate, suggesting that accumulation of photorespiratory metabolites caused P. patens cells to bend.	[Nakahara, Jin; Takechi, Katsuaki; Moriyama, Yasuko; Takio, Susumu; Takano, Hiroyoshi] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Myouga, Fumiyoshi] RIKEN, CSRS, Gene Discovery Res Grp, Yokohama, Kanagawa 2300045, Japan; [Sato, Hiroshi] Kumamoto Univ, Fac Sci, Kumamoto 8608555, Japan; [Takio, Susumu] Kumamoto Univ, Ctr Marine Environm Studies, Kumamoto 8608555, Japan; [Takano, Hiroyoshi] Kumamoto Univ, Inst Pulsed Power Sci, Kumamoto 8608555, Japan	Kumamoto University; RIKEN; Kumamoto University; Kumamoto University; Kumamoto University	Takano, H (corresponding author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	takano@kumamoto-u.ac.jp	Myouga, Fumiyoshi/R-4070-2017	Myouga, Fumiyoshi/0000-0003-0957-808X; Takano, Hiroyoshi/0000-0003-4720-5057	Japan Society for the Promotion of Science (KAKENHI) [26117720, 25440158]; Grants-in-Aid for Scientific Research [25440158, 26430191] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (KAKENHI Grant Numbers 26117720 and 25440158 to H.T. and K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Eisenhut M, 2013, PLANT BIOLOGY, V15, P676, DOI 10.1111/j.1438-8677.2012.00690.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferro M, 2002, P NATL ACAD SCI USA, V99, P11487, DOI 10.1073/pnas.172390399; Gerotto C, 2012, NEW PHYTOL, V196, P763, DOI 10.1111/j.1469-8137.2012.04345.x; Hiwatashi Y, 2008, PLANT CELL, V20, P3094, DOI 10.1105/tpc.108.061705; Homi S, 2009, PLANT CELL PHYSIOL, V50, P2047, DOI 10.1093/pcp/pcp158; HOWITZ KT, 1986, PLANT PHYSIOL, V80, P390, DOI 10.1104/pp.80.2.390; Khatoon M, 2009, J BIOL CHEM, V284, P25343, DOI 10.1074/jbc.M109.007740; Kubo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077356; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Mueller SJ, 2014, PLANT PHYSIOL, V164, P2081, DOI 10.1104/pp.114.235754; Nei M., 2000, MOL EVOLUTION PHYLOG; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Pick TR, 2013, P NATL ACAD SCI USA, V110, P3185, DOI 10.1073/pnas.1215142110; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Saavedra L, 2006, PLANT J, V45, P237, DOI 10.1111/j.1365-313X.2005.02603.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakaguchi E, 2011, PLANT SCI, V180, P789, DOI 10.1016/j.plantsci.2011.02.003; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; Schneidereit J, 2006, PLANT J, V45, P206, DOI 10.1111/j.1365-313X.2005.02594.x; Somerville CR, 2001, PLANT PHYSIOL, V125, P20, DOI 10.1104/pp.125.1.20; TAKAHASHI K, 1972, J BIOCHEM, V71, P563; TAKAMI S, 1988, PHYSIOL PLANTARUM, V73, P227, DOI 10.1111/j.1399-3054.1988.tb00590.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timm S, 2013, PLANT BIOLOGY, V15, P737, DOI 10.1111/j.1438-8677.2012.00691.x; Tyra HM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r212; Vidali L, 2012, CURR OPIN PLANT BIOL, V15, P625, DOI 10.1016/j.pbi.2012.09.008; Yamaguchi M, 2012, PLANT CELL PHYSIOL, V53, P125, DOI 10.1093/pcp/pcr180; Yang YJ, 2012, NEW PHYTOL, V193, P81, DOI 10.1111/j.1469-8137.2011.03867.x	33	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118804	10.1371/journal.pone.0118804	http://dx.doi.org/10.1371/journal.pone.0118804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793376	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200042
J	Ronowicz, M; Kuklinski, P; Mapstone, GM				Ronowicz, Marta; Kuklinski, Piotr; Mapstone, Gillian M.			Trends in the Diversity, Distribution and Life History Strategy of Arctic Hydrozoa (Cnidaria)	PLOS ONE			English	Article							EUROPEAN ATHECATE HYDROIDS; MEDUSAE HYDROZOA; MARINE-ENVIRONMENT; SPECIES RICHNESS; SHELF WATERS; LAPTEV SEA; SP-NOV; EVOLUTION; BIOGEOGRAPHY; ZOOPLANKTON	This is the first attempt to compile a comprehensive and updated species list for Hydrozoa in the Arctic, encompassing both hydroid and medusa stages and including Siphonophorae. We address the hypothesis that the presence of a pelagic stage (holo-or meroplanktonic) was not necessary to successfully recolonize the Arctic by Hydrozoa after the Last Glacial Maximum. Presence-absence data of Hydrozoa in the Arctic were prepared on the basis of historical and present-day literature. The Arctic was divided into ecoregions. Species were grouped into distributional categories according to their worldwide occurrences. Each species was classified according to life history strategy. The similarity of species composition among regions was calculated with the Bray-Curtis index. Average and variation in taxonomic distinctness were used to measure diversity at the taxonomic level. A total of 268 species were recorded. Arctic-boreal species were the most common and dominated each studied region. Nineteen percent of species were restricted to the Arctic. There was a predominance of benthic species over holo-and meroplanktonic species. Arctic, Arctic-Boreal and Boreal species were mostly benthic, while widely distributed species more frequently possessed a pelagic stage. Our results support hypothesis that the presence of a pelagic stage (holo- or meroplanktonic) was not necessary to successfully recolonize the Arctic. The predominance of benthic Hydrozoa suggests that the Arctic could have been colonised after the Last Glacial Maximum by hydroids rafting on floating substrata or recolonising from glacial refugia.	[Ronowicz, Marta; Kuklinski, Piotr] Polish Acad Sci, Inst Oceanol, Marine Ecol Dept, Sopot, Poland; [Kuklinski, Piotr; Mapstone, Gillian M.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; Natural History Museum London	Ronowicz, M (corresponding author), Polish Acad Sci, Inst Oceanol, Marine Ecol Dept, Sopot, Poland.	martar@iopan.gda.pl		Ronowicz, Marta/0000-0001-8703-9132; Kuklinski, Piotr/0000-0002-1507-215X	Polish National Science Centre [2012/04/M/NZ8/00670, 2011/03/B/NZ8/02872]	Polish National Science Centre	This work was supported by the Polish National Science Centre grant nrs 2012/04/M/NZ8/00670 to MR and 2011/03/B/NZ8/02872 to PK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antsulevich Alexander E., 1992, Scientia Marina, V56, P213; ARAI MN, 1980, CAN B FISH AQUAT SCI, P1; Berrill N.J., 1961, GROWTH DEV PATTERN; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; BOERO F, 1984, MAR ECOL-P S Z N I, V5, P93, DOI 10.1111/j.1439-0485.1984.tb00310.x; Bonnevie K., 1899, Norwegian North Atlantic Expedition 1876-1878 Zool, Vxxvi, P1; Bouillon J., 2006, INTRO HYDROZOA; Broch H, 1925, NATURWISSENSCHAFTEN, V13, P447, DOI 10.1007/BF01558740; BROCH H, 1910, FAUNA ARCTICA, V5, P127; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Cairns SD, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.158.1910; CALDER DR, 1990, CAN J ZOOL, V68, P442, DOI 10.1139/z90-065; CALDER DR, 1972, J FISH RES BOARD CAN, V29, P217, DOI 10.1139/f72-040; CALDER DR, 1970, J FISH RES BOARD CAN, V27, P1501, DOI 10.1139/f70-175; Cantero ALP, 2004, POLAR BIOL, V27, P767, DOI 10.1007/s00300-004-0654-9; Cartwright P, 2010, INTEGR COMP BIOL, V50, P456, DOI 10.1093/icb/icq089; Clark SF, 1877, P ACAD NAT SCI PHILA, V1876, P209; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cooney R. T., 1981, E BERING SEA SHELF O, V2, P947; Cornelius P.F.S., 1981, Porcupine Newsletter, V2, P47; Cornelius P.F.S., 1992, ARQUIPELAGO LIFE EAR, V10, P75; Cornelius Paul F. S., 1992, Scientia Marina, V56, P245; CORNELIUS PFS, 1990, J NAT HIST, V24, P579, DOI 10.1080/00222939000770391; Cornelius PFS, 1995, SYNOPSIS BRIT FAUNA, V50, P1; Curtis M.A., 1975, Polar Record, VNo. 111, P595; Cusson M, 2007, MAR ECOL PROG SER, V331, P291, DOI 10.3354/meps331291; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; Darby DA, 2006, PROG OCEANOGR, V71, P129, DOI 10.1016/j.pocean.2006.09.009; DUNBAR M. J., 1942, CANADIAN JOUR RES SECT D ZOOL SCI, V20, P71; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Fisher W. K., 1938, Proceedings of the United States National Museum, V84, P493; Fraser C.M., 1944, HYDROIDS ATLANTIC CO; Gibbons MJ, 2010, J BIOGEOGR, V37, P606, DOI 10.1111/j.1365-2699.2009.02237.x; Gibbons MJ, 2010, J BIOGEOGR, V37, P441, DOI 10.1111/j.1365-2699.2009.02226.x; Golikov A.N., 1989, P257; Govindarajan AF, 2005, MAR BIOL, V146, P213, DOI 10.1007/s00227-004-1434-3; GRAINGER EH, 1965, J FISH RES BOARD CAN, V22, P543, DOI 10.1139/f65-049; Grainger EH, 1975, FISH MAR SERV RES DE, P591; Gravier-Bonnet N., 2006, P 10 INT COR REEF S, P188; Gravier-Bonnet Nicole, 1992, Scientia Marina, V56, P229; Hand C, 1961, ARCTIC I N AM TECHNI, V6, P1; Henry LA, 2004, MAR ECOL PROG SER, V266, P123, DOI 10.3354/meps266123; Hughes RN, 1989, FUNCTIONAL BIOL CLON; JACKSON JBC, 1986, B MAR SCI, V39, P588; JACKSON JBC, 1986, PHILOS T R SOC B, V313, P7, DOI 10.1098/rstb.1986.0022; Jaderholm E, 1916, BIHANG KUNGLIGA SVEN, V54, P1; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; Jones EP, 2001, POLAR RES, V20, P139, DOI 10.1111/j.1751-8369.2001.tb00049.x; Kinne O., 1956, Zeitschrift fuer Morphologie und Oekologie der Tiere, V45, P217, DOI 10.1007/BF00430254; Kosobokova K, 2000, DEEP-SEA RES PT I, V47, P2029, DOI 10.1016/S0967-0637(00)00015-7; Kosobokova KN, 1998, POLAR BIOL, V19, P63; Kosobokova Ksenia N., 2011, Marine Biodiversity, V41, P29, DOI 10.1007/s12526-010-0057-9; Kramp P, 1942, MEDD GRONLAND, V80, P3; Kramp P. L., 1947, Danish Ingolf-Expedition, V5, P1; Kramp P. L., 1943, MEDDELELSER OM GRONLAND, V121, P1; Kramp P. L., 1959, Dana Reports, V46, P1; KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347; KRAMP PL, 1932, MEDDELELSER GRONLAND, V91, P1; Leclere L, 2009, SYST BIOL, V58, P509, DOI 10.1093/sysbio/syp044; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Mapstone G.M., 2009, SIPHONOPHORA CNIDARI; Mapstone GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087737; MARGULIS RY, 1982, ZOOL ZH, V61, P440; Margulis RYa, 1978, 16 BIOLOGIYA, V3, P1; Marktanner-Turneretscher G., 1895, ZOOLOGISCHE JB ABTHE, V8, P391; Miglietta MP, 2006, J MAR BIOL ASSOC UK, V86, P993, DOI 10.1017/S0025315406013968; MILEIKOVSKY SA, 1971, MAR BIOL, V10, P193, DOI 10.1007/BF00352809; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Motoda S., 1974, OCEANOGRAPHY BERING, P207; Moura CJ, 2008, ZOOL SCR, V37, P93, DOI 10.1111/j.1463-6409.2007.00312.x; Naumov D. V, 1969, HYDROIDS HYDROMEDUSA; NESIS KN, 1983, BIOL MORYA-VLAD+, P3; NURNBERG D, 1995, POLAR RES, V14, P43, DOI 10.1111/j.1751-8369.1995.tb00709.x; Nutting CC, 1901, P WASHINGTON ACAD SC, V3, P157; Pagliara P, 2000, SCI MAR, V64, P173, DOI 10.3989/scimar.2000.64s1173; Palerud Rune, 2004, Norsk Polarinstitutt Skrifter, V201, P5; PETERSEN KW, 1990, ZOOL J LINN SOC-LOND, V100, P101, DOI 10.1111/j.1096-3642.1990.tb01862.x; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Piepenburg Dieter, 2011, Marine Biodiversity, V41, P51, DOI 10.1007/s12526-010-0059-7; Piraino S, 2008, J MAR BIOL ASSOC UK, V88, P1637, DOI 10.1017/S0025315408002166; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; PUGH PR, 1995, SCI MAR, V59, P181; Raskoff KA, 2005, POLAR BIOL, V28, P207, DOI 10.1007/s00300-004-0677-2; Raskoff KA, 2010, DEEP SEA RES 2, V57, P111; Raskoff KA, 2010, ZOOTAXA, P57; Ronowicz M, 2007, J MAR BIOL ASSOC UK, V87, P1089, DOI 10.1017/S0025315407055142; Ronowicz M, 2007, ZOOTAXA, P55; Ronowicz M, 2013, POLAR BIOL, V36, P705, DOI 10.1007/s00300-013-1297-5; Ronowicz M, 2013, MAR ECOL-EVOL PERSP, V34, P165, DOI 10.1111/maec.12034; Rudels B, 1999, DEEP-SEA RES PT II, V46, P1023, DOI 10.1016/S0967-0645(99)00015-6; RUNGGER D, 1969, PUBB STA ZOOL NAPOLI, V37, P95; SCHELTEMA RS, 1983, B MAR SCI, V33, P545; Schmid Michael K., 1993, Meddelelser om Gronland Bioscience, V37, P1; Schuchert P., 2012, SYNOPSES BRIT FAUNA, V59; Schuchert P, 2008, REV SUISSE ZOOL, V115, P221, DOI 10.5962/bhl.part.80426; Schuchert P, 2006, REV SUISSE ZOOL, V113, P325, DOI 10.5962/bhl.part.80356; Schuchert P, 2014, MOL PHYLOGENET EVOL, V76, P1, DOI 10.1016/j.ympev.2014.02.020; Schuchert P, 2010, REV SUISSE ZOOL, V117, P337; Schuchert Peter, 2001, Meddelelser om Gronland Bioscience, V53, P1; Schuchert P, 2008, REV SUISSE ZOOL, V115, P677, DOI 10.5962/bhl.part.80453; Shih C T, 1971, Bull Fish Res Bd Can, V176, P1; Shirley WD, 1960, TAXONOMIC GUIDES ARC; Sommer Christian, 1992, Scientia Marina, V56, P205; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stepanjants SD, 2006, MAR BIOL RES, V2, P388, DOI 10.1080/17451000601012402; Stepanjants S.D., 1994, Issledovaniya Fauny Morei, V48, P116; Stepanjants SD, 2008, J MAR BIOL ASSOC UK, V88, P1619, DOI 10.1017/S0025315408001380; Stepanjants S.D., 1989, P397; Stepanjants SD, 2001, ISSLEDOVANIA FAUNI M, V51, P31; Stepanjants SD, 1967, SIPHONOPHORES SEAS U; Stylasteridae Broch H., 1914, DAN INGOLF EXPED, V5, P1; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Thiel M. E., 1932, Romer und Schaudinn Fauna Arctica Jena, V6, P119; Thiel M, 2006, OCEANOGR MAR BIOL, V44, P323, DOI 10.1201/9781420006391.ch7; Tomczak M., 1994, REGIONAL OCEANOGRAPH; UCHIDA T, 1969, Publications of the Seto Marine Biological Laboratory, V17, P285; Van Soest R.W.M., 1973, Bijdragen tot de Dierkunde, V43, P119; Voronkov A, 2010, J MAR BIOL ASSOC UK, V90, P1337, DOI 10.1017/S0025315409991573; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Watson JE, 1996, SCI MAR, V60, P75; WESLAWSKI JM, 1991, ARCTIC, V44, P115; Yashnov VA, 1948, CHECK LIST FAUNA FLO, P65; ZELICKMAN EA, 1972, MAR BIOL, V17, P256, DOI 10.1007/BF00366301	123	21	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120204	10.1371/journal.pone.0120204	http://dx.doi.org/10.1371/journal.pone.0120204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793294	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200158
J	Sahraoui, A; Winzell, MS; Gorman, T; Smith, DM; Skrtic, S; Hoeyem, M; Abadpour, S; Johansson, L; Korsgren, O; Foss, A; Scholz, H				Sahraoui, Afaf; Winzell, Maria Soerhede; Gorman, Tracy; Smith, Dave M.; Skrtic, Stanko; Hoeyem, Merete; Abadpour, Shadab; Johansson, Lars; Korsgren, Olle; Foss, Aksel; Scholz, Hanne			The Effects of Exendin-4 Treatment on Graft Failure: An Animal Study Using a Novel Re-Vascularized Minimal Human Islet Transplant Model	PLOS ONE			English	Article							BETA-CELL REPLICATION; ALLOGRAFT DYSFUNCTION; PROTEIN-KINASE; DIABETIC-RATS; IN-VITRO; APOPTOSIS; EXENATIDE; NEOGENESIS; RECEPTOR; RECIPIENTS	Islet transplantation has become a viable clinical treatment, but is still compromised by long-term graft failure. Exendin-4, a glucagon-like peptide 1 receptor agonist, has in clinical studies been shown to improve insulin secretion in islet transplanted patients. However, little is known about the effect of exendin-4 on other metabolic parameters. We therefore aimed to determine what influence exendin-4 would have on revascularized minimal human islet grafts in a state of graft failure in terms of glucose metabolism, body weight, lipid levels and graft survival. Introducing the bilateral, subcapsular islet transplantation model, we first transplanted diabetic mice with a murine graft under the left kidney capsule sufficient to restore normoglycemia. After a convalescent period, we performed a second transplantation under the right kidney capsule with a minimal human islet graft and allowed for a second recovery. We then performed a left-sided nephrectomy, and immediately started treatment with exendin-4 with a low (20 mu g/kg/day) or high (200 mu g/kg/day) dose, or saline subcutaneously twice daily for 15 days. Blood was sampled, blood glucose and body weight monitored. The transplanted human islet grafts were collected at study end point and analyzed. We found that exendin-4 exerts its effect on failing human islet grafts in a bell-shaped dose-response curve. Both doses of exendin-4 equally and significantly reduced blood glucose. Glucagon-like peptide 1 (GLP-1), C-peptide and pro-insulin were conversely increased. In the course of the treatment, body weight and cholesterol levels were not affected. However, immunohistochemistry revealed an increase in beta cell nuclei count and reduced TUNEL staining only in the group treated with a low dose of exendin-4 compared to the high dose and control. Collectively, these results suggest that exendin-4 has a potential rescue effect on failing, revascularized human islets in terms of lowering blood glucose, maintaining beta cell numbers, and improving metabolic parameters during hyperglycemic stress.	[Sahraoui, Afaf; Hoeyem, Merete; Abadpour, Shadab; Foss, Aksel; Scholz, Hanne] Oslo Univ Hosp, Inst Surg Res, Oslo, Norway; [Sahraoui, Afaf; Hoeyem, Merete; Abadpour, Shadab; Foss, Aksel; Scholz, Hanne] Oslo Univ Hosp, Sect Transplantat Surg, Oslo, Norway; [Winzell, Maria Soerhede; Smith, Dave M.; Skrtic, Stanko] AstraZeneca R&D, Molndal, Sweden; [Gorman, Tracy] AstraZeneca, Alderley Pk, Cheshire, England; [Johansson, Lars] Univ Uppsala Hosp, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Korsgren, Olle] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Foss, Aksel] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; AstraZeneca; AstraZeneca; Uppsala University; Uppsala University Hospital; Uppsala University; University of Oslo	Sahraoui, A (corresponding author), Oslo Univ Hosp, Inst Surg Res, Oslo, Norway.	Afaf.Sahraoui2@rr-research.no	Scholz, Hanne/J-8150-2016; Johansson, Lars/AAF-4845-2019	Korsgren, Olle/0000-0002-8524-9547; Skrtic, Stanko/0000-0002-1950-5418; Smith, David/0000-0001-6831-280X; Scholz, Hanne/0000-0003-2755-4399	Oslo University Hospital (OUS) - AstraZeneca in a scientific collaboration (OUS project) [37813]; Novo Nordisk Fonden [NNF14OC0010935] Funding Source: researchfish	Oslo University Hospital (OUS) - AstraZeneca in a scientific collaboration (OUS project); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded through a research program established at Oslo University Hospital (OUS) supported by AstraZeneca in a scientific collaboration (OUS project number 37813). AS and HS received financial support from this program funding. MH has no relevant disclosures. The funder provided support in the form of salaries for authors MSW, TG, DMS, SS and LJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Al-Adra DP, 2014, TRANSPLANTATION; Arakawa M, 2009, BIOCHEM BIOPH RES CO, V390, P809, DOI 10.1016/j.bbrc.2009.10.054; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Berney T, 2010, TRANSPLANTATION, V90, P238, DOI 10.1097/TP.0b013e3181e25a40; Broca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092066; Chen JQ, 2006, BIOCHEM BIOPH RES CO, V346, P1067, DOI 10.1016/j.bbrc.2006.06.027; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Faradji RN, 2009, CELL TRANSPLANT, V18, P1247, DOI 10.3727/096368909X474456; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; FEHMANN HC, 1991, ENDOCRINOLOGY, V128, P2880, DOI 10.1210/endo-128-6-2880; Froud T, 2008, TRANSPLANTATION, V86, P36, DOI 10.1097/TP.0b013e31817c4ab3; Gao W, 2012, DRUG METAB DISPOS, V40, P990, DOI 10.1124/dmd.111.042291; GOKE R, 1993, LIFE SCI, V53, P1367, DOI 10.1016/0024-3205(93)90597-V; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Kanak MA, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/451035; Kemp DM, 2001, ENDOCRINOLOGY, V142, P1179, DOI 10.1210/en.142.3.1179; King A, 2005, DIABETOLOGIA, V48, P2074, DOI 10.1007/s00125-005-1922-0; Kwon DY, 2009, J PHARMACOL SCI, V111, P361, DOI 10.1254/jphs.09178FP; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Luo J, 2013, METABOLISM, V62, P90, DOI 10.1016/j.metabol.2012.07.010; Nadkarni P, 2014, PROG MOL BIOL TRANSL, V121, P23, DOI 10.1016/B978-0-12-800101-1.00002-8; Nikfar S, 2012, J PHARM PHARM SCI, V15, P1; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Parlevliet ET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049152; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Suarez-Pinzon WL, 2011, CELL TRANSPLANT, V20, P1343, DOI 10.3727/096368910X557263; Szot GL, 2007, JOVE-J VIS EXP, V7, P255, DOI DOI 10.3791/255; Tian L, 2011, TRANSPL INT, V24, P856, DOI 10.1111/j.1432-2277.2011.01275.x; Velmurugan K, 2012, ENDOCRINOLOGY, V153, P1116, DOI 10.1210/en.2011-1895; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121204	10.1371/journal.pone.0121204	http://dx.doi.org/10.1371/journal.pone.0121204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793295	Green Published, gold			2022-12-26	WOS:000352083900111
J	Sola, E; Alvarez-Presas, M; Frias-Lopez, C; Littlewood, DTJ; Rozas, J; Riutort, M				Sola, Eduard; Alvarez-Presas, Marta; Frias-Lopez, Cristina; Littlewood, D. Timothy J.; Rozas, Julio; Riutort, Marta			Evolutionary Analysis of Mitogenomes from Parasitic and Free-Living Flatworms	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; PLANARIAN MITOCHONDRIA; MOLECULAR EVOLUTION; BACTERIAL GENOMES; COMPLETE SEQUENCE; CAUTIONARY TALE; INCREASED RATES; GENETIC-CODE; PLATYHELMINTHES; DNA	Mitochondrial genomes (mitogenomes) are useful and relatively accessible sources of molecular data to explore and understand the evolutionary history and relationships of eukaryotic organisms across diverse taxonomic levels. The availability of complete mitogenomes from Platyhelminthes is limited; of the 40 or so published most are from parasitic flatworms (Neodermata). Here, we present the mitogenomes of two free-living flatworms (Tricladida): the complete genome of the freshwater species Crenobia alpina (Planariidae) and a nearly complete genome of the land planarian Obama sp. (Geoplanidae). Moreover, we have reanotated the published mitogenome of the species Dugesia japonica (Dugesiidae). This contribution almost doubles the total number of mtDNAs published for Tricladida, a species-rich group including model organisms and economically important invasive species. We took the opportunity to conduct comparative mitogenomic analyses between available free-living and selected parasitic flatworms in order to gain insights into the putative effect of life cycle on nucleotide composition through mutation and natural selection. Unexpectedly, we did not find any molecular hallmark of a selective relaxation in mitogenomes of parasitic flatworms; on the contrary, three out of the four studied free-living triclad mitogenomes exhibit higher A+T content and selective relaxation levels. Additionally, we provide new and valuable molecular data to develop markers for future phylogenetic studies on planariids and geoplanids.	[Sola, Eduard; Alvarez-Presas, Marta; Frias-Lopez, Cristina; Rozas, Julio; Riutort, Marta] Univ Barcelona, Fac Biol, Inst Recerca Biodiversitat, Catalonia, Spain; [Sola, Eduard; Alvarez-Presas, Marta; Frias-Lopez, Cristina; Rozas, Julio; Riutort, Marta] Univ Barcelona, Fac Biol, Dept Genet, Catalonia, Spain; [Littlewood, D. Timothy J.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	University of Barcelona; University of Barcelona; Natural History Museum London	Riutort, M (corresponding author), Univ Barcelona, Fac Biol, Inst Recerca Biodiversitat, Catalonia, Spain.	mriutort@ub.edu	Álvarez-Presas, Marta/J-8078-2012; Littlewood, Tim/B-5230-2008; Riutort, Marta/B-6441-2009; Frías-López, Cristina/AAL-9385-2020; Rozas, Julio/A-1733-2009	Álvarez-Presas, Marta/0000-0002-4825-9965; Littlewood, Tim/0000-0002-2718-4001; Riutort, Marta/0000-0002-2134-7674; Frías-López, Cristina/0000-0002-8078-9552; Rozas, Julio/0000-0002-6839-9148; Sola, Eduard/0000-0003-1848-4085	Ministerio de Economia y competitividad (Spain) [CGL 2008-00378 MR, CGL 2011-23466 MR, CGL2013-45211-C2-1-P]; Natural Environment Research Council [NER/A/S/2003/00313] Funding Source: researchfish	Ministerio de Economia y competitividad (Spain); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was received from Ministerio de Economia y competitividad (Spain): CGL 2008-00378 MR, CGL 2011-23466 MR, CGL2013-45211-C2-1-P (http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2006, NUCLEIC ACIDS RES, V34, pW389, DOI 10.1093/nar/gkl044; Alvarez-Presas M, 2014, HEREDITY, V112, P656, DOI 10.1038/hdy.2014.3; Alvarez-Presas M, 2014, PEERJ, V2, DOI 10.7717/peerj.430; Ballard JWO, 2014, FUNCT ECOL, V28, P218, DOI 10.1111/1365-2435.12177; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; BERNARDI G, 1986, J MOL EVOL, V24, P1, DOI 10.1007/BF02099946; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bessho Y, 1997, MOL ECOL, V6, P129, DOI 10.1046/j.1365-294X.1997.00162.x; BESSHO Y, 1992, J MOL EVOL, V34, P331, DOI 10.1007/BF00160240; Biomatters, 2014, GENEIOUS; BOORE JL, 1995, GENETICS, V141, P305; Breton S, 2010, MAR GENOM, V3, P11, DOI 10.1016/j.margen.2010.01.001; Bromham L, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-126; Castro LR, 2002, MOL BIOL EVOL, V19, P1100, DOI 10.1093/oxfordjournals.molbev.a004168; Chen H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085631, 10.1371/journal.pone.0086214, 10.1371/journal.pone.0087753]; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huyse T, 2005, TRENDS PARASITOL, V21, P469, DOI 10.1016/j.pt.2005.08.009; Huyse T, 2008, GENE, V417, P27, DOI 10.1016/j.gene.2008.03.008; Jeon HK, 2007, PARASITOL INT, V56, P243, DOI 10.1016/j.parint.2007.04.001; Kang S, 2012, MITOCHONDR DNA, V23, P176, DOI 10.3109/19401736.2012.668900; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527; Le TH, 2000, MOL BIOL EVOL, V17, P1123, DOI 10.1093/oxfordjournals.molbev.a026393; Le TH, 2002, PARASITOLOGY, V124, P97, DOI 10.1017/S0031182001008976; Le Thanh Hoa, 2004, Korean Journal of Parasitology, V42, P159, DOI 10.3347/kjp.2004.42.4.159; Marin A, 2008, J THEOR BIOL, V253, P508, DOI 10.1016/j.jtbi.2008.04.004; Nakao M, 2003, J PARASITOL, V89, P633, DOI 10.1645/0022-3395(2003)089[0633:TMGOTT]2.0.CO;2; Necsulea A, 2007, MOL BIOL EVOL, V24, P2169, DOI 10.1093/molbev/msm148; Page RDM, 1998, MOL PHYLOGENET EVOL, V9, P276, DOI 10.1006/mpev.1997.0458; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Poh YP, 2012, GENOME BIOL EVOL, V4, P1245, DOI 10.1093/gbe/evs097; Riutort M, 2012, INT J DEV BIOL, V56, P5, DOI 10.1387/ijdb.113441mr; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Sakai M, 2012, ZOOL SCI, V29, P672, DOI 10.2108/zsj.29.672; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; Sluys R, 2013, ZOOL J LINN SOC-LOND, V169, P523, DOI 10.1111/zoj.12077; Sola E, 2013, MOL PHYLOGENET EVOL, V66, P877, DOI 10.1016/j.ympev.2012.11.010; Stock M, 2006, MOL PHYLOGENET EVOL, V41, P663, DOI 10.1016/j.ympev.2006.05.026; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; Weber M, 2013, MOL PHYLOGENET EVOL, V66, P182, DOI 10.1016/j.ympev.2012.09.017; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Wey-Fabrizius AR, 2013, MOL PHYLOGENET EVOL, V69, P365, DOI 10.1016/j.ympev.2012.12.015; Woolfit M, 2003, MOL BIOL EVOL, V20, P1545, DOI 10.1093/molbev/msg167; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yamasaki H, 2012, PARASITOL INT, V61, P260, DOI 10.1016/j.parint.2011.10.007; Zhang J, 2014, MITOCHONDR DNA, V1736, P1	56	30	32	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120081	10.1371/journal.pone.0120081	http://dx.doi.org/10.1371/journal.pone.0120081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793530	gold, Green Submitted, Green Published			2022-12-26	WOS:000352084200142
J	Chung-Delgado, K; Guillen-Bravo, S; Revilla-Montag, A; Bernabe-Ortiz, A				Chung-Delgado, Kocfa; Guillen-Bravo, Sonia; Revilla-Montag, Alejandro; Bernabe-Ortiz, Antonio			Mortality among MDR-TB Cases: Comparison with Drug-Susceptible Tuberculosis and Associated Factors	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS; TREATMENT OUTCOMES; SURVIVAL; DEFAULT; PROGRAM; BURDEN; IMPACT; DEATH; LIMA	Background An increase in multidrug-resistant tuberculosis (MDR-TB) cases is evident worldwide. Its management implies a complex treatment, high costs, more toxic anti-tuberculosis drug use, longer treatment time and increased treatment failure and mortality. The aims of this study were to compare mortality between MDR and drug-susceptible cases of tuberculosis, and to determine risk factors associated with mortality among MDR-TB cases. Methods and Results A retrospective cohort study was performed using data from clinical records of the National Strategy for Prevention and Control of Tuberculosis in Lima, Peru. In the first objective, MDR-TB, compared to drug-susceptible cases, was the main exposure variable and time to death, censored at 180 days, the outcome of interest. For the second objective, different variables obtained from clinical records were assessed as potential risk factors for death among MDR-TB cases. Cox regression analysis was used to determine hazard ratios (HR) and 95% confidence intervals (95% CI). A total of 1,232 patients were analyzed: mean age 30.9 +/- 14.0 years, 60.0% were males. 61 patients (5.0%) died during treatment, whereas the MDR-TB prevalence was 19.2%. MDR-TB increased the risk of death during treatment (HR = 7.5; IC95%: 4.1-13.4) when compared to presumed drug-susceptible cases after controlling for potential confounders. Education level (p = 0.01), previous TB episodes (p<0.001), diabetes history (p<0.001) and HIV infection (p = 0.04) were factors associated with mortality among MDR-TB cases. Conclusions MDR-TB is associated with an increased risk of death during treatment. Lower education, greater number of previous TB episodes, diabetes history, and HIV infection were independently associated with mortality among MDR-TB cases. New strategies for appropriate MDR-TB detection and management should be implemented, including drug sensitivity tests, diabetes and HIV screening, as well as guarantee for a complete adherence to therapy.	[Chung-Delgado, Kocfa; Guillen-Bravo, Sonia; Revilla-Montag, Alejandro; Bernabe-Ortiz, Antonio] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru	Universidad Peruana de Ciencias Aplicadas (UPC)	Chung-Delgado, K (corresponding author), Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru.	kocfachung@gmail.com		Chung-Delgado, Kocfa/0000-0003-1962-9434; Bernabe-Ortiz, Antonio/0000-0002-6834-1376				Asencios Luis, 2009, Rev. perú. med. exp. salud publica, V26, P278; Becerra MC, 2010, CLIN INFECT DIS, V51, P709, DOI 10.1086/655892; Bernabe-Ortiz A, 2008, REV CHIL INFECTOL, V25, P104, DOI /S0716-10182008000300002; Bonilla Cesar A, 2008, PLoS One, V3, pe2957, DOI 10.1371/journal.pone.0002957; Chu R, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-19; Chung-Delgado K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027610; Chuquiyauri Haro Raul, 2004, Rev Med Hered, V15, P203; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Kang YA, 2013, RESPIRATION, V86, P472, DOI 10.1159/000348374; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Kliiman K, 2010, INT J TUBERC LUNG D, V14, P454; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lerner Alana G, 2013, Crit Pathw Cardiol, V12, P53, DOI 10.1097/HPC.0b013e318285ef60; Lockman S, 2001, CLIN INFECT DIS, V32, P373, DOI 10.1086/318489; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Ministerio de Salud, 2006, NORM TECN SAL CONTR; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Shieh SH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-174; Shin SS, 2006, EMERG INFECT DIS, V12, P687, DOI 10.3201/eid1204.041256; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, MULTIDRUG AND EXTENS	30	59	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119332	10.1371/journal.pone.0119332	http://dx.doi.org/10.1371/journal.pone.0119332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790076	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400075
J	Larrinaga, G; Perez, I; Sanz, B; Beitia, M; Errarte, P; Fernandez, A; Blanco, L; Etxezarraga, MC; Gil, J; Lopez, JI				Larrinaga, Gorka; Perez, Itxaro; Sanz, Begona; Beitia, Maider; Errarte, Peio; Fernandez, Ainhoa; Blanco, Lorena; Etxezarraga, Maria C.; Gil, Javier; Lopez, Jose I.			Dipeptidyl-Peptidase IV Activity Is Correlated with Colorectal Cancer Prognosis	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; CARCINOMA-ASSOCIATED FIBROBLASTS; COLON-CANCER; AMINOPEPTIDASE N/CD13; SERUM CD26; EXPRESSION; MARKERS; IMPACT	Background Dipeptidyl-peptidase IV (EC 3.4.14.5) (DPPIV) is a serine peptidase involved in cell differentiation, adhesion, immune modulation and apoptosis, functions that control neoplastic transformation. Previous studies have demonstrated altered expression and activity of tissue and circulating DPPIV in several cancers and proposed its potential usefulness for early diagnosis in colorectal cancer (CRC). Methods and principal findings The activity and mRNA and protein expression of DPPIV was prospectively analyzed in adenocarcinomas, adenomas, uninvolved colorectal mucosa and plasma from 116 CRC patients by fluorimetric, quantitative RT-PCR and immunohistochemical methods. Results were correlated with the most important classic pathological data related to aggressiveness and with 5-year survival rates. Results showed that: 1) mRNA levels and activity of DPPIV increased in colorectal neoplasms (Kruskal-Wallis test, p<0.01); 2) Both adenomas and CRCs displayed positive cytoplasmic immunostaining with luminal membrane reinforcement; 3) Plasmatic DPPIV activity was lower in CRC patients than in healthy subjects (Mann-U test, p<0.01); 4) Plasmatic DPPIV activity was associated with worse overall and disease-free survivals (log-rank p<0.01, Cox analysis p<0.01). Conclusion/significance 1) Up-regulation of DPPIV in colorectal tumors suggests a role for this enzyme in the neoplastic transformation of colorectal tissues. This finding opens the possibility for new therapeutic targets in these patients. 2) Plasmatic DPPIV is an independent prognostic factor in survival of CRC patients. The determination of DPPIV activity levels in the plasma may be a safe, minimally invasive and inexpensive way to define the aggressiveness of CRC in daily practice.	[Larrinaga, Gorka; Perez, Itxaro; Beitia, Maider] Univ Basque Country, UPV EHU, Sch Nursing, Dept Nursing 1, Leioa, Bizkaia, Spain; [Larrinaga, Gorka; Perez, Itxaro; Sanz, Begona; Beitia, Maider; Errarte, Peio; Fernandez, Ainhoa; Blanco, Lorena; Gil, Javier] Univ Basque Country, UPV EHU, Fac Med & Dent, Dept Physiol, Leioa, Bizkaia, Spain; [Etxezarraga, Maria C.] Univ Basque Country, UPV EHU, Basurto Univ Hosp, Dept Anat Pathol, Bilbao, Bizkaia, Spain; [Lopez, Jose I.] Univ Basque Country, UPV EHU, Cruces Univ Hosp, Dept Anat Pathol, Baracaldo, Bizkaia, Spain; [Larrinaga, Gorka; Perez, Itxaro; Sanz, Begona; Beitia, Maider; Errarte, Peio; Fernandez, Ainhoa; Blanco, Lorena; Etxezarraga, Maria C.; Gil, Javier; Lopez, Jose I.] BioCruces Hlth Res Inst, Baracaldo, Bizkaia, Spain	University of Basque Country; University of Basque Country; Basurto Hospital; University of Basque Country; Hospital Universitario Cruces; University of Basque Country	Larrinaga, G (corresponding author), Univ Basque Country, UPV EHU, Sch Nursing, Dept Nursing 1, Leioa, Bizkaia, Spain.	gorka.larrinaga@ehu.es	Errarte, Peio/AAD-4169-2020; Fernández-Atutxa, Ainhoa/AAZ-1764-2021; Lopez, Jose Ignacio/L-3884-2019; Sanz, Begoña/ABE-7948-2020; Lopez, Jose Ignacio/E-2973-2012; Beitia, Maider/AAD-1618-2020	Errarte, Peio/0000-0002-1581-5152; Fernández-Atutxa, Ainhoa/0000-0002-1554-0291; Lopez, Jose Ignacio/0000-0003-0842-5348; Lopez, Jose Ignacio/0000-0003-0842-5348; LARRINAGA ENBEITA, GORKA/0000-0002-6744-818X; Sanz Echevarria, Begona/0000-0002-6354-6401; Perez Urzelai, Itxaro/0000-0003-1860-1755	Basque Government [IT8-11/13]; University of the Basque Country UPV/EHU [UFI 11/44]; Gangoiti Barrera Foundation	Basque Government(Basque Government); University of the Basque Country UPV/EHU; Gangoiti Barrera Foundation	This work was supported by grants from the Basque Government (IT8-11/13), the University of the Basque Country UPV/EHU (UFI 11/44), and the Gangoiti Barrera Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alponti RF, 2011, METABOLISM, V60, P234, DOI 10.1016/j.metabol.2009.12.031; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Candenas L, 2006, EUR J PHARMACOL, V541, P9, DOI 10.1016/j.ejphar.2006.04.025; Carl-McGrath S, 2006, HISTOL HISTOPATHOL, V21, P1339, DOI 10.14670/HH-21.1339; Cordero OJ, 2000, BRIT J CANCER, V83, P1139, DOI 10.1054/bjoc.2000.1410; Cordero OJ, 2011, WORLD J CLIN ONCOL, V2, P245, DOI 10.5306/wjco.v2.i6.245; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; De Chiara L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107470; De Chiara L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-333; Edge SB, 2010, AJCC CANC STAGING MA; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Hundt S, 2007, CANCER EPIDEM BIOMAR, V16, P1935, DOI 10.1158/1055-9965.EPI-06-0994; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Javidroozi M, 2012, DIS MARKERS, V32, P309, DOI [10.3233/DMA-2011-0889, 10.1155/2012/706745]; Kim EC, 1997, GASTROENTEROL CLIN N, V26, P1, DOI 10.1016/S0889-8553(05)70280-6; Lam CSC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098582; Larrinaga G, 2014, INT J MED SCI, V11, P199, DOI 10.7150/ijms.7178; Larrinaga G, 2013, TRANSL RES, V162, P297, DOI 10.1016/j.trsl.2013.07.010; Larrinaga G, 2012, AM J PHYSIOL-RENAL, V303, pF1584, DOI 10.1152/ajprenal.00477.2012; Larrinaga G, 2010, REGUL PEPTIDES, V163, P102, DOI 10.1016/j.regpep.2010.03.012; Leslie A, 2002, BRIT J SURG, V89, P845, DOI 10.1046/j.1365-2168.2002.02120.x; de la Fuente IM, 2014, SPRINGER SER BIOPHYS, V16, P179, DOI 10.1007/978-3-642-38505-6_8; Murakami H, 2005, CLIN CANCER RES, V11, P8674, DOI 10.1158/1078-0432.CCR-05-1005; Nazarian A, 2014, MOL CELL PROTEOMICS, V13, P3082, DOI 10.1074/mcp.M114.038836; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Thirunavukarasu P, 2011, JNCI-J NATL CANCER I, V103, P689, DOI 10.1093/jnci/djr078; van Hensbergen Y, 2002, CLIN CANCER RES, V8, P3747; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas AJ, 2012, NUTR CLIN PRACT, V27, P613, DOI 10.1177/0884533612454885; Varona A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-193; Washington MK, 2009, ARCH PATHOL LAB MED, V133, P1539, DOI 10.1043/1543-2165-133.10.1539; Wickstrom M, 2011, CANCER SCI, V102, P501, DOI 10.1111/j.1349-7006.2010.01826.x; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2	38	26	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119436	10.1371/journal.pone.0119436	http://dx.doi.org/10.1371/journal.pone.0119436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790122	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400085
J	Liu, LJ; Guo, LN; Zhao, C; Wu, XW; Wang, RF; Liu, C				Liu, Lijia; Guo, Lina; Zhao, Can; Wu, Xiuwen; Wang, Rufeng; Liu, Chen			Characterization of the Intestinal Absorption of Seven Flavonoids from the Flowers of Trollius chinensis Using the Caco-2 Cell Monolayer Model	PLOS ONE			English	Article							TRANSPORT	The human Caco-2 cell monolayer model was used to investigate the absorption property, mechanism, and structure-property relationship of seven representative flavonoids, namely, orientin, vitexin, 2 ''-O-beta-L-galactopyranosylorientin, 2 ''-O-beta-L-galactopyranosylvitexin, iso-swertisin, isoswertiajaponin, and 2 ''-O-(2'''-methylbutanoyl) isoswertisin from the flowers of Trollius chinensis. The results showed that these flavonoids were hardly transported through the Caco-2 cell monolayer. The compounds with 7-OCH3 including isoswertisin, isoswertiajaponin and 2 ''-O-(2'''-methylbutanoyl) isoswertisin were absorbed in a passive diffusion manner, and their absorbability was increased in the same order as their polarity. The absorption of the remaining compounds with 7-OH including orientin, vitexin, 2 ''-O-beta-L-galactopyranosylorientin, and 2 ''-O-beta-L-galactopyranosylvitexin involved transporter mediated efflux in addition to passive diffusion. Among the four compounds with 7-OH, those with a free hydroxyl group at C-2 '' such as orientin and vitexin were the substrates of P-glycoprotein (P-gp) and that with a free hydroxyl group at C-2' such as 2 ''-O-beta-L-galactopyranosylorientin was the substrate of multidrug resistance protein 2 (MRP2). The results of this study also implied that the absorbability of the flavonoids should be taken into account when estimating the effective components of T. chinensis.	[Liu, Lijia; Guo, Lina; Zhao, Can; Wu, Xiuwen; Wang, Rufeng; Liu, Chen] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China	Beijing University of Chinese Medicine	Wang, RF (corresponding author), Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China.	wangrf2003@sina.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1974, J TSINGHUA U SCI TEC, V1, P165; Cai SQ, 2006, CHEM BIODIVERS, V3, P343, DOI 10.1002/cbdv.200690037; Chong SH, 1997, PHARMACEUT RES, V14, P1835, DOI 10.1023/A:1012112820371; Gao J, 2001, Curr Protoc Pharmacol, VChapter 7, DOI 10.1002/0471141755.ph0702s08; Hao YF, 2013, J SHENYANG PHARM U, V30, P197; Jiangsu New College of Medicine, 1997, CHIN MAT MED DICT, P1398; Li YL, 2002, J ETHNOPHARMACOL, V79, P365, DOI 10.1016/S0378-8741(01)00410-X; [林俊芝 Lin Junzhi], 2013, [中成药, Chinese Traditional Patent Medicine], V35, P483; Lin QF, 2003, CHIN J ANAL LAB, V22, P310; [林秋凤 Lin Qiufeng], 2004, [浙江大学学报. 理学版, Journal of Zhejiang University], V31, P412; Liu Zhi, 2004, Zhongguo Zhongyao Zazhi, V29, P1049; Qu CH, 2009, J HEBEI N U, V25, P21; Su LJ, 2005, FOREIGN MED SCI, V20, P14; Tang JZ, 2003, FOOD SCI, V23, P88; van der Sandt ICJ, 2000, EUR J PHARM SCI, V11, P207, DOI 10.1016/S0928-0987(00)00097-X; Versantvoort CHM, 1995, INT J CANCER, V63, P855, DOI 10.1002/ijc.2910630617; Walle UK, 1999, RES COMMUN MOL PATH, V103, P45; Wang GJ, 2005, PHARMACOKINETICS, P6; Wang RF, 2004, J ASIAN NAT PROD RES, V6, P139, DOI 10.1080/1028602031000147393; Wang RF, 2004, HETEROCYCLES, V63, P1443; [王如峰 Wang Rufeng], 2012, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V23, P2115; [吴新安 Wu Xinan], 2012, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V23, P632; Yang YX, 2006, CHIN MED MAT, V29, P1312; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Yuan M, 2013, CHIN J NAT MEDICINES, V11, P699, DOI [10.1016/S1875-5364(13)60082-5, 10.3724/SP.J.1009.2013.00699]; Yuan M, 2013, CHIN J NAT MEDICINES, V11, P449, DOI [10.1016/S1875-5364(13)60083-7, 10.3724/SP.J.1009.2013.00449]; 王凌云, 2003, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V14, P252	27	15	19	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119263	10.1371/journal.pone.0119263	http://dx.doi.org/10.1371/journal.pone.0119263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789809	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400073
J	Qi, JJ; Sun, P; Liao, DQ; Sun, TY; Zhu, J; Li, XN				Qi, Jianjun; Sun, Peng; Liao, Dengqun; Sun, Tongyu; Zhu, Juan; Li, Xianen			Transcriptomic Analysis of American Ginseng Seeds during the Dormancy Release Process by RNA-Seq	PLOS ONE			English	Article							GENE-EXPRESSION; GIBBERELLIN BIOSYNTHESIS; LOW-TEMPERATURE; ARABIDOPSIS; TOOL; GIGANTEA; BARLEY	American ginseng (Panax quinquefolius L.) is an important herb that is cultivated in China, North American, and South Korea. It is propagated from seed, but the seed has deep dormancy characteristics described as morphophysiological dormancy. Two-stage temperature stratification, a warm (15-20 degrees C) and cold (2 degrees C) stratification period of 6 months, has been used successfully for seed dormancy release. However, little is known about the molecular mechanisms of seed dormancy release in the stratification process. In this study, seed development after pollination and seed development in the dormancy release process were investigated in American ginseng. The transcriptome during seed dormancy release was analyzed using RNA-Seq technology and 78,207 unigenes (mean length 531 bp) were generated. Based on similarity searches of public databases, 54,292 of the unigenes (69.4%) were functionally annotated. Further, three digital gene expression (DGE) libraries were sequenced and differences in gene expression at three stages during seed cold stratification were examined. The greatest number of differentially expressed genes occurred in the 90DCS versus 180DCS libraries, while the lowest number of differentially expressed genes occurred in the 135DCS verus 180DCS libraries. GO enrichment analysis revealed that 59, 29, and 39 GO terms were significantly enriched in the biological process, molecular function, and cell component GO categories, respectively. There were 25,190 genes with KEGG pathway annotation in the three DGE libraries and their enrichment pathways were compared. The gene expressions of 30 selected unigenes were validated using quantitative PCR. This study is the first to provide the transcriptome sequences for seed dormancy release in American ginseng, and demonstrates the successful use of DGE profiling data for analyzing transcriptomic variation during dormancy release. These data provide a basis for future researches of seed dormancy in morphophysiological dormancy seeds in non-model plants.	[Qi, Jianjun; Sun, Peng; Liao, Dengqun; Sun, Tongyu; Zhu, Juan; Li, Xianen] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plants Dev, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Li, XN (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plants Dev, Beijing 100730, Peoples R China.	xeli@implad.ac.cn			National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX09304006]	National Science and Technology Major Project of the Ministry of Science and Technology of China	This work was funded by the National Science and Technology Major Project of the Ministry of Science and Technology of China (2012ZX09304006) (http//www.nmp.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Cadman CS, 2006, PLANT, V46, P67; Chen Shi-lin, 2008, Yaoxue Xuebao, V43, P657; Chen Y, 1998, TECHNICAL MANUAL CHI; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fei HM, 2007, GENOMICS, V89, P419, DOI 10.1016/j.ygeno.2006.11.008; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Gao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088804; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; Hedley PE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-202; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Li HQ, 1995, SPECIAL WILD EC ANIM, V3, P4; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li T. S. C., 2000, HortTechnology, V10, P131; Li T. S. C., 1995, HortTechnology, V5, P27; Li T. S. C., 2002, Native Plants Journal, V3, P109; Li XZ, 2000, RENSHEN YAN JIU, V12, P11; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Meng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064485; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Qi JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-358; ROSS JJ, 1995, PLANT J, V7, P513, DOI 10.1046/j.1365-313X.1995.7030513.x; Seiler C, 2011, J EXP BOT, V62, P2615, DOI 10.1093/jxb/erq446; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Sun Yong-zhen, 2011, Yaoxue Xuebao, V46, P1008; Wang WQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-60; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-564; Wu Q, 2010, PHYSIOL PLANTARUM, V138, P134, DOI 10.1111/j.1399-3054.2009.01309.x; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	42	15	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118558	10.1371/journal.pone.0118558	http://dx.doi.org/10.1371/journal.pone.0118558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790114	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400035
J	Sun, WQ; Zhou, QL; Yao, Y; Qiu, XJ; Xie, K; Yu, SB				Sun, Wenqian; Zhou, Qiaoling; Yao, Yue; Qiu, Xianjin; Xie, Kun; Yu, Sibin			Identification of Genomic Regions and the Isoamylase Gene for Reduced Grain Chalkiness in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; AMYLOPECTIN BIOSYNTHESIS; FLOURY ENDOSPERM; STARCH SYNTHESIS; QUALITY TRAITS; ENCODES; SIZE; QTL; MUTATIONS; KNOCKOUT	Grain chalkiness is an important grain quality related to starch granules in the endosperm. A high percentage of grain chalkiness is a major problem because it diminishes grain quality in rice. Here, we report quantitative trait loci identification for grain chalkiness using high-throughput single nucleotide polymorphism genotyping of a chromosomal segment substitution line population in which each line carried one or a few introduced japonica cultivar Nipponbare segments in the genetic background of the indica cultivar ZS97. Ten quantitative trait loci regions were commonly identified for the percentage of grain chalkiness and the degree of endosperm chalkiness. The allelic effects at nine of these quantitative trait loci reduced grain chalkiness. Furthermore, a quantitative trait locus (qPGC8-2) on chromosome 8 was validated in a chromosomal segment substitution line-derived segregation population, and had a stable effect on chalkiness in a multiple-environment evaluation of the near-isogenic lines. Residing on the qPGC8-2 region, the isoamylase gene (ISA1) was preferentially expressed in the endosperm and revealed some nucleotide polymorphisms between two varieties, Nipponbare and ZS97. Transgenic lines with suppression of ISA1 by RNA interference produced grains with 20% more chalkiness than the control. The results support that the gene may underlie qPGC8-2 for grain chalkiness. The multiple-environment trials of the near-isogenic lines also show that combination of the favorable alleles such as the ISA1 gene for low chalkiness and the GS3 gene for long grains considerably improved grain quality of ZS97, which proves useful for grain quality improvement in rice breeding programs.	[Sun, Wenqian; Qiu, Xianjin; Yu, Sibin] Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Sun, Wenqian; Zhou, Qiaoling; Yao, Yue; Qiu, Xianjin; Xie, Kun; Yu, Sibin] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University	Yu, SB (corresponding author), Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	ysb@mail.hzau.edu.cn		, sibin/0000-0003-0458-7526	National Natural Science Foundation of China [31261140369, 31271695]; Ministry of Science and Technology [2013CB127006]; Bill & Melinda Gates Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by the National Natural Science Foundation of China (Grant No. 31261140369, 31271695), the Ministry of Science and Technology (Grant No. 2013CB127006), and the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Chen QQ, 2007, SCI AGR SIN, V40, P2379; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Cule E, 2013, GENET EPIDEMIOL, V37, P704, DOI 10.1002/gepi.21750; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Fujita N, 2003, PLANT CELL PHYSIOL, V44, P607, DOI 10.1093/pcp/pcg079; Groemping U., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I01; Guo T, 2011, J INTEGR PLANT BIOL, V53, P598, DOI 10.1111/j.1744-7909.2011.01041.x; Hao W, 2009, J INTEGR PLANT BIOL, V51, P500, DOI 10.1111/j.1744-7909.2009.00822.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Kang HG, 2005, PLANT J, V42, P901, DOI 10.1111/j.1365-313X.2005.02423.x; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; Kubo A, 2005, PLANT PHYSIOL, V137, P43, DOI 10.1104/pp.104.051359; Li JJ, 2011, BREEDING SCI, V61, P338, DOI 10.1270/jsbbs.61.338; Li M, 2011, THEOR APPL GENET, V123, P411, DOI 10.1007/s00122-011-1593-9; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Liu XL, 2011, GENOME, V54, P64, DOI 10.1139/G10-070; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; McCouch SR, 2008, RICE, V1, P72, DOI 10.1007/s12284-008-9004-9; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Pandey MK, 2012, BIOTECHNOL ADV, V30, P1697, DOI 10.1016/j.biotechadv.2012.08.011; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; Peng C, 2014, PLANT J, V77, P917, DOI 10.1111/tpj.12444; Ryoo N, 2007, PLANT CELL REP, V26, P1083, DOI 10.1007/s00299-007-0309-8; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; StatSoft, 1997, STATSOFT STAT; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Wan XY, 2005, THEOR APPL GENET, V110, P1334, DOI 10.1007/s00122-005-1976-x; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang P, 2011, THEOR APPL GENET, V123, P1319, DOI 10.1007/s00122-011-1669-6; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Yan CJ, 2011, THEOR APPL GENET, V122, P63, DOI 10.1007/s00122-010-1423-5; Yu HH, 2014, PLANT BIOTECHNOL J, V12, P28, DOI 10.1111/pbi.12113; [余四斌 Yu Sibin], 2005, [分子植物育种, Molecular Plant Breeding], V3, P629; Zhang DP, 2012, PLANT MOL BIOL REP, V30, P1303, DOI 10.1007/s11105-012-0435-5; Zhou LJ, 2009, THEOR APPL GENET, V118, P581, DOI 10.1007/s00122-008-0922-0; Zhou PH, 2003, THEOR APPL GENET, V106, P326, DOI 10.1007/s00122-002-1023-0	45	39	48	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122013	10.1371/journal.pone.0122013	http://dx.doi.org/10.1371/journal.pone.0122013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790260	Green Submitted, gold, Green Published			2022-12-26	WOS:000351425400207
J	Del-Rio, G; Rego, MA; Silveira, LF				Del-Rio, Glaucia; Rego, Marco Antonio; Silveira, Luis Fabio			A Multiscale Approach Indicates a Severe Reduction in Atlantic Forest Wetlands and Highlights that Sao Paulo Marsh Antwren Is on the Brink of Extinction	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HABITAT; DISTRIBUTIONS; CONSERVATION; PREDICTION; PERFORMANCE; SELECTION; ACCURACY; NUTRIENT; HOTSPOTS	Over the last 200 years the wetlands of the Upper Tiete and Upper Paraiba do Sul basins, in the southeastern Atlantic Forest, Brazil, have been almost-completely transformed by urbanization, agriculture and mining. Endemic to these river basins, the Sao Paulo Marsh Antwren (Formicivora paludicola) survived these impacts, but remained unknown to science until its discovery in 2005. Its population status was cause for immediate concern. In order to understand the factors imperiling the species, and provide guidelines for its conservation, we investigated both the species' distribution and the distribution of areas of suitable habitat using a multiscale approach encompassing species distribution modeling, fieldwork surveys and occupancy models. Of six species distribution models methods used (Generalized Linear Models, Generalized Additive Models, Multivariate Adaptive Regression Splines, Classification Tree Analysis, Artificial Neural Networks and Random Forest), Random Forest showed the best fit and was utilized to guide field validation. After surveying 59 sites, our results indicated that Formicivora paludicola occurred in only 13 sites, having narrow habitat specificity, and restricted habitat availability. Additionally, historic maps, distribution models and satellite imagery showed that human occupation has resulted in a loss of more than 346 km2 of suitable habitat for this species since the early twentieth century, so that it now only occupies a severely fragmented area (area of occupancy) of 1.42 km2, and it should be considered Critically Endangered according to IUCN criteria. Furthermore, averaged occupancy models showed that marshes with lower cattail (Typha dominguensis) densities have higher probabilities of being occupied. Thus, these areas should be prioritized in future conservation efforts to protect the species, and to restore a portion of Atlantic Forest wetlands, in times of unprecedented regional water supply problems.	[Del-Rio, Glaucia] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, Brazil; [Del-Rio, Glaucia; Rego, Marco Antonio; Silveira, Luis Fabio] Univ Sao Paulo, Museu Zool, Secao Aves, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Del-Rio, G (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	gdelri1@lsu.edu	Silveira, Luis/V-6161-2019; Silveira, Luis Fabio/F-8337-2012	Silveira, Luis/0000-0003-2576-7657; Silveira, Luis Fabio/0000-0003-2576-7657	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/16251]; CNPq [313818/2009-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by 2011/16251 (http://www.fapesp.br/) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo to GDR. CNPq 313818/2009-6 (http://www.cnpq.br/) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to LFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amaral S, 2013, AN 15 S BRAS SENS RE, V16, P6930; [Anonymous], 2010, WETLAND ECOLOGY PRIN; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; AUCLAIR AND, 1976, ECOLOGY, V57, P941, DOI 10.2307/1941059; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barthram G.T., 1986, 198485 HFRO, P29; BirdLife International, 2013, SPEC FACTSH FORM LIT; BirdLife International, 2013, SPEC FACTSH MYRM SNO; Bolenbaugh JR, 2011, J FISH WILDL MANAG, V2, P49, DOI 10.3996/012011-JFWM-001; Boscolo D, 2011, ECOGRAPHY, V34, P1018, DOI 10.1111/j.1600-0587.2011.06763.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2003, SETTING USING UNDERS; Breiman L., 2017, CLASSIFICATION REGRE; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Coelho V., 2012, PARAIBA RIO ESTRATEG; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coimbra-Filho AF, 1996, LIMITES ORIGINAIS BI; Buzzetti DRC, 2013, REV BRAS ORNITOL, V21, P269; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; DAVIS SM, 1991, AQUAT BOT, V40, P203, DOI 10.1016/0304-3770(91)90059-E; Dean W., 1995, With broadax and firebrand: the destruction of the Brazilian Atlantic forest.; EDDLEMAN WR, 1988, WILSON BULL, V100, P458; Elith J, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P303; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fonseca GAB, 1995, BIOL CONSERV, V34, P17; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Galindo-Leal C, 2003, STATE HOTS, P3; Garcia PCA, 2009, FAUNA AMEACADA EXTIN, P329; GOLDSMITH F B, 1986, P437; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; GRUMBINE E, 1990, Natural Areas Journal, V10, P114; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hastie T., 1986, STAT SCI, V1, P297; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirata RCA, 2001, REV BRASIL GEOCIENC, V31, P43, DOI DOI 10.25249/0375-7536.20013114350; IBGE-Instituto Brasileiro de Geografiae Estatistica, 2010, PESQ NAC AM DOM SINT; International Union for Conservation of Nature (IUCN), 2010, GUID US IUCN RED LIS; Iserhagem I, 2009, PACTO PELA RESTAURAC, P87; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jorge J, 2006, TIETE RIO QUE CIDADE; Jorge J, 2012, HIST PERSPEC, V25, P103; Ko CY, 2009, ZOOL STUD, V48, P418; Laurance WF, 2009, BIOL CONSERV, V142, P1137, DOI 10.1016/j.biocon.2008.10.011; Ledig FT, 2010, AM J BOT, V97, P970, DOI 10.3732/ajb.0900329; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Li XH, 2013, INTEGR ZOOL, V8, P124, DOI 10.1111/1749-4877.12000; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Lu N, 2012, BIOL CONSERV, V152, P102, DOI 10.1016/j.biocon.2012.04.004; MacKenzie D. I., 2006, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; Mazerolle MJ, 2012, AICCMODAVG MODEL SEL; McCoy J, 2001, USING ARCGISTM SPATI; McPherson JM, 2007, ECOGRAPHY, V30, P135, DOI 10.1111/j.2006.0906-7590.04823.x; METI/NASA, 2012, GLOB DIG EL MOD VERS; Mitsch W. J., 1993, WETLANDS; Mitsch WJ, 2000, ECOL ECON, V35, P25, DOI 10.1016/S0921-8009(00)00165-8; Munoz J, 2004, J VEG SCI, V15, P285, DOI 10.1111/j.1654-1103.2004.tb02263.x; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Newman S, 1998, AQUAT BOT, V60, P265, DOI 10.1016/S0304-3770(97)00089-2; North American Bird Conservation Initiative, 2009, BIRD CONS PLANS; OYAKAWA O.T., 2009, FAUNA AMEACADA EXTIN, P349; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Petit LJ, 2003, CONSERV BIOL, V17, P687, DOI 10.1046/j.1523-1739.2003.00124.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reinert BL, 2007, REV BRAS ORNITOL, V15, P493; REJMANKOVA E, 1995, BIOTROPICA, V27, P28, DOI 10.2307/2388900; Renno CD, 2008, REMOTE SENS ENVIRON, V112, P3469, DOI 10.1016/j.rse.2008.03.018; Reside AE, 2012, ECOL EVOL, V2, P705, DOI 10.1002/ece3.197; RIBIC CA, 1999, P MARSH BIRD MON WOR; Ripley B. D., 1996, PATTERN RECOGNITION; Roberts DR, 2012, ECOGRAPHY, V35, P792, DOI 10.1111/j.1600-0587.2011.07147.x; Silveira LF, 2009, FAUNA AMEACADA EXTIN; Silveira LF, 2011, BIOTA NEOTROP, V11, P2; Sutherland WJ, 2004, TECH ECOL CONSERVAT, P251; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; United States Geological Survey Project, 2013, EARTH EXPL LANDSAT 8; URBAN NH, 1993, AQUAT BOT, V46, P203, DOI 10.1016/0304-3770(93)90002-E; Verry ES, 1989, FRESHWATER WETLANDS, P1177; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Ximenes AC, 2008, THESIS I NACL PESQUI; Kamino LHY, 2012, NAT CONSERVACAO, V10, P191, DOI 10.4322/natcon.2012.033; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zimmer K.J., 2003, P448	98	5	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121315	10.1371/journal.pone.0121315	http://dx.doi.org/10.1371/journal.pone.0121315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798608	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300233
J	Granata, S; Masola, V; Zoratti, E; Scupoli, MT; Baruzzi, A; Messa, M; Sallustio, F; Gesualdo, L; Lupo, A; Zaza, G				Granata, Simona; Masola, Valentina; Zoratti, Elisa; Scupoli, Maria Teresa; Baruzzi, Anna; Messa, Michele; Sallustio, Fabio; Gesualdo, Loreto; Lupo, Antonio; Zaza, Gianluigi			NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; OXIDATIVE STRESS; INTERLEUKIN-1-BETA; PROTEIN; LINK; BIOCOMPATIBILITY; BIOSYNTHESIS; MALNUTRITION; MITOCHONDRIA; HEMODIALYSIS	To assess whether NLR pyrin domain-containing protein 3 (NLRP3) inflammasome, a multi-protein complex that mediates the activation of caspase-1 (CASP-1) and pro-inflammatory cytokines IL-18 and IL-1 beta, could be involved in the chronic inflammatory state observed in chronic kidney disease patients undergoing hemodialysis treatment (CKD-HD), we employed several biomolecular techniques including RT-PCR, western blot, FACS analysis, confocal microscopy and microarray. Interestingly, peripheral blood mononuclear cells from 15 CKD-HD patients showed higher mRNA levels of NLRP3, CASP-1, ASC, IL-1 beta, IL-18 and P2X7receptor compared to 15 healthy subjects. Western blotting analysis confirmed the above results. In particular, active forms of CASP-1, IL1-beta and IL-18 resulted significantly up-regulated in CKD-HD versus controls. Additionally, elevated mitochondrial ROS level, colocalization of NLRP3/ASC/ mitochondria in peripheral blood mononuclear cells from CKD-HD patients and down-regulation of CASP-1, IL1-beta and IL-18 protein levels in immune-cells of CKD-HD patients stimulated with LPS/ATP in presence of mitoTEMPO, inhibitor of mitochondrial ROS production, suggested a possible role of this organelle in the aforementioned CKD-associated inflammasome activation. Then, microarray analysis confirmed, in an independent microarray study cohort, that NLRP3 and CASP-1, along with other inflammasome-related genes, were up-regulated in 17 CKD-HD patients and they were able to clearly discriminate these patients from 5 healthy subjects. All together these data showed, for the first time, that NLRP3 inflammasome was activated in uremic patients undergoing dialysis treatment and they suggested that this unphysiological condition could be possibly induced by mitochondrial dysfunction.	[Granata, Simona; Masola, Valentina; Messa, Michele; Lupo, Antonio; Zaza, Gianluigi] Univ Hosp Verona, Dept Med, Renal Unit, Verona, Italy; [Zoratti, Elisa; Scupoli, Maria Teresa] Univ Verona, Interdept Lab Med Res LURM, I-37100 Verona, Italy; [Baruzzi, Anna] Univ Verona, Sect Gen Pathol, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Sallustio, Fabio; Gesualdo, Loreto] Univ Bari, Dialysis & Transplantat Unit, Dept Emergency & Organ Transplantat Nephrol, Bari, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; Universita degli Studi di Bari Aldo Moro	Zaza, G (corresponding author), Univ Hosp Verona, Dept Med, Renal Unit, Verona, Italy.	gianluigi.zaza@univr.it	Sallustio, Fabio/AFP-7212-2022; Zaza, Gianluigi/K-3827-2018; Gesualdo, Loreto/K-7751-2016; Sallustio, Fabio/D-2326-2011; SCUPOLI, Maria/AAX-9712-2021; granata, simona/K-4148-2016	Sallustio, Fabio/0000-0002-5132-6532; Gesualdo, Loreto/0000-0002-4861-0911; Sallustio, Fabio/0000-0002-5132-6532; SCUPOLI, Maria/0000-0002-3352-7859; Masola, Valentina/0000-0003-2341-2481; granata, simona/0000-0002-3740-7598; Zaza, Gianluigi/0000-0002-6004-6196				Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Akahoshi T, 1995, NEPHROL DIAL TRANSPL, V10, P2244, DOI 10.1093/ndt/10.12.2244; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; CHAN SI, 1990, BIOCHEMISTRY-US, V29, P1, DOI 10.1021/bi00453a001; Chanard J, 2003, NEPHROL DIAL TRANSPL, V18, P252, DOI 10.1093/ndt/18.2.252; CHEUNG AK, 1990, KIDNEY INT, V37, P1055, DOI 10.1038/ki.1990.85; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fritz JH, 2005, J ENDOTOXIN RES, V11, P390, DOI 10.1179/096805105X76850; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; Gohh R., 2013, R I MED J, V104, P14; Granata S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-388; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hamer RA, 2006, BMJ-BRIT MED J, V332, P563, DOI 10.1136/bmj.332.7541.563; Handelman GJ, 2001, KIDNEY INT, V59, P1960, DOI 10.1046/j.1523-1755.2001.0590051960.x; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Ito S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4483; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kotur-Stevuljevic J, 2012, CLIN BIOCHEM, V45, P1202, DOI 10.1016/j.clinbiochem.2012.04.021; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; LAZARUS JM, 1994, AM J KIDNEY DIS, V24, P1019, DOI 10.1016/S0272-6386(12)81077-8; Liang D, 2007, NEPHROLOGY, V12, P53, DOI 10.1111/j.1440-1797.2006.00737.x; Libetta C, 2011, CLIN BIOCHEM, V44, P1189, DOI 10.1016/j.clinbiochem.2011.06.988; LONNEMANN G, 1987, NEW ENGL J MED, V317, P963; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mezzano D, 2001, KIDNEY INT, V60, P1844, DOI 10.1046/j.1523-1755.2001.00998.x; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; NAKANISHI I, 1994, NEPHROL DIAL TRANSPL, V9, P1435; Patel UD, 2005, AM J KIDNEY DIS, V46, P406, DOI 10.1053/j.ajkd.2005.05.027; Pertosa G, 2009, AM J KIDNEY DIS, V53, P467, DOI 10.1053/j.ajkd.2008.10.046; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Rossier MF, 2006, CELL CALCIUM, V40, P155, DOI 10.1016/j.ceca.2006.04.020; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Schreiber A, 2015, J AM SOC NEPHROL, V26, P411, DOI 10.1681/ASN.2013111177; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Slee AD, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-36; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tomo T, 2011, CONTRIB NEPHROL, V168, P89, DOI 10.1159/000321747; van der Burgh R, 2014, J BIOL CHEM, V289, P5000, DOI 10.1074/jbc.M113.536920; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vesey DA, 2002, J LAB CLIN MED, V140, P342, DOI 10.1067/mlc.2002.128468; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wang MR, 2012, EXP DIABETES RES, DOI 10.1155/2012/647914; WARD RA, 1995, J AM SOC NEPHROL, V5, P1697; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Zaza G, 2008, NEPHROL DIAL TRANSPL, V23, P1673, DOI 10.1093/ndt/gfm804; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhuang YB, 2014, J BIOL CHEM, V289, P25101, DOI 10.1074/jbc.M114.578260	64	59	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122272	10.1371/journal.pone.0122272	http://dx.doi.org/10.1371/journal.pone.0122272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798846	Green Published, gold			2022-12-26	WOS:000351987300324
J	Irvin, SC; Herold, BC				Irvin, Susan C.; Herold, Betsy C.			Molecular Mechanisms Linking High Dose Medroxyprogesterone with HIV-1 Risk	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HORMONAL CONTRACEPTION; VAGINAL EPITHELIUM; GENITAL HERPES; CELL-LINES; IN-VITRO; INFECTION; EXPRESSION; ACETATE; LYMPHOCYTES	Background Epidemiological studies suggest that medroxyprogesterone acetate (MPA) may increase the risk of HIV-1. The current studies were designed to identify potential underlying biological mechanisms. Methods Human vaginal epithelial (VK2/E6E7), peripheral blood mononuclear (PBMC), and polarized endometrial (HEC-1-A) cells were treated with a range of concentrations of MPA (0.015-150 mu g/ml) and the impact on gene expression, protein secretion, and HIV infection was evaluated. Results Treatment of VK2/E6E7 cells with high doses (>15 mu g/ml] of MPA significantly upregulated proinflammatory cytokines, which resulted in a significant increase in HIV p24 levels secreted by latently infected U1 cells following exposure to culture supernatants harvested from MPA compared to mock-treated cells. MPA also increased syndecan expression by VK2/E6E7 cells and cells treated with 15 mu g/ml of MPA bound and transferred more HIV-1 to T cells compared to mock-treated cells. Moreover, MPA treatment of epithelial cells and PBMC significantly decreased cell proliferation resulting in disruption of the epithelial barrier and decreased cytokine responses to phytohaemagglutinin, respectively. Conclusion We identified several molecular mechanisms that could contribute to an association between DMPA and HIV including proinflammatory cytokine and chemokine responses that could activate the HIV promoter and recruit immune targets, increased expression of syndecans to facilitate the transfer of virus from epithelial to immune cells and decreased cell proliferation. The latter could impede the ability to maintain an effective epithelial barrier and adversely impact immune cell function. However, these responses were observed primarily following exposure to high (15-150 mu g/ml) MPA concentrations. Clinical correlation is needed to determine whether the prolonged MPA exposure associated with contraception activates these mechanisms in vivo.	[Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Herold, BC (corresponding author), Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA.	betsy.herold@einstein.yu.edu		Herold, Betsy/0000-0001-9974-0786	National Institutes of Health [T32A1007501, U19AI03461, R01AI065309]; Montefiore Medical Center [AI51519]; Center for AIDS Research at the Albert Einstein College of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI103461, R01AI065309, T32AI007501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montefiore Medical Center; Center for AIDS Research at the Albert Einstein College of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [grant numbers T32A1007501 to SCI, U19AI03461 and R01AI065309 to BCH, and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center AI51519]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africander D, 2011, CONTRACEPTION, V84, P423, DOI 10.1016/j.contraception.2011.06.006; Bacsa S, 2011, J GEN VIROL, V92, P733, DOI 10.1099/vir.0.027052-0; Bahamondes L, 2000, CONTRACEPTION, V62, P23, DOI 10.1016/S0010-7824(00)00132-3; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Butler AR, 2013, AIDS, V27, P105, DOI 10.1097/QAD.0b013e32835a5a52; Chandra N, 2013, AIDS RES HUM RETROV, V29, P592, DOI 10.1089/aid.2012.0271; Day S, 2014, J ACQUIR IMMUNE DEFI; Fears CY, 2006, MATRIX BIOL, V25, P443, DOI 10.1016/j.matbio.2006.07.003; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hel Z, 2010, ENDOCR REV, V31, P79, DOI 10.1210/er.2009-0018; Huijbregts RPH, 2013, ENDOCRINOLOGY, V154, P1282, DOI 10.1210/en.2012-1850; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; KURAMOTO H, 1972, AM J OBSTET GYNECOL, V114, P1012, DOI 10.1016/0002-9378(72)90861-7; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Mauck CK, 1999, CONTRACEPTION, V60, P15, DOI 10.1016/S0010-7824(99)00058-X; Mesquita PMM, 2008, J VIROL, V82, P6576, DOI 10.1128/JVI.00335-08; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Miller L, 2000, OBSTET GYNECOL, V96, P431, DOI 10.1016/S0029-7844(00)00906-6; Mishell DR, 1996, J REPROD MED, V41, P381; Mitchell CM ML, 2014, J INFECT DIS; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Morrison C, 2014, JAIDS-J ACQ IMM DEF, V66, P109, DOI 10.1097/QAI.0000000000000103; Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778; Murphy K, 2014, AM J REPROD IMMUNOL; Nixon B, 2013, J VIROL, V87, P6257, DOI 10.1128/JVI.00012-13; Phillips SJ, 2013, AIDS, V27, P787, DOI 10.1097/QAD.0b013e32835bb672; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Radzio J, 2014, AIDS; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005; Tiwari V, 2012, GLYCOBIOLOGY, V22, P1402, DOI 10.1093/glycob/cws106; Vassiliadou N, 1999, J IMMUNOL, V162, P7510; Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3; Wilson SS, 2009, ANTIVIR THER, V14, P1113, DOI 10.3851/IMP1463	39	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121135	10.1371/journal.pone.0121135	http://dx.doi.org/10.1371/journal.pone.0121135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798593	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300213
J	Ahmed, MM; Dhanasekaran, AR; Block, A; Tong, SH; Costa, ACS; Stasko, M; Gardiner, KJ				Ahmed, Md Mahiuddin; Dhanasekaran, A. Ranjitha; Block, Aaron; Tong, Suhong; Costa, Alberto C. S.; Stasko, Melissa; Gardiner, Katheleen J.			Protein Dynamics Associated with Failed and Rescued Learning in the Ts65Dn Mouse Model of Down Syndrome	PLOS ONE			English	Article							NMDA RECEPTOR ANTAGONIST; COGNITIVE DEFICITS; SYNAPTIC PLASTICITY; SYNDROME PHENOTYPES; CONTROLLED-TRIAL; SYNDROME MICE; MEMANTINE; MEMORY; MODULATION; PROFILES	Down syndrome (DS) is caused by an extra copy of human chromosome 21 (Hsa21). Although it is the most common genetic cause of intellectual disability (ID), there are, as yet, no effective pharmacotherapies. The Ts65Dn mouse model of DS is trisomic for orthologs of similar to 55% of Hsa21 classical protein coding genes. These mice display many features relevant to those seen in DS, including deficits in learning and memory (L/M) tasks requiring a functional hippocampus. Recently, the N-methyl-D-aspartate (NMDA) receptor antagonist, memantine, was shown to rescue performance of the Ts65Dn in several L/M tasks. These studies, however, have not been accompanied by molecular analyses. In previous work, we described changes in protein expression induced in hippocampus and cortex in control mice after exposure to context fear conditioning (CFC), with and without memantine treatment. Here, we extend this analysis to Ts65Dn mice, measuring levels of 85 proteins/protein modifications, including components of MAP kinase and MTOR pathways, and subunits of NMDA receptors, in cortex and hippocampus of Ts65Dn mice after failed learning in CFC and after learning was rescued by memantine. We show that, compared with wild type littermate controls, (i) of the dynamic responses seen in control mice in normal learning, >40% also occur in Ts65Dn in failed learning or are compensated by baseline abnormalities, and thus are considered necessary but not sufficient for successful learning, and (ii) treatment with memantine does not in general normalize the initial protein levels but instead induces direct and indirect responses in approximately half the proteins measured and results in normalization of the endpoint protein levels. Together, these datasets provide a first view of the complexities associated with pharmacological rescue of learning in the Ts65Dn. Extending such studies to additional drugs and mouse models of DS will aid in identifying pharmacotherapies for effective clinical trials.	[Ahmed, Md Mahiuddin; Dhanasekaran, A. Ranjitha; Block, Aaron; Gardiner, Katheleen J.] Univ Colorado Denver, Dept Pediat, Linda Crn Inst Syndrome, Aurora, CO 80045 USA; [Tong, Suhong] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO 80045 USA; [Costa, Alberto C. S.; Stasko, Melissa] Rainbow Babies & Childrens Hosp, Case Western Reserve Sch Med, Dept Pediat, Div Pediat Neurol, Cleveland, OH 44106 USA; [Gardiner, Katheleen J.] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Gardiner, Katheleen J.] Univ Colorado Denver, Human Med Genet & Genom Program, Aurora, CO 80045 USA; [Gardiner, Katheleen J.] Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Gardiner, KJ (corresponding author), Univ Colorado Denver, Dept Pediat, Linda Crn Inst Syndrome, Mail Stop 8608,12700 E 19th Ave, Aurora, CO 80045 USA.	katheleen.gardiner@ucdenver.edu		Costa, Alberto/0000-0002-7855-1190	National Institute of Child Health and Human Disease [HD056235]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056235] Funding Source: NIH RePORTER	National Institute of Child Health and Human Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	HD056235 National Institute of Child Health and Human Disease https://www.nichd.nih.gov to KG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 2014, MOL CELL PROTEOMICS, V13, P919, DOI 10.1074/mcp.M113.035568; Ahmed MM, 2013, HUM MOL GENET, V22, P1709, DOI 10.1093/hmg/ddt017; Ahmed MM, 2012, J PROTEOME RES, V11, P1251, DOI 10.1021/pr2011582; Boada R, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.66; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; Busciglio J, 2013, CYTOGENET GENOME RES, V141, P260, DOI 10.1159/000354306; CDC Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V54, P6; Chang Q, 2008, NEUROBIOL LEARN MEM, V89, P167, DOI 10.1016/j.nlm.2007.05.007; Chapman RS, 2000, MENT RETARD DEV D R, V6, P84, DOI 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.3.CO;2-G; Chen HSV, 2005, J PHARMACOL EXP THER, V314, P961, DOI 10.1124/jpet.105.085142; Contestabile A, 2013, J CLIN INVEST, V123, P348, DOI 10.1172/JCI64650; Corrales A, 2013, J PINEAL RES, V54, P346, DOI 10.1111/jpi.12037; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Costa ACS, 2010, BEHAV BRAIN RES, V206, P52, DOI 10.1016/j.bbr.2009.08.034; Das I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005983; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; De la Torre R, 2014, MOL NUTR FOOD RES, V58, P278, DOI 10.1002/mnfr.201300325; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Garcia-Cerro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106572; Gardiner KJ, 2014, DRUG DES DEV THER, V9, P103, DOI 10.2147/DDDT.S51476; Gardiner KJ, 2010, TRENDS PHARMACOL SCI, V31, P66, DOI 10.1016/j.tips.2009.10.010; Hanney M, 2012, LANCET, V379, P528, DOI 10.1016/S0140-6736(11)61676-0; Irving C, 2008, EUR J HUM GENET, V16, P1336, DOI 10.1038/ejhg.2008.122; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Kleschevnikov AM, 2012, J NEUROSCI, V32, P9217, DOI 10.1523/JNEUROSCI.1673-12.2012; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Krzywinski M, 2014, NAT METHODS, V11, P355, DOI 10.1038/nmeth.2900; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Liu DP, 2003, BIOTECHNIQUES, V35, P1170, DOI 10.2144/03356st02; Lockrow J, 2011, BEHAV BRAIN RES, V221, P610, DOI 10.1016/j.bbr.2010.03.036; Martinez-Cue C, 2013, J NEUROSCI, V33, P3953, DOI 10.1523/JNEUROSCI.1203-12.2013; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Radulovic J, 1999, J NEUROSCI, V19, P5016; RAHMANI Z, 1990, AM J MED GENET, P98; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Rozeske RR, 2015, GENES BRAIN BEHAV, V14, P22, DOI 10.1111/gbb.12181; Rueda N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/584071; Rueda N, 2010, J ALZHEIMERS DIS, V21, P277, DOI 10.3233/JAD-2010-100240; Scott-McKean JJ, 2011, LEARN MEMORY, V18, P774, DOI 10.1101/lm.024182.111; Siddiqui A, 2008, GENES BRAIN BEHAV, V7, P810, DOI 10.1111/j.1601-183X.2008.00428.x; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sturgeon X, 2012, PROG BRAIN RES, V197, P73, DOI 10.1016/B978-0-444-54299-1.00005-4; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Vilardell M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-229; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	51	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119491	10.1371/journal.pone.0119491	http://dx.doi.org/10.1371/journal.pone.0119491			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793384	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200087
J	Liu, JP; Kachelmeier, A; Dai, CF; Li, HZ; Steyger, PS				Liu, Jianping; Kachelmeier, Allan; Dai, Chunfu; Li, Hongzhe; Steyger, Peter S.			Uptake of Fluorescent Gentamicin by Peripheral Vestibular Cells after Systemic Administration	PLOS ONE			English	Article							30S RIBOSOMAL-SUBUNIT; COCHLEAR HAIR-CELLS; PIG INNER-EAR; INTRATYMPANIC GENTAMICIN; COMPARATIVE MORPHOLOGY; INDUCED OTOTOXICITY; MENIERES-DISEASE; OTOLITH FUNCTION; GUINEA-PIGS; AMINOGLYCOSIDES	Objective In addition to cochleotoxicity, systemic aminoglycoside pharmacotherapy causes vestibulotoxicity resulting in imbalance and visual dysfunction. The underlying trafficking routes of systemically-administered aminoglycosides from the vasculature to the vestibular sensory hair cells are largely unknown. We investigated the trafficking of systemically-administered gentamicin into the peripheral vestibular system in C56Bl/6 mice using fluorescence-tagged gentamicin (gentamicin-Texas-Red, GTTR) imaged by scanning laser confocal microscopy to determine the cellular distribution and intensity of GTTR fluorescence in the three semicircular canal cristae, utricular, and saccular maculae at 5 time points over 4 hours. Results Low intensity GTTR fluorescence was detected at 0.5 hours as both discrete puncta and diffuse cytoplasmic fluorescence. The intensity of cytoplasmic fluorescence peaked at 3 hours, while punctate fluorescence was plateaued after 3 hours. At 0.5 and 1 hour, higher levels of diffuse GTTR fluorescence were present in transitional cells compared to hair cells and supporting cells. Sensory hair cells typically exhibited only diffuse cytoplasmic fluorescence at all time-points up to 4 hours in this study. In contrast, non-sensory cells rapidly exhibited both intense fluorescent puncta and weaker, diffuse fluorescence throughout the cytosol. The numbers and size of fluorescent puncta in dark cells and transitional cells increased over time. There is no preferential GTTR uptake by the five peripheral vestibular organs' sensory cells. Control vestibular tissues exposed to Dulbecco's phosphate-buffered saline or hydrolyzed Texas Red had negligible fluorescence. Conclusions All peripheral vestibular cells rapidly take up systemically-administered GTTR, reaching peak intensity 3 hours after injection. Sensory hair cells exhibited only diffuse fluorescence, while non-sensory cells displayed both diffuse and punctate fluorescence. Transitional cells may act as a primary pathway for trafficking of systemic GTTR from the vasculature to endolymph prior to entering hair cells.	[Liu, Jianping; Kachelmeier, Allan; Li, Hongzhe; Steyger, Peter S.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Liu, Jianping; Dai, Chunfu] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otol & Skull Base Surg, Shanghai 200433, Peoples R China	Oregon Health & Science University; Fudan University	Steyger, PS (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	steygerp@ohsu.edu	Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237	National Institutes of Health from the National Institute of Deafness and other Communication Disorders [R01 DC04555, DC05983]; National natural science foundation of China [30600704]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004555, P30DC005983, R01DC012588] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National natural science foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants grants R01 DC04555 (PSS), and DC05983 (P30) from the National Institute of Deafness and other Communication Disorders (http://www.nidcd.nih.gov/Pages/default.aspx), and by National natural science foundation of China (http://www.nsfc.gov.cn/) grant NSFC No. 30600704 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2013, J NEUROL, V260, P876, DOI 10.1007/s00415-012-6724-y; Alharazneh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022347; Aran JM, 1999, ANN NY ACAD SCI, V884, P60, DOI 10.1111/j.1749-6632.1999.tb08636.x; Ariano RE, 2008, ANN PHARMACOTHER, V42, P1282, DOI 10.1345/aph.1L001; Basta D, 2005, HUM MOVEMENT SCI, V24, P268, DOI 10.1016/j.humov.2005.04.002; BEAUCHAMP D, 1991, ANTIMICROB AGENTS CH, V35, P2173, DOI 10.1128/AAC.35.11.2173; Bhattacharyya TK, 2005, AM J OTOLARYNG, V26, P91, DOI 10.1016/j.amjoto.2004.08.007; Black FO, 2004, OTOL NEUROTOL, V25, P559, DOI 10.1097/00129492-200407000-00025; BLACK FO, 1993, OTOLARYNG CLIN N AM, V26, P713; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CAWTHORNE T, 1957, BRIT MED J, V1, P1444, DOI 10.1136/bmj.1.5033.1444; Cheng PW, 2010, NEUROTOXICOLOGY, V31, P121, DOI 10.1016/j.neuro.2009.10.009; Clarke AH, 2003, J VESTIBUL RES-EQUIL, V13, P215; Dai CF, 2008, HEARING RES, V235, P114, DOI 10.1016/j.heares.2007.10.010; DEGROOT JCMJ, 1990, HEARING RES, V50, P35, DOI 10.1016/0378-5955(90)90031-J; Desai SS, 2005, J NEUROPHYSIOL, V93, P267, DOI 10.1152/jn.00747.2003; Desai SS, 2005, J NEUROPHYSIOL, V93, P251, DOI 10.1152/jn.00746.2003; Durante-Mangoni E, 2009, INT J ANTIMICROB AG, V33, P201, DOI 10.1016/j.ijantimicag.2008.09.001; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; GRAYBIEL A, 1967, AEROSPACE MED, V38, P1099; Hain TC, 2013, SEMIN NEUROL, V33, P195, DOI 10.1055/s-0033-1354597; Hashino E, 1995, BRAIN RES, V704, P135, DOI 10.1016/0006-8993(95)01198-6; HAYASHIDA T, 1985, ARCH OTO-RHINO-LARYN, V242, P257, DOI 10.1007/BF00453548; HAYASHIDA T, 1989, ARCH OTO-RHINO-LARYN, V246, P161, DOI 10.1007/BF00456659; Helling K, 2007, LARYNGOSCOPE, V117, P2244, DOI 10.1097/MLG.0b013e3181453a3c; Hirvonen TP, 2005, J NEUROPHYSIOL, V93, P643, DOI 10.1152/jn.00160.2004; HUY PTB, 1986, J CLIN INVEST, V77, P1492, DOI 10.1172/JCI112463; Imamura S, 2003, JARO-J ASSOC RES OTO, V4, P176, DOI 10.1007/s10162-002-2036-8; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; Jiang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108941; Jones Sherri M., 2009, Seminars in Hearing, V30, P231, DOI 10.1055/s-0029-1241124; Karasawa T, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.80; Karasawa T, 2011, TOXICOL SCI, V124, P378, DOI 10.1093/toxsci/kfr196; Koo JW, 2011, AUDIOL NEURO-OTOL, V16, P347, DOI 10.1159/000322851; Li HZ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00159; Li HZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019130; LINDEMAN HH, 1969, ACTA OTO-LARYNGOL, V67, P177, DOI 10.3109/00016486909125441; Lyford-Pike S, 2007, JARO-J ASSOC RES OTO, V8, P497, DOI 10.1007/s10162-007-0093-8; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Mendel B, 1999, CLIN OTOLARYNGOL, V24, P286, DOI 10.1046/j.1365-2273.1999.00261.x; Myrdal SE, 2005, HEARING RES, V204, P156, DOI 10.1016/j.heares.2005.02.002; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PARK JC, 1982, AM J OTOLARYNG, V3, P117, DOI 10.1016/S0196-0709(82)80042-2; Selimoglu E, 2007, CURR PHARM DESIGN, V13, P119, DOI 10.2174/138161207779313731; Steyger PS, 2003, JARO-J ASSOC RES OTO, V4, P565, DOI 10.1007/s10162-003-4002-5; Vicens Q, 2003, CHEMBIOCHEM, V4, P1018, DOI 10.1002/cbic.200300684; Wang Q, 2010, HEARING RES, V268, P250, DOI 10.1016/j.heares.2010.06.008; Wang Q, 2009, JARO-J ASSOC RES OTO, V10, P205, DOI 10.1007/s10162-009-0160-4; WERSALL J, 1971, ARCH KLIN EXP OHR, V200, P1, DOI 10.1007/BF00302186; Zhai F, 2013, AUDIOL NEURO-OTOL, V18, P297, DOI 10.1159/000351805; Zhang R, 2013, HEARING RES, V298, P49, DOI 10.1016/j.heares.2013.01.010; Zhang YB, 2012, HEARING RES, V283, P169, DOI 10.1016/j.heares.2011.10.003	52	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120612	10.1371/journal.pone.0120612	http://dx.doi.org/10.1371/journal.pone.0120612			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793391	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900058
J	Mazumdar, S; Arendt, LM; Phillips, S; Sedic, M; Kuperwasser, C; Gill, G				Mazumdar, Sohini; Arendt, Lisa M.; Phillips, Sarah; Sedic, Maja; Kuperwasser, Charlotte; Gill, Grace			CoREST1 Promotes Tumor Formation and Tumor Stroma Interactions in a Mouse Model of Breast Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; EPITHELIAL-MESENCHYMAL TRANSITION; DEMETHYLASE 1; HISTONE DEMETHYLASE; GENE-EXPRESSION; STEM-CELLS; LSD1; MACROPHAGES; COMPLEX	Regulators of chromatin structure and gene expression contribute to tumor formation and progression. The co-repressor CoREST1 regulates the localization and activity of associated histone modifying enzymes including lysine specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1). Although several CoREST1 associated proteins have been reported to enhance breast cancer progression, the role of CoREST1 in breast cancer is currently unclear. Here we report that knockdown of CoREST1 in the basal-type breast cancer cell line, MDA-MB-231, led to significantly reduced incidence and diminished size of tumors compared to controls in mouse xenograft studies. Notably, CoREST1-depleted cells gave rise to tumors with a marked decrease in angiogenesis. CoREST1 knockdown led to a decrease in secreted angiogenic and inflammatory factors, and mRNA analysis suggests that CoREST1 promotes expression of genes related to angiogenesis and inflammation including VEGF-A and CCL2. CoREST1 knockdown decreased the ability of MDA-MB-231 conditioned media to promote endothelial cell tube formation and migration. Further, tumors derived from CoREST1-depleted cells had reduced macrophage infiltration and the secretome of CoREST1 knockdown cells was deficient in promoting macrophage migration and macrophage-mediated angiogenesis. Taken together, these findings reveal that the epigenetic regulator CoREST1 promotes tumorigenesis in a breast cancer model at least in part through regulation of gene expression patterns in tumor cells that have profound non-cell autonomous effects on endothelial and inflammatory cells in the tumor microenvironment.	[Mazumdar, Sohini; Arendt, Lisa M.; Phillips, Sarah; Sedic, Maja; Kuperwasser, Charlotte; Gill, Grace] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Mazumdar, Sohini; Phillips, Sarah] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Genet Program, Boston, MA 02111 USA; [Sedic, Maja] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Cellular Mol & Dev Biol Program, Boston, MA 02111 USA; [Arendt, Lisa M.; Phillips, Sarah; Sedic, Maja; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA	Tufts University; Tufts University; Tufts University; Tufts Medical Center	Gill, G (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	Grace.Gill@tufts.edu		Arendt, Lisa/0000-0002-7954-3635	Sackler Families Fund for Collaborative Cancer Biology Research Award; Breast Cancer Research Foundation; National Institutes of Health/National Cancer Institute [CA125554, CA170851]; NATIONAL CANCER INSTITUTE [R01CA170851, R01CA125554, P01CA092644] Funding Source: NIH RePORTER	Sackler Families Fund for Collaborative Cancer Biology Research Award; Breast Cancer Research Foundation; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported by a Sackler Families Fund for Collaborative Cancer Biology Research Award (G.G. and S.M.), the Breast Cancer Research Foundation (C.K.), and the National Institutes of Health/National Cancer Institute Awards CA125554 and CA170851 (C.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Barrios AP, 2014, MOL CELL BIOL, V34, P2760, DOI 10.1128/MCB.00083-14; Cai CM, 2014, CELL REP, V9, P1618, DOI 10.1016/j.celrep.2014.11.008; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Domanitskaya E, 2012, J CELL SCI, V125, P399, DOI 10.1242/jcs.089797; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Ferrari-Amorotti G, 2014, NEOPLASIA, V16, P1047, DOI 10.1016/j.neo.2014.10.006; Foekens JA, 2001, CANCER RES, V61, P5407; Gasparini G, 1997, J NATL CANCER I, V89, P139, DOI 10.1093/jnci/89.2.139; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Gordillo GM, 2004, AM J PHYSIOL-CELL PH, V287, pC866, DOI 10.1152/ajpcell.00238.2003; Guo CQ, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-20; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang Y, 2012, BREAST CANCER RES TR, V131, P777, DOI 10.1007/s10549-011-1480-8; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Jin LH, 2013, BIOCHEM J, V449, P459, DOI 10.1042/BJ20121360; Kang FW, 2012, ONCOL REP, V28, P193, DOI 10.3892/or.2012.1784; Kashyap V, 2013, MOL ONCOL, V7, P555, DOI 10.1016/j.molonc.2013.01.003; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Komohara Y, 2012, CANCER SCI, V103, P2165, DOI 10.1111/cas.12015; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Linderholm B, 2000, J CLIN ONCOL, V18, P1423, DOI 10.1200/JCO.2000.18.7.1423; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Lv T, 2009, PLOS ONE, V7; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Meier K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002676; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pollock JA, 2012, ACS CHEM BIOL, V7, P1221, DOI 10.1021/cb300108c; Porta C, 2007, ADV EXP MED BIOL, V604, P67, DOI 10.1007/978-0-387-69116-9_5; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Thillainadesan G, 2008, MOL CELL BIOL, V28, P6066, DOI 10.1128/MCB.00246-08; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Upadhyay G, 2014, P NATL ACAD SCI USA, V111, P8071, DOI 10.1073/pnas.1404292111; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang J, 2013, STEM CELLS, V31, P248, DOI 10.1002/stem.1281; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhu QS, 2012, AMINO ACIDS, V42, P887, DOI 10.1007/s00726-011-1004-1	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121281	10.1371/journal.pone.0121281	http://dx.doi.org/10.1371/journal.pone.0121281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793264	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900120
J	Schweiger, T; Nikolowsky, C; Starlinger, P; Traxler, D; Zimmermann, M; Birner, P; Hegedus, B; Dome, B; Bergmann, M; Mildner, M; Klepetko, W; Hoetzenecker, K; Ankersmit, HJ				Schweiger, Thomas; Nikolowsky, Christoph; Starlinger, Patrick; Traxler, Denise; Zimmermann, Matthias; Birner, Peter; Hegedues, Balazs; Dome, Balazs; Bergmann, Michael; Mildner, Michael; Klepetko, Walter; Hoetzenecker, Konrad; Ankersmit, Hendrik Jan			Stromal Expression of Heat-Shock Protein 27 Is Associated with Worse Clinical Outcome in Patients with Colorectal Cancer Lung Metastases	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; TUMOR STROMA; COLON-CANCER; PULMONARY METASTASECTOMY; PROGNOSTIC INDICATOR; HSP27 EXPRESSION; CELLS; ANGIOGENESIS; MORTALITY; MARKERS	Background Pulmonary metastases are common in patients with primary colorectal cancer (CRC). Heat-shock protein 27 (Hsp27) is upregulated in activated fibroblasts during wound healing and systemically elevated in various diseases. Cancer-associated fibroblasts (CAFs) are also thought to play a role as prognostic and predictive markers in various malignancies including CRC. Surprisingly, the expression of Hsp27 has never been assessed in CAFs. Therefore we aimed to investigate the expression level of Hsp27 in CAFs and its clinical implications in patients with CRC lung metastases. Methods FFPE tissue samples from 51 pulmonary metastases (PMs) and 33 paired primary tumors were evaluated for alpha-SMA, CD31, Hsp27 and vimentin expression by immunohistochemistry and correlated with clinicopathological variables. 25 liver metastases served as control group. Moreover, serum samples (n= 10) before and after pulmonary metastasectomy were assessed for circulating phospho-Hsp27 and total Hsp27 by ELISA. Results Stromal expression of Hsp27 was observed in all PM and showed strong correlation with alpha-SMA (P< 0.001) and vimentin (P< 0.001). Strong stromal Hsp27 was associated with higher microvessel density in primary CRC and PM. Moreover, high stromal Hsp27 and alpha SMA expression were associated with decreased recurrence-free survival after pulmonary metastasectomy (P= 0.018 and P= 0.008, respectively) and overall survival (P= 0.031 and P= 0.017, respectively). Serum levels of phospho-and total Hsp27 dropped after metastasectomy to levels comparable to healthy controls. Conclusions Herein we describe for the first time that Hsp27 is highly expressed in tumor stroma of CRC. Stromal alpha-SMA and Hsp27 expressions correlate with the clinical outcome after pulmonary metastasectomy. Moreover, serum Hsp27 might pose a future marker for metastatic disease in CRC.	[Schweiger, Thomas; Nikolowsky, Christoph; Traxler, Denise; Hegedues, Balazs; Dome, Balazs; Klepetko, Walter; Hoetzenecker, Konrad; Ankersmit, Hendrik Jan] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Schweiger, Thomas; Nikolowsky, Christoph; Traxler, Denise; Zimmermann, Matthias; Hoetzenecker, Konrad; Ankersmit, Hendrik Jan] Med Univ Vienna, Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria; [Starlinger, Patrick; Bergmann, Michael] Med Univ Vienna, Dept Gen Surg, Vienna, Austria; [Birner, Peter] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Hegedues, Balazs] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Hegedues, Balazs] Semmelweis Univ, Hungarian Acad Sci, Mol Oncol Res Grp, H-1085 Budapest, Hungary; [Birner, Peter; Hegedues, Balazs] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Dome, Balazs] Natl Koranyi Inst Pulmonol, Budapest, Hungary; [Dome, Balazs] Semmelweis Univ, Natl Inst Oncol, Dept Thorac Surg, H-1085 Budapest, Hungary; [Hegedues, Balazs; Dome, Balazs] Med Univ Vienna, Div Mol & Gender Imaging, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Mildner, Michael] Med Univ Vienna, Dept Dermatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Medical University of Vienna; National Institute of Oncology Hungary; Semmelweis University; Medical University of Vienna; Medical University of Vienna	Ankersmit, HJ (corresponding author), Med Univ Vienna, Dept Thorac Surg, Vienna, Austria.	hendrik.ankersmit@meduniwien.ac.at	Hegedus, Balazs/B-6076-2008; Bergmann, Michael/GZK-7700-2022; Zimmermann, Matthias/AAE-9681-2020	Hegedus, Balazs/0000-0002-4341-4153; Ankersmit, Hendrik Jan/0000-0002-8761-3517; Starlinger, Patrick/0000-0002-4666-5337; Traxler-Weidenauer, Denise/0000-0001-8679-1525; Bergmann, Michael/0000-0001-8529-1166; Hoetzenecker, Konrad/0000-0001-6775-7460; Dome, Balazs/0000-0001-8799-8624; Schweiger, Thomas/0000-0002-0173-7536; Mildner, Michael/0000-0002-6892-925X; Zimmermann, Matthias/0000-0002-4610-7853	Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration; Medical University of Vienna	Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration; Medical University of Vienna	This study was supported by the Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration and by the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankersmit HJ, 2012, RESPIRATION, V83, P391, DOI 10.1159/000336557; Bosman JD, 2010, BREAST CANCER RES TR, V119, P63, DOI 10.1007/s10549-009-0330-4; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Driessen A, 2006, ANN SURG, V243, P334, DOI 10.1097/01.sla.0000201452.09591.f3; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ghosh A, 2013, EXP MOL PATHOL, V94, P103, DOI 10.1016/j.yexmp.2012.09.001; Hacker S, 2009, CLIN LAB, V55, P31; Hadaschik BA, 2008, BJU INT, V102, P610, DOI 10.1111/j.1464-410X.2008.07669.x; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Herrera M, 2013, CLIN CANCER RES, V19, P5914, DOI 10.1158/1078-0432.CCR-13-0694; Hirano S, 2004, CELL STRESS CHAPERON, V9, P29, DOI 10.1379/1466-1268(2004)009<0029:HRFAMA>2.0.CO;2; Hirano S, 2002, J SURG RES, V102, P77, DOI 10.1006/jsre.2001.6315; Kahlert C, 2014, BRIT J CANCER, V110, P441, DOI 10.1038/bjc.2013.745; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Lofdahl M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-48; Malvezzi M, 2011, ANN ONCOL, V22, P947, DOI 10.1093/annonc/mdq774; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Ngan CY, 2007, BRIT J CANCER, V96, P986, DOI 10.1038/sj.bjc.6603651; Oncogenex Corp, 2014, APATORSEN OGX 427; Orimo A, 2001, CLIN CANCER RES, V7, P3097; Piotrowicz RS, 1998, FASEB J, V12, P1481, DOI 10.1096/fasebj.12.14.1481; Sato T, 2002, APMIS, V110, P347, DOI 10.1034/j.1600-0463.2002.100410.x; Schweiger T, 2013, EUR J CARDIOTHORAC S; Schweiger T, 2014, ANN SURG ONCOL, V21, P946, DOI 10.1245/s10434-013-3386-7; Schweiger T, 2014, EUR J CARDIO-THORAC, V45, P408, DOI 10.1093/ejcts/ezt288; Smith NR, 2013, CLIN CANCER RES, V19, P6943, DOI 10.1158/1078-0432.CCR-13-1637; Suarez E, 2013, PLAST RECONSTR SURG, V131, p158E, DOI 10.1097/PRS.0b013e3182789b2b; Thuringer D, 2013, FASEB J, V27, P4169, DOI 10.1096/fj.12-226977; Torres S, 2013, CLIN CANCER RES, V19, P6006, DOI 10.1158/1078-0432.CCR-13-1130; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; Urosevic J, 2014, NAT CELL BIOL, V16, P685, DOI 10.1038/ncb2977; Wang F, 2012, MED ONCOL, V29, P1780, DOI 10.1007/s12032-011-0037-3; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Wettstein G, 2013, FASEB J, V27, P1549, DOI 10.1096/fj.12-220053; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Yeung TM, 2013, BRIT J CANCER, V108, P2106, DOI 10.1038/bjc.2013.209; Yoshimura T, 2011, EPIGENETICS-US, V6, P1001, DOI 10.4161/epi.6.8.16063; Yu ZJ, 2010, MOL MED REP, V3, P953, DOI 10.3892/mmr.2010.372; Zhao M, 2014, TUMOR BIOL, V35, P1051, DOI 10.1007/s13277-013-1139-7; Zimmermann M, 2012, CLIN CHIM ACTA, V413, P1115, DOI 10.1016/j.cca.2012.03.008	46	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120724	10.1371/journal.pone.0120724	http://dx.doi.org/10.1371/journal.pone.0120724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793600	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900069
J	Huang, LH; Lee, WC; You, ST; Cheng, CC; Yu, CJ				Huang, Lien-Hung; Lee, Wei-Chung; You, Shu-Ting; Cheng, Chia-Chen; Yu, Chia-Jung			Arfaptin-1 Negatively Regulates Arl1-Mediated Retrograde Transport	PLOS ONE			English	Article							BIN/AMPHIPHYSIN/RVS BAR DOMAIN; INHIBITS PHOSPHOLIPASE-D; ADP-RIBOSYLATION FACTOR; ARF-LIKE GTPASES; GOLGI NETWORK; STRUCTURAL BASIS; GRIP DOMAIN; ARL1 GTPASE; MEMBRANE; PROTEIN	The small GTPase Arf-like protein 1 (Arl1) is well known for its role in intracellular vesicular transport at the trans-Golgi network (TGN). In this study, we used differential affinity chromatography combined with mass spectrometry to identify Arf-interacting protein 1b (arfaptin- 1b) as an Arl1-interacting protein and characterized a novel function for arfaptin-1 (including the arfaptin-1a and 1b isoforms) in Arl1-mediated retrograde transport. Using a Shiga-toxin subunit B (STxB) transportation assay, we demonstrated that knockdown of arfaptin-1 accelerated the retrograde transport of STxB from the endosome to the Golgi apparatus, whereas Arl1 knockdown inhibited STxB transport compared with control cells. Arfaptin-1 overexpression, but not an Arl1 binding-defective mutant (arfaptin-1b-F317A), consistently inhibited STxB transport. Exogenous arfaptin-1 expression did not interfere with the localization of the Arl1-interacting proteins golgin-97 and golgin-245 to the TGN and vice versa. Moreover, we found that the N-terminal region of arfaptin-1 was involved in the regulation of retrograde transport. Our results show that arfaptin-1 acts as a negative regulator in Arl1-mediated retrograde transport and suggest that different functional complexes containing Arl1 form in distinct microdomains and are responsible for different functions.	[Huang, Lien-Hung; Lee, Wei-Chung; Yu, Chia-Jung] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [You, Shu-Ting] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Cheng, Chia-Chen; Yu, Chia-Jung] Chang Gung Univ, Coll Med, Dept Cell & Mol Biol, Taoyuan, Taiwan; [Yu, Chia-Jung] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan	Chang Gung University; National Taiwan University; Chang Gung University; Chang Gung University	Yu, CJ (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan.	yucj1124@mail.cgu.edu.tw		Huang, Lien-Hung/0000-0001-8641-9897	National Science Council, R.O.C. [97-2320-B182-026-MY3, 101-2320-B-182-035-MY3]	National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, R.O.C. (97-2320-B182-026-MY3 and 101-2320-B-182-035-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin JJR, 2011, MOL BIOL CELL, V22, P2337, DOI 10.1091/mbc.E10-09-0765; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Chen KY, 2012, J CELL SCI, V125, P4586, DOI 10.1242/jcs.107797; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; Cruz-Garcia D, 2013, EMBO J, V32, P1717, DOI 10.1038/emboj.2013.116; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Gleeson PA, 2004, TRAFFIC, V5, P315, DOI 10.1111/j.1398-9219.2004.00182.x; Graham TR, 2013, P NATL ACAD SCI USA, V110, P2691, DOI 10.1073/pnas.1300420110; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Liu YW, 2006, J CELL SCI, V119, P3845, DOI 10.1242/jcs.03148; Lu L, 2005, METHOD ENZYMOL, V404, P432, DOI 10.1016/S0076-6879(05)04038-3; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Lu L, 2001, J CELL SCI, V114, P4543; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Munson AM, 2004, J CELL SCI, V117, P2309, DOI 10.1242/jcs.01050; Munson AM, 2004, BIOCHEM BIOPH RES CO, V315, P617, DOI 10.1016/j.bbrc.2004.01.099; Nakamura K, 2012, J BIOL CHEM, V287, P25478, DOI 10.1074/jbc.M112.365783; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Peters PJ, 2002, NAT CELL BIOL, V4, P240, DOI 10.1038/ncb761; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Rao YJ, 2011, CELL MOL LIFE SCI, V68, P3983, DOI 10.1007/s00018-011-0768-5; Tai GH, 2005, METHOD ENZYMOL, V404, P442, DOI 10.1016/S0076-6879(05)04039-5; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tsai PC, 2013, P NATL ACAD SCI USA, V110, pE668, DOI 10.1073/pnas.1221484110; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Williger BT, 1999, FEBS LETT, V443, P197, DOI 10.1016/S0014-5793(98)01707-4; Williger BT, 1999, FEBS LETT, V454, P85, DOI 10.1016/S0014-5793(99)00771-1; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118743	10.1371/journal.pone.0118743	http://dx.doi.org/10.1371/journal.pone.0118743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789876	Green Published, gold			2022-12-26	WOS:000351425400043
J	Liu, B; Li, Q; Li, KW; Deng, N; He, P; Qin, CC; Yang, DY; Li, ZW; Xie, P				Liu, Bo; Li, Qi; Li, Kewei; Deng, Nan; He, Peng; Qin, Chunchang; Yang, Deyu; Li, Zhiwei; Xie, Peng			A Non-Invasive Method to Assess Cerebral Perfusion Pressure in Geriatric Patients with Suspected Cerebrovascular Disease	PLOS ONE			English	Article							TO-DOOR SURVEY; PREVALENCE	Background Cerebral perfusion pressure (CPP) can adversely impact cerebrovascular hemodynamics but cannot be practically measured in most clinical settings. Here, we aimed to establish a representative mathematical model for CPP in geriatric patients with suspected cerebrovascular disease. Methods A total of 100 patients (54 males and 46 females between 60-80 years of age) with suspected cerebrovascular disease and no obvious cerebrovascular stenosis were selected for invasive CPP monitoring via catheterization of the middle segment of the common carotid arteries and openings of the vertebral arteries bilaterally. Curves were function-fitted using MATLAB 7.0, and data was statistically processed by SPSS 20.0. Results MATLAB 7.0 constructed eighth-order Fourier functions that fit all recorded CPP curves. Since the coefficients of the 100 functions were significantly different, all functions were standardized to derive one representative function. By manipulating the heart rate and maximum/minimum CPP of the representative function, estimated CPP curves can be constructed for patients with differing heart rates, intracranial pressures (ICPs) and blood pressures. Conclusions CPP can be well-modeled through an eighth-order Fourier function that can be constructed from a patient's brachial artery blood pressure (BABP), ICP and heart rate. This function is representative of geriatric patients with cerebrovascular disease and can be used in the future study of cerebral hemodynamics.	[Liu, Bo; Deng, Nan; Yang, Deyu; Li, Zhiwei; Xie, Peng] Chongqing Med Univ, Yong Chuan Hosp, Dept Neurol, Chongqing, Peoples R China; [Li, Qi; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Liu, Bo; Li, Qi; He, Peng; Yang, Deyu; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Liu, Bo; Li, Qi; He, Peng; Yang, Deyu; Xie, Peng] Chongqing Med Univ, Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Li, Kewei] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Chongqing, Peoples R China; [Qin, Chunchang] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Li, ZW (corresponding author), Chongqing Med Univ, Yong Chuan Hosp, Dept Neurol, Chongqing, Peoples R China.	lzw023@126.com; xiepeng818@126.com	Li, Qi/ABE-4182-2021; 秦, 春/GRJ-9478-2022	Li, Qi/0000-0002-9144-148X; 	Natural Science Foundation of the Yongchuan District of Chongqing Municipality [2013nc8031, Ycstc]; Foundation of the Chongqing Health and Family Planning Commission [20143001]; National Natural Science Foundation of China [81200899]	Natural Science Foundation of the Yongchuan District of Chongqing Municipality; Foundation of the Chongqing Health and Family Planning Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of the Yongchuan District of Chongqing Municipality (grant no. Ycstc, 2013nc8031), the Foundation of the Chongqing Health and Family Planning Commission (grant no. 20143001), and the National Natural Science Foundation of China (grant No. 81200899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2012, J KOREAN MED SCI, V27, P625, DOI 10.3346/jkms.2012.27.6.625; Annaidh AN, 2012, ANN BIOMED ENG, V40, P1666, DOI 10.1007/s10439-012-0542-3; ATTINGER EO, 1966, BIOPHYS J, V6, P291, DOI 10.1016/S0006-3495(66)86657-2; Bracewell R., 1999, FOURIER TRANSFORM IT, P62; Brandi G, 2010, ACTA NEUROCHIR, V152, P965, DOI 10.1007/s00701-010-0643-4; Brosche TM, 2011, CRIT CARE NURSE, V31, P18, DOI 10.4037/ccn2011812; Kadojic D., 2007, Acta Medica Croatica, V61, P315; Kim BR, 2008, GENETICS, V180, P821, DOI 10.1534/genetics.108.093690; Liu WH, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026005; Oncel C, 2014, NEUROL SCI, V35, P373, DOI 10.1007/s10072-013-1521-7; Pedelty L, 2008, AM J MED, V121, pS23, DOI 10.1016/j.amjmed.2008.05.019; Prasad K, 2012, JRSM CARDIOVASC DIS, V1; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Sende J, 2009, EMERG MED J, V26, P210, DOI 10.1136/emj.2008.060608; Shinohara Y., 2006, NIHON RINSHO, V6, P201; Veglio F, 1994, J CARDIOVASC PHARM S, V5, pS113; Vibha D, 2012, JRSM CARDIOVASC DIS, V1	17	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120146	10.1371/journal.pone.0120146	http://dx.doi.org/10.1371/journal.pone.0120146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789855	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400133
J	Song, HW; Bettegowda, A; Oliver, D; Yan, W; Phan, MH; de Rooij, DG; Corbett, MA; Wilkinson, MF				Song, Hye-Won; Bettegowda, Anilkumar; Oliver, Daniel; Yan, Wei; Phan, Mimi H.; de Rooij, Dirk G.; Corbett, Mark A.; Wilkinson, Miles F.			shRNA Off-Target Effects In Vivo: Impaired Endogenous siRNA Expression and Spermatogenic Defects	PLOS ONE			English	Article							HOMEOBOX GENE-CLUSTER; MALE GERM-CELLS; SEX-CHROMOSOME INACTIVATION; INDUCED RNA INTERFERENCE; SHORT HAIRPIN RNAS; SERTOLI-CELLS; MOUSE OOCYTES; MICE; DICER; RHOX	RNA interference (RNAi) is widely used to determine the function of genes. We chose this approach to assess the collective function of the highly related reproductive homeobox 3 (Rhox3) gene paralogs. Using a Rhox3 short hairpin (sh) RNA with 100% complementarity to all 8 Rhox3 paralogs, expressed from a CRE-regulated transgene, we successfully knocked down Rhox3 expression in male germ cells in vivo. These Rhox3-shRNA transgenic mice had dramatic defects in spermatogenesis, primarily in spermatocytes and round spermatids. To determine whether this phenotype was caused by reduced Rhox3 expression, we generated mice expressing the Rhox3-shRNA but lacking the intended target of the shRNA-Rhox3. These double-mutant mice had a phenotype indistinguishable from Rhox3-shRNA-expressing mice that was different from mice lacking the Rhox3 paralogs, indicating that the Rhox3 shRNA disrupts spermatogenesis independently of Rhox3. Rhox3-shRNA transgenic mice displayed few alterations in the expression of protein-coding genes, but instead exhibited reduced levels of all endogenous siRNAs we tested. This supported a model in which the Rhox3 shRNA causes spermatogenic defects by sequestering one or more components of the endogenous small RNA biogenesis machinery. Our study serves as a warning for those using shRNA approaches to investigate gene functions in vivo.	[Song, Hye-Won; Bettegowda, Anilkumar; Phan, Mimi H.; Wilkinson, Miles F.] Univ Calif San Diego, Sch Med, Dept Reprod Med, La Jolla, CA 92093 USA; [Oliver, Daniel; Yan, Wei] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [de Rooij, Dirk G.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Corbett, Mark A.] Univ Adelaide, Sch Pediat & Reprod Hlth, Adelaide, SA, Australia	University of California System; University of California San Diego; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Amsterdam; Academic Medical Center Amsterdam; University of Adelaide	Wilkinson, MF (corresponding author), Univ Calif San Diego, Sch Med, Dept Reprod Med, La Jolla, CA 92093 USA.	mfwilkinson@ucsd.edu	Yan, Wei/AAH-7943-2019; de Rooij, D.G./AAW-1195-2021; Corbett, Mark/A-8063-2010	Corbett, Mark/0000-0001-9298-3072; de Rooij, Dirk/0000-0003-3932-4419	National Institutes of Health [R01-HD053808, R01-HD45595]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045595] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053808] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (www.nih.gov/) R01-HD053808 and-HD45595 (to MFW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brown JR, 2014, GENESIS, V52, P39, DOI 10.1002/dvg.22718; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Coumoul X, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh083; de Rooij DG, 1999, BIOL REPROD, V61, P842, DOI 10.1095/biolreprod61.3.842; Ehlert EM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-20; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Gao X, 2007, PHYSIOLOGY, V22, P161, DOI 10.1152/physiol.00002.2007; Geyer CB, 2008, GENE, V423, P194, DOI 10.1016/j.gene.2008.06.031; Geyer CB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094938; Greenlee AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046359; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hu Z, 2008, J BIOL CHEM, V283, P3866, DOI 10.1074/jbc.M706717200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-212; Kan L, 2005, BIOESSAYS, V27, P14, DOI 10.1002/bies.20172; Kaneda M, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-9; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lawrence RJ, 2003, PLANT J, V36, P114, DOI 10.1046/j.1365-313X.2003.01857.x; Lee HY, 2013, NUCLEIC ACIDS RES, V41, P6568, DOI 10.1093/nar/gkt361; Lindsey JS, 1996, DEV BIOL, V179, P471, DOI 10.1006/dbio.1996.0276; Liu DK, 2012, BIOCHEM BIOPH RES CO, V422, P114, DOI 10.1016/j.bbrc.2012.04.118; Liu HC, 2010, J ASSIST REPROD GEN, V27, P571, DOI 10.1007/s10815-010-9456-x; Ma HM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.27; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; MacLean JA, 2006, GENESIS, V44, P122, DOI 10.1002/gene.20193; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Morris L, 2006, MAMM GENOME, V17, P178, DOI 10.1007/s00335-005-0138-4; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Rao MK, 2003, MOL ENDOCRINOL, V17, P223, DOI 10.1210/me.2002-0232; Richardson ME, 2014, HUM MOL GENET, V23, P12, DOI 10.1093/hmg/ddt392; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Sandy P, 2005, BIOTECHNIQUES, V39, P215, DOI 10.2144/05392RV01; Shukla V, 2007, INT J BIOL SCI, V3, P91; Song HW, 2013, HUM REPROD, V28, P1635, DOI 10.1093/humrep/det043; Song HW, 2012, REPRODUCTION, V143, P611, DOI 10.1530/REP-11-0479; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Wang XX, 2006, GENOMICS, V88, P34, DOI 10.1016/j.ygeno.2006.02.007; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Yamamoto Y, 2013, GENOME RES, V23, P292, DOI 10.1101/gr.137224.112; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98	65	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118549	10.1371/journal.pone.0118549	http://dx.doi.org/10.1371/journal.pone.0118549			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790000	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400034
J	Yuan, G; Yan, SF; Xue, H; Zhang, P; Sun, JT; Li, G				Yuan, Guang; Yan, Shaofeng; Xue, Hao; Zhang, Ping; Sun, Jintang; Li, Gang			JSI-124 Suppresses Invasion and Angiogenesis of Glioblastoma Cells In Vitro	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; SIGNALING PATHWAY; CANCER-CELLS; TUMOR ANGIOGENESIS; ANTITUMOR-ACTIVITY; GASTRIC-CANCER; CUCURBITACIN-I; BRAIN-TUMORS; STAT3	Glioblastoma multiforme (GBM) is one of the utmost malignant tumors. Excessive angiogenesis and invasiveness are the major reasons for their uncontrolled growth and resistance toward conventional strategies resulting in poor prognosis. In this study, we found that low-dose JSI-124 reduced invasiveness and tumorigenicity of GBM cells. JSI-124 effectively inhibited VEGF expression in GBM cells. In a coculture study, JSI-124 completely prevented U87MG cell-mediated capillary formation of HUVECs and the migration of HUVECs when cultured alone or cocultured with U87MG cells. Furthermore, JSI-124 inhibited VEGF-induced cell proliferation, motility, invasion and the formation of capillary-like structures in HUVECs in a dose-dependent manner. JSI-124 suppressed VEGF-induced pVEGFR2 activity through STAT3 signaling cascade in HUVECs. Immunohistochemistry analysis showed that the expression of CD34, Ki67, p-STAT3 and p-VEGFR2 protein in xenografts was remarkably decreased. Taken together, our findings provide the first evidence that JSI-124 effectively inhibits tumor angiogenesis and invasion, which might be a viable drug in anti-angiogenesis and anti-invasion therapies.	[Yuan, Guang; Yan, Shaofeng; Xue, Hao; Zhang, Ping; Li, Gang] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan 250012, Peoples R China; [Yuan, Guang; Li, Gang] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Peoples R China; [Sun, Jintang] Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250012, Peoples R China; [Sun, Jintang] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250012, Peoples R China; [Yuan, Guang] Cent Hosp Zibo City, Dept Neurosurg, Zibo 255036, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Li, G (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurosurg, 107 Wenhua Xi Rd, Jinan 250012, Peoples R China.	doctorligang@126.com	Xue, Hao/GXV-4717-2022		Natural Science Foundation of China [81172403, 81372719]; Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province [BS2010SW013]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province	This work was supported by Natural Science Foundation of China (81172403 and 81372719) and Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province (BS2010SW013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bellou S, 2013, CANCER LETT, V338, P219, DOI 10.1016/j.canlet.2013.05.015; Blaskovich MA, 2003, CANCER RES, V63, P1270; Buettner R, 2002, CLIN CANCER RES, V8, P945; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chaudhry IH, 2001, HISTOPATHOLOGY, V39, P409, DOI 10.1046/j.1365-2559.2001.01230.x; Chen J, 2012, MOL CANCER THER, V11, P277, DOI 10.1158/1535-7163.MCT-11-0648; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Cook KM, 2010, CA-CANCER J CLIN, V60, P222, DOI 10.3322/caac.20075; de Groot J, 2012, ONCOTARGET, V3, P1036; Doucette TA, 2012, NEURO-ONCOLOGY, V14, P1136, DOI 10.1093/neuonc/nos139; Dunn IF, 2000, J NEURO-ONCOL, V50, P121, DOI 10.1023/A:1006436624862; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; DVORAK HF, 1995, INT ARCH ALLERGY IMM, V107, P233, DOI 10.1159/000236988; Fan SZ, 2010, CANCER LETT, V291, P158, DOI 10.1016/j.canlet.2009.10.011; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gamero AM, 2004, CANCER CELL, V5, P111, DOI 10.1016/S1535-6108(04)00028-5; Grunstein J, 1999, CANCER RES, V59, P1592; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Ishdorj G, 2010, MOL CANCER THER, V9, P3302, DOI 10.1158/1535-7163.MCT-10-0550; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim MJ, 2013, CANCER LETT, V335, P145, DOI 10.1016/j.canlet.2013.02.010; Kwiatkowska A, 2013, ADV EXP MED BIOL, V986, P121, DOI 10.1007/978-94-007-4719-7_7; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2002, CANCER CELL, V1, P125, DOI 10.1016/S1535-6108(02)00040-5; Lu JM, 2010, CARCINOGENESIS, V31, P481, DOI 10.1093/carcin/bgp292; Machein MR, 2000, J NEURO-ONCOL, V50, P109, DOI 10.1023/A:1006416003964; Omuro AMP, 2007, MOL CANCER THER, V6, P1909, DOI 10.1158/1535-7163.MCT-07-0047; Onishi M, 2011, BRAIN TUMOR PATHOL, V28, P13, DOI 10.1007/s10014-010-0007-z; Patan S, 2004, CANC TREAT, V117, P3; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Ren ZY, 2002, J BIOL CHEM, V277, P38486, DOI 10.1074/jbc.M112438200; Salhia B, 2006, EXPERT REV MOL DIAGN, V6, P613, DOI 10.1586/14737159.6.4.613; Saraswati S, 2013, CANCER LETT, V332, P83, DOI 10.1016/j.canlet.2013.01.012; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; Siegelin MD, 2010, NEUROSCI LETT, V478, P165, DOI 10.1016/j.neulet.2010.05.009; Skobe M, 1997, NAT MED, V3, P1222, DOI 10.1038/nm1197-1222; Su YH, 2008, CANCER BIOL THER, V7, P1243, DOI 10.4161/cbt.7.8.6263; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Yuan G, 2014, J BIOL CHEM, V289, P10607, DOI 10.1074/jbc.M113.528760; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6	51	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118894	10.1371/journal.pone.0118894	http://dx.doi.org/10.1371/journal.pone.0118894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789853	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400053
J	Orlandi, C; Xie, KQ; Masuho, I; Fajardo-Serrano, A; Lujan, R; Martemyanov, KA				Orlandi, Cesare; Xie, Keqiang; Masuho, Ikuo; Fajardo-Serrano, Ana; Lujan, Rafael; Martemyanov, Kirill A.			Orphan Receptor GPR158 Is an Allosteric Modulator of RGS7 Catalytic Activity with an Essential Role in Dictating Its Expression and Localization in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACCELERATING PROTEIN; HETEROTRIMERIC G-PROTEINS; MUSCARINIC M3 RECEPTOR; MEMBRANE ANCHOR; SIGNALING RGS; PROTEOLYTIC STABILITY; LIGHT RESPONSE; DEP DOMAIN; COMPLEX; R7BP	Regulators of G protein signaling control the duration and extent of signaling via G protein-coupled receptor (GPCR) pathways by accelerating the GTP hydrolysis on G protein alpha subunits thereby promoting termination of GPCR signaling. A member of this family, RGS7, plays a critical role in the nervous system where it regulates multiple neurotransmitter GPCRs that mediate vision, memory, and the action of addictive drugs. Previous studies have established that in vivo RGS7 forms mutually exclusive complexes with the membrane protein RGS7-binding protein or the orphan receptor GPR158. In this study, we examine the impact of GPR158 on RGS7 in the brain. We report that knock-out of GPR158 in mice results in marked post-transcriptional destabilization of RGS7 and substantial loss of its association with membranes in several brain regions. We further identified the RGS7-binding site in the C terminus of GPR158 and found that it shares significant homology with the RGS7-binding protein. The proximal portion of the GPR158 C terminus additionally contained a conserved sequence that was capable of enhancing RGS7 GTPase-activating protein activity in solution by an allosteric mechanism acting in conjunction with the regulators of the G protein signaling-binding domain. The distal portion of the GPR158 C terminus contained several phosphodiesterase E gamma-like motifs and selectively recruited G proteins in their activated state. The results of this study establish GPR158 as an essential regulator of RGS7 in the native nervous system with a critical role in controlling its expression, membrane localization, and catalytic activity.	[Orlandi, Cesare; Xie, Keqiang; Masuho, Ikuo; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Fajardo-Serrano, Ana; Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Inst Invest Descapacidades Neuronales IDINE, Albacete 02006, Spain	Scripps Research Institute; Universidad de Castilla-La Mancha	Martemyanov, KA (corresponding author), Scripps Res Inst Florida, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	kirill@scripps.edu	Lujan, Rafael/G-2555-2015; Xie, Keqiang/J-9668-2012; Fajardo-Serrano, Ana/AAB-4166-2021; Regan, Clinton/E-6250-2012; Orlandi, Cesare/O-4332-2015; Orlandi, Cesare/AAK-3180-2020	Fajardo-Serrano, Ana/0000-0003-0645-8808; Orlandi, Cesare/0000-0002-4992-9350; Lujan Miras, Rafael/0000-0003-2001-9545	National Institutes of Health [DA036082, DA036596]; Spanish Ministry of Education and Science [BFU-2012-38348]; Junta de Comunidades de Castilla-La Mancha [PPII11-0284-9301]; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405, R01DA036596, R21DA036082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science(Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA036082 and DA036596 (to K. A. M.). This work was also supported by Spanish Ministry of Education and Science Grant BFU-2012-38348 and Junta de Comunidades de Castilla-La Mancha Grant PPII11-0284-9301 (to R. L.).	Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Anderson GR, 2009, MOL CELL BIOL, V29, P3033, DOI 10.1128/MCB.01449-08; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Baker SA, 2006, BIOCHEMISTRY-US, V45, P10690, DOI 10.1021/bi060376a; Benzing T, 1999, NAT MED, V5, P913, DOI 10.1038/11354; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Cao Y, 2008, J NEUROSCI, V28, P10443, DOI 10.1523/JNEUROSCI.3282-08.2008; Cao Y, 2012, P NATL ACAD SCI USA, V109, P7905, DOI 10.1073/pnas.1202332109; Cao Y, 2010, J NEUROSCI, V30, P13784, DOI 10.1523/JNEUROSCI.1191-10.2010; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Cowan CW, 2001, PROG NUCLEIC ACID RE, V65, P341; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Gold SJ, 1997, J NEUROSCI, V17, P8024; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Hausmann ON, 2002, EUR J NEUROSCI, V15, P602, DOI 10.1046/j.1460-9568.2002.01916.x; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; Holden NS, 2014, J PHARMACOL EXP THER, V348, P12, DOI 10.1124/jpet.113.204586; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Ingi T, 1998, J NEUROSCI, V18, P7178; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Jeffrey BG, 2010, VISUAL NEUROSCI, V27, P9, DOI 10.1017/S0952523809990319; Kach J, 2012, AM J PHYSIOL-HEART C, V303, pH19, DOI 10.1152/ajpheart.00764.2011; Karpinsky-Semper D, 2015, BIOCHEMISTRY-US, V54, P1077, DOI 10.1021/bi500980d; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Lishko PV, 2002, J BIOL CHEM, V277, P24376, DOI 10.1074/jbc.M203237200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martemyanov KA, 2003, NEURON, V38, P857, DOI 10.1016/S0896-6273(03)00320-9; Masuho I, 2013, J BIOL CHEM, V288, P25129, DOI 10.1074/jbc.M113.462283; Masuho I, 2011, J BIOL CHEM, V286, P21806, DOI 10.1074/jbc.M111.241513; Masuho I, 2010, J BIOL CHEM, V285, P4781, DOI 10.1074/jbc.M109.058511; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Orlandi C, 2013, INVEST OPHTH VIS SCI, V54, P7153, DOI 10.1167/iovs.13-12907; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Ostrovskaya O, 2014, ELIFE, V3, DOI 10.7554/eLife.02053; Panicker LM, 2010, J NEUROCHEM, V113, P1101, DOI 10.1111/j.1471-4159.2010.06616.x; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Patel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057843; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; Porter MY, 2010, J BIOL CHEM, V285, P41100, DOI 10.1074/jbc.M110.163600; Ray TA, 2014, J NEUROSCI, V34, P6334, DOI 10.1523/JNEUROSCI.4044-13.2014; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Seeman P, 2007, SYNAPSE, V61, P303, DOI 10.1002/syn.20368; SELF AJ, 1995, METHOD ENZYMOL, V256, P67; Singh RK, 2007, J PHARMACOL EXP THER, V322, P133, DOI 10.1124/jpet.107.120386; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Skiba NP, 2001, J BIOL CHEM, V276, P37365, DOI 10.1074/jbc.M106431200; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Terzi D, 2012, NEUROPSYCHOPHARMACOL, V37, P1005, DOI 10.1038/npp.2011.284; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang JM, 2010, INVEST OPHTH VIS SCI, V51, P1121, DOI 10.1167/iovs.09-4163; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19977, DOI 10.1073/pnas.1214337109	77	40	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13622	13639		10.1074/jbc.M115.645374	http://dx.doi.org/10.1074/jbc.M115.645374			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25792749	Green Published, hybrid			2022-12-26	WOS:000355313000001
J	Zhang, M; Huang, R; Im, SC; Waskell, L; Ramamoorthy, A				Zhang, Meng; Huang, Rui; Im, Sang-Choul; Waskell, Lucy; Ramamoorthy, Ayyalusamy			Effects of Membrane Mimetics on Cytochrome P450-Cytochrome b(5) Interactions Characterized by NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; TRANSIENT ENCOUNTER COMPLEXES; PROTEIN SECONDARY STRUCTURE; MICROSOMAL CYTOCHROME-P450; ESCHERICHIA-COLI; NADPH-CYTOCHROME-P450 REDUCTASE; OMEGA-HYDROXYLATION; NH2-TERMINAL REGION; CATALYTIC-ACTIVITY; HEMOPROTEIN P-450	Mammalian cytochrome P450 (P450) is a membrane-bound monooxygenase whose catalytic activities require two electrons to be sequentially delivered from its redox partners: cytochrome b(5) (cytb(5)) and cytochrome P450 reductase, both of which are membrane proteins. Although P450 functional activities are known to be affected by lipids, experimental evidence to reveal the effect of membrane on P450-cytb(5) interactions is still lacking. Here, we present evidence for the influence of phospholipid bilayers on complex formation between rabbit P450 2B4 (CYP2B4) and rabbit cytb(5) at the atomic level, utilizing NMR techniques. General line broadening and modest chemical shift perturbations of cytb(5) resonances characterize CYP2B4-cytb(5) interactions on the intermediate time scale. More significant intensity attenuation and a more specific protein-protein binding interface are observed in bicelles as compared with lipid-free solution, highlighting the importance of the lipid bilayer in stabilizing stronger and more specific interactions between CYP2B4 and cytb(5), which may lead to a more efficient electron transfer. Similar results observed for the interactions between CYP2B4 lacking the transmembrane domain (tr-CYP2B4) and cytb(5) imply interactions between tr-CYP2B4 and the membrane surface, which might assist in CYP2B4-cytb(5) complex formation by orienting tr-CYP2B4 for efficient contact with cytb(5). Furthermore, the observation of weak and nonspecific interactions between CYP2B4 and cytb(5) in micelles suggests that lipid bilayer structures and low curvature membrane surface are preferable for CYP2B4-cytb(5) complex formation. Results presented in this study provide structural insights into the mechanism behind the important role that the lipid bilayer plays in the interactions between P450s and their redox partners.	[Zhang, Meng; Huang, Rui; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Im, Sang-Choul; Waskell, Lucy] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48105 USA; [Im, Sang-Choul; Waskell, Lucy] Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu	Regan, Clinton/E-6250-2012; Huang, Rui/N-4022-2017; Zhang, Meng/P-6278-2017	Huang, Rui/0000-0002-4064-6397; Ramamoorthy, Ayyalusamy/0000-0003-1964-1900; Zhang, Meng/0000-0003-4497-3253	National Institutes of Health [GM084018, GM095640, GM35533]; VA Merit grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035533, R01GM084018, R01GM095640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084018 and GM095640 (to A. R.) and GM35533 (to L. W.). This work was also supported by a VA Merit grant (to L. W.).	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; [Anonymous], 1976, STRUCTURAL BASIS MEM; Arora A, 2001, CURR OPIN STRUC BIOL, V11, P540, DOI 10.1016/S0959-440X(00)00246-3; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; BLANCK J, 1984, EUR J BIOCHEM, V144, P509, DOI 10.1111/j.1432-1033.1984.tb08495.x; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; CANOVADAVIS E, 1985, BIOCHEM PHARMACOL, V34, P1907, DOI 10.1016/0006-2952(85)90307-7; CLARK BJ, 1991, J BIOL CHEM, V266, P5898; COLEMAN R, 1973, BIOCHIM BIOPHYS ACTA, V300, P1, DOI 10.1016/0304-4157(73)90010-5; CULLIN C, 1992, BIOCHEM BIOPH RES CO, V184, P1490, DOI 10.1016/S0006-291X(05)80051-8; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; DEPIERRE JW, 1975, BIOCHIM BIOPHYS ACTA, V415, P411, DOI 10.1016/0304-4157(75)90006-4; DEPIERRE JW, 1977, ANNU REV BIOCHEM, V46, P201, DOI 10.1146/annurev.bi.46.070177.001221; Durr UHN, 2012, CHEM REV, V112, P6054, DOI 10.1021/cr300061w; Durr UHN, 2007, BBA-BIOMEMBRANES, V1768, P3235, DOI 10.1016/j.bbamem.2007.08.007; Durr UHN, 2007, J AM CHEM SOC, V129, P6670, DOI 10.1021/ja069028m; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Guengerich FP, 2005, BIOCHEM BIOPH RES CO, V338, P465, DOI 10.1016/j.bbrc.2005.08.079; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; INGELMANSUNDBERG M, 1977, FEBS LETT, V78, P72, DOI 10.1016/0014-5793(77)80275-5; KAWATO S, 1982, J BIOL CHEM, V257, P7023; KNELLER DG, 1993, J CELL BIOCHEM, P254; Koberova M, 2013, INT J ELECTROCHEM SC, V8, P125; KOMINAMI S, 1992, J STEROID BIOCHEM, V42, P57, DOI 10.1016/0960-0760(92)90011-7; LARSON JR, 1991, J BIOL CHEM, V266, P7321; Lee D, 2008, J AM CHEM SOC, V130, P13822, DOI 10.1021/ja803686p; LU AYH, 1969, J BIOL CHEM, V244, P3714; LU AYH, 1970, MOL PHARMACOL, V6, P213; LU AYH, 1969, BIOCHEM BIOPH RES CO, V36, P545, DOI 10.1016/0006-291X(69)90339-8; LU AYH, 1968, J BIOL CHEM, V243, P1331; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; MIWA GT, 1981, ARCH BIOCHEM BIOPHYS, V211, P454, DOI 10.1016/0003-9861(81)90477-X; MORGAN ET, 1984, DRUG METAB DISPOS, V12, P358; MULLERENOCH D, 1984, J BIOL CHEM, V259, P8174; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; OHTA Y, 1994, J BIOL CHEM, V269, P15597; PERNECKY SJ, 1993, P NATL ACAD SCI USA, V90, P2651, DOI 10.1073/pnas.90.7.2651; PERNECKY SJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P446, DOI 10.1006/abbi.1995.1253; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; SAGARA Y, 1993, ARCH BIOCHEM BIOPHYS, V304, P272, DOI 10.1006/abbi.1993.1349; SANDERS CR, 1995, BIOCHEMISTRY-US, V34, P4030, DOI 10.1021/bi00012a022; Saribas AS, 2001, PROTEIN EXPRES PURIF, V21, P303, DOI 10.1006/prep.2000.1377; Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574; Shank-Retzlaff ML, 1998, ARCH BIOCHEM BIOPHYS, V359, P82, DOI 10.1006/abbi.1998.0889; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; STROBEL HW, 1970, J BIOL CHEM, V245, P4851; Suh JY, 2007, J AM CHEM SOC, V129, P12954, DOI 10.1021/ja0760978; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; VANDERHO.TA, 1974, J BIOL CHEM, V249, P6302; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Volkov AN, 2010, J BIOMOL NMR, V48, P225, DOI 10.1007/s10858-010-9452-6; Volkov AN, 2005, PROTEIN SCI, V14, P799, DOI 10.1110/ps.041150205; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Yamamoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02556; Yamamoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02538; YANG CS, 1977, J BIOL CHEM, V252, P293; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200	71	25	25	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12705	12718		10.1074/jbc.M114.597096	http://dx.doi.org/10.1074/jbc.M114.597096			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25795780	Green Published, hybrid			2022-12-26	WOS:000354569000023
J	Bottinger, L; Oeljeklaus, S; Guiard, B; Rospert, S; Warscheid, B; Becker, T				Boettinger, Lena; Oeljeklaus, Silke; Guiard, Bernard; Rospert, Sabine; Warscheid, Bettina; Becker, Thomas			Mitochondrial Heat Shock Protein (Hsp) 70 and Hsp10 Cooperate in the Formation of Hsp60 Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; IMPORT MOTOR; YEAST MITOCHONDRIA; PREPROTEIN TRANSLOCASE; MOLECULAR CHAPERONES; SEQUENTIAL ACTION; ATP HYDROLYSIS; MATRIX HSP70; IN-VIVO; HOMOLOG	Mitochondrial Hsp70 (mtHsp70) mediates essential functions for mitochondrial biogenesis, like import and folding of proteins. In these processes, the chaperone cooperates with cochaperones, the presequence translocase, and other chaperone systems. The chaperonin Hsp60, together with its cofactor Hsp10, catalyzes folding of a subset of mtHsp70 client proteins. Hsp60 forms heptameric ring structures that provide a cavity for protein folding. How the Hsp60 rings are assembled is poorly understood. In a comprehensive interaction study, we found that mtHsp70 associates with Hsp60 and Hsp10. Surprisingly, mtHsp70 interacts with Hsp10 independently of Hsp60. The mtHsp70-Hsp10 complex binds to the unassembled Hsp60 precursor to promote its assembly into mature Hsp60 complexes. Weconclude that coupling to Hsp10 recruits mtHsp70 to mediate the biogenesis of the heptameric Hsp60 rings.	[Boettinger, Lena; Rospert, Sabine; Becker, Thomas] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Boettinger, Lena; Becker, Thomas] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, Inst Biol 2, Abt Biochem & Funkt Prote, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Rospert, Sabine; Warscheid, Bettina; Becker, Thomas] CNRS, BIOSS Ctr Biol Signalling Studies, F-91190 Gif Sur Yvette, France; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Becker, T (corresponding author), Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.becker@biochemie.uni-freiburg.de	Becker, Thomas/AAS-9404-2020	Warscheid, Bettina/0000-0001-5096-1975; Rospert, Sabine/0000-0002-3089-9614	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 746 and the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS).	Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Blamowska M, 2012, J CELL BIOL, V199, P125, DOI 10.1083/jcb.201205012; Bottinger L, 2013, MOL BIOL CELL, V24, P2609, DOI 10.1091/mbc.E13-02-0106; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHENG MY, 1990, NATURE, V348, P455, DOI 10.1038/348455a0; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CRAIG EA, 1987, P NATL ACAD SCI USA, V84, P4156, DOI 10.1073/pnas.84.12.4156; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dubaquie Y, 1997, P NATL ACAD SCI USA, V94, P9011, DOI 10.1073/pnas.94.17.9011; Dubaquie Y, 1998, EMBO J, V17, P5868, DOI 10.1093/emboj/17.20.5868; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; HALLBERG EM, 1993, MOL CELL BIOL, V13, P3050, DOI 10.1128/MCB.13.5.3050; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HERRMANN JM, 1994, J CELL BIOL, V127, P893, DOI 10.1083/jcb.127.4.893; HOHFELD J, 1994, J CELL BIOL, V126, P305, DOI 10.1083/jcb.126.2.305; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; HUTCHINSON EG, 1989, EMBO J, V8, P1485, DOI 10.1002/j.1460-2075.1989.tb03532.x; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LALORAYA S, 1995, MOL CELL BIOL, V15, P7098; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Lewrenz I, 2013, J BIOL CHEM, V288, P30931, DOI 10.1074/jbc.M113.465997; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Lytovchenko O, 2014, EMBO J, V33, P1624, DOI 10.15252/embj.201488076; MANNINGKRIEG UC, 1991, EMBO J, V10, P3273, DOI 10.1002/j.1460-2075.1991.tb04891.x; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; MOCZKO M, 1995, J MOL BIOL, V254, P538, DOI 10.1006/jmbi.1995.0636; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; NAKAI M, 1994, BIOCHEM BIOPH RES CO, V200, P435, DOI 10.1006/bbrc.1994.1468; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; ROSPERT S, 1993, P NATL ACAD SCI USA, V90, P10967, DOI 10.1073/pnas.90.23.10967; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; RYAN MT, 1995, J BIOL CHEM, V270, P22037, DOI 10.1074/jbc.270.37.22037; SCHMITT M, 1995, EMBO J, V14, P3434, DOI 10.1002/j.1460-2075.1995.tb07349.x; Schneider HC, 1996, EMBO J, V15, P5796, DOI 10.1002/j.1460-2075.1996.tb00966.x; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Slutsky-Leiderman O, 2007, J BIOL CHEM, V282, P33935, DOI 10.1074/jbc.M704435200; Sokol AM, 2014, FEBS LETT, V588, P2484, DOI 10.1016/j.febslet.2014.05.028; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; VOOS W, 1994, MOL CELL BIOL, V14, P6627, DOI 10.1128/MCB.14.10.6627; Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005; Wenz LS, 2014, EMBO REP, V15, P678, DOI 10.1002/embr.201338144; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x; Westermann B, 1996, MOL CELL BIOL, V16, P7063; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018	68	48	50	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11611	11622		10.1074/jbc.M115.642017	http://dx.doi.org/10.1074/jbc.M115.642017			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792736	hybrid, Green Published			2022-12-26	WOS:000353719400036
J	Islam, Z; Kumar, A; Singh, S; Salmon, L; Karthikeyan, S				Islam, Zeyaul; Kumar, Adarsh; Singh, Suruchi; Salmon, Laurent; Karthikeyan, Subramanian			Structural Basis for Competitive Inhibition of 3,4-Dihydroxy-2-butanone-4-phosphate Synthase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP CYCLOHYDROLASE-II; 4-PHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RIBOFLAVIN; BIOSYNTHESIS; MECHANISM; PROTEIN; 6,7-DIMETHYL-8-RIBITYLLUMAZINE; DEAMINASE	The riboflavin biosynthesis pathway has been shown to be essential in many pathogens and is absent in humans. Therefore, enzymes involved in riboflavin synthesis are considered as potential antibacterial drug targets. The enzyme 3,4-dihydroxy-2-butanone-4-phosphate synthase (DHBPS) catalyzes one of the two committed steps in the riboflavin pathway and converts D-ribulose 5-phosphate (Ru5P) to L-3,4-dihydroxy-2-butanone 4-phosphate and formate. Moreover, DHBPS is shown to be indispensable for Mycobacterium, Salmonella, and Helicobacter species. Despite the essentiality of this enzyme in bacteria, no inhibitor has been identified hitherto. Here, we describe kinetic and crystal structure characterization of DHBPS from Vibrio cholerae (vDHBPS) with a competitive inhibitor 4-phospho-D-erythronohydroxamic acid (4PEH) at 1.86 angstrom resolution. In addition, we also report the structural characterization of vDHBPS in its apo form and in complex with its substrate and substrate plus metal ions at 1.96-, 1.59-, and 2.04 angstrom resolution, respectively. Comparison of these crystal structures suggests that 4PEH inhibits the catalytic activity of DHBPS as it is unable to form a proposed intermediate that is crucial for DHBPS activity. Furthermore, vDHBPS structures complexed with substrate and metal ions reveal that, unlike Candida albicans, binding of substrate to vDHBPS induces a conformational change from an open to closed conformation. Interestingly, the position of second metal ion, which is different from that of Methanococcus jannaschii, strongly supports an active role in the catalytic mechanism. Thus, the kinetic and structural characterization of vDHBPS reveals the molecular mechanism of inhibition shown by 4PEH and that it can be explored further for designing novel antibiotics.	[Islam, Zeyaul; Kumar, Adarsh; Singh, Suruchi; Karthikeyan, Subramanian] CSIR, Inst Microbial Technol, Chandigarh 160036, India; [Salmon, Laurent] Univ Paris 11, CNRS UMR8182, Lab Chim Bioorgan & Bioinorgan, Inst Chim Mol & Mat Orsay, F-91405 Orsay, France	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Karthikeyan, S (corresponding author), CSIR, Inst Microbial Technol, Sect 39-A, Chandigarh 160036, India.	skarthik@imtech.res.in	Islam, Zeyaul/AAZ-5625-2020; Singh, Suruchi/AFZ-0966-2022; Salmon, Laurent/T-5179-2018	Islam, Zeyaul/0000-0002-5444-3910; Singh, Suruchi/0000-0002-4306-9345; Salmon, Laurent/0000-0003-1946-8458; Kumar, Adarsh/0000-0002-8219-0332	CSIR Network [BSC-210, BSC-104]; Department of Biotechnology, Government of India; CSIR, Government of India; University Grant Commission Government of India	CSIR Network(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission Government of India(University Grants Commission, India)	This work was supported in part by CSIR Network Projects BSC-210 and BSC-104 and by the Department of Biotechnology, Government of India (for synchrotron data collection in France).; Supported by the CSIR, Government of India.; Supported by University Grant Commission Government of India doctoral fellowships.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Bacher A, 1997, METHOD ENZYMOL, V280, P382; Bacher A., 1991, CHEM BIOCH FLAVOENZY, P349; Bacher A., 1996, ESCHERICHIA COLI SAL, V1, P657; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BURROWS RB, 1978, J BACTERIOL, V136, P657, DOI 10.1128/JB.136.2.657-667.1978; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; DeLano WL, 2010, PYMOL MOL GRAPH SYST; Echt S, 2004, J MOL BIOL, V341, P1085, DOI 10.1016/j.jmb.2004.06.053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fassbinder F, 2000, FEMS MICROBIOL LETT, V191, P191, DOI 10.1111/j.1574-6968.2000.tb09339.x; Fischer M, 2008, ARCH BIOCHEM BIOPHYS, V474, P252, DOI 10.1016/j.abb.2008.02.008; FOOR F, 1975, J BIOL CHEM, V250, P3545; Foor F, 1980, Methods Enzymol, V66, P303; Frago S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-160; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Herguedas B, 2010, J MOL BIOL, V400, P218, DOI 10.1016/j.jmb.2010.05.018; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jin L, 2013, PROTEIN EXPRES PURIF, V91, P161, DOI 10.1016/j.pep.2013.07.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kelly MJS, 2001, P NATL ACAD SCI USA, V98, P13025, DOI 10.1073/pnas.231323598; KIS K, 1995, J BIOL CHEM, V270, P16788, DOI 10.1074/jbc.270.28.16788; KIS K, 1995, BIOCHEMISTRY-US, V34, P2883, DOI 10.1021/bi00009a019; KLEYWEGT GJ, 1995, STRUCTURE, V3, P535, DOI 10.1016/S0969-2126(01)00187-3; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2010, PROTEINS, V78, P3292, DOI 10.1002/prot.22837; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao DI, 2002, BIOCHEMISTRY-US, V41, P1795, DOI 10.1021/bi015652u; Liao DI, 2001, STRUCTURE, V9, P11, DOI 10.1016/S0969-2126(00)00550-5; Long QX, 2010, CHEM BIOL DRUG DES, V75, P339, DOI 10.1111/j.1747-0285.2010.00946.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Philipp WJ, 1996, P NATL ACAD SCI USA, V93, P3132, DOI 10.1073/pnas.93.7.3132; Picollelli MA, 2000, ANAL BIOCHEM, V287, P347, DOI 10.1006/abio.2000.4867; PLAUT GWE, 1960, J BIOL CHEM, V235, pPC41; PLAUT GWE, 1970, BIOCHEMISTRY-US, V9, P771, DOI 10.1021/bi00806a010; Ren J, 2005, J BIOL CHEM, V280, P36912, DOI 10.1074/jbc.M507725200; RICHTER G, 1993, J BACTERIOL, V175, P4045, DOI 10.1128/JB.175.13.4045-4051.1993; RICHTER G, 1992, J BACTERIOL, V174, P4050, DOI 10.1128/jb.174.12.4050-4056.1992; Richter G, 1997, J BACTERIOL, V179, P2022, DOI 10.1128/jb.179.6.2022-2028.1997; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006; Roos AK, 2005, J BIOL CHEM, V280, P6416, DOI 10.1074/jbc.M412018200; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh M, 2013, ACTA CRYSTALLOGR D, V69, P1633, DOI 10.1107/S0907444913011402; Singh M, 2011, J STRUCT BIOL, V174, P374, DOI 10.1016/j.jsb.2011.01.013; Steinbacher S, 2003, J BIOL CHEM, V278, P42256, DOI 10.1074/jbc.M307301200; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; VOLK R, 1990, J BIOL CHEM, V265, P19479; VOLK R, 1991, J BIOL CHEM, V266, P20610; Wang WR, 2003, PROTEINS, V52, P633, DOI 10.1002/prot.10353; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	62	10	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11293	11308		10.1074/jbc.M114.611830	http://dx.doi.org/10.1074/jbc.M114.611830			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792735	hybrid, Green Published			2022-12-26	WOS:000353719400008
J	Bradley, DT; Bourke, TW; Fairley, DJ; Borrow, R; Shields, MD; Zipfel, PF; Hughes, AE				Bradley, Declan T.; Bourke, Thomas W.; Fairley, Derek J.; Borrow, Raymond; Shields, Michael D.; Zipfel, Peter F.; Hughes, Anne E.			Susceptibility to Invasive Meningococcal Disease: Polymorphism of Complement System Genes and Neisseria meningitidis Factor H Binding Protein	PLOS ONE			English	Article							DEFICIENCIES; ASSOCIATION; HAPLOTYPE; VARIANTS; RISK; CD46	Background Neisseria meningitidis can cause severe infection in humans. Polymorphism of Complement Factor H (CFH) is associated with altered risk of invasive meningococcal disease (IMD). We aimed to find whether polymorphism of other complement genes altered risk and whether variation of N. meningitidis factor H binding protein (fHBP) affected the risk association. Methods We undertook a case-control study with 309 European cases and 5,200 1958 Birth Cohort and National Blood Service cohort controls. We used additive model logistic regression, accepting P<0.05 as significant after correction for multiple testing. The effects of fHBP subfamily on the age at infection and severity of disease was tested using the independent samples median test and Student's T test. The effect of CFH polymorphism on the N. meningitidis fHBP subfamily was investigated by logistic regression and Chi squared test. Results Rs12085435 A in C8B was associated with odds ratio (OR) of IMD (0.35 [95% CI 0.19-0.67]; P = 0.03 after correction). A CFH haplotype tagged by rs3753396 G was associated with IMD (OR 0.56 [95% CI 0.42-0.76], P = 1.6x10(-4)). There was no bacterial load (CtrA cycle threshold) difference associated with carriage of this haplotype. Host CFH haplotype and meningococcal fHBP subfamily were not associated. Individuals infected with meningococci expressing subfamily A fHBP were younger than those with subfamily B fHBP meningococci (median 1 vs 2 years; P = 0.025). Discussion The protective CFH haplotype alters odds of IMD without affecting bacterial load for affected heterozygotes. CFH haplotype did not affect the likelihood of infecting meningococci having either fHBP subfamily. The association between C8B rs12085435 and IMD requires independent replication. The CFH association is of interest because it is independent of known functional polymorphisms in CFH. As fHBP-containing vaccines are now in use, relationships between CFH polymorphism and vaccine effectiveness and side-effects may become important.	[Bradley, Declan T.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Bradley, Declan T.] Publ Hlth Agcy, Belfast, Antrim, North Ireland; [Bourke, Thomas W.; Shields, Michael D.] Queens Univ Belfast, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Fairley, Derek J.] Belfast Hlth & Social Care Trust, Reg Virus Lab, Belfast, Antrim, North Ireland; [Borrow, Raymond] Publ Hlth England, Vaccine Evaluat Unit, Manchester, Lancs, England; [Borrow, Raymond] Univ Manchester, Sch Translat Med, Inflammat Sci Res Grp, Manchester, Lancs, England; [Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Zipfel, Peter F.] Univ Jena, Jena, Germany; [Hughes, Anne E.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast; Public Health England; University of Manchester; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Queens University Belfast	Bradley, DT (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland.	dbradley09@qub.ac.uk	Bradley, Declan T/AFO-1353-2022; Bradley, Declan/AFN-7904-2022	Bourke, Thomas/0000-0003-4786-962X; Bradley, Declan/0000-0003-1468-1823	Northern Ireland Health and Social Care Research and Development Office [EAT/3976/08]; Medical Research Council [G1001799, MR/N01104X/1] Funding Source: researchfish; Public Health Agency [EAT/3976/08] Funding Source: researchfish; MRC [G1001799, MR/N01104X/1] Funding Source: UKRI	Northern Ireland Health and Social Care Research and Development Office; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Public Health Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DTB was supported by a doctoral fellowship from the Northern Ireland Health and Social Care Research and Development Office: EAT/3976/08 (http://www.publichealth.hscni.net/directorate-public-health/hsc-research-and-development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beernink PT, 2009, MICROBIOL-SGM, V155, P2873, DOI 10.1099/mic.0.029876-0; Bradley DT, 2012, INT J IMMUNOGENET, V39, P328, DOI 10.1111/j.1744-313X.2012.01095.x; Bradley DT, 2011, EYE, V25, P683, DOI 10.1038/eye.2011.37; Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Costa I, 2014, MBIO, V5, DOI 10.1128/mBio.01625-14; Dale AP, 2013, EXPERT REV ANTI-INFE, V11, P187, DOI [10.1586/eri.12.161, 10.1586/ERI.12.161]; Darton T, 2009, CLIN INFECT DIS, V48, P587, DOI 10.1086/596707; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Dunphy KY, 2011, INFECT IMMUN, V79, P353, DOI 10.1128/IAI.00849-10; Esposito S, 2014, HUM VACC IMMUNOTHER, V10, P2005, DOI 10.4161/hv.29218; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Guiver M, 2000, FEMS IMMUNOL MED MIC, V28, P173, DOI 10.1111/j.1574-695X.2000.tb01473.x; Hackett SJ, 2002, ARCH DIS CHILD, V86, P44, DOI 10.1136/adc.86.1.44; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2007, PLOS MED, V4, P1993, DOI 10.1371/journal.pmed.0040355; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jarva H, 2005, J IMMUNOL, V174, P6299, DOI 10.4049/jimmunol.174.10.6299; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Joint Committee on Vaccination and Immunisation, 2014, JCVI POS STAT US BEX; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Ladhani S, 2014, PREVENTING SECONDARY; Lewis LA, 2012, J IMMUNOL, V188, P5063, DOI 10.4049/jimmunol.1103748; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P273, DOI 10.1016/j.fsigen.2007.06.008; Piet JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047973; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Ramsay M, 1997, Commun Dis Rep CDR Rev, V7, pR49; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Tedesco F, 2008, VACCINE, V26, pI3, DOI 10.1016/j.vaccine.2008.11.010; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	43	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120757	10.1371/journal.pone.0120757	http://dx.doi.org/10.1371/journal.pone.0120757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798599	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300173
J	Andersen, V; Vogel, LK; Kopp, TI; Saebo, M; Nonboe, AW; Hamfjord, J; Kure, EH; Vogel, U				Andersen, Vibeke; Vogel, Lotte K.; Kopp, Tine Iskov; Saebo, Mona; Nonboe, Annika W.; Hamfjord, Julian; Kure, Elin H.; Vogel, Ulla			High ABCC2 and Low ABCG2 Gene Expression Are Early Events in the Colorectal Adenoma-Carcinoma Sequence	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; INFLAMMATORY-BOWEL-DISEASE; MESSENGER-RNA EXPRESSION; BLOOD MONONUCLEAR-CELLS; TOLL-LIKE RECEPTORS; P-GLYCOPROTEIN; INTESTINAL INFLAMMATION; DRUG-RESISTANCE; ANIMAL-MODELS; BCRP ABCG2	Development of colorectal cancer (CRC) may result from a dysfunctional interplay between diet, gut microbes and the immune system. The ABC transport proteins ABCB1 (P-glycoprotein, Multidrug resistance protein 1, MDR1), ABCC2 (MRP2) and ABCG2 (BCRP) are involved in transport of various compounds across the epithelial barrier. Low mRNA level of ABCB1 has previously been identified as an early event in colorectal carcinogenesis (Andersen et al., PLoS One. 2013 Aug 19; 8(8): e72119). ABCC2 and ABCG2 mRNA levels were assessed in intestinal tissue from 122 CRC cases, 106 adenoma cases (12 with severe dysplasia, 94 with mild-moderate dysplasia) and from 18 controls with normal endoscopy. We found significantly higher level of ABCC2 in adenomas with mild to moderate dysplasia and carcinoma tissue compared to the levels in unaffected tissue from the same individual (P = 0.037, P = 0.037, and P< 0.0001) and in carcinoma and distant unaffected tissue from CRC cases compared to the level in the healthy individuals (P = 0.0046 and P = 0.036). Furthermore, ABCG2 mRNA levels were significantly lower in adenomas and carcinomas compared to the level in unaffected tissue from the same individuals and compared to tissue from healthy individuals (P< 0.0001 for all). The level of ABCB2 in adjacent normal tissue was significantly higher than in tissue from healthy individuals (P = 0.011). In conclusion, this study found that ABCC2 and ABCG2 expression levels were altered already in mild/moderate dysplasia in carcinogenesis suggesting that these ABC transporters are involved in the early steps of carcinogenesis as previously reported for ABCB1. These results suggest that dysfunctional transport across the epithelial barrier may contribute to colorectal carcinogenesis.	[Andersen, Vibeke] Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark; [Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Andersen, Vibeke] Reg Hosp Viborg, Dept Med, Viborg, Denmark; [Vogel, Lotte K.; Nonboe, Annika W.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Kopp, Tine Iskov] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Saebo, Mona] Telemark Univ Coll, Fac Arts & Sci, Dept Environm & Hlth Studies, Telemark, Norway; [Hamfjord, Julian; Kure, Elin H.] Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen; Technical University of Denmark; University College of Southeast Norway; University of Oslo; National Research Centre for the Working Environment	Andersen, V (corresponding author), Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark.	vandersen@health.sdu.dk; elin.kure@rr-research.no	Vogel, Ulla B/I-5048-2012; Nonboe, Annika W./GQZ-2531-2022; Andersen, Vibeke/I-7932-2012; Vogel, Ulla/ABC-2212-2020	Vogel, Ulla B/0000-0001-6807-1524; Andersen, Vibeke/0000-0002-0127-2863; Vogel, Ulla/0000-0001-6807-1524; Kopp, Tine/0000-0003-3729-4420; Nonboe, Annika W./0000-0003-2948-278X; Vogel, Lotte K./0000-0001-9920-0982	Viborg Regional Hospital; Telemark Hospital; Oslo University Hospital; Norwegian Colorectal Cancer Prevention (NORCCAP); Norwegian Cancer Society; Department of Health and Social Affairs	Viborg Regional Hospital; Telemark Hospital; Oslo University Hospital; Norwegian Colorectal Cancer Prevention (NORCCAP); Norwegian Cancer Society(Norwegian Cancer Society); Department of Health and Social Affairs	Funding for this study has been obtained from Viborg Regional Hospital (http://www.hospitalsenhedmidt.dk/), and funding for establishing the KAM cohort has been obtained from Telemark Hospital, Oslo University Hospital, and the Norwegian Colorectal Cancer Prevention (NORCCAP) study (Grants from the Norwegian Cancer Society (http://www.uicc.org/membership/norwegian-cancer-society), Department of Health and Social Affairs) have supported the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qare AW, 2003, J TOXICOL ENV HEAL B, V6, P279, DOI 10.1080/10937400306466; Albermann N, 2005, BIOCHEM PHARMACOL, V70, P949, DOI 10.1016/j.bcp.2005.06.018; Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072119; Andersen V, 2012, SCAND J GASTROENTERO, V47, P572, DOI 10.3109/00365521.2012.668933; Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Arthur JC, 2013, GUT MICROBES, V4, P253, DOI 10.4161/gmic.24220; Aye ILMH, 2009, CHEM-BIOL INTERACT, V180, P327, DOI 10.1016/j.cbi.2009.04.012; Bornholdt J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-65; Campa D, 2008, MUTAT RES-FUND MOL M, V645, P56, DOI 10.1016/j.mrfmmm.2008.08.001; Chen C, 2014, CURR MED CHEM, V21, P3007, DOI 10.2174/092986732126140804160443; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Collett A, 2008, INFLAMM BOWEL DIS, V14, P620, DOI 10.1002/ibd.20375; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dietrich CG, 2011, INT J CANCER, V129, P546, DOI 10.1002/ijc.25958; Ebert B, 2005, CARCINOGENESIS, V26, P1754, DOI 10.1093/carcin/bgi139; Englund G, 2007, INFLAMM BOWEL DIS, V13, P291, DOI 10.1002/ibd.20030; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Gollapudi S, 2000, GENES IMMUN, V1, P371, DOI 10.1038/sj.gene.6363693; Goncalves P, 2011, AM J PHYSIOL-CELL PH, V301, pC984, DOI 10.1152/ajpcell.00146.2011; Gondal G, 2005, EUR J CANCER PREV, V14, P373, DOI 10.1097/00008469-200508000-00010; Hansen R, 2005, CANCER LETT, V229, P85, DOI 10.1016/j.canlet.2005.04.019; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Johnson RL, 2013, CANCER METAST REV, V32, P39, DOI 10.1007/s10555-012-9404-6; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kawase A, 2014, J PHARM SCI-US, V103, P2556, DOI 10.1002/jps.24043; Larsen UL, 2007, SCAND J CLIN LAB INV, V67, P123, DOI 10.1080/00365510600986084; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Mercado-Lubo R, 2010, GUT MICROBES, V1, P301, DOI 10.4161/gmic.1.5.12925; Mosaffa F, 2012, MOL CELL BIOCHEM, V363, P385, DOI 10.1007/s11010-011-1191-9; Nones K, 2009, J APPL MICROBIOL, V107, P557, DOI 10.1111/j.1365-2672.2009.04225.x; Ostergaard M, 2009, SCAND J GASTROENTERO, V44, P65, DOI 10.1080/00365520802400826; Panwala CM, 1998, J IMMUNOL, V161, P5733; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Pawlik A, 2005, J PHARM PHARMACOL, V57, P1421, DOI 10.1211/jpp.57.11.0007; Saebo M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-208; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Saxena M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00327; Selzer-Plon J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-201; Skjelbred CF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-175; Skjelbred CF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-228; Skjelbred CF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-67; Skovbjerg H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-136; Staley EM, 2011, J PEDIATR GASTR NUTR, V53, P666, DOI 10.1097/MPG.0b013e31822860f1; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Tolson AH, 2010, ADV DRUG DELIVER REV, V62, P1238, DOI 10.1016/j.addr.2010.08.006; UEG, 2014, COL CANC EUR; Uno S, 2009, BIOPHARM DRUG DISPOS, V30, P49, DOI 10.1002/bdd.639; van de Wetering K, 2012, FASEB J, V26, P4014, DOI 10.1096/fj.12-210039; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Vlaming MLH, 2014, MOL PHARMACOL, V85, P520, DOI 10.1124/mol.113.088823; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Vogel LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105254; Vogel U, 2002, CARCINOGENESIS, V23, P1505, DOI 10.1093/carcin/23.9.1505; Zhang JS, 2006, INT IMMUNOL, V18, P485, DOI 10.1093/intimm/dxh389	56	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119255	10.1371/journal.pone.0119255	http://dx.doi.org/10.1371/journal.pone.0119255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793771	gold, Green Submitted, Green Published			2022-12-26	WOS:000352084200064
J	Fernandez-Beaskoetxea, S; Carrascal, LM; Fernandez-Loras, A; Fisher, MC; Bosch, J				Fernandez-Beaskoetxea, Saioa; Carrascal, Luis M.; Fernandez-Loras, Andres; Fisher, Matthew C.; Bosch, Jaime			Short Term Minimum Water Temperatures Determine Levels of Infection by the Amphibian Chytrid Fungus in Alytes obstetricans Tadpoles	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; SEASONAL DYNAMICS; MIDWIFE TOAD; CHYTRIDIOMYCOSIS; DISEASE; FROGS; TRANSMISSION; PREVALENCE; MORTALITY; TIME	Amphibians are one of the groups of wildlife most seriously threatened by emerging infectious disease. In particular, chytridiomycosis, caused by the aquatic fungus Batrachochytrium dendrobatidis, is responsible for amphibian species declines on a worldwide scale. Population-level outcomes following the introduction of the pathogen are context dependent and mediated by a large suite of abiotic and biotic variables. In particular, studies have shown that temperature has a key role in determining infection dynamics owing to the ecto-thermic nature of the amphibian host and temperature-dependency of pathogen growth rates. To assess the temperature-dependent seasonality of infectious burdens in a susceptible host species, we monitored lowland populations of larval midwife toads, Alytes obstetricians, in Central Spain throughout the year. We found that infections were highly seasonal, and inversely correlated against water temperature, with the highest burdens of infection seen during the colder months. Short-term impacts of water-temperature were found, with the minimum temperatures occurring before sampling being more highly predictive of infectious burdens than were longer-term spans of temperature. Our results will be useful for selecting the optimal time for disease surveys and, more broadly, for determining the key periods to undertake disease mitigation.	[Fernandez-Beaskoetxea, Saioa; Carrascal, Luis M.; Fernandez-Loras, Andres; Bosch, Jaime] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, St Marys Hosp, London, England; [Bosch, Jaime] Ctr Invest Seguimiento & Evaluac, Rascafria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Imperial College London	Fisher, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, St Marys Hosp, London, England.	matthew.fisher@imperial.ac.uk; bosch@mncn.cisc.es	Fisher, Matthew/B-9094-2011; Bosch, Jaime/H-3042-2011; Carrascal, Luis M./B-8381-2008; Carrascal, Luis M./Q-2190-2016	Fisher, Matthew/0000-0002-1862-6402; Bosch, Jaime/0000-0002-0099-7934; Carrascal, Luis M./0000-0003-1288-5531; Carrascal, Luis M./0000-0003-1288-5531	Fundacion General CSIC; Banco Santander; Biodiversa project RACE: Risk Assessment of Chytridiomycosis to European Amphibian Biodiversity; UK Natural Environmental Research Council NERC; Natural Environment Research Council [NE/G001944/1, NE/K014455/1] Funding Source: researchfish; NERC [NE/G001944/1, NE/K014455/1] Funding Source: UKRI	Fundacion General CSIC; Banco Santander; Biodiversa project RACE: Risk Assessment of Chytridiomycosis to European Amphibian Biodiversity; UK Natural Environmental Research Council NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was funded by Fundacion General CSIC and Banco Santander. S Fernandez-Beaskoetxea was supported by Biodiversa project RACE: Risk Assessment of Chytridiomycosis to European Amphibian Biodiversity. MC Fisher was funded by the UK Natural Environmental Research Council NERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Altizer S, 2004, J ANIM ECOL, V73, P309, DOI 10.1111/j.0021-8790.2004.00807.x; Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Burnham K P, 2003, MODEL SELECT MULTIMO; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Cattadori IM, 2005, P ROY SOC B-BIOL SCI, V272, P1163, DOI 10.1098/rspb.2004.3050; Cheng AC, 2009, FISH SHELLFISH IMMUN, V26, P768, DOI 10.1016/j.fsi.2009.03.011; Doddington BJ, 2013, ECOLOGY, V94, P1795, DOI 10.1890/12-1270.1; Drew A, 2006, DIS AQUAT ORGAN, V68, P245, DOI 10.3354/dao068245; Duncan AB, 2011, P ROY SOC B-BIOL SCI, V278, P3412, DOI 10.1098/rspb.2011.0287; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Geiger CC, 2011, AMPHIBIA-REPTILIA, V32, P276, DOI 10.1163/017353711X556970; Gosner K. L., 1960, Herpetologica, V16, P183; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hosseini PR, 2004, P ROY SOC B-BIOL SCI, V271, P2569, DOI 10.1098/rspb.2004.2938; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Knapp RA, 2006, COPEIA, P188, DOI 10.1643/0045-8511(2006)6[188:TMDAAA]2.0.CO;2; Knapp RA, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00028.1; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIS AQUAT ORGAN, V73, P257, DOI 10.3354/dao073257; Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7; Laakkonen J, 1999, PARASITOLOGY, V118, P1, DOI 10.1017/S0031182098003497; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; Murray KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061061; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Phillott AD, 2013, CONSERV BIOL, V27, P1058, DOI 10.1111/cobi.12073; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Schmeller DS, 2014, CURR BIOL, V24, P176, DOI 10.1016/j.cub.2013.11.032; Sparrow FK, 1968, FUNGI, V3; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tamerius JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021009; Tobler U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034667; Voordouw Maarten J., 2010, BMC Ecology, V10, P6, DOI 10.1186/1472-6785-10-6; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Waller PJ, 2004, VET PARASITOL, V122, P207, DOI 10.1016/j.vetpar.2004.04.007; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	58	22	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120237	10.1371/journal.pone.0120237	http://dx.doi.org/10.1371/journal.pone.0120237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793985	Green Published, gold			2022-12-26	WOS:000352083900001
J	Gibbins, HL; Proctor, GB; Yakubov, GE; Wilson, S; Carpenter, GH				Gibbins, Hannah L.; Proctor, Gordon B.; Yakubov, Gleb E.; Wilson, Stephen; Carpenter, Guy H.			SIgA Binding to Mucosal Surfaces Is Mediated by Mucin-Mucin Interactions	PLOS ONE			English	Article							PROLINE-RICH PROTEIN; SALIVARY; STATHERIN; PELLICLE; IDENTIFICATION; MUC5B; TRANSGLUTAMINASE; ADSORPTION; EXPRESSION; SECRETION	The oral mucosal pellicle is a layer of absorbed salivary proteins, including secretory IgA (SIgA), bound onto the surface of oral epithelial cells and is a useful model for all mucosal surfaces. The mechanism by which SIgA concentrates on mucosal surfaces is examined here using a tissue culture model with real saliva. Salivary mucins may initiate the formation of the mucosal pellicle through interactions with membrane-bound mucins on cells. Further protein interactions with mucins may then trigger binding of other pellicle proteins. HT29 colon cell lines, which when treated with methotrexate (HT29-MTX) produce a gel-forming mucin, were used to determine the importance of these mucin-mucin interactions. Binding of SIgA to cells was then compared using whole mouth saliva, parotid (mucin-free) saliva and a source of purified SIgA. Greatest SIgA binding occurred when WMS was incubated with HT29-MTX expressing mucus. Since salivary MUC5B was only able to bind to cells which produced mucus and purified SIgA showed little binding to the same cells we conclude that most SIgA binding to mucosal cells occurs because SIgA forms complexes with salivary mucins which then bind to cells expressing membrane-bound mucins. This work highlights the importance of mucin interactions in the development of the mucosal pellicle.	[Gibbins, Hannah L.; Proctor, Gordon B.; Carpenter, Guy H.] Kings Coll London, Inst Dent, Salivary Res Unit, London WC2R 2LS, England; [Yakubov, Gleb E.] Univ Queensland, Australian Res Council Ctr Excellence Plant Cell, Sch Chem Engn, Brisbane, Qld 4072, Australia; [Wilson, Stephen] Unilever R&D Discover, Sharnbrook, Beds, England	University of London; King's College London; University of Queensland; Unilever	Carpenter, GH (corresponding author), Kings Coll London, Inst Dent, Salivary Res Unit, London WC2R 2LS, England.	guy.carpenter@kcl.ac.uk	Yakubov, Gleb E/J-8817-2012	Yakubov, Gleb E/0000-0001-5420-9422; Carpenter, Guy/0000-0003-3084-3415; Proctor, Gordon/0000-0002-5684-841X	BBSRC; Unilever [BB/F01827/1]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unilever(Unilever)	The funding for this work was provided by a PhD Case Studentship from the BBSRC and then subsidised also by Unilever. Grant number: BB/F01827/1. URLs: http://www.bbsrc.ac.uk/home/home.aspx and http://www.unilever.co.uk/.Supervisors of the PhD student who worked/work at Unilever helped contribute to the design of the experiment, although the original idea was not from the company itself. This work was partly funded by a commercial source, Unilever, which also employs SW and previously employed GY. However, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIESBROCK AR, 1991, INFECT IMMUN, V59, P3492, DOI 10.1128/IAI.59.10.3492-3497.1991; BRADWAY SD, 1992, BIOCHEM J, V284, P557, DOI 10.1042/bj2840557; Carpenter GH, 2000, EXP PHYSIOL, V85, P281, DOI 10.1017/S0958067000019680; Carpenter GH, 2013, ANNU REV FOOD SCI T, V4, P267, DOI 10.1146/annurev-food-030212-182700; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; D'Agostino EM, 2012, J AGR FOOD CHEM, V60, P3318, DOI 10.1021/jf205111k; Dickinson ME, 2006, J MATER RES, V21, P1996, DOI 10.1557/JMR.2006.0248; DOUGLAS WH, 1991, BIOCHEM BIOPH RES CO, V180, P91, DOI 10.1016/S0006-291X(05)81259-8; Everest-Dass AV, 2012, GLYCOBIOLOGY, V22, P1465, DOI 10.1093/glycob/cws112; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Gibbins HL, 2014, ORAL DIS, V20, P707, DOI 10.1111/odi.12194; Gibbins HL, 2014, COLLOID SURFACE B, V120, P184, DOI 10.1016/j.colsurfb.2014.05.020; Iontcheva I, 2000, J DENT RES, V79, P732; LESUFFLEUR T, 1993, J CELL SCI, V106, P771; Leteurtre E, 2004, BIOL CELL, V96, P145, DOI 10.1016/j.biolcel.2003.12.005; Lindh L, 2001, BIOFOULING, V17, P227, DOI 10.1080/08927010109378482; Lindh L, 2002, COLLOID SURFACE B, V25, P139, DOI 10.1016/S0927-7765(01)00300-9; Ma JKC, 1998, NAT MED, V4, P601, DOI 10.1038/nm0598-601; Macakova L, 2010, COLLOID SURFACE B, V77, P31, DOI 10.1016/j.colsurfb.2009.12.022; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Nielsen PA, 1997, CANCER RES, V57, P634; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Pramanik R, 2010, EUR J ORAL SCI, V118, P245, DOI 10.1111/j.1600-0722.2010.00728.x; Proctor GB, 2005, BIOCHEM J, V389, P111, DOI 10.1042/BJ20042012; Slomiany BL, 1996, GEN PHARMACOL, V27, P761, DOI 10.1016/0306-3623(95)02050-0; SLOMIANY BL, 1993, BIOCHEM MOL BIOL INT, V31, P1091; Soares RV, 2004, ARCH ORAL BIOL, V49, P337, DOI 10.1016/j.archoralbio.2003.11.007; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Yakubov GE, 2009, LANGMUIR, V25, P2313, DOI 10.1021/la8018666; Yao Y, 2000, J DENT RES, V79, P930, DOI 10.1177/00220345000790040801	30	31	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119677	10.1371/journal.pone.0119677	http://dx.doi.org/10.1371/journal.pone.0119677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793390	gold, Green Submitted, Green Published			2022-12-26	WOS:000352084200105
J	Li, KW; Chiu, WS				Li, Kai Way; Chiu, Wen-Sheng			Isometric Arm Strength and Subjective Rating of Upper Limb Fatigue in Two-Handed Carrying Tasks	PLOS ONE			English	Article							MUSCLE FATIGUE; MUSCULAR FATIGUE; PHYSICAL WORK; MODEL; ENDURANCE	Sustained carrying could result in muscular fatigue of the upper limb. Ten male and ten female subjects were recruited for measurements of isometric arm strength before and during carrying a load for a period of 4 minutes. Two levels of load of carrying were tested for each of the male and female subjects. Exponential function based predictive equations for the isometric arm strength were established. The mean absolute deviations of these models in predicting the isometric arm strength were in the range of 3.24 to 17.34 N. Regression analyses between the subjective ratings of upper limb fatigue and force change index (FCI) for the carrying were also performed. The results indicated that the subjective rating of muscular fatigue may be estimated by multiplying the FCI with a constant. The FCI may, therefore, be adopted as an index to assess muscular fatigue for two-handed carrying tasks.	[Li, Kai Way] Chung Hua Univ, Dept Ind Management, Hsinchu, Taiwan; [Chiu, Wen-Sheng] Chung Hua Univ, PhD Program Technol Management, Hsinchu, Taiwan	Chung Hua University; Chung Hua University	Li, KW (corresponding author), Chung Hua Univ, Dept Ind Management, Hsinchu, Taiwan.	kai@chu.edu.tw		Li, Kai Way/0000-0003-0138-183X				[Anonymous], 1989, APPL LINEAR REGRESSI; ARMSTRONG TJ, 1993, SCAND J WORK ENV HEA, V19, P73, DOI 10.5271/sjweh.1494; AYOUB MM, 1974, AM I IND ENG T, V6, P185, DOI DOI 10.1080/05695557408974953; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Chaffin D. B., 1999, OCCUPATIONAL BIOMECH; CHAFFIN DB, 1975, AM IND HYG ASSOC J, V36, P505, DOI 10.1080/0002889758507283; CHAFFIN DB, 1983, HUM FACTORS, V25, P541, DOI 10.1177/001872088302500508; Dempsey PG, 1999, ERGONOMICS, V42, P183, DOI 10.1080/001401399185883; Edwards R H, 1981, Ciba Found Symp, V82, P1; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Iridiastadi H, 2006, ERGONOMICS, V49, P344, DOI 10.1080/00140130500475666; Ma L, 2013, ERGONOMICS, V56, P1889, DOI 10.1080/00140139.2013.851283; Ma LA, 2011, INT J IND ERGONOM, V41, P10, DOI 10.1016/j.ergon.2010.11.005; Ma L, 2009, INT J IND ERGONOM, V39, P211, DOI 10.1016/j.ergon.2008.04.004; Mamansari DU, 1996, APPL ERGON, V27, P53, DOI 10.1016/0003-6870(95)00055-0; ROHMERT W, 1986, ERGONOMICS, V29, P1235, DOI 10.1080/00140138608967237; Roman-Liu D, 2005, ERGONOMICS, V48, P930, DOI 10.1080/00140130500182312; Roman-Liu D, 2004, J ELECTROMYOGR KINES, V14, P671, DOI 10.1016/j.jelekin.2004.04.002; Sanders MS, 1992, HUMAN FACTORS IN ENG, P248; SNOOK SH, 1978, ERGONOMICS, V21, P963, DOI 10.1080/00140137808931804; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; Waters TR, 2007, J OCCUP ENVIRON MED, V49, P172, DOI 10.1097/JOM.0b013e3180322559; Wood DD, 1997, HUM FACTORS, V39, P83, DOI 10.1518/001872097778940678; Zhang ZW, 2014, INT J IND ERGONOM, V44, P292, DOI 10.1016/j.ergon.2012.08.006	26	13	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119550	10.1371/journal.pone.0119550	http://dx.doi.org/10.1371/journal.pone.0119550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794159	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200094
J	Liu, YT; Garrett, ME; Dennis, MF; Green, KT; Ashley-Koch, AE; Hauser, MA; Beckham, JC; Kimbrel, NA				Liu, Yutao; Garrett, Melanie E.; Dennis, Michelle F.; Green, Kimberly T.; Ashley-Koch, Allison E.; Hauser, Michael A.; Beckham, Jean C.; Kimbrel, Nathan A.		VA Mid-Atlantic MIRECC Registry	An Examination of the Association between 5-HTTLPR, Combat Exposure, and PTSD Diagnosis among US Veterans	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SEROTONIN TRANSPORTER GENE; TRAUMA EXPOSURE; ENVIRONMENT INTERACTION; LIFE EVENTS; GENOTYPE; POLYMORPHISM; DEPRESSION; MODERATION; LIABILITY	Objective To examine the association between the 5-HTTLPR polymorphism of the serotonin transporter (SLC6A4) gene, combat exposure, and posttraumatic stress disorder (PTSD) diagnosis and among two samples of combat-exposed veterans. Method The first sample included 550 non-Hispanic Black (NHB) combat-exposed veterans. The second sample included 555 non-Hispanic White (NHW) combat-exposed veterans. Participants were genotyped for the 5-HTTLPR/rs25531 variants of the SLC6A4 gene. A structured clinical interview was used to diagnose PTSD. Combat and civilian trauma exposure were assessed with validated self-report instruments. Logistic regression was used to test for main effects of 5-HTTLPR on PTSD diagnosis as well as gene x environment (GxE) interactions after adjusting for sex, ancestry proportion scores, civilian trauma exposure, and combat exposure. Results Within the NHB sample, a significant additive effect was observed for 5-HTTLPR (OR = 1.502, p = .0025), such that the odds of having a current diagnosis of PTSD increased by 1.502 for each additional S' allele. No evidence for an association between 5-HTTLPR and PTSD was observed in the NHW sample. In addition, no evidence for combat x 5-HTTLPR effects were observed in either sample. Conclusion The present study suggests that there may be an association between 5-HTTLPR genotype and PTSD diagnosis among NHB veterans; however, no evidence for the hypothesized 5-HTTLPR x combat interaction was found.	[Liu, Yutao] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA USA; [Garrett, Melanie E.; Ashley-Koch, Allison E.; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Dennis, Michelle F.; Beckham, Jean C.; Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, Durham, NC 27705 USA; [Dennis, Michelle F.; Beckham, Jean C.; Kimbrel, Nathan A.; VA Mid-Atlantic MIRECC Registry] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Dennis, Michelle F.; Green, Kimberly T.; Beckham, Jean C.; Kimbrel, Nathan A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA	University System of Georgia; Augusta University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Kimbrel, NA (corresponding author), Durham Vet Affairs Med Ctr, Durham, NC 27705 USA.	Nathan.Kimbrel@va.gov	Kimbrel, Nathan/P-3109-2016	Kimbrel, Nathan/0000-0001-7218-1005; Ashley-Koch, Allison/0000-0001-5409-9155	Career Development Award [IK2 CX000525]; Research Career Scientist Award from the Clinical Science Research and Development Service of the VA Office of Research and Development; NATIONAL CANCER INSTITUTE [R01CA081595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA016388] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000525] Funding Source: NIH RePORTER	Career Development Award; Research Career Scientist Award from the Clinical Science Research and Development Service of the VA Office of Research and Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by the facilities and resources of the Department of Veterans Affairs (VA) Mid-Atlantic Mental Illness Research, Education, and Clinical Center, the Research & Development and Mental Health Services of the Durham VA Medical Center, and the Clinical Science Research and Development Service of the VA Office of Research and Development, and NIMH 2R01MH062482, NCI 2R01CA81595, and NIDA 2K24DA016388. In addition, NAK was supported by a Career Development Award (IK2 CX000525) and JCB was supported by Research Career Scientist Award from the Clinical Science Research and Development Service of the VA Office of Research and Development. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the National Institutes of Health, or the United States government. The above funding agencies played no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cerda M, 2010, J AFFECT DISORDERS, V126, P14, DOI 10.1016/j.jad.2009.11.006; Clancy CP, 2006, J CLIN PSYCHIAT, V67, P1346, DOI 10.4088/JCP.v67n0904; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Gibbon M., 1994, STRUCTURAL CLIN INTE, Vsecond; Grabe HJ, 2009, AM J PSYCHIAT, V166, P926, DOI 10.1176/appi.ajp.2009.08101542; Gressier F, 2013, J TRAUMA STRESS, V26, P645, DOI 10.1002/jts.21855; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Kilpatrick DG, 2007, AM J PSYCHIAT, V164, P1693, DOI 10.1176/appi.ajp.2007.06122007; Kimbrel NA, DEPRESSION AND ANXIE; Koenen KC, 2009, AM J EPIDEMIOL, V169, P704, DOI 10.1093/aje/kwn397; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Kremen WS, 2012, NEUROPHARMACOLOGY, V62, P647, DOI 10.1016/j.neuropharm.2011.03.012; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lotrich Francis E, 2003, Am J Pharmacogenomics, V3, P145, DOI 10.2165/00129785-200303020-00007; Lyons MJ, 2013, AM J MED GENET B, V162, P762, DOI 10.1002/ajmg.b.32154; LYONS MJ, 1993, AM J MED GENET, V48, P22, DOI 10.1002/ajmg.1320480107; Mellman TA, 2009, DEPRESS ANXIETY, V26, P993, DOI 10.1002/da.20627; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Navarro-Mateu F, 2013, PLOS ONE, pe6627; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Ravindran LN, 2010, CURR TOP BEHAV NEURO, V2, P505, DOI 10.1007/7854_2009_15; Smits KM, 2008, PSYCHIAT GENET, V18, P184, DOI 10.1097/YPG.0b013e3283050aca; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Strug LJ, 2010, MOL PSYCHIATR, V15, P166, DOI 10.1038/mp.2008.79; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; Wang ZW, 2011, DEPRESS ANXIETY, V28, P1067, DOI 10.1002/da.20872; Wolf EJ, 2014, PSYCHOL MED, V44, P1499, DOI 10.1017/S0033291713002286; Xie PX, 2012, AM J MED GENET B, V159B, P644, DOI 10.1002/ajmg.b.32068; Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153	38	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119998	10.1371/journal.pone.0119998	http://dx.doi.org/10.1371/journal.pone.0119998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793742	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200135
J	Vagnini, LD; Renzi, A; Oliveira-Pelegrin, GR; Canas, MDT; Petersen, CG; Mauri, AL; Oliveira, JBA; Baruffi, RLR; Cavagna, M; Franco, JG				Vagnini, Laura Diniz; Renzi, Adriana; Oliveira-Pelegrin, Gabriela Ravanelli; Tomitao Canas, Maria do Carmo; Petersen, Claudia Guilhermino; Mauri, Ana Lucia; Alcantara Oliveira, Joao Batista; Razera Baruffi, Ricardo Luiz; Cavagna, Mario; Franco Junior, Jose Goncalves			The TP73 Gene Polymorphism (rs4648551, A > G) Is Associated with Diminished Ovarian Reserve	PLOS ONE			English	Article							PREDICTION INDEX ORPI; P53; REPRODUCTION; STIMULATION; FERTILITY; TAP73	It's known that the members of the TP53 family are involved in the regulation of female reproduction. Studies in mice showed that the TP73 gene (member of this family) plays a role in the size of follicular pool, ovulation rate and maintenance of genomic stability. In the present study we analyzed data from 605 patients with <= 37 years attending their first intracytoplasmic sperm injection (ICSI). The association between the TP73 polymorphism (rs4648551, A>G) and the following parameters related to ovarian reserve, like age, antral follicular count (AFC), anti-Mullerian hormone levels (AMH) and ovarian response prediction index (ORPI) was evaluated. Our results showed an association of the AA genotype with diminished ovarian reserve (AMH <1, AFC <= 9). Women presenting the AA genotype had a 2.0-fold increased risk for having AMH <1 and AFC <= 9 (OR 2.0, 95% CI 1.23-3.31, P = 0.005). Patients presenting AA genotype had the lowest levels of AMH (P = 0.02), the lowest number of antral follicles (P = 0.01) and the lowest ORPI (P = 0.007). Analyzing the alleles, we can see an enrichment of the A allele in the group of diminished ovarian reserve (OR 1.4, 95% CI 1.02-1.83, P = 0.04). To the best of our knowledge, the present study is the first to analyze this polymorphism in humans for assessing the numbers of ovarian follicles and AMH levels and, therefore, the ovarian reserve. Our findings can contribute to the use of this polymorphism as a potential marker of diminished ovarian reserve.	[Vagnini, Laura Diniz; Renzi, Adriana; Oliveira-Pelegrin, Gabriela Ravanelli; Tomitao Canas, Maria do Carmo] Paulista Ctr Diag Res & Training, Sao Paulo, Brazil; [Petersen, Claudia Guilhermino; Mauri, Ana Lucia; Alcantara Oliveira, Joao Batista; Razera Baruffi, Ricardo Luiz; Cavagna, Mario; Franco Junior, Jose Goncalves] Ctr Human Reprod Prof Franco Jr, Sao Paulo, Brazil		Franco, JG (corresponding author), Ctr Human Reprod Prof Franco Jr, Sao Paulo, Brazil.	franco@crh.com.br	Oliveira, Joao Batista A/E-3132-2015; Renzi, Adriana/M-9287-2019; Petersen, Claudia/AAS-5581-2020; Vagnini, Laura Diniz/N-3726-2019; Luchesi, Ana/N-9378-2019; Oliveira, João/GXN-3304-2022; Franco, José Gonçalves/G-3381-2019; Petersen, Claudia/N-9391-2019	Oliveira, Joao Batista A/0000-0003-4670-6650; Renzi, Adriana/0000-0002-8052-8125; Vagnini, Laura Diniz/0000-0001-5225-0608; Luchesi, Ana/0000-0002-9064-9430; Franco, José Gonçalves/0000-0001-5082-0240; 	Merck Serono grant [GFI-2014-16]	Merck Serono grant	This research was supported by Merck Serono grant (GFI-2014-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmae S, 2011, HUM REPROD UPDATE, V17, P813, DOI 10.1093/humupd/dmr034; Bhattacharya S, 2010, CLIN EVID, V2010; Boudjenah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038700; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Feng ZH, 2011, FASEB J, V25, P2245, DOI 10.1096/fj.10-180166; Hardarson T, 2001, HUM REPROD, V16, P313, DOI 10.1093/humrep/16.2.313; Hu WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001073; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Kohler HP, 2006, INT J ANDROL, V29, P46, DOI 10.1111/j.1365-2605.2005.00606.x; Kosova G, 2010, P NATL ACAD SCI USA, V107, P1772, DOI 10.1073/pnas.0906196106; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Muller M, 2005, CELL DEATH DIFFER, V12, P1564, DOI 10.1038/sj.cdd.4401774; Nardo LG, 2009, FERTIL STERIL, V92, P1586, DOI 10.1016/j.fertnstert.2008.08.127; Nelson SM, 2013, FERTIL STERIL, V99, P963, DOI 10.1016/j.fertnstert.2012.11.051; Oliveira JBA, 2013, FERTIL STERIL, V100, pS275, DOI 10.1016/j.fertnstert.2013.07.1145; Oliveira JBA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-94; Simoni M, 2014, EUR J ENDOCRINOL, V170, pR91, DOI 10.1530/EJE-13-0624; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Steuerwald NM, 2007, REPROD BIOMED ONLINE, V14, P700, DOI 10.1016/S1472-6483(10)60671-2; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Wang JL, 2007, J BIOL CHEM, V282, P29152, DOI 10.1074/jbc.M703408200; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607	23	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120048	10.1371/journal.pone.0120048	http://dx.doi.org/10.1371/journal.pone.0120048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794170	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200139
J	Wang, JT; Wu, UI; Lauderdale, TLY; Chen, MC; Li, SY; Hsu, LY; Chang, SC				Wang, Jann-Tay; Wu, Un-In; Lauderdale, Tsai-Ling Yang; Chen, Mei-Chen; Li, Shu-Ying; Hsu, Le-Yin; Chang, Shan-Chwen			Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; SUSCEPTIBLE ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; EXTENDED-SPECTRUM; 1ST IDENTIFICATION; MULTIPLEX PCR; RESISTANCE; ERTAPENEM; CLOACAE; GENES	A total of 1135 carbapenem-resistant (nonsusceptible) Enterobacteriaceae (CRE) isolates were recovered between November 2010 and July 2012 (517 from 2010-2011 and 618 from 2012) from 4 hospitals in Taiwan. Carbapenemase-producing Enterobacteriaceae (CPE) comprised 5.0% (57 isolates), including 17 KPC-2 (16 Klebsiella pneumoniae and 1 Escherichia coli), 1 NDM-1 (K. oxytoca), 37 IMP-8 (26 Enterobacter cloacae, 4 Citrobacter freundii, 4 Raoultella planticola, 1 K. pneumoniae, 1 E. coli and 1 K. oxytoca), and 2 VIM-1 (1 E. cloacae, 1 E. coli). The KPC-2-positive K. pneumoniae were highly clonal even in isolates from different hospitals, and all were ST11. IMP-8 positive E. cloacae from the same hospitals showed higher similarity in PFGE pattern than those from different hospitals. A total of 518 CRE isolates (45.6%) were positive for bla(ESBL), while 704 (62.0%) isolates were bla(AmpC)-positive, 382 (33.6% overall) of which carried both bla(ESBL) and bla(AmpC). CTX-M (414, 80.0%) was the most common bla(ESBL), while DHA (497, 70.6%) and CMY (157, 22.3%) were the most common bla(AmpC). Co-carriage of bla(ESBL) and bla(AmpC) was detected in 31 (54.4%) and 15 (26.3%) of the 57 CPE, respectively. KPC-2 was the most common carbapenemase detected in K. pneumoniae (2.8%), while IMP-8 was the most common in E. cloacae (9.7%). All KPC-2-positive CRE were resistant to all three tested carbapenems. However, fourteen of the 37 IMP-8-positive CRE were susceptible to both imipenem and meropenem in vitro. Intra-and inter-hospital spread of KPC-2-producing K. pneumoniae and IMP-8-producing E. cloacae likely occurred. Although the prevalence of CPE is still low, careful monitoring is urgently needed. Non-susceptibility to ertapenem might need to be considered as one criterion of definition for CRE in areas where IMP type carbapenemase is prevalent.	[Wang, Jann-Tay; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wu, Un-In] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Lauderdale, Tsai-Ling Yang; Chen, Mei-Chen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Li, Shu-Ying] Ctr Dis Control, Taipei, Taiwan; [Hsu, Le-Yin] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chang, Shan-Chwen] Natl Taiwan Univ, Grad Inst Clin Pharm, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan; Centers For Disease Control - Taiwan; National Taiwan University; National Taiwan University	Chang, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	changsc@ntu.edu.tw	Lauderdale, Tsai-Ling/B-2660-2010	CHANG, SHAN-CHWEN/0000-0001-6505-4139; WANG, JANN-TAY/0000-0002-0924-3469; WU, UN-IN/0000-0001-8182-6071	National Science Council, Taiwan [NSC 100-2321-B-002-021]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This study was supported by a grant from the National Science Council, Taiwan (NSC 100-2321-B-002-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PERF STAND ANT SUSC; Bonomo RA, 2011, CLIN INFECT DIS, V52, P485, DOI 10.1093/cid/ciq179; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Centers for Disease Control and Prevention (CDC), 2012, GUIDANCE FOR CONTROL; Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428; Chung KP, 2011, J ANTIMICROB CHEMOTH, V66, P1182, DOI 10.1093/jac/dkr025; Clinical and Laboratory Standards Institute (CLSI), 2009, METH DIL ANT SUSC TE, DOI [10.1016/j.diagmicrobio.2013.01.001, DOI 10.1016/J.DIAGMICROBIO.2013.01.001]; CLSI, 2012, PERF STAND ANT SUSC; Cornaglia G., 2011, Lancet Infectious Diseases, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Endimiani A, 2010, J CLIN MICROBIOL, V48, P4417, DOI 10.1128/JCM.02458-09; EUCAST, 2014, BREAKP TABL INT MICS; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hayakawa K, 2014, ANTIMICROB AGENTS CH, V58, P3441, DOI 10.1128/AAC.02652-13; Hu AY, 2012, J MED MICROBIOL, V61, P1488, DOI 10.1099/jmm.0.041129-0; Huang TW, 2013, ANTIMICROB AGENTS CH, V57, P4072, DOI 10.1128/AAC.02266-12; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lee CH, 2010, ANTIMICROB AGENTS CH, V54, P5395, DOI 10.1128/AAC.00083-10; Lee CM, 2012, ANTIMICROB AGENTS CH, V56, P5016, DOI 10.1128/AAC.00878-12; Leggiadro RJ, 1997, INFECT DIS CLIN N AM, V11, P875, DOI 10.1016/S0891-5520(05)70395-0; Liao Chun-Hsing, 2006, Journal of Microbiology Immunology and Infection, V39, P59; Liu YF, 2008, J ANTIMICROB CHEMOTH, V61, P1020, DOI 10.1093/jac/dkn049; Livermore DM, 2008, J ANTIMICROB CHEMOTH, V62, pII41, DOI [10.1093/jac/dkn371, 10.1093/jac/dkn351]; Livermore DM, 2011, INT J ANTIMICROB AG, V37, P415, DOI 10.1016/j.ijantimicag.2011.01.012; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Ma L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-599; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; O'Brien TF, 2011, CLIN MICROBIOL REV, V24, P281, DOI 10.1128/CMR.00021-10; Olson DS, 2013, INFECTION, V41, P259, DOI 10.1007/s15010-012-0294-x; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217/17460913.2.5.501; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Szabo D, 2006, ANTIMICROB AGENTS CH, V50, P2833, DOI 10.1128/AAC.01591-05; Teo I, 2012, CASE REP MED, V2012, DOI 10.1155/2012/601641; Trevino M, 2009, EUR J CLIN MICROBIOL, V28, P1253, DOI 10.1007/s10096-009-0765-x; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Vaneechoutte M, 2011, MANUAL CLIN MICROBIO, P539; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Yan JJ, 2010, EUR J CLIN MICROBIOL, V29, P1417, DOI 10.1007/s10096-010-1020-1; Yan JJ, 2002, J ANTIMICROB CHEMOTH, V50, P503, DOI 10.1093/jac/dkf170; Yang FC, 2012, J CLIN MICROBIOL, V50, P223, DOI 10.1128/JCM.01263-11; Yang K, 2007, ANN PHARMACOTHER, V41, P1427, DOI 10.1345/aph.1K213	49	76	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121668	10.1371/journal.pone.0121668	http://dx.doi.org/10.1371/journal.pone.0121668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794144	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900145
J	Yamanobe, Y; Nagahara, N; Matsukawa, T; Ito, T; Niimori-Kita, K; Chiba, M; Yokoyama, K; Takizawa, T				Yamanobe, Yoshiharu; Nagahara, Noriyuki; Matsukawa, Takehisa; Ito, Takaaki; Niimori-Kita, Kanako; Chiba, Momoko; Yokoyama, Kazuhito; Takizawa, Toshihiro			Sex Differences in Shotgun Proteome Analyses for Chronic Oral Intake of Cadmium in Mice	PLOS ONE			English	Article							SARCOSINE OXIDASE; EPITHELIAL-CELLS; UP-REGULATION; METALLOTHIONEIN; TOXICITY; RAT; KIDNEY; PURIFICATION; ADAPTATION; MECHANISMS	Environmental diseases related to cadmium exposure primarily develop owing to industrial wastewater pollution and/or contaminated food. In regions with high cadmium exposure in Japan, cadmium accumulation occurs primarily in the kidneys of individuals who are exposed to the metal. In contrast, in the itai-itai disease outbreak that occurred in the Jinzu River basin in Toyama Prefecture in Japan, cadmium primarily accumulated in the liver. On the other hand, high concentration of cadmium caused renal tubular disorder and osteomalacia (multiple bone fracture), probably resulting from the renal tubular dysfunction and additional pathology. In this study, we aimed to establish a mouse model of chronic cadmium intake. We administered cadmium-containing drinking water (32 mg/l) to female and male mice ad libitum for 11 weeks. Metal analysis using inductively coupled plasma mass spectrometry revealed that cadmium accumulated in the kidneys (927 x 10 + 185 ng/g in females and 661 x 10 + 101 ng/g in males), liver (397 x 10 + 199 ng/g in females and 238 x 10 + 652 ng/g in males), and thyroid gland (293 + 93.7 ng/g in females and 129 + 72.7 ng/g in males) of mice. Female mice showed higher cadmium accumulation in the kidney, liver, and thyroid gland than males did (p = 0.00345, p = 0.00213, and p = 0.0331, respectively). Shotgun proteome analyses after chronic oral administration of cadmium revealed that protein levels of glutathione S-transferase Mu2, Mu4, and Mu7 decreased in the liver, and those of A1 and A2 decreased in the kidneys in both female and male mice.	[Yamanobe, Yoshiharu; Nagahara, Noriyuki; Takizawa, Toshihiro] Nippon Med Sch, Isotope Res Ctr, Bunkyo Ku, Tokyo 113, Japan; [Matsukawa, Takehisa; Chiba, Momoko; Yokoyama, Kazuhito] Juntendo Univ, Fac Med, Dept Epidemiol & Environm Hlth, Bunkyo Ku, Tokyo, Japan; [Ito, Takaaki; Niimori-Kita, Kanako] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Hongo, Kumamoto, Japan	Nippon Medical School; Juntendo University; Kumamoto University	Nagahara, N (corresponding author), Nippon Med Sch, Isotope Res Ctr, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	noriyuki@nms.ac.jp		Yamanobe, Yoshiharu/0000-0002-2647-0073	Grants-in-Aid for Scientific Research [15K08322] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aoshima Keiko, 2012, Nihon Eiseigaku Zasshi, V67, P455; Aoyagi T, 2003, INT J UROL, V10, P332, DOI 10.1046/j.1442-2042.2003.00627.x; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF CADM; Baba H, 2014, J TOXICOL SCI, V39, P91, DOI 10.2131/jts.39.91; Chen DJ, 2014, BIOCHEM BIOPH RES CO, V445, P95, DOI 10.1016/j.bbrc.2014.01.146; Chen HY, 2008, BIRTH DEFECTS RES A, V82, P187, DOI 10.1002/bdra.20444; Go YM, 2013, TOXICOL SCI, V139, P59; Go YM, 2014, TOXICOL SCI, V139, P59, DOI 10.1093/toxsci/kfu018; Go YM, 2013, AM J PHYSIOL-LUNG C, V305, pL831, DOI 10.1152/ajplung.00203.2013; Gottschalg E, 2006, CHEM-BIOL INTERACT, V161, P251, DOI 10.1016/j.cbi.2006.04.003; HAYASHI S, 1983, BIOCHIM BIOPHYS ACTA, V742, P630, DOI 10.1016/0167-4838(83)90282-0; Honda A, 2010, J TOXICOL SCI, V35, P209, DOI 10.2131/jts.35.209; HORIGUCHI H, 1994, ARCH TOXICOL, V68, P632, DOI 10.1007/s002040050124; Horiguchi Hyogo, 2012, Nihon Eiseigaku Zasshi, V67, P447; Ishizaki A, 1968, Nihon Eiseigaku Zasshi, V23, P271; Johri N, 2010, BIOMETALS, V23, P783, DOI 10.1007/s10534-010-9328-y; Koizumi N, 1975, Nihon Eiseigaku Zasshi, V30, P300; Krajnc E. I., 1987, 758476004 NAT I PUBL; Kuzuhara Y, 1985, KANKYO HOKEN REP, V51, P162; Lau ATY, 2007, CANCER RES, V67, P2107, DOI 10.1158/0008-5472.CAN-06-3771; Mehus AA, 2014, MOL CELL PROTEOMICS, V13, P1020, DOI 10.1074/mcp.M113.033373; Nagahara N, 1990, J TOXICOL PATHOL, V3, P45; NOGAWA K, 1986, ENVIRON RES, V40, P251, DOI 10.1016/S0013-9351(86)80101-3; Nogawa K, 1979, Nihon Eiseigaku Zasshi, V34, P574; OGUSHI S, 1988, CHEM PHARM BULL, V36, P1445; Ohta H, 2001, BIOMED RES TRACE ELE, V12, P335; ONOSAKA S, 1985, EISEI KAGAKU, V31, P352, DOI 10.1248/jhs1956.31.352; ONOSAKA S, 1981, TOXICOLOGY, V22, P91, DOI 10.1016/0300-483X(81)90109-8; Prozialeck WC, 2012, J PHARMACOL EXP THER, V343, P2, DOI 10.1124/jpet.110.166769; REHM S, 1990, TOXICOL APPL PHARM, V104, P94, DOI 10.1016/0041-008X(90)90285-3; Round table conference, 1967, NIHON RINSHO, V25, P378; Rousselet E, 2008, PROTEOMICS, V8, P2244, DOI 10.1002/pmic.200701067; Son J, 2011, PROTEOMICS, V11, P2294, DOI 10.1002/pmic.200900690; SQUIBB KS, 1974, ENVIRON PHYSIOL BIOC, V4, P24; SUMINO K, 1975, ARCH ENVIRON HEALTH, V30, P487, DOI 10.1080/00039896.1975.10666759; SUZUKI M, 1981, J BIOCHEM-TOKYO, V89, P599, DOI 10.1093/oxfordjournals.jbchem.a133236; Takase B, 1968, Naika, V21, P885; Takeuchi J, 1968, Naika, V21, P876; The Ministry of Health and Welfare Opinion, 1968, KITANIPPON NEWS 0509; Thijssen S, 2007, TOXICOLOGY, V238, P200, DOI 10.1016/j.tox.2007.06.087; Tokumoto M, 2011, J TOXICOL SCI, V36, P127, DOI 10.2131/jts.36.127; Tripathi S, 2011, TISSUE CELL, V43, P131, DOI 10.1016/j.tice.2011.01.001; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z; Yamaguchi M, 1980, Nihon Eiseigaku Zasshi, V34, P719; Yin ZK, 2009, PROTEOMICS, V9, P4686, DOI 10.1002/pmic.200800958; Yoshida M, 1998, BIOL TRACE ELEM RES, V63, P167, DOI 10.1007/BF02778875; Zhu JY, 2006, AQUAT TOXICOL, V78, P127, DOI 10.1016/j.aquatox.2006.02.010	47	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121819	10.1371/journal.pone.0121819	http://dx.doi.org/10.1371/journal.pone.0121819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793409	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900157
J	Zhu, H; Yu, JJ; Yu, RB; Ding, H; Bai, J; Chen, J; Liu, H				Zhu, Hui; Yu, Jia-Jia; Yu, Rong-Bin; Ding, Hui; Bai, Jing; Chen, Ji; Liu, Hu			Association between Childhood Strabismus and Refractive Error in Chinese Preschool Children	PLOS ONE			English	Article							POPULATION-BASED SAMPLE; PSYCHOSOCIAL-ASPECTS; AMBLYOPIA; PREVALENCE; EYE; ANISOMETROPIA; PREDICTION; INFANTS; MYOPIA; AGE	Purpose To investigate the association between concomitant esotropia or concomitant exotropia and refractive error in preschool children Methods A population-based sample of 5831 children aged 3 to 6 years was selected from all kindergartens in a representative county (Yuhuatai District, Nanjing, Jiangsu Province) of Nanjing, China. Clinical examinations including ocular alignment, ocular motility, visual acuity, optometry, stereopsis screening, slit lamp examination and fundus examination were performed by trained ophthalmologists and optometrists. Odd ratios (OR) and 95% confidence intervals (95% CI) were calculated to evaluate the association of refractive error with concomitant esotropia and concomitant exotropia. Results In multivariate logistic regression analysis, concomitant esotropia was associated independently with spherical equivalent anisometropia (OR, 3.15 for 0.50 to < 1.00 diopter (D) of anisometropia, and 7.41 for > = 1.00 D of anisometropia) and hyperopia. There was a severity-dependent association of hyperopia with the development of concomitant esotropia, with ORs increasing from 9.3 for 2.00 to < 3.00 D of hyperopia, to 180.82 for > = 5.00 D of hyperopia. Concomitant exotropia was associated with astigmatism (OR, 3.56 for 0.50 to 1.00 D of astigmatism, and 1.9 for < 0.00 D of astigmatism), myopia (OR, 40.54 for -1.00 to < 0.00 D of myopia, and 18.93 for <-1.00 D of myopia), and hyperopia (OR, 67.78 for 1.00 to < 2.00 D of hyperopia, 23.13 for 2.00 to < 3.00 D of hyperopia, 25.57 for 3.00 to < 4.00 D of hyperopia, and 8.36 for 4.00 to < 5.00 D of hyperopia). Conclusions This study highlights the close associations between refractive error and the prevalence of concomitant esotropia and concomitant exotropia, which should be considered when managing childhood refractive error.	[Zhu, Hui] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China; [Yu, Jia-Jia] Wuxi 2 Peoples Hosp, Dept Ophthalmol, Wuxi, Jiangsu, Peoples R China; [Yu, Rong-Bin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Ding, Hui; Bai, Jing; Chen, Ji] Maternal & Child Healthcare Hosp Yuhua Dist, Nanjing, Jiangsu, Peoples R China; [Liu, Hu] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liu, H (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	liuhu66@163.com		Liu, Hu/0000-0002-3952-4165	Science and Technology Bureau of Yuhuatai District [201001110]	Science and Technology Bureau of Yuhuatai District	The authors received funding from the Science and Technology Bureau of Yuhuatai District. The grant numbers are 201001110 and the URL is http://www.njkj.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker S, 2003, INVEST OPHTH VIS SCI, V44, P497, DOI 10.1167/iovs.02-0070; Atkinson J, 1996, EYE, V10, P189, DOI 10.1038/eye.1996.46; Atkinson J, 2000, INVEST OPHTH VIS SCI, V41, P3726; Chia A, 2013, OPHTHAL EPIDEMIOL, V20, P138, DOI 10.3109/09286586.2013.767354; Colburn JD, 2010, J AAPOS, V14, P211, DOI 10.1016/j.jaapos.2010.02.006; Cotter SA, 2011, OPHTHALMOLOGY, V118, P2251, DOI 10.1016/j.ophtha.2011.06.032; Ekdawi NS, 2010, AM J OPHTHALMOL, V149, P503, DOI 10.1016/j.ajo.2009.10.009; Fu J, 2014, OPHTHAL EPIDEMIOL, V21, P197, DOI 10.3109/09286586.2014.904371; Holmstrom G, 2006, J PEDIAT OPHTH STRAB, V43, P346, DOI 10.3928/01913913-20061101-04; Huynh SC, 2006, BRIT J OPHTHALMOL, V90, P597, DOI 10.1136/bjo.2005.083154; INGRAM RM, 1990, BRIT J OPHTHALMOL, V74, P158, DOI 10.1136/bjo.74.3.158; INGRAM RM, 1986, BRIT J OPHTHALMOL, V70, P12, DOI 10.1136/bjo.70.1.12; Ip JM, 2008, OPHTHALMOLOGY, V115, P678, DOI 10.1016/j.ophtha.2007.04.061; Kushner BJ, 1998, ARCH OPHTHALMOL-CHIC, V116, P478, DOI 10.1001/archopht.116.4.478; Lin SB, 2014, AM J OPHTHALMOL, V157, P894, DOI 10.1016/j.ajo.2014.01.012; Menon V, 2002, J PEDIAT OPHTH STRAB, V39, P203, DOI 10.3928/0191-3913-20020701-07; Miller JM, 2009, OPTOMETRY VISION SCI, V86, P599, DOI 10.1097/OPX.0b013e3181a6a211; Nelson BA, 2008, J AAPOS, V12, P72, DOI 10.1016/j.jaapos.2007.08.006; O'Connor AR, 2002, ARCH OPHTHALMOL-CHIC, V120, P767; Ojaimi E, 2005, OPHTHAL EPIDEMIOL, V12, P59, DOI 10.1080/09286580490921296; Raab E L, 1982, Trans Am Ophthalmol Soc, V80, P657; Robaei D, 2006, OPHTHALMOLOGY, V113, P1146, DOI 10.1016/j.ophtha.2006.02.019; Robaei D, 2006, ARCH OPHTHALMOL-CHIC, V124, P878, DOI 10.1001/archopht.124.6.878; SATTERFIELD D, 1993, ARCH OPHTHALMOL-CHIC, V111, P1100, DOI 10.1001/archopht.1993.01090080096024; Von Noorden GK, 2002, BINOCULAR VISION OCU, DOI [10.3368/aoj.51.1.161, DOI 10.3368/AOJ.51.1.161]; Walsh LA, 2000, J AAPOS, V4, P154, DOI 10.1016/S1091-8531(00)70005-X; Weakley D R, 1999, Trans Am Ophthalmol Soc, V97, P987; Weakley DR, 2001, OPHTHALMOLOGY, V108, P163, DOI 10.1016/S0161-6420(00)00425-5; Xu JL, 2012, J PEDIAT OPHTH STRAB, V49, P170, DOI 10.3928/01913913-20110920-02	29	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120720	10.1371/journal.pone.0120720	http://dx.doi.org/10.1371/journal.pone.0120720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793499	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900068
J	Zhu, WZ; Lin, YQ; Liao, HH; Wang, Y				Zhu, Wuzheng; Lin, Yaqiu; Liao, Honghai; Wang, Yong			Selection of Reference Genes for Gene Expression Studies Related to Intramuscular Fat Deposition in Capra hircus Skeletal Muscle	PLOS ONE			English	Article							REAL-TIME PCR; SUITABLE REFERENCE GENES; REVERSE TRANSCRIPTION-PCR; INTERNAL REFERENCE GENES; SYBR GREEN QPCR; BEEF-CATTLE; HOUSEKEEPING GENES; FEEDING SYSTEM; SOMATIC-CELLS; MEAT QUALITY	The identification of suitable reference genes is critical for obtaining reliable results from gene expression studies using quantitative real-time PCR (qPCR) because the expression of reference genes may vary considerably under different experimental conditions. In most cases, however, commonly used reference genes are employed in data normalization without proper validation, which may lead to incorrect data interpretation. Here, we aim to select a set of optimal reference genes for the accurate normalization of gene expression associated with intramuscular fat (IMF) deposition during development. In the present study, eight reference genes (PPIB, HMBS, RPLP0, B2M, YWHAZ, 18S, GAPDH and ACTB) were evaluated by three different algorithms (geNorm, NormFinder and BestKeeper) in two types of muscle tissues (longissimus dorsi muscle and biceps femoris muscle) across different developmental stages. All three algorithms gave similar results. PPIB and HMBS were identified as the most stable reference genes, while the commonly used reference genes 18S and GAPDH were the most variably expressed, with expression varying dramatically across different developmental stages. Furthermore, to reveal the crucial role of appropriate reference genes in obtaining a reliable result, analysis of PPARG expression was performed by normalization to the most and the least stable reference genes. The relative expression levels of PPARG normalized to the most stable reference genes greatly differed from those normalized to the least stable one. Therefore, evaluation of reference genes must be performed for a given experimental condition before the reference genes are used. PPIB and HMBS are the optimal reference genes for analysis of gene expression associated with IMF deposition in skeletal muscle during development.	[Zhu, Wuzheng; Lin, Yaqiu; Liao, Honghai; Wang, Yong] Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu 610041, Peoples R China	Southwest Minzu University	Wang, Y (corresponding author), Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu 610041, Peoples R China.	wangyong010101@swun.cn			"twelfth Five-Year" Key Projects of Animal and Poultry Breeding Research of Sichuan Province [2011NZ0099-36]; National High Technology Research and Development Program of China [2012BAD13B06]; Key Demonstration Project of Science and Technology Innovation Industrial Chain in Sichuan province [2011NZ0003]	"twelfth Five-Year" Key Projects of Animal and Poultry Breeding Research of Sichuan Province; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Demonstration Project of Science and Technology Innovation Industrial Chain in Sichuan province	Funding: The work was supported by the "twelfth Five-Year" Key Projects of Animal and Poultry Breeding Research of Sichuan Province (No. 2011NZ0099-36), National High Technology Research and Development Program of China (No. 2012BAD13B06), the Key Demonstration Project of Science and Technology Innovation Industrial Chain in Sichuan province (No. 2011NZ0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bai WL, 2014, J DAIRY SCI, V97, P902, DOI 10.3168/jds.2012-6437; Bonnet M, 2013, ANIMAL, V7, P1344, DOI 10.1017/S1751731113000475; Bruge F, 2011, J BIOTECHNOL, V156, P153, DOI 10.1016/j.jbiotec.2011.09.018; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaillou T, 2011, PHYSIOL GENOMICS, V43, P228, DOI 10.1152/physiolgenomics.00109.2010; Cinar Mehmet Ulas, 2013, BMC Res Notes, V6, P56, DOI 10.1186/1756-0500-6-56; Deloffre LAM, 2012, GENE, V506, P69, DOI 10.1016/j.gene.2012.06.047; Dervishi E, 2011, MEAT SCI, V89, P91, DOI 10.1016/j.meatsci.2011.04.003; Feng XT, 2010, J BIOTECHNOL, V150, P288, DOI 10.1016/j.jbiotec.2010.09.949; Gerbens F, 2001, J ANIM SCI, V79, P347; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; da Costa ASH, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-118; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hu Q, 2014, FISH PHYSIOL BIOCHEM, V40, P1721, DOI 10.1007/s10695-014-9962-3; Huth A, 2013, INT J LEGAL MED, V127, P335, DOI 10.1007/s00414-012-0787-2; Jarczak J, 2014, GENE, V549, P280, DOI 10.1016/j.gene.2014.07.063; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; Lancaster PA, 2014, J ANIM SCI, V92, P1462, DOI 10.2527/jas.2013-6976; Leal MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105002; Li L, 2013, GENE, V528, P195, DOI 10.1016/j.gene.2013.07.013; Mannen H, 2011, ANIM SCI J, V82, P1, DOI 10.1111/j.1740-0929.2010.00845.x; McBryan J, 2010, MEAT SCI, V86, P436, DOI 10.1016/j.meatsci.2010.05.030; Modesto P, 2013, J DAIRY SCI, V96, P7932, DOI 10.3168/jds.2012-6383; Montero-Melendez T, 2014, INFLAMMATION, V37, P1059, DOI 10.1007/s10753-014-9829-x; Najafpanah MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083041; Naoumov NV, 2014, J HEPATOL, V61, P1166, DOI 10.1016/j.jhep.2014.07.008; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Peletto S, 2011, INT J MOL SCI, V12, P7732, DOI 10.3390/ijms12117732; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Saremi B, 2012, J DAIRY SCI, V95, P3131, DOI 10.3168/jds.2011-4803; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serrano M, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-36; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Talpur FN, 2008, MEAT SCI, V80, P819, DOI 10.1016/j.meatsci.2008.03.028; Thomas KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088653; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Vossaert L, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-21; Wang LJ, 2015, MOL BIOL REP, V42, P201, DOI 10.1007/s11033-014-3759-4; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Wang YH, 2005, MAMM GENOME, V16, P201, DOI 10.1007/s00335-004-2419-8; Waters SM, 2009, J ANIM SCI, V87, P244, DOI 10.2527/jas.2008-1005; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Yue Hua, 2010, Virologica Sinica, V25, P425, DOI 10.1007/s12250-010-3114-4; Zhang HB, 2014, ANIM SCI J, V85, P411, DOI 10.1111/asj.12161; Zhang Y, 2013, ASIAN AUSTRAL J ANIM, V26, P1665, DOI 10.5713/ajas.2013.13199; Zhao DJ, 2012, FEBS OPEN BIO, V2, P235, DOI 10.1016/j.fob.2012.08.001; Zhao JP, 2012, J ANIM SCI, V90, P4337, DOI 10.2527/jas.2012-5100; Zinzow-Kramer WM, 2014, HORM BEHAV, V66, P267, DOI 10.1016/j.yhbeh.2014.04.011	53	30	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121280	10.1371/journal.pone.0121280	http://dx.doi.org/10.1371/journal.pone.0121280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794179	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900119
J	Guler, R; Parihar, SP; Savvi, S; Logan, E; Schwegmann, A; Roy, S; Nieuwenhuizen, NE; Ozturk, M; Schmeier, S; Suzuki, H; Brombacher, F				Guler, Reto; Parihar, Suraj P.; Savvi, Suzana; Logan, Erin; Schwegmann, Anita; Roy, Sugata; Nieuwenhuizen, Natalie E.; Ozturk, Mumin; Schmeier, Sebastian; Suzuki, Harukazu; Brombacher, Frank			IL-4R alpha-Dependent Alternative Activation of Macrophages Is Not Decisive for Mycobacterium tuberculosis Pathology and Bacterial Burden in Mice	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; T-CELLS; EXPRESSION; RECEPTOR; IL-4; INTERLEUKIN-4; DEPENDS; ALPHA; DELTA	Classical activation of macrophages (caMph or M1) is crucial for host protection against Mycobacterium tuberculosis (Mtb) infection. Evidence suggests that IL-4/IL-13 alternatively activated macrophages (aaMph or M2) are exploited by Mtb to divert microbicidal functions of caMph. To define the functions of M2 macrophages during tuberculosis (TB), we infected mice deficient for IL-4 receptor alpha on macrophages (LysM(cre)IL-4R alpha(-/lox)) with Mtb. We show that absence of IL-4R alpha on macrophages does not play a major role during infection with Mtb H37Rv, or the clinical Beijing strain HN878. This was demonstrated by similar mortality, bacterial burden, histopathology and T cell proliferation between infected wild-type (WT) and LysM(cre)IL-4R alpha(-/lox) mice. Interestingly, we observed no differences in the lung expression of inducible nitric oxide synthase (iNOS) and Arginase 1 (Arg1), well-established markers for M1/M2 macrophages among the Mtb-infected groups. Kinetic expression studies of IL-4/IL-13 activated bone marrow-derived macrophages (BMDM) infected with HN878, followed by gene set enrichment analysis, revealed that the MyD88 and IL-6, IL-10, G-CSF pathways are significantly enriched, but not the IL-4R alpha driven pathway. Together, these results suggest that IL-4R alpha-macrophages do not play a central role in TB disease progression.	[Guler, Reto; Parihar, Suraj P.; Savvi, Suzana; Logan, Erin; Schwegmann, Anita; Nieuwenhuizen, Natalie E.; Ozturk, Mumin; Brombacher, Frank] Univ Cape Town, Int Ctr Genet Engn & Biotechnol, Cape Town Component & Inst Infect Dis & Mol Med I, Div Immunol, ZA-7925 Cape Town, South Africa; [Schmeier, Sebastian] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand; [Roy, Sugata; Suzuki, Harukazu] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Massey University; RIKEN	Brombacher, F (corresponding author), Univ Cape Town, Int Ctr Genet Engn & Biotechnol, Cape Town Component & Inst Infect Dis & Mol Med I, Div Immunol, ZA-7925 Cape Town, South Africa.	frank.brombacher@icgeb.org	Parihar, Suraj/HCI-2597-2022; Schmeier, Sebastian/D-4731-2011; Nieuwenhuizen, Natalie/AAP-2400-2021; Ozturk, Mumin/G-9739-2016; Suzuki, Harukazu/N-9553-2015	Parihar, Suraj/0000-0002-4932-7990; Schmeier, Sebastian/0000-0002-3947-8226; Ozturk, Mumin/0000-0001-9152-7614; Suzuki, Harukazu/0000-0002-8087-0836; Aldera, Erin/0000-0001-7935-1337; Roy, Sugata/0000-0001-7183-7957; Nieuwenhuizen, Natalie/0000-0001-5749-2462	International Centre for Genetic Engineering & Biotechnology (ICGEB); Cape Town Component with Arturo Falaschi; Claude Leon Foundation; CIDRI; Wellcome trust [084323]; South African Medical Research Council; ICGEB Arturo Falaschi PhD Fellowship	International Centre for Genetic Engineering & Biotechnology (ICGEB)(Department of Biotechnology (DBT) India); Cape Town Component with Arturo Falaschi; Claude Leon Foundation; CIDRI; Wellcome trust(Wellcome TrustEuropean Commission); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ICGEB Arturo Falaschi PhD Fellowship	This work was supported by the International Centre for Genetic Engineering & Biotechnology (ICGEB), Cape Town Component with Arturo Falaschi, Claude Leon Foundation and CIDRI, Wellcome trust (Grant No. 084323) post-doctoral fellowships to SPP. South African Medical Research Council (SAMRC) Unit on Immunology of Infectious Diseases (FB). A National Research Funding (NRF) South Africa and the South African Research Chair initiative (SARChi) to FB, the NRF Competitive Programme for Unrated Researchers (CSUR) and South African Medical Research Council (Self-Initiated Research Grant) to RG, the JST Strategic International Research Cooperative Program to HS and ICGEB Arturo Falaschi PhD Fellowship to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashenafi S, 2014, CLIN IMMUNOL, V151, P84, DOI 10.1016/j.clim.2014.01.010; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dewals BG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000689; Dheda K, 2007, TUBERCULOSIS, V87, P237, DOI 10.1016/j.tube.2006.11.001; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Guler R, 2011, VACCINE, V29, P1339, DOI 10.1016/j.vaccine.2010.10.045; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Holscher C, 2006, J IMMUNOL, V176, P1115, DOI 10.4049/jimmunol.176.2.1115; Howard AD, 1999, CLIN EXP IMMUNOL, V115, P428; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Muller U, 2013, INT IMMUNOL, V25, P459, DOI 10.1093/intimm/dxt003; Nieuwenhuizen NE, 2012, J ALLERGY CLIN IMMUN, V130, P743, DOI 10.1016/j.jaci.2012.03.011; Nolan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059461; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ordway DJ, 2004, J INFECT DIS, V190, P756, DOI 10.1086/422532; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pessanha AP, 2012, FEMS IMMUNOL MED MIC, V66, P265, DOI 10.1111/j.1574-695X.2012.01012.x; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schwegmann A, 2007, P NATL ACAD SCI USA, V104, P16251, DOI 10.1073/pnas.0703496104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; Welsh KJ, 2008, MICROBIOL-SGM, V154, P1813, DOI 10.1099/mic.0.2008/016923-0; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	36	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121070	10.1371/journal.pone.0121070	http://dx.doi.org/10.1371/journal.pone.0121070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790379	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400188
J	Luz, D; Chen, G; Maranhao, AQ; Rocha, LB; Sidhu, S; Piazza, RMF				Luz, Daniela; Chen, Gang; Maranhao, Andrea Q.; Rocha, Leticia B.; Sidhu, Sachdev; Piazza, Roxane M. F.			Development and Characterization of Recombinant Antibody Fragments That Recognize and Neutralize In Vitro Stx2 Toxin from Shiga Toxin-Producing Escherichia coli	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; MONOCLONAL-ANTIBODIES; TYPE-2 STX2; BINDING; DIARRHEA; CHAIN; MICE; PATHOGENESIS; DISEASE	Background Stx toxin is a member of the AB(5) family of bacterial toxins: the active A subunit has N-glyco-sidase activity against 28S rRNA, resulting in inhibition of protein synthesis in eukaryotic cells, and the pentamer ligand B subunits (StxB) bind to globotria(tetra) osylceramide receptors (Gb3/Gb4) on the cell membrane. Shiga toxin-producing Escherichia coli strains (STEC) may produce Stx1 and/or Stx2 and variants. Strains carrying Stx2 are considered more virulent and related to the majority of outbreaks, besides being usually associated with hemolytic uremic syndrome in humans. The development of tools for the detection and/or neutralization of these toxins is a turning point for early diagnosis and therapeutics. Antibodies are an excellent paradigm for the design of high-affinity, protein-based binding reagents used for these purposes. Methods and Findings In this work, we developed two recombinant antibodies; scFv fragments from mouse hybridomas and Fab fragments by phage display technology using a human synthetic antibody library. Both fragments showed high binding affinity to Stx2, and they were able to bind specifically to the GKIEFSKYNEDDTF region of the Stx2 B subunit and to neutralize in vitro the cytotoxicity of the toxin up to 80%. Furthermore, the scFv fragments showed 79% sensitivity and 100% specificity in detecting STEC strains by ELISA. Conclusion In this work, we developed and characterized two recombinant antibodies against Stx2, as promising tools to be used in diagnosis or therapeutic approaches against STEC, and for the first time, we showed a human monovalent molecule, produced in bacteria, able to neutralize the cytotoxicity of Stx2 in vitro.	[Luz, Daniela; Rocha, Leticia B.; Piazza, Roxane M. F.] Inst Butantan, Lab Bacteriol, Sao Paulo, Brazil; [Maranhao, Andrea Q.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Maranhao, Andrea Q.] Univ Brasilia, Lab Imunol, Brasilia, DF, Brazil	Instituto Butantan; University of Toronto; Universidade de Brasilia	Piazza, RMF (corresponding author), Inst Butantan, Lab Bacteriol, Sao Paulo, Brazil.	roxane@butantan.gov.br	Piazza, Roxane/ABD-9196-2020; Maranhão, Andrea Q/L-4474-2013; Piazza, Roxane MF/A-9915-2018; Maranhão, Andrea/AAC-3560-2019; Piazza, Roxane Maria F/K-9807-2016; Rocha, Letícia/F-1225-2015; Maranhão, Andrea Queiroz/S-8696-2019; Luz, Daniela/C-2374-2019	Piazza, Roxane/0000-0003-0068-8506; Maranhão, Andrea Q/0000-0002-1946-7191; Piazza, Roxane MF/0000-0003-0068-8506; Maranhão, Andrea/0000-0002-1946-7191; Chen, Gang/0000-0002-6304-9173; Luz, Daniela/0000-0001-9622-0320	Sao Paulo Research Foundation (FAPESP) [11/12928-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [-301302/2013-8]; FAPESP [10/20148-4, 13/03160-9]; FAPESP fellowships	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP fellowships(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grants 11/12928-2 from Sao Paulo Research Foundation (FAPESP) and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq -301302/2013-8) to RMFP. DL (FAPESP - 10/20148-4 and 13/03160-9) and LBR were recipients of FAPESP fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 2010, INFECT IMMUN, V78, P1376, DOI 10.1128/IAI.00867-09; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Caldas C, 2000, PROTEIN ENG, V13, P353, DOI 10.1093/protein/13.5.353; Cheng LW, 2013, TOXINS, V5, P1845, DOI 10.3390/toxins5101845; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cornick NA, 2002, J INFECT DIS, V186, P57, DOI 10.1086/341295; Davis TK, 2013, INFECT DIS CLIN N AM, V27, P577, DOI 10.1016/j.idc.2013.05.010; de Andrade EV, 2005, BBA-GEN SUBJECTS, V1726, P293, DOI 10.1016/j.bbagen.2005.08.013; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Fernandez-Brando RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019136; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Gould L. Hannah, 2009, Morbidity and Mortality Weekly Report, V58, P1; He XH, 2013, J IMMUNOL METHODS, V389, P18, DOI 10.1016/j.jim.2012.12.005; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Ibarra C, 2013, IUBMB LIFE, V65, P827, DOI 10.1002/iub.1206; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Laing CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037362; Lopez EL, 2010, ANTIMICROB AGENTS CH, V54, P239, DOI 10.1128/AAC.00343-09; Ma Y, 2008, IMMUNOL LETT, V121, P110, DOI 10.1016/j.imlet.2008.09.008; Mendes-Ledesma MRB, 2008, MICROBIOL IMMUNOL, V52, P484, DOI 10.1111/j.1348-0421.2008.00068.x; Miethe S, 2014, MABS-AUSTIN, V6, P446, DOI 10.4161/mabs.27773; Mohawk KL, 2010, VACCINE, V28, P4777, DOI 10.1016/j.vaccine.2010.04.099; Mukherjee J, 2002, INFECT IMMUN, V70, P5896, DOI 10.1128/IAI.70.10.5896-5899.2002; Mukherjee J, 2002, INFECT IMMUN, V70, P612, DOI 10.1128/IAI.70.2.612-619.2002; Murase K, 2003, CHEM BIOL, V10, P161, DOI 10.1016/S1074-5521(03)00025-5; Nakao H, 1999, INFECT IMMUN, V67, P5717, DOI 10.1128/IAI.67.11.5717-5722.1999; Neri P, 2011, VACCINE, V29, P5340, DOI 10.1016/j.vaccine.2011.05.093; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; Parma YR, 2011, TOXICON, V58, P380, DOI 10.1016/j.toxicon.2011.07.009; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rivas M, 2006, FOODBORNE PATHOG DIS, V3, P88, DOI 10.1089/fpd.2006.3.88; Rocha B, 2007, LETT APPL MICROBIOL, V45, P411, DOI 10.1111/j.1472-765X.2007.02214.x; Rocha LB, 2012, TOXINS, V4, P729, DOI 10.3390/toxins4090729; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Sheoran AS, 2005, INFECT IMMUN, V73, P4607, DOI 10.1128/IAI.73.8.4607-4613.2005; Skinner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099854; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076563; Thompson GS, 2000, BIOCHEMISTRY-US, V39, P13153, DOI 10.1021/bi001394+; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; YAMADA S, 1993, MICROBIOL IMMUNOL, V37, P111, DOI 10.1111/j.1348-0421.1993.tb03187.x; Yamagami S, 2001, J INFECT DIS, V184, P738, DOI 10.1086/323082	46	25	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120481	10.1371/journal.pone.0120481	http://dx.doi.org/10.1371/journal.pone.0120481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790467	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400159
J	Tapia, O; Fong, LG; Huber, MD; Young, SG; Gerace, L				Tapia, Olga; Fong, Loren G.; Huber, Michael D.; Young, Stephen G.; Gerace, Larry			Nuclear Envelope Protein Lem2 is Required for Mouse Development and Regulates MAP and AKT Kinases	PLOS ONE			English	Article							MEMBRANE-PROTEIN; ESSENTIAL ROLES; DOMAIN PROTEIN; MAN1; EMERIN; LAMINA; INTERACTS; ERYTHROPOIETIN; ACTIVATION; MECHANISMS	The nuclear lamina, along with associated nuclear membrane proteins, is a nexus for regulating signaling in the nucleus. Numerous human diseases arise from mutations in lamina proteins, and experimental models for these disorders have revealed aberrant regulation of various signaling pathways. Previously, we reported that the inner nuclear membrane protein Lem2, which is expressed at high levels in muscle, promotes the differentiation of cultured myoblasts by attenuating ERK signaling. Here, we have analyzed mice harboring a disrupted allele for the Lem2 gene (Lemd2). No gross phenotypic defects were seen in heterozygotes, although muscle regeneration induced by cardiotoxin was delayed. By contrast, homozygous Lemd2 knockout mice died by E11.5. Although many normal morphogenetic hallmarks were observed in E10.5 knockout embryos, most tissues were substantially reduced in size. This was accompanied by activation of multiple MAP kinases (ERK1/2, JNK, p38) and AKT. Knockdown of Lem2 expression in C2C12 myoblasts also led to activation of MAP kinases and AKT. These findings indicate that Lemd2 plays an essential role in mouse embryonic development and that it is involved in regulating several signaling pathways. Since increased MAP kinase and AKT/mTORC signaling is found in other animal models for diseases linked to nuclear lamina proteins, LEMD2 should be considered to be another candidate gene for human disease.	[Tapia, Olga; Huber, Michael D.; Gerace, Larry] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	Scripps Research Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gerace, L (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lgerace@scripps.edu	Tapia, Olga/AAN-2427-2020; Tapia, Olga/AAH-8651-2020	Tapia, Olga/0000-0002-0802-7975; Young, Stephen/0000-0001-7270-3176	NIH [GM028521, HL086683, HL089781, AG035626]; Imaging Core of NIH grant [AR061303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086683, R01HL089781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Imaging Core of NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants GM028521 to L.G., HL086683 and HL089781 (to L.G. F.), and AG035626 (to S.G.Y.). Support also was provided by the Imaging Core of NIH grant AR061303 (San Diego Skeletal Muscle Research Center).	Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043; Barkan R, 2012, MOL BIOL CELL, V23, P543, DOI 10.1091/mbc.E11-06-0505; Barton LJ, 2014, GENETICS, V197, P653, DOI 10.1534/genetics.114.162941; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bourgeois B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003411; Brachner A, 2005, J CELL SCI, V118, P5797, DOI 10.1242/jcs.02701; Burke B, 2014, CURR TOP DEV BIOL, V109, P1, DOI 10.1016/B978-0-12-397920-9.00006-8; Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Caputo S, 2006, J BIOL CHEM, V281, P18208, DOI 10.1074/jbc.M601980200; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Cohen TV, 2007, DEVELOPMENT, V134, P1385, DOI 10.1242/dev.02816; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Huber MD, 2009, MOL CELL BIOL, V29, P5718, DOI 10.1128/MCB.00270-09; Ishimura A, 2006, DEVELOPMENT, V133, P3919, DOI 10.1242/DEV.02538; Li L, 2007, GENESIS, V45, P560, DOI 10.1002/dvg.20325; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2009, BBA-MOL BASIS DIS, V1792, P75, DOI 10.1016/j.bbadis.2008.10.012; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Raju GP, 2003, J BIOL CHEM, V278, P428, DOI 10.1074/jbc.M210505200; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Reil M, 2013, EUR J CELL BIOL, V92, P280, DOI 10.1016/j.ejcb.2013.10.008; ROBER RA, 1989, DEVELOPMENT, V105, P365; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shimi T, 2010, COLD SH Q B, V75, P525, DOI 10.1101/sqb.2010.75.045; Shin JY, 2013, DEV CELL, V26, P591, DOI 10.1016/j.devcel.2013.08.012; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Ulbert S, 2006, FEBS LETT, V580, P6435, DOI 10.1016/j.febslet.2006.10.060; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Wong XR, 2014, CURR OPIN CELL BIOL, V28, P105, DOI 10.1016/j.ceb.2014.04.005; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Wu H, 1995, BLOOD, V86, P2356; Young SG, 2012, J BIOL CHEM, V287, P16103, DOI 10.1074/jbc.R112.354407; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zuela N, 2012, EMBO REP, V13, P1070, DOI 10.1038/embor.2012.167; Zuleger N, 2012, CELL MOL LIFE SCI, V69, P2205, DOI 10.1007/s00018-012-0929-1; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	48	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116196	10.1371/journal.pone.0116196	http://dx.doi.org/10.1371/journal.pone.0116196			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790465	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400009
J	Carrillo, E; Pacheco, L; Balleza, D; Gomez-Lagunas, F				Carrillo, Elisa; Pacheco, Lucero; Balleza, Daniel; Gomez-Lagunas, Froylan			K+-Dependent Selectivity and External Ca2+ Block of Shab K+ Channels	PLOS ONE			English	Article							SHAKER POTASSIUM CHANNELS; ION SELECTIVITY; BINDING-SITE; CONDUCTION; NA+; PORE; PERMEABILITY; PERMEATION	Potassium channels allow the selective flux of K+ excluding the smaller, and more abundant in the extracellular solution, Na+ ions. Here we show that Shab is a typical K+ channel that excludes Na+ under bi-ionic, Nao/Ki or Nao/Rbi, conditions. However, when internal K+ is replaced by Cs+ (Nao/Csi), stable inward Na+ and outward Cs+ currents are observed. These currents show that Shab selectivity is not accounted for by protein structural elements alone, as implicit in the snug-fit model of selectivity. Additionally, here we report the block of Shab channels by external Ca2+ ions, and compare the effect that internal K+ replacement exerts on both Ca2+ and TEA block. Our observations indicate that Ca2+ blocks the channels at a site located near the external TEA binding site, and that this pore region changes conformation under conditions that allow Na+ permeation. In contrast, the latter ion conditions do not significantly affect the binding of quinidine to the pore central cavity. Based on our observations and the structural information derived from the NaK bacterial channel, we hypothesize that Ca2+ is probably coordinated by main chain carbonyls of the pore's first K+-binding site.	[Carrillo, Elisa; Pacheco, Lucero; Balleza, Daniel; Gomez-Lagunas, Froylan] Univ Nacl Autonoma Mexico, Dept Fisiol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Gomez-Lagunas, F (corresponding author), Univ Nacl Autonoma Mexico, Dept Fisiol, Mexico City 04510, DF, Mexico.	froylangl@yahoo.com	Balleza, Daniel/B-2886-2017	Balleza, Daniel/0000-0002-6848-9135; Carrillo, Elisa/0000-0002-0419-395X	DGAPA_UNAM [IN220914]; CONACYT [153504]	DGAPA_UNAM(Universidad Nacional Autonoma de Mexico); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Support was provided by DGAPA_UNAM grant IN220914 and CONACYT grant 153504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; Allen TW, 2004, J GEN PHYSIOL, V124, P679, DOI 10.1085/jgp.200409111; ALMERS W, 1980, J GEN PHYSIOL, V75, P61, DOI 10.1085/jgp.75.1.61; Ambriz-Rivas M, 2005, PFLUG ARCH EUR J PHY, V450, P255, DOI 10.1007/s00424-005-1411-9; ARMSTRONG CM, 1974, Q REV BIOPHYS, V7, P179, DOI 10.1017/S0033583500001402; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; Dang TX, 1998, J GEN PHYSIOL, V111, P185, DOI 10.1085/jgp.111.2.185; Derebe MG, 2011, P NATL ACAD SCI USA, V108, P598, DOI 10.1073/pnas.1013636108; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gomez-Lagunas F, 2003, P NATL ACAD SCI USA, V100, P347, DOI 10.1073/pnas.0237122100; Gomez-Lagunas F, 2001, J GEN PHYSIOL, V118, P639, DOI 10.1085/jgp.118.6.639; Gomez- Lagunas F, 2010, J PHISIOL, V588, P2691, DOI DOI 10.1113/JPHYSI0L.2010.193128; Gomez-Lagunas F, 1993, BIOPHYS J, V66, pA109; GomezLagunas F, 1997, J PHYSIOL-LONDON, V499, P3, DOI 10.1113/jphysiol.1997.sp021907; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1993, BIOPHYS J, V65, P2089, DOI 10.1016/S0006-3495(93)81244-X; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; IKEDA SR, 1995, J PHYSIOL-LONDON, V486, P267, DOI 10.1113/jphysiol.1995.sp020809; Immke D, 1999, J GEN PHYSIOL, V113, P819, DOI 10.1085/jgp.113.6.819; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P13335, DOI 10.1073/pnas.94.24.13335; KORN SJ, 1995, SCIENCE, V269, P410, DOI 10.1126/science.7618108; Lagunas FG, 2007, BIOPHYS J, V93, P4197, DOI 10.1529/biophysj.106.095794; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Melishchuk A, 1998, BIOPHYS J, V75, P1828, DOI 10.1016/S0006-3495(98)77624-6; NEHER E, 1992, METHOD ENZYMOL, V207, P123; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; Noskov SY, 2006, BIOPHYS CHEM, V124, P279, DOI 10.1016/j.bpc.2006.05.033; Ogielska EM, 1998, J GEN PHYSIOL, V112, P243, DOI 10.1085/jgp.112.2.243; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Voet D., 2005, BIOCHEMISTRY-US; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; ZHU Y, 1993, J PHYSIOL-LONDON, V468, P441, DOI 10.1113/jphysiol.1993.sp019781; Zhuren W, 2000, J PHYSL, V523, P575	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120431	10.1371/journal.pone.0120431	http://dx.doi.org/10.1371/journal.pone.0120431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798591	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300143
J	Agorastos, T; Chatzistamatiou, K; Katsamagkas, T; Koliopoulos, G; Daponte, A; Constantinidis, T; Constantinidis, TC				Agorastos, Theodoros; Chatzistamatiou, Kimon; Katsamagkas, Taxiarchis; Koliopoulos, George; Daponte, Alexandros; Constantinidis, Theocharis; Constantinidis, Theodoros C.		HERMES Study Grp	Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology	PLOS ONE			English	Article							FOLLOW-UP; INTRAEPITHELIAL NEOPLASIA; WOMEN; PREVENTION; METAANALYSIS; PREVALENCE; INFECTION; TRIAGE; TESTS; DNA	Objectives The objective of the present study is to assess the performance of a high-risk human papillomavirus (HR-HPV) DNA test with individual HPV-16/HPV-18 genotyping as a method for primary cervical cancer screening compared with liquid-based cytology (LBC) in a population of Greek women taking part in routine cervical cancer screening. Methods The study, conducted by the "HEllenic Real life Multicentric cErvical Screening" (HERMES) study group, involved the recruitment of 4,009 women, aged 25-55, who took part in routine cervical screening at nine Gynecology Departments in Greece. At first visit cervical specimens were collected for LBC and HPV testing using the Roche Cobas 4800 system. Women found positive for either cytology or HPV were referred for colposcopy, whereas women negative for both tests will be retested after three years. The study is ongoing and the results of the first screening round are reported herein. Results Valid results for cytology and HPV testing were obtained for 3,993 women. The overall prevalence of HR-HPV was 12.7%, of HPV-16 2.7% and of HPV-18 1.4%. Of those referred for colposcopy, cervical intraepithelial neoplasia grade 2 or worse (CIN2+) was detected in 41 women (1.07%). At the threshold of CIN2+, cytology [atypical squamous cells of undetermined significance (ASC-US) or worse] and HPV testing showed a sensitivity of 53.7% and 100% respectively, without change between age groups. Cytology and HPV testing showed specificity of 96.8% and 90.3% respectively, which was increased in older women (>= 30) in comparison to younger ones (25-29). Genotyping for HPV16/18 had similar accuracy to cytology for the detection of CIN2+ (sensitivity: 58.5%; specificity 97.5%) as well as for triage to colposcopy (sensitivity: 58.5% vs 53.7% for cytology). Conclusion HPV testing has much better sensitivity than cytology to identify high-grade cervical lesions with slightly lower specificity. HPV testing with individual HPV-16/HPV-18 genotyping could represent a more accurate methodology for primary cervical cancer screening in comparison to liquid-based cytology, especially in older women.	[Agorastos, Theodoros; Chatzistamatiou, Kimon; Katsamagkas, Taxiarchis] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 4, Hippokratio Gen Hosp, GR-54006 Thessaloniki, Greece; [Koliopoulos, George] Univ Athens, Dept Obstet & Gynecol 3, Attikon Hosp, Athens, Greece; [Daponte, Alexandros] Univ Thessaly, Dept Obstet & Gynecol, Gen Univ Hosp, Larisa, Greece; [Constantinidis, Theocharis] Minist Hlth, Peripheral Lab Publ Hlth, Hellen Ctr Dis Control & Prevent, Alexandroupolis, Greece; [Constantinidis, Theodoros C.] Democritus Univ Thrace, Microbiol Lab, Lab Hyg & Environm Protect, Alexandroupolis, Greece	Aristotle University of Thessaloniki; National & Kapodistrian University of Athens; University Hospital Attikon; General University Hospital of Larissa; University of Thessaly; Democritus University of Thrace	Chatzistamatiou, K (corresponding author), Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 4, Hippokratio Gen Hosp, GR-54006 Thessaloniki, Greece.	kimon.chatzistamatiou@gmail.com	Chatzistamatiou, Kimon/H-3490-2019	Chatzistamatiou, Kimon/0000-0002-5357-4708; Konstantinidis, Theocharis/0000-0003-4296-3414	Roche Diagnostics; Vianex/Sanofi Pasteur MSD	Roche Diagnostics; Vianex/Sanofi Pasteur MSD	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: KC and TK had their travel expenses and fees for two Congresses (EUROGIN 2012 and EUROGIN 2013) covered by Roche Diagnostics. GK, AD, TC and TCC have declared that no competing interests exist. TA has performed research trials partially supported by Vianex/Sanofi Pasteur MSD and has had travel expenses for conferences/meetings/symposia occasionally Cover Letter covered by either Vianex/Sanofi Pasteur MSD, GlaxoSmithKline and Roche Diagnostics. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All the authors declare no competing interests related to the commercial funder, Roche Diagnostics, concerning employment, consultancy, patents, products in development, marketed products etc.	Agorastos T, 2005, GYNECOL ONCOL, V96, P714, DOI 10.1016/j.ygyno.2004.11.042; Agorastos T, 2014, EUR J CANCER PREV, V23, P425, DOI 10.1097/CEJ.0000000000000060; Agorastos Theodoros, 2009, Cancer Inform, V8, P31; Agorastos T, 2009, EUR J CANCER PREV, V18, P504, DOI 10.1097/CEJ.0b013e32832abd5e; Arbyn M, 2004, JNCI-J NATL CANCER I, V96, P280, DOI 10.1093/jnci/djh037; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bornstein J, 2012, OBSTET GYNECOL, V120, P166, DOI 10.1097/AOG.0b013e318254f90c; BOSCH FX, 1992, INT J CANCER, V52, P171, DOI 10.1002/ijc.2910520202; Bosch XF, 2003, J NATL CANC I MONOGR, V31, P3, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003479; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Bulk S, 2007, INT J CANCER, V121, P361, DOI 10.1002/ijc.22677; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Cox JT, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.020; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Cuzick J, 2008, INT J CANCER, V122, P2294, DOI 10.1002/ijc.23339; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dillner J, 2013, CURR OPIN OBSTET GYN, V25, P11, DOI 10.1097/GCO.0b013e32835c5d10; Elfstrom KM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g130; Franco EL, 2009, ARCH MED RES, V40, P478, DOI 10.1016/j.arcmed.2009.06.003; Gage JC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju153; HAUSEN HZ, 1977, CURR TOP MICROBIOL, P1; Heideman DAM, 2011, J CLIN MICROBIOL, V49, P3983, DOI 10.1128/JCM.05552-11; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kinney W, 2011, GYNECOL ONCOL, V121, P309, DOI 10.1016/j.ygyno.2010.12.361; Kitchener HC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18230; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; KOSS LG, 1989, JAMA-J AM MED ASSOC, V261, P737, DOI 10.1001/jama.261.5.737; Leinonen M, 2009, JNCI-J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiffman M, 2015, J CLIN MICROBIOL, V53, P52, DOI 10.1128/JCM.02116-14; Schiffman M, 2011, CANCER EPIDEM BIOMAR, V20, P1398, DOI 10.1158/1055-9965.EPI-11-0206; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Sherman ME, 2002, J NATL CANCER I, V94, P102, DOI 10.1093/jnci/94.2.102; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Traut H F, 1943, Cal West Med, V59, P121; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008667; Wilber ST, 2010, ACAD EMERG MED, V17, P649, DOI 10.1111/j.1553-2712.2010.00773.x; Wright Thomas C Jr, 2007, J Low Genit Tract Dis, V11, P201, DOI 10.1097/LGT.0b013e3181585870; Wright TC, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.024; Wright TC, 2011, AM J CLIN PATHOL, V136, P578, DOI 10.1309/AJCPTUS5EXAS6DKZ	66	77	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119755	10.1371/journal.pone.0119755	http://dx.doi.org/10.1371/journal.pone.0119755			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793281	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200113
J	Brennan, MS; Matos, MF; Li, B; Hronowski, X; Gao, BB; Juhasz, P; Rhodes, KJ; Scannevin, RH				Brennan, Melanie S.; Matos, Maria F.; Li, Bing; Hronowski, Xiaoping; Gao, Benbo; Juhasz, Peter; Rhodes, Kenneth J.; Scannevin, Robert H.			Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro	PLOS ONE			English	Article							PHASE-II ENZYMES; MULTIPLE-SCLEROSIS; HEME OXYGENASE-1; CYSTEINE RESIDUES; OXIDATIVE STRESS; INDUCTION; SULFORAPHANE; MECHANISMS; PROTEIN; GENES	Delayed-release dimethyl fumarate (also known as gastro-resistant dimethyl fumarate), an oral therapeutic containing dimethyl fumarate (DMF) as the active ingredient, is currently approved for the treatment of relapsing multiple sclerosis. DMF is also a component in a distinct mixture product with 3 different salts of monoethyl fumarate (MEF), which is marketed for the treatment of psoriasis. Previous studies have provided insight into the pharmacologic properties of DMF, including modulation of kelch-like ECH-associated protein 1 (KEAP1), activation of the nuclear factor (erythroid-derived 2)-like 2 (NRF2) pathway, and glutathione (GSH) modulation; however, those of MEF remain largely unexplored. Therefore, the aim of this study was to evaluate the in vitro effects of DMF and MEF on KEAP1 modification, activation of the NRF2 pathway, and GSH conjugation. Using mass spectrometry, DMF treatment resulted in a robust modification of specific cysteine residues on KEAP1. In comparison, the overall degree of KEAP1 modification following MEF treatment was significantly less or undetectable. Consistent with KEAP1 cysteine modification, DMF treatment resulted in nuclear translocation of NRF2 and a robust transcriptional response in treated cells, as did MEF; however, the responses to MEF were of a lower magnitude or distinct compared to DMF. DMF was also shown to produce an acute concentration-dependent depletion of GSH; however, GSH levels eventually recovered and rose above baseline by 24 hours. In contrast, MEF did not cause acute reductions in GSH, but did produce an increase by 24 hours. Overall, these studies demonstrate that DMF and MEF are both pharmacologically active, but have differing degrees of activity as well as unique actions. These differences would be expected to result in divergent effects on downstream biology.	[Brennan, Melanie S.; Matos, Maria F.; Li, Bing; Rhodes, Kenneth J.; Scannevin, Robert H.] Biogen Idec Inc, Dept Neurol Res, Cambridge, MA 02142 USA; [Hronowski, Xiaoping; Gao, Benbo; Juhasz, Peter] Biogen Idec Inc, Dept Discovery Prote & Mass Spectrometry, Cambridge, MA USA	Biogen; Biogen	Scannevin, RH (corresponding author), Biogen Idec Inc, Dept Neurol Res, Cambridge, MA 02142 USA.	robert.scannevin@biogenidec.com		Scannevin, Robert/0000-0002-5749-2785	Biogen Idec, Inc.	Biogen Idec, Inc.(Biogen)	This study was funded by Biogen Idec, Inc. The authors had full editorial control of the content of manuscript, and all authors approved the content of the submitted manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni C, 2009, J AGR FOOD CHEM, V57, P5615, DOI 10.1021/jf900549c; [Anonymous], 2009, FUM SUMM PROD CHAR; Aschner M, 2000, NEUROTOXICOLOGY, V21, P1101; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Chen H, 2014, J CLIN INVEST; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; EWING JF, 1993, J NEUROCHEM, V60, P1512, DOI 10.1111/j.1471-4159.1993.tb03315.x; Fox RJ, 2006, CLEV CLIN J MED, V73, P91, DOI 10.3949/ccjm.73.1.91; Freedman MS, 2006, EXPERT OPIN PHARMACO, V7, pS1, DOI 10.1517/14656566.7.1.S1; Garg R, 2008, CARCINOGENESIS, V29, P1022, DOI 10.1093/carcin/bgn064; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Holland R, 2010, ANTIOXID REDOX SIGN, V13, P1749, DOI 10.1089/ars.2010.3273; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Horikawa S, 2002, FEBS LETT, V510, P221, DOI 10.1016/S0014-5793(01)03270-7; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lehmann JCU, 2007, J INVEST DERMATOL, V127, P835, DOI 10.1038/sj.jid.5700686; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Matusheski NV, 2004, PHYTOCHEMISTRY, V65, P1273, DOI 10.1016/j.phytochem.2004.04.013; Morris G, 2014, MOL NEUROBIOL, V50, P1059, DOI 10.1007/s12035-014-8705-x; Nathens AB, 1998, J SURG RES, V77, P75, DOI 10.1006/jsre.1998.5338; Nelson KC, 1999, INVEST OPHTH VIS SCI, V40, P1927; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Schmidt MM, 2010, NEUROCHEM INT, V57, P460, DOI 10.1016/j.neuint.2010.01.006; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Thimmulappa RK, 2002, CANCER RES, V62, P5196; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Wiesner D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076670; Witherick J, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/164608; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	41	105	106	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120254	10.1371/journal.pone.0120254	http://dx.doi.org/10.1371/journal.pone.0120254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793262	Green Submitted, gold, Green Published			2022-12-26	WOS:000352083900003
J	Habicher, J; Haitina, T; Eriksson, I; Holmborn, K; Dierker, T; Ahlberg, PE; Ledin, J				Habicher, Judith; Haitina, Tatjana; Eriksson, Inger; Holmborn, Katarina; Dierker, Tabea; Ahlberg, Per E.; Ledin, Johan			Chondroitin/Dermatan Sulfate Modification Enzymes in Zebrafish Development	PLOS ONE			English	Article							ACETYLGALACTOSAMINE 4-SULFATE 6-O-SULFOTRANSFERASE; IN-SITU HYBRIDIZATION; MOLECULAR-CLONING; DERMATAN SULFATE; HEPARAN-SULFATE; IDURONIC ACID; EXPRESSION; BIOSYNTHESIS; 4-O-SULFOTRANSFERASE-1; MUTATIONS	Chondroitin/dermatan sulfate (CS/DS) proteoglycans consist of unbranched sulfated polysaccharide chains of repeating GalNAc-GlcA/IdoA disaccharide units, attached to serine residues on specific proteins. The CS/DS proteoglycans are abundant in the extracellular matrix where they have essential functions in tissue development and homeostasis. In this report a phylogenetic analysis of vertebrate genes coding for the enzymes that modify CS/DS is presented. We identify single orthologous genes in the zebrafish genome for the sulfotransferases chst7, chst11, chst13, chst14, chst15 and ust and the epimerase dse. In contrast, two copies were found for mammalian sulfotransferases CHST3 and CHST12 and the epimerase DSEL, named chst3a and chst3b, chst12a and chst12b, dsela and dselb, respectively. Expression of CS/DS modification enzymes is spatially and temporally regulated with a large variation between different genes. We found that CS/DS 4-O-sulfotransferases and 6-O-sulfotransferases as well as CS/DS epimerases show a strong and partly overlapping expression, whereas the expression is restricted for enzymes with ability to synthesize di-sulfated disaccharides. A structural analysis further showed that CS/DS sulfation increases during embryonic development mainly due to synthesis of 4-O-sulfated GalNAc while the proportion of 6-O-sulfated GalNAc increases in later developmental stages. Di-sulfated GalNAc synthesized by Chst15 and 2-O-sulfated GlcA/IdoA synthesized by Ust are rare, in accordance with the restricted expression of these enzymes. We also compared CS/DS composition with that of heparan sulfate (HS). Notably, CS/DS biosynthesis in early zebrafish development is more dynamic than HS biosynthesis. Furthermore, HS contains disaccharides with more than one sulfate group, which are virtually absent in CS/DS.	[Habicher, Judith; Haitina, Tatjana; Holmborn, Katarina; Ahlberg, Per E.; Ledin, Johan] Uppsala Univ, Dept Organismal Biol, Sci Life Lab, Uppsala, Sweden; [Eriksson, Inger; Dierker, Tabea] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University	Ledin, J (corresponding author), Uppsala Univ, Dept Organismal Biol, Sci Life Lab, Uppsala, Sweden.	Johan.Ledin@ebc.uu.se		Haitina, Tatjana/0000-0002-8754-5534; Ahlberg, Per/0000-0001-9054-2900; Ledin, Johan/0000-0002-7319-7735	Knut and Alice Wallenberg Foundation; Swedish Research Council VR	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council VR(Swedish Research Council)	This work was supported by grants from the Knut and Alice Wallenberg Foundation (https://www.wallenberg.com/kaw/en), and the Swedish Research Council VR (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini B, 2012, GLYCOBIOLOGY, V22, P1007, DOI 10.1093/glycob/cws065; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Filipek-Gorniok B, 2013, DEV DYNAM, V242, P964, DOI 10.1002/dvdy.23981; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; Hayes AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075787; Hayes AJ, 2013, DEV DYNAM, V242, P778, DOI 10.1002/dvdy.23970; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Izumikawa T, 2012, BIOCHEM J, V441, P697, DOI 10.1042/BJ20111472; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kluppel M, 2002, MECH DEVELOP, V118, P77, DOI 10.1016/S0925-4773(02)00198-3; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Malfait F, 2010, HUM MUTAT, V31, P1233, DOI 10.1002/humu.21355; MALMSTROM A, 1975, J BIOL CHEM, V250, P3419; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Mizumoto S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/495764; Mizumoto S, 2013, J BIOL CHEM, V288, P10953, DOI 10.1074/jbc.R112.437038; Mizumoto S, 2009, BIOCHEM J, V419, P387, DOI 10.1042/BJ20081639; Muller T, 2013, HUM MOL GENET, V22, P3761, DOI 10.1093/hmg/ddt227; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Ohtake-Niimi S, 2010, J BIOL CHEM, V285, P20793, DOI 10.1074/jbc.M109.084749; Pacheco B, 2009, GLYCOBIOLOGY, V19, P1197, DOI 10.1093/glycob/cwp110; Pacheco B, 2009, J BIOL CHEM, V284, P9788, DOI 10.1074/jbc.M809339200; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9; Reynard LN, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.4; Sakai K, 2007, J BIOL CHEM, V282, P4152, DOI 10.1074/jbc.M606870200; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Thelin MA, 2013, FEBS J, V280, P2431, DOI 10.1111/febs.12214; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Unger S, 2010, AM J MED GENET A, V152A, P2543, DOI 10.1002/ajmg.a.33641; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; van der Zwaag B, 2005, GENOMICS, V86, P55, DOI 10.1016/j.ygeno.2005.03.007; Yamada S, 2009, GLYCOBIOLOGY, V19, P488, DOI 10.1093/glycob/cwp005	55	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121957	10.1371/journal.pone.0121957	http://dx.doi.org/10.1371/journal.pone.0121957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793894	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900161
J	Jecz, P; Bartosik, AA; Glabski, K; Jagura-Burdzy, G				Jecz, Paulina; Bartosik, Aneta A.; Glabski, Krzysztof; Jagura-Burdzy, Grazyna			A Single parS Sequence from the Cluster of Four Sites Closest to oriC Is Necessary and Sufficient for Proper Chromosome Segregation in Pseudomonas aeruginosa	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR A3(2); DNA-REPLICATION INITIATION; PROTEIN SPO0J PARB; BACILLUS-SUBTILIS; BACTERIAL CHROMOSOME; CELL-DIVISION; PARTITIONING PROTEINS; SOJ PARA; CAULOBACTER-CRESCENTUS; PLASMID PARTITION	Among the mechanisms that control chromosome segregation in bacteria are highly-conserved partitioning systems comprising three components: ParA protein (a deviant Walker-type ATPase), ParB protein (a DNA-binding element) and multiple cis-acting palindromic centromere-like sequences, designated parS. Ten putative parS sites have been identified in the P. aeruginosa PAO1 genome, four localized in close proximity of oriC and six, diverged by more than one nucleotide from a perfect palindromic sequence, dispersed along the chromosome. Here, we constructed and analyzed P. aeruginosa mutants deprived of each single parS sequence and their different combinations. The analysis included evaluation of a set of phenotypic features, chromosome segregation, and ParB localization in the cells. It was found that ParB binds specifically to all ten parS sites, although with different affinities. The P. aeruginosa parS mutant with all ten parS sites modified (parSnull) is viable however it demonstrates the phenotype characteristic for parAnull or parBnull mutants: slightly slower growth rate, high frequency of anucleate cells, and defects in motility. The genomic position and sequence of parS determine its role in P. aeruginosa biology. It transpired that any one of the four parS sites proximal to oriC (parS1 to parS4), which are bound by ParB with the highest affinity, is necessary and sufficient for the parABS role in chromosome partitioning. When all these four sites are mutated simultaneously, the strain shows the parSnull phenotype, which indicates that none of the remaining six parS sites can substitute for these four oriC-proximal sites in this function. A single ectopic parS2 (inserted opposite oriC in the parSnull mutant) facilitates ParB organization into regularly spaced condensed foci and reverses some of the mutant phenotypes but is not sufficient for accurate chromosome segregation.	[Jecz, Paulina; Bartosik, Aneta A.; Glabski, Krzysztof; Jagura-Burdzy, Grazyna] Polish Acad Sci, Dept Microbial Biochem, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Jagura-Burdzy, G (corresponding author), Polish Acad Sci, Dept Microbial Biochem, Inst Biochem & Biophys, Warsaw, Poland.	gjburdzy@ibb.waw.pl	Bartosik, Aneta/AAR-9347-2021; Jecz, Paulina/S-7566-2018; Jagura-Burdzy, Grazyna/AAU-7423-2021	Bartosik, Aneta/0000-0002-2091-3101; Jecz, Paulina/0000-0001-7612-8631; Jagura-Burdzy, Grazyna/0000-0002-0794-2565	Foundation for Polish Science; European Union-Regional Development Fund	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union-Regional Development Fund(European Commission)	PJ was supported by the International PhD Projects Programme "Studies of nucleic acids and proteins-from basic to applied research" of the Foundation for Polish Science co-financed by the European Union-Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autret S, 2003, MOL MICROBIOL, V47, P159, DOI 10.1046/j.1365-2958.2003.03264.x; Baek JH, 2014, MBIO, V5, DOI 10.1128/mBio.01061-14; Bartosik AA, 2009, MICROBIOL-SGM, V155, P1080, DOI 10.1099/mic.0.024661-0; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Bartosik AA, 2014, MICROBIOL-SGM, V160, P2406, DOI 10.1099/mic.0.081216-0; Bartosik AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087276; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Broedersz CP, 2014, P NATL ACAD SCI USA, V111, P8809, DOI 10.1073/pnas.1402529111; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Ditkowski B, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130006; Dubarry N, 2006, J BACTERIOL, V188, P1489, DOI 10.1128/JB.188.4.1489-1496.2006; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; Fogel MA, 2005, MOL MICROBIOL, V55, P125, DOI 10.1111/j.1365-2958.2004.04379.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Ginda K, 2013, MOL MICROBIOL, V87, P998, DOI 10.1111/mmi.12146; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; Irani VR, 1997, BIOTECHNIQUES, V22, P54, DOI 10.2144/97221bm09; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; JAGURA-BURDZY G, 1991, J BACTERIOL, V173, P826, DOI 10.1128/jb.173.2.826-833.1991; Jakimowicz D, 2002, MOL MICROBIOL, V45, P1365, DOI 10.1046/j.1365-2958.2002.03102.x; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; Jakimowicz D, 2012, MOL MICROBIOL, V85, P393, DOI 10.1111/j.1365-2958.2012.08107.x; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Kadoya R, 2011, J BACTERIOL, V193, P1504, DOI 10.1128/JB.01067-10; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Kusiak M, 2011, J BACTERIOL, V193, P3342, DOI 10.1128/JB.00328-11; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Lobocka M, 1996, J MOL BIOL, V259, P366, DOI 10.1006/jmbi.1996.0326; Mierzejewska J, 2012, MICROBIOL-SGM, V158, P1183, DOI 10.1099/mic.0.056234-0; Mierzejewska J, 2012, PLASMID, V67, P1, DOI 10.1016/j.plasmid.2011.08.003; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; OGASAWARA N, 1992, MOL MICROBIOL, V6, P629, DOI 10.1111/j.1365-2958.1992.tb01510.x; Ptacin JL, 2014, P NATL ACAD SCI USA, V111, pE2046, DOI 10.1073/pnas.1405188111; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Quisel JD, 2000, J BACTERIOL, V182, P3446, DOI 10.1128/JB.182.12.3446-3451.2000; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Real G, 2005, MOL MICROBIOL, V55, P349, DOI 10.1111/j.1365-2958.2004.04399.x; Resnekov O, 1996, GENES CELLS, V1, P529, DOI 10.1046/j.1365-2443.1996.d01-262.x; Ringgaard S, 2007, J BIOL CHEM, V282, P28216, DOI 10.1074/jbc.M703733200; Ringgaard S, 2007, J BIOL CHEM, V282, P3134, DOI 10.1074/jbc.M609092200; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Saint-Dic D, 2006, J BACTERIOL, V188, P5626, DOI 10.1128/JB.00250-06; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schofield WB, 2010, EMBO J, V29, P3068, DOI 10.1038/emboj.2010.207; Scholefield G, 2011, MOL MICROBIOL, V79, P1089, DOI 10.1111/j.1365-2958.2010.07507.x; Schumacher MA, 2012, CURR OPIN STRUC BIOL, V22, P72, DOI 10.1016/j.sbi.2011.11.001; Sharpe ME, 1998, MOL MICROBIOL, V28, P981, DOI 10.1046/j.1365-2958.1998.00857.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Venkova-Canova T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003579; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x; Wu LJ, 2002, EMBO J, V21, P4001, DOI 10.1093/emboj/cdf393; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656; Yamaichi Y, 2007, J BACTERIOL, V189, P5314, DOI 10.1128/JB.00416-07; Yamaichi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002189	80	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120867	10.1371/journal.pone.0120867	http://dx.doi.org/10.1371/journal.pone.0120867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794281	Green Published, gold			2022-12-26	WOS:000352083900083
J	Jin, A; Lalonde, CE; Brussoni, M; McCormick, R; George, MA				Jin, Andrew; Lalonde, Christopher E.; Brussoni, Mariana; McCormick, Rod; George, M. Anne			Injury Hospitalizations Due to Unintentional Falls among the Aboriginal Population of British Columbia, Canada: Incidence, Changes over Time, and Ecological Analysis of Risk Markers, 1991-2010	PLOS ONE			English	Article								Background Aboriginal people in British Columbia (BC) have higher injury incidence than the general population. Our project describes variability among injury categories, time periods, and geographic, demographic and socio-economic groups. This report focuses on unintentional falls. Methods We used BC's universal health care insurance plan as a population registry, linked to hospital separation and vital statistics databases. We identified Aboriginal people by insurance premium group and birth and death record notations. We identified residents of specific Aboriginal communities by postal code. We calculated crude incidence and Standardized Relative Risk (SRR) of hospitalization for unintentional fall injury, standardized for age, gender and Health Service Delivery Area (HSDA), relative to the total population of BC. We tested hypothesized associations of geographic, socio-economic, and employment-related characteristics with community SRR of injury by linear regression. Results During 1991 through 2010, the crude rate of hospitalization for unintentional fall injury in BC was 33.6 per 10,000 person-years. The Aboriginal rate was 49.9 per 10,000 and SRR was 1.89 (95% confidence interval 1.85-1.94). Among those living on reserves SRR was 2.00 (95% CI 1.93-2.07). Northern and non-urban HSDAs had higher SRRs, within both total and Aboriginal populations. In every age and gender category, the HSDA-standardized SRR was higher among the Aboriginal than among the total population. Between 1991 and 2010, crude rates and SRRs declined substantially, but proportionally more among the Aboriginal population, so the gap between the Aboriginal and total population is narrowing, particularly among females and older adults. These community characteristics were associated with higher risk: lower income, lower educational level, worse housing conditions, and more hazardous types of employment. Conclusions Over the years, as socio-economic conditions improve, risk of hospitalization due to unintentional fall injury has declined among the Aboriginal population. Women and older adults have benefited more.	[Jin, Andrew] Epidemiol Consultant, Surrey, BC, Canada; [Lalonde, Christopher E.] Univ Victoria, Dept Psychol, Fac Social Sci, Victoria, BC, Canada; [Brussoni, Mariana; George, M. Anne] Univ British Columbia, Dept Pediat, Fac Med, Vancouver, BC V6T 1W5, Canada; [Brussoni, Mariana; George, M. Anne] Child & Family Res Inst, Vancouver, BC, Canada; [Brussoni, Mariana; George, M. Anne] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [McCormick, Rod] Thompson Rivers Univ, Fac Human Social & Educ Dev, Kamloops, BC, Canada	University of Victoria; University of British Columbia; Child & Family Research Institute; University of British Columbia	George, MA (corresponding author), Univ No British Columbia, Prince George, BC V2L 5P2, Canada.	ageorge@mail.ubc.ca	Brussoni, Mariana/U-9404-2018; Jin, Andrew/H-5725-2019	Brussoni, Mariana/0000-0002-1495-816X; Jin, Andrew/0000-0002-8708-2381; George, M. Anne/0000-0001-7129-2117; Lalonde, Christopher/0000-0002-0446-0464	Canadian Institutes of Health Research, Institute of Aboriginal Peoples Health [81043]; Child & Family Research Institute; Michael Smith Foundation; British Columbia Region, First Nations and Inuit Health, Health Canada	Canadian Institutes of Health Research, Institute of Aboriginal Peoples Health(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute; Michael Smith Foundation(Michael Smith Foundation for Health Research); British Columbia Region, First Nations and Inuit Health, Health Canada	Funding: This work was funded by the Canadian Institutes of Health Research, Institute of Aboriginal Peoples Health [grant number AHR # 81043]. Salary support for authors was provided by the Child & Family Research Institute (MAG, MB), by a Michael Smith Foundation for Health Research Scholar Award (MB), and the British Columbia Region, First Nations and Inuit Health, Health Canada (AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BC Ministry of Health [creator], 2012, CONS FIL MSP REG PRE; BC Ministry of Health [creator], 2011, DISCH ABSTR DAT HOSP; BC Vital Statistics Agency, 2011, VIT STAT DEATHS; BC Vital Statistics Agency [creator], 2011, VIT STAT BIRTHS; Bell N, 2011, INJURY PREV, V17, P394, DOI 10.1136/ip.2010.030866; Bridges FS, 2005, PSYCHOL REP, V97, P739, DOI 10.2466/pr0.97.3.739-749; *BRIT COL VIT STAT, 2004, REG AN HLTH STAT STA; British Columbia. Provincial Health Officer, 2009, PATHW HLTH HEAL 2 RE; Brussoni M, 2014, PREV SCI; Chandler M. J., 1998, TRANSCULT PSYCHIATRY, V35, P191, DOI DOI 10.1177/136346159803500202; Cloutier E, 2001, EC BURDEN UNINTENTIO; Corporate Information Management Directorate, 2005, INF MAN BRACH BAND C; Desapriya E, 2011, INJURY PREV, V17, P4, DOI 10.1136/ip.2010.026914; Evans RG, 1994, WHY ARE SOME POEPLE; George MA, 2015, HEALTH REP, V26, P3; George MA, 2013, INT J CIRCUMPOL HEAL, V72, P441, DOI 10.3402/ijch.v72i0.21182; Jin A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-710; Kahn HA, 1989, STAT METHODS EPIDEMI, P95; Penney C, 2012, COMMUNITY WELL BEING; Sayer P, 2009, DEMOGRAPHIC SOCIOECO; Scott V., 2004, PREVENTION FALLS INJ; *SMARTRISK, 2009, EC BURD INJ CAN; Tjepkema Michael, 2011, Health Rep, V22, P25	23	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121694	10.1371/journal.pone.0121694	http://dx.doi.org/10.1371/journal.pone.0121694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793298	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900147
J	Li, Y; Chen, L; Ngoc, DM; Duan, YP; Lu, ZB; Wen, ZH; Meng, XZ				Li, Yue; Chen, Ling; Ngoc, Duong Minh; Duan, Yan-Ping; Lu, Zhi-Bo; Wen, Zhi-Hao; Meng, Xiang-Zhou			Polybrominated Diphenyl Ethers (PBDEs) in PM2.5, PM10, TSP and Gas Phase in Office Environment in Shanghai, China: Occurrence and Human Exposure	PLOS ONE			English	Article							BROMINATED FLAME RETARDANTS; INDOOR AIR-QUALITY; PARTICULATE MATTER; URBAN AREAS; PERSONAL EXPOSURE; DIURNAL-VARIATION; OUTDOOR AIR; DUST; PARTICLES; ASSOCIATIONS	To evaluate risk via inhalation exposure of polybrominated diphenyl ethers (PBDEs) in office environment, thirty-six pairs air samples including PM2.5 (particles with aerodynamic diameter less than 2.5 mu m), PM10 (particles with aerodynamic diameter less than 10 mu m), total suspended particles (TSP) with matching gas phase were collected in office environment in Shanghai, China. The average concentrations of PM2.5, PM10 and TSP were 20.4, 27.2 and 50.3 mu g/m(3), respectively. Sigma 15PBDEs mean concentrations in PM2.5, PM10, TSP and gas phase were 51.8, 110.7, 148 and 59.6 pg/m(3), respectively. Much more PBDEs distributed in fine fractions than coarse ones. PBDEs congener profiles found in PM2.5, PM10 and TSP (dominated by BDE-209) were different from that in gas phase (dominated by the tri-to penta-BDEs). Approximately 3.20 pg/kg/d PM2.5 bound PBDEs can be inhaled into the lung; 3.62 pg/kg/d PM10-PM2.5(particles with aerodynamic diameter of 2.5-10 mu m) bound PBDEs tended to be deposited in the upper part of respiratory system, and the intake of PBDEs via gas-phase was 2.74 pg/kg/d. The exposure of PBDEs was far below the minimal risk levels (MRLs), indicating lower risk from PBDEs via inhalation in the studied office in Shanghai.	[Li, Yue; Chen, Ling; Ngoc, Duong Minh; Duan, Yan-Ping; Lu, Zhi-Bo; Wen, Zhi-Hao; Meng, Xiang-Zhou] Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China; [Duan, Yan-Ping] Shanghai Fisheries Res Inst, Shanghai, Peoples R China	Tongji University	Chen, L (corresponding author), Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China.	duanyanping@tongji.edu.cn; chenling@tongji.edu.cn	ZHIBO, LU/HHS-4083-2022		National Key Technology R&D Program in the 12th Five-Year Plan of China: Research & Development on Suitable Key Technologies of the Village Environmental Monitoring [2012BAJ24B01]	National Key Technology R&D Program in the 12th Five-Year Plan of China: Research & Development on Suitable Key Technologies of the Village Environmental Monitoring(National Key Technology R&D Program)	This study is financed by the National Key Technology R&D Program in the 12th Five-Year Plan of China: Research & Development on Suitable Key Technologies of the Village Environmental Monitoring (2012BAJ24B01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AfTSaD R, 2004, TOX PROF POL BIPH PO, P45; Agrell C, 2004, ATMOS ENVIRON, V38, P5139, DOI 10.1016/j.atmosenv.2004.05.024; Allen JG, 2007, ENVIRON SCI TECHNOL, V41, P4574, DOI 10.1021/es0703170; Baek SO, 1997, ATMOS ENVIRON, V31, P529, DOI 10.1016/S1352-2310(96)00215-4; Batterman S, 2010, ENVIRON INT, V36, P548, DOI 10.1016/j.envint.2010.04.008; Biphenyls P., 2004, TOXICOLOGICAL PROFIL; Branis M, 2005, ENVIRON RES, V99, P143, DOI 10.1016/j.envres.2004.12.001; Chen DH, 2011, CHEMOSPHERE, V82, P1246, DOI 10.1016/j.chemosphere.2010.12.035; Chen DH, 2009, ENVIRON POLLUT, V157, P1051, DOI 10.1016/j.envpol.2008.06.005; Chen SJ, 2010, J HAZARD MATER, V176, P979, DOI 10.1016/j.jhazmat.2009.11.138; Darnerud PO, 2001, ENVIRON HEALTH PERSP, V109, P49, DOI 10.2307/3434846; Diapouli E, 2004, C PROT REST ENV MYK; Duan YP, 2010, ENVIRON SCI POLLUT R, V17, P948, DOI 10.1007/s11356-010-0295-1; Gadkari NM, 2010, ENVIRON MONIT ASSESS, V165, P365, DOI 10.1007/s10661-009-0952-3; Gemenetzis P, 2006, ATMOS ENVIRON, V40, P3195, DOI 10.1016/j.atmosenv.2006.01.049; Gevao B, 2006, ATMOS ENVIRON, V40, P1419, DOI 10.1016/j.atmosenv.2005.10.053; Han WL, 2009, B ENVIRON CONTAM TOX, V83, P783, DOI 10.1007/s00128-009-9855-9; Hardy ML, 2002, CHEMOSPHERE, V46, P757, DOI 10.1016/S0045-6535(01)00240-5; Harley KG, 2011, AM J EPIDEMIOL, V174, P885, DOI 10.1093/aje/kwr212; Harrad S, 2006, ENVIRON SCI TECHNOL, V40, P4633, DOI 10.1021/es0609147; Hayakawa K, 2004, CHEMOSPHERE, V57, P343, DOI 10.1016/j.chemosphere.2004.06.038; He C, 2007, ENVIRON SCI TECHNOL, V41, P6039, DOI 10.1021/es063049z; Heavner DL, 1996, ENVIRON INT, V22, P159, DOI 10.1016/0160-4120(96)00003-7; Horemans B, 2010, ATMOS ENVIRON, V44, P1497, DOI 10.1016/j.atmosenv.2010.01.010; Johnson PI, 2012, ENVIRON INT, V45, P9, DOI 10.1016/j.envint.2012.04.004; Koivisto AJ, 2010, ATMOS ENVIRON, V44, P2140, DOI 10.1016/j.atmosenv.2010.02.023; La Guardia MJ, 2006, ENVIRON SCI TECHNOL, V40, P6247, DOI 10.1021/es060630m; Lee CW, 2007, ATMOS ENVIRON, V41, P6598, DOI 10.1016/j.atmosenv.2007.04.016; Liu YS, 2004, ENVIRON INT, V30, P189, DOI 10.1016/S0160-4120(03)00173-9; Luoma M, 2001, INDOOR AIR, V11, P35, DOI 10.1034/j.1600-0668.2001.011001035.x; Mandalakis M, 2008, ENVIRON POLLUT, V155, P375, DOI 10.1016/j.envpol.2007.11.016; Mandalakis M, 2009, ENVIRON POLLUT, V157, P1227, DOI 10.1016/j.envpol.2008.12.010; Naeher LP, 2000, INDOOR AIR, V10, P200; Ni HG, 2011, ENVIRON POLLUT, V159, P1957, DOI 10.1016/j.envpol.2010.12.007; Ohura T, 2005, ENVIRON SCI TECHNOL, V39, P5592, DOI 10.1021/es050571x; Ott W, 1996, J AIR WASTE MANAGE, V46, P1120, DOI 10.1080/10473289.1996.10467548; Park H-R, 2014, TOXICOL APPL PHARM; Phillips K, 1998, ENVIRON INT, V24, P405, DOI 10.1016/S0160-4120(98)00020-8; Qi H, 2014, SCI TOTAL ENV; Qu WY, 2007, ENVIRON INT, V33, P1029, DOI 10.1016/j.envint.2007.05.009; Rodriguez S, 2001, ATMOS ENVIRON, V35, P2433, DOI 10.1016/S1352-2310(00)00496-9; Shoeib M, 2004, ENVIRON SCI TECHNOL, V38, P1313, DOI 10.1021/es0305555; Sjodin A, 2001, ENVIRON SCI TECHNOL, V35, P448, DOI 10.1021/es000077n; Stapleton HM, 2008, ENVIRON SCI TECHNOL, V42, P3453, DOI 10.1021/es7028813; Staskal DF, 2008, ENVIRON SCI TECHNOL, V42, P6755, DOI 10.1021/es800613k; Toms LML, 2009, CHEMOSPHERE, V76, P173, DOI 10.1016/j.chemosphere.2009.03.057; Tung EWY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094583; Wang W, 2014, ATMOS ENVIRON, V89, P786, DOI 10.1016/j.atmosenv.2014.01.030; Watkins DJ, 2013, ENVIRON INT, V59, P124, DOI 10.1016/j.envint.2013.06.001; Watkins DJ, 2011, ENVIRON HEALTH PERSP, V119, P1247, DOI 10.1289/ehp.1003271; Wensing M, 2006, P HLTH BUILD 2006 C, V2, P4; Wilford BH, 2008, ENVIRON INT, V34, P412, DOI 10.1016/j.envint.2007.09.007; World Health Organization, 2006, WHO AIR QUAL GUID PA; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]	55	27	30	6	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119144	10.1371/journal.pone.0119144	http://dx.doi.org/10.1371/journal.pone.0119144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793925	Green Submitted, gold, Green Published			2022-12-26	WOS:000352084200056
J	Meyer, BJ; Byrne, MK; Collier, C; Parletta, N; Crawford, D; Winberg, PC; Webster, D; Chapman, K; Thomas, G; Dally, J; Batterham, M; Farquhar, I; Martin, AM; Grant, L				Meyer, Barbara J.; Byrne, Mitchell K.; Collier, Carole; Parletta, Natalie; Crawford, Donna; Winberg, Pia C.; Webster, David; Chapman, Karen; Thomas, Gayle; Dally, Jean; Batterham, Marijka; Farquhar, Ian; Martin, Anne-Marie; Grant, Luke			Baseline Omega-3 Index Correlates with Aggressive and Attention Deficit Disorder Behaviours in Adult Prisoners	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; HYPERACTIVITY DISORDER; DOCOSAHEXAENOIC ACID; FOOD SOURCES; CHILDREN; DIETARY; ANGER; RISK; ADHD; N-3	Background There is emerging evidence that the supplementation of omega-3 contributes to a decrease in aggressive behaviour in prison populations. A challenge of such research is achieving statistical power against effect sizes which may be affected by the baseline omega-3 index. There are no published data on the blood omega-3 index with studies of this kind to assess the variability of the blood omega-3 index in conjunction with aggression and attention deficit assessments. Objective To determine if the variance of the omega-3 index is correlated with aggressive and attention deficit behaviour in a prison population. Design 136 adult male prisoners were recruited from South Coast Correctional Centre (SCCC), NSW Australia. A 7 point categorisation was used to quantify levels of aggressive behaviour (4 weeks) from individual SCCC case notes, whereby higher scores correspond to increasingly aggressive behaviour. Study participants completed the Aggression Questionnaire (AQ) and the Brown's Attention Deficit Disorder Scales (BADDS), provided a blood sample for erythrocyte fatty acid analysis using gas chromatography and the omega-3 index was calculated. Results The baseline omega-3 index ranged from 2.3% to 10.3%, indicating that some participants already had substantial omega-3 intake, however a median of 4.7% indicated a lower overall omega-3 intake than the general Australian population. Assessment of aggressive and attention deficit behaviour shows that there were negative correlations between baseline omega-3 index and baseline aggression categorisation scores (r = -0.21, P = 0.016); total AQ score (r = -0.234, P = 0.011); Anger (r = -0.222 p = 0.016); Hostility AQ (r = -0.239, P = 0.009); indirect aggression (r = -0.188 p = 0.042); total BADDS (r = -0.263, p = 0.005); Activation (r = -0.224, p = 0.016); Attention (r = -0.192, p = 0.043); Effort (r = -0.253, p = 0.007); Affect (r = -0.330, p = 0.000) and Memory (r = -0.240, p = 0.010). Conclusions There is a high variability in omega-3 status of a NSW prison population, and inmates with lower omega-3 index were more aggressive and had higher ADD scores.	[Meyer, Barbara J.; Webster, David] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Meyer, Barbara J.; Byrne, Mitchell K.] Univ Wollongong, Illawarra Heath & Med Res Inst, Wollongong, NSW, Australia; [Byrne, Mitchell K.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Collier, Carole; Crawford, Donna; Chapman, Karen; Thomas, Gayle; Dally, Jean; Farquhar, Ian] South Coast Correct Ctr, Nowra, NSW, Australia; [Parletta, Natalie] Univ S Australia, Sansom Inst Hlth Res, Sch Populat Hlth, Adelaide, SA 5001, Australia; [Winberg, Pia C.] Univ Wollongong, Venus Shell Syst & Shoalhaven Marine & Freshwater, Wollongong, NSW, Australia; [Batterham, Marijka] Univ Wollongong, Stat Consulting Serv, Wollongong, NSW 2522, Australia; [Martin, Anne-Marie; Grant, Luke] Correct Serv New South Wales, Sydney, NSW, Australia	University of Wollongong; University of Wollongong; University of Wollongong; University of South Australia; University of Wollongong; University of Wollongong	Meyer, BJ (corresponding author), Univ Wollongong, Sch Med, Wollongong, NSW, Australia.	bmeyer@uow.edu.au	Meyer, Barbara/AAC-6078-2019; Winberg, Pia/G-4008-2018; Parletta, Natalie/A-7880-2008	Meyer, Barbara/0000-0001-7962-7890; Winberg, Pia/0000-0003-2554-4955; Parletta, Natalie/0000-0003-2322-5555; Byrne, Mitchell/0000-0003-0823-2917; Batterham, Marijka/0000-0002-9520-6508	University of Wollongong Research Partnership Grant; Corrective Services NSW	University of Wollongong Research Partnership Grant; Corrective Services NSW	The work was supported by a University of Wollongong Research Partnership Grant with the Corrective Services NSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker G, 2007, J RES PERS, V41, P434, DOI 10.1016/j.jrp.2006.05.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown TE., 1996, BROWN ATTENTION DEFI; Brown TE, 2011, CURR MED RES OPIN, V27, P23, DOI 10.1185/03007995.2011.605441; Burgess GC, 2010, BIOL PSYCHIAT, V67, P632, DOI 10.1016/j.biopsych.2009.10.036; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Butler T., 2003, MENTAL ILLNESS NEW S; Buydens-Branchey L, 2008, PSYCHIAT RES, V157, P95, DOI 10.1016/j.psychres.2007.01.004; Fite PJ, 2014, AGGRESSIVE BEHAV, V40, P69, DOI 10.1002/ab.21498; Gao Q, 2011, J NUTR HEALTH AGING, V15, P32, DOI 10.1007/s12603-011-0010-z; Gesch CB, 2002, BRIT J PSYCHIAT, V181, P22, DOI 10.1192/bjp.181.1.22; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; HARRIS JA, 1995, BEHAV RES THER, V33, P991, DOI 10.1016/0005-7967(95)00038-Y; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hibbeln JR, 2006, INT REV PSYCHIATR, V18, P107, DOI 10.1080/09540260600582967; Hibbeln JR, 2001, WORLD REV NUTR DIET, V88, P41; Iribarren C, 2004, EUR J CLIN NUTR, V58, P24, DOI 10.1038/sj.ejcn.1601739; Johnstone SJ, 2012, ADHD-ATTEND DEFICIT, V4, P11, DOI 10.1007/s12402-011-0069-8; Byrne M, 2015, PSYCHIAT PSYCHOL LAW, V22, P407, DOI 10.1080/13218719.2014.960027; Kavanagh L, 2010, INT J LAW PSYCHIAT, V33, P20, DOI 10.1016/j.ijlp.2009.10.004; Kidd PM, 2007, ALTERN MED REV, V12, P207; Kooij JJS, 2008, J ATTEN DISORD, V11, P445, DOI 10.1177/1087054707299367; LEPAGE G, 1986, J LIPID RES, V27, P114; Lobbestael J, 2013, J PERS DISORD, V27, P53, DOI 10.1521/pedi.2013.27.1.53; Lopez LB, 2011, J NUTR HEALTH AGING, V15, P25, DOI 10.1007/s12603-011-0009-5; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Meyer BJ, 2011, NUTRITION, V27, P1136, DOI 10.1016/j.nut.2011.01.004; Meyer BJ, 2003, LIPIDS, V38, P391, DOI 10.1007/s11745-003-1074-0; Milte CM, 2011, J CHILD HEALTH CARE, V15, P299, DOI 10.1177/1367493511403953; Milte CM, 2009, NUTR REV, V67, P573, DOI 10.1111/j.1753-4887.2009.00229.x; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Ollis TE, 1999, ANN NUTR METAB, V43, P346, DOI 10.1159/000012803; Parletta N, 2013, J NUTR BIOCHEM, V24, P725, DOI 10.1016/j.jnutbio.2013.01.002; R Development Core Team, 2008, LANG ENV STAT COMP, V3; Ramirez JM, 2006, NEUROSCI BIOBEHAV R, V30, P276, DOI 10.1016/j.neubiorev.2005.04.015; Ricciardelli R, 2013, QUAL SOCIOL REV, V9, P97; Shinkfield AJ, 2014, INT J OFFENDER THER, V58, P435, DOI 10.1177/0306624X12470525; Sinn N, 2008, PROSTAG LEUKOTR ESS, V78, P311, DOI 10.1016/j.plefa.2008.04.004; Sinn N, 2010, NUTRIENTS, V2, P128, DOI 10.3390/nu2020128; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Sontrop J, 2006, PREV MED, V42, P4, DOI 10.1016/j.ypmed.2005.11.005; Steadham JA, 2013, J FORENSIC PSYCHOL P, V13, P411, DOI 10.1080/15228932.2013.847350; Stevens LJ, 1996, PHYSIOL BEHAV, V59, P915, DOI 10.1016/0031-9384(95)02207-4; Sullivan BL, 2006, LIPIDS, V41, P845, DOI 10.1007/s11745-006-5039-0; Suris A, 2004, AGGRESS VIOLENT BEH, V9, P165, DOI 10.1016/S1359-1789(03)00012-0; Swierk M, 2011, NUTRITION, V27, P641, DOI 10.1016/j.nut.2010.06.011; VIRKKUNEN ME, 1987, BIOL PSYCHIAT, V22, P1087, DOI 10.1016/0006-3223(87)90051-5; White BA, 2013, J PSYCHOPATHOL BEHAV, V35, P1, DOI 10.1007/s10862-012-9310-9; Zaalberg A, 2010, AGGRESSIVE BEHAV, V36, P117, DOI 10.1002/ab.20335	50	23	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120220	10.1371/journal.pone.0120220	http://dx.doi.org/10.1371/journal.pone.0120220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793501	Green Published, gold, Green Accepted			2022-12-26	WOS:000352084200160
J	Richard, JE; Anderberg, RH; Goteson, A; Gribble, FM; Reimann, F; Skibicka, KP				Richard, Jennifer E.; Anderberg, Rozita H.; Goteson, Andreas; Gribble, Fiona M.; Reimann, Frank; Skibicka, Karolina P.			Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; VENTRAL TEGMENTAL AREA; ENERGY-BALANCE; MESSENGER-RNAS; NEURONS; ACCUMBENS; DOPAMINE; OPIOIDS; OVERCONSUMPTION; SUPPRESSION	The gut/brain peptide, glucagon like peptide 1 (GLP-1), suppresses food intake by acting on receptors located in key energy balance regulating CNS areas, the hypothalamus or the hindbrain. Moreover, GLP-1 can reduce reward derived from food and motivation to obtain food by acting on its mesolimbic receptors. Together these data suggest a neuroanatomical segregation between homeostatic and reward effects of GLP-1. Here we aim to challenge this view and hypothesize that GLP-1 can regulate food reward behavior by acting directly on the hindbrain, the nucleus of the solitary tract (NTS), GLP-1 receptors (GLP-1R). Using two models of food reward, sucrose progressive ratio operant conditioning and conditioned place preference for food in rats, we show that intra-NTS microinjections of GLP-1 or Exendin-4, a stable analogue of GLP-1, inhibit food reward behavior. When the rats were given a choice between palatable food and chow, intra-NTS Exendin-4 treatment preferentially reduced intake of palatable food but not chow. However, chow intake and body weight were reduced by the NTS GLP-1R activation if chow was offered alone. The NTS GLP-1 activation did not alter general locomotor activity and did not induce nausea, measured by PICA. We further show that GLP-1 fibers are in close apposition to the NTS noradrenergic neurons, which were previously shown to provide a monosynaptic connection between the NTS and the mesolimbic system. Central GLP-1R activation also increased NTS expression of dopamine-beta-hydroxylase, a key enzyme in noradrenaline synthesis, indicating a biological link between these two systems. Moreover, NTS GLP-1R activation altered the expression of dopamine-related genes in the ventral tegmental area. These data reveal a food reward-suppressing role of the NTS GLP-1R and indicate that the neurobiological targets underlying food reward control are not limited to the mesolimbic system, instead they are distributed throughout the CNS.	[Richard, Jennifer E.; Anderberg, Rozita H.; Goteson, Andreas; Skibicka, Karolina P.] Univ Gothenburg, Dept Physiol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Gribble, Fiona M.; Reimann, Frank] Univ Cambridge, MRC Metab Dis Unit, Cambridge, England; [Gribble, Fiona M.; Reimann, Frank] Univ Cambridge, Inst Metab Sci, Cambridge, England	University of Gothenburg; University of Cambridge; University of Cambridge	Skibicka, KP (corresponding author), Univ Gothenburg, Dept Physiol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	Karolina.Skibicka@neuro.gu.se		Richard, Jennifer/0000-0002-8473-5455; Reimann, Frank/0000-0001-9399-6377; Goteson, Andreas/0000-0001-6118-6054; Gribble, Fiona/0000-0002-4232-2898	Novo Nordisk Foundation Excellence project grant; Swedish Research Council [2011-3054]; Wellcome Trust [WT088357/Z/09/Z, WT084210/Z/07/Z]; Medical Research Council [MC_UU_12012/3] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0003886] Funding Source: researchfish; MRC [MC_UU_12012/3] Funding Source: UKRI	Novo Nordisk Foundation Excellence project grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the Novo Nordisk Foundation Excellence project grant (to KPS), Swedish Research Council (2011-3054 to KPS). FMG and FR were funded by the Wellcome Trust (WT088357/Z/09/Z, WT084210/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2004, NEUROSCI BIOBEHAV R, V28, P415, DOI 10.1016/j.neubiorev.2004.05.001; Alhadeff AL, 2014, AM J PHYSL REGUL INT; Alhadeff AL, 2011, ENDOCRINOLOGY; Alhadeff AL, 2012, ENDOCRINOLOGY, V153, P647, DOI 10.1210/en.2011-1443; Anderberg RH, 2014, PHYSIOL BEHAV; Barrera JG, 2009, DIABETES, V58, P2820, DOI 10.2337/db09-0281; Berthoud HR, 2011, CURR OPIN NEUROBIOL, V21, P888, DOI 10.1016/j.conb.2011.09.004; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; Delfs JM, 1998, BRAIN RES, V806, P127, DOI 10.1016/S0006-8993(98)00672-6; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dossat AM, 2011, J NEUROSCI, V31, P14453, DOI 10.1523/JNEUROSCI.3262-11.2011; Gaykema RPA, 2009, BRAIN RES, V1294, P61, DOI 10.1016/j.brainres.2009.07.076; GOSNELL BA, 1990, PHARMACOL BIOCHEM BE, V37, P207, DOI 10.1016/0091-3057(90)90322-9; Grill HJ, 2007, CELL METAB, V6, P423, DOI 10.1016/j.cmet.2007.11.007; Grill HJ, 2004, AM J PHYSIOL-REG I, V287, pR1190, DOI 10.1152/ajpregu.00163.2004; HAN VKM, 1986, J NEUROSCI RES, V16, P97, DOI 10.1002/jnr.490160110; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hayes MR, 2012, PHYSIOL BEHAV, V106, P413, DOI 10.1016/j.physbeh.2012.02.017; Hayes MR, 2010, PHYSIOL BEHAV, V100, P503, DOI 10.1016/j.physbeh.2010.02.029; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; HERNANDEZ L, 1988, PHYSIOL BEHAV, V44, P599, DOI 10.1016/0031-9384(88)90324-1; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Hisadome K, 2010, DIABETES, V59, P1890, DOI 10.2337/db10-0128; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Kanoski SE, 2014, NEUROPSYCHOPHARMACOL, V39, P605, DOI 10.1038/npp.2013.235; Kanoski SE, 2012, NEUROPHARMACOLOGY, V62, P1916, DOI 10.1016/j.neuropharm.2011.12.022; Kay K, 2014, PSYCHOPHARMACOLOGY, V231, P419, DOI 10.1007/s00213-013-3248-9; Kotz CM, 1997, AM J PHYSIOL-REG I, V272, pR1028, DOI 10.1152/ajpregu.1997.272.4.R1028; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; LEVINE AS, 1995, AM J PHYSIOL-REG I, V268, pR248, DOI 10.1152/ajpregu.1995.268.1.R248; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llewellyn-Smith IJ, 2013, NEUROSCIENCE, V229, P130, DOI 10.1016/j.neuroscience.2012.09.071; Llewellyn-Smith IJ, 2011, NEUROSCIENCE, V180, P111, DOI 10.1016/j.neuroscience.2011.02.023; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Mietlicld-Baase E. G., 2013, AM J PHYSL ENDOCRINO; Naleid AM, 2007, AM J PHYSIOL-REG I, V293, pR99, DOI 10.1152/ajpregu.00675.2006; Nowak A, 2008, J PHYSIOL PHARMACOL, V59, P501; Olson VG, 2006, SCIENCE, V311, P1017, DOI 10.1126/science.1119311; Olszewski PK, 2007, PHYSIOL BEHAV, V91, P506, DOI 10.1016/j.physbeh.2007.01.011; Olszewski PK, 2011, PHYSIOL BEHAV, V104, P105, DOI 10.1016/j.physbeh.2011.04.033; Peyron C, 1998, J NEUROSCI, V18, P9996; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; RITTER RC, 1984, PHYSIOL BEHAV, V32, P923, DOI 10.1016/0031-9384(84)90279-8; RITTER RC, 1981, SCIENCE, V213, P451, DOI 10.1126/science.6264602; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schick RR, 2003, AM J PHYSIOL-REG I, V284, pR1427, DOI 10.1152/ajpregu.00479.2002; Skibicka KP, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00181; Skibicka KP, 2011, ENDOCRINOLOGY, V152, P2400, DOI 10.1210/en.2010-1309; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P5351, DOI 10.1210/en.2009-0804; SOUTH EH, 1983, BRAIN RES, V288, P243, DOI 10.1016/0006-8993(83)90100-2; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Vucetic Z, 2010, WIRES SYST BIOL MED, V2, P577, DOI 10.1002/wsbm.77; WANG ZJ, 1992, BRAIN RES, V578, P347, DOI 10.1016/0006-8993(92)90269-F; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65; Zheng HY, 2005, J COMP NEUROL, V485, P127, DOI 10.1002/cne.20515	60	92	93	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119034	10.1371/journal.pone.0119034	http://dx.doi.org/10.1371/journal.pone.0119034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793511	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200052
J	Sivasankar, S; Lavanya, R; Brindha, P; Angayarkanni, N				Sivasankar, Shanmuganathan; Lavanya, Ramu; Brindha, Pemaiah; Angayarkanni, Narayanasamy			Aqueous and Alcoholic Extracts of Triphala and Their Active Compounds Chebulagic Acid and Chebulinic Acid Prevented Epithelial to Mesenchymal Transition in Retinal Pigment Epithelial Cells, by Inhibiting SMAD-3 Phosphorylation	PLOS ONE			English	Article							PROLIFERATIVE VITREORETINOPATHY; MATRIX-METALLOPROTEINASE; DIABETIC-RETINOPATHY; RISK-FACTORS; EXPRESSION; GROWTH; RPE; ANTIOXIDANTS; FORMULATION; DETACHMENT	Epithelial to Mesenchymal Transition (EMT) of the retinal pigment epitheliumis involved in the pathogenesis of proliferative vitreoretinopathy (PVR) that often leads to retinal detachment. In this study, Triphala, an ayurvedic formulation and two of its active ingredients, namely chebulagic acid and chebulinic acid were evaluated for anti-EMT properties based on in vitro experiments in human retinal pigment epithelial cell line (ARPE-19) under TGF beta 1 induced conditions. ARPE-19 cells were treated with TGF beta 1 alone or co-treated with various concentrations of aqueous extract (AqE) (30 - 300 mu g/ml); alcoholic extract (AlE) (50 -500 mu g/ml) of triphala and the active principles chebulagic acid (CA) and chebulinic acid (CI) (CA, CI: 50 -200 mu M). The expression of EMT markers namely MMP-2, alpha SMA, vimentin and the tight junction protein ZO-1 were evaluated by qPCR, western blot and immunofluorescence. The functional implications of EMT, namelymigration and proliferation of cells were assessed by proliferation assay, scratch assay and transwell migration assay. AqE, AlE, CA and CI reduced the expression and activity of MMP-2 at an ED50 value of 100 mu g/ml, 50 mu g/ml, 100 mu M and 100 mu M, respectively. At these concentrations, a significant down-regulation of the expression of alpha SMA, vimentin and up-regulation of the expression of ZO-1 altered by TGF beta 1 were observed. These concentrations also inhibited proliferation and migration of ARPE-19 cells induced by TGF beta 1. EMT was found to be induced in ARPE-19 cells, through SMAD-3 phosphorylation and it was inhibited by AqE, AlE, CA and CI. Further studies in experimental animals are required to attribute therapeutic potential of these extracts and their active compounds, as an adjuvant therapy in the disease management of PVR.	[Sivasankar, Shanmuganathan; Angayarkanni, Narayanasamy] Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, Kamalnayan Bajaj Inst Res Vis & Ophthalmol, Madras, Tamil Nadu, India; [Sivasankar, Shanmuganathan] SASTRA Univ, Sch Chem & Biotechnol, Thanjavur, India; [Lavanya, Ramu; Brindha, Pemaiah] SASTRA Univ, Ctr Adv Res Indian Syst Med, Thanjavur, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Angayarkanni, N (corresponding author), Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, Kamalnayan Bajaj Inst Res Vis & Ophthalmol, Madras, Tamil Nadu, India.	drak@snmail.org	Narayanasamy, Angayarkanni/ABD-8584-2020		Council of Scientific and Industrial Research [27/0219/09/EMR-II]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	Funding provided by a Council of Scientific and Industrial Research grant (27/0219/09/EMR-II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2005, J PERIODONTOL, V76, P497, DOI 10.1902/jop.2005.76.4.497; Baliga MS, 2012, CHIN J INTEGR MED, V18, P946, DOI 10.1007/s11655-012-1299-x; Bochaton-Piallat ML, 2000, INVEST OPHTH VIS SCI, V41, P2336; Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858; Burke JM, 2006, INVEST OPHTH VIS SCI, V47, P3635, DOI 10.1167/iovs.06-0104; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chan CM, 2010, MOL VIS, V16, P586; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; Coral K, 2008, INVEST OPHTH VIS SCI, V49, P4746, DOI 10.1167/iovs.07-1550; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465; Eichler W, 2002, INVEST OPHTH VIS SCI, V43, P2767; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; KIM J, 2013, NATL GEOGR, V224, P8; Kon CH, 1998, INVEST OPHTH VIS SCI, V39, P1524; Krishnan G, 2012, GLIA, V60, P1629, DOI 10.1002/glia.22380; Kumar MS, 2008, J SURG RES, V144, P94, DOI 10.1016/j.jss.2007.02.049; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023322; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043934; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nagasaki H, 1998, PROG RETIN EYE RES, V17, P77, DOI 10.1016/S1350-9462(97)00007-4; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Pawar V, 2009, INDIAN J PHARM SCI, V71, P382, DOI 10.4103/0250-474X.57286; Reddy DB, 2009, BIOCHEM BIOPH RES CO, V381, P112, DOI 10.1016/j.bbrc.2009.02.022; Rothmeier AS, 2009, FASEB J, V23, P1127, DOI 10.1096/fj.08-117127; RYAN SJ, 1993, AM J OPHTHALMOL, V115, P1; Sadaka A, 2012, CLIN OPHTHALMOL, V6, P1325, DOI 10.2147/OPTH.S27896; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Sandhya T, 2006, CANCER LETT, V231, P206, DOI 10.1016/j.canlet.2005.01.035; Shi Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-294; Sumantran VN, 2007, J BIOSCIENCES, V32, P755, DOI 10.1007/s12038-007-0075-3; Sun XD, 2013, ONCOL REP, V29, P2401, DOI 10.3892/or.2013.2385; Symeonidis C, 2011, ACTA OPHTHALMOL, V89, P339, DOI 10.1111/j.1755-3768.2009.01701.x; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	51	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120512	10.1371/journal.pone.0120512	http://dx.doi.org/10.1371/journal.pone.0120512			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793924	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900045
J	Wang, H; Qiao, YQ; Chai, BZ; Qiu, CX; Chen, XD				Wang, He; Qiao, Yunqian; Chai, Baozhong; Qiu, Chenxi; Chen, Xiangdong			Identification and Molecular Characterization of the Homogentisate Pathway Responsible for Pyomelanin Production, the Major Melanin Constituents in Aeromonas media WS	PLOS ONE			English	Article							4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; PSEUDOMONAS-AERUGINOSA; PHENYLALANINE-HYDROXYLASE; TRANSPOSON MUTAGENESIS; SHEWANELLA-COLWELLIANA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GENUS AEROMONAS; SP-NOV; TYROSINASE	The pigmentation of many Aeromonas species has been thought to be due to the production of a L-DOPA (L-3,4-dihydroxyphenylalanine) based melanin. However, in this study we found that although L-DOPA synthesis occurs in the high-melanin-yielding Aeromonas media strain WS, it plays a minor, if any, role in pigmentation. Instead, the pigmentation of A. media strain WS is due to the production of pyomelanin through HGA (homogentisate). Gene products of phhA (encodes phenylalanine hydroxylase), tyrB and aspC (both encode aromatic amino acid aminotransferase), and hppD (encodes 4-hydroxyphenylpyruvate dioxygenase) constitute a linear pathway of converting phenylalanine to HGA and disruption of any one of these genes impairs or blocks pigmentation of A. media strain WS. This HGA biosynthesis pathway is widely distributed in Aeromonas, but HGA is only detectable in the cultures of pigmented Aeromonas species. Heterologous expression of HppD from both pigmented and non-pigmented Aeromonas species in E. coli leads to the production of pyomelanin and thus pigmentation, suggesting that most Aeromonas species have the critical enzymes to produce pyomelanin through HGA. Taken together, we have identified a widely conserved biosynthesis pathway of HGA based pyomelanin in Aeromonas that may be responsible for pigmentation of many Aeromonas species.	[Wang, He; Qiao, Yunqian; Chai, Baozhong; Qiu, Chenxi; Chen, Xiangdong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Chen, Xiangdong] Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Wuhan, Peoples R China	Wuhan University	Chen, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	xdchen@whu.edu.cn		Qiu, Chenxi/0000-0002-0314-5307	National Basic Research Program of China (973 Program) [2011CB808800]; National Natural Science Foundation of China [31070077]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program) (No. 2011CB808800) and National Natural Science Foundation of China (No. 31070077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SL, 2003, J CLIN MICROBIOL, V41, P2348, DOI 10.1128/JCM.41.6.2348-2357.2003; AURSTAD K, 1972, ACTA VET SCAND, V13, P251; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Borowski T, 2005, J AM CHEM SOC, V127, P17303, DOI 10.1021/ja054433j; Chai BZ, 2012, J BACTERIOL, V194, P6693, DOI 10.1128/JB.01807-12; Chatfield CH, 2007, INFECT IMMUN, V75, P4062, DOI 10.1128/IAI.00489-07; COON SL, 1994, APPL ENVIRON MICROB, V60, P3006, DOI 10.1128/AEM.60.8.3006-3010.1994; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; DENOYA CD, 1994, J BACTERIOL, V176, P5312, DOI 10.1128/JB.176.17.5312-5319.1994; ESTEVE C, 1995, INT J SYST BACTERIOL, V45, P462, DOI 10.1099/00207713-45-3-462; Flydal MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046209; Gibson LF, 1998, FEMS MICROBIOL LETT, V169, P261, DOI 10.1016/S0378-1097(98)00495-9; GOODWIN PH, 1994, CAN J MICROBIOL, V40, P28, DOI 10.1139/m94-005; Green MR, 2012, MOL CLONING LAB MANU, V1; GRIFFIN PJ, 1953, J BACTERIOL, V65, P652, DOI 10.1128/JB.65.6.652-659.1953; Gu W, 1998, MICROBIOL-SGM, V144, P3127, DOI 10.1099/00221287-144-11-3127; Hernandez-Romero D, 2005, APPL ENVIRON MICROB, V71, P6808, DOI 10.1128/AEM.71.11.6808-6815.2005; Hunter RC, 2010, J BACTERIOL, V192, P5962, DOI 10.1128/JB.01021-10; IGBINOSA IH, 2012, SCI WORLD J; Keith KE, 2007, J BACTERIOL, V189, P9057, DOI 10.1128/JB.00436-07; Kong KH, 2000, BIOTECHNOL APPL BIOC, V31, P113, DOI 10.1042/BA19990096; KOTOB SI, 1995, APPL ENVIRON MICROB, V61, P1620, DOI 10.1128/AEM.61.4.1620-1622.1995; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krol ES, 1998, CHEM RES TOXICOL, V11, P1434, DOI 10.1021/tx980114c; LEU WM, 1992, J BIOL CHEM, V267, P20108; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lopez-Serrano D, 2002, PIGM CELL RES, V15, P104; MARTINEZMURCIA AJ, 1992, FEMS MICROBIOL LETT, V91, P199; MCINTOSH D, 1991, J GEN MICROBIOL, V137, P1341, DOI 10.1099/00221287-137-6-1341; Milcamps A, 1999, MICROBIOL-UK, V145, P935, DOI 10.1099/13500872-145-4-935; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Pinero S, 2007, J MOL MICROB BIOTECH, V13, P35, DOI 10.1159/000103595; Rholl DA, 2008, APPL ENVIRON MICROB, V74, P7529, DOI 10.1128/AEM.01973-08; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Rodriguez JM, 2000, HUM MOL GENET, V9, P2341, DOI 10.1093/oxfordjournals.hmg.a018927; Rozanowska M, 1999, FREE RADICAL BIO MED, V26, P518, DOI 10.1016/S0891-5849(98)00234-2; Ruan L, 2005, ANTON LEEUW INT J G, V87, P283, DOI 10.1007/s10482-004-4775-5; RUETSCHI U, 1992, EUR J BIOCHEM, V205, P459, DOI 10.1111/j.1432-1033.1992.tb16800.x; RUNDGREN M, 1977, J BIOL CHEM, V252, P5094; RUNDGREN M, 1982, BIOCHIM BIOPHYS ACTA, V704, P59, DOI 10.1016/0167-4838(82)90132-7; SARNA T, 1976, SCIENCE, V192, P1132, DOI 10.1126/science.179142; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Serre L, 1999, STRUCTURE, V7, P977, DOI 10.1016/S0969-2126(99)80124-5; SHIEH HS, 1974, INT J BIOCHEM, V5, P643, DOI 10.1016/0020-711X(74)90028-7; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Song J, 1999, J BACTERIOL, V181, P2789, DOI 10.1128/JB.181.9.2789-2796.1999; Swan G, 1974, PROGR CHEM ORGANIC N, P521; Titus GP, 2000, NAT STRUCT BIOL, V7, P542; Turick CE, 2009, FEMS MICROBIOL ECOL, V68, P223, DOI 10.1111/j.1574-6941.2009.00670.x; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Wan X, 2007, J APPL MICROBIOL, V103, P2533, DOI 10.1111/j.1365-2672.2007.03502.x; Wan X, 2009, APPL MICROBIOL BIOT, V82, P261, DOI 10.1007/s00253-008-1742-5; Wang YL, 2005, J BASIC MICROB, V45, P83, DOI 10.1002/jobm.200410446; WHITE LP, 1958, NATURE, V182, P1427, DOI 10.1038/1821427a0; YABUUCHI E, 1972, International Journal of Systematic Bacteriology, V22, P53; ZHAO GS, 1994, P NATL ACAD SCI USA, V91, P1366, DOI 10.1073/pnas.91.4.1366	61	29	29	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120923	10.1371/journal.pone.0120923	http://dx.doi.org/10.1371/journal.pone.0120923			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793756	Green Submitted, gold, Green Published			2022-12-26	WOS:000352083900088
J	Wang, JC; Sindhu, H; Chen, C; Kundra, A; Kafeel, MI; Wong, C; Lichter, S				Wang, Jen C.; Sindhu, Hemant; Chen, Chi; Kundra, Ajay; Kafeel, Muhammad I.; Wong, Ching; Lichter, Stephen			Immune Derangements in Patients with Myelofibrosis: The Role of Treg, Th17, and sIL2R alpha	PLOS ONE			English	Article							REGULATORY T-CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; PREDICTS REDUCED SURVIVAL; ACUTE MYELOID-LEUKEMIA; NON-HODGKIN-LYMPHOMA; PERIPHERAL-BLOOD; SOLUBLE INTERLEUKIN-2-RECEPTOR; AUTOIMMUNE INFLAMMATION; INCREASED POPULATIONS; MULTIPLE-SCLEROSIS	Myelofibrosis (MF), including primary myelofibrosis, post-essential thrombocythemia MF, and post-polycythemia vera MF, has been reported to be associated with autoimmune phenomena. IMiDs have been reported to be effective in some patients with MF, presumably for their immune-modulator effects. We therefore sought to elucidate the immune derangements in patients with MF. We found no differences in T regulatory cells (Treg) and T helper 17 (Th17) cells in MF patients and normal healthy controls. However, we found significantly elevated soluble interleukin 2 alpha (sIL2R alpha) in MF patients compared to those with other myeloproliferative neoplasm diseases and normal healthy controls. Our studies with MF patients further revealed that Treg cells were the predominant cells producing sIL2R alpha. sIL2R alpha and IL2 complex induced the formation of Treg cells but not the formation of Th1 or Th17 cells. sIL2R alpha induced CD8(+) T cell proliferation in the presence of Treg cells. Monocytes or neutrophils had no effect on the production of sIL2R alpha by Treg cells. Furthermore, we found plasma sIL2R alpha levels were correlated to the auto-immune serology in MPN patients and ruxolitinib significantly inhibits the sIL2R alpha production by the Treg cells in MF patients which may explain the effects of ruxolitinib on the relief of constitutional symptoms. All these findings suggest that sIL2R alpha likely plays a significant role in autoimmune phenomena seen in patients with MF. Further studies of immune derangement may elucidate the mechanism of IMiD, and exploration of immune modulators may prove to be important for treating myelofibrosis.	[Wang, Jen C.; Sindhu, Hemant; Chen, Chi; Kundra, Ajay; Kafeel, Muhammad I.; Wong, Ching; Lichter, Stephen] Brookdale Univ Hosp, Div Hematol Oncol, Med Ctr, Brooklyn, NY 11212 USA		Wang, JC (corresponding author), Brookdale Univ Hosp, Div Hematol Oncol, Med Ctr, Brooklyn, NY 11212 USA.	jcwang5@aol.com			ECRIP Program, NY Department of Health; Brookdale University Research Fund	ECRIP Program, NY Department of Health; Brookdale University Research Fund	This work is supported by the grants from the ECRIP Program, NY Department of Health and the Brookdale University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1989, LANCET, V1, P559; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Barcellini W, 2013, LEUKEMIA RES, V37, P1509, DOI 10.1016/j.leukres.2013.09.001; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; BERNHARDT B, 1976, AM J MED SCI, V272, P229, DOI 10.1097/00000441-197609000-00016; Beyer M, 2005, BLOOD, V106, P2018, DOI 10.1182/blood-2005-02-0642; Bien E, 2008, BIOMARKERS, V13, P1, DOI 10.1080/13547500701674063; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Fabre-Guillevin E, 2006, LEUKEMIA LYMPHOMA, V47, P603, DOI 10.1080/10428190500361029; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; GORDON BR, 1981, BLOOD, V58, P904; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; HASSELBALCH H, 1990, AM J HEMATOL, V34, P291, DOI 10.1002/ajh.2830340411; Heine A, 2013, BLOOD, V122, P1192, DOI 10.1182/blood-2013-03-484642; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Javia LR, 2003, J IMMUNOTHER, V26, P85, DOI 10.1097/00002371-200301000-00009; Kesselring R, 2011, CELL IMMUNOL, V269, P74, DOI 10.1016/j.cellimm.2011.03.026; KHUMBANONDA M, 1969, AM J MED SCI, V258, P89, DOI 10.1097/00000441-196908000-00004; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Kordasti SY, 2007, BLOOD, V110, P847, DOI 10.1182/blood-2007-01-067546; Kundra A, 2013, BLOOD S; LEWIS CM, 1978, BRIT J HAEMATOL, V39, P233, DOI 10.1111/j.1365-2141.1978.tb01093.x; Lewis CM, 1997, LANCET, V115, P1151; Lindqvist CA, 2010, IMMUNOLOGY, V131, P371, DOI 10.1111/j.1365-2567.2010.03308.x; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Marshall NA, 2004, BLOOD, V103, P1755, DOI 10.1182/blood-2003-07-2594; Mesa RA, 2003, BLOOD, V101, P2534, DOI 10.1182/blood-2002-09-2928; Mesa RA, 2010, AM J HEMATOL, V85, P129, DOI 10.1002/ajh.21598; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Motta M, 2005, LEUKEMIA, V19, P1788, DOI 10.1038/sj.leu.2403907; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Prabhala RH, 2006, BLOOD, V107, P301, DOI 10.1182/blood-2005-08-3101; Quintas-Cardama A, 2009, J CLIN ONCOL, V27, P5418, DOI 10.1200/JCO.2009.23.6075; Riley CH, 2011, BLOOD, V118, P2170, DOI 10.1182/blood-2011-03-340992; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Schaefer C, 2005, BRIT J CANCER, V92, P913, DOI 10.1038/sj.bjc.6602407; Shakil SA, 2010, ASH ANN M; Tefferi A, 2006, BLOOD, V108, P1158, DOI 10.1182/blood-2006-02-004572; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Waldmann H, 2004, SEMIN IMMUNOL, V16, P119, DOI 10.1016/j.smim.2003.12.007; WANG JC, 1994, BRIT J HAEMATOL, V86, P380, DOI 10.1111/j.1365-2141.1994.tb04744.x; Wang XB, 2005, EUR J HAEMATOL, V75, P468, DOI 10.1111/j.1600-0609.2005.00537.x; Woo EY, 2001, CANCER RES, V61, P4766; Wu C, 2009, CLIN EXP IMMUNOL, V158, P199, DOI 10.1111/j.1365-2249.2009.04011.x; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060	55	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0116723	10.1371/journal.pone.0116723	http://dx.doi.org/10.1371/journal.pone.0116723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793623	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200008
J	Zhou, WP; Zhang, H; Zhao, YX; Liu, GQ; Zhang, JY				Zhou, Wen-ping; Zhang, Hui; Zhao, Yu-xia; Liu, Gang-qiong; Zhang, Jin-ying			RNA Interference of Myocyte Enhancer Factor 2A Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TRANSCRIPTION FACTOR MEF2A; CAG REPEAT POLYMORPHISM; MATRIX METALLOPROTEINASE-8; MYOCARDIAL-INFARCTION; GENE; ASSOCIATION; MUTATIONS; INFLAMMATION	Objective Myocyte enhancer factor-2A (MEF 2A) has been shown to be involved in atherosclerotic lesion development, but its role in preexisting lesions is still unclear. In the present study we aim to assess the role of MEF 2A in the progression of pre-existing atherosclerosis. Methods Eighty apolipoprotein E-deficient mice (APOE KO) were randomly allocated to control, scramble and MEF 2A RNA interference (RNAi) groups, and constrictive collars were used to induce plaque formation. Six weeks after surgery, lentiviral shRNA construct was used to silence the expression of MEF 2A. Carotid plaques were harvested for analysis 4 weeks after viral vector transduction. Inflammatory gene expression in the plasma and carotid plaques was determined by using ELISAs and real-time RT-PCR. Results The expression level of MEF 2A was significantly reduced in plasma and plaque in the RNAi group, compared to the control and NC groups, whereas the expression level of pro-inflammatory cytokines was markedly increased. Silencing MEF 2A using lentiviral shRNA significantly reduced the plaque collagen content and fibrous cap thickness, as well as increased plaque area. However, silencing MEF 2A had no obvious effect on plaque lipid content. Conclusions Lentivirus-mediated MEF 2A shRNA accelerates inflammation and atherosclerosis in APOE KO mice, but has no effect on lipoprotein levels in plasma.	[Zhou, Wen-ping; Zhang, Hui; Liu, Gang-qiong; Zhang, Jin-ying] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China; [Zhao, Yu-xia] Zhengzhou Univ, Affiliated Hosp 1, Dept Med Equipment, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Zhang, JY (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China.	jyzhang@zzu.edu.cn			Key Scientific and Technological Project of Henan Province [112102310174]; Scientific Fund for Distinguished Young Scholars in Henan Province [094100510017]; Research Team Project of the First Affiliated Hospital of Zhengzhou University; Science and Technology Fund for Innovation Leading Talents of Health in Henan province [3027]	Key Scientific and Technological Project of Henan Province; Scientific Fund for Distinguished Young Scholars in Henan Province; Research Team Project of the First Affiliated Hospital of Zhengzhou University; Science and Technology Fund for Innovation Leading Talents of Health in Henan province	This work was supported by grants from the Key Scientific and Technological Project of Henan Province (No. 112102310174), the Scientific Fund for Distinguished Young Scholars in Henan Province (No. 094100510017), the Research Team Project of the First Affiliated Hospital of Zhengzhou University, and the Science and Technology Fund for Innovation Leading Talents of Health in Henan province (No. 3027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, J CLIN INVEST, V115, P831, DOI 10.1172/JCI200524715; Bhagavatula MRK, 2004, HUM MOL GENET, V13, P3181, DOI 10.1093/hmg/ddh329; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Dai DP, 2010, EUR J CLIN INVEST, V40, P669, DOI 10.1111/j.1365-2362.2010.02307.x; Elhawari S, 2010, ATHEROSCLEROSIS, V209, P152, DOI 10.1016/j.atherosclerosis.2009.09.005; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Follenzi Antonia, 2002, Methods Mol Med, V69, P259; Gonzalez P, 2006, J MED GENET, V43, P167, DOI 10.1136/jmg.2005.035071; Guella I, 2009, CIRC-CARDIOVASC GENE, V2, P165, DOI 10.1161/CIRCGENETICS.108.819326; Han YL, 2007, CLIN CHEM LAB MED, V45, P987, DOI 10.1515/CCLM.2007.159; Horan PG, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-65; Hsu LA, 2010, CLIN APPL THROMB-HEM, V16, P301, DOI 10.1177/1076029608330476; Kajimoto K, 2005, CIRC J, V69, P1192, DOI 10.1253/circj.69.1192; Laxton RC, 2009, CIRC RES, V105, P921, DOI 10.1161/CIRCRESAHA.109.200279; Lenglet S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/659282; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Lieb W, 2008, CIRCULATION, V117, P185, DOI 10.1161/CIRCULATIONAHA.107.728485; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031406, 10.1371/journal.pone.0048083]; Makinen PI, 2006, J GENE MED, V8, P433, DOI 10.1002/jgm.860; Manrique C, 2009, MED CLIN N AM, V93, P569, DOI 10.1016/j.mcna.2009.02.014; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Morris KV, 2006, GENE THER, V13, P553, DOI 10.1038/sj.gt.3302688; Qi LH, 2009, HUM GENE THER, V20, P739, DOI 10.1089/hum.2008.203; Rahatloo KI, 2013, IRAN J BASIC MED SCI, V16, P950; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Weng L, 2005, J CLIN INVEST, V115, P1016, DOI 10.1172/JCI24186; Yanai H, 2008, NUTR J, V17, P7; Zhang H, 2013, CLIN INVEST MED, V36, pE32; Zhang H, 2013, INT J MOL MED, V31, P651, DOI 10.3892/ijmm.2013.1248; Zhang H, 2012, BIOCHEM BIOPH RES CO, V427, P557, DOI 10.1016/j.bbrc.2012.09.096; Zhao W, 2012, CELL BIOCHEM FUNCT, V30, P108, DOI 10.1002/cbf.1823	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121823	10.1371/journal.pone.0121823	http://dx.doi.org/10.1371/journal.pone.0121823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793529	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900158
J	Lagman, M; Ly, J; Saing, T; Singh, MK; Tudela, EV; Morris, D; Chi, PT; Ochoa, C; Sathananthan, A; Venketaraman, V				Lagman, Minette; Ly, Judy; Saing, Tommy; Singh, Manpreet Kaur; Tudela, Enrique Vera; Morris, Devin; Chi, Po-Ting; Ochoa, Cesar; Sathananthan, Airani; Venketaraman, Vishwanath			Investigating the Causes for Decreased Levels of Glutathione in Individuals with Type II Diabetes	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; OXIDATIVE STRESS; RESISTANCE; INFECTION; RESPONSES; INNATE; CELLS; SUPPRESSION; CYTOKINES; IMMUNITY	Tuberculosis (TB) remains an eminent global burden with one third of the world's population latently infected with Mycobacterium tuberculosis (M. tb). Individuals with compromised immune systems are especially vulnerable to M. tb infection. In fact, individuals with Type 2 Diabetes Mellitus (T2DM) are two to three times more susceptible to TB than those without T2DM. In this study, we report that individuals with T2DM have lower levels of glutathione (GSH) due to compromised levels of GSH synthesis and metabolism enzymes. Transforming growth factor beta (TGF-beta), a cytokine that is known to decrease the expression of the catalytic subunit of glutamine-cysteine ligase (GCLC) was found in increased levels in the plasma samples from individuals with T2DM, explaining the possible underlying mechanism that is responsible for decreased levels of GSH in individuals with T2DM. Moreover, increased levels of pro-inflammatory cytokines such as interleukin-6 (IL-6) and interleukin-17 (IL-17) were observed in plasma samples isolated from individuals with T2DM. Increased levels of IL-6 and IL-17 was accompanied by enhanced production of free radicals further indicating an alternative mechanism for the decreased levels of GSH in individuals with T2DM. Augmenting the levels of GSH in macrophages isolated from individuals with T2DM resulted in improved control of M. tb infection. Furthermore, cytokines that are responsible for controlling M. tb infection at the cellular and granuloma level such as tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-2 (IL-2), interferon-gamma (IFN-gamma), and interleukin-12 (IL-12), were found to be compromised in plasma samples isolated from individuals with T2DM. On the other hand, interleukin-10 (IL-10), an immunosuppressive cytokine was increased in plasma samples isolated from individuals with T2DM. Overall, these findings suggest that lower levels of GSH in individuals with T2DM lead to their increased susceptibility to M. tb infection.	[Lagman, Minette; Saing, Tommy; Singh, Manpreet Kaur; Tudela, Enrique Vera; Chi, Po-Ting; Venketaraman, Vishwanath] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA; [Lagman, Minette; Ly, Judy; Singh, Manpreet Kaur; Tudela, Enrique Vera; Morris, Devin; Chi, Po-Ting; Venketaraman, Vishwanath] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Dept Basic Med Sci, Pomona, CA USA; [Ochoa, Cesar; Sathananthan, Airani] Western Diabet Inst, Pomona, CA USA	Western University of Health Sciences; Western University of Health Sciences	Venketaraman, V (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA.	vvenketaraman@westernu.edu	venketaraman, Vishwanath/AAW-6945-2020	venketaraman, Vishwanath/0000-0002-2586-1160	Western University of Health Sciences; Your Energy Systems	Western University of Health Sciences; Your Energy Systems	This work was supported in part by Western University of Health Sciences and Your Energy Systems to VV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam K, 2010, J IMMUNOL, V184, P2918, DOI 10.4049/jimmunol.0900439; Alkozai Edris M, 2014, F1000Res, V3, P85, DOI 10.12688/f1000research.3316.1; American Diabetes Association, 2013, DAT STAT DIAB; [Anonymous], 2014, TUB; Bakin AV, 2005, FREE RADICAL BIO MED, V38, P375, DOI 10.1016/j.freeradbiomed.2004.10.033; CDC, 2014, NAT DIAB STAT REP; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; COUSENS LP, 1995, J IMMUNOL, V155, P5690; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Gan YH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003794; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Guerra C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028378; Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]; Lai YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007766; Lee YJ, 2007, AM J PHYSIOL-RENAL, V293, pF1036, DOI 10.1152/ajprenal.00034.2007; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Millman AC, 2008, J INTERF CYTOK RES, V28, P153, DOI 10.1089/jir.2007.0095; Morris D, 2013, J INTERF CYTOK RES, V33, P270, DOI 10.1089/jir.2012.0103; Morris D, 2013, BBA-GEN SUBJECTS, V1830, P3329, DOI 10.1016/j.bbagen.2012.10.012; Oni T, 2013, LANCET RESP MED, V1, P356, DOI 10.1016/S2213-2600(13)70116-4; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Roberts CK, 2006, METABOLISM, V55, P928, DOI 10.1016/j.metabol.2006.02.022; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Tan KS, 2012, J CLIN INVEST, V122, P2289, DOI 10.1172/JCI57817; Tobin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067828; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Venketaraman V, 2005, INFECT IMMUN, V73, P1886, DOI 10.1128/IAI.73.3.1886-1889.2005; Venketaraman V, 2003, INFECT IMMUN, V71, P1864, DOI 10.1128/IAI.71.4.1864-1871.2003; Venketaraman V, 2008, MICROB PATHOGENESIS, V44, P255, DOI 10.1016/j.micpath.2007.09.002; Wieser V, 2013, ARCH IMMUNOL THER EX, V61, P119, DOI 10.1007/s00005-012-0210-1; World Health Organization, 2011, TUB DIAB; World Health Organization, 2011, US GLYC HAEM HBA1C D; Zhang HQ, 2005, METHOD ENZYMOL, V401, P468, DOI 10.1016/S0076-6879(05)01028-1	38	51	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118436	10.1371/journal.pone.0118436	http://dx.doi.org/10.1371/journal.pone.0118436			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790445	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400029
J	Tang, ED; Wang, CY				Tang, Eric D.; Wang, Cun-Yu			Single Amino Acid Change in STING Leads to Constitutive Active Signaling	PLOS ONE			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE SENSOR; DI-GMP; DNA SENSOR; CGAS; SYNTHASE; PATHWAY; ADAPTER; MPYS; ACTIVATION	The production of cytokines by the immune system in response to cytosolic DNA plays an important role in host defense, autoimmune disease, and cancer immunogenicity. Recently a cytosolic DNA signaling pathway that is dependent on the endoplasmic reticulum adaptor and cyclic dinucleotide sensor protein STING has been identified. Association of cytosolic DNA with cyclic-GMP-AMP synthase (cGAS) activates its enzymatic activity to synthesize the cyclic dinucleotide second messenger cGAMP from GTP and ATP. Direct detection of cGAMP by STING triggers the activation of IRF3 and NF-kB, and the production of type I interferons and proinflammatory cytokines. The mechanism of how STING is able to mediate downstream signaling remains incompletely understood although it has been shown that dimerization is a prerequisite. Here, we identify a single amino acid change in STING that confers constitutive active signaling. This mutation appears to both enhance ability of STING to both dimerize and associate with its downstream target TBK1.	[Tang, Eric D.; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Tang, ED (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90024 USA.	edtang@ucla.edu; cwang@dentistry.ucla.edu			National Institutes of Health [R01DE023874, K99DE21083]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K99DE021083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by grants from the National Institutes of Health to C.Y.W. (R01DE023874) and E.D.T. (K99DE21083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	28	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120090	10.1371/journal.pone.0120090	http://dx.doi.org/10.1371/journal.pone.0120090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790474	Green Submitted, gold, Green Published			2022-12-26	WOS:000351425400129
J	Ahn, J; Hogan, N				Ahn, Jooeun; Hogan, Neville			Improved Assessment of Orbital Stability of Rhythmic Motion with Noise	PLOS ONE			English	Article							WALKING; ROBOTS; SERIES	Mathematical techniques have provided tools to quantify the stability of rhythmic movements of humans and machines as well as mathematical models. One archetypal example is the use of Floquet multipliers: assuming periodic motion to be a limit-cycle of a nonlinear oscillator, local stability has been assessed by evaluating the rate of convergence to the limit-cycle. However, the accuracy of the assessment in experiments is questionable: Floquet multipliers provide a measure of orbital stability for deterministic systems, but various components of biological systems and machines involve inevitable noise. In this study, we show that the conventional estimate of orbital stability, which depends on regression, has bias in the presence of noise. We quantify the bias, and devise a new method to estimate orbital stability more accurately. Compared with previous methods, our method substantially reduces the bias, providing acceptable estimates of orbital stability with an order-of-magnitude fewer cycles.	[Ahn, Jooeun] Univ Victoria, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada; [Hogan, Neville] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Hogan, Neville] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Victoria; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ahn, J (corresponding author), Univ Victoria, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada.	jooeun@uvic.ca		Ahn, Jooeun/0000-0002-7964-5148	Eric P. and Evelyn E. Newman Fund; Gloria Blake Endowment Fund	Eric P. and Evelyn E. Newman Fund; Gloria Blake Endowment Fund	Support was provided by the Eric P. and Evelyn E. Newman Fund, and the Gloria Blake Endowment Fund to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J., 2011, FEASIBILITY NOVEL GA; Ahn J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073239; Broersen PMT, 2009, IEEE T INSTRUM MEAS, V58, P1354, DOI 10.1109/TIM.2008.2009400; Burg J. P., 1967, 37 ANN INT M SOC EXP; Coleman M. J, 1998, STABILITY STUDY 3 DI; Coleman MJ, 1997, DYNAM STABIL SYST, V12, P139, DOI 10.1080/02681119708806242; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; deHoon MJL, 1996, ANN NUCL ENERGY, V23, P1219, DOI 10.1016/0306-4549(95)00126-3; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; Floquet G., 1883, ANN SCI ECOLE NORM S, V12, P47, DOI DOI 10.24033/ASENS.220; Garcia M, 1998, J BIOMECH ENG-T ASME, V120, P281, DOI 10.1115/1.2798313; Goswami A, 1997, AUTON ROBOT, V4, P273, DOI 10.1023/A:1008844026298; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hurmuzlu Y, 2004, AUTOMATICA, V40, P1647, DOI 10.1016/j.automatica.2004.01.031; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; Hyun DJ, 2014, INT J ROBOT RES, V33, P1417, DOI 10.1177/0278364914532150; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Klausmeier CA, 2008, THEOR ECOL-NETH, V1, P153, DOI 10.1007/s12080-008-0016-2; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; McAndrew PM, 2011, J BIOMECH, V44, P644, DOI 10.1016/j.jbiomech.2010.11.007; MCGEER T, 1993, J THEOR BIOL, V163, P277, DOI 10.1006/jtbi.1993.1121; MIURA H, 1984, INT J ROBOT RES, V3, P60, DOI 10.1177/027836498400300206; Morimoto J, 2009, AUTON ROBOT, V27, P131, DOI 10.1007/s10514-009-9133-z; Oh J-H, 2006, INT ROB SYST 2006 IE; Peshkin M, 2005, REH ROB 2005 ICORR 2; Playter R, 2006, BIG DOG; Saranli U, 2001, INT J ROBOT RES, V20, P616, DOI 10.1177/02783640122067570; SKINNER JE, 1990, BIO-TECHNOL, V8, P1018, DOI 10.1038/nbt1190-1018; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; van Schooten KS, 2011, GAIT POSTURE, V33, P656, DOI 10.1016/j.gaitpost.2011.02.017; Walker G, 1931, P R SOC LOND A-CONTA, V131, P518, DOI 10.1098/rspa.1931.0069; Yule GU, 1927, PHILOS T R SOC LOND, V226, P267, DOI 10.1098/rsta.1927.0007	33	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119596	10.1371/journal.pone.0119596	http://dx.doi.org/10.1371/journal.pone.0119596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798610	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300063
J	Hettinga, KA; Reina, FM; Boeren, S; Zhang, LN; Koppelman, GH; Postma, DS; Vervoort, JJM; Wijga, AH				Hettinga, Kasper A.; Reina, Fabiola M.; Boeren, Sjef; Zhang, Lina; Koppelman, Gerard H.; Postma, Dirkje S.; Vervoort, Jacques J. M.; Wijga, Alet H.			Difference in the Breast Milk Proteome between Allergic and Non-Allergic Mothers	PLOS ONE			English	Article							BIRTH COHORT; FED INFANTS; ASTHMA; DISEASE; APOLIPOPROTEINS; QUANTIFICATION; PREVENTION; CHILDHOOD; SYMPTOMS; PROTEINS	Background Breastfeeding has been linked to a reduction in the prevalence of allergy and asthma. However, studies on this relationship vary in outcome, which may partly be related to differences in breast milk composition. In particular breast milk composition may differ between allergic and non-allergic mothers. Important components that may be involved are breast milk proteins, as these are known to regulate immune development in the newborn. The objective of this study was therefore to explore differences in the proteins of breast milk from 20 allergic and non-allergic mothers. The results from this comparison may then be used to generate hypotheses on proteins associated with allergy in their offspring. Methods Milk samples from allergic and non-allergic mothers were obtained from the PIAMA project, a prospective birth cohort study on incidence, risk factors, and prevention of asthma and inhalant allergy. Non-targeted proteomics technology, based on liquid chromatography and mass spectrometry, was used to compare breast milk from allergic and non-allergic mothers. Results Nineteen proteins, out of a total of 364 proteins identified in both groups, differed significantly in concentration between the breast milk of allergic and non-allergic mothers. Protease inhibitors and apolipoproteins were present in much higher concentrations in breast milk of allergic than non-allergic mothers. These proteins have been suggested to be linked to allergy and asthma. Conclusions The non-targeted milk proteomic analysis employed has provided new targets for future studies on the relation between breast milk composition and allergy.	[Hettinga, Kasper A.; Reina, Fabiola M.; Zhang, Lina] Wageningen Univ, Dairy Sci & Technol, Food Qual & Design Grp, NL-6700 AP Wageningen, Netherlands; [Boeren, Sjef; Vervoort, Jacques J. M.] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp,GRIAC Res Inst, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, GRIAC Res Inst, Groningen, Netherlands; [Wijga, Alet H.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands	Wageningen University & Research; Wageningen University & Research; University of Groningen; University of Groningen; Netherlands National Institute for Public Health & the Environment	Hettinga, KA (corresponding author), Wageningen Univ, Dairy Sci & Technol, Food Qual & Design Grp, NL-6700 AP Wageningen, Netherlands.	kasper.hettinga@wur.nl	Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252	Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Netherlands Lung Fund; Netherlands Ministry of Spatial Planning, Housing, and the Environment; Netherlands Ministry of Health, Welfare, and Sport	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Lung Fund; Netherlands Ministry of Spatial Planning, Housing, and the Environment; Netherlands Ministry of Health, Welfare, and Sport	The PIAMA study is supported by The Netherlands Organization for Health Research and Development, The Netherlands Organization for Scientific Research, The Netherlands Lung Fund, The Netherlands Ministry of Spatial Planning, Housing, and the Environment, and The Netherlands Ministry of Health, Welfare, and Sport. No additional funding was received for the proteomics study described in this paper. The funders of the PIAMA study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belderbos ME, 2012, PEDIAT ALLERG IMM-UK, V23, P65, DOI 10.1111/j.1399-3038.2011.01230.x; Bjorksten B, 2011, ALLERGOL IMMUNOPATH, V39, P318, DOI 10.1016/j.aller.2011.02.005; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DAVIDSON LA, 1990, ACTA PAEDIATR SCAND, V79, P137, DOI 10.1111/j.1651-2227.1990.tb11429.x; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Jacquet A, 2011, INT ARCH ALLERGY IMM, V155, P95, DOI 10.1159/000320375; Jarvinen KM, 2001, CLIN EXP ALLERGY, V31, P978, DOI 10.1046/j.1365-2222.2001.01151.x; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Loss G, 2011, J ALLERGY CLIN IMMUN, V128, P766, DOI 10.1016/j.jaci.2011.07.048; Lu J, 2011, J PROTEOMICS, V75, P34, DOI 10.1016/j.jprot.2011.07.031; Matheson MC, 2012, CLIN EXP ALLERGY, V42, P827, DOI 10.1111/j.1365-2222.2011.03925.x; Nagel G, 2009, INT ARCH ALLERGY IMM, V149, P259, DOI 10.1159/000199722; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Oberle D, 2001, THORAX, V56, P896; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Smith PK, 2006, ALLERGY, V61, P1441, DOI 10.1111/j.1398-9995.2006.01233.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; Verhasselt V, 2010, MUCOSAL IMMUNOL, V3, P326, DOI 10.1038/mi.2010.25; Walker A, 2010, J PEDIATR-US, V156, pS3, DOI 10.1016/j.jpeds.2009.11.021; Wijga AH, 2006, J ALLERGY CLIN IMMUN, V117, P440, DOI 10.1016/j.jaci.2005.10.022; Wijga AH, 2013, INT J EPIDEMIOL, V11, P11; Wright AL, 1999, J ALLERGY CLIN IMMUN, V104, P589, DOI 10.1016/S0091-6749(99)70328-3; Yao XL, 2011, CHEST, V140, P1048, DOI 10.1378/chest.11-0158; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116710	28	33	33	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122234	10.1371/journal.pone.0122234	http://dx.doi.org/10.1371/journal.pone.0122234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798592	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300323
J	Zaballos, MA; Cantero, W; Azpiazu, N				Angel Zaballos, Miguel; Cantero, Walter; Azpiazu, Natalia			The TALE Transcription Factor Homothorax Functions to Assemble Heterochromatin during Drosophila Embryogenesis	PLOS ONE			English	Article							PROXIMODISTAL AXIS; DNA-SEQUENCES; EXTRADENTICLE; CHROMATIN; METHYLATION; GENES; LEG; LOCALIZATION; PURIFICATION; CHROMOSOME	We have previously identified Homothorax (Hth) as an important factor for the correct assembly of the pericentromeric heterochromatin during the first fast syncytial divisions of the Drosophila embryo. Here we have extended our studies to later stages of embryonic development. We were able to show that hth mutants exhibit a drastic overall reduction in the tri-methylation of H3 in Lys9, with no reduction of the previous di-methylation. One phenotypic outcome of such a reduction is a genome instability visualized by the many DNA breaks observed in the mutant nuclei. Moreover, loss of Hth leads to the opening of closed heterochromatic regions, including the rDNA genomic region. Our data show that the satellite repeats get transcribed in wild type embryos and that this transcription depends on the presence of Hth, which binds to them as well as to the rDNA region. This work indicates that there is an important role of transcription of non-coding RNAs for constitutive heterochromatin assembly in the Drosophila embryo, and suggests that Hth plays an important role in this process.	[Angel Zaballos, Miguel; Cantero, Walter; Azpiazu, Natalia] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Azpiazu, N (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera,1 Univ Autonoma Madrid, Madrid, Spain.	nazpiazu@cbm.csic.es	Zaballos, Miguel A/E-7877-2016	Zaballos, Miguel A/0000-0001-8940-6477	Ministerio de Ciencia e Innovacion Fundacion Ramon Areces [BFU2009-12152]	Ministerio de Ciencia e Innovacion Fundacion Ramon Areces	Funding from BFU2009-12152 Ministerio de Ciencia e Innovacion Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JP, 2000, MOL GEN GENET, V264, P371, DOI 10.1007/s004380000331; ABAD JP, 1992, P NATL ACAD SCI USA, V89, P4663, DOI 10.1073/pnas.89.10.4663; Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; Agudo M, 1999, NUCLEIC ACIDS RES, V27, P3318, DOI 10.1093/nar/27.16.3318; Aldaz S, 2005, DEVELOPMENT, V132, P439, DOI 10.1242/dev.01585; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; Azpiazu N, 2002, MECH DEVELOP, V119, P55, DOI 10.1016/S0925-4773(02)00295-2; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Casanova M, 2013, CELL REP, V4, P1156, DOI 10.1016/j.celrep.2013.08.015; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Casares F, 2000, DEVELOPMENT, V127, P1499; Chan SK, 1996, EMBO J, V15, P2476, DOI 10.1002/j.1460-2075.1996.tb00605.x; Corsetti E, 2013, DEV BIOL, V384, P72, DOI 10.1016/j.ydbio.2013.09.018; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Dong PDS, 2002, DEVELOPMENT, V129, P1967; Gonzalez-Crespo S, 1998, NATURE, V394, P196, DOI 10.1038/28197; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Guetg C, 2010, EMBO J, V29, P2135, DOI 10.1038/emboj.2010.17; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurant E, 1998, DEVELOPMENT, V125, P1037; Lamb JC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-214; LOHE AR, 1993, GENETICS, V134, P1149; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Negre N, 2006, METHOD ENZYMOL, V410, P316, DOI 10.1016/S0076-6879(06)10015-4; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; PEIFER M, 1990, GENE DEV, V4, P1209, DOI 10.1101/gad.4.7.1209; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Rauskolb C, 1993, CELL, V91, P171; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Salvany L, 2012, MOL CELL BIOL, V32, P2407, DOI 10.1128/MCB.06311-11; Salvany L, 2009, CELL CYCLE, V8, P2748, DOI 10.4161/cc.8.17.9388; Santoro R, 2010, EMBO REP, V11, P52, DOI 10.1038/embor.2009.254; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Tessarz P, 2014, NATURE, V505, P564, DOI 10.1038/nature12819; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Usakin L, 2007, GENETICS, V176, P1343, DOI 10.1534/genetics.107.071720; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wu J, 1999, DEVELOPMENT, V126, P109; Zhang YP, 2008, DEV CELL, V14, P481, DOI 10.1016/j.devcel.2008.01.018	61	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120662	10.1371/journal.pone.0120662	http://dx.doi.org/10.1371/journal.pone.0120662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794008	Green Published, gold			2022-12-26	WOS:000352083900064
J	Bose, ME; He, J; Shrivastava, S; Nelson, MI; Bera, J; Halpin, RA; Town, CD; Lorenzi, HA; Noyola, DE; Falcone, V; Gerna, G; De Beenhouwer, H; Videla, C; Kok, T; Venter, M; Williams, JV; Henrickson, KJ				Bose, Michael E.; He, Jie; Shrivastava, Susmita; Nelson, Martha I.; Bera, Jayati; Halpin, Rebecca A.; Town, Christopher D.; Lorenzi, Hernan A.; Noyola, Daniel E.; Falcone, Valeria; Gerna, Giuseppe; De Beenhouwer, Hans; Videla, Cristina; Kok, Tuckweng; Venter, Marietjie; Williams, John V.; Henrickson, Kelly J.			Sequencing and Analysis of Globally Obtained Human Respiratory Syncytial Virus A and B Genomes	PLOS ONE			English	Article							G-PROTEIN GENE; GROUP-A; MOLECULAR EPIDEMIOLOGY; HUMAN METAPNEUMOVIRUS; CIRCULATION PATTERNS; GLYCOPROTEIN-G; SUBGROUP-B; VARIABILITY; STRAINS; DIVERSITY	Background Human respiratory syncytial virus (RSV) is the leading cause of respiratory tract infections in children globally, with nearly all children experiencing at least one infection by the age of two. Partial sequencing of the attachment glycoprotein gene is conducted routinely for genotyping, but relatively few whole genome sequences are available for RSV. The goal of our study was to sequence the genomes of RSV strains collected from multiple countries to further understand the global diversity of RSV at a whole-genome level. Methods We collected RSV samples and isolates from Mexico, Argentina, Belgium, Italy, Germany, Australia, South Africa, and the USA from the years 1998-2010. Both Sanger and next-generation sequencing with the Illumina and 454 platforms were used to sequence the whole genomes of RSV A and B. Phylogenetic analyses were performed using the Bayesian and maximum likelihood methods of phylogenetic inference. Results We sequenced the genomes of 34 RSVA and 23 RSVB viruses. Phylogenetic analysis showed that the RSVA genome evolves at an estimated rate of 6.72 x 10(-4) substitutions/site/year (95% HPD 5.61 x 10(-4) to 7.6 x 10(-4)) and for RSVB the evolutionary rate was 7.69 x 10(-4) substitutions/site/year (95% HPD 6.81 x 10(-4) to 8.62 x 10(-4)). We found multiple clades co-circulating globally for both RSV A and B. The predominant clades were GA2 and GA5 for RSVA and BA for RSVB. Conclusions Our analyses showed that RSV circulates on a global scale with the same predominant clades of viruses being found in countries around the world. However, the distribution of clades can change rapidly as new strains emerge. We did not observe a strong spatial structure in our trees, with the same three main clades of RSV co-circulating globally, suggesting that the evolution of RSV is not strongly regionalized.	[Bose, Michael E.; He, Jie; Henrickson, Kelly J.] Med Coll Wisconsin, Midwest Resp Virus Program, Milwaukee, WI 53226 USA; [Shrivastava, Susmita; Bera, Jayati; Halpin, Rebecca A.; Town, Christopher D.; Lorenzi, Hernan A.] J Craig Venter Inst, Rockville, MD USA; [Nelson, Martha I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Noyola, Daniel E.] Univ Autonoma San Luis Potosi, Fac Med, Dept Microbiol, San Luis Potosi, Mexico; [Falcone, Valeria] Univ Med Ctr Freiburg, Dept Virol, Inst Med Microbiol & Hyg, Freiburg, Germany; [Gerna, Giuseppe] Fdn IRCCS Policlin San Matteo, Lab Sperimentali Ric, Pavia, Italy; [De Beenhouwer, Hans] OLV Hosp Aalst, Dept Microbiol, Aalst, Belgium; [Videla, Cristina] Ctr Educ Med & Invest Clin Univ Hosp, Clin Virol Lab, Buenos Aires, DF, Argentina; [Kok, Tuckweng] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Venter, Marietjie] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, ZA-0001 Pretoria, South Africa; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Microbiol, Nashville, TN 37212 USA; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Immunol, Nashville, TN 37212 USA	Medical College of Wisconsin; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Universidad Autonoma de San Luis Potosi; University of Freiburg; IRCCS Fondazione San Matteo; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); University of Adelaide; University of Pretoria; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Henrickson, KJ (corresponding author), Med Coll Wisconsin, Midwest Resp Virus Program, Milwaukee, WI 53226 USA.	khenrick@mcw.edu	Venter, Marietjie/P-9604-2016; Williams, John/ABE-3227-2020; Williams, John/F-6962-2010; Noyola, Daniel/AAL-9773-2020	Venter, Marietjie/0000-0003-2696-824X; Williams, John/0000-0001-8377-5175; Williams, John/0000-0001-8377-5175; Lorenzi, Hernan/0000-0003-0910-7894; Noyola, Daniel/0000-0002-4840-6742; Gerna, Giuseppe/0000-0001-5956-2786; Kok, Tuck-Weng/0000-0003-1924-1261	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C, 5U01AI070428, 5U01AI077988]; Multinational Influenza Seasonal Mortality Study (MISMS); Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077988] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Multinational Influenza Seasonal Mortality Study (MISMS); Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services (www.niaid.nih.gov) under contract number HHSN272200900007C and grant numbers 5U01AI070428 and 5U01AI077988. This work was supported in part by the Multinational Influenza Seasonal Mortality Study (MISMS), led by the Fogarty International Center, National Institutes of Health, with funding from the Department of Health and Human Services (www.fic.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbach E, 2005, VIRUS GENES, V30, P267, DOI 10.1007/s11262-004-5633-2; Almajhdi FN, 2014, ARCH VIROL, V159, P73, DOI 10.1007/s00705-013-1792-6; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Bonroy C, 2007, CLIN MICROBIOL INFEC, V13, P504, DOI 10.1111/j.1469-0691.2007.01682.x; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; Cane PA, 1997, J MED VIROL, V51, P297, DOI 10.1002/(SICI)1096-9071(199704)51:4<297::AID-JMV7>3.0.CO;2-0; Choi EH, 2000, J INFECT DIS, V181, P1547, DOI 10.1086/315468; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Deng J, 1999, CHINESE J PEDIAT, V37, P287; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Faghihloo E, 2011, ACTA VIROL, V55, P81, DOI 10.4149/av_2011_01_81; Faghihloo E, 2014, INFECT GENET EVOL, V22, P130, DOI 10.1016/j.meegid.2014.01.009; Faghihloo E, 2011, IRAN J PEDIATR, V21, P58; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Gan SW, 2012, J BIOL CHEM, V287, P24671, DOI 10.1074/jbc.M111.332791; Gaunt ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017427; Gerna G, 2008, J CLIN VIROL, V41, P49, DOI 10.1016/j.jcv.2007.10.018; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; KOK T, 1994, J VIROL METHODS, V50, P87, DOI 10.1016/0166-0934(94)90166-X; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kuo L, 1997, J VIROL, V71, P4944, DOI 10.1128/JVI.71.7.4944-4953.1997; Li K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-261; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; NORRBY E, 1987, P NATL ACAD SCI USA, V84, P6572, DOI 10.1073/pnas.84.18.6572; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; SCHEPETIUK SK, 1993, J VIROL METHODS, V42, P241, DOI 10.1016/0166-0934(93)90036-Q; SORVILLO FJ, 1984, J INFECTION, V9, P252, DOI 10.1016/S0163-4453(84)90530-9; Sutherland KA, 2001, VIROLOGY, V288, P295, DOI 10.1006/viro.2001.1105; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan L, 2013, J VIROL, V87, P8213, DOI 10.1128/JVI.03278-12; Tan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051439; Treangen Todd J, 2011, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1108s33; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; van Niekerk S, 2011, J VIROL, V85, P8789, DOI 10.1128/JVI.02623-10; Wang SL, 2012, NUCLEIC ACIDS RES, V40, pW186, DOI 10.1093/nar/gks528; Whitehead SS, 1998, VIROLOGY, V247, P232, DOI 10.1006/viro.1998.9248; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004	54	44	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120098	10.1371/journal.pone.0120098	http://dx.doi.org/10.1371/journal.pone.0120098			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793751	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200144
J	Brignell, JL; Perry, MD; Nelson, CP; Willets, JM; Challiss, RAJ; Davies, NW				Brignell, Jennifer L.; Perry, Matthew D.; Nelson, Carl P.; Willets, Jonathon M.; Challiss, R. A. John; Davies, Noel W.			Steady-State Modulation of Voltage-Gated K+ Channels in Rat Arterial Smooth Muscle by Cyclic AMP-Dependent Protein Kinase and Protein Phosphatase 2B	PLOS ONE			English	Article							MEDIATED SIGNAL-TRANSDUCTION; GENE-RELATED PEPTIDE; POTASSIUM CHANNELS; ANCHORING PROTEIN; ATP CHANNELS; PHYSIOLOGICAL ROLES; CELLS; ACTIVATION; CURRENTS; EXPRESSION	Voltage-gated potassium channels (K-v) are important regulators of membrane potential in vascular smooth muscle cells, which is integral to controlling intracellular Ca2+ concentration and regulating vascular tone. Previous work indicates that K-v channels can be modulated by receptor-driven alterations of cyclic AMP-dependent protein kinase (PKA) activity. Here, we demonstrate that K-v channel activity is maintained by tonic activity of PKA. Whole-cell recording was used to assess the effect of manipulating PKA signalling on K-v and ATPdependent K+ channels of rat mesenteric artery smooth muscle cells. Application of PKA inhibitors, KT5720 or H89, caused a significant inhibition of K-v currents. Tonic PKA-mediated activation of K-v appears maximal as application of isoprenaline (a beta-adrenoceptor agonist) or dibutyryl-cAMP failed to enhance K-v currents. We also show that this modulation of K-v by PKA can be reversed by protein phosphatase 2B/calcineurin (PP2B). PKA-dependent inhibition of K-v by KT5720 can be abrogated by pre-treatment with the PP2B inhibitor cyclosporin A, or inclusion of a PP2B auto-inhibitory peptide in the pipette solution. Finally, we demonstrate that tonic PKA-mediated modulation of K-v requires intact caveolae. Pre-treatment of the cells with methyl-beta-cyclodextrin to deplete cellular cholesterol, or adding caveolin-scaffolding domain peptide to the pipette solution to disrupt caveolae-dependent signalling each attenuated PKA-mediated modulation of the K-v current. These findings highlight a novel, caveolae-dependent, tonic modulatory role of PKA on K-v channels providing new insight into mechanisms and the potential for pharmacological manipulation of vascular tone.	[Brignell, Jennifer L.; Perry, Matthew D.; Nelson, Carl P.; Willets, Jonathon M.; Challiss, R. A. John; Davies, Noel W.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Willets, Jonathon M.] Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester, Leics, England	University of Leicester; University of Leicester	Davies, NW (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	nwd@le.ac.uk	Challiss, R.A. John/A-9412-2008; Nelson, Carl/H-6782-2014	Nelson, Carl/0000-0003-1034-140X; Challiss, John/0000-0001-5506-2848	British Heart Foundation [RG06/008/22062]; British Heart Foundation [RG/06/008/22062] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Funding: This study was funded by a British Heart Foundation grant (RG06/008/22062) to JMW, RAJC and NWD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; AIELLO EA, 1995, AM J PHYSIOL-HEART C, V268, pH926, DOI 10.1152/ajpheart.1995.268.2.H926; Aiello EA, 1998, AM J PHYSIOL-HEART C, V275, pH448, DOI 10.1152/ajpheart.1998.275.2.H448; Alto NM, 2004, CELL BIOCHEM BIOPHYS, P201; Barman SA, 2003, AM J PHYSIOL-LUNG C, V284, pL1004, DOI 10.1152/ajplung.00295.2002; Brainard AM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-131; CARR DW, 1992, J BIOL CHEM, V267, P13376; Cheong A, 2002, J VASC RES, V39, P122, DOI 10.1159/000057761; ClementChomienne O, 1996, J PHYSIOL-LONDON, V495, P689, DOI 10.1113/jphysiol.1996.sp021626; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Cox RH, 2005, CELL BIOCHEM BIOPHYS, V42, P167, DOI 10.1385/CBB:42:2:167; DART C, 1993, J PHYSIOL-LONDON, V471, P767, DOI 10.1113/jphysiol.1993.sp019927; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Davies LM, 2010, J PHYSIOL-LONDON, V588, P3254, DOI 10.1113/jphysiol.2010.194779; DOBROWSKY RT, 1993, ADV LIPID RES, V25, P91; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Greenwood IA, 2009, BRIT J PHARMACOL, V156, P1196, DOI 10.1111/j.1476-5381.2009.00131.x; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V536, P421, DOI 10.1111/j.1469-7793.2001.0421c.xd; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; Hayabuchi Y, 2001, AM J PHYSIOL-HEART C, V281, pH2480, DOI 10.1152/ajpheart.2001.281.6.H2480; Ko Eun A., 2008, Journal of Smooth Muscle Research, V44, P65, DOI 10.1540/jsmr.44.65; Ko EA, 2010, PROG BIOPHYS MOL BIO, V103, P95, DOI 10.1016/j.pbiomolbio.2009.10.001; Kyle B, 2011, AM J PHYSIOL-CELL PH, V301, pC1186, DOI 10.1152/ajpcell.00455.2010; Li HW, 2003, AM J PHYSIOL-HEART C, V285, pH1213, DOI 10.1152/ajpheart.00226.2003; Luykenaar KD, 2007, AM J PHYSIOL-HEART C, V292, pH2654, DOI 10.1152/ajpheart.01255.2006; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Mason HS, 2002, MOL PHARMACOL, V61, P285, DOI 10.1124/mol.61.2.285; McEwen DP, 2008, MOL PHARMACOL, V73, P678, DOI 10.1124/mol.107.042093; MIYOSHI H, 1995, BASIC RES CARDIOL, V90, P332, DOI 10.1007/BF00797911; Moore CL, 2014, CIRC RES, V114, P1258, DOI 10.1161/CIRCRESAHA.114.303167; Moral-Sanz J, 2011, AM J PHYSIOL-CELL PH, V301, pC186, DOI 10.1152/ajpcell.00243.2010; Moreno-Dominguez A, 2009, J PHYSIOL-LONDON, V587, P625, DOI 10.1113/jphysiol.2008.165217; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Nelson CP, 2011, CARDIOVASC RES, V91, P694, DOI 10.1093/cvr/cvr137; Nelson CP, 2008, AM J PHYSIOL-CELL PH, V295, pC1590, DOI 10.1152/ajpcell.00365.2008; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Orie NN, 2009, BRIT J PHARMACOL, V157, P554, DOI 10.1111/j.1476-5381.2009.00221.x; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Plane F, 2005, CIRC RES, V96, P216, DOI 10.1161/01.RES.0000154070.06421.25; Purves GI, 2009, J PHYSIOL-LONDON, V587, P3639, DOI 10.1113/jphysiol.2009.173534; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Rainbow RD, 2006, J PHYSIOL-LONDON, V575, P833, DOI 10.1113/jphysiol.2006.114009; Rainbow RD, 2011, BRIT J PHARMACOL, V163, P845, DOI 10.1111/j.1476-5381.2011.01268.x; Rainbow RD, 2009, CARDIOVASC RES, V83, P493, DOI 10.1093/cvr/cvp143; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 1999, J BIOL CHEM, V274, P26353, DOI 10.1074/jbc.274.37.26353; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; Santana LF, 2002, J PHYSIOL-LONDON, V544, P57, DOI 10.1113/jphysiol.2002.020552; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Stott JB, 2014, DRUG DISCOV TODAY, V19, P413, DOI 10.1016/j.drudis.2013.12.003; Turner JD, 2009, CELL CALCIUM, V46, P242, DOI 10.1016/j.ceca.2009.07.006; Wellman GC, 1998, J PHYSIOL-LONDON, V507, P117, DOI 10.1111/j.1469-7793.1998.117bu.x; Wilson AJ, 2000, CIRC RES, V87, P1019, DOI 10.1161/01.RES.87.11.1019; Yang Y, 2007, BIOCHIM BIOPHYS ACTA, V1778, P88	58	7	9	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121285	10.1371/journal.pone.0121285	http://dx.doi.org/10.1371/journal.pone.0121285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793374	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900121
J	Chen, CH; Hsu, CL; Huang, SH; Chen, SY; Hung, YL; Chen, HR; Wu, YC; Su, LJ; Lee, HC				Chen, Chih-Hao; Hsu, Chueh-Lin; Huang, Shih-Hao; Chen, Shih-Yuan; Hung, Yi-Lin; Chen, Hsiao-Rong; Wu, Yu-Chung; Su, Li-Jen; Lee, H. C.			Method Designed to Respect Molecular Heterogeneity Can Profoundly Correct Present Data Interpretations for Genome-Wide Expression Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; SUBSTANTIA-NIGRA; BIPOLAR DISORDER; MICROARRAY ANALYSIS; SCHIZOPHRENIA; DYSREGULATION; UBIQUITIN; CORTEX; PATHOGENESIS; CONSISTENCY	Although genome-wide expression analysis has become a routine tool for gaining insight into molecular mechanisms, extraction of information remains a major challenge. It has been unclear why standard statistical methods, such as the t-test and ANOVA, often lead to low levels of reproducibility, how likely applying fold-change cutoffs to enhance reproducibility is to miss key signals, and how adversely using such methods has affected data interpretations. We broadly examined expression data to investigate the reproducibility problem and discovered that molecular heterogeneity, a biological property of genetically different samples, has been improperly handled by the statistical methods. Here we give a mathematical description of the discovery and report the development of a statistical method, named HTA, for better handling molecular heterogeneity. We broadly demonstrate the improved sensitivity and specificity of HTA over the conventional methods and show that using fold-change cutoffs has lost much information. We illustrate the especial usefulness of HTA for heterogeneous diseases, by applying it to existing data sets of schizophrenia, bipolar disorder and Parkinson's disease, and show it can abundantly and reproducibly uncover disease signatures not previously detectable. Based on 156 biological data sets, we estimate that the methodological issue has affected over 96% of expression studies and that HTA can profoundly correct 86% of the affected data interpretations. The methodological advancement can better facilitate systems understandings of biological processes, render biological inferences that are more reliable than they have hitherto been and engender translational medical applications, such as identifying diagnostic biomarkers and drug prediction, which are more robust.	[Chen, Chih-Hao; Hsu, Chueh-Lin; Huang, Shih-Hao; Chen, Shih-Yuan; Su, Li-Jen; Lee, H. C.] Natl Cent Univ, Inst Syst Biol & Bioinformat, Chungli 32001, Taiwan; [Chen, Chih-Hao] Cathay Gen Hosp, Cathay Med Res Inst, Taipei 10630, Taiwan; [Hung, Yi-Lin] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Chen, Hsiao-Rong] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wu, Yu-Chung] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei 11217, Taiwan; [Wu, Yu-Chung] Natl Yang Ming Univ, Sch Med, Taipei 11221, Taiwan; [Lee, H. C.] Natl Ctr Theoret Sci, Hsinchu 30043, Taiwan; [Lee, H. C.] Natl Cent Univ, Dept Phys, Chungli 32001, Taiwan; [Lee, H. C.] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32001, Taiwan	National Central University; Cathay General Hospital; National Tsing Hua University; Boston University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; National Central University	Chen, CH (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Chungli 32001, Taiwan.	chih_hao_chen@yahoo.com; sulijen@gmail.com; hclee12345@gmail.com			Ministry of Science and Technology (ROC) [98-2627-M-008-004, 99-2911-I-008-100, 100-2911-I-008-001, 101-2320-B-008-001-MY3]; Cathay General Hospital-NCU Collaboration Grants [99CGH-NCU-A3, 101-CGH-NCU-B4]; Landseed Hospital-NCU Collaboration Grant [NCU-LSH-101-A-008]	Ministry of Science and Technology (ROC); Cathay General Hospital-NCU Collaboration Grants; Landseed Hospital-NCU Collaboration Grant	This work is partly supported by Grants 98-2627-M-008-004, 99-2911-I-008-100, 100-2911-I-008-001 and 101-2320-B-008-001-MY3 from the Ministry of Science and Technology (ROC), the Cathay General Hospital-NCU Collaboration Grants 99CGH-NCU-A3 and 101-CGH-NCU-B4, and Landseed Hospital-NCU Collaboration Grant NCU-LSH-101-A-008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blandini F, 2013, J NEUROIMMUNE PHARM, V8, P189, DOI 10.1007/s11481-013-9435-y; Chang SH, 2013, BIOL PSYCHIAT, V74, P727, DOI 10.1016/j.biopsych.2013.04.016; Chen CH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr137; Dracheva S, 2006, NEUROBIOL DIS, V21, P531, DOI 10.1016/j.nbd.2005.08.012; Fortunel NO, 2003, SCIENCE, V302, P393; Frantz S, 2005, NAT REV DRUG DISCOV, V4, P362, DOI 10.1038/nrd1746; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Kobayashi S, 2010, MOL ENDOCRINOL, V24, P2292, DOI 10.1210/me.2010-0289; Lewandowski NM, 2010, P NATL ACAD SCI USA, V107, P16970, DOI 10.1073/pnas.1011751107; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Miklos GLG, 2004, NAT BIOTECHNOL, V22, P615, DOI 10.1038/nbt965; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Miller RM, 2004, J NEUROSCI, V24, P7445, DOI 10.1523/JNEUROSCI.4204-03.2004; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seifuddin F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-213; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763	37	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121154	10.1371/journal.pone.0121154	http://dx.doi.org/10.1371/journal.pone.0121154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793610	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900105
J	Chen, LZ; Li, ZZ; Li, YY; Xue, J; Chen, P; Yan, SP; Jiang, CX; Hu, YY; Qiao, X				Chen, Lizhang; Li, Zhanzhan; Li, Yanyan; Xue, Jing; Chen, Peng; Yan, Shipeng; Jiang, Caixiao; Hu, Yingyun; Qiao, Xing			Red Cell Distribution Width and Inappropriateness of Left Ventricular Mass in Patients with Untreated Essential Hypertension	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; ORGAN DAMAGE; RISK-FACTORS; INFLAMMATION; HYPERTROPHY; MARKER; MICROALBUMINURIA; QUANTITATION	Background Left ventricular hypertrophy (LVH) was suggested to be an important risk factor for hypertensive vascular complications. Previous studies had also shown that red cell distribution width (RDW) was associated with morbidity and mortality of cardiovascular disease. However, few have yet investigated possible association between RDW and LVH. The aim of the present study was to evaluate the relationship between LVH and RDW levels in hypertensive patients. Methods Physical examination, laboratory tests and echocardiography were conducted in 330 untreated newly diagnosed hypertensive patients attending the cardiology consultation unit at the Anzhen Hospital of Beijing. The multivariate logistic regression model was used to verify the independent association between RDW and LVH. Results 174 patients without LVH and 156 patients with LVH were rolled in the study. The patients with LVH had higher mean SBP, albumin to creatinine ratio, total cholesterol, RDW and fasting glucose compared with non-LVH group. The mean HDL-cholesterol level was significantly lower in patients with LVH than patients without LVH. The multiple logistic regression model suggested that patients with a higher RDW level were more likely to be LVH (OR=2.187, 95%CI: 1.447-3.307, P<0.001). Other predictive factors for LVH were mean SBP, serum creatinine, glucose level. The receiver operating characteristics (ROC) curves indicated area under the curve was 0.688(95%CI: 0.635-0.737, P<0.001) with a cut-off value of 12.9, the RDW predicted LVH status among hypertensive patients with a sensitivity of 72.4% and a specificity of 60.3%. Conclusions The higher RDW level was observed in the LVH group compared with the non-LVH group. RDW might be associated with LVH in hypertensive patients. These data highlight the role of RDW as a predictor of organ damage in essential hypertensive patients.	[Chen, Lizhang; Li, Zhanzhan; Xue, Jing; Yan, Shipeng; Jiang, Caixiao] Cent South Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Li, Yanyan] Henan Prov Hosp Tradit Chinese Med, Dept Emergency, Zhengzhou, Henan Province, Peoples R China; [Chen, Peng] Cent South Univ, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Hu, Yingyun] Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Qiao, Xing] Xinjiang Med Univ, Teaching Hosp 1, Dept Plast Surg, Urumqi, Xinjiang Uygur, Peoples R China	Central South University; Central South University; Xinjiang Medical University	Qiao, X (corresponding author), Xinjiang Med Univ, Teaching Hosp 1, Dept Plast Surg, Urumqi, Xinjiang Uygur, Peoples R China.	xingqiaoxj@126.com			Graduate Innovation Project of Hunan Province [CX2014B097]; fundamental research funds for the central universities of central south university [2014zzts069]; Hunan Province Science and Technology Project [2014SK2013]	Graduate Innovation Project of Hunan Province; fundamental research funds for the central universities of central south university; Hunan Province Science and Technology Project	This work was supported by Graduate Innovation Project of Hunan Province (CX2014B097), the fundamental research funds for the central universities of central south university (2014zzts069), and the Hunan Province Science and Technology Project (2014SK2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancey C, 2003, CARDIOVASC RES, V59, P78, DOI 10.1016/S0008-6363(03)00346-8; Assadi FK, 2002, PEDIATR NEPHROL, V17, P107, DOI 10.1007/s00467-001-0762-5; BERSE B, 1992, MOL BIOL CELL, V3, P211, DOI 10.1091/mbc.3.2.211; Cave A, 2005, PHILOS T R SOC B, V360, P2327, DOI 10.1098/rstb.2005.1772; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Demirkol S, 2013, CARDIOL J, V20, P209, DOI 10.5603/CJ.2013.0037; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Fornal M, 2014, CLIN HEMORHEOL MICRO, V56, P325, DOI 10.3233/CH-131745; Furumoto T, 2002, HYPERTENS RES, V25, P475, DOI 10.1291/hypres.25.475; Grandi AM, 2001, AM J HYPERTENS, V14, P644, DOI 10.1016/S0895-7061(01)01305-X; Inanc T, 2010, BLOOD PRESSURE, V19, P81, DOI 10.3109/08037050903516284; Kilicaslan B, 2014, HYPERTENS RES, V37, P560, DOI 10.1038/hr.2014.39; Kohler JJ, 2009, LAB INVEST, V89, P782, DOI 10.1038/labinvest.2009.39; Lappe JM, 2011, CLIN CHIM ACTA, V412, P2094, DOI 10.1016/j.cca.2011.07.018; Leoncini G, 2004, J HUM HYPERTENS, V18, P511, DOI 10.1038/sj.jhh.1001689; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li ZC, 2013, EUR REV MED PHARMACO, V17, P3318; Luo JD, 2002, ACTA PHARMACOL SIN, V23, P124; Macdougall IAC, 2002, NEPHROL DIAL TRANSPL, V17, P48, DOI 10.1093/ndt/17.suppl_1.48; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; Ozcan F, 2013, BLOOD PRESSURE, V22, P80, DOI 10.3109/08037051.2012.707336; Sabri A, 2003, ANTIOXID REDOX SIGN, V5, P731, DOI 10.1089/152308603770380034; Sahin DY, 2013, BLOOD PRESSURE, V22, P329, DOI 10.3109/08037051.2013.778006; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Semba RD, 2010, CLIN NUTR, V29, P600, DOI 10.1016/j.clnu.2010.03.001; Subramaniam A, 2003, BIOCHIM BIOPHYS ACTA, V1835, P46; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Tanindi A, 2012, BLOOD PRESSURE, V21, P177, DOI 10.3109/08037051.2012.645335; Uysal OK, 2012, CARDIOL J, V19, P597, DOI 10.5603/CJ.2012.0111; Vasdev S, 2011, INT J ANGIOL, V20, P189, DOI 10.1055/s-0031-1288941; Wang SX, 2012, CHINESE MED J-PEKING, V125, P21, DOI 10.3760/cma.j.issn.0366-6999.2012.01.005; Zalawadiya SK, 2010, AM J CARDIOL, V106, P988, DOI 10.1016/j.amjcard.2010.06.006; Zhang YH, 2010, J HYPERTENS, V28, P35, DOI 10.1097/HJH.0b013e3283324650	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120300	10.1371/journal.pone.0120300	http://dx.doi.org/10.1371/journal.pone.0120300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793884	gold, Green Submitted, Green Published			2022-12-26	WOS:000352083900009
J	Fox, GA; Cooper, AM; Hayes, WK				Fox, Gerad A.; Cooper, Allen M.; Hayes, William K.			The Dilemma of Choosing a Reference Character for Measuring Sexual Size Dimorphism, Sexual Body Component Dimorphism, and Character Scaling: Cryptic Dimorphism and Allometry in the Scorpion Hadrurus arizonensis	PLOS ONE			English	Article							PARUROCTONUS-MESAENSIS SCORPIONIDA; MESOBUTHUS-GIBBOSUS SCORPIONES; HAIRY DESERT SCORPION; PREY-CAPTURE; STATIC ALLOMETRY; FEEDING-BEHAVIOR; LIFE-HISTORY; EVOLUTION; EUSCORPIUS; SELECTION	Sexual differences in morphology, ranging from subtle to extravagant, occur commonly in many animal species. These differences can encompass overall body size (sexual size dimorphism, SSD) or the size and/or shape of specific body parts (sexual body component dimorphism, SBCD). Interacting forces of natural and sexual selection shape much of the expression of dimorphism we see, though non-adaptive processes may be involved. Differential scaling of individual features can result when selection favors either exaggerated (positive allometry) or reduced (negative allometry) size during growth. Studies of sexual dimorphism and character scaling rely on multivariate models that ideally use an unbiased reference character as an overall measure of body size. We explored several candidate reference characters in a cryptically dimorphic taxon, Hadrurus arizonensis. In this scorpion, essentially every body component among the 16 we examined could be interpreted as dimorphic, but identification of SSD and SBCD depended on which character was used as the reference (prosoma length, prosoma area, total length, principal component 1, or metasoma segment 1 width). Of these characters, discriminant function analysis suggested that metasoma segment 1 width was the most appropriate. The pattern of dimorphism in H. arizonensis mirrored that seen in other more obviously dimorphic scorpions, with static allometry trending towards isometry in most characters. Our findings are consistent with the conclusions of others that fecundity selection likely favors a larger prosoma in female scorpions, whereas sexual selection may favor other body parts being larger in males, especially the metasoma, pectines, and possibly the chela. For this scorpion and probably most other organisms, the choice of reference character profoundly affects interpretations of SSD, SBCD, and allometry. Thus, researchers need to broaden their consideration of anappropriate reference and exercise caution in interpreting findings. We highly recommend use of discriminant function analysis to identify the least-biased reference character.	[Fox, Gerad A.; Cooper, Allen M.; Hayes, William K.] Loma Linda Univ, Sch Med, Dept Earth & Biol Sci, Loma Linda, CA 92354 USA	Loma Linda University	Fox, GA (corresponding author), Loma Linda Univ, Sch Med, Dept Earth & Biol Sci, Loma Linda, CA 92354 USA.	gfox411@gmail.com	Hayes, William/L-1284-2013	Hayes, William/0000-0002-0903-0519	Department of Earth and Biological Sciences at Loma Linda University	Department of Earth and Biological Sciences at Loma Linda University	The authors are grateful toward the Department of Earth and Biological Sciences at Loma Linda University for laboratory space and funding of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abushama F. T., 1968, Revue de Zoologie et de Botanique Africaines, V77, P37; Aisenberg A, 2010, J NAT HIST, V44, P1189, DOI 10.1080/00222931003632716; ALEXANDER ANNE J., 1957, PROC ZOOL SOC LONDON, V128, P529; ALLRED D M, 1973, Great Basin Naturalist, V33, P251; Andersson Malte, 1994; Benton T, 2001, SCORPION BIOLOGY AND RESEARCH, P278; BENTON TG, 1992, ANIM BEHAV, V43, P125, DOI 10.1016/S0003-3472(05)80078-8; BENTON TG, 1991, J ARACHNOL, V19, P105; Bidau Claudio J., 2013, Journal of Insect Biodiversity, V1, P1; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; BOOKSTEIN FL, 1989, SYST ZOOL, V38, P173, DOI 10.2307/2992387; Booncham U, 2007, NU SCI J, V4, P42; Brana F, 1996, OIKOS, V75, P511, DOI 10.2307/3545893; Brown CA, 2004, J ARACHNOL, V32, P193, DOI 10.1636/M02-56; Brown Christopher A., 2001, P307; BUB K, 1979, J ARACHNOL, V7, P243; Carlson BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097648; Carrera PC, 2009, ZOOLOGY, V112, P332, DOI 10.1016/j.zool.2009.01.002; CASPER GS, 1985, J ARACHNOL, V13, P277; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colgoni A, 2006, ENTOMOL SCI, V9, P171, DOI 10.1111/j.1479-8298.2006.00164.x; Cothran RD, 2010, EVOLUTION, V64, P2535, DOI 10.1111/j.1558-5646.2010.00998.x; Cox RM, 2003, EVOLUTION, V57, P1653, DOI 10.1554/02-227; Cox RM, 2010, EVOLUTION, V64, P798, DOI 10.1111/j.1558-5646.2009.00851.x; Cuervo JJ, 2009, J EVOLUTION BIOL, V22, P1503, DOI 10.1111/j.1420-9101.2009.01758.x; Darwin C., 1871, P423; Darwin C, 1859, ORIGIN SPECIES MEANS, DOI [10.1007/s12064-009-0058-z, DOI 10.1007/S12064-009-0058-Z]; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Eberhard WG, 2002, CAN ENTOMOL, V134, P667, DOI 10.4039/Ent134667-5; Edmunds MC, 2010, J ARACHNOL, V38, P123, DOI 10.1636/Hi09-38.1; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; FAIRBAIRN DJ, 1990, AM NAT, V136, P61, DOI 10.1086/285082; Falster D., SMATR STANDARDISED M; Fet Victor, 2013, Revista Iberica de Aracnologia, V23, P3; Fet Victor, 2013, Euscorpius, V165, P1; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Foelix RF, 1996, BIOL SPIDERS; FORMANOWICZ DR, 1993, OECOLOGIA, V94, P368, DOI 10.1007/BF00317111; FRANCKE O F, 1981, Southwestern Naturalist, V25, P517, DOI 10.2307/3670851; FRANCKE OF, 1982, J ARACHNOL, V10, P223; FRANCKE OF, 1984, J ARACHNOL, V12, P1; Gaffin DD, 1997, J COMP PHYSIOL A, V181, P291, DOI 10.1007/s003590050115; GAFFIN DD, 1992, ETHOLOGY, V91, P59; Gosnell JS, 2009, HERPETOLOGICA, V65, P70, DOI 10.1655/07-057R2.1; Graham MR, 2012, J ARACHNOL, V40, P281, DOI 10.1636/Ha11-78.1; Graham MR, 2010, J ARACHNOL, V38, P285, DOI 10.1636/Ha09-90.1; Green AJ, 2000, J AVIAN BIOL, V31, P345, DOI 10.1034/j.1600-048X.2000.310310.x; GREEN AJ, 1992, ANIM BEHAV, V43, P170, DOI 10.1016/S0003-3472(05)80086-7; HAGSTRUM DW, 1971, ANN ENTOMOL SOC AM, V64, P757, DOI 10.1093/aesa/64.4.757; Hayek LAC, 2005, AN ACAD BRAS CIENC, V77, P45, DOI 10.1590/S0001-37652005000100005; HEATWOLE H, 1967, Caribbean Journal of Science, V7, P15; Hidalgo JR, 2012, RES J COSTA RICAN DI, V4, P157; JACKSON DA, 1991, OECOLOGIA, V86, P147, DOI 10.1007/BF00317404; Jiao G, 2009, EUSCORPIUS, V84, P1, DOI [10.18590/euscorpius.2009.vol2009.iss84.1, DOI 10.18590/EUSCORPIUS.2009.VOL2009.ISS84.1]; Jiao Guo-Bin, 2009, Euscorpius, V80, P1; Kaltsas D, 2008, J NAT HIST, V42, P513, DOI 10.1080/00222930701835498; Kaltsas D, 2010, J NAT HIST, V44, P1445, DOI 10.1080/00222931003632732; Kladt N, 2007, J COMP PHYSIOL A, V193, P1033, DOI 10.1007/s00359-007-0254-6; Koch L.E., 1977, Records W Aust Mus, V5, P83; Kovarik Frantisek, 2013, Euscorpius, V178, P1; Kovarik Frantisek, 2013, Euscorpius, V168, P1; Kovarik Frantisek, 2012, Euscorpius, V150, P1; Stathi Iasmi, 2010, Euscorpius, V101, P1; Kovarik Frantisek, 2007, Euscorpius, V54, P1; Kratochvil L, 2003, CAN J ZOOL, V81, P1112, DOI 10.1139/Z03-078; Lourenco WR, 2010, ZOOKEYS, P13, DOI 10.3897/zookeys.37.369; Lourenco WR, 1996, J BIOGEOGR, V23, P681, DOI 10.1111/j.1365-2699.1996.tb00028.x; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; MCMAHON TA, 1975, AM NAT, V109, P547, DOI 10.1086/283026; Melville JM, 2003, J INSECT BEHAV, V16, P97, DOI 10.1023/A:1022853413104; Melville JM, 2000, THESIS OREGON STATE; Mertler C.A., 2021, ADV MULTIVARIATE STA; Miller AL, 2011, J ETHOL, V29, P251, DOI 10.1007/s10164-010-0250-0; Mineo MF, 2006, ACTA ETHOL, V9, P79, DOI 10.1007/s10211-006-0021-7; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nisani Z, 2011, ANIM BEHAV, V81, P627, DOI 10.1016/j.anbehav.2010.12.010; Okada K, 2009, ANIM BEHAV, V77, P1057, DOI 10.1016/j.anbehav.2009.01.008; Outeda-Jorge S, 2009, ZOOLOGIA-CURITIBA, V26, P43, DOI 10.1590/S1984-46702009000100008; Outomuro D, 2014, ECOL ENTOMOL, V39, P399, DOI 10.1111/een.12098; Packard GC, 1999, COMP BIOCHEM PHYS A, V122, P37, DOI 10.1016/S1095-6433(98)10170-8; Painting CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082467; Pelabon C, 2014, ANN NY ACAD SCI, V1320, P58, DOI 10.1111/nyas.12470; Pelabon C, 2013, AM NAT, V181, P195, DOI 10.1086/668820; Peretti Alfredo V., 2001, P331; Peretti Alfredo Vicente, 1997, Revue Arachnologique, V12, P31; PETRIE M, 1992, ANIM BEHAV, V43, P173, DOI 10.1016/S0003-3472(05)80087-9; Polis G.A., 1990, P161; POLIS GA, 1985, OECOLOGIA, V67, P273, DOI 10.1007/BF00384298; POLIS GA, 1979, J ARACHNOL, V7, P33; POLIS GA, 1979, J ZOOL, V187, P517; PRENTER J, 1995, BIOL J LINN SOC, V55, P345, DOI 10.1111/j.1095-8312.1995.tb01070.x; QUINLAN TG, 1995, J AUST ENTOMOL SOC, V34, P277; Quiroga M., 2004, J. Venom. Anim. Toxins incl. Trop. Dis, V10, P10, DOI 10.1590/S1678-91992004000100003; Ravosa MJ, 2000, AM J PHYS ANTHROPOL, V112, P493, DOI 10.1002/1096-8644(200008)112:4<493::AID-AJPA6>3.0.CO;2-P; Sanchez-Quiros C, 2012, J ARACHNOL, V40, P338, DOI 10.1636/B12-14.1; Santos AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063616; Sarhan Moustafa M.H., 2013, Serket, V13, P201; Scharf I, 2013, BIOL J LINN SOC, V110, P665, DOI 10.1111/bij.12147; Schulte-Hostedde AI, 2011, J EVOLUTION BIOL, V24, P1154, DOI 10.1111/j.1420-9101.2011.02256.x; Shingleton AW, 2013, BIOESSAYS, V35, P100, DOI 10.1002/bies.201200139; Simmons L. W., 2001, MG BEH ECOL; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Soleglad Michael E., 2004, Revista Iberica de Aracnologia, V10, P81; STAHNKE H L, 1969, Entomological News, V80, P57; Stahnke H. L., 1945, American Museum Novitates, VNo. 1298, P1; STAHNKE H L, 1971, Entomological News, V82, P121; STAHNKE H L, 1970, Entomological News, V81, P297; STAHNKE HL, 1972, BIOSCIENCE, V22, P604, DOI 10.2307/1296207; Steinmetz Steffany B., 2004, Euscorpius, V12-17, P1; Stillwell RC, 2007, OECOLOGIA, V153, P273, DOI 10.1007/s00442-007-0724-0; Suter RB, 2011, J ARACHNOL, V39, P174, DOI 10.1636/B10-10.1; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tallarovic S., 2000, THESIS OREGON STATE; Tallarovic SK, 2000, J INSECT BEHAV, V13, P827, DOI 10.1023/A:1007858400402; Taylor MS, 2012, J ARACHNOL, V40, P240, DOI 10.1636/Hi11-75.1; Teruel Rolando, 2013, Euscorpius, V177, P1; Teruel Rolando, 2008, Euscorpius, V68, P1; Tomkins JL, 1996, J EVOLUTION BIOL, V9, P753, DOI 10.1046/j.1420-9101.1996.9060753.x; Toscano-Gadea CA, 2010, J ARACHNOL, V38, P360, DOI 10.1636/Hi09-31.1; TOURTLOTTE G I, 1974, Great Basin Naturalist, V34, P167; Tropea Gioele, 2013, Euscorpius, V169, P1; van der Meijden A, 2010, J ZOOL, V280, P319, DOI 10.1111/j.1469-7998.2009.00628.x; van der Meijden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078955; van der Meijden A, 2012, J ANAT, V220, P423, DOI 10.1111/j.1469-7580.2012.01485.x; Voje KL, 2013, EVOLUTION, V67, P453, DOI 10.1111/j.1558-5646.2012.01777.x; VONBERTALANFFY L, 1952, EVOLUTION, V6, P387, DOI 10.1111/j.1558-5646.1952.tb01438.x; Walker SE, 2008, CAN J ZOOL, V86, P253, DOI 10.1139/Z08-001; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Williams S. C., 1970, Occ. Pap. Calif. Acad. Sci., VNo. 87, P1; Williams SC, 1966, P CALIF ACAD SCI, V34, P419; Zelditch ML, 2004, GEOMETRIC MORPHOMETR	134	15	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120392	10.1371/journal.pone.0120392	http://dx.doi.org/10.1371/journal.pone.0120392			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793523	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900023
J	Li, MH; Holmes, V; Ni, HP; Sanzari, JK; Romero-Weaver, AL; Lin, LY; Carabe-Fernandez, A; Diffenderfer, ES; Kennedy, AR; Weissman, D				Li, Minghong; Holmes, Veronica; Ni, Houping; Sanzari, Jenine K.; Romero-Weaver, Ana L.; Lin, Liyong; Carabe-Fernandez, Alejandro; Diffenderfer, Eric S.; Kennedy, Ann R.; Weissman, Drew			Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight	PLOS ONE			English	Article							HINDLIMB-UNLOADING MODEL; INDUCED OXIDATIVE STRESS; SOLAR PARTICLE EVENTS; SPACE-FLIGHT; IMMUNE FUNCTION; GENE-EXPRESSION; RODENT MODEL; IN-VITRO; RADIATION; MICE	A major risk for astronauts during prolonged space flight is infection as a result of the combined effects of microgravity, situational and confinement stress, alterations in food intake, altered circadian rhythm, and radiation that can significantly impair the immune system and the body's defense systems. We previously reported a massive increase in morbidity with a decrease in the ability to control a bacterial challenge when mice were maintained under hindlimb suspension (HS) conditions and exposed to solar particle event (SPE)-like radiation. HS and SPE-like radiation treatment alone resulted in a borderline significant increase in morbidity. Therefore, development and testing of countermeasures that can be used during extended space missions in the setting of exposure to SPE radiation becomes a serious need. In the present study, we investigated the efficacy of enrofloxacin (an orally bioavailable antibiotic) and Granulocyte colony stimulating factor (G-CSF) (Neulasta) on enhancing resistance to Pseudomonas aeruginosa infection in mice subjected to HS and SPE-like radiation. The results revealed that treatment with enrofloxacin or G-CSF enhanced bacterial clearance and significantly decreased morbidity and mortality in challenged mice exposed to suspension and radiation. These results establish that antibiotics, such as enrofloxacin, and G-CSF could be effective countermeasures to decrease the risk of bacterial infections after exposure to SPE radiation during extended space flight, thereby reducing both the risk to the crew and the danger of mission failure.	[Li, Minghong; Holmes, Veronica; Ni, Houping; Weissman, Drew] Univ Penn, Perelman Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Sanzari, Jenine K.; Romero-Weaver, Ana L.; Lin, Liyong; Carabe-Fernandez, Alejandro; Diffenderfer, Eric S.; Kennedy, Ann R.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Weissman, D (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Infect Dis, 3610 Hamilton Walk, Philadelphia, PA 19104 USA.	dreww@mail.med.upenn.edu	Lin, Liyong/I-1195-2019; Carabe Fernandez, Alejandro/J-8719-2012	Lin, Liyong/0000-0002-0820-8063; Carabe Fernandez, Alejandro/0000-0002-1378-3337	National Space Biomedical Research Institute (NSBRI)-Center of Acute Radiation Research (CARR) grant; NIH [2T32CA009677]; NASA [NCC 9-58]; NATIONAL CANCER INSTITUTE [T32CA009677] Funding Source: NIH RePORTER	National Space Biomedical Research Institute (NSBRI)-Center of Acute Radiation Research (CARR) grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Space Biomedical Research Institute (NSBRI)-Center of Acute Radiation Research (CARR) grant and NIH Training Grant 2T32CA009677 to ALRW. The NSBRI is funded through NASA NCC 9-58. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alali WQ, 2008, APPL ENVIRON MICROB, V74, P3672, DOI 10.1128/AEM.02624-07; Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007; ARMSTRONG JW, 1993, J APPL PHYSIOL, V75, P2734, DOI 10.1152/jappl.1993.75.6.2734; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2004, J APPL PHYSIOL, V97, P1437, DOI 10.1152/japplphysiol.00259.2004; Aviles H, 2003, J APPL PHYSIOL, V95, P491, DOI 10.1152/japplphysiol.00259.2003; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Aviles Hernan, 2006, Surg Infect (Larchmt), V7, P527, DOI 10.1089/sur.2006.7.527; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Cena H, 2003, EUR J NUTR, V42, P99, DOI 10.1007/s00394-003-0392-8; Cermakian N, 2013, CHRONOBIOL INT, V30, P870, DOI 10.3109/07420528.2013.782315; CHOI KH, 1994, J ANTIMICROB CHEMOTH, V33, P1233, DOI 10.1093/jac/33.6.1233; Crucian B, 2009, RISK OF CREW ADVERSE; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; Fischer JC, 2011, TRANSFUSION, V51, P1431, DOI 10.1111/j.1537-2995.2010.02998.x; FLEMING SD, 1990, AVIAT SPACE ENVIR MD, V61, P327; Goud SR, 1999, TOXICOLOGY, V135, P69, DOI 10.1016/S0300-483X(99)00037-2; Gridley DS, 2008, IN VIVO, V22, P159; Gridley DS, 2006, IN VIVO, V20, P781; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hamilton-Miller JMT, 2000, J ANTIMICROB CHEMOTH, V46, P852, DOI 10.1093/jac/46.5.852; Hu SW, 2009, HEALTH PHYS, V96, P465, DOI 10.1097/01.HP.0000339020.92837.61; Kantemiris I, 2011, MED PHYS, V38, P6585, DOI 10.1118/1.3662911; Kaur I, 2004, BRAIN BEHAV IMMUN, V18, P443, DOI 10.1016/j.bbi.2003.10.005; Kennedy AR, 2007, RADIAT ENVIRON BIOPH, V46, P201, DOI 10.1007/s00411-007-0105-4; Kim MHY, 2009, HEALTH PHYS, V97, P68, DOI 10.1097/01.HP.0000346799.65001.9c; Kita M, 2004, J GRAVIT PHYSL, V11, pP67; Klaus DM, 2006, TRENDS BIOTECHNOL, V24, P131, DOI 10.1016/j.tibtech.2006.01.008; Lee EH, 2005, AVIAT SPACE ENVIR MD, V76, P536; Levine DS, 1998, AVIAT SPACE ENVIR MD, V69, P172; Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085665; Maks CJ, 2011, RADIAT RES, V176, P170, DOI 10.1667/RR2413.1; Matsui Y, 2002, J HEPATOL, V37, P78, DOI 10.1016/S0168-8278(02)00091-0; Mavroudis PD, 2013, J INNATE IMMUN, V5, P153, DOI 10.1159/000342427; MEEHAN R, 1993, J LEUKOCYTE BIOL, V54, P236, DOI 10.1002/jlb.54.3.236; Mehta SK, 2000, J INFECT DIS, V182, P1761, DOI 10.1086/317624; Mehta SK, 2004, J MED VIROL, V72, P174, DOI 10.1002/jmv.10555; Mermel LA, 2013, CLIN INFECT DIS, V56, P123, DOI 10.1093/cid/cis861; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Musacchia X J, 1985, Physiologist, V28, pS237; NASH PV, 1991, EXP CELL RES, V195, P353, DOI 10.1016/0014-4827(91)90384-7; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Novikova N, 2006, RES MICROBIOL, V157, P5, DOI 10.1016/j.resmic.2005.07.010; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Romero-Weaver AL, 2013, RADIAT RES, V180, P177, DOI 10.1667/RR3055.1; Romero-Weaver AL, 2013, ASTROBIOLOGY, V13, P570, DOI 10.1089/ast.2012.0916; Romero-Weaver Ana L, 2012, Int J Biomed Sci, V8, P7; Sanzari JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071757; Sastry KJ, 2001, IN VITRO CELL DEV-AN, V37, P203; Satomi M, 2006, INT J SYST EVOL MICR, V56, P1735, DOI 10.1099/ijs.0.64189-0; Secher T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073396; Shearer WT, 2005, J ALLERGY CLIN IMMUN, V115, P1297, DOI 10.1016/j.jaci.2005.03.003; Song B, 2005, MICROBIOL RES, V160, P111, DOI 10.1016/j.micres.2004.10.005; Sonnenfeld G, 1999, ADV SPACE RES, V23, P1945, DOI 10.1016/S0273-1177(99)00455-X; Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6; STEFFEN JM, 1986, AVIAT SPACE ENVIR MD, V57, P162; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; TAYLOR GR, 1974, AEROSPACE MED, V45, P824; Vieira A, 2012, EUR J CLIN MICROBIOL, V31, P3241, DOI 10.1007/s10096-012-1691-x; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; Walker Clare, 2006, Curr Protoc Cytom, VChapter 6, DOI 10.1002/0471142956.cy0624s36; Wan XS, 2006, INT J RADIAT ONCOL, V64, P1475, DOI 10.1016/j.ijrobp.2005.11.024; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Ware JH, 2010, RADIAT RES, V174, P325, DOI 10.1667/RR1979.1; Yamauchi K, 2002, J APPL PHYSIOL, V93, P161, DOI 10.1152/japplphysiol.01084.2001	70	9	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120126	10.1371/journal.pone.0120126	http://dx.doi.org/10.1371/journal.pone.0120126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793272	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200149
J	Trissal, MC; DeMoya, RA; Schmidt, AP; Link, DC				Trissal, Maria C.; DeMoya, Ricardo A.; Schmidt, Amy P.; Link, Daniel C.			MicroRNA-223 Regulates Granulopoiesis but Is Not Required for HSC Maintenance in Mice	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM; SELF-RENEWAL; EXPRESSION; HIERARCHY	MIR233 is genetically or epigenetically silenced in a subset of acute myeloid leukemia (AML). MIR223 is normally expressed throughout myeloid differentiation and highly expressed in hematopoietic stem cells (HSCs). However, the contribution of MIR223 loss to leukemic transformation and HSC function is largely unknown. Herein, we characterize HSC function and myeloid differentiation in Mir223 deficient mice. We show that Mir223 loss results in a modest expansion of myeloid progenitors, but is not sufficient to induce a myeloproliferative disorder. Loss of Mir223 had no discernible effect on HSC quiescence, long-term repopulating activity, or self-renewal capacity. These results suggest that MIR223 loss is likely not an initiating event in AML but may cooperate with other AML associated oncogenes to induce leukemogenesis.	[Trissal, Maria C.; DeMoya, Ricardo A.; Schmidt, Amy P.; Link, Daniel C.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA	Washington University (WUSTL)	Link, DC (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	dlink@dom.wustl.edu			Translational Research Program Award from the Leukemia & Lymphoma Society; National Institute of Health [PO1-CA101937, T32-HL7088-37]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059244] Funding Source: NIH RePORTER	Translational Research Program Award from the Leukemia & Lymphoma Society; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Translational Research Program Award from the Leukemia & Lymphoma Society (DCL) and by the National Institute of Health grants PO1-CA101937 (DCL) and T32-HL7088-37 (MCT).	Bailey E, 2013, P NATL ACAD SCI USA, V110, P21113, DOI 10.1073/pnas.1310559110; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chu SHH, 2012, CELL STEM CELL, V11, P346, DOI 10.1016/j.stem.2012.05.027; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kent DG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001576; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Petriv OI, 2010, P NATL ACAD SCI USA, V107, P15443, DOI 10.1073/pnas.1009320107; Ramsingh G, 2013, BLOOD, V122, pE44, DOI 10.1182/blood-2013-03-488007; Richards MK, 2003, BLOOD, V102, P3562, DOI 10.1182/blood-2003-02-0593; Schuettpelz LG, 2014, LEUKEMIA, V28, P1851, DOI 10.1038/leu.2014.68; Schuettpelz LG, 2012, BLOOD, V120, P2981, DOI 10.1182/blood-2012-02-409839; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhou KS, 2012, LEUKEMIA LYMPHOMA, V53, P1155, DOI 10.3109/10428194.2011.642303	17	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119304	10.1371/journal.pone.0119304	http://dx.doi.org/10.1371/journal.pone.0119304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793640	Green Submitted, gold, Green Published			2022-12-26	WOS:000352084200071
J	Zhou, JY; Yu, XM; Wang, J; Li, T; Jin, T; Lei, DP; Pan, XL				Zhou, Jieyu; Yu, Xuemin; Wang, Juan; Li, Tao; Jin, Tong; Lei, Dapeng; Pan, Xinliang			Aberrant Expression of PHLPP1 and PHLPP2 Correlates with Poor Prognosis in Patients with Hypopharyngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; SIGNALING PATHWAY; AKT; PHOSPHATASE; PROTEIN; CANCER; DEPHOSPHORYLATES; METASTASIS; ACTIVATION; GROWTH	The PHLPP (pleckstrin homology [PH] domain leucine rich repeat protein phosphatase) family, which represents a family of novel Ser/Thr protein phosphatases, is composed of 2 members: PHLPP1 and PHLPP2. PHLPPs partake in diverse cellular activities to exhibit their antitumor and metastasis suppressor functions. It is necessary to investigate the expression patterns of PHLPP1 and PHLPP2 in hypopharyngeal squamous cell carcinomas (HSCCs) and clarify their clinical significance. A total of 138 patients with primary HSCC who underwent curative surgical treatment as an initial treatment were enrolled in this study. A total of 138 HSCC specimens and 64 adjacent noncancerousmucosal epithelial tissues were collected. The expression levels of PHLPP1 and PHLPP2 were examined by quantitative reverse transcription polymerase chain reaction and immunohistochemistry assays. Correlations between clinicopathological parameters of the patients were further evaluated. PHLPP1 and PHLPP2mRNA transcript levels were significantly lower in tumor samples than in paired adjacent nontumor mucosae (P< 0.0001, both). Positive correlations were observed between the mRNA levels of PHLPP1 and PHLPP2 in HSCC tissues (correlation coefficient r = 0.678, P< 0.001) and in adjacent nontumormucosae (r = 0.460, P< 0.001). The majority of the non-cancerous tissues showed high expression levels of PHLPP1 (87.5%, 56/64) and PHLPP2 (85.9%, 55/64). However, the expressions of PHLPP1 and PHLPP2 were significantly decreased in 83.3%(115/138) and 82.6%(114/138) of tumor tissues, respectively (P< 0.0001, both). The expressions of both PHLPP isoforms were significantly related to the tumor clinical stage, differentiation, and cervical lymph node metastasis (P< 0.05, all). It was PHLPP1 but not PHLPP2 that was significantly related to the tumor T stage. Low PHLPP1 and PHLPP2 expressions were associated with poor overall survival (OS) in HSCC patients (P = 0.004, P = 0.008, respectively). Multivariate analysis revealed that PHLPP1 was an independent prognostic factor for OS. This study indicates that, in HSCC, aberrant expressions of PHLPP1 and PHLPP2 are common events, and loss of PHLPPs might identify patients with poor prognostic outcomes.	[Zhou, Jieyu; Yu, Xuemin; Wang, Juan; Li, Tao; Jin, Tong; Lei, Dapeng; Pan, Xinliang] Shandong Univ, Qilu Hosp, Dept Otorhinolaryngol, Jinan 250100, Shandong, Peoples R China	Shandong University	Pan, XL (corresponding author), Shandong Univ, Qilu Hosp, Dept Otorhinolaryngol, Jinan 250100, Shandong, Peoples R China.	panxinl915@126.com			Shandong Provincial Natural Science Foundation, China [ZR2013HM107]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This work was supported by Shandong Provincial Natural Science Foundation, China (No. #ZR2013HM107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gupta T, 2009, ACTA ONCOL, V48, P541, DOI 10.1080/02841860802488839; Hall SF, 2008, LARYNGOSCOPE, V118, P1362, DOI 10.1097/MLG.0b013e318173dc4a; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lei DP, 2010, CARCINOGENESIS, V31, P222, DOI 10.1093/carcin/bgp279; Li X, 2013, ONCOGENE, V32, P471, DOI 10.1038/onc.2012.66; Liao WT, 2013, CLIN CANCER RES, V19, P4662, DOI 10.1158/1078-0432.CCR-13-0244; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Liu J, 2011, ASIAN PAC J CANCER P, V12, P2653; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; O'Neill AK, 2013, FEBS J, V280, P572, DOI 10.1111/j.1742-4658.2012.08537.x; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Patael-Karasik Y, 2000, CANCER GENET CYTOGEN, V121, P26, DOI 10.1016/S0165-4608(00)00224-7; Pattje WJ, 2010, BRIT J CANCER, V102, P1778, DOI 10.1038/sj.bjc.6605707; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Rakha EA, 2006, GENE CHROMOSOME CANC, V45, P527, DOI 10.1002/gcc.20318; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang JR, 2013, NONLINEAR ANAL-HYBRI, V8, P1, DOI 10.1016/j.nahs.2012.08.003; Wang ZX, 2013, J SURG ONCOL, V108, P427, DOI 10.1002/jso.23419; Wycliffe Nathaniel D, 2007, Top Magn Reson Imaging, V18, P243, DOI 10.1097/RMR.0b013e3181570c3f; Yu XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066975; Zhao XN, 2011, ASIAN PAC J CANCER P, V12, P397	38	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119405	10.1371/journal.pone.0119405	http://dx.doi.org/10.1371/journal.pone.0119405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793736	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200081
J	Chitra, S; Kumaratharan, N				Chitra, S.; Kumaratharan, N.			Intercarrier Interference Reduction in MC-CDMA System through Second Order Duobinary Coded Phase Rotated Conjugate Cancellation Scheme	PLOS ONE			English	Article							ICI REDUCTION; OFDM; TRANSMISSION; MITIGATION	Multi-carrier code division multiple access (MC-CDMA) technique is one of the strong candidates for next generation wireless mobile communication systems. Multi-carrier systems are very much sensitive to carrier frequency offset (CFO) results in intercarrier interference (ICI). To mitigate ICI without any spectral loss, a second order duobinary coded phase rotated conjugate cancellation algorithm is proposed in this paper. In the conventional phase rotated conjugate cancellation (PRCC) technique, one path carries the MC-CDMA signal with a phase spin of phi and the other path carries the conjugate of the first path signal with -phi phase spin. This artificial phase rotation allows the transmitter to tune the transmitted signals so that the ICI effects could be mutually cancelled at the receiver. Although the PRCC technique reduces the spectral efficiency, the limitation can be overcome by the joint second order duobinary coding scheme with PRCC technique. In the proposed method, the correlative coding between the binary symbols modulated on adjacent subcarriers is used to reduce the ICI without any spectral loss. Simulation results show that the proposed PRCC method provides better carrier to interference ratio (CIR) and bit error rate (BER) performances compared to the conventional conjugate cancellation (CC) technique.	[Chitra, S.] Rajalakshmi Engn Coll, Dept Elect & Commun Engn, Madras, Tamil Nadu, India; [Kumaratharan, N.] Sri Venkateswara Coll Engn, Dept Informat Technol, Madras, Tamil Nadu, India	Rajalakshmi Engineering College	Chitra, S (corresponding author), Rajalakshmi Engn Coll, Dept Elect & Commun Engn, Madras, Tamil Nadu, India.	chitraece80@gmail.com	Chitra, S./AAA-8906-2019; S, CHITRA/AAB-6253-2019; N, KUMARATHARAN/S-1774-2019	S, CHITRA/0000-0002-9161-5857; N, KUMARATHARAN/0000-0002-0097-3385				Dwivedi VK, 2012, IET COMMUN, V6, P599, DOI 10.1049/iet-com.2010.0870; Dwivedi VK, 2009, J INFRARED MILLIM TE, V30, P1170, DOI 10.1007/s10762-009-9543-1; Entesargemeay MK, 2011, INT J COMPUT ELECT E, V3, P130; Fazel K, 2008, MULTICARRIER SPREAD, P151; Hara S, 1997, IEEE COMMUN MAG, V35, P126, DOI 10.1109/35.642841; Khedr ME, 2010, INT CONF ADV COMMUN, P859; Lin KY, 2012, IEEE T BROADCAST, V58, P472, DOI 10.1109/TBC.2012.2197450; Mohseni S, 2012, INT J COMPUT SCI NET, V12, P472, DOI DOI 10.1109/90.87934318; Morelli M, 2014, IEEE T WIREL COMMUN, V13, P1582, DOI 10.1109/TWC.2014.011714.131271; Sanguinetti L, 2009, IEEE T WIREL COMMUN, V8, P5461, DOI 10.1109/TWC.2009.090236; Steendam H, 2001, IEEE J SEL AREA COMM, V19, P2528, DOI 10.1109/49.974617; Wang CL, 2010, IEEE T COMMUN, V58, P812, DOI 10.1109/TCOMM.2010.03.080288; Wen MW, 2014, IEEE T VEH TECHNOL, V63, P987, DOI 10.1109/TVT.2013.2277575; Yeh HG, 2007, IEEE T WIREL COMMUN, V6, P3, DOI 10.1109/TWC.2007.04541; Zhao YP, 2001, IEEE T COMMUN, V49, P1185, DOI 10.1109/26.935159	15	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116326	10.1371/journal.pone.0116326	http://dx.doi.org/10.1371/journal.pone.0116326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790029	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400014
J	Davis, NE; Forsyth, DM; Triggs, B; Pascoe, C; Benshemesh, J; Robley, A; Lawrence, J; Ritchie, EG; Nimmo, DG; Lumsden, LF				Davis, Naomi E.; Forsyth, David M.; Triggs, Barbara; Pascoe, Charlie; Benshemesh, Joe; Robley, Alan; Lawrence, Jenny; Ritchie, Euan G.; Nimmo, Dale G.; Lumsden, Lindy F.			Interspecific and Geographic Variation in the Diets of Sympatric Carnivores: Dingoes/Wild Dogs and Red Foxes in South-Eastern Australia	PLOS ONE			English	Article							CANIS-LUPUS-DINGO; FLUCTUATING PREY POPULATIONS; VULPES-VULPES; WESTERN-AUSTRALIA; WILD DOGS; FEEDING ECOLOGY; GREY KANGAROOS; ARID AUSTRALIA; TOP-PREDATOR; BIODIVERSITY CONSERVATION	Dingoes/wild dogs (Canis dingo/familiaris) and red foxes (Vulpes vulpes) are widespread carnivores in southern Australia and are controlled to reduce predation on domestic livestock and native fauna. We used the occurrence of food items in 5875 dingo/wild dog scats and 11,569 fox scats to evaluate interspecific and geographic differences in the diets of these species within nine regions of Victoria, south-eastern Australia. The nine regions encompass a wide variety of ecosystems. Diet overlap between dingoes/wild dogs and foxes varied among regions, from low to near complete overlap. The diet of foxes was broader than dingoes/wild dogs in all but three regions, with the former usually containing more insects, reptiles and plant material. By contrast, dingoes/wild dogs more regularly consumed larger mammals, supporting the hypothesis that niche partitioning occurs on the basis of mammalian prey size. The key mammalian food items for dingoes/wild dogs across all regions were black wallaby (Wallabia bicolor), brushtail possum species (Trichosurus spp.), common wombat (Vombatus ursinus), sambar deer (Rusa unicolor), cattle (Bos taurus) and European rabbit (Oryctolagus cuniculus). The key mammalian food items for foxes across all regions were European rabbit, sheep (Ovis aries) and house mouse (Mus musculus). Foxes consumed 6.1 times the number of individuals of threatened Critical Weight Range native mammal species than did dingoes/wild dogs. The occurrence of intraguild predation was asymmetrical; dingoes/wild dogs consumed greater biomass of the smaller fox. The substantial geographic variation in diet indicates that dingoes/wild dogs and foxes alter their diet in accordance with changing food availability. We provide checklists of taxa recorded in the diets of dingoes/wild dogs and foxes as a resource for managers and researchers wishing to understand the potential impacts of policy and management decisions on dingoes/wild dogs, foxes and the food resources they interact with.	[Davis, Naomi E.; Forsyth, David M.] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Forsyth, David M.; Robley, Alan; Lumsden, Lindy F.] Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, Heidelberg, Vic, Australia; [Triggs, Barbara] Dead Finish, Genoa, Vic, Australia; [Pascoe, Charlie] Parks Victoria, Bright, Vic, Australia; [Benshemesh, Joe] La Trobe Univ, Melbourne, Vic, Australia; [Lawrence, Jenny] Parks Victoria, Heyfield, Vic, Australia; [Ritchie, Euan G.; Nimmo, Dale G.] Deakin Univ, Ctr Integrat Ecol, Burwood, Vic, Australia; [Ritchie, Euan G.; Nimmo, Dale G.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia	University of Melbourne; Arthur Rylah Institute for Environmental Research (ARI); La Trobe University; Deakin University; Deakin University	Davis, NE (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia.	ndavis@unimelb.edu.au	Ritchie, Euan/N-1088-2014	Ritchie, Euan/0000-0003-4410-8868; Forsyth, David/0000-0001-5356-9573; Lumsden, Lindy/0000-0002-4967-4626	Biosecurity Division of the Victorian Department of Environment and Primary Industries	Biosecurity Division of the Victorian Department of Environment and Primary Industries	The work presented was funded by the Biosecurity Division of the Victorian Department of Environment and Primary Industries (www.depi.vic.gov.au). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than in the form of two of the authors being employees within the organization.	Abbott I., 2014, CARNIVORES AUSTR PRE, P69; Allen BL, 2012, WILDLIFE RES, V39, P35, DOI 10.1071/WR11128; Allen BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036426; Allen Benjamin L., 2011, Ecological Management & Restoration, V12, P26, DOI 10.1111/j.1442-8903.2011.00571.x; Allen Benjamin L., 2010, Australian Mammalogy, V32, P207, DOI 10.1071/AM10012; Allen L. R., 2004, Sheep & Goat Research Journal, V19, P97; Allen L, 2012, RANGELAND J, V34, P211, DOI 10.1071/RJ11092; Amundsen PA, 1996, J FISH BIOL, V48, P607, DOI 10.1111/j.1095-8649.1996.tb01455.x; [Anonymous], 1995, CONSERVATION ATLAS P; ARNOLD GW, 1994, WILDLIFE RES, V21, P307, DOI 10.1071/WR9940307; Australian Government Bureau of Meteorology, 2014, VICT FOR AR MAP; Banks PB, 2000, AUSTRAL ECOL, V25, P283, DOI 10.1046/j.1442-9993.2000.01039.x; BELOVSKY GE, 1991, OECOLOGIA, V88, P521, DOI 10.1007/BF00317715; Breckwoldt R., 1988, VERY ELEGANT ANIMAL; Brook LA, 2011, RANGELAND J, V33, P79, DOI 10.1071/RJ10052; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; BROWN G W, 1990, Australian Mammalogy, V13, P209; BRUNNER H, 1975, Australian Wildlife Research, V2, P147, DOI 10.1071/WR9750147; Brunner H., 1986, Victorian Naturalist (Blackburn), V103, P79; Burbidge A.A., 2014, P15; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Caro TM, 2003, BIOL CONSERV, V110, P67, DOI 10.1016/S0006-3207(02)00177-5; CATLING PC, 1988, AUST WILDLIFE RES, V15, P307, DOI 10.1071/WR9880307; CAUGHLEY G, 1980, AUST WILDLIFE RES, V7, P1, DOI 10.1071/WR9800001; Choquenot D, 2013, OIKOS, V122, P1292, DOI 10.1111/j.1600-0706.2012.20976.x; Claridge A. W., 2014, CARNIVORES AUSTR PRE, P151; Claridge Andrew W., 2010, Australian Mammalogy, V32, P117, DOI 10.1071/AM09038; Coates T. D., 2003, Australian Mammalogy, V25, P107; COMAN B J, 1973, Australian Journal of Zoology, V21, P391, DOI 10.1071/ZO9730391; COMAN BJ, 1972, AUST VET J, V48, P456, DOI 10.1111/j.1751-0813.1972.tb02281.x; Conner MM, 1998, J WILDLIFE MANAGE, V62, P690, DOI 10.2307/3802345; Corbett L. K., 2001, DINGO AUSTR ASIA; CORBETT LK, 1987, OECOLOGIA, V74, P215, DOI 10.1007/BF00379362; Corbett LK, 1974, THESIS MONASH U; Courchamp F, 1999, J ANIM ECOL, V68, P282, DOI 10.1046/j.1365-2656.1999.00285.x; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Cozzi B, 2014, BRAIN BEHAV EVOLUT, V83, P9, DOI 10.1159/000356527; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; Crowther MS, 2014, J ZOOL, V293, P192, DOI 10.1111/jzo.12134; Cupples JB, 2011, J MAMMAL, V92, P590, DOI 10.1644/10-MAMM-A-164.1; Department of Environment and Primary Industries, 2013, ACT PLAN MAN WILD DO; Department of Environment and Primary Industries, 2014, VICT BIOD ATL; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dexter N, 2009, WILDLIFE RES, V36, P252, DOI 10.1071/WR08135; Diaz-Ruiz F, 2013, MAMMAL REV, V43, P59, DOI 10.1111/j.1365-2907.2011.00206.x; Dickman CR, 1996, WILDLIFE BIOL, V2, P185, DOI 10.2981/wlb.1996.018; DICKMAN CR, 1992, TRENDS ECOL EVOL, V7, P194, DOI 10.1016/0169-5347(92)90072-J; Duncan J. S., 1982, ATLAS OF VICTORIA; EDWARDS G P, 1975, Australian Mammalogy, V1, P307; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Ferreras P, 2011, BASIC APPL ECOL, V12, P116, DOI 10.1016/j.baae.2011.01.005; Fleming P., 2001, MANAGING IMPACTS DIN; Fleming PJS, 2006, AUST J EXP AGR, V46, P753, DOI 10.1071/EA06009; Fleming PJS, 1986, P AUST SOC ANIM PROD, V16, P87; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; Forsyth DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097937; Forsyth DM, 2012, WILDLIFE RES, V39, P555, DOI 10.1071/WR12033; Foster CN, 2014, J APPL ECOL, V51, P929, DOI 10.1111/1365-2664.12268; Friend GR, 1978, WILDLIFE RES, V5, P75; Gelin U, 2013, ANIM BEHAV, V86, P885, DOI 10.1016/j.anbehav.2013.08.016; GITTLEMAN JL, 1985, OECOLOGIA, V67, P540, DOI 10.1007/BF00790026; Gittleman JL, 2001, SCIENCE, V291, P997, DOI 10.1126/science.291.5506.997; Glen A. S., 2006, Australian Mammalogy, V28, P101; Glen AS, 2008, J APPL ECOL, V45, P700, DOI 10.1111/j.1365-2664.2007.01449.x; Glen AS, 2011, AUSTRAL ECOL, V36, P290, DOI 10.1111/j.1442-9993.2010.02149.x; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; GOSZCZYNSKI J, 1974, Acta Theriologica, V19, P1; Grainger HJ, 1996, INT J PARASITOL, V26, P1263, DOI 10.1016/S0020-7519(96)00109-9; Green K, 2002, AUSTRAL ECOL, V27, P353, DOI 10.1046/j.1442-9993.2002.01187.x; Greentree C, 2000, J APPL ECOL, V37, P935, DOI 10.1046/j.1365-2664.2000.00530.x; Handasyde, 1999, KOALA NATURAL HIST C; Hornsby P.E., 1982, Australian Mammalogy, V5, P225; HURLBERT SH, 1978, ECOLOGY, V59, P67, DOI 10.2307/1936632; IUCN, 2013, IUCN RED LIST THREAT; Jacomo ATDA, 2004, J ZOOL, V262, P99; Jedrzejewska B., 1998, PREDATION VERTEBRATE; Jenkins DJ, 2003, PARASITOLOGY, V127, pS63, DOI 10.1017/S0031182003003871; Johnson C, 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2009, J APPL ECOL, V46, P641, DOI 10.1111/j.1365-2664.2009.01650.x; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2000, J ZOOL, V250, P255; Kinnear JE, 2002, BIOL CONSERV, V108, P335, DOI 10.1016/S0006-3207(02)00116-7; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Leckie FM, 1998, ECOGRAPHY, V21, P599, DOI 10.1111/j.1600-0587.1998.tb00552.x; Letnic M., 2014, CARNIVORES AUSTR PRE, P53; Letnic M, 2013, OIKOS, V122, P761, DOI 10.1111/j.1600-0706.2012.20425.x; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Lobert B, 2001, WILDLIFE RES, V28, P637, DOI 10.1071/WR00124; LOCKIE J. D., 1959, JOUR WILDLIFE MANAGEMENT, V23, P224, DOI 10.2307/3797647; Lugton IW., 1993, RANGELAND J, V15, P39, DOI [10.1071/RJ9930039, DOI 10.1071/RJ9930039]; MARSACK P, 1990, AUST WILDLIFE RES, V17, P349, DOI 10.1071/WR9900349; McINTOSH D. L., 1963, C S I R O WILD LIFE RES, V8, P1; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Menkhorst KA, 1995, MAMMALS VICTORIA DIS; Menkhorst P.W., 2011, FIELD GUIDE MAMMALS, V3rd; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Meriggi A, 1996, ECOGRAPHY, V19, P287, DOI 10.1111/j.1600-0587.1996.tb00238.x; Miller EJ, 2010, REPROD FERT DEVELOP, V22, P539, DOI 10.1071/RD09061; Mitchell BD, 2005, AUSTRAL ECOL, V30, P581, DOI 10.1111/j.1442-9993.2005.01473.x; Moseby Katherine E., 2012, International Journal of Ecology, P1; NEWSOME AE, 1983, AUST WILDLIFE RES, V10, P477; NEWSOME AE, 1983, AUST J ECOL, V8, P345, DOI 10.1111/j.1442-9993.1983.tb01332.x; Newsome AE, 1989, FAUNA AUSTR B; Newsome TM, 2014, OECOLOGIA, V175, P139, DOI 10.1007/s00442-014-2889-7; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Paltridge R, 2002, WILDLIFE RES, V29, P389, DOI 10.1071/WR00010; PAQUET PC, 1992, J MAMMAL, V73, P337, DOI 10.2307/1382067; Pascoe JH, 2011, AUST J ZOOL, V59, P295, DOI 10.1071/ZO11082; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Polisar J, 2003, BIOL CONSERV, V109, P297, DOI 10.1016/S0006-3207(02)00157-X; Pople AR, 2000, WILDLIFE RES, V27, P269, DOI 10.1071/WR99030; Ray JC, 2001, OECOLOGIA, V127, P395, DOI 10.1007/s004420000604; Read J, 2001, WILDLIFE RES, V28, P195, DOI 10.1071/WR99065; Reddiex B, 2006, WILDLIFE RES, V33, P691, DOI 10.1071/WR05102; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Risbey DA, 1999, WILDLIFE RES, V26, P621; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROBERTSHAW JD, 1985, AUST WILDLIFE RES, V12, P39; ROBERTSHAW JD, 1986, AUST WILDLIFE RES, V13, P141, DOI 10.1071/WR9860141; Rolls E.C., 1969, THEY ALL RAN WILD; Ruhe F, 2008, WILDLIFE BIOL, V14, P500, DOI 10.2981/0909-6396-14.4.500; Ruscoe WA, 2011, ECOL LETT, V14, P1035, DOI 10.1111/j.1461-0248.2011.01673.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Saunders G, 1999, WILDLIFE RES, V26, P335, DOI 10.1071/WR98056; Saunders G., 1995, MANAGING VERTEBRATE; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Scott Thos. G., 1943, ECOL MONOGR, V13, P427, DOI 10.2307/1948591; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; SHORT J, 1994, J MAMMAL, V75, P288, DOI 10.2307/1382547; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; Soule ME, 1989, CONSERV BIOL, V2, P75; Sweitzer RA, 1997, CONSERV BIOL, V11, P1407, DOI 10.1046/j.1523-1739.1997.96138.x; THOMSON PC, 1992, WILDLIFE RES, V19, P531, DOI 10.1071/WR9920531; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; TRIGGS B, 1984, AUST WILDLIFE RES, V11, P491; Trites AW, 2005, J MAMMAL, V86, P704, DOI 10.1644/1545-1542(2005)086[0704:DAFFSH]2.0.CO;2; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; Wallis RL., 1986, AUST MAMMAL, V10, P43; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278; White JG, 2006, WILDLIFE RES, V33, P175, DOI 10.1071/WR05037	151	53	59	0	190	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120975	10.1371/journal.pone.0120975	http://dx.doi.org/10.1371/journal.pone.0120975			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790230	Green Published, gold			2022-12-26	WOS:000351425400186
J	Franz, E; van Hoek, AHAM; Wuite, M; van der Wal, FJ; de Boer, AG; Bouw, EI; Aarts, HJM				Franz, Eelco; van Hoek, Angela H. A. M.; Wuite, Mark; van der Wal, Fimme J.; de Boer, Albert G.; Bouw, E. I.; Aarts, Henk J. M.			Molecular Hazard Identification of Non-O157 Shiga Toxin-Producing Escherichia coli (STEC)	PLOS ONE			English	Article							VIRULENCE FACTORS; 5'-NUCLEASE PCR; GENOMIC ISLAND; STRAINS; O157; GENE; RPOS; COLONIZATION; ASSOCIATION; UREASE	The complexity regarding Shiga toxin-producing Escherichia coli (STEC) in food safety enforcement as well as clinical care primarily relates to the current inability of an accurate risk assessment of individual strains due to the large variety in serotype and genetic content associated with (severe) disease. In order to classify the clinical and/or epidemic potential of a STEC isolate at an early stage it is crucial to identify virulence characteristics of putative pathogens from genomic information, which is referred to as 'predictive hazard identification'. This study aimed at identifying associations between virulence factors, phylogenetic groups, isolation sources and seropathotypes. Most non-O157 STEC in the Netherlands belong to phylogroup B1 and are characterized by the presence of ehxA, iha and stx(2), but absence of eae. The large variability in the number of virulence factors present among serogroups and seropathotypes demonstrated that this was merely indicative for the virulence potential. While all the virulence gene associations have been worked out, it appeared that there is no specific pattern that would unambiguously enable hazard identification for an STEC strain. However, the strong correlations between virulence factors indicate that these arrays are not a random collection but are rather specific sets. Especially the presence of eae was strongly correlated to the presence of many of the other virulence genes, including all non-LEE encoded effectors. Different stx-subtypes were associated with different virulence profiles. The factors ehxA and ureC were significantly associated with HUS-associated- strains (HAS) and not correlated to the presence of eae. This indicates their candidacy as important pathogenicity markers next to eae and stx(2)a.	[Franz, Eelco; van Hoek, Angela H. A. M.; Wuite, Mark; Bouw, E. I.; Aarts, Henk J. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van der Wal, Fimme J.; de Boer, Albert G.] Wageningen Univ & Res Ctr, Cent Vet Inst, Lelystad, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research	Franz, E (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	eelco.franz@rivm.nl		van der Wal, Fimme/0000-0002-6859-1252	Ministry of Economic Affairs	Ministry of Economic Affairs	This work was funded by the Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3138; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; BEUTIN L, 1994, MED MICROBIOL IMMUN, V183, P13, DOI 10.1007/BF00193627; Bolton DJ, 2011, FOODBORNE PATHOG DIS, V8, P357, DOI 10.1089/fpd.2010.0699; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Bugarel M, 2010, APPL ENVIRON MICROB, V76, P203, DOI 10.1128/AEM.01921-09; Buvens G, 2012, FOODBORNE PATHOG DIS, V9, P530, DOI 10.1089/fpd.2011.1073; Chaudhuri RR, 2012, INFECT GENET EVOL, V12, P214, DOI 10.1016/j.meegid.2012.01.005; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Coombes BK, 2011, FRONT MICROBIOL, V2; Coombes BK, 2008, APPL ENVIRON MICROB, V74, P2153, DOI 10.1128/AEM.02566-07; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Franz E, 2014, INT J FOOD MICROBIOL, V187, P57, DOI 10.1016/j.ijfoodmicro.2014.07.002; Friedrich AW, 2006, CLIN MICROBIOL INFEC, V12, P483, DOI 10.1111/j.1469-0691.2006.01379.x; Friesema I, 2014, EUROSURVEILLANCE, V19, P20787; Friesema IHM, 2013, INFECT B, V9, P285; Girardeau JP, 2005, J CLIN MICROBIOL, V43, P6098, DOI 10.1128/JCM.43.12.6098-6107.2005; Gould LH, 2013, FOODBORNE PATHOG DIS, V10, P453, DOI 10.1089/fpd.2012.1401; Grant M. A., 2011, Food Protection Trends, V31, P33; Imamovic L, 2010, INFECT IMMUN, V78, P4697, DOI 10.1128/IAI.00512-10; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Ju WT, 2013, APPL ENVIRON MICROB, V79, P3406, DOI 10.1128/AEM.03661-12; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Krogfelt KA, 2000, INFECT IMMUN, V68, P2518, DOI 10.1128/IAI.68.5.2518-2524.2000; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Meric G, 2013, ENVIRON MICROBIOL, V15, P487, DOI 10.1111/j.1462-2920.2012.02852.x; Nakano M, 2001, J CLIN MICROBIOL, V39, P4541, DOI 10.1128/JCM.39.12.4541-4543.2001; Newton HJ, 2009, EMERG INFECT DIS, V15, P372, DOI [10.3201/eid1502.080631, 10.3201/eid1503.080631]; Nielsen EM, 2003, J CLIN MICROBIOL, V41, P2884, DOI 10.1128/JCM.41.7.2884-2893.2003; Nowrouzian FL, 2005, J INFECT DIS, V191, P1078, DOI 10.1086/427996; Paton AW, 2010, TOXINS, V2, P215, DOI 10.3390/toxins2020215; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; Paton AW, 2002, J CLIN MICROBIOL, V40, P271, DOI 10.1128/JCM.40.1.271-274.2002; Paton AW, 2005, J CLIN MICROBIOL, V43, P2944, DOI 10.1128/JCM.43.6.2944-2947.2005; Perelle S, 2004, MOL CELL PROBE, V18, P185, DOI 10.1016/j.mcp.2003.12.004; Price SB, 2000, APPL ENVIRON MICROB, V66, P632, DOI 10.1128/AEM.66.2.632-637.2000; Ratajczak M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-222; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 1997, FEMS MICROBIOL LETT, V148, P265, DOI 10.1016/S0378-1097(97)00047-5; Schmidt H, 2001, INFECT IMMUN, V69, P6863, DOI 10.1128/IAI.69.11.6863-6873.2001; Skinner C, 2013, PLOS ONE, V8; Steyert SR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00133; Steyert SR, 2012, INFECT IMMUN, V80, P2589, DOI 10.1128/IAI.00210-12; Tarr PI, 2000, INFECT IMMUN, V68, P1400, DOI 10.1128/IAI.68.3.1400-1407.2000; Tzschoppe M, 2012, INT J FOOD MICROBIOL, V152, P19, DOI 10.1016/j.ijfoodmicro.2011.10.009; van Hoek AHAM, 2013, FEMS MICROBIOL LETT, V338, P18, DOI 10.1111/1574-6968.12024; Vanaja SK, 2010, APPL ENVIRON MICROB, V76, P60, DOI 10.1128/AEM.01666-09; White AP, 2011, APPL ENVIRON MICROB, V77, P7620, DOI 10.1128/AEM.05909-11; Yamamoto T, 1996, INFECT IMMUN, V64, P1441, DOI 10.1128/IAI.64.4.1441-1445.1996; Yin XH, 2009, APPL ENVIRON MICROB, V75, P5779, DOI 10.1128/AEM.00507-09	56	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120353	10.1371/journal.pone.0120353	http://dx.doi.org/10.1371/journal.pone.0120353			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789994	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400154
J	Lai, YC; Kao, CF; Lu, ML; Chen, HC; Chen, PY; Chen, CH; Shen, WW; Wu, JY; Lu, RB; Kuo, PH				Lai, Yin-Chieh; Kao, Chung-Feng; Lu, Mong-Liang; Chen, Hsi-Chung; Chen, Po-Yu; Chen, Chien-Hsiun; Shen, Winston W.; Wu, Jer-Yuarn; Lu, Ru-Band; Kuo, Po-Hsiu			Investigation of Associations between NR1D1, RORA and RORB Genes and Bipolar Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTIFACTOR DIMENSIONALITY REDUCTION; ERB-ALPHA-GENE; CIRCADIAN-RHYTHMS; MOOD DISORDERS; CLOCK; SLEEP; POPULATION; DEPRESSION; EXPRESSION	Several genes that are involved in the regulation of circadian rhythms are implicated in the susceptibility to bipolar disorder (BD). The current study aimed to investigate the relationships between genetic variants in NR1D1 RORA, and RORB genes and BD in the Han Chinese population. We conducted a case-control genetic association study with two samples of BD patients and healthy controls. Sample I consisted of 280 BD patients and 200 controls. Sample II consisted of 448 BD patients and 1770 healthy controls. 27 single nucleotide polymorphisms in the NR1D1, RORA, and RORB genes were genotyped using GoldenGate VeraCode assays in sample I, and 492 markers in the three genes were genotyped using Affymetrix Genome-Wide CHB Array in sample II. Single marker and genebased association analyses were performed using PLINK. A combined p-value for the joining effects of all markers within a gene was calculated using the rank truncated product method. Multifactor dimensionality reduction (MDR) method was also applied to test gene-gene interactions in sample I. All markers were in Hardy-Weinberg equilibrium (P>0.001). In sample I, the associations with BD were observed for rs4774388 in RORA (OR = 1.53, empirical p-value, P = 0.024), and rs1327836 in RORB (OR = 1.75, P = 0.003). In Sample II, there were 45 SNPs showed associations with BD, and the most significant marker in RORA was rs11639084 (OR = 0.69, P = 0.002), and in RORB was rs17611535 (OR = 3.15, P = 0.027). A combined p-value of 1.6x10-6, 0.7, and 1.0 was obtained for RORA, RORB and NR1D1, respectively, indicting a strong association for RORA with the risk of developing BD. A four way interaction was found among markers in NR1D1, RORA, and RORB with the testing accuracy 53.25% and a cross-validation consistency of 8 out of 10. In sample II, 45 markers had empirical p-values less than 0.05. The most significant markers in RORA and RORB genes were rs11639084 (OR = 0.69, P = 0.002), and rs17611535 (OR = 3.15, P = 0.027), respectively. Gene-based association was significant for RORA gene (P = 0.0007). Our results support for the involvement of RORs genes in the risk of developing BD. Investigation of the functional properties of genes in the circadian pathway may further enhance our understanding about the pathogenesis of bipolar illness.	[Lai, Yin-Chieh; Kao, Chung-Feng; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Lai, Yin-Chieh; Kao, Chung-Feng; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lu, Mong-Liang; Shen, Winston W.] Taipei Med Univ, Wan Fang Med Ctr, Dept Psychiat, Taipei, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Ctr Sleep Disorders, Taipei, Taiwan; [Chen, Po-Yu] Taipei City Hosp, Taipei City Psychiat Ctr, Dept Psychiat, Taipei, Taiwan; [Chen, Chien-Hsiun; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan 70428, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei City Hospital; Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University	Kuo, PH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan.	phkuo@ntu.edu.tw	Chen, Hsi-Chung/E-9949-2017; Wu, Jer-Yuarn/S-7010-2018; Chen, Chien Hsiun/Q-3826-2018	Chen, Hsi-Chung/0000-0003-3191-0093; Lu, Mong-Liang/0000-0003-3184-6554; Kuo, Po-Hsiu/0000-0003-0365-3587	National Science Council [NSC 99-2314-B-002-140-MY3, NSC 102-2314-B-002-117-MY3]; National Health Research Institute [NHRI-EX101-9918NC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This research was supported by National Science Council (NSC 99-2314-B-002-140-MY3, NSC 102-2314-B-002-117-MY3) and National Health Research Institute (NHRI-EX101-9918NC) Grants to Dr.P.-H. Kuo (PI). The funding sources had no further role in the study design, collection, analysis, or interpretation of data; in writing of the report; and in the decision to submit the paper for publication.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475; Borenstein M., 2005, COMPREHENSIVE META A; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campos-de-Sousa S, 2010, J BIOL RHYTHM, V25, P132, DOI 10.1177/0748730410362713; Edvardsen J, 2008, J AFFECT DISORDERS, V106, P229, DOI 10.1016/j.jad.2007.07.001; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Harvey AG, 2006, DEV PSYCHOPATHOL, V18, P1147, DOI 10.1017/S095457940606055X; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kishi T, 2008, NEUROSCI RES, V62, P211, DOI 10.1016/j.neures.2008.08.008; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le-Niculescu H, 2008, AM J MED GENET B, V147B, P134, DOI 10.1002/ajmg.b.30707; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; McGrath CL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-70; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Murray G, 2010, BIPOLAR DISORD, V12, P459, DOI 10.1111/j.1399-5618.2010.00843.x; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Perlman CA, 2006, BIPOLAR DISORD, V8, P271, DOI 10.1111/j.1399-5618.2006.00330.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Serretti A, 2003, AM J MED GENET B, V121B, P35, DOI 10.1002/ajmg.b.20053; Severino G, 2009, BIPOLAR DISORD, V11, P215, DOI 10.1111/j.1399-5618.2009.00667.x; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Solt LA, 2010, CURR OPIN LIPIDOL, V21, P204, DOI 10.1097/MOL.0b013e328338ca18; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; Tsai HC, 2012, J AFFECT DISORDERS, V136, P81, DOI 10.1016/j.jad.2011.08.015; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Utge SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009259; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zheng G, 2003, ANN HUM GENET, V67, P589, DOI 10.1046/j.1529-8817.2003.00065.x	46	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121245	10.1371/journal.pone.0121245	http://dx.doi.org/10.1371/journal.pone.0121245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789810	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400193
J	Ngunjiri, JM; Ali, A; Boyaka, P; Marcus, PI; Lee, CW				Ngunjiri, John M.; Ali, Ahmed; Boyaka, Prosper; Marcus, Philip I.; Lee, Chang-Won			In Vivo Assessment of NS1-Truncated Influenza Virus with a Novel SLSYSINWRH Motif as a Self-Adjuvanting Live Attenuated Vaccine	PLOS ONE			English	Article							A VIRUS; NS1 PROTEIN; IMMUNE-RESPONSE; T-CELLS; INFECTION; IFN; SUBPOPULATIONS; DIMERIZATION; PREVENTION; INDUCTION	Mutants of influenza virus that encode C-terminally truncated NS1 proteins (NS1-truncated mutants) characteristically induce high interferon responses. The dual activity of interferon in blocking virus replication and enhancing the development of adaptive immune responses makes these mutants promising as self-adjuvanting live-attenuated influenza vaccine (LAIV) candidates. Yet, among the NS1-truncated mutants, the length of NS1 is not directly correlated with the interferon-inducing efficiency, the level of attenuation, or effectiveness as LAIV. Using quantitative in vitro biologically active particle subpopulation analysis as a tool to identify potential LAIV candidates from a pool of NS1-truncated mutants, we previously predicted that a NS1-truncated mutant pc2, which was less effective as a LAIV in chickens, would be sufficiently effective as a LAIV in mammalian hosts. In this study, we confirmed that pc2 protected mice and pigs against heterologous virus challenge in terms of preventing clinical signs and reducing virus shedding. pc2 expresses a unique SLSYSINWRH motif at the C-terminus of its truncated NS1. Deletion of the SLSYSINWRH motif led to similar to 821-fold reduction in the peak yield of type I interferon induced in murine cells. Furthermore, replacement of the SLSYSINWRH motif with the wildtype MVKMDQAIMD sequence did not restore the interferon-inducing efficiency. The diminished interferon induction capacity in the absence of the SLSYSINWRH motif was similar to that observed in other mutants which are less effective LAIV candidates. Remarkably, pc2 induced 16-fold or more interferon in human lung and monkey kidney cells compared to the temperature-sensitive, cold-adapted Ann Arbor virus that is currently used as a master backbone for LAIVs such as FluMist. Although the mechanism by which the SLSYSINWRH motif regulates the vaccine properties of pc2 has not been elucidated, this motif has potential use in engineering self-adjuvanting NS1-truncated-based LAIVs.	[Ngunjiri, John M.; Marcus, Philip I.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Ngunjiri, John M.; Lee, Chang-Won] Ohio State Univ, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Ali, Ahmed] Beni Suef Univ, Dept Poultry Dis, Fac Vet Med, Bani Suwayf 62511, Egypt; [Ali, Ahmed; Lee, Chang-Won] Ohio State Univ, Dept Prevent Med, Columbus, OH 43210 USA; [Boyaka, Prosper] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	University of Connecticut; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Beni Suef University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lee, CW (corresponding author), Ohio State Univ, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	lee.2854@osu.edu	Ali, Ahmed/B-5108-2013; Ngunjiri, John/AAB-3798-2021	Ali, Ahmed/0000-0002-2576-2031; Ngunjiri, John/0000-0002-2131-1698; Boyaka, Prosper/0000-0001-6857-9088	Ohio Agricultural Research and Development Center, The Ohio State University [2012009]; NIH [R01 AI04197]	Ohio Agricultural Research and Development Center, The Ohio State University(Ohio State University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was partially supported by the SEEDS fund (2012009) from the Ohio Agricultural Research and Development Center, The Ohio State University, a donation to the University of Connecticut's Virus and Interferon Research Laboratory, and NIH grant R01 AI04197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2011, J CLIN MICROBIOL, V49, P4101, DOI 10.1128/JCM.05415-11; Ayllon J, 2012, J VIROL, V86, P13095, DOI 10.1128/JVI.02237-12; BEAN WJ, 1985, J VIROL, V54, P151, DOI 10.1128/JVI.54.1.151-160.1985; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Bracci L, 2006, VACCINE, V24, pS56, DOI 10.1016/j.vaccine.2005.01.121; Bracci L, 2005, VACCINE, V23, P2994, DOI 10.1016/j.vaccine.2004.12.006; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Cyranoski D, 2001, NATURE, V412, P261, DOI 10.1038/35085715; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; GORSE GJ, 1995, J INFECT DIS, V172, P1, DOI 10.1093/infdis/172.1.1; Kochs G, 2007, J GEN VIROL, V88, P1403, DOI 10.1099/vir.0.82764-0; Kochs G, 2009, J GEN VIROL, V90, P2990, DOI 10.1099/vir.0.015727-0; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lee CW, 2014, METHODS MOL BIOL, V1161, P37, DOI 10.1007/978-1-4939-0758-8_4; Marcus PI, 2010, J VIROL, V84, P10974, DOI 10.1128/JVI.00502-10; Marcus PI, 2009, J VIROL, V83, P8122, DOI 10.1128/JVI.02680-08; Marcus PI, 2005, J VIROL, V79, P2880, DOI 10.1128/JVI.79.5.2880-2890.2005; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mueller SN, 2010, J VIROL, V84, P1847, DOI 10.1128/JVI.01317-09; Nagao Y, 1998, J INTERF CYTOK RES, V18, P661, DOI 10.1089/jir.1998.18.661; Nelson KM, 1998, VACCINE, V16, P1306, DOI 10.1016/S0264-410X(98)00009-7; NEMEROFF ME, 1995, VIROLOGY, V212, P422, DOI 10.1006/viro.1995.1499; Neumann G, 2011, INFLUENZA OTHER RESP, V5, P157, DOI 10.1111/j.1750-2659.2011.00231.x; Ngunjiri JM, 2012, NAT MED, V18, P1456, DOI 10.1038/nm.2879; Ngunjiri JM, 2012, J INTERF CYTOK RES, V32, P280, DOI 10.1089/jir.2011.0102; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Palese P, 2002, J CLIN INVEST, V110, P9, DOI 10.1172/JCI200215999; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Richt JA, 2009, CURR TOP MICROBIOL, V333, P177, DOI 10.1007/978-3-540-92165-3_9; Salvatore M, 2002, J VIROL, V76, P1206, DOI 10.1128/JVI.76.3.1206-1212.2002; Solorzano A, 2005, J VIROL, V79, P7535, DOI 10.1128/JVI.79.12.7535-7543.2005; Staats HF, 2001, J IMMUNOL, V167, P5386, DOI 10.4049/jimmunol.167.9.5386; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Tang Y, 2005, AVIAN DIS, V49, P207, DOI 10.1637/7288-101304R; Van Reeth K, 2013, CURR TOP MICROBIOL, V370, P173, DOI 10.1007/82_2012_266; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Wang L, 2008, VACCINE, V26, P3580, DOI 10.1016/j.vaccine.2008.05.001; Wang XY, 2002, J VIROL, V76, P12951, DOI 10.1128/JVI.76.24.12951-12962.2002	49	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118934	10.1371/journal.pone.0118934	http://dx.doi.org/10.1371/journal.pone.0118934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790187	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400056
J	Taylor, NJ; Busam, KJ; From, L; Groben, PA; Anton-Culver, H; Cust, AE; Begg, CB; Dwyer, T; Gallagher, RP; Gruber, SB; Orlow, I; Rosso, S; Thomas, NE; Zanetti, R; Rebbeck, TR; Berwick, M; Kanetsky, PA				Taylor, Nicholas J.; Busam, Klaus J.; From, Lynn; Groben, Pamela A.; Anton-Culver, Hoda; Cust, Anne E.; Begg, Colin B.; Dwyer, Terence; Gallagher, Richard P.; Gruber, Stephen B.; Orlow, Irene; Rosso, Stefano; Thomas, Nancy E.; Zanetti, Roberto; Rebbeck, Timothy R.; Berwick, Marianne; Kanetsky, Peter A.			Inherited Variation at MC1R and Histological Characteristics of Primary Melanoma	PLOS ONE			English	Article							MELANOCORTIN 1 RECEPTOR; PRIMARY CUTANEOUS MELANOMA; STAGE-I MELANOMA; RISK PHENOTYPES; CANCER RISK; HAIR COLOR; SKIN TYPE; RED HAIR; POPULATION; GENE	Variation in the melanocortin-1receptor (MC1R) gene is associated with pigmentary phenotypes and risk of malignant melanoma. Few studies have reported on MC1R variation with respect to tumor characteristics, especially clinically important prognostic features. We examined associations between MC1R variants and histopathological melanoma characteristics. Study participants were enrolled from nine geographic regions in Australia, Canada, Italy and the United States and were genotyped for MC1R variants classified as high-risk [R] (D84E, R142H, R151C, R160W, and D294H, all nonsense and insertion/deletion) or low-risk [r] (all other nonsynonymous) variants. Tissue was available for 2,160 white participants of the Genes, Environment and Melanoma (GEM) Study with a first incident primary melanoma diagnosis, and underwent centralized pathologic review. No statistically significant associations were observed between MC1R variants and AJCC established prognostic tumor characteristics: Breslow thickness, presence of mitoses or presence of ulceration. However, MC1R was significantly associated with anatomic site of melanoma (p = 0.002) and a positive association was observed between carriage of more than one [ R] variant and melanomas arising on the arms (OR = 2.39; 95% CI: 1.40, 4.09). We also observed statistically significant differences between sun-sensitive and sun-resistant individuals with respect to associations between MC1R genotype and AJCC prognostic tumor characteristics. Our results suggest inherited variation in MC1R may play an influential role in anatomic site presentation of melanomas and may differ with respect to skin pigmentation phenotype.	[Taylor, Nicholas J.; Kanetsky, Peter A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA; [Busam, Klaus J.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [From, Lynn] Womens Coll Hosp, Toronto, ON, Canada; [Groben, Pamela A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Dermatol, Chapel Hill, NC 27599 USA; [Groben, Pamela A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol, Chapel Hill, NC 27599 USA; [Groben, Pamela A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Lab Med, Chapel Hill, NC 27599 USA; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Cust, Anne E.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Begg, Colin B.; Orlow, Irene] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Dwyer, Terence] Int Agcy Res Canc, F-69372 Lyon, France; [Gallagher, Richard P.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Gruber, Stephen B.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90033 USA; [Rosso, Stefano; Zanetti, Roberto] Piedmont Tumor Registry, Turin, Italy; [Thomas, Nancy E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Dermatol, Chapel Hill, NC 27599 USA; [Rebbeck, Timothy R.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Berwick, Marianne] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Berwick, Marianne] Univ New Mexico, Dept Dermatol, Albuquerque, NM 87131 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Irvine; University of Sydney; Memorial Sloan Kettering Cancer Center; World Health Organization; International Agency for Research on Cancer (IARC); British Columbia Cancer Agency; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of New Mexico; University of New Mexico	Kanetsky, PA (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA.	peter.kanetsky@moffitt.org	Rebbeck, Timothy/GLU-8348-2022; Cust, Anne/J-1797-2019; Taylor, Nicholas/B-7960-2018	Rebbeck, Timothy/0000-0002-4799-1900; Cust, Anne/0000-0002-5331-6370; Taylor, Nicholas/0000-0003-4811-8529; Orlow, Irene/0000-0001-6234-6961; Berwick, Marianne/0000-0001-5062-2180	National Cancer Institute, US [U01CA83180, R01CA112524, P30CA008748, R01CA112243, R01CA112243S1, R01CA112524S2, R01CA098438, R25CA147832]; University of Sydney Medical Foundation Program; Michael Smith Foundation for Health Research Infrastructure Award; NATIONAL CANCER INSTITUTE [R01CA163251, R25CA147832, U01CA083180, R01CA112243, P30CA008748, R01CA112524, R01CA098438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Cancer Institute, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Sydney Medical Foundation Program(University of Sydney); Michael Smith Foundation for Health Research Infrastructure Award(Michael Smith Foundation for Health Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Results presented in this report represent work from the Genes, Environment, and Melanoma (GEM) Study that was funded by the following grant awards: U01CA83180 (MB), R01CA112524 (MB), P30CA008748 (CBB), R01CA112243 (NET), R01CA112243S1 (NET), R01CA112524S2 (NET), and R01CA098438 (CBB) from the National Cancer Institute, US, the University of Sydney Medical Foundation Program, and by the Michael Smith Foundation for Health Research Infrastructure Award (RPG). NJT is supported by a training award R25CA147832 from the National Cancer Institute, US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzola MF, 2003, CANCER-AM CANCER SOC, V97, P1488, DOI 10.1002/cncr.11196; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Barnhill RL, 1996, CANCER-AM CANCER SOC, V78, P427; Begg CB, 2004, CANCER CAUSE CONTROL, V15, P957, DOI 10.1007/s10552-004-2474-1; Begg CB, 2006, INT J EPIDEMIOL, V35, P756, DOI 10.1093/ije/dyl044; Callender GG, 2011, AM J SURG, V202, P659, DOI 10.1016/j.amjsurg.2011.06.048; CLARK WH, 1969, CANCER RES, V29, P705; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Cust AE, 2012, INT J CANCER, V131, pE269, DOI 10.1002/ijc.27357; DAY CL, 1981, AM J SURG, V142, P247, DOI 10.1016/0002-9610(81)90286-5; Debniak T, 2006, INT J CANCER, V119, P2597, DOI 10.1002/ijc.22210; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Gimotty PA, 2007, J CLIN ONCOL, V25, P1129, DOI 10.1200/JCO.2006.08.1463; Hoiom V, 2009, PIGM CELL MELANOMA R, V22, P196, DOI 10.1111/j.1755-148X.2008.00526.x; Ichii-Jones F, 1998, J INVEST DERMATOL, V111, P218, DOI 10.1046/j.1523-1747.1998.00287.x; Kanetsky PA, 2004, CANCER EPIDEM BIOMAR, V13, P808; Kanetsky PA, 2006, CANCER RES, V66, P9330, DOI 10.1158/0008-5472.CAN-06-1634; Kanetsky PA, 2010, CANCER-AM CANCER SOC, V116, P2416, DOI 10.1002/cncr.24994; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; MCGOVERN VJ, 1973, CANCER, V32, P1446, DOI 10.1002/1097-0142(197312)32:6<1446::AID-CNCR2820320623>3.0.CO;2-8; Mervic L, 2012, ACTA DERMATOVEN ALP, V21, P27, DOI 10.2478/v10162-012-0008-1; Millikan RC, 2006, CARCINOGENESIS, V27, P610, DOI 10.1093/carcin/bgi252; Pasquali E, 2014, INT J CANC; Pena-Vilabelda MM, 2014, ACTAS DERMO-SIFILOGR, V105, P159, DOI 10.1016/j.ad.2013.10.001; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Stratigos AJ, 2006, J INVEST DERMATOL, V126, P1842, DOI 10.1038/sj.jid.5700292; Sturm RA, 2003, PIGM CELL RES, V16, P266, DOI 10.1034/j.1600-0749.2003.00041.x; Thomas NE, 2013, J CLIN ONCOL, V31, P4252, DOI 10.1200/JCO.2013.51.3002; Williams PF, 2011, INT J CANCER, V129, P1730, DOI 10.1002/ijc.25804	30	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119920	10.1371/journal.pone.0119920	http://dx.doi.org/10.1371/journal.pone.0119920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790105	Green Published, gold			2022-12-26	WOS:000351425400115
J	Mitra, AK; Chiang, CY; Tiwari, P; Tomar, S; Watters, KM; Peter, ME; Lengyel, E				Mitra, A. K.; Chiang, C. Y.; Tiwari, P.; Tomar, S.; Watters, K. M.; Peter, M. E.; Lengyel, E.			Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis	ONCOGENE			English	Article							UROKINASE PLASMINOGEN-ACTIVATOR; MESOTHELIAL CELLS; DNA METHYLATION; TUMOR INVASION; EXPRESSION; MICRORNA; PROGRESSION; SYSTEM; FIBROBLASTS; INHIBITOR	The cross-talk between ovarian cancer (OvCa) cells and the metastatic microenvironment is an essential determinant of successful colonization. MicroRNAs (miRNAs) have several critical roles during metastasis; however, the role of microenvironmental cues in the regulation of miRNAs in metastasizing cancer cells has not been studied. Using a three-dimensional culture model that mimics the human omentum, one of the principal sites of OvCa metastasis, we identified and characterized the microenvironment-induced downregulation of a tumor suppressor miRNA, miR-193b, in metastasizing OvCa cells. The direct interaction of the OvCa cells with mesothelial cells, which cover the surface of the omentum, caused a DNA methyltransferase 1-mediated decrease in the expression of miR-193b in the cancer cells. The reduction in miR-193b enabled the metastasizing cancer cells to invade and proliferate into human omental pieces ex vivo and into the omentum of a mouse xenograft model of OvCa metastasis. The functional effects of miR-193b were mediated, in large part, by the concomitant increased expression of its target, urokinase-type plasminogen activator, a known tumor-associated protease. These findings link paracrine signals from the microenvironment to the regulation of a key miRNA in cancer cells. Targeting miR-193b, which is essential for metastatic colonization of cancer cells could prove effective in the treatment of OvCa metastasis.	[Mitra, A. K.; Chiang, C. Y.; Tiwari, P.; Watters, K. M.; Lengyel, E.] Univ Chicago, Dept Obstet & Gynecol, Gynecol Oncol Sect, Ctr Integrat Sci, Chicago, IL 60637 USA; [Mitra, A. K.; Tomar, S.] Indiana Univ, Sch Med, Med Sci Program, Bloomington, IN 47405 USA; [Peter, M. E.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA	University of Chicago; Indiana University System; Indiana University Bloomington; Northwestern University; Feinberg School of Medicine	Lengyel, E (corresponding author), Univ Chicago, Dept Obstet & Gynecol, Gynecol Oncol Sect, Ctr Integrat Sci, MC 2050,5841 South Maryland Ave, Chicago, IL 60637 USA.	anmitra@indiana.edu; elengyel@uchicago.edu	Lengyel, Ernst/D-9220-2014	Lengyel, Ernst/0000-0001-8624-1507; Tomar, Sunil/0000-0002-9258-399X; Tiwari, Payal/0000-0002-7822-6857; Peter, Marcus Ernst/0000-0003-3216-036X	Marsha Rivkin Pilot Award; National Cancer Institute [R01 CA111882, RO1 CA169604]; Ovarian Cancer Research Fund Program Project Development Grant; NATIONAL CANCER INSTITUTE [R01CA169604, R01CA111882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075702] Funding Source: NIH RePORTER	Marsha Rivkin Pilot Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund Program Project Development Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We want to thank Dr AF Haney for collecting omental biopsies, Dr Abir Mukherjee for helpful discussions and G Isenberg for carefully editing the manuscript (all at the University of Chicago, Department of Obstetrics and Gynecology). We are indebted to all the patients, resident and attending physicians in the Department of Obstetrics and Gynecology at the University of Chicago for their participation in tissue collection for these experiments. This research was supported by a Marsha Rivkin Pilot Award (AKM) and by National Cancer Institute R01 CA111882 and RO1 CA169604 grants (EL) and an Ovarian Cancer Research Fund Program Project Development Grant (EL, MEP).	Ahluwalia A, 2001, GYNECOL ONCOL, V82, P299, DOI 10.1006/gyno.2001.6284; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Brader KR, 1997, CLIN CANCER RES, V3, P2017; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Gao XN, 2011, LEUKEMIA RES, V35, P1226, DOI 10.1016/j.leukres.2011.06.010; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kenny HA, 2014, J CLIN INVEST, V124, P4614, DOI 10.1172/JCI74778; Konecny G, 2001, CLIN CANCER RES, V7, P1743; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061658; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Lwin T, 2013, J CLIN INVEST, V123, P4612, DOI 10.1172/JCI64210; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mitra AK, 2011, ONCOGENE, V30, P1566, DOI 10.1038/onc.2010.532; Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; NIEDBALA MJ, 1985, EXP CELL RES, V160, P499, DOI 10.1016/0014-4827(85)90197-1; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Noh Hyangsoon, 2011, Genes Cancer, V2, P140, DOI 10.1177/1947601911408888; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Samudio-Ruiz SL, 2012, EPIGENETICS-US, V7, P216, DOI 10.4161/epi.7.3.19273; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Tang CH, 2008, J CELL SCI, V121, P3747, DOI 10.1242/jcs.029769; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang L, 2009, GYNECOL ONCOL, V114, P265, DOI 10.1016/j.ygyno.2009.04.031; White EA, 2014, ADV DRUG DELIVER REV, V79-80, P184, DOI 10.1016/j.addr.2014.07.003; Xie C, 2013, ONCOGENE, V32, P2282, DOI 10.1038/onc.2012.251; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang W, 2013, ONCOL REP, V29, P637, DOI 10.3892/or.2012.2148; Zhang YL, 2013, MOL CANCER THER, V12, P2628, DOI 10.1158/1535-7163.MCT-13-0204	45	59	60	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2015	34	48					5923	5932		10.1038/onc.2015.43	http://dx.doi.org/10.1038/onc.2015.43			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CX1CO	25798837	Green Accepted, Green Submitted			2022-12-26	WOS:000365434000007
J	Almeida, TCA; Larentis, AL; Ferraz, HC				Abreu Almeida, Teresa Cristina; Larentis, Ariane Leites; Ferraz, Helen Conceicao			Evaluation of the Stability of Concentrated Emulsions for Lemon Beverages Using Sequential Experimental Designs	PLOS ONE			English	Article							WATER EMULSIONS; RHEOLOGY; GROWTH; GUM	The study of the stability of concentrated oil-in-water emulsions is imperative to provide a scientific approach for an important problem in the beverage industry, contributing to abolish the empiricism still present nowadays. The use of these emulsions would directly imply a reduction of transportation costs between production and the sales points, where dilution takes place. The goal of this research was to evaluate the influence of the main components of a lemon emulsion on its stability, aiming to maximize the concentration of oil in the beverage and to correlate its physicochemical characteristics to product stability, allowing an increase of shelf life of the final product. For this purpose, analyses of surface and interface tension, electrokinetic potential, particle size and rheological properties of the emulsions were conducted. A 24-1 fractional factorial design was performed with the following variables: lemon oil/water ratio (30% to 50%), starch and Arabic gum concentrations (0% to 30%) and dioctyl sodium sulfosuccinate (0 mg/L to 100 mg/L), including an evaluation of the responses at the central conditions of each variable. Sequentially, a full design was prepared to evaluate the two most influential variables obtained in the first plan, in which concentration of starch and gum ranged from 0% to 20%, while concentration of lemon oil/water ratio was fixed at 50%, without dioctyl sodium sulfosuccinate. Concentrated emulsions with stability superior to 15 days were obtained with either starch or Arabic gum and 50% lemon oil. The most stable formulations presented viscosity over 100 cP and ratio between the surface tension of the emulsion and the mucilage of over 1. These two answers were selected, since they better represent the behavior of emulsions in terms of stability and could be used as tools for an initial selection of the most promising formulations.	[Abreu Almeida, Teresa Cristina; Ferraz, Helen Conceicao] Univ Fed Rio de Janeiro, COPPE, Chem Engn Program, BR-21941972 Rio De Janeiro, RJ, Brazil; [Larentis, Ariane Leites] Fiocruz MS, ENSP, CESTEH, BR-21041210 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Larentis, AL (corresponding author), Fiocruz MS, ENSP, CESTEH, BR-21041210 Rio De Janeiro, RJ, Brazil.	arianelarentis@fiocruz.br; helen@peq.coppe.ufrj.br	Ferraz, Helen/AAF-1060-2019	FERRAZ, HELEN/0000-0002-6058-5296	Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Coordination for the Improvement of Higher Education Personnel); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/National Counsel of Technological and Scientific Development) from Brazil	Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Coordination for the Improvement of Higher Education Personnel); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/National Counsel of Technological and Scientific Development) from Brazil	No specific funding was received for this work. Scholarships and laboratory material was supported by Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Coordination for the Improvement of Higher Education Personnel) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/National Counsel of Technological and Scientific Development) from Brazil; ENSP/Fiocruz supported language revision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo-Carrillo JI, 2006, CARBOHYD POLYM, V65, P327, DOI 10.1016/j.carbpol.2006.01.016; Byrd S. J., 2006, SAIB OLDEST NEW INGR; Cottrell T., 2004, Emulsifiers in food technology, P162, DOI 10.1002/9780470995747.ch7; Dickinson E., 1992, INTRO FOOD COLLOIDS; Einsfeldt K, 2011, VACCINE, V29, P7136, DOI 10.1016/j.vaccine.2011.05.073; Friberg SE., 2004, FOOD EMULSIONS; Iemma AF, 2014, EXPT DESIGN PROCESS; Marini G, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-1; McClements D.J., 1999, FOOD EMULSIONS PRINC, P267; McClements DJ, 2007, CRIT REV FOOD SCI, V47, P611, DOI 10.1080/10408390701289292; Mirhosseini H, 2008, COLLOID SURFACE A, V315, P47, DOI 10.1016/j.colsurfa.2007.07.007; Mirhosseini H, 2007, J AGR FOOD CHEM, V55, P7659, DOI 10.1021/jf071061k; Myers D, 1999, SURFACES INTERFACES; Niraula B, 2004, COLLOID SURFACE A, V251, P117, DOI 10.1016/j.colsurfa.2004.08.071; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P227, DOI 10.1016/j.cis.2003.10.025; Tadros T.F., 2009, EMULSION SCI TECHNOL; Tesch S, 2002, J FOOD ENG, V54, P167, DOI 10.1016/S0260-8774(01)00206-0; Walstra P., 2003, PHYS CHEM FOODS	18	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118690	10.1371/journal.pone.0118690	http://dx.doi.org/10.1371/journal.pone.0118690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793301	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200032
J	Bibiloni, MD; Salas, R; Novelo, HI; Villarreal, JZ; Sureda, A; Tur, JA				del Mar Bibiloni, Maria; Salas, Rogelio; Novelo, Hilda I.; Villarreal, Jesus Z.; Sureda, Antoni; Tur, Josep A.			Serum Lipid Levels and Dyslipidaemia Prevalence among 2-10 Year-Old Northern Mexican Children	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; BODY-MASS INDEX; CARDIOVASCULAR RISK; ADOLESCENTS; TRACKING; OBESITY; CHILDHOOD; ASSOCIATION; POPULATION; OVERWEIGHT	Background and Aims The increase in overweight and obese children may be linked to increased rates of dyslipidaemia. The aim was to assess the prevalence of dyslipidaemia and associated risk factors among the Northern Mexican child population. Methods and Results Four hundred and fifty-one subjects aged between 2 and 10 (47.5% girls) took part in the Nuevo Leon State Survey of Nutrition and Health 2011-2012. According to the 2011 Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, serum lipid levels (mg/dL) were categorized into three subgroups (acceptable, borderline-high/low or high/low) as follows: TChol: acceptable <170, borderline-high 170-199, high >= 200; LDL-chol: acceptable <110, borderline-high 110-129, high >= 130; non-HDL-chol: acceptable <120, borderline-high 120-144, high >= 145; HDL-chol: acceptable >45, borderline-low 40-45, low <40; and TG: acceptable <75, borderline-high 75-99, high >= 100 in <= 9 year-old children, and acceptable <90, borderline-high 90-129, and high >= 130 in 10 year-old children. The overall prevalence of borderline-high + high TG, non-HDL-chol, TChol, and LDL-chol was 63.0%, 44.1%, 43.5%, and 29.9%, respectively. The overall prevalence of borderline-low + low HDL-chol was 46.3%. The overall frequency of dyslipidaemia was 54.3%. Thirteen children (2.9%) had all five symptoms of dyslipidaemia. The most common dyslipidaemia was high TG in combination (26.2%) and in isolation (10.6%). Conclusions Half of the children had at least one abnormal lipid concentration. A high TG level was the most frequent dyslipidaemia. Obesity was associated with the occurrence of at least one abnormal lipid level. These findings emphasize the need to pay further attention to the prevention of cardiovascular disease and obesity from an early age.	[del Mar Bibiloni, Maria; Sureda, Antoni; Tur, Josep A.] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain; [del Mar Bibiloni, Maria; Sureda, Antoni; Tur, Josep A.] CIBEROBN Physiopathol Obes & Nutr, Palma De Mallorca, Spain; [Salas, Rogelio; Novelo, Hilda I.] Autonomous Univ Nuevo Leon, Fac Publ Hlth Nutr, Monterrey, Mexico; [Villarreal, Jesus Z.] Dept Hlth State Nuevo Leon, Monterrey, Mexico	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidad Autonoma de Nuevo Leon	Tur, JA (corresponding author), Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain.	pep.tur@uib.es	del Mar Bibiloni, Maria/M-3123-2014; Sureda, Antoni/N-9588-2019; Tur, Josep Antoni/F-5576-2014; Gomila, Antonio Sureda/L-7191-2014; Tur, Josep/AAE-5748-2020; Bibiloni, Maria del Mar/H-9734-2015; , Antoni/AAB-5250-2019	del Mar Bibiloni, Maria/0000-0001-8926-9206; Sureda, Antoni/0000-0001-8656-6838; Tur, Josep Antoni/0000-0002-6940-0761; Gomila, Antonio Sureda/0000-0003-2101-616X; Tur, Josep/0000-0002-6940-0761; , Antoni/0000-0001-8656-6838; /0000-0001-9835-1594	Department of Health, Government of the State of Nuevo Leon (Mexico); State Survey of Nutrition and Health-Nuevo Leon; Spanish Ministry of Health and Consumer Affairs [11/01791, RD06/0045/1004, CB12/03/30038]; Balearic Islands Gov. [35/2011]; Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands under the Centre Catala de la Nutricio (IEC); Exernet Network; EU FEDER funds [35/2011]	Department of Health, Government of the State of Nuevo Leon (Mexico); State Survey of Nutrition and Health-Nuevo Leon; Spanish Ministry of Health and Consumer Affairs(Spanish Government); Balearic Islands Gov.; Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands under the Centre Catala de la Nutricio (IEC); Exernet Network; EU FEDER funds(European Commission)	This study was financially supported by the Department of Health, Government of the State of Nuevo Leon (Mexico), State Survey of Nutrition and Health-Nuevo Leon 2011/2012 (EESN-NL 2011/2012); Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences, Projects 11/01791, Red Predimed-RETIC RD06/0045/1004, and CIBEROBN CB12/03/30038); grant of support to research groups no. 35/2011 (Balearic Islands Gov. and EU FEDER funds); and the Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands, coming under the Centre Catala de la Nutricio (IEC) and Exernet Network.	Agency for Healhcare Research and Quality, 2012, GUID CLIN PREV SERV; [Anonymous], 2011, Rev. salud pública, V13, P196, DOI 10.1590/S0124-00642011000200002; Azizi F, 2001, EUR J EPIDEMIOL, V17, P281, DOI 10.1023/A:1017932212350; Caamano MC, 2011, OJPM, V1, P171; Can M, 2013, PEDIATR CARDIOL, V34, P566, DOI 10.1007/s00246-012-0495-1; Cardoso-Saldaña Guillermo C., 2010, Arch. Cardiol. Méx., V80, P12; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dai SF, 2014, J PEDIATR-US, V164, P247, DOI 10.1016/j.jpeds.2013.08.069; Alcântara Neto Osvaldo Dário de, 2012, Rev. bras. epidemiol., V15, P335, DOI 10.1590/S1415-790X2012000200011; Franca Everaldo de, 2006, Arq. Bras. Cardiol., V87, P722, DOI 10.1590/S0066-782X2006001900007; DELONG DM, 1986, JAMA-J AM MED ASSOC, V256, P2372, DOI 10.1001/jama.256.17.2372; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Ford ES, 2009, CIRCULATION, V119, P1108, DOI 10.1161/CIRCULATIONAHA.108.816769; Ghergerehchi Robabeh, 2009, Ther Clin Risk Manag, V5, P739; Gidding SS, 1995, AM J MED SCI, V310, pS68, DOI 10.1097/00000441-199512000-00012; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Hernandez-Valero MA, 2012, J IMMIGR MINOR HEALT, V14, P517, DOI 10.1007/s10903-011-9535-9; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Kelder SH, 2002, PREV MED, V34, P324, DOI 10.1006/pmed.2001.0990; Kell KP, 2014, AM J CLIN NUTR, V100, P46, DOI 10.3945/ajcn.113.076505; Kosova EC, 2013, J ACAD NUTR DIET, V113, P219, DOI 10.1016/j.jand.2012.10.020; Li J, 2010, PHARMACOEPIDEM DR S, V19, P1031, DOI 10.1002/pds.1982; McCrindle BW, 2012, PEDIATRICS, V130, P353, DOI 10.1542/peds.2012-1137; Monge-Rojas R, 2001, ARCH LATINOAM NUTR, V51, P236; National Heart Lung and Blood Institute, 2012, NIH PUBLICATION, V12-7486; Nobre LN, 2013, J PEDIAT-BRAZIL, V89, P462, DOI 10.1016/j.jped.2013.02.020; oecd, OBESITY EC PREVENTIO; Okada M, 2001, PREV MED, V32, P224, DOI 10.1006/pmed.2000.0805; Pereira A, 2009, ARQ BRAS CARDIOL, V93, P253, DOI 10.1590/S0066-782X2009000900009; Peterson Amy L, 2012, WMJ, V111, P274; PORKKA KVK, 1994, AM J EPIDEMIOL, V140, P1096, DOI 10.1093/oxfordjournals.aje.a117210; PORKKA KVK, 1991, PREV MED, V20, P713, DOI 10.1016/0091-7435(91)90066-D; Posadas-Sanchez R, 2007, METABOLISM, V56, P1666, DOI 10.1016/j.metabol.2007.07.009; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Roche Diagnostics Corporation, 2005, COB 6000 AN SER OP M; Martinez MDR, 2014, J PHYS ACT HEALTH, V11, pS74, DOI 10.1123/jpah.2014-0172; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652; Sundvall J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-63; United States Preventive Services Task Force, 2007, SCREEN LIP DIS CHILD; Vieira ACR, 2009, REV SAUDE PUBL, V43, P44, DOI 10.1590/S0034-89102008005000062; Lima SCVC, 2011, NUTR HOSP, V26, P304, DOI [10.3305/nh.2011.26.24961, 10.1590/S0212-16112011000200010]; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968; Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166; Welsh JA, 2010, JAMA-J AM MED ASSOC, V303, P1490, DOI 10.1001/jama.2010.449; Yang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049253	48	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119877	10.1371/journal.pone.0119877	http://dx.doi.org/10.1371/journal.pone.0119877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793380	gold, Green Submitted, Green Published			2022-12-26	WOS:000352084200123
J	Hasegawa, Y; Suyama, Y; Seiwa, K				Hasegawa, Yoichi; Suyama, Yoshihisa; Seiwa, Kenji			Variation in Pollen-Donor Composition among Pollinators in an Entomophilous Tree Species, Castanea crenata, Revealed by Single-Pollen Genotyping	PLOS ONE			English	Article							BIPARENTAL INBREEDING DEPRESSION; FLORAL DISPLAY SIZE; MULTIPLE PATERNITY; COMPUTER-PROGRAM; GENE FLOW; PLANT; CONSEQUENCES; DISPERSAL; CARRYOVER; DISTANCE	Background In plants, reproductive success is largely determined by the composition of pollen (i.e., self-pollen and outcross-pollen from near and distant pollen-donors) transported as a result of pollinator foraging behavior (e.g., pollen carryover). However, little evidence is available on how and to what extent the pollen carryover affects the pollen-donor composition and on which insect taxa are effective outcross-pollen transporters under field conditions. In this study, we explored roles of foraging behavior of insect pollinators on pollen-donor composition and subsequent reproductive success in a woody plant. Methods We performed paternity analyses based on microsatellite genotyping of individual pollen grains found on diurnal pollinators (i.e., bumblebee, small bee, fly, small beetle, and honeybee) visiting Castanea crenata trees. Results The outcross-pollen rate was highest in bumblebees (66%), followed by small bees (35%), flies (31%), and small beetles (18%). The effective number of pollen donors, representing pollen carryover, was greater in bumblebees (9.71) than in flies (3.40), small bees (3.32), and small beetles (3.06). The high percentages of pollen from outside the plot on bumblebees (65.4%) and flies (71.2%) compared to small bees (35.3%) and small beetles (13.5%) demonstrated their longer pollen dispersal distances. Conclusions All of the diurnal insects carried outcross-pollen grains for long distances via pollen carryover. This fact suggests that a wide range of insect taxa are potential outcross-pollen transporters for the self-incompatible C. crenata.	[Hasegawa, Yoichi; Suyama, Yoshihisa; Seiwa, Kenji] Tohoku Univ, Grad Sch Agr Sci, Osaki, Miyagi, Japan; [Hasegawa, Yoichi] Akita Prefectural Univ, Inst Wood Technol, Noshiro, Akita, Japan	Tohoku University; Akita Prefectural University	Hasegawa, Y (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Osaki, Miyagi, Japan.	yohase@gmail.com	Suyama, Yoshihisa/H-6115-2017	Suyama, Yoshihisa/0000-0002-3136-5489	Japan Society for the Promotion of Science [17380095]; Sasakawa Scientific Research Grant from the Japan Science Society; Grants-in-Aid for Scientific Research [25850113] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sasakawa Scientific Research Grant from the Japan Science Society; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was financially supported by the Japan Society for the Promotion of Science (No. 17380095) to YS and a Sasakawa Scientific Research Grant from the Japan Science Society to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, SINGLE-POLLEN GENOTYPING, P47, DOI 10.1007/978-4-431-53901-8_5; Aigner PA, 2001, OIKOS, V95, P177, DOI 10.1034/j.1600-0706.2001.950121.x; Barthelmess EL, 2006, NEW PHYTOL, V169, P689, DOI 10.1111/j.1469-8137.2005.01580.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Brunet J, 2009, MOL ECOL, V18, P3745, DOI 10.1111/j.1365-294X.2009.04304.x; Buck EJ, 2003, MOL ECOL NOTES, V3, P239, DOI 10.1046/j.1471-8286.2003.00410.x; Chifflet R, 2011, J APPL ECOL, V48, P689, DOI 10.1111/j.1365-2664.2010.01904.x; Cozzolino S, 2005, P ROY SOC B-BIOL SCI, V272, P1271, DOI 10.1098/rspb.2005.3069; de Oliveira D, 2001, ACTA HORTIC, P269, DOI 10.17660/ActaHortic.2001.561.40; DUDASH MR, 1991, AM J BOT, V78, P1746, DOI 10.2307/2444854; Farrington L, 2009, AUST J BOT, V57, P276, DOI 10.1071/BT08138; GALEN C, 1988, J THEOR BIOL, V135, P419, DOI 10.1016/S0022-5193(88)80257-1; Harder LD, 1998, ECOLOGY, V79, P2789, DOI 10.1890/0012-9658(1998)079[2789:TCOHTC]2.0.CO;2; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hasegawa Y, 2009, NEW PHYTOL, V182, P994, DOI 10.1111/j.1469-8137.2009.02806.x; Herlihy CR, 2004, EVOLUTION, V58, P2693, DOI 10.1111/j.0014-3820.2004.tb01622.x; Herrera Carlos M., 1996, P65; Herrera CM, 2000, ECOLOGY, V81, P15, DOI 10.1890/0012-9658(2000)081[0015:FTSCOD]2.0.CO;2; HERRERA CM, 1987, OIKOS, V50, P79, DOI 10.2307/3565403; Heywood John S., 1993, American Journal of Botany, V80, P545, DOI [10.1002/j.1537-2197.1993.tb13838.x, 10.2307/2445370]; Hirao AS, 2006, MOL ECOL, V15, P1165, DOI 10.1111/j.1365-294X.2006.02853.x; Hirota SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085601; Holmquist KG, 2012, PLANT SPEC BIOL, V27, P77, DOI 10.1111/j.1442-1984.2011.00329.x; Indsto JO, 2006, AUST J BOT, V54, P669, DOI 10.1071/BT05146; Jaynes R. A., 1975, Advances in fruit breeding. Temperate nuts., P490; Jha S, 2010, P NATL ACAD SCI USA, V107, P13760, DOI 10.1073/pnas.1002490107; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kamm U, 2009, HEREDITY, V103, P476, DOI 10.1038/hdy.2009.70; Karron JD, 2004, HEREDITY, V92, P242, DOI 10.1038/sj.hdy.6800402; KLINAC DJ, 1995, NEW ZEAL J CROP HORT, V23, P331, DOI 10.1080/01140671.1995.9513906; Kondo T, 2011, SINGLE-POLLEN GENOTYPING, P63, DOI 10.1007/978-4-431-53901-8_6; Lertzman K.P., 1983, P474; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Marinoni D, 2003, MOL BREEDING, V11, P127, DOI 10.1023/A:1022456013692; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matsuki Y, 2007, MOL ECOL NOTES, V7, P194, DOI 10.1111/j.1471-8286.2006.01588.x; Matsuki Y, 2008, AM J BOT, V95, P925, DOI 10.3732/ajb.0800036; Matsuki Y, 2011, SINGLE-POLLEN GENOTYPING, P17, DOI 10.1007/978-4-431-53901-8_3; MEAGHER TR, 1986, AM NAT, V128, P199, DOI 10.1086/284554; Mitchell RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076312; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1355, DOI 10.1093/aob/mcp122; MURAWSKI DA, 1986, OECOLOGIA, V68, P161, DOI 10.1007/BF00384782; NASON JD, 1995, EVOLUTION, V49, P307, DOI [10.1111/j.1558-5646.1995.tb02243.x, 10.2307/2410341]; Ohashi K, 1998, AM J BOT, V85, P219, DOI 10.2307/2446309; Ohashi K, 2009, ANN BOT-LONDON, V103, P1365, DOI 10.1093/aob/mcp088; RAMSEY MW, 1988, OECOLOGIA, V76, P119, DOI 10.1007/BF00379609; RITLAND K, 1989, EVOLUTION, V43, P848, DOI [10.2307/2409312, 10.1111/j.1558-5646.1989.tb05182.x]; ROBERTSON AW, 1992, BIOL J LINN SOC, V46, P333, DOI 10.1111/j.1095-8312.1992.tb00868.x; Sampson JF, 1998, HEREDITY, V81, P349, DOI 10.1046/j.1365-2540.1998.00404.x; Sasaki M, 2010, BEES VIEW FLOWERING; SCHEMSKE DW, 1984, SCIENCE, V225, P519, DOI 10.1126/science.225.4661.519; SEAVEY SR, 1986, BOT REV, V52, P195, DOI 10.1007/BF02861001; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Suyama Y, 1996, GENES GENET SYST, V71, P145, DOI 10.1266/ggs.71.145; Suyama Y, 2011, SINGLE-POLLEN GENOTYPING, P7, DOI 10.1007/978-4-431-53901-8_2; Teixeira S, 2007, MOL ECOL, V16, P4370, DOI 10.1111/j.1365-294X.2007.03493.x; Wadl PA, 2009, HORTSCIENCE, V44, P1527; Wagenius S, 2010, EVOLUTION, V64, P761, DOI 10.1111/j.1558-5646.2009.00860.x; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WASER NM, 1984, OECOLOGIA, V62, P262, DOI 10.1007/BF00379024; Widmer A, 2000, MOL ECOL, V9, P1911, DOI 10.1046/j.1365-294x.2000.01103.x; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; WILSON P, 1991, ECOLOGY, V72, P1503, DOI 10.2307/1941124; Yamamoto T, 2003, J HORTIC SCI BIOTECH, V78, P197, DOI 10.1080/14620316.2003.11511606; Young HJ, 2002, AM J BOT, V89, P433, DOI 10.3732/ajb.89.3.433; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	67	22	25	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120393	10.1371/journal.pone.0120393	http://dx.doi.org/10.1371/journal.pone.0120393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793619	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900024
J	Higgins, MA; Asner, GP; Anderson, CB; Martin, RE; Knapp, DE; Tupayachi, R; Perez, E; Elespuru, N; Alonso, A				Higgins, Mark A.; Asner, Gregory P.; Anderson, Christopher B.; Martin, Roberta E.; Knapp, David E.; Tupayachi, Raul; Perez, Eneas; Elespuru, Nydia; Alonso, Alfonso			Regional-Scale Drivers of Forest Structure and Function in Northwestern Amazonia	PLOS ONE			English	Article							RAIN-FOREST; IMAGING SPECTROSCOPY; TROPICAL FORESTS; FOOTPRINT LIDAR; PATTERNS; TREE; BIOMASS; SOILS; PTERIDOPHYTES; TURNOVER	Field studies in Amazonia have found a relationship at continental scales between soil fertility and broad trends in forest structure and function. Little is known at regional scales, however, about how discrete patterns in forest structure or functional attributes map onto underlying edaphic or geological patterns. We collected airborne LiDAR (Light Detection and Ranging) data and VSWIR (Visible to Shortwave Infrared) imaging spectroscopy measurements over 600 km(2) of northwestern Amazonian lowland forests. We also established 83 inventories of plant species composition and soil properties, distributed between two widespread geological formations. Using these data, we mapped forest structure and canopy reflectance, and compared them to patterns in plant species composition, soils, and underlying geology. We found that variations in soils and species composition explained up to 70% of variation in canopy height, and corresponded to profound changes in forest vertical profiles. We further found that soils and plant species composition explained more than 90% of the variation in canopy reflectance as measured by imaging spectroscopy, indicating edaphic and compositional control of canopy chemical properties. We last found that soils explained between 30% and 70% of the variation in gap frequency in these forests, depending on the height threshold used to define gaps. Our findings indicate that a relatively small number of edaphic and compositional variables, corresponding to underlying geology, may be responsible for variations in canopy structure and chemistry over large expanses of Amazonian forest.	[Higgins, Mark A.; Asner, Gregory P.; Anderson, Christopher B.; Martin, Roberta E.; Knapp, David E.; Tupayachi, Raul] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Perez, Eneas; Elespuru, Nydia] Univ Nacl Amazonia Peruana, Fac Ciencias Biol, Iquitos, Peru; [Alonso, Alfonso] Smithsonian Conservat Biol Inst, Ctr Conservat Educ & Sustainabil, Washington, DC USA	Carnegie Institution for Science; Universidad Nacional de la Amazonia Peruana; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Asner, GP (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	gpa@stanford.edu	Tupayachi, Raul/F-3986-2011; Asner, Gregory/G-9268-2013; Martin, Roberta/A-5073-2015	Tupayachi, Raul/0000-0002-4661-2075; Asner, Gregory/0000-0001-7893-6421; Martin, Roberta/0000-0003-3509-8530; Anderson, Christopher/0000-0001-7392-4368	Carnegie Institution for Science (USA); National Science Foundation (USA); American-Scandinavian Foundation (USA); Duke University (USA)	Carnegie Institution for Science (USA); National Science Foundation (USA)(National Science Foundation (NSF)); American-Scandinavian Foundation (USA); Duke University (USA)	This work was supported by the Carnegie Institution for Science (USA; www.carnegiescience.edu), Fellowship support to MAH. Grant number not available. This work was also supported by the National Science Foundation (USA; www.nsf.gov), Fellowship support to MAH. Grant number not available. This study was further supported by the American-Scandinavian Foundation (USA; www.amscan.org), Fellowship support to MAH. Grant number not available. Finally, the study was supported by Duke University (USA; www.duke.edu), Small travel grant to MAH. Grant numbers not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sanchez-Azofeifa GA, 2009, REMOTE SENS ENVIRON, V113, P2076, DOI 10.1016/j.rse.2009.05.013; Asner GP, 2013, BIOGEOSCI DISCUSS, V10, P15415; Asner GP, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2794018; Asner GP, 2008, REMOTE SENS ENVIRON, V112, P3958, DOI 10.1016/j.rse.2008.07.003; Asner GP, 2015, REMOTE SENS ENVIRON, V158, P15, DOI 10.1016/j.rse.2014.11.011; Asner GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060875; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Asner GP, 2011, REMOTE SENS ENVIRON, V115, P3587, DOI 10.1016/j.rse.2011.08.020; Asner GP, 2011, NEW PHYTOL, V189, P999, DOI 10.1111/j.1469-8137.2010.03549.x; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baldeck CA, 2013, REMOTE SENS-BASEL, V5, P2057, DOI 10.3390/rs5052057; Botschek J, 1996, GEODERMA, V72, P119, DOI 10.1016/0016-7061(96)00026-2; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Clark ML, 2012, REMOTE SENS-BASEL, V4, P1820, DOI 10.3390/rs4061820; Clark ML, 2011, REMOTE SENS ENVIRON, V115, P2931, DOI 10.1016/j.rse.2010.08.029; Colgan MS, 2012, REMOTE SENS-BASEL, V4, P3462, DOI 10.3390/rs4113462; Drake JB, 2002, REMOTE SENS ENVIRON, V81, P378, DOI 10.1016/S0034-4257(02)00013-5; Feret JB, 2012, REMOTE SENS-BASEL, V4, P2457, DOI 10.3390/rs4082457; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Higgins MA, 2004, CONSERV BIOL, V18, P799, DOI 10.1111/j.1523-1739.2004.00235.x; Higgins MA, 2014, REMOTE SENS ENVIRON, V154, P358, DOI 10.1016/j.rse.2013.09.032; Higgins MA, 2011, J BIOGEOGR, V38, P2136, DOI 10.1111/j.1365-2699.2011.02585.x; Higgins MA, 2012, REMOTE SENS-BASEL, V4, P2401, DOI 10.3390/rs4082401; INGEMMET, 2000, MAP GEOL PER; Jones MM, 2013, J ECOL, V101, P506, DOI 10.1111/1365-2745.12053; Kellner JR, 2011, ECOSYSTEMS, V14, P1156, DOI 10.1007/s10021-011-9472-4; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Kellner JR, 2009, ECOL LETT, V12, P155, DOI 10.1111/j.1461-0248.2008.01274.x; Kokaly RF, 2009, REMOTE SENS ENVIRON, V113, pS78, DOI 10.1016/j.rse.2008.10.018; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Mascaro J, 2011, BIOGEOSCIENCES, V8, P1615, DOI 10.5194/bg-8-1615-2011; Myneni RB, 1997, IEEE T GEOSCI REMOTE, V35, P1380, DOI 10.1109/36.649788; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; Ruokolainen K, 1997, J TROP ECOL, V13, P243, DOI 10.1017/S0266467400010439; Ruokolainen K, 2007, J TROP ECOL, V23, P13, DOI 10.1017/S0266467406003889; SANCHEZ PA, 1974, SOIL SCI SOC AM J, V38, P117, DOI 10.2136/sssaj1974.03615995003800010036x; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Thiers B., INDEX HERBARIORUM GL; Toomey M, 2009, REMOTE SENS ENVIRON, V113, P1787, DOI 10.1016/j.rse.2009.04.002; Tuomisto H, 2003, J ECOL, V91, P743, DOI 10.1046/j.1365-2745.2003.00802.x; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Ustin SL, 2009, REMOTE SENS ENVIRON, V113, pS67, DOI 10.1016/j.rse.2008.10.019; Vitousek P, 2009, ECOLOGY, V90, P3074, DOI 10.1890/08-0813.1; WESSMAN CA, 1988, NATURE, V335, P154, DOI 10.1038/335154a0	51	15	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119887	10.1371/journal.pone.0119887	http://dx.doi.org/10.1371/journal.pone.0119887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793602	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200125
J	Holloway, DM; Spirov, AV				Holloway, David M.; Spirov, Alexander V.			Mid-Embryo Patterning and Precision in Drosophila Segmentation: Kruppel Dual Regulation of hunchback	PLOS ONE			English	Article							GENE-EXPRESSION; GAP GENES; POSITIONAL INFORMATION; MORPHOGEN GRADIENT; REACTION-DIFFUSION; SHARP BORDERS; HOX PRO; TRANSCRIPTION; REPRESSION; ACTIVATION	In early development, genes are expressed in spatial patterns which later define cellular identities and tissue locations. The mechanisms of such pattern formation have been studied extensively in early Drosophila (fruit fly) embryos. The gap gene hunchback (hb) is one of the earliest genes to be expressed in anterior-posterior (AP) body segmentation. As a transcriptional regulator for a number of downstream genes, the spatial precision of hb expression can have significant effects in the development of the body plan. To investigate the factors contributing to hb precision, we used fine spatial and temporal resolution data to develop a quantitative model for the regulation of hb expression in the mid-embryo. In particular, modelling hb pattern refinement in mid nuclear cleavage cycle 14 (NC14) reveals some of the regulatory contributions of simultaneously-expressed gap genes. Matching the model to recent data from wild-type (WT) embryos and mutants of the gap gene Kruppel (Kr) indicates that a mid-embryo Hb concentration peak important in thoracic development (at parasegment 4, PS4) is regulated in a dual manner by Kr, with low Kr concentration activating hb and high Kr concentration repressing hb. The processes of gene expression (transcription, translation, transport) are intrinsically random. We used stochastic simulations to characterize the noise generated in hb expression. We find that Kr regulation can limit the positional variability of the Hb mid-embryo border. This has been recently corroborated in experimental comparisons of WT and Kr-mutant embryos. Further, Kr regulation can decrease uncertainty in mid-embryo hb expression (i.e. contribute to a smooth Hb boundary) and decrease between-copy transcriptional variability within nuclei. Since many tissue boundaries are first established by interactions between neighbouring gene expression domains, these properties of Hb-Kr dynamics to diminish the effects of intrinsic expression noise may represent a general mechanism contributing to robustness in early development.	[Holloway, David M.] British Columbia Inst Technol, Dept Math, Burnaby, BC V5G 3H2, Canada; [Spirov, Alexander V.] SUNY Stony Brook, Comp Sci, Stony Brook, NY 11794 USA; [Spirov, Alexander V.] SUNY Stony Brook, Ctr Excellence Wireless & Informat Technol, Stony Brook, NY 11794 USA; [Spirov, Alexander V.] IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia	British Columbia Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Holloway, DM (corresponding author), British Columbia Inst Technol, Dept Math, Burnaby, BC V5G 3H2, Canada.	David_Holloway@bcit.ca	Spirov, Alexander V/G-4806-2010; Holloway, David/B-1075-2015	Spirov, Alexander V/0000-0002-0509-6203; Holloway, David/0000-0002-3865-0725	United States National Institutes of Health [R01-GM072022]; Russian Foundation for Basic Research [13-04-02137]; Dynasty Foundation [NG13-083]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072022, R56GM072022] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Dynasty Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States National Institutes of Health (www.nih.gov), grant R01-GM072022 (to DMH AVS); the Russian Foundation for Basic Research (www.rfbr.ru/rffi/eng), grant 13-04-02137 (to AVS); and The Dynasty Foundation (www.dynastyfdn.com/english/), grant NG13-083 (to AVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2010, BIOPHYS J, V99, pL33, DOI 10.1016/j.bpj.2010.05.031; Alves F, 2006, J THEOR BIOL, V241, P342, DOI 10.1016/j.jtbi.2005.11.034; Ay A, 2011, CRIT REV BIOCHEM MOL, V46, P137, DOI 10.3109/10409238.2011.556597; Bauer DC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-366; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Bieler J, 2011, BIOPHYS J, V101, P287, DOI 10.1016/j.bpj.2011.05.060; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bonneton F, 1997, MECH DEVELOP, V66, P143, DOI 10.1016/S0925-4773(97)00100-7; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Dubuis JO, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.72; Elf J., 2004, Systems Biology, V1, P230, DOI 10.1049/sb:20045021; Elf J, 2003, P SOC PHOTO-OPT INS, V5110, P114, DOI 10.1117/12.497009; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Garcia HG, 2013, CURR BIOL, V23, P2140, DOI 10.1016/j.cub.2013.08.054; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gray S, 1996, GENE DEV, V10, P700, DOI 10.1101/gad.10.6.700; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Hardway H, 2008, J THEOR BIOL, V254, P390, DOI 10.1016/j.jtbi.2008.05.021; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; He F, 2008, DEV CELL, V15, P558, DOI 10.1016/j.devcel.2008.09.004; He F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060876; He F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019122; He X, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000935; HOCH M, 1991, EMBO J, V10, P2267, DOI 10.1002/j.1460-2075.1991.tb07763.x; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; Holloway DM, 2002, TRENDS GENET, V18, P385, DOI 10.1016/S0168-9525(02)02724-5; Holloway DM, 1999, MATH BIOSCI, V156, P271, DOI 10.1016/S0025-5564(98)10070-6; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; HULSKAMP M, 1991, BIOESSAYS, V13, P261, DOI 10.1002/bies.950130602; Ilsley GR, 2013, ELIFE, V2, DOI 10.7554/eLife.00522; JACKLE H, 1986, NATURE, V324, P668, DOI 10.1038/324668a0; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2009, MOL BIOSYST, V5, P1549, DOI 10.1039/b904722k; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Kozlov K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002635; KRAUT R, 1991, DEVELOPMENT, V111, P601; KRAUT R, 1991, DEVELOPMENT, V111, P611; Lacalli T.C., 1991, Seminars in Developmental Biology, V2, P107; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Liu JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062641; Lopes FJP, 2012, DEV BIOL, V370, P165, DOI 10.1016/j.ydbio.2012.07.020; Lopes FJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000184; Lucas T, 2013, CURR BIOL, V23, P2135, DOI 10.1016/j.cub.2013.08.053; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; MANU, 2009, PLOS COMPUT BIOL, V5, P53908, DOI DOI 10.1371/JOURNAL.PBIO.1000049; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; McGregor AP, 2001, DEV GENES EVOL, V211, P315, DOI 10.1007/s004270100148; Okabe-Oho Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000486; Papatsenko D, 2008, P NATL ACAD SCI USA, V105, P2901, DOI 10.1073/pnas.0711941105; Papatsenko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021145; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; Perry MW, 2012, CURR BIOL, V22, P2247, DOI 10.1016/j.cub.2012.09.051; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Porcher A, 2010, DEVELOPMENT, V137, P2795, DOI 10.1242/dev.051300; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; Samee MA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003467; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; Sauer F, 1996, PHILOS T ROY SOC B, V351, P579, DOI 10.1098/rstb.1996.0057; SCHRODER C, 1988, EMBO J, V7, P2881, DOI 10.1002/j.1460-2075.1988.tb03145.x; SCHULZ C, 1994, DEVELOPMENT, V120, P3043; Sokolowski TR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002654; Spirov AV, 2000, NUCLEIC ACIDS RES, V28, P337, DOI 10.1093/nar/28.1.337; Spirov AV, 2002, NUCLEIC ACIDS RES, V30, P351, DOI 10.1093/nar/30.1.351; Surkova S, 2013, DEV BIOL, V376, P99, DOI 10.1016/j.ydbio.2013.01.008; TREISMAN J, 1989, NATURE, V341, P335, DOI 10.1038/341335a0; Umulis D, 2008, CURR TOP DEV BIOL, V81, P65, DOI 10.1016/S0070-2153(07)81002-7; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wu XL, 2001, DEV BIOL, V237, P79, DOI 10.1006/dbio.2001.0355; Yu D, 2008, CURR BIOL, V18, P868, DOI 10.1016/j.cub.2008.05.050; Zagrijchuk EA, 2014, J BIOINF COMPUT BIOL, V12, DOI 10.1142/S0219720014410091; Zamparo L, 2009, BIOINFORMATICS, V25, P2670, DOI 10.1093/bioinformatics/btp415; ZUO P, 1991, GENE DEV, V5, P254, DOI 10.1101/gad.5.2.254	83	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118450	10.1371/journal.pone.0118450	http://dx.doi.org/10.1371/journal.pone.0118450			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793381	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200024
J	Horiuchi, H; Parajuli, B; Wang, Y; Azuma, YT; Mizuno, T; Takeuchi, H; Suzumura, A				Horiuchi, Hiroshi; Parajuli, Bijay; Wang, Yue; Azuma, Yasu-Taka; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio			Interleukin-19 Acts as a Negative Autocrine Regulator of Activated Microglia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INTERFERON-GAMMA; CUTTING EDGE; IL-19; EXPRESSION; CYTOKINES; FAMILY; HEMICHANNELS; BRAIN; IL-20	Activated microglia can exert either neurotoxic or neuroprotective effects, and they play pivotal roles in the pathogenesis and progression of various neurological diseases. In this study, we used cDNA microarrays to show that interleukin-19 (IL-19), an IL-10 family cytokine, is markedly upregulated in activated microglia. Furthermore, we found that microglia are the only cells in the nervous system that express the IL-19 receptor, a heterodimer of the IL-20R alpha and IL-20R beta subunits. IL-19 deficiency increased the production of such pro-inflammatory cytokines as IL-6 and tumor necrosis factor-alpha in activated microglia, and IL-19 treatment suppressed this effect. Moreover, in a mouse model of Alzheimer's disease, we observed upregulation of IL-19 in affected areas in association with disease progression. Our findings demonstrate that IL-19 is an anti-inflammatory cytokine, produced by activated microglia, that acts negatively on microglia in an autocrine manner. Thus, microglia may self-limit their inflammatory response by producing the negative regulator IL-19.	[Horiuchi, Hiroshi; Parajuli, Bijay; Wang, Yue; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Azuma, Yasu-Taka] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pharmacol, Div Vet Sci, Osaka 5988531, Japan	Nagoya University; Osaka Metropolitan University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	htake@riem.nagoya-u.ac.jp	Parajuli, Bijay/G-2961-2015; Bijay, Parajuli/AAT-5590-2021	Parajuli, Bijay/0000-0003-3813-113X; Takeuchi, Hideyuki/0000-0001-5912-7581; Horiuchi, Hiroshi/0000-0001-9008-2027; Azuma, Yasu-Taka/0000-0002-3515-171X	Ministry of Health, Labour and Welfare of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation)	This work was supported by a grant-in-aid for Scientific Research on Innovative Areas; grants from the Ministry of Health, Labour and Welfare of Japan; and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma YT, 2010, INFLAMM BOWEL DIS, V16, P1017, DOI 10.1002/ibd.21151; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Cooley ID, 2014, GLIA, V62, P818, DOI 10.1002/glia.22644; Cuneo AA, 2010, J MOL CELL CARDIOL, V49, P647, DOI 10.1016/j.yjmcc.2010.04.016; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Ellison S, 2014, AM J PATHOL, V184, P2134, DOI 10.1016/j.ajpath.2014.04.001; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Hsing CH, 2008, SHOCK, V29, P7, DOI 10.1097/shk.0b013e318067de40; Hsing CH, 2006, ANN THORAC SURG, V81, P2196, DOI 10.1016/j.athoracsur.2006.01.092; Hsing CH, 2008, CYTOKINE, V44, P221, DOI 10.1016/j.cyto.2008.06.007; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Kawanokuchi J, 2006, MULT SCLER J, V12, P558, DOI 10.1177/1352458506070763; Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Liao SC, 2004, J IMMUNOL, V173, P6712, DOI 10.4049/jimmunol.173.11.6712; Liao YC, 2002, J IMMUNOL, V169, P4288, DOI 10.4049/jimmunol.169.8.4288; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Menon R, 2006, J MATERN-FETAL NEO M, V19, P209, DOI 10.1080/14767050500440986; Nakanishi H, 2009, BEHAV BRAIN RES, V201, P1, DOI 10.1016/j.bbr.2009.02.001; Nelson PT, 2002, ANN MED, V34, P491, DOI 10.1080/078538902321117698; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Preimel D, 2004, J MOL MODEL, V10, P290, DOI 10.1007/s00894-004-0195-8; Sabat R, 2007, EXPERT OPIN THER TAR, V11, P601, DOI 10.1517/14728222.11.5.601; Sakurai N, 2008, RHEUMATOLOGY, V47, P815, DOI 10.1093/rheumatology/ken061; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Sawada M, 2009, PARKINSONISM RELAT D, V15, pS39, DOI 10.1016/S1353-8020(09)70011-2; Sonobe Y, 2005, BRAIN RES, V1040, P202, DOI 10.1016/j.brainres.2005.01.100; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Takeuchi H, 2006, NEUROBIOL DIS, V22, P33, DOI 10.1016/j.nbd.2005.09.014; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Takeuchi H., 2010, CLIN EXP NEUROIMMUNO, V1, P12, DOI [10.1111/j.1759-1961.2009.00001.x, DOI 10.1111/J.1759-1961.2009.00001.X]; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Takeuchi H, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00189; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; Wang XS, 2007, J INTERF CYTOK RES, V27, P599, DOI 10.1089/jir.2006.0157; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397	48	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118640	10.1371/journal.pone.0118640	http://dx.doi.org/10.1371/journal.pone.0118640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794104	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200031
J	Hwang, JC; Jiang, MY; Lu, YH; Wang, CT				Hwang, Jyh-Chang; Jiang, Ming-Yan; Lu, Yi-Hua; Wang, Charn-Ting			Precedent Fluctuation of Serum hs-CRP to Albumin Ratios and Mortality Risk of Clinically Stable Hemodialysis Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CHRONIC KIDNEY-DISEASE; PERITONEAL-DIALYSIS PATIENTS; INFLAMMATION; MALNUTRITION; NUTRITION	Background A high sensitivity C-reactive protein to albumin ratio (hs-CRP/Alb) predicts mortality risk in patients with acute kidney injury. However, it varies dynamically. This study was conducted to evaluate whether a variation of this marker was associated with long-term outcome in clinically stable hemodialysis (HD) patients. Methods hs-CRP/Alb was checked bimonthly in 284 clinically stable HD outpatients throughout all of 2008. Based on the "slope" of trend equation derived from 5-6 hs-CRP/alb ratios for each patient, the total number of patients was divided into quartiles-Group 1: beta <=-0.13, n = 71; group 2: beta>-0.13 <= 0.003; n = 71, group 3: beta>0.003 <= 0.20; and group 4: beta>0.20, n = 71. The observation period was from January 1, 2009 to August 31, 2012. Results Group 1+4 showed a worse long-term survival (p = 0.04) and a longer 5-year hospitalization stay than Group 2+3 (38.7 +/- 44.4 vs. 16.7 +/- 22.4 days, p<0.001). Group 1+4 were associated with older age (OR = 1.03, 95% CI = 1.01-1.05) and a high prevalence of congestive heart failure (OR = 2.02, 95% CI = 1.00-4.11). Standard deviation (SD) of hs-CRP/Alb was associated with male sex (beta = 0.17, p = 0.003), higher Davies co-morbidity score (beta = 0.16, p = 0.03), and baseline hs-CRP (beta = 0.39, p<0.001). Patients with lower baseline and stable trend of hs-CRP/Alb had a better prognosis. By multivariate Cox proportional methods, SD of hs-CRP/alb (HR: 1.05, 95% CI: 1.01-1.08) rather than baseline hs-CRP/Alb was an independent predictive factor for long-term mortality after adjusting for sex and HD vintage. Conclusion Clinically stable HD patients with a fluctuating variation of hs-CRP/Alb are characterized by old age, and more co-morbidity, and they tend to have longer subsequent hospitalization stay and higher mortality risk.	[Hwang, Jyh-Chang; Jiang, Ming-Yan; Lu, Yi-Hua; Wang, Charn-Ting] Chi Mei Med Ctr, Div Nephrol, Tainan, Taiwan; [Hwang, Jyh-Chang] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Hwang, JC (corresponding author), Chi Mei Med Ctr, Div Nephrol, Tainan, Taiwan.	alfonjch@seed.net.tw						Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Cooper BA, 2004, AM J KIDNEY DIS, V43, P61, DOI 10.1053/j.ajkd.2003.08.045; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; DEVILLOTA ED, 1980, INTENS CARE MED, V7, P19, DOI 10.1007/BF01692917; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147; Jindal KK, 1988, SEMIN DIALYSIS, V1, P82, DOI DOI 10.1111/J.1525-139X.1988.TB00710.X; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Menon V, 2003, AM J KIDNEY DIS, V42, P44, DOI 10.1016/S0272-6386(03)00407-4; Panichi V, 2008, NEPHROL DIAL TRANSPL, V23, P2337, DOI 10.1093/ndt/gfm951; Ranzani OT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059321; Snaedal S, 2009, AM J KIDNEY DIS, V53, P1024, DOI 10.1053/j.ajkd.2009.02.008; Stenvinkel P, 2004, SEMIN DIALYSIS, V17, P505, DOI 10.1111/j.0894-0959.2004.17611.x; Su YJ, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-185; Tsirpanlis G, 2005, NEPHROL DIAL TRANSPL, V20, P658, DOI 10.1093/ndt/gfh663; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9	17	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120266	10.1371/journal.pone.0120266	http://dx.doi.org/10.1371/journal.pone.0120266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793462	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900005
J	Ju, GQ; Cheng, J; Zhong, L; Wu, S; Zou, XY; Zhang, GY; Gu, D; Miao, S; Zhu, YJ; Sun, J; Du, T				Ju, Guan-qun; Cheng, Jun; Zhong, Liang; Wu, Shuai; Zou, Xiang-yu; Zhang, Guang-yuan; Gu, Di; Miao, Shuai; Zhu, Ying-jian; Sun, Jie; Du, Tao			Microvesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Facilitate Tubular Epithelial Cell Dedifferentiation and Growth via Hepatocyte Growth Factor Induction	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ISCHEMIA-REPERFUSION INJURY; POSTISCHEMIC KIDNEY; PROTECT; REPAIR; PATHOPHYSIOLOGY; PROGRESSION	During acute kidney injury (AKI), tubular cell dedifferentiation initiates cell regeneration; hepatocyte growth factor (HGF) is involved in modulating cell dedifferentiation. Mesenchymal stem cell (MSC)-derived microvesicles (MVs) deliver RNA into injured tubular cells and alter their gene expression, thus regenerating these cells. We boldly speculated that MVs might induce HGF synthesis via RNA transfer, thereby facilitating tubular cell dedifferentiation and regeneration. In a rat model of unilateral AKI, the administration of MVs promoted kidney recovery. One of the mechanisms of action is the acceleration of tubular cell dedifferentiation and growth. Both in vivo and in vitro, rat HGF expression in damaged rat tubular cells was greatly enhanced by MV treatment. In addition, human HGF mRNA present in MVs was delivered into rat tubular cells and translated into the HGF protein as another mechanism of HGF induction. RNase treatment abrogated all MV effects. In the in vitro experimental setting, the conditioned medium of MV-treated injured tubular cells, which contains a higher concentration of HGF, strongly stimulated cell dedifferentiation and growth, as well as Erk1/2 signaling activation. Intriguingly, these effects were completely abrogated by either c-Met inhibitor or MEK inhibitor, suggesting that HGF induction is a crucial contributor to the acceleration of cell dedifferentiation and growth. All these findings indicate that MV-induced HGF synthesis in damaged tubular cells via RNA transfer facilitates cell dedifferentiation and growth, which are important regenerative mechanisms.	[Ju, Guan-qun; Zhong, Liang; Sun, Jie] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Urol, Shanghai 200030, Peoples R China; [Zou, Xiang-yu; Zhang, Guang-yuan; Gu, Di; Miao, Shuai; Zhu, Ying-jian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China; [Du, Tao] Henan Prov Peoples Hosp, Dept Urol, Zhengzhou, Peoples R China; [Cheng, Jun] Nantong Tongzhou Peoples Hosp, Dept Urol, Nantong, Peoples R China; [Wu, Shuai] Qingdao Municipal Hosp, Dept Urol, Qingdao, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Zhengzhou University; Qingdao Municipal Hospital	Sun, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Urol, Shanghai 200030, Peoples R China.	ppdrsun@gmail.com; ddtcwxdzy@hotmail.com			National Natural Science Foundation of China [81170642, 81270689]; Research Program of Science and Technology Commission of Shanghai Municipality [12ZR1419200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Program of Science and Technology Commission of Shanghai Municipality	Funding: This study is supported by grants from the National Natural Science Foundation of China (81170642, 81270689), and the Research Program of Science and Technology Commission of Shanghai Municipality (12ZR1419200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192; Camussi G, 2010, CURR OPIN NEPHROL HY, V19, P7, DOI 10.1097/MNH.0b013e328332fb6f; Chawla LS, 2011, CONTRIB NEPHROL, V174, P182, DOI 10.1159/000329396; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Du T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096836; Du T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/261697; Du T, 2012, CYTOTHERAPY, V14, P1215, DOI 10.3109/14653249.2012.711471; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Gobe GC, 2007, INT J BIOCHEM CELL B, V39, P1551, DOI 10.1016/j.biocel.2007.04.025; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; He J, 2012, NEPHROLOGY, V17, P493, DOI 10.1111/j.1440-1797.2012.01589.x; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Kilpinen L, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.21927; Kusaba T, 2013, P NATL ACAD SCI US; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; ROGERS SA, 1993, AM J PHYSIOL, V264, pF963, DOI 10.1152/ajprenal.1993.264.6.F963; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061366; Zhuang SG, 2005, J BIOL CHEM, V280, P21036, DOI 10.1074/jbc.M413300200; Zou XY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt428	40	97	102	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121534	10.1371/journal.pone.0121534	http://dx.doi.org/10.1371/journal.pone.0121534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793303	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900138
J	Klein, HJ; Csordas, A; Falk, V; Slankamenac, K; Rudiger, A; Schonrath, F; Biefer, HRC; Starck, CT; Graf, R				Klein, Holger J.; Csordas, Adam; Falk, Volkmar; Slankamenac, Ksenija; Rudiger, Alain; Schoenrath, Felix; Biefer, Hector Rodriguez Cetina; Starck, Christoph T.; Graf, Rolf			Pancreatic Stone Protein Predicts Postoperative Infection in Cardiac Surgery Patients Irrespective of Cardiopulmonary Bypass or Surgical Technique	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; SEPSIS BIOMARKERS; PROCALCITONIN; EXPRESSION; MORTALITY	Introduction We investigated the role of pancreatic stone protein (PSP) in predicting the occurrence of infection in the postoperative course of cardiac surgery patients. Several biomarkers indicating the presence of inflammation and infection are available in the clinical routine; yet, their utility in the postoperative course of patients following cardiac surgery remains uncertain. Moreover, cardiopulmonary bypass, also referred to as "on-pump surgery", increases the susceptibility to an exaggerated inflammatory state. However, the impact of such extracorporeal circulation on circulating PSP levels remains poorly understood. Methods In a prospective cohort of unselected patients undergoing cardiac surgery, we set out to elucidate the diagnostic accuracy of serum PSP levels as opposed to canonical biomarkers (CRP, WBC) of inflammation to discriminate between the presence of infection and surgical trauma,. In addition, we investigated whether the biomarkers were influenced by the surgical technique employed, i.e. on-pump vs. off-pump and minimally invasive surgery vs. sternotomy. Levels of circulating PSP and routine inflammatory biomarkers (CRP, WBC) were measured in samples taken from 120 patients at baseline as well as at postoperative day 1-3. Results Univariate analysis showed that among the biomarkers investigated, only PSP levels had discriminatory power to differentiate infection from surgical trauma in the postoperative course of the entire cohort of patients following cardiac surgery. With regard to cardiac surgical interventions, there was no significant association between the absence or presence of extracorporeal circulation and PSP levels. However, there was a significant difference in the slope of the rise of postoperative PSP between minimally invasive surgery as opposed to patients subjected to sternotomy. Conclusion In an unselected population of cardiac surgery patients, post-operative serum PSP levels were significantly associated with the presence of infection in both the on-pump and off-pump setting. Of note, the surgical technique employed (sternotomy vs. minimally invasive approach) had a significant impact on postoperative PSP levels.	[Klein, Holger J.; Falk, Volkmar; Schoenrath, Felix; Biefer, Hector Rodriguez Cetina; Starck, Christoph T.] Univ Zurich Hosp, Div Cardiovasc Surg, CH-8091 Zurich, Switzerland; [Csordas, Adam] Univ Heart Ctr Zurich, Dept Cardiol, Zurich, Switzerland; [Slankamenac, Ksenija; Graf, Rolf] Univ Zurich Hosp, Div Visceral & Transplant Surg, CH-8091 Zurich, Switzerland; [Rudiger, Alain] Univ Zurich Hosp, Div Anesthesiol, Cardiosurg Intens Care Unit, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Klein, HJ (corresponding author), Univ Zurich Hosp, Div Cardiovasc Surg, CH-8091 Zurich, Switzerland.	holger.klein@usz.ch	Starck, Christoph/AAC-7252-2022	Starck, Christoph/0000-0002-2753-1456; Graf, Rolf/0000-0001-7449-7302; Rudiger, Alain/0000-0001-7943-7624; Falk, Volkmar/0000-0002-7911-8620; Rodriguez Cetina Biefer, Hector/0000-0002-5855-8993; Slankamenac, Ksenija/0000-0002-3568-9253	Gebert-Ruef Foundation	Gebert-Ruef Foundation	This study was supported by a grant from the Gebert-Ruef Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Boeck L, 2011, CHEST, V140, P925, DOI 10.1378/chest.11-0018; Busani S, 2012, CRIT CARE, V16, DOI 10.1186/cc11433; CARRERE J, 1992, DIFFERENTIATION, V51, P55, DOI 10.1111/j.1432-0436.1992.tb00680.x; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cremer J, 1996, ANN THORAC SURG, V61, P1714, DOI 10.1016/0003-4975(96)00055-0; DECARO A, 1979, BIOCHEM BIOPH RES CO, V87, P1176, DOI 10.1016/S0006-291X(79)80031-5; Erdfelder E., 2004, ALLGEMEINE PSYCHOL D, P148; Gukasjan R, 2013, CRIT CARE MED, V41, P1027, DOI 10.1097/CCM.0b013e3182771193; Holmes JH, 2002, INFLAMM RES, V51, P579, DOI 10.1007/PL00012432; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; IOVANNA J, 1993, PANCREAS, V8, P597, DOI 10.1097/00006676-199309000-00011; Keel M, 2009, CRIT CARE MED, V37, P1642, DOI 10.1097/CCM.0b013e31819da7d6; KEIM V, 1994, DIGESTION, V55, P65, DOI 10.1159/000201127; Kopterides P, 2010, CRIT CARE MED, V38, P2229, DOI 10.1097/CCM.0b013e3181f17bf9; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Litmathe J, 2011, HELL J CARDIOL, V52, P493; Llewelyn MJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12588; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Prondzinsky R, 2005, J THORAC CARDIOV SUR, V129, P760, DOI 10.1016/j.jtcvs.2004.07.052; Que YA, 2012, CRIT CARE, V16, DOI 10.1186/cc11406; Sablotzki A, 2002, PERFUSION-UK, V17, P103, DOI 10.1191/0267659102pf543oa; Sinning JM, 2012, EUR HEART J, V33, P1459, DOI 10.1093/eurheartj/ehs002; Yang J, 2014, ENDOCRINE; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	26	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120276	10.1371/journal.pone.0120276	http://dx.doi.org/10.1371/journal.pone.0120276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793700	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000352083900007
J	Knigge, A; Kloting, N; Schon, MR; Dietrich, A; Fasshauer, M; Gartner, D; Lohmann, T; Dressler, M; Stumvoll, M; Kovacs, P; Bluher, M				Knigge, Anja; Kloeting, Nora; Schoen, Michael R.; Dietrich, Arne; Fasshauer, Mathias; Gaertner, Daniel; Lohmann, Tobias; Dressler, Miriam; Stumvoll, Michael; Kovacs, Peter; Blueher, Matthias			ADCY5 Gene Expression in Adipose Tissue Is Related to Obesity in Men and Mice	PLOS ONE			English	Article							TYPE-2 DIABETES RISK; ADENYLYL-CYCLASE; BIRTH-WEIGHT; FAT; VARIANTS; LIFE	Genome wide association studies revealed an association of the single nucleotide polymorphism rs11708067 within the ADCY5 gene-encoding adenylate cyclase 5-with increased type 2 diabetes (T2D) risk and higher fasting glucose. However, it remains unclear whether the association between ADCY5 variants and glycemic traits may involve adipose tissue (AT) related mechanisms. We therefore tested the hypothesis that ADCY5 mRNA expression in human and mouse AT is related to obesity, fat distribution, T2D in humans and high fat diet (HFD) in mice. We measured ADCY5 mRNA expression in paired samples of visceral and subcutaneous adipose tissue from 244 individuals with a wide range of body weight and parameters of hyperglycemia, which have been genotyped for rs11708067. In addition, AT ADCY5 mRNA was assessed in C57BL/6NTac which underwent a 10 weeks standard chow (n = 6) or high fat diet (HFD, n = 6). In humans, visceral ADCY5 expression is significantly higher in obese compared to lean individuals. ADCY5 expression correlates with BMI, body fat mass, circulating leptin, fat distribution, waist and hip circumference, but not with fasting plasma glucose and HbA1c. Adcy5 expression in mouse AT is significantly higher after a HFD compared to chow (p< 0.05). Importantly, rs11708067 is not associated with ADCY5 mRNA expression levels in either fat depot in any of the genetic models tested. Our results suggest that changes in AT ADCY5 expression are related to obesity and fat distribution, but not with impaired glucose metabolism and T2D. However, altered ADCY5 expression in AT does not seem to be the mechanism underlying the association between rs11708067 and increased T2D risk.	[Knigge, Anja; Kloeting, Nora; Fasshauer, Mathias; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Endocrinol & Nephrol, Dept Med Dermatol & Neurol, D-04109 Leipzig, Germany; [Kloeting, Nora] Univ Leipzig, Integriertes Forsch & Behandlungszentrum IFB Adip, Jr Res Grp Anim Models Obes 2, D-04109 Leipzig, Germany; [Schoen, Michael R.; Gaertner, Daniel] Stadt Klinikum Karlsruhe, Clin Visceral Surg, Karlsruhe, Germany; [Dietrich, Arne] Univ Leipzig, Dept Surg, D-04109 Leipzig, Germany; [Lohmann, Tobias; Dressler, Miriam] Municipal Clin Dresden Neustadt, Dresden, Germany; [Kovacs, Peter] Univ Leipzig, Integriertes Forsch & Behandlungszentrum IFB Adip, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Municipal Hospital Karlsruhe; Leipzig University; Leipzig University	Bluher, M (corresponding author), Univ Leipzig, Dept Endocrinol & Nephrol, Dept Med Dermatol & Neurol, D-04109 Leipzig, Germany.	bluma@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423	Deutsche Diabetes Gesellschaft, Germany; Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank) [FKZ 01GI1128]; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 1052]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	Deutsche Diabetes Gesellschaft, Germany; Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	This work was supported by grants of Deutsche Diabetes Gesellschaft, Germany. This work was further supported by the Kompetenznetz Adipositas (Competence network for Obesity) funded by the Federal Ministry of Education and Research (German Obesity Biomaterial Bank; FKZ 01GI1128), a grant from Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 1052, Obesity Mechanisms"; projects B01 and B03), and by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EA, 2010, DIABETOLOGIA, V53, P1908, DOI 10.1007/s00125-010-1790-0; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Bluher M, 2013, BEST PRACT RES CL EN, V27, P163, DOI 10.1016/j.beem.2013.02.005; Bluher M, 2008, OBESITY FACTS, V1, P176, DOI 10.1159/000145930; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Cash TP, 2014, AGING CELL, V13, P1087, DOI 10.1111/acel.12261; de Gortari P, 2010, BRAIN RES, V1310, P37, DOI 10.1016/j.brainres.2009.11.009; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Du WW, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.305; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hodson DJ, 2014, DIABETES, V63, P3009, DOI 10.2337/db13-1607; Hu CL, 2009, AM J PHYSIOL-HEART C, V297, pH1776, DOI 10.1152/ajpheart.00050.2009; Huopio H, 2013, EUR J ENDOCRINOL, V169, P291, DOI 10.1530/EJE-13-0286; Jones RH, 2009, MOL CELL ENDOCRINOL, V297, P4, DOI 10.1016/j.mce.2008.06.020; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Ortiz-Capisano MC, 2007, HYPERTENSION, V49, P618, DOI 10.1161/01.HYP.0000255172.84842.d2; Vasan SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021331; Wagner R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023639; Windholz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022101; Yaghootkar H, 2012, CURR OPIN CLIN NUTR, V15, P258, DOI 10.1097/MCO.0b013e328351f543	23	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120742	10.1371/journal.pone.0120742	http://dx.doi.org/10.1371/journal.pone.0120742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793868	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900071
J	Lopez-Sanchez, P; Cersosimo, J; Wang, DJ; Flanagan, B; Stokes, JR; Gidley, MJ				Lopez-Sanchez, Patricia; Cersosimo, Julie; Wang, Dongjie; Flanagan, Bernadine; Stokes, Jason R.; Gidley, Michael J.			Poroelastic Mechanical Effects of Hemicelluloses on Cellulosic Hydrogels under Compression	PLOS ONE			English	Article							PLANT-CELL WALL; XYLOGLUCAN; ARCHITECTURE; COMPOSITES; DEFICIENT; GROWTH	Hemicelluloses exhibit a range of interactions with cellulose, the mechanical consequences of which in plant cell walls are incompletely understood. We report the mechanical properties of cell wall analogues based on cellulose hydrogels to elucidate the contribution of xyloglucan or arabinoxylan as examples of two hemicelluloses displaying different interactions with cellulose. We subjected the hydrogels to mechanical pressures to emulate the compressive stresses experienced by cell walls in planta. Our results revealed that the presence of either hemicellulose increased the resistance to compression at fast strain rates. However, at slow strain rates, only xyloglucan increased composite strength. This behaviour could be explained considering the microstructure and the flow of water through the composites confirming their poroelastic nature. In contrast, small deformation oscillatory rheology showed that only xyloglucan decreased the elastic moduli. These results provide evidence for contrasting roles of different hemicelluloses in plant cell wall mechanics and man-made cellulose-based composite materials.	[Lopez-Sanchez, Patricia; Cersosimo, Julie; Wang, Dongjie; Flanagan, Bernadine; Gidley, Michael J.] Univ Queensland, Australian Res Ctr, Ctr Excellence Plant Cell Walls, Ctr Nutr & Food Sci,Queensland Alliance Agr & Foo, Brisbane, Qld, Australia; [Stokes, Jason R.] Univ Queensland, Australian Res Ctr, Ctr Excellence Plant Cell Walls, Sch Chem Engn, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Lopez-Sanchez, P (corresponding author), Univ Queensland, Australian Res Ctr, Ctr Excellence Plant Cell Walls, Ctr Nutr & Food Sci,Queensland Alliance Agr & Foo, Brisbane, Qld, Australia.	p.lopezsanchez@uq.edu.au	Stokes, Jason R/A-1608-2009; Flanagan, Bernadine/A-7130-2011; Flanagan, Bernadine/AAO-2273-2020; Gidley, Mike/AAT-9543-2021; Flanagan, Bernadine/U-7222-2019; Lopez-Sanchez, Patricia/AAA-8259-2021	Stokes, Jason R/0000-0001-7784-9297; Flanagan, Bernadine/0000-0002-5220-190X; Flanagan, Bernadine/0000-0002-5220-190X; Lopez-Sanchez, Patricia/0000-0002-2461-327X				Astley OM, 2003, INT J BIOL MACROMOL, V32, P28, DOI 10.1016/S0141-8130(03)00022-9; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575; Buyanov AL, 2010, J MECH BEHAV BIOMED, V3, P102, DOI 10.1016/j.jmbbm.2009.06.001; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Carpita NC, 2001, PLANT PHYSIOL, V127, P551, DOI 10.1104/pp.010146; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Chanliaud E, 1999, PLANT J, V20, P25, DOI 10.1046/j.1365-313X.1999.00571.x; Chanliaud E, 2004, PLANT J, V38, P27, DOI 10.1111/j.1365-313X.2004.02018.x; Chanliaud E, 2002, PLANTA, V215, P989, DOI 10.1007/s00425-002-0783-8; CLARK AH, 1985, BRIT POLYM J, V17, P164, DOI 10.1002/pi.4980170214; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Doblin MS, 2014, CURR OPIN BIOTECH, V26, P108, DOI 10.1016/j.copbio.2013.11.012; Ebringerova A, 2005, ADV POLYM SCI, V186, P1, DOI 10.1007/b136816; FRY SC, 1989, J EXP BOT, V40, P1, DOI 10.1093/jxb/40.1.1; GIDLEY MJ, 1991, CARBOHYD RES, V214, P299, DOI 10.1016/0008-6215(91)80037-N; Hamant O, 2010, CURR OPIN GENET DEV, V20, P454, DOI 10.1016/j.gde.2010.04.009; LOESCHER WH, 1973, PLANT PHYSIOL, V52, P248, DOI 10.1104/pp.52.3.248; Lopez-Sanchez P, 2014, BIOMACROMOLECULES, V15, P2274, DOI 10.1021/bm500405h; Macosko C.W., 1993, RHEOLOGY PRINCIPLES; MCCANN MC, 1990, J CELL SCI, V96, P323; McKenna BA, 2009, CELLULOSE, V16, P1047, DOI 10.1007/s10570-009-9340-y; Mikkelsen D, 2011, J AGR FOOD CHEM, V59, P4025, DOI 10.1021/jf104855e; Mikkelsen D, 2011, METHODS MOL BIOL, V715, P197, DOI 10.1007/978-1-61779-008-9_14; Moeendarbary E, 2013, NAT MATER, V12, P253, DOI [10.1038/NMAT3517, 10.1038/nmat3517]; Park YB, 2012, PLANT PHYSIOL, V158, P1933, DOI 10.1104/pp.111.192880; Park YB, 2012, PLANT PHYSIOL, V158, P465, DOI 10.1104/pp.111.189779; Pauly M, 1999, PLANT J, V20, P629, DOI 10.1046/j.1365-313X.1999.00630.x; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; SHEDLETZKY E, 1992, PLANT PHYSIOL, V100, P120, DOI 10.1104/pp.100.1.120; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Wang T, 2013, P NATL ACAD SCI USA, V110, P16444, DOI 10.1073/pnas.1316290110; Whitney SEC, 2006, AM J BOT, V93, P1402, DOI 10.3732/ajb.93.10.1402; WHITNEY SEC, 1995, PLANT J, V8, P491, DOI 10.1046/j.1365-313X.1995.8040491.x; Whitney SEC, 1999, PLANT PHYSIOL, V121, P657, DOI 10.1104/pp.121.2.657; Whitney SEC, 1998, CARBOHYD RES, V307, P299, DOI 10.1016/S0008-6215(98)00004-4; Zabotina OA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00134	39	35	36	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122132	10.1371/journal.pone.0122132	http://dx.doi.org/10.1371/journal.pone.0122132			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794048	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900172
J	Oster, M; Scheel, M; Murani, E; Ponsuksili, S; Zebunke, M; Puppe, B; Wimmers, K				Oster, Michael; Scheel, Mathias; Murani, Eduard; Ponsuksili, Siriluck; Zebunke, Manuela; Puppe, Birger; Wimmers, Klaus			The Fight-Or-Flight Response Is Associated with PBMC Expression Profiles Related to Immune Defence and Recovery in Swine	PLOS ONE			English	Article							INDIVIDUAL BEHAVIORAL-CHARACTERISTICS; HOUSING CONDITION; HUMORAL IMMUNITY; PIGS; STRESS; ANIMALS; GENE; PERFORMANCE; PHYSIOLOGY; BACKTEST	Defining phenotypes according to molecular features would promote the knowledge of functional traits like behaviour in both human and animal research. Beside physiological states or environmental factors, an innate predisposition of individual coping strategies was discussed, including the proactive and reactive pattern. According to backtest reactivity, animals assigned as high-resisting (proactive) and low-resisting (reactive) were immune challenged with tetanus toxoid in a time course experiment. Using the Affymetrix platform and qPCR, individual coping characteristics were reflected as gene expression signatures in porcine peripheral blood mononuclear cells (PBMC) at naive state (day 0) and in response to the model antigen (day 14, day 28, and day 140). Further, the blood cell count was analysed at all stages. On the transcriptional level, processes acting on cell communication, vasculogenesis, and blood coagulation were highlighted in high-resisting animals at naive state (day 0), temporarily blurred due to immune challenge (day 14) but subsequently restored and intensified (day 28). Notably, similar amounts of white and red blood cells, platelets and haematocrit between high-resisting and low-resisting samples suggest coping-specific expression patterns rather than alterations in blood cell distribution. Taken together, the gene expression patterns indicate that proactive pigs might favour molecular pathways enabling an effective strategy for defence and recovery. This corroborates the previously suggested belief, that proactive animals are prone to an increased number of injuries as an evolutionary inherited mechanism. In contrast to previous assumptions, coping-specific immunity in pigs lacks inherited shifts between cellular and humoral immune responses.	[Oster, Michael; Scheel, Mathias; Murani, Eduard; Ponsuksili, Siriluck; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany; [Zebunke, Manuela; Puppe, Birger] Leibniz Inst Farm Anim Biol FBN, Inst Behav Physiol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Wimmers, K (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Wilhelm Stahl Allee 2, Dummerstorf, Germany.	wimmers@fbn-dummerstorf.de	Wimmers, Klaus/AAF-9434-2020	Puppe, Birger/0000-0002-5513-7907; Wimmers, Klaus/0000-0002-9523-6790; Zebunke, Manuela/0000-0002-5232-5873	Federal Ministry of Education and Research (BMBF) [0315536F]; Leibniz Institute for Farm Animal Biology (FBN)	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Leibniz Institute for Farm Animal Biology (FBN)	This work was partly funded by the Federal Ministry of Education and Research (BMBF; www.bmbf.de) as part of the PHENOMICS project (support code: 0315536F; www.phaenomics.auf.uni-rostock.de). The Leibniz Institute for Farm Animal Biology (FBN) provided own matched funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2013, INT J BIOL SCI, V9, P907, DOI 10.7150/ijbs.6769; Adler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058306; BLECHA F, 1983, J ANIM SCI, V56, P396, DOI 10.2527/jas1983.562396x; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Camm AJ, 1996, CIRCULATION, V93, P1043; Cannon W., 1915, BODILY CHANGES IN PA; Cerletti C, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.023; Chmielowiec-Korzeniowska A, 2012, ARCH TIERZUCHT, V55, P469, DOI 10.5194/aab-55-469-2012; Dhabhar FS, 2003, ANN NY ACAD SCI, V992, P205, DOI 10.1111/j.1749-6632.2003.tb03151.x; ELGHAZALI GEB, 1993, EUR J IMMUNOL, V23, P2740, DOI 10.1002/eji.1830231103; Engel G L, 1972, Ciba Found Symp, V8, P57; Freeman TC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-90; Geverink NA, 2004, J ANIM SCI, V82, P1227; Geverink NA, 2004, PHYSIOL BEHAV, V80, P541, DOI 10.1016/j.physbeh.2003.10.013; Geverink NA, 2003, APPL ANIM BEHAV SCI, V81, P29, DOI 10.1016/S0168-1591(02)00253-8; Geverink NA, 2002, APPL ANIM BEHAV SCI, V77, P43, DOI 10.1016/S0168-1591(02)00024-2; Graunke KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074579; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; HESSING MJC, 1995, VET IMMUNOL IMMUNOP, V45, P97, DOI 10.1016/0165-2427(94)05338-S; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; HESSING MJC, 1994, PHYSIOL BEHAV, V55, P39, DOI 10.1016/0031-9384(94)90007-8; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LEDIVIDICH J, 1994, LIVEST PROD SCI, V38, P79, DOI 10.1016/0301-6226(94)90052-3; Li N, 2008, J LEUKOCYTE BIOL, V83, P1069, DOI 10.1189/jlb.0907615; Maier SF, 2003, BRAIN BEHAV IMMUN, V17, P69, DOI 10.1016/S0889-1591(03)00032-1; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Mayer S, 2002, IMMUNOBIOLOGY, V205, P282, DOI 10.1078/0171-2985-00131; Olsson IAS, 1999, BEHAV PROCESS, V46, P201, DOI 10.1016/S0376-6357(99)00036-4; Petelle MB, 2013, ANIM BEHAV, V86, P1147, DOI 10.1016/j.anbehav.2013.09.016; Ponsuksili S, 2002, DEV BIOL BASEL, V132, P185; Rauw Wendy M., 2012, Frontiers in Genetics, V3, P267, DOI 10.3389/fgene.2012.00267; Ruis MAW, 2000, APPL ANIM BEHAV SCI, V66, P31, DOI 10.1016/S0168-1591(99)00070-2; Schrama JW, 1997, J ANIM SCI, V75, P2588; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sutherland MA, 2005, J ANIM SCI, V83, P2087; Tierney TJ, 1997, VET IMMUNOL IMMUNOP, V57, P229, DOI 10.1016/S0165-2427(97)00011-1; Trillmich F, 2011, DEV PSYCHOBIOL, V53, P505, DOI 10.1002/dev.20573; Turner SP, 2008, BEHAV GENET, V38, P67, DOI 10.1007/s10519-007-9171-2; van Erp-van der Kooij E, 2000, APPL ANIM BEHAV SCI, V66, P171, DOI 10.1016/S0168-1591(99)00094-5; Van Reenen CG, 2005, PHYSIOL BEHAV, V85, P557, DOI 10.1016/j.physbeh.2005.06.015; Velie BD, 2009, J ANIM SCI, V87, P2767, DOI 10.2527/jas.2008-1328; Wilkie B, 1999, VET IMMUNOL IMMUNOP, V72, P231, DOI 10.1016/S0165-2427(99)00136-1; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Zebunke M., 2013, KTBL SCHRIFT, V503, P188; Zen M, 2011, AUTOIMMUN REV, V10, P305, DOI 10.1016/j.autrev.2010.11.009	49	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120153	10.1371/journal.pone.0120153	http://dx.doi.org/10.1371/journal.pone.0120153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793368	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200150
J	Oudijk, L; van Nederveen, F; Badoual, C; Tissier, F; Tischler, AS; Smid, M; Gaal, J; Lepoutre-Lussey, C; Gimenez-Roqueplo, AP; Dinjens, WNM; Korpershoek, E; de Krijger, R; Favier, J				Oudijk, Lindsey; van Nederveen, Francien; Badoual, Cecile; Tissier, Frederique; Tischler, Arthur S.; Smid, Marcel; Gaal, Jose; Lepoutre-Lussey, Charlotte; Gimenez-Roqueplo, Anne-Paule; Dinjens, Winand N. M.; Korpershoek, Esther; de Krijger, Ronald; Favier, Judith			Vascular Pattern Analysis for the Prediction of Clinical Behaviour in Pheochromocytomas and Paragangliomas	PLOS ONE			English	Article							GLAND SCALED SCORE; TUMOR ANGIOGENESIS; EXPRESSION; GENETICS; BENIGN; KI-67	Pheochromocytomas (PCCs) are neuroendocrine tumors arising from chromaffin cells of the adrenal medulla. Related tumors that arise from the paraganglia outside the adrenal medulla are called paragangliomas (PGLs). PCC/PGLs are usually benign, but approximately 17% of these tumors are malignant, as defined by the development of metastases. Currently, there are no generally accepted markers for identifying a primary PCC or PGL as malignant. In 2002, Favier et al. described the use of vascular architecture for the distinction between benign and malignant primary PCC/PGLs. The aim of this study was to validate the use of vascular pattern analysis as a test for malignancy in a large series of primary PCC/PGLs. Six independent observers scored a series of 184 genetically well-characterized PCCs and PGLs for the CD34 immunolabeled vascular pattern and these findings were correlated to the clinical outcome. Tumors were scored as malignant if an irregular vascular pattern was observed, including vascular arcs, parallels and networks, while tumors with a regular pattern of short straight capillaries were scored as benign. Mean sensitivity and specificity of vascular architecture, as a predictor of malignancy was 59.7% and 72.9%, respectively. There was significant agreement between the 6 observers (mean kappa = 0.796). Mean sensitivity of vascular pattern analysis was higher in tumors > 5 cm (63.2%) and in genotype cluster 2 tumors (100%). In conclusion, vascular pattern analysis cannot be used in a stand-alone manner as a prognostic tool for the distinction between benign and malignant PCC, but could be used as an indicator of malignancy and might be a useful tool in combination with other morphological characteristics.	[Oudijk, Lindsey; Gaal, Jose; Dinjens, Winand N. M.; Korpershoek, Esther; de Krijger, Ronald] Erasmus MC, Univ Med Ctr, Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands; [van Nederveen, Francien] PAL Dordrecht, Pathol Lab, Dordrecht, Netherlands; [Badoual, Cecile; Lepoutre-Lussey, Charlotte; Gimenez-Roqueplo, Anne-Paule; Favier, Judith] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75006 Paris, France; [Badoual, Cecile] Hop Europeen Georges Pompidou, AP HP, Dept Anatomopathol, F-75015 Paris, France; [Tissier, Frederique] Univ Paris 06, Sorbonne Univ, Pitie Salpetriere Hosp, AP HP,Dept Pathol, Paris, France; [Tissier, Frederique] Univ Paris 05, Sorbonne Paris Cite, Inst Cochin, INSERM,CNRS,UMR8104,U1016, F-75006 Paris, France; [Tischler, Arthur S.] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; [Tischler, Arthur S.] Tufts Med Ctr, Boston, MA USA; [Smid, Marcel] Canc Genom Netherlands, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [Lepoutre-Lussey, Charlotte; Gimenez-Roqueplo, Anne-Paule; Favier, Judith] INSERM, UMR970, Paris Cardiovasc Res Ctr, F-75015 Paris, France; [Gimenez-Roqueplo, Anne-Paule] Hop Europeen Georges Pompidou, AP HP, Serv Genet, F-75015 Paris, France; [de Krijger, Ronald] Reinier de Graaf Hosp, Dept Pathol, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Tufts University; Tufts Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Reinier de Graaf Hospital	Favier, J (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75006 Paris, France.	judith.favier@inserm.fr	Favier, Judith/M-7601-2017; Lussey-Lepoutre, Charlotte/AAO-7653-2020; de Krijger, Ronald/J-2564-2019; GIMENEZ-ROQUEPLO, Anne-Paule/T-6752-2018	Favier, Judith/0000-0001-8190-5853; Lussey-Lepoutre, Charlotte/0000-0003-2228-0106; GIMENEZ-ROQUEPLO, Anne-Paule/0000-0002-4816-670X; Tischler, Arthur/0000-0002-9726-5739; Smid, Marcel/0000-0003-0605-1901; Badoual, Cecile/0000-0002-1143-3085				August C, 2004, MODERN PATHOL, V17, P1119, DOI 10.1038/modpathol.3800160; Ayala-Ramirez M, 2011, J CLIN ENDOCR METAB, V96, P717, DOI 10.1210/jc.2010-1946; Crona J., 2013, J CLIN ENDOCRINOL ME; Dahia PLM, 2014, NAT REV CANCER, V14, P108, DOI 10.1038/nrc3648; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Eisenhofer G, 2012, ENDOCR PATHOL, V23, P4, DOI 10.1007/s12022-011-9188-1; Elder EE, 2003, MODERN PATHOL, V16, P246, DOI 10.1097/01.MP.0000056982.07160.E3; Favier J, 2002, AM J PATHOL, V161, P1235, DOI 10.1016/S0002-9440(10)64400-8; Feng F, 2011, J UROLOGY, V185, P1583, DOI 10.1016/j.juro.2010.12.050; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Kimura NTR, 2014, ENDOCR RELAT CANC; Lenders JWM, 2014, J CLIN ENDOCR METAB, V99, P1915, DOI 10.1210/jc.2014-1498; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Liu Q, 1996, SURGERY, V120, P938, DOI 10.1016/S0039-6060(96)80037-7; Lloyd R, 2004, WHO CLASSIFICATION T; Lorenzo FR, 2012, J MOL MED BERL; Ohji H, 2001, BJU INT, V87, P381, DOI 10.1046/j.1464-410x.2001.00102.x; Ronald A, 2004, PATHOLOGY GENETICS T; Rooijens PPGM, 2004, ENDOCR PATHOL, V15, P39, DOI 10.1385/EP:15:1:39; Thompson LDR, 2002, AM J SURG PATHOL, V26, P551, DOI 10.1097/00000478-200205000-00002; Tischler AS, 2008, ARCH PATHOL LAB MED, V132, P1272, DOI 10.1043/1543-2165(2008)132[1272:PAEPU]2.0.CO;2; Welander J, 2011, ENDOCR-RELAT CANCER, V18, pR253, DOI 10.1530/ERC-11-0170; Wu D, 2009, AM J SURG PATHOL, V33, P599, DOI 10.1097/PAS.0b013e318190d12e; Zielke A, 2002, SURGERY, V132, P1056, DOI 10.1067/msy.2002.128613	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121361	10.1371/journal.pone.0121361	http://dx.doi.org/10.1371/journal.pone.0121361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794004	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900127
J	Qin, WD; Mi, SH; Li, C; Wang, GX; Zhang, JN; Wang, H; Zhang, F; Ma, Y; Wu, DW; Zhang, MX				Qin, Wei-dong; Mi, Shao-hua; Li, Chen; Wang, Gui-xia; Zhang, Jian-ning; Wang, Hao; Zhang, Fan; Ma, Yang; Wu, Da-wei; Zhang, Mingxiang			Low Shear Stress Induced HMGB1 Translocation and Release via PECAM-1/PARP-1 Pathway to Induce Inflammation Response	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; GLYCATION END-PRODUCTS; POLY(ADP-RIBOSE) POLYMERASE; WALL SHEAR; PROTEIN; ACTIVATION; EXPRESSION; CELLS; DNA; DYSFUNCTION	Low shear stress (LSS) plays a critical role in the site predilection of atherosclerosis through activation of cellular mechanosensors, such as platelet endothelial cell adhesion molecule 1 (PECAM-1). Poly(ADP-ribose) polymerase 1 (PARP-1) is a nuclear enzyme that regulates the expression of various inflammatory cytokines. The nuclear enzyme high mobility group box 1 (HMGB1) can induce inflammation response by binding to toll-like receptor 4 (TLR4). In the present study, we aimed to investigate the role and mechanism of HMGB1 in LSS induced inflammation in human umbilical vein endothelial cells (HUVECs). HUVECs were stimulated by undisturbed shear stress (USS, 1 Pa) and LSS (0.4 Pa) in our experiments. Gene expression was inhibited by small interfering RNA (siRNA). ICAM-1 expression was regulated by LSS in a time dependent manner. LSS can induce HMGB1 translocation from nucleus to cytoplasm and release. Compared with the USS, LSS could increase the protein expression of PECAM-1 and PARP-1 as well as the secretion of TNF-alpha and IL-1 beta. LSS induced the translocation of HMGB1 from nucleus to cytoplasm. Inhibition of HGMB1 reduced LSS-induced inflammatory response. Inhibition of PARP-1 suppressed inflammatory response through inhibiting TLR4 expression and HMGB1 translocation. PECAM-1 inhibition reduced LSS-induced ICAM-1 expression, TNF-alpha and IL-1 beta secretion, and monocytes adhesion. LSS can induce inflammatory response via PECAM-1/PARP-1/HMGB1 pathway. PARP-1 plays a fundamental role in HMGB1 translocation and TLR4 expression. Inhibition of PARP-1 may shed light on the treatment of HMGB1 involved inflammation during atherosclerosis.	[Qin, Wei-dong; Li, Chen; Zhang, Jian-ning; Wang, Hao; Zhang, Fan; Ma, Yang; Wu, Da-wei] Shandong Univ, Qilu Hosp, Dept Crit Care Unit, Jinan, Shandong, Peoples R China; [Mi, Shao-hua] Yu Huang Ding Hosp, Dept Cardiol, Yantai, Shandong, Peoples R China; [Wang, Gui-xia] Linyi Peoples Hosp, Dept Radiol, Linyi, Shandong, Peoples R China; [Zhang, Mingxiang] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China; [Zhang, Mingxiang] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Wu, DW (corresponding author), Shandong Univ, Qilu Hosp, Dept Crit Care Unit, Jinan, Shandong, Peoples R China.	wdw.55@163.com; season__202@163.com	, 秦伟栋/AAF-8151-2020; Qin, Weidong/GLU-1903-2022; Wang, Hao/AGS-5901-2022	Qin, Weidong/0000-0001-7238-6860; Wang, Hao/0000-0003-4493-3147	National 973 Basic Research Program of China [2009CB521904]; National Natural Science Foundation of China for Innovative Research Group [81021001]; State Key Program of National Natural Science of China [60831003]; National Natural Science Foundation of China [81170275, 30871037, 30873325, 81400340]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 Basic Research Program of China (No. 2009CB521904), the State Program of National Natural Science Foundation of China for Innovative Research Group (No. 81021001), the State Key Program of National Natural Science of China (No. 60831003), and the National Natural Science Foundation of China (Nos. 81170275, 30871037, 30873325, and 81400340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Bustin M, 1999, MOL CELL BIOL, V19, P5237; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Cohen-Armon M, 2007, TRENDS PHARM SCI; Dhawan SS, 2010, SHEAR STRESS PLAQUE; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Han JY, 2008, DIABETES, V57, P2118, DOI 10.2337/db07-1499; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hill DA, 1999, NUCLEIC ACIDS RES, V27, P2135, DOI 10.1093/nar/27.10.2135; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Karlsson S, 2008, INTENS CARE MED, V34, P1046, DOI 10.1007/s00134-008-1032-9; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; McNally JS, 2003, AM J PHYSIOL-HEART C, V285, pH2290, DOI 10.1152/ajpheart.00515.2003; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Pacher P, 2004, J PHARMACOL EXP THER, V311, P485, DOI 10.1124/jpet.104.069658; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Paul A, 2003, ARTERIOSCLER THROMB; Poelmann RE, 2008, CIRCULATION, V117, P1124, DOI 10.1161/CIRCULATIONAHA.107.753889; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schierbeck H, 2011, MOL MED, V17, P1039, DOI 10.2119/molmed.2010.00264; Sharp C, 2001, INFLAMMATION, V25, P157, DOI 10.1023/A:1011032313445; Soriano FG, 2001, CIRC RES, V89, P684, DOI 10.1161/hh2001.097797; Szabo C, 2002, CIRCULATION, V106, P2680, DOI 10.1161/01.CIR.0000038365.78031.9C; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; WALPOLA PL, 1995, ARTERIOSCL THROM VAS, V15, P2, DOI 10.1161/01.ATV.15.1.2; Wang J, 2011, MOL MED, V17, P990, DOI 10.2119/molmed.2011.00073; WEINBAUM S, 1993, J BIOMECH ENG-T ASME, V115, P602, DOI 10.1115/1.2895547; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502; Zhou Z, 2005, EUR J PHARMACOL, V513, P1, DOI 10.1016/j.ejphar.2005.01.059	40	26	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120586	10.1371/journal.pone.0120586	http://dx.doi.org/10.1371/journal.pone.0120586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793984	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900055
J	Thieme, K; Oliveira-Souza, M				Thieme, Karina; Oliveira-Souza, Maria			Renal Hemodynamic and Morphological Changes after 7 and 28 Days of Leptin Treatment: The Participation of Angiotensin II via the AT(1) Receptor	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; BLOOD-PRESSURE; INDUCED HYPERTENSION; ANTIOXIDANT TREATMENT; ENDOTHELIAL-CELLS; INFUSED RATS; OBESE RATS; KIDNEY; DISEASE; SYSTEM	The role of hyperleptinemia in cardiovascular diseases is well known; however, in the renal tissue, the exact site of leptin's action has not been established. This study was conducted to assess the effect of leptin treatment for 7 and 28 days on renal function and morphology and the participation of angiotensin II (Ang II), through its AT(1) receptor. Rats were divided into four groups: sham, losartan (10 mg/kg/day, s.c.), leptin (0.5 mg/kg/day for the 7 days group and 0.25 mg/kg/day for the 28 days group) and leptin plus losartan. Plasma leptin, Ang II and endothelin 1 (ET-1) levels were measured using an enzymatic immuno assay. The systolic blood pressure (SBP) was evaluated using the tail-cuff method. The renal plasma flow (RPF) and the glomerular filtration rate (GFR) were determined by p-aminohippuric acid and inulin clearance, respectively. Urinary Na+ and K+ levels were also analyzed. Renal morphological analyses, desmin and ED-1 immunostaining were performed. Proteinuria was analyzed by silver staining. mRNA expression of renin-angiotensin system (RAS) components, TNF-alpha and collagen type III was analyzed by quantitative PCR. Our results showed that leptin treatment increased Ang II plasma levels and progressively increased the SBP, achieving a pre-hypertension state. Rats treated with leptin 7 days showed a normal RPF and GFR, but increased filtration fraction (FF) and natriuresis. However, rats treated with leptin for 28 showed a decrease in the RPF, an increase in the FF and no changes in the GFR or tubular function. Leptin treatment-induced renal injury was demonstrated by: glomerular hypertrophy, increased desmin staining, macrophage infiltration in the renal tissue, TNF-a and collagen type III mRNA expression and proteinuria. In conclusion, our study demonstrated the progressive renal morphological changes in experimental hyperleptinemia and the interaction between leptin and the RAS on these effects.	[Thieme, Karina; Oliveira-Souza, Maria] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade de Sao Paulo	Thieme, K (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	kathieme@icb.usp.br	Thieme, Karina/C-8560-2013; Oliveira-Souza, Maria/J-5800-2013	Thieme, Karina/0000-0003-2896-4445; Oliveira-Souza, Maria/0000-0003-0946-9377	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/58287-5, 10/51117-7, 10/19656-5, 13/19569-3, 13/23087-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471946/2009-5, 1413112010-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Grants 08/58287-5, 10/51117-7, 10/19656-5, 13/19569-3, 13/23087-4) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grants 471946/2009-5 and 1413112010-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa-Abe M, 2000, J CLIN INVEST, V105, P1243, DOI 10.1172/JCI8341; Barton M, 2010, BBA-MOL BASIS DIS, V1802, P1203, DOI 10.1016/j.bbadis.2010.03.012; Beltowski J, 2002, OBES RES, V10, P939, DOI 10.1038/oby.2002.128; Beltowski J, 2006, ARCH MED RES, V37, P307, DOI 10.1016/j.arcmed.2005.06.008; Beltowski J, 2005, LIFE SCI, V77, P1855, DOI 10.1016/j.lfs.2005.02.013; Beltowski J, 2005, PHARMACOL RES, V51, P523, DOI 10.1016/j.phrs.2005.01.007; Beltowski J, 2005, ATHEROSCLEROSIS, V178, P403, DOI 10.1016/j.atherosclerosis.2004.10.002; Beltowski J, 2004, LIFE SCI, V74, P2987, DOI 10.1016/j.lfs.2003.10.029; Beltowski J, 2008, MOL CELL BIOCHEM, V319, P163, DOI 10.1007/s11010-008-9889-z; Beltowski J, 2008, J HYPERTENS, V26, P827, DOI 10.1097/HJH.0b013e3282f47688; Beltowski J, 2006, LIFE SCI, V79, P63, DOI 10.1016/j.lfs.2005.12.041; Beltowski J, 2007, REGUL PEPTIDES, V140, P168, DOI 10.1016/j.regpep.2006.12.007; Beltowski J, 2010, PEPTIDES, V31, P155, DOI 10.1016/j.peptides.2009.10.012; Beltowski J, 2009, LIFE SCI, V85, P557, DOI 10.1016/j.lfs.2009.08.002; Benigni A, 2001, AM J KIDNEY DIS, V37, pS21, DOI 10.1053/ajkd.2001.20734; Bettowski J, 2006, PEPTIDES, V27, P3234, DOI 10.1016/j.peptides.2006.08.010; Bornstein SR, 1998, HYPERTENSION, V32, P376, DOI 10.1161/01.HYP.32.2.376; Campos R, 2012, AM J PHYSIOL-LUNG C, V302, P1640, DOI 10.1152/ajplung.00097.2011; Castillo A, 2012, AM J PHYSIOL-RENAL, V302, pF1650, DOI 10.1152/ajprenal.00426.2011; Chen YC, 2011, EUR J PHARMACOL, V658, P213, DOI 10.1016/j.ejphar.2011.02.025; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; DiBona GF, 2004, HYPERTENSION, V43, P147, DOI 10.1161/01.HYP.0000113047.47711.fa; El-Gharbawy AH, 2002, AM J HYPERTENS, V15, P989, DOI 10.1016/S0895-7061(02)03089-3; Fortuno A, 2002, ENDOCRINOLOGY, V143, P3555, DOI 10.1210/en.2002-220075; FUHR J, 1955, KLIN WOCHENSCHR, V33, P729, DOI 10.1007/BF01473295; Gunduz Z, 2005, REGUL PEPTIDES, V132, P59, DOI 10.1016/j.regpep.2005.09.017; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hama H, 2004, ENDOCRINOLOGY, V145, P3935, DOI 10.1210/en.2004-0074; Han DC, 2001, KIDNEY INT, V59, P1315, DOI 10.1046/j.1523-1755.2001.0590041315.x; Hsu YH, 2012, EUR J PHARMACOL, V689, P65, DOI 10.1016/j.ejphar.2012.06.008; Ivy JR, 2014, J PHYSIOL-LONDON, V592, P3955, DOI 10.1113/jphysiol.2014.271676; Jackson EK, 1997, AM J PHYSIOL-RENAL, V272, pF333, DOI 10.1152/ajprenal.1997.272.3.F333; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kuo JJ, 2001, HYPERTENSION, V37, P670, DOI 10.1161/01.HYP.37.2.670; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Mark AL, 2002, J HYPERTENS, V20, P1245, DOI 10.1097/00004872-200207000-00001; Mark AL, 1999, J HYPERTENS, V17, P1949, DOI 10.1097/00004872-199917121-00026; Martinez-Anso E, 1999, KIDNEY INT, V55, P1129; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Meyer C, 1997, AM J PHYSIOL-ENDOC M, V273, pE903, DOI 10.1152/ajpendo.1997.273.5.E903; Misra A, 1996, J INVEST MED, V44, P540; Morgan DA, 2008, AM J PHYSIOL-REG I, V295, pR1730, DOI 10.1152/ajpregu.90324.2008; Nasrallah MP, 2013, SEMIN NEPHROL, V33, P54, DOI 10.1016/j.semnephrol.2012.12.005; Navar LG, 2001, J RENIN-ANGIO-ALDO S, V2, pS176, DOI 10.1177/14703203010020013001; Nunes FC, 2011, J RENIN-ANGIO-ALDO S, V12, P440, DOI 10.1177/1470320310394891; Quehenberger P, 2002, CIRC RES, V90, P711, DOI 10.1161/01.RES.0000014226.74709.90; Marin ECS, 2011, NEPHRON EXP NEPHROL, V119, pE49, DOI 10.1159/000328337; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Shek EW, 1998, HYPERTENSION, V31, P409, DOI 10.1161/01.HYP.31.1.409; Shimizu MHM, 2013, EXP GERONTOL, V48, P298, DOI 10.1016/j.exger.2012.11.006; Skurk T, 2005, OBES RES, V13, P969, DOI 10.1038/oby.2005.113; SMITH HW, 1945, J CLIN INVEST, V24, P388, DOI 10.1172/JCI101618; Stenvinkel P, 1999, NEPHROL DIAL TRANSPL, V14, P1103, DOI 10.1093/ndt/14.5.1103; Villarreal D, 1998, AM J PHYSIOL-REG I, V275, pR2056, DOI 10.1152/ajpregu.1998.275.6.R2056; VONTHUN AM, 1994, AM J PHYSIOL, V266, pF120, DOI 10.1152/ajprenal.1994.266.1.F120; Wojcicka G, 2008, LIFE SCI, V82, P402, DOI 10.1016/j.lfs.2007.11.029; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Wollert KC, 1999, CARDIOVASC RES, V43, P838, DOI 10.1016/S0008-6363(99)00145-5; Zhang JD, 2014, HYPERTENSION, V64, P1275, DOI 10.1161/HYPERTENSIONAHA.114.03863; Zou LX, 1996, HYPERTENSION, V28, P669, DOI 10.1161/01.HYP.28.4.669; Zou LX, 1996, HYPERTENSION, V27, P658, DOI 10.1161/01.HYP.27.3.658	63	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122265	10.1371/journal.pone.0122265	http://dx.doi.org/10.1371/journal.pone.0122265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793389	gold, Green Submitted, Green Published			2022-12-26	WOS:000352083900175
J	Zhao, MQ; Zheng, SG; Yang, JR; Wu, YJ; Ren, YN; Kong, X; Li, W; Xuan, JL				Zhao, Mengqiu; Zheng, Shuguo; Yang, Jieren; Wu, Yuanjie; Ren, Younan; Kong, Xiang; Li, Wei; Xuan, Jiali			Suppression of TGF-beta(1)/Smad Signaling Pathway by Sesamin Contributes to the Attenuation of Myocardial Fibrosis in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ANGIOTENSIN-II; CARDIAC FIBROBLASTS; INVOLVEMENT; EXPRESSION	This study investigated the effect of sesamin on myocardial fibrosis in spontaneously hypertensive rats (SHRs) and the possible mechanisms involved. Twenty-eight male SHRs were randomly allocated to SHR group, Ses160 group (sesamin 160 mg/kg), Ses80 group (sesamin 80 mg/kg) and Cap30 group (captopril 30 mg/kg). Seven male WKY rats were used as control. Sesamin and captopril were administered intragastrically for 12 weeks. Captopril significantly reduced systolic blood pressure and angiotensin II (Ang II) levels in SHRs, accompanied by a marked attenuation of left ventricular hypertrophy (LVH) and collagen deposition (P < 0.05 or P < 0.01). Though sesamin had no significant influence on Ang II levels, and the hypotensive effect was also significantly inferior to that of captopril (P < 0.05 or P < 0.01), however, the improvement of LVH and collagen deposition was similar to that in captopril group. Sesamin markedly reduced transforming growth factor-beta(1) (TGF-beta(1)) content in cardiac tissues, with Smad3 phosphorylation decreased and Smad7 protein expression increased notably (P < 0.05 or P < 0.01). Protein expression of type I collagen and type III collagen, target genes of Smad3, was down-regulated markedly by sesamin (P < 0.05 or P < 0.01). In addition, sesamin significantly increased total antioxidant capacity and superoxide dismutase protein in cardiac tissues (P < 0.05 or P < 0.01), while the expression of NADPH oxidase subunit p47phox and malondialdehyde content were reduced markedly (P < 0.05 or P < 0.01). In vitro studies also demonstrated that sesamin was able to suppress Ang II induced phosphorylation of Smad3 and secretion of TGF-beta 1 and type I and type III collagen in cultured rat cardiac fibroblasts. These data suggest that sesamin is capable of attenuating hypertensive myocardial fibrosis through, at least partly, suppression of TGF-beta(1)/Smad signaling pathway.	[Zhao, Mengqiu; Zheng, Shuguo; Yang, Jieren; Ren, Younan; Kong, Xiang; Li, Wei; Xuan, Jiali] Wannan Med Coll, Dept Pharmacol, Wuhu 241002, Peoples R China; [Wu, Yuanjie] Anhui Univ Chinese Med, Dept Basic Theory Chinese Med, Hefei 230038, Peoples R China	Wannan Medical College; Anhui University of Chinese Medicine	Zheng, SG (corresponding author), Wannan Med Coll, Dept Pharmacol, Wuhu 241002, Peoples R China.	zhengsg2000@163.com; anhuiwuyuanjie@126.com			Anhui Provincial Natural Science Foundation [1308085QH145]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	Funding: This work was supported by Anhui Provincial Natural Science Foundation (No. 1308085QH145) (http://220.178.98.52/zrkxjj) to Xiang Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Cat AND, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI 10.1089/ars.2012.4641; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Donekal S, 2014, CIRC-CARDIOVASC IMAG, V7, P292, DOI 10.1161/CIRCIMAGING.113.001073; Golden HB, 2012, METHODS MOL BIOL, V843, P205, DOI 10.1007/978-1-61779-523-7_20; Gonzalez-Ramos M, 2013, INT J BIOCHEM CELL B, V45, P232, DOI 10.1016/j.biocel.2012.10.001; Graf K, 2010, HYPERTENSION, V55, P1088, DOI 10.1161/HYPERTENSIONAHA.110.150466; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Kannan A, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0447-7; Kong X, 2009, EUR J PHARMACOL, V620, P84, DOI 10.1016/j.ejphar.2009.08.023; Li WX, 2013, FOOD FUNCT, V4, P453, DOI 10.1039/c2fo30220a; Lijnen PJ, 2012, CARDIOVASC THER, V30, pe1, DOI 10.1111/j.1755-5922.2010.00205.x; Muxfeldt ES, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0471-7; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Purnomo Y, 2013, OXID ANTIOXID MED SC, V2, P5; Purnomo Yudi, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P165; Qin YW, 2010, ACTA PHARMACOL SIN, V31, P1350, DOI 10.1038/aps.2010.109; Rehman A, 2012, HYPERTENSION, V59, P291, DOI 10.1161/HYPERTENSIONAHA.111.180158; Rizzi E, 2013, INT J CARDIOL, V165, P165, DOI 10.1016/j.ijcard.2011.08.060; Roghani M, 2011, INT J ENDOCRINOL MET, V9, P248, DOI 10.5812/Kowsar.1726913X.2142; Silva R. B. da, 2013, Health, V5, P78; Su SW, 2014, TOXICOL LETT, V224, P257, DOI 10.1016/j.toxlet.2013.10.034; Xu JA, 2010, AM J PHYSIOL-HEART C, V299, pH1328, DOI 10.1152/ajpheart.00538.2010; Yang L, 2009, EXP MOL MED, V41, P508, DOI 10.3858/emm.2009.41.7.056; Zhang YC, 2013, PROCEEDINGS OF THE EIGHTH INTERNATIONAL SYMPOSIUM ON VITICULTURE AND ENOLOGY (2013), P37	25	27	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121312	10.1371/journal.pone.0121312	http://dx.doi.org/10.1371/journal.pone.0121312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793583	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900123
J	Zou, X; Wang, YK; Tu, GW; Zan, ZQ; Wu, XY				Zou, Xiang; Wang, Yongkang; Tu, Guangwei; Zan, Zhanquan; Wu, Xiaoyan			Adaptation and Transcriptome Analysis of Aureobasidium pullulans in Corncob Hydrolysate for Increased Inhibitor Tolerance to Malic Acid Production	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROPIONIBACTERIUM-ACIDIPROPIONICI; SACCHAROMYCES-CEREVISIAE; FURFURAL TOLERANCE; POLYMALIC ACID; ORGANIC-ACIDS; FERMENTATION; PRETREATMENTS; ETHANOL	Malic acid is a dicarboxylic acid widely used in the food industry, and is also a potential C4 platform chemical. Corncob is a low-cost renewable feedstock from agricultural industry. However, side-reaction products (furfural, 5-hydroxymethylfurfural (HMF), formic acid, and acetic acid) that severely hinder fermentation are formed during corncob pretreatment. The process for producing malic acid from a hydrolysate of corncob was investigated with a polymalic acid (PMA)-producing Aureobasidium pullulans strain. Under the optimal hydrolysate sugar concentration 110 g/L, A. pullulans was further adapted in an aerobic fibrous bed bioreactor (AFBB) by gradually increasing the sugar concentration of hydrolysate. After nine batches of fermentation, the production and productivity of malic acid reached 38.6 g/L and 0.4 g/L h, respectively, which was higher than that in the first batch (27.6 g/L and 0.29 g/L h, respectively). The adapted strain could grow under the stress of 0.5 g/L furfural, 3 g/L HMF, 2g/L acetic acid, and 0.5 g/L formic acid, whereas the wild type did not. Transcriptome analysis revealed that the differentially expressed genes were related to carbohydrate transport and metabolism, lipid transport and metabolism, signal transduction mechanism, redox metabolism, and energy production and conversion under 0.5 g/L furfural and 3 g/L HMF stress conditions. In total, 42 genes in the adapted strain were upregulated by 15-fold or more, and qRT-PCR also confirmed that the expression levels of key genes (i.e. SIR, GSS, CYS, and GSR) involved in sulfur assimilation pathway were upregulated by over 10-fold in adapted strain for cellular protection against oxidative stress.	[Zou, Xiang; Wang, Yongkang; Tu, Guangwei; Zan, Zhanquan; Wu, Xiaoyan] Southwest Univ, Chongqing Engn Res Ctr Pharmaceut Proc & Qual Con, Coll Pharmaceut Sci, Chongqing 400715, Peoples R China; [Zou, Xiang] Chongqing Univ, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China	Southwest University - China; Chongqing University	Zou, X (corresponding author), Southwest Univ, Chongqing Engn Res Ctr Pharmaceut Proc & Qual Con, Coll Pharmaceut Sci, Chongqing 400715, Peoples R China.	zhx1030@swu.edu.cn		, xiang/0000-0002-5875-1224	National High Technology Research and Development Program of China (863 Program) [SS2015AA021005, 2014AA021205]; Fundamental Research Funds for the Central Universities [XDJK2013B039, 2362014XK07]; Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education [CQKLBST- 2014-006]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education	Funding: This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (SS2015AA021005 and 2014AA021205), Fundamental Research Funds for the Central Universities (XDJK2013B039 and 2362014XK07), and Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education (CQKLBST- 2014-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SA, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-2; ASK M, 2013, BIOTECHNOL BIOFUELS, V6; BATTAT E, 1991, BIOTECHNOL BIOENG, V37, P1108, DOI 10.1002/bit.260371117; Brown SH, 2013, APPL MICROBIOL BIOT, V97, P8903, DOI 10.1007/s00253-013-5132-2; Cheng KK, 2010, APPL MICROBIOL BIOT, V87, P411, DOI 10.1007/s00253-010-2612-5; Chi ZM, 2009, APPL MICROBIOL BIOT, V82, P793, DOI 10.1007/s00253-009-1882-2; Davila JA, 2014, BIORESOURCE TECHNOL, V161, P84, DOI 10.1016/j.biortech.2014.02.131; Eken-Saracoglu N, 2000, BIOTECHNOL LETT, V22, P855, DOI 10.1023/A:1005663313597; Goldberg I, 2006, J CHEM TECHNOL BIOT, V81, P1601, DOI 10.1002/jctb.1590; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Jiang L, 2011, BIOTECHNOL BIOENG, V108, P31, DOI 10.1002/bit.22927; Kawagoe M, 1997, J FERMENT BIOENG, V84, P333, DOI 10.1016/S0922-338X(97)89254-9; Kim D, 2013, APPL ENVIRON MICROB, V79, P5069, DOI 10.1128/AEM.00643-13; Liu HM, 2011, APPL BIOCHEM BIOTECH, V164, P1150, DOI 10.1007/s12010-011-9201-7; Liu XG, 2006, PROCESS BIOCHEM, V41, P801, DOI 10.1016/j.procbio.2005.10.009; Moon SY, 2008, BIOCHEM ENG J, V40, P312, DOI 10.1016/j.bej.2008.01.001; Robinson T, 2002, BIORESOURCE TECHNOL, V85, P119, DOI 10.1016/S0960-8524(02)00099-8; Sanchez C, 2012, CHEM ENG J, V181, P655, DOI 10.1016/j.cej.2011.12.033; Sauer M, 2008, TRENDS BIOTECHNOL, V26, P100, DOI 10.1016/j.tibtech.2007.11.006; Suwannakham S, 2005, BIOTECHNOL BIOENG, V91, P325, DOI 10.1002/bit.20473; Taing O, 2007, EUR FOOD RES TECHNOL, V224, P343, DOI 10.1007/s00217-006-0323-z; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Wang X, 2011, APPL ENVIRON MICROB, V77, P5132, DOI 10.1128/AEM.05008-11; Wang X, 2013, P NATL ACAD SCI USA, V110, P4021, DOI 10.1073/pnas.1217958110; Werpy T., 2004, TOP VALUE ADDED CHEM, DOI DOI 10.2172/15008859; Yang J, 2012, OMICS, V16, P374, DOI 10.1089/omi.2011.0127; Yu J, 2010, J IND MICROBIOL BIOT, V37, P1033, DOI 10.1007/s10295-010-0750-5; Zalar P, 2008, STUD MYCOL, P21, DOI 10.3114/sim.2008.61.02; Zan ZQ, 2013, J CHEM TECHNOL BIOT, V88, P1822, DOI 10.1002/jctb.4033; Zelle RM, 2008, APPL ENVIRON MICROB, V74, P2766, DOI 10.1128/AEM.02591-07; Zhang A, 2009, BIOTECHNOL BIOENG, V104, P766, DOI 10.1002/bit.22437; Zhang X, 2011, APPL ENVIRON MICROB, V77, P427, DOI 10.1128/AEM.01971-10; Zou X, 2013, BIOTECHNOL BIOENG, V110, P2105, DOI 10.1002/bit.24876	33	23	26	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121416	10.1371/journal.pone.0121416	http://dx.doi.org/10.1371/journal.pone.0121416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793624	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900132
J	Aguilera, SE; Cole, J; Finkbeiner, EM; Le Cornu, E; Ban, NC; Carr, MH; Cinner, JE; Crowder, LB; Gelcich, S; Hicks, CC; Kittinger, JN; Martone, R; Malone, D; Pomeroy, C; Starr, RM; Seram, S; Zuercher, R; Broad, K				Aguilera, Stacy E.; Cole, Jennifer; Finkbeiner, Elena M.; Le Cornu, Elodie; Ban, Natalie C.; Carr, Mark H.; Cinner, Joshua E.; Crowder, Larry B.; Gelcich, Stefan; Hicks, Christina C.; Kittinger, John N.; Martone, Rebecca; Malone, Daniel; Pomeroy, Carrie; Starr, Richard M.; Seram, Sanah; Zuercher, Rachel; Broad, Kenneth			Managing Small-Scale Commercial Fisheries for Adaptive Capacity: Insights from Dynamic Social-Ecological Drivers of Change in Monterey Bay	PLOS ONE			English	Article							CLIMATE-CHANGE; SUSTAINABILITY; MANAGEMENT; OUTCOMES; RISK; FISH	Globally, small-scale fisheries are influenced by dynamic climate, governance, and market drivers, which present social and ecological challenges and opportunities. It is difficult to manage fisheries adaptively for fluctuating drivers, except to allow participants to shift effort among multiple fisheries. Adapting to changing conditions allows small-scale fishery participants to survive economic and environmental disturbances and benefit from optimal conditions. This study explores the relative influence of large-scale drivers on shifts in effort and outcomes among three closely linked fisheries in Monterey Bay since the Magnuson-Stevens Fisheries Conservation and Management Act of 1976. In this region, Pacific sardine (Sardinops sagax), northern anchovy (Engraulis mordax), and market squid (Loligo opalescens) fisheries comprise a tightly linked system where shifting focus among fisheries is a key element to adaptive capacity and reduced social and ecological vulnerability. Using a cluster analysis of landings, we identify four modes from 1974 to 2012 that are dominated (i.e., a given species accounting for the plurality of landings) by squid, sardine, anchovy, or lack any dominance, and seven points of transition among these periods. This approach enables us to determine which drivers are associated with each mode and each transition. Overall, we show that market and climate drivers are predominantly attributed to dominance transitions. Model selection of external drivers indicates that governance phases, reflected as perceived abundance, dictate long-term outcomes. Our findings suggest that globally, small-scale fishery managers should consider enabling shifts in effort among fisheries and retaining existing flexibility, as adaptive capacity is a critical determinant for social and ecological resilience.	[Aguilera, Stacy E.; Broad, Kenneth] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA; [Cole, Jennifer; Finkbeiner, Elena M.; Crowder, Larry B.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Le Cornu, Elodie; Crowder, Larry B.; Hicks, Christina C.; Kittinger, John N.; Martone, Rebecca] Stanford Univ, Stanford Woods Inst Environm, Ctr Ocean Solut, Monterey, CA 93940 USA; [Ban, Natalie C.] Univ Victoria, Sch Environm Studies, Victoria, BC V8W 2Y2, Canada; [Carr, Mark H.] Univ Calif Santa Cruz, Long Marine Lab, Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA; [Cinner, Joshua E.; Hicks, Christina C.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Gelcich, Stefan] Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil CAPES, Fac Ciencias Biol, Santiago, Chile; [Gelcich, Stefan] Pontificia Univ Catolica Chile, Ctr Conservac Marina, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Kittinger, John N.] Betty & Gordon Moore Ctr Sci & Oceans, Conservat Int, Honolulu, HI 96825 USA; [Pomeroy, Carrie] Univ Calif Santa Cruz, Univ Calif Sea Grant Extens Program, Ctr Ocean Hlth, Santa Cruz, CA 95060 USA; [Pomeroy, Carrie] Univ Calif Santa Cruz, Inst Marine Sci, Ctr Ocean Hlth, Santa Cruz, CA 95060 USA; [Starr, Richard M.] Univ Calif Sea Grant Extens Program, Moss Landing Marine Labs, Moss Landing, CA 95039 USA; [Zuercher, Rachel] McGill Univ, McGill Sch Environm, Montreal, PQ H3A 2A7, Canada	University of Miami; Stanford University; Stanford University; University of Victoria; University of California System; University of California Santa Cruz; James Cook University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Conservation International; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Moss Landing Marine Laboratories; McGill University	Aguilera, SE (corresponding author), Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, 1365 Mem Dr,Ungar Bldg 230M, Coral Gables, FL 33124 USA.	s.aguilera1@umiami.edu	Hicks, Christina/M-6182-2015; Cinner, Joshua/AAA-6823-2021; Cinner, Joshua e/E-8966-2011	Hicks, Christina/0000-0002-7399-4603; Cinner, Joshua e/0000-0003-2675-9317; Ban, Natalie/0000-0002-4682-2144	Center for Ocean Solutions at Stanford University; David and Lucile and Packard Foundation; Leonard and Jayne Abess Center for Ecosystem Science and Policy at the University of Miami	Center for Ocean Solutions at Stanford University; David and Lucile and Packard Foundation; Leonard and Jayne Abess Center for Ecosystem Science and Policy at the University of Miami	This work was supported by the Center for Ocean Solutions at Stanford University (LCB) (http://www.centerforoceansolutions.org), the David and Lucile and Packard Foundation (LCB) (http://www.packard.org), and the Leonard and Jayne Abess Center for Ecosystem Science and Policy at the University of Miami (KB) (http://abess.miami.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Andrew NL, 2007, FISH FISH, V8, P227, DOI 10.1111/j.1467-2679.2007.00252.x; Aseltine-Neilson D, 2006, CAL COOP OCEAN FISH, V47, P9; Badjeck M.-C., 2008, THESIS U BREMEN; Badjeck MC, 2010, MAR POLICY, V34, P375, DOI 10.1016/j.marpol.2009.08.007; Bakgaard M., 1992, Fishing for development: small scale fisheries in Africa., P173; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Berkes F., 2003, ENVIRONMENTS, V31, P5; Berkes F., 2001, MANAGING SMALL SCALE; Bodin O, 2012, GLOBAL ENVIRON CHANG, V22, P430, DOI 10.1016/j.gloenvcha.2012.01.005; BREAKER LC, 1994, OCEANOGR MAR BIOL, V32, P1; Brewer JF, 2011, ECOL SOC, V16; BUTLER JL, 1989, FISH B-NOAA, V87, P645; CalCOFI, 1984, CAL COOP OCEAN FISH, V25, P7; California Department of Fish and Wildlife, 2014, 2014 CAL LEG FISH FO; California Department of Fish and Wildlife, 2013, TABL 18 PUB POUND VA; California Wetfish Producers Association, 2013, CAL WETF IND TRAD IN; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chen C, 2012, ESTABLISHING BASELIN; Chuenpagdee R, 2006, 148 FISH CTR, V14, P1, DOI DOI 10.14288/1.0074761; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Clark C.W., 1990, MATH BIOECONOMICS OP; Dalton MG, 2001, J ENVIRON ECON MANAG, V42, P336, DOI 10.1006/jeem.2000.1158; Degnbol P, 2007, ICES J MAR SCI, V64, P793, DOI 10.1093/icesjms/fsm040; Ernst B, 2013, GLOBAL ENVIRON CHANG, V23, P1381, DOI 10.1016/j.gloenvcha.2013.08.002; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Evans LS, 2013, HUM ECOL, V41, P841, DOI 10.1007/s10745-013-9601-0; Food and Agriculture Organization, 2012, FAO WORKSH INT GUID; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Hanan D, 1996, CAL COOP OCEAN FISH, V37, P7; Hilborn R, 2001, CAN J FISH AQUAT SCI, V58, P99, DOI 10.1139/cjfas-58-1-99; Hilborn R, 2007, AMBIO, V36, P296, DOI 10.1579/0044-7447(2007)36[296:MTSBLF]2.0.CO;2; Hobday AJ, 2011, VULNERABILITY TROPIC, P493; Holland DS, 1999, CAN J FISH AQUAT SCI, V56, P253, DOI 10.1139/cjfas-56-2-253; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Johnson J, 2005, SMALL SCALE ARTISANA, V1, P1; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Kittinger JN, 2013, CURR OPIN ENV SUST, V5, P352, DOI 10.1016/j.cosust.2013.06.008; Kittinger JN, 2013, PAC SCI, V67, P315, DOI 10.2984/67.3.1; Koslow JA, 2011, CAL COOP OCEAN FISH, V52, P205; Le Gallic B, 2006, P 13 IIFET C 2006 JU; LYNN RJ, 1983, GEOPHYS RES LETT, V10, P1093, DOI 10.1029/GL010i011p01093; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; MCCAY BJ, 1978, HUM ECOL, V6, P397, DOI 10.1007/BF00889417; McEvoy Arthur, 1986, FISHERMANS PROBLEM E; National Research Council, 1999, SHAR FISH NAT POL IN; Nislow KH, 2006, FRESHWATER BIOL, V51, P388, DOI 10.1111/j.1365-2427.2005.01492.x; Norman KC, 2012, RESILIENT EC VIABLE; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pacific Fishery Management Council, 2011, COAST PEL SPEC FISH; Pacific Fishery Management Council, 2013, PAC SARD HARV PAR WO; Pacific Fishery Management Council, 2011, STAT PAC COAST COAST; Palumbi S.R., 2010, DEATH LIFE MONTEREY; Phillips G, 2002, MAR POLICY, V26, P459, DOI 10.1016/S0308-597X(02)00026-X; Pinkerton E, 2009, MAR POLICY, V33, P707, DOI 10.1016/j.marpol.2009.02.004; POMEROY C, 2002, CALIFORNIAS WETFISH, P46; Pomeroy C., 2004, MARINE SANCTUARIES C, VMSD-04-2, P73; Pomeroy C, 2005, ITS NOT JUST FISH PR; Pradhan NC, 2004, FISH RES, V68, P209, DOI 10.1016/j.fishres.2003.12.006; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Radovich J., 1982, CALCOFI REPORTS, V23, P56; Randall RG, 1996, CAN J FISH AQUAT SCI, V53, P35, DOI 10.1139/cjfas-53-S1-35; Rogers-Bennett L, 2002, CAL COOP OCEAN FISH, V43, P13; Salmi P, 2005, SOCIOL RURALIS, V45, P22, DOI 10.1111/j.1467-9523.2005.00288.x; Sanchirico JN, 2006, MAR POLICY, V30, P767, DOI 10.1016/j.marpol.2006.02.002; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shivlani M, 2010, P 62 GULF CAR FISH I; Silvano RAM, 2001, FISH RES, V51, P69, DOI 10.1016/S0165-7836(00)00229-0; State of California Resources Agency, 2005, FIN MARK SQUID FISH; Steneck RS, 2011, CONSERV BIOL, V25, P904, DOI 10.1111/j.1523-1739.2011.01717.x; Sweetnam D, 2005, CAL COOP OCEAN FISH, V46, P10; Sweetnam D, 2010, CAL COOP OCEAN FISH, V51, P14; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; Ueber E., 1992, P31, DOI 10.1017/CBO9780511565625.003; USA California Department of Fish and Game, 2003, California Cooperative Oceanic Fisheries Investigations Reports, V44, P10; Vestergaard TA, 1997, SOCIAL IMPLICATIONS, P297; Wallace C, 1999, NZJEL, V3, P33; Windle MJS, 2008, MAR POLICY, V32, P701, DOI 10.1016/j.marpol.2007.12.003	80	40	40	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118992	10.1371/journal.pone.0118992	http://dx.doi.org/10.1371/journal.pone.0118992			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790464	gold, Green Accepted, Green Published			2022-12-26	WOS:000351425400059
J	Oliveira, J; Etain, B; Lajnef, M; Hamdani, N; Bennabi, M; Bengoufa, D; Sundaresh, A; Ben Chaabane, A; Bellivier, F; Henry, C; Kahn, JP; Charron, D; Krishnamoorthy, R; Leboyer, M; Tamouza, R				Oliveira, Jose; Etain, Bruno; Lajnef, Mohamed; Hamdani, Nora; Bennabi, Meriem; Bengoufa, Djaouida; Sundaresh, Aparna; Ben Chaabane, Arij; Bellivier, Frank; Henry, Chantal; Kahn, Jean-Pierre; Charron, Dominique; Krishnamoorthy, Rajagopal; Leboyer, Marion; Tamouza, Ryad			Combined Effect of TLR2 Gene Polymorphism and Early Life Stress on the Age at Onset of Bipolar Disorders	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TOXOPLASMA-GONDII INFECTION; HERPES-SIMPLEX-VIRUS; CHILDHOOD TRAUMA; PSYCHOLOGICAL STRESS; NEUROTROPHIC FACTOR; IMMUNE ACTIVATION; ASSOCIATION; DISEASE; ABUSE	Gene-environment interactions may play an important role in modulating the impact of earlylife stressful events on the clinical course of bipolar disorder (BD), particularly associated to early age at onset. Immune dysfunction is thought to be an important mechanism linking childhood trauma with early-onset BD, thus the genetic diversity of immune-related loci may account for an important part of the interindividual susceptibility to this severe subform. Here we investigated the potential interaction between genetic variants of Toll-like receptors 2 (TLR2) and 4 (TLR4), major innate immune response molecules to pathogens, and the childhood trauma questionnaire (CTQ) in age at onset of BD. We recruited 531 BD patients (type I and II or not otherwise specified), genotyped for the TLR2 rs4696480 and rs3804099 and TLR4 rs1927914 and rs11536891 single-nucleotide polymorphisms and recorded for history of childhood trauma using the CTQ. TLR2 and TLR4 risk genotype carrier state and history of childhood emotional, physical and sexual abuses were evaluated in relation to age at onset as defined by the age at first manic or depressive episode. We observed a combined effect of TLR2 rs3804099 TT genotype and reported sexual abuse on determining an earlier age at onset of BD by means of a Kaplan-Meier survival curve (p = 0.002; corrected p = 0.02). Regression analysis, however, was non-significant for the TLR2-CTQ sexual abuse interaction term. The negative effects of childhood sexual abuse on age at onset of BD may be amplified in TLR2 rs3804099 risk genotype carriers through immune-mediated pathways. Clinical characteristics of illness severity, immune phenotypes and history of early life infectious insults should be included in future studies involving large patient cohorts.	[Oliveira, Jose; Bennabi, Meriem; Bengoufa, Djaouida; Sundaresh, Aparna; Ben Chaabane, Arij; Charron, Dominique; Krishnamoorthy, Rajagopal; Tamouza, Ryad] Hop St Louis, INSERM, U1160, Paris, France; [Etain, Bruno; Lajnef, Mohamed; Hamdani, Nora; Bellivier, Frank; Henry, Chantal; Leboyer, Marion] INSERM, Psychiat Genet U955, Creteil, France; [Bengoufa, Djaouida; Charron, Dominique; Tamouza, Ryad] Hop St Louis, Lab Jean Dausset, Paris, France; [Bengoufa, Djaouida; Charron, Dominique; Tamouza, Ryad] Hop St Louis, LabEx Transplantex, Paris, France; [Etain, Bruno; Lajnef, Mohamed; Hamdani, Nora; Bellivier, Frank; Henry, Chantal; Leboyer, Marion] Univ Paris Est, Fac Med, Creteil, France; [Etain, Bruno; Hamdani, Nora; Bellivier, Frank; Henry, Chantal; Leboyer, Marion] DHU PePSY, Hop Univ Henri Mondor, AP HP, Pole Psychiat, Creteil, France; [Oliveira, Jose; Etain, Bruno; Lajnef, Mohamed; Hamdani, Nora; Bennabi, Meriem; Sundaresh, Aparna; Ben Chaabane, Arij; Bellivier, Frank; Henry, Chantal; Kahn, Jean-Pierre; Charron, Dominique; Krishnamoorthy, Rajagopal; Leboyer, Marion; Tamouza, Ryad] Fdn FondaMental, Creteil, France; [Kahn, Jean-Pierre] CHU Nancy, Hop Brabois, Serv Psychiat & Psychol Clin, Vandoeuvre Les Nancy, France; [Charron, Dominique; Tamouza, Ryad] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Nancy; UDICE-French Research Universities; Universite Paris Cite	Tamouza, R (corresponding author), Hop St Louis, INSERM, U1160, Paris, France.	tamouza.ryad@gmail.com	Leboyer, Marion/AAW-3648-2021; Tamouza, Ryad/AGQ-6644-2022; Etain, Bruno/L-6647-2017	Leboyer, Marion/0000-0001-5473-3697; BELLIVIER, FRANK/0000-0002-3660-6640; SUNDARESH, Aparna/0000-0001-7579-8959; Oliveira, Jose/0000-0003-3475-4794; Etain, Bruno/0000-0002-5377-1488; Charron, Dominique/0000-0001-7689-8038	Foundation for Science and Technology (Portugal) [SFRH/BD/76170/2011]	Foundation for Science and Technology (Portugal)(Portuguese Foundation for Science and Technology)	J. Oliveira acknowledges the financial support of the Foundation for Science and Technology (Portugal) doctoral degree grant (SFRH/BD/76170/2011).	Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Arji N, 2014, J INFECT DEV COUNTR, V8, P430, DOI 10.3855/jidc.3820; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; BECH P, 1978, NEUROPHARMACOLOGY, V17, P430, DOI 10.1016/0028-3908(78)90022-9; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Cai MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054586; Carpenter LL, 2010, NEUROPSYCHOPHARMACOL, V35, P2617, DOI 10.1038/npp.2010.159; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen KH, 2011, SHOCK, V35, P35, DOI 10.1097/SHK.0b013e3181eb45b3; Coelho R, 2014, ACTA PSYCHIAT SCAND, V129, P180, DOI 10.1111/acps.12217; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Copeland WE, 2014, P NATL ACAD SCI USA, V111, P7570, DOI 10.1073/pnas.1323641111; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Dickerson FB, 2004, BIOL PSYCHIAT, V55, P588, DOI 10.1016/j.biopsych.2003.10.008; Etain B, 2008, BIPOLAR DISORD, V10, P867, DOI 10.1111/j.1399-5618.2008.00635.x; Etain B, 2013, J CLIN PSYCHIAT, V74, P991, DOI 10.4088/JCP.13m08353; Etain Bruno, 2012, J Clin Psychiatry, V73, pe561, DOI 10.4088/JCP.10m06504; Fang J, 2013, INVEST OPHTH VIS SCI, V54, P8384, DOI 10.1167/iovs.13-12878; Femenia T, 2012, BRAIN RES, V1476, P58, DOI 10.1016/j.brainres.2012.03.053; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde; FU ZF, 1993, J AFFECT DISORDERS, V27, P61, DOI 10.1016/0165-0327(93)90098-5; Geoffroy PA, 2013, J PHYSIOL-PARIS, V107, P278, DOI 10.1016/j.jphysparis.2013.03.006; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Goldstein BI, 2011, J CHILD ADOL PSYCHOP, V21, P479, DOI 10.1089/cap.2011.0009; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Hamdani N, 2013, J AFFECT DISORDERS, V148, P444, DOI 10.1016/j.jad.2012.11.034; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Henn A, 2011, J IMMUNOL, V186, P3237, DOI 10.4049/jimmunol.1002787; Jerrell JM, 2010, J CLIN PSYCHIAT, V71, P1518, DOI 10.4088/JCP.09m05585ora; Junpee A, 2010, PARASITOL RES, V107, P807, DOI 10.1007/s00436-010-1932-9; Kang WS, 2013, GENE, V526, P182, DOI 10.1016/j.gene.2013.04.058; Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9; Kelly-Irving M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-767; Khandaker GM, 2014, JAMA PSYCHIAT, V71, P1121, DOI 10.1001/jamapsychiatry.2014.1332; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Koga K, 2014, AM J REPROD IMMUNOL, V72, P192, DOI 10.1111/aji.12258; Leboyer M, 2005, BIPOLAR DISORD, V7, P111, DOI 10.1111/j.1399-5618.2005.00181.x; Leboyer M, 2010, J CLIN PSYCHIAT, V71, P1689, DOI 10.4088/JCP.10m06347yel; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Miller S, 2013, J PSYCHIATR RES, V47, P252, DOI 10.1016/j.jpsychires.2012.10.015; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Oliveira J, 2014, J AFFECT DISORDERS, V165, P135, DOI 10.1016/j.jad.2014.04.059; Oliveira J, 2014, J AFFECT DISORDERS, V152, P395, DOI 10.1016/j.jad.2013.09.043; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Paquette Daniel, 2004, Sante Ment Que, V29, P201; Parboosing R, 2013, JAMA PSYCHIAT, V70, P677, DOI 10.1001/jamapsychiatry.2013.896; Perroud N, 2008, GENES BRAIN BEHAV, V7, P314, DOI 10.1111/j.1601-183X.2007.00354.x; Perroud N, 2010, GENES BRAIN BEHAV, V9, P193, DOI 10.1111/j.1601-183X.2009.00547.x; Rich-Edwards JW, 2010, AM J PREV MED, V39, P529, DOI 10.1016/j.amepre.2010.09.007; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Romens SE, 2015, CHILD DEV, V86, P303, DOI 10.1111/cdev.12270; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Slopen N, 2012, BRAIN BEHAV IMMUN, V26, P239, DOI 10.1016/j.bbi.2011.11.003; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Wang X, 2013, NEOPLASMA, V60, P459, DOI 10.4149/neo_2013_060; Yu JT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-136; Zhang F, 2013, INFECTION, V41, P941, DOI 10.1007/s15010-013-0444-9	74	39	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119702	10.1371/journal.pone.0119702	http://dx.doi.org/10.1371/journal.pone.0119702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790282	Green Published, gold			2022-12-26	WOS:000351425400097
J	Tareen, SHK; Ahmad, J				Tareen, Samar Hayat Khan; Ahmad, Jamil			Modelling and Analysis of the Feeding Regimen Induced Entrainment of Hepatocyte Circadian Oscillators Using Petri Nets	PLOS ONE			English	Article							BIOLOGICAL REGULATORY NETWORKS; LIFE-SPAN; SIRT1; CLOCK; RHYTHMS; METABOLISM; EXPRESSION; NAD(+); DEACETYLASE; INHIBITION	Circadian rhythms are certain periodic behaviours exhibited by living organism at different levels, including cellular and system-wide scales. Recent studies have found that the circadian rhythms of several peripheral organs in mammals, such as the liver, are able to entrain their clocks to received signals independent of other system level clocks, in particular when responding to signals generated during feeding. These studies have found SIRT1, PARP1, and HSF1 proteins to be the major influencers of the core CLOCKBMAL1: PER-CRY circadian clock. These entities, along with abstracted feeding induced signals were modelled collectively in this study using Petri Nets. The properties of the model show that the circadian system itself is strongly robust, and is able to continually evolve. The modelled feeding regimens suggest that the usual 3 meals/day and 2 meals/day feeding regimens are beneficial with any more or less meals/day negatively affecting the system.	[Tareen, Samar Hayat Khan; Ahmad, Jamil] Natl Univ Sci & Technol, Dept Computat Sci, Res Ctr Modeling & Simulat, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Ahmad, J (corresponding author), Natl Univ Sci & Technol, Dept Computat Sci, Res Ctr Modeling & Simulat, Islamabad, Pakistan.	jamil.ahmad@rcms.nust.edu.pk	Ahmad, Jamil/AAF-5499-2021; Tareen, Samar Hayat Khan/P-3416-2014	Ahmad, Jamil/0000-0001-6618-6811; Tareen, Samar Hayat Khan/0000-0002-3902-6633				Ahmad J, 2006, LECT NOTES COMPUT SC, V3992, P887, DOI 10.1007/11758525_118; Ahmad J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033532; Ahmad J, 2010, INT J DATA MIN BIOIN, V4, P553, DOI 10.1504/IJDMB.2010.035900; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Baier C, 2008, PRINCIPLES OF MODEL CHECKING, P1; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Becker-Weimann S, 2004, BIOPHYS J, V87, P3023, DOI 10.1529/biophysj.104.040824; Bellet MM, 2011, COLD SH Q B, V76, P31, DOI 10.1101/sqb.2011.76.010520; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Bernot G, 2004, J THEOR BIOL, V229, P339, DOI 10.1016/j.jtbi.2004.04.003; Blatke M. A., 2011, TECHNICAL REPORT; Brauer W, 2009, C ADAM PETRI PETRI N, V3; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Chaouiya C, 2012, METHODS MOL BIOL, V804, P463, DOI 10.1007/978-1-61779-361-5_23; Chaouiya C, 2008, J DISCRET ALGORITHMS, V6, P165, DOI 10.1016/j.jda.2007.06.003; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Cimatti A, 2002, TECHNICAL REPORT; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; David R, 2010, DISCRETE, CONTINUOUS, AND HYBRID PETRI NETS, SECOND EDITION, P1, DOI 10.1007/978-3-642-10669-9; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Ehrenfried JA, 1996, ANN SURG, V223, P592, DOI 10.1097/00000658-199605000-00015; Ethier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047978; Formanowicz D, 2007, J BIOMED INFORM, V40, P476, DOI 10.1016/j.jbi.2006.12.001; Franzke A, 2009, THESIS BTU COTTBUS; Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011; Froy O, 2010, AGING-US, V2, P7, DOI 10.18632/aging.100116; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Gross Liza, 2007, PLoS Biol, V5, pe50, DOI 10.1371/journal.pbio.0050050; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Heiner M, 2004, BIOSYSTEMS, V75, P15, DOI 10.1016/j.biosystems.2004.03.003; Heiner M., 2012, LNCS, P398, DOI [DOI 10.1007/978-3-642-31131-4_22, DOI 10.1007/978-3-642-31131-422]; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Imai SI, 2010, BBA-PROTEINS PROTEOM, V1804, P1584, DOI 10.1016/j.bbapap.2009.10.024; Inoue K., 2011, P 22 INT JOINT C ART, P924, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-160; Jr Clarke EM, 1999, MODEL CHECKING; Katsuki K, 2004, FEBS LETT, V571, P187, DOI 10.1016/j.febslet.2004.06.087; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Khalis Z, 2009, GENES GENOMES GENOMI; Koch I, 2011, COMPUT BIOL SER, V16, P3, DOI 10.1007/978-1-84996-474-6_1; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Li L, 2009, GENE REGUL SYST BIO, V3, P105; Liu F, 2013, NAT COMPUT, V12, P617, DOI 10.1007/s11047-013-9367-8; Luna Augustin, 2013, Genome Integr, V4, P6, DOI 10.1186/2041-9414-4-6; Lynch CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013502; Majumdar A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S13; Matsuno Hiroshi, 2006, Journal of Bioinformatics and Computational Biology, V4, P139, DOI 10.1142/S021972000600176X; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Paetkau V, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-12; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Raynes Rachel, 2013, Genes Cancer, V4, P172, DOI 10.1177/1947601913484497; Richard A., 2006, MODERN FORMAL METHOD, V5, P83, DOI [DOI 10.1007/1-4020-4223-X5, 10.1007/1-4020-4223-X_5, DOI 10.1007/1-4020-4223-X_5]; Richard A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024651; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Scheer FAJL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000721; Schuldt A, 2010, NAT REV MOL CELL BIO, V11, DOI 10.1038/nrm2998; Simao E, 2005, BIOINFORMATICS, V21, P190, DOI 10.1093/bioinformatics/bti1130; Sriram K., 2006, ComPlexUs, V3, P185, DOI 10.1159/000095479; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; STROGATZ SH, 1987, J MATH BIOL, V25, P327, DOI 10.1007/BF00276440; Tamaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082006; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9; Thomas R., 1990, BIOL FEEDBACK; Thomas R, 1979, LECT NOTES BIOMATH, V29, P107, DOI [10.1007/978-3-642-49321-8_6, DOI 10.1007/978-3-642-49321-8_]; Trepanowski JF, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-57; Wang E, 2010, SYSTEMS BIOL; Wang T, 2013, ONCOL LETT, V6, P600, DOI 10.3892/ol.2013.1400	77	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0117519	10.1371/journal.pone.0117519	http://dx.doi.org/10.1371/journal.pone.0117519			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789928	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400024
J	He, C; Lv, X; Hua, G; Lele, SM; Remmenga, S; Dong, J; Davis, JS; Wang, C				He, C.; Lv, X.; Hua, G.; Lele, S. M.; Remmenga, S.; Dong, J.; Davis, J. S.; Wang, C.			YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression	ONCOGENE			English	Article							YES-ASSOCIATED PROTEIN; SURFACE EPITHELIAL-CELLS; HIPPO PATHWAY; TRANSCRIPTIONAL COACTIVATOR; TUMOR-SUPPRESSOR; GROWTH-FACTOR; PROLIFERATION; DROSOPHILA; EXPRESSION; MIGRATION	Mechanisms underlying ovarian cancer initiation and progression are unclear. Herein, we report that the Yes-associated protein (YAP), a major effector of the Hippo tumor suppressor pathway, interacts with ERBB signaling pathways to regulate the initiation and progression of ovarian cancer. Immunohistochemistry studies indicate that YAP expression is associated with poor clinical outcomes in patients. Overexpression or constitutive activation of YAP leads to transformation and tumorigenesis in human ovarian surface epithelial cells, and promotes growth of cancer cells in vivo and in vitro. YAP induces the expression of epidermal growth factor (EGF) receptors (EGFR, ERBB3) and production of EGF-like ligands (HBEGF, NRG1 and NRG2). HBEGF or NRG1, in turn, activates YAP and stimulates cancer cell growth. Knockdown of ERBB3 or HBEGF eliminates YAP effects on cell growth and transformation, whereas knockdown of YAP abrogates NRG1- and HBEGF-stimulated cell proliferation. Collectively, our study demonstrates the existence of HBEGF & NRGs/ERBBs/YAP/HBEGF & NRGs autocrine loop that controls ovarian cell tumorigenesis and cancer progression.	[He, C.; Lv, X.; Hua, G.; Remmenga, S.; Davis, J. S.; Wang, C.] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, Omaha, NE 68198 USA; [He, C.; Hua, G.] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Hubei Province, Peoples R China; [Lele, S. M.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Remmenga, S.; Dong, J.; Davis, J. S.; Wang, C.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Davis, J. S.] Omaha Vet Affairs Med Ctr, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; Huazhong Agricultural University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Wang, C (corresponding author), Univ Nebraska Med Ctr, Dept Obstet & Gynecol, Fred & Pamela Buffett Canc Ctr, Olson Ctr Womens Hlth,Dept OB GYN, Omaha, NE 68198 USA.	chengwang@unmc.edu	Davis, John S/C-3234-2014; Lv, Xiangmin/I-7106-2019	Lv, Xiangmin/0000-0001-8338-6014; Davis, John/0000-0003-3468-4079	Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R00HD059985, 5P01AG029531]; Olson Center for Women's Health; Fred & Pamela Buffett Cancer Center [LB595]; Omaha Veterans Administration Medical Center [5I01BX000512]; National Institute of Food and Agriculture [2011-67015-20076]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD059985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG029531] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000512] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Olson Center for Women's Health; Fred & Pamela Buffett Cancer Center; Omaha Veterans Administration Medical Center; National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (5R00HD059985, 5P01AG029531); The Olson Center for Women's Health (no number); The Fred & Pamela Buffett Cancer Center (LB595); the Omaha Veterans Administration Medical Center (5I01BX000512) and The National Institute of Food and Agriculture (2011-67015-20076). We wish to thank for Melody A. Montgomery at the University of Nebraska Medical Center Research Editorial Office for her professional assistance in editing this manuscript.	Amsellem-Ouazana D, 2006, J UROLOGY, V175, P1127, DOI 10.1016/S0022-5347(05)00317-4; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Banerjee S, 2013, CLIN CANCER RES, V19, P961, DOI 10.1158/1078-0432.CCR-12-2243; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Fu D, 2014, ENDOCR-RELAT CANCER, V21, P297, DOI 10.1530/ERC-13-0339; Gregoire L, 2001, CLIN CANCER RES, V7, P4280; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kim JM, 2011, HUM PATHOL, V42, P315, DOI 10.1016/j.humpath.2010.08.003; Kojic N, 2010, FASEB J, V24, P1604, DOI 10.1096/fj.09-145367; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lucas EP, 2013, J CELL BIOL, V201, P875, DOI 10.1083/jcb.201210073; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Omerovic J, 2004, EXP CELL RES, V294, P469, DOI 10.1016/j.yexcr.2003.12.002; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Tschumperlin DJ, 2004, CELL CYCLE, V3, P996; Wang C, 2010, ENDOCRINOLOGY, V151, P2319, DOI 10.1210/en.2009-1489; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091770; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang N, 2012, CELL CYCLE, V11, P2922, DOI 10.4161/cc.21386; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	46	68	71	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2015	34	50					6040	6054		10.1038/onc.2015.52	http://dx.doi.org/10.1038/onc.2015.52			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RQ	25798835	Green Accepted			2022-12-26	WOS:000366113800002
J	Kemp, MG; Lindsey-Boltz, LA; Sancar, A				Kemp, Michael G.; Lindsey-Boltz, Laura A.; Sancar, Aziz			UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autoimmunity; Autophagy; Cell Signaling; DNA Damage; DNA Damage Response; DNA Repair; Innate Immunity; Interferon; Nucleotide Excision Repair	NUCLEOTIDE EXCISION-REPAIR; CYCLIC GMP-AMP; CUTANEOUS LUPUS-ERYTHEMATOSUS; NF-KAPPA-B; CYTOSOLIC DNA; DI-GMP; HUMAN-CELLS; DARK SIDE; ACTIVATION; AMBRA1	Background: UV wavelengths of sunlight exacerbate the symptoms of autoimmunity. Results: UV and UV-mimetic chemical carcinogens stimulate STING-dependent innate immune signaling in keratinocytes and other human cells by disrupting the STING negative regulator ULK1. Conclusion: STING-dependent innate immune signaling is elevated in UV-irradiated human cells. Significance: Deregulation of innate immune signaling by UV light may contribute to autoimmunity. The mechanism by which ultraviolet (UV) wavelengths of sunlight trigger or exacerbate the symptoms of the autoimmune disorder lupus erythematosus is not known but may involve a role for the innate immune system. Here we show that UV radiation potentiates STING (stimulator of interferon genes)-dependent activation of the immune signaling transcription factor interferon regulatory factor 3 (IRF3) in response to cytosolic DNA and cyclic dinucleotides in keratinocytes and other human cells. Furthermore, we find that modulation of this innate immune response also occurs with UV-mimetic chemical carcinogens and in a manner that is independent of DNA repair and several DNA damage and cell stress response signaling pathways. Rather, we find that the stimulation of STING-dependent IRF3 activation by UV is due to apoptotic signaling-dependent disruption of ULK1 (Unc51-like kinase 1), a pro-autophagic protein that negatively regulates STING. Thus, deregulation of ULK1 signaling by UV-induced DNA damage may contribute to the negative effects of sunlight UV exposure in patients with autoimmune disorders.	[Kemp, Michael G.; Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kemp, MG (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	michael_kemp@med.unc.edu; aziz_sancar@med.unc.edu	Kemp, Michael G./AAT-1545-2021; Lindsey-Boltz, Laura/A-3121-2010; Regan, Clinton/E-6250-2012	Kemp, Michael G./0000-0001-8203-0745; Lindsey-Boltz, Laura/0000-0001-6493-8194; 	National Institutes of Health [R01GM32833, R21ES024425, P30ES010126]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024425, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM32833 and R21ES024425 (to A. S.) and P30ES010126 (UNC Center for Environmental Health and Susceptibility Pilot Project Award; to M. K.).	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; BAER RL, 1965, ARCH DERMATOL, V92, P124, DOI 10.1001/archderm.92.2.124; Barbhaiya M, 2014, LUPUS, V23, P588, DOI 10.1177/0961203314530488; Bijl M, 2006, LUPUS, V15, P724, DOI 10.1177/0961203306071705; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Caricchio R, 2003, J IMMUNOL, V171, P5778, DOI 10.4049/jimmunol.171.11.5778; Choi JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1179; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Corazzari M, 2012, AUTOPHAGY, V8, P1255, DOI 10.4161/auto.20671; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; EPSTEIN JH, 1965, ARCH DERMATOL, V91, P483, DOI 10.1001/archderm.1965.01600110069013; Fimia GM, 2013, ONCOGENE, V32, P3311, DOI 10.1038/onc.2012.455; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Goubau D, 2009, EUR J IMMUNOL, V39, P527, DOI 10.1002/eji.200838832; Hildesheim J, 2004, DNA REPAIR, V3, P567, DOI 10.1016/j.dnarep.2004.02.012; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kemp MG, 2014, J BIOL CHEM, V289, P26574, DOI 10.1074/jbc.M114.597088; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kuhn A, 2006, ARTHRITIS RHEUM-US, V54, P939, DOI 10.1002/art.21658; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Nelson P, 2014, LUPUS, V23, P596, DOI 10.1177/0961203314531637; O'Neill LAJ, 2013, SCIENCE, V339, P763, DOI 10.1126/science.1234724; Pagliarini V, 2012, CELL DEATH DIFFER, V19, P1495, DOI 10.1038/cdd.2012.27; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Schaap P, 2013, IUBMB LIFE, V65, P897, DOI 10.1002/iub.1212; Schmidt E, 2007, ANN NY ACAD SCI, V1108, P35, DOI 10.1196/annals.1422.004; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; STERN RS, 1986, JAMA-J AM MED ASSOC, V255, P3120, DOI 10.1001/jama.255.22.3120; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yu C, 2013, J AUTOIMMUN, V41, P34, DOI 10.1016/j.jaut.2013.01.007; Zandman-Goddard G, 2003, CLIN REV ALLERG IMMU, V25, P29, DOI 10.1385/CRIAI:25:1:29; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	53	35	36	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12184	12194		10.1074/jbc.M115.649301	http://dx.doi.org/10.1074/jbc.M115.649301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25792739	Green Published, hybrid			2022-12-26	WOS:000354388600030
J	Wright, CM; van der Merwe, M; DeBrot, AH; Bjornsti, MA				Wright, Christine M.; van der Merwe, Marie; DeBrot, Amanda H.; Bjornsti, Mary-Ann			DNA Topoisomerase I Domain Interactions Impact Enzyme Activity and Sensitivity to Camptothecin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; DNA Topoisomerase; Protein Chimera; Protein Domain; Saccharomyces cerevisiae; Camptothecin	N-TERMINAL DOMAIN; CATALYTIC-ACTIVITY; FUNCTIONAL LINKER; MECHANISM; SITE; RESISTANCE; CLAMP; IDENTIFICATION; MUTATION; ARCHITECTURE	Background: Despite similarities in mechanism and architecture, human DNA topoisomerase I (Top1) is approximate to 100-fold more sensitive to camptothecin (CPT) than yeast Top1. Results: Reciprocal swaps of conserved and divergent protein domains alter chimeric Top1 activity. Conclusion: Conserved core and C-terminal domains dictate Top1 biochemical behavior and intrinsic CPT sensitivity. Significance: Interactions between nonconserved structural domains of Top1 impair cell viability, independent of enzyme catalysis. During processes such as DNA replication and transcription, DNA topoisomerase I (Top1) catalyzes the relaxation of DNA supercoils. The nuclear enzyme is also the cellular target of camptothecin (CPT) chemotherapeutics. Top1 contains four domains: the highly conserved core and C-terminal domains involved in catalysis, a coiled-coil linker domain of variable length, and a poorly conserved N-terminal domain. Yeast and human Top1 share a common reaction mechanism and domain structure. However, the human Top1 is approximate to 100-fold more sensitive to CPT. Moreover, substitutions of a conserved Gly(717) residue, which alter intrinsic enzyme sensitivity to CPT, induce distinct phenotypes in yeast. To address the structural basis for these differences, reciprocal swaps of yeast and human Top1 domains were engineered in chimeric enzymes. Here we report that intrinsic Top1 sensitivity to CPT is dictated by the composition of the conserved core and C-terminal domains. However, independent of CPT, biochemically similar chimeric enzymes produced strikingly distinct phenotypes in yeast. Expression of a human Top1 chimera containing the yeast linker domain proved toxic, even in the context of a catalytically inactive Y723F enzyme. Lethality was suppressed either by splicing the yeast N-terminal domain into the chimera, deleting the human N-terminal residues, or in enzymes reconstituted by polypeptide complementation. These data demonstrate a functional interaction between the N-terminal and linker domains, which, when mispaired between yeast and human enzymes, induces cell lethality. Because toxicity was independent of enzyme catalysis, the inappropriate coordination of N-terminal and linker domains may induce aberrant Top1-protein interactions to impair cell growth.	[Wright, Christine M.; DeBrot, Amanda H.; Bjornsti, Mary-Ann] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [van der Merwe, Marie] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	University of Alabama System; University of Alabama Birmingham; St Jude Children's Research Hospital	Bjornsti, MA (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, 1670 Univ Blvd, Birmingham, AL 35294 USA.	bjornsti@uab.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [CA58755]; University of Alabama at Birmingham Cancer Center [P30CA013148]; NATIONAL CANCER INSTITUTE [R01CA058755, P30CA013148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA58755 (to M.-A. B.). This work was also supported by University of Alabama at Birmingham Cancer Center Core Grant P30CA013148.	Albor A, 1998, CANCER RES, V58, P2091; ALSNER J, 1992, J BIOL CHEM, V267, P12408; Arno B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068404; Bharti AK, 1996, J BIOL CHEM, V271, P1993, DOI 10.1074/jbc.271.4.1993; BJORNSTI MA, 1987, P NATL ACAD SCI USA, V84, P8971, DOI 10.1073/pnas.84.24.8971; Bjornsti MA, 2002, CANCER CELL, V2, P267, DOI 10.1016/S1535-6108(02)00160-5; Carey JF, 2003, P NATL ACAD SCI USA, V100, P5640, DOI 10.1073/pnas.1031537100; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; Christensen MO, 2002, J BIOL CHEM, V277, P35932, DOI 10.1074/jbc.M204738200; Colley WC, 2004, J BIOL CHEM, V279, P54069, DOI 10.1074/jbc.M409764200; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Czubaty A, 2005, BBA-PROTEINS PROTEOM, V1749, P133, DOI 10.1016/j.bbapap.2005.03.007; DARPA P, 1988, P NATL ACAD SCI USA, V85, P2543, DOI 10.1073/pnas.85.8.2543; Fertala J, 2000, J BIOL CHEM, V275, P15246, DOI 10.1074/jbc.275.20.15246; Fiorani P, 1999, MOL PHARMACOL, V56, P1105, DOI 10.1124/mol.56.6.1105; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Frohlich RF, 2004, J MOL BIOL, V336, P93, DOI 10.1016/j.jmb.2003.12.007; Frohlich RF, 2008, BIOCHEMISTRY-US, V47, P7127, DOI 10.1021/bi800031k; Frohlich RF, 2007, NUCLEIC ACIDS RES, V35, P6170, DOI 10.1093/nar/gkm669; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Girstun A, 2008, BIOCHEM BIOPH RES CO, V366, P250, DOI 10.1016/j.bbrc.2007.11.131; Gongora C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-64; Haluska P, 1998, ADV ENZYME REGUL, V38, P253, DOI 10.1016/S0065-2571(97)00008-3; Ioanoviciu A, 2005, J MED CHEM, V48, P4803, DOI 10.1021/jm050076b; Jansen JG, 2007, MOL CELL, V28, P522, DOI 10.1016/j.molcel.2007.11.005; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Krogh BO, 2002, P NATL ACAD SCI USA, V99, P1853, DOI 10.1073/pnas.032613199; Laco GS, 2008, BIOCHEM J, V411, P523, DOI 10.1042/BJ20071436; Lisby M, 2001, J BIOL CHEM, V276, P20220, DOI 10.1074/jbc.M010991200; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Palle K, 2008, J BIOL CHEM, V283, P27767, DOI 10.1074/jbc.M804826200; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; Shykind BM, 1997, GENE DEV, V11, P397, DOI 10.1101/gad.11.3.397; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; Tesauro C., 2012, J AMINO ACIDS, V2012; van der Merwe M, 2008, J BIOL CHEM, V283, P3305, DOI 10.1074/jbc.M705781200; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; Villa H, 2003, J BIOL CHEM, V278, P3521, DOI 10.1074/jbc.M203991200; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100; Woo MH, 2002, J BIOL CHEM, V277, P3813, DOI 10.1074/jbc.M110484200; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998	55	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12068	12078		10.1074/jbc.M114.635078	http://dx.doi.org/10.1074/jbc.M114.635078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25795777	Green Published, hybrid			2022-12-26	WOS:000354388600022
J	Burmeister, WP; Buisson, M; Estrozi, LF; Schoehn, G; Billet, O; Hannas, Z; Sigoillot, C; Poulet, H				Burmeister, Wim P.; Buisson, Marlyse; Estrozi, Leandro F.; Schoehn, Guy; Billet, Olivier; Hannas, Zahia; Sigoillot, Cecile; Poulet, Herve			Structure Determination of Feline Calicivirus Virus-Like Particles in the Context of a Pseudo-Octahedral Arrangement	PLOS ONE			English	Article							MOLECULAR REPLACEMENT; ELECTRON-MICROSCOPY; RESOLUTION; RECONSTRUCTIONS; CRYSTALLOGRAPHY; REFINEMENT; GRAPHICS; SOFTWARE; RECEPTOR; PROGRAM	The vesivirus feline calicivirus (FCV) is a positive strand RNA virus encapsidated by an icosahedral T= 3 shell formed by the viral VP1 protein. Upon its expression in the insect cell baculovirus system in the context of vaccine development, two types of virus-like particles (VLPs) were formed, a majority built of 60 subunits (T= 1) and a minority probably built of 180 subunits (T= 3). The structure of the small particles was determined by x-ray crystallography at 0.8 nm resolution helped by cryo-electron microscopy in order to understand their formation. Cubic crystals belonged to space group P2(1)3. Their self-rotation function showed the presence of an octahedral pseudo-symmetry similar to the one described previously by Agerbandje and co-workers for human parvovirus VLPs. The crystal structure could be solved starting from the published VP1 structure in the context of the T= 3 viral capsid. In contrast to viral capsids, where the capsomers are interlocked by the exchange of the N-terminal arm (NTA) domain, this domain is disordered in the T= 1 capsid of the VLPs. Furthermore it is prone to proteolytic cleavage. The relative orientation of P (protrusion) and S (shell) domains is alerted so as to fit VP1 to the smaller T= 1 particle whereas the intermolecular contacts around 2-fold, 3-fold and 5-fold axes are conserved. By consequence the surface of the VLP is very similar compared to the viral capsid and suggests a similar antigenicity. The knowledge of the structure of the VLPs will help to improve their stability, in respect to a use for vaccination.	[Burmeister, Wim P.; Buisson, Marlyse] Univ Grenoble Alpes, Unit Virus Host Cell Interact, Grenoble, France; [Burmeister, Wim P.; Buisson, Marlyse] CNRS, Unite Mixte Int 3265, Unit Virus Host Cell Interact, Grenoble, France; [Buisson, Marlyse] CHU Grenoble, Virol Lab, F-38043 Grenoble, France; [Estrozi, Leandro F.; Schoehn, Guy] Commissariat Energie Atom, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Estrozi, Leandro F.; Schoehn, Guy] CNRS, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Estrozi, Leandro F.; Schoehn, Guy] Univ Grenoble Alpes, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Billet, Olivier; Hannas, Zahia; Sigoillot, Cecile; Poulet, Herve] Merial R&D, Lyon Gerland Lab, Lyon, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Merial SASU	Burmeister, WP (corresponding author), Univ Grenoble Alpes, Unit Virus Host Cell Interact, Grenoble, France.	wpb@uvhci.fr	Estrozi, Leandro F/A-6578-2013	Estrozi, Leandro F/0000-0003-2548-2547; Burmeister, Wim/0000-0003-0876-6118; Schoehn, Guy/0000-0002-1459-3201	FRISBI [ANR-10-INSB-05-02]; GRAL within the PSB [ANR-10-LABX-49-01]	FRISBI; GRAL within the PSB	This work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the PSB. The electron microscope facility (Polara electron microscope) is supported by the Rhone-Alpes Region, FRM, CNRS, University of Grenoble and the GIS-IBISA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abente EJ, 2013, J VIROL, V87, P3003, DOI 10.1128/JVI.02480-12; AGBANDJE M, 1994, VIROLOGY, V203, P106, DOI 10.1006/viro.1994.1460; Barcena J, 2004, VIROLOGY, V322, P118, DOI 10.1016/j.virol.2004.01.021; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bertolotti-Ciarlet A, 2002, J VIROL, V76, P4044, DOI 10.1128/JVI.76.8.4044-4055.2002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Di Martino B, 2007, VET MICROBIOL, V120, P173, DOI 10.1016/j.vetmic.2006.10.021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrozi LF, 2010, J STRUCT BIOL, V172, P253, DOI 10.1016/j.jsb.2010.06.023; Gan L, 2006, STRUCTURE, V14, P1655, DOI 10.1016/j.str.2006.09.006; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Katpally U, 2010, J VIROL, V84, P5836, DOI 10.1128/JVI.00314-10; Kaufmann B, 2004, P NATL ACAD SCI USA, V101, P11628, DOI 10.1073/pnas.0402992101; Klug A, 1972, COLD SPRING HARB SYM, V36, P483; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makino A, 2006, J VIROL, V80, P4482, DOI 10.1128/JVI.80.9.4482-4490.2006; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natarajan P, 2005, NAT REV MICROBIOL, V3, P809, DOI 10.1038/nrmicro1283; Navaza J, 2003, J STRUCT BIOL, V144, P13, DOI 10.1016/j.jsb.2003.09.007; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Ossiboff RJ, 2007, J GEN VIROL, V88, P506, DOI 10.1099/vir.0.82488-0; Ossiboff RJ, 2010, J VIROL, V84, P5550, DOI 10.1128/JVI.02371-09; Pedersen NC, 2000, VET MICROBIOL, V73, P281, DOI 10.1016/S0378-1135(00)00183-8; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Schlesinger S, 1999, VIRUSES STRUCTURE BI; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Wang X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003132; White LJ, 1997, J VIROL, V71, P8066, DOI 10.1128/JVI.71.10.8066-8072.1997; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zwart P. H., 2005, CCP4 NEWSL, V43, P26	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119289	10.1371/journal.pone.0119289	http://dx.doi.org/10.1371/journal.pone.0119289			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794153	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200067
J	Castaneda-Ortiz, EJ; Ueti, MW; Camacho-Nuez, M; Mosqueda, JJ; Mousel, MR; Johnson, WC; Palmer, GH				Castaneda-Ortiz, Elizabeth J.; Ueti, Massaro W.; Camacho-Nuez, Minerva; Mosqueda, Juan J.; Mousel, Michelle R.; Johnson, Wendell C.; Palmer, Guy H.			Association of Anaplasma marginale Strain Superinfection with Infection Prevalence within Tropical Regions	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; BOOPHILUS-MICROPLUS; ANTIGENIC VARIATION; TRANSMISSION; CONSERVATION; DIVERSITY; TICK; EXPRESSION; PATHOGENS; IXODIDAE	Strain superinfection occurs when a second strain infects a host already infected with and having mounted an immune response to a primary strain. The incidence of superinfection with Anaplasma marginale, a tick-borne rickettsial pathogen of domestic and wild ruminants, has been shown to be higher in tropical versus temperate regions. This has been attributed to the higher prevalence of infection, with consequent immunity against primary strains and thus greater selective pressure for superinfection with antigenically distinct strains. However an alternative explanation would be the differences in the transmitting vector, Dermacentor andersoni in the studied temperate regions and Rhipicephalus microplus in the studied tropical regions. To address this question, we examined two tropical populations sharing the same vector, R. microplus, but with significantly different infection prevalence. Using two separate markers, msp1 alpha (one allele per genome) and msp2 (multiple alleles per genome), there were higher levels of multiple strain infections in the high infection prevalence as compared to the low prevalence population. The association of higher strain diversity with infection prevalence supports the hypothesis that high levels of infection prevalence and consequent population immunity is the predominant driver of strain superinfection.	[Castaneda-Ortiz, Elizabeth J.; Camacho-Nuez, Minerva] Univ Autonoma Ciudad Mexico, Posgrad Ciencias Genom, Mexico City, DF, Mexico; [Ueti, Massaro W.; Mousel, Michelle R.; Johnson, Wendell C.] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Ueti, Massaro W.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Mosqueda, Juan J.] Univ Autonoma Queretaro, Juriquilla, Mexico; [Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University; Washington State University; Universidad Autonoma de Queretaro; Washington State University	Palmer, GH (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	gpalmer@vetmed.wsu.edu	Camacho-Nuez, Minerva/AAG-4359-2020	Camacho-Nuez, Minerva/0000-0002-6354-3200	Universidad Autonoma de la Ciudad de Mexico; U.S. Department of Agriculture, Agricultural Research Service [5348-32000-033-00D]; National Institutes of Health [R37 AI44005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044005] Funding Source: NIH RePORTER	Universidad Autonoma de la Ciudad de Mexico(Universidad Nacional Autonoma de Mexico); U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Elizabeth J. Castaneda Ortiz was supported by Universidad Autonoma de la Ciudad de Mexico. This research was supported by the U.S. Department of Agriculture, Agricultural Research Service Grant 5348-32000-033-00D (MWU, MRM, WCJ) and the National Institutes of Health R37 AI44005 (GHP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED DR, 1990, P NATL ACAD SCI USA, V87, P3220, DOI 10.1073/pnas.87.8.3220; Barbet AF, 2000, INFECT IMMUN, V68, P6133, DOI 10.1128/IAI.68.11.6133-6138.2000; Blackard JT, 2012, ANTIVIR THER, V17, P1443, DOI 10.3851/IMP2460; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brayton KA, 2001, P NATL ACAD SCI USA, V98, P4130, DOI 10.1073/pnas.071056298; Chen DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016629; Dark MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-16; de la Fuente J, 2007, VET MICROBIOL, V119, P375, DOI 10.1016/j.vetmic.2006.09.011; Esquerra EV, 2014, INFECT IMMUN, V82, P5286, DOI 10.1128/IAI.02537-14; Estrada-Pena A, 2006, EXP APPL ACAROL, V38, P307, DOI 10.1007/s10493-006-7251-2; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Futse JE, 2005, MOL MICROBIOL, V57, P212, DOI 10.1111/j.1365-2958.2005.04670.x; Futse JE, 2003, J CLIN MICROBIOL, V41, P3829, DOI 10.1128/JCM.41.8.3829-3834.2003; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hutchinson OC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-234; James AM, 2006, J MED ENTOMOL, V43, P17, DOI 10.1603/0022-2585(2006)043[0017:DSAHOT]2.0.CO;2; Noh SM, 2006, INFECT IMMUN, V74, P3471, DOI 10.1128/IAI.01843-05; Palmer GH, 2001, J CLIN MICROBIOL, V39, P631, DOI 10.1128/JCM.39.2.631-635.2001; Palmer GH, 2013, CELL MICROBIOL, V15, P1969, DOI 10.1111/cmi.12182; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rodriguez JL, 2005, GENE, V361, P127, DOI 10.1016/j.gene.2005.06.038; Rodriguez SD, 2009, INFECT GENET EVOL, V9, P1092, DOI 10.1016/j.meegid.2009.09.007; Rogovskyy AS, 2014, INFECT IMMUN, V82, P4542, DOI 10.1128/IAI.01817-14; Scoles GA, 2005, J MED ENTOMOL, V42, P153, DOI 10.1603/0022-2585(2005)042[0153:VAGSPO]2.0.CO;2; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Ueti MW, 2012, INFECT IMMUN, V80, P2354, DOI 10.1128/IAI.00341-12	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120748	10.1371/journal.pone.0120748	http://dx.doi.org/10.1371/journal.pone.0120748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793966	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900072
J	Davis, ZW; Sun, C; Derieg, B; Chapman, B; Cheng, HJ				Davis, Zachary W.; Sun, Chao; Derieg, Brittany; Chapman, Barbara; Cheng, Hwai-Jong			Epibatidine Blocks Eye-Specific Segregation in Ferret Dorsal Lateral Geniculate Nucleus during Stage III Retinal Waves	PLOS ONE			English	Article							PATTERNED SPONTANEOUS ACTIVITY; GANGLION-CELL ACTIVITY; RETINOGENICULATE CONNECTIVITY; ACTION-POTENTIALS; BURSTING ACTIVITY; MAMMALIAN RETINA; INSTRUCTIVE ROLE; VISUAL-SYSTEM; ON-CENTER; REQUIREMENT	The segregation and maintenance of eye-specific inputs in the dorsal lateral geniculate nucleus (dLGN) during early postnatal development requires the patterned spontaneous activity of retinal waves. In contrast to the development of the mouse, ferret eye-specific segregation is not complete at the start of stage III glutamatergic retinal waves, and the remaining overlap is limited to the C/C1 lamina of the dLGN. To investigate the role of patterned spontaneous activity in this late segregation, we disrupted retinal waves pharmacologically for 5 day windows from postnatal day (P) 10 to P25. Multi-electrode array recordings of the retina in vitro reveal that the cholinergic agonist epibatidine disrupts correlated retinal activity during stage III waves. Epibatidine also prevents the segregation of eye-specific inputs in vivo during that period. Our results reveal a novel role for cholinergic influence on stage III retinal waves as an instructive signal for the continued segregation of eye-specific inputs in the ferret dLGN.	[Davis, Zachary W.; Derieg, Brittany; Chapman, Barbara; Cheng, Hwai-Jong] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Sun, Chao; Chapman, Barbara; Cheng, Hwai-Jong] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Cheng, Hwai-Jong] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Cheng, HJ (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	hjcheng@ucdavis.edu	Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567	National Eye Institute [EY11369, EY020743, EY015387]; NATIONAL EYE INSTITUTE [R01EY011369, R21EY020743, P30EY012576, T32EY015387] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute (http://www.nei.nih.gov/) grants to BC and HC, (EY11369 and EY020743) and a vision training grant to Jack Werner (EY015387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Bansal A, 2000, J NEUROSCI, V20, P7672; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; Butts DA, 2001, J NEUROSCI, V21, P961, DOI 10.1523/JNEUROSCI.21-03-00961.2001; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chapman B, 2000, J NEUROSCI, V20, P1922; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; CUCCHIARO J, 1984, PROC R SOC SER B-BIO, V223, P141, DOI 10.1098/rspb.1984.0087; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Ford KJ, 2012, VISUAL NEUROSCI, V29, P61, DOI 10.1017/S0952523811000216; Ford KJ, 2012, J NEUROSCI, V32, P850, DOI 10.1523/JNEUROSCI.5309-12.2012; Gjorgjieva J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000618; Huberman AD, 2002, J NEUROSCI, V22, P9419; Kerschensteiner D, 2008, NEURON, V58, P851, DOI 10.1016/j.neuron.2008.04.025; Lee CW, 2002, J NEUROPHYSIOL, V88, P2311, DOI 10.1152/jn.00372.2002; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; ROE AW, 1989, J COMP NEUROL, V288, P208, DOI 10.1002/cne.902880203; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Shoham S, 2003, J NEUROSCI METH, V127, P111, DOI 10.1016/S0165-0270(03)00120-1; Speer CM, 2010, ANAT REC, V293, P1, DOI 10.1002/ar.21001; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STRYKER MP, 1983, J NEUROSCI, V3, P1943; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; VITEK DJ, 1985, J COMP NEUROL, V241, P1, DOI 10.1002/cne.902410102; Warland DK, 2006, J NEUROSCI, V26, P5190, DOI 10.1523/JNEUROSCI.0328-06.2006; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118783	10.1371/journal.pone.0118783	http://dx.doi.org/10.1371/journal.pone.0118783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794280	Green Published, gold			2022-12-26	WOS:000352084200040
J	Fang, Y; Qin, YF; Zhang, NQ; Wang, J; Wang, HY; Zheng, XQ				Fang, Yun; Qin, Yufang; Zhang, Naiqian; Wang, Jun; Wang, Haiyun; Zheng, Xiaoqi			DISIS: Prediction of Drug Response through an Iterative Sure Independence Screening	PLOS ONE			English	Article							VARIABLE SELECTION; GENE-EXPRESSION; CHEMOSENSITIVITY; METHYLATION; BIOMARKERS; RELEVANCE	Prediction of drug response based on genomic alterations is an important task in the research of personalized medicine. Current elastic net model utilized a sure independence screening to select relevant genomic features with drug response, but it may neglect the combination effect of some marginally weak features. In this work, we applied an iterative sure independence screening scheme to select drug response relevant features from the Cancer Cell Line Encyclopedia (CCLE) dataset. For each drug in CCLE, we selected up to 40 features including gene expressions, mutation and copy number alterations of cancer-related genes, and some of them are significantly strong features but showing weak marginal correlation with drug response vector. Lasso regression based on the selected features showed that our prediction accuracies are higher than those by elastic net regression for most drugs.	[Fang, Yun; Zhang, Naiqian; Wang, Jun; Zheng, Xiaoqi] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Qin, Yufang] Shanghai Ocean Univ, Dept Math, Shanghai, Peoples R China; [Wang, Haiyun] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China	Shanghai Normal University; Shanghai Ocean University; Tongji University	Wang, HY (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China.	wanghaiyun@tongji.edu.cn; xqzheng@shnu.edu.cn			National Natural Science Foundation of China [31100953, 31100912, 11201306]; Innovation Program of Shanghai Municipal Education Commission [12YZ088, 13YZ065]; Program of Shanghai Normal University [DZL121, SK201207]; Supporting Program for Young College Teachers of Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Program of Shanghai Normal University; Supporting Program for Young College Teachers of Shanghai	This work was supported by the National Natural Science Foundation of China (31100953, 31100912 and 11201306), the Innovation Program of Shanghai Municipal Education Commission (12YZ088 and 13YZ065), the Program of Shanghai Normal University (DZL121, SK201207) and the Supporting Program for Young College Teachers of Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudukadeer A, 2012, INT J MOL SCI, V13, P8353, DOI 10.3390/ijms13078353; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; DeRemer DL, 2008, CLIN THER, V30, P1956, DOI 10.1016/j.clinthera.2008.11.014; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Endoh M, 2005, BRIT J CANCER, V93, P1395, DOI 10.1038/sj.bjc.6602854; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan JQ, 2009, J MACH LEARN RES, V10, P2013; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Hernandez-Caballero E, 2009, BMB REP, V42, P747, DOI 10.5483/BMBRep.2009.42.11.747; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Kaczmarek LK, 2006, NEURON, V49, P642, DOI 10.1016/j.neuron.2006.02.011; Kataoka T, 2001, J BIOL CHEM, V276, P19548, DOI 10.1074/jbc.M010520200; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; Niu Yue S, 2011, BMC Proc, V5 Suppl 9, pS108, DOI 10.1186/1753-6561-5-S9-S108; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Ren XW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1288; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Shen LL, 2007, CANCER RES, V67, P11335, DOI 10.1158/0008-5472.CAN-07-1502; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Ueki M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-72; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Wang Y, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S15	28	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120408	10.1371/journal.pone.0120408	http://dx.doi.org/10.1371/journal.pone.0120408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794193	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900029
J	Marcus, U; Hickson, F; Weatherburn, P; Furegato, M; Breveglieri, M; Berg, RC; Schmidt, AJ				Marcus, Ulrich; Hickson, Ford; Weatherburn, Peter; Furegato, Martina; Breveglieri, Michele; Berg, Rigmor C.; Schmidt, Axel J.		EMIS Network	Antiretroviral Therapy and Reasons for Not Taking It among Men Having Sex with Men (MSM)-Results from the European MSM Internet Survey (EMIS)	PLOS ONE			English	Article							HIV	Background The preventive effects of antiretroviral treatment (ART) on onward transmission of HIV are a major reason for broadening eligibility for ART. In the WHO European Region, surveillance reveals substantial differences in access to ART across regions and sub-populations. We analysed self-reported data on ART and reasons for not taking ART from EMIS, a large Pan-European Internet survey among men-who-have-sex-with-men (MSM). Methods Respondents from 38 European countries reported their last HIV test result and, if diagnosed with HIV, their treatment status, and reasons for not taking or having stopped ART from a 7 item multiple choice list and/or answered an open-ended question to give other reasons. Responses were classified as fear of consequences, perceived lack of need, and ART inaccessibility based on factor analysis. Associations between not taking ART because of fear of consequences, and demographic, behavioural and contextual indicators were identified in a multivariable regression model. Results 13,353 (7.7%) of 174,209 respondents had been diagnosed with HIV. Among them 3,391 (25.4%) had never received ART, and 278 (2.1%) had stopped taking ART. Perceived lack of need was by far the most common reason for not taking or stopping ART (mentioned by 3259 (88.8%) respondents), followed by fear of consequences (428 (11.7%)), and ART inaccessibility (86 (2.3%)). For all reasons, an East- West gradient could be seen, with larger proportions of men living in Central and Eastern Europe reporting reasons other than medical advice for not taking ART. A minority of men were reluctant to start ART independent of medical advice and this was associated with experiences of discrimination in health care systems. Conclusions ART is widely available for MSM diagnosed with HIV across Europe. Not being on treatment is predominantly due to treatment not being recommended by their physician and/or not perceived to be needed by the respondent.	[Marcus, Ulrich; Schmidt, Axel J.] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Hickson, Ford; Weatherburn, Peter] London Sch Hyg & Trop Med, Sigma Res, London WC1, England; [Furegato, Martina; Breveglieri, Michele] Reg Veneto, Dept Hlth, Verona, Italy; [Berg, Rigmor C.] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway	Robert Koch Institute; University of London; London School of Hygiene & Tropical Medicine; Norwegian Knowledge Centre for Health Services	Marcus, U (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	MarcusU@rki.de	Schmidt, Axel J/J-1855-2019; Weatherburn, Peter/AAC-2701-2019; Marcus, Ulrich/AAF-3085-2020	Schmidt, Axel J/0000-0002-6910-4399; Marcus, Ulrich/0000-0002-3143-2717; Weatherburn, Peter/0000-0002-4950-6163; , Martina/0000-0003-2168-8396	Executive Agency for Health and Consumers, EU Health Programme; CEEISCat-Centre d'Estudis Epidemiologics sobre les ITS/HIV/SIDA de Catalunya; Terrence Higgins Trust (CHAPS) for Department of Health for England; Maastricht University; Regione del Veneto; Robert Koch Institute; BZgA (Bundeszentrale fur gesundheitliche Aufklarung, Koln); German Ministry of Health; Finnish Ministry of Health; Norwegian Institute of Public Health; Swedish Board of Health and Welfare	Executive Agency for Health and Consumers, EU Health Programme; CEEISCat-Centre d'Estudis Epidemiologics sobre les ITS/HIV/SIDA de Catalunya; Terrence Higgins Trust (CHAPS) for Department of Health for England; Maastricht University; Regione del Veneto(Regione Veneto); Robert Koch Institute; BZgA (Bundeszentrale fur gesundheitliche Aufklarung, Koln); German Ministry of Health; Finnish Ministry of Health; Norwegian Institute of Public Health; Swedish Board of Health and Welfare	The EMIS project was funded by: Executive Agency for Health and Consumers, EU Health Programme 2008-2013 (funding period: 14.3.2009-13.9.2011); CEEISCat-Centre d'Estudis Epidemiologics sobre les ITS/HIV/SIDA de Catalunya (2009-2012); Terrence Higgins Trust (CHAPS) for Department of Health for England (2009-2012); Maastricht University (2009-2012); Regione del Veneto (2009-2012); Robert Koch Institute (2009-2012); BZgA (Bundeszentrale fur gesundheitliche Aufklarung, Koln: 2010-2011); German Ministry of Health (2010); Finnish Ministry of Health (2010); Norwegian Institute of Public Health (2010-2011); Swedish Board of Health and Welfare (2010-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WJ, 2004, INT J STD AIDS, V15, P793, DOI 10.1258/0956462042563602; Berg RC, 2013, SOC SCI MED, V78, P61, DOI 10.1016/j.socscimed.2012.11.033; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; European AIDS Clinical Society, EUR GUID TREATM HIV; European AIDS Clinical Society, 2013, EUR GUID TREATM HIV; Fehr J, 2013, 14 EUR AIDS C OCT 20; Hoen B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19034; Hsu LC, 2014, J INFECT DIS, V209, P1310, DOI 10.1093/infdis/jit599; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Lundgren JD, 2013, CLIN INFECT DIS, V57, P888, DOI 10.1093/cid/cit381; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Ross MW, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2014-006175, 10.1136/bmjopen-2012-001928]; Russian Harm Reduction Network, CIV SOC REP 2008 RUS; Sabin CA, 2009, CURR OPIN INFECT DIS, V22, P191, DOI 10.1097/QCO.0b013e328326cd34; The EMIS Network, 2013, EMIS 2010 EUR MEN WH, P76; UNAIDS, UNAIDS REP GLOB AIDS; Weatherburn P, 2013, SEX RES SOC POLICY, V10, P243, DOI 10.1007/s13178-013-0119-4; Williams I, 2012, HIV MED, V13, P1, DOI [10.1111/j.1468-1293.2012.01029_1.x, 10.1111/j.1468-1293.2012.01029.x]	18	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121047	10.1371/journal.pone.0121047	http://dx.doi.org/10.1371/journal.pone.0121047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793882	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000352083900099
J	Newsom, SA; Everett, AC; Park, S; van Pelt, DW; Hinko, A; Horowitz, JF				Newsom, Sean A.; Everett, Allison C.; Park, Sanghee; van Pelt, Douglas W.; Hinko, Alexander; Horowitz, Jeffrey F.			Lipid Mixtures Containing a Very High Proportion of Saturated Fatty Acids Only Modestly Impair Insulin Signaling in Cultured Muscle Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; MORPHOLOGICAL-CHANGES; BETA-CELLS; RESISTANCE; CERAMIDE; OBESITY; DIACYLGLYCEROL; ACCUMULATION; SENSITIVITY; PALMITATE	In vitro examinations of the effect of saturated fatty acids on skeletal muscle insulin action often use only one or two different fatty acid species, which does not resemble the human plasma fatty acid profile. We compared graded concentrations (0.1-0.8mM) of 3 different lipid mixtures: 1) a physiologic fatty acid mixture (NORM; 40% saturated fatty acids), 2) a physiologic mixture high in saturated fatty acids (HSFA; 60% saturated fatty acids), and 3) 100% palmitate (PALM) on insulin signaling and fatty acid partitioning into triacylglycerol (TAG) and diacylglycerol (DAG) in cultured muscle cells. As expected, PALM readily impaired insulin-stimulated pAkt(Thr308)/Akt and markedly increased intracellular DAG content. In contrast, the fatty acid mixtures only modestly impaired insulin-stimulated pAkt(Thr308M)/Akt, and we found no differences between NORM and HSFA. Importantly, NORM and HSFA did not increase DAG content, but instead dose-dependently increased TAG accumulation. Therefore, the robust impairment in insulin signaling found with palmitate exposure was attenuated with physiologic mixtures of fatty acids, even with a very high proportion of saturated fatty acids. This may be explained in part by selective partitioning of fatty acids into neutral lipid (i.e., TAG) when muscle cells were exposed to physiologic lipid mixtures.	[Newsom, Sean A.; Everett, Allison C.; Park, Sanghee; van Pelt, Douglas W.; Hinko, Alexander; Horowitz, Jeffrey F.] Univ Michigan, Sch Kinesiol, Substrate Metab Lab, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Horowitz, JF (corresponding author), Univ Michigan, Sch Kinesiol, Substrate Metab Lab, Ann Arbor, MI 48109 USA.	jeffhoro@umich.edu		Newsom, Sean/0000-0003-0585-3830	National Institutes of Health [DK077966]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077966, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK077966, awarded to JFH (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Bachmann OP, 2001, DIABETES, V50, P2579, DOI 10.2337/diabetes.50.11.2579; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Horowitz JF, 1999, AM J PHYSIOL-ENDOC M, V276, pE278, DOI 10.1152/ajpendo.1999.276.2.E278; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997; Moffitt JH, 2005, DIABETOLOGIA, V48, P1819, DOI 10.1007/s00125-005-1861-9; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Newsom SA, 2013, DIABETES CARE; Newsom SA, 2011, METABOLISM, V60, P852, DOI 10.1016/j.metabol.2010.08.004; Pinnick K, 2010, J CELL BIOCHEM, V109, P683, DOI 10.1002/jcb.22445; ROUST LR, 1993, DIABETES, V42, P1567, DOI 10.2337/diabetes.42.11.1567; Sawada K, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-36; Schenk S, 2005, AM J PHYSIOL-ENDOC M, V288, pE519, DOI 10.1152/ajpendo.00401.2004; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Thompson DB, 1996, J CLIN INVEST, V98, P2346, DOI 10.1172/JCI119046; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1, DOI 10.1152/ajpendo.00418.2011	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120871	10.1371/journal.pone.0120871	http://dx.doi.org/10.1371/journal.pone.0120871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793412	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900085
J	Pei, JS; Hsu, CM; Tsai, CW; Chang, WS; Ji, HX; Hsiao, CL; Miao, CE; Hsu, YN; Bau, DT				Pei, Jen-Sheng; Hsu, Chin-Mu; Tsai, Chia-Wen; Chang, Wen-Shin; Ji, Hong-Xue; Hsiao, Chieh-Lun; Miao, Chia-En; Hsu, Yuan-Nian; Bau, Da-Tian			The Association of Methylenetetrahydrofolate Reductase Genotypes with the Risk of Childhood Leukemia in Taiwan	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SINGLE NUCLEOTIDE POLYMORPHISMS; MTHFR GENETIC POLYMORPHISMS; ACUTE LYMPHOCYTIC-LEUKEMIA; FOLATE METABOLIC PATHWAY; A1298C POLYMORPHISMS; C677T POLYMORPHISM; CANCER SUSCEPTIBILITY; CHINESE POPULATION; SMOKING HABIT	Background Acute lymphoblastic leukemia (ALL) is the most prevalent type of pediatric cancer, the causes of which are likely to involve an interaction between genetic and environmental factors. To evaluate the effects of the genotypic polymorphisms in methylenetetrahydrofolate reductase (MTHFR) on childhood ALL risk in Taiwan, two well-known polymorphic genotypes of MTHFR, C677T (rs1801133) and A1298C (rs1801131), were analyzed to examine the extent of their associations with childhood ALL susceptibility and to discuss the MTHFR genotypic contribution to childhood ALL risk among different populations. Methodology/Principal Findings In total, 266 patients with childhood ALL and an equal number of non-cancer controls recruited were genotyped utilizing PCR-RFLP methodology. The MTHFR C677T genotype, but not the A1298C, was differently distributed between childhood ALL and control groups. The CT and TT of MTHFR C677T genotypes were significantly more frequently found in controls than in childhood ALL patients (odds ratios=0.60 and 0.48, 95% confidence intervals=0.42-0.87 and 0.24-0.97, respectively). As for gender, the boys carrying the MTHFR C677T CT or TT genotype conferred a lower odds ratio of 0.51 (95% confidence interval=0.32-0.81, P=0.0113) for childhood ALL. As for age, those equal to or greater than 3.5 years of age at onset of disease carrying the MTHFR C677T CT or TT genotype were of lower risk (odds ratio=0.43 and 95% confidence interval=0.26-0.71, P=0.0016). Conclusions Our results indicated that the MTHFR C677T T allele was a protective biomarker for childhood ALL in Taiwan, and the association was more significant in male patients and in patients 3.5 years of age or older at onset of disease.	[Pei, Jen-Sheng] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Pediat, Taoyuan, Taiwan; [Hsu, Chin-Mu; Tsai, Chia-Wen; Chang, Wen-Shin; Ji, Hong-Xue; Hsiao, Chieh-Lun; Miao, Chia-En; Bau, Da-Tian] China Med Univ Hosp, Terry Fox Canc Res Lab, Taichung, Taiwan; [Tsai, Chia-Wen; Bau, Da-Tian] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Wen-Shin; Ji, Hong-Xue; Bau, Da-Tian] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hsu, Yuan-Nian] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Family Med, Taoyuan, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Bau, DT (corresponding author), China Med Univ Hosp, Terry Fox Canc Res Lab, Taichung, Taiwan.	artbau1@yahoo.com.tw			Terry Fox Cancer Research Foundation of China Medical University Hospital; Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, ROC [PTH10332]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]	Terry Fox Cancer Research Foundation of China Medical University Hospital; Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, ROC; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by research grants from the Terry Fox Cancer Research Foundation of China Medical University Hospital and Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, ROC (grant number: PTH10332) and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcasabas P, 2008, PEDIATR BLOOD CANCER, V51, P178, DOI 10.1002/pbc.21511; Amigou A, 2012, CANCER CAUSE CONTROL, V23, P1265, DOI 10.1007/s10552-012-0004-0; Azhar MR, 2012, GENET TEST MOL BIOMA, V16, P198, DOI 10.1089/gtmb.2011.0041; Bailey LB, 1999, J NUTR, V129, P919, DOI 10.1093/jn/129.5.919; Balta G, 2003, AM J HEMATOL, V73, P154, DOI 10.1002/ajh.10339; Barry Elly V, 2008, Curr Hematol Malig Rep, V3, P161, DOI 10.1007/s11899-008-0023-9; Bau DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016374; Belson M, 2007, ENVIRON HEALTH PERSP, V115, P138, DOI 10.1289/ehp.9023; Cartwright RA, 2002, BRIT J HAEMATOL, V118, P1071, DOI 10.1046/j.1365-2141.2002.03750.x; Chan JYS, 2011, HEMATOL ONCOL, V29, P116, DOI 10.1002/hon.965; Chatzidakis K, 2006, PEDIATR BLOOD CANCER, V47, P147, DOI 10.1002/pbc.20574; Damnjanovic T, 2010, J PEDIAT HEMATOL ONC, V32, pE148, DOI 10.1097/MPH.0b013e3181cbd252; de Jonge R, 2009, BLOOD, V113, P2284, DOI 10.1182/blood-2008-07-165928; Dierkes J, 2001, METABOLISM, V50, P640, DOI 10.1053/meta.2001.23286; Franco RF, 2001, BRIT J HAEMATOL, V115, P616, DOI 10.1046/j.1365-2141.2001.03140.x; Homberger A, 2000, EUR J HUM GENET, V8, P725, DOI 10.1038/sj.ejhg.5200522; Jia J, 2011, TUMOR BIOL, V35, P4943; Jiang Y, 2013, ASIAN PAC J CANCER P, V14, P6357, DOI 10.7314/APJCP.2013.14.11.6357; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Kamel Azza M, 2007, J Egypt Natl Canc Inst, V19, P96; Kang S, 2005, GYNECOL ONCOL, V96, P173, DOI 10.1016/j.ygyno.2004.09.031; KANG SS, 1988, AM J HUM GENET, V43, P414; Kim NK, 2006, ANTICANCER RES, V26, P2879; Knock E, 2006, CANCER RES, V66, P10349, DOI 10.1158/0008-5472.CAN-06-2477; Krajinovic M, 2004, BLOOD, V103, P252, DOI 10.1182/blood-2003-06-1794; Li XL, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-5; Lightfoot TJ, 2010, BLOOD, V115, P3923, DOI 10.1182/blood-2009-10-249722; Liu Chiu-Shong, 2009, Cancer Genomics & Proteomics, V6, P325; Liu ZB, 2013, GENE, V515, P214, DOI 10.1016/j.gene.2012.11.036; Mathew CG, 2006, ONCOGENE, V25, P5875, DOI 10.1038/sj.onc.1209878; Matsuo K, 2001, BLOOD, V97, P3205, DOI 10.1182/blood.V97.10.3205; Metayer C, 2011, CANCER CAUSE CONTROL, V22, P1243, DOI 10.1007/s10552-011-9795-7; Milne E, 2010, INT J CANCER, V126, P2690, DOI 10.1002/ijc.24969; Mossuz P, 1998, LEUKEMIA RES, V22, P1063, DOI 10.1016/S0145-2126(98)00101-5; Narayanan S, 2004, CANCER EPIDEM BIOMAR, V13, P1436; Nikbakht M., 2012, Experimental Oncology, V34, P43; Oliveira E, 2005, J PEDIAT HEMATOL ONC, V27, P425, DOI 10.1097/01.mph.0000177513.81465.94; Papoutsakis C, 2006, EUR J CLIN NUTR, V60, P155, DOI 10.1038/sj.ejcn.1602280; Pearce MS, 2001, INT J CANCER, V91, P402, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1048&gt;3.0.CO;2-F; Pereira AC, 2004, CLIN CHIM ACTA, V340, P99, DOI 10.1016/j.cccn.2003.09.016; Petra BG, 2007, LEUKEMIA LYMPHOMA, V48, P786, DOI 10.1080/10428190601187711; Reddy H, 2006, LEUKEMIA LYMPHOMA, V47, P1333, DOI 10.1080/10428190600562773; Robien K, 2003, AM J EPIDEMIOL, V157, P571, DOI 10.1093/aje/kwg024; Sadananda AMN, 2010, INDIAN J CANCER, V47, P40, DOI 10.4103/0019-509X.58858; Schnakenberg E, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-23; Silva RMS, 2013, GENET TEST MOL BIOMA, V17, P147, DOI 10.1089/gtmb.2012.0174; Skibola CF, 1999, P NATL ACAD SCI USA, V96, P12810, DOI 10.1073/pnas.96.22.12810; Sohn KJ, 2004, JNCI-J NATL CANCER I, V96, P134, DOI 10.1093/jnci/djh015; Sood S, 2010, LEUKEMIA LYMPHOMA, V51, P928, DOI 10.3109/10428191003719023; Szczepanski T, 2010, LANCET ONCOL, V11, P880, DOI 10.1016/S1470-2045(09)70369-9; Teng Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055332; Thirumaran RK, 2005, BLOOD, V106, P2590, DOI 10.1182/blood-2005-04-1719; Tong N, 2010, CANCER SCI, V101, P782, DOI 10.1111/j.1349-7006.2009.01429.x; Tsai CW, 2011, ANTICANCER RES, V31, P2395; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wiemels JL, 2001, P NATL ACAD SCI USA, V98, P4004, DOI 10.1073/pnas.061408298; Wu HC, 2010, ANTICANCER RES, V30, P3573; Wu KH, 2010, ANTICANCER RES, V30, P529; Yan JR, 2012, PEDIATR BLOOD CANCER, V58, P513, DOI 10.1002/pbc.23137; Yeoh AEJ, 2010, LEUKEMIA RES, V34, P276, DOI 10.1016/j.leukres.2009.07.003; Yu LW, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-171; Zanrosso CW, 2006, LEUKEMIA RES, V30, P477, DOI 10.1016/j.leukres.2005.08.008; Zwaan CM, 2010, HEMATOL ONCOL CLIN N, V24, P19, DOI 10.1016/j.hoc.2009.11.009	63	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119776	10.1371/journal.pone.0119776	http://dx.doi.org/10.1371/journal.pone.0119776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793509	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200115
J	Pfirrmann, T; Villavicencio-Lorini, P; Subudhi, AK; Menssen, R; Wolf, DH; Hollemann, T				Pfirrmann, Thorsten; Villavicencio-Lorini, Pablo; Subudhi, Abinash K.; Menssen, Ruth; Wolf, Dieter H.; Hollemann, Thomas			RMND5 from Xenopus laevis Is an E3 Ubiquitin-Ligase and Functions in Early Embryonic Forebrain Development	PLOS ONE			English	Article							GID COMPLEX; CATABOLITE DEGRADATION; PROTEASOME-SYSTEM; PROTEIN; MUSKELIN; RANBPM; DOMAIN; ARMC8-ALPHA; EXPRESSION; HOMOLOG	In Saccharomyces cerevisiae the Gid-complex functions as an ubiquitin-ligase complex that regulates the metabolic switch between glycolysis and gluconeogenesis. In higher organisms six conserved Gid proteins form the CTLH protein-complex with unknown function. Here we show that Rmnd5, the Gid2 orthologue from Xenopus laevis, is an ubiquitin-ligase embedded in a high molecular weight complex. Expression of rmnd5 is strongest in neuronal ectoderm, prospective brain, eyes and ciliated cells of the skin and its suppression results in malformations of the fore-and midbrain. We therefore suggest that Xenopus laevis Rmnd5, as a subunit of the CTLH complex, is a ubiquitin-ligase targeting an unknown factor for polyubiquitination and subsequent proteasomal degradation for proper fore-and midbrain development.	[Pfirrmann, Thorsten; Subudhi, Abinash K.; Hollemann, Thomas] Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Germany; [Villavicencio-Lorini, Pablo] Univ Halle Wittenberg, Inst Human Genet, D-06108 Halle, Germany; [Menssen, Ruth; Wolf, Dieter H.] Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; University of Stuttgart	Pfirrmann, T (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Germany.	thorsten.pfirrmann@medizin.uni-halle.de	Pfirrmann, Thorsten/AAC-5563-2019	Pfirrmann, Thorsten/0000-0002-9474-9535	Fonds der Chemischen Industrie, Frankfurt; Wilhelm Roux program, Halle (Saale) [FKZ 26/22]	Fonds der Chemischen Industrie, Frankfurt(Fonds der Chemischen Industrie); Wilhelm Roux program, Halle (Saale)	The project was supported by funding from the Fonds der Chemischen Industrie, Frankfurt and the Wilhelm Roux program (FKZ 26/22), Halle (Saale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; Cornesse Y, 2005, DEV BIOL, V277, P296, DOI 10.1016/j.ydbio.2004.09.016; Cox JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062857; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Francis O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075217; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Heisler FF, 2011, NEURON, V70, P66, DOI 10.1016/j.neuron.2011.03.008; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Hollemann T, 1998, DEVELOPMENT, V125, P2425; Kelberman D, 2008, J CLIN ENDOCR METAB, V93, P1865, DOI 10.1210/jc.2007-2337; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Li J, 2014, NUCLEIC ACIDS RES, V42, P458, DOI 10.1093/nar/gkt839; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; Pfirrmann T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064870; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Sommer T, 2014, BBA-MOL CELL RES, V1843, P1, DOI 10.1016/j.bbamcr.2013.09.009; Suzuki T, 2008, BIOCHEM J, V411, P581, DOI 10.1042/BJ20071312; Tagnaouti N, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-28; Tomaru Koji, 2010, Open Biochem J, V4, P1, DOI 10.2174/1874091X01004010001; Tomastikova E, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-83; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Vogel TW, 2012, J NEUROSURG-PEDIATR, V10, P25, DOI 10.3171/2012.3.PEDS11559	30	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120342	10.1371/journal.pone.0120342	http://dx.doi.org/10.1371/journal.pone.0120342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793641	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900015
J	Reich, A; Dunn, C; Akasaka, K; Wessel, G				Reich, Adrian; Dunn, Casey; Akasaka, Koji; Wessel, Gary			Phylogenomic Analyses of Echinodermata Support the Sister Groups of Asterozoa and Echinozoa	PLOS ONE			English	Article							EVOLUTION; TRANSCRIPTOME; INSIGHTS; GENOME; CLASSIFICATION; RECONSTRUCTION; TOPOLOGIES; RESOLUTION; TREE	Echinoderms (sea urchins, sea stars, brittle stars, sea lilies and sea cucumbers) are a group of diverse organisms, second in number within deuterostome species to only the chordates. Echinoderms serve as excellent model systems for developmental biology due to their diverse developmental mechanisms, tractable laboratory use, and close phylogenetic distance to chordates. In addition, echinoderms are very well represented in the fossil record, including some larval features, making echinoderms a valuable system for studying evolutionary development. The internal relationships of Echinodermata have not been consistently supported across phylogenetic analyses, however, and this has hindered the study of other aspects of their biology. In order to test echinoderm phylogenetic relationships, we sequenced 23 de novo transcriptomes from all five clades of echinoderms. Using multiple phylogenetic methods at a variety of sampling depths we have constructed a well-supported phylogenetic tree of Echinodermata, including support for the sister groups of Asterozoa (sea stars and brittle stars) and Echinozoa (sea urchins and sea cucumbers). These results will help inform developmental and evolutionary studies specifically in echinoderms and deuterostomes in general.	[Reich, Adrian; Wessel, Gary] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Dunn, Casey] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Akasaka, Koji] Univ Tokyo, Misaki Marine Biol Stn, Miura, Kanagawa, Japan	Brown University; Brown University; University of Tokyo	Wessel, G (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	gary_wessel@brown.edu		Dunn, Casey/0000-0003-0628-5150	National Science Foundation [IOS-1120972]; National Institutes Health [2R01HD028152, 5T32 GM007601]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Science Foundation IOS-1120972 (GW); National Institutes Health 2R01HD028152 (GW); National Institutes Health 5T32 GM007601 (AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bather F, 1900, ECHINODERMATA TREA 3; Burns G, 2013, MAR GENOM, V9, P9, DOI 10.1016/j.margen.2012.05.003; Cannon JT, 2014, CURR BIOL, V24, P2827, DOI 10.1016/j.cub.2014.10.016; Carnevali MDC, 2001, MICROSC RES TECHNIQ, V55, P403; Church SH, 2014, AUTOMATION AND EVALU; DERBES AA, 1847, ANN SCI NAT ZOOL, V8, P80; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Dunn CW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-330; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ernst SG, 1997, AM ZOOL, V37, P250; Gahn Forest J, 2010, Integr Comp Biol, V50, p514a, DOI 10.1093/icb/icq155; GALE AS, 1987, ZOOL J LINN SOC-LOND, V89, P107, DOI 10.1111/j.1096-3642.1987.tb00652.x; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hart MW, 1997, EVOLUTION, V51, P1848, DOI 10.1111/j.1558-5646.1997.tb05108.x; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hinman VF, 2014, GENESIS, V52, P193, DOI 10.1002/dvg.22757; Howison M, 2012, P 4 USENIX WORKSH TH; Jangoux M., 1982, ECHINODERM NUTR, DOI DOI 10.1201/9781003078920; Janies D, 2001, CAN J ZOOL, V79, P1232, DOI 10.1139/cjz-79-7-1232; Janies DA, 2011, SYST BIOL, V60, P420, DOI 10.1093/sysbio/syr044; KANATANI H, 1969, NATURE, V221, P273, DOI 10.1038/221273a0; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Knott KE, 2000, AM ZOOL, V40, P382, DOI 10.1668/0003-1569(2000)040[0382:CACIAS]2.0.CO;2; Kouchinsky A, 2012, GEOL MAG, V149, P221, DOI 10.1017/S0016756811000720; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le HS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt215; Mac Bride EW, 1906, ECHINODERMATA; Mah CL, 2000, AM ZOOL, V40, P375, DOI 10.1668/0003-1569(2000)040[0375:PPOTFA]2.0.CO;2; Matsubara M, 2005, MOL PHYLOGENET EVOL, V36, P598, DOI 10.1016/j.ympev.2005.03.018; Perseke M, 2013, MOL PHYLOGENET EVOL, V66, P898, DOI 10.1016/j.ympev.2012.11.019; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Pisani D, 2012, MOL PHYLOGENET EVOL, V62, P27, DOI 10.1016/j.ympev.2011.08.028; Raff RA, 2006, HEREDITY, V97, P244, DOI 10.1038/sj.hdy.6800866; Reich A, 2014, PHYLOGENETIC ANAL EC; Reich A, DATA PHYLOGENOMIC AN; Schlegel M, 2014, DEEP METAZOAN PHYLOGENY: THE BACKBONE OF THE TREE OF LIFE, P413; SMITH AB, 1984, PALAEONTOLOGY, V27, P431; Smith AB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2391; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swofford David L., 1996, P407; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; Vaughn R, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-19; Wada H, 1996, MOL PHYLOGENET EVOL, V6, P97, DOI 10.1006/mpev.1996.0062; Wessel GM, 2010, SYST BIOL REPROD MED, V56, P236, DOI 10.3109/19396361003674879	48	63	64	8	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119627	10.1371/journal.pone.0119627	http://dx.doi.org/10.1371/journal.pone.0119627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794146	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200102
J	Su, ZM; Li, XM; Zhou, WQ; Ouyang, ZY				Su, Zhimin; Li, Xiaoma; Zhou, Weiqi; Ouyang, Zhiyun			Effect of Landscape Pattern on Insect Species Density within Urban Green Spaces in Beijing, China	PLOS ONE			English	Article							LEAST-SQUARES REGRESSION; LAND-USE; AGRICULTURAL LANDSCAPE; HABITAT FRAGMENTATION; TROPHIC LEVELS; URBANIZATION; COMMUNITIES; ASSEMBLAGES; DIVERSITY; GRADIENT	Urban green space is an important refuge of biodiversity in urban areas. Therefore, it is crucial to understand the relationship between the landscape pattern of green spaces and biodiversity to mitigate the negative effects of urbanization. In this study, we collected insects from 45 green patches in Beijing during July 2012 using suction sampling. The green patches were dominated by managed lawns, mixed with scattered trees and shrubs. We examined the effects of landscape pattern on insect species density using hierarchical partitioning analysis and partial least squares regression. The results of the hierarchical partitioning analysis indicated that five explanatory variables, i.e., patch area (with 19.9% independent effects), connectivity (13.9%), distance to nearest patch (13.8%), diversity for patch types (11.0%), and patch shape (8.3%), significantly contributed to insect species density. With the partial least squares regression model, we found species density was negatively related to patch area, shape, connectivity, diversity for patch types and proportion of impervious surface at the significance level of p < 0.05 and positively related to proportion of vegetated land. Regression tree analysis further showed that the highest species density was found in green patches with an area < 500 m(2). Our results indicated that improvement in habitat quality, such as patch area and connectivity that are typically thought to be important for conservation, did not actually increase species density. However, increasing compactness (low-edge) of patch shape and landscape composition did have the expected effect. Therefore, it is recommended that the composition of the surrounding landscape should be considered simultaneously with planned improvements in local habitat quality.	[Su, Zhimin; Li, Xiaoma; Zhou, Weiqi; Ouyang, Zhiyun] Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Ouyang, ZY (corresponding author), Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.	zyouyang@rcees.ac.cn	Zhou, Weiqi/G-2427-2010		National Natural Science Foundation of China [41030744]; China Postdoctoral Science Foundation [2013M541053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (41030744) and China Postdoctoral Science Foundation (2013M541053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijing Municipal Bureau of Statistics, 2013, BEIJ STAT YB; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Blair RB, 1997, BIOL CONSERV, V80, P113, DOI 10.1016/S0006-3207(96)00056-0; Bowman J, 2002, CONSERV ECOL, V6; Cai W. Z., 2011, GEN ENTOMOLOGY; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Colwell R. K., 2009, ESTIMATES 8 2 USERS; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Denys C, 1998, OECOLOGIA, V113, P269, DOI 10.1007/s004420050378; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; FAETH SH, 1978, OECOLOGIA, V32, P127, DOI 10.1007/BF00344697; Fahrig L, 1998, ECOSYSTEMS, V1, P197, DOI 10.1007/s100219900015; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GUSTAFSON EJ, 1992, LANDSCAPE ECOL, V7, P101, DOI 10.1007/BF02418941; Heikkinen RK, 2005, P ROY SOC B-BIOL SCI, V272, P2203, DOI 10.1098/rspb.2005.3212; Herbst C, 2013, ENTOMOL EXP APPL, V147, P269, DOI 10.1111/eea.12072; Huang DC, 2010, LANDSCAPE URBAN PLAN, V96, P163, DOI 10.1016/j.landurbplan.2010.03.004; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; Koh LP, 2004, ECOL APPL, V14, P1695, DOI 10.1890/03-5269; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Li XM, 2013, APPL GEOGR, V38, P1, DOI 10.1016/j.apgeog.2012.11.004; Li XM, 2012, LANDSCAPE ECOL, V27, P887, DOI 10.1007/s10980-012-9731-6; Li Z, 2011, COMMON INSECTS OTHER; Lizee MH, 2012, LANDSCAPE ECOL, V27, P159, DOI 10.1007/s10980-011-9651-x; Luo Y., 1995, SOIL ENTOMOLOGY, P29; Martens H, 2000, FOOD QUAL PREFER, V11, P5, DOI 10.1016/S0950-3293(99)00039-7; Matteson KC, 2013, OIKOS, V122, P682, DOI 10.1111/j.1600-0706.2012.20229.x; McCabe DJ, 2000, OECOLOGIA, V124, P270, DOI 10.1007/s004420000369; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McGarigal K, 2002, COMPUTER SOFTWARE PR; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; [牟凤云 MU Fengyun], 2007, [遥感学报, Journal of Remote Sensing], V11, P257; Niu W, 2012, CHINAS NEW URBANIZAT; R Development Core Team, 2012, R LANG ENV STAT COMP; Rosch V, 2013, J APPL ECOL, V50, P387, DOI 10.1111/1365-2664.12056; Rossi JP, 2010, ECOL INDIC, V10, P452, DOI 10.1016/j.ecolind.2009.07.016; Sadler JP, 2006, J BIOGEOGR, V33, P1126, DOI 10.1111/j.1365-2699.2006.01476.x; SIMPSON GG, 1964, SYST ZOOL, V13, P57, DOI 10.2307/2411825; Torma A, 2013, J INSECT CONSERV, V17, P35, DOI 10.1007/s10841-012-9484-1; WALSH C., 2013, HIER PART HIERARCHIC; Walz U, 2013, ECOL INDIC, V31, P1, DOI 10.1016/j.ecolind.2013.01.032; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu J.G., 2007, LANDSCAPE ECOLOGY PA, V2nd	45	20	23	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119276	10.1371/journal.pone.0119276	http://dx.doi.org/10.1371/journal.pone.0119276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793897	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200065
J	Vick, B; Rothenberg, M; Sandhofer, N; Carlet, M; Finkenzeller, C; Krupka, C; Grunert, M; Trumpp, A; Corbacioglu, S; Ebinger, M; Andre, MC; Hiddemann, W; Schneider, S; Subklewe, M; Metzeler, KH; Spiekermann, K; Jeremias, I				Vick, Binje; Rothenberg, Maja; Sandhoefer, Nadine; Carlet, Michela; Finkenzeller, Cornelia; Krupka, Christina; Grunert, Michaela; Trumpp, Andreas; Corbacioglu, Selim; Ebinger, Martin; Andre, Maya C.; Hiddemann, Wolfgang; Schneider, Stephanie; Subklewe, Marion; Metzeler, Klaus H.; Spiekermann, Karsten; Jeremias, Irmela			An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS; IL2R-GAMMA(NULL) MICE; INITIATING CELLS; SCID MOUSE; AML CELLS; T-CELLS; ENGRAFTMENT; CANCER; HETEROGENEITY	Acute myeloid leukemia (AML) is a clinically and molecularly heterogeneous disease with poor outcome. Adequate model systems are required for preclinical studies to improve understanding of AML biology and to develop novel, rational treatment approaches. Xenografts in immunodeficient mice allow performing functional studies on patient-derived AML cells. We have established an improved model system that integrates serial retransplantation of patient-derived xenograft (PDX) cells in mice, genetic manipulation by lentiviral transduction, and essential quality controls by immunophenotyping and targeted resequencing of driver genes. 17/29 samples showed primary engraftment, 10/17 samples could be retransplanted and some of them allowed virtually indefinite serial transplantation. 5/6 samples were successfully transduced using lentiviruses. Neither serial transplantation nor genetic engineering markedly altered sample characteristics analyzed. Transgene expression was stable in PDX AML cells. Example given, recombinant luciferase enabled bioluminescence in vivo imaging and highly sensitive and reliable disease monitoring; imaging visualized minimal disease at 1 PDX cell in 10000 mouse bone marrow cells and facilitated quantifying leukemia initiating cells. We conclude that serial expansion, genetic engineering and imaging represent valuable tools to improve the individualized xenograft mouse model of AML. Prospectively, these advancements enable repetitive, clinically relevant studies on AML biology and preclinical treatment trials on genetically defined and heterogeneous subgroups.	[Vick, Binje; Carlet, Michela; Finkenzeller, Cornelia; Grunert, Michaela; Jeremias, Irmela] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Dept Gene Vectors, Grp Apoptosis, Munich, Germany; [Vick, Binje; Sandhoefer, Nadine; Trumpp, Andreas; Ebinger, Martin; Hiddemann, Wolfgang; Subklewe, Marion; Spiekermann, Karsten; Jeremias, Irmela] German Canc Consortium DKTK, Heidelberg, Germany; [Vick, Binje; Sandhoefer, Nadine; Trumpp, Andreas; Ebinger, Martin; Hiddemann, Wolfgang; Subklewe, Marion; Spiekermann, Karsten; Jeremias, Irmela] German Canc Res Ctr, Heidelberg, Germany; [Rothenberg, Maja; Sandhoefer, Nadine; Krupka, Christina; Hiddemann, Wolfgang; Schneider, Stephanie; Subklewe, Marion; Metzeler, Klaus H.; Spiekermann, Karsten] Univ Munich, Univ Hosp Grosshadern, Dept Internal Med 3, Munich, Germany; [Sandhoefer, Nadine; Hiddemann, Wolfgang; Metzeler, Klaus H.; Spiekermann, Karsten] Helmholtz Zentrum Munchen, Clin Cooperat Grp Leukemia, German Res Ctr Environm Hlth, Munich, Germany; [Krupka, Christina; Subklewe, Marion] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Clin Cooperat Grp Immunotherapy, Munich, Germany; [Trumpp, Andreas] German Canc Res Ctr, Div Stem Cells & Canc, Heidelberg, Germany; [Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, Heidelberg, Germany; [Corbacioglu, Selim] Univ Regensburg, Dept Pediat, D-93053 Regensburg, Germany; [Ebinger, Martin; Andre, Maya C.] Univ Tubingen, Univ Childrens Hosp, Dept Pediat Hematol Oncol, Tubingen, Germany; [Andre, Maya C.] Univ Childrens Hosp UKBB, Dept Pediat Intens Care Med, Basel, Switzerland; [Jeremias, Irmela] Univ Munich, Dr von Haunersches Kinderspital, Dept Oncol, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); University of Regensburg; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Jeremias, I (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Dept Gene Vectors, Grp Apoptosis, Munich, Germany.	Irmela.Jeremias@helmholtz-muenchen.de	Metzeler, Klaus H./C-2118-2009; Ebinger, Martin/O-4936-2016; Trumpp, Andreas/Z-2141-2019; Subklewe, Marion/N-5873-2014; Corbacioglu, Selim/N-6152-2019; Jeremias, Irmela/Q-5934-2019; Spiekermann, Karsten/L-2065-2016	Metzeler, Klaus H./0000-0003-3920-7490; Ebinger, Martin/0000-0002-4229-8058; Trumpp, Andreas/0000-0002-6212-3466; Subklewe, Marion/0000-0001-9154-9469; Jeremias, Irmela/0000-0003-1773-7677; Vick, Binje/0000-0003-1956-2778	German Jose Carreras Leukemia Foundation [R 10/26]; Collaborative Research Center 684 "Molecular Mechanisms of Normal and Malignant Hematopoiesis" [A12, A22]; Bettina Brau-Foundation; Dr. Helmut Legerlotz Foundation; Alexander von Humboldt-Foundation	German Jose Carreras Leukemia Foundation; Collaborative Research Center 684 "Molecular Mechanisms of Normal and Malignant Hematopoiesis"; Bettina Brau-Foundation; Dr. Helmut Legerlotz Foundation; Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	This work was supported by German Jose Carreras Leukemia Foundation (http://www.carreras-stiftung.de, R 10/26, KS and IJ); the Collaborative Research Center 684 "Molecular Mechanisms of Normal and Malignant Hematopoiesis" (http://www.sfb684.med.uni-muenchen.de/index.html, A12 (KS) and A22 (IJ)); Bettina Brau-Foundation (http://www.bettina-braeu-stiftung.de, IJ); Dr. Helmut Legerlotz Foundation(IJ); and Alexander von Humboldt-Foundation (http://www.humboldt-foundation.de/web/home.html, MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Alves CC, 2012, BLOOD, V119, P4224, DOI 10.1182/blood-2011-08-370114; Barrett DM, 2011, BLOOD, V118, pE112, DOI 10.1182/blood-2011-04-346528; Bomken S, 2013, LEUKEMIA, V27, P718, DOI 10.1038/leu.2012.206; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; CESANO A, 1992, ONCOGENE, V7, P827; Christoph S, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-10; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Dick JE, 2005, ANN NY ACAD SCI, V1044, P1, DOI 10.1196/annals.1349.001; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Distler E, 2008, EXP HEMATOL, V36, P451, DOI 10.1016/j.exphem.2007.12.011; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Edinger Matthias, 1999, Neoplasia (New York), V1, P303, DOI 10.1038/sj.neo.7900048; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Goyama S, 2013, J CLIN INVEST, V123, P3876, DOI 10.1172/JCI68557; Guzman ML, 2014, STEM CELLS, V32, P844, DOI 10.1002/stem.1597; Harismendy O, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r124; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Inoue Y, 2008, EXP HEMATOL, V36, P1634, DOI 10.1016/j.exphem.2008.08.004; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krupka C, 2014, BLOOD, V123, P356, DOI 10.1182/blood-2013-08-523548; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lumkul R, 2002, LEUKEMIA, V16, P1818, DOI 10.1038/sj.leu.2402632; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Malaise M, 2011, LEUKEMIA, V25, P1635, DOI 10.1038/leu.2011.121; McCormack E, 2013, BLOOD, V121, pE34, DOI 10.1182/blood-2012-05-429555; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Paietta E, 2012, HEMATOL-AM SOC HEMAT, P35, DOI 10.1182/asheducation-2012.1.35; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Rombouts WJC, 2000, LEUKEMIA, V14, P889, DOI 10.1038/sj.leu.2401777; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sanchez PV, 2009, LEUKEMIA, V23, P2109, DOI 10.1038/leu.2009.143; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; SAWYERS CL, 1992, BLOOD, V79, P2089, DOI 10.1182/blood.V79.8.2089.bloodjournal7982089; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Terziyska N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052798; Vascotto C, 2014, ONCOGENE, V33, P2876, DOI 10.1038/onc.2013.251; von Bonin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060680; Wang XL, 2003, BLOOD, V102, P3478, DOI 10.1182/blood-2003-05-1432; Woiterski J, 2013, INT J CANCER, V133, P1547, DOI 10.1002/ijc.28170; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Wunderlich M, 2013, BLOOD, V121, pE90, DOI 10.1182/blood-2012-10-464677; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Ye P, 2014, CANCER LETT, V343, P98, DOI 10.1016/j.canlet.2013.09.022; Zimmerman EI, 2013, BLOOD, V122, P3607, DOI 10.1182/blood-2013-07-513044	60	63	65	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120925	10.1371/journal.pone.0120925	http://dx.doi.org/10.1371/journal.pone.0120925			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793878	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900089
J	Wienand, K; Shires, K				Wienand, Kirsty; Shires, Karen			The Use of MAGE C1 and Flow Cytometry to Determine the Malignant Cell Type in Multiple Myeloma	PLOS ONE			English	Article							CLONOTYPIC B-LYMPHOCYTES; HUMAN-BONE-MARROW; PERIPHERAL-BLOOD; PLASMA-CELLS; EXPRESSION; ANTIGENS; GENES; DIFFERENTIATION; SYSTEM; GROWTH	The malignant cell phenotype of Multiple Myeloma (MM) remains unclear with studies proposing it to be either clonotypic B or proliferating plasma cells. Cancer/testis antigen MAGE C1 is being extensively studied in MM and it has been suggested that it is involved in the pathogenesis of the cancer. Therefore, we report on the use of MAGE C1 to determine the malignant cell phenotype in MM using flow cytometry. Bone marrow aspirate (BM) and peripheral blood (PB) was collected from twelve MM patients at diagnosis, as well as three MM disease-free controls. Mononuclear cells were isolated using density-gradient centrifugation, and stabilized in 80% ethanol, before analysis via flow cytometry using relevant antibodies against B cell development cell-surface markers and nuclear MAGE C1. MAGE C1 expression was observed consistently in the early stem cells (CD34(+)) and early pro-B to pre-B cells (CD34(+/-)/CD19(+)), as well as the proliferating plasma cells in both the MM PB and BM, while no expression was observed in the corresponding control samples. Monoclonality indicated a common origin of these cell types suggesting that the CD34(+)/MAGE C1(+) are the primary malignant cell phenotype that sustains the downstream B cell maturation processes. Furthermore, this malignant cell phenotype was not restricted to the BM but also found in the circulating PB cells.	[Wienand, Kirsty; Shires, Karen] Univ Cape Town, Div Haematol, ZA-7925 Cape Town, South Africa; [Shires, Karen] Groote Schuur Hosp, Natl Hlth Lab Serv, Div Haematol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Shires, K (corresponding author), Univ Cape Town, Div Haematol, ZA-7925 Cape Town, South Africa.	karen.shires@uct.ac.za	Shires, karen/U-2196-2019	Shires, karen/0000-0001-8570-3714	Medical Research Council; Cancer Association of South Africa; National Health Laboratory Research Trust	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Association of South Africa; National Health Laboratory Research Trust	This work was supported by the Medical Research Council (WWW.MRC.ac.za) to KS, the Cancer Association of South Africa (WWW.CANSA.ORG.ZA) to KS and National Health Laboratory Research Trust (WWW.NHLS.AC.ZA) to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Andrade Valeria C C, 2008, Cancer Immun, V8, P2; Atanackovic D, 2010, HAEMATOL-HEMATOL J, V95, P785, DOI 10.3324/haematol.2009.014464; Atanackovic D, 2009, CLIN CANCER RES, V15, P1343, DOI 10.1158/1078-0432.CCR-08-0989; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Bataille R, 2006, HAEMATOLOGICA, V91, P1234; BERGSAGEL PL, 1995, BLOOD, V85, P436, DOI 10.1182/blood.V85.2.436.bloodjournal852436; BILLADEAU D, 1993, J EXP MED, V178, P1023, DOI 10.1084/jem.178.3.1023; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Condomines M, 2007, J IMMUNOL, V178, P3307, DOI 10.4049/jimmunol.178.5.3307; Conway EJ, 2009, ARCH PATHOL LAB MED, V133, P1594, DOI 10.1043/1543-2165-133.10.1594; de Carvalho F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027707; Dhodapkar Madhav V, 2003, Cancer Immun, V3, P9; DREWINKO B, 1981, BLOOD, V57, P333; DURIE BGM, 1986, SEMIN ONCOL, V13, P300; Durie GMB, 1975, CANCER, V36, P842; Gonzalez M, 1999, HAEMATOLOGICA, V84, P779; Jeong Tae-Dong, 2012, Korean J Hematol, V47, P260, DOI 10.5045/kjh.2012.47.4.260; Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; LOKEN MR, 1987, BLOOD, V70, P1316; Luque R, 1998, CLIN EXP IMMUNOL, V112, P410; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Ocqueteau M, 1996, BRIT J HAEMATOL, V95, P489, DOI 10.1111/j.1365-2141.1996.tb08993.x; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Owen RG, 1996, J CLIN PATHOL, V49, P672, DOI 10.1136/jcp.49.8.672; Pellat-Deceunynck C, 2004, BLOOD CELL MOL DIS, V32, P293, DOI 10.1016/j.bcmd.2003.12.001; PILARSKI LM, 1994, BLOOD, V83, P724; PILARSKI LM, 1992, HEMATOL ONCOL CLIN N, V6, P297, DOI 10.1016/S0889-8588(18)30346-0; Rapoport AP, 2014, CLIN CANCER RES, V20, P1355, DOI 10.1158/1078-0432.CCR-13-2817; Rasmussen T, 2004, LEUKEMIA LYMPHOMA, V45, P1413, DOI 10.1080/10428190410001655157; Rawstron AC, 2008, HAEMATOLOGICA, V93, P431, DOI 10.3324/haematol.11080; SANMIGUEL JF, 1995, BLOOD, V85, P448; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STELZER GT, 1993, ANN NY ACAD SCI, V677, P265, DOI 10.1111/j.1749-6632.1993.tb38783.x; Stewart AK, 2001, J CLIN ONCOL, V19, P3771, DOI 10.1200/JCO.2001.19.17.3771; Szczepek AJ, 1998, BLOOD, V92, P2844, DOI 10.1182/blood.V92.8.2844.420k17_2844_2855; Szczepek AJ, 1997, BLOOD, V89, P1824, DOI 10.1182/blood.V89.5.1824.1824_1824_1833; TERSTAPPEN LWMM, 1990, BLOOD, V76, P1739; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; van Baren N, 1999, BLOOD, V94, P1156; Yaccoby S, 1999, BLOOD, V94, P3576, DOI 10.1182/blood.V94.10.3576.422k01_3576_3582; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513	45	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120734	10.1371/journal.pone.0120734	http://dx.doi.org/10.1371/journal.pone.0120734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793710	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900070
J	Salpeter, SJ; Pozniak, Y; Merquiol, E; Ben-Nun, Y; Geiger, T; Blum, G				Salpeter, S. J.; Pozniak, Y.; Merquiol, E.; Ben-Nun, Y.; Geiger, T.; Blum, G.			A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression	ONCOGENE			English	Article							PROTEASE ACTIVITY; METASTASIS; AUTOPHAGY; PROLIFERATION; POLARIZATION; PROGRESSION; IDENTIFICATION; FRACTIONATION; PLASTICITY; INVASION	Although cysteine cathepsins have been identified as key regulators of cancer growth, their specific role in tumor development remains unclear. Recent studies have shown that high activity levels of tumor cathepsins are primarily a result of increased cathepsin activity in cancer-promoting tumor-associated macrophages (TAMs). To further investigate the role of cysteine cathepsin activity in normal and polarized macrophages, we established in vitro and in vivo models of macrophage differentiation and polarization and used a novel cysteine cathepsin inhibitor, GB111-NH2, to block the activity of cathepsins B, L and S. Here we show that in vitro, cysteine cathepsin inhibition yields both apoptosis and proliferation of macrophages, owing to increased oxidative stress. Proteomic analysis of cathepsin-inhibited macrophages demonstrates inhibition of autophagy, suggesting a likely cause of elevated reactive oxygen species (ROS) levels. In vivo models of mammary cancer further show that cathepsin inhibition yields TAM death owing to increased ROS levels. Strikingly, apoptosis in TAMs yields a seemingly cell non-autonomous death of neighboring cancer cells, and regression of the primary growth. These results show that cysteine cathepsin inhibitors can specifically trigger macrophage cell death and may function as an effective anticancer therapy in tumors with high levels of TAMs.	[Salpeter, S. J.; Merquiol, E.; Ben-Nun, Y.; Blum, G.] Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel; [Pozniak, Y.; Geiger, T.] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Ramat Aviv, Israel	Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine	Blum, G (corresponding author), Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel.	galiabl@ekmd.huji.ac.il		Ben-Nun, Yael/0000-0002-5123-649X	Israel Cancer Research Foundation (ICRF); European Research Council (Marie Curie International Reintegration Grant)	Israel Cancer Research Foundation (ICRF); European Research Council (Marie Curie International Reintegration Grant)	We thank Dr Michael Berger (The Hebrew University) for providing reagents and advice regarding the project. We would like to acknowledge Boris Turk (Lubljana, Slovenia) for supplying the recombinant cathepsins. This work was supported by the Israel Cancer Research Foundation (ICRF) (to GB, SJS and TG) and the European Research Council (Marie Curie International Reintegration Grant) (to GB).	Bell-McGuinn KM, 2007, CANCER RES, V67, P7378, DOI 10.1158/0008-5472.CAN-07-0602; Blum G, 2005, NAT CHEM BIOL, V1, P203, DOI 10.1038/nchembio728; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Concha C, 2005, J CELL PHYSIOL, V204, P693, DOI 10.1002/jcp.20338; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dennemarker J, 2010, BIOL CHEM, V391, P913, DOI 10.1515/BC.2010.097; Dragin N, 2006, FEBS LETT, V580, P3845, DOI 10.1016/j.febslet.2006.06.006; Elie BT, 2010, BIOCHIMIE, V92, P1618, DOI 10.1016/j.biochi.2010.04.023; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Goulet B, 2006, BIOL CHEM, V387, P1285, DOI 10.1515/BC.2006.159; Hawker KM, 1998, AM J PHYSIOL-LUNG C, V275, pL469, DOI 10.1152/ajplung.1998.275.3.L469; Hsu KF, 2009, AUTOPHAGY, V5, P451, DOI 10.4161/auto.5.4.7666; Jacquel A, 2012, BLOOD, V119, P4527, DOI 10.1182/blood-2011-11-392167; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Katunuma Nobuhiko, 2010, J Signal Transduct, V2010, P375345, DOI 10.1155/2010/375345; Larghi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045279; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; Lin YY, 2013, CANCER SCI, V104, P1217, DOI 10.1111/cas.12202; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Meara JP, 1996, J MED CHEM, V39, P3357, DOI 10.1021/jm950445b; MIKKELSEN T, 1995, J NEUROSURG, V83, P285, DOI 10.3171/jns.1995.83.2.0285; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Pan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035315; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Schurigt U, 2008, BIOL CHEM, V389, P1067, DOI 10.1515/BC.2008.115; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; White ES, 2013, J PATHOL, V229, P141, DOI 10.1002/path.4126; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Zavasnik-Bergant T, 2007, BIOL CHEM, V388, P1141, DOI 10.1515/BC.2007.144; Zhang Y, 2012, BLOOD, V119, P2895, DOI 10.1182/blood-2011-08-372383	45	41	41	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2015	34	50					6066	6078		10.1038/onc.2015.51	http://dx.doi.org/10.1038/onc.2015.51			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RQ	25798843				2022-12-26	WOS:000366113800004
J	Besnard-Guerin, C; Jacquier, C; Pidoux, J; Deddouche, S; Antoniewsk, C				Besnard-Guerin, Corinne; Jacquier, Caroline; Pidoux, Josette; Deddouche, Safia; Antoniewsk, Christophe			The Cricket Paralysis Virus Suppressor Inhibits microRNA Silencing Mediated by the Drosophila Argonaute-2 Protein	PLOS ONE			English	Article							RNA INTERFERENCE; ANTIVIRAL IMMUNITY; VIRAL SUPPRESSORS; MAMMALIAN-CELLS; RECOGNITION; DEFENSE; MELANOGASTER; REPLICATION; PATHWAYS; B2	Small RNAs are potent regulators of gene expression. They also act in defense pathways against invading nucleic acids such as transposable elements or viruses. To counteract these defenses, viruses have evolved viral suppressors of RNA silencing (VSRs). Plant viruses encoded VSRs interfere with siRNAs or miRNAs by targeting common mediators of these two pathways. In contrast, VSRs identified in insect viruses to date only interfere with the siRNA pathway whose effector Argonaute protein is Argonaute-2 (Ago-2). Although a majority of Drosophila miRNAs exerts their silencing activity through their loading into the Argonaute-1 protein, recent studies highlighted that a fraction of miRNAs can be loaded into Ago-2, thus acting as siRNAs. In light of these recent findings, we re-examined the role of insect VSRs on Ago-2-mediated miRNA silencing in Drosophila melanogaster. Using specific reporter systems in cultured Schneider-2 cells and transgenic flies, we showed here that the Cricket Paralysis virus VSR CrPV1-A but not the Flock House virus B2 VSR abolishes silencing by miRNAs loaded into the Ago-2 protein. Thus, our results provide the first evidence that insect VSR have the potential to directly interfere with the miRNA silencing pathway.	[Antoniewsk, Christophe] CNRS, UMR7622, Inst Biol Paris Seine, Drosophila Genet & Epigenet, F-75005 Paris, France; Univ Paris 06, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Antoniewsk, C (corresponding author), CNRS, UMR7622, Inst Biol Paris Seine, Drosophila Genet & Epigenet, 9 Quai St Bernard, F-75005 Paris, France.	christophe.antoniewski@upmc.fr	Besnard-Guerin, Corinne/J-3985-2017; Antoniewski, Christophe/G-4519-2011	Antoniewski, Christophe/0000-0001-7709-2116	Centre National de la Recherche Scientifique University Pierre et Marie Curie Institut National de la Sante et de la Recherche Medicale Agence Nationale de la Recherche [ANR BLAN 1210 01]; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique University Pierre et Marie Curie Institut National de la Sante et de la Recherche Medicale Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Centre National de la Recherche Scientifique University Pierre et Marie Curie Institut National de la Sante et de la Recherche Medicale Agence Nationale de la Recherche [grant number ANR BLAN 1210 01 "nuclear endosiRNA"] to CA and Fondation pour la Recherche Medicale [post-doctoral fellowship] to SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2014, GENE DEV, V28, P44, DOI 10.1101/gad.226654.113; Alvarado V, 2009, SEMIN CELL DEV BIOL, V20, P1032, DOI 10.1016/j.semcdb.2009.06.001; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berry B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005866; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Carre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074296; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chou YT, 2007, FLY, V1, P311, DOI 10.4161/fly.5606; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Habayeb MS, 2006, J GEN VIROL, V87, P3045, DOI 10.1099/vir.0.81997-0; Haley B, 2008, DEV BIOL, V321, P482, DOI 10.1016/j.ydbio.2008.06.015; Haley B, 2010, P NATL ACAD SCI USA, V107, P11435, DOI 10.1073/pnas.1006689107; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Leuschner PJF, 2005, CURR BIOL, V15, pR603, DOI 10.1016/j.cub.2005.07.044; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Singh G, 2009, FASEB J, V23, P1845, DOI 10.1096/fj.08-125120; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; van Mierlo JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002872; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vijayendran D, 2013, J INVERTEBR PATHOL, V114, P186, DOI 10.1016/j.jip.2013.07.006; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	41	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120205	10.1371/journal.pone.0120205	http://dx.doi.org/10.1371/journal.pone.0120205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793377	Green Published, gold			2022-12-26	WOS:000352084200159
J	Boneparth, A; Huang, WQ; Bethunaickan, R; Woods, M; Sahu, R; Arora, S; Akerman, M; Lesser, M; Davidson, A				Boneparth, Alexis; Huang, Weiqing; Bethunaickan, Ramalingam; Woods, Megan; Sahu, Ranjit; Arora, Shitij; Akerman, Meredith; Lesser, Martin; Davidson, Anne			TLR7 Influences Germinal Center Selection in Murine SLE	PLOS ONE			English	Article							CELL-INTRINSIC TLR7; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DNA B-CELLS; AUTOANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; TOLERANCE; MECHANISM; RECEPTOR; CHAIN; ACCELERATION	TLR7 enhances germinal center maturation and migration of B cells to the dark zone where proliferation and somatic hypermutation occur. Our goal was to determine how Tlr7 dose influences selection of the autoreactive B cell repertoire in NZW/BXSB. Yaa mice bearing the site-directed heavy chain transgene 3H9 that encodes for the TLR7 regulated anti-CL response. To create a physiologic setting in which autoreactive B cells compete for survival with non-autoreactive B cells, we generated bone marrow chimeras in which disease onset occurred with similar kinetics and the transferred 3H9+ female non-Yaa, male Yaa or male TLR7-/Yaa cells could be easily identified by positivity for GFP. Deletion of 3H9 B cells occurred in the bone marrow and the remaining 3H9 follicular B cells manifested a decrease in surface IgM. Although there were differences in the naive repertoire between the chimeras it was not possible to distinguish a clear pattern of selection against lupus related autoreactivity in TLR7(-/Yaa) or female chimeras. By contrast, preferential expansion of 3H9+ B cells occurred in the germinal centers of male Yaa chimeras. In addition, although all chimeras preferentially selected 3H9/V kappa 5 encoded B cells into the germinal center and plasma cell compartments, 3H9 male Yaa chimeras had a more diverse repertoire and positively selected the 3H9/V kappa 5-48/J kappa 4 pair that confers high affinity anti-cardiolipin activity. We were unable to demonstrate a consistent effect of Tlr7 dose or Yaa on somatic mutations. Our data show that TLR7 excess influences the selection, expansion and diversification of B cells in the germinal center, independent of other genes in the Yaa locus.	[Boneparth, Alexis; Huang, Weiqing; Bethunaickan, Ramalingam; Woods, Megan; Sahu, Ranjit; Arora, Shitij; Davidson, Anne] Feinstein Inst Med Res, Ctr Autoimmun & Musculoskeletal Dis, Manhasset, NY 11030 USA; [Akerman, Meredith; Lesser, Martin] Feinstein Inst Med Res, Biostat Unit, Manhasset, NY 11030 USA	Northwell Health; Northwell Health	Davidson, A (corresponding author), Feinstein Inst Med Res, Ctr Autoimmun & Musculoskeletal Dis, Manhasset, NY 11030 USA.	adavidson1@nshs.edu	Bethunaickan, Ramalingam/AAZ-6429-2020; Bethunaickan, Ramalingam/N-6463-2015	Bethunaickan, Ramalingam/0000-0003-4595-5233; Davidson, Anne/0000-0002-4081-6464; Arora, Shitij/0000-0002-8927-6171	National Institutes of Health [R01 AI083901, R01 AR064811]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants R01 AI083901 and R01 AR064811 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman A, 2004, AUTOIMMUNITY, V37, P445, DOI 10.1080/08916930400008524; Alabyev B, 2007, J IMMUNOL, V178, P5623, DOI 10.4049/jimmunol.178.9.5623; Arango D, 2004, BRIT J CANCER, V91, P1931, DOI 10.1038/sj.bjc.6602215; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Clingan JM, 2013, J IMMUNOL, V191, P810, DOI 10.4049/jimmunol.1300244; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Fossati L, 1995, EUR J IMMUNOL, V25, P3412, DOI 10.1002/eji.1830251231; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Hua ZL, 2014, J IMMUNOL, V192, P875, DOI 10.4049/jimmunol.1300683; Huang WQ, 2011, J IMMUNOL, V187, P6571, DOI 10.4049/jimmunol.1101784; Huber W, 2005, STAT BIOL HEALTH, P161; Hwang IY, 2009, J EXP MED, V206, P2641, DOI 10.1084/jem.20091982; Hwang SH, 2012, J IMMUNOL, V189, P5786, DOI 10.4049/jimmunol.1202195; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; Jackson SW, 2014, J IMMUNOL, V192, P4525, DOI 10.4049/jimmunol.1400098; Kahn P, 2008, ARTHRITIS RHEUM, V58, P2824, DOI 10.1002/art.23764; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kirchenbaum GA, 2014, EUR J IMMUNOL, V44, P970, DOI 10.1002/eji.201344276; Koh YT, 2013, J IMMUNOL, V190, P4982, DOI 10.4049/jimmunol.1202986; Lesser ML, 2014, J MOD APPL STAT METH, V13, P91; Li YJ, 2002, J EXP MED, V196, P1543, DOI 10.1084/jem.20021560; Liu Z, 2011, ARTHRITIS RHEUM-US, V63, P219, DOI 10.1002/art.30087; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; Meyer-Bahlburg A, 2008, J EXP MED, V205, P155, DOI 10.1084/jem.20071088; Moisini I, 2012, J IMMUNOL, V189, P4305, DOI 10.4049/jimmunol.1200745; Paul E, 2004, INT IMMUNOL, V16, P377, DOI 10.1093/intimm/dxh035; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; RADIC MZ, 1991, J IMMUNOL, V146, P176; RADIC MZ, 1993, J IMMUNOL, V150, P4966; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Ramanujam M, 2004, J IMMUNOL, V173, P3524, DOI 10.4049/jimmunol.173.5.3524; Ramanujam M, 2009, ARTHRITIS RHEUM-US, V60, P1096, DOI 10.1002/art.24414; Rubtsov AV, 2013, IMMUNOL RES, V55, P210, DOI 10.1007/s12026-012-8365-8; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Santiago-Raber ML, 2008, J IMMUNOL, V181, P1556, DOI 10.4049/jimmunol.181.2.1556; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; Simon R. M, 2004, DESIGN ANAL DNA MICR, P121; Soni C, 2014, J IMMUNOL, V193, P4400, DOI 10.4049/jimmunol.1401720; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Vuyyuru R, 2009, J IMMUNOL, V183, P5716, DOI 10.4049/jimmunol.0804215; Wang XB, 2002, J IMMUNOL, V168, P2046, DOI 10.4049/jimmunol.168.4.2046; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8	50	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119925	10.1371/journal.pone.0119925	http://dx.doi.org/10.1371/journal.pone.0119925			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794167	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200130
J	Bucchieri, F; Gammazza, AM; Pitruzzella, A; Fucarino, A; Farina, F; Howarth, P; Holgate, ST; Zummo, G; Davies, DE				Bucchieri, Fabio; Gammazza, Antonella Marino; Pitruzzella, Alessandro; Fucarino, Alberto; Farina, Felicia; Howarth, Peter; Holgate, Stephen T.; Zummo, Giovanni; Davies, Donna E.			Cigarette Smoke Causes Caspase-Independent Apoptosis of Bronchial Epithelial Cells from Asthmatic Donors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; AIRWAY HYPERRESPONSIVENESS; MOLECULAR-MECHANISMS; BARRIER FUNCTION; TOBACCO-SMOKE; LUNG; ANTIOXIDANT; DEATH; EXPRESSION	Background Epidemiologic studies have demonstrated important links between air pollution and asthma. Amongst these pollutants, environmental cigarette smoke is a risk factor both for asthma pathogenesis and exacerbation. As the barrier to the inhaled environment, the bronchial epithelium is a key structure that is exposed to cigarette smoke. Objectives Since primary bronchial epithelial cells (PBECs) from asthmatic donors are more susceptible to oxidant-induced apoptosis, we hypothesized that they would be susceptible to cigarette smoke-induced cell death. Methods PBECs from normal and asthmatic donors were exposed to cigarette smoke extract (CSE); cell survival and apoptosis were assessed by fluorescence-activated cell sorting, and protective effects of antioxidants evaluated. The mechanism of cell death was evaluated using caspase inhibitors and immunofluorescent staining for apoptosis-inducing factor (AIF). Results Exposure of PBEC cultures to CSE resulted in a dose-dependent increase in cell death. At 20% CSE, PBECs from asthmatic donors exhibited significantly more apoptosis than cells from non-asthmatic controls. Reduced glutathione (GSH), but not ascorbic acid (AA), protected against CSE-induced apoptosis. To investigate mechanisms of CSE-induced apoptosis, caspase-3 or -9 inhibitors were tested, but these failed to prevent apoptosis; in contrast, CSE promoted nuclear translocation of AIF from the mitochondria. GSH reduced the number of nuclear-AIF positive cells whereas AA was ineffective. Conclusion Our results show that PBECs from asthmatic donors are more susceptible to CSE-induced apoptosis. This response involves AIF, which has been implicated in DNA damage and ROS-mediated cell-death. Epithelial susceptibility to CSE may contribute to the impact of environmental tobacco smoke in asthma.	[Bucchieri, Fabio; Howarth, Peter; Holgate, Stephen T.; Davies, Donna E.] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Sir Henry Wellcome Labs,Univ Hosp Southampton, Southampton SO9 5NH, Hants, England; [Howarth, Peter; Holgate, Stephen T.; Davies, Donna E.] Univ Southampton, Fac Med, Southampton Natl Inst Hlth Res NIHR, Resp Biomed Res Unit,Sir Henry Wellcome Labs,Univ, Southampton SO9 5NH, Hants, England; [Bucchieri, Fabio; Gammazza, Antonella Marino; Pitruzzella, Alessandro; Fucarino, Alberto; Farina, Felicia; Zummo, Giovanni] Univ Palermo, Dipartimento Biomed Sperimentale & Neurosci Clin, Palermo, Italy; [Bucchieri, Fabio; Gammazza, Antonella Marino; Pitruzzella, Alessandro; Fucarino, Alberto] Ist Euromediterraneo Sci & Tecnol IEMEST, Palermo, Italy; [Bucchieri, Fabio] Italian Natl Res Council CNR, Inst Biomed & Mol Immunol IBIM, Palermo, Italy	University of Southampton; University of Southampton; University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Istituto di Neuroscienze (IN-CNR)	Davies, DE (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Sir Henry Wellcome Labs,Univ Hosp Southampton, Southampton SO9 5NH, Hants, England.	donnad@soton.ac.uk	Bucchieri, Fabio/F-8877-2012; Davies, Donna E/H-2993-2012; Gammazza, Antonella Marino/AAV-3123-2020	PITRUZZELLA, Alessandro/0000-0002-4618-4963; Marino Gammazza, Antonella/0000-0002-1683-3803; fucarino, alberto/0000-0001-8958-525X; BUCCHIERI, Fabio/0000-0002-0209-8668; Howarth, Peter/0000-0003-0619-7927; Davies, Donna/0000-0002-5117-2991	Medical Research Council (United Kingdom) [G0900453]; Asthma Allergy and Inflammation Research (AAIR) Charity; Asthma United Kingdom; MRC [G0900453, G19/34] Funding Source: UKRI; Medical Research Council [G19/34, G0900453] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma Allergy and Inflammation Research (AAIR) Charity; Asthma United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding provided by Medical Research Council (United Kingdom) Grant number G0900453 (STH, DED, PHH), http://www.mrc.ac.uk/, Asthma Allergy and Inflammation Research (AAIR) Charity (DED FB), http://www.aaircharity.org/, and Asthma United Kingdom (DED STH), http://www.asthma.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubier M, 2009, B ACAD NAT MED PARIS, V193, P1303, DOI 10.1016/S0001-4079(19)32469-0; Bazzini C, 2013, CELL PHYSIOL BIOCHEM, V32, P129, DOI 10.1159/000356633; Bergren Dale R., 2009, Inflammation & Allergy Drug Targets, V8, P340; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI [10.1089/ars.2008.2425, 10.1089/ARS.2008.2425]; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; CURVALL M, 1984, CELL BIOL TOXICOL, V1, P173, DOI 10.1007/BF00125573; Davies DE, 2003, J ALLERGY CLIN IMMUN, V111, P215, DOI 10.1067/mai.2003.128; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Gangl K, 2009, ALLERGY, V64, P398, DOI 10.1111/j.1398-9995.2008.01861.x; Gonzalez-Suarez I, 2014, CHEM RES TOXICOL, V27, P367, DOI 10.1021/tx400405s; Gumral N, 2009, CELL BIOCHEM FUNCT, V27, P276, DOI 10.1002/cbf.1569; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; HALLIWELL B, 1993, HAEMOSTASIS, V23, P118; Hellermann GR, 2002, RESP RES, V3, DOI 10.1186/rr172; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Iwanaga K, 2013, INHAL TOXICOL, V25, P653, DOI 10.3109/08958378.2013.827283; Kirkham P, 2006, PHARMACOL THERAPEUT, V111, P476, DOI 10.1016/j.pharmthera.2005.10.015; Kovacs K, 2012, FREE RADICAL BIO MED, V53, P1680, DOI 10.1016/j.freeradbiomed.2012.08.579; Liu XD, 2005, AM J RESP CELL MOL, V33, P121, DOI 10.1165/rcmb.2003-0341OC; Merendino AM, 2006, AM J RESP CELL MOL, V35, P155, DOI 10.1165/rcmb.2005-0433OC; Nadeem A, 2014, PULM PHARMACOL THER, V29, P31, DOI 10.1016/j.pupt.2014.06.001; Olatunji-Bello I I, 2008, West Afr J Med, V27, P78; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; POSTMA DS, 1988, AM REV RESPIR DIS, V137, P57, DOI 10.1164/ajrccm/137.1.57; Puddicombe SM, 2003, AM J RESP CELL MOL, V28, P61, DOI 10.1165/rcmb.4715; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; SEDGWICK JB, 1992, J IMMUNOL, V149, P3710; Siedlinski M, 2009, EUR RESPIR J, V33, P986, DOI 10.1183/09031936.00171507; Smith LJ, 1997, FREE RADICAL BIO MED, V22, P1301, DOI 10.1016/S0891-5849(96)00550-3; STONE KK, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432235; Sugiura H, 2008, ANTIOXID REDOX SIGN, V10, P785, DOI 10.1089/ars.2007.1937; Swindle EJ, 2009, J ALLERGY CLIN IMMUN, V124, P23, DOI 10.1016/j.jaci.2009.05.037; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-293; van der Toorn M, 2009, AM J PHYSIOL-LUNG C, V297, pL109, DOI 10.1152/ajplung.90461.2008; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wood LG, 2010, ANTIOXID REDOX SIGN, V13, P1535, DOI 10.1089/ars.2009.3064; Wood LG, 2010, BRIT J NUTR, V103, P735, DOI 10.1017/S0007114509992376; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	45	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120510	10.1371/journal.pone.0120510	http://dx.doi.org/10.1371/journal.pone.0120510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793769	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000352083900044
J	Jia, YH; Zheng, Z; Wang, YC; Zhou, Q; Cai, WX; Jia, WB; Yang, LL; Dong, ML; Zhu, XX; Su, LL; Hu, DH				Jia, Yanhui; Zheng, Zhao; Wang, Yunchuan; Zhou, Qin; Cai, Weixia; Jia, Wenbin; Yang, Longlong; Dong, Maolong; Zhu, Xiongxiang; Su, Linlin; Hu, Dahai			SIRT1 Is a Regulator in High Glucose-Induced Inflammatory Response in RAW264.7 Cells	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; TNF-ALPHA; INHIBITION; PATHWAY; DISEASE; PROTEIN; SEPSIS; LIPOPOLYSACCHARIDE; INACTIVATION	Sepsis is defined as a systemic inflammatory response syndrome that disorders the functions of host immune system, including the imbalance between pro-and anti-inflammatory responses mediated by immune macrophages. Sepsis could also induce acute hyperglycemia. Studies have shown that the silent mating type information regulation 2 homolog 1 (SIRT1), an NAD(+)-dependent deacetylase, mediates NF-kappa b deacetylation and inhibits its function. Therefore, SIRT1 is likely to play an important role in high glucose-mediated inflammatory signalings. Here we demonstrate that high glucose significantly downregulates both the mRNA and protein levels of SIRT1 and upregulates the mRNA level and the release of two pro-inflammatory cytokines, IL-1 beta and TNF-alpha, in RAW264.7 macrophages. Interestingly, the reduced level of SIRT1 by high glucose is remarkably upregulated by SIRT1 activator SRT1720, while the level and the release of IL-1 beta and TNF-alpha significantly decrease with the use of SRT1720. However, when the function of SIRT1 is inhibited by EX527 or its expression is suppressed by RNAi, the upregulated level and release of IL-1 beta and TNF-alpha by high glucose are further increased. Taken together, these findings collectively suggest that SIRT1 is an important regulator in many high glucose-related inflammatory diseases such as sepsis.	[Jia, Yanhui; Zheng, Zhao; Wang, Yunchuan; Zhou, Qin; Cai, Weixia; Jia, Wenbin; Yang, Longlong; Dong, Maolong; Zhu, Xiongxiang; Su, Linlin; Hu, Dahai] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Su, LL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, Peoples R China.	linlinsu@fmmu.edu.cn; hudhai@fmmu.edu.cn		Hu, Dahai/0000-0001-5543-092X; /0000-0002-3640-6729	National Natural Science Foundation of China (NSFC) [81372069, 81272084, 81372055]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) to Dahai Hu (81372069), Xiongxiang Zhu (81272084) and Maolong Dong (81372055). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centeno-Baez C, 2011, AM J PHYSIOL-ENDOC M, V301, pE922, DOI 10.1152/ajpendo.00530.2010; Chung EY, 2003, PLANTA MED, V69, P710, DOI 10.1055/s-2003-42787; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; De Simone R, 2010, CHEM BIOL DRUG DES, V76, P17, DOI 10.1111/j.1747-0285.2010.00984.x; Dong J, 2010, GENE DEV, V24, P1709, DOI 10.1101/gad.1958410; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Ichikawa T, 2013, RESPIROLOGY, V18, P332, DOI 10.1111/j.1440-1843.2012.02284.x; Jungo F, 2001, CYTOKINE, V14, P272, DOI 10.1006/cyto.2001.0884; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Luan RH, 2009, CARDIOVASC RES, V83, P294, DOI 10.1093/cvr/cvp085; Ma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097985; Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514; Murakami A, 2003, CANCER LETT, V195, P17, DOI 10.1016/S0304-3835(03)00058-2; Peng CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079739; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048621; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Takeda-Watanabe A, 2012, BIOCHEM BIOPH RES CO, V427, P191, DOI 10.1016/j.bbrc.2012.09.042; Vachharajani VT, 2014, J LEUKOCYTE BIOL, V96, P785, DOI 10.1189/jlb.3MA0114-034RR; Vachharajani VT, 2014, J LEUKOC BIOL; Wang Y, 2013, INVEST OPHTH VIS SCI, V54, P3806, DOI 10.1167/iovs.13-12091; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Yang HY, 2013, J BIOL CHEM, V288, P37256, DOI 10.1074/jbc.M113.527531; Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yi CO, 2011, ANAT CELL BIOL, V44, P194, DOI 10.5115/acb.2011.44.3.194; Yoo CH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04220; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	36	36	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120849	10.1371/journal.pone.0120849	http://dx.doi.org/10.1371/journal.pone.0120849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793995	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900081
J	Ni, I; Ji, C; Vij, N				Ni, Inzer; Ji, Changhoon; Vij, Neeraj			Second-Hand Cigarette Smoke Impairs Bacterial Phagocytosis in Macrophages by Modulating CFTR Dependent Lipid-Rafts	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY EPITHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA INFECTIONS; COMPLEMENT-MEDIATED PHAGOCYTOSIS; PROINFLAMMATORY CYTOKINE RELEASE; SMALL-MOLECULE MODULATOR; CYSTIC-FIBROSIS; ALVEOLAR MACROPHAGES; BIOFILM FORMATION	Introduction First/Second-hand cigarette-smoke (FHS/SHS) exposure weakens immune defenses inducing chronic obstructive pulmonary disease (COPD) but the underlying mechanisms are not fully understood. Hence, we evaluated if SHS induced changes in membrane/lipid-raft (m-/r)-CFTR (cystic fibrosis transmembrane conductance regulator) expression/activity is a potential mechanism for impaired bacterial phagocytosis in COPD. Methods RAW264.7 murine macrophages were exposed to freshly prepared CS-extract (CSE) containing culture media and/or Pseudomonas-aeruginosa-PA01-GFP for phagocytosis (fluorescence-microscopy), bacterial survival (colony-forming-units-CFU), and immunoblotting assays. The CFTR-expression/activity and lipid-rafts were modulated by transienttransfection or inhibitors/inducers. Next, mice were exposed to acute/sub-chronic-SHS or room-air (5-days/3-weeks) and infected with PA01-GFP, followed by quantification of bacterial survival by CFU-assay. Results We investigated the effect of CSE treatment on RAW264.7 cells infected by PA01-GFP and observed that CSE treatment significantly (p<0.01) inhibits PA01-GFP phagocytosis as compared to the controls. We also verified this in murine model, exposed to acute/subchronic-SHS and found significant (p<0.05, p<0.02) increase in bacterial survival in the SHS-exposed lungs as compared to the room-air controls. Next, we examined the effect of impaired CFTR ion-channel-activity on PA01-GFP infection of RAW264.7 cells using CFTR172-inhibitor and found no significant change in phagocytosis. We also similarly evaluated the effect of a CFTR corrector-potentiator compound, VRT-532, and observed no significant rescue of CSE impaired PA01-GFP phagocytosis although it significantly (p < 0.05) decreases CSE induced bacterial survival. Moreover, induction of CFTR expression in macrophages significantly (p<0.03) improves CSE impaired PA01-GFP phagocytosis as compared to the control. Next, we verified the link between m-/r-CFTR expression and phagocytosis using methyl-beta-cyclodextran (CD), as it is known to deplete CFTR from membrane lipid-rafts. We observed that CD treatment significantly (p<0.01) inhibits bacterial phagocytosis in RAW264.7 cells and adding CSE further impairs phagocytosis suggesting synergistic effect on CFTR dependent lipid-rafts. Conclusion Our data suggest that SHS impairs bacterial phagocytosis by modulating CFTR dependent lipid-rafts.	[Ni, Inzer; Ji, Changhoon; Vij, Neeraj] Johns Hopkins Univ, Sch Med, Dept Pediat Resp Sci, Baltimore, MD 21205 USA; [Ni, Inzer; Ji, Changhoon] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Vij, Neeraj] Cent Michigan Univ, Coll Med, Dept Fdn Sci, Mt Pleasant, MI 48859 USA	Johns Hopkins University; Johns Hopkins University; Central Michigan University	Vij, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat Resp Sci, Baltimore, MD 21205 USA.	neeraj.vij@cmich.edu			Flight Attendant Medical Research Institute's (FAMRI), Young Clinical Scientist Award (YCSA); other National Institute of Health (NIH) [U54CA141868, R01HL59410-04]; NATIONAL CANCER INSTITUTE [R43CA141868] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute's (FAMRI), Young Clinical Scientist Award (YCSA); other National Institute of Health (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Flight Attendant Medical Research Institute's (FAMRI), Young Clinical Scientist Award (YCSA) to NV. NV was also supported by other National Institute of Health (NIH, U54CA141868 and R01HL59410-04) grants during this period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; Ballok AE, 2013, J BACTERIOL, V195, P4013, DOI 10.1128/JB.00339-13; Barnes PJ, 2007, PLOS MED, V4, P779, DOI 10.1371/journal.pmed.0040112; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barriere H, 2009, MOL BIOL CELL, V20, P3125, DOI 10.1091/mbc.E09-01-0061; Bodas M, 2011, AM J PHYSIOL-LUNG C, V300, pL811, DOI 10.1152/ajplung.00408.2010; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Cantin AM, 2006, AM J PHYSIOL-CELL PH, V290, pC262, DOI 10.1152/ajpcell.00070.2005; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Chiaw PK, 2010, MOL PHARMACOL, V78, P411, DOI 10.1124/mol.110.065862; Childers M, 2007, MED HYPOTHESES, V68, P101, DOI 10.1016/j.mehy.2006.06.020; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; Deriy LV, 2009, J BIOL CHEM, V284, P35926, DOI 10.1074/jbc.M109.057372; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dockrell DH, 2003, J IMMUNOL, V171, P5380, DOI 10.4049/jimmunol.171.10.5380; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Donova MV, 2007, MICROBIOL-SGM, V153, P1981, DOI 10.1099/mic.0.2006/001636-0; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Dransfield MT, 2013, CHEST, V144, P498, DOI 10.1378/chest.13-0274; Filosto S, 2011, AM J RESP CELL MOL, V44, P350, DOI 10.1165/rcmb.2009-0422OC; Goldberg JB, 2000, TRENDS MICROBIOL, V8, P514, DOI 10.1016/S0966-842X(00)01872-2; GREEN GM, 1967, NEW ENGL J MED, V276, P421, DOI 10.1056/NEJM196702232760801; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hunter MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011598; Huvenne W, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-69; Johannesson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044059; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; LAURENZI GA, 1963, SCIENCE, V142, P1572, DOI 10.1126/science.142.3599.1572; Li CY, 2010, CANCER LETT, V292, P246, DOI 10.1016/j.canlet.2009.12.009; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; Marin L, 2011, EXPERT OPIN DRUG DEL, V8, P1205, DOI 10.1517/17425247.2011.588697; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Minematsu N, 2011, AM J RESP CELL MOL, V44, P474, DOI 10.1165/rcmb.2009-0463OC; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; Phipps JC, 2010, INFECT IMMUN, V78, P1214, DOI 10.1128/IAI.00963-09; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822; Pyle LC, 2010, AM J RESP CELL MOL, V43, P607, DOI 10.1165/rcmb.2009-0281OC; Radtke AL, 2005, P NATL ACAD SCI USA, V108, P1633; Rennolds J, 2010, TOXICOL SCI, V116, P349, DOI 10.1093/toxsci/kfq101; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Sethi Sanjay, 2009, Proc Am Thorac Soc, V6, P532, DOI 10.1513/pats.200905-025DS; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; THOMAS WR, 1978, INFECT IMMUN, V20, P468, DOI 10.1128/IAI.20.2.468-475.1978; Van de Weert-van Leeuwen PB, 2013, AM J RESP CELL MOL, V49, P463, DOI 10.1165/rcmb.2012-0502OC; Vij N, 2013, AM J RESP CRIT CARE, V187, P120, DOI 10.1164/rccm.201211-2011ED; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Xu YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011004; Zaidi T, 2008, INVEST OPHTH VIS SCI, V49, P1000, DOI 10.1167/iovs.07-0993; Zhang S, 2005, AM J RHINOL ALLERGY, V25, P307; Zhang Y, 2010, J IMMUNOL, V184, P5104, DOI 10.4049/jimmunol.0902851	72	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121200	10.1371/journal.pone.0121200	http://dx.doi.org/10.1371/journal.pone.0121200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794013	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900109
J	Martinez, PRRD; Soares, MB				Romo de Vivar Martinez, Paula Rosario; Soares, Marina Bento			Dentary Morphological Variation in Clevosaurus brasiliensis (Rhynchocephalia, Clevosauridae) from the Upper Triassic of Rio Grande do Sul, Brazil	PLOS ONE			English	Article							SPHENODONTIAN DIAPSIDA LEPIDOSAURIA; FOSSIL RELATIVES; SKULL SHAPE; REPTILE; TOOTH; EUCYNODONTIA; PATAGONIA; PACKAGE; ORIGIN; RECORD	Clevosaurus was a cosmopolitan rhynchocephalian genus, known from the Late Triassic to the Early Jurassic. In South America this genus is represented by C. brasiliensis, an important component of the Linha Sao Luiz taphocoenosis, on the top of the Norian Santa Maria 2 Sequence of Southern Brazil. The best preserved and most abundant bone elements of C. brasiliensis are dentaries, in which variations of shape and size are observed. The aim of this study is to describe and evaluate the variation, using geometric morphometrics methods. Geometric morphometric analysis of 10 specimens highlights variations in relative size of the dentary. Most of the variation observed for PC1 (83.3%) is likely related to ontogeny, and PC2 (10.0%) is likely related to taphonomic signatures. The development patterns observed, such as the growth of the dentary, consists of differential growth in length between the posterior portion of the dentary, that grows at a higher rate, regarding the anterior portion of the element. This allometric growth is similar to what is observed in other rhynchocephalians and is accompanied by the allometric skull growth, similar to the trend exhibited by clevosaurs. The taphocoenosis is bimodal (juveniles and adults) with a bias towards adult preservation. Some diagenetic influence is reflected in deformed skulls and this is observed in the tangent-plot. Finally, a strong correlation was detected between the taphonomic signatures and the PC2, regarding specially disarticulation and degree of fragmentation.	[Romo de Vivar Martinez, Paula Rosario; Soares, Marina Bento] Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Lab Paleontol Vertebrados, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Martinez, PRRD (corresponding author), Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Lab Paleontol Vertebrados, Porto Alegre, RS, Brazil.	paulaoirasor@gmail.com	Soares, Marina Bento/M-9477-2017; Soares, Marina/AAN-8513-2020	Soares, Marina Bento/0000-0002-8393-2406; Soares, Marina/0000-0002-8393-2406; Romo de Vivar Martinez, Paulo R./0000-0002-4959-6349	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for financial support (PRM) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) for MBS financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Apesteguia S, 2003, NATURE, V425, P609, DOI 10.1038/nature01995; Apesteguia S, 2014, J VERTEBR PALEONTOL, V34, P303, DOI 10.1080/02724634.2013.803974; Apesteguia S, 2012, ZOOL J LINN SOC-LOND, V166, P342, DOI 10.1111/j.1096-3642.2012.00837.x; Arantes BD, 2009, REV BRAS PALEONTOLOG, V12, P43, DOI 10.4072/rbp.2009.1.04; Arbour J, 2013, LOST 1 0; Behrensmeyer Anna K., 1992, P15; Bonaparte J.F., 2007, Historical Biology, V19, P73, DOI 10.1080/08912960600866862; Bonaparte JF, 2001, PALAEONTOLOGY, V44, P623, DOI 10.1111/1475-4983.00194; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bonaparte JF, 2006, PALAEONTOLOGY, V49, P917, DOI 10.1111/j.1475-4983.2006.00568.x; Bonaparte Jose F., 2003, Revista Brasileira de Paleontologia, V5, P5; Bonaparte JF, 2010, REV BRAS PALEONTOLOG, V13, P233, DOI 10.4072/rbp.2010.3.07; Bonaparte Jose F., 1999, National Science Museum Monographs, V15, P89; Brown CM, 2012, SYST BIOL, V61, P941, DOI 10.1093/sysbio/sys047; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Cisneros JC, 2003, NEUES JAHRB GEOL P-A, V227, P365; Costa da Silva R, 2012, J S AM EARTH SCI, V39, P16; Dendy A., 1899, Q J MICROSC SCI, Vs2-42, P1, DOI 10.1242/jcs.s2-42.165.1; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Evans SE, 2010, NEW ASPECTS MESOZOIC, P27, DOI [DOI 10.1007/978-3-642-10311-7_2, DOI 10.1007/978-3-642-10311-7]; Farina RA, 2001, ACTA PALAEONTOL POL, V46, P219; Ferigolo J., 2000, PALEONTOLOGIA RIO GR, P236; Ferigolo J, 2009, VERTEBRADOS FOSSEIS, P89, DOI [10.1371/journal.pone.0116716, DOI 10.1371/JOURNAL.PONE.0116716]; Foth C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072007; FRASER NC, 1988, PHILOS T ROY SOC B, V321, P125, DOI 10.1098/rstb.1988.0092; FRASER NC, 1983, PALAEOGEOGR PALAEOCL, V42, P341, DOI 10.1016/0031-0182(83)90031-7; FRASER NC, 1986, PALAEONTOLOGY, V29, P165; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Harrison HS, 1901, ANAT ANZEIGER, V20, P145; Hedrick BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069265; Herrel A, 2009, COPEIA, P727, DOI 10.1643/CG-08-136; Hoffstetter R, 1953, B MUSEUM, V25, P145; Holz M, 1998, LETHAIA, V31, P335; Howes G.B., 1901, T ZOOL SOC LONDON, V16, P1, DOI [10.1111/j.1096-3642.1901.tb00026.x, DOI 10.1111/J.1096-3642.1901.TB00026.X]; Humphries ED, 2010, J VERTEBR PALEONTOL, V2010, P108; Jones MEH, 2009, FRONT ORAL BIOL, V13, P9, DOI 10.1159/000242382; Jones Marc E.H., 2006, P55; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Jones MEH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-208; Jones Marc E.H., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P548; Jones MEH, 2009, J ROY SOC NEW ZEAL, V39, P71, DOI 10.1080/03014220909510565; Kidwell SM, 2002, ANNU REV ECOL SYST, V33, P561, DOI 10.1146/annurev.ecolsys.33.030602.152151; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinez RN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2057; Maxwell EE, 2013, PALEOBIOLOGY, V39, P123, DOI 10.1666/0094-8373-39.1.123; Meloro C, 2012, J EVOLUTION BIOL, V25, P2194, DOI 10.1111/j.1420-9101.2012.02595.x; Meloro C, 2012, BIOL J LINN SOC, V106, P70, DOI 10.1111/j.1095-8312.2011.01843.x; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rauhut OWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046839; Renesto S, 1955, MOD GEOL, V20, P149; Reynoso V.-H., 2014, DINOSAURS OTHER REPT, P4; Reynoso VH, 2003, CAN J EARTH SCI, V40, P609, DOI 10.1139/E02-097; Reynoso VH, 1997, J VERTEBR PALEONTOL, V17, P52, DOI 10.1080/02724634.1997.10010953; Reynoso VH, 1996, J VERTEBR PALEONTOL, V16, P210, DOI 10.1080/02724634.1996.10011309; Robinson P.L., 1976, Linnean Soc Symp Ser, V3, P43; Rohlf F. J., 2013, TPSDIG 2 17; Saila LK, 2005, PALAEONTOLOGY, V48, P817, DOI 10.1111/j.1475-4983.2005.00486.x; Soares M.B., 2013, INT S PTER RIO PTER, V50, P95; Soares MB, 2011, AN ACAD BRAS CIENC, V83, P329, DOI 10.1590/S0001-37652011000100021; Stacklies W, 2013, PCA METHODS; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; SUES HD, 1995, J PALEONTOL, V69, P123, DOI 10.1017/S0022336000026974; Uetz P., REPTILE DATABASE; Vincent SE, 2007, INTEGR COMP BIOL, V47, P172, DOI 10.1093/icb/icm019; Wu XC, 1999, SHADOW DINOSAURS EAR, P38; Zeldicht ML, 2004, GEOMETRIC MORPHOMETR; Zerfass H, 2004, SEDIMENT GEOL, V166, P265, DOI 10.1016/j.sedgeo.2003.12.008; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4	72	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119307	10.1371/journal.pone.0119307	http://dx.doi.org/10.1371/journal.pone.0119307			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793754	Green Published, gold			2022-12-26	WOS:000352084200072
J	Sakurai, G; Yonemura, S; Kishimoto-Mo, AW; Murayama, S; Ohtsuka, T; Yokozawa, M				Sakurai, Gen; Yonemura, Seiichiro; Kishimoto-Mo, Ayaka W.; Murayama, Shohei; Ohtsuka, Toshiyuki; Yokozawa, Masayuki			Inversely Estimating the Vertical Profile of the Soil CO2 Production Rate in a Deciduous Broadleaf Forest Using a Particle Filtering Method	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; CARBON DECOMPOSITION; RESPIRATION; MODEL; EFFLUX; TRANSPORT; ROOT	Carbon dioxide (CO2) efflux from the soil surface, which is a major source of CO2 from terrestrial ecosystems, represents the total CO2 production at all soil depths. Although many studies have estimated the vertical profile of the CO2 production rate, one of the difficulties in estimating the vertical profile is measuring diffusion coefficients of CO2 at all soil depths in a nondestructive manner. In this study, we estimated the temporal variation in the vertical profile of the CO2 production rate using a data assimilation method, the particle filtering method, in which the diffusion coefficients of CO2 were simultaneously estimated. The CO2 concentrations at several soil depths and CO2 efflux from the soil surface (only during the snow-free period) were measured at two points in a broadleaf forest in Japan, and the data were assimilated into a simple model including a diffusion equation. We found that there were large variations in the pattern of the vertical profile of the CO2 production rate between experiment sites: the peak CO2 production rate was at soil depths around 10 cm during the snow-free period at one site, but the peak was at the soil surface at the other site. Using this method to estimate the CO2 production rate during snow-cover periods allowed us to estimate CO2 efflux during that period as well. We estimated that the CO2 efflux during the snow-cover period (about half the year) accounted for around 13% of the annual CO2 efflux at this site. Although the method proposed in this study does not ensure the validity of the estimated diffusion coefficients and CO2 production rates, the method enables us to more closely approach the "actual" values by decreasing the variance of the posterior distribution of the values.	[Sakurai, Gen; Yonemura, Seiichiro; Kishimoto-Mo, Ayaka W.] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan; [Murayama, Shohei] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Ohtsuka, Toshiyuki] Gifu Univ, River Basin Res Ctr, Gifu, Gifu, Japan; [Yokozawa, Masayuki] Shizuoka Univ, Grad Sch Engn, Hamamatsu, Shizuoka 4328561, Japan	National Institute for Agro-Environmental Sciences (NIAES) Japan; National Institute of Advanced Industrial Science & Technology (AIST); Gifu University; Shizuoka University	Yokozawa, M (corresponding author), Shizuoka Univ, Grad Sch Engn, Hamamatsu, Shizuoka 4328561, Japan.	yokozawa@sys.eng.shizuoka.ac.jp	Murayama, Shohei/L-2973-2018; Yokozawa, Masayuki/O-2829-2014; , 大塚俊之/V-6687-2019	Murayama, Shohei/0000-0003-1923-6059; Yokozawa, Masayuki/0000-0001-7053-2465; , 大塚俊之/0000-0002-9032-7933	Ministry of Education, Culture, Sports, Science and Technology of Japan [23119520, 70452737]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research in Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 23119520 to M.Y. and no. 70452737 to G.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer J, 2012, BIOGEOCHEMISTRY, V108, P119, DOI 10.1007/s10533-011-9583-1; Breecker DO, 2012, ECOSYSTEMS, V15, P83, DOI 10.1007/s10021-011-9495-x; Candy J.V., 2009, ADAPTIVE LEARNING SY; Cook FJ, 1998, ECOL MODEL, V109, P155, DOI 10.1016/S0304-3800(98)00034-9; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P944, DOI 10.1111/j.1365-2486.2005.01142.x; Hashimoto S, 2007, J FOREST RES-JPN, V12, P209, DOI 10.1007/s10310-007-0009-9; Hendry MJ, 1999, WATER RESOUR RES, V35, P2189, DOI 10.1029/1999WR900060; Hirano T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003766; Jassal R, 2005, AGR FOREST METEOROL, V130, P176, DOI 10.1016/j.agrformet.2005.03.005; Jassal RS, 2004, AGR FOREST METEOROL, V124, P219, DOI 10.1016/j.agrformet.2004.01.013; Kitagawa G, 1998, J AM STAT ASSOC, V93, P1203, DOI 10.2307/2669862; Lee MS, 2005, AGR FOREST METEOROL, V134, P95, DOI 10.1016/j.agrformet.2005.08.011; Liptzin D, 2009, BIOGEOCHEMISTRY, V95, P151, DOI 10.1007/s10533-009-9303-2; Mariko S, 2000, ECOL RES, V15, P363, DOI 10.1046/j.1440-1703.2000.00357.x; MILLINGTON R, 1961, T FARADAY SOC, V57, P1200, DOI 10.1039/tf9615701200; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Murayama S, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013626; Powers LD, 2009, BOUNDARY VALUE PROBL; Pumpanen J, 2003, SOIL SCI SOC AM J, V67, P402, DOI 10.2136/sssaj2003.0402; R Core Team, 2021, R LANGUAGE ENV STAT; Saigusa N, 2002, AGR FOREST METEOROL, V112, P203, DOI 10.1016/S0168-1923(02)00082-5; Sakurai G, 2012, SOIL BIOL BIOCHEM, V46, P191, DOI 10.1016/j.soilbio.2011.11.005; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SUAREZ DL, 1993, WATER RESOUR RES, V29, P499, DOI 10.1029/92WR02226; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Tang JW, 2005, AGR FOREST METEOROL, V132, P212, DOI 10.1016/j.agrformet.2005.07.011; Vargas R, 2008, VADOSE ZONE J, V7, P1055, DOI 10.2136/vzj2007.0138; Vargas R, 2010, GLOBAL CHANGE BIOL, V16, P1589, DOI 10.1111/j.1365-2486.2009.02111.x; von Lutzow M, 2009, BIOL FERT SOILS, V46, P1, DOI 10.1007/s00374-009-0413-8; Western AW, 2002, ANNU REV EARTH PL SC, V30, P149, DOI 10.1146/annurev.earth.30.091201.140434; Yasuda Y, 2012, J FOREST RES-JPN, V17, P253, DOI 10.1007/s10310-011-0298-x; Yonemura S, 2013, J FOREST RES-JPN, V18, P49, DOI 10.1007/s10310-012-0385-7; Yonemura Seiiehiro, 2009, Journal of Agricultural Meteorology, V65, P141	34	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119001	10.1371/journal.pone.0119001	http://dx.doi.org/10.1371/journal.pone.0119001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793387	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200051
J	Santoro, FR; Ferreira, WS; Araujo, TAD; Ladio, AH; Albuquerque, UP				Santoro, Flavia Rosa; Ferreira Junior, Washington Soares; de Souza Araujo, Thiago Antonio; Haydee Ladio, Ana; Albuquerque, Ulysses Paulino			Does Plant Species Richness Guarantee the Resilience of Local Medical Systems? A Perspective from Utilitarian Redundancy	PLOS ONE			English	Article							MEDICINAL-PLANTS; KNOWLEDGE; MEMORY	Resilience is related to the ability of a system to adjust to disturbances. The Utilitarian Redundancy Model has emerged as a tool for investigating the resilience of local medical systems. The model determines the use of species richness for the same therapeutic function as a facilitator of the maintenance of these systems. However, predictions generated from this model have not yet been tested, and a lack of variables exists for deeper analyses of resilience. This study aims to address gaps in the Utilitarian Redundancy Model and to investigate the resilience of two medical systems in the Brazilian semi-arid zone. As a local illness is not always perceived in the same way that biomedicine recognizes, the term "therapeutic targets" is used for perceived illnesses. Semi-structured interviews with local experts were conducted using the free-listing technique to collect data on known medicinal plants, usage preferences, use of redundant species, characteristics of therapeutic targets, and the perceived severity for each target. Additionally, participatory workshops were conducted to determine the frequency of targets. The medical systems showed high species richness but low levels of species redundancy. However, if redundancy was present, it was the primary factor responsible for the maintenance of system functions. Species richness was positively associated with therapeutic target frequencies and negatively related to target severity. Moreover, information about redundant species seems to be largely idiosyncratic; this finding raises questions about the importance of redundancy for resilience. We stress the Utilitarian Redundancy Model as an interesting tool to be used in studies of resilience, but we emphasize that it must consider the distribution of redundancy in terms of the treatment of important illnesses and the sharing of information. This study has identified aspects of the higher and lower vulnerabilities of medical systems, adding variables that should be considered along with richness and redundancy.	[Santoro, Flavia Rosa; Ferreira Junior, Washington Soares; de Souza Araujo, Thiago Antonio; Albuquerque, Ulysses Paulino] Univ Fed Rural Pernambuco, Dept Biol, Lab Appl & Theoret Ethnobiol, Recife, PE, Brazil; [Haydee Ladio, Ana] Univ Nacl Comahue, CONICET, Ecotono Lab, San Carlos De Bariloche, Rio Negro, Argentina	Universidade Federal Rural de Pernambuco (UFRPE); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Santoro, FR (corresponding author), Univ Fed Rural Pernambuco, Dept Biol, Lab Appl & Theoret Ethnobiol, Recife, PE, Brazil.	flaviarsantoro@gmail.com; upa@db.ufrpe.br	Albuquerque, Ulysses P/I-5037-2012; Ladio, Ana Haydeé/W-2651-2019	Albuquerque, Ulysses P/0000-0002-8131-8429; Ladio, Ana/0000-0002-2844-6704	Improvement of Higher Education Personnel (CAPES); Pernambuco State Foundation for Science and Technology (FACEPE - APQ) [1264-2.05/10]; National Counsel of Technological and Scientific Development (CNPq) [Proc. 471989/2012-6]	Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pernambuco State Foundation for Science and Technology (FACEPE - APQ); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank Coordination for the Improvement of Higher Education Personnel (CAPES), the Pernambuco State Foundation for Science and Technology (FACEPE - APQ - 1264-2.05/10), and the National Counsel of Technological and Scientific Development (CNPq - Proc. 471989/2012-6) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque U.P., 2006, J ETHNOBIOL ETHNOMED, V2, P1, DOI DOI 10.1186/1746-4269-2-30; Albuquerque U. P., 2014, METHODS TECHNIQUES E, Vfirst, P1, DOI DOI 10.1007/978-1-4614-8636-7; Albuquerque UP, 2007, INTERCIENCIA, V27, P336; [Anonymous], 2007, WHO INT STAT CLASS D; AYRES M., 2007, BIOESTAT; BARRETT B, 1995, J COMMUN HEALTH, V20, P403, DOI 10.1007/BF02260437; Berkes F, 2002, CONSERV ECOL, V5; BOSTER JS, 1989, AM ANTHROPOL, V91, P866, DOI 10.1525/aa.1989.91.4.02a00040; BOYD R, 1995, ETHOL SOCIOBIOL, V16, P125, DOI 10.1016/0162-3095(94)00073-G; Brown KA, 2011, PLOS ONE, V6; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Albuquerque UP, 2007, J ETHNOPHARMACOL, V113, P156, DOI 10.1016/j.jep.2007.05.025; de Albuquerque UP, 2012, SCI WORLD J, DOI [10.1100/2012/205182, 10.1155/2012/202508]; de Medeiros PM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/807452; Dunn F., 1976, ASIAN MEDICAL SYSTEM; Ferreira FS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/126938; Ferreira WS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/543207; Ferreira WS, 2013, ETHNOBIOL CONSERV, V2, DOI 10.15451/ec2013-8-2.1-1-10; Ferreira WS, 2011, J ETHNOPHARMACOL, V138, P238, DOI 10.1016/j.jep.2011.09.018; Ferreira Junior WS, 2013, ETNOBIOLOGIA BASES E, P63; FUNCEME IPECE, 2009, PERF BAS MUN CRAT FO; Greene S, 1998, AM ETHNOL, V25, P634, DOI 10.1525/ae.1998.25.4.634; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hopkins AL, 2012, ECON BOT, V66, P249, DOI 10.1007/s12231-012-9202-7; IUCN, 2013, IUCN RED LIST THREAT; Klein SB, 2002, PSYCHOL REV, V109, P306, DOI 10.1037//0033-295X.109.2.306; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; Ladio AH, 2008, CURRENT TOPICS ETHNO, P39; Laland KN, 2004, LEARN BEHAV, V32, P4; Low B., 2003, NAVIGATING SOCIAL EC, P83; Medeiros PM, 2013, ETNOBIOLOGIA BASES E, P63; Mesoudi A., 2011, CULTURAL EVOLUTION D; Molares S, 2012, BIODIVERS CONSERV, V21, P1079, DOI 10.1007/s10531-012-0241-2; Nairne JS, 2008, J MEM LANG, V59, P377, DOI 10.1016/j.jml.2008.06.001; Salas-Zapata Walter A, 2012, Ecol. austral, V22, P74; Sieber S, 2014, METHODS TECHNIQUES E, P39, DOI [DOI 10.1007/978, 10.1007/978, DOI 10.1007/978-1-4614-8636-7]; Stewart K, 2009, FOREST ECOL MANAG, V258, P1121, DOI 10.1016/j.foreco.2009.05.039; Tanaka MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005192; Tomasello Michael, 2003, CULTURAL ORIGINS HUM; Ungar M, 2012, SOCIAL ECOLOGY OF RESILIENCE: A HANDBOOK OF THEORY AND PRACTICE, P1, DOI 10.1007/978-1-4614-0586-3_1; Vandebroek I, 2010, ECON BOT, V64, P303, DOI 10.1007/s12231-010-9135-y; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Walker B, 2006, ECOL SOC, V11; Winter K, 2008, FUNC ECOSYST COMMUN, V2, P1	45	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119826	10.1371/journal.pone.0119826	http://dx.doi.org/10.1371/journal.pone.0119826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793930	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200119
J	Zwemer, CF; Davenport, RD; Gomez-Espina, J; Blanco-Gonzalez, E; Whitesall, SE; D'Alecy, LG				Zwemer, Charles F.; Davenport, Robertson D.; Gomez-Espina, Juan; Blanco-Gonzalez, Elisa; Whitesall, Steven E.; D'Alecy, Louis G.			Packed Red Blood Cells Are an Abundant and Proximate Potential Source of Nitric Oxide Synthase Inhibition	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE ADMA; L-ARGININE; SYMMETRIC DIMETHYLARGININE; ENDOGENOUS METHYLARGININES; BANKED BLOOD; RAT-KIDNEY; DIMETHYLAMINOHYDROLASE; PLASMA; STORAGE; HEMOGLOBIN	Objective We determined, for packed red blood cells (PRBC) and fresh frozen plasma, the maximum content, and ability to release the endogenous nitric oxide synthase (NOS) inhibitors asymmetric dimethylarginine (ADMA) and monomethylarginine (LNMMA). Background ADMA and LNMMA are near equipotent NOS inhibitors forming blood's total NOS inhibitory content. The balance between removal from, and addition to plasma determines their free concentrations. Removal from plasma is by well-characterized specific hydrolases while formation is restricted to posttranslational protein methylation. When released into plasma they can readily enter endothelial cells and inhibit NOS. Fresh rat and human whole blood contain substantial protein incorporated ADMA however; the maximum content of ADMA and LNMMA in PRBC and fresh frozen plasma has not been determined. Methods We measured total (free and protein incorporated) ADMA and LNMMA content in PRBCs and fresh frozen plasma, as well as their incubation induced release, using HPLC with fluorescence detection. We tested the hypothesis that PRBC and fresh frozen plasma contain substantial inhibitory methylarginines that can be released chemically by complete in vitro acid hydrolysis or physiologically at 37 degrees C by enzymatic blood proteolysis. Results In vitro strong-acid-hydrolysis revealed a large PRBC reservoir of ADMA (54.5 +/- 9.7 mu M) and LNMMA (58.9 +/- 28.9 mu M) that persisted over 42-d at 6 degrees or -80 degrees C. In vitro 5h incubation at 37 degrees C nearly doubled free ADMA and LNMMNA concentration from PRBCs while no change was detected in fresh frozen plasma. Conclusion The compelling physiological ramifications are that regardless of storage age, 1) PRBCs can rapidly release pathologically relevant quantities of ADMA and LNMMA when incubated and 2) PRBCs have a protein-incorporated inhibitory methylarginines reservoir 100 times that of normal free inhibitory methylarginines in blood and thus could represent a clinically relevant and proximate risk for iatrogenic NOS inhibition upon transfusion.	[Zwemer, Charles F.] Dickinson Coll, Dept Biol, Carlisle, PA 17013 USA; [Davenport, Robertson D.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Gomez-Espina, Juan; Blanco-Gonzalez, Elisa] Univ Oviedo, Dept Phys & Analyt Chem, Oviedo, Spain; [Whitesall, Steven E.; D'Alecy, Louis G.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA	Dickinson College; University of Michigan System; University of Michigan; University of Oviedo; University of Michigan System; University of Michigan	Zwemer, CF (corresponding author), Dickinson Coll, Dept Biol, Carlisle, PA 17013 USA.	zwemer@dickinson.edu		/0000-0002-2844-6739	Michigan Institute for Clinical and Health Research Pilot Grant [P/GU032484]	Michigan Institute for Clinical and Health Research Pilot Grant	Sources of support for this work are from the following organizations: 1) Michigan Institute for Clinical and Health Research Pilot Grant (P/GU032484) for LGD and RDD at http://www.michr.umich.edu/home; 2) donation of blood products (RDD) from The University of Michigan Health System Blood Bank at http://www.pathology.med.umich.edu/index.php?t=page & id=619; and 3) sabbatical leave for CFZ granted by The Provost and Dean of the College Office at Dickinson College at http://www.dickinson.edu/homepage/81/provost_and_dean_of_the_college. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Achan V, 2002, CIRC RES, V90, P764, DOI 10.1161/01.RES.0000014450.40853.2B; [Anonymous], 2000, NORMAL CIRCULATING A, P135; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Bernard A, 2007, J TRAUMA, V63, P1108, DOI 10.1097/TA.0b013e31814b2b17; Billecke SS, 2006, AM J PHYSIOL-HEART C, V291, pH1788, DOI 10.1152/ajpheart.00066.2006; Billecke SS, 2009, NEPHROL DIAL TRANSPL, V24, P489, DOI 10.1093/ndt/gfn500; Blackwell S, 2009, CLIN CHIM ACTA, V401, P14, DOI 10.1016/j.cca.2008.10.032; Bohmer A, 2012, NITRIC OXIDE-BIOL CH, V27, P72, DOI 10.1016/j.niox.2012.03.013; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; BOGLE RG, 1995, AM J PHYSIOL-CELL PH, V269, pC750, DOI 10.1152/ajpcell.1995.269.3.C750; Bonaventura J, 2007, P NATL ACAD SCI USA, V104, P19165, DOI 10.1073/pnas.0708871105; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; Carello KA, 2006, AM J PHYSIOL-HEART C, V290, pH209, DOI 10.1152/ajpheart.00208.2005; Chae JW, 2011, ARZNEIMITTELFORSCH, V61, P340, DOI 10.1055/s-0031-1296208; Damkjaer M, 2010, AM J PHYSIOL-REG I, V299, pR1449, DOI 10.1152/ajpregu.00440.2010; Davids M, 2012, AM J PHYSIOL-HEART C, V302, pH1762, DOI 10.1152/ajpheart.01205.2011; Davids M, 2012, METABOLISM, V61, P482, DOI 10.1016/j.metabol.2011.08.007; DAVIES MG, 1973, J SCI FOOD AGR, V24, P1525, DOI 10.1002/jsfa.2740241208; Frenchik MD, 2004, CLIN CHIM ACTA, V339, P199, DOI 10.1016/j.cccn.2003.09.017; Fullerton JN, 2013, J PATHOL, V231, P8, DOI 10.1002/path.4232; Gladwin MT, 2009, CURR OPIN HEMATOL, V16, P515, DOI 10.1097/MOH.0b013e32833157f4; Gladwin MT, 2004, CIRC RES, V94, P851, DOI 10.1161/01.RES.0000126697.64381.37; Hasegawa K, 2007, CIRC RES; HECKER M, 1991, FEBS LETT, V294, P221, DOI 10.1016/0014-5793(91)81434-A; Hov GG, 2007, SCAND J CLIN LAB INV, V67, P868, DOI 10.1080/00365510701429836; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912; IGNARRO LJ, 1988, J PHARMACOL EXP THER, V244, P181; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Kang ES, 2001, FREE RADIC RES; Knipp M, 2001, J BIOL CHEM, V276, P40449, DOI 10.1074/jbc.M104056200; KUROSE I, 1995, AM J PHYSIOL-HEART C, V268, pH2224, DOI 10.1152/ajpheart.1995.268.6.H2224; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Lu TM, 2003, CLIN CARDIOL, V26, P458, DOI 10.1002/clc.4960261006; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; Mihout F, 2010, J PATHOL; MOLINA CR, 1987, J CARDIOVASC PHARM, V10, P371, DOI 10.1097/00005344-198710000-00001; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Procter LD, 2013, J SURG RES, V179, pE183, DOI 10.1016/j.jss.2012.01.054; Rael LT, 2009, OXID MED CELL LONGEV, V2, P166, DOI 10.4161/oxim.2.3.8608; Reynolds JD, 2007, P NATL ACAD SCI USA, V104, P17058, DOI 10.1073/pnas.0707958104; Richir MC, 2009, CRIT CARE MED, V37, P2010, DOI 10.1097/CCM.0b013e31819ffdaf; Salit ML, 2001, ANAL CHEM, V73, P4821, DOI 10.1021/ac0155097; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Teerlink T, 2009, PHARMACOL RES, V60, P448, DOI 10.1016/j.phrs.2009.08.002; Tojo A, 1997, KIDNEY INT, V52, P1593, DOI 10.1038/ki.1997.490; Tsikas D, 2000, FEBS LETT, V478, P1, DOI 10.1016/S0014-5793(00)01686-0; Tsikas D, 2009, CLIN BIOCHEM, V42, P1739, DOI 10.1016/j.clinbiochem.2009.07.024; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; von Leitner EC, 2011, CIRCULATION, V124, P2735, DOI 10.1161/CIRCULATIONAHA.111.060541; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yokoro M, 2012, BIOSCI BIOTECH BIOCH, V76, P1334, DOI 10.1271/bbb.120086; Yoo JH, 2001, ATHEROSCLEROSIS, V158, P425, DOI 10.1016/S0021-9150(01)00444-0; Zani BG, 2005, AM J PHYSIOL-HEART C, V289, pH1381, DOI 10.1152/ajpheart.01231.2004	56	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119991	10.1371/journal.pone.0119991	http://dx.doi.org/10.1371/journal.pone.0119991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793525	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200133
J	Bhutani, I; Loharch, S; Gupta, P; Madathil, R; Parkesh, R				Bhutani, Isha; Loharch, Saurabh; Gupta, Pawan; Madathil, Rethi; Parkesh, Raman			Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies	PLOS ONE			English	Article							D-RIBOSE 2'-EPIMERASE; PROTEIN-STRUCTURE; CELL-WALL; RESISTANT TUBERCULOSIS; TRANSIENT POCKETS; DRUG-RESISTANT; D-ARABINOSE; WEB SERVER; DOCKING; CLUSPRO	The enzymes decaprenylphosphoryl-beta-D-ribose oxidase (DprE1) and decaprenylphosphoryl-beta-D-ribose-2-epimerase (DprE2) catalyze epimerization of decaprenylphosporyl ribose (DPR) todecaprenylphosporyl arabinose (DPA) and are critical for the survival of Mtb. Crystal structures of DprE1 so far reported display significant disordered regions and no structural information is known for DprE2. We used homology modeling, protein threading, molecular docking and dynamics studies to investigate the structural and dynamic features of Mtb DprE1 and DprE2 and DprE1-DprE2 complex. A three-dimensional model for DprE2 was generated using the threading approach coupled with ab initio modeling. A 50 ns simulation of DprE1 and DprE2 revealed the overall stability of the structures. Principal Component Analysis (PCA) demonstrated the convergence of sampling in both DprE1 and DprE2. In DprE1, residues in the 269-330 area showed considerable fluctuation in agreement with the regions of disorder observed in the reported crystal structures. In DprE2, large fluctuations were detected in residues 95-113, 146-157, and 197-226. The study combined docking and MD simulation studies to map and characterize the key residues involved in DprE1-DprE2 interaction. A 60 ns MD simulation for DprE1-DprE2 complex was also performed. Analysis of data revealed that the docked complex is stabilized by H-bonding, hydrophobic and ionic interactions. The key residues of DprE1 involved in DprE1-DprE2 interactions belong to the disordered region. We also examined the docked complex of DprE1-BTZ043 to investigate the binding pocket of DprE1 and its interactions with the inhibitor BTZ043. In summary, we hypothesize that DprE1-DprE2 interaction is crucial for the synthesis of DPA and DprE1-DprE2 complex may be a new therapeutic target amenable to pharmacological validation. The findings have important implications in tuberculosis (TB) drug discovery and will facilitate drug development efforts against TB.	[Bhutani, Isha; Loharch, Saurabh; Gupta, Pawan; Madathil, Rethi; Parkesh, Raman] Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Parkesh, R (corresponding author), Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India.	rparkesh@imtech.res.in		Loharch, Saurabh/0000-0002-5496-8784	Institute of Microbial Technology [Infra 62]; DST [SB/SO/BB/023/2014]; DBT [BT/Bio-CARe/ 05/9923/2013-14]; IMTECH	Institute of Microbial Technology(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India)); DBT(Department of Biotechnology (DBT) India); IMTECH	The authors acknowledge the Institute of Microbial Technology (grant Infra 62 to R.P.) and DST (SB/SO/BB/023/2014 to R. P.) and DBT (BT/Bio-CARe/ 05/9923/2013-14 to R. M.) for financial support. I.B. and S.L. are grateful to IMTECH for a Research Intern Fellowship and CSIR for JRF respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderwick LJ, 2011, GLYCOBIOLOGY, V21, P410, DOI 10.1093/glycob/cwq173; Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arvind A, 2012, INTERDISCIP SCI, V4, P223, DOI 10.1007/s12539-012-0133-x; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batt SM, 2012, P NATL ACAD SCI USA, V109, P11354, DOI 10.1073/pnas.1205735109; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Brooijmans N, 2003, ANNU REV BIOPH BIOM, V32, P335, DOI 10.1146/annurev.biophys.32.110601.142532; Burman WJ, 2010, CLIN INFECT DIS, V50, pS165, DOI 10.1086/651487; Campbell AJ, 2014, J CHEM INF MODEL, V54, P2127, DOI 10.1021/ci400729j; Chahine EB, 2014, ANN PHARMACOTHER, V48, P107, DOI 10.1177/1060028013504087; Chatterji M, 2014, ANTIMICROB AGENTS CH, V58, P5325, DOI 10.1128/AAC.03233-14; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cohen EML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S4-S7; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gabdoulline RR, 2003, NUCLEIC ACIDS RES, V31, P3349, DOI 10.1093/nar/gkg588; Gabdoulline RR, 1999, TRENDS BIOCHEM SCI, V24, P285, DOI 10.1016/S0968-0004(99)01412-7; Garnier J., 1989, PREDICTION PROTEIN S, P417; Gohlke H, 2004, PROTEINS, V56, P322, DOI 10.1002/prot.20116; Gouet P, 2002, BIOINFORMATICS, V18, P767, DOI 10.1093/bioinformatics/18.5.767; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HOLM L, 1992, J MOL BIOL, V225, P93, DOI 10.1016/0022-2836(92)91028-N; Horta BAC, 2007, PROTEINS, V67, P517, DOI 10.1002/prot.21306; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jolliffe I., 2005, ENCY STAT BEHAV SCI, V1, DOI DOI 10.1002/0470013192.BSA501; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kolly GS, 2014, MOL MICROBIOL, V92, P194, DOI 10.1111/mmi.12546; Korf J, 2005, EUR J IMMUNOL, V35, P890, DOI 10.1002/eji.200425332; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Laberge M, 2008, BIOPHYS J, V94, P2737, DOI 10.1529/biophysj.107.114942; Larrouy-Maumus G, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400986; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li H, 2013, PROTEINS, V81, P538, DOI 10.1002/prot.24220; Li SC, 2008, PROTEIN SCI, V17, P1925, DOI 10.1110/ps.036442.108; Lin JH, 2003, BIOPOLYMERS, V68, P47, DOI 10.1002/bip.10218; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Liu ZJ, 2004, J AM CHEM SOC, V126, P8515, DOI 10.1021/ja032018q; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Madhusudana P, 2012, INTERDISCIP SCI, V4, P142, DOI 10.1007/s12539-012-0127-8; Mahajan Rajiv, 2013, Int J Appl Basic Med Res, V3, P1, DOI 10.4103/2229-516X.112228; Makarov V, 2014, EMBO MOL MED, V6, P372, DOI 10.1002/emmm.201303575; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, CURR MED CHEM, V17, P3099, DOI 10.2174/092986710791959693; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meniche X, 2008, MICROBIOL-SGM, V154, P2315, DOI 10.1099/mic.0.2008/016378-0; Metz A, 2012, J CHEM INF MODEL, V52, P120, DOI 10.1021/ci200322s; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mustyala KK, 2014, J RECEPT SIG TRANSD, V34, P162, DOI 10.3109/10799893.2013.868903; Neres J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004395; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schroeder EK, 2005, BIOPHYS J, V89, P876, DOI 10.1529/biophysj.104.053512; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Shirude PS, 2013, J MED CHEM, V56, P9701, DOI 10.1021/jm401382v; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; SUDRE P, 1992, B WORLD HEALTH ORGAN, V70, P149; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Udwadia ZF, 2014, INT J TUBERC LUNG D, V18, P1315, DOI 10.5588/ijtld.14.0284; VanAalten DMF, 1997, J COMPUT CHEM, V18, P169, DOI 10.1002/(SICI)1096-987X(19970130)18:2<169::AID-JCC3>3.0.CO;2-T; VANAALTEN DMF, 1995, PROTEINS, V22, P45, DOI 10.1002/prot.340220107; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang F, 2013, P NATL ACAD SCI USA, V110, pE2510, DOI 10.1073/pnas.1309171110; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yoon HJ, 2013, J SYNCHROTRON RADIAT, V20, P929, DOI 10.1107/S0909049513021341; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	98	20	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119771	10.1371/journal.pone.0119771	http://dx.doi.org/10.1371/journal.pone.0119771			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789990	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400104
J	Bucci, MP; Wiener-Vacher, S; Trousson, C; Baud, O; Biran, V				Bucci, Maria Pia; Wiener-Vacher, Sylvette; Trousson, Clemence; Baud, Olivier; Biran, Valerie			Subjective Visual Vertical and Postural Capability in Children Born Prematurely	PLOS ONE			English	Article							BIRTH-WEIGHT CHILDREN; PRETERM INFANTS; PUSHER SYNDROME; BRAIN-INJURY; PERCEPTION; INFORMATION; INTEGRATION; PARAMETERS; LESIONS; HUMANS	Purpose We compared postural stability and subjective visual vertical performance in a group of very preterm-born children aged 3-4 years and in a group of age-matched full-term children. Materials and Methods A platform (from TechnoConcept) was used to measure postural control in children. Perception of subjective visual vertical was also recorded with posture while the child had to adjust the vertical in the dark or with visual perturbation. Two other conditions (control conditions) were also recorded while the child was on the platform: for a fixation of the vertical bar, and in eyes closed condition. Results Postural performance was poor in preterm-born children compared to that of age-matched full-term children: the surface area, the length in medio-lateral direction and the mean speed of the center of pressure (CoP) were significantly larger in the preterm-born children group (p < 0.04, p < 0.01, and p < 0.04, respectively). Dual task in both groups of children significantly affected postural control. The subjective visual vertical (SVV) values were more variable and less precise in preterm-born children. Discussion-Conclusions We suggest that poor postural control as well as perception of verticality observed in preterm-born children could be due to immaturity of the cortical processes involved in the motor control and in the treatment of perception and orientation of verticality.	[Bucci, Maria Pia; Wiener-Vacher, Sylvette; Baud, Olivier; Biran, Valerie] Univ Paris 07, Hop Robert Debre, INSERM, UMR1141, F-75019 Paris, France; [Bucci, Maria Pia; Wiener-Vacher, Sylvette] Robert Debre Paediat Hosp, ENT Dept, Vestibular & Oculomotor Evaluat Unit EFEE, F-75019 Paris, France; [Trousson, Clemence] Hop Robert Debre, DHU PROTECT, Neuropsychol, F-75019 Paris, France; [Baud, Olivier; Biran, Valerie] Hop Robert Debre, Neonatal Intens Care Unit, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Bucci, MP (corresponding author), Univ Paris 07, Hop Robert Debre, INSERM, UMR1141, 48 Blvd Serurier, F-75019 Paris, France.	maria-pia.bucci@inserm.fr	Biran, Valerie/GQY-8192-2022					AFP, 1984, AGRESSOLOGIE, V25, P1001; Ajrezo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081066; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Bair WN, 2007, EXP BRAIN RES, V183, P435, DOI 10.1007/s00221-007-1057-2; Barela JA, 2003, EXP BRAIN RES, V150, P434, DOI 10.1007/s00221-003-1441-5; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Bertenthal BI, 1997, J EXP PSYCHOL HUMAN, V23, P1631, DOI 10.1037/0096-1523.23.6.1631; BERTENTHAL BI, 1989, DEV PSYCHOL, V25, P936, DOI 10.1037/0012-1649.25.6.936; Borel L, 2008, NEUROPHYSIOL CLIN, V38, P375, DOI 10.1016/j.neucli.2008.09.002; Bortolami SB, 2006, EXP BRAIN RES, V173, P374, DOI 10.1007/s00221-006-0387-9; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Brunet O., 1997, BRUNET LEZINE REVISE; Bucci MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077920; Bucci MP, 2013, ISRN NEUROSCIENCE; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Foster EC, 1996, J MOTOR BEHAV, V28, P101, DOI 10.1080/00222895.1996.9941737; Gaertner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079623; Gagey P.M., 1999, POSTUROLOGIE REGULAT; Geldof CJA, 2012, RES DEV DISABIL, V33, P726, DOI 10.1016/j.ridd.2011.08.025; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Haas G, 1988, POSTURE GAIT DEV ADA; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Johannsen L, 2006, J NEUROL, V253, P1367, DOI 10.1007/s00415-006-0216-x; Karnath HO, 2005, NEUROLOGY, V64, P1014, DOI 10.1212/01.WNL.0000154527.72841.4A; Kim S, 2004, THESIS U MARYLAND CO; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; Lopez C, 2011, NEUROSCIENCE, V181, P134, DOI 10.1016/j.neuroscience.2011.02.009; Lopez C., 2005, BIPEDIE CONTROLE POS, P35; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Mallau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013078; MASDEU JC, 1988, ANN NEUROL, V23, P596, DOI 10.1002/ana.410230612; Mazibrada G, 2008, GAIT POSTURE, V27, P202, DOI 10.1016/j.gaitpost.2007.03.006; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Ohlmann T, 2001, NOUVEAUTES CONCEPTUE; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Rutherford MA, 2010, NEURORADIOLOGY, V52, P505, DOI 10.1007/s00234-010-0700-y; Schmitz C, 2002, EXP BRAIN RES, V142, P354, DOI 10.1007/s00221-001-0910-y; Schmuckler MA, 1997, J EXP PSYCHOL HUMAN, V23, P528, DOI 10.1037/0096-1523.23.2.528; Scott MN, 2012, J DEV BEHAV PEDIATR, V33, P202, DOI 10.1097/DBP.0b013e3182475287; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Wright WG, 2005, J VESTIBUL RES-EQUIL, V15, P185	50	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121616	10.1371/journal.pone.0121616	http://dx.doi.org/10.1371/journal.pone.0121616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790327	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400198
J	Hause, BM; Collin, EA; Anderson, J; Hesse, RA; Anderson, G				Hause, Ben M.; Collin, Emily A.; Anderson, Joe; Hesse, Richard A.; Anderson, Gary			Bovine Rhinitis Viruses Are Common in US Cattle with Bovine Respiratory Disease	PLOS ONE			English	Article							STRAIN RS 3X; RHINOVIRUS; TRANSLATION; PATHOGENESIS; INITIATION; PROTEIN; ORIGIN; CALVES; SITES; CALF	Bovine rhinitis viruses (BRV) are established etiological agents of bovine respiratory disease complex however little research into their epidemiology and ecology has been published for several decades. In the U.S., only bovine rhinitis A virus 1 (BRAV1) has been identified while bovine rhinitis A virus 2 (BRAV2) and bovine rhinitis B virus (BRBV) were previously only identified in England and Japan, respectively. Metagenomic sequencing of a nasal swab from a bovine respiratory disease (BRD) diagnostic submission from Kansas identified contigs with approximately 90% nucleotide similarity to BRAV2 and BRBV. A combination of de novo and templated assemblies using reference genomes yielded near complete BRAV2 and BRBV genomes. The near complete genome of bovine rhinitis A virus 1 (BRAV1) was also determined from a historical isolate to enable further molecular epidemiological studies. A 5'-nuclease reverse transcription PCR assay targeting the 3D polymerase gene was designed and used to screen 204 archived BRD clinical specimens. Thirteen (6.4%) were positive. Metagenomic sequencing of six positive samples identified mixed BRAV1/BRAV2, BRAV1/BRBV and BRAV2/BRBV infections for five samples. One sample showed infection only with BRAV1. Seroprevalence studies using a cell culture adapted BRBV found immunofluorescence assay-reactive antibodies were common in the herds analyzed. Altogether, these results demonstrate that BRV infections are common in cattle with respiratory disease and that BRAV1, BRAV2 and BRBV co-circulate in U.S. cattle and have high similarity to viruses isolated more than 30 years ago from diverse locations.	[Hause, Ben M.] Kansas State Univ, Vet Diagnost Lab, Manhattan, KS 66506 USA; Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Hause, BM (corresponding author), Kansas State Univ, Vet Diagnost Lab, Manhattan, KS 66506 USA.	bhause@vet.k-state.edu			Kansas State Veterinary Diagnostic Laboratory, College of Veterinary Medicine; Kansas Agricultural Experiment Station; USDA's Animal Health and Disease Research Program [95-113]	Kansas State Veterinary Diagnostic Laboratory, College of Veterinary Medicine; Kansas Agricultural Experiment Station; USDA's Animal Health and Disease Research Program	This work was supported by the Kansas State Veterinary Diagnostic Laboratory, College of Veterinary Medicine and the Kansas Agricultural Experiment Station and by funds through USDA's Animal Health and Disease Research Program under the provisions of Section 1433 of Subtitle E, Title XIV of Public Law 95-113. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; BAXT B, 1984, J VIROL, V51, P298, DOI 10.1128/JVI.51.2.298-305.1984; BETTS AO, 1971, J COMP PATHOL, V81, P41, DOI 10.1016/0021-9975(71)90053-3; BOGEL K, 1968, J AM VET MED ASSOC, V152, P780; BOGEL K, 1962, ZBL BAKT PARASIT, V187, P2; CLARKE BE, 1985, J GEN VIROL, V66, P2615, DOI 10.1099/0022-1317-66-12-2615; Collin EA, 2015, J VIROL, V89, P1036, DOI 10.1128/JVI.02718-14; Dan A, 1998, J GEN VIROL, V79, P1453; Gorden PJ, 2010, VET CLIN N AM-FOOD A, V26, P243, DOI 10.1016/j.cvfa.2010.03.004; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Hause BM, 2014, MBIO, V5, DOI 10.1128/mBio.00031-14; Hause BM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003176; Hilton WM, 2014, ANIM HEALTH RES REV, V15, P120, DOI 10.1017/S1466252314000115; Hinton TM, 2000, J VIROL, V74, P11708, DOI 10.1128/JVI.74.24.11708-11716.2000; Hollister JR, 2008, VIROLOGY, V373, P411, DOI 10.1016/j.virol.2007.12.019; Ide P R, 1969, Br Vet J, V125, P7; IDE PR, 1972, ARCH GES VIRUSFORSCH, V36, P335, DOI 10.1007/BF01249864; IDE PR, 1972, ARCH GES VIRUSFORSCH, V36, P343, DOI 10.1007/BF01249865; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI DOI 10.1083/JCB.108.2.229; KUROGI H, 1974, ARCH GES VIRUSFORSCH, V44, P215, DOI 10.1007/BF01240609; LEA S, 1994, STRUCTURE, V2, P123, DOI 10.1016/S0969-2126(00)00014-9; MEDINA M, 1993, VIROLOGY, V194, P355, DOI 10.1006/viro.1993.1267; MOHANTY SB, 1969, AM J VET RES, V30, P1105; MOHANTY SB, 1968, P SOC EXP BIOL MED, V128, P850, DOI 10.3181/00379727-128-33140; Mosier D, 2014, ANIM HEALTH RES REV, V15, P166, DOI 10.1017/S1466252314000176; Neill JD, 2014, J VIROL METHODS, V201, P68, DOI 10.1016/j.jviromet.2014.02.016; Palmenberg AC, 1997, SEMIN VIROL, V8, P231, DOI 10.1006/smvy.1997.0126; Persechino A., 1974, Acta Medica Veterinaria, V20, P333; PILIPENKO EV, 1989, NUCLEIC ACIDS RES, V17, P5701, DOI 10.1093/nar/17.14.5701; REED SE, 1971, J COMP PATHOL, V81, P33, DOI 10.1016/0021-9975(71)90052-1; ROSENQUIST BD, 1971, AM J VET RES, V32, P685; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; SHIMIZU Y, 1974, NATL I ANIM HEALTH Q, V14, P35; Stewart SR, 1997, SEMIN VIROL, V8, P242, DOI 10.1006/smvy.1997.0127; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMAS AAM, 1988, J VIROL, V62, P2782, DOI 10.1128/JVI.62.8.2782-2789.1988; Urban-Chmiel R, 2012, J LIVEST SCI, V3, P27; YAMASHITA H, 1985, ARCH VIROL, V83, P113, DOI 10.1007/BF01310969; Zhang X, 2007, VIROLOGY, V363, P1, DOI 10.1016/j.virol.2007.03.018	39	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121998	10.1371/journal.pone.0121998	http://dx.doi.org/10.1371/journal.pone.0121998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789939	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400204
J	Konno, Y; Ueki, S; Takeda, M; Kobayashi, Y; Tamaki, M; Moritoki, Y; Oyamada, H; Itoga, M; Kayaba, H; Omokawa, A; Hirokawa, M				Konno, Yasunori; Ueki, Shigeharu; Takeda, Masahide; Kobayashi, Yoshiki; Tamaki, Mami; Moritoki, Yuki; Oyamada, Hajime; Itoga, Masamichi; Kayaba, Hiroyuki; Omokawa, Ayumi; Hirokawa, Makoto			Functional Analysis of Free Fatty Acid Receptor GPR120 in Human Eosinophils: Implications in Metabolic Homeostasis	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; ALLERGIC INFLAMMATION; PROTEIN-KINASE; PPAR-GAMMA; CHEMOTAXIS; APOPTOSIS; RELEASE; AGONIST; OBESITY; POTENT	Recent evidence has shown that eosinophils play an important role in metabolic homeostasis through Th2 cytokine production. GPR120 (FFA4) is a G protein-coupled receptor (GPCR) for long-chain fatty acids that functions as a regulator of physiological energy metabolism. In the present study, we aimed to investigate whether human eosinophils express GPR120 and, if present, whether it possesses a functional capacity on eosinophils. Eosinophils isolated from peripheral venous blood expressed GPR120 at both the mRNA and protein levels. Stimulation with a synthetic GPR120 agonist, GW9508, induced rapid down-regulation of cell surface expression of GPR120, suggesting ligand-dependent receptor internalization. Although GPR120 activation did not induce eosinophil chemotactic response and degranulation, we found that GW9508 inhibited eosinophil spontaneous apoptosis and Fas receptor expression. The anti-apoptotic effect was attenuated by phosphoinositide 3-kinase (PI3K) inhibitors and was associated with inhibition of caspase-3 activity. Eosinophil response investigated using ELISpot assay indicated that stimulation with a GPR120 agonist induced IL-4 secretion. These findings demonstrate the novel functional properties of fatty acid sensor GPR120 on human eosinophils and indicate the previously unrecognized link between nutrient metabolism and the immune system.	[Konno, Yasunori; Ueki, Shigeharu; Takeda, Masahide; Kobayashi, Yoshiki; Tamaki, Mami; Moritoki, Yuki; Oyamada, Hajime; Itoga, Masamichi; Kayaba, Hiroyuki; Omokawa, Ayumi; Hirokawa, Makoto] Akita Univ, Grad Sch Med, Dept Gen Internal Med & Clin Lab Med, Akita 010, Japan; [Kobayashi, Yoshiki] Kansai Med Univ, Dept Otolaryngol, Hirakata, Osaka, Japan; [Itoga, Masamichi; Kayaba, Hiroyuki] Hirosaki Univ, Grad Sch Med, Dept Clin Lab Med, Hirosaki, Aomori, Japan	Akita University; Kansai Medical University; Hirosaki University	Ueki, S (corresponding author), Akita Univ, Grad Sch Med, Dept Gen Internal Med & Clin Lab Med, Akita 010, Japan.	ueki-shige@nifty.com	Ueki, Shigeharu/I-3566-2019	Ueki, Shigeharu/0000-0002-3537-7735; Itoga, Masamichi/0000-0002-9400-5245	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590952, 13383320, 23791097, 26860743, 24790547]; Grants-in-Aid for Scientific Research [25460670] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided in part by Grants-in-Aid for Scientific Research (C) (24590952 Y. Moritoki, 13383320 S. Ueki) and Grants-in-Aid for Young Scientists (23791097 and 26860743 M. Takeda, 24790547 Y. Kobayashi) supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2000, J IMMUNOL, V165, P2198, DOI 10.4049/jimmunol.165.4.2198; Bandeira-Melo C, 2003, J IMMUNOL METHODS, V276, P227, DOI 10.1016/S0022-1759(03)00076-0; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Carvalheira JBC, 2013, BLOOD, V122, P3263, DOI 10.1182/blood-2013-04-459446; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Druilhe A, 1996, BLOOD, V87, P2822, DOI 10.1182/blood.V87.7.2822.bloodjournal8772822; Fredriksson R, 2003, FEBS LETT, V554, P381, DOI 10.1016/S0014-5793(03)01196-7; Giembycz MA, 1999, PHARMACOL REV, V51, P213; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kato H, 2011, INT ARCH ALLERGY IMM, V155, P335, DOI 10.1159/000321195; Katsuma S, 2005, J BIOL CHEM, V280, P19507, DOI 10.1074/jbc.M412385200; KITA H, 1992, J IMMUNOL, V149, P629; Kobayashi Y, 2005, J IMMUNOL, V175, P5744, DOI 10.4049/jimmunol.175.9.5744; Lloyd CM, 2013, NAT MED, V19, P976, DOI 10.1038/nm.3296; Matsuwaki Y, 2005, PHARMACOLOGY, V74, P169, DOI 10.1159/000085034; Miyata J, 2013, J ALLERGY CLIN IMMUN, V131, P353, DOI 10.1016/j.jaci.2012.07.048; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Saito Y, 2014, PULM PHARMACOL THER, V27, P164, DOI 10.1016/j.pupt.2013.11.006; Sanchez-Reyes OB, 2014, EUR J PHARMACOL, V723, P368, DOI 10.1016/j.ejphar.2013.11.003; Shamri R, 2011, CELL TISSUE RES, V343, P57, DOI 10.1007/s00441-010-1049-6; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Tamaki M, 2014, IMMUNOL LETT, V160, P72, DOI 10.1016/j.imlet.2014.03.012; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Tanigai T, 2012, INT ARCH ALLERGY IMM, V158, P375, DOI 10.1159/000332965; Ueki S, 2003, IMMUNOL LETT, V86, P183, DOI 10.1016/S0165-2478(03)00003-8; Ueki S, 2008, J IMMUNOL, V181, P7689, DOI 10.4049/jimmunol.181.11.7689; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Woerly G, 2003, J EXP MED, V198, P411, DOI 10.1084/jem.20021384; Wong CK, 2007, EUR J IMMUNOL, V37, P2337, DOI 10.1002/eji.200636866; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu Q, 2013, ONCOGENE, V32, P5541, DOI 10.1038/onc.2013.264; Yamamoto R, 2013, J ASTHMA	37	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120386	10.1371/journal.pone.0120386	http://dx.doi.org/10.1371/journal.pone.0120386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790291	gold, Green Published			2022-12-26	WOS:000351425400157
J	Mirza, Z; Schulten, HJ; Farsi, HM; Al-Maghrabi, JA; Gari, MA; Chaudhary, AG; Abuzenadah, AM; Al-Qahtani, MH; Karim, S				Mirza, Zeenat; Schulten, Hans-Juergen; Farsi, Hasan Ma; Al-Maghrabi, Jaudah A.; Gari, Mamdooh A.; Chaudhary, Adeel Ga; Abuzenadah, Adel M.; Al-Qahtani, Mohammed H.; Karim, Sajjad			Molecular Interaction of a Kinase Inhibitor Midostaurin with Anticancer Drug Targets, S100A8 and EGFR: Transcriptional Profiling and Molecular Docking Study for Kidney Cancer Therapeutics	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; AKT PATHWAY; IN-SITU; PROTEINS; EXPRESSION; DISCOVERY; CARCINOMAS; THERAPY; OVEREXPRESSION; PROGRESSION	The S100A8 and epidermal growth factor receptor (EGFR) proteins are proto-oncogenes that are strongly expressed in a number of cancer types. EGFR promotes cellular proliferation, differentiation, migration and survival by activating molecular pathways. Involvement of proinflammatory S100A8 in tumor cell differentiation and progression is largely unclear and not studied in kidney cancer (KC). S100A8 and EGFR are potential therapeutic biomarkers and anticancer drug targets for KC. In this study, we explored molecular mechanisms of interaction profiles of both molecules with potential anticancer drugs. We undertook transcriptional profiling in Saudi KCs using Affymetrix HuGene 1.0 ST arrays. We identified 1478 significantly expressed genes, including S100A8 and EGFR overexpression, using cut-off p=value <0.05 and fold change >= 2. Additionally, we compared and confirmed our findings with expression data available at NCBI's GEO database. A significant number of genes associated with cancer showed involvement in cell cycle progression, DNA repair, tumor morphology, tissue development, and cell survival. Atherosclerosis signaling, leukocyte extravasation signaling, notch signaling, and IL-12 signaling were the most significantly disrupted signaling pathways. The present study provides an initial transcriptional profiling of Saudi KC patients. Our analysis suggests distinct transcriptomic signatures and pathways underlying molecular mechanisms of KC progression. Molecular docking analysis revealed that the kinase inhibitor "midostaurin" has amongst the selected drug targets, the best ligand properties to S100A8 and EGFR, with the implication that its binding inhibits downstream signaling in KC. This is the first structure-based docking study for the selected protein targets and anticancer drug, and the results indicate S100A8 and EGFR as attractive anticancer targets and midostaurin with effective drug properties for therapeutic intervention in KC.	[Mirza, Zeenat; Chaudhary, Adeel Ga; Abuzenadah, Adel M.] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia; [Schulten, Hans-Juergen; Gari, Mamdooh A.; Chaudhary, Adeel Ga; Abuzenadah, Adel M.; Al-Qahtani, Mohammed H.; Karim, Sajjad] King Abdulaziz Univ, Fac Appl Med Sci, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia; [Farsi, Hasan Ma] King Abdulaziz Univ Hosp, Fac Med, Dept Urol, Jeddah, Saudi Arabia; [Al-Maghrabi, Jaudah A.] King Abdulaziz Univ Hosp, Fac Med, Dept Pathol, Jeddah, Saudi Arabia; [Al-Maghrabi, Jaudah A.] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Jeddah, Saudi Arabia; [Chaudhary, Adeel Ga] King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21589, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh; King Faisal Specialist Hospital & Research Center; King Abdulaziz University	Al-Qahtani, MH (corresponding author), King Abdulaziz Univ, Fac Appl Med Sci, Ctr Excellence Genom Med Res, POB 80216, Jeddah 21589, Saudi Arabia.	mhalqahtani@kau.edu.sa; skarim1@kau.edu.sa	Mirza, Zeenat/H-9498-2012; Schulten, Hans-Juergen/AAP-4754-2021; Al-Maghrabi, Jaudah/L-4367-2013; Karim, Sajjad/H-9897-2012; Schulten, Hans-Juergen/H-9854-2012; Al-Qahtani, Mohammed Hussain/AAZ-1729-2020	Mirza, Zeenat/0000-0002-6222-4873; Schulten, Hans-Juergen/0000-0002-4907-3222; Al-Maghrabi, Jaudah/0000-0002-0812-9592; Karim, Sajjad/0000-0003-0907-2097; 	King Abdullah City for Science and Technology, Riyadh, Saudi Arabia (KACST) [10-BIO1258-03, 10-BIO1073-03]; Deanship of Research, King Abdulaziz University [HiCi-1434-1172]	King Abdullah City for Science and Technology, Riyadh, Saudi Arabia (KACST); Deanship of Research, King Abdulaziz University	This work was supported by King Abdullah City for Science and Technology, Riyadh, Saudi Arabia (KACST, Strategic Project ID. 10-BIO1258-03 and 10-BIO1073-03) and Deanship of Research, King Abdulaziz University (Project ID: HiCi-1434-1172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Baba Y, 2012, J ONCOL, V2012, DOI 10.1155/2012/986725; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; BURNETT G, 1954, J BIOL CHEM, V211, P969; Chen KT, 2014, PANCREAS, V43, P22, DOI 10.1097/MPA.0b013e3182a6867e; Chow WH, 2000, NEW ENGL J MED, V343, P1305, DOI 10.1056/NEJM200011023431804; Ciardiello F, 2003, EUR J CANCER, V39, P1348, DOI 10.1016/S0959-8049(03)00235-1; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Duan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062092; El Fitori J, 2007, CANCER-AM CANCER SOC, V110, P1457, DOI 10.1002/cncr.22931; El-Rifai W, 2002, CANCER RES, V62, P6823; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Frye SV, 1999, CHEM BIOL, V6, pR3, DOI 10.1016/S1074-5521(99)80013-1; Fukihara J, 2014, ONCOLOGY-BASEL, V86, P86, DOI 10.1159/000357129; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Gelardi T, 2008, BRIT J CANCER, V99, P473, DOI 10.1038/sj.bjc.6604493; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; Grebhardt S, 2014, J CELL PHYSIOL, V229, P661, DOI 10.1002/jcp.24489; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heizmann C. W., 2007, V45, P93; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kerkhoff C, 2012, EXP DERMATOL, V21, P822, DOI 10.1111/j.1600-0625.2012.01571.x; Kim Y, 2012, BIOCHEMISTRY-US, V51, P5212, DOI 10.1021/bi300476v; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Lee HJ, 2010, LUNG CANCER, V68, P375, DOI 10.1016/j.lungcan.2009.07.014; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Moody TW, 2014, LIFE SCI; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Motzer RJ, 2006, J CLIN ONCOL, V24, P5601, DOI 10.1200/JCO.2006.08.5415; Muhsin M, 2003, NAT REV DRUG DISCOV, V2, P515, DOI 10.1038/nrd1136; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Passey RJ, 1999, J IMMUNOL, V163, P2209; Pomerantz RG, 2004, SEMIN ONCOL, V31, P734, DOI 10.1053/j.seminoncol.2004.09.015; Pu YS, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-82; Rafii S, 2006, NAT CELL BIOL, V8, P1321, DOI 10.1038/ncb1206-1321; Rizvi MA, 2006, MOL CANCER THER, V5, P1783, DOI 10.1158/1535-7163.MCT-05-0465; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Seth A, 2003, ANTICANCER RES, V23, P2043; Shiogama K, 2013, INT J CLIN EXP PATHO, V6, P24; Shiomitsu K, 2009, VET COMP ONCOL, V7, P106, DOI 10.1111/j.1476-5829.2009.00178.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; Stone RM, 2012, LEUKEMIA, V26, P2061, DOI 10.1038/leu.2012.115; Stulik J, 1999, ELECTROPHORESIS; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; WAKELING AE, 2002, ZD1839 IRESSA ORALLY, V62, P5749; Yamaguchi NH, 2014, J GASTROINTEST ONCOL, V5, P57, DOI 10.3978/j.issn.2078-6891.2013.056; Yin CG, 2013, BREAST CANCER RES TR, V142, P297, DOI 10.1007/s10549-013-2737-1; Yong HY, 2007, ARCH PHARM RES, V30, P75, DOI 10.1007/BF02977781	70	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119765	10.1371/journal.pone.0119765	http://dx.doi.org/10.1371/journal.pone.0119765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789858	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400103
J	Nzakizwanayo, J; Kumar, S; Ogilvie, LA; Patel, BA; Dedi, C; Macfarlane, WM; Jones, BV				Nzakizwanayo, Jonathan; Kumar, Sandeep; Ogilvie, Lesley A.; Patel, Bhavik A.; Dedi, Cinzia; Macfarlane, Wendy M.; Jones, Brian V.			Disruption of Escherichia coli Nissle 1917 K5 Capsule Biosynthesis, through Loss of Distinct kfi genes, Modulates Interaction with Intestinal Epithelial Cells and Impact on Cell Health	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MAINTAINING REMISSION; STRAIN NISSLE-1917; BIOFILM FORMATION; EXPRESSION; POLYSACCHARIDE; COLONIZATION; PROTEINS; ACID; GLYCOSYLTRANSFERASE	Escherichia coli Nissle 1917 (EcN) is among the best characterised probiotics, with a proven clinical impact in a range of conditions. Despite this, the mechanisms underlying these "probiotic effects" are not clearly defined. Here we applied random transposon mutagenesis to identify genes relevant to the interaction of EcN with intestinal epithelial cells. This demonstrated mutants disrupted in the kfiB gene, of the K5 capsule biosynthesis cluster, to be significantly enhanced in attachment to Caco-2 cells. However, this phenotype was distinct from that previously reported for EcN K5 deficient mutants (kfiC null mutants), prompting us to explore further the role of kfiB in EcN: Caco-2 interaction. Isogenic mutants with deletions in kfiB (EcN Delta kfiB), or the more extensively characterised K5 capsule biosynthesis gene kfiC (EcN Delta kfiC), were both shown to be capsule deficient, but displayed divergent phenotypes with regard to impact on Caco-2 cells. Compared with EcN Delta kfiC and the EcN wildtype, EcN Delta kfiB exhibited significantly greater attachment to Caco-2 cells, as well as apoptotic and cytotoxic effects. In contrast, EcN Delta kfiC was comparable to the wild-type in these assays, but was shown to induce significantly greater COX-2 expression in Caco-2 cells. Distinct differences were also apparent in the pervading cell morphology and cellular aggregation between mutants. Overall, these observations reinforce the importance of the EcN K5 capsule in host-EcN interactions, but demonstrate that loss of distinct genes in the K5 pathway can modulate the impact of EcN on epithelial cell health.	[Nzakizwanayo, Jonathan; Kumar, Sandeep; Ogilvie, Lesley A.; Patel, Bhavik A.; Dedi, Cinzia; Macfarlane, Wendy M.; Jones, Brian V.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England; [Jones, Brian V.] Queen Victoria Hosp NHS Fdn Trust, E Grinstead, W Sussex, England	University of Brighton	Jones, BV (corresponding author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.	B.V.Jones@brighton.ac.uk		Nzakizwanayo, Jonathan/0000-0003-2673-6051; Jones, Brian/0000-0002-1211-9186; Ogilvie, Lesley/0000-0001-9794-2915	Medical Research Council [G0901553]; University of Brighton Studentship; Society of Applied Microbiology; Queen Victoria Hospital Charitable Trust; MRC [G0901553] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Brighton Studentship; Society of Applied Microbiology; Queen Victoria Hospital Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support is provided by the Medical Research Council (G0901553) awarded to BVJ; University of Brighton Studentship to JN; Society of Applied Microbiology; BVJ is also supported by the Queen Victoria Hospital Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bliss JM, 1996, MOL MICROBIOL, V21, P221, DOI 10.1046/j.1365-2958.1996.6461357.x; Bloor AE, 2006, APPL ENVIRON MICROB, V72, P2520, DOI 10.1128/AEM.72.4.2520-2525.2006; Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Corbett D, 2008, ADV APPL MICROBIOL, V65, P1, DOI 10.1016/S0065-2164(08)00601-1; Cress BF, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00047-13; Cukrowska B, 2002, SCAND J IMMUNOL, V55, P204, DOI 10.1046/j.1365-3083.2002.01005.x; Food and Agriculture Organization of the United Nations World Health Organization, 2002, GUIDELINES EVALUATIO; Fox-Orenstein A. E, 2012, AM J GASTROENTEROL S, V1, P41, DOI DOI 10.1038/AJGSUP.2012.8; Grabig A, 2006, INFECT IMMUN, V74, P4075, DOI 10.1128/IAI.01449-05; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Grozdanov L, 2002, J BACTERIOL, V184, P5912, DOI 10.1128/JB.184.21.5912-5925.2002; GUPTA DS, 1982, FEMS MICROBIOL LETT, V14, P75, DOI 10.1111/j.1574-6968.1982.tb08638.x; Guzy C, 2008, INT IMMUNOL, V20, P829, DOI 10.1093/intimm/dxn041; Hafez M, 2010, INFECT IMMUN, V78, P2153, DOI 10.1128/IAI.01406-09; Hafez M, 2009, INFECT IMMUN, V77, P2995, DOI 10.1128/IAI.00040-09; Hanna A, 2003, APPL ENVIRON MICROB, V69, P4474, DOI 10.1128/AEM.69.8.4474-4481.2003; Henker J, 2007, EUR J PEDIATR, V166, P311, DOI 10.1007/s00431-007-0419-x; Hodson N, 2000, J BIOL CHEM, V275, P27311; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Kruis W, 1997, ALIMENT PHARM THER, V11, P853, DOI 10.1046/j.1365-2036.1997.00225.x; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Lasaro MA, 2009, APPL ENVIRON MICROB, V75, P246, DOI 10.1128/AEM.01144-08; LodinovaZadnikova R, 1997, BIOL NEONATE, V71, P224, DOI 10.1159/000244421; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Manoil C, 2000, METHOD ENZYMOL, V326, P35; Matthes H, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-13; Nissle, 1918, MED KLIN, V2, P29; O'Sullivan GC, 2005, CURR PHARM DESIGN, V11, P3, DOI 10.2174/1381612053382368; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Otte JM, 2009, NUTR CANCER, V61, P103, DOI 10.1080/01635580802372625; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; PELKONEN S, 1990, CURR MICROBIOL, V21, P23, DOI 10.1007/BF02090095; PELKONEN S, 1992, J BACTERIOL, V174, P7757, DOI 10.1128/JB.174.23.7757-7761.1992; PETIT C, 1995, MOL MICROBIOL, V17, P611, DOI 10.1111/j.1365-2958.1995.mmi_17040611.x; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3; Rigg GP, 1998, MICROBIOL-SGM, V144, P2905, DOI 10.1099/00221287-144-10-2905; Ringel Y, 2012, AM J GASTROENTEROL S, V1, P34, DOI DOI 10.1038/AJGSUP.2012.7; Ritland SR, 1999, CARCINOGENESIS, V20, P51, DOI 10.1093/carcin/20.1.51; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Schlee M, 2007, INFECT IMMUN, V75, P2399, DOI 10.1128/IAI.01563-06; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Shanahan F, 2009, J PHYSIOL-LONDON, V587, P4175, DOI 10.1113/jphysiol.2009.174649; Sonnenborn Ulrich, 2009, Microbial Ecology in Health and Disease, V21, P122, DOI 10.3109/08910600903444267; Sturm A, 2005, INFECT IMMUN, V73, P1452, DOI 10.1128/IAI.73.3.1452-1465.2005; Troge A, 2012, INT J MED MICROBIOL, V302, P304, DOI 10.1016/j.ijmm.2012.09.004; Ukena SN, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-43; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Vejborg RM, 2010, MOL GENET GENOMICS, V283, P469, DOI 10.1007/s00438-010-0532-9; Wallace JL, 2001, GASTROENTEROL CLIN N, V30, P971, DOI 10.1016/S0889-8553(05)70223-5; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110	59	8	8	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120430	10.1371/journal.pone.0120430	http://dx.doi.org/10.1371/journal.pone.0120430			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790373	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400158
J	Shen, XY; Li, T; Chen, S; Fan, L; Gao, J; Hou, CL				Shen, Xiao-Ye; Li, Tong; Chen, Shuang; Fan, Li; Gao, Jian; Hou, Cheng-Lin			Characterization and Phylogenetic Analysis of the Mitochondrial Genome of Shiraia bambusicola Reveals Special Features in the Order of Pleosporales	PLOS ONE			English	Article							TRANSFER-RNA GENES; FUNGUS; HYPOCRELLIN; SEQUENCE; EVOLUTION; PROGRAM; ORIGIN; WHEAT; IDENTIFICATION; VERTICILLIUM	Shiraia bambusicola P. Henn. is a pathogenic fungus of bamboo, and its fruiting bodies are regarded as folk medicine. We determined and analyzed its complete mitochondrial DNA sequence (circular DNA molecule of 39,030 bp, G + C content of 25.19%). It contains the typical genes encoding proteins involved in electron transport and coupled oxidative phosphorylation (nad1-6 and nad4L, cob and cox1-3), one ATP synthase subunit (atp6), 4 hypothetical proteins, and two genes for large and small rRNAs (rnl and rns). There is a set of 32 tRNA genes comprising all 20 amino acids, and these genes are evenly distributed on the two strands. Phylogenetic analyses based on concatenated mitochondrial proteins indicated that S. bambusicola clustered with members of the order Pleosporales, which is in agreement with previous results. The gene arrangements of Dothideomycetes species contained three regions of gene orders partitioned in their mitochondrial genomes, including block 1 (nad6-atp6), block 2 (nad1-cox3) and block 3 (genes around rns). S. bambusicola displayed unique special features that differed from the other Pleosporales species, especially in the coding regions around rns (trnR-trnY). Moreover, a comparison of gene orders in mitochondrial genomes from Pezizomycotina revealed that although all encoded regions are located on the same strand in most Pezizomycotina mtDNAs, genes from Dothideomycetes species had different orientations, as well as diverse positions and colocalization of genes (such as cox3, cox1-cox2 and nad2-nad3); these distinctions were regarded as classspecific features. Interestingly, two incomplete copies of the atp6 gene were found on different strands of the mitogenomic DNA, a finding that has not been observed in the other analyzed fungal species. In our study, mitochondrial genomes from Dothideomycetes species were comprehensively analyzed for the first time, including many species that have not appeared in previous reports.	[Shen, Xiao-Ye; Li, Tong; Chen, Shuang; Fan, Li; Hou, Cheng-Lin] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Gao, Jian] Int Ctr Bamboo & Rattan, Key Lab Bamboo & Rattan Sci & Technol, SFA, Beijing, Peoples R China	Capital Normal University; International Centre for Bamboo & Rattan	Fan, L (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	fanli@mail.cnu.edu.cn			Key Program of Science and Technology Development Project of Beijing Municipal Education Commission [KZ201110028036]; National Natural Science Foundation of China [31170019, 31270058]; Beijing Natural Science Foundation [5132009, 5122003]	Key Program of Science and Technology Development Project of Beijing Municipal Education Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	CLH was supported by Key Program of Science and Technology Development Project of Beijing Municipal Education Commission (KZ201110028036), the National Natural Science Foundation of China (No. 31170019), and the Beijing Natural Science Foundation (and No. 5132009). LF was supported by the National Natural Science Foundation of China (No. 31270058) and the Beijing Natural Science Foundation (No. 5122003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; Ali SM, 2002, INT J ONCOL, V21, P1229; Ali SM, 2001, J PHOTOCH PHOTOBIO B, V65, P59, DOI 10.1016/S1011-1344(01)00252-4; Amano N, 1980, B NATL SCI MUSEUM B; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Beck N., 2010, MFANNOT ORGANELLE GE; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bhathal JS, 2003, EUR J PLANT PATHOL, V109, P435, DOI 10.1023/A:1024277420773; BORNER GV, 1995, MOL GEN GENET, V246, P739, DOI 10.1007/BF00290721; Cardoso MAG, 2007, YEAST, V24, P607, DOI 10.1002/yea.1500; CHAPDELAINE Y, 1991, CELL, V65, P465, DOI 10.1016/0092-8674(91)90464-A; Cheng TF, 2004, J BASIC MICROB, V44, P339, DOI 10.1002/jobm.200410434; Daub ME, 2013, ANTIOXID REDOX SIGN, V19, P970, DOI 10.1089/ars.2012.5080; Diwu ZJJ, 1996, FREE RADICAL BIO MED, V20, P589, DOI 10.1016/0891-5849(95)02061-6; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Ferandon C, 2013, FUNGAL GENET BIOL, V55, P85, DOI 10.1016/j.fgb.2013.01.009; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Ghikas DV, 2006, ARCH MICROBIOL, V185, P393, DOI 10.1007/s00203-006-0104-x; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Hennings P, 1900, BOT JB, V28, P259; Herrmann JM, 2003, TRENDS MICROBIOL, V11, P74, DOI 10.1016/S0966-842X(02)00033-1; Hino I., 1961, ICONES FUNGORUM BAMB; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kirk P.M., 2011, AINSWORTH BISBYS DIC; Kirk PM., 2008, DICT FUNGI, V10th ed; Kosa P, 2006, NUCLEIC ACIDS RES, V34, P2472, DOI 10.1093/nar/gkl327; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; Kruys A, 2006, MYCOL RES, V110, P527, DOI 10.1016/j.mycres.2006.03.002; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lang BF, 2007, NAT PROTOC, V2, P652, DOI 10.1038/nprot.2007.58; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Li Xiang-min, 2009, Forest Research, V22, P279; Liu YX, 2013, PHYTOTAXA, V103, P51, DOI 10.11646/phytotaxa.103.1.4; Losada L, 2014, FEMS MICROBIOL LETT, V352, P165, DOI 10.1111/1574-6968.12387; Ma GY, 2004, ANTIMICROB AGENTS CH, V48, P4450, DOI 10.1128/AAC.48.11.4450-4452.2004; Ma L, 2013, FASEB J, V27, P1962, DOI 10.1096/fj.12-224444; Mirossay A, 2000, PHYTOMEDICINE, V7, P471, DOI 10.1016/S0944-7113(00)80032-X; Morakotkarn D, 2008, MYCOSCIENCE, V49, P258, DOI 10.1007/s10267-008-0419-3; Mulrooney CA, 2012, EUR J ORG CHEM, V2012, P3887, DOI 10.1002/ejoc.201200184; Nadimi M, 2012, MOL BIOL EVOL, V29, P2199, DOI 10.1093/molbev/mss088; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Olivo M, 2006, J ENVIRON PATHOL TOX, V25, P223, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.140; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; Pelin A, 2012, NEW PHYTOL, V194, P836, DOI 10.1111/j.1469-8137.2012.04072.x; Poole AM, 2007, BIOESSAYS, V29, P74, DOI 10.1002/bies.20516; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saccardo PA, 1901, SYLLOGE FUNGORUM OMN; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; Shen XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095838, 10.1371/journal.pone.0092845]; Su YJ, 2011, EUR FOOD RES TECHNOL, V232, P935, DOI 10.1007/s00217-011-1461-5; Su YJ, 2011, J PHOTOCH PHOTOBIO B, V103, P29, DOI 10.1016/j.jphotobiol.2011.01.008; Tambor JHM, 2006, CURR GENET, V49, P302, DOI 10.1007/s00294-006-0057-2; Torriani SFF, 2008, FUNGAL GENET BIOL, V45, P628, DOI 10.1016/j.fgb.2007.12.005; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; West JS, 2001, PLANT PATHOL, V50, P10, DOI 10.1046/j.1365-3059.2001.00546.x; White DG, 1999, COMPENDIUM CORN DIS; Wu T, 2000, J PHOTOCH PHOTOBIO B, V57, P14, DOI 10.1016/S1011-1344(00)00068-3; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Youssar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074792; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	66	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116466	10.1371/journal.pone.0116466	http://dx.doi.org/10.1371/journal.pone.0116466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790308	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400017
J	Song, DP; Huang, DY; Peng, Q; Huang, T; Chen, YJ; Zhang, TS; Nie, XW; He, HJ; Wang, P; Liu, QL; Tang, YX				Song, Deping; Huang, Dongyan; Peng, Qi; Huang, Tao; Chen, Yanjun; Zhang, Tiansheng; Nie, Xiaowei; He, Houjun; Wang, Ping; Liu, Qinglan; Tang, Yuxin			Molecular Characterization and Phylogenetic Analysis of Porcine Epidemic Diarrhea Viruses Associated with Outbreaks of Severe Diarrhea in Piglets in Jiangxi, China 2013	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; 5'-UNTRANSLATED REGION; STEM-LOOP; STRAINS; IDENTIFICATION; GENES	Porcine epidemic diarrhea (PED), caused by porcine epidemic diarrhea virus (PEDV), is a highly contagious, acute enteric viral disease of swine characterized by vomiting, watery diarrhea, dehydration and death. To identify and characterize the field PEDVs associated with the outbreaks of severe diarrhea in piglets in Jiangxi, 2013, the complete genome sequences of two representative strains of PEDV, designated CH/JX-1/2013 and CH/JX-2/2013, were determined and analyzed. The genome sequences of both emergent Jiangxi PEDV strains, CH/JX-1/2013 and CH/JX-2/2013, were 28,038 nucleotides in length excluding 3 ' poly (A) tail. Compared to the PEDV CV777 strain, CH/JX-1/2013 and CH/JX-2/2013 had some unique genetic characteristics in the proximal region of the 5 '-UTRs. Phylogenetic analysis of the complete genomes and the structural proteins revealed that CH/JX-1/2013 and CH/JX-2/2013 had a close relationship with post-2010 Chinese PEDV strains and US strains identified in 2013. The nucleotide identity between the two Jiangxi strains (CH/JX-1/2013 and CH/JX-2/2013) and 30 strains of PEDV identified ante-2010 and post-2010 ranged from 96.3-97.0% and 97.3-99.7%, respectively. Multiple nucleotide and deduced amino acid mutations were observed in the ORF1a/b, S, ORF3, E, M and N genes among the current field PEDV strains when compared to the CV777 strain. Some of the mutations altered the amino acid charge and hydrophilicity, and notably, there was an amino acid substitution in the middle of one neutralizing epitope (L1371I) of the S gene of both CH/JX-1/2013 and CH/JX-2/2013. Taken together, the accumulated genetic variations of the current field PEDV strains might have led to antigenic changes of the viruses, which might confer the less effectiveness or failure of the CV777-based vaccines currently being widely used in Jiangxi, China.	[Song, Deping; Huang, Dongyan; Peng, Qi; Huang, Tao; Chen, Yanjun; Zhang, Tiansheng; Nie, Xiaowei; He, Houjun; Wang, Ping; Tang, Yuxin] Jiangxi Agr Univ, Dept Vet Prevent Med, Coll Anim Sci & Technol, Nanchang, Jiangxi, Peoples R China; [Liu, Qinglan] Jiangxi Acad Agr Sci, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University	Tang, YX (corresponding author), Jiangxi Agr Univ, Dept Vet Prevent Med, Coll Anim Sci & Technol, Nanchang, Jiangxi, Peoples R China.	tang53ster@gmail.com	tang, yuxin/GZN-2336-2022	Song, Deping/0000-0001-5949-287X	National Natural Science Foundation of China [31260611, 31372457]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Natural Science Foundation of China (grant numbers: 31260611 and 31372457; URLs: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2002, J VIROL, V76, P1293, DOI 10.1128/JVI.76.3.1293-1308.2002; Bi J, 2012, J VIROL, V86, P10910, DOI 10.1128/JVI.01919-12; Bridgen A, 1998, ADV EXP MED BIOL, V440, P781; Chang SH, 2002, MOL CELLS, V14, P295; Chen JF, 2011, J VIROL, V85, P11538, DOI 10.1128/JVI.06024-11; Chen JF, 2010, ARCH VIROL, V155, P1471, DOI 10.1007/s00705-010-0720-2; Cima Greg, 2013, J Am Vet Med Assoc, V243, P469; Cruz DJM, 2006, VIROLOGY, V354, P28, DOI 10.1016/j.virol.2006.04.027; DUARTE M, 1993, ADV EXP MED BIOL, V342, P55; Gao YY, 2013, ARCH VIROL, V158, P711, DOI 10.1007/s00705-012-1541-2; Ge FF, 2013, ARCH VIROL, V158, P2227, DOI 10.1007/s00705-013-1722-7; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Lee DK, 2010, VIRUS RES, V149, P175, DOI 10.1016/j.virusres.2010.01.015; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Li ZL, 2013, ARCH VIROL, V158, P1267, DOI 10.1007/s00705-012-1592-4; Liu PH, 2007, RNA, V13, P763, DOI 10.1261/rna.261807; Luo YW, 2012, J VIROL, V86, P9551, DOI 10.1128/JVI.01455-12; Marthaler D, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00555-13; Mole B, 2013, NATURE, V499, P388, DOI 10.1038/499388a; Oldham J, 1972, PIG FARMING S    OCT, P72; Pan YF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-195; Park SJ, 2008, VIRUS GENES, V36, P95, DOI 10.1007/s11262-007-0164-2; Park SJ, 2007, VIRUS GENES, V35, P321, DOI 10.1007/s11262-007-0096-x; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Raman S, 2005, J VIROL, V79, P12434, DOI 10.1128/JVI.79.19.12434-12446.2005; Sola I, 2005, J VIROL, V79, P2506, DOI 10.1128/JVI.79.4.2506-2516.2005; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Sun DB, 2008, VET MICROBIOL, V131, P73, DOI 10.1016/j.vetmic.2008.02.022; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Sun RQ, 2014, SCI WORLD J, DOI 10.1155/2014/208439; VANREETH K, 1994, VET REC, V135, P594; Yang X, 2013, VIRUS GENES, V46, P337, DOI 10.1007/s11262-012-0867-x	35	49	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120310	10.1371/journal.pone.0120310	http://dx.doi.org/10.1371/journal.pone.0120310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790462	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400149
J	Xu, CH; Zhu, L; Chan, T; Lu, XX; Shen, WY; Gillies, MC; Zhou, FF				Xu, Chenghao; Zhu, Ling; Chan, Ting; Lu, Xiaoxi; Shen, Weiyong; Gillies, Mark C.; Zhou, Fanfan			The Altered Renal and Hepatic Expression of Solute Carrier Transporters (SLCs) in Type 1 Diabetic Mice	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; DRUG TRANSPORTERS; INSULIN; MELLITUS; GENE; PHARMACOKINETICS; POLYMORPHISMS; ROSUVASTATIN; NEPHROPATHY; DISPOSITION	Diabetes mellitus is a chronic metabolic disorder that significantly affects human health and well-being. The Solute carrier transporters (SLCs), particularly the Organic anion/cation transporters (Oats/Octs/Octns), Organic anion transporting polypeptides (Oatps) and Oligopeptide transporters (Pepts) are essential membrane proteins responsible for cellular uptake of many endogenous and exogenous substances such as clinically important drugs. They are widely expressed in mammalian key organs especially the kidney and liver, in which they facilitate the influx of various drug molecules, thereby determining their distribution and elimination in body. The altered expression of SLCs in diabetes mellitus could have a profound and clinically significant influence on drug therapies. In this study, we extensively investigated the renal and hepatic expression of twenty essential SLCs in the type 1 diabetic Ins2(Akita) murine model that develops both hyperglycemia and diabetes-related complications using real-time PCR and immunoblotting analysis. We found that the renal expression of mOatp1a1, mOatp1a6, mOat1, mOat3, mOat5, mOct2 and mPept2 was decreased; while that of mPept1 was increased at the mRNA level in the diabetic mice compared with non-diabetic controls. We found up-regulated mRNA expression of mOatp1a4, mOatp1c1, mOctn2, mOct3 and mPept1 as well as down-regulation of mOatp1a1 in the livers of diabetic mice. We confirmed the altered protein expression of several SLCs in diabetic mice, especially the decreased renal and hepatic expression of mOatp1a1. We also found down-regulated protein expression of mOat3 and mOctn1 in the kidneys as well as increased protein expression of mOatp1a4 and mOct3 in the livers of diabetic mice. Our findings contribute to better understanding the modulation of SLC transporters in type 1 diabetes mellitus, which is likely to affect the pharmacokinetic performance of drugs that are transported by these transporters and therefore, forms the basis of future therapeutic optimization of regimens in patients with type 1 diabetes mellitus.	[Xu, Chenghao; Chan, Ting; Lu, Xiaoxi; Zhou, Fanfan] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Zhu, Ling; Shen, Weiyong; Gillies, Mark C.] Univ Sydney, Save Sight Inst, Retinal Therapeut Res Grp, Sydney, NSW 2000, Australia	University of Sydney; University of Sydney	Zhou, FF (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	fanfan.zhou@sydney.edu.au	Zhou, Fanfan/M-4404-2013; Zhou, Fanfan/J-2327-2019; Zhu, Ling/M-3887-2013	Zhou, Fanfan/0000-0002-1982-1541; Zhou, Fanfan/0000-0002-1982-1541; Zhu, Ling/0000-0003-0776-1630				Arabi YM, 2011, CRIT CARE, V15, DOI 10.1186/cc10420; Barthelmes D, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-42; Bikhazi AB, 2004, MOL PHARMACEUT, V1, P300, DOI 10.1021/mp049972u; Chan T, 2014, MOL PHARM; Chang Jae-Hyung, 2012, Methods Mol Biol, V933, P17, DOI 10.1007/978-1-62703-068-7_2; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Cheng QQ, 2008, MOL PHARMACEUT, V5, P77, DOI 10.1021/mp700114j; DeGorter MK, 2012, ANNU REV PHARMACOL, V52, P249, DOI 10.1146/annurev-pharmtox-010611-134529; DOMINGUEZ JH, 1994, J AM SOC NEPHROL, V5, pS29; Durmus S, 2014, INT J CANCER, V135, P1700, DOI 10.1002/ijc.28797; El Feghali R, 2007, VASC HEALTH RISK MAN, V3, P165; Gangopadhyay A, 2002, AM J PHYSIOL-GASTR L, V283, pG133, DOI 10.1152/ajpgi.00445.2001; Giannoukakis N, 2002, DIABETES NUTR METAB, V15, P173; Gong L, 2011, TOXICOL SCI, V122, P587, DOI 10.1093/toxsci/kfr114; Grover B, 2004, J PHARMACOL EXP THER, V308, P949, DOI 10.1124/jpet.103.058388; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Hobbs M, 2012, XENOBIOTICA, V42, P327, DOI 10.3109/00498254.2011.625452; Horiuchi I, 2009, BIOPHARM DRUG DISPOS, V30, P326, DOI 10.1002/bdd.671; Imbert P, 2014, THROMB RES, V133, P756, DOI 10.1016/j.thromres.2014.02.003; Iusuf D, 2013, MOL PHARMACOL, V83, P919, DOI 10.1124/mol.112.081927; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kasichayanula S, 2013, BRIT J CLIN PHARMACO, V76, P432, DOI 10.1111/bcp.12056; Kaul K, 2013, ADV EXP MED BIOL, V771, P1; Kidokoro K, 2013, J AM SOC NEPHROL, V24, P1139, DOI 10.1681/ASN.2012080783; Kikawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095451; Kim HJ, 2011, TOXICOL RES-GER, V27, P37, DOI 10.5487/TR.2011.27.1.037; Lungkaphin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096236; Mallat SG, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-32; More Vijay R, 2012, Comp Hepatol, V11, P1, DOI 10.1186/1476-5926-11-1; More VR, 2011, DRUG METAB DISPOS, V39, P992, DOI 10.1124/dmd.110.037507; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Nowicki Michael T, 2008, Drug Metab Lett, V2, P11; Nunez C, 2008, IMMUNOGENETICS, V60, P19, DOI 10.1007/s00251-007-0265-z; Ontawong A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/820786; Patel H, 2013, J ORAL PATHOL MED, V42, P250, DOI 10.1111/j.1600-0714.2012.01196.x; Patti Mary-Elizabeth, 2004, Curr Diab Rep, V4, P176, DOI 10.1007/s11892-004-0020-x; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; Phatchawan A, 2014, AM J MED SCI, V347, P221, DOI 10.1097/MAJ.0b013e3182831740; Planas R, 2010, IMMUNOL LETT, V133, P55, DOI 10.1016/j.imlet.2010.08.001; Powell DA, 2011, BIOORG MED CHEM LETT, V21, P7281, DOI 10.1016/j.bmcl.2011.10.040; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; RETT K, 1995, J HYPERTENS, V13, pS81, DOI 10.1097/00004872-199508001-00013; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Sakamoto K, 1990, Gan No Rinsho, V36, P865; Salem ESB, 2014, AM J PHYSIOL-RENAL, V306, pF629, DOI 10.1152/ajprenal.00516.2013; Sciullo E, 1997, Early Pregnancy, V3, P172; Seok SJ, 2013, NEPHROL DIAL TRANSPL, V28, P1700, DOI 10.1093/ndt/gfs555; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; Song IS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-251; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Toh DSL, 2011, BIOCHEM PHARMACOL, V82, P1692, DOI 10.1016/j.bcp.2011.08.008; Tramonti G, 2006, AM J PHYSIOL-RENAL, V291, pF972, DOI 10.1152/ajprenal.00110.2006; van de Steeg E, 2013, CLIN CANCER RES, V19, P821, DOI 10.1158/1078-0432.CCR-12-2080; Vogt L, 2004, Minerva Med, V95, P395; Wang CP, 2010, J PHARM PHARM SCI, V13, P411, DOI 10.18433/J3Q30H; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094712; Zhou FF, 2007, PHARM RES-DORDR, V24, P28, DOI 10.1007/s11095-006-9144-9; Zhou FF, 2013, AAPS J, V15, P1099, DOI 10.1208/s12248-013-9515-1; Zhou FF, 2011, BRIT J PHARMACOL, V162, P1380, DOI 10.1111/j.1476-5381.2010.01144.x; Zhou FF, 2010, BRIT J PHARMACOL, V159, P419, DOI 10.1111/j.1476-5381.2009.00545.x	65	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120760	10.1371/journal.pone.0120760	http://dx.doi.org/10.1371/journal.pone.0120760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789863	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400173
J	Ma, LL; Ma, J; Xu, KY				Ma, Lingling; Ma, Jun; Xu, Kanyan			Effect of Spaceflight on the Circadian Rhythm, Lifespan and Gene Expression of Drosophila melanogaster	PLOS ONE			English	Article							SLEEP; CLOCK; METABOLISM; DURATION; BIOLOGY; SYSTEM; RISK	Space travelers are reported to experience circadian rhythm disruption during spaceflight. However, how the space environment affects circadian rhythm is yet to be determined. The major focus of this study was to investigate the effect of spaceflight on the Drosophila circadian clock at both the behavioral and molecular level. We used China's Shenzhou-9 spaceship to carry Drosophila. After 13 days of spaceflight, behavior tests showed that the flies maintained normal locomotor activity rhythm and sleep pattern. The expression level and rhythm of major clock genes were also unaffected. However, expression profiling showed differentially regulated output genes of the circadian clock system between space flown and control flies, suggesting that spaceflight affected the circadian output pathway. We also investigated other physiological effects of spaceflight such as lipid metabolism and lifespan, and searched genes significantly affected by spaceflight using microarray analysis. These results provide new information on the effects of spaceflight on circadian rhythm, lipid metabolism and lifespan. Furthermore, we showed that studying the effect of spaceflight on gene expression using samples collected at different Zeitgeber time could obtain different results, suggesting the importance of appropriate sampling procedures in studies on the effects of spaceflight.	[Ma, Lingling; Ma, Jun; Xu, Kanyan] China Acad Space Technol, Lab Space Microbiol, Shenzhou Space Biotechnol Grp, Beijing, Peoples R China		Xu, KY (corresponding author), China Acad Space Technol, Lab Space Microbiol, Shenzhou Space Biotechnol Grp, Beijing, Peoples R China.	xukanyan@cast.cn						Agarwal R, 2010, CURR OPIN NEPHROL HY, V19, P51, DOI 10.1097/MNH.0b013e3283336ddb; ALPATOV AM, 1994, BIOL RHYTHM RES, V25, P168, DOI 10.1080/09291019409360284; Balsalobre A, 2002, CELL TISSUE RES, V309, P193, DOI 10.1007/s00441-002-0585-0; Basner M, 2013, P NATL ACAD SCI USA, V110, P2635, DOI 10.1073/pnas.1212646110; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Campos Costa Ines, 2013, Am J Neurodegener Dis, V2, P228; Casey T, 2012, BIOL OPEN, V1, P570, DOI 10.1242/bio.2012687; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; Da Silva MS, 2002, NUTRITION, V18, P805, DOI 10.1016/S0899-9007(02)00915-2; Dayanandan P, 2011, J BIOSCIENCES, V36, P911, DOI 10.1007/s12038-011-9150-x; Dijk DJ, 2001, AM J PHYSIOL-REG I, V281, pR1647, DOI 10.1152/ajpregu.2001.281.5.R1647; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Frigeri A, 2008, EXP BRAIN RES, V191, P289, DOI 10.1007/s00221-008-1523-5; Fuller C A, 1989, Adv Space Res, V9, P283, DOI 10.1016/0273-1177(89)90084-7; Fuller CA, 1996, J APPL PHYSIOL, V81, P188, DOI 10.1152/jappl.1996.81.1.188; Fuller CA, 1984, PHYSIOLOGIST S, V27, P93; Fuller CA, 1992, PHYSL S, V35, P63; Giebultowicz JM, 2000, ANNU REV ENTOMOL, V45, P769, DOI 10.1146/annurev.ento.45.1.769; Goel N, 2012, ACTA ASTRONAUT, V77, P207, DOI 10.1016/j.actaastro.2012.04.002; Gundel A, 1997, J SLEEP RES, V6, P1, DOI 10.1046/j.1365-2869.1997.00028.x; Hoban-Higgins TM, 2003, J INSECT PHYSIOL, V49, P671, DOI 10.1016/S0022-1910(03)00068-4; Hoban-Higgins TM, 1995, J GRAVI PHYSL, V2, P58; Holley DC, 2003, J APPL PHYSIOL, V95, P1266, DOI 10.1152/japplphysiol.00707.2002; Honda Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00487; Ikenaga M, 1997, Biol Sci Space, V11, P346, DOI 10.2187/bss.11.346; Inan OT, 2009, IEEE T BIO-MED ENG, V56, P522, DOI 10.1109/TBME.2008.2006018; Karemaker JM, 2009, RESP PHYSIOL NEUROBI, V169, pS55, DOI 10.1016/j.resp.2009.05.006; Le Bourg E, 1999, EXP GERONTOL, V34, P319, DOI 10.1016/S0531-5565(99)00004-2; Leandro LJ, 2007, ADV SPACE RES, V40, P506, DOI 10.1016/j.asr.2007.05.070; LeBlanc A, 2000, J APPL PHYSIOL, V89, P2158, DOI 10.1152/jappl.2000.89.6.2158; LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; LEONARD JI, 1983, AM J CLIN NUTR, V38, P667, DOI 10.1093/ajcn/38.5.667; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; Matsumoto A, 2011, AVIAT SPACE ENVIR MD, V82, P615, DOI 10.3357/ASEM.2792.2011; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mavroudis PD, 2013, J INNATE IMMUN, V5, P153, DOI 10.1159/000342427; Miller MS, 1999, J GRAVIT PHYSL, V6, pP99; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Monk TH, 1998, J BIOL RHYTHM, V13, P188, DOI 10.1177/074873098129000039; Monk TH, 2001, PSYCHOSOM MED, V63, P881, DOI 10.1097/00006842-200111000-00005; Morey-Holton E. R., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P17; Murakami D M, 2000, J Gravit Physiol, V7, P79; Ohnishi Ken, 2004, Biol Sci Space, V18, P201, DOI 10.2187/bss.18.201; Paschos GK, 2010, CIRC RES, V106, P833, DOI 10.1161/CIRCRESAHA.109.211706; Rakshit K, 2012, CHRONOBIOL INT, V29, P5, DOI 10.3109/07420528.2011.635237; Schimmerling W, 2003, ADV SPACE RES, V31, P27, DOI 10.1016/S0273-1177(02)00653-1; STAMPI C, 1994, J CLIN PHARMACOL, V34, P518, DOI 10.1002/j.1552-4604.1994.tb04996.x; Stein TP, 1999, AM J PHYSIOL-REG I, V276, pR1739; SULZMAN FM, 1984, SCIENCE, V225, P232, DOI 10.1126/science.11540800; Vernikos J, 2010, GERONTOLOGY, V56, P157, DOI 10.1159/000252852; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Xu KY, 2011, CELL METAB, V13, P639, DOI 10.1016/j.cmet.2011.05.001	56	31	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121600	10.1371/journal.pone.0121600	http://dx.doi.org/10.1371/journal.pone.0121600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798821	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300274
J	Ammar, ED; Hentz, M; Hall, DG; Shatters, RG				Ammar, El-Desouky; Hentz, Matthew; Hall, David G.; Shatters, Robert G., Jr.			Ultrastructure of Wax-Producing Structures on the Integument of the Melaleuca Psyllid Boreioglycaspis melaleucae (Hemiptera: Psyllidae), with Honeydew Excretion Behavior in Males and Females	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENT; DIAPHORINA-CITRI; FINE-STRUCTURE; SCALE INSECTS; HOST-RANGE; QUINQUENERVIA; HOMOPTERA; GLANDS; APHID; PSYLLOIDEA	The melaleuca psyllid, Boreioglycaspis melaleucae (Hemiptera: Psyllidae), was introduced to Florida as a biological control agent against Melaleuca quinquenervia, an invasive evergreen tree that has invaded large areas of Florida Everglades. Colonies of B. melaleucae nymphs are normally covered by white waxy secretions, and nymphs of various instars produce long bundles of white waxy filaments extending laterally and posteriorly from their abdomen. Scanning electron microscopy of 'naturally waxed' and 'dewaxed' nymphs (cleaned from wax) revealed two types of wax pore plates located dorsally and laterally on the integument of posterior abdominal segments starting with the 4th segment. Type-1 wax pore plates, with raised rim, peripheral groove, slits and pits, produce long ribbons and filaments of waxy secretions that are wound together forming long wax bundles, whereas type-2 wax pore plates, with slits only, produce shorter wax curls. Additionally, in both nymphs and adult females, the circumanal ring contained ornate rows of wax pores that produce wax filaments covering their honeydew excretions. Video recordings with stereomicroscopy showed that adult females produce whitish honeydew balls, powerfully propelled away from their body, probably to get these sticky excretions away from their eggs and newly hatched nymphs. Adult males, however, produce clear droplets of honeydew immediately behind them, simply by bending the posterior end of the abdomen downward. The possible role(s) of waxy secretions by nymphs and adults of B. melaleucae in reducing contamination of their colonies with honeydew, among other possibilities, are discussed.	[Ammar, El-Desouky; Hentz, Matthew; Hall, David G.; Shatters, Robert G., Jr.] USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA	United States Department of Agriculture (USDA)	Ammar, ED (corresponding author), USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA.	desoukyammar@gmail.com		Shatters, Robert/0000-0002-3903-772X	Agricultural Research Service, United States Department of Agriculture	Agricultural Research Service, United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding: This work was supported by Agricultural Research Service, United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alene DC, 2011, AFR INVERTEBR, V52, P353, DOI 10.5733/afin.052.0210; Ammar E., 2013, J MICROSCOPY ULTRAST, V1, P43, DOI DOI 10.1016/J.JMAU.2013.05.001; Ammar ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064938; Balentine KM, 2009, ENVIRON ENTOMOL, V38, P1145, DOI 10.1603/022.038.0422; Brittain W. H., 1923, Proceedings Acadian Ent Soc Fredericton NB, V8, P23; CATLING HD, 1970, FAO PLANT PROTECT B, V18, P8; Center TD, 2007, ENVIRON ENTOMOL, V36, P569, DOI 10.1603/0046-225X(2007)36[569:IIAFVO]2.0.CO;2; Center TD, 2012, BIOCONTROL, V57, P151, DOI 10.1007/s10526-011-9390-6; Chiarelli RN, 2011, ANN ENTOMOL SOC AM, V104, P488, DOI 10.1603/AN10163; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; FOLDI I, 1991, ANN SOC ENTOMOL FR, V27, P163; FOLDI I, 1985, INT J INSECT MORPHOL, V14, P259, DOI 10.1016/0020-7322(85)90041-8; Franks SJ, 2006, ENVIRON ENTOMOL, V35, P366, DOI 10.1603/0046-225X-35.2.366; Franks SJ, 2011, CONSERV GENET, V12, P201, DOI 10.1007/s10592-010-0133-5; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hodkinson I, 2009, J NAT HIST, V43, P65, DOI 10.1080/00222930802354167; Husain M. A., 1927, MEMOIRS DEP AGR INDI, V10, P1; Kumar V, 1997, ITAL J ZOOL, V64, P307, DOI 10.1080/11250009709356218; Lucchi A, 2004, ANN ENTOMOL SOC AM, V97, P1294, DOI 10.1603/0013-8746(2004)097[1294:WPIAOP]2.0.CO;2; Morath SU, 2006, ENVIRON ENTOMOL, V35, P1372, DOI 10.1603/0046-225X(2006)35[1372:HBBMHP]2.0.CO;2; Nelson DR, 2000, COMP BIOCHEM PHYS B, V125, P265, DOI 10.1016/S0305-0491(99)00177-7; Nelson DR, 1997, COMP BIOCHEM PHYS B, V117, P241, DOI 10.1016/S0305-0491(97)00047-3; POPE RD, 1983, J NAT HIST, V17, P489, DOI 10.1080/00222938300770431; Purcell MF, 1997, ENVIRON ENTOMOL, V26, P366, DOI 10.1093/ee/26.2.366; RETNAKARAN A, 1979, CAN ENTOMOL, V111, P67, DOI 10.4039/Ent11167-1; Smith RG, 1999, J NAT HIST, V33, P513, DOI 10.1080/002229399300227; WAKU Y, 1978, J MORPHOL, V158, P243, DOI 10.1002/jmor.1051580302	28	6	6	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121354	10.1371/journal.pone.0121354	http://dx.doi.org/10.1371/journal.pone.0121354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793934	Green Submitted, gold, Green Published			2022-12-26	WOS:000352083900126
J	Gisladottir, RS; Chwilla, DJ; Levinson, SC				Gisladottir, Rosa S.; Chwilla, Dorothee J.; Levinson, Stephen C.			Conversation Electrified: ERP Correlates of Speech Act Recognition in Underspecified Utterances	PLOS ONE			English	Article							RIGHT-HEMISPHERE; TIME-COURSE; LANGUAGE; WORD; SENTENCE; PERSPECTIVE; DISCOURSE; INFORMATION; ADDRESSEES; PREDICTION	The ability to recognize speech acts (verbal actions) in conversation is critical for everyday interaction. However, utterances are often underspecified for the speech act they perform, requiring listeners to rely on the context to recognize the action. The goal of this study was to investigate the time-course of auditory speech act recognition in action-underspecified utterances and explore how sequential context (the prior action) impacts this process. We hypothesized that speech acts are recognized early in the utterance to allow for quick transitions between turns in conversation. Event-related potentials (ERPs) were recorded while participants listened to spoken dialogues and performed an action categorization task. The dialogues contained target utterances that each of which could deliver three distinct speech acts depending on the prior turn. The targets were identical across conditions, but differed in the type of speech act performed and how it fit into the larger action sequence. The ERP results show an early effect of action type, reflected by frontal positivities as early as 200 ms after target utterance onset. This indicates that speech act recognition begins early in the turn when the utterance has only been partially processed. Providing further support for early speech act recognition, actions in highly constraining contexts did not elicit an ERP effect to the utterance-final word. We take this to show that listeners can recognize the action before the final word through predictions at the speech act level. However, additional processing based on the complete utterance is required in more complex actions, as reflected by a posterior negativity at the final word when the speech act is in a less constraining context and a new action sequence is initiated. These findings demonstrate that sentence comprehension in conversational contexts crucially involves recognition of verbal action which begins as soon as it can.	[Gisladottir, Rosa S.; Levinson, Stephen C.] Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands; [Chwilla, Dorothee J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Gelderland, Netherlands	Max Planck Society; Radboud University Nijmegen	Gisladottir, RS (corresponding author), Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands.	rosa.gisladottir@mpi.nl		Gisladottir, Rosa Signy/0000-0003-0941-1888	International Max Planck Research School for Language Sciences fellowship; European Research Council [269484]; Donders Centre of Cognition, Radboud University	International Max Planck Research School for Language Sciences fellowship; European Research Council(European Research Council (ERC)European Commission); Donders Centre of Cognition, Radboud University	This work was supported by an International Max Planck Research School for Language Sciences fellowship to RSG and Advance Grant INTERACT #269484 from the European Research Council to SCL. The research was also supported by Donders Centre of Cognition, Radboud University.lysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Austin John, 1960, DO THINGS WORDS; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Basnakova J, 2014, CEREB CORTEX, V24, P2572, DOI 10.1093/cercor/bht112; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beeman MJ, 2000, BRAIN LANG, V71, P310, DOI 10.1006/brln.1999.2268; Blakemore D., 1992, UNDERSTANDING UTTERA; Brown CM, 2000, ARCHITECTURES MECH L, P213; Brown-Schmidt S, 2008, COGNITION, V107, P1122, DOI 10.1016/j.cognition.2007.11.005; Cole Peter, 1975, SYNTAX SEMANTICSVOL, P59, DOI DOI 10.1017/CBO9780511609213.004; Coulson S, 2005, J COGNITIVE NEUROSCI, V17, P494, DOI 10.1162/0898929053279568; Coulson S, 2004, PALG STUD PRAGM LANG, P187; Coulson S, 2010, ITAL J LINGUIST, V22, P107; De Ruiter JP, 2006, LANGUAGE, V82, P515, DOI 10.1353/lan.2006.0130; Dimitrova DV, 2012, J COGNITIVE NEUROSCI, V24, P2400, DOI 10.1162/jocn_a_00302; Dwivedi VD, 2006, BRAIN RES, V1117, P135, DOI 10.1016/j.brainres.2006.07.048; Dwivedi VD, 2010, NEUROREPORT, V21, P791, DOI 10.1097/WNR.0b013e32833cae0d; Egorova N, 2014, BRAIN TOPOGR, V27, P375, DOI 10.1007/s10548-013-0329-3; Egorova N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00086; Federmeier KD, 2008, LANG LINGUIST COMPAS, V2, P1, DOI 10.1111/j.1749-818x.2007.00042.x; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; FOLDI NS, 1987, BRAIN LANG, V31, P88, DOI 10.1016/0093-934X(87)90062-9; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gisladottir Rosa S., 2012, P 34 ANN M COGN SCI, P1596; Grainger J, 2012, PSYCHOPHYSIOLOGY, V49, P604, DOI 10.1111/j.1469-8986.2011.01337.x; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Hagoort P., 1999, NEUROCOGNITION LANGU, P273, DOI DOI 10.1093/ACPROF:OSO/9780198507932.001.0001; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; Hanna JE, 2004, COGNITIVE SCI, V28, P105, DOI 10.1016/j.cogsci.2003.10.002; Hanna JE, 2003, J MEM LANG, V49, P43, DOI 10.1016/S0749-596X(03)00022-6; Heldner M, 2010, J PHONETICS, V38, P555, DOI 10.1016/j.wocn.2010.08.002; Heller D, 2008, COGNITION, V108, P831, DOI 10.1016/j.cognition.2008.04.008; Heritage J, 2012, RES LANG SOC INTERAC, V45, P30, DOI 10.1080/08351813.2012.646685; Holtgraves T, 2012, BRAIN LANG, V121, P58, DOI 10.1016/j.bandl.2012.01.003; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Karkkainen E, 2012, DISCOURSE STUD, V14, P587, DOI 10.1177/1461445612454069; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; KLUENDER R, 1993, J COGNITIVE NEUROSCI, V5, P196, DOI 10.1162/jocn.1993.5.2.196; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kutas M, 1997, PSYCHOPHYSIOLOGY, V34, P383, DOI 10.1111/j.1469-8986.1997.tb02382.x; KUTAS M, 1993, LANG COGNITIVE PROC, V8, P533, DOI 10.1080/01690969308407587; Kutas M., 2011, PREDICTIONBRAIN US, P190, DOI DOI 10.1093/ACPROF:OSO/9780195395518.003.0065; Kwon N, 2013, LANGUAGE, V89, P537, DOI 10.1353/lan.2013.0044; MacGregor LJ, 2010, NEUROPSYCHOLOGIA, V48, P3982, DOI 10.1016/j.neuropsychologia.2010.09.024; MAGLIANO JP, 1993, DISCOURSE PROCESS, V16, P35, DOI 10.1080/01638539309544828; Magne C, 2005, J COGNITIVE NEUROSCI, V17, P740, DOI 10.1162/0898929053747667; Meinhardt J, 2012, NEUROIMAGE, V63, P623, DOI 10.1016/j.neuroimage.2012.07.019; Menenti L, 2009, J COGNITIVE NEUROSCI, V21, P2358, DOI 10.1162/jocn.2008.21163; Munte TF, 1998, NATURE, V395, P71, DOI 10.1038/25731; Nieuwland MS, 2010, J MEM LANG, V63, P324, DOI 10.1016/j.jml.2010.06.005; Noveck IA, 2003, BRAIN LANG, V85, P203, DOI 10.1016/S0093-934X(03)00053-1; Nurmsoo E, 2008, PSYCHOL SCI, V19, P211, DOI 10.1111/j.1467-9280.2008.02069.x; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; R Core Team, 2021, R LANGUAGE ENV STAT; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Sabbagh MA, 2000, PSYCHOL SCI, V11, P46, DOI 10.1111/1467-9280.00213; Sadock Jerrold M., 1985, LANGUAGE TYPOLOGY SY, V1, P155; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schank RC., 1977, SCRIPTS PLANS GOALS; Schegloff E.A., 1973, SEMIOTICA, V8, P289, DOI [10.1515/semi.1973.8.4.289, DOI 10.1515/SEMI.1973.8.4.289]; Schegloff EA, 2007, SEQUENCE ORGANIZATION IN INTERACTION: A PRIMER IN CONVERSATION ANALYSIS I, P1, DOI 10.2277/ 0521532795; SCHEGLOFF EA, 1988, J PRAGMATICS, V12, P55, DOI 10.1016/0378-2166(88)90019-7; Schnur TT, 2006, J PSYCHOLINGUIST RES, V35, P189, DOI 10.1007/s10936-005-9011-6; SCHOBER MF, 1989, COGNITIVE PSYCHOL, V21, P211, DOI 10.1016/0010-0285(89)90008-X; Searle John, 1969, SPEECH ACTS ESSAY PH; Sidnell J., 2013, HDB CONVERSATION ANA, P103, DOI DOI 10.1002/9781118325001.CH6; Spotorno N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066839; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; ten Bosch L, 2005, SPEECH COMMUN, V47, P80, DOI 10.1016/j.specom.2005.05.009; Thornhill DE, 2012, INT J PSYCHOPHYSIOL, V83, P382, DOI 10.1016/j.ijpsycho.2011.12.007; van Ackeren MJ, 2012, J COGNITIVE NEUROSCI, V24, P2237, DOI 10.1162/jocn_a_00274; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; van Berkum JJA, 2003, COGNITIVE BRAIN RES, V17, P701, DOI 10.1016/S0926-6410(03)00196-4; van Berkum JJA, 2003, PSYCHOPHYSIOLOGY, V40, P235, DOI 10.1111/1469-8986.00025; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; Wang L, 2011, NEUROPSYCHOLOGIA, V49, P813, DOI 10.1016/j.neuropsychologia.2010.12.035; WARD G, 1985, LANGUAGE, V61, P747, DOI 10.2307/414489; Wilson E.O., 1975, P1	82	43	44	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120068	10.1371/journal.pone.0120068	http://dx.doi.org/10.1371/journal.pone.0120068			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793289	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200140
J	Hou, XJ; Jin, ZD; Xu, C; Zhang, MM; Zhu, JW; Jiang, F; Li, ZS				Hou, Xiaojia; Jin, Zhendong; Xu, Can; Zhang, Minmin; Zhu, Jianwei; Jiang, Fei; Li, Zhaoshen			Contrast-Enhanced Harmonic Endoscopic Ultrasound-Guided Fine-Needle Aspiration in the Diagnosis of Solid Pancreatic Lesions: A Retrospective Study	PLOS ONE			English	Article							ON-SITE EVALUATION; DIFFERENTIAL-DIAGNOSIS; COMPUTED-TOMOGRAPHY; EUS; ACCURACY; BIOPSY; CANCER; IMPACT; TUMORS; FNA	Background The negative predictive value of endoscopic ultrasonography-guided fine needle aspiration for the diagnosis of solid pancreatic lesions remains low, and the biopsy specimens are sometimes inadequate for appropriate pathological diagnosis. Aims To evaluate the usefulness of a novel method of contrast-enhanced harmonic endoscopic ultrasonography-guided fine-needle aspiration for the differential diagnosis and adequate sampling of solid pancreatic lesions. Methods Patients with a diagnosis of solid pancreatic lesions who underwent fine-needle aspiration guided by contrast-enhanced harmonic endoscopic ultrasonography or by endoscopic ultrasonography from October 2010 to July 2013 were retrospectively identified and classified into the CH-EUS or EUS group, respectively. Surgical pathology and/or follow-up results were defined as the final diagnosis. Operating characteristics and adequacy of biopsy specimens by fine-needle aspiration were compared between the two groups. Results Operating characteristics for contrast-enhanced harmonic endoscopic ultrasonography-guided fine-needle aspiration in solid pancreatic lesions were as follows: area under the curve = 0.908, sensitivity = 81.6%, specificity = 100%, positive predictive value = 100%, negative predictive value = 74.1%, and accuracy = 87.9%. The percentage of adequate biopsy specimens in the CH-EUS group (96.6%) was greater than that in the EUS group (86.7%). Conclusion Simultaneous contrast-enhanced harmonic endoscopic ultrasonography during fine-needle aspiration is useful for improving the diagnostic yield and adequate sampling of solid pancreatic lesions.	[Hou, Xiaojia; Jin, Zhendong; Xu, Can; Zhang, Minmin; Zhu, Jianwei; Jiang, Fei; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China	Naval Medical University	Jin, ZD (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	zhendjin@163.com; zhaoshenli11@163.com						Alsibai KD, 2006, CYTOPATHOLOGY, V17, P18, DOI 10.1111/j.1365-2303.2006.00312.x; Bhutani MS, 2004, ENDOSCOPY, V36, P385, DOI 10.1055/s-2004-814320; Brand B, 2000, SCAND J GASTROENTERO, V35, P1221; Chen G, 2013, PANCREATOLOGY, V13, P298, DOI 10.1016/j.pan.2013.01.013; DeWitt J, 2004, ANN INTERN MED, V141, P753, DOI 10.7326/0003-4819-141-10-200411160-00006; Dewitt J, 2006, CLIN GASTROENTEROL H, V4, P717, DOI 10.1016/j.cgh.2006.02.020; Eloubeidi MA, 2003, CANCER CYTOPATHOL, V99, P285, DOI 10.1002/cncr.11643; Erickson RA, 2000, GASTROINTEST ENDOSC, V51, P184, DOI 10.1016/S0016-5107(00)70416-0; Faigel DO, 1997, J CLIN ONCOL, V15, P1439, DOI 10.1200/JCO.1997.15.4.1439; Fisher L, 2009, J GASTROEN HEPATOL, V24, P90, DOI 10.1111/j.1440-1746.2008.05569.x; Fusaroli P, 2010, CLIN GASTROENTEROL H, V8, P629, DOI 10.1016/j.cgh.2010.04.012; Gincul R, 2014, ENDOSCOPY, V46, P373, DOI 10.1055/s-0034-1364969; Giovannini M, 2009, WORLD J GASTROENTERO, V15, P1587, DOI 10.3748/wjg.15.1587; Gong TT, 2012, GASTROINTEST ENDOSC, V76, P301, DOI 10.1016/j.gie.2012.02.051; Harewood GC, 2002, AM J GASTROENTEROL, V97, P1386, DOI 10.1016/S0002-9270(02)04133-3; Hebert-Magee S, 2013, CYTOPATHOLOGY, V24, P159, DOI 10.1111/cyt.12071; Hewitt MJ, 2012, GASTROINTEST ENDOSC, V75, P319, DOI 10.1016/j.gie.2011.08.049; Hocke M, 2011, ENDOSCOPY, V43, P163, DOI 10.1055/s-0030-1256022; Ibrahim Ashley A, 2014, J Am Soc Cytopathol, V3, P227, DOI 10.1016/j.jasc.2014.04.005; Iglesias-Garcia J, 2007, WORLD J GASTROENTERO, V13, P289, DOI 10.3748/wjg.v13.i2.289; Kedia P, 2013, CLIN ENDOSC, V46, P552, DOI 10.5946/ce.2013.46.5.552; Kitano M, 2008, GASTROINTEST ENDOSC, V67, P141, DOI 10.1016/j.gie.2007.07.045; Kitano M, 2014, DIGEST ENDOSC, V26, P79, DOI 10.1111/den.12179; Kitano M, 2012, AM J GASTROENTEROL, V107, P303, DOI 10.1038/ajg.2011.354; Klapman JB, 2003, AM J GASTROENTEROL, V98, P1289, DOI 10.1016/S0002-9270(03)00246-6; Legmann P, 1998, AM J ROENTGENOL, V170, P1315, DOI 10.2214/ajr.170.5.9574609; Maguchi H, 2006, ENDOSCOPY, V38, pS53, DOI 10.1055/s-2006-946653; Matynia AP, 2014, J GASTROEN HEPATOL, V29, P697, DOI 10.1111/jgh.12431; Park JS, 2014, WORLD J GASTROENTERO, V20, P518, DOI 10.3748/wjg.v20.i2.518; Reddy NK, 2011, WORLD J GASTROENTERO, V17, P42, DOI 10.3748/wjg.v17.i1.42; Romagnuolo J, 2011, GASTROINTEST ENDOSC, V73, P52, DOI 10.1016/j.gie.2010.09.014; ROSCH T, 1991, GASTROINTEST ENDOSC, V37, P347, DOI 10.1016/S0016-5107(91)70729-3; Rosch T, 1997, BRIT J SURG, V84, P1329, DOI 10.1002/bjs.1800841002; Sahai AV, 2010, ENDOSCOPY, V42, P900, DOI 10.1055/s-0030-1255676; Sakamoto H, 2008, ULTRASOUND MED BIOL, V34, P525, DOI 10.1016/j.ultrasmedbio.2007.09.018; Sakamoto H, 2010, WORLD J RADIOL, V2, P122, DOI 10.4329/wjr.v2.i4.122; Savides TJ, 2007, GASTROINTEST ENDOSC, V66, P277, DOI 10.1016/j.gie.2007.01.017; Schmidt RL, 2013, DIGEST DIS SCI, V58, P872, DOI 10.1007/s10620-012-2411-1; Takahashi K, 2005, GASTROINTEST ENDOSC, V61, P76, DOI 10.1016/S0016-5107(04)02224-2; Tamm E, 2001, CANCER J, V7, P298; Tarantino I, 2014, DIGEST LIVER DIS, V46, P523, DOI 10.1016/j.dld.2014.02.023; Volmar KE, 2005, GASTROINTEST ENDOSC, V61, P854, DOI 10.1016/S0016-5107(05)00364-0; Voss M, 2000, GUT, V46, P244, DOI 10.1136/gut.46.2.244; Wang Y, 2007, INT J CANCER, V121, P2716, DOI 10.1002/ijc.22997; Xu Can, 2012, Diagn Ther Endosc, V2012, P786239, DOI 10.1155/2012/786239	45	30	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121236	10.1371/journal.pone.0121236	http://dx.doi.org/10.1371/journal.pone.0121236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793739	Green Submitted, gold, Green Published			2022-12-26	WOS:000352083900115
J	Kapetanovic, S; Aaron, L; Montepiedra, G; Anthony, P; Thuvamontolrat, K; Pahwa, S; Burchett, S; Weinberg, A; Kovacs, A				Kapetanovic, Suad; Aaron, Lisa; Montepiedra, Grace; Anthony, Patricia; Thuvamontolrat, Kasalyn; Pahwa, Savita; Burchett, Sandra; Weinberg, Adriana; Kovacs, Andrea		Pediatric AIDS Clinical Trials Grp	Effect of Cytomegalovirus Co-Infection on Normalization of Selected T-Cell Subsets in Children with Perinatally Acquired HIV Infection Treated with Combination Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNE RECONSTITUTION; IN-VITRO; EXPRESSION; ACTIVATION; CD4(+); DIFFERENTIATION; LYMPHOCYTES; ANTIGENS; INDIVIDUALS; RESPONSES	Background We examined the effect of cytomegalovirus (CMV) co-infection and viremia on reconstitution of selected CD4+ and CD8+ T-cell subsets in perinatally HIV-infected (PHIV+) children >= 1-year old who participated in a partially randomized, open-label, 96-week combination antire-troviral therapy (cART)-algorithmstudy. Methods Participants were categorized as CMV-naive, CMV-positive (CMV+) viremic, and CMV+ aviremic, based on blood, urine, or throat culture, CMV IgG and DNA polymerase chain reaction measured at baseline. At weeks 0, 12, 20 and 40, T-cell subsets including naive (CD62L+CD45RA+; CD95-CD28+), activated (CD38+HLA-DR+) and terminally differentiated (CD62L-CD45RA+; CD95+CD28-) CD4+ and CD8+ T-cells were measured by flow cytometry. Results Of the 107 participants included in the analysis, 14% were CMV+ viremic; 49% CMV+ aviremic; 37% CMV-naive. In longitudinal adjusted models, compared with CMV+ status, baseline CMV-naive status was significantly associated with faster recovery of CD8+CD62L +CD45RA+% and CD8+CD95-CD28+% and faster decrease of CD8+CD95+CD28-%, independent of HIV VL response to treatment, cART regimen and baseline CD4%. Surprisingly, CMV status did not have a significant impact on longitudinal trends in CD8+CD38+HLA-DR+%. CMV status did not have a significant impact on any CD4+ T-cell subsets. Conclusions In this cohort of PHIV+ children, the normalization of naive and terminally differentiated CD8+ T-cell subsets in response to cART was detrimentally affected by the presence of CMV co-infection. These findings may have implications for adjunctive treatment strategies targeting CMV co-infection in PHIV+ children, especially those that are now adults or reaching young adulthood and may have accelerated immunologic aging, increased opportunistic infections and aging diseases of the immune system.	[Kapetanovic, Suad] NIMH, NIH, Bethesda, MD 20892 USA; [Aaron, Lisa; Montepiedra, Grace] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Anthony, Patricia; Thuvamontolrat, Kasalyn; Kovacs, Andrea] Univ So Calif, Keck Sch Med, Maternal Child & Adolescent Ctr Infect Dis & Viro, Los Angeles, CA 90033 USA; [Pahwa, Savita] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Burchett, Sandra] Childrens Hosp Boston, Boston, MA USA; [Burchett, Sandra] Harvard Univ, Sch Med, Boston, MA USA; [Weinberg, Adriana] Univ Colorado, Denver, CO 80202 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Harvard T.H. Chan School of Public Health; University of Southern California; University of Miami; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Denver	Kapetanovic, S (corresponding author), NIMH, NIH, Bethesda, MD 20892 USA.	suad.kapetanovic@nih.gov	Pahwa, Savita/AAA-4900-2019	Pahwa, Savita/0000-0002-4470-4216; Bonagura, Vincent/0000-0002-0681-2099	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); Intramural Research Program of the NIMH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106716, UM1AI068616, UM1AI069477, UM1AI068632, UM1AI069415] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural Research Program of the NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). This project was also supported in part by the Intramural Research Program of the NIMH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Betensky RA, 2000, CLIN DIAGN LAB IMMUN, V7, P759, DOI 10.1128/CDLI.7.5.759-763.2000; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; De Martino M, 1998, PEDIATR RES, V43, P752, DOI 10.1203/00006450-199806000-00007; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; Gantt S, 2011, ANTIMICROB AGENTS CH, V55, P2696, DOI 10.1128/AAC.01295-10; Hengel RL, 2003, J IMMUNOL, V170, P28, DOI 10.4049/jimmunol.170.1.28; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Jiang JD, 1997, J CLIN IMMUNOL, V17, P185, DOI 10.1023/A:1027386701052; Kapetanovic S, 2012, AIDS, V26, P959, DOI 10.1097/QAD.0b013e328352cee7; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Kovacs A, 2005, J INFECT DIS, V192, P296, DOI 10.1086/430922; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Rosenblatt HM, 2005, J INFECT DIS, V192, P445, DOI 10.1086/431597; Roxby AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087855; SCHLESINGER M, 1995, PEDIATR RES, V38, P390, DOI 10.1203/00006450-199509000-00020; Solana R, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-23; Weinberg A, 2008, CLIN VACCINE IMMUNOL, V15, P1398, DOI 10.1128/CVI.00479-07; Weinberg A, 2004, CLIN INFECT DIS, V39, P107, DOI 10.1086/420931	24	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120474	10.1371/journal.pone.0120474	http://dx.doi.org/10.1371/journal.pone.0120474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794163	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900038
J	Kouba, M; Bartos, L; Korpimaki, E; Zarybnicka, M				Kouba, Marek; Bartos, Ludek; Korpimaki, Erkki; Zarybnicka, Marketa			Factors Affecting the Duration of Nestling Period and Fledging Order in Tengmalm's Owl (Aegolius funereus): Effect of Wing Length and Hatching Sequence	PLOS ONE			English	Article							DEVELOPMENTAL RATES; PARENTAL BEHAVIOR; FOOD ABUNDANCE; GROWTH-RATE; HOLE SHIFT; SEX-RATIO; AGE; PREDATION; EVOLUTION; SIZE	In altricial birds, the nestling period is an important part of the breeding phase because the juveniles may spend quite a long time in the nest, with associated high energy costs for the parents. The length of the nestling period can be variable and its duration may be influenced by both biotic and abiotic factors; however, studies of this have mostly been undertaken on passerine birds. We studied individual duration of nestling period of 98 Tengmalm's owl chicks (Aegolius funereus) at 27 nests during five breeding seasons using a camera and chip system and radio-telemetry. We found the nestlings stayed in the nest box for 27-38 days from hatching (mean +/- SD, 32.4 +/- 2.2 days). The individual duration of nestling period was negatively related to wing length, but no formally significant effect was found for body weight, sex, prey availability and/or weather conditions. The fledging sequence of individual nestlings was primarily related to hatching order; no relationship with wing length and/or other factors was found in this case. We suggest the length of wing is the most important measure of body condition and individual quality in Tengmalm's owl young determining the duration of the nestling period. Other differences from passerines (e.g., the lack of effect of weather or prey availability on nestling period) are considered likely to be due to different life-history traits, in particular different food habits and nesting sites and greater risk of nest predation among passerines.	[Kouba, Marek; Zarybnicka, Marketa] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Bartos, Ludek] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Anim Sci & Ethol, Prague, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Korpimaki, Erkki] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; University of Turku	Kouba, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	marekkouba8@gmail.com	ZÃrybnickÃ, MarkÃ©ta/AAM-3181-2020; Kouba, Marek/A-1350-2019	Kouba, Marek/0000-0003-2262-5733; Zarybnicka, Marketa/0000-0001-5883-0988	Czech University of Life Sciences Prague (CIGA) [20104205, 20144203]; Ministry of Education, Youth and Sports of the Czech Republic (MSMT) [1321/213205]; Ministry of Agriculture of the Czech Republic (MZERO) [0714]	Czech University of Life Sciences Prague (CIGA); Ministry of Education, Youth and Sports of the Czech Republic (MSMT)(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Agriculture of the Czech Republic (MZERO)	Funding: This study was supported by the Czech University of Life Sciences Prague (CIGA Grant No. 20104205 [MK] and 20144203 [MZ MK]), the Ministry of Education, Youth and Sports of the Czech Republic (MSMT Grant No. 1321/213205 [LB]), and Ministry of Agriculture of the Czech Republic (MZERO Grant No. 0714 [LB]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEZOUSKA V, 2005, ITCE 2005 C, P173; Bize P, 2003, J ANIM ECOL, V72, P633, DOI 10.1046/j.1365-2656.2003.00734.x; Bize P, 2006, FUNCT ECOL, V20, P857, DOI 10.1111/j.1365-2435.2006.01157.x; BOSQUE C, 1995, AM NAT, V145, P234, DOI 10.1086/285738; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CRUZ JB, 1990, CONDOR, V92, P160, DOI 10.2307/1368394; Davis SK, 2009, J FIELD ORNITHOL, V80, P265, DOI 10.1111/j.1557-9263.2009.00229.x; Drdakova Marketa, 2003, Sylvia, V39, P35; Drdakova-Zarybnicka M., 2005, BUTEO, V14, P37; Durant JM, 2006, BIOL LETT-UK, V2, P628, DOI 10.1098/rsbl.2006.0520; Eldegard K, 2012, J ORNITHOL, V153, P385, DOI 10.1007/s10336-011-0753-7; Eldegard K, 2010, BEHAV ECOL SOCIOBIOL, V64, P815, DOI 10.1007/s00265-009-0898-z; Eldegard K, 2009, P ROY SOC B-BIOL SCI, V276, P1713, DOI 10.1098/rspb.2008.1775; EMLEN ST, 1991, CONDOR, V93, P591, DOI 10.2307/1368191; FREED LA, 1988, NATL GEOGR RES, V4, P395; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Granadeiro JP, 2000, BEHAV ECOL, V11, P274, DOI 10.1093/beheco/11.3.274; Hipkiss T, 2004, POPUL ECOL, V46, P263, DOI 10.1007/s10144-004-0195-7; Johnson LS, 2013, J FIELD ORNITHOL, V84, P367, DOI 10.1111/jofo.12036; Johnson LS, 2004, ETHOLOGY, V110, P693, DOI 10.1111/j.1439-0310.2004.01001.x; Karell P, 2009, CAN J ZOOL, V87, P8, DOI 10.1139/Z08-133; Killpack TL, 2012, J EXP BIOL, V215, P1806, DOI 10.1242/jeb.066316; Konig C, 2008, OWLS WORLD; Korpimaki E, 2012, BOREAL OWL: ECOLOGY, BEHAVIOUR AND CONSERVATION OF A FOREST-DWELLING PREDATOR, P1, DOI 10.1017/CBO9780511844164; KORPIMAKI E, 1991, OECOLOGIA, V85, P543, DOI 10.1007/BF00323767; KORPIMAKI E, 1988, ORNIS FENNICA, V65, P21; KORPIMAKI E, 1987, J ANIM ECOL, V56, P185, DOI 10.2307/4808; KORPIMAKI E, 1992, J ANIM ECOL, V61, P103, DOI 10.2307/5513; KORPIMAKI E, 1986, ORNIS SCAND, V17, P326, DOI 10.2307/3676820; Korpimaki E., 1981, ACTA U OULUENSIS SER, V118, P1; Kouba M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097504; Kouba M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095594; Kouba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067034; Kouba Marek, 2012, Sylvia, V48, P115; Kuhk R., 1969, BONNER ZOOL BEITR, V20, P141; Lack D., 1954, P343; LEMEL J, 1989, AUK, V106, P490; Lyons DE, 2011, J FIELD ORNITHOL, V82, P88, DOI 10.1111/j.1557-9263.2010.00311.x; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Michaud T, 2000, AUK, V117, P996, DOI 10.1642/0004-8038(2000)117[0996:TRODPB]2.0.CO;2; Mikkola H., 2020, OWLS, P97; Miller DA, 2010, P ROY SOC B-BIOL SCI, V277, P1659, DOI 10.1098/rspb.2010.0022; Nilsson J.-A., 1990, POPULATION BIOL PASS, P369; NILSSON JA, 1993, ANIM BEHAV, V46, P379, DOI 10.1006/anbe.1993.1200; Oyan HS, 1996, AUK, V113, P830; Pennycuick C.J., 1975, AVIAN BIOL, P1, DOI DOI 10.1016/B978-0-12-249405-5.50009-4; Radersma R, 2011, ANIM BEHAV, V81, P69, DOI 10.1016/j.anbehav.2010.09.007; Remes V, 2002, EVOLUTION, V56, P2505; Remes V, 2007, J EVOLUTION BIOL, V20, P320, DOI 10.1111/j.1420-9101.2006.01191.x; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Risely A, 2013, BIRD STUDY, V60, P539, DOI 10.1080/00063657.2013.846293; Roff DA, 2005, J EVOLUTION BIOL, V18, P1425, DOI 10.1111/j.1420-9101.2005.00958.x; Searcy WA, 2004, J AVIAN BIOL, V35, P269, DOI 10.1111/j.0908-8857.2004.03247.x; SONERUD GA, 1985, J ANIM ECOL, V54, P179, DOI 10.2307/4629; Stodola KW, 2010, AUK, V127, P204, DOI 10.1525/auk.2009.09151; Takenaka M, 2005, CAN J ZOOL, V83, P1476, DOI 10.1139/Z05-145; Tao J, 2002, MIXED MODEL ANALYSES; TRENT B, 1977, WILSON BULL, V89, P609; Trivers R. L., 1985, SOCIAL EVOLUTION; TRIVERS RL, 1974, AM ZOOL, V14, P249; Vacik R, 1991, SYLVIA, V28, P95; Valkama J, 2002, OECOLOGIA, V133, P334, DOI 10.1007/s00442-002-1033-2; Wright J, 2006, P ROY SOC B-BIOL SCI, V273, P1895, DOI 10.1098/rspb.2006.3533; Zarybnicka M, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-36; Zarybnicka M, 2013, POPUL ECOL, V55, P353, DOI 10.1007/s10144-013-0367-4; Zarybnicka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036932; Zarybnicka M, 2011, ORNIS FENNICA, V88, P147; Zarybnicka M, 2009, ACTA ORNITHOL, V44, P81, DOI 10.3161/000164509X464911; Zarybnicka M, 2009, FOLIA ZOOL, V58, P104; Zarybnicka M, 2009, J ORNITHOL, V150, P231, DOI 10.1007/s10336-008-0342-6	70	7	7	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121641	10.1371/journal.pone.0121641	http://dx.doi.org/10.1371/journal.pone.0121641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793880	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900143
J	Lerksuthirat, T; Lohnoo, T; Inkomlue, R; Rujirawat, T; Yingyong, W; Khositnithikul, R; Phaonakrop, N; Roytrakul, S; Sullivan, TD; Krajaejun, T				Lerksuthirat, Tassanee; Lohnoo, Tassanee; Inkomlue, Ruchuros; Rujirawat, Thidarat; Yingyong, Wanta; Khositnithikul, Rommanee; Phaonakrop, Narumon; Roytrakul, Sittiruk; Sullivan, Thomas D.; Krajaejun, Theerapong			The Elicitin-Like Glycoprotein, ELI025, Is Secreted by the Pathogenic Oomycete Pythium insidiosum and Evades Host Antibody Responses	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; GENOME SEQUENCE; HUMAN PYTHIOSIS; APHANOMYCES-EUTEICHES; EVOLUTIONARY HISTORY; RAPID SERODIAGNOSIS; HELICOBACTER-PYLORI; CANDIDA-ALBICANS; PHYTOPHTHORA; PROTEIN	Pythium insidiosum is a unique oomycete that can infect humans and animals. Patients with a P. insidiosum infection (pythiosis) have high rates of morbidity and mortality. The pathogen resists conventional antifungal drugs. Information on the biology and pathogenesis of P. insidiosum is limited. Many pathogens secrete proteins, known as effectors, which can affect the host response and promote the infection process. Elicitins are secretory proteins and are found only in the oomycetes, primarily in Phytophthora and Pythium species. In plant-pathogenic oomycetes, elicitins function as pathogen-associated molecular pattern molecules, sterol carriers, and plant defense stimulators. Recently, we reported a number of elicitin-encoding genes from the P. insidiosum transcriptome. The function of elicitins during human infections is unknown. One of the P. insidiosum elicitin-encoding genes, ELI025, is highly expressed and up-regulated at body temperature. This study aims to characterize the biochemical, immunological, and genetic properties of the elicitin protein, ELI025. A 12.4-kDa recombinant ELI025 protein (rELI025) was expressed in Escherichia coli. Rabbit anti-rELI025 antibodies reacted strongly with the native ELI025 in P. insidiosum's culture medium. The detected ELI025 had two isoforms: glycosylated and non-glycosylated. ELI025 was not immunoreactive with sera from pythiosis patients. The region near the transcriptional start site of ELI025 contained conserved oomycete core promoter elements. In conclusion, ELI025 is a small, abundant, secreted glycoprotein that evades host antibody responses. ELI025 is a promising candidate for development of diagnostic and therapeutic targets for pythiosis.	[Lerksuthirat, Tassanee; Inkomlue, Ruchuros; Khositnithikul, Rommanee; Krajaejun, Theerapong] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10400, Thailand; [Lohnoo, Tassanee; Rujirawat, Thidarat; Yingyong, Wanta] Mahidol Univ, Ramathibodi Hosp, Fac Med, Res Ctr, Bangkok 10400, Thailand; [Lerksuthirat, Tassanee; Rujirawat, Thidarat] Mahidol Univ, Fac Sci, Multidisciplinary Unit, Program Mol Med, Bangkok 10400, Thailand; [Phaonakrop, Narumon; Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Genome Inst, Prote Res Lab, Pathum Thani, Thailand; [Sullivan, Thomas D.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA	Mahidol University; Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; University of Wisconsin System; University of Wisconsin Madison	Krajaejun, T (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10400, Thailand.	mr_en@hotmail.com	Krajaejun, Theerapong/P-2550-2017; Lerksuthirat, Tassanee/A-1930-2016	Krajaejun, Theerapong/0000-0003-0545-3765; Lerksuthirat, Tassanee/0000-0001-9526-951X; Rujirawat, Thidarat/0000-0003-1256-7330	Thailand Research Fund [BRG5680011]; Mahidol University [E01/2557]; Royal Golden Jubilee Ph.D. Scholarship [PHD/0092/2553]	Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Royal Golden Jubilee Ph.D. Scholarship	This work is supported by the Thailand Research Fund (TK; grant number, BRG5680011; URL, http://www.trf.or.th), a Research Fund from Mahidol University (TK; grant number, E01/2557; URL, http://www.op.mahidol.ac.th/orra), and the Royal Golden Jubilee Ph.D. Scholarship (TLE; grant number, PHD/0092/2553; URL, http://rgj.trf.or.th, Lerksuthirat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, TERRIFIC BROTH; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bhavsar AP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003518; Boissy G, 1996, STRUCTURE, V4, P1429, DOI 10.1016/S0969-2126(96)00150-5; Boissy G, 1999, PROTEIN SCI, V8, P1191, DOI 10.1110/ps.8.6.1191; Bosco SDG, 2005, EMERG INFECT DIS, V11, P715; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; CHAIPRASERT A, 1990, MYCOSES, V33, P317, DOI 10.1111/myc.1990.33.6.317; Chareonsirisuthigul T, 2013, DIAGN MICR INFEC DIS, V76, P42, DOI 10.1016/j.diagmicrobio.2013.02.025; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cisse OH, 2013, MBIO, V4, DOI 10.1128/mBio.00428-12; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; DECOCK AWAM, 1987, J CLIN MICROBIOL, V25, P344, DOI 10.1128/JCM.25.2.344-349.1987; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Gaastra W, 2010, VET MICROBIOL, V146, P1, DOI 10.1016/j.vetmic.2010.07.019; Gaulin E, 2010, PLANT SIGNAL BEHAV, V5, P258, DOI 10.4161/psb.5.3.10551; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; HENDRIX JW, 1975, MYCOLOGIA, V67, P663, DOI 10.2307/3758403; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Jiang RHY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003272; Jiang RHY, 2006, MOL BIOL EVOL, V23, P338, DOI 10.1093/molbev/msj039; Jiang RHY, 2005, MOL GENET GENOMICS, V273, P20, DOI 10.1007/s00438-005-1114-0; Jindayok T, 2009, CLIN VACCINE IMMUNOL, V16, P1047, DOI 10.1128/CVI.00113-09; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Judelson HS, 2009, OOMYCETE GENETICS GE, P435; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kamoun S, 1998, PLANT CELL, V10, P1413, DOI 10.1105/tpc.10.9.1413; Keeratijarut A, 2009, SE ASIAN J TROP MED, V40, P1298; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Krajaejun T, 2002, CLIN DIAGN LAB IMMUN, V9, P378, DOI 10.1128/CDLI.9.2.378-382.2002; Krajaejun T, 2006, CLIN INFECT DIS, V43, P569, DOI 10.1086/506353; Krajaejun T, 2014, FUNGAL BIOL-UK, V118, P640, DOI 10.1016/j.funbio.2014.01.009; Krajaejun T, 2011, FUNGAL BIOL-UK, V115, P683, DOI 10.1016/j.funbio.2011.05.001; Krajaejun T, 2009, CLIN VACCINE IMMUNOL, V16, P506, DOI 10.1128/CVI.00276-08; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lascombe MB, 2007, ACTA CRYSTALLOGR D, V63, P1102, DOI 10.1107/S0907444907043363; Lascombe MB, 2002, ACTA CRYSTALLOGR D, V58, P1442, DOI 10.1107/S0907444902011745; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lohnoo Tassanee, 2014, Journal of the Medical Association of Thailand, V97, P342; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Madoui MA, 2009, NEW PHYTOL, V183, P291, DOI 10.1111/j.1469-8137.2009.02895.x; MENDOZA L, 1986, MYCOPATHOLOGIA, V94, P123, DOI 10.1007/BF00437377; Mendoza L, 2004, MYCOSES, V47, P14, DOI 10.1046/j.1439-0507.2003.00950.x; Mendoza L, 2013, CURR FUNGAL INFECT R, V7, P198, DOI 10.1007/s12281-013-0144-z; Mikes V, 1998, BIOCHEM BIOPH RES CO, V245, P133, DOI 10.1006/bbrc.1998.8341; Mikes V, 1997, FEBS LETT, V416, P190, DOI 10.1016/S0014-5793(97)01193-9; MortBontemps M, 1997, CURR GENET, V31, P272, DOI 10.1007/s002940050205; Mosbah E, 2012, J EQUINE VET SCI, V32, P164, DOI 10.1016/j.jevs.2011.08.014; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Murdoch D, 1997, AUST NZ J OPHTHALMOL, V25, P177, DOI 10.1111/j.1442-9071.1997.tb01304.x; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Oldenhoff W, 2014, VET DERMATOL, V25, P52, DOI 10.1111/vde.12101; Osman H, 2001, MOL BIOL CELL, V12, P2825, DOI 10.1091/mbc.12.9.2825; Panabieres F, 1997, MYCOL RES, V101, P1459, DOI 10.1017/S0953756297004413; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prasertwitayakij N, 2003, SEMIN ARTHRITIS RHEU, V33, P204, DOI 10.1016/j.semarthrit.2003.09.003; Qutob D, 2003, MOL PLANT PATHOL, V4, P119, DOI 10.1046/j.1364-3703.2003.00158.x; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Rivierre C, 2005, EMERG INFECT DIS, V11, P479; Rodrigues ML, 2006, BBA-PROTEINS PROTEOM, V1764, P110, DOI 10.1016/j.bbapap.2005.09.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schurko A, 2003, MYCOLOGIA, V95, P200, DOI 10.2307/3762031; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Supabandhu J, 2008, MED MYCOL, V46, P41, DOI 10.1080/13693780701513840; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto-Alalibo T, 2010, MICROBIOL MOL BIOL R, V74, P479, DOI 10.1128/MMBR.00017-10; Torto-Alalibo T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S3; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Vanittanakom N, 2004, J CLIN MICROBIOL, V42, P3970, DOI 10.1128/JCM.42.9.3970-3974.2004; Wawra S, 2012, CURR OPIN MICROBIOL, V15, P685, DOI 10.1016/j.mib.2012.10.008; Weiland JJ, 2003, CURR GENET, V42, P344, DOI 10.1007/s00294-002-0359-y; Wilkins MR, 1999, METH MOL B, V112, P531; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; YU LM, 1995, P NATL ACAD SCI USA, V92, P4088, DOI 10.1073/pnas.92.10.4088	88	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118547	10.1371/journal.pone.0118547	http://dx.doi.org/10.1371/journal.pone.0118547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793767	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200028
J	Lockhart, SN; Luck, SJ; Geng, J; Beckett, L; Disbrow, EA; Carmichael, O; DeCarli, C				Lockhart, Samuel N.; Luck, Steven J.; Geng, Joy; Beckett, Laurel; Disbrow, Elizabeth A.; Carmichael, Owen; DeCarli, Charles			White Matter Hyperintensities among Older Adults Are Associated with Futile Increase in Frontal Activation and Functional Connectivity during Spatial Search	PLOS ONE			English	Article							PREFRONTAL CORTEX FUNCTION; VISUAL-ATTENTION; AGE-DIFFERENCES; COGNITIVE CONTROL; BRAIN; MRI; HYPOTHESIS; PERFORMANCE; MECHANISMS; DEFICITS	The mechanisms by which aging and other processes can affect the structure and function of brain networks are important to understanding normal age-related cognitive decline. Advancing age is known to be associated with various disease processes, including clinically asymptomatic vascular and inflammation processes that contribute to white matter structural alteration and potential injury. The effects of these processes on the function of distributed cognitive networks, however, are poorly understood. We hypothesized that the extent of magnetic resonance imaging white matter hyperintensities would be associated with visual attentional control in healthy aging, measured using a functional magnetic resonance imaging search task. We assessed cognitively healthy older adults with search tasks indexing processing speed and attentional control. Expanding upon previous research, older adults demonstrate activation across a frontal-parietal attentional control network. Further, greater white matter hyperintensity volume was associated with increased activation of a frontal network node independent of chronological age. Also consistent with previous research, greater white matter hyperintensity volume was associated with anatomically specific reductions in functional magnetic resonance imaging functional connectivity during search among attentional control regions. White matter hyperintensities may lead to subtle attentional network dysfunction, potentially through impaired frontal-parietal and frontal interhemispheric connectivity, suggesting that clinically silent white matter biomarkers of vascular and inflammatory injury can contribute to differences in search performance and brain function in aging, and likely contribute to advanced age-related impairments in cognitive control.	[Lockhart, Samuel N.; Carmichael, Owen; DeCarli, Charles] Univ Calif Davis, Imaging Dementia & Aging Lab, Davis, CA 95616 USA; [Lockhart, Samuel N.; Beckett, Laurel; Carmichael, Owen; DeCarli, Charles] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Lockhart, Samuel N.; Luck, Steven J.; Geng, Joy; Disbrow, Elizabeth A.; DeCarli, Charles] Univ Calif Davis, Neurosci Grad Grp, Davis, CA 95616 USA; [Luck, Steven J.; Geng, Joy; DeCarli, Charles] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Luck, Steven J.; Geng, Joy] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Beckett, Laurel] Univ Calif Davis, Div Biostat, Davis, CA 95616 USA; [Disbrow, Elizabeth A.] Louisiana State Univ, Dept Neurol, Hlth Sci Ctr Shreveport, Shreveport, LA 71105 USA; [Carmichael, Owen] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Lockhart, SN (corresponding author), Univ Calif Davis, Imaging Dementia & Aging Lab, Davis, CA 95616 USA.	snlockhart@ucdavis.edu	Carmichael, Owen/N-1955-2017; Geng, Joy/J-6225-2019; Lockhart, Samuel Neal/AET-0265-2022; DeCarli, Charles/B-5541-2009	Lockhart, Samuel Neal/0000-0002-0893-5420; Carmichael, Owen/0000-0002-0576-0047	National Institute on Aging [R01AG021028, P30AG010129, K01AG030514]; NATIONAL INSTITUTE ON AGING [K01AG030514, R01AG021028, P30AG010129] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (nia.nih.gov) grants R01AG021028 (CD), P30AG010129 (CD), and K01AG030514 (OC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bergstrom ZM, 2013, NEUROIMAGE, V68, P141, DOI 10.1016/j.neuroimage.2012.11.030; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Bronge L, 2002, ACTA RADIOL, V43, P7; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Carmichael O, 2012, NEUROBIOL AGING, V33, P83, DOI 10.1016/j.neurobiolaging.2010.01.021; Carmichael O, 2010, ARCH NEUROL-CHICAGO, V67, P1370, DOI 10.1001/archneurol.2010.284; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 1998, PHILOS T ROY SOC B, V353, P1353, DOI 10.1098/rstb.1998.0289; Cui X, 2003, STAT APPL GENET MOL, V2, P1009; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; DeCarli C, 1996, JMRI-J MAGN RESON IM, V6, P519, DOI 10.1002/jmri.1880060316; DECARLI C, 1995, NEUROLOGY, V45, P2077, DOI 10.1212/WNL.45.11.2077; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; DECARLI C, 1992, J COMPUT ASSIST TOMO, V16, P274, DOI 10.1097/00004728-199203000-00018; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gazzaniga M. S, 2013, COGNITIVE NEUROSCIEN; Gold JM, 2007, SCHIZOPHR RES, V94, P148, DOI 10.1016/j.schres.2007.04.023; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Greenwood PM, 2000, J INT NEUROPSYCH SOC, V6, P705, DOI 10.1017/S1355617700666092; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hedden T, 2014, CEREBRAL CORTEX; Huang CM, 2010, J NEUROSCI METH, V189, P257, DOI 10.1016/j.jneumeth.2010.03.021; Huijbers W, 2014, J NEUROSCI, V34, P5200, DOI 10.1523/JNEUROSCI.3579-13.2014; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lockhart SN, 2014, NEUROPSYCHOLOGIA, V52, P93, DOI 10.1016/j.neuropsychologia.2013.10.011; Lockhart SN, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00056; Madden DJ, 2007, CURR DIR PSYCHOL SCI, V16, P70, DOI 10.1111/j.1467-8721.2007.00478.x; Madden DJ, 2007, NEUROBIOL AGING, V28, P459, DOI 10.1016/j.neurobiolaging.2006.01.005; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Mayda ABV, 2011, BRAIN, V134, P1673, DOI 10.1093/brain/awr065; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/089892906775990552; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rabbitt P, 2007, NEUROPSYCHOLOGY, V21, P363, DOI 10.1037/0894-4105.21.3.363; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Rush BK, 2006, AGING NEUROPSYCHOL C, V13, P588, DOI 10.1080/13825580600680703; SALTHOUSE TA, 1985, J GERONTOL, V40, P443, DOI 10.1093/geronj/40.4.443; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Samanez-Larkin GR, 2008, SOC COGN AFFECT NEUR, V3, P290, DOI 10.1093/scan/nsn029; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; Sokal RR, 1995, BIOMETRY PRINCIPLES, V3, P1995; Stewart JC, 2014, NEUROIMAGE, V86, P326, DOI 10.1016/j.neuroimage.2013.10.016; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Todd RM, 2012, J NEUROSCI, V32, P11201, DOI 10.1523/JNEUROSCI.0155-12.2012; Tullberg M, 2004, NEUROLOGY, V63, P246, DOI 10.1212/01.WNL.0000130530.55104.B5; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Vartanian O, 2013, P NATL ACAD SCI USA, V110, P10446, DOI 10.1073/pnas.1301227110; Voets NL, 2014, J NEUROSCI, V34, P4920, DOI 10.1523/JNEUROSCI.4281-13.2014; West R, 2000, J INT NEUROPSYCH SOC, V6, P727, DOI 10.1017/S1355617700666109; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Xu HC, 2010, STROKE, V41, P2744, DOI 10.1161/STROKEAHA.110.591875	60	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122445	10.1371/journal.pone.0122445	http://dx.doi.org/10.1371/journal.pone.0122445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793922	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900180
J	Takata, N; Yoshida, K; Komaki, Y; Xu, M; Sakai, Y; Hikishima, K; Mimura, M; Okano, H; Tanaka, KF				Takata, Norio; Yoshida, Keitaro; Komaki, Yuji; Xu, Ming; Sakai, Yuki; Hikishima, Keigo; Mimura, Masaru; Okano, Hideyuki; Tanaka, Kenji F.			Optogenetic Activation of CA1 Pyramidal Neurons at the Dorsal and Ventral Hippocampus Evokes Distinct Brain-Wide Responses Revealed by Mouse fMRI	PLOS ONE			English	Article							AXONAL PROJECTIONS; OPTICAL CONTROL; BOLD RESPONSE; LESIONS; MICE; CONNECTIVITY; ORGANIZATION; STIMULATION; EXPRESSION; NETWORKS	The dorsal and ventral hippocampal regions (dHP and vHP) are proposed to have distinct functions. Electrophysiological studies have revealed intra-hippocampal variances along the dorsoventral axis. Nevertheless, the extra-hippocampal influences of dHP and vHP activities remain unclear. In this study, we compared the spatial distribution of brain-wide responses upon dHP or vHP activation and further estimate connection strengths between the dHP and the vHP with corresponding extra-hippocampal areas. To achieve this, we first investigated responses of local field potential (LFP) and multi unit activities (MUA) upon light stimulation in the hippocampus of an anesthetized transgenic mouse, whose CA1 pyramidal neurons expressed a step-function opsin variant of channelrhodopsin-2 (ChR2). Optogenetic stimulation increased hippocampal LFP power at theta, gamma, and ultra-fast frequency bands, and augmented MUA, indicating light-induced activation of CA1 pyramidal neurons. Brain-wide responses examined using fMRI revealed that optogenetic activation at the dHP or vHP caused blood oxygenation level-dependent (BOLD) fMRI signals in situ. Although activation at the dHP induced BOLD responses at the vHP, the opposite was not observed. Outside the hippocampal formation, activation at the dHP, but not the vHP, evoked BOLD responses at the retrosplenial cortex (RSP), which is in line with anatomical evidence. In contrast, BOLD responses at the lateral septum (LS) were induced only upon vHP activation, even though both dHP and vHP send axonal fibers to the LS. Our findings suggest that the primary targets of dHP and vHP activation are distinct, which concurs with attributed functions of the dHP and RSP in spatial memory, as well as of the vHP and LS in emotional responses.	[Takata, Norio; Yoshida, Keitaro; Xu, Ming; Sakai, Yuki; Mimura, Masaru; Tanaka, Kenji F.] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo, Japan; [Komaki, Yuji; Hikishima, Keigo; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Takata, Norio; Komaki, Yuji; Sakai, Yuki; Hikishima, Keigo] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Sakai, Yuki] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Psychiat, Kyoto, Japan	Keio University; Keio University; Kyoto Prefectural University of Medicine	Takata, N (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo, Japan.	takata.norio@keio.jp; kftanaka@keio.jp	Hikishima, Keigo/L-1202-2013; Hikishima, Keigo/AAP-9586-2020; Okano, Hideyuki/X-9131-2019; Sakai, Yuki/AAV-6231-2021; Okano, Hideyuki/I-7584-2019	Hikishima, Keigo/0000-0003-1133-1297; Hikishima, Keigo/0000-0003-1133-1297; Okano, Hideyuki/0000-0001-7482-5935; Sakai, Yuki/0000-0003-2475-8548; Tanaka, Kenji/0000-0003-2511-0057; Komaki, Yuji/0000-0002-0250-0354; Yoshida, Keitaro/0000-0003-2196-7635; xu, ming/0000-0001-7974-0658	KAKENHI [25430011, 25115726, 24111551]; "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" from Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [15H03123, 25115726, 25116523, 23680042] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" from Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This work was supported by KAKENHI Grants (25430011 and 25115726 to N.T., 24111551 to K.F.T.) and "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" to H.O. from Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, NEUROSCI RES, V74, P248, DOI 10.1016/j.neures.2012.08.007; Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Angenstein F, 2007, NEUROIMAGE, V38, P150, DOI 10.1016/j.neuroimage.2007.07.022; Baltes C, 2011, NMR BIOMED, V24, P439, DOI 10.1002/nbm.1613; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Canals S, 2008, MAGN RESON IMAGING, V26, P978, DOI 10.1016/j.mri.2008.02.018; Canals S, 2009, CURR BIOL, V19, P398, DOI 10.1016/j.cub.2009.01.037; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Cenquizca LA, 2006, J COMP NEUROL, V497, P101, DOI 10.1002/cne.20985; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Christie IN, 2013, NEUROIMAGE, V66, P634, DOI 10.1016/j.neuroimage.2012.10.074; Cowansage KK, 2014, NEURON, V84, P432, DOI 10.1016/j.neuron.2014.09.022; Desai M, 2011, J NEUROPHYSIOL, V105, P1393, DOI 10.1152/jn.00828.2010; Dougherty KA, 2012, J PHYSIOL-LONDON, V590, P5707, DOI 10.1113/jphysiol.2012.242693; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Ferbinteanu J, 2003, NEUROSCI LETT, V345, P131, DOI 10.1016/S0304-3940(03)00473-7; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Grandjean J, 2014, NEUROIMAGE, V102, P838, DOI 10.1016/j.neuroimage.2014.08.043; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; HUGHES KR, 1965, CAN J PSYCHOLOGY, V19, P325, DOI 10.1037/h0082915; Huttunen JK, 2008, NEUROIMAGE, V39, P775, DOI 10.1016/j.neuroimage.2007.06.042; Jinno S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.013.2009; Jonckers E, 2014, MAGN RESON MED, V72, P1103, DOI 10.1002/mrm.24990; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; MCLENNAN H, 1974, J PHYSIOL-LONDON, V237, P607, DOI 10.1113/jphysiol.1974.sp010500; MELLO LEAM, 1992, BRAIN RES, V587, P24, DOI 10.1016/0006-8993(92)91425-E; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MOSER E, 1993, J NEUROSCI, V13, P3916; Nair G, 2004, MAGN RESON MED, V52, P430, DOI 10.1002/mrm.20158; Patel J, 2012, NEURON, V75, P410, DOI 10.1016/j.neuron.2012.07.015; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Rudy JW, 2005, BEHAV NEUROSCI, V119, P154, DOI 10.1037/0735-7044.119.1.154; Seki F, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00045; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Sinclair MD, 2003, CAN VET J, V44, P885; Singewald GM, 2011, NEUROPSYCHOPHARMACOL, V36, P793, DOI 10.1038/npp.2010.213; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stark E, 2014, NEURON, V83, P467, DOI 10.1016/j.neuron.2014.06.023; Stark E, 2012, J NEUROPHYSIOL, V108, P349, DOI 10.1152/jn.00153.2012; Takata N, 2014, NEUROMETHODS, V85, P191, DOI 10.1007/978-1-62703-785-3_12; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; van Zijl PCM, 2012, NEUROIMAGE, V62, P1092, DOI 10.1016/j.neuroimage.2012.01.029; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Weitz AJ, 2015, NEUROIMAGE, V107, P229, DOI 10.1016/j.neuroimage.2014.10.039	51	38	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121417	10.1371/journal.pone.0121417	http://dx.doi.org/10.1371/journal.pone.0121417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793741	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900133
J	Zhang, X; Cui, J; Liu, LN; Jiang, P; Wang, H; Qi, X; Wu, XQ; Wang, ZQ				Zhang, Xi; Cui, Jing; Liu, Li Na; Jiang, Peng; Wang, Han; Qi, Xin; Wu, Xing Qi; Wang, Zhong Quan			Genetic Structure Analysis of Spirometra erinaceieuropaei Isolates from Central and Southern China	PLOS ONE			English	Article							MITOCHONDRIAL-DNA REGIONS; TAPEWORM TAENIA-SOLIUM; SEQUENCE VARIABILITY; POPULATION-GROWTH; HUMAN SPARGANOSIS; DIVERSITY; PHYLOGEOGRAPHY; HYPOTHESIS; EVOLUTION; PROVINCE	Background Sparganosis caused by invasion of the plerocercoid larvae (spargana) of Spirometra erinaceieuropaei have increased in recent years in China. However, the population genetic structure regarding this parasite is still unclear. In this study, we used the sequences of two mitochondrial genes cytochrome b (cytb) and cytochrome c oxidase subunit I (cox1) to analyze genetic variation and phylogeographic structure of the S. erinaceieuropaei populations. Methodology/Principal Findings A total of 88 S. erinaceieuropaei isolates were collected from naturally infected frogs in 14 geographical locations of China. The complete cytb and cox1 genes of each sample was amplified and sequenced. Total 61 haplotypes were found in these 88 concatenated sequences. Each sampled population and the total population have high haplotype diversity (Hd), accompanied by very low nucleotide diversity (Pi). Phylogenetic analyses of haplotypes revealed two distinct clades (HeN+ HuN+ GZ-AS clade and GX+ HN+ GZ-GY clade) corresponding two sub-networks yielded by the median-joining network. Pairwise F-ST values supported great genetic differentiation between S. erinaceieuropaei populations. Both negative Fu's F-S value of neutrality tests and unimodal curve of mismatch distribution analyses supported demographic population expansion in the HeN+ HuN+ GZ-AS clade. The BEAST analysis showed that the divergence time between the two clades took place in the early Pleistocene (1.16 Myr), and by Bayesian skyline plot (BSP) an expansion occurred after about 0.3 Myr ago. Conclusions S. erinaceieuropaei from central and southern China has significant phylogeographic structure, and climatic oscillations during glacial periods in the Quaternary may affect the demography and diversification of this species.	[Zhang, Xi; Cui, Jing; Liu, Li Na; Jiang, Peng; Wang, Han; Qi, Xin; Wu, Xing Qi; Wang, Zhong Quan] Zhengzhou Univ, Dept Parasitol, Coll Med, Zhengzhou 450052, Peoples R China	Zhengzhou University	Cui, J (corresponding author), Zhengzhou Univ, Dept Parasitol, Coll Med, Zhengzhou 450052, Peoples R China.	cuij@zzu.edu.cn; wangzq@zzu.edu.cn			National Natural Science Foundation of China [81172612]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantaphruti MT, 2011, ACTA TROP, V118, P171, DOI 10.1016/j.actatropica.2011.03.011; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Cui J, 2014, PARASITOL RES, V113, P3511, DOI 10.1007/s00436-014-4065-8; Cui J, 2011, EMERG INFECT DIS, V17, P146, DOI 10.3201/eid1701.101095; Dai RS, 2012, J HELMINTHOL, V86, P245, DOI 10.1017/S0022149X11000319; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Fukushima T, 1999, PARASITOL TODAY, V15, P124, DOI 10.1016/S0169-4758(99)01405-2; Glenn TC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-300; Hoberg EP, 2001, P ROY SOC B-BIOL SCI, V268, P781, DOI 10.1098/rspb.2000.1579; Jia WZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-447; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li MW, 2009, EMERG INFECT DIS, V15, P1317, DOI 10.3201/eid1508.090099; Liang L, 2013, THAI J VET MED, V43, P291; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu W, 2012, J HELMINTHOL, V86, P271, DOI 10.1017/S0022149X1100037X; Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3; Magnino S, 2009, INT J FOOD MICROBIOL, V134, P163, DOI 10.1016/j.ijfoodmicro.2009.07.001; Makhawi AM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-290; Martinez-Hernandez F, 2009, INFECT GENET EVOL, V9, P1108, DOI 10.1016/j.meegid.2009.09.005; Michelet L, 2012, BIOL REV, V87, P731, DOI 10.1111/j.1469-185X.2012.00217.x; Michelet L, 2010, MOL PHYLOGENET EVOL, V55, P744, DOI 10.1016/j.ympev.2010.01.008; Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEIGEL JE, 1993, GENETICS, V135, P1209; Nithiuthai S, 2004, VET PARASITOL, V126, P167, DOI 10.1016/j.vetpar.2004.09.018; Okamoto M, 2007, PARASITOL INT, V56, P235, DOI 10.1016/j.parint.2007.03.003; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu Ming-Hua, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P251; Rambaut A, FIGTREE 1 3; Rambaut A, TRACER V1 5; Roberts L., 2009, FDN PARASITOLOGY, V8th ed.; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seah IM, 2013, INT J PARASITOL, V43, P825, DOI 10.1016/j.ijpara.2013.05.004; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1995, GENETICS, V139, P457; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valderrama A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-9; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wiwanitkit V, 2005, INT J INFECT DIS, V9, P312, DOI 10.1016/j.ijid.2004.08.003; Yanagida T, 2010, PARASITOL INT, V59, P268, DOI 10.1016/j.parint.2009.12.006; Yang DY, 2013, KOREAN J PARASITOL, V51, P449, DOI 10.3347/kjp.2013.51.4.449; Zhang X, 2014, IRAN J PARASITOL, V9, P319; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	53	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119295	10.1371/journal.pone.0119295	http://dx.doi.org/10.1371/journal.pone.0119295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793277	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200068
J	Shin, JY; Choi, NK; Lee, J; Seong, JM; Park, MJ; Lee, SH; Park, BJ				Shin, Ju-Young; Choi, Nam-Kyong; Lee, Joongyub; Seong, Jong-Mi; Park, Mi-Ju; Lee, Shin Haeng; Park, Byung-Joo			Risk of Ischemic Stroke Associated with the Use of Antipsychotic Drugs in Elderly Patients: A Retrospective Cohort Study in Korea	PLOS ONE			English	Article							CEREBROVASCULAR EVENTS; ATYPICAL ANTIPSYCHOTICS; LOGISTIC-REGRESSION; DEMENTIA; 2ND-GENERATION; METAANALYSIS; MEDICATION; ADJUSTMENT; DISORDERS; BEHAVIORS	Objective Strong concerns have been raised about whether the risk of ischemic stroke differs between conventional antipsychotics (CAPs) and atypical antipsychotics (AAPs). This study compared the risk of ischemic stroke in elderly patients taking CAPs and AAPs. Method We conducted a retrospective cohort study of 71,584 elderly patients who were newly prescribed the CAPs (haloperidol or chlorpromazine) and those prescribed the AAPs (risperidone, quetiapine, or olanzapine). We used the National Claims Database from the Health Insurance Review and Assessment Service (HIRA) from January 1, 2006 to December 31, 2009. Incident cases for ischemic stroke (ICD-10, I63) were identified. The hazard ratios (HR) for AAPs, CAPs, and for each antipsychotic were calculated using multivariable Cox regression models, with risperidone as a reference. Results Among a total of 71,584 patients, 24,668 patients were on risperidone, 15,860 patients on quetiapine, 3,888 patients on olanzapine, 19,564 patients on haloperidol, and 7,604 patients on chlorpromazine. A substantially higher risk was observed with chlorpromazine (HR = 3.47, 95% CI, 1.97-5.38), which was followed by haloperidol (HR = 2.43, 95% CI, 1.18-3.14), quetiapine (HR = 1.23, 95% CI, 0.78-2.12), and olanzapine (HR = 1.12, 95% CI, 0.59-2.75). Patients who were prescribed chlorpromazine for longer than 150 days showed a higher risk (HR = 3.60, 95% CI, 1.83-6.02) than those who took it for a shorter period of time. Conclusions A much greater risk of ischemic stroke was observed in patients who used chlorpromazine and haloperidol compared to risperidone. The evidence suggested that there is a strong need to exercise caution while prescribing these agents to the elderly in light of severe adverse events with atypical antipsychotics.	[Shin, Ju-Young; Seong, Jong-Mi; Park, Mi-Ju; Lee, Shin Haeng; Park, Byung-Joo] Korea Inst Drug Safety & Risk Management, Seoul, South Korea; [Choi, Nam-Kyong; Lee, Joongyub] Seoul Natl Univ Hosp, Seoul Natl Univ Coll Med, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, BJ (corresponding author), Korea Inst Drug Safety & Risk Management, Seoul, South Korea.	bjpark@snu.ac.kr		Shin, Ju-Young/0000-0003-1010-7525; Lee, Shin Haeng/0000-0002-4062-7903; Choi, Nam-Kyong/0000-0003-1153-9928	Ministry of Food and Drug Safety [14172MFDS174]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This study was supported by a grant (14172MFDS174) from the Ministry of Food and Drug Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi S, 2003, CAN J PSYCHIAT, V48, P749, DOI 10.1177/070674370304801107; Becg CB, 1984, BIOMETRIKA, V71, P11; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Burke AD, 2009, EXPERT OPIN PHARMACO, V10, P2407, DOI 10.1517/14656560903200659; Cadarette SM, 2010, PHARMACOEPIDEM DR S, V19, P2, DOI 10.1002/pds.1845; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Davis JM, 2004, J CLIN PSYCHOPHARM, V24, P192, DOI 10.1097/01.jcp.0000117422.05703.ae; Devanand DP, 1998, AM J PSYCHIAT, V155, P1512, DOI 10.1176/ajp.155.11.1512; Douglas IJ, 2008, BMJ-BRIT MED J, P337, DOI DOI 10.1136/BMJ.A1277; Dusetzina SB, 2012, MED CARE, V50, P466, DOI 10.1097/MLR.0b013e318245a160; Falissard B, 2011, INT CLIN PSYCHOPHARM, V26, P291, DOI 10.1097/YIC.0b013e32834a5bf6; Finkel S, 2005, INT PSYCHOGERIATR, V17, P617, DOI 10.1017/S1041610205002280; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Haddad PM, 2007, CNS DRUGS, V21, P911, DOI 10.2165/00023210-200721110-00004; Huybrechts K, 2012, BMJ-BRIT MED J, P344; Kales HC, 2012, AM J PSYCHIAT, V169, P71, DOI 10.1176/appi.ajp.2011.11030347; Kim Y, 2013, JPERM, V6, P93; Kinon BJ, 2003, PSYCHONEUROENDOCRINO, V28, P69, DOI 10.1016/S0306-4530(02)00128-2; Kleijer BC, 2009, J PSYCHOPHARMACOL, V23, P909, DOI 10.1177/0269881108093583; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Kwon S, 2003, HEALTH POLICY PLANN, V18, P84, DOI 10.1093/heapol/18.1.84; Laredo L, 2011, J AM GERIATR SOC, V59, P1182, DOI 10.1111/j.1532-5415.2011.03479.x; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Ministry of Health and Welfare, 2000, NAT CARD DIS SURV SY; Park B., 2003, REPORT EVALUATION VA, P19; Park JK, 2000, KOREAN J PREV MED, V33, P76, DOI DOI 10.1161/01.STR.0000078562.82918.F6; Patrick AR, 2011, PHARMACOEPIDEM DR S, V20, P551, DOI 10.1002/pds.2098; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rafaniello C, 2014, EUR J CLIN PHARMACOL, V70, P187, DOI 10.1007/s00228-013-1588-3; Roukema J, 2008, J CLIN EPIDEMIOL, V61, P135, DOI 10.1016/j.jclinepi.2007.07.005; Sacchetti E, 2010, J PSYCHOPHARMACOL, V24, P1131, DOI 10.1177/0269881109103202; Sacchetti E, 2008, J PSYCHOPHARMACOL, V22, P39, DOI 10.1177/0269881107080792; Sacchetti E, 2010, DRUG SAFETY, V33, P273, DOI 10.2165/11319120-000000000-00000; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; Shin JY, 2011, J KOREAN MED SCI, V26, P1461, DOI 10.3346/jkms.2011.26.11.1461; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; Sultana J, 2014, INT J GERIATR PSYCH, V29, P1249, DOI 10.1002/gps.4101; Sung SK, 2009, CLIN THER, V31, P1309, DOI 10.1016/j.clinthera.2009.06.011; Vasilyeva I, 2013, J CLIN PSYCHOPHARM, V33, P24, DOI 10.1097/JCP.0b013e31827934a4; Wallaschofski H, 2001, J CLIN ENDOCR METAB, V86, P5912, DOI 10.1210/jc.86.12.5912; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wooltorton E, 2002, CAN MED ASSOC J, V167, P1269; Wu CS, 2013, BIOL PSYCHIAT, V73, P414, DOI 10.1016/j.biopsych.2012.07.006; Zhang JP, 2013, INT J NEUROPSYCHOPH, V16, P1205, DOI 10.1017/S1461145712001277	47	84	87	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119931	10.1371/journal.pone.0119931	http://dx.doi.org/10.1371/journal.pone.0119931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790285	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400117
J	Gionbelli, MP; Duarte, MS; Valadares, SC; Detmann, E; Chizzotti, ML; Rodrigues, FC; Zanetti, D; Gionbelli, TRS; Machado, MG				Gionbelli, Mateus P.; Duarte, Marcio S.; Valadares Filho, Sebastiao C.; Detmann, Edenio; Chizzotti, Mario L.; Rodrigues, Felipe C.; Zanetti, Diego; Gionbelli, Tathyane R. S.; Machado, Marcelo G.			Achieving Body Weight Adjustments for Feeding Status and Pregnant or Non-Pregnant Condition in Beef Cows	PLOS ONE			English	Article							VISCERAL ORGAN MASS; GESTATION LENGTH; GRAVID UTERUS; CATTLE; GROWTH; MODEL; IDENTIFICATION; RESTRICTION; VASCULARITY; PARAMETERS	Background Beef cows herd accounts for 70% of the total energy used in the beef production system. However, there are still limited studies regarding improvement of production efficiency in this category, mainly in developing countries and in tropical areas. One of the limiting factors is the difficulty to obtain reliable estimates of weight variation in mature cows. This occurs due to the interaction of weight of maternal tissues with specific physiological stages such as pregnancy. Moreover, variation in gastrointestinal contents due to feeding status in ruminant animals is a major source of error in body weight measurements. Objectives Develop approaches to estimate the individual proportion of weight from maternal tissues and from gestation in pregnant cows, adjusting for feeding status and stage of gestation. Methods and Findings Dataset of 49 multiparous non-lactating Nellore cows (32 pregnant and 17 non-pregnant) were used. To establish the relationships between the body weight, depending on the feeding status of pregnant and non-pregnant cows as a function of days of pregnancy, a set of general equations was tested, based on theoretical suppositions. We proposed the concept of pregnant compound (PREG), which represents the weight that is genuinely related to pregnancy. The PREG includes the gravid uterus minus the non-pregnant uterus plus the accretion in udder related to pregnancy. There was no accretion in udder weight up to 238 days of pregnancy. By subtracting the PREG from live weight of a pregnant cow, we obtained estimates of the weight of only maternal tissues in pregnant cows. Non-linear functions were adjusted to estimate the relationship between fasted, non-fasted and empty body weight, for pregnant and non-pregnant cows. Conclusions Our results allow for estimating the actual live weight of pregnant cows and their body constituents, and subsequent comparison as a function of days of gestation and feeding status.	[Gionbelli, Mateus P.] Univ Fed Lavras, Dept Anim Sci, Lavras, MG, Brazil; [Duarte, Marcio S.; Valadares Filho, Sebastiao C.; Detmann, Edenio; Chizzotti, Mario L.; Rodrigues, Felipe C.; Zanetti, Diego; Gionbelli, Tathyane R. S.; Machado, Marcelo G.] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil	Universidade Federal de Lavras; Universidade Federal de Vicosa	Gionbelli, MP (corresponding author), Univ Fed Lavras, Dept Anim Sci, Lavras, MG, Brazil.	mateus.gionbelli@dzo.ufla.br	Duarte, Marcio/G-3815-2015; Gionbelli, Mateus P./W-5729-2019; Detmann, Edenio/O-9048-2019; Chizzotti, Mario/C-4854-2013; Gionbelli, Mateus P/W-4420-2018	Duarte, Marcio/0000-0002-5795-6420; Gionbelli, Mateus P./0000-0002-5168-4794; Chizzotti, Mario/0000-0001-9770-6891; Gionbelli, Mateus P/0000-0002-5168-4794; Gionbelli, Tathyane R. S./0000-0003-0087-2848	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais) [APQ-01121-10]; INCT-CA (Instituto Nacional de Ciencia e Tecnologia-Ciencia Animal) [573592/2008-0]; Conselho Nacional de Ciencia e Tecnologia-CNPq [202062/2011-2]	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); INCT-CA (Instituto Nacional de Ciencia e Tecnologia-Ciencia Animal); Conselho Nacional de Ciencia e Tecnologia-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais) (Grant: APQ-01121-10), the INCT-CA (Instituto Nacional de Ciencia e Tecnologia-Ciencia Animal) (Grant: 573592/2008-0) and the Conselho Nacional de Ciencia e Tecnologia-CNPq (Grant: 202062/2011-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFRC, 1993, ENERGY PROTEIN REQUI; Agricultural Research Council (ARC), 1980, NUTR REQ RUM LIV; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; American VeterinaryMedical Association (AVMA), 2013, ANIMALS-BASEL, DOI DOI 10.1016/B978-012088449-0.50009-1; ANDERSEN H, 1965, J DAIRY SCI, V48, P1224, DOI 10.3168/jds.S0022-0302(65)88431-4; AOAC, 2000, OFFICIAL METHODS ANA; BERESKIN B, 1967, J DAIRY SCI, V50, P220, DOI 10.3168/jds.S0022-0302(67)87391-0; Bibby J., 1977, PREDICTION IMPROVED; Caton JS, 2009, J ANIM SCI, V87, P222, DOI 10.2527/jas.2008-1043; Duarte MS, 2013, MEAT SCI, V94, P139, DOI 10.1016/j.meatsci.2013.01.008; Duchesne C, 2001, J PROCESS CONTR, V11, P553, DOI 10.1016/S0959-1524(00)00025-1; Fadel JG, 2004, J DAIRY SCI, V87, P169, DOI 10.3168/jds.S0022-0302(04)73154-9; FERRELL CL, 1976, J ANIM SCI, V42, P1477, DOI 10.2527/jas1976.4261477x; FOX DG, 1976, J ANIM SCI, V43, P566, DOI 10.2527/jas1976.433566x; Gionbelli MP, 2013, J ANIM SCI, V91, P320; INRA, 2007, AL BOV OV CAPR BES A; KOONG LJ, 1975, J ANIM SCI, V41, P1065, DOI 10.2527/jas1975.4141065x; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; LOFGREEN GP, 1962, J ANIM SCI, V21, P20, DOI 10.2527/jas1962.21120x; Martin O, 2007, ANIMAL, V1, P1143, DOI 10.1017/S1751731107000377; Martin O, 2003, P 10 RENC AUT RECH R, P167; MAYER DG, 1994, AGR SYST, V45, P93, DOI 10.1016/S0308-521X(94)90282-8; McNeill DM, 1997, J ANIM SCI, V75, P809; Meyer AM, 2010, J ANIM SCI, V88, P2410, DOI 10.2527/jas.2009-2220; Motulsky H, 2003, PRACTICAL GUIDE CURV; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nicholson M.J., 1986, GUIDE CONDITION SCOR; NRC (National Research Council), 2000, NUTR REQ BEEF CATTL, DOI DOI 10.17226/19014; Paulino P. V. R., 2010, Nutrient requirements of Zebu beef cattle - BR - Corte, P167; RICHARDS MW, 1986, J ANIM SCI, V62, P300, DOI 10.2527/jas1986.622300x; Ritchie RW, 1995, RES S ANN M KANS CIT, V27, P126; Rocha JCMC, 2005, ARQ BRAS MED VET ZOO, V57, P784, DOI 10.1590/S0102-09352005000600013; Scheaffer AN, 2004, J ANIM SCI, V82, P1826; Scheaffer AN, 2001, J ANIM SCI, V79, P2481; SILVEY MW, 1978, ANIM PROD, V27, P113, DOI 10.1017/S0003356100035881; Tedeschi LO, 2006, AGR SYST, V89, P225, DOI 10.1016/j.agsy.2005.11.004; Valadares Filho SC, 2010, NUTR REQUIREMENTS ZE; WILLIAMS WT, 1975, AUST J AGR RES, V26, P665, DOI 10.1071/AR9750665; Witteveen H. J., 1961, CONTRIBUTIONS EC ANA, P6	39	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0112111	10.1371/journal.pone.0112111	http://dx.doi.org/10.1371/journal.pone.0112111			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793770	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200001
J	Hepp, D; Goncalves, GL; de Freitas, TRO				Hepp, Diego; Goncalves, Gislene Lopes; Ochotorena de Freitas, Thales Renato			Prediction of the Damage-Associated Non-Synonymous Single Nucleotide Polymorphisms in the Human MC1R Gene	PLOS ONE			English	Article							HUMAN MELANOCORTIN-1 RECEPTOR; GENOME-WIDE ASSOCIATION; AMINO-ACID SUBSTITUTIONS; IN-SILICO ANALYSIS; RED HAIR; HUMAN PIGMENTATION; MELANOMA RISK; MISSENSE MUTATIONS; PROTEIN MUTATIONS; VARIANT ALLELES	The melanocortin 1 receptor (MC1R) is involved in the control of melanogenesis. Polymorphisms in this gene have been associated with variation in skin and hair color and with elevated risk for the development of melanoma. Here we used 11 computational tools based on different approaches to predict the damage-associated non-synonymous single nucleotide polymorphisms (nsSNPs) in the coding region of the human MC1R gene. Among the 92 nsSNPs arranged according to the predictions 62% were classified as damaging in more than five tools. The classification was significantly correlated with the scores of two consensus programs. Alleles associated with the red hair color (RHC) phenotype and with the risk of melanoma were examined. The R variants D84E, R142H, R151C, I155T, R160W and D294H were classified as damaging by the majority of the tools while the r variants V60L, V92M and R163Q have been predicted as neutral in most of the programs The combination of the prediction tools results in 14 nsSNPs indicated as the most damaging mutations in MC1R (L48P, R67W, H70Y, P72L, S83P, R151H, S172I, L206P, T242I, G255R, P256S, C273Y, C289R and R306H); C273Y showed to be highly damaging in SIFT, Polyphen-2, MutPred, PANTHER and PROVEAN scores. The computational analysis proved capable of identifying the potentially damaging nsSNPs in MC1R, which are candidates for further laboratory studies of the functional and pharmacological significance of the alterations in the receptor and the phenotypic outcomes.	[Hepp, Diego; Goncalves, Gislene Lopes; Ochotorena de Freitas, Thales Renato] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Goncalves, Gislene Lopes] Univ Tarapaca, Inst Alta Invest, Antofagasta 1520, Arica, Chile; [Hepp, Diego] Inst Fed Educ Ciencia & Tecnol Rio Grande Sul, BR-90049 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidad de Tarapaca; Instituto Federal do Rio Grande do Sul (IFRS)	Hepp, D (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	diego.hepp@gmail.com	Goncalves, Gislene Lopes/D-3567-2013; Freitas, Thales Renato Ochotorena de/G-1160-2012	Goncalves, Gislene Lopes/0000-0002-1459-4888; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Moreira LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081979; Balu K, 2013, GENE, V513, P184, DOI 10.1016/j.gene.2012.09.128; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Beaumont KA, 2005, HUM MOL GENET, V14, P2145, DOI 10.1093/hmg/ddi219; Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Beaumont KA, 2011, EUR J PHARMACOL, V660, P103, DOI 10.1016/j.ejphar.2010.11.040; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Brunham LR, 2005, PLOS GENET, V1, P739, DOI 10.1371/journal.pgen.0010083; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; de Carvalho MDC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065558; Choi Y., 2012, P ACM C BIOINF COMP, P414, DOI 10.1145/2382936.2382989; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Doss CGP, 2008, J BIOMED INFORM, V41, P607, DOI 10.1016/j.jbi.2007.12.004; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Esaki S, 2012, EUR J HUM GENET, V20, P428, DOI 10.1038/ejhg.2011.198; Fernandez LP, 2007, CARCINOGENESIS, V28, P1659, DOI 10.1093/carcin/bgm084; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Gorlatova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027269; Gorski M, 2014, KIDNEY INT; Hichiya H, 2005, DRUG METAB DISPOS, V33, P630, DOI 10.1124/dmd.105.003830; Jimenez-Cervantes C, 2001, FEBS LETT, V508, P44, DOI 10.1016/S0014-5793(01)03025-3; Josephy PD, 2009, ARCH BIOCHEM BIOPHYS, V490, P24, DOI 10.1016/j.abb.2009.07.025; Kamaraj B, 2014, CELL BIOCHEM BIOPHYS, V68, P97, DOI 10.1007/s12013-013-9697-2; Kamaraj B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/697051; Kanetsky PA, 2004, CANCER EPIDEM BIOMAR, V13, P808; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Klein RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-58; Koppula SV, 1997, HUM MUTAT, V9, P30, DOI 10.1002/(SICI)1098-1004(1997)9:1<30::AID-HUMU5>3.3.CO;2-5; Kumar A, 2014, CELL BIOCHEM BIOPHYS, V68, P233, DOI 10.1007/s12013-013-9705-6; Kumar A, 2012, FEBS OPEN BIO, V2, P285, DOI 10.1016/j.fob.2012.09.003; Kumar A, 2012, MUTAT RES-FUND MOL M, V738, P28, DOI 10.1016/j.mrfmmm.2012.08.005; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; Mas JS, 2002, EUR J BIOCHEM, V269, P6133, DOI 10.1046/j.1432-1033.2002.03329.x; Mooney S, 2005, BRIEF BIOINFORM, V6, P44, DOI 10.1093/bib/6.1.44; Morisseau C, 2014, J LIPID RES, V55, P1131, DOI 10.1194/jlr.M049718; Nakayama K, 2006, HUM GENET, V119, P322, DOI 10.1007/s00439-006-0141-1; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; NG PC, 2001, NUCLEIC ACIDS RES, V31, P3812; Ohashi J, 2001, J HUM GENET, V46, P478, DOI 10.1007/s100380170048; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; Oliva ABP, 2009, HUM MUTAT, V30, P811, DOI 10.1002/humu.20971; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Rajasekaran R, 2007, GENOMICS, V90, P447, DOI 10.1016/j.ygeno.2007.07.004; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ringholm A, 2004, J INVEST DERMATOL, V123, P917, DOI 10.1111/j.0022-202X.2004.23444.x; Scherer D, 2009, INT J CANCER, V125, P1868, DOI 10.1002/ijc.24548; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Scott MC, 2002, J CELL SCI, V115, P2349; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Sturm RA, 2003, ANN NY ACAD SCI, V994, P348, DOI 10.1111/j.1749-6632.2003.tb03199.x; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Tully G, 2007, FORENSIC SCI INT-GEN, V1, P105, DOI 10.1016/j.fsigen.2007.01.005; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vanajothi R, 2012, Pak J Biol Sci, V15, P121; Vendruscolo M, 2003, PHILOS T R SOC A, V361, P1205, DOI 10.1098/rsta.2003.1194; Wong TH, 2005, PEPTIDES, V26, P1965, DOI 10.1016/j.peptides.2004.11.021; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017; Zhang CS, 2011, J ANIM VET ADV, V10, P928, DOI 10.3923/javaa.2011.928.931	75	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121812	10.1371/journal.pone.0121812	http://dx.doi.org/10.1371/journal.pone.0121812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794181	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900155
J	Kim, MK; Cho, JH; Lee, JJ; Son, MH; Lee, KJ				Kim, Mi-Kyung; Cho, Jin-Hwan; Lee, Jae-Jin; Son, Moon-Ho; Lee, Kong-Joo			Proteomic Analysis of INS-1 Rat Insulinoma Cells: ER Stress Effects and the Protective Role of Exenatide, a GLP-1 Receptor Agonist	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; THIOREDOXIN-INTERACTING PROTEIN; MASS; PHOSPHORYLATION; IDENTIFICATION; APOPTOSIS; DEATH	Beta cell death caused by endoplasmic reticulum (ER) stress is a key factor aggravating type 2 diabetes. Exenatide, a glucagon-like peptide (GLP)-1 receptor agonist, prevents beta cell death induced by thapsigargin, a selective inhibitor of ER calcium storage. Here, we report on our proteomic studies designed to elucidate the underlying mechanisms. We conducted comparative proteomic analyses of cellular protein profiles during thapsigargin-induced cell death in the absence and presence of exenatide in INS-1 rat insulinoma cells. Thapsigargin altered cellular proteins involved in metabolic processes and protein folding, whose alterations were variably modified by exenatide treatment. We categorized the proteins with thapsigargin initiated alterations into three groups: those whose alterations were 1) reversed by exenatide, 2) exaggerated by exenatide, and 3) unchanged by exenatide. The most significant effect of thapsigargin on INS-1 cells relevant to their apoptosis was the appearance of newly modified spots of heat shock proteins, thimet oligopeptidase and 14-3-3 beta, epsilon, and theta, and the prevention of their appearance by exenatide, suggesting that these proteins play major roles. We also found that various modifications in 14-3-3 isoforms, which precede their appearance and promote INS-1 cell death. This study provides insights into the mechanisms in ER stress-caused INS-1 cell death and its prevention by exenatide.	[Kim, Mi-Kyung; Cho, Jin-Hwan; Lee, Jae-Jin; Lee, Kong-Joo] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea; [Kim, Mi-Kyung; Cho, Jin-Hwan; Lee, Jae-Jin; Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea; [Kim, Mi-Kyung; Son, Moon-Ho] Dong A ST Res Inst, Yongin 446905, Gyeonggi Do, South Korea	Ewha Womans University; Ewha Womans University	Lee, KJ (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea.	kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020	Global Research Lab Program [2012K1A1A2045441]; Proteogenomics Research Program [2012M3A9B90036680]	Global Research Lab Program; Proteogenomics Research Program	This work was supported by the Global Research Lab Program (No. 2012K1A1A2045441), the Proteogenomics Research Program (No. 2012M3A9B90036680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2006, BIOCHEM BIOPH RES CO, V346, P1067, DOI 10.1016/j.bbrc.2006.06.027; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; D'Hertog W, 2011, PROTEOMICS, V11, P1365, DOI 10.1002/pmic.201000006; Dalle S, 2013, CELL SIGNAL, V25, P570, DOI 10.1016/j.cellsig.2012.11.009; Dalle S, 2011, CELL SIGNAL, V23, P522, DOI 10.1016/j.cellsig.2010.09.014; Furman BL, 2012, TOXICON, V59, P464, DOI 10.1016/j.toxicon.2010.12.016; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Kim MK, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/573734; Kim S, 2006, NUCLEIC ACIDS RES, V34, pW258, DOI 10.1093/nar/gkl245; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Sheikh-Ali M, 2010, NUTRITION, V26, P1146, DOI 10.1016/j.nut.2009.08.019; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Tian R, 2008, DIGEST DIS SCI, V53, P65, DOI 10.1007/s10620-007-9823-3; Tonnesen MF, 2009, ENDOCRINOLOGY, V150, P4094, DOI 10.1210/en.2009-0029; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	23	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120536	10.1371/journal.pone.0120536	http://dx.doi.org/10.1371/journal.pone.0120536			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793496	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900050
J	Penailillo, R; Guajardo, A; Llanos, M; Hirsch, S; Ronco, AM				Penailillo, Reyna; Guajardo, Angelica; Llanos, Miguel; Hirsch, Sandra; Maria Ronco, Ana			Folic Acid Supplementation during Pregnancy Induces Sex-Specific Changes in Methylation and Expression of Placental 11 beta-Hydroxysteroid Dehydrogenase 2 in Rats	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; EPIGENETIC MECHANISMS; FOLATE-DEFICIENCY; DNA METHYLATION; BIRTH-WEIGHT; FETAL-GROWTH; GLUCOCORTICOIDS; PRETERM; GENE; TRANSCRIPTION	In the placenta, 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) limits fetal glucocorticoid exposure and its inhibition has been associated to low birth weight. Its expression, encoded by the HSD11B2 gene is regulated by DNA methylation. We hypothesized that maternal diets supplemented with folic acid (FA) during pregnancy modify the expression of placental HSD11B2 through gene methylation. Wistar rats were fed with high (8 mg/kg) or normal low (1mg/kg, control) levels of FA during pregnancy. Concentrations of mRNA and protein in placentas were determined by qRT-PCR and Western blot respectively. Methylation in five CpG sites of the placental HSD11B2 promoter (-378 to -275) was analyzed by bacterial cloning and subsequent sequencing. In the FA-supplemented group, mRNA and protein levels of 11 beta-HSD2 decreased by 58% and increased by 89%, respectively, only in placentas attached to males. In controls, most CpG sites were not methylated except for the CpG2 site which was 80% methylated. CpG2 methylation level increased under the FA treatment; however, only in placentas attached to females was this increase significant (113%). This change was not related to HSD11B2 expression. Fetal weight of females from FA-supplemented mothers was 6% higher than females from control mothers. In conclusion, this is the first study reporting that FA over supplementation during pregnancy modifies the placental HSD11B2 gene expression and methylation in a sex-dependent manner, suggesting that maternal diets with high content of FA can induce early sex-specific responses, which may lead to long-term consequences for the offspring.	[Penailillo, Reyna; Guajardo, Angelica; Llanos, Miguel; Hirsch, Sandra; Maria Ronco, Ana] Univ Chile, Lab Nutr & Metab Regulat, Human Nutr Unit, Inst Nutr & Food Technol INTA, Santiago, Chile	Universidad de Chile	Ronco, AM (corresponding author), Univ Chile, Lab Nutr & Metab Regulat, Human Nutr Unit, Inst Nutr & Food Technol INTA, Santiago, Chile.	amronco@inta.uchile.cl	Ronco, Ana M/F-9393-2015; Hirsch, Sandra/R-2431-2016; Llanos, Miguel/M-9595-2017		Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (Fondecyt) [1130188]	Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (Fondecyt # 1130188 to AMR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; AVMA Panel on Euthanasia. American Veterinary Medical Association, 2000, J AM VET MED ASSOC, V218, P669; Baserga M, 2010, AM J PHYSIOL-REG I, V299, pR334, DOI 10.1152/ajpregu.00122.2010; Benediktsson R, 1997, CLIN ENDOCRINOL, V46, P161, DOI 10.1046/j.1365-2265.1997.1230939.x; Burdge GC, 2008, BRIT J NUTR, V99, P540, DOI 10.1017/S0007114507815819; Burdge GC, 2007, BRIT J NUTR, V97, P1036, DOI 10.1017/S0007114507682920; Burdge GC, 2012, BRIT J NUTR, V108, P1924, DOI 10.1017/S0007114512003765; Burton PJ, 1999, BIOL REPROD, V60, P234, DOI 10.1095/biolreprod60.2.234; Castillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044139; Catov JM, 2011, AM J CLIN NUTR, V94, P906, DOI 10.3945/ajcn.111.012393; Challis J, 2013, PLACENTA, V34, P95, DOI 10.1016/j.placenta.2012.11.007; Cuffe JSM, 2012, ENDOCRINOLOGY, V153, P5500, DOI 10.1210/en.2012-1479; Fekete K, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-75; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Green NS, 2002, J NUTR, V132, p2356S, DOI 10.1093/jn/132.8.2356S; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hertrampf E, 2003, J NUTR, V133, P3166, DOI 10.1093/jn/133.10.3166; Hogg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062969; Imbard A, 2013, INT J ENV RES PUB HE, V10, P4352, DOI 10.3390/ijerph10094352; Jagerstad M, 2012, ACTA PAEDIATR, V101, P1007, DOI 10.1111/j.1651-2227.2012.02781.x; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jiang XY, 2012, FASEB J, V26, P3563, DOI 10.1096/fj.12-207894; Kim HW, 2011, NUTR RES PRACT, V5, P112, DOI 10.4162/nrp.2011.5.2.112; Kim JM, 2009, J NUTR BIOCHEM, V20, P172, DOI 10.1016/j.jnutbio.2008.01.010; Kulkarni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017706; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ly A, 2011, CANCER RES, V71, P988, DOI 10.1158/0008-5472.CAN-10-2379; Marsit CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033794; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Mericq V, 2009, EUR J ENDOCRINOL, V161, P419, DOI 10.1530/EJE-09-0308; [National Research Council National Research Council], 1995, NUTR REQ LAB AN, P11, DOI DOI 10.17226/4758; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; O'Connell BA, 2011, BIOL REPROD, V85, P1040, DOI 10.1095/biolreprod.111.093369; Pandrangi S, 2004, INT J FOOD SCI TECH, V39, P525, DOI 10.1111/j.1365-2621.2004.00812.x; Pena CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039791; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Seckl JR, 2000, KIDNEY INT, V57, P1412, DOI 10.1046/j.1523-1755.2000.00984.x; Sie KKY, 2013, MOL NUTR FOOD RES, V57, P677, DOI 10.1002/mnfr.201200186; Sie KKY, 2011, GUT, V60, P1687, DOI 10.1136/gut.2011.238782; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Tamura T, 2006, AM J CLIN NUTR, V83, P993, DOI 10.1093/ajcn/83.5.993; Timmermans S, 2009, BRIT J NUTR, V102, P777, DOI 10.1017/S0007114509288994; World Health Organization, 2006, JOINT FAO WHO TECHN, P151; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100	49	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121098	10.1371/journal.pone.0121098	http://dx.doi.org/10.1371/journal.pone.0121098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793274	Green Submitted, gold, Green Published			2022-12-26	WOS:000352083900102
J	Zhang, Z; Wang, JY; Chai, RY; Qiu, HP; Jiang, H; Mao, XQ; Wang, YL; Liu, FQ; Sun, GC				Zhang, Zhen; Wang, Jiaoyu; Chai, Rongyao; Qiu, Haiping; Jiang, Hua; Mao, Xueqin; Wang, Yanli; Liu, Fengquan; Sun, Guochang			An S-(Hydroxymethyl) Glutathione Dehydrogenase Is Involved in Conidiation and Full Virulence in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							S-NITROSOGLUTATHIONE REDUCTASE; DEPENDENT FORMALDEHYDE DEHYDROGENASE; PLANT-PATHOGEN INTERACTIONS; III ALCOHOL-DEHYDROGENASE; GASEOUS NITRIC-OXIDE; NITROSATIVE STRESS; CELL-DEATH; CONIOTHYRIUM-MINITANS; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE	Magnaporthe oryzae is a hemibiotrophic fungal pathogen that causes rice blast disease. A compatible interaction requires overcoming plant defense responses to initiate colonization during the early infection process. Nitric oxide (NO) plays important roles in defense responses during host-pathogen interactions. Microbes generally protect themselves against NO-induced damage by using enzymes. Here, we characterized an S-(hydroxymethyl)-glutathione dehydrogenase gene in M. oryzae, MoSFA1, the homologs of which are involved in NO metabolism by specifically catalyzing the reduction of S-nitrosoglutathione (GSNO) in yeasts and plants. As expected from the activities of S-(hydroxymethyl) glutathione dehydrogenase in formaldehyde detoxification and GSNO reduction, MoSFA1 deletion mutants were lethal in formaldehyde containing medium, sensitive to exogenous NO and exhibited a higher level of S-nitrosothiols (SNOs) than that of the wild type. Notably, the mutants showed severe reduction of conidiation and appressoria turgor pressure, as well as significantly attenuated the virulence on rice cultivar CO-39. However, the virulence of MoSFA1 deletion mutants on wounded rice leaf was not affected. An infection assay on barley leaf further revealed that MoSFA1 deletion mutants exhibited a lower infection rate, and growth of infectious hyphae of the mutants was retarded not only in primary infected cells but also in expansion from cell to cell. Furthermore, barley leaf cell infected by MoSFA1 deletion mutants exhibited a stronger accumulation of H2O2 at 24 and 36 hpi. MoSFA1 deletion mutants displayed hypersensitivity to different oxidants, reduced activities of superoxide dismutases and peroxidases, and lower glutathione content in cells, compared with the wild type. These results imply that MoSFA1-mediated NO metabolism is important in redox homeostasis in response to development and host infection of M. oryzae. Taken together, this work identifies that MoSFA1 is required for conidiation and contributes to virulence in the penetration and biotrophic phases in M. oryzae.	[Zhang, Zhen; Liu, Fengquan] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhen; Wang, Jiaoyu; Chai, Rongyao; Qiu, Haiping; Jiang, Hua; Mao, Xueqin; Wang, Yanli; Sun, Guochang] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Zhejiang Academy of Agricultural Sciences	Liu, FQ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	fqliu20011@sina.com; sungc01@sina.com			Special Fund for Agro-Scientific Research in the Public Interest [201203014]; Zhejiang Academy of Agriculture Science; State Education Ministry; Key Subject Construction Program of Zhejiang for Modern Agricultural Biotechnology and Crop Disease control [2010DS700124-KF1101, 2010DS700124-KF1203]	Special Fund for Agro-Scientific Research in the Public Interest; Zhejiang Academy of Agriculture Science; State Education Ministry; Key Subject Construction Program of Zhejiang for Modern Agricultural Biotechnology and Crop Disease control	This project was supported by the Special Fund for Agro-Scientific Research in the Public Interest (201203014), Zhejiang Academy of Agriculture Science Innovate Found (2013), and State Education Ministry and Key Subject Construction Program of Zhejiang for Modern Agricultural Biotechnology and Crop Disease control (2010DS700124-KF1101; 2010DS700124-KF1203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arasimowicz-Jelonek M, 2014, MOL PLANT PATHOL, V15, P406, DOI 10.1111/mpp.12095; ASAHI M, 1995, J BIOL CHEM, V270, P21035, DOI 10.1074/jbc.270.36.21035; Balhadere PV, 2001, PLANT CELL, V13, P1987, DOI 10.1105/tpc.13.9.1987; Belozerskaya TA, 2007, APPL BIOCHEM MICRO+, V43, P506, DOI 10.1134/S0003683807050031; Carreras Maria C., 2004, Molecular Aspects of Medicine, V25, P125, DOI 10.1016/j.mam.2004.02.014; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; de Pinto MC, 2013, PLANT PHYSIOL, V163, P1766, DOI 10.1104/pp.113.222703; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; ENGELAND K, 1993, P NATL ACAD SCI USA, V90, P2491, DOI 10.1073/pnas.90.6.2491; Fang EGC, 2000, MOL PLANT MICROBE IN, V13, P1214, DOI 10.1094/MPMI.2000.13.11.1214; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Fernandez J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087300, 10.1371/journal.pone.0100872]; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Ghaffari A, 2006, NITRIC OXIDE-BIOL CH, V14, P21, DOI 10.1016/j.niox.2005.08.003; Gong XY, 2007, FUNGAL GENET BIOL, V44, P1368, DOI 10.1016/j.fgb.2007.07.007; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Haque Mohammad Mahfuzul, 2005, Indian Journal of Experimental Biology, V43, P873; Hong JK, 2008, J EXP BOT, V59, P147, DOI 10.1093/jxb/erm244; Hu XY, 2003, CHINESE SCI BULL, V48, P358, DOI 10.1360/03tb9076; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Lai TF, 2011, CURR MICROBIOL, V62, P229, DOI 10.1007/s00284-010-9695-1; Lazar EE, 2008, LETT APPL MICROBIOL, V46, P688, DOI 10.1111/j.1472-765X.2008.02373.x; Lee U, 2008, PLANT CELL, V20, P786, DOI 10.1105/tpc.107.052647; Li B, 2010, APPL ENVIRON MICROB, V76, P2830, DOI 10.1128/AEM.02214-09; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085252; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macherla C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00193; Maldonado-Alconada AM, 2011, ACTA PHYSIOL PLANT, V33, P1493, DOI 10.1007/s11738-010-0688-2; Martinez LR, 2009, J INVEST DERMATOL, V129, P2463, DOI 10.1038/jid.2009.95; Missall TA, 2006, EUKARYOT CELL, V5, P518, DOI 10.1128/EC.5.3.518-529.2006; Mur LAJ, 2006, J EXP BOT, V57, P489, DOI 10.1093/jxb/erj052; Mur LAJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls052; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Prats E, 2008, RES MICROBIOL, V159, P476, DOI 10.1016/j.resmic.2008.04.001; Romero-Puertas MC, 2004, CELL MICROBIOL, V6, P795, DOI 10.1111/j.1462-5822.2004.00428.x; Rusterucci C, 2007, PLANT PHYSIOL, V143, P1282, DOI 10.1104/pp.106.091686; Sakamoto A, 2002, FEBS LETT, V515, P20, DOI 10.1016/S0014-5793(02)02414-6; Samalova M, 2013, NEW PHYTOL, V197, P207, DOI 10.1111/j.1469-8137.2012.04368.x; Sanghani PC, 2006, BIOCHEMISTRY-US, V45, P4819, DOI 10.1021/bi052554q; Sanghani PC, 2003, CHEM-BIOL INTERACT, V143, P195, DOI 10.1016/S0009-2797(02)00203-X; Sanghani PC, 2002, BIOCHEMISTRY-US, V41, P15189, DOI 10.1021/bi026705q; Schonhoff CM, 2011, CURRENT PROTOCOLS PR; Stroeher UH, 2007, J INFECT DIS, V196, P1820, DOI 10.1086/523107; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Thompson CM, 2010, TOXICOL LETT, V193, P1, DOI 10.1016/j.toxlet.2009.11.023; Wang J, 2005, FUNGAL GENET BIOL, V42, P284, DOI 10.1016/j.fgb.2004.12.006; Wang JR, 2013, NONLINEAR ANAL-HYBRI, V8, P1, DOI 10.1016/j.nahs.2012.08.003; Wang YQ, 2006, J EXP BOT, V57, P1777, DOI 10.1093/jxb/erj211; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Yang ZN, 1997, J MOL BIOL, V265, P330, DOI 10.1006/jmbi.1996.0731; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zaffagnini M, 2013, J BIOL CHEM, V288, P22777, DOI 10.1074/jbc.M113.475467	60	22	23	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120627	10.1371/journal.pone.0120627	http://dx.doi.org/10.1371/journal.pone.0120627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793615	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900060
J	Zheng, YW; Adams, T; Zhi, HY; Yu, M; Wen, RR; Newman, PJ; Wang, DM; Newman, DK				Zheng, Yongwei; Adams, Tamara; Zhi, Huiying; Yu, Mei; Wen, Renren; Newman, Peter J.; Wang, Demin; Newman, Debra K.			Restoration of Responsiveness of Phospholipase C gamma 2-Deficient Platelets by Enforced Expression of Phospholipase C gamma 1	PLOS ONE			English	Article							B-CELL DEVELOPMENT; SIGNAL-TRANSDUCTION; THROMBUS FORMATION; C ISOZYMES; IN-VITRO; ACTIVATION; INTEGRIN; INVOLVEMENT; COLLAGEN; ROLES	Receptor-mediated platelet activation requires phospholipase C (PLC) activity to elevate intracellular calcium and induce actin cytoskeleton reorganization. PLCs are classified into structurally distinct beta, gamma, delta, epsilon, zeta and eta isoforms. There are two PLC gamma isoforms (PLC gamma 1, PLC gamma 2), which are critical for activation by tyrosine kinase-dependent receptors. Platelets express both PLC gamma 1 and PLC gamma 2. Although PLC gamma 2 has been shown to play a dominant role in platelet activation, the extent to which PLC gamma 1 contributes has not been evaluated. To ascertain the relative contributions of PLC gamma 1 and PLC gamma 2 to platelet activation, we generated conditionally PLC gamma 1-deficient, wild-type (WT), PLC gamma 2-deficient, and PLC gamma 1/PLC gamma 2 doubledeficient mice and measured the ability of platelets to respond to different agonists. We found that PLC gamma 2 deficiency abrogated alpha llb beta 3-dependent platelet spreading, GPVI-dependent platelet aggregation, and thrombus formation on collagen-coated surfaces under shear conditions, which is dependent on both GPVI and alpha llb beta 3. Addition of exogenous ADP overcame defective spreading of PLC gamma 2-deficient platelets on immobilized fibrinogen, suggesting that PLC gamma 2 is required for granule secretion in response to alpha llb beta 3 ligation. Consistently, alpha llb beta 3-mediated release of granule contents was impaired in the absence of PLC gamma 2. In contrast, PLC gamma 1-deficient platelets spread and released granule contents normally on fibrinogen, exhibited normal levels of GPVI-dependent aggregation, and formed thrombi normally on collagen-coated surfaces. Interestingly, enforced expression of PLC gamma 1 fully restored GPVI-dependent aggregation and alpha llb beta 3-dependent spreading of PLC gamma 2-deficient platelets. We conclude that platelet activation through GPVI and alpha llb beta 3 utilizes PLC gamma 2 because PLC gamma 1 levels are insufficient to support responsiveness, but that PLC gamma 1 can restore responsiveness if expressed at levels normally achieved by PLC gamma 2.	[Zheng, Yongwei; Adams, Tamara; Zhi, Huiying; Yu, Mei; Wen, Renren; Newman, Peter J.; Wang, Demin; Newman, Debra K.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53223 USA; [Zheng, Yongwei] Southeast Univ, Key Lab Dev Genes & Human Dis, Minist Educ, Inst Life Sci, Nanjing, Jiangsu, Peoples R China; [Newman, Peter J.; Newman, Debra K.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Newman, Peter J.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Wang, Demin; Newman, Debra K.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Southeast University - China; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Newman, DK (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53223 USA.	Debra.Newman@bcw.edu	Yu, Mei/K-2206-2017; Wang, Demin/AAX-4449-2020	Wang, Demin/0000-0001-5549-3795	National Institutes of Health Grant [P01 HL44612, R01 AI079087]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant #P01 HL44612 (to DW, PJN and DKN) and #R01 AI079087 (to DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmeier W, 2013, CURR OPIN HEMATOL, V20, P445, DOI 10.1097/MOH.0b013e3283642267; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BRASS LF, 1984, J BIOL CHEM, V259, P2563; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; Choi JH, 2007, ADV ENZYME REGUL, V47, P104, DOI 10.1016/j.advenzreg.2006.12.010; Fu GP, 2012, J IMMUNOL, V189, P2326, DOI 10.4049/jimmunol.1103458; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Gorjestani S, 2011, J BIOL CHEM, V286, P43651, DOI 10.1074/jbc.M111.307389; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Jakus Z, 2009, J EXP MED, V206, P577, DOI 10.1084/jem.20081859; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; KAPLAN KL, 1979, BLOOD, V53, P604; Keenan C, 1998, CELL SIGNAL, V10, P225, DOI 10.1016/S0898-6568(97)00121-6; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Mangin P, 2003, FEBS LETT, V542, P53, DOI 10.1016/S0014-5793(03)00337-5; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Nonne C, 2005, ARTERIOSCL THROM VAS, V25, P1293, DOI 10.1161/01.ATV.0000163184.02484.69; Rathore V, 2004, FEBS LETT, V573, P26, DOI 10.1016/j.febslet.2004.07.048; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2007, THROMB RES, V120, P251, DOI 10.1016/j.thromres.2006.09.003; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Wen RR, 2004, EMBO J, V23, P4007, DOI 10.1038/sj.emboj.7600405; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Williams RL, 1996, STRUCTURE, V4, P1387, DOI 10.1016/S0969-2126(96)00146-3; Wonerow P, 2003, J BIOL CHEM, V278, P37520, DOI 10.1074/jbc.M305077200; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Zhi HY, 2013, BLOOD, V121, P1858, DOI 10.1182/blood-2012-07-443325	42	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119739	10.1371/journal.pone.0119739	http://dx.doi.org/10.1371/journal.pone.0119739			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793864	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200109
J	Akil, H; Abbaci, A; Lalloue, F; Bessette, B; Costes, LMM; Domballe, L; Charreau, S; Guilloteau, K; Karayan-Tapon, L; Bernard, FX; Morel, F; Jauberteau, MO; Lecron, JC				Akil, Hussein; Abbaci, Amazigh; Lalloue, Fabrice; Bessette, Barbara; Costes, Lea M. M.; Domballe, Linda; Charreau, Sandrine; Guilloteau, Karline; Karayan-Tapon, Lucie; Bernard, Francois-Xavier; Morel, Franck; Jauberteau, Marie-Odile; Lecron, Jean-Claude			IL22/IL-22R Pathway Induces Cell Survival in Human Glioblastoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR; GENE-EXPRESSION; IL-22 RECEPTOR; STEM-CELLS; IL-TIF; INTERLEUKIN-22; CANCER; ACTIVATION; IL-10; STAT3	Interleukin-22 (IL-22) is a member of the IL-10 cytokine family that binds to a heterodimeric receptor consisting of IL-22 receptor 1 (IL-22R1) and IL-10R2. IL-22R expression was initially characterized on epithelial cells, and plays an essential role in a number of inflammatory diseases. Recently, a functional receptor was detected on cancer cells such as hepatocarcinoma and lung carcinoma, but its presence was not reported in glioblastoma (GBM). Two GBM cell lines and 10 primary cell lines established from patients undergoing surgery for malignant GBM were used to investigate the expression of IL-22 and IL-22R by using quantitative RT-PCR, western blotting and confocal microscopy studies. The role of IL-22 in proliferation and survival of GBM cell lines was investigated in vitro by BrdU and ELISA cell death assays. We report herein that the two subunits of the IL-22R complex are expressed on human GBM cells. Their activation, depending on exogenous IL-22, induced antiapoptotic effect and cell proliferation. IL-22 treatment of GBM cells resulted in increased levels of phosphorylated Akt, STAT3 signaling protein and its downstream antiapoptotic protein Bcl-xL and decreased level of phosphorylated ERK1/2. In addition, IL-22R subunits were expressed in all the 10 tested primary cell lines established from GBM tumors. Our results showed that IL-22R is expressed on GBM established and primary cell lines. Depending on STAT3, ERK1/2 and PI3K/Akt pathways, IL-22 induced GBM cell survival. These data are consistent with a potential role of IL-22R in tumorigenesis of GBM. Since endogenous IL-22 was not detected in all studied GBM cells, we hypothesize that IL-22R could be activated by immune microenvironmental IL-22 producing cells.	[Akil, Hussein; Abbaci, Amazigh; Lalloue, Fabrice; Bessette, Barbara; Costes, Lea M. M.; Domballe, Linda; Jauberteau, Marie-Odile] Univ Limoges, Fac Med & Pharm, LHCP, EA 3842, Limoges, France; [Charreau, Sandrine; Bernard, Francois-Xavier; Morel, Franck; Lecron, Jean-Claude] Univ Poitiers, LITEC, EA 4331, Poitiers, France; [Guilloteau, Karline; Karayan-Tapon, Lucie] Univ Poitiers, INSERM, U1084, Poitiers, France; [Guilloteau, Karline; Karayan-Tapon, Lucie] CHU Poitiers, Lab Cancerol Biol, Poitiers, France; [Bernard, Francois-Xavier] BIOalternatives, Gencay, France; [Lecron, Jean-Claude] CHU Poitiers, Serv Immunol & Inflammat, Poitiers, France	Universite de Limoges; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Akil, H (corresponding author), Univ Limoges, Fac Med & Pharm, LHCP, EA 3842, Limoges, France.	hussein.akil@outlook.fr	Bessette, Barbara/G-2317-2015; Morel, Franck/AAI-4274-2021	Bessette, Barbara/0000-0001-6673-3694; Morel, Franck/0000-0003-3812-9304; Jauberteau, Marie-Odile/0000-0002-8811-8948; AKIL, Hussein/0000-0002-8177-6833; Lalloue, Fabrice/0000-0003-0382-4948; LECRON, Jean-Claude/0000-0003-3990-5213	Pole de Recherche et d'Enseignement Superieur (PRES) Limousin Poitou-Charentes; Conseil Regional du Limousin; BIOalternatives	Pole de Recherche et d'Enseignement Superieur (PRES) Limousin Poitou-Charentes(Region Nouvelle-Aquitaine); Conseil Regional du Limousin(Region Nouvelle-Aquitaine); BIOalternatives	This work was supported by grants from the Pole de Recherche et d'Enseignement Superieur (PRES) Limousin Poitou-Charentes and the Conseil Regional du Limousin; MOJ JCL. BIOalternatives provided support in the form of salaries for authors [FXB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brand S, 2007, AM J PHYSIOL-GASTR L, V292, pG1019, DOI 10.1152/ajpgi.00239.2006; Cha JH, 2012, ONCOL REP, V28, P41, DOI 10.3892/or.2012.1772; Chen YL, 2007, J PHARMACOL EXP THER, V323, P746, DOI 10.1124/jpet.107.126193; Cheray M, 2011, CANCER LETT, V312, P24, DOI 10.1016/j.canlet.2011.07.027; Curd LM, 2012, CLIN EXP IMMUNOL, V168, P192, DOI 10.1111/j.1365-2249.2012.04570.x; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Dumoutier L, 2009, J BIOL CHEM, V284, P26377, DOI 10.1074/jbc.M109.007955; Fukui H, 2014, BRIT J CANCER, V111, P763, DOI 10.1038/bjc.2014.336; Giraud S, 2007, INT J ONCOL, V30, P273; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Jiang RQ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-59; Jiang RQ, 2011, HEPATOLOGY, V54, P900, DOI 10.1002/hep.24486; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kim G, 2015, ONCOGENE, V34, P671, DOI 10.1038/onc.2014.4; Kim K, 2014, CARCINOGENESIS, V35, P1352, DOI 10.1093/carcin/bgu044; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Kronblad A, 2005, ONCOGENE, V24, P6835, DOI 10.1038/sj.onc.1208830; Lecart S, 2002, INT IMMUNOL, V14, P1351, DOI 10.1093/intimm/dxf096; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li RH, 2010, ONCOL REP, V23, P1553, DOI 10.3892/or_00000795; Lim C, 2014, CYTOKINE GROWTH F R, V25, P257, DOI 10.1016/j.cytogfr.2014.04.005; MALEFYT RD, 1991, J EXP MED, V174, P915; Mitra A, 2012, CYTOKINE, V60, P38, DOI 10.1016/j.cyto.2012.06.316; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Naher L, 2012, INT J ONCOL, V41, P1577, DOI 10.3892/ijo.2012.1594; Petanidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073616; Qiu B, 2011, MOL BIOL REP, V38, P3585, DOI 10.1007/s11033-010-0469-4; Rabeony H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101937; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Tchirkov A, 2001, BRIT J CANCER, V85, P518, DOI 10.1054/bjoc.2001.1942; Tewari R, 2008, J NEUROCHEM, V107, P616, DOI 10.1111/j.1471-4159.2008.05625.x; Todaro M, 2006, CANCER RES, V66, P1491, DOI 10.1158/0008-5472.CAN-05-2514; Villalva C, 2011, INT J CANCER, V128, P826, DOI 10.1002/ijc.25416; Wainwright DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015390; Weber GF, 2006, J IMMUNOL, V177, P8266, DOI 10.4049/jimmunol.177.11.8266; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wen Z, 2014, ANN SURG ONCOL, V21, P125, DOI 10.1245/s10434-013-3322-x; Whittington HA, 2004, AM J RESP CELL MOL, V31, P220, DOI 10.1165/rcmb.2003-0285OC; Wu TY, 2013, CLIN IMMUNOL, V147, P38, DOI 10.1016/j.clim.2013.02.007; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Ye ZJ, 2012, CANCER LETT, V326, P23, DOI 10.1016/j.canlet.2012.07.013; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Zhang FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020382; Zhang WC, 2008, CLIN CANCER RES, V14, P6432, DOI 10.1158/1078-0432.CCR-07-4401; Zhu VF, 2012, CANCER LETT, V316, P139, DOI 10.1016/j.canlet.2011.11.001	52	20	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119872	10.1371/journal.pone.0119872	http://dx.doi.org/10.1371/journal.pone.0119872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793261	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200122
J	Corouge, M; Loridant, S; Fradin, C; Salleron, J; Damiens, S; Moragues, MD; Souplet, V; Jouault, T; Robert, R; Dubucquoi, S; Sendid, B; Colombel, JF; Poulain, D				Corouge, Marion; Loridant, Severine; Fradin, Chantal; Salleron, Julia; Damiens, Sebastien; Moragues, Maria Dolores; Souplet, Vianney; Jouault, Thierry; Robert, Raymond; Dubucquoi, Sylvain; Sendid, Boualem; Colombel, Jean Frederic; Poulain, Daniel			Humoral Immunity Links Candida albicans Infection and Celiac Disease	PLOS ONE			English	Article							INVASIVE CANDIDIASIS; GENE-EXPRESSION; DENDRITIC CELLS; TRANSGLUTAMINASE; ANTIBODIES; RESPONSES; COLONIZATION; COMMENSAL; PEPTIDES; EPITOPES	Objective The protein Hwp1, expressed on the pathogenic phase of Candida albicans, presents sequence analogy with the gluten protein gliadin and is also a substrate for transglutaminase. This had led to the suggestion that C. albicans infection (CI) may be a triggering factor for Celiac disease (CeD) onset. We investigated cross-immune reactivity between CeD and CI. Methods Serum IgG levels against recombinant Hwp1 and serological markers of CeD were measured in 87 CeD patients, 41 CI patients, and 98 healthy controls (HC). IgA and IgG were also measured in 20 individuals from each of these groups using microchips sensitized with 38 peptides designed from the N-terminal of Hwp1. Results CI and CeD patients had higher levels of anti-Hwp1 (p= 0.0005 and p= 0.004) and anti-gliadin (p= 0.002 and p= 0.0009) antibodies than HC but there was no significant difference between CeD and CI patients. CeD and CI patients had higher levels of anti-transglutaminase IgA than HC (p= 0.0001 and p= 0.0039). During CI, the increase in anti-Hwp1 paralleled the increase in anti-gliadin antibodies. Microchip analysis showed that CeD patients were more reactive against some Hwp1 peptides than CI patients, and that some deamidated peptides were more reactive than their native analogs. Binding of IgG from CeD patients to Hwp1 peptides was inhibited by gamma III gliadin peptides. Conclusions Humoral cross-reactivity between Hwp1 and gliadin was observed during CeD and CI. Increased reactivity to Hwp1 deamidated peptide suggests that transglutaminase is involved in this interplay. These results support the hypothesis that CI may trigger CeD onset in genetically-susceptible individuals.	[Corouge, Marion; Fradin, Chantal; Salleron, Julia; Souplet, Vianney; Jouault, Thierry; Sendid, Boualem; Poulain, Daniel] Univ Lille Nord France, Lille, France; [Corouge, Marion; Fradin, Chantal; Salleron, Julia; Souplet, Vianney; Jouault, Thierry; Sendid, Boualem; Poulain, Daniel] UDSL, Lille, France; [Fradin, Chantal; Damiens, Sebastien; Jouault, Thierry; Sendid, Boualem; Poulain, Daniel] INSERM, U995, F-59045 Lille, France; [Salleron, Julia] EA2694, Lille, France; [Salleron, Julia] InVS EPIMAD, INSERM, Pole Sante Publ Registre, Lille, France; [Corouge, Marion; Colombel, Jean Frederic] Serv Malad Appareil Digestif & Nutr, Lille, France; [Sendid, Boualem; Poulain, Daniel] Inst Microbiol, Serv Parasitol Mycol, Lille, France; [Loridant, Severine; Jouault, Thierry; Dubucquoi, Sylvain; Sendid, Boualem; Poulain, Daniel] CHRU, Lille, France; [Moragues, Maria Dolores] Univ Basque Country, Escuela Univ Enfermeria, Dept Enfermeria 1, Leioa 48940, Spain; [Dubucquoi, Sylvain] Inst Immunol, Pole Biol, Lille, France; [Robert, Raymond] Univ Angers, Grp Etude Interact Hote Pathogene, UPRES EA 3142, Angers, France; [Souplet, Vianney] Innobiochips, F-59000 Lille, France; [Colombel, Jean Frederic] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; University of Basque Country; Universite d'Angers; Icahn School of Medicine at Mount Sinai	Poulain, D (corresponding author), Univ Lille Nord France, Lille, France.	dpoulain@univ-lille2.fr	Sendid, Boualem/ABE-9870-2020; Dubucquoi, Sylvain/I-5756-2018; Moragues, Maria D/F-5264-2010; SENDID, Boualem/B-7510-2014; Fradin, Chantal/N-2382-2018; Jouault, Thierry/I-1071-2018; Poulain, Daniel/I-6095-2018	Sendid, Boualem/0000-0003-1577-7325; Dubucquoi, Sylvain/0000-0002-8962-3719; Moragues, Maria D/0000-0002-7272-8610; Fradin, Chantal/0000-0002-3883-4401; Jouault, Thierry/0000-0003-1988-8647; LORIDANT, Severine/0000-0002-9440-7869; Poulain, Daniel/0000-0002-0729-5468	INSERM-Lille2 University [U995-2]; European Community [F2-2010-260338]; Digest Science Foundation; Innobiochips	INSERM-Lille2 University; European Community(European Commission); Digest Science Foundation; Innobiochips	Funding: This work received the following grant support: Unit U995-2 INSERM-Lille2 University; the European Community's 7th Framework program (FP7-2007-2013) grant agreement No Health F2-2010-260338 (ALLFUN); Digest Science Foundation. Co-author VS is affiliated to Innobiochips. Innobiochips provided support in the form of salary for author VS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Innobiochips played an indirect role through the participation of the co-author VS. The specific role of this author is articulated in the 'author contributions' section.	Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Ashorn S, 2009, J CLIN IMMUNOL, V29, P190, DOI 10.1007/s10875-008-9255-7; Bethune MT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040034; Brinkert F, 2009, ACTA PAEDIATR, V98, P1685, DOI 10.1111/j.1651-2227.2009.01350.x; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Dahle C, 2010, ALIMENT PHARM THER, V32, P254, DOI 10.1111/j.1365-2036.2010.04337.x; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Facchiano A, 2009, AMINO ACIDS, V36, P599, DOI 10.1007/s00726-008-0124-8; Fairweather D, 2001, J AUTOIMMUN, V16, P175, DOI 10.1006/jaut.2000.0492; Fradin C, 2008, INFECT IMMUN, V76, P4509, DOI 10.1128/IAI.00368-08; Garcia YH, 2002, PEDIATR DERMATOL, V19, P415, DOI 10.1046/j.1525-1470.2002.00117.x; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hodrea J, 2010, IMMUNOL LETT, V130, P74, DOI 10.1016/j.imlet.2009.12.010; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Lain A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-35; Ludvigsson JF, 2014, NEW ENGL J MED, V371, P1341, DOI 10.1056/NEJMe1408011; Maddur MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001077; Marot-Leblond A, 2004, J CLIN MICROBIOL, V42, P4956, DOI 10.1128/JCM.42.11.4956-4960.2004; Matthias T, 2010, CLIN REV ALLERG IMMU, V38, P298, DOI 10.1007/s12016-009-8160-z; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; Naglik JR, 2006, J MED MICROBIOL, V55, P1323, DOI 10.1099/jmm.0.46737-0; Nieuwenhuizen WF, 2003, LANCET, V361, P2152, DOI 10.1016/S0140-6736(03)13695-1; Odds, 1988, CAND CAND REV BIBL; Papp M, 2009, WORLD J GASTROENTERO, V15, P3891, DOI 10.3748/wjg.15.3891; Perez JC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001510; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Plantinga TS, 2012, MED MYCOL, V50, P785, DOI 10.3109/13693786.2012.690902; Ponniah G, 2007, J ORAL PATHOL MED, V36, P456, DOI 10.1111/j.1600-0714.2007.00565.x; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Qiao SW, 2009, CURR OPIN IMMUNOL, V21, P111, DOI 10.1016/j.coi.2009.03.004; Qiao SW, 2005, J IMMUNOL, V175, P254, DOI 10.4049/jimmunol.175.1.254; Ress K, 2007, DIGEST LIVER DIS, V39, P136, DOI 10.1016/j.dld.2006.07.012; Rubio-Tapia A, 2010, CURR OPIN GASTROEN, V26, P116, DOI 10.1097/MOG.0b013e3283365263; Schuppan D, 2003, CHEM BIOL, V10, P199, DOI 10.1016/S1074-5521(03)00055-3; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Staab JF, 2004, J BIOL CHEM, V279, P40737, DOI 10.1074/jbc.M406005200; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Toumi D, 2007, SCAND J GASTROENTERO, V42, P821, DOI 10.1080/00365520601154996; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; Viitasalo L, 2014, J CLIN GASTROENTEROL, V48, P620, DOI 10.1097/MCG.0000000000000089; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wolters VM, 2010, HUM IMMUNOL, V71, P392, DOI 10.1016/j.humimm.2010.01.016	48	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121776	10.1371/journal.pone.0121776	http://dx.doi.org/10.1371/journal.pone.0121776			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793717	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900151
J	Hippert, C; Graca, AB; Barber, AC; West, EL; Smith, AJ; Ali, RR; Pearson, RA				Hippert, Claire; Graca, Anna B.; Barber, Amanda C.; West, Emma L.; Smith, Alexander J.; Ali, Robin R.; Pearson, Rachael A.			Muller Glia Activation in Response to Inherited Retinal Degeneration Is Highly Varied and Disease-Specific	PLOS ONE			English	Article							TRANSPLANTED PHOTORECEPTOR PRECURSORS; CHONDROITIN SULFATE PROTEOGLYCANS; RECESSIVE RETINITIS-PIGMENTOSA; LEBERS CONGENITAL AMAUROSIS; EXTERNAL LIMITING MEMBRANE; FIBRILLARY ACIDIC PROTEIN; MEDIATED GENE-TRANSFER; REACTIVE ASTROCYTES; LENTIVIRAL VECTOR; TARGETED DISRUPTION	Despite different aetiologies, most inherited retinal disorders culminate in photoreceptor loss, which induces concomitant changes in the neural retina, one of the most striking being reactive gliosis by Muller cells. It is typically assumed that photoreceptor loss leads to an upregulation of glial fibrilliary acidic protein (Gfap) and other intermediate filament proteins, together with other gliosis-related changes, including loss of integrity of the outer limiting membrane (OLM) and deposition of proteoglycans. However, this is based on a mix of both injury-induced and genetic causes of photoreceptor loss. There are very few longitudinal studies of gliosis in the retina and none comparing these changes across models over time. Here, we present a comprehensive spatiotemporal assessment of features of gliosis in the degenerating murine retina that involves Muller glia. Specifically, we assessed Gfap, vimentin and chondroitin sulphate proteoglycan (CSPG) levels and outer limiting membrane (OLM) integrity over time in four murine models of inherited photoreceptor degeneration that encompass a range of disease severities (Crb1(rd8/rd8), Prph2(+/Delta 307), Rho(-/-), Pde6b(rd1/rd1)). These features underwent very different changes, depending upon the disease-causing mutation, and that these changes are not correlated with disease severity. Intermediate filament expression did indeed increase with disease progression in Crb1(rd8/rd8) and Prph2(+/Delta 307), but decreased in the Prph2(+/Delta 307) and Pde6b(rd1/rd1) models. CSPG deposition usually, but not always, followed the trends in intermediate filament expression. The OLM adherens junctions underwent significant remodelling in all models, but with differences in the composition of the resulting junctions; in Rho(-/-) mice, the adherens junctions maintained the typical rod-Muller glia interactions, while in the Pde6b(rd1/rd1) model they formed predominantly between Muller cells in late stage of degeneration. Together, these results show that gliosis and its associated processes are variable and disease-dependent.	[Hippert, Claire; Graca, Anna B.; Barber, Amanda C.; West, Emma L.; Smith, Alexander J.; Ali, Robin R.; Pearson, Rachael A.] UCL, Inst Ophthalmol, Dept Genet, London EC1V 9EL, England; [Ali, Robin R.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London EC1V 2PD, England; [Ali, Robin R.] UCL Inst Ophthalmol, London EC1V 2PD, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Pearson, RA (corresponding author), UCL, Inst Ophthalmol, Dept Genet, 11-43 Bath St, London EC1V 9EL, England.	rachael.pearson@ucl.ac.uk	Pearson, Rachael/Y-3339-2018; Smith, Alexander/A-5142-2009; West, Emma L/C-5252-2013	Pearson, Rachael/0000-0002-1107-1969; Ali, Robin/0000-0003-3126-6517; West, Emma/0000-0002-7006-3686	Fight For Sight [1448/1449]; Medical Research Council UK [mr/j004553/1]; Retinitis Pigmentosa Fighting Blindness [GR566]; National Institute for Health Research (NIHR) Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Alcon Research Institute; MRC [MR/J004553/1] Funding Source: UKRI; Medical Research Council [1085159, MR/J004553/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10130, NF-SI-0513-10074] Funding Source: researchfish; Fight for Sight [1448/49] Funding Source: researchfish	Fight For Sight; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Retinitis Pigmentosa Fighting Blindness; National Institute for Health Research (NIHR) Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Alcon Research Institute(Novartis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	This work was supported by grants from Fight For Sight (http://www.fightforsight.org.uk/ grant number: 1448/1449), the Medical Research Council UK (http://www.mrc.ac.uk/ grant number: mr/j004553/1), and Retinitis Pigmentosa Fighting Blindness (http://www.rpfightingblindness.org.uk/ grant number: GR566). A.B.G. is an MRC-DTA Clinical Neuroscience Ph.D. student. R.R.A. is part-funded by National Institute for Health Research (NIHR) Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital (http://www.moorfields.nhs.uk/), UCL Institute of Ophthalmology (http://www.ucl.ac.uk/ioo/), and the Alcon Research Institute (http://www.alcon.com/en/ARI/index.asp). R.A.P. is a Royal Society University Research Fellow (https://royalsociety.org/) and supported by the Alcon Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari FT, 2010, GLIA, V58, P857, DOI 10.1002/glia.20970; Ali SAM, 2011, J VET MED SCI, V73, P13, DOI 10.1292/jvms.10-0201; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110; Bringmann A, 2009, GRAEF ARCH CLIN EXP, V247, P865, DOI 10.1007/s00417-009-1082-x; BUNTMILAM AH, 1985, INVEST OPHTH VIS SCI, V26, P1377; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Campbell M, 2006, EXP EYE RES, V83, P484, DOI 10.1016/j.exer.2006.01.032; Campbell M, 2007, EXP EYE RES, V85, P714, DOI 10.1016/j.exer.2007.08.004; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; Crespo D, 2007, EXP NEUROL, V206, P159, DOI 10.1016/j.expneurol.2007.05.001; DANCIGER M, 1995, GENOMICS, V30, P1, DOI 10.1006/geno.1995.0001; Day AJ, 2011, EXPERT REV OPHTHALMO, V6, P123, DOI 10.1586/EOP.11.10; Dinet V, 2012, AGING CELL, V11, P683, DOI 10.1111/j.1474-9726.2012.00834.x; Dornowicz MS, 2008, DEV BIOL, V315, P114, DOI 10.1016/j.ydbio.2007.12.014; EKSTROM P, 1988, INVEST OPHTH VIS SCI, V29, P1363; Escher P, 2008, MOL VIS, V14, P2126; Fan W, 1996, EXP EYE RES, V63, P9, DOI 10.1006/exer.1996.0086; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Gruter O, 2005, GENE THER, V12, P942, DOI 10.1038/sj.gt.3302485; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Inatani M, 2001, INVEST OPHTH VIS SCI, V42, P1930; Inatani M, 2000, INVEST OPHTH VIS SCI, V41, P2748; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; Keenan TDL, 2012, INVEST OPHTH VIS SCI, V53, P7528, DOI 10.1167/iovs.12-10797; Kim KY, 2004, NEUROBIOL AGING, V25, P491, DOI 10.1016/j.neurobiolaging.2003.07.005; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Kostic C, 2003, GENE THER, V10, P818, DOI 10.1038/sj.gt.3301948; Laties AM, 1978, PROCEEDINGS OF THE F, P285; Lewis GP, 2010, MOL VIS, V16, P1361; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Luhmann UFO, 2015, HUM MOL GENET, V24, P128, DOI 10.1093/hmg/ddu424; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Ma J, 2011, MOL VIS, V17, P1759; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; McNally N, 2002, HUM MOL GENET, V11, P1005, DOI 10.1093/hmg/11.9.1005; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268; OAKLEY RA, 1991, DEV BIOL, V147, P187, DOI 10.1016/S0012-1606(05)80017-X; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Pardue MT, 2001, EXP EYE RES, V73, P333, DOI 10.1006/exer.2001.1041; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Pearson RA, 2010, CELL TRANSPLANT, V19, P487, DOI 10.3727/096368909X486057; Pearson RA, 2014, VISUAL NEUROSCI, V31, P333, DOI 10.1017/S0952523814000200; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Popp S, 2004, EXP EYE RES, V79, P351, DOI 10.1016/j.exer.2004.05.016; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; RICH KA, 1995, EXP EYE RES, V61, P235, DOI 10.1016/S0014-4835(05)80043-0; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Roesch Karin, 2012, Mol Vis, V18, P1197; Schwartz NB, 1996, PERSPECT DEV NEUROBI, V3, P291; SHEEDLO HJ, 1995, DEV BRAIN RES, V85, P171, DOI 10.1016/0165-3806(94)00203-C; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stingl K, 2013, OPHTHALMIC RES, V50, P215, DOI 10.1159/000354424; Strettoi E, 2002, J NEUROSCI, V22, P5492; Suzuki T, 2007, CELL TRANSPLANT, V16, P493, DOI 10.3727/000000007783464966; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Tepass U, 2002, BIOESSAYS, V24, P690, DOI 10.1002/bies.10129; Tserentsoodol N, 1998, HISTOCHEM CELL BIOL, V110, P543, DOI 10.1007/s004180050316; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; Vazquez-Chona FR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-98; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; Zhang YQ, 2003, INVEST OPHTH VIS SCI, V44, P4936, DOI 10.1167/iovs.02-0640	77	78	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120415	10.1371/journal.pone.0120415	http://dx.doi.org/10.1371/journal.pone.0120415			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793273	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900030
J	Assis-Marques, MA; Oliveira, AF; Ruas, LP; dos Reis, TF; Roque-Barreira, MC; Coelho, PSR				Assis-Marques, Mariana Aprigio; Oliveira, Aline Ferreira; Ruas, Luciana Pereira; dos Reis, Thaila Fernanda; Roque-Barreira, Maria Cristina; Rodrigues Coelho, Paulo Sergio			Saccharomyces cerevisiae Expressing Gp43 Protects Mice against Paracoccidioides brasiliensis Infection	PLOS ONE			English	Article							GAMMA-INTERFERON; DENDRITIC CELLS; IFN-GAMMA; BLASTOMYCES-DERMATITIDIS; LYMPHOCYTE-PROLIFERATION; VACCINE; MACROPHAGES; IMMUNITY; ACTIVATION; CYTOKINES	The dimorphic fungus Paracoccidioides brasiliensis is the etiological agent of paracoccidioidomycosis (PCM). It is believed that approximately 10 million people are infected with the fungus and approximately 2% will eventually develop the disease. Unlike viral and bacterial diseases, fungal diseases are the ones against which there is no commercially available vaccine. Saccharomyces cerevisiae may be a suitable vehicle for immunization against fungal infections, as they require the stimulation of different arms of the immune response. Here we evaluated the efficacy of immunizing mice against PCM by using S. cerevisiae yeast expressing gp43. When challenged by inoculation of P. brasiliensis yeasts, immunized animals showed a protective profile in three different assays. Their lung parenchyma was significantly preserved, exhibiting fewer granulomas with fewer fungal cells than found in non-immunized mice. Fungal burden was reduced in the lung and spleen of immunized mice, and both organs contained higher levels of IL-12 and IFN-gamma. compared to those of non-vaccinated mice, a finding that suggests the occurrence of Th1 immunity. Taken together, our results indicate that the recombinant yeast vaccine represents a new strategy to confer protection against PCM.	[Assis-Marques, Mariana Aprigio; Oliveira, Aline Ferreira; Ruas, Luciana Pereira; dos Reis, Thaila Fernanda; Roque-Barreira, Maria Cristina; Rodrigues Coelho, Paulo Sergio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Coelho, PSR (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	pacoelho@fmrp.usp.br	de Oliveira Pereira, Aline Ferreira/AAT-5134-2020; Ruas, Luciana/A-4259-2013; Roque-Barreira, Maria-Cristina/A-4552-2008; dos Reis, Thaila F/N-6237-2014	Ruas, Luciana/0000-0002-1028-7872; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; dos Reis, Thaila F/0000-0002-7776-977X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2006/60642-2, 2013/04088-0, 2014/05359-0, 08/558316]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq [306298/2013-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was partially funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (grant numbers 2006/60642-2; 2013/04088-0; 2014/05359-0 to M.C.R.-B. and 08/558316 to P.S.R.C.) (www.fapesp.br), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (grant number 306298/2013-9 to M.C.R.-B. and a scholarship to P.S.R.C.). M.A.A.-M. received a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendoerfer R, 1997, INFECT IMMUN, V65, P2564, DOI 10.1128/IAI.65.7.2564-2569.1997; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Bernstein MB, 2008, VACCINE, V26, P509, DOI 10.1016/j.vaccine.2007.11.033; Blotta MHSL, 1999, AM J TROP MED HYG, V61, P390, DOI 10.4269/ajtmh.1999.61.390; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Borghi M, 2014, FRONTIERS IMMUNOLOGY; BRUMMER E, 1988, J IMMUNOL, V140, P2786; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BRUMMER E, 1988, INT J IMMUNOPHARMACO, V10, P945, DOI 10.1016/0192-0561(88)90041-0; CALICH VLG, 1979, MYCOPATHOLOGIA, V66, P175, DOI 10.1007/BF00683967; Cano LE, 1998, INFECT IMMUN, V66, P800, DOI 10.1128/IAI.66.2.800-806.1998; Capilla J, 2009, VACCINE, V27, P3662, DOI 10.1016/j.vaccine.2009.03.030; Da Silva FC, 2009, AM J TROP MED HYG, V80, P798, DOI 10.4269/ajtmh.2009.80.798; Soares CMD, 2008, MYCOPATHOLOGIA, V165, P179, DOI 10.1007/s11046-008-9114-3; de Oliveira LL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000183; Franco M, 1987, MED MYCOL, V25, P5, DOI [DOI 10.1080/02681-218780000021, DOI 10.1080/02681218780000021]; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gonzalez A, 2000, INFECT IMMUN, V68, P2546, DOI 10.1128/IAI.68.5.2546-2552.2000; Hahn RC, 2003, MYCOSES, V46, P342; Haller AA, 2007, VACCINE, V25, P1452, DOI 10.1016/j.vaccine.2006.10.035; Karhawi ASK, 2000, MED MYCOL, V38, P225, DOI 10.1080/714030939; KASHINO SS, 1985, MYCOPATHOLOGIA, V92, P173, DOI 10.1007/BF00437630; Liu M, 2012, IMMUNOL INVEST, V41, P847, DOI 10.3109/08820139.2012.692418; Liu M, 2011, VACCINE, V29, P1745, DOI 10.1016/j.vaccine.2010.12.119; Majumder T, 2014, MYCOPATHOLOGIA, V178, P189, DOI 10.1007/s11046-014-9798-5; Mendes RP., 1994, PARACOCCIDIOIDOMYCOS, V1st ed, P373; MIYAJI M, 1983, MYCOPATHOLOGIA, V82, P129, DOI 10.1007/BF00439218; MODY CH, 1993, INFECT IMMUN, V61, P464, DOI 10.1128/IAI.61.2.464-469.1993; MODY CH, 1991, AM J RESP CELL MOL, V5, P19, DOI 10.1165/ajrcmb/5.1.19; Mota F T, 1979, Rev Inst Med Trop Sao Paulo, V21, P82; Oliveira SJ, 2002, MICROBES INFECT, V4, P139, DOI 10.1016/S1286-4579(01)01521-0; PUCCIA R, 1986, INFECT IMMUN, V53, P199, DOI 10.1128/IAI.53.1.199-206.1986; Restrepo-Moreno A., 1993, PARACOCCIDIOIDOMYCOS, P251; Ribeiro AM, 2010, VACCINE, V28, P1528, DOI 10.1016/j.vaccine.2009.11.062; Ribeiro AM, 2009, VACCINE, V27, P606, DOI 10.1016/j.vaccine.2008.10.022; Rittner GMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001519; Roy RM, 2012, CELL HOST MICROBE, V11, P436, DOI 10.1016/j.chom.2012.04.005; Ruas LP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004519; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; SCOTT P, 1991, IMMUNOL TODAY, V12, P346, DOI 10.1016/0167-5699(91)90063-Y; Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017; Souto JT, 2003, AM J PATHOL, V163, P583, DOI 10.1016/S0002-9440(10)63686-3; Stevens DA, 2011, MED MYCOL, V49, pS170, DOI 10.3109/13693786.2010.497775; Stubbs AC, 2001, NAT MED, V7, P625, DOI 10.1038/87974; Taborda CP, 1998, INFECT IMMUN, V66, P786, DOI 10.1128/IAI.66.2.786-793.1998; Travassos LR, 2012, HUM VACC IMMUNOTHER, V8, P1450, DOI 10.4161/hv.21283; Wansley EK, 2008, CLIN CANCER RES, V14, P4316, DOI 10.1158/1078-0432.CCR-08-0393	47	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120201	10.1371/journal.pone.0120201	http://dx.doi.org/10.1371/journal.pone.0120201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790460	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400139
J	da Silva, R; Uno, M; Marie, SKN; Oba-Shinjo, SM				da Silva, Roseli; Uno, Miyuki; Nagahashi Marie, Suely K.; Oba-Shinjo, Sueli M.			LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation	PLOS ONE			English	Article							FOCAL ADHESION KINASE; LYSYL OXIDASE EXPRESSION; BETA-AMINOPROPIONITRILE; GENE-EXPRESSION; HYPOXIA; CELL; MIGRATION; GLIOBLASTOMA; ANGIOGENESIS; METASTASIS	Lysyl oxidase (LOX) is involved in vital biological processes such as cell motility, cell signaling and gene regulation. Deregulation of this protein can contribute to tumor formation and progression. Although it is known that LOX is involved in invasion, proliferation and tumor migration in other types of tumors, studies of LOX in astrocytomas of different grades are scarce. The purpose of our study was to characterize LOX, BMP1 and HIF1A expression by real-time PCR in astrocytomas with WHO grades I to IV compared to non-neoplastic brain tissue. IDH1 mutational status was determined by PCR and sequencing. LOX protein expression was also analyzed by immunohistochemistry. LOX functional analyses were performed using siRNA knockdown and the specific inhibitor BAPN in two glioblastoma cell lines. The expression levels of LOX, BMP1 and HIF1A were correlated and analyzed according to IDH1 mutation status and to the clinical end-point of overall survival of glioblastoma patients. The results demonstrate that increased expression and activity of LOX, BMP1 and HIF1A were positively correlated with the malignant grade of astrocytomas. LOX protein expression also increased according to the degree of malignancy, with localization in the cytoplasm and nucleus and staining observed in endothelial cells. Glioblastoma with a mutation in IDH1 expressed lower levels of LOX in the nucleus, and IDH1-mutated cases showed lower LOX expression levels when compared to wild-type IDH1 cases. LOX knockdown and inhibition by BAPN in U87MG and A172 cell lines affected migration, invasion and soft agar colony formation. Taken together, these results corroborate the role of LOX in the migration, invasion and angiogenesis of astrocytomas. Furthermore, LOX expression is influenced by IDH1 mutational status. This work provides new insights for researchers aiming to design targeted therapies to control astrocytomas.	[da Silva, Roseli; Nagahashi Marie, Suely K.; Oba-Shinjo, Sueli M.] Univ Sao Paulo, Fac Med, Dept Neurol, Lab Mol & Cellular Biol, BR-01246903 Sao Paulo, Brazil; [Uno, Miyuki] ICESP, Ctr Translat Res Oncol, BR-01246000 Sao Paulo, Brazil; [Nagahashi Marie, Suely K.] Univ Sao Paulo, Ctr Studies Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	da Silva, R (corresponding author), Univ Sao Paulo, Fac Med, Dept Neurol, Lab Mol & Cellular Biol, BR-01246903 Sao Paulo, Brazil.	roselis@usp.br	Marie, Suely Kazue Nagahashi/D-1870-2012; Oba-Shinjo, Sueli M./C-4017-2012; Uno, Miyuki/AAB-5486-2022	Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Oba-Shinjo, Sueli M./0000-0002-1650-5973; 	Sao Paulo Research Foundation (FAPESP) [04/12133-6]; Ludwig Institute for Cancer Research, National Council for Scientific and Technological Development (CNPq); Fundacao Faculdade de Medicina (FFM); National Council for Scientific and Technological Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ludwig Institute for Cancer Research, National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Faculdade de Medicina (FFM); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Sao Paulo Research Foundation (FAPESP, grant #04/12133-6), the Ludwig Institute for Cancer Research, National Council for Scientific and Technological Development (CNPq), and Fundacao Faculdade de Medicina (FFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourbih DA, 2010, MELANOMA RES, V20, P97, DOI 10.1097/CMR.0b013e328336edfe; Albinger-Hegyi A, 2010, INT J CANCER, V126, P2653, DOI 10.1002/ijc.24948; AREM AJ, 1975, SURG FORUM, V26, P67; Baker AM, 2013, CANCER RES, V73, P583, DOI 10.1158/0008-5472.CAN-12-2447; Baker AM, 2011, JNCI-J NATL CANCER I, V103, P407, DOI 10.1093/jnci/djq569; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Basuroy S, 2010, AM J PHYSIOL-GASTR L, V299, pG186, DOI 10.1152/ajpgi.00368.2009; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Carvalho PO, 2014, INT J BIOL MARKER, V29, pE120, DOI 10.5301/JBM.5000045; Chen LC, 2012, BREAST CANCER RES TR, V134, P989, DOI 10.1007/s10549-012-1986-8; Chesnelong C, 2014, NEURO-ONCOLOGY, V16, P686, DOI 10.1093/neuonc/not243; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dong YY, 2014, BIOCHEM BIOPH RES CO, V444, P427, DOI 10.1016/j.bbrc.2014.01.079; El-Osta A, 2000, GENE EXPRESSION, V9, P63; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Gravendeel LAM, 2010, HUM MUTAT, V31, pE1186, DOI 10.1002/humu.21201; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Ji F, 2013, INT J ONCOL, V42, P1578, DOI 10.3892/ijo.2013.1878; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kirschmann DA, 2002, CANCER RES, V62, P4478; Laczko R, 2007, NEUROPATH APPL NEURO, V33, P631, DOI 10.1111/j.1365-2990.2007.00858.x; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Lazarus HM, 1995, MATRIX BIOL, V14, P727, DOI 10.1016/S0945-053X(05)80015-0; Lee K, 2006, CHEM RES TOXICOL, V19, P1284, DOI 10.1021/tx060068d; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li PA, 2004, MOL BRAIN RES, V120, P115, DOI 10.1016/j.molbrainres.2003.10.013; Li WD, 1997, P NATL ACAD SCI USA, V94, P12817, DOI 10.1073/pnas.94.24.12817; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mammoto T, 2013, AM J PATHOL, V183, P1293, DOI 10.1016/j.ajpath.2013.06.026; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Mustafa D, 2013, J NEUROPATH EXP NEUR, V72, P1171, DOI 10.1097/NEN.0000000000000015; Nellaiappan K, 2000, J CELL BIOCHEM, V79, P576, DOI 10.1002/1097-4644(20001215)79:4<576::AID-JCB60>3.0.CO;2-A; Nishioka T, 2012, CELL STRUCT FUNCT, V37, P75, DOI 10.1247/csf.11015; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ohgaki H, 2011, BRAIN TUMOR PATHOL, V28, P177, DOI 10.1007/s10014-011-0029-1; Osawa T, 2013, BRIT J CANCER, V109, P2237, DOI 10.1038/bjc.2013.535; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pez F, 2011, CANCER RES, V71, P1647, DOI 10.1158/0008-5472.CAN-10-1516; Ping W, 2013, ASIAN PAC J CANCER P, V14, P3613, DOI 10.7314/APJCP.2013.14.6.3613; Saad FA, 2010, BIOCHEM BIOPH RES CO, V396, P944, DOI 10.1016/j.bbrc.2010.05.028; Sakai M, 2009, ANN SURG ONCOL, V16, P2494, DOI 10.1245/s10434-009-0559-5; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHERIDAN PJ, 1979, EXP MOL PATHOL, V30, P315, DOI 10.1016/0014-4800(79)90063-7; Shih YH, 2013, HEAD NECK-J SCI SPEC, V35, P250, DOI 10.1002/hed.22959; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Stewart GD, 2008, ONCOL REP, V20, P1561, DOI 10.3892/or_00000180; Uno M, 2005, CANCER LETT, V224, P321, DOI 10.1016/j.canlet.2004.10.022; Uno M, 2011, CLINICS, V66, P163, DOI 10.1590/S1807-59322011000100028; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Weller M, 2011, GLIA, V59, P1200, DOI 10.1002/glia.21130; Wiel C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.382; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang XX, 2013, ONCOL REP, V29, P541, DOI 10.3892/or.2012.2146	65	26	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119781	10.1371/journal.pone.0119781	http://dx.doi.org/10.1371/journal.pone.0119781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790191	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400106
J	Hamed, YA; Yasuda, H; Persson, M; Berndtsson, R; Wang, XP				Hamed, Yasser Ahmed; Yasuda, Hiroshi; Persson, Magnus; Berndtsson, Ronny; Wang, Xin-ping			Modeling Solute Transport by DLA in Soils of Northeastern Egypt	PLOS ONE			English	Article							DIFFUSION-LIMITED AGGREGATION; DYE TRACER; GENETIC ALGORITHM; FLOOD IRRIGATION; IMAGE-ANALYSIS; CLAY SOIL; FIELD; RESOLUTION	Arid soils in Egypt display large variability in solute transport properties, causing problems in soil management. To characterize this variability, dye infiltration experiments were conducted on four plots representing three main soil types in northeastern Egypt. The plots represented both cultivated and uncultivated land use. The observed dye patterns displayed a large variability and especially the clay soils indicated a high degree of preferential flow. The loamy sand and sandy soils displayed a more uniform dye distribution indicating more homogeneous soil properties. The observed dye patterns were modeled using a diffusion limited aggregation (DLA) model. The DLA is a random walk model where model parameters can be optimized using genetic algorithms (GA). The DLA model reproduced the observed dye patterns for all soils in an excellent way. The best fit was obtained with a specific combination of directional random walk probabilities P-u, P-d, P-r, and P-l for each plot (correlation 0.97-0.99). To account for soil layers with different hydraulic properties a two layer DLA model was developed. For all plots the Pu (upward random walk probability) was higher for the upper more homogeneous soil layer. The overall results showed that spatial variability resulting from solute transport for the investigated soils can be modeled using a DLA approach.	[Hamed, Yasser Ahmed] Port Said Univ, Fac Engn, Dept Civil Engn, Port Fouad Port Said, Egypt; [Yasuda, Hiroshi] Tottori Univ, Arid Land Res Ctr, Hamasaka Tottori, Japan; [Persson, Magnus; Berndtsson, Ronny] Lund Univ, Dept Water Resources Engn, Lund, Sweden; [Berndtsson, Ronny] Lund Univ, Ctr Middle Eastern Studies, Lund, Sweden; [Wang, Xin-ping] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou, Peoples R China	Egyptian Knowledge Bank (EKB); Port Said University; Lund University; Lund University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Berndtsson, R (corresponding author), Lund Univ, Dept Water Resources Engn, Lund, Sweden.	ronny.berndtsson@tvrl.lth.se	Wang, Xin/GYU-1129-2022; YASUDA, Hiroshi/D-5835-2019; Hamed, Yasser/AAB-3710-2022; Wang, Xin/AAN-8435-2021; Berndtsson, Ronny/C-7449-2015; Persson, Magnus/A-4062-2009	Wang, Xin/0000-0002-4457-7376; Berndtsson, Ronny/0000-0003-1473-0138; Persson, Magnus/0000-0003-0013-2321	Swedish International Development Authority (SIDA); MECW project at the Center for Middle Eastern Studies, Lund University; Swedish Institute; MFS SIDA scholarships; Chinese Academy of Sciences [2012T1Z0029]	Swedish International Development Authority (SIDA); MECW project at the Center for Middle Eastern Studies, Lund University; Swedish Institute; MFS SIDA scholarships; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was financially supported by the Swedish International Development Authority (SIDA) and the MECW project at the Center for Middle Eastern Studies, Lund University. The research was also supported by the Swedish Institute through a scholarship to the first author and MFS SIDA scholarships to M.Sc. students Martin Karlsson and Mikael Winqvist. RB was supported by the Chinese Academy of Sciences visiting professorship for senior international scientists, grant no. 2012T1Z0029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elhamid HF, 2011, WATER RESOUR MANAG, V25, P2755, DOI 10.1007/s11269-011-9837-7; Aeby P, 1997, SOIL SCI SOC AM J, V61, P33, DOI 10.2136/sssaj1997.03615995006100010006x; Baveye P, 1998, WATER RESOUR RES, V34, P2783, DOI 10.1029/98WR01209; BOWMAN RS, 1986, WATER RESOUR RES, V22, P1531, DOI 10.1029/WR022i011p01531; Cey EE, 2009, HYDROL PROCESS, V23, P1768, DOI 10.1002/hyp.7302; FLURY M, 1994, J ENVIRON QUAL, V23, P1108, DOI 10.2134/jeq1994.00472425002300050037x; FLURY M, 1995, WATER RESOUR RES, V31, P2443, DOI 10.1029/95WR02039; Gwo JP, 2001, WATER RESOUR RES, V37, P1589, DOI 10.1029/2000WR900384; Hamed Y, 2008, HYDROLOG SCI J, V53, P466, DOI 10.1623/hysj.53.2.466; JAYNES DB, 1988, SOIL SCI SOC AM J, V52, P618, DOI 10.2136/sssaj1988.03615995005200030003x; Jha MK, 2008, J HYDROL, V359, P71, DOI 10.1016/j.jhydrol.2008.06.018; KEMBLOWSKI MW, 1993, WATER RESOUR RES, V29, P419, DOI 10.1029/92WR01861; Li SJ, 2005, MOD PHYS LETT B, V19, P1727, DOI 10.1142/S0217984905010323; MEAKIN P, 1983, PHYS REV A, V27, P2616, DOI 10.1103/PhysRevA.27.2616; Olsson J, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000880; Pachepsky Y, 2006, GEODERMA, V134, P253, DOI 10.1016/j.geoderma.2006.03.003; Perret JS, 2003, EUR J SOIL SCI, V54, P569, DOI 10.1046/j.1365-2389.2003.00546.x; Persson M, 1998, J HYDROL, V205, P232, DOI 10.1016/S0022-1694(97)00151-0; Persson M, 2005, VADOSE ZONE J, V4, P856, DOI 10.2136/vzj2004.0129; Persson M, 2001, J HYDROL, V250, P98, DOI 10.1016/S0022-1694(01)00422-X; Prasad KL, 2001, J HYDROL, V243, P149, DOI 10.1016/S0022-1694(00)00364-4; Wang M, 1997, GROUND WATER, V35, P757, DOI 10.1111/j.1745-6584.1997.tb00144.x; Yasuda H, 1998, SOIL SCI, V163, P544, DOI 10.1097/00010694-199807000-00004; Yasuda H, 2001, GEODERMA, V100, P49, DOI 10.1016/S0016-7061(00)00080-X; YASUDA H, 1994, SOIL SCI SOC AM J, V58, P1052, DOI 10.2136/sssaj1994.03615995005800040008x	25	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119943	10.1371/journal.pone.0119943	http://dx.doi.org/10.1371/journal.pone.0119943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790463	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400119
J	Kohler, P; Wolff, A; Ejserholm, F; Wallman, L; Schouenborg, J; Linsmeier, CE				Kohler, Per; Wolff, Anette; Ejserholm, Fredrik; Wallman, Lars; Schouenborg, Jens; Linsmeier, Cecilia E.			Influence of Probe Flexibility and Gelatin Embedding on Neuronal Density and Glial Responses to Brain Implants	PLOS ONE			English	Article							TISSUE; BIOCOMPATIBILITY; INTERFACES; MOTION; CORTEX	To develop long-term high quality communication between brain and computer, a key issue is how to reduce the adverse foreign body responses. Here, the impact of probe flexibility and gelatine embedding on long-term (6w) tissue responses, was analyzed. Probes of same polymer material, size and shape, flexible mainly in one direction, were implanted in rat cerebral cortex (n(implants) = 3 x 8) in two orientations with respect to the major movement direction of the brain relative to the skull: parallel to (flex mode) or transverse to (rigid mode). Flex mode implants were either embedded in gelatin or non-embedded. Neurons, activated microglia and astrocytes were visualized using immunohistochemistry. The astrocytic reactivity, but not microglial response, was significantly lower to probes implanted in flex mode as compared to rigid mode. The microglial response, but not astrocytic reactivity, was significantly smaller to gelatin embedded probes (flex mode) than non-embedded. Interestingly, the neuronal density was preserved in the inner zone surrounding gelatin embedded probes. This contrasts to the common reports of reduced neuronal density close to implanted probes. In conclusion, sheer stress appears to be an important factor for astrocytic reactivity to implanted probes. Moreover, gelatin embedding can improve the neuronal density and reduce the microglial response close to the probe.	[Kohler, Per; Wolff, Anette; Ejserholm, Fredrik; Wallman, Lars; Schouenborg, Jens; Linsmeier, Cecilia E.] Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, Lund, Sweden; [Ejserholm, Fredrik; Wallman, Lars] Lund Univ, Fac Engn, Dept Measurement Technol & Ind Elect Engn, Elect Measurements, Lund, Sweden	Lund University; Lund University	Schouenborg, J (corresponding author), Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, Lund, Sweden.	Jens.Schouenborg@med.lu.se; Cecilia.Eriksson_Linsmeier@med.lu.se	LInsmeier, Cecilia Eriksson/N-2212-2015	Schouenborg, Jens/0000-0002-2815-6918; Ejserholm, Fredrik/0000-0003-0849-1185	Swedish research council [600012701]; Medical Faculty at Lund University; Knut and Alice Wallenberg foundation [KAW 2004.0119]	Swedish research council(Swedish Research CouncilEuropean Commission); Medical Faculty at Lund University; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	This study was financed by a Linnaeus grant (Project number 600012701) from the Swedish research council and the Medical Faculty at Lund University as well as a grant from the Knut and Alice Wallenberg foundation (KAW 2004.0119). The funding sources were not involved in the design, analysis or writing of this study in any way.	Basu S, 2005, TISSUE ENG, V11, P940, DOI 10.1089/ten.2005.11.940; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Chen TY, 2010, LECT NOTES COMPUT SC, V6363, P473; EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202; Ejserholm F, 2014, IEEE J TRANSLATIONAL, V2, P1, DOI DOI 10.1109/JTEHM.2014.2326859; Freire MAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027554; Grill WM, 2009, ANNU REV BIOMED ENG, V11, P1, DOI 10.1146/annurev-bioeng-061008-124927; He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021; Karumbaiah L, 2012, BIOMATERIALS, V33, P5983, DOI 10.1016/j.biomaterials.2012.05.021; Kim TH, 2013, SEMICOND SCI TECH, V28, DOI 10.1088/0268-1242/28/4/045001; Lebedev MA, 2011, CLINICS, V66, P25, DOI 10.1590/S1807-59322011001300004; Lind G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02942; Lind G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047509; Lind G, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046005; Linsmeier CE, 2011, PROG BRAIN RES, V194, P181, DOI 10.1016/B978-0-444-53815-4.00008-X; McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/056003; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Parker-Ure RA CM, 2008, SOC NEUR ABSTR VIEW; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; PONCELET BP, 1992, RADIOLOGY, V185, P645, DOI 10.1148/radiology.185.3.1438740; Purcell E TD, 2009, SOC NEUR ABSTR VIEW; Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024; Stice P, 2007, J NEURAL ENG, V4, P42, DOI 10.1088/1741-2560/4/2/005; Subbaroyan Jeyakumar, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3588; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267; Ward MP, 2009, BRAIN RES, V1282, P183, DOI 10.1016/j.brainres.2009.05.052; Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049	28	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119340	10.1371/journal.pone.0119340	http://dx.doi.org/10.1371/journal.pone.0119340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790172	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400076
J	Li, L; Long, Y; Zhang, LB; Dalton-Morgan, J; Batley, J; Yu, LJ; Meng, JL; Li, MT				Li, Lun; Long, Yan; Zhang, Libin; Dalton-Morgan, Jessica; Batley, Jacqueline; Yu, Longjiang; Meng, Jinling; Li, Maoteng			Genome Wide Analysis of Flowering Time Trait in Multiple Environments via High-Throughput Genotyping Technique in Brassica napus L.	PLOS ONE			English	Article							SUPPORT VECTOR REGRESSION; ASSISTED PREDICTION; RIDGE-REGRESSION; GENETIC VALUE; SELECTION; ACCURACY; PLANT; ASSOCIATION; POPULATIONS; ALIGNMENT	The prediction of the flowering time (FT) trait in Brassica napus based on genome-wide markers and the detection of underlying genetic factors is important not only for oilseed producers around the world but also for the other crop industry in the rotation system in China. In previous studies the low density and mixture of biomarkers used obstructed genomic selection in B. napus and comprehensive mapping of FT related loci. In this study, a high-density genome-wide SNP set was genotyped from a double-haploid population of B. napus. We first performed genomic prediction of FT traits in B. napus using SNPs across the genome under ten environments of three geographic regions via eight existing genomic predictive models. The results showed that all the models achieved comparably high accuracies, verifying the feasibility of genomic prediction in B. napus. Next, we performed a large-scale mapping of FT related loci among three regions, and found 437 associated SNPs, some of which represented known FT genes, such as AP1 and PHYE. The genes tagged by the associated SNPs were enriched in biological processes involved in the formation of flowers. Epistasis analysis showed that significant interactions were found between detected loci, even among some known FT related genes. All the results showed that our large scale and high-density genotype data are of great practical and scientific values for B. napus. To our best knowledge, this is the first evaluation of genomic selection models in B. napus based on a high-density SNP dataset and large-scale mapping of FT loci.	[Li, Lun; Zhang, Libin; Yu, Longjiang; Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Li, Lun; Zhang, Libin] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Peoples R China; [Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Long, Yan] Chinese Acad Agr Sci, Biotechnol Res Inst, Wuhan, Peoples R China; [Dalton-Morgan, Jessica; Batley, Jacqueline] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; University of Queensland	Li, MT (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	limaoteng426@hust.edu.cn	Batley, Jacqueline/A-5723-2008	Batley, Jacqueline/0000-0002-5391-5824	National Key Technology RD Program [2010BAD01B03]; National Natural Science Foundation of China [31171582, 31071447]; New Century Talents Support Program of the Ministry of Education of China [NCET110172]	National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Talents Support Program of the Ministry of Education of China	The work was supported by National Key Technology R&D Program (2010BAD01B03), the National Natural Science Foundation of China (31171582, 31071447) and the New Century Talents Support Program of the Ministry of Education of China (NCET110172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chao DY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002923; Crossa J, 2013, HEREDITY EDINB  0310; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Dimitriadou E, MISC FUNCTIONS DEP S; Drucker H, 1997, ADV NEUR IN, V9, P155; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Fritsche S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00129; GdlCaPP Rodriguez, 2013, BGLR BAYESIAN GEN LI; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gouy M, 2013, THEOR APPL GENET, V126, P2575, DOI 10.1007/s00122-013-2156-z; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Jimenez-Montero JA, 2013, J DAIRY SCI, V96, P625, DOI 10.3168/jds.2012-5631; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin HY, 2008, J HUM GENET, V53, P802, DOI 10.1007/s10038-008-0313-z; Lin HY, 2012, ANN HUM GENET, V76, P53, DOI 10.1111/j.1469-1809.2011.00692.x; Long N, 2011, THEOR APPL GENET, V123, P1065, DOI 10.1007/s00122-011-1648-y; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Massman JM, 2013, THEOR APPL GENET, V126, P13, DOI 10.1007/s00122-012-1955-y; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen Theo, 2010, Genetics, V185, P623, DOI 10.1534/genetics.110.116590; Morota G, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-17; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Moser G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-56; Neves HHR, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-100; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Ogutu Joseph O, 2011, BMC Proc, V5 Suppl 3, pS11, DOI 10.1186/1753-6561-5-S3-S11; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Perez-Rodriguez P, 2012, G3-GENES GENOM GENET, V2, P1595, DOI 10.1534/g3.112.003665; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Qiu J., 2003, GEOCARTO INT, V18, P3, DOI [10.1080/10106040308542268, DOI 10.1080/10106040308542268]; Rahman M, 2008, THEOR APPL GENET, V117, P895, DOI 10.1007/s00122-008-0829-9; Raman H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-277; Raman H, 2013, THEOR APPL GENET, V126, P119, DOI 10.1007/s00122-012-1966-8; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Riedelsheimer C, 2013, GENETICS, V194, P493, DOI 10.1534/genetics.113.150227; Riedelsheimer C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-452; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; Storlie E, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.01.0001; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Sun YV, 2010, ADV GENET, V72, P73, DOI [10.1016/S0065-2660(10)72004-6, 10.1016/B978-0-12-380862-2.00004-7]; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM., 2007, INTERBULL B, V37, P33; Wang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050038; Wimmer V, 2013, GENETICS, V195, P573, DOI 10.1534/genetics.113.150078; Wurschum T, 2012, THEOR APPL GENET, V124, P153, DOI 10.1007/s00122-011-1694-5; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	62	21	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119425	10.1371/journal.pone.0119425	http://dx.doi.org/10.1371/journal.pone.0119425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790019	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400084
J	Otero-Losada, M; Cao, G; Gonzalez, J; Muller, A; Ottaviano, G; Lillig, C; Capani, F; Ambrosio, G; Milei, J				Otero-Losada, Matilde; Cao, Gabriel; Gonzalez, Julian; Muller, Angelica; Ottaviano, Graciela; Lillig, Christopher; Capani, Francisco; Ambrosio, Giuseppe; Milei, Jose			Functional and Morphological Changes in Endocrine Pancreas following Cola Drink Consumption in Rats	PLOS ONE			English	Article							BETA-CELL DEDIFFERENTIATION; GLUCOSE; SWEETENERS; BEVERAGES; PLASMA; ADULTS; MODEL	Aim We report the effects of long-term cola beverage drinking on glucose homeostasis, endocrine pancreas function and morphology in rats. Methods Wistar rats drank: water (group W), regular cola beverage (group C, sucrose sweetened) or "light" cola beverage (group L, artificially sweetened). After 6 months, 50% of the animals in each group were euthanized and the remaining animals consumed water for the next 6 months when euthanasia was performed. Biochemical assays, insulinemia determination, estimation of insulin resistance (HOMA-IR), morphometry and immunohistochemistry evaluations were performed in pancreas. Results Hyperglycemia (16%, p < 0.05), CoQ(10) (coenzyme-Q(10)) decrease (-52%, p < 0.01), strong hypertriglyceridemia (2.8-fold, p < 0.01), hyperinsulinemia (2.4 fold, p < 0.005) and HOMA-IR increase (2.7 fold, p < 0.01) were observed in C. Group C showed a decrease in number of alpha cells (-42%, p < 0.01) and beta cells (-58%, p < 0.001) and a moderate increase in alpha cells' size after wash-out (+ 14%, p < 0.001). Group L showed reduction in beta cells' size (-9%, p < 0.001) and only after wash-out (L-12) a 19% increase in size (p < 0.0001) with 35% decrease in number of a cells (p< 0.01). Groups C and L showed increase in alpha/beta-cell ratio which was irreversible only in C (alpha/beta = +38% in C-6,+30% in C-12, p < 0.001vs. W-6). Regular cola induced a striking increase in the cytoplasmic expression of Trx1 (Thioredoxin-1) (2.25-fold in C-6 vs. W-6; 2.7-fold in C-12 vs. W-12, p < 0.0001) and Prx2 (Peroxiredoxin-2) (3-fold in C-6 vs. W-6; 2-fold in C-12 vs. W-12, p < 0.0001). Light cola induced increase in Trx1 (3-fold) and Prx2 (2-fold) after wash-out (p < 0.0001, L-12 vs. W-12). Conclusion Glucotoxicity may contribute to the loss of beta cell function with depletion of insulin content. Oxidative stress, suggested by increased expression of thioredoxins and low circulating levels of CoQ(10), may follow sustained hyperglycemia. A likely similar panorama may result from the effects of artificially sweetened cola though via other downstream routes.	[Otero-Losada, Matilde; Cao, Gabriel; Gonzalez, Julian; Muller, Angelica; Ottaviano, Graciela; Capani, Francisco; Milei, Jose] Univ Buenos Aires, CONICET, ININCA, Inst Invest Cardiol, Buenos Aires, DF, Argentina; [Lillig, Christopher] Ernst Moritz Arndt Univ Greifswald, Univ Med Greifswald KdoR, Dept Biochem & Mol Biol, Greifswald, Germany; [Ambrosio, Giuseppe] Univ Perugia, Cardiol & Fisiopatol Cardiovasc, I-06100 Perugia, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University of Perugia	Otero-Losada, M (corresponding author), Univ Buenos Aires, CONICET, ININCA, Inst Invest Cardiol, Buenos Aires, DF, Argentina.	mol@fmed.uba.ar	Lillig, Christopher Horst/AAD-7098-2019; capani, Francisco/D-9781-2016; Otero-Losada, Matilde/J-3050-2019; Ambrosio, Giuseppe/C-6596-2013	Lillig, Christopher Horst/0000-0003-2509-5117; Otero-Losada, Matilde/0000-0001-6650-1033; Ambrosio, Giuseppe/0000-0002-9677-980X	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina [PIP 6549]; Universidad de Buenos Aires, Argentina [UBACYT M052]; University of Buenos Aires - Instituto de Investigaciones Cardiologicas; University of Perugia Division of Cardiology	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Argentina(University of Buenos Aires); University of Buenos Aires - Instituto de Investigaciones Cardiologicas; University of Perugia Division of Cardiology	This work was supported by PIP 6549, http://www.conicet.gov.ar/, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina (JM); UBACYT M052, http://www.uba.ar/, Universidad de Buenos Aires, Argentina (JM); Framework Agreement between the University of Buenos Aires - Instituto de Investigaciones Cardiologicas - and the University of Perugia Division of Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772; Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20; Brown RJ, 2009, DIABETES CARE, V32, P2184, DOI 10.2337/dc09-1185; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Canadian Council on Animal Care, 1993, GUIDE CARE USE EXPT; Carpenter KLH, 2014, EUR J PHARM SCI, V57, P87, DOI 10.1016/j.ejps.2013.12.012; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Ejarque M, 2013, J BIOL CHEM, V288, P11705, DOI 10.1074/jbc.M112.388173; Humphries P, 2008, EUR J CLIN NUTR, V62, P451, DOI 10.1038/sj.ejcn.1602866; Kaplan A, 1995, CLIN CHEM INTERPRETA, P220; Karpinska J, 2006, J PHARMACEUT BIOMED, V42, P232, DOI 10.1016/j.jpba.2006.03.037; Ladeia AM, 2014, WORLD J DIABETES, V5, P601, DOI 10.4239/wjd.v5.i5.601; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mezza T, 2014, DIABETOLOGIA, V57, P1291, DOI 10.1007/s00125-014-3251-7; Milei J, 2011, WORLD J CARDIOL, V3, P111, DOI 10.4330/wjc.v3.i4.111; Montonen J, 2007, J NUTR, V137, P1447, DOI 10.1093/jn/137.6.1447; Naryzhny SN, 2010, FEBS LETT, V584, P4292, DOI 10.1016/j.febslet.2010.09.021; Nseir W, 2010, WORLD J GASTROENTERO, V16, P2579, DOI 10.3748/wjg.v16.i21.2579; Otero-Losada M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089838; Otero-Losada ME, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-57; Otero-Losada ME, 2011, INT J CARDIOL, V146, P106, DOI 10.1016/j.ijcard.2010.09.066; Palmnas MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109841; Puri S, 2013, GENE DEV, V27, P2563, DOI 10.1101/gad.227785.113; Rochette L, 2014, BBA-GEN SUBJECTS, V1840, P2709, DOI 10.1016/j.bbagen.2014.05.017; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Slack JMW, 2001, CURR OPIN GENET DEV, V11, P581, DOI 10.1016/S0959-437X(00)00236-7; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; WEIBEL ER, 1963, LAB INVEST, V12, P131; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Weir GC, 2013, ISLETS, V5, P233, DOI 10.4161/isl.27494; Zheng J, 2014, CHEM-BIOL INTERACT, V215, P1, DOI 10.1016/j.cbi.2014.02.016	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118700	10.1371/journal.pone.0118700	http://dx.doi.org/10.1371/journal.pone.0118700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790473	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400039
J	Papageorgiou, A; Rapley, J; Mesirov, JP; Tamayo, P; Avruch, J				Papageorgiou, Angela; Rapley, Joseph; Mesirov, Jill P.; Tamayo, Pablo; Avruch, Joseph			A Genome-Wide siRNA Screen in Mammalian Cells for Regulators of S6 Phosphorylation	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN S6; AMINO-ACID SUFFICIENCY; MTOR COMPLEX 1; RAG GTPASES; TUMOR-SUPPRESSOR; GROWTH-CONTROL; TRANSFER-RNA; DNA-DAMAGE; IN-VITRO; RAPAMYCIN	mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly activated in most cancers. We performed a genome-wide RNAi screen in a human cancer cell line, seeking genes that regulate S6 phosphorylation, readout of mTORC1 activity. Applying a stringent selection, we retrieved nearly 600 genes wherein at least two RNAis gave significant reduction in S6-P. This cohort contains known regulators of mTOR complex 1 and is significantly enriched in genes whose depletion affects the proliferation/viability of the large set of cancer cell lines in the Achilles database in a manner paralleling that caused by mTOR depletion. We next examined the effect of RNAi pools directed at 534 of these gene products on S6-P in TSC1 null mouse embryo fibroblasts. 76 RNAis reduced S6 phosphorylation significantly in 2 or 3 replicates. Surprisingly, among this cohort of genes the only elements previously associated with the maintenance of mTORC1 activity are two subunits of the vacuolar ATPase and the CUL4 subunit DDB1. RNAi against a second set of 84 targets reduced S6-P in only one of three replicates. However, an indication that this group also bears attention is the presence of rpS6KB1 itself, Rac1 and MAP4K3, a protein kinase that supports amino acid signaling to rpS6KB1. The finding that S6 phosphorylation requires a previously unidentified, functionally diverse cohort of genes that participate in fundamental cellular processes such as mRNA translation, RNA processing, DNA repair and metabolism suggests the operation of feedback pathways in the regulation of mTORC1 operating through novel mechanisms.	[Papageorgiou, Angela; Rapley, Joseph; Avruch, Joseph] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Papageorgiou, Angela; Rapley, Joseph; Avruch, Joseph] Massachusetts Gen Hosp, Med Serv, Diabet Unit, Boston, MA 02114 USA; [Papageorgiou, Angela; Rapley, Joseph; Avruch, Joseph] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Mesirov, Jill P.; Tamayo, Pablo] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Avruch, J (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	avruch@molbio.mgh.harvard.edu	Mesirov, Jill/AGF-7626-2022		NIH [CA73818, DK17776, NIH-R37DK17776, NIH-R01CA73818]; NATIONAL CANCER INSTITUTE [R01CA073818, R01CA121941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017776, P30DK040561, R37DK017776, DP2DK083111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH grants (CA73818 and DK17776) and institutional funds. JA received funding from the NIH (NIH-R37DK17776 and NIH-R01CA73818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Cam M, 2014, J BIOL CHEM, V289, P4083, DOI 10.1074/jbc.M113.530303; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Grewe M, 1999, CANCER RES, V59, P3581; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Hussain S, 2013, MOL CELL BIOL, V33, P1188, DOI 10.1128/MCB.01389-12; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim YM, 2012, MOL CELL, V46, P833, DOI 10.1016/j.molcel.2012.04.007; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lai KP, 2010, EMBO J, V29, P2994, DOI 10.1038/emboj.2010.166; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Linfoot EH, 1957, INFORM CONTR, V1, P85, DOI DOI 10.1016/S0019-9958(57)90116-X; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lu J, 2013, BLOOD, V122, P1610, DOI 10.1182/blood-2013-01-481457; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Nemazanyy I, 2004, FEBS LETT, V578, P357, DOI 10.1016/j.febslet.2004.10.091; Ogmundsdottir MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036616; Orlova KA, 2010, J CLIN INVEST, V120, P1591, DOI 10.1172/JCI41592; Papageorgiou A, 2012, METHODS MOL BIOL, V821, P187, DOI 10.1007/978-1-61779-430-8_11; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Rapley J, 2011, J BIOL CHEM, V286, P38043, DOI 10.1074/jbc.M111.245449; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Rubio-Texeira M, 2007, FEBS LETT, V581, P541, DOI 10.1016/j.febslet.2007.01.019; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Wu XN, 2011, J BIOL CHEM, V286, P31501, DOI 10.1074/jbc.M111.233122; Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	62	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116096	10.1371/journal.pone.0116096	http://dx.doi.org/10.1371/journal.pone.0116096			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790369	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400008
J	Zhang, WJ; Yang, GW; Sun, JJ; Chen, JS; Zhang, YJ				Zhang, Wenjun; Yang, Gaowen; Sun, Juanjuan; Chen, Jishan; Zhang, Yingjun			Clonal Integration Enhances the Performance of a Clonal Plant Species under Soil Alkalinity Stress	PLOS ONE			English	Article							PHYSIOLOGICAL INTEGRATION; WATER TRANSLOCATION; LEYMUS-CHINENSIS; DAUGHTER RAMETS; GROWTH; HETEROGENEITY; BENEFITS; SALINE; HERB; POPULATIONS	Clonal plants have been shown to successfully survive in stressful environments, including salinity stress, drought and depleted nutrients through clonal integration between original and subsequent ramets. However, relatively little is known about whether clonal integration can enhance the performance of clonal plants under alkalinity stress. We investigated the effect of clonal integration on the performance of a typical rhizomatous clonal plant, Leymus chinensis, using a factorial experimental design with four levels of alkalinity and two levels of rhizome connection treatments, connected (allowing integration) and severed (preventing integration). Clonal integration was estimated by comparing physiological and biomass features between the rhizome-connected and rhizome-severed treatments. We found that rhizome-connected treatment increased the biomass, height and leaf water potential of subsequent ramets at highly alkalinity treatments but did not affect them at low alkalinity treatments. However, rhizome-connected treatment decreased the root biomass of subsequent ramets and did not influence the photosynthetic rates of subsequent ramets. The biomass of original ramets was reduced by rhizome-connected treatment at the highest alkalinity level. These results suggest that clonal integration can increase the performance of clonal plants under alkalinity stress. Rhizome-connected plants showed dramatically increased survival of buds with negative effects on root weight, indicating that clonal integration influenced the resource allocation pattern of clonal plants. A cost-benefit analysis based on biomass measures showed that original and subsequent ramets significantly benefited from clonal integration in highly alkalinity stress, indicating that clonal integration is an important adaptive strategy by which clonal plants could survive in local alkalinity soil.	[Zhang, Wenjun; Yang, Gaowen; Sun, Juanjuan; Chen, Jishan; Zhang, Yingjun] China Agr Univ, Dept Grassland Sci, Beijing 100094, Peoples R China; [Yang, Gaowen] Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China	China Agricultural University; Nanjing Agricultural University	Zhang, YJ (corresponding author), China Agr Univ, Dept Grassland Sci, Beijing 100094, Peoples R China.	zhangyj@cau.edu.cn	Yang, Gaowen/P-7854-2019	Yang, Gaowen/0000-0001-5154-011X; Zhang, Yingjun/0000-0001-5776-4392	Modern Agro-industry Technology Research System [CARS-35]	Modern Agro-industry Technology Research System	This study was supported by the Modern Agro-industry Technology Research System (CARS-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P1804, DOI 10.1890/0012-9658(2000)081[1804:BACOIP]2.0.CO;2; ALPERT P, 1991, ECOLOGY, V72, P69, DOI 10.2307/1938903; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; Alpert P, 1996, J ECOL, V84, P395, DOI 10.2307/2261201; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; Degenhardt B, 2000, PLANT SOIL, V225, P83, DOI 10.1023/A:1026539311358; deKroon H, 1996, OECOLOGIA, V106, P73, DOI 10.1007/BF00334409; Dorken ME, 2004, J ECOL, V92, P32, DOI 10.1111/j.1365-2745.2004.00857.x; EVANS JP, 1992, AM J BOT, V79, P1344, DOI 10.2307/2445132; Gao L, 2013, AQUAT BOT, V107, P47, DOI 10.1016/j.aquabot.2013.01.010; Gomez S, 2007, OECOLOGIA, V153, P921, DOI 10.1007/s00442-007-0792-1; Herben T, 2004, EVOL ECOL, V18, P493, DOI 10.1007/s10682-004-5141-9; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Jonsdottir I.S., 1997, ECOLOGY EVOLUTION CL, P109; Li Q, 2011, FLORA, V206, P712, DOI 10.1016/j.flora.2010.11.013; Liu J, 2010, PHOTOSYNTHETICA, V48, P278, DOI 10.1007/s11099-010-0034-3; Lv BS, 2013, AGRON J, V105, P1119, DOI 10.2134/agronj2013.0017; Oborny B, 2000, ECOLOGY, V81, P3291; Pennings SC, 2000, ECOLOGY, V81, P709; Peterson AG, 2002, AUSTRAL ECOL, V27, P647, DOI 10.1046/j.1442-9993.2002.01219.x; Roiloa SR, 2006, ANN BOT-LONDON, V98, P1043, DOI 10.1093/aob/mcl185; Roiloa SR, 2005, INT J PLANT SCI, V166, P795, DOI 10.1086/431804; SALZMAN AG, 1985, OECOLOGIA, V65, P273, DOI 10.1007/BF00379229; SHUMWAY SW, 1995, ANN BOT-LONDON, V76, P225, DOI 10.1006/anbo.1995.1091; Tworkoski TJ, 2001, SCI HORTIC-AMSTERDAM, V88, P97, DOI 10.1016/S0304-4238(00)00198-9; van Kleunen M, 1999, OIKOS, V85, P135, DOI 10.2307/3546799; Wang N, 2009, PLANT BIOLOGY, V11, P483, DOI 10.1111/j.1438-8677.2008.00133.x; Wang ZW, 2004, ACTA OECOL, V26, P255, DOI 10.1016/j.actao.2004.08.007; Xiao Y, 2011, FLORA, V206, P736, DOI 10.1016/j.flora.2010.12.003; Xiao Y, 2010, AQUAT BOT, V92, P9, DOI 10.1016/j.aquabot.2009.09.001; Xie YC, 2010, ISPRS J PHOTOGRAMM, V65, P182, DOI 10.1016/j.isprsjprs.2009.10.007; Yu FH, 2001, EVOL ECOL, V15, P303, DOI 10.1023/A:1016032831038; Yu FH, 2002, ACTA BOT SIN, V44, P468; Zhang XQ, 2006, FLORA, V201, P547, DOI 10.1016/j.flora.2005.12.002; Zhu MJ, 2013, FEMS MICROBIOL LETT, V340, P135, DOI 10.1111/1574-6968.12083; Zhu T.C., 1981, P 14 INT GRASSL C, P429	39	15	18	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119942	10.1371/journal.pone.0119942	http://dx.doi.org/10.1371/journal.pone.0119942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790352	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400118
J	Bart, G; Vico, NO; Hassinen, A; Pujol, FM; Deen, AJ; Ruusala, A; Tammi, RH; Squire, A; Heldin, P; Kellokumpu, S; Tammi, MI				Bart, Genevieve; Vico, Nuria Ortega; Hassinen, Antti; Pujol, Francois M.; Deen, Ashik Jawahar; Ruusala, Aino; Tammi, Raija H.; Squire, Anthony; Heldin, Paraskevi; Kellokumpu, Sakari; Tammi, Markku I.			Fluorescence Resonance Energy Transfer (FRET) and Proximity Ligation Assays Reveal Functionally Relevant Homo-and Heteromeric Complexes among Hyaluronan Synthases HAS1, HAS2, and HAS3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; DERMAL FIBROBLASTS; CANCER-CELLS; ACTIVATION; GLYCOSYLTRANSFERASES; TRANSLOCATION; GOLGI; LOCALIZATION; EXPRESSION; SINGLE	In vertebrates, hyaluronan is produced in the plasma membrane from cytosolic UDP-sugar substrates by hyaluronan synthase 1-3 (HAS1-3) isoenzymes that transfer N-acetylglucosamine (GlcNAc) and glucuronic acid (GlcUA) in alternative positions in the growing polysaccharide chain during its simultaneous extrusion into the extracellular space. It has been shown that HAS2 immunoprecipitates contain functional HAS2 homomers and also heteromers with HAS3 (Karousou, E., Kamiryo, M., Skandalis, S. S., Ruusala, A., Asteriou, T., Passi, A., Yamashita, H., Hellman, U., Heldin, C. H., and Heldin, P. (2010) The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J. Biol. Chem. 285, 23647-23654). Here we have systematically screened in live cells, potential interactions among the HAS isoenzymes using fluorescence resonance energy transfer (FRET) and flow cytometric quantification. We show that all HAS isoenzymes form homomeric and also heteromeric complexes with each other. The same complexes were detected both in Golgi apparatus and plasma membrane by using FRET microscopy and the acceptor photobleaching method. Proximity ligation assays with HAS antibodies confirmed the presence of HAS1-HAS2, HAS2-HAS2, and HAS2-HAS3 complexes between endogenously expressed HASs. C-terminal deletions revealed that the enzymes interact mainly via uncharacterized N-terminal 86-amino acid domain(s), but additional binding site(s) probably exist in their C-terminal parts. Of all the homomeric complexes HAS1 had the lowest and HAS3 the highest synthetic activity. Interestingly, HAS1 transfection reduced the synthesis of hyaluronan obtained by HAS2 and HAS3, suggesting functional cooperation between the isoenzymes. These data indicate a general tendency of HAS isoenzymes to form both homomeric and heteromeric complexes with potentially important functional consequences on hyaluronan synthesis.	[Bart, Genevieve; Deen, Ashik Jawahar; Tammi, Raija H.; Tammi, Markku I.] Univ Eastern Finland, Inst Biomed Anat, FI-70211 Kuopio, Finland; [Vico, Nuria Ortega; Hassinen, Antti; Pujol, Francois M.; Kellokumpu, Sakari] Univ Oulu, Fac Biochem & Mol Med, FI-90014 Oulu, Finland; [Ruusala, Aino; Heldin, Paraskevi] Uppsala Univ, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Squire, Anthony] Univ Clin Essen, Inst Expt Immunol & Imaging, D-45147 Essen, Germany	University of Eastern Finland; University of Oulu; Ludwig Institute for Cancer Research; Uppsala University; University of Duisburg Essen	Tammi, MI (corresponding author), Univ Eastern Finland, Inst Biomed, Sch Med, Yliopistonranta 1E,POB 1627, FI-70211 Kuopio, Finland.	tammi@uef.fi	Tammi, Markku/AAQ-7878-2021	Hassinen, Antti/0000-0001-9491-2868; Bart, Genevieve/0000-0001-9809-150X	Academy of Finland; Sigrid Juselius Foundation; National Glycoscience Graduate School; Kuopio University Hospital (EVO/VTR funds); University of Eastern Finland Spearhead Funds (Cancer Center of Eastern Finland); Magnus Ehrnrooth Foundation; Finnish Cultural Foundation; Ludwig Institute for Cancer Research; Swedish Cancer Society; Northern Savo Cultural Foundation; Northern Savo Cancer Funds; Centre for International Mobility	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Glycoscience Graduate School; Kuopio University Hospital (EVO/VTR funds); University of Eastern Finland Spearhead Funds (Cancer Center of Eastern Finland); Magnus Ehrnrooth Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Ludwig Institute for Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Northern Savo Cultural Foundation; Northern Savo Cancer Funds; Centre for International Mobility	This work was supported by grants from the Academy of Finland (to S. K. and M. I. T.), the Sigrid Juselius Foundation (to M. I. T. and R. H. T.), the National Glycoscience Graduate School (to A. J. D., S. K., and M. I. T.), the Kuopio University Hospital (EVO/VTR funds) (to M. I. T.), the University of Eastern Finland Spearhead Funds (Cancer Center of Eastern Finland) (to M. I. T. and R. H. T.), the Magnus Ehrnrooth Foundation and the Finnish Cultural Foundation (to A. H.), and the Ludwig Institute for Cancer Research and the Swedish Cancer Society (to P. H.).; Recipient of grants from the Northern Savo Cultural Foundation, the Northern Savo Cancer Funds, and Centre for International Mobility.	Asplund T, 1998, BBA-GEN SUBJECTS, V1380, P377, DOI 10.1016/S0304-4165(98)00010-5; Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Declves AE, 2012, NEPHROL DIAL TRANSPL, V27, P3771, DOI 10.1093/ndt/gfs098; Deen AJ, 2014, J BIOL CHEM, V289, P8375, DOI 10.1074/jbc.M114.552133; Hagenfeld D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039096; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; Kozlova I, 2012, CELL SIGNAL, V24, P1856, DOI 10.1016/j.cellsig.2012.05.013; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; McDonald TO, 2007, J HISTOCHEM CYTOCHEM, V55, P1149, DOI 10.1369/jhc.7A7221.2007; Medina AP, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-2; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Mullegger J, 2003, BIOL CHEM, V384, P175, DOI 10.1515/BC.2003.019; Oikari S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P39; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; PREHM P, 1984, BIOCHEM J, V220, P597, DOI 10.1042/bj2200597; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pummill PE, 2001, J BIOL CHEM, V276, P39832, DOI 10.1074/jbc.M105489200; Rauhala L, 2013, J BIOL CHEM, V288, P17999, DOI 10.1074/jbc.M113.472530; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rilla K, 2013, EXP CELL RES, V319, P2006, DOI 10.1016/j.yexcr.2013.05.021; Rilla K, 2013, J BIOL CHEM, V288, P5973, DOI 10.1074/jbc.M112.443879; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Siiskonen H, 2014, EXP CELL RES, V320, P153, DOI 10.1016/j.yexcr.2013.09.021; Siiskonen H, 2013, GLYCOBIOLOGY, V23, P222, DOI 10.1093/glycob/cws149; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Thomas NK, 2010, EXP CELL RES, V316, P1241, DOI 10.1016/j.yexcr.2010.01.004; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Tlapak-Simmons VL, 1998, J BIOL CHEM, V273, P26100, DOI 10.1074/jbc.273.40.26100; Tolg C, 2012, AM J PATHOL, V181, P1250, DOI 10.1016/j.ajpath.2012.06.036; Torronen K, 2014, HISTOCHEM CELL BIOL, V141, P17, DOI 10.1007/s00418-013-1143-4; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x	49	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11479	11490		10.1074/jbc.M115.640581	http://dx.doi.org/10.1074/jbc.M115.640581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25795779	Green Published, hybrid			2022-12-26	WOS:000353719400024
J	Galusca, B; Prevost, G; Germain, N; Dubuc, I; Ling, Y; Anouar, Y; Estour, B; Chartrel, N				Galusca, Bogdan; Prevost, Gaetan; Germain, Natacha; Dubuc, Isabelle; Ling, Yiin; Anouar, Youssef; Estour, Bruno; Chartrel, Nicolas			Neuropeptide Y and alpha-MSH Circadian Levels in Two Populations with Low Body Weight: Anorexia Nervosa and Constitutional Thinness	PLOS ONE			English	Article							BULIMIA-NERVOSA; PLASMA-LEVELS; LEPTIN; GHRELIN; APPETITE; WOMEN; METABOLISM; PERIPHERY; OBESTATIN; HORMONE	Context Anorexia nervosa (AN) presents an adaptive appetite regulating profile including high levels of ghrelin and 26RFa (orexigenic) and low levels of leptin and PYY (anorexigenic). However, this adaptive mechanism is not effective in promoting food intake. The NPY/proopiome-lanocortin (POMC) system plays a crucial role in the regulation of feeding behavior as NPY is the most potent orexigenic neuropeptide identified so far and as the POMC-derived peptide alpha-MSH drastically reduces food intake, and this peptidergic system has not been thoroughly studied in AN. Objective The aim of the present study was thus to investigate whether a dysfunction of the NPY/POMC occurs in two populations with low body weight, AN and constitutional thinness (CT). Design and Settings This was a cross-sectional study performed in an endocrinological unit and in an academic laboratory. Investigated Subjects Three groups of age-matched young women were studied: 23 with AN (AN), 22 CT and 14 normal weight controls. Main Outcome Measures Twelve-point circadian profiles of plasma NPY and alpha-MSH levels were measured in the three groups of investigated subjects. Results No significant circadian variation of NPY was detected between the three groups. Plasma alpha-MSH levels were significantly lower in AN (vs controls) all over the day. The CT group, compared to controls, presented lower levels of alpha-MSH in the morning and the evening, and an important rise during lunchtime. Conclusion In AN patients, the NPY system is not up-regulated under chronic undernutrition suggesting that this may play a role in the inability of anorectic women to adapt food intake to their energy demand. In contrast, low circadian alpha-MSH levels integrate the adaptive profile of appetite regulation of this disease. Finally, in CT women, the important alpha-MSH peak detected during lunchtime could explain why these patients are rapidly food satisfied.	[Galusca, Bogdan; Germain, Natacha; Ling, Yiin; Estour, Bruno] CHU St Etienne, Dept Endocrinol, St Etienne, France; [Prevost, Gaetan; Dubuc, Isabelle; Anouar, Youssef; Chartrel, Nicolas] Univ Rouen, IRIB, INSERM,Unite 982, Lab Neuronal & Neuroendocrine Differentiat & Comm, Mont St Aignan, France	CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Chartrel, N (corresponding author), Univ Rouen, IRIB, INSERM,Unite 982, Lab Neuronal & Neuroendocrine Differentiat & Comm, Mont St Aignan, France.	nicolas.chartrel@univ-rouen.fr	chartrel, nicolas/E-5545-2016; PREVOST, Gaetan/AAD-4865-2019; Anouar, Youssef/F-9683-2017					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Baranowska B, 1997, METABOLISM, V46, P1384, DOI 10.1016/S0026-0495(97)90136-0; Baranowska B, 2001, NEUROENDOCRINOL LETT, V22, P356; Beranova L, 2009, Vnitr Lek, V55, P925; Bossu C, 2007, AM J PHYSIOL-ENDOC M, V292, pE132, DOI 10.1152/ajpendo.00241.2006; Bronsky J, 2011, INT J EAT DISORDER, V44, P547, DOI 10.1002/eat.20857; Ehrlich S, 2010, J PSYCHIATR RES, V44, P827, DOI 10.1016/j.jpsychires.2010.01.011; Escobar L, 2002, Rev Esp Med Nucl, V21, P3; Estour B, 2010, J CLIN ENDOCR METAB, V95, P2203, DOI 10.1210/jc.2009-2608; Forbes S, 2001, P NATL ACAD SCI USA, V98, P4233, DOI 10.1073/pnas.071054298; Galusca B, 2008, J CLIN ENDOCR METAB, V93, P110, DOI 10.1210/jc.2007-1591; Galusca B, 2012, J CLIN ENDOCR METAB, V97, P2012, DOI 10.1210/jc.2011-3396; Germain N, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.17; Germain N, 2009, PSYCHONEUROENDOCRINO, V34, P413, DOI 10.1016/j.psyneuen.2008.10.001; Germain N, 2007, AM J CLIN NUTR, V85, P967, DOI 10.1093/ajcn/85.4.967; Germain N, 2010, J CLIN ENDOCR METAB, V95, P3057, DOI 10.1210/jc.2009-2196; Iqbal R, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-18; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Niedzwiedzka B, 2013, GINEKOL POL, V84, P268; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Sedlackova D, 2011, PHYSIOL RES, V60, P165, DOI 10.33549/physiolres.931952; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Tennoune N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.98; Tolle V, 2003, J CLIN ENDOCR METAB, V88, P109, DOI 10.1210/jc.2002-020645; VAUDRY H, 1978, NEUROENDOCRINOLOGY, V27, P9, DOI 10.1159/000122796; Xie F, 2012, CELL PHYSIOL BIOCHEM, V29, P111, DOI 10.1159/000337592; Zhang W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-27	27	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122040	10.1371/journal.pone.0122040	http://dx.doi.org/10.1371/journal.pone.0122040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798605	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300313
J	Liang, XY; Xing, WJ; He, JX; Fu, F; Zhang, W; Su, FF; Liu, F; Ji, LL; Gao, F; Su, H; Sun, X; Zhang, HF				Liang, Xiangyan; Xing, Wenjuan; He, Jinxiao; Fu, Feng; Zhang, Wei; Su, Feifei; Liu, Fange; Ji, Lele; Gao, Feng; Su, Hui; Sun, Xin; Zhang, Haifeng			Magnolol Administration in Normotensive Young Spontaneously Hypertensive Rats Postpones the Development of Hypertension: Role of Increased PPAR Gamma, Reduced TRB3 and Resultant Alleviative Vascular Insulin Resistance	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; STIMULATE GLUCOSE-UPTAKE; MYOCARDIAL ISCHEMIA/REPERFUSION; TRIBBLES HOMOLOG; BLOOD-PRESSURE; PREHYPERTENSION; EXPRESSION; HONOKIOL; AKT; INFLAMMATION	Patients with prehypertension are more likely to progress to manifest hypertension than those with optimal or normal blood pressure. However, the mechanisms underlying the development from prehypertension to hypertension still remain largely elusive and the drugs for antihypertensive treatment in prehypertension are absent. Here we determined the effects of magnolol (MAG) on blood pressure and aortic vasodilatation to insulin, and investigated the underlying mechanisms. Four-week-old male spontaneous hypertensive rats (SHR) and age-matched normotensive Wistar-Kyoto (WKY) control rats were used. Our results shown that treatment of young SHRs with MAG (100 mg/kg/day, o.g.) for 3 weeks decreased blood pressure, improved insulin-induced aorta vasodilation, restored Akt and eNOS activation stimulated by insulin, and increased PPAR gamma and decreased TRB3 expressions. In cultured human umbilical vein endothelial cells (HUVECs), MAG incubation increased PPAR gamma, decreased TRB3 expressions, and restored insulin-induced phosphorylated Akt and eNOS levels and NO production, which was blocked by both PPAR gamma antagonist and siRNA targeting PPAR gamma. Improved insulin signaling in HUVECs by MAG was abolished by upregulating TRB3 expression. In conclusion, treatment of young SHRs with MAG beginning at the prehypertensive stage decreases blood pressure via improving vascular insulin resistance that is at least partly attributable to upregulated PPAR gamma, downregulated TRB3 and consequently increased Akt and eNOS activations in blood vessels in SHRs.	[Liang, Xiangyan; Liu, Fange; Ji, Lele; Zhang, Haifeng] Fourth Mil Med Univ, Expt Teaching Ctr, Xian 710032, Peoples R China; [Xing, Wenjuan; Fu, Feng; Gao, Feng] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China; [He, Jinxiao; Sun, Xin] Fourth Mil Med Univ, Xijing Hosp, Dept Pediat, Xian 710032, Peoples R China; [Zhang, Wei; Su, Feifei] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Su, Hui] Fourth Mil Med Univ, Xijing Hosp, Dept Geratol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Su, H (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Geratol, Xian 710032, Peoples R China.	huisu2011@gmail.com; sunxin6@fmmu.edu.cn; hfzhang@fmmu.edu.cn	Gao, Feng/X-4385-2019	Zhang, Haifeng/0000-0003-1938-3796	National Natural Science Foundation of China [81270330, 31371151, 81470537, 81300077, 81400197]; Shaanxi Province Science and Technology Research and Development Program [2013KJXX-89, 2013KW30-02]; Shaanxi Province Social Development Project in Science and Technology Research [2014K11-02-03-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province Science and Technology Research and Development Program; Shaanxi Province Social Development Project in Science and Technology Research	This work was supported by the National Natural Science Foundation of China (Nos. 81270330, 31371151, 81470537, 81300077, and 81400197), the Shaanxi Province Science and Technology Research and Development Program (Nos. 2013KJXX-89 and 2013KW30-02), and the Shaanxi Province Social Development Project in Science and Technology Research (No. 2014K11-02-03-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JH, 2003, N-S ARCH PHARMACOL, V368, P127, DOI 10.1007/s00210-003-0779-3; Chen YH, 2002, BRIT J PHARMACOL, V135, P37, DOI 10.1038/sj.bjp.0704458; Chen Yung-Hsiang, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P279; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi SS, 2012, BIOFACTORS, V38, P372, DOI 10.1002/biof.1029; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Fakhrudin N, 2010, MOL PHARMACOL, V77, P559, DOI 10.1124/mol.109.062141; Gupta AK, 2010, HYPERTENS RES, V33, P905, DOI 10.1038/hr.2010.91; Huang YL, 2014, AM HEART J, V167, P160, DOI 10.1016/j.ahj.2013.10.023; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Jin YC, 2008, EXP BIOL MED, V233, P1280, DOI 10.3181/0803-RM-79; Alonso-Castro AJ, 2011, PHYTOMEDICINE, V18, P926, DOI 10.1016/j.phymed.2011.02.015; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Julius S, 2014, J HYPERTENS, V32, P251, DOI 10.1097/HJH.0000000000000032; Karki R, 2013, EXP CELL RES, V319, P3238, DOI 10.1016/j.yexcr.2013.07.016; Karki R, 2013, BBA-GEN SUBJECTS, V1830, P2619, DOI 10.1016/j.bbagen.2012.12.015; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Kim GD, 2013, INT J ONCOL, V43, P600, DOI 10.3892/ijo.2013.1959; Kim HM, 2007, INT IMMUNOPHARMACOL, V7, P1083, DOI 10.1016/j.intimp.2007.04.004; Kim YJ, 2013, MOL NUTR FOOD RES, V57, P1988, DOI 10.1002/mnfr.201300113; Kuo WW, 2005, CELL BIOCHEM FUNCT, V23, P325, DOI 10.1002/cbf.1244; Lee YM, 2001, EUR J PHARMACOL, V422, P159, DOI 10.1016/S0014-2999(01)01069-X; Li J, 2008, CRIT CARE MED, V36, P1551, DOI 10.1097/CCM.0b013e3181782335; Li R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1703, DOI 10.1152/ajpendo.00462.2007; Li R, 2010, EUR J PHARMACOL, V628, P140, DOI 10.1016/j.ejphar.2009.11.038; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Rieusset J, 2001, DIABETOLOGIA, V44, P544, DOI 10.1007/s001250051660; Taguchi K, 2012, DIABETES, V61, P1978, DOI 10.2337/db11-1729; Ungvari Z, 2001, AM J PHYSIOL-HEART C, V281, pH606, DOI 10.1152/ajpheart.2001.281.2.H606; Wu LY, 2004, AM J HYPERTENS, V17, P749, DOI 10.1016/j.amjhyper.2004.04.010; Xing WJ, 2013, AM J PHYSIOL-HEART C, V305, pH1111, DOI 10.1152/ajpheart.00290.2013; Xing WJ, 2013, HYPERTENSION, V61, P1028, DOI 10.1161/HYPERTENSIONAHA.111.00728; Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1; Zhang HF, 2008, J HYPERTENS, V26, P560, DOI 10.1097/HJH.0b013e3282f343e1	35	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120366	10.1371/journal.pone.0120366	http://dx.doi.org/10.1371/journal.pone.0120366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793876	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900017
J	Luo, ZF; Li, YA; Wang, HM; Fleming, J; Li, M; Kang, Y; Zhang, R; Li, DH				Luo, Zhaofan; Li, Yanan; Wang, Huamin; Fleming, Jason; Li, Min; Kang, Yaan; Zhang, Ran; Li, Donghui			Hepatocyte Nuclear Factor 1A (HNF1A) as a Possible Tumor Suppressor in Pancreatic Cancer	PLOS ONE			English	Article							DOMINANT-NEGATIVE SUPPRESSION; BETA-CELL FUNCTION; TRANSCRIPTION FACTORS; FACTOR 1-ALPHA; ACTIVATED AKT; GENE; HNF1-ALPHA; EXPRESSION; INACTIVATION; HNF-1-ALPHA	Background HNF1A (Hepatocyte nuclear factor 1 alpha) is a transcription factor that is known to regulate pancreatic differentiation and maintain homeostasis of endocrine pancreas. Recently, genome-wide association studies have implicated HNF1A as a susceptibility gene for pancreatic cancer. However, the functional significance and molecular mechanism of HNF1A in pancreatic carcinogenesis remains unclear. Methods Using RT-PCR, Western blot and immunohistochemistry methods, we examined HNF1A gene expression in eight pancreatic carcinoma cell lines and in paired tumor and normal tissue samples from patients with resected pancreatic ductal adenocarcinoma. We knocked down the HNF1A gene expression in two cancer cell lines using three siRNA sequences. The impacts on cell proliferation, apoptosis, and cell cycle as well as the phosphorylation of Akt signaling transduction proteins were examined using ATP assay, flow cytometry and Western blot. Results HNF1A was expressed in three out of eight pancreatic adenocarcinoma cell lines and the level of HNF1A mRNA and protein expression was significantly lower in tumors than in normal adjacent tissues by both RT-PCR and Western Blot analyses. Immunohistochemistry revealed that the level of HNF1A expression was significantly lower in tumor tissues than in non-tumor tissues. Selective blocking of HNF1A by specific siRNA conferred a 2-fold higher rate of cell proliferation, 20% increased S phase and G2 phase cells, and 30-40% reduced apoptosis in pancreatic cancer cell lines. We further demonstrated that HNF1A knockdown activated Akt and its downstream target, the mammalian target of rapamycin ( mTOR) in pancreatic cancer cells. Conclusion These observations provide experimental evidence supporting a possible tumor suppressor role of HNF1A in pancreatic cancer.	[Luo, Zhaofan; Li, Yanan; Li, Donghui] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Fleming, Jason; Kang, Yaan; Zhang, Ran] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Li, Min] Univ Texas Med Sch, Vivian L Smith Dept Neurosurg, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Li, DH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA.	dli@mdanderson.org			G.S. Hogan Research Funds; Sheikh Ahmed Center for Pancreatic Cancer Research Funds; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	G.S. Hogan Research Funds; Sheikh Ahmed Center for Pancreatic Cancer Research Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	G.S. Hogan Research Funds and the Sheikh Ahmed Center for Pancreatic Cancer Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, ONCOGENE, V23, P8571, DOI 10.1038/sj.onc.1207902; Bellanne-Chantelot C, 2008, DIABETES, V57, P503, DOI 10.2337/db07-0859; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Cerf ME, 2006, EUR J ENDOCRINOL, V155, P671, DOI 10.1530/eje.1.02277; D'Angelo A, 2010, DEVELOPMENT, V137, P1573, DOI 10.1242/dev.044420; Furukawa T, 1996, AM J PATHOL, V148, P1763; Furuta H, 2002, J CLIN ENDOCR METAB, V87, P3859, DOI 10.1210/jc.87.8.3859; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Holmkvist J, 2006, DIABETOLOGIA, V49, P2882, DOI 10.1007/s00125-006-0450-x; Hoskins JW, 2014, CARCINOGENESIS, V35, P2670, DOI 10.1093/carcin/bgu193; Kleber ME, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-157; Lauc G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001256; Lemm I, 1999, MOL CARCINOGEN, V24, P305, DOI 10.1002/(SICI)1098-2744(199904)24:4<305::AID-MC9>3.0.CO;2-8; Ley SH, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-39; Li DH, 2012, CARCINOGENESIS, V33, P1384, DOI 10.1093/carcin/bgs151; Lussier CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012378; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Martin M, 2007, ENDOCR DEV, V12, P24, DOI 10.1159/000109602; Molero X, 2012, GUT, V61, P1187, DOI 10.1136/gutjnl-2011-300360; Pelletier L, 2010, HEPATOLOGY, V51, P557, DOI 10.1002/hep.23362; Pierce BL, 2011, CANCER RES, V71, P4352, DOI 10.1158/0008-5472.CAN-11-0124; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 1997, MOL CELL BIOL, V17, P4948, DOI 10.1128/MCB.17.9.4948; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Rebouissou S, 2004, ONCOGENE, V23, P7588, DOI 10.1038/sj.onc.1207989; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Song SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042699; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang H, 2000, ADV IND CON; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; Wobser H, 2006, DIABETOLOGIA, V49, P519, DOI 10.1007/s00125-005-0119-x; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441	37	32	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121082	10.1371/journal.pone.0121082	http://dx.doi.org/10.1371/journal.pone.0121082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793983	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900100
J	McCrea, RL; Nazareth, I; Evans, SJW; Osborn, DPJ; Pinfold, V; Cowen, PJ; Petersen, I				McCrea, Rachel L.; Nazareth, Irwin; Evans, Stephen J. W.; Osborn, David P. J.; Pinfold, Vanessa; Cowen, Phil J.; Petersen, Irene			Lithium Prescribing during Pregnancy: A UK Primary Care Database Study	PLOS ONE			English	Article								Background Women taking lithium must decide whether to continue the medication if they conceive or plan to conceive. Little is known about the extent of prescribing of lithium during pregnancy. Aims To determine: 1) the prevalence of lithium prescribing during pregnancy and 2) to assess whether pregnancy is associated with discontinuation of lithium. Method First, we identified women receiving any lithium prescriptions before and during pregnancy using The Health Improvement Network (THIN) primary care database. Subsequently, we used a Kaplan-Meier plot to compare time to last prescription in women prescribed lithium continuously three months before pregnancy and a comparison group of non-pregnant women. Finally, we described the characteristics of the women prescribed lithium in pregnancy. Results Very few women were prescribed lithium during pregnancy; out of 458,761 pregnancies, we identified 47 (0.01%) in which lithium was prescribed after the 6th week of pregnancy (when the pregnancy was likely to be known). In our study of discontinuation, we found pregnant women were more likely to stop lithium than those who were not pregnant. Of the 52 women who were being continuously prescribed lithium three months before pregnancy, only 17 (33%) continued receiving prescriptions beyond the 6th week of pregnancy. However, most of these 17 women continued treatment throughout pregnancy. Conclusions Pregnancy was strongly associated with discontinuation of lithium. Further evidence on the risks of lithium is needed so that women can weight these against the risk of a deterioration in maternal mental health.	[McCrea, Rachel L.; Nazareth, Irwin; Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London, England; [Evans, Stephen J. W.] London Sch Hyg & Trop Med, London WC1, England; [Osborn, David P. J.] UCL, Div Psychiat, London, England; [Pinfold, Vanessa] McPin Fdn, London, England; [Cowen, Phil J.] Univ Oxford, Univ Dept Psychiat, Oxford, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Oxford	Petersen, I (corresponding author), UCL, Dept Primary Care & Populat Hlth, London, England.	Irene.petersen@ucl.ac.uk	; Osborn PhD FRCPsych, David/B-8165-2009; Petersen, Irene/C-5702-2009	Cowen, Philip/0000-0001-5518-6138; Osborn PhD FRCPsych, David/0000-0003-2519-1539; Evans, Stephen/0000-0002-1474-2596; Petersen, Irene/0000-0002-0037-7524	National Institute of Health Research Health Technology Assessment (HTA) program [11/35/06]; National Institute for Health Research [11/35/06] Funding Source: researchfish	National Institute of Health Research Health Technology Assessment (HTA) program; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute of Health Research Health Technology Assessment (HTA) program. Project 11/35/06 - Risks and benefits of psychotropic medication in pregnancy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blak Betina T, 2011, Inform Prim Care, V19, P251; KALLEN B, 1983, ACTA PSYCHIAT SCAND, V68, P134, DOI 10.1111/j.1600-0447.1983.tb06991.x; Man SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052339; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; NICE, 2014, ANT POSTN MENT HLTH; NORA JJ, 1974, LANCET, V2, P594; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Viguera AC, 2007, AM J PSYCHIAT, V164, P1817, DOI 10.1176/appi.ajp.2007.06101639	8	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121024	10.1371/journal.pone.0121024	http://dx.doi.org/10.1371/journal.pone.0121024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793580	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000352083900096
J	Montecchia, MS; Tosi, M; Soria, MA; Vogrig, JA; Sydorenko, O; Correa, OS				Montecchia, Marcela S.; Tosi, Micaela; Soria, Marcelo A.; Vogrig, Jimena A.; Sydorenko, Oksana; Correa, Olga S.			Pyrosequencing Reveals Changes in Soil Bacterial Communities after Conversion of Yungas Forests to Agriculture	PLOS ONE			English	Article							LAND-USE CHANGE; MICROBIAL COMMUNITY; DIVERSITY; MANAGEMENT; DEFORESTATION; BIOGEOGRAPHY; STABILITY; DYNAMICS; NITROGEN; ECOLOGY	The Southern Andean Yungas in Northwest Argentina constitute one of the main biodiversity hotspots in the world. Considerable changes in land use have taken place in this ecoregion, predominantly related to forest conversion to croplands, inducing losses in above-ground biodiversity and with potential impact on soil microbial communities. In this study, we used high-throughput pyrosequencing of the 16S ribosomal RNA gene to assess whether land-use change and time under agriculture affect the composition and diversity of soil bacterial communities. We selected two areas dedicated to sugarcane and soybean production, comprising both short-and long-term agricultural sites, and used the adjacent native forest soils as a reference. Land-use change altered the composition of bacterial communities, with differences between productive areas despite the similarities between both forests. At the phylum level, only Verrucomicrobia and Firmicutes changed in abundance after deforestation for sugarcane and soybean cropping, respectively. In cultivated soils, Verrucomicrobia decreased sharply (similar to 80%), while Firmicutes were more abundant. Despite the fact that local diversity was increased in sugarcane systems and was not altered by soybean cropping, phylogenetic beta diversity declined along both chronosequences, evidencing a homogenization of soil bacterial communities over time. In spite of the detected alteration in composition and diversity, we found a core microbiome resistant to the disturbances caused by the conversion of forests to cultivated lands and few or none exclusive OTUs for each land-use type. The overall changes in the relative abundance of copiotrophic and oligotrophic taxa may have an impact in soil ecosystem functionality. However, communities with many taxa in common may also share many functional attributes, allowing to maintain at least some soil ecosystem services after forest conversion to croplands.	[Montecchia, Marcela S.; Tosi, Micaela; Soria, Marcelo A.; Vogrig, Jimena A.; Sydorenko, Oksana; Correa, Olga S.] Univ Buenos Aires, Fac Agron, Catedra Microbiol Agr, Inst Invest Biociencias Agr & Ambientales INBA CO, Buenos Aires, DF, Argentina	University of Buenos Aires	Correa, OS (corresponding author), Univ Buenos Aires, Fac Agron, Catedra Microbiol Agr, Inst Invest Biociencias Agr & Ambientales INBA CO, Buenos Aires, DF, Argentina.	correa@agro.uba.ar		Montecchia, Marcela Susana/0000-0002-2718-7309; Tosi, Micaela/0000-0001-6552-951X	Universidad de Buenos Aires [UBACYT 20020100100767, 20020130100286BA]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 114 201101 00247]	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Universidad de Buenos Aires (UBACYT 20020100100767 and 20020130100286BA) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 114 201101 00247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Bahr E, 2014, AGR ECOSYST ENVIRON, V188, P275, DOI 10.1016/j.agee.2014.03.005; Becerra AG, 2011, MYCOLOGIA, V103, P273, DOI 10.3852/10-193; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bissett A, 2011, APPL SOIL ECOL, V51, P66, DOI 10.1016/j.apsoil.2011.08.010; Brown A.D., 2001, BOSQUES NUBLADOS NEO, P623; Brown AD., 2009, SELVA PEDEMONTANA YU; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; Cabrera AL., 1976, REGIONES FITOGEOGRAF, DOI DOI 10.1038/ncomms2415; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Daniele C, 1994, REGIONES NATURALES A; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Deng H, 2012, J ENVIRON SCI, V24, P1027, DOI 10.1016/S1001-0742(11)60846-2; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Figuerola ELM, 2015, ENVIRON MICROBIOL, V17, P678, DOI 10.1111/1462-2920.12497; Food and Agriculture Organization of the United Nations, 2012, STAT WORLDS FOR; Geml J, 2014, MOL ECOL, V23, P2452, DOI 10.1111/mec.12765; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Grau HR, 2005, ENVIRON CONSERV, V32, P140, DOI 10.1017/S0376892905002092; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Gasparri NI, 2009, FOREST ECOL MANAG, V258, P913, DOI 10.1016/j.foreco.2009.02.024; Izquierdo AE, 2009, J ENVIRON MANAGE, V90, P858, DOI 10.1016/j.jenvman.2008.02.013; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee-Cruz L, 2013, APPL ENVIRON MICROB, V79, P7290, DOI 10.1128/AEM.02541-13; Lupatini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076465; Madsen EL, 2011, CURR OPIN BIOTECH, V22, P456, DOI 10.1016/j.copbio.2011.01.008; Malizia L., 2012, Ecosistemas, V21, P53; Montecchia MS, 2011, APPL SOIL ECOL, V47, P176, DOI 10.1016/j.apsoil.2010.12.008; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Nemergut DR, 2010, SOIL BIOL BIOCHEM, V42, P2153, DOI 10.1016/j.soilbio.2010.08.011; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paula FS, 2014, MOL ECOL, V23, P2988, DOI 10.1111/mec.12786; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; R Core Team, 2021, R LANGUAGE ENV STAT; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; Roberts DW, 2002, STEREOT FUNCT NEUROS, V78, P1, DOI 10.1159/000066929; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tardy V, 2014, ENV MICROBIOL REP, V6, P173, DOI 10.1111/1758-2229.12126; Tosi M, 2013, APORTES MICROBIOLOGI, P179; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Upchurch R, 2008, SOIL BIOL BIOCHEM, V40, P1294, DOI 10.1016/j.soilbio.2007.06.027; Volante JN, 2012, AGR ECOSYST ENVIRON, V154, P12, DOI 10.1016/j.agee.2011.08.012; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x	62	37	37	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119426	10.1371/journal.pone.0119426	http://dx.doi.org/10.1371/journal.pone.0119426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793893	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200082
J	Notas, G; Bariotakis, M; Kalogrias, V; Andrianaki, M; Azariadis, K; Kampouri, E; Theodoropoulou, K; Lavrentaki, K; Kastrinakis, S; Kampa, M; Agouridakis, P; Pirintsos, S; Castanas, E				Notas, George; Bariotakis, Michail; Kalogrias, Vaios; Andrianaki, Maria; Azariadis, Kalliopi; Kampouri, Errika; Theodoropoulou, Katerina; Lavrentaki, Katerina; Kastrinakis, Stelios; Kampa, Marilena; Agouridakis, Panagiotis; Pirintsos, Stergios; Castanas, Elias			Accurate Prediction of Severe Allergic Reactions by a Small Set of Environmental Parameters (NDVI, Temperature)	PLOS ONE			English	Article							ATOPIC ECZEMA; ASTHMA; PREVALENCE; CHILDREN; SYMPTOMS; VEGETATION; CHILDHOOD; RHINITIS; CLIMATE; DISEASE	Severe allergic reactions of unknown etiology, necessitating a hospital visit, have an important impact in the life of affected individuals and impose a major economic burden to societies. The prediction of clinically severe allergic reactions would be of great importance, but current attempts have been limited by the lack of a well-founded applicable methodology and the wide spatiotemporal distribution of allergic reactions. The valid prediction of severe allergies (and especially those needing hospital treatment) in a region, could alert health authorities and implicated individuals to take appropriate preemptive measures. In the present report we have collecterd visits for serious allergic reactions of unknown etiology from two major hospitals in the island of Crete, for two distinct time periods (validation and test sets). We have used the Normalized Difference Vegetation Index (NDVI), a satellite-based, freely available measurement, which is an indicator of live green vegetation at a given geographic area, and a set of meteorological data to develop a model capable of describing and predicting severe allergic reaction frequency. Our analysis has retained NDVI and temperature as accurate identifiers and predictors of increased hospital severe allergic reactions visits. Our approach may contribute towards the development of satellite-based modules, for the prediction of severe allergic reactions in specific, well-defined geographical areas. It could also probably be used for the prediction of other environment related diseases and conditions.	[Notas, George; Andrianaki, Maria; Azariadis, Kalliopi; Kampouri, Errika; Theodoropoulou, Katerina; Lavrentaki, Katerina; Kampa, Marilena; Castanas, Elias] Univ Crete, Sch Med, Dept Expt Endocrinol, Iraklion, Greece; [Notas, George; Agouridakis, Panagiotis] Univ Crete, Sch Med, Dept Emergency Med, Iraklion, Greece; [Bariotakis, Michail; Kalogrias, Vaios; Pirintsos, Stergios] Univ Crete, Sch Sci & Technol, Dept Biol, Iraklion, Greece; [Kastrinakis, Stelios] Chania Gen Hosp, Hlth Ctr Gerani, Mournies Chania, Greece; [Pirintsos, Stergios] Univ Crete, Bot Garden, Rethimnon, Greece	University of Crete; University of Crete; University of Crete; University of Crete	Notas, G (corresponding author), Univ Crete, Sch Med, Dept Expt Endocrinol, Iraklion, Greece.	gnotas@med.uoc.gr; castanas@med.uoc.gr	Castanas, Elias/E-7007-2010; Notas, George/K-3709-2019	Castanas, Elias/0000-0002-8370-1835; Notas, George/0000-0002-2506-5252; Bariotakis, Michael/0000-0002-7624-5675; Kampouri, Eleftheria/0000-0001-8019-3073				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calcagno V, 2010, J STAT SOFTW, V34, P1; Fuertes E, 2014, ANN ALLERG ASTHMA IM, V113, P386, DOI 10.1016/j.anai.2014.06.021; Galan C, 2001, INT J BIOMETEOROL, V45, P8, DOI 10.1007/s004840000081; Geerken R, 2005, INT J REMOTE SENS, V26, P5535, DOI 10.1080/01431160500300297; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V125, pS81, DOI 10.1016/j.jaci.2009.10.071; Karlsen SR, 2009, AEROBIOLOGIA, V25, P15, DOI 10.1007/s10453-008-9105-3; Kiechl-Kohlendorfer U, 2007, ARCH DIS CHILD, V92, P339, DOI 10.1136/adc.2006.106278; Martiny N, 2010, THEOR APPL CLIMATOL, V100, P467, DOI 10.1007/s00704-009-0223-9; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; R Core Team, 2013, R LANG ENV STAT COMP; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Spiegelhalter D J, 2000, Health Technol Assess, V4, P1; Stewart AW, 2001, INT J EPIDEMIOL, V30, P173, DOI 10.1093/ije/30.1.173; Stingone JA, 2006, ANN ALLERG ASTHMA IM, V97, P244, DOI 10.1016/S1081-1206(10)60021-X; Stoms DM, 2000, INT J REMOTE SENS, V21, P401, DOI 10.1080/014311600210920; Weiland SK, 2004, OCCUP ENVIRON MED, V61, P609, DOI 10.1136/oem.2002.006809; Wong GWK, 2006, INT J TUBERC LUNG D, V10, P242; Worm M, 2010, ALLERGY, V65, P671, DOI 10.1111/j.1398-9995.2010.02332.x	23	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121475	10.1371/journal.pone.0121475	http://dx.doi.org/10.1371/journal.pone.0121475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794106	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900136
J	Novak, M; Lah, L; Sala, M; Stojan, J; Bohlmann, J; Komel, R				Novak, Metka; Lah, Ljerka; Sala, Martin; Stojan, Jure; Bohlmann, Joerg; Komel, Radovan			Oleic Acid Metabolism via a Conserved Cytochrome P450 System-Mediated omega-Hydroxylation in the Bark Beetle-Associated Fungus Grosmannia clavigera	PLOS ONE			English	Article							FATTY-ACIDS; OPHIOSTOMA-PICEAE; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; NEIGHBORING GENES; PINUS-CONTORTA; BETA-OXIDATION; EXPRESSION; PATHOGEN; REDUCTASE	The bark beetle-associated fungus Grosmannia clavigera participates in the large-scale destruction of pine forests. In the tree, it must tolerate saturating levels of toxic conifer defense chemicals (e.g. monoterpenes). The fungus can metabolize some of these compounds through the beta-oxidation pathway and use them as a source of carbon. It also uses carbon from pine triglycerides, where oleic acid is the most common fatty acid. High levels of free fatty acids, however, are toxic and can cause additional stress during host colonization. Fatty acids induce expression of neighboring genes encoding a cytochrome P450 (CYP630B18) and its redox partner, cytochrome P450 reductase (CPR2). The aim of this work was to study the function of this novel P450 system. Using LC/MS, we biochemically characterized CYP630 as a highly specific oleic acid.-hydroxylase. We explain oleic acid specificity using protein interaction modeling. Our results underscore the importance of omega-oxidation when the main beta-oxidation pathway may be overwhelmed by other substrates such as host terpenoid compounds. Because this CYP-CPR gene cluster is evolutionarily conserved, our work has implications for metabolism studies in other fungi.	[Novak, Metka; Lah, Ljerka; Sala, Martin; Komel, Radovan] Natl Inst Chem, SI-1000 Ljubljana, Slovenia; [Stojan, Jure] Univ Ljubljana, Fac Med, Inst Biochem, SI-1000 Ljubljana, Slovenia; [Novak, Metka; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	National Institute of Chemistry - Slovenia; University of Ljubljana; University of British Columbia	Lah, L (corresponding author), Univ Potsdam, Inst Biochem & Biol, Evolutionary Biol, D-14476 Potsdam, Germany.	ljerka.lah@ki.si; radovan.komel@ki.si	Novak, Metka/AAX-5743-2021; Sala, Martin/A-3250-2011	Novak, Metka/0000-0002-3041-1156; Sala, Martin/0000-0001-7845-860X	Slovenian Research Agency (ARRS) [P1-010]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	Project funded by the Slovenian Research Agency (ARRS) P1-010; Functional genomics and biotechnology for health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham L, 1998, CAN J MICROBIOL, V44, P698, DOI 10.1139/cjm-44-7-698; Alamouti SM, 2011, MOL ECOL, V20, P2581, DOI 10.1111/j.1365-294X.2011.05109.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avis TJ, 2001, APPL ENVIRON MICROB, V67, P956, DOI 10.1128/AEM.67.2.956-960.2001; Benyagoub M, 1996, LIPIDS, V31, P1077, DOI 10.1007/BF02522465; Bohlmann J, 2012, TREE PHYSIOL, V32, P943, DOI 10.1093/treephys/tps065; Bojja RS, 2004, J AGR FOOD CHEM, V52, P2855, DOI 10.1021/jf035429z; Brase S, 2009, CHEM REV, V109, P3903, DOI 10.1021/cr050001f; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen WP, 2014, GENOME BIOL EVOL, V6, P1620, DOI 10.1093/gbe/evu132; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Dorado J, 2000, J BIOTECHNOL, V80, P231, DOI 10.1016/S0168-1656(00)00264-9; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Eschenfeldt WH, 2003, APPL ENVIRON MICROB, V69, P5992, DOI 10.1128/AEM.69.10.5992-5999.2003; Feng J, 2011, PLANT PATHOL, V60, P698, DOI 10.1111/j.1365-3059.2011.02434.x; Fleet C, 2001, HOLZFORSCHUNG, V55, P340, DOI 10.1515/HF.2001.057; Gabriel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114531; GAO Y, 1995, WORLD J MICROB BIOT, V11, P638, DOI 10.1007/BF00361006; GAO Y, 1995, HOLZFORSCHUNG, V49, P20, DOI 10.1515/hfsg.1995.49.1.20; GARG AP, 1993, MYCOSES, V36, P51, DOI 10.1111/j.1439-0507.1993.tb00687.x; GRAHAMLORENCE S, 1995, PROTEIN SCI, V4, P1065, DOI 10.1002/pro.5560040605; Grauslund M, 1999, NUCLEIC ACIDS RES, V27, P4391, DOI 10.1093/nar/27.22.4391; GRAY SN, 1990, FEMS MICROBIOL LETT, V68, P131, DOI 10.1111/j.1574-6968.1990.tb04136.x; Gruber S, 2012, MICROBIOL-SGM, V158, P26, DOI 10.1099/mic.0.052613-0; Hamann T, 2007, PROTEIN EXPRES PURIF, V56, P121, DOI 10.1016/j.pep.2007.06.007; Haridas S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-373; Hesse-Orce U, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-536; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes MJ, 2011, EUKARYOT CELL, V10, P547, DOI 10.1128/EC.00295-10; Jacquier N, 2010, J CELL SCI, V123, P2218, DOI 10.1242/jcs.063073; Kelly DE, 2009, FUNGAL GENET BIOL, V46, pS53, DOI 10.1016/j.fgb.2008.08.010; Kim D, 2007, ARCH BIOCHEM BIOPHYS, V464, P213, DOI 10.1016/j.abb.2007.02.032; Kitazume T, 2002, EUR J BIOCHEM, V269, P2075, DOI 10.1046/j.1432-1033.2002.02855.x; Kitazume T, 2008, APPL MICROBIOL BIOT, V79, P981, DOI 10.1007/s00253-008-1513-3; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Lah L, 2008, FUNGAL GENET BIOL, V45, P446, DOI 10.1016/j.fgb.2007.10.004; Lah L, 2013, FUNGAL GENET BIOL, V50, P72, DOI 10.1016/j.fgb.2012.10.002; Lah L, 2011, MOL MICROBIOL, V81, P1374, DOI 10.1111/j.1365-2958.2011.07772.x; LARM JA, 1994, J BIOL CHEM, V269, P30097; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; McGary KL, 2013, P NATL ACAD SCI USA, V110, P11481, DOI 10.1073/pnas.1304461110; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama N, 1996, J BIOCHEM-TOKYO, V119, P435; Nelson D., 2005, LEHNINGER PRINCIPLES, P647; Nicol RW, 2012, APPL MICROBIOL BIOT, V93, P1865, DOI 10.1007/s00253-012-3921-7; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; Park HG, 2010, BIOCHEM BIOPH RES CO, V396, P534, DOI 10.1016/j.bbrc.2010.04.138; Podobnik B, 2008, J MED CHEM, V51, P3480, DOI 10.1021/jm800030e; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Scheller U, 1998, J BIOL CHEM, V273, P32528, DOI 10.1074/jbc.273.49.32528; Scheller U, 1996, ARCH BIOCHEM BIOPHYS, V328; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Syed K, 2013, APPL ENVIRON MICROB, V79, P2692, DOI 10.1128/AEM.03767-12; Syed K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028286; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Thomas MC, 2012, ANAL CHEM, V84, P5976, DOI 10.1021/ac3006523; Wang GZ, 2011, GENOME BIOL EVOL, V3, P320, DOI [10.1093/gbe/evr049, 10.1093/gbe/evr025]; Wang Y, 2014, APPL ENVIRON MICROB; Wang Y, 2013, NEW PHYTOL, V197, P886, DOI 10.1111/nph.12063; Warrilow AGS, 2002, BIOCHEM BIOPH RES CO, V299, P189, DOI 10.1016/S0006-291X(02)02600-1; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Yim SK, 2004, J BIOCHEM MOL BIOL, V37, P629; Zimmer T, 1998, EUR J BIOCHEM, V256, P398, DOI 10.1046/j.1432-1327.1998.2560398.x	71	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120119	10.1371/journal.pone.0120119	http://dx.doi.org/10.1371/journal.pone.0120119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794012	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200147
J	Povinelli, BJ; Kokolus, KM; Eng, JWL; Dougher, CW; Curtin, L; Capitano, ML; Sailsbury-Ruf, CT; Repasky, EA; Nemeth, MJ				Povinelli, Benjamin J.; Kokolus, Kathleen M.; Eng, Jason W. -L.; Dougher, Christopher W.; Curtin, Leslie; Capitano, Maegan L.; Sailsbury-Ruf, Christi T.; Repasky, Elizabeth A.; Nemeth, Michael J.			Standard Sub-Thermoneutral Caging Temperature Influences Radiosensitivity of Hematopoietic Stem and Progenitor Cells	PLOS ONE			English	Article							BETA-ADRENERGIC STIMULATION; PANCREATIC-CANCER CELLS; WHOLE-BODY HYPERTHERMIA; MILD COLD-STRESS; LABORATORY MICE; BONE; THERMOGENESIS; INDUCTION; APOPTOSIS; RATS	The production of new blood cells relies on a hierarchical network of hematopoietic stem and progenitor cells (HSPCs). To maintain lifelong hematopoiesis, HSPCs must be protected from ionizing radiation or other cytotoxic agents. For many years, murine models have been a valuable source of information regarding factors that either enhance or reduce the survival of HSPCs after exposure of marrow to ionizing radiation. In a recent series of studies, however, it has become clear that housing-related factors such as the cool room temperature required for laboratory mice can exert a surprising influence on the outcome of experiments. Here we report that the mild, but chronic cold-stress endured by mice housed under these conditions exerts a protective effect on HSPCs after both non-lethal and lethal doses of total body irradiation (TBI). Alleviation of this cold-stress by housing mice at a thermoneutral temperature (30 degrees C) resulted in significantly greater baseline radiosensitivity to a lethal dose of TBI with more HSPCs from mice housed at thermoneutral temperature undergoing apoptosis following non-lethal TBI. Cold-stressed mice have elevated levels of norepinephrine, a key molecule of the sympathetic nervous system that binds to beta-adrenergic receptors. We show that blocking this signaling pathway in vivo through use of the beta-blocker propanolol completely mitigates the protective effect of cold-stress on HSPC apoptosis. Collectively this study demonstrates that chronic stress endured by the standard housing conditions of laboratory mice increases the resistance of HSPCs to TBI-induced apoptosis through a mechanism that depends upon beta-adrenergic signaling. Since beta-blockers are commonly prescribed to a wide variety of patients, this information could be important when predicting the clinical impact of HSPC sensitivity to TBI.	[Povinelli, Benjamin J.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Kokolus, Kathleen M.; Eng, Jason W. -L.; Dougher, Christopher W.; Capitano, Maegan L.; Sailsbury-Ruf, Christi T.; Repasky, Elizabeth A.; Nemeth, Michael J.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Curtin, Leslie] Roswell Pk Canc Inst, Dept Lab Anim Resources, Buffalo, NY 14263 USA; [Nemeth, Michael J.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Nemeth, MJ (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Elm & Carlton St, Buffalo, NY 14263 USA.	Michael.Nemeth@RoswellPark.org	Kokolus, Kathleen M./I-8779-2019; Salisbury-Ruf, Christi/AAJ-9353-2020	Kokolus, Kathleen M./0000-0002-9088-5409; Salisbury-Ruf, Christi/0000-0003-2163-5876; Eng, Jason/0000-0002-8219-2290	National Institutes of Health [R01CA135368, R01 T32 CA085183]; Roswell Park Development Funds; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA135368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roswell Park Development Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health R01CA135368 to EAR, National Institutes of Health R01 T32 CA085183 to JW-LE and KMK, and Roswell Park Development Funds to BJP and MJN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartke A, 2013, ENDOKRYNOL POL, V64, P46; Bartke Andrzej, 2012, Frontiers in Genetics, V3, P288, DOI 10.3389/fgene.2012.00288; BENVENUTO R, 1960, Surg Forum, V10, P558; Blumberg MS, 2004, BODY HEAT TEMPERATUR; Boon MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074083; BYRON JW, 1972, EXP CELL RES, V71, P228, DOI 10.1016/0014-4827(72)90283-2; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Capitano ML, 2012, BLOOD, V120, P2600, DOI 10.1182/blood-2012-02-409805; Casarett AP, 1968, RAD BIOL; Cummings KJ, 2009, AM J PHYSIOL-REG I, V297, pR124, DOI 10.1152/ajpregu.91011.2008; Dacks PA, 2010, ENDOCRINOLOGY, V151, P1187, DOI 10.1210/en.2009-1112; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; David JM, 2013, COMPARATIVE MED, V63, P386; DEPOCAS F, 1960, CAN J BIOCHEM PHYS, V38, P107, DOI 10.1139/o60-012; Eng JWL, 2014, INT J HYPERTHER, V30, P540, DOI 10.3109/02656736.2014.981300; Eng JW-L, 2014, NAT COMMUN IN PRESS; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Flowers MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019734; Garami A, 2011, J NEUROSCI, V31, P1721, DOI 10.1523/JNEUROSCI.4671-10.2011; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Gordon CJ, 2014, J THERM BIOL, V44, P41, DOI 10.1016/j.jtherbio.2014.06.006; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; HORNSEY S, 1957, PROC R SOC SER B-BIO, V147, P547, DOI 10.1098/rspb.1957.0080; HSIEH ACL, 1957, AM J PHYSIOL, V190, P243, DOI 10.1152/ajplegacy.1957.190.2.243; JELKMANN W, 1980, EXP HEMATOL, V8, P742; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kokolus KM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00023; Kokolus KM, 2013, P NATL ACAD SCI USA, V110, P20176, DOI 10.1073/pnas.1304291110; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; LIPSKI S, 1976, INT J RADIAT BIOL, V29, P359, DOI 10.1080/09553007614550411; Lo Martire V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047032; Lutaif NA, 2008, NEPHROL DIAL TRANSPL, V23, P3798, DOI 10.1093/ndt/gfn368; Maestroni GJM, 1997, EXP HEMATOL, V25, P491; Mallick Hruda Nanda, 2012, Front Neurol, V3, P102, DOI 10.3389/fneur.2012.00102; Maloney SK, 2014, PHYSIOLOGY, V29, P413, DOI 10.1152/physiol.00029.2014; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Messmer MN, 2014, BIOESSAYS, V36, P884, DOI 10.1002/bies.201400066; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Muthu K, 2005, J NEUROIMMUNOL, V165, P129, DOI 10.1016/j.jneuroim.2005.04.015; National Research Council, 2011, GUIDE CARE USE LAB A; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; OKADA S, 1992, BLOOD, V80, P3044; Povinelli BJ, 2014, STEM CELLS, V32, P105, DOI 10.1002/stem.1513; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Ramanantsoa N, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00061; Ravussin Y, 2012, AM J PHYSIOL-REG I, V303, pR438, DOI 10.1152/ajpregu.00092.2012; Sastry KSR, 2007, J BIOL CHEM, V282, P14094, DOI 10.1074/jbc.M611370200; Serrat MA, 2014, COMPR PHYSIOL, V4, P621, DOI 10.1002/cphy.c130023; Serrat MA, 2008, P NATL ACAD SCI USA, V105, P19348, DOI 10.1073/pnas.0803319105; Shan T, 2011, EUR J PHARMACOL, V665, P1, DOI 10.1016/j.ejphar.2011.04.055; SHEN RN, 1991, INT J RADIAT ONCOL, V20, P525, DOI 10.1016/0360-3016(91)90065-C; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Swoap SJ, 2008, AM J PHYSIOL-HEART C, V294, pH1581, DOI 10.1152/ajpheart.01000.2007; Uchida K, 2010, PFLUG ARCH EUR J PHY, V459, P765, DOI 10.1007/s00424-010-0795-3; Virtue S, 2012, CELL METAB, V16, P665, DOI 10.1016/j.cmet.2012.10.008; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Zaidi AK, 2002, J THERM BIOL, V27, P29, DOI 10.1016/S0306-4565(01)00012-2; Zhang D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-146	65	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120078	10.1371/journal.pone.0120078	http://dx.doi.org/10.1371/journal.pone.0120078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793392	Green Submitted, gold, Green Published			2022-12-26	WOS:000352084200141
J	Smith, D; Leary, P; Craggs, J; Bythell, J; Sweet, M				Smith, David; Leary, Peter; Craggs, Jamie; Bythell, John; Sweet, Michael			Microbial Communities Associated with Healthy and White Syndrome-Affected Echinopora lamellosa in Aquaria and Experimental Treatment with the Antibiotic Ampicillin	PLOS ONE			English	Article							BROWN BAND DISEASE; BACTERIAL COMMUNITIES; ANTIMICROBIAL PROPERTIES; CORAL DISEASE; REEF CORAL; CILIATE; PHAEOBACTER; DYNAMICS; IDENTIFICATION; DRIVERS	Prokaryotic and ciliate communities of healthy and aquarium White Syndrome (WS)-affected coral fragments were screened using denaturing gradient gel electrophoresis (DGGE). A significant difference (R = 0.907, p < 0.001) in 16S rRNA prokaryotic diversity was found between healthy (H), sloughed tissue (ST), WS-affected (WSU) and antibiotic treated (WST) samples. Although 3 Vibrio spp were found in WS-affected samples, two of these species were eliminated following ampicillin treatment, yet lesions continued to advance, suggesting they play a minor or secondary role in the pathogenesis. The third Vibrio sp increased slightly in relative abundance in diseased samples and was abundant in non-diseased samples. Interestingly, a Tenacibaculum sp showed the greatest increase in relative abundance between healthy and WS-affected samples, demonstrating consistently high abundance across all WS-affected and treated samples, suggesting Tenacibaculum sp could be a more likely candidate for pathogenesis in this instance. In contrast to previous studies bacterial abundance did not vary significantly (ANOVA, F2, 6 = 1.000, p = 0.422) between H, ST, WSU or WST. Antimicrobial activity (assessed on Vibrio harveyi cultures) was limited in both H and WSU samples (8.1% +/- 8.2 and 8.0% +/- 2.5, respectively) and did not differ significantly (Kruskal-Wallis, chi(2) (2) = 3.842, p = 0.146). A Philaster sp, a Cohnilembus sp and a Pseudokeronopsis sp. were present in all WS-affected samples, but not in healthy samples. The exact role of ciliates in WS is yet to be determined, but it is proposed that they are at least responsible for the neat lesion boundary observed in the disease.	[Smith, David; Leary, Peter; Bythell, John; Sweet, Michael] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Smith, David] Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Craggs, Jamie] Horniman Museum & Gardens Aquarium, London SE23 3PQ, England; [Sweet, Michael] Univ Derby, Biol Sci Res Grp, Derby DE22 1GB, England	Newcastle University - UK; Queens University Belfast; University of Derby	Smith, D (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	dsmith37@qub.ac.uk	Bythell, John/ABE-6138-2021; Bythell, John C/E-7962-2010; Smith, David/AAH-4738-2020; Sweet, Michael/E-9661-2012	Bythell, John/0000-0003-2416-9786; Bythell, John C/0000-0003-2416-9786; Smith, David/0000-0002-5158-0522; Craggs, Jamie/0000-0002-3787-2203; Sweet, Michael/0000-0003-4983-8333	Natural Environment Research Council [NE/H020616/1]; NERC [NE/H020616/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding: This work was supported by the Natural Environment Research Council grant (NE/H020616/1) (www.nerc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Galil M., 2012, INT J ENV SCI ENG, V3, P25; Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; [Anonymous], 2011, PLOS PATHOG; Avendano-Herrera R, 2006, DIS AQUAT ORGAN, V71, P255, DOI 10.3354/dao071255; Bourne DG, 2008, APPL ENVIRON MICROB, V74, P883, DOI 10.1128/AEM.01124-07; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Croquer A, 2013, ENV MICROBIOL REP, V5, P90, DOI 10.1111/j.1758-2229.2012.00397.x; D'Alvise PW, 2013, AQUACULTURE, V384, P82, DOI 10.1016/j.aquaculture.2012.12.013; D'Alvise PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043996; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Foden W, SPECIES SUSCEPTIBILI, P77; Gochfeld DJ, 2011, VARIABILITY ANTIBACT; GUNTHORPE L, 1990, TOXICON, V28, P1199, DOI 10.1016/0041-0101(90)90120-V; Harder T, 2008, FEMS MICROBIOLOGY EC, V43, P337; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hayes RL, 1998, REV BIOL TROP, V46, P173; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; Jousset A, 2010, SCI TOTAL ENVIRON, V408, P1221, DOI 10.1016/j.scitotenv.2009.09.056; Kennedy J, 2009, MAR BIOTECHNOL, V11, P384, DOI 10.1007/s10126-008-9154-1; Kumar K.S., 2011, RES J MICROBIOL, V6, P385; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; Luna GM, 2007, ENVIRON MICROBIOL, V9, P1851, DOI 10.1111/j.1462-2920.2007.01287.x; Luna GM, 2010, ENV MICROBIOL REP, V2, P120, DOI 10.1111/j.1758-2229.2009.00114.x; Manivasagan P, 2009, ADV BIOL RES, V3, P231; Marquis CP, 2005, CORAL REEFS, V24, P248, DOI 10.1007/s00338-005-0473-7; Messick GA, 1996, INVERTEBR BIOL, V115, P1, DOI 10.2307/3226937; Morado JF, 1999, DIS AQUAT ORGAN, V38, P143, DOI 10.3354/dao038143; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Piskorska M, 2007, AFRICAN J ENV SCI TE, V1, P93; Porsby CH, 2008, APPL ENVIRON MICROB, V74, P7356, DOI 10.1128/AEM.01738-08; Prado S, 2009, INT MICROBIOL, V12, P107, DOI 10.2436/20.1501.01.87; Qin L, 2007, ACTA HYDROBIOL, V31, P622; Radjasa OK, 2008, MICROBIOLOGY INDONES, V2, P84; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sato Y, 2010, ISME J, V4, P203, DOI 10.1038/ismej.2009.103; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Shimeta J, 2001, LIMNOL OCEANOGR, V46, P1709, DOI 10.4319/lo.2001.46.7.1709; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Small HJ, 2005, DIS AQUAT ORGAN, V67, P225, DOI 10.3354/dao067225; Smith D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097018; Sokolow S, 2009, DIS AQUAT ORGAN, V87, P5, DOI 10.3354/dao02099; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004511; Sweet M, 2015, MOL ECOLOGY IN PRESS; Sweet MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0094; Sweet MJ, 2011, CORAL REEFS, V30, P1121, DOI 10.1007/s00338-011-0800-0; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Sweet M, 2012, J MAR BIOL ASSOC UK, V92, P791, DOI 10.1017/S0025315411001688; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; Sweet MJ, 2013, J EXPT ANAL BEHAV, V1, P1; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; WAGNER M, 1993, APPL ENVIRON MICROB, V59, P1520, DOI 10.1128/AEM.59.5.1520-1525.1993; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69	66	6	6	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121780	10.1371/journal.pone.0121780	http://dx.doi.org/10.1371/journal.pone.0121780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794037	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900154
J	Testa, R; Vanhooren, V; Bonfigli, AR; Boemi, M; Olivieri, F; Ceriello, A; Genovese, S; Spazzafumo, L; Borelli, V; Bacalini, MG; Salvioli, S; Garagnani, P; Dewaele, S; Libert, C; Franceschi, C				Testa, Roberto; Vanhooren, Valerie; Bonfigli, Anna Rita; Boemi, Massimo; Olivieri, Fabiola; Ceriello, Antonio; Genovese, Stefano; Spazzafumo, Liana; Borelli, Vincenzo; Bacalini, Maria Giulia; Salvioli, Stefano; Garagnani, Paolo; Dewaele, Sylviane; Libert, Claude; Franceschi, Claudio			N-Glycomic Changes in Serum Proteins in Type 2 Diabetes Mellitus Correlate with Complications and with Metabolic Syndrome Parameters	PLOS ONE			English	Article							O-GLCNAC MODIFICATION; INSULIN-RESISTANCE; GLYCOSYLATION; GLYCAN; GLYCOPROTEIN; OLIGOSACCHARIDES; MECHANISMS; PATHWAY; BLOOD; MICE	Background Glycosylation, i.e the enzymatic addition of oligosaccharides (or glycans) to proteins and lipids, known as glycosylation, is one of the most common co-/posttranslational modifications of proteins. Many important biological roles of glycoproteins are modulated by N-linked oligosaccharides. As glucose levels can affect the pathways leading to glycosylation of proteins, we investigated whether metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM), pathological conditions characterized by altered glucose levels, are associated with specific modifications in serum N-glycome. Methods We enrolled in the study 562 patients with Type 2 Diabetes Mellitus (T2DM) (mean age 65.6 +/- 8.2 years) and 599 healthy control subjects (CTRs) (mean age, 58.5 +/- 12.4 years). N-glycome was evaluated in serum glycoproteins. Results We found significant changes in N-glycan composition in the sera of T2DM patients. In particular, alpha(1,6)-linked arm monogalactosylated, core-fucosylated diantennary N-glycans (NG1(6)A2F) were significantly reduced in T2DM compared with CTR subjects. Importantly, they were equally reduced in diabetic patients with and without complications (P<0.001) compared with CTRs. Macro vascular-complications were found to be related with decreased levels of NG1(6) A2F. In addition, NG1(6) A2F and NG1(3) A2F, identifying, respectively, monogalactosylated N-glycans with alpha(1,6)- and alpha(1,3)-antennary galactosylation, resulted strongly correlated with most MS parameters. The plasmatic levels of these two glycans were lower in T2DM as compared to healthy controls, and even lower in patients with complications and MS, that is the extreme "unhealthy" phenotype (T2DM+ with MS). Conclusions Imbalance of glycosyltransferases, glycosidases and sugar nucleotide donor levels is able to cause the structural changes evidenced by our findings. Serum N-glycan profiles are thus sensitive to the presence of diabetes and MS. Serum N-glycan levels could therefore provide a non-invasive alternative marker for T2DM and MS.	[Testa, Roberto] INRCA Ancona, Expt Models Clin Pathol, I-60127 Ancona, Italy; [Vanhooren, Valerie; Dewaele, Sylviane; Libert, Claude] VIB Inflammat Res Ctr, B-9052 Ghent, Belgium; [Vanhooren, Valerie; Dewaele, Sylviane; Libert, Claude] Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium; [Bonfigli, Anna Rita] INRCA Ancona, Sci Direct, I-60124 Ancona, Italy; [Boemi, Massimo] INRCA Ancona, Metab Dis & Diabetol Unit, I-60127 Ancona, Italy; [Olivieri, Fabiola] Univ Politecn Marche, Dept Clin & Mol Sci, I-60020 Ancona, Italy; [Olivieri, Fabiola] INRCA Ancona, Ctr Clin Pathol & Innovat Therapy, I-60127 Ancona, Italy; [Ceriello, Antonio] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona 08036, Spain; [Ceriello, Antonio] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08017, Spain; [Genovese, Stefano] IRCCS Grp Multimed Sesto San Giovanni MI, Dept Cardiovasc & Metab Dis, I-20099 Sesto San Giovanni, Italy; [Spazzafumo, Liana] INRCA Ancona, Ctr Biostat, I-60124 Ancona, Italy; [Borelli, Vincenzo; Bacalini, Maria Giulia; Salvioli, Stefano; Garagnani, Paolo; Franceschi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med Expt Pathol, I-40126 Bologna, Italy; [Garagnani, Paolo; Franceschi, Claudio] St Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res, I-40138 Bologna, Italy; [Garagnani, Paolo; Franceschi, Claudio] Univ Bologna, Interdept Ctr L Galvani CIG, I-40126 Bologna, Italy; [Franceschi, Claudio] Inst Neurol Sci Bologna, IRCCS, I-40124 Bologna, Italy	IRCCS INRCA; Flanders Institute for Biotechnology (VIB); Ghent University; IRCCS INRCA; IRCCS INRCA; Marche Polytechnic University; IRCCS INRCA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; IRCCS INRCA; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB)	Testa, R (corresponding author), INRCA Ancona, Expt Models Clin Pathol, I-60127 Ancona, Italy.	r.testa@inrca.it	Bonfigli, Anna Rita R/J-7248-2016; Spazzafumo, Liana/E-5488-2015; Bacalini, Maria Giulia/K-4931-2016; Ceriello, Antonio/J-9575-2016; Testa, Roberto/ABH-7467-2020; Salvioli, Stefano/K-6663-2016; Olivieri, Fabiola/K-6465-2016; Franceschi, Claudio/L-4484-2017; Genovese, Stefano/F-9706-2017	Bonfigli, Anna Rita R/0000-0002-9619-0181; Bacalini, Maria Giulia/0000-0003-1618-2673; Testa, Roberto/0000-0001-8308-7663; Salvioli, Stefano/0000-0002-6191-1225; Olivieri, Fabiola/0000-0002-9606-1144; Franceschi, Claudio/0000-0001-9841-6386; Ceriello, Antonio/0000-0001-8122-3203; Garagnani, Paolo/0000-0002-4161-3626; Genovese, Stefano/0000-0002-6085-437X; Spazzafumo, Liana/0000-0002-9718-1658				Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Bunz SC, 2013, ANAL CHEM, V85, P10218, DOI 10.1021/ac401930j; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Callewaert N, 2001, GLYCOBIOLOGY, V11, P275, DOI 10.1093/glycob/11.4.275; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dall'Olio F, 2011, SPR CARB CH, V37, P21, DOI 10.1039/9781849732765-00021; Dall'Olio F, 2013, AGEING RES REV, V12, P685, DOI 10.1016/j.arr.2012.02.002; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Durand G, 2000, CLIN CHEM, V46, P795; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Einarsdottir HK, 2013, GLYCOCONJUGATE J, V30, P147, DOI 10.1007/s10719-012-9381-6; Ellis TP, 2013, CURR DIABETES REV, V9, P146, DOI 10.2174/1573399811309020006; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Haltiwanger RS, 1997, BIOCHEM BIOPH RES CO, V231, P237, DOI 10.1006/bbrc.1997.6110; Higai K, 2003, CLIN CHIM ACTA, V329, P117, DOI 10.1016/S0009-8981(02)00427-8; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975; Kobata A, 2003, BIOCHIMIE, V85, P13, DOI 10.1016/S0300-9084(03)00003-8; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; LEE LPK, 1977, CLIN BIOCHEM, V10, P111, DOI 10.1016/S0009-9120(77)91508-9; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Leibowitz A, 2009, DIABETES CARE, V32, pS275, DOI 10.2337/dc09-S323; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; MCMILLAN DE, 1972, DIABETES, V21, P863, DOI 10.2337/diab.21.8.863; Myslicki JP, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-96; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SPIRO MJ, 1984, DIABETOLOGIA, V26, P70; Springhorn C, 2012, J CLIN ENDOCR METAB, V97, P4640, DOI 10.1210/jc.2012-2229; Strazzullo P, 2008, METABOLISM, V57, P355, DOI 10.1016/j.metabol.2007.10.010; Taniguchi N, 2011, BMB REP, V44, P772, DOI 10.5483/BMBRep.2011.44.12.772; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z; Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556; WAJCHENBERG BL, 1994, DIABETES METAB REV, V10, P19, DOI 10.1002/dmr.5610100103; Wang Z, 2009, DIABETES, V58, P309, DOI 10.2337/db08-0994; Yarema KJ, 2001, GENOME BIOL, V2; YODAIKEN RE, 1975, DIABETES, V24, P286, DOI 10.2337/diabetes.24.3.286	46	73	75	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119983	10.1371/journal.pone.0119983	http://dx.doi.org/10.1371/journal.pone.0119983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793407	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200132
J	Wuest, W; Lell, M; May, M; Scharf, M; Schlundt, C; Achenbach, S; Uder, M; Schmid, A				Wuest, Wolfgang; Lell, Michael; May, Matthias; Scharf, Michael; Schlundt, Christian; Achenbach, Stephan; Uder, Michael; Schmid, Axel			Determining Microvascular Obstruction and Infarct Size with Steady-State Free Precession Imaging Cardiac MRI	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; NO-REFLOW PHENOMENON; LEFT-VENTRICULAR FUNCTION; PROGNOSTIC-SIGNIFICANCE; FUNCTIONAL RECOVERY; TIME-COURSE; CORONARY; ENHANCEMENT; PREDICTOR; PERFUSION	Purpose In cardiac MRI (cMRI) injection of contrast medium may be performed prior to the acquisition of cine steady-state free precession (SSFP) imaging to speed up the protocol and avoid delay before late Gadolinium enhancement (LGE) imaging. Aim of this study was to evaluate whether a condensed clinical protocol with contrast cine SSFP imaging is able to detect early microvascular obstruction (MO) and determine the infarct size compared to the findings of LGE inversion recovery sequences. Materials and Methods The study complies with the Declaration of Helsinki and was performed following approval by the ethic committee of the University of Erlangen-Nuremberg. Written informed consent was obtained from every patient. 68 consecutive patients (14 females/54 males) with acute ST-elevation myocardial infarction (STEMI) treated by percutaneous coronary revascularization were included in this study. CMRI was performed 6.6 +/- 2 days after symptom onset and MO and infarct size in early contrast SSFP cine imaging were compared to LGE imaging. Results MO was detected in 47/68 (69%) patients on cine SSFP and in 41/68 (60%) patients on LGE imaging. In 6 patients MO was found on cine SSFP imaging but was not detectable on LGE imaging. Infarct size on cine SSFP showed a strong agreement to LGE imaging (intraclass correlation coefficient [ICC] of 0.96 for enddiastolic, p<0.001 and 0.96 for endsystolic, p<0.001 respectively). Significant interobserver agreement was found measuring enddiastolic and endsystolic infarct size on cine SSFP imaging (p<0.01). Conclusions In patients after STEMI infarct size and presence of MO can be detected with contrast cine SSFP imaging. This could be an option in patients who are limited in their ability to comply with the demands of a cMRI protocol.	[Wuest, Wolfgang; Lell, Michael; May, Matthias; Scharf, Michael; Uder, Michael; Schmid, Axel] Univ Erlangen Nurnberg, Inst Radiol, D-91054 Erlangen, Germany; [Schlundt, Christian; Achenbach, Stephan] Univ Erlangen Nurnberg, Div Cardiol, Dept Internal Med 2, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Wuest, W (corresponding author), Univ Erlangen Nurnberg, Inst Radiol, D-91054 Erlangen, Germany.	wolfgang.wuest@uk-erlangen.de	May, Matthias/AAZ-4877-2021	May, Matthias/0000-0002-2540-850X				Bekkers SCAM, 2009, EUR RADIOL, V19, P2904, DOI 10.1007/s00330-009-1489-0; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bogaert J, 2007, EUR RADIOL, V17, P2572, DOI 10.1007/s00330-007-0627-9; de Waha S, 2010, EUR HEART J, V31, P2660, DOI 10.1093/eurheartj/ehq247; Gerber BL, 2002, CIRCULATION, V106, P1083, DOI 10.1161/01.CIR.0000027818.15792.1E; Gibson CM, 2004, CIRCULATION, V109, P3096, DOI 10.1161/01.CIR.0000134278.50359.CB; Grines CL, 1999, N ENGL J MED; Hombach V, 2005, EUR HEART J, V26, P549, DOI 10.1093/eurheartj/ehi147; ITO H, 1992, CIRCULATION, V85, P1699, DOI 10.1161/01.CIR.85.5.1699; Ito H, 1996, CIRCULATION, V93, P223, DOI 10.1161/01.CIR.93.2.223; Judd RM, 2002, CIRCULATION, V106, P1083; Kim RJ, 1996, CIRCULATION, V94, P3318, DOI 10.1161/01.CIR.94.12.3318; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Krombach GA, 2011, EUR RADIOL, V21, P702, DOI 10.1007/s00330-010-1969-2; Lund GK, 2004, RADIOLOGY, V232, P49, DOI 10.1148/radiol.2321031127; Lund GK, 2007, RADIOLOGY, V245, P95, DOI 10.1148/radiol.2451061219; MANCIET LH, 1994, AM J PHYSIOL, V266, pH1541, DOI 10.1152/ajpheart.1994.266.4.H1541; Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2; Nijveldt R, 2008, J AM COLL CARDIOL, V52, P181, DOI 10.1016/j.jacc.2008.04.006; PIANA RN, 1994, CIRCULATION, V89, P2514, DOI 10.1161/01.CIR.89.6.2514; Raff GL, 2006, RADIOLOGY, V240, P529, DOI 10.1148/radiol.2402050369; Rochitte CE, 1998, CIRCULATION, V98, P1006, DOI 10.1161/01.CIR.98.10.1006; Roe MT, 2001, J AM COLL CARDIOL, V37, P9, DOI 10.1016/S0735-1097(00)01101-3; Rogers WJ, 1999, CIRCULATION, V99, P744, DOI 10.1161/01.CIR.99.6.744; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; SHEEHAN FH, 1988, J AM COLL CARDIOL, V12, P289, DOI 10.1016/0735-1097(88)90397-X; Topol EJ, 2000, CIRCULATION, V101, P570, DOI 10.1161/01.CIR.101.5.570; Wu KC, 1998, J AM COLL CARDIOL, V32, P1756, DOI 10.1016/S0735-1097(98)00429-X; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Yan AT, 2006, J CARDIOVASC MAGN R, V8, P831, DOI 10.1080/10976640600778049	30	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119788	10.1371/journal.pone.0119788	http://dx.doi.org/10.1371/journal.pone.0119788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793609	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200116
J	Xu, JW; Lan, HX; Fang, HM; Huang, X; Zhang, HS; Huang, J				Xu, Jianwen; Lan, Hongxia; Fang, Huimin; Huang, Xi; Zhang, Hongsheng; Huang, Ji			Quantitative Proteomic Analysis of the Rice (Oryza sativa L.) Salt Response	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PHOTOSYSTEM-I; SPIRULINA-PLATENSIS; DROUGHT STRESS; MODEL SYSTEM; PHOTOSYNTHESIS; PLANTS; GROWTH; SALINITY; PATHWAYS	Salt stress is one of most serious limiting factors for crop growth and production. An isobaric Tags for Relative and Absolute Quantitation (iTRAQ) approach was used to analyze proteomic changes in rice shoots under salt stress in this study. A total of 56 proteins were significantly altered and 16 of them were enriched in the pathways of photosynthesis, antioxidant and oxidative phosphorylation. Among these 16 proteins, peroxiredoxin Q and photosystem I subunit D were up-regulated, while thioredoxin M-like, thioredoxin x, thioredoxin peroxidase, glutathione S-transferase F3, PSI subunit H, light-harvesting antenna complex I subunits, chloroplast chaperonin, vacuolar ATP synthase subunit H, and ATP synthase delta chain were down-regulated. Moreover, physiological data including total antioxidant capacity, peroxiredoxin activity, chlorophyll a/b content, glutathione S-transferase activity, reduced glutathione content and ATPase activity were consistent with changes in the levels of these proteins. The levels of the mRNAs encoding these proteins were also analyzed by real-time quantitative reverse transcription PCR, and approximately 86% of the results were consistent with the iTRAQ data. Importantly, our data suggest the important role of PSI in balancing energy supply and ROS generation under salt stress. This study provides information for an improved understanding of the function of photosynthesis and PSI in the salt-stress response of rice.	[Xu, Jianwen; Lan, Hongxia; Fang, Huimin; Huang, Xi; Zhang, Hongsheng; Huang, Ji] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Xu, Jianwen; Fang, Huimin; Huang, Xi; Zhang, Hongsheng; Huang, Ji] Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing 210095, Jiangsu, Peoples R China; [Lan, Hongxia] Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Zhang, HS (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	hszhang@njau.edu.cn; huangji@njau.edu.cn	Huang, Ji/AAY-2852-2020; lan, hongxia/GWC-5420-2022	Huang, Ji/0000-0002-9057-4299; 	National Science Foundation of China [31071069]; Jiangsu Provincial Natural Science Foundation [BK20141362]; State Key Laboratory of Rice Biology [110101]; 111 Project; Fundamental Research Funds for the Central Universities [KYZ201137]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); State Key Laboratory of Rice Biology; 111 Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded by the National Science Foundation of China (31071069): JH. Jiangsu Provincial Natural Science Foundation (BK20141362): JH. State Key Laboratory of Rice Biology (110101): JH. The 111 Project, and the Fundamental Research Funds for the Central Universities (KYZ201137): JH	Abbasi FM, 2004, PROTEOMICS, V4, P2072, DOI 10.1002/pmic.200300741; Allakhverdiev SI, 2000, PLANT PHYSIOL, V123, P1047, DOI 10.1104/pp.123.3.1047; Carius AB, 2011, J BACTERIOL, V193, P1893, DOI 10.1128/JB.01353-10; Ceppi MG, 2012, PHYSIOL PLANTARUM, V144, P277, DOI 10.1111/j.1399-3054.2011.01549.x; Cheng YW, 2009, PROTEOMICS, V9, P3100, DOI 10.1002/pmic.200800340; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Courteille A, 2013, PLANT PHYSIOL, V161, P508, DOI 10.1104/pp.112.207019; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Gruber AV, 2013, TRENDS PLANT SCI, V18, P688, DOI 10.1016/j.tplants.2013.08.001; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; Kao WY, 2001, J PLANT PHYSIOL, V158, P841, DOI 10.1078/0176-1617-00248; Khavari-Nejad RA, 1998, PHOTOSYNTHETICA, V35, P151, DOI 10.1023/A:1006846504261; Kim DW, 2005, ELECTROPHORESIS, V26, P4521, DOI 10.1002/elps.200500334; Kim SR, 2013, MOL CELLS, V35, P402, DOI 10.1007/s10059-013-2337-2; Kurban H, 1999, SOIL SCI PLANT NUTR, V45, P851, DOI 10.1080/00380768.1999.10414334; Lamkemeyer P, 2006, PLANT J, V45, P968, DOI 10.1111/j.1365-313X.2006.02665.x; Ledford HK, 2007, EUKARYOT CELL, V6, P919, DOI 10.1128/EC.00207-06; Liu DW, 2013, PROTEOMICS, V13, P2046, DOI 10.1002/pmic.201200425; Lu C, 2002, PHYSIOL PLANTARUM, V114, P405, DOI 10.1034/j.1399-3054.2002.1140310.x; Lu CM, 1999, NEW PHYTOL, V141, P231, DOI 10.1046/j.1469-8137.1999.00340.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Moradi F, 2007, ANN BOT-LONDON, V99, P1161, DOI 10.1093/aob/mcm052; Munekage YN, 2008, PLANT CELL PHYSIOL, V49, P1688, DOI 10.1093/pcp/pcn140; Naver H, 1999, J BIOL CHEM, V274, P10784, DOI 10.1074/jbc.274.16.10784; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Pulido P, 2010, J EXP BOT, V61, P4043, DOI 10.1093/jxb/erq218; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tiwari BS, 1997, PHOTOSYNTHETICA, V34, P303, DOI 10.1023/A:1006857027398; Unal D, 2013, PHOTOSYNTHESIS, DOI [10.5772/55350, DOI 10.5772/55350]; Wang XM, 2013, ACTA PHYSIOL PLANT, V35, P891, DOI 10.1007/s11738-012-1132-6; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yu QB, 2014, MOL PLANT, V7, P206, DOI 10.1093/mp/sst092; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069046; Zhang T, 2010, J PLANT PHYSIOL, V167, P951, DOI 10.1016/j.jplph.2009.12.020; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074229	41	36	38	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120978	10.1371/journal.pone.0120978	http://dx.doi.org/10.1371/journal.pone.0120978			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793471	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900095
J	Ye, S; Yang, JX; Cao, DY; Bai, HM; Huang, HF; Wu, M; Chen, J; You, Y; Lang, JH; Shen, K				Ye, Shuang; Yang, Jiaxin; Cao, Dongyan; Bai, Huimin; Huang, Huifang; Wu, Ming; Chen, Jie; You, Yan; Lang, Jinghe; Shen, Keng			Characteristic and Prognostic Implication of Venous Thromboembolism in Ovarian Clear Cell Carcinoma: A 12-Year Retrospective Study	PLOS ONE			English	Article							CANCER; LYMPHADENECTOMY; PROPHYLAXIS; THROMBOSIS; SURVIVAL	Purpose To profile the characteristic and prognostic implications of venous thromboembolism (VTE) in Chinese ovarian clear cell carcinoma (CCC) patients. Methods We identified all of the cases between 2000 and 2012 by searching our institutional Ovarian CCC Database. A comprehensive review of the medical documentation was performed to collect relevant data. Kaplan-Meier models and Cox regression were employed for survival analysis. Results Of the 227 patients, 33 (14.5%) experienced VTE events. There was no significant difference between VTE and non-VTE group patients regarding age, serum cancer antigen 125 or tumor size. The optimal cytoreduction rate was higher in patients without VTE (70.1%) than in those with VTE (51.5%). VTE events were more likely to occur at presentation (36.4%) and recurrence (33.3%), followed by an adjuvant chemotherapy period (18.2%). VTE was more common in patients with advanced-stage disease than those with earlystage disease (P=0.003), whereas pulmonary embolism (PE) was 10-fold as common in advanced-stage disease as in early-stage disease (8.6% vs. 0.8%, P = 0.012). Patients with advanced disease tended to have thrombi in the proximal veins. Two patients died of PE, as confirmed by autopsy. Patients with VTE had reduced survival compared to those without VTE (median overall survival 54 vs. 140 months, P<0.001; median progression-free survival 17 vs. 43 months, P<0.001). Conclusions Overall, 14.5% of the patients with ovarian CCC experienced VTE, mainly before their cancer diagnosis or at a time of recurrence. VTE adversely impacted patient survival.	[Ye, Shuang; Yang, Jiaxin; Cao, Dongyan; Bai, Huimin; Huang, Huifang; Wu, Ming; Lang, Jinghe; Shen, Keng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China; [Ye, Shuang; Yang, Jiaxin; Cao, Dongyan; Bai, Huimin; Huang, Huifang; Wu, Ming; Chen, Jie; You, Yan; Lang, Jinghe; Shen, Keng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Jie; You, Yan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Shen, K (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China.	shenkeng@vip.sina.com		Ye, Shuang/0000-0001-5624-7908	National High Technology Research Development Program of China (863 program) [2012AA02A507]; National Natural Science Foundation of China [81172482, 81372780]	National High Technology Research Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research Development Program of China (863 program): Grant No. 2012AA02A507; URLs: http://www.863.gov.cn/ and the National Natural Science Foundation of China: Grant No. 81172482 and No. 81372780; URLs: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen AT, 2010, THROMB RES, V125, pS21, DOI 10.1016/S0049-3848(10)70008-6; Diaz ES, 2013, GYNECOL ONCOL, V131, P541, DOI 10.1016/j.ygyno.2013.09.005; DONATI MB, 1994, HAEMOSTASIS, V24, P128; du Bois A, 2010, J CLIN ONCOL, V28, P1733, DOI 10.1200/JCO.2009.25.3617; Duska LR, 2010, GYNECOL ONCOL, V116, P374, DOI 10.1016/j.ygyno.2009.10.069; Einstein MH, 2007, GYNECOL ONCOL, V105, P813, DOI 10.1016/j.ygyno.2007.03.004; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Lim MC, 2010, ARCH GYNECOL OBSTET, V281, P329, DOI 10.1007/s00404-009-1120-2; Lyman GH, 2013, J CLIN ONCOL, V31, P2189, DOI 10.1200/JCO.2013.49.1118; Mandala M, 2006, CRIT REV ONCOL HEMAT, V59, P194, DOI 10.1016/j.critrevonc.2006.05.001; Matsuura Y, 2007, GYNECOL ONCOL, V104, P406, DOI 10.1016/j.ygyno.2006.08.026; Okamoto A, 2014, INT J GYNECOL CANCER, V24, pS20, DOI 10.1097/IGC.0000000000000289; Panici PB, 2005, JNCI-J NATL CANCER I, V97, P560, DOI 10.1093/jnci/dji102; Rodriguez AO, 2007, GYNECOL ONCOL, V105, P784, DOI 10.1016/j.ygyno.2007.02.024; Sandhu R, 2010, CANCER-AM CANCER SOC, V116, P2596, DOI 10.1002/cncr.25004; Satoh T, 2007, BRIT J CANCER, V97, P1053, DOI 10.1038/sj.bjc.6603989; Scarvelis D, 2006, CAN MED ASSOC J, V175, P1087, DOI 10.1503/cmaj.060366; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Zhang Yu, 2003, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V25, P471	20	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121818	10.1371/journal.pone.0121818	http://dx.doi.org/10.1371/journal.pone.0121818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793293	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900156
J	Ascenzi, P; Leboffe, L; di Masi, A; Trezza, V; Fanali, G; Gioia, M; Coletta, M; Fasano, M				Ascenzi, Paolo; Leboffe, Loris; di Masi, Alessandra; Trezza, Viviana; Fanali, Gabriella; Gioia, Magda; Coletta, Massimo; Fasano, Mauro			Ligand Binding to the FA3-FA4 Cleft Inhibits the Esterase-Like Activity of Human Serum Albumin	PLOS ONE			English	Article							PSEUDO-ENZYMATIC HYDROLYSIS; PLASMA-CONCENTRATIONS; INDOXYL SULFATE; NITROPHENYL ESTERS; PRACTICAL ASPECTS; INDIVIDUAL STEPS; PH-DEPENDENCE; PROPOFOL; DIAZEPAM; MECHANISM	The hydrolysis of 4-nitrophenyl esters of hexanoate (NphOHe) and decanoate (NphODe) by human serum albumin (HSA) at Tyr411, located at the FA3-FA4 site, has been investigated between pH 5.8 and 9.5, at 22.0 degrees C. Values of K-s, k(+2), and k(+2)/K-s obtained at [HSA] >= 5x[NphOXx] and [NphOXx] >= 5x[HSA] (Xx is NphOHe or NphODe) match very well each other; moreover, the deacylation step turns out to be the rate limiting step in catalysis (i.e., k(+3) << k(+2)). The pH dependence of the kinetic parameters for the hydrolysis of NphOHe and NphODe can be described by the acidic pK(a)-shift of a single amino acid residue, which varies from 8.9 in the free HSA to 7.6 and 7.0 in the HSA: NphOHe and HSA: NphODe complex, respectively; the pK>(a)-shift appears to be correlated to the length of the fatty acid tail of the substrate. The inhibition of the HSA-Tyr411-catalyzed hydrolysis of NphOHe, NphODe, and 4-nitrophenyl myristate (NphOMy) by five inhibitors (i.e., diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol) has been investigated at pH 7.5 and 22.0 degrees C, resulting competitive. The affinity of diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol for HSA reflects the selectivity of the FA3-FA4 cleft. Under conditions where Tyr411 is not acylated, the molar fraction of diazepam, diflunisal, ibuprofen, and 3-indoxylsulfate bound to HSA is higher than 0.9 whereas the molar fraction of propofol bound to HSA is ca. 0.5.	[Ascenzi, Paolo] Univ Rome Tre, Interdept Lab Electron Microscopy, I-00146 Rome, Italy; [Leboffe, Loris; di Masi, Alessandra; Trezza, Viviana] Univ Rome Tre, Dept Sci, I-00146 Rome, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Dept Theoret & Appl Sci, Biomed Res Div, I-21052 Busto Arsizio, VA, Italy; [Gioia, Magda; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, I-00133 Rome, Italy; [Gioia, Magda; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, I-70126 Bari, Italy	Roma Tre University; Italfarmaco; Roma Tre University; University of Insubria; University of Rome Tor Vergata	Ascenzi, P (corresponding author), Univ Rome Tre, Interdept Lab Electron Microscopy, Via Vasca Navale 79, I-00146 Rome, Italy.	ascenzi@uniroma3.it	Gioia, Magda/AAD-4781-2022; Leboffe, Loris/K-7838-2016; di Masi, Alessandra/K-2300-2018; Coletta, Massimo/N-9049-2015; Gioia, Magda/ABF-8909-2020; Fasano, Mauro/A-7100-2008; Coletta, Massimiliano/GSN-5927-2022; Trezza, Viviana/K-4418-2016	Leboffe, Loris/0000-0001-8272-1896; Fasano, Mauro/0000-0003-0628-5871; Gioia, Magda/0000-0003-0352-3547; COLETTA, Massimiliano/0000-0002-5489-9467	Ministero dell'Istruzione; dell'Universita e della Ricerca of Italy (Universita Roma Tre, Roma, Italy [CLAR 2014]; Consorzio Interuniversitario Italiano per l'Argentina [CUIA 2014]	Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca of Italy (Universita Roma Tre, Roma, Italy; Consorzio Interuniversitario Italiano per l'Argentina	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (Universita Roma Tre, Roma, Italy; CLAR 2014 to PA) and Consorzio Interuniversitario Italiano per l'Argentina (CUIA 2014 to PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SR, 1968, J BIOL CHEM, V243, P2918; ANTONINI E, 1981, J BIOL CHEM, V256, P2449; ASCENZI P, 1987, BIOCHEM EDUC, V15, P134, DOI 10.1016/0307-4412(87)90043-4; Ascenzi P, 2013, IUBMB LIFE, V65, P836, DOI 10.1002/iub.1208; Ascenzi P, 2012, BIOCHEM BIOPH RES CO, V424, P451, DOI 10.1016/j.bbrc.2012.06.131; Ascenzi P, 2012, BIOCHEM BIOPH RES CO, V422, P219, DOI 10.1016/j.bbrc.2012.04.111; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Buller AR, 2013, P NATL ACAD SCI USA, V110, pE653, DOI 10.1073/pnas.1221050110; Cheruvallath VK, 1997, J PHARMACEUT BIOMED, V15, P1719, DOI 10.1016/S0731-7085(96)01956-5; Curry S, 2009, DRUG METAB PHARMACOK, V24, P342, DOI 10.2133/dmpk.24.342; Davilas A, 2006, J PHARM PHARMACOL, V58, P1467, DOI 10.1211/jpp.58.11.0007; Devine E, 2014, TOXINS, V6, P416, DOI 10.3390/toxins6020416; Diaz N, 2001, J MED CHEM, V44, P250, DOI 10.1021/jm000340v; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fanali G, 2011, IUBMB LIFE, V63, P446, DOI 10.1002/iub.466; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; HOLLAWAY MR, 1971, EUR J BIOCHEM, V24, P332, DOI 10.1111/j.1432-1033.1971.tb19691.x; JANSSEN GME, 1985, J INT MED RES, V13, P68, DOI 10.1177/030006058501300110; KANTO J, 1989, CLIN PHARMACOKINET, V17, P308, DOI 10.2165/00003088-198917050-00002; KANTO J, 1974, PSYCHOPHARMACOLOGIA, V36, P123, DOI 10.1007/BF00421784; Khan MS, 2014, BASIC CLIN PHARMACOL, V115, P565, DOI 10.1111/bcpt.12277; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Kragh-Hansen U, 2013, BBA-GEN SUBJECTS, V1830, P5535, DOI 10.1016/j.bbagen.2013.03.015; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; KURONO Y, 1992, CHEM PHARM BULL, V40, P2169; LASKA EM, 1986, CLIN PHARMACOL THER, V40, P1, DOI 10.1038/clpt.1986.129; Liyasova MS, 2010, BIOCHEM PHARMACOL, V79, P784, DOI 10.1016/j.bcp.2009.10.007; Lockridge O, 2008, J BIOL CHEM, V283, P22582, DOI 10.1074/jbc.M802555200; Macquaire V, 2002, ACTA ANAESTH SCAND, V46, P1010, DOI 10.1034/j.1399-6576.2002.460814.x; MEANS GE, 1975, BIOCHEMISTRY-US, V14, P4989, DOI 10.1021/bi00693a031; MOJAVERIAN P, 1985, PHARMACOTHERAPY, V5, P336; OHTA N, 1983, J PHARM SCI, V72, P385, DOI 10.1002/jps.2600720416; PELLER L, 1959, J AM CHEM SOC, V81, P5907, DOI 10.1021/ja01531a017; Peters Jr T., 1996, ALL ALBUMIN BIOCH GE, DOI [10.1021/jp076583h, DOI 10.1021/JP076583H]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REIDENBERG MM, 1978, CLIN PHARMACOL THER, V23, P371; RUTHERFORD DM, 1978, BRIT J CLIN PHARMACO, V6, P69, DOI 10.1111/j.1365-2125.1978.tb01684.x; Sakai T, 2001, PHARMACEUT RES, V18, P520, DOI 10.1023/A:1011014629551; Sakurai Y, 2004, PHARM RES-DORDR, V21, P285, DOI 10.1023/B:PHAM.0000016241.84630.06; Sawas AH, 2004, BIOCHEMISTRY-US, V43, P12675, DOI 10.1021/bi035941d; STANFEL LA, 1986, CLIN CHEM, V32, P938; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Tempero KF, 1977, BR J CLIN PHARM, V1, p31S; WALKER JE, 1976, FEBS LETT, V66, P173, DOI 10.1016/0014-5793(76)80496-6; Watanabe H, 2000, BIOCHEM J, V349, P813, DOI 10.1042/bj3490813; Yang F, 2007, J STRUCT BIOL, V157, P348, DOI 10.1016/j.jsb.2006.08.015	46	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120603	10.1371/journal.pone.0120603	http://dx.doi.org/10.1371/journal.pone.0120603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790235	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400166
J	Narsale, AA; Enos, RT; Puppa, MJ; Chatterjee, S; Murphy, EA; Fayad, R; O'Pena, M; Durstine, JL; Carson, JA				Narsale, Aditi A.; Enos, Reilly T.; Puppa, Melissa J.; Chatterjee, Saurabh; Murphy, E. Angela; Fayad, Raja; O'Pena, Majorette; Durstine, J. Larry; Carson, James A.			Liver Inflammation and Metabolic Signaling in Apc(Min/+) Mice: The Role of Cachexia Progression	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CANCER CACHEXIA; COLORECTAL-CANCER; GLYCOGEN-SYNTHESIS; APCMIN/+ MOUSE; KAPPA-B; INTERLEUKIN-6; INFILTRATION; ACTIVATION; EXPRESSION	The Apc(Min/+) mouse exhibits an intestinal tumor associated loss of muscle and fat that is accompanied by chronic inflammation, insulin resistance and hyperlipidemia. Since the liver governs systemic energy demands through regulation of glucose and lipid metabolism, it is likely that the liver is a pathological target of cachexia progression in the Apc(Min/+) mouse. The purpose of this study was to determine if cancer and the progression of cachexia affected liver endoplasmic reticulum (ER)-stress, inflammation, metabolism, and protein synthesis signaling. The effect of cancer (without cachexia) was examined in wild-type and weight-stable Apc(Min/+) mice. Cachexia progression was examined in weight-stable, pre-cachectic, and severely-cachectic Apc(Min/+) mice. Livers were analyzed for morphology, glycogen content, ER-stress, inflammation, and metabolic changes. Cancer induced hepatic expression of ER-stress markers BiP (binding immunoglobulin protein), IRE-1 alpha (endoplasmic reticulum to nucleus signaling 1), and inflammatory intermediate STAT-3 (signal transducer and activator of transcription 3). While gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression was suppressed by cancer, glycogen content or protein synthesis signaling remained unaffected. Cachexia progression depleted liver glycogen content and increased mRNA expression of glycolytic enzyme PFK (phosphofrucktokinase) and gluconeogenic enzyme PEPCK. Cachexia progression further increased pSTAT-3 but suppressed p-65 and JNK (c-Jun NH2-terminal kinase) activation. Interestingly, progression of cachexia suppressed upstream ER-stress markers BiP and IRE-1 alpha, while inducing its downstream target CHOP (DNA-damage inducible transcript 3). Cachectic mice exhibited a dysregulation of protein synthesis signaling, with an induction of p-mTOR (mechanistic target of rapamycin), despite a suppression of Akt (thymoma viral proto-oncogene 1) and S6 (ribosomal protein S6) phosphorylation. Thus, cancer induced ER-stress markers in the liver, however cachexia progression further deteriorated liver ER-stress, disrupted protein synthesis regulation and caused a differential inflammatory response related to STAT-3 and NF-kappa B (Nuclear factor-kappa B) signaling.	[Narsale, Aditi A.; Puppa, Melissa J.; Carson, James A.] Univ S Carolina, Dept Exercise Sci, Integrat Muscle Biol Lab, Columbia, SC 29208 USA; [Fayad, Raja; O'Pena, Majorette; Carson, James A.] Ctr Colon Canc Res, Columbia, SC USA; [Narsale, Aditi A.; Puppa, Melissa J.; Fayad, Raja; Durstine, J. Larry; Carson, James A.] Univ S Carolina, Dept Exercise Sci, Div Appl Physiol, Columbia, SC 29208 USA; [Enos, Reilly T.; Murphy, E. Angela] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Chatterjee, Saurabh] Univ S Carolina, Dept Environm Hlth Sci, Environm Hlth & Dis Lab, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Carson, JA (corresponding author), Univ S Carolina, Dept Exercise Sci, Integrat Muscle Biol Lab, Columbia, SC 29208 USA.	carsonj@mailbox.sc.edu	Carson, James/Q-5693-2019; Enos, Reilly/AFO-4814-2022; Narsale, Aditi/U-4643-2019	Carson, James/0000-0003-3733-8796; Enos, Reilly/0000-0001-5571-4586; Puppa, Melissa/0000-0003-3826-0003; Narsale, Aditi/0000-0002-1421-5104	National Institute of Health [R01 CA121249, R00ES019875]; NATIONAL CANCER INSTITUTE [R01CA121249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES019875] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grant #: R01 CA121249 - awarded to JAC by the National Institute of Health - http://grants.nih.gov/grants/oer.htm. Grant # R00ES019875 - awarded to SC by the National Institute of Health - http://grants.nih.gov/grants/oer.htm.	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Baltgalvis KA, 2007, ROLE IL 6 MUSCLE WAS; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Bansal MB, 2005, J HEPATOL, V42, P548, DOI 10.1016/j.jhep.2004.11.043; Barton BE, 2001, CYTOKINE, V16, P251, DOI 10.1006/cyto.2001.0968; Bautista AP, 2002, ALCOHOL, V27, P17, DOI 10.1016/S0741-8329(02)00206-9; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; BRADLEY SG, 1979, ANNU REV MICROBIOL, V33, P67, DOI 10.1146/annurev.mi.33.100179.000435; BRAUER M, 1994, CANCER RES, V54, P6383; Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Hagens WI, 2008, J PHARMACOL EXP THER, V324, P902, DOI 10.1124/jpet.107.132290; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; HOLROYDE CP, 1984, CANCER RES, V44, P5910; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jassem W, 2003, TRANSPLANTATION, V75, P2001, DOI 10.1097/01.TP.0000061605.30685.03; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Johnson JL, 2011, INFECT IMMUN, V79, P3607, DOI 10.1128/IAI.05043-11; Jones A, 2013, EMBO MOL MED, V5, P294, DOI 10.1002/emmm.201201869; KAHN CR, 1989, MOL ENDOCRINOL, V3, P840, DOI 10.1210/mend-3-5-840; Keeffe E B, 1997, Liver Transpl Surg, V3, P197; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Koukourakis MI, 2006, CANCER SCI, V97, P582, DOI 10.1111/j.1349-7006.2006.00220.x; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Leitch EF, 2007, BRIT J CANCER, V97, P1266, DOI 10.1038/sj.bjc.6604027; Lieffers JR, 2009, AM J CLIN NUTR, V89, P1173, DOI 10.3945/ajcn.2008.27273; Lunz JG, 2007, HEPATOLOGY, V46, P1946, DOI 10.1002/hep.21906; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; MCCALLUM RE, 1973, INFECT IMMUN, V7, P642, DOI 10.1128/IAI.7.4.642-654.1973; McClellan JL, 2012, CYTOKINE, V57, P113, DOI 10.1016/j.cyto.2011.09.027; McMillan DC, 1998, NUTR CANCER, V31, P101, DOI 10.1080/01635589809514687; Narsale AA, 2014, CURR OPIN SUPPORT PA, V8, P321, DOI 10.1097/SPC.0000000000000091; Preston T, 1998, J NUTR, V128, P1355, DOI 10.1093/jn/128.8.1355; Puppa MJ, 2011, BBA-MOL BASIS DIS, V1812, P1601, DOI 10.1016/j.bbadis.2011.08.010; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; SASSE D, 1975, HISTOCHEMISTRY, V45, P237, DOI 10.1007/BF00507698; Seth RK, 2013, TOXICOL SCI, V134, P291, DOI 10.1093/toxsci/kft104; Sutherland C, 1996, PHILOS T ROY SOC B, V351, P191, DOI 10.1098/rstb.1996.0016; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Tazi E, 2010, INDIAN J PALLIAT CAR, V16, P129, DOI 10.4103/0973-1075.73644; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Uskokovic A, 2012, MOL BIOL REP, V39, P167, DOI 10.1007/s11033-011-0722-5; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; White JP, 2009, ACTA PHYSIOL, V197, P321, DOI 10.1111/j.1748-1716.2009.02029.x; White JP, 2013, BIOL OPEN, V2, P1346, DOI 10.1242/bio.20136544; White JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE1042, DOI 10.1152/ajpendo.00410.2012; White JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024650; White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010; White JP, 2009, J APPL PHYSIOL, V107, P1420, DOI 10.1152/japplphysiol.00668.2009; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zimmers TA, 2003, HEPATOLOGY, V38, P326, DOI 10.1053/jhep.2003.50318	57	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119888	10.1371/journal.pone.0119888	http://dx.doi.org/10.1371/journal.pone.0119888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789991	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400114
J	Xu, FF; Sun, W; Li, P; Chen, JL; Zhu, DD; Sun, XL; Wang, JX; Feng, JR; Song, K; Duan, YN				Xu, Feifan; Sun, Wei; Li, Pan; Chen, Jinling; Zhu, Dandan; Sun, Xiaolei; Wang, Jianxin; Feng, Jinrong; Song, Ke; Duan, Yinong			Specificity Protein 1 Transcription Factor Regulates Human ARTS Promoter Activity through Multiple Binding Sites	PLOS ONE			English	Article							EXPRESSION; SEPTINS; GENE; APOPTOSIS; FAMILY; CYTOKINESIS; METHYLATION; COMPLEX; ROLES; SP1	Apoptosis-related protein in the TGF-beta signaling pathway (ARTS) is an unusual mitochondrial Septin-like protein which functions as a tumor suppressor. There are various splice variants derived from the human Septin4 gene, one of which is ARTS, also known as Septin4_i2. Unlike other Septin4 members, ARTS can induce apoptosis in many cells, however, the underlying molecular mechanism for the transcriptional regulation of ARTS has yet to be deciphered. In this study, we attempted to analyze the promoter region of ARTS in cultured HEK-293T and LX-2 cells with the purpose of elucidating the underlying transcriptional mechanisms driving ARTS expression. We effectively demonstrated that the -824 to -5 bp region of the ARTS promoter was essential for ARTS transcription and identified four putative specificity protein 1 (Sp1) binding sites within this core promoter region. ChIP analysis showed that Sp1 protein could bind to two of these sites (-735/-718 and -173/-157) and mutation of each Sp1 binding site led to a significant decrease in ARTS promoter activity. In conclusion, all the results indicated that the Sp1 transcription factor could contribute to ARTS gene transcription. The underlying molecular events of the specific promoter of ARTS could also be used to explain why ARTS is selectively silenced during some human diseases. This would provide basis for further study on the function of ARTS on cell apoptosis.	[Xu, Feifan; Sun, Wei; Li, Pan; Chen, Jinling; Zhu, Dandan; Sun, Xiaolei; Wang, Jianxin; Feng, Jinrong; Song, Ke; Duan, Yinong] Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China; [Xu, Feifan] Sixth Peoples Hosp Nantong, Clin Lab, Nantong 226001, Jiangsu, Peoples R China; [Wang, Jianxin] Nantong Univ, Affiliated Hosp, Lab Med Ctr, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Nantong University	Duan, YN (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	yinongduan@gmail.com	Duan, yinong/GSD-9438-2022	Chen, Jinling/0000-0003-2992-6571	National Natural Science Foundation of China [81171589, 81471975, 81401683]; Jiangsu provincial Natural Science Foundation [BK20140435]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Student Research and Innovation Program of Nantong University [YKC13060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Student Research and Innovation Program of Nantong University	This work was supported by National Natural Science Foundation of China (Grant Numbers 81171589, 81471975, 81401683), the Jiangsu provincial Natural Science Foundation (Grant Number BK20140435), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Graduate Student Research and Innovation Program of Nantong University (Grant Number YKC13060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerveira Nuno, 2009, Critical Reviews in Oncogenesis, V15, P91; Connolly D, 2011, BIOL CHEM, V392, P725, DOI 10.1515/BC.2011.073; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; Dolat L, 2014, BIOL CHEM, V395, P123, DOI 10.1515/hsz-2013-0233; Edison N, 2012, CELL DEATH DIFFER, V19, P356, DOI 10.1038/cdd.2011.112; Elhasid R, 2004, ONCOGENE, V23, P5468, DOI 10.1038/sj.onc.1207725; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Furihata K, 2002, ARTERIOSCL THROM VAS, V22, P1733, DOI 10.1161/01.ATV.0000034493.76465.FF; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Gottfried Y, 2007, SCHIZOPHR RES, V96, P257, DOI 10.1016/j.schres.2007.05.031; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Kemeny S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038837; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Lee JW, 2006, PATHOL RES PRACT, V202, P67, DOI 10.1016/j.prp.2005.11.001; Lin Ying-Hung, 2011, Spermatogenesis, V1, P298; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Lotan R, 2005, J BIOL CHEM, V280, P25802, DOI 10.1074/jbc.M501955200; Mandel-Gutfreund Y, 2011, BIOL CHEM, V392, P783, DOI 10.1515/BC.2011.089; Mostowy S, 2011, BIOL CHEM, V392, P831, DOI 10.1515/BC.2011.078; Pang RTK, 2004, MOL ENDOCRINOL, V18, P471, DOI 10.1210/me.2003-0245; Peterson EA, 2010, CLIN GENET, V77, P511, DOI 10.1111/j.1399-0004.2010.01392.x; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Reingewertz TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024655; Roeseler S, 2009, KLIN PADIATR, V221, P150, DOI 10.1055/s-0029-1220706; Singh DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037012; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Wang JX, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003106; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zhao LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076581	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120072	10.1371/journal.pone.0120072	http://dx.doi.org/10.1371/journal.pone.0120072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790304	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400127
J	Chernov, AV; Dolkas, J; Hoang, K; Angert, M; Srikrishna, G; Vogl, T; Baranovskaya, S; Strongin, AY; Shubayev, VI				Chernov, Andrei V.; Dolkas, Jennifer; Hoang, Khang; Angert, Mila; Srikrishna, Geetha; Vogl, Thomas; Baranovskaya, Svetlana; Strongin, Alex Y.; Shubayev, Veronica I.			The Calcium-binding Proteins S100A8 and S100A9 Initiate the Early Inflammatory Program in Injured Peripheral Nerves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWANN-CELL PROLIFERATION; WALLERIAN DEGENERATION; SCIATIC-NERVE; GENE-EXPRESSION; BIOINFORMATIC ANALYSIS; AXONAL DEGENERATION; FUNCTIONAL RECOVERY; NEUROPATHIC PAIN; IN-VIVO; REGENERATION	To shed light on the early immune response processes in severed peripheral nerves, we performed genome-wide transcriptional profiling and bioinformatics analyses of the proximal (P, regenerating) and distal (D, degenerating) nerve stumps on day 1 in the sciatic nerve axotomy model in rats. Multiple cell death-related pathways were activated in the degenerating D stump, whereas activation of the cytoskeletal motility and gluconeogenesis/glycolysis pathways was most prominent in the P stump of the axotomized nerve. Our bioinformatics analyses also identified the specific immunomodulatory genes of the chemokine, IL, TNF, MHC, immunoglobulin-binding Fc receptor, calcium-binding S100, matrix metalloproteinase, tissue inhibitor of metalloproteinase, and ion channel families affected in both the P and D segments. S100a8 and S100a9 were the top up-regulated genes in both the P and D segments. Stimulation of cultured Schwann cells using the purified S100A8/A9 heterodimer recapitulated activation of the myeloid cell and phagocyte chemotactic genes and pathways, which we initially observed in injured nerves. S100A8/A9 heterodimer injection into the intact nerve stimulated macrophage infiltration. We conclude that, following peripheral nerve injury, an immediate acute immune response occurs both distal and proximal to the lesion site and that the rapid transcriptional activation of the S100a8 and S100a9 genes results in S100A8/A9 hetero- and homodimers, which stimulate the release of chemokines and cytokines by activated Schwann cells and generate the initial chemotactic gradient that guides the transmigration of hematogenous immune cells into the injured nerve.	[Chernov, Andrei V.; Srikrishna, Geetha; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Dolkas, Jennifer; Hoang, Khang; Angert, Mila; Shubayev, Veronica I.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Dolkas, Jennifer; Hoang, Khang; Angert, Mila; Shubayev, Veronica I.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92037 USA; [Vogl, Thomas] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Baranovskaya, Svetlana] Agilent Technol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Munster; Agilent Technologies	Shubayev, VI (corresponding author), Univ Calif San Diego, Mail Code 0629,9500 Gilman Dr, La Jolla, CA 92093 USA.	vshubayev@ucsd.edu	Chernov, Andrei/I-1623-2019; Regan, Clinton/E-6250-2012; Strongin, Alex/R-6609-2019	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [RO1DE022757]; Department of Veterans Affairs Merit Review Award [5I01BX000638]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DE022757 (to V. I. S. and A. Y. S.). This work was also supported by Department of Veterans Affairs Merit Review Award 5I01BX000638 (to V. I. S.).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Bosse F, 2006, J NEUROCHEM, V96, P1441, DOI 10.1111/j.1471-4159.2005.03635.x; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chattopadhyay S, 2009, GLIA, V57, P1316, DOI 10.1002/glia.20851; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309; FERNANDEZVALLE C, 1995, J NEUROCYTOL, V24, P667, DOI 10.1007/BF01179817; Goethals S, 2010, GLIA, V58, P1701, DOI 10.1002/glia.21041; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Jiang N, 2014, NEURAL REGEN RES, V9, P1186, DOI 10.4103/1673-5374.135325; Kamon y Cajal S., 1991, CAJALS DEGENERATION, p144 ; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kieseier BC, 2006, CURR OPIN NEUROL, V19, P437, DOI 10.1097/01.wco.0000245365.51823.72; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; Kubo T, 2002, J NEUROCHEM, V82, P1129, DOI 10.1046/j.1471-4159.2002.01060.x; LACKMANN M, 1992, J BIOL CHEM, V267, P7499; LACKMANN M, 1993, J IMMUNOL, V150, P2981; Li SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Mcdonald D, 2006, NEURON GLIA BIOL, V2, P139, DOI 10.1017/S1740925X05000347; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043436; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008; Yao DB, 2013, NEUROSCI BULL, V29, P321, DOI 10.1007/s12264-013-1340-0; Zochodne DW, 2012, J PERIPHER NERV SYST, V17, P1, DOI 10.1111/j.1529-8027.2012.00378.x; Zrouri H, 2004, EUR J NEUROSCI, V20, P1811, DOI 10.1111/j.1460-9568.2004.03641.x	51	44	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11771	11784		10.1074/jbc.M114.622316	http://dx.doi.org/10.1074/jbc.M114.622316			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792748	Green Published, hybrid			2022-12-26	WOS:000353719400049
J	Pardo, V; Gonzalez-Rodriguez, A; Guijas, C; Balsinde, J; Valverde, AM				Pardo, Virginia; Gonzalez-Rodriguez, Agueda; Guijas, Carlos; Balsinde, Jesus; Valverde, Angela M.			Opposite Cross-Talk by Oleate and Palmitate on Insulin Signaling in Hepatocytes through Macrophage Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE 1B; NECROSIS-FACTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; SATURATED FATTY-ACIDS; NF-KAPPA-B; ADIPOSE-TISSUE; INDUCED INFLAMMATION; GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; LIPID HOMEOSTASIS	Chronic low grade inflammation in adipose tissue during obesity is associated with an impairment of the insulin signaling cascade. In this study, we have evaluated the impact of palmitate or oleate overload of macrophage/Kupffer cells in triggering stress-mediated signaling pathways, in lipoapoptosis, and in the cross-talk with insulin signaling in hepatocytes. RAW 264.7 macrophages or Kupffer cells were stimulated with oleate or palmitate, and levels of M1/M2 polarization markers and the lipidomic profile of eicosanoids were analyzed. Whereas proinflammatory cytokines and total eicosanoids were elevated in macrophages/Kupffer cells stimulated with palmitate, enhanced arginase 1 and lower leukotriene B-4 (LTB4) levels were detected in macrophages stimulated with oleate. When hepatocytes were pretreated with conditioned medium (CM) from RAW 264.7 or Kupffer cells loaded with palmitate (CM-P), phosphorylation of stress kinases and endoplasmic reticulum stress signaling was increased, insulin signaling was impaired, and lipoapoptosis was detected. Conversely, enhanced insulin receptor-mediated signaling and reduced levels of the phosphatases protein tyrosine phosphatase 1B (PTP1B) and phosphatase and tensin homolog (PTEN) were found in hepatocytes treated with CM from macrophages stimulated with oleate (CM-O). Supplementation ofCM-OwithLTB(4) suppressed insulin sensitization and increased PTP1B and PTEN. Furthermore, LTB4 decreased insulin receptor tyrosine phosphorylation in hepatocytes, activated the NF kappa B pathway, and up-regulated PTP1B and PTEN, these effects being mediated by LTB4 receptor BTL1. In conclusion, oleate and palmitate elicit an opposite cross-talk between macrophages/Kupffer cells and hepatocytes. Whereas CM-P interferes at the early steps of insulin signaling, CM-O increases insulin sensitization, possibly by reducing LTB4.	[Pardo, Virginia; Gonzalez-Rodriguez, Agueda] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Pardo, Virginia; Gonzalez-Rodriguez, Agueda; Guijas, Carlos; Balsinde, Jesus; Valverde, Angela M.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain; [Guijas, Carlos; Balsinde, Jesus; Valverde, Angela M.] CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM)	Valverde, AM (corresponding author), Inst Invest Biomed Alberto Sols, C Arturo Duperier 4, Madrid 28029, Spain.	avalverde@iib.uam.es	Balsinde, Jesús/C-7833-2018; Pardo Marques, Virginia/B-3062-2015	Balsinde, Jesús/0000-0002-4157-6714; Guijas, Carlos/0000-0001-7993-3388; Gonzalez-Rodriguez, Agueda/0000-0003-2851-2318; Pardo Marques, Virginia/0000-0001-9787-8722	Ministerio de Economia y Competitividad, Spain [SAF2012-33283, SAF2013-48201-R]; Comunidad de Madrid (Spain) [S2010/BMD-2423]; European Foundation for the Studies of Diabetes and Amylin Paul Langerhans grant; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, Instituto de Salud Carlos III, Spain); CIBERDEM (ISCIII) postdoctoral contract	Ministerio de Economia y Competitividad, Spain; Comunidad de Madrid (Spain)(Comunidad de Madrid); European Foundation for the Studies of Diabetes and Amylin Paul Langerhans grant; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, Instituto de Salud Carlos III, Spain); CIBERDEM (ISCIII) postdoctoral contract	This work was supported by Ministerio de Economia y Competitividad, Spain, Grants SAF2012-33283 and SAF2013-48201-R; Comunidad de Madrid Grant S2010/BMD-2423 (Spain); an European Foundation for the Studies of Diabetes and Amylin Paul Langerhans grant; and the Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, Instituto de Salud Carlos III, Spain).; Holder of a CIBERDEM (ISCIII) postdoctoral contract. To whom correspondence may be addressed: Instituto de Investigaciones Biomedicas Alberto Sols, C/Arturo Duperier 4, 28029 Madrid, Spain. Tel.: 34-915854497; Fax: 34-915854401; E-mail: aguedagr@iib.uam.es.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; BENVENISTE R, 1988, CELL BIOCHEM FUNCT, V6, P231, DOI 10.1002/cbf.290060403; Camell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075147; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gao B, 2010, HEPATOLOGY, V51, P8, DOI 10.1002/hep.23320; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gonzalez-Rodriguez A, 2007, ENDOCRINOLOGY, V148, P594, DOI 10.1210/en.2006-0644; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Grant L, 2014, DIABETES, V63, P456, DOI 10.2337/db13-0885; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Han SW, 2008, AM J PHYSIOL-LUNG C, V294, pL1238, DOI 10.1152/ajplung.00017.2008; Henkel J, 2009, HEPATOLOGY, V50, P781, DOI 10.1002/hep.23064; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kewalramani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026947; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lei HW, 2011, J HUAZHONG U SCI-MED, V31, P185, DOI 10.1007/s11596-011-0249-y; Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lopez-Parra M, 2008, J LIPID RES, V49, P2513, DOI 10.1194/jlr.M800101-JLR200; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nieto-Vazquez I, 2007, DIABETES, V56, P404, DOI 10.2337/db06-0989; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Norris Paul C., 2014, Advances in Biological Regulation, V54, P99, DOI 10.1016/j.jbior.2013.09.009; Novgorodtseva TP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-82; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Owen C, 2013, DIABETOLOGIA, V56, P2286, DOI 10.1007/s00125-013-2992-z; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park E, 2007, J ENDOCRINOL, V195, P323, DOI 10.1677/JOE-07-0005; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Samokhvalov V, 2009, AM J PHYSIOL-ENDOC M, V296, pE37, DOI 10.1152/ajpendo.90667.2008; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Schwenger KJP, 2014, WORLD J GASTROENTERO, V20, P1712, DOI 10.3748/wjg.v20.i7.1712; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Song P, 2009, J BIOL CHEM, V284, P17120, DOI 10.1074/jbc.M109.012583; SPECTOR AA, 1986, METHOD ENZYMOL, V128, P320; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Suchy D, 2013, CELL BIOCHEM FUNCT, V31, P181, DOI 10.1002/cbf.2940; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu JF, 2003, AM J HUM GENET, V72, P208, DOI 10.1086/345802; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhao Y, 2012, BIOCHEM BIOPH RES CO, V418, P647, DOI 10.1016/j.bbrc.2012.01.068; Zhou L, 2007, FEBS LETT, V581, P4303, DOI 10.1016/j.febslet.2007.07.076	75	38	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11663	11677		10.1074/jbc.M115.649483	http://dx.doi.org/10.1074/jbc.M115.649483			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792746	hybrid, Green Published			2022-12-26	WOS:000353719400040
J	Hammer, H; Ebert, B; Jensen, HS; Jensen, AA				Hammer, Harriet; Ebert, Bjarke; Jensen, Henrik Sindal; Jensen, Anders A.			Functional Characterization of the 1,5-Benzodiazepine Clobazam and Its Major Active Metabolite N-Desmethylclobazam at Human GABA(A) Receptors Expressed in Xenopus laevis Oocytes	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; BENZODIAZEPINE BINDING-SITE; RECOMBINANT GABA(A); DELTA-SUBUNIT; 2 DISTINCT; SUBTYPES; SELECTIVITY; MODULATION; PHARMACOLOGY; CLONAZEPAM	The 1,5-benzodiazepine clobazam is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients 2 years of age or older in the United States, and for treatment of anxiety and various forms of epilepsy elsewhere. Clobazam has been reported to exhibit different in vivo adverse effects and addiction liability profile than the classic 1,4-benzodiazepines. In this study, it was investigated whether the in vitro pharmacological properties of clobazam and its major active metabolite N-desmethylclobazam could explain some of these clinical differences. The functional properties of the two 1,5-benzodiazepines were characterized at the human.-aminobutyric acid type A receptor (GABA(A)R) subtypes alpha(1)beta(2)gamma(2S), alpha(2)beta(2)gamma(2S), alpha(3)beta(2)gamma(2S), alpha(5)beta(2)gamma(2S) and alpha(6)beta(2)delta expressed in Xenopus laevis oocytes by use of two-electrode voltage-clamp electrophysiology and compared to those exhibited by the 1,4-benzodiazepine clonazepam. All three compounds potentiated GABA EC20-evoked responses through the alpha(1,2,3,5)beta(2)gamma(2S) GABA(A)Rs in a reversible and concentration-dependent manner, with each displaying similar EC50 values at the four subtypes. Furthermore, the degrees of potentiation of the GABA EC20 currents through the four receptors mediated by saturating modulator concentrations did not differ substantially for any of the three benzodiazepines. The three compounds were substantially less potent (200-3900 fold) as positive allosteric modulators at the alpha(6)beta(2)(o) over bar GABA(A)R than at the alpha(1,2,3,5)beta(2)gamma(2S) receptors. Interestingly, however, clobazam and especially N-desmethylclobazam were highly efficacious potentiators of alpha(6)beta(2)delta receptor signaling. Although this activity component is unlikely to contribute to the in vivo effects of clobazam/N-desmethylclobazam, the 1,5-benzodiazepine could constitute an interesting lead for novel modulators targeting this low-affinity binding site in GABA(A)Rs. In conclusion, the non-selective modulation exerted by clobazam, N-desmethylclobazam and clonazepam at the alpha(1)beta(2)gamma(2S), alpha(2)beta(2)gamma(2S), alpha(3)beta(2)gamma(2S) and alpha(5)beta(2)gamma(2S) GABA(A)Rs indicate that the observed clinical differences between clobazam and 1,4-benzodiazepines are likely to arise from factors other than their respective pharmacological properties at the GABA(A)Rs as investigated here.	[Hammer, Harriet; Jensen, Anders A.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Ebert, Bjarke; Jensen, Henrik Sindal] H Lundbeck & Co AS, Valby, Denmark	University of Copenhagen; Lundbeck Corporation	Jensen, AA (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark.	aaj@sund.ku.dk	Jensen, Anders/AAJ-3335-2020	Jensen, Anders/0000-0002-7927-5052; Hammer, Harriet/0000-0002-5705-446X	Lundbeck (US); Novo Nordisk Foundation; Lundbeck (Denmark); Novo Nordisk Fonden [NNF11OC1014338] Funding Source: researchfish	Lundbeck (US); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck (Denmark)(Lundbeck Corporation); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding: HH and AAJ received an unrestricted grant from Lundbeck (US) to conduct this work. AAJ thanks the Novo Nordisk Foundation for financial support. Lundbeck (Denmark) provided support in the form of salaries for authors HSJ and BE, but neither Lundbeck (US) or Lundbeck (Denmark) have had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atack JR, 2011, CURR TOP MED CHEM, V11, P1176; Atack JR, 2011, CURR TOP MED CHEM, V11, P1203; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Baur R, 2008, J NEUROCHEM, V106, P2353, DOI 10.1111/j.1471-4159.2008.05574.x; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Buhr A, 1996, MOL PHARMACOL, V49, P1080; Cramer JA, 2013, ACTA NEUROL SCAND, V128, P91, DOI 10.1111/ane.12086; Ebert B, 2006, PHARMACOL THERAPEUT, V112, P612, DOI 10.1016/j.pharmthera.2005.04.014; Engin E, 2012, PHARMACOL THERAPEUT, V136, P142, DOI 10.1016/j.pharmthera.2012.08.006; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; Feng HJ, 2004, MOL PHARMACOL, V66, P1517, DOI 10.1124/mol.104.003426; Feng HJ, 2010, J BIOL CHEM, V285, P23614, DOI 10.1074/jbc.M110.122564; Fisher JL, 2011, EUR J PHARMACOL, V654, P160, DOI 10.1016/j.ejphar.2010.12.037; Fradley RL, 2007, J PSYCHOPHARMACOL, V21, P384, DOI 10.1177/0269881106067255; HAIGH JRM, 1987, BRIT J CLIN PHARMACO, V23, P213, DOI 10.1111/j.1365-2125.1987.tb03032.x; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Hoestgaard-Jensen K, 2013, BRIT J PHARMACOL, V170, P919, DOI 10.1111/bph.12340; Hoestgaard-Jensen K, 2014, J NEUROSCI, V34, P16256, DOI 10.1523/JNEUROSCI.1495-14.2014; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Jensen AA, 2010, J BIOL CHEM, V285, P10141, DOI 10.1074/jbc.M109.079319; Jensen HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088456; Karim N, 2013, AMINO ACIDS, V44, P1139, DOI 10.1007/s00726-012-1456-y; Karim N, 2012, BIOCHEM PHARMACOL, V84, P549, DOI 10.1016/j.bcp.2012.05.017; Khom S, 2006, MOL PHARMACOL, V69, P640, DOI 10.1124/mol.105.017236; Kinoshita M, 2007, J NEUROL SCI, V263, P44, DOI 10.1016/j.jns.2007.05.025; Krishek BJ, 1998, J PHYSIOL-LONDON, V507, P639, DOI 10.1111/j.1469-7793.1998.639bs.x; Leahy JT, 2011, NEUROPSYCH DIS TREAT, V7, P673, DOI [10.2147/NDT.520173, 10.2147/NDT.S20173]; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mirheydari P, 2014, NEUROCHEM RES, V39, P1057, DOI 10.1007/s11064-013-1156-3; Miura Y, 2002, EPILEPSY RES, V49, P189, DOI 10.1016/S0920-1211(02)00032-3; Morlock EV, 2011, MOL PHARMACOL, V80, P14, DOI 10.1124/mol.110.069542; Ng YT, 2007, NEUROTHERAPEUTICS, V4, P138, DOI 10.1016/j.nurt.2006.11.002; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Petroski RE, 2006, J PHARMACOL EXP THER, V317, P369, DOI 10.1124/jpet.105.096701; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Pistis M, 1997, BRIT J PHARMACOL, V122, P1707, DOI 10.1038/sj.bjp.0701563; Rabe H, 2007, NEUROPHARMACOLOGY, V52, P796, DOI 10.1016/j.neuropharm.2006.09.013; Rahman M, 2006, EUR J PHARMACOL, V547, P37, DOI 10.1016/j.ejphar.2006.07.039; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Rowlett JK, 2005, P NATL ACAD SCI USA, V102, P915, DOI 10.1073/pnas.0405621102; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; SANGER DJ, 1994, NEUROSCI BIOBEHAV R, V18, P355, DOI 10.1016/0149-7634(94)90049-3; Sankar R, 2012, CNS DRUGS, V26, P229, DOI 10.2165/11599020-000000000-00000; Sanna E, 2002, EUR J PHARMACOL, V451, P103, DOI 10.1016/S0014-2999(02)02191-X; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sieghart W, ADV PHARMACOL IN PRE; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sigel E, 2011, CURR TOP MED CHEM, V11, P241, DOI 10.2174/156802611794863562; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; Steru L, 1986, EPILEPSIA, P27; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Strustovu SI, 2003, EUR J PHARMACOL, V467, P49, DOI 10.1016/S0014-2999(03)01603-0; Tolbert D, 2013, EPILEPSY CURRENTS S1, V13; VANDERMEYDEN CH, 1989, EUR J CLIN PHARMACOL, V37, P365, DOI 10.1007/BF00558501; Varagic Z, 2013, BRIT J PHARMACOL, V169, P384, DOI 10.1111/bph.12153; Wafford KA, 2009, NEUROPHARMACOLOGY, V56, P182, DOI 10.1016/j.neuropharm.2008.08.004; Wallner M, 2014, NEUROCHEM RES, V39, P1118, DOI 10.1007/s11064-014-1243-0; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; WILDIN JD, 1990, BRIT J CLIN PHARMACO, V29, P169, DOI 10.1111/j.1365-2125.1990.tb03616.x; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Wu TY, 2008, MOL PHARMACOL, V74, P466, DOI 10.1124/mol.107.044388; You H, 2007, J NEUROCHEM, V103, P1092, DOI 10.1111/j.1471-4159.2007.04817.x; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	77	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120239	10.1371/journal.pone.0120239	http://dx.doi.org/10.1371/journal.pone.0120239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798598	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300113
J	Chen, YK; Hou, HA; Tang, JL; Jhuang, JY; Lai, YJ; Lee, MC; Kuo, YY; Chou, WC; Liu, CY; Lin, CW; Chuang, SS; Chen, CY; Tseng, MH; Huang, CF; Chiang, YC; Lee, FY; Liu, MC; Liu, CW; Yao, M; Huang, SY; Ko, BS; Hsu, SC; Wu, SJ; Tsay, W; Chen, YC; Tien, HF				Chen, Yin-Kai; Hou, Hsin-An; Tang, Jih-Luh; Jhuang, Jie-Yang; Lai, Yan-Jun; Lee, Ming-Cheng; Kuo, Yuan-Yeh; Chou, Wen-Chien; Liu, Chieh-Yu; Lin, Chung-Wu; Chuang, Shih-Sung; Chen, Chien-Yuan; Tseng, Mei-Hsuan; Huang, Chi-Fei; Chiang, Ying-Chieh; Lee, Fen-Yu; Liu, Ming-Chih; Liu, Chia-Wen; Yao, Ming; Huang, Shang-Yi; Ko, Bor-Sheng; Hsu, Szu-Chun; Wu, Shang-Ju; Tsay, Woei; Chen, Yao-Chang; Tien, Hwei-Fang			Clinical and Prognostic Implications of Roundabout 4 (Robo4) in Adult Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							PRIMARY MYELODYSPLASTIC SYNDROME; BONE-MARROW ANGIOGENESIS; TUMOR ENDOTHELIAL MARKER; DISEASE PROGRESSION; MAGIC ROUNDABOUT; LUNG-CANCER; EXPRESSION; MUTATION; STABILITY; SURVIVAL	Background Robo4 is involved in hematopoietic stem/progenitor cell homeostasis and essential for tumor angiogenesis. Expression of Robo4 was recently found in solid tumors and leukemia stem cells. However, the clinical implications of Robo4 expression in patients with acute myeloid leukemia (AML) remain unclear. Methods We investigated the clinical and prognostic relevance of mRNA expression of Robo4 in bone marrow (BM) mononuclear cells from 218 adult patients with de novo AML. We also performed immunohistochemical staining to assess the Robo4 protein expression in the BM biopsy specimens from 30 selected AML patients in the cohort. Results Higher Robo4 expression was closely associated with lower white blood cell counts, expression of HLA-DR, CD13, CD34 and CD56 on leukemia cells, t(8; 21) and ASXL1 mutation, but negatively correlated with t(15; 17) and CEBPA mutation. Compared to patients with lower Robo4 expression, those with higher expression had significantly shorter disease- free survival (DFS) and overall survival (OS). This result was confirmed in an independent validation cohort. Furthermore, multivariate analyses showed that higher Robo4 expression was an independent poor prognostic factor for DFS and OS in total cohort and patients with intermediate-risk cytogenetics, irrespective of age, WBC count, karyotype, and mutation status of NPM1/FLT3-ITD, and CEBPA. Conclusions BM Robo4 expression can serve as a new biomarker to predict clinical outcomes in AML patients and Robo4 may serve as a potential therapeutic target in patients with higher Robo4 expression.	[Chen, Yin-Kai; Hou, Hsin-An; Tang, Jih-Luh; Lai, Yan-Jun; Lee, Ming-Cheng; Chou, Wen-Chien; Chen, Chien-Yuan; Tseng, Mei-Hsuan; Huang, Chi-Fei; Chiang, Ying-Chieh; Yao, Ming; Huang, Shang-Yi; Ko, Bor-Sheng; Wu, Shang-Ju; Tsay, Woei; Chen, Yao-Chang; Tien, Hwei-Fang] Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan; [Chen, Yin-Kai] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yun Lin, Brazil; [Hou, Hsin-An] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Jhuang, Jie-Yang] Far Eastern Mem Hosp, Dept Pathol, New Taipei City, Taiwan; [Kuo, Yuan-Yeh] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Chou, Wen-Chien; Hsu, Szu-Chun; Chen, Yao-Chang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Biostat Consulting Lab, Dept Nursing, Taipei, Taiwan; [Lin, Chung-Wu; Lee, Fen-Yu; Liu, Ming-Chih; Liu, Chia-Wen] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Chuang, Shih-Sung] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University; National Taiwan University Hospital; Chi Mei Hospital	Tang, JL (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan.	hftien@ntu.edu.tw; hftien@ntu.edu.tw	Liu, Chieh-Yu/J-3789-2019; Liu, Chieh-Yu/AAR-9654-2021	Liu, Chieh-Yu/0000-0003-3283-028X; YAO, MING/0000-0003-2932-0019; Huang, Shang-Yi/0000-0001-5688-3410; HOU, HSIN-AN/0000-0003-2780-4845; KO, BOR-SHENG/0000-0002-7965-7579; KUO, YUAN-YEH/0000-0002-6090-9000; TIEN, HWEI-FANG/0000-0002-1384-5593; LIN, CHUNG-WU/0000-0001-5042-0503; CHOU, WEN-CHIEN/0000-0003-2967-698X; TANG, JIH-LUH/0000-0003-4021-3281	National Science Council (Taiwan) [NSC 100-2314-B002-057-MY3, NSC 100-314-B-002-112-MY3, NSC 100-2628-B-002-003-MY3]; Ministry of Health and Welfare (Taiwan) [MOHW103-TD-B-111-04]; Department of Medical Research, National Taiwan University Hospital [NTUH 102P06, UN 102-015]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare (Taiwan); Department of Medical Research, National Taiwan University Hospital	This work was partially sponsored by grants NSC 100-2314-B002-057-MY3, NSC 100-314-B-002-112-MY3 and NSC 100-2628-B-002-003-MY3 from the National Science Council (Taiwan), MOHW103-TD-B-111-04 from the Ministry of Health and Welfare (Taiwan) and NTUH 102P06 and UN 102-015 from the Department of Medical Research, National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin G, 2005, HUM PATHOL, V36, P1302, DOI 10.1016/j.humpath.2005.08.016; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; BENDALL LJ, 1994, EXP HEMATOL, V22, P1252; Braig M, 2014, LEUKEMIA, V28, P2028, DOI 10.1038/leu.2014.95; Chen CY, 2006, LEUKEMIA, V20, P1155, DOI 10.1038/sj.leu.2404190; Chen CY, 2007, BRIT J HAEMATOL, V139, P405, DOI 10.1111/j.1365-2141.2007.06811.x; Chen TC, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.74; Cheng CL, 2011, BRIT J CANCER, V105, P975, DOI 10.1038/bjc.2011.340; Cheng WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017347; Chou WC, 2011, LEUKEMIA, V25, P246, DOI 10.1038/leu.2010.267; Chou WC, 2006, CANCER RES, V66, P3310, DOI 10.1158/0008-5472.CAN-05-4316; Chou WC, 2011, BLOOD; Edelman MJ, 2008, J CLIN ONCOL, V26, P848, DOI 10.1200/JCO.2007.13.8081; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Giles FJ, 2003, BRIT J HAEMATOL, V121, P578, DOI 10.1046/j.1365-2141.2003.04306.x; Gorn M, 2005, LUNG CANCER-J IASLC, V49, P71, DOI 10.1016/j.lungcan.2004.12.005; Goto-Koshino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050849; Grone J, 2006, ONCOL REP, V15, P1437; Hou HA, 2008, LEUKEMIA, V22, P1075, DOI 10.1038/sj.leu.2405005; Hou HA, 2014, LEUKEMIA, V28, P50, DOI 10.1038/leu.2013.236; Hou HA, 2009, BRIT J CANCER, V101, P738, DOI 10.1038/sj.bjc.6605207; Hou HA, 2008, LEUKEMIA RES, V32, P904, DOI 10.1016/j.leukres.2007.08.010; Hou HA, 2012, BLOOD, V119, P559, DOI 10.1182/blood-2011-07-369934; Hou HA, 2010, HAEMATOL-HEMATOL J, V95, P1420, DOI 10.3324/haematol.2009.019364; Hou HA, 2010, BLOOD, V115, P5222, DOI 10.1182/blood-2009-12-259390; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Lin CC, 2013, AM J HEMATOLOGY; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Marcucci G, 2000, CANCER INVEST, V18, P768, DOI 10.3109/07357900009012209; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; SCHOLZEL C, 1985, EXP HEMATOL, V13, P664; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Shiah HS, 2002, LEUKEMIA, V16, P196, DOI 10.1038/sj.leu.2402352; Shibata F, 2009, STEM CELLS, V27, P183, DOI 10.1634/stemcells.2008-0292; Shih TTF, 2009, BLOOD, V113, P3161, DOI 10.1182/blood-2008-08-173104; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Tien HF, 1995, CANCER GENET CYTOGEN, V84, P60, DOI 10.1016/0165-4608(95)00084-4; Yoshikawa M, 2013, BLOOD, V121, P2804, DOI 10.1182/blood-2012-12-468363	47	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119831	10.1371/journal.pone.0119831	http://dx.doi.org/10.1371/journal.pone.0119831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794001	gold, Green Submitted, Green Published			2022-12-26	WOS:000352084200120
J	Costa, VV; Amaral, FA; Coelho, FM; Queiroz, CM; Malagoli, BG; Gomes, JHS; Lopes, F; Silveira, KD; Sachs, D; Fagundes, CT; Tavares, LD; Pinho, V; Silva, TA; Teixeira, MM; Braga, FC; Souza, DG				Costa, Vivian V.; Amaral, Flavio A.; Coelho, Fernanda M.; Queiroz-Junior, Celso M.; Malagoli, Bruna G.; Gomes, Jose Hugo S.; Lopes, Fernando; Silveira, Katia D.; Sachs, Daniela; Fagundes, Caio T.; Tavares, Livia D.; Pinho, Vanessa; Silva, Tarcilia A.; Teixeira, Mauro M.; Braga, Fernao C.; Souza, Danielle G.			Lithothamnion muelleri Treatment Ameliorates Inflammatory and Hypernociceptive Responses in Antigen-Induced Arthritis in Mice	PLOS ONE			English	Article							SULFATED POLYSACCHARIDES; CHLORELLA-STIGMATOPHORA; NEUTROPHIL RECRUITMENT; SYNOVIAL-FLUID; MURINE MODEL; INVOLVEMENT; MICROALGAE; THERAPIES; ADHESION; DISEASE	Rheumatoid Arthritis (RA) is a chronic disease characterized by persistent inflammation and pain. Alternative therapies to reduce these symptoms are needed. Marine algae are valuable sources of diverse bioactive compounds. Lithothamnion muelleri (Hapalidiaceae) is a marine algae with anti-inflammatory, antitumor, and immunomodulatory properties. Here, we investigated the potential anti-inflammatory and analgesic activities of L. muelleri in a murine model of antigen-induced arthritis (AIA) in mice. Our results demonstrate that treatment with L. muelleri prevented inflammation and hypernociception in arthritic mice. Mechanistically, the crude extract and the polysaccharide-rich fractions of L. muelleri may act impairing the production of the chemokines CXCL1 and CXCL2, and consequently inhibit neutrophil influx to the knee joint by dampening the adhesion step of leukocyte recruitment in the knee microvessels. Altogether our results suggest that treatment with L. muelleri has a potential therapeutic application in arthritis treatment.	[Costa, Vivian V.; Queiroz-Junior, Celso M.; Fagundes, Caio T.; Tavares, Livia D.; Souza, Danielle G.] Univ Fed Minas Gerais, ICB, Dept Microbiol, Lab Interacao Microrganismo Hospedeiro, Belo Horizonte, MG, Brazil; [Costa, Vivian V.; Amaral, Flavio A.; Coelho, Fernanda M.; Lopes, Fernando; Silveira, Katia D.; Fagundes, Caio T.; Tavares, Livia D.; Pinho, Vanessa; Silva, Tarcilia A.; Teixeira, Mauro M.; Souza, Danielle G.] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Imunofarmacol, Belo Horizonte, MG, Brazil; [Costa, Vivian V.] Singapore MIT Alliance Res & Technol, Interdisciplinary Res Grp Infect Dis, Singapore, Singapore; [Queiroz-Junior, Celso M.; Silva, Tarcilia A.] Univ Fed Minas Gerais, Dept Clin Patol & Cirurgia Odontol, Fac Odontol, Belo Horizonte, MG, Brazil; [Malagoli, Bruna G.; Gomes, Jose Hugo S.; Braga, Fernao C.] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Belo Horizonte, MG, Brazil; [Lopes, Fernando; Pinho, Vanessa] Univ Fed Minas Gerais, ICB, Dept Morfol, Belo Horizonte, MG, Brazil; [Sachs, Daniela] Univ Fed Itajuba UNIFEI, Inst Ciencias Exatas, Dept Fis & Quim, Itajuba, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Singapore-MIT Alliance for Research & Technology Centre (SMART); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Itajuba	Souza, DG (corresponding author), Univ Fed Minas Gerais, ICB, Dept Microbiol, Lab Interacao Microrganismo Hospedeiro, Belo Horizonte, MG, Brazil.	souzadg@gmail.com	Pinho, Vanessa/AAR-1686-2021; da Silva, Tarcília Aparecida/O-7530-2015; SILVEIRA, KATIA D/N-3036-2013; pinho, vanessa/AAC-8437-2020; Sachs, Daniela DS/I-3741-2012; Fagundes, Caio/AAK-9336-2020; Silva, Tarcilia/AAP-3760-2021; Amaral, Flávio Almeida/C-3768-2018; Braga, Fernão/AAO-3888-2020; Costa, Vivian VVC/I-2499-2018; Teixeira, Mauro M/A-4587-2008; Queiroz-Junior, Celso/L-5438-2013; Braga, Fernão C/E-3236-2016; Pinho, Vanessa/GXM-8532-2022	da Silva, Tarcília Aparecida/0000-0001-9623-7835; SILVEIRA, KATIA D/0000-0003-4955-3709; pinho, vanessa/0000-0003-1038-2324; Fagundes, Caio/0000-0002-6747-5233; Silva, Tarcilia/0000-0001-9623-7835; Amaral, Flávio Almeida/0000-0002-1695-0612; Braga, Fernão/0000-0001-9468-376X; Costa, Vivian VVC/0000-0002-0175-642X; Teixeira, Mauro M/0000-0002-6944-3008; Queiroz-Junior, Celso/0000-0002-7884-7709; Braga, Fernão C/0000-0001-9468-376X; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Cordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil; Instituto Nacional de Ciencia e Tecnologia em Dengue - INCTem Dengue; "Science without borders" program (CNPq, Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Cordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia em Dengue - INCTem Dengue; "Science without borders" program (CNPq, Brazil)	The authors study is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Cordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil, and Instituto Nacional de Ciencia e Tecnologia em Dengue - INCTem Dengue. VVC was also supported by "Science without borders" program (CNPq, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral FA, 2012, ARTHRITIS RHEUM-US, V64, P474, DOI 10.1002/art.33355; Aslam MN, 2010, INTEGR CANCER THER, V9, P93, DOI 10.1177/1534735409360360; BENDER JG, 1986, INFLAMMATION, V10, P443, DOI 10.1007/BF00915828; BOISSET M, 1994, J RHEUMATOL, V21, P148; Chaves LD, 2013, IMMUNOPHARM IMMUNOT, V35, P93, DOI 10.3109/08923973.2012.707211; Coelho FM, 2008, ARTHRITIS RHEUM-US, V58, P2329, DOI 10.1002/art.23622; Courtois J, 2009, CURR OPIN MICROBIOL, V12, P261, DOI 10.1016/j.mib.2009.04.007; Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654; Dias G. T. M, 2000, BRAZILIAN J GEOPHYS, V18, DOI [10.1590/S0102-261X2000000300008, DOI 10.1590/S0102-261X2000000300008]; EDWARDS SW, 1988, BIOCHEM J, V250, P81, DOI 10.1042/bj2500081; Faulkner DJ, 2000, NAT PROD REP, V17, P7, DOI 10.1039/a809395d; Figueiredo JG, 2010, PHARMACOL BIOCHEM BE, V96, P371, DOI 10.1016/j.pbb.2010.06.008; Frestedt JL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-9; Frestedt JL, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-7; Grespan R, 2008, ARTHRITIS RHEUM, V58, P2030, DOI 10.1002/art.23597; Guzman S, 2003, PHYTOTHER RES, V17, P665, DOI 10.1002/ptr.1227; Guzman S, 2001, PHYTOTHER RES, V15, P224, DOI 10.1002/ptr.715; Jiao GL, 2011, MAR DRUGS, V9, P196, DOI 10.3390/md9020196; KITSIS E, 1991, CLIN ORTHOP RELAT R, P63; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kowanko IC, 1996, CLIN IMMUNOL IMMUNOP, V79, P36, DOI 10.1006/clin.1996.0048; LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Malagoli BG, 2014, INT J BIOL MACROMOL, V66, P332, DOI 10.1016/j.ijbiomac.2014.02.053; Matsui MS, 2003, APPL BIOCHEM BIOTECH, V104, P13, DOI 10.1385/ABAB:104:1:13; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Queiroz CM, 2011, J IMMUNOL, V187, P3821, DOI 10.4049/jimmunol.1101195; Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003; Rezende BM, 2013, MAR DRUGS, V11, P2595, DOI 10.3390/md11072595; Rodrigues JAG, 2012, PHARMACOL REP, V64, P282, DOI 10.1016/S1734-1140(12)70766-1; Sachs D, 2011, BRIT J PHARMACOL, V162, P72, DOI 10.1111/j.1476-5381.2010.00895.x; Assreuy AMS, 2008, BIOL PHARM BULL, V31, P691, DOI 10.1248/bpb.31.691; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Soares CM, 2012, Z NATURFORSCH C, V67, P391; Tanaka D, 2006, IMMUNOLOGY, V119, P195, DOI 10.1111/j.1365-2567.2006.02424.x; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	41	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118356	10.1371/journal.pone.0118356	http://dx.doi.org/10.1371/journal.pone.0118356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793994	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200021
J	Cozzi, G; Borger, L; Hutter, P; Abegg, D; Beran, C; McNutt, JW; Ozgul, A				Cozzi, Gabriele; Borger, Luca; Hutter, Pascale; Abegg, Daniela; Beran, Celine; McNutt, J. Weldon; Ozgul, Arpat			Effects of Trophy Hunting Leftovers on the Ranging Behaviour of Large Carnivores: A Case Study on Spotted Hyenas	PLOS ONE			English	Article							HOME-RANGE; CROCUTA-CROCUTA; POPULATION-DYNAMICS; HABITAT USE; FOOD; LIVESTOCK; PATTERNS; PREY; PREFERENCES; YELLOWSTONE	Human-related food resources such as garbage dumps and feeding sites have been shown to significantly influence space use, breeding success and population dynamics in a variety of animal species. In contrast, relatively little is known on the effects of unpredictable sources of food, such as carcasses discarded by hunters, on carnivore species. We evaluated the effect of elephant carcasses, mainly deriving from trophy hunting, on the ranging and feeding behavior of spotted hyenas (Crocuta crocuta) in the Okavango Delta, Botswana. Using data from hyenas monitored before and during carcass availability via GPS radio-collars and camera traps, we investigated changes in ranging and feeding behavior over time. Carcass availability influenced hyenas' ranging behavior for an average of 10-12 days, after which their movements returned to patterns observed before carcass availability. In particular, we observed an increased spatial clustering of locations and reduced speeds (up to 15% less) between successive locations with carcass availability. Consistent feeding at carcasses during the first two weeks was typical, and some individuals fed from elephant carcasses for as long as 50 days. The impact and conservation value of hunting are often assessed based solely on the effects on the hunted species. Our results show that hunting remains can influence other species and suggest that such extra food could have important effects on critical life history processes and ultimately population dynamics. We recommend conservationists and wildlife managers evaluate management strategies and hunting practices regarding carcass disposal in order to incorporate the potential collateral impacts of hunting on non-hunted species in the same community.	[Cozzi, Gabriele; Hutter, Pascale; Abegg, Daniela; Beran, Celine; Ozgul, Arpat] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Populat Ecol Res Grp, Zurich, Switzerland; [Cozzi, Gabriele; McNutt, J. Weldon] Botswana Predator Conservat Trust, Maun, Botswana; [Borger, Luca] Swansea Univ, Coll Sci, Dept Biosci, Swansea, W Glam, Wales	University of Zurich; Swansea University	Cozzi, G (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Populat Ecol Res Grp, Zurich, Switzerland.	gabriele.cozzi@uzh.ch	Cozzi, Gabriele/ABI-8232-2020; Ozgul, Arpat/K-2032-2012; Börger, Luca/C-6003-2008	Ozgul, Arpat/0000-0001-7477-2642; Börger, Luca/0000-0001-8763-5997; Cozzi, Gabriele/0000-0002-1744-1940	Basel Zoo; Forschungskredit der Universitat Zurich; Vontobel Stiftung	Basel Zoo; Forschungskredit der Universitat Zurich; Vontobel Stiftung	Funding: This work was funded by the Basel Zoo (http://www.zoobasel.ch), the Forschungskredit der Universitat Zurich (http://www.researchers.uzh.ch/promotion/forschungskredit_en.html) and the Vontobel Stiftung (http://www.vontobel-stiftung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; Bartlam-Brooks HLA, 2011, ORYX, V45, P210, DOI 10.1017/S0030605310000414; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Bennitt E., 2012, THESIS U BRISTOL; Binder WJ, 2000, J ZOOL, V252, P273, DOI 10.1111/j.1469-7998.2000.tb00622.x; Bischof R, 2012, J APPL ECOL, V49, P824, DOI 10.1111/j.1365-2664.2012.02167.x; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Bowman AW, 1997, APPL SMOOTHING TECHN; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Bronson FH, 1989, MAMMALIAN REPROD BIO; Burroughs R, 2012, CHEM PHYS RESTRAINT, P183; Chavez AS, 2006, J WILDLIFE MANAGE, V70, P1079, DOI 10.2193/0022-541X(2006)70[1079:LUAMOW]2.0.CO;2; Ciucci P, 1997, J ZOOL, V243, P803, DOI 10.1111/j.1469-7998.1997.tb01977.x; Cozzi G, 2013, BIODIVERS CONSERV, V22, P2937, DOI 10.1007/s10531-013-0564-7; Cozzi G., 2013, THESIS ZURICH U; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Dassis M, 2012, MAMM BIOL, V77, P47, DOI 10.1016/j.mambio.2011.07.003; Department of Wildlife and National Parks, 2012, AER CENS AN BOTSW DR; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Forsyth DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097937; Gilchrist JS, 2002, CAN J ZOOL, V80, P1795, DOI 10.1139/Z02-113; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Guerbois C, 2012, J APPL ECOL, V49, P1149, DOI 10.1111/j.1365-2664.2012.02192.x; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hemson G, 2005, J ANIM ECOL, V74, P455, DOI 10.1111/j.1365-2656.2005.00944.x; HENSCHEL JR, 1990, AFR J ECOL, V28, P69, DOI 10.1111/j.1365-2028.1990.tb01138.x; HENSCHEL JR, 1988, AFR J ECOL, V26, P247, DOI 10.1111/j.1365-2028.1988.tb00977.x; HOFER H, 1993, ANIM BEHAV, V46, P559, DOI 10.1006/anbe.1993.1223; Holekamp KE, 1997, J ZOOL, V242, P1, DOI 10.1111/j.1469-7998.1997.tb02925.x; Honer OP, 2005, OIKOS, V108, P544, DOI 10.1111/j.0030-1299.2005.13533.x; Karlsson J, 2010, J APPL ECOL, V47, P166, DOI 10.1111/j.1365-2664.2009.01747.x; Kie J.G., 2013, ANIM BIOTELEM, V1, P13, DOI [10.1186/2050-3385-1-13, DOI 10.1186/2050-3385-1-13]; Kolowski JM, 2008, AFR J ECOL, V46, P341, DOI 10.1111/j.1365-2028.2007.00846.x; Kolowski JM, 2006, BIOL CONSERV, V128, P529, DOI 10.1016/j.biocon.2005.10.021; Kruuk H., 1972, P1; Lopez-Lopez P, 2014, ECOL APPL, V24, P938, DOI 10.1890/13-2000.1; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Macdonald D, 2001, NEW ENCY MAMMALS; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Mendelsohn J.M., 2010, OKAVANGO DELTA FLOOD; Moreno-Opo R, 2010, WILDLIFE BIOL, V16, P25, DOI 10.2981/09-037; Ogada DL, 2012, CONSERV BIOL, V26, P453, DOI 10.1111/j.1523-1739.2012.01827.x; Olea PP, 2008, IBIS, V150, P98; OWENS D, 1979, J MAMMAL, V60, P405, DOI 10.2307/1379816; Palazy L, 2012, ANIM CONSERV, V15, P4, DOI 10.1111/j.1469-1795.2011.00476.x; Price SA, 2007, P R SOC B, V274, P1845, DOI 10.1098/rspb.2007.0505; Ruth TK, 2003, WILDLIFE SOC B, V31, P1150; Silverman B.W., 1986, DENSITY ESTIMATION S; Sorensen A, 2014, PREV VET MED, V113, P356, DOI 10.1016/j.prevetmed.2013.11.010; TILSON RL, 1984, ANIM BEHAV, V32, P715, DOI 10.1016/S0003-3472(84)80147-5; Tortosa FS, 2002, WATERBIRDS, V25, P39, DOI 10.1675/1524-4695(2002)025[0039:EORDOB]2.0.CO;2; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; WHITE TCR, 1978, OECOLOGIA, V33, P71, DOI 10.1007/BF00376997; Whyte Ian J., 2003, P332; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Yamada A, 2010, PRIMATES, V51, P159, DOI 10.1007/s10329-009-0183-9; Yirga G, 2012, J ANIM ECOL, V81, P1052, DOI 10.1111/j.1365-2656.2012.01977.x; Zuur Alain F., 2009, P1	64	7	7	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121471	10.1371/journal.pone.0121471	http://dx.doi.org/10.1371/journal.pone.0121471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793976	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000352083900135
J	de Hollander, G; Keuken, MC; Forstmann, BU				de Hollander, Gilles; Keuken, Max C.; Forstmann, Birte U.			The Subcortical Cocktail Problem; Mixed Signals from the Subthalamic Nucleus and Substantia Nigra	PLOS ONE			English	Article							BASAL GANGLIA; FUNCTIONAL CONNECTIVITY; DOPAMINERGIC MIDBRAIN; RESPONSE-INHIBITION; SELECTIVE ATTENTION; PARKINSONS-DISEASE; WORKING-MEMORY; FRONTAL-CORTEX; REWARD SYSTEM; NOVELTY	The subthalamic nucleus and the directly adjacent substantia nigra are small and important structures in the basal ganglia. Functional magnetic resonance imaging studies have shown that the subthalamic nucleus and substantia nigra are selectively involved in response inhibition, conflict processing, and adjusting global and selective response thresholds. However, imaging these nuclei is complex, because they are in such close proximity, they can vary in location, and are very small relative to the resolution of most fMRI sequences. Here, we investigated the consistency in localization of these nuclei in BOLD fMRI studies, comparing reported coordinates with probabilistic atlas maps of young human participants derived from ultra-high resolution 7T MRI scanning. We show that the fMRI signal reported in previous studies is likely not unequivocally arising from the subthalamic nucleus but represents a mixture of subthalamic nucleus, substantia nigra, and surrounding tissue. Using a simulation study, we also tested to what extent spatial smoothing, often used in fMRI preprocessing pipelines, influences the mixture of BOLD signals. We propose concrete steps how to analyze fMRI BOLD data to allow inferences about the functional role of small subcortical nuclei like the subthalamic nucleus and substantia nigra.	[de Hollander, Gilles; Keuken, Max C.; Forstmann, Birte U.] Univ Amsterdam, Amsterdam Brain & Cognit Ctr, Amsterdam, Netherlands; [Keuken, Max C.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	University of Amsterdam; Max Planck Society	Forstmann, BU (corresponding author), Univ Amsterdam, Amsterdam Brain & Cognit Ctr, Amsterdam, Netherlands.	buforstmann@gmail.com	Forstmann, Birte/AAS-8515-2020	de Hollander, Gilles/0000-0003-1988-5091; Keuken, Max/0000-0002-9703-9125	Netherlands Organization for Scientific Research (NWO); ERC	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	This work was supported by a VIDI (BUF) grant from the Netherlands Organization for Scientific Research (NWO) and an ERC starter grant (BUF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CHINESE MEDICAL JOUR; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Beauregard M, 2006, APPL PSYCHOPHYS BIOF, V31, P3, DOI 10.1007/s10484-006-9001-y; Bishop C. M, 2006, PATTERN RECOGNITION; Boecker H, 2008, NEUROIMAGE, V39, P1356, DOI 10.1016/j.neuroimage.2007.09.069; Boehler CN, 2011, J NEUROSCI, V31, P4955, DOI 10.1523/JNEUROSCI.4845-10.2011; Boehler CN, 2011, J COGNITIVE NEUROSCI, V23, P362, DOI 10.1162/jocn.2010.21473; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Brunenberg EJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039061; Bryclon L, 2008, BIOL PSYCHIAT, V63, P1022, DOI 10.1016/j.biopsych.2007.12.007; Bunzeck N, 2007, CEREB CORTEX, V17, P2940, DOI 10.1093/cercor/bhm020; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; Chase HW, 2010, J NEUROSCI, V30, P6180, DOI 10.1523/JNEUROSCI.5758-09.2010; Colpan ME, 2010, PARKINSONISM RELAT D, V16, P398, DOI 10.1016/j.parkreldis.2010.03.008; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Coxon JP, 2010, CEREB CORTEX, V20, P2368, DOI 10.1093/cercor/bhp306; D'Ardenne K, 2013, COGN AFFECT BEHAV NE, V13, P747, DOI 10.3758/s13415-013-0191-5; D'Ardenne K, 2012, P NATL ACAD SCI USA, V109, P19900, DOI 10.1073/pnas.1116727109; de Hollander G, 2014, HUM BRAIN MAPP, V35, P4440, DOI 10.1002/hbm.22485; den Dunnen WFA, 2005, MOVEMENT DISORD, V20, P893, DOI 10.1002/mds.20417; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Erika-Florence M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5073; Fleming SM, 2010, J NEUROPHYSIOL, V103, P3238, DOI 10.1152/jn.01084.2009; Fleming SM, 2010, P NATL ACAD SCI USA, V107, P6005, DOI 10.1073/pnas.0910380107; Forstmann BU, 2012, NEUROIMAGE, V60, P370, DOI 10.1016/j.neuroimage.2011.12.044; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Forstmann BU, 2014, SCIENTIFIC DATA; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Fussenich M, 1967, VERGLEICHEND ANATOMI, P1; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; Guitart-Masip M, 2011, J NEUROSCI, V31, P7867, DOI 10.1523/JNEUROSCI.6376-10.2011; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Hardman CD, 1997, J NEUROPATH EXP NEUR, V56, P132, DOI 10.1097/00005072-199702000-00003; Herz DM, 2014, J NEUROSCI, V34, P3210, DOI 10.1523/JNEUROSCI.4081-13.2014; Hu SE, 2014, HUM BRAIN MAPP, V35, P2531, DOI 10.1002/hbm.22347; Jahanshahi M, 2013, FRONTIERS IN SYSTEMS, V7, DOI [10.3389/fnsys.2013.00118/abstract, DOI 10.3389/FNSYS.2013.00118/ABSTRACT]; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Keuken MC, 2014, NEUROIMAGE, V94, P40, DOI 10.1016/j.neuroimage.2014.03.032; Keuken MC, 2013, J NEUROSCI, V33, P4896, DOI 10.1523/JNEUROSCI.3241-12.2013; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Kitajima M, 2008, NEURORADIOLOGY, V50, P675, DOI 10.1007/s00234-008-0388-4; Krebs RM, 2011, NEUROIMAGE, V58, P647, DOI 10.1016/j.neuroimage.2011.06.038; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Krebs RM, 2009, BIOL PSYCHIAT, V65, P103, DOI 10.1016/j.biopsych.2008.08.019; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; LANGE H, 1976, J NEUROL SCI, V28, P401, DOI 10.1016/0022-510X(76)90114-3; Lefranc M, 2014, NEUROSURGERY, V74, P615, DOI 10.1227/NEU.0000000000000319; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Lenglet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029153; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; Levesque J, 2006, NEUROSCI LETT, V394, P216, DOI 10.1016/j.neulet.2005.10.100; Levesque JC, 2005, MOVEMENT DISORD, V20, P574, DOI 10.1002/mds.20374; Li CSR, 2008, NEUROIMAGE, V41, P1352, DOI 10.1016/j.neuroimage.2008.04.023; Mansfield EL, 2011, J NEUROSCI, V31, P14688, DOI 10.1523/JNEUROSCI.2390-11.2011; Marani E, 2008, THE SUBTHALAMIC NUCL; Marchand WR, 2013, HUM BRAIN MAPP, V34, P1194, DOI 10.1002/hbm.21505; Menz MM, 2012, J NEUROSCI, V32, P6937, DOI 10.1523/JNEUROSCI.3553-11.2012; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Prodoehl J, 2008, J NEUROPHYSIOL, V99, P3042, DOI 10.1152/jn.01108.2007; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Sacchet MD, 2013, NEUROIMAGE, V66, P270, DOI 10.1016/j.neuroimage.2012.10.056; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Shohamy D, 2008, NEUROSCI BIOBEHAV R, V32, P219, DOI 10.1016/j.neubiorev.2007.07.008; Spraker MB, 2007, J NEUROPHYSIOL, V98, P821, DOI 10.1152/jn.00239.2007; Stelzer J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00462; Tabelow K, 2009, J NEUROSCI METH, V178, P357, DOI 10.1016/j.jneumeth.2008.12.011; Turner R, 2013, MICROSTRUCTURAL PARC; Vaillancourt DE, 2007, NEUROIMAGE, V36, P793, DOI 10.1016/j.neuroimage.2007.03.002; Vaillancourt DE, 2004, NEUROIMAGE, V23, P175, DOI 10.1016/j.neuroimage.2004.04.040; van Maanen L, 2011, J NEUROSCI, V31, P17488, DOI 10.1523/JNEUROSCI.2924-11.2011; VONBONIN G, 1951, J COMP NEUROL, V94, P427, DOI 10.1002/cne.900940306; Weiss M, 2014, BRAIN STRUCT FUNCT; Wen X, 2012, THE SPATIAL PATTERN, P43; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wittmann BC, 2007, NEUROIMAGE, V38, P194, DOI 10.1016/j.neuroimage.2007.06.038; Yelnik J, 2002, MOVEMENT DISORD, V17, pS15, DOI 10.1002/mds.10138; Yoon JH, 2013, BIOL PSYCHIAT, V74, P122, DOI 10.1016/j.biopsych.2012.11.018; Yu Y, 2013, J NEUROSCI, V33, P14040, DOI 10.1523/JNEUROSCI.1176-13.2013	91	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120572	10.1371/journal.pone.0120572	http://dx.doi.org/10.1371/journal.pone.0120572			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793883	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900054
J	Ferrario, M; Moissl, U; Garzotto, F; Cruz, DN; Tetta, C; Signorini, MG; Ronco, C; Grassmann, A; Cerutti, S; Guzzetti, S				Ferrario, Manuela; Moissl, Ulrich; Garzotto, Francesco; Cruz, Dinna N.; Tetta, Ciro; Signorini, Maria G.; Ronco, Claudio; Grassmann, Aileen; Cerutti, Sergio; Guzzetti, Stefano			The Forgotten Role of Central Volume in Low Frequency Oscillations of Heart Rate Variability	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; POWER SPECTRAL-ANALYSIS; BODY NEGATIVE-PRESSURE; MAYER WAVES; RESPONSES; FAILURE; DISCHARGE; PATTERNS; HUMANS; SHOCK	The hypothesis that central volume plays a key role in the source of low frequency (LF) oscillations of heart rate variability (HRV) was tested in a population of end stage renal disease patients undergoing conventional hemodialysis (HD) treatment, and thus subject to large fluid shifts and sympathetic activation. Fluid overload (FO) in 58 chronic HD patients was assessed by whole body bioimpedance measurements before the midweek HD session. Heart Rate Variability (HRV) was measured using 24-hour Holter electrocardiogram recordings starting before the same HD treatment. Time domain and frequency domain analyses were performed on HRV signals. Patients were retrospectively classified in three groups according to tertiles of FO normalized to the extracellular water (FO/ECW%). These groups were also compared after stratification by diabetes mellitus. Patients with the low to medium hydration status before the treatment (i.e. 1st and 2nd FO/ECW% tertiles) showed a significant increase in LF power during last 30 min of HD compared to dialysis begin, while no significant change in LF power was seen in the third group (i.e. those with high pre-treatment hydration values). In conclusion, several mechanisms can generate LF oscillations in the cardiovascular system, including baroreflex feedback loops and central oscillators. However, the current results emphasize the role played by the central volume in determining the power of LF oscillations.	[Ferrario, Manuela; Signorini, Maria G.; Cerutti, Sergio] Politecn Milan, DEIB, Milan, Italy; [Moissl, Ulrich; Tetta, Ciro; Grassmann, Aileen] Fresenius Med Care R&D, Bad Homburg, Germany; [Garzotto, Francesco; Cruz, Dinna N.; Ronco, Claudio] San Bortolo Hosp, Vicenza, Italy; [Guzzetti, Stefano] Univ Milan, L Sacco Hosp, Milan, Italy	Polytechnic University of Milan; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; University of Milan; Luigi Sacco Hospital	Ferrario, M (corresponding author), Politecn Milan, DEIB, Milan, Italy.	manuela.ferrario@polimi.it	garzotto, francesco/K-3552-2018; Cerutti, Sergio/A-3155-2009; signorini, maria g/A-4248-2014	garzotto, francesco/0000-0002-0233-3752; signorini, maria g/0000-0002-9391-9846; Ferrario, Manuela/0000-0001-7371-3624; Ronco, Claudio/0000-0002-6697-4065	Fresenius Medical Care Deutschland GmbH	Fresenius Medical Care Deutschland GmbH	Fresenius Medical Care Deutschland GmbH provided support in the form of salaries for authors UM, CT and AG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Cabezas-Cerrato J, 2009, DIABETES METAB, V35, P305, DOI 10.1016/j.diabet.2009.01.006; Convertino VA, 2004, AUTON NEUROSCI-BASIC, V111, P127, DOI 10.1016/j.autneu.2004.02.007; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; Cooke WH, 2004, J APPL PHYSIOL, V96, P1249, DOI 10.1152/japplphysiol.01155.2003; Ferrario M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-26; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Kiviniemi AM, 2011, EXP PHYSIOL, V96, P718, DOI 10.1113/expphysiol.2011.058768; Manner J, 2010, DEV DYNAM, V239, P1035, DOI 10.1002/dvdy.22265; Mayer S, 1876, SITZUNGSBERICHT MATH, V74, P281; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Petretta M, 1995, AM J HYPERTENS, V8, P1206, DOI 10.1016/0895-7061(95)00252-9; POLOSA C, 1984, P27; PREISS G, 1974, AM J PHYSIOL, V226, P724, DOI 10.1152/ajplegacy.1974.226.3.724; Ramchandra R, 2009, AM J PHYSIOL-REG I, V297, pR665, DOI 10.1152/ajpregu.00191.2009; Ramchandra R, 2008, AM J PHYSIOL-REG I, V295, pR719, DOI 10.1152/ajpregu.00824.2007; SELLER H, 1967, PFLUG ARCH GES PHYS, V296, P110, DOI 10.1007/BF00362724; Siegel G, 1984, VASCULAR SMOOTH MUSC, P319; Slama K, 2012, J INSECT PHYSIOL, V58, P1072, DOI 10.1016/j.jinsphys.2012.04.014; vandeBorne P, 1997, CIRCULATION, V95, P1449; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; WASSERTHAL LT, 1976, EXPERIENTIA, V32, P577, DOI 10.1007/BF01990172	24	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120167	10.1371/journal.pone.0120167	http://dx.doi.org/10.1371/journal.pone.0120167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793464	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200151
J	Hargreaves, JR; Davey, C; Fearon, E; Hensen, B; Krishnaratne, S				Hargreaves, James R.; Davey, Calum; Fearon, Elizabeth; Hensen, Bernadette; Krishnaratne, Shari			Trends in Socioeconomic Inequalities in HIV Prevalence among Young People in Seven Countries in Eastern and Southern Africa	PLOS ONE			English	Article							POPULATION-BASED SURVEYS; EDUCATIONAL-ATTAINMENT; INFECTION; RISK; ASSOCIATION; BIAS	Background In Eastern and Southern Africa, HIV prevalence was highest among higher socioeconomic groups during the 1990s. It has been suggested that this is changing, with HIV prevalence falling among higher-educated groups while stable among lower-educated groups. A multi-country analysis has not been undertaken. Methods We analysed data on socio-demographic factors and HIV infection from 14 nationally representative surveys of adults aged 15-24 (seven countries, two surveys each, 4-8 years apart). Sample sizes ranged from 2,408-12,082 (72,135 total). We used logistic regression to assess gender-stratified associations between highest educational level attended and HIV status in each survey, adjusting for age and urban/rural setting. We tested for interactions with urban/rural setting and age. Our primary hypothesis was that higher education became less of a risk factor for HIV over time. We tested for interaction between survey-year and the education-HIV association in each country and all countries pooled. Findings In Ethiopia and Malawi, HIV prevalence was higher in more educated women in both surveys. In Lesotho, Kenya and Zimbabwe, HIV prevalence was lower in higher educated women in both surveys. In Ethiopia, HIV prevalence fell among no and secondary educated women only (interaction p< 0.01). Only among young men in Tanzania there was some evidence that the association between education and HIV changed over time (p= 0.07). Pooled analysis found little evidence for an interaction between survey year and the education-HIV association among men (p= 0.60) or women (p= 0.37). Interpretation The pattern of prevalent HIV infection among young adults by level of education in different sub-Saharan African countries was heterogeneous. There was little statistical evidence that this pattern changed between 2003-5 and 2008-12. Explanations for the social epidemiology of HIV in Africa will need to account for time-trends and inter-country differences.	[Hargreaves, James R.] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; London Sch Hyg & Trop Med, Ctr Evaluat, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Hargreaves, JR (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England.	james.hargreaves@lshtm.ac.uk		Fearon, Elizabeth/0000-0001-5574-251X; Hargreaves, James/0000-0002-3509-3572; Hensen, Bernadette/0000-0001-6719-6720	STRIVE consortium by UKaid from Department for International Development; Department for International Development (DFID) [201447] Funding Source: researchfish	STRIVE consortium by UKaid from Department for International Development; Department for International Development (DFID)	Funding: The study was supported through the STRIVE consortium by UKaid from the Department for International Development (http://strive.lshtm.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Corsi D, 2012, INT J EPIDEMIOL; de Lay Paul, 2007, BMJ, V334, P345, DOI 10.1136/bmj.39113.539595.94; de Walque D, 2005, TROP MED INT HEALTH, V10, P993, DOI 10.1111/j.1365-3156.2005.01475.x; England R, 2007, BMJ-BRIT MED J, V334, P344, DOI 10.1136/bmj.39113.402361.94; Fox AM, 2012, J BIOSOC SCI, V44, P459, DOI 10.1017/S0021932011000745; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Glick PJ, 2008, ECON DEV CULT CHANGE, V56, P397, DOI 10.1086/522893; Gregson S., 2001, Journal of International Development, V13, P467, DOI 10.1002/jid.798; Hargreaves J, 2011, J EPIDEMIOL COMMUN H, V65, pA363, DOI 10.1136/jech.2011.142976m.42; Hargreaves J, 2012, J EPIDEMIOL COMMUNIT; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hargreaves JR, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17363; Hargreaves JR, 2010, AIDS, V24, P754, DOI 10.1097/QAD.0b013e328336672e; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; Hogan DR, 2012, SEX TRANSM INFECT, V88, pI17, DOI 10.1136/sextrans-2012-050636; Johnson LF, 2009, AIDS, V23, P1583, DOI 10.1097/QAD.0b013e32832d407e; Kayeyi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033652; Larose A, 2011, J PUBLIC HEALTH-UK, V33, P345, DOI 10.1093/pubmed/fdr001; Marston M, 2008, SEX TRANSM INFECT, V84, pI71, DOI 10.1136/sti.2008.030353; Measure DHS, 2010, DEM HLTH SURV ZIMB 2; Measure DHS, 2005, DEM HLTH SURV ZIMB 2; Measure DHS, DEM HLTH SURV ETH 20; Measure DHS, 2011, DEM HLTH SURV TANZ 2; Measure DHS [Internet], 2003, DEM HLTH SURV TANZ 2; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Mishra V, 2006, B WORLD HEALTH ORGAN, V84, P537, DOI 10.2471/BLT.05.029520; Mmbaga EJ, 2007, SEX TRANSM DIS, V34, P947, DOI 10.1097/OLQ.0b013e31813e0c15; Parkhurst JO, 2010, UNDERSTANDING CORREL; Sandoy IF, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-60; UNAIDS, 2012, REP GLOB AIDS EP; UNAIDS, 1998, REP GLOB AIDS EP; UNAIDS, 2013, REP GLOB AIDS EP; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0	36	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121775	10.1371/journal.pone.0121775	http://dx.doi.org/10.1371/journal.pone.0121775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793608	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000352083900150
J	King, PT; Sharma, R; O'Sullivan, K; Selemidis, S; Lim, S; Radhakrishna, N; Lo, C; Prasad, J; Callaghan, J; McLaughlin, P; Farmer, M; Steinfort, D; Jennings, B; Ngui, J; Broughton, BRS; Thomas, B; Essilfie, AT; Hickey, M; Holmes, PW; Hansbro, P; Bardin, PG; Holdsworth, SR				King, Paul T.; Sharma, Roleen; O'Sullivan, Kim; Selemidis, Stavros; Lim, Steven; Radhakrishna, Naghmeh; Lo, Camden; Prasad, Jyotika; Callaghan, Judy; McLaughlin, Peter; Farmer, Michael; Steinfort, Daniel; Jennings, Barton; Ngui, James; Broughton, Bradley R. S.; Thomas, Belinda; Essilfie, Ama-Tawiah; Hickey, Michael; Holmes, Peter W.; Hansbro, Philip; Bardin, Philip G.; Holdsworth, Stephen R.			Nontypeable Haemophilus influenzae Induces Sustained Lung Oxidative Stress and Protease Expression	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INFLAMMATION; EXACERBATIONS; CIGARETTE	Nontypeable Haemophilus influenzae (NTHi) is a prevalent bacterium found in a variety of chronic respiratory diseases. The role of this bacterium in the pathogenesis of lung inflammation is not well defined. In this study we examined the effect of NTHi on two important lung inflammatory processes 1), oxidative stress and 2), protease expression. Bronchoalveolar macrophages were obtained from 121 human subjects, blood neutrophils from 15 subjects, and human-lung fibroblast and epithelial cell lines from 16 subjects. Cells were stimulated with NTHi to measure the effect on reactive oxygen species (ROS) production and extracellular trap formation. We also measured the production of the oxidant, 3-nitrotyrosine (3-NT) in the lungs of mice infected with this bacterium. NTHi induced widespread production of 3-NT in mouse lungs. This bacterium induced significantly increased ROS production in human fibroblasts, epithelial cells, macrophages and neutrophils; with the highest levels in the phagocytic cells. In human macrophages NTHi caused a sustained, extracellular production of ROS that increased over time. The production of ROS was associated with the formation of macrophage extracellular trap-like structures which co-expressed the protease metalloproteinase-12. The formation of the macrophage extracellular trap-like structures was markedly inhibited by the addition of DNase. In this study we have demonstrated that NTHi induces lung oxidative stress with macrophage extracellular trap formation and associated protease expression. DNase inhibited the formation of extracellular traps.	[King, Paul T.; Sharma, Roleen; O'Sullivan, Kim; Lim, Steven; Hickey, Michael; Holdsworth, Stephen R.] Monash Univ, Monash Med Ctr, Dept Med, Melbourne, Vic 3004, Australia; [King, Paul T.; Sharma, Roleen; Radhakrishna, Naghmeh; Prasad, Jyotika; McLaughlin, Peter; Farmer, Michael; Steinfort, Daniel; Jennings, Barton; Thomas, Belinda; Holmes, Peter W.; Bardin, Philip G.] Monash Med Ctr, Monash Lung & Sleep, Melbourne, Vic, Australia; [Selemidis, Stavros; Broughton, Bradley R. S.] Monash Univ, Dept Pharmacol, Melbourne, Vic 3004, Australia; [Lo, Camden; Callaghan, Judy] Monash Univ, Monash Micro Imaging, Melbourne, Vic 3004, Australia; [Ngui, James] Monash Med Ctr, Clin Immunol, Melbourne, Vic, Australia; [Thomas, Belinda; Bardin, Philip G.] Monash Inst Med Res, Melbourne, Vic, Australia; [Essilfie, Ama-Tawiah; Hansbro, Philip] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia	Monash University; Monash University; Monash University; Monash University; Monash University; Monash University; University of Newcastle	King, PT (corresponding author), Monash Univ, Monash Med Ctr, Dept Med, Melbourne, Vic 3004, Australia.	paul.king@monash.edu	Hansbro, Phil/G-7486-2013; Steinfort, Daniel/AAO-6898-2020; Hickey, Michael/A-5429-2012	Hansbro, Phil/0000-0002-4741-3035; Steinfort, Daniel/0000-0002-8998-2949; O'Sullivan, Kim Maree/0000-0002-3098-7948; Essilfie, Ama-Tawiah/0000-0003-0443-9005; Hickey, Michael/0000-0003-2354-357X; Lo, Camden/0000-0002-6215-2363; /0000-0001-8844-974X; Selemidis, Stavros/0000-0002-3989-7615	Monash University Faculty of Medicine, Nursing and Health Sciences Strategic Grants; Australian Research Council Discovery Grant; Australian Research Council Future Fellowship	Monash University Faculty of Medicine, Nursing and Health Sciences Strategic Grants; Australian Research Council Discovery Grant(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council)	Supported by Monash University Faculty of Medicine, Nursing and Health Sciences Strategic Grants (to PK) and an Australian Research Council Discovery Grant and an Australian Research Council Future Fellowship Support (to SS).	Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Barcelo B, 2006, CLIN EXP IMMUNOL, V145, P474, DOI 10.1111/j.1365-2249.2006.03167.x; Barnes PJ, 2013, NAT REV DRUG DISCOV, V12, P543, DOI 10.1038/nrd4025; Bolduc GR, 2000, INFECT IMMUN, V68, P4505, DOI 10.1128/IAI.68.8.4505-4517.2000; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chaudhuri R, 2012, J ALLERGY CLIN IMMUN, V129, P655, DOI 10.1016/j.jaci.2011.12.996; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Dromann D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-67; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Eldika N, 2006, CURR OPIN PULM MED, V12, P118, DOI 10.1097/01.mcp.0000208451.50231.8f; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Harrison A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00040; Hector A, 2014, EUR RESPIR J, V44, P17, DOI 10.1183/09031936.00038114; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Juneau RA, 2011, INFECT IMMUN, V79, P431, DOI 10.1128/IAI.00660-10; Keely S, 2012, MUCOSAL IMMUNOL, V5, P7, DOI 10.1038/mi.2011.55; King PT, 2013, J ALLERGY CLIN IMMUN, V131, P1314, DOI 10.1016/j.jaci.2012.09.030; Konstan MW, 2012, J CYST FIBROS, V11, P78, DOI 10.1016/j.jcf.2011.10.003; Moller LVM, 1998, AM J RESP CRIT CARE, V157, P950; Murphy TF, 2005, HARRISONS PRINCIPLES, P824; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naylor EJ, 2007, AM J RESP CELL MOL, V37, P135, DOI 10.1165/rcmb.2006-0375OC; O'Donnell AE, 1998, CHEST, V113, P1329, DOI 10.1378/chest.113.5.1329; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Rahman I, 2012, CURR OPIN PHARMACOL, V12, P256, DOI 10.1016/j.coph.2012.01.015; Sethi S, 2007, AM J RESP CRIT CARE, V176, P356, DOI 10.1164/rccm.200703-417OC; Shapiro SD, 2001, AM J RESP CRIT CARE, V164, P339, DOI 10.1164/ajrccm.164.3.2105072c; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271; Wong C, 2013, RESPIROLOGY, V18, P1037, DOI 10.1111/resp.12161; Wong KW, 2013, J INFECT DIS, V208, P109, DOI 10.1093/infdis/jit097	36	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120371	10.1371/journal.pone.0120371	http://dx.doi.org/10.1371/journal.pone.0120371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793977	Green Published, gold			2022-12-26	WOS:000352083900018
J	Laut, J; Cappa, F; Nov, O; Porfiri, M				Laut, Jeffrey; Cappa, Francesco; Nov, Oded; Porfiri, Maurizio			Increasing Patient Engagement in Rehabilitation Exercises Using Computer-Based Citizen Science	PLOS ONE			English	Article							UPPER-LIMB; FUNCTIONAL RECOVERY; MOTOR IMPAIRMENT; STROKE; IMPROVES; THERAPY; CHILDREN; MOTIVATION; ADHERENCE; ENHANCE	Patient motivation is an important factor to consider when developing rehabilitation programs. Here, we explore the effectiveness of active participation in web-based citizen science activities as a means of increasing participant engagement in rehabilitation exercises, through the use of a low-cost haptic joystick interfaced with a laptop computer. Using the joystick, patients navigate a virtual environment representing the site of a citizen science project situated in a polluted canal. Participants are tasked with following a path on a laptop screen representing the canal. The experiment consists of two conditions: in one condition, a citizen science component where participants classify images from the canal is included; and in the other, the citizen science component is absent. Both conditions are tested on a group of young patients undergoing rehabilitation treatments and a group of healthy subjects. A survey administered at the end of both tasks reveals that participants prefer performing the scientific task, and are more likely to choose to repeat it, even at the cost of increasing the time of their rehabilitation exercise. Furthermore, performance indices based on data collected from the joystick indicate significant differences in the trajectories created by patients and healthy subjects, suggesting that the low-cost device can be used in a rehabilitation setting for gauging patient recovery.	[Laut, Jeffrey; Porfiri, Maurizio] NYU, Dept Mech & Aerosp Engn, Polytech Sch Engn, MetroTech Ctr 6, Brooklyn, NY 11201 USA; [Laut, Jeffrey; Porfiri, Maurizio] Univ Roma La Sapienza, Dept Mech & Aerosp Engn, I-00185 Rome, Italy; [Cappa, Francesco] LUISS Guido Carli Univ, Dept Business & Management, I-00198 Rome, Italy; [Nov, Oded] NYU, Dept Technol Management & Innovat, Polytech Sch Engn, MetroTech Ctr 5, Brooklyn, NY USA	New York University; New York University Tandon School of Engineering; Sapienza University Rome; Luiss Guido Carli University; New York University; New York University Tandon School of Engineering	Porfiri, M (corresponding author), NYU, Dept Mech & Aerosp Engn, Polytech Sch Engn, MetroTech Ctr 6, Brooklyn, NY 11201 USA.	mporfiri@nyu.edu	Cappa, Francesco/D-5055-2016	Cappa, Francesco/0000-0001-5628-731X; Porfiri, Maurizio/0000-0002-1480-3539	National Science Foundation [BCS-1124795]; COOPERLINK	National Science Foundation(National Science Foundation (NSF)); COOPERLINK	This research was supported by the National Science Foundation under Grant #BCS-1124795 and through a scholarship to J. Laut from COOPERLINK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CONCISE ENCY STAT, P344; Betker AL, 2006, ARCH PHYS MED REHAB, V87, P1141, DOI 10.1016/j.apmr.2006.04.010; Burke JW, 2009, PROCEEDINGS OF THE IEEE VIRTUAL WORLDS FOR SERIOUS APPLICATIONS, P103, DOI 10.1109/VS-GAMES.2009.17; Burke JW, 2009, VISUAL COMPUT, V25, P1085, DOI 10.1007/s00371-009-0387-4; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Campbell R, 2001, J EPIDEMIOL COMMUN H, V55, P132, DOI 10.1136/jech.55.2.132; Cappa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083945; Carpinella I, 2009, J REHABIL MED, V41, P966, DOI 10.2340/16501977-0401; Casella G., 2021, STAT INFERENCE; Charles SK, 2005, INT C REHAB ROBOT, P13; Colombo R, 2005, IEEE T NEUR SYS REH, V13, P311, DOI 10.1109/TNSRE.2005.848352; Colombo R, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-3; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Cordova DI, 1996, J EDUC PSYCHOL, V88, P715, DOI 10.1037/0022-0663.88.4.715; De Weyer Tom, 2012, Entertainment Computing, 11th International Conference (ICEC - 2012). Proceedings, P476, DOI 10.1007/978-3-642-33542-6_57; Deutsch JE, 2008, PHYS THER, V88, P1196, DOI 10.2522/ptj.20080062; DISHMAN R K, 1981, Journal of Behavioral Medicine, V4, P421, DOI 10.1007/BF00846151; DISHMAN RK, 1980, J APPL SOC PSYCHOL, V10, P115, DOI 10.1111/j.1559-1816.1980.tb00697.x; Duncan PW, 2002, STROKE, V33, P167, DOI 10.1161/hs0102.101014; Ellul C, 2011, ENGAGING LOCAL COMMU; Fasoli SE, 2003, ARCH PHYS MED REHAB, V84, P477, DOI 10.1053/apmr.2003.50110; Forster J, 2003, ORGAN BEHAV HUM DEC, V90, P148, DOI 10.1016/S0749-5978(02)00509-5; Frascarelli F, 2009, J REHABIL MED, V41, P988, DOI 10.2340/16501977-0412; Gentile D, 2009, PSYCHOL SCI, V20, P594, DOI 10.1111/j.1467-9280.2009.02340.x; GLOBERSON S, 1989, IIE TRANS, V21, P376, DOI 10.1080/07408178908966244; Greenberg BS, 2010, SIMULAT GAMING, V41, P238, DOI 10.1177/1046878108319930; GUNASEKERA WSL, 2005, SPR SP SURG SER, P407; Haklay M, 2013, CROWDSOURCING GEOGRA, P105, DOI [10.1007/978-94-007-4587-2_7, DOI 10.1007/978-94-007-4587-2_7]; Harris JE, 2009, STROKE, V40, P2123, DOI 10.1161/STROKEAHA.108.544585; Hidler Joseph, 2005, Top Stroke Rehabil, V12, P22, DOI 10.1310/RYT5-62N4-CTVX-8JTE; Hill AM, 2011, ARCH PHYS MED REHAB, V92, P1395, DOI 10.1016/j.apmr.2011.04.009; ICE R, 1985, PHYS THER, V65, P1832, DOI 10.1093/ptj/65.12.1832; Jaramillo P, 2012, PROCEEDINGS OF THE ASME 5TH ANNUAL DYNAMIC SYSTEMS AND CONTROL DIVISION CONFERENCE AND JSME 11TH MOTION AND VIBRATION CONFERENCE, DSCC 2012, VOL 2, P483; JAY S, 1984, J ADOLESCENT HEALTH, V5, P124, DOI 10.1016/S0197-0070(84)80012-1; Kafai YB, 1998, FROM BARBIE TO MORTAL KOMBAT, P90; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Lange B, 2009, PHYS THER REV, V14, P355, DOI 10.1179/108331909X12488667117258; Laut J, 2014, IEEE-ASME T MECH, V19, P1541, DOI 10.1109/TMECH.2013.2287705; Lee H, 2014, IEEE T NEUR SYS REH, V22, P44, DOI 10.1109/TNSRE.2013.2262689; Leversen JSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038830; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Masiero S, 2007, ARCH PHYS MED REHAB, V88, P142, DOI 10.1016/j.apmr.2006.10.032; Mazzoleni S, 2014, IEEE T HAPTICS, V7, P175, DOI 10.1109/TOH.2013.73; Nov O., 2010, PROC 19 INT C WORLD, P741, DOI [10.1145/1772690.1772766, DOI 10.1145/1772690.1772766]; Nov O, 2011, P 2011 ICONFERENCE, P68, DOI [DOI 10.1145/1940761.1940771, 10.1145/1940761.1940771]; Nov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090375; Patton JL, 2006, EXP BRAIN RES, V168, P368, DOI 10.1007/s00221-005-0097-8; Prestopnik N. R., 2011, Proceedings of the 2011 IEEE Seventh International Conference on e-Science Workshops (eScienceW 2011), P28, DOI 10.1109/eScienceW.2011.14; Raddick M. Jordan, 2010, Astronomy Education Review, V9, DOI 10.3847/AER2009036; Rand Debbie, 2008, J Neurol Phys Ther, V32, P155, DOI 10.1097/NPT.0b013e31818ee779; Ravichandran R, 2010, J R SOC INTERFACE, V7, pS559, DOI 10.1098/rsif.2010.0120.focus; Reinkensmeyer DJ, 2002, IEEE T NEUR SYS REH, V10, P102, DOI 10.1109/TNSRE.2002.1031978; Reker DM, 2002, ARCH PHYS MED REHAB, V83, P750, DOI 10.1053/apmr.2002.99736; Riener R, 2005, MED BIOL ENG COMPUT, V43, P2, DOI 10.1007/BF02345116; Rohrer B, 2002, J NEUROSCI, V22, P8297; Sandlund M, 2011, DEV NEUROREHABIL, V14, P15, DOI 10.3109/17518423.2010.533329; Sandlund M, 2009, DEV MED CHILD NEUROL, V51, P173, DOI 10.1111/j.1469-8749.2008.03184.x; Shelton FDAP, 2001, NEUROREHAB NEURAL RE, V15, P229, DOI 10.1177/154596830101500311; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; SLUIJS EM, 1993, PHYS THER, V73, P786, DOI 10.1093/ptj/73.11.786; THOMAS KW, 1990, ACAD MANAGE REV, V15, P666, DOI 10.2307/258687; Timmermans AAA, 2010, IEEE T NEUR SYS REH, V18, P284, DOI 10.1109/TNSRE.2010.2047608; Trewin S, 1999, INT J HUM-COMPUT ST, V50, P109, DOI 10.1006/ijhc.1998.0238; Vischer P, 1998, ROBOTICA, V16, P207, DOI 10.1017/S0263574798000538; Von Ahn Luis, 2004, P SIGCHI C HUM FACT, P319, DOI DOI 10.1145/985692.985733; Vong SK, 2011, ARCH PHYS MED REHAB, V92, P176, DOI 10.1016/j.apmr.2010.10.016; Whitall J, 2000, STROKE, V31, P2390, DOI 10.1161/01.STR.31.10.2390; Wong WY, 2007, PROSTHET ORTHOT INT, V31, P62, DOI 10.1080/03093640600983949; Zollo L, 2011, MED BIOL ENG COMPUT, V49, P1131, DOI 10.1007/s11517-011-0808-1; Zyda M, 2005, COMPUTER, V38, P25, DOI 10.1109/MC.2005.297	73	31	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117013	10.1371/journal.pone.0117013	http://dx.doi.org/10.1371/journal.pone.0117013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793867	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200010
J	Schmitt, A; Rodel, P; Anamur, C; Seeliger, C; Imhoff, AB; Herbst, E; Vogt, S; van Griensven, M; Winter, G; Engert, J				Schmitt, Andreas; Roedel, Philipp; Anamur, Cihad; Seeliger, Claudine; Imhoff, Andreas B.; Herbst, Elmar; Vogt, Stephan; van Griensven, Martijn; Winter, Gerhard; Engert, Julia			Calcium Alginate Gels as Stem Cell Matrix - Making Paracrine Stem Cell Activity Available for Enhanced Healing after Surgery	PLOS ONE			English	Article							HYDROGELS	Regeneration after surgery can be improved by the administration of anabolic growth factors. However, to locally maintain these factors at the site of regeneration is problematic. The aim of this study was to develop a matrix system containing human mesenchymal stem cells (MSCs) which can be applied to the surgical site and allows the secretion of endogenous healing factors from the cells. Calcium alginate gels were prepared by a combination of internal and external gelation. The gelling behaviour, mechanical stability, surface adhesive properties and injectability of the gels were investigated. The permeability of the gels for growth factors was analysed using bovine serum albumin and lysozyme as model proteins. Human MSCs were isolated, cultivated and seeded into the alginate gels. Cell viability was determined by AlamarBlue assay and fluorescence microscopy. The release of human VEGF and bFGF from the cells was determined using an enzyme-linked immunoassay. Gels with sufficient mechanical properties were prepared which remained injectable through a syringe and solidified in a sufficient time frame after application. Surface adhesion was improved by the addition of polyethylene glycol 300,000 and hyaluronic acid. Humans MSCs remained viable for the duration of 6 weeks within the gels. Human VEGF and bFGF was found in quantifiable concentrations in cell culture supernatants of gels loaded with MSCs and incubated for a period of 6 weeks. This work shows that calcium alginate gels can function as immobilization matrices for human MSCs.	[Roedel, Philipp; Anamur, Cihad; Winter, Gerhard; Engert, Julia] Univ Munich, Dept Pharm Pharmaceut Technol & Biopharmaceut, D-81377 Munich, Germany; [Schmitt, Andreas; Imhoff, Andreas B.; Herbst, Elmar; Vogt, Stephan] Tech Univ Munich, Dept Sports Orthoped, D-81675 Munich, Germany; [Seeliger, Claudine; van Griensven, Martijn] Tech Univ Munich, Dept Trauma Surg, D-81675 Munich, Germany; [Herbst, Elmar] Med Univ Innsbruck, Dept Trauma Surg, A-6020 Innsbruck, Austria	University of Munich; Technical University of Munich; Technical University of Munich; Medical University of Innsbruck	Schmitt, A (corresponding author), Tech Univ Munich, Dept Sports Orthoped, Ismaninger Str 22, D-81675 Munich, Germany.	dr.schmitt@tum.de	van Griensven, Martijn/F-5808-2012; Vogt, Stephan/AAQ-7456-2021	van Griensven, Martijn/0000-0001-5104-9881; Seeliger, Claudine/0000-0002-7631-444X	German Research Foundation (DFG); Technische Universitat Munchen	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allodi I, 2014, GLIA, V62, P1736, DOI 10.1002/glia.22712; ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227; Asane GS, 2008, DRUG DEV IND PHARM, V34, P1246, DOI 10.1080/03639040802026012 ; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Buchmann S, 2013, J ORTHOP RES, V31, P300, DOI 10.1002/jor.22211; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018; DeVolder R, 2012, WIRES SYST BIOL MED, V4, P351, DOI 10.1002/wsbm.1174; DRAGET KI, 1990, CARBOHYD POLYM, V14, P159; Ehnert S, 2009, LANGENBECKS ARCH SUR; Ehnert S, 2009, LANGENBECK ARCH SURG, V394, P985, DOI 10.1007/s00423-009-0546-0; Elliott RB, 2005, TRANSPL P, V37, P3505, DOI 10.1016/j.transproceed.2005.09.038; Fannon M, 1996, J BIOL CHEM, V271, P17949, DOI 10.1074/jbc.271.30.17949; Hatef DA, 2008, ANN PLAS SURG, V61, P468, DOI 10.1097/SAP.0b013e3181641c17; Hou Y, 2009, MATRIX BIOL, V28, P324, DOI 10.1016/j.matbio.2009.04.007; Jeon O, 2014, ACTA BIOMATER, V10, P47, DOI 10.1016/j.actbio.2013.09.004; Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009; Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Liu C, 2014, BIOTECHNOL APPL BIOC; Lyras DN, 2010, ACTA ORTHOP BELG, V76, P380; Mandal K, 2011, ANGEW CHEM INT EDIT, V50, P8029, DOI 10.1002/anie.201103237; Oryan A, 2014, J TISSUE ENG REGEN M, V8, P421, DOI 10.1002/term.1534; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Rijcken E, 2014, J SURG RES, V187, P202, DOI 10.1016/j.jss.2013.10.013; Schmitt A, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/394962; Schnabel LV, 2009, J ORTHOP RES, V27, P1392, DOI 10.1002/jor.20887; Vaithilingam Vijayaganapathy, 2011, Rev Diabet Stud, V8, P51, DOI 10.1900/RDS.2011.8.51	30	34	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118937	10.1371/journal.pone.0118937	http://dx.doi.org/10.1371/journal.pone.0118937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793885	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200047
J	Schurink, M; Kooi, EMW; Hulzebos, CV; Kox, RG; Groen, H; Heineman, E; Bos, AF; Hulscher, JBF				Schurink, Maarten; Kooi, Elisabeth M. W.; Hulzebos, Christian V.; Kox, Rozemarijn G.; Groen, Henk; Heineman, Erik; Bos, Arend F.; Hulscher, Jan B. F.			Intestinal Fatty Acid-Binding Protein as a Diagnostic Marker for Complicated and Uncomplicated Necrotizing Enterocolitis: A Prospective Cohort Study	PLOS ONE			English	Article							GUT-ASSOCIATED BIOMARKERS; LIVER-FABP; SEVERITY	Background Early NEC symptoms are non-specific and diagnostic tests lack discriminative power. Intestinal fatty acid-binding protein (I-FABP), mainly located in small bowel enterocytes, is released into the blood following NEC-associated enterocyte disruption. Aim of this prospective cohort trial was to determine the diagnostic value of I-FABP measured in plasma (I-FABPp) and urine (I-FABPu) for the presence of NEC, to evaluate I-FABP levels during NEC development, and to assess its prognostic value for the progression from suspected to complicated disease. Methods Between 2010 and 2012 we prospectively enrolled neonates with suspected NEC. We measured I-FABP levels eight-hourly from onset of suspected NEC for at least 48 hours, or until surgery. NEC diagnosis was confirmed radiologically or during operation. We defined NEC as complicated if it resulted in surgery and/or death. We determined disease course and diagnostic I-FABP cut-off points. Results The study comprised 37 neonates (24M, 13F), gestational age 28 (24-36) weeks, birth weight 1190 (570-2,400) grams. We found significantly higher I-FABPp and I-FABPu levels in NEC patients (n = 22) than in patients with other diagnoses (n = 15). Cut-off values for diagnosing NEC were 9 ng/mL I-FABPp and 218 ngmL I-FABPu, with corresponding likelihood ratios (LRs) of 5.6 (95% CI 0.89-35) and 5.1 (95% CI 0.73-36), respectively. I-FABP levels were highest in the first eight hours after symptom onset and gradually decreased over time. Cut-off values for complicated disease were 19 ng/mL I-FABPp and 232 ng/mL I-FABPu, with LRs of 10 (95% CI 1.6-70) and 11 (95% CI 1.6-81), respectively. Conclusions Both plasma and urinary I-FABP levels specifically identify NEC in preterm infants prior to appearance of diagnostic radiological signs suggestive for NEC. Moreover, serial I-FABP measurements accurately predict development of complicated disease.	[Schurink, Maarten; Heineman, Erik; Hulscher, Jan B. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat Surg, Groningen, Netherlands; [Kooi, Elisabeth M. W.; Hulzebos, Christian V.; Bos, Arend F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Neonatol, Groningen, Netherlands; [Kox, Rozemarijn G.] Univ Groningen, Univ Med Ctr Groningen, Surg Res Lab, Groningen, Netherlands; [Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Hulscher, JBF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Paediat Surg, Groningen, Netherlands.	j.b.f.hulscher@umcg.nl	Heineman, Erik/ABG-9592-2021; Groen, Henk/B-2163-2013; Schurink, Maarten/P-7215-2015; Hulzebos, Christian Victor/AAY-6803-2021; Hulscher, Jan/AAD-3026-2021; Kooi, Elisabeth/AAD-3926-2022	Groen, Henk/0000-0002-6629-318X; Schurink, Maarten/0000-0003-4671-5565; Hulzebos, Christian Victor/0000-0002-8159-7501; Kooi, Elisabeth/0000-0001-9195-4018; Hulscher, Jan/0000-0003-4491-486X	NutsOhra Foundation; Doelmatigheidsfonds; University Medical Centre Groningen; Jan Kornelis de Cock Foundation	NutsOhra Foundation; Doelmatigheidsfonds; University Medical Centre Groningen; Jan Kornelis de Cock Foundation	Funding: This study was supported by grants from the following Dutch funding organizations: 1. NutsOhra Foundation, 2. Doelmatigheidsfonds [fitness for purpose fund], intramural funding by University Medical Centre Groningen, and 3. Jan Kornelis de Cock Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir C, 2011, EARLY HUM DEV, V87, P659, DOI 10.1016/j.earlhumdev.2011.05.004; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Benkoe TM, 2014, J PEDIATR SURG, V49, P1446, DOI 10.1016/j.jpedsurg.2014.03.012; Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006; Derikx JPM, 2007, GUT, V56, P1473, DOI 10.1136/gut.2007.128934; Dutch Trial Register, 2004, ID NTR3239 NOV DIAGN; Edelson MB, 1999, J PEDIATR SURG, V34, P1453, DOI 10.1016/S0022-3468(99)90102-1; Evennett NJ, 2010, J PEDIATR SURG, V45, P735, DOI 10.1016/j.jpedsurg.2009.09.024; Guthmann F, 2002, MOL CELL BIOCHEM, V239, P227, DOI 10.1023/A:1020508420058; Hallstrom M, 2006, J PEDIATR SURG, V41, P792, DOI 10.1016/j.jpedsurg.2005.12.034; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Lin JC, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e19; Ng EWY, 2013, ANN SURG, V258, P1111, DOI 10.1097/SLA.0b013e318288ea96; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Reisinger KW, 2012, J PEDIATR SURG, V47, P1640, DOI 10.1016/j.jpedsurg.2012.02.027; Relja B, 2010, ACAD EMERG MED, V17, P729, DOI 10.1111/j.1553-2712.2010.00792.x; Tam AL, 2002, J PEDIATR SURG, V37, P1688, DOI 10.1053/jpsu.2002.36696; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767; Thuijls G, 2010, ANN SURG, V251, P1174, DOI 10.1097/SLA.0b013e3181d778c4; Valentine SL, 2012, PEDIATR CRIT CARE ME, V13, P22, DOI 10.1097/PCC.0b013e318219681d; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6	21	62	66	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121336	10.1371/journal.pone.0121336	http://dx.doi.org/10.1371/journal.pone.0121336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793701	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900124
J	Volis, S; Ormanbekova, D; Yermekbayev, K; Song, MS; Shulgina, I				Volis, Sergei; Ormanbekova, Danara; Yermekbayev, Kanat; Song, Minshu; Shulgina, Irina			Multi-Approaches Analysis Reveals Local Adaptation in the Emmer Wheat (Triticum dicoccoides) at Macro- but not Micro-Geographical Scale	PLOS ONE			English	Article							WILD TETRAPLOID WHEAT; NATURAL-SELECTION; GENETIC DIFFERENTIATION; ALLOZYME POLYMORPHISMS; EVOLUTIONARY SIGNIFICANCE; ADAPTIVE DIVERGENCE; TEMPORAL VARIATION; PLANT ADAPTATION; SPECIES RANGE; POPULATION	Detecting local adaptation and its spatial scale is one of the most important questions of evolutionary biology. However, recognition of the effect of local selection can be challenging when there is considerable environmental variation across the distance at the whole species range. We analyzed patterns of local adaptation in emmer wheat, Triticum dicoccoides, at two spatial scales, small (inter-population distance less than one km) and large (inter-population distance more than 50 km) using several approaches. Plants originating from four distinct habitats at two geographic scales (cold edge, arid edge and two topographically dissimilar core locations) were reciprocally transplanted and their success over time was measured as 1) lifetime fitness in a year of planting, and 2) population growth four years after planting. In addition, we analyzed molecular (SSR) and quantitative trait variation and calculated the Q(ST)/F-ST ratio. No home advantage was detected at the small spatial scale. At the large spatial scale, home advantage was detected for the core population and the cold edge population in the year of introduction via measuring life-time plant performance. However, superior performance of the arid edge population in its own environment was evident only after several generations via measuring experimental population growth rate through genotyping with SSRs allowing counting the number of plants and seeds per introduced genotype per site. These results highlight the importance of multi-generation surveys of population growth rate in local adaptation testing. Despite predominant self-fertilization of T. dicoccoides and the associated high degree of structuring of genetic variation, the results of the Q(ST) - F-ST comparison were in general agreement with the pattern of local adaptation at the two spatial scales detected by reciprocal transplanting.	[Volis, Sergei; Song, Minshu; Shulgina, Irina] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650204, Peoples R China; [Ormanbekova, Danara; Yermekbayev, Kanat] Inst Plant Biol & Biotechnol, Alma Ata 050040, Kazakhstan	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Institute of Plant Biology & Biotechnology in Kazakhstan	Volis, S (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650204, Peoples R China.	volis@mail.kib.ac.cn	Yermekbayev, Kanat/CAJ-5791-2022; Volis, Sergei/GLU-5848-2022	ORMANBEKOVA, DANARA/0000-0002-6564-3109	Israel Academy of Sciences [ISF 958/07]; CAS/SAFEA International Partnership Program for Creative Research Teams	Israel Academy of Sciences; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	The current study was supported by Israel Academy of Sciences (ISF 958/07) and the CAS/SAFEA International Partnership Program for Creative Research Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; Angert AL, 2008, EVOLUTION, V62, P2660, DOI 10.1111/j.1558-5646.2008.00471.x; ANIKSTER Y, 1991, ISRAEL J BOT, V40, P351; ANIKSTER Y, 1991, ISRAEL J BOT, V40, P397; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; BENNINGTON CC, 1995, ECOL MONOGR, V65, P303, DOI 10.2307/2937062; Bischoff A, 2006, J ECOLOGY, V94; Blanquart F, 2013, ECOL LETT, V16, P1195, DOI 10.1111/ele.12150; Bradshaw AD, 1984, PERSPECTIVES PLANT P, P213; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Bridle JR, 2010, ECOL LETT, V13, P485, DOI 10.1111/j.1461-0248.2010.01442.x; Capaul M, 2003, EVOLUTION, V57, P249, DOI 10.1111/j.0014-3820.2003.tb00260.x; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Clausen JC, 1940, CARNEGIE I WASHINGTO, V520; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; CREEL S, 1990, P ROY SOC B-BIOL SCI, V241, P229, DOI 10.1098/rspb.1990.0090; Endler J.A., 1977, Monographs in Population Biology, pi; Feldman M., 1995, EVOLUTION CROP PLANT, V2nd, P184; Feldman M, 2007, ISR J PLANT SCI, V55, P207, DOI 10.1560/IJPS.55.3-4.207; FELSENBURG T, 1991, ISRAEL J BOT, V40, P451; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI 10.2307/2410956; Geyer CJ, 2007, BIOMETRIKA, V94, P415, DOI 10.1093/biomet/asm030; GOLDING GB, 1980, GENETICS, V94, P777; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; GRAFEN A, 1982, NATURE, V298, P425, DOI 10.1038/298425a0; Hangartner S, 2012, EVOLUTION, V66, P867, DOI 10.1111/j.1558-5646.2011.01472.x; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; HASTINGS A, 1989, GENETICS, V121, P857; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Holt RD, 2005, OIKOS, V108, P18, DOI 10.1111/j.0030-1299.2005.13147.x; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kawecki TJ, 2002, AM NAT, V160, P333, DOI 10.1086/341519; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Levin D. A., 2000, OX ECOL EV; Lewis PO, 1999, GDA SOFTWARE ANAL DI; Li YC, 2000, MOL BIOL EVOL, V17, P851, DOI 10.1093/oxfordjournals.molbev.a026365; Li YC, 1999, THEOR APPL GENET, V98, P873, DOI 10.1007/s001220051146; Li YC, 2000, THEOR APPL GENET, V100, P985, DOI 10.1007/s001220051380; Li You-Chun, 2000, Conservation Genetics, V1, P191, DOI 10.1023/A:1011545403198; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; NEVO E, 1988, THEOR APPL GENET, V76, P737, DOI 10.1007/BF00303521; NEVO E, 1988, THEOR APPL GENET, V75, P529, DOI 10.1007/BF00276761; NEVO E, 1991, ISRAEL J BOT, V40, P419; Norton LR, 2005, OECOLOGIA, V144, P407, DOI 10.1007/s00442-005-0102-8; NOYMEIR I, 1991, ISRAEL J BOT, V40, P363; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pregitzer CC, 2010, EVOL ECOL, V24, P1045, DOI 10.1007/s10682-010-9363-8; PRIMACK RB, 1989, ANNU REV ECOL SYST, V20, P367, DOI 10.1146/annurev.es.20.110189.002055; R Core Team, 2020, R LANG ENV STAT COMP; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Ren J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-169; Richardson JL, 2014, TRENDS ECOL EVOL, V29, P165, DOI 10.1016/j.tree.2014.01.002; RODER MS, 1995, MOL GEN GENET, V246, P327, DOI 10.1007/BF00288605; Roder MS, 1998, GENETICS, V149, P2007; Roff Derek A., 1992; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Sambatti JBM, 2006, EVOLUTION, V60, P696, DOI 10.1111/j.0014-3820.2006.tb01149.x; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Shaw RG, 2008, AM NAT, V172, pE35, DOI 10.1086/588063; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Smith DS, 2012, PLANT SOIL, V352, P243, DOI 10.1007/s11104-011-0992-7; Stanton-Geddes J, 2012, ECOLOGY, V93, P1604, DOI 10.1890/11-1701.1; Stanton-Geddes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036015; Stearns S.C., 1992, pi; Thompson JN, 2005, LOCAL ADAPTATION; Turesson G, 1922, HEREDITAS, V3, P211, DOI 10.1111/j.1601-5223.1922.tb02734.x; Vander Mijnsbrugge K, 2010, BASIC APPL ECOL, V11, P300, DOI 10.1016/j.baae.2009.09.002; Venables WN., 2002, MODERN APPL STAT S 4; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x; Volis S, 2005, HEREDITY, V95, P466, DOI 10.1038/sj.hdy.6800745; Volis S, 2014, HEREDITY, V113, P268, DOI 10.1038/hdy.2014.25; Volis S, 2004, AM NAT, V163, P312, DOI 10.1086/381406; Volis S, 2011, NEW PHYTOL, V192, P237, DOI 10.1111/j.1469-8137.2011.03799.x; Volis S, 2002, OECOLOGIA, V133, P131, DOI 10.1007/s00442-002-0999-0; Volis S, 2014, EVOL BIOL, V41, P166, DOI 10.1007/s11692-013-9256-1; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Whitlock MC, 2012, MOL ECOL RESOUR, V12, P481, DOI 10.1111/j.1755-0998.2012.03122.x; Zohary M., 1973, Geobotanical foundations of the Middle East.	89	18	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121153	10.1371/journal.pone.0121153	http://dx.doi.org/10.1371/journal.pone.0121153			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793512	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900104
J	Weinheimer-Haus, EM; Mirza, RE; Koh, TJ				Weinheimer-Haus, Eileen M.; Mirza, Rita E.; Koh, Timothy J.			Nod-Like Receptor Protein-3 Inflammasome Plays an Important Role during Early Stages of Wound Healing	PLOS ONE			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; NF-KAPPA-B; CELLULAR INFILTRATE; MICE DEFICIENT; DIABETIC MICE; ACTIVATION; SECRETION; REPAIR; MACROPHAGE; IL-1	The Nod-like receptor protein (NLRP)-3 inflammasome/IL-1 beta pathway is involved in the pathogenesis of various inflammatory skin diseases, but its biological role in wound healing remains to be elucidated. Since inflammation is typically thought to impede healing, we hypothesized that loss of NLRP-3 activity would result in a downregulated inflammatory response and accelerated wound healing. NLRP-3 null mice, caspase-1 null mice and C57Bl/6 wild type control mice (WT) received four 8 mm excisional cutaneous wounds; inflammation and healing were assessed during the early stage of wound healing. Consistent with our hypothesis, wounds from NLRP-3 null and caspase-1 null mice contained lower levels of the pro-inflammatory cytokines IL-1 beta and TNF-alpha compared to WT mice and had reduced neutrophil and macrophage accumulation. Contrary to our hypothesis, re-epithelialization, granulation tissue formation, and angiogenesis were delayed in NLRP-3 null mice and caspase-1 null mice compared to WT mice, indicating that NLRP-3 signaling is important for early events in wound healing. Topical treatment of excisional wounds with recombinant IL-1 beta partially restored granulation tissue formation in wounds of NLRP-3 null mice, confirming the importance of NLRP-3-dependent IL-1 beta production during early wound healing. Despite the improvement in healing, angiogenesis and levels of the pro-angiogenic growth factor VEGF were further reduced in IL-1 beta treated wounds, suggesting that IL-1 beta has a negative effect on angiogenesis and that NLRP-3 promotes angiogenesis in an IL-1 beta-independent manner. These findings indicate that the NLRP-3 inflammasome contributes to the early inflammatory phase following skin wounding and is important for efficient healing.	[Weinheimer-Haus, Eileen M.; Mirza, Rita E.; Koh, Timothy J.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60607 USA; [Weinheimer-Haus, Eileen M.; Koh, Timothy J.] Univ Illinois, Ctr Wound Healing & Tissue Regenerat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Koh, TJ (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60607 USA.	tjkoh@uic.edu		Koh, Timothy/0000-0001-6549-7060; Weinheimer-Haus, Eileen/0000-0001-5408-0024	National Institutes of Health [R01GM092850, T32DE018381]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (R01GM092850 to TJK and T32DE018381 to EMW; www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barichello JM, 1999, INT J PHARM, V184, P189, DOI 10.1016/S0378-5173(99)00119-2; Bitto A, 2014, BRIT J PHARMACOL, V171, P2300, DOI 10.1111/bph.12557; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doyle SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007616; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fix C, 2011, CYTOKINE, V53, P19, DOI 10.1016/j.cyto.2010.10.002; Goren I, 2003, DIABETES, V52, P2821, DOI 10.2337/diabetes.52.11.2821; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Graves DT, 2001, J IMMUNOL, V167, P5316, DOI 10.4049/jimmunol.167.9.5316; Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598; Kampfer H, 1999, J INVEST DERMATOL, V113, P369, DOI 10.1046/j.1523-1747.1999.00704.x; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lee JG, 2012, INVEST OPHTH VIS SCI, V53, P1530, DOI 10.1167/iovs.11-9102; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Leslie KS, 2006, ARCH DERMATOL, V142, P1591, DOI 10.1001/archderm.142.12.1591; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liechty KW, 2000, J PEDIATR SURG, V35, P866, DOI 10.1053/jpsu.2000.6868; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Mirza RE, 2014, CYTOKINE; Mirza RE, 2013, DIABETES; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; ROSNER K, 1995, APMIS, V103, P293, DOI 10.1111/j.1699-0463.1995.tb01109.x; Salven P, 2002, FASEB J, V16, P1471, DOI 10.1096/fj.02-0134fje; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Thomay AA, 2009, AM J PATHOL, V174, P2129, DOI 10.2353/ajpath.2009.080765; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Voronov E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00114; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Weinheimer-Haus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091355; Wietecha MS, 2011, AM J PHYSIOL-HEART C, V300, pH459, DOI 10.1152/ajpheart.00244.2010; Yazdi AS, 2010, J CLIN IMMUNOL, V30, P623, DOI 10.1007/s10875-010-9437-y; Yin H, 2013, MOL IMMUNOL, V56, P347, DOI 10.1016/j.molimm.2013.05.225; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	53	61	61	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119106	10.1371/journal.pone.0119106	http://dx.doi.org/10.1371/journal.pone.0119106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793779	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200055
J	Yamamoto, T; Shimojima, K; Sangu, N; Komoike, Y; Ishii, A; Abe, S; Yamashita, S; Imai, K; Kubota, T; Fukasawa, T; Okanishi, T; Enoki, H; Tanabe, T; Saito, A; Furukawa, T; Shimizu, T; Milligan, CJ; Petrou, S; Heron, SE; Dibbens, LM; Hirose, S; Okumura, A				Yamamoto, Toshiyuki; Shimojima, Keiko; Sangu, Noriko; Komoike, Yuta; Ishii, Atsushi; Abe, Shinpei; Yamashita, Shintaro; Imai, Katsumi; Kubota, Tetsuo; Fukasawa, Tatsuya; Okanishi, Tohru; Enoki, Hideo; Tanabe, Takuya; Saito, Akira; Furukawa, Toru; Shimizu, Toshiaki; Milligan, Carol J.; Petrou, Steven; Heron, Sarah E.; Dibbens, Leanne M.; Hirose, Shinichi; Okumura, Akihisa			Single Nucleotide Variations in CLCN6 Identified in Patients with Benign Partial Epilepsies in Infancy and/or Febrile Seizures	PLOS ONE			English	Article							CHLORIDE CHANNEL; MUTATIONS; VARIANTS; PRRT2; PROTEINS; CHILDREN; GENES; CLC-6	Nucleotide alterations in the gene encoding proline-rich transmembrane protein 2 (PRRT2) have been identified in most patients with benign partial epilepsies in infancy (BPEI)/benign familial infantile epilepsy (BFIE). However, not all patients harbor these PRRT2 mutations, indicating the involvement of genes other than PRRT2. In this study, we performed whole exome sequencing analysis for a large family affected with PRRT2-unrelated BPEI. We identified a non-synonymous single nucleotide variation (SNV) in the voltage-sensitive chloride channel 6 gene (CLCN6). A cohort study of 48 BPEI patients without PRRT2 mutations revealed a different CLCN6 SNV in a patient, his sibling and his father who had a history of febrile seizures (FS) but not BPEI. Another study of 48 patients with FS identified an additional SNV in CLCN6. Chloride channels (CLCs) are involved in a multitude of physiologic processes and some members of the CLC family have been linked to inherited diseases. However, a phenotypic correlation has not been confirmed for CLCN6. Although we could not detect significant biological effects linked to the identified CLCN6 SNVs, further studies should investigate potential CLCN6 variants that may underlie the genetic susceptibility to convulsive disorders.	[Yamamoto, Toshiyuki; Shimojima, Keiko; Sangu, Noriko; Furukawa, Toru] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan; [Komoike, Yuta] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth 1, Tokyo, Japan; [Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Fac Med, Dept Pediat, Fukuoka 81401, Japan; [Abe, Shinpei; Shimizu, Toshiaki; Okumura, Akihisa] Juntendo Univ, Fac Med, Dept Pediat, Tokyo, Japan; [Yamashita, Shintaro] Juntendo Nerima Hosp, Dept Pediat, Tokyo, Japan; [Imai, Katsumi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan; [Kubota, Tetsuo; Fukasawa, Tatsuya] Anjo Kosei Hosp, Dept Pediat, Anjo, Japan; [Okanishi, Tohru; Enoki, Hideo] Seirei Hamamatsu Gen Hosp, Dept Child Neurol, Hamamatsu, Shizuoka, Japan; [Tanabe, Takuya] Tanabe Monbayashi Child Clin, Hirakata, Osaka, Japan; [Saito, Akira] StaGen Co Ltd, Tokyo, Japan; [Milligan, Carol J.; Petrou, Steven] Univ Melbourne, Florey Neurosci Inst, Melbourne Brain Ctr, Melbourne, Vic, Australia; [Heron, Sarah E.; Dibbens, Leanne M.] Univ S Australia, Sch Pharm & Med Sci, Epilepsy Res Program, Adelaide, SA 5001, Australia	Tokyo Women's Medical University; Tokyo Women's Medical University; Fukuoka University; Juntendo University; Juntendo University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of South Australia	Yamamoto, T (corresponding author), Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan.	yamamoto.toshiyuki@twmu.ac.jp	Furukawa, Toru/AAF-5596-2021; Heron, Sarah/F-4222-2013	Furukawa, Toru/0000-0002-1083-2324; Heron, Sarah/0000-0001-8759-6748; HIROSE, Shinichi/0000-0001-6796-3790; Petrou, Steven/0000-0002-4960-6375; Okanishi, Tohru/0000-0003-3295-2236; Dibbens, Leanne/0000-0002-5824-3342	Foundation of Synapse and Neurocircuit Pathology [23110534]; Ministry of Health, Labor and Welfare, Japan; Mother and Child Health Foundation in Japan; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Japan Society for the Promotion of Science (JSPS) [24791090]; Japan Epilepsy Research Foundation (JERF); Kanae Foundation for the promotion of Medical Science in Japan; Grants-in-Aid for Scientific Research [15H02548] Funding Source: KAKEN	Foundation of Synapse and Neurocircuit Pathology; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Mother and Child Health Foundation in Japan; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Epilepsy Research Foundation (JERF); Kanae Foundation for the promotion of Medical Science in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by a Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology" (23110534); a Grant-in-Aid for scientific research and a Grant-in-Aid of Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan; a Grant from the Mother and Child Health Foundation in Japan; and a Grant from Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (T.Y.). This study was partially supported by a Grant-in-Aid for Young Scientists (B) (24791090), Japan Society for the Promotion of Science (JSPS), a Grant from the Japan Epilepsy Research Foundation (JERF), and a Grant from Kanae Foundation for the promotion of Medical Science in Japan (K.S.). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; Buyse G, 1998, BIOCHEM J, V330, P1015, DOI 10.1042/bj3301015; Chen TT, 2013, NEUROLOGY, V80, P1078, DOI 10.1212/WNL.0b013e31828868e7; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Del Greco FM, 2011, HUM MOL GENET, V20, P1660, DOI 10.1093/hmg/ddr035; Heron SE, 2012, AM J HUM GENET, V90, P152, DOI 10.1016/j.ajhg.2011.12.003; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Kleefuss-Lie A, 2009, NAT GENET, V41, P954, DOI 10.1038/ng0909-954; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kugler SL, 1998, BRAIN DEV-JPN, V20, P265, DOI 10.1016/S0387-7604(98)00020-5; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li N, 2010, INT J NEUROSCI, V120, P217, DOI 10.3109/00207450903477779; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Niemeyer MI, 2010, NAT GENET, V42, P3, DOI 10.1038/ng0110-3; Okumura A, 2006, NEUROPEDIATRICS, V37, P359, DOI 10.1055/s-2007-964905; Okumura A, 2006, EPILEPSIA, V47, P181, DOI 10.1111/j.1528-1167.2006.00385.x; Okumura A, 2006, EPILEPSY RES, V70, pS168, DOI 10.1016/j.eplepsyres.2005.11.019; Okumura A, 2013, NEUROPATHOLOGY, V33, P553, DOI 10.1111/neup.12007; Okumura A, 2013, BRAIN DEV-JPN, V35, P641, DOI 10.1016/j.braindev.2012.09.015; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Pressey SNR, 2010, J NEUROPATH EXP NEUR, V69, P1228, DOI 10.1097/NEN.0b013e3181ffe742; Saghazadeh A, 2014, REV NEUROSCI, P1; Saint-Martin C, 2009, HUM MUTAT, V30, P397, DOI 10.1002/humu.20876; Sander T, 2000, HUM MOL GENET, V9, P1465, DOI 10.1093/hmg/9.10.1465; Shimojima K, 2009, GENOMICS, V94, P414, DOI 10.1016/j.ygeno.2009.08.015; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Waldegger S, 2000, J AM SOC NEPHROL, V11, P1331, DOI 10.1681/ASN.V1171331; Watanabe K, 2000, BRAIN DEV-JPN, V22, P296, DOI 10.1016/S0387-7604(00)00112-1	33	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118946	10.1371/journal.pone.0118946	http://dx.doi.org/10.1371/journal.pone.0118946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794116	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200049
J	Bayne, RAL; Kinnell, HL; Coutts, SM; He, J; Childs, AJ; Anderson, RA				Bayne, Rosemary A. L.; Kinnell, Hazel L.; Coutts, Shiona M.; He, Jing; Childs, Andrew J.; Anderson, Richard A.			GDF9 is Transiently Expressed in Oocytes before Follicle Formation in the Human Fetal Ovary and is Regulated by a Novel NOBOX Transcript	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; BONE MORPHOGENETIC PROTEIN-15; GERM-CELLS; GENE-EXPRESSION; SOMATIC-CELLS; DNA; FOLLICULOGENESIS; INITIATION; MUTATIONS; RECEPTORS	During human fetal ovary development, the process of primordial follicle formation is immediately preceded by a highly dynamic period of germ cell and somatic cell reorganisation. This is regulated by germ-cell specific transcription regulators, by the conserved RNA binding proteins DAZL and BOLL and by secreted growth factors of the TGF beta family, including activin beta A: these all show changing patterns of expression preceding follicle formation. In mice, the transcription factor Nobox is essential for follicle formation and oocyte survival, and NOBOX regulates the expression of GDF9 in humans. We have therefore characterised the expression of GDF9 in relation to these known key factors during follicle formation in the human fetal ovary. mRNA levels of GDF9, BMP15 and NOBOX were quantified by qRT-PCR and showed dramatic increases across gestation. GDF9 protein expression was localised by immunohistochemistry to the same population of germ cells as those expressing activin beta A prior to follicle formation but did not co-localise with either BOLL or DAZL. A novel NOBOX isoform was identified in fetal ovary that was shown to be capable of up-regulating the GDF9 promoter in reporter assays. Thus, during oogenesis in humans, oocytes go through a dynamic and very sharply demarcated sequence of changes in expression of these various proteins, even within individual germ cell nests, likely to be of major functional significance in determining selective germ cell survival at this key stage in ovarian development. Transcriptional variation may contribute to the range of age of onset of POI in women with NOBOX mutations.	[Bayne, Rosemary A. L.; Kinnell, Hazel L.; Coutts, Shiona M.; He, Jing; Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Childs, Andrew J.] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England	University of Edinburgh; University of London; University of London Royal Veterinary College	Bayne, RAL (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	r.bayne@ed.ac.uk		Bayne, Rosemary (Rosey)/0000-0001-5820-6050	UK Medical Research Council [G1100357]; MRC [G1100357] Funding Source: UKRI; Medical Research Council [G1100357] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council [grant G1100357 to RAA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini DF, 2011, J ASSIST REPROD GEN, V28, P567, DOI 10.1007/s10815-011-9615-8; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; Bouilly J, 2011, HUM MUTAT, V32, P1108, DOI 10.1002/humu.21543; Childs AJ, 2012, STEM CELLS DEV, V21, P2343, DOI 10.1089/scd.2011.0730; Childs AJ, 2012, METHODS MOL BIOL, V825, P199, DOI 10.1007/978-1-61779-436-0_15; Childs AJ, 2009, FERTIL STERIL, V92, P1416, DOI 10.1016/j.fertnstert.2009.03.095; Choi M, 2010, FEBS LETT, V584, P3629, DOI 10.1016/j.febslet.2010.07.037; Choi YS, 2007, BIOL REPROD, V77, P312, DOI 10.1095/biolreprod.107.060459; Choi Y, 2006, J BIOL CHEM, V281, P35747, DOI 10.1074/jbc.M604008200; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; da Silva SJM, 2004, DEV BIOL, V266, P334, DOI 10.1016/j.ydbio.2003.10.030; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Feng CW, 2014, MOL CELL ENDOCRINOL, V382, P488, DOI 10.1016/j.mce.2013.09.026; Fowler PA, 2014, HUM REPROD, V29, P1471, DOI 10.1093/humrep/deu117; Fowler PA, 2009, J CLIN ENDOCR METAB, V94, P1427, DOI 10.1210/jc.2008-2619; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; GONDOS B, 1986, AM J OBSTET GYNECOL, V155, P189, DOI 10.1016/0002-9378(86)90109-2; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; He J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073996; Huntriss J, 2006, MOL HUM REPROD, V12, P283, DOI 10.1093/molehr/gal035; Joyce IM, 2000, BIOL REPROD, V63, P1669, DOI 10.1095/biolreprod63.6.1669; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Lechowska A, 2011, J ASSIST REPROD GEN, V28, P583, DOI 10.1007/s10815-011-9553-5; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Margulis S, 2009, FERTIL STERIL, V92, P1666, DOI 10.1016/j.fertnstert.2008.08.119; MAXWELL IH, 1989, BIOTECHNIQUES, V7, P276; Mottershead DG, 2008, MOL CELL ENDOCRINOL, V283, P58, DOI 10.1016/j.mce.2007.11.007; Nilsson EE, 2002, BIOL REPROD, V67, P1018, DOI 10.1095/biolreprod.101.002527; Norling A, 2014, HUM REPROD, V29, P1818, DOI 10.1093/humrep/deu149; Oron G, 2010, REPROD BIOMED ONLINE, V21, P109, DOI 10.1016/j.rbmo.2010.03.011; Pangas SA, 2006, HUM REPROD UPDATE, V12, P65, DOI 10.1093/humupd/dmi033; Pangas SA, 2012, MOL CELL ENDOCRINOL, V356, P40, DOI 10.1016/j.mce.2011.06.021; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Peterson AJ, 2013, DEVELOPMENT, V140, P649, DOI 10.1242/dev.085605; Pulkki MM, 2011, MOL CELL ENDOCRINOL, V332, P106, DOI 10.1016/j.mce.2010.10.002; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Sarraj MA, 2012, REPRODUCTION, V143, P151, DOI 10.1530/REP-11-0247; Simpson CM, 2012, ENDOCRINOLOGY, V153, P1301, DOI 10.1210/en.2011-1632; Sun RZ, 2010, J MOL HISTOL, V41, P325, DOI 10.1007/s10735-010-9294-2; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073; Wang C, 2006, ENDOCRINOLOGY, V147, P1725, DOI 10.1210/en.2005-1208; Wang JR, 2004, BIOL REPROD, V70, P577, DOI 10.1095/biolreprod.103.023234; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854	47	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119819	10.1371/journal.pone.0119819	http://dx.doi.org/10.1371/journal.pone.0119819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790371	Green Published, Green Accepted, gold			2022-12-26	WOS:000351425400108
J	Heine, EM; Berger, TR; Pluciennik, A; Orr, CR; Zboray, L; Merry, DE				Heine, Erin M.; Berger, Tamar R.; Pluciennik, Anna; Orr, Christopher R.; Zboray, Lori; Merry, Diane E.			Proteasome-mediated Proteolysis of the Polyglutamine-expanded Androgen Receptor Is a Late Event in Spinal and Bulbar Muscular Atrophy (SBMA) Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; HUNTINGTONS-DISEASE; INTRANUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; AGGREGATE FORMATION; IN-VITRO; TOXICITY; NEURODEGENERATION; EXPRESSION; FRAGMENTS	Proteolysis of polyglutamine-expanded proteins is thought to be a required step in the pathogenesis of several neurodegenerative diseases. The accepted view for many polyglutamine proteins is that proteolysis of the mutant protein produces a "toxic fragment" that induces neuronal dysfunction and death in a soluble form; toxicity of the fragment is buffered by its incorporation into amyloid-like inclusions. In contrast to this view, we show that, in the polyglutamine disease spinal and bulbar muscular atrophy, proteolysis of the mutant androgen receptor (AR) is a late event. Immunocytochemical and biochemical analyses revealed that the mutant AR aggregates as a full-length protein, becoming proteolyzed to a smaller fragment through a process requiring the proteasome after it is incorporated into intranuclear inclusions. Moreover, the toxicity-predicting conformational antibody 3B5H10 bound to soluble full-length AR species but not to fragment-containing nuclear inclusions. These data suggest that the AR is toxic as a full-length protein, challenging the notion of polyglutamine protein fragment-associated toxicity by redefining the role of AR proteolysis in spinal and bulbar muscular atrophy pathogenesis.	[Heine, Erin M.; Berger, Tamar R.; Pluciennik, Anna; Orr, Christopher R.; Zboray, Lori; Merry, Diane E.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Merry, DE (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 228 Bluemle Life Sci Bldg,233 S 10th St, Philadelphia, PA 19107 USA.	Diane.merry@jefferson.edu			National Institutes of Health National Cancer Institute [5 P30 CA-56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076919, R01NS032214] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Yolanda Covarrubias and the Bio-imaging Shared Resource of the Sidney Kimmel Cancer Center (supported by National Institutes of Health National Cancer Institute Grant 5 P30 CA-56036) for imaging support, Yuhong Liu for technical assistance, Dr. Marc Diamond (University of Texas Southwestern, Dallas, TX) for CFP/YFP-AR plasmids, Dr. Steven Finkbeiner (Gladstone Institutes, University of California, San Francisco) for antibody 3B5H10, and Dr. Emily Sontag (University of California, San Francisco) and Dr. Leslie Thompson (University of California, Irvine) for advice on SDS-AGE. We also thank Dr. Heather Montie for discussions and critical reading of the paper.	Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Klein FAC, 2013, HUM MOL GENET, V22, P4215, DOI 10.1093/hmg/ddt273; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Li I, 1998, AM J PATHOL, V153, P695, DOI 10.1016/S0002-9440(10)65612-X; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Mitra S, 2009, J BIOL CHEM, V284, P4398, DOI 10.1074/jbc.M806269200; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Montie HL, 2011, J NEUROSCI, V31, P17425, DOI 10.1523/JNEUROSCI.3958-11.2011; Montie HL, 2009, HUM MOL GENET, V18, P1937, DOI 10.1093/hmg/ddp115; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; Orr CR, 2010, J BIOL CHEM, V285, P35567, DOI 10.1074/jbc.M110.146845; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Peters-Libeu C, 2012, J MOL BIOL, V421, P587, DOI 10.1016/j.jmb.2012.01.034; Roy J, 1998, J NEUROSCI, V18, P9673; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schilling G, 1999, NEURON, V24, P275, DOI 10.1016/S0896-6273(00)80839-9; Schipper-Krom S, 2014, FEBS LETT, V588, P151, DOI 10.1016/j.febslet.2013.11.023; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Sontag EM, 2012, J HUNTINGTONS DIS, V1, P119, DOI 10.3233/JHD-2012-129004; Sontag EM, 2012, J NEUROSCI, V32, P11109, DOI 10.1523/JNEUROSCI.0895-12.2012; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Walcott JL, 2002, J BIOL CHEM, V277, P50855, DOI 10.1074/jbc.M209466200; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009; Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773	43	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12572	12584		10.1074/jbc.M114.617894	http://dx.doi.org/10.1074/jbc.M114.617894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25795778	Green Published, hybrid			2022-12-26	WOS:000354569000013
J	Holley, CL; Li, MW; Scruggs, BS; Matkovich, SJ; Ory, DS; Schaffer, JE				Holley, Christopher L.; Li, Melissa W.; Scruggs, Benjamin S.; Matkovich, Scot J.; Ory, Daniel S.; Schaffer, Jean E.			Cytosolic Accumulation of Small Nucleolar RNAs (snoRNAs) Is Dynamically Regulated by NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRERIBOSOMAL RNA; NUCLEAR; DOXORUBICIN; STRESS; U8	Small nucleolar RNAs (snoRNAs) guide nucleotide modifications of cellular RNAs in the nucleus. We previously showed that box C/D snoRNAs from the Rpl13a locus are unexpected mediators of physiologic oxidative stress, independent of their predicted ribosomal RNA modifications. Here we demonstrate that oxidative stress induced by doxorubicin causes rapid cytoplasmic accumulation of the Rpl13a snoRNAs through a mechanism that requires superoxide and a nuclear splice variant of NADPH oxidase. RNA-sequencing analysis reveals that box C/D snoRNAs as a class are present in the cytoplasm, where their levels are dynamically regulated by NADPH oxidase. These findings suggest that snoRNAs may orchestrate the response to environmental stress through molecular interactions outside of the nucleus.	[Holley, Christopher L.; Li, Melissa W.; Scruggs, Benjamin S.; Ory, Daniel S.; Schaffer, Jean E.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Matkovich, Scot J.] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Schaffer, JE (corresponding author), Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA.	jschaff@wustl.edu	Holley, Christopher/T-1312-2019; Matkovich, Scot J/B-9077-2009; Matkovich, Scot J/AFP-0908-2022; Holley, Christopher/ABB-6677-2020; Regan, Clinton/E-6250-2012	Holley, Christopher/0000-0002-2870-3352; Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857; Scruggs, Benjamin/0000-0002-0990-9478	National Institutes of Health [P30 CA91842, UL1 TR000448, P30 DK052574]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007081, K08HL114889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK064989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to John Edwards for critical reading of this manuscript and to Xiaowen Wang for assistance with Partek analysis. RNA-seq was performed by the Genome Technology Access Center at Washington University School of Medicine, supported by National Institutes of Health Grants P30 CA91842, UL1 TR000448, and P30 DK052574.	Anilkumar N, 2013, ARTERIOSCL THROM VAS, V33, pE104, DOI 10.1161/ATVBAHA.112.300956; Avitabile D, 2011, P NATL ACAD SCI USA, V108, P6145, DOI 10.1073/pnas.1017935108; Deng SW, 2007, FREE RADICAL BIO MED, V42, P466, DOI 10.1016/j.freeradbiomed.2006.11.013; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Rio Donald C, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5441; Samarsky DA, 1998, EMBO J, V17, P3747, DOI 10.1093/emboj/17.13.3747; Schubert T, 2012, MOL CELL, V48, P434, DOI 10.1016/j.molcel.2012.08.021; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Scruggs BS, 2012, MOL CELL BIOL, V32, P4092, DOI 10.1128/MCB.00022-12; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; TYC K, 1989, EMBO J, V8, P3113, DOI 10.1002/j.1460-2075.1989.tb08463.x; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Watkins NJ, 2007, MOL CELL BIOL, V27, P7018, DOI 10.1128/MCB.00516-07; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664	21	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11741	11748		10.1074/jbc.M115.637413	http://dx.doi.org/10.1074/jbc.M115.637413			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792744	Green Published, hybrid			2022-12-26	WOS:000353719400046
J	Inaguma, A; Tsukamoto, H; Kato, HE; Kimura, T; Ishizuka, T; Oishi, S; Yawo, H; Nureki, O; Furutani, Y				Inaguma, Asumi; Tsukamoto, Hisao; Kato, Hideaki E.; Kimura, Tetsunari; Ishizuka, Toru; Oishi, Satomi; Yawo, Hiromu; Nureki, Osamu; Furutani, Yuji			Chimeras of Channelrhodopsin-1 and-2 from Chlamydomonas reinhardtii Exhibit Distinctive Light-induced Structural Changes from Channelrhodopsin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL CHROMOPHORE; PROTONATION CHANGES; RESONANCE RAMAN; WATER-MOLECULES; OPTICAL CONTROL; CHANNEL; SPECTROSCOPY; PHOTOINTERMEDIATE; PHOTOCYCLE; RHODOPSINS	Channelrhodopsin-2 (ChR2) from the green alga Chlamydomonas reinhardtii functions as a light-gated cation channel that has been developed as an optogenetic tool to stimulate specific nerve cells in animals and control their behavior by illumination. The molecular mechanism of ChR2 has been extensively studied by a variety of spectroscopic methods, including light-induced difference Fourier transform infrared (FTIR) spectroscopy, which is sensitive to structural changes in the protein upon light activation. An atomic structure of channelrhodopsin was recently determined by x-ray crystallography using a chimera of channelrhodopsin-1 (ChR1) and ChR2. Electrophysiological studies have shown that ChR1/ChR2 chimeras are less desensitized upon continuous illumination than native ChR2, implying that there are some structural differences between ChR2 and chimeras. In this study, we applied light-induced difference FTIR spectroscopy to ChR2 and ChR1/ChR2 chimeras to determine the molecular basis underlying these functional differences. Upon continuous illumination, ChR1/ChR2 chimeras exhibited structural changes distinct from those in ChR2. In particular, the protonation state of a glutamate residue, Glu-129 (Glu-90 in ChR2 numbering), in the ChR chimeras is not changed as dramatically as in ChR2. Moreover, using mutants stabilizing particular photointermediates as well as time-resolved measurements, we identified some differences between the major photointermediates of ChR2 and ChR1/ChR2 chimeras. Taken together, our data indicate that the gating and desensitizing processes in ChR1/ChR2 chimeras are different from those in ChR2 and that these differences should be considered in the rational design of new optogenetic tools based on channelrhodopsins.	[Inaguma, Asumi; Tsukamoto, Hisao; Kimura, Tetsunari; Furutani, Yuji] Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi 4448585, Japan; [Inaguma, Asumi; Furutani, Yuji] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Inaguma, Asumi; Tsukamoto, Hisao; Kimura, Tetsunari; Furutani, Yuji] Grad Univ Adv Studies SOKENDAI, Dept Struct Mol Sci, Okazaki, Aichi 4448585, Japan; [Kato, Hideaki E.; Oishi, Satomi; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Ishizuka, Toru; Yawo, Hiromu] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Japan Science & Technology Agency (JST); Graduate University for Advanced Studies - Japan; University of Tokyo; Japan Science & Technology Agency (JST); Tohoku University	Furutani, Y (corresponding author), Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan.	furutani@ims.ac.jp	Ishizuka, Toru/L-8191-2017; Furutani, Yuji/J-8337-2019; Kimura, Tetsunari/AAN-9156-2021; Yawo, Hiromu/I-4871-2015; NUREKI, OSAMU/G-4960-2014; Kato, Hideaki/AAQ-4323-2020	Ishizuka, Toru/0000-0003-4405-8792; Furutani, Yuji/0000-0001-5284-8773; Kimura, Tetsunari/0000-0003-1650-7298; Yawo, Hiromu/0000-0002-4299-3288; Kato, Hideaki/0000-0002-1941-5535	Core Research for Evolutional Science and Technology (CREST) Program of "Creation of Nanosystems with Novel Function through Process Integration" from the Japan Science and Technology Agency (JST); Precursory Research for Embryonic Science and Technology (PRESTO) Program of "Chemical Conversion of Light Energy" from the Japan Science and Technology Agency (JST); KAKENHI Japan Society for Promotion of Science (JSPS) [22770159, 24650203]; Grants-in-Aid for Scientific Research [25840122, 15K15025, 26640047, 15H01413] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) Program of "Creation of Nanosystems with Novel Function through Process Integration" from the Japan Science and Technology Agency (JST); Precursory Research for Embryonic Science and Technology (PRESTO) Program of "Chemical Conversion of Light Energy" from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); KAKENHI Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Core Research for Evolutional Science and Technology (CREST) Program of "Creation of Nanosystems with Novel Function through Process Integration" and the Precursory Research for Embryonic Science and Technology (PRESTO) Program of "Chemical Conversion of Light Energy" from the Japan Science and Technology Agency (JST). This work was also supported in part by KAKENHI Japan Society for Promotion of Science (JSPS) Grant 22770159 and 24650203 (to Y. F.).	ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Furutani Y, 2002, BIOPHYS J, V83, P3482, DOI 10.1016/S0006-3495(02)75347-2; Furutani Y, 2013, J PHYS CHEM B, V117, P3449, DOI 10.1021/jp308765t; Furutani Y, 2012, J PHYS CHEM LETT, V3, P2964, DOI 10.1021/jz301287n; Gerwert K, 2014, BBA-BIOENERGETICS, V1837, P606, DOI 10.1016/j.bbabio.2013.09.006; Hososhima S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119558; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Kandori H, 2002, BIOCHEMISTRY-US, V41, P4554, DOI 10.1021/bi0120749; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kuhne J, 2015, ANGEW CHEM INT EDIT, V54, P4953, DOI 10.1002/anie.201410180; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lorenz-Fonfria VA, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895796; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Muders V, 2014, FEBS LETT, V588, P2301, DOI 10.1016/j.febslet.2014.05.019; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Ogren JI, 2014, BIOCHEMISTRY-US, V53, P3961, DOI 10.1021/bi500445c; Radu I, 2009, PHOTOCH PHOTOBIO SCI, V8, P1517, DOI 10.1039/b9pp00050j; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	41	23	23	2	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11623	11634		10.1074/jbc.M115.642256	http://dx.doi.org/10.1074/jbc.M115.642256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25796616	hybrid, Green Published			2022-12-26	WOS:000353719400037
J	Saur, IML; Conlan, BF; Rathjen, JP				Saur, Isabel Marie-Luise; Conlan, Brendon Francis; Rathjen, John Paul			The N-Terminal Domain of the Tomato Immune Protein Prf Contains Multiple Homotypic and Pto Kinase Interaction Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-DISEASE RESISTANCE; RICH REPEAT DOMAINS; STRUCTURAL BASIS; CELL-DEATH; PATHOGEN INTERACTIONS; EFFECTOR RECOGNITION; SELF-ASSOCIATION; LRR PROTEINS; BACTERIAL; AVRPTO	Resistance to Pseudomonas syringae bacteria in tomato (Solanum lycopersicum) is conferred by the Prf recognition complex, composed of the nucleotide-binding leucine-rich repeats protein Prf and the protein kinase Pto. The complex is activated by recognition of the P. syringae effectors AvrPto and AvrPtoB. The N-terminal domain is responsible for Prf homodimerization, which brings two Pto kinases into close proximity and holds them in inactive conformation in the absence of either effector. Negative regulation is lost by effector binding to the catalytic cleft of Pto, leading to disruption of its P+1 loop within the activation segment. This change is translated through Prf to a second Pto molecule in the complex. Here we describe a schematic model of the unique Prf N-terminal domain dimer and its interaction with the effector binding determinant Pto. Using heterologous expression in Nicotiana benthamiana, we define multiple sites of N domain homotypic interaction and infer that it forms a parallel dimer folded centrally to enable contact between the N and C termini. Furthermore, we found independent binding sites for Pto at either end of the N-terminal domain. Using the constitutively active mutant ptoL205D, we identify a potential repression site for Pto in the first similar to 100 amino acids of Prf. Finally, we find that the Prf leucine-rich repeats domain also binds the N-terminal region, highlighting a possible mechanism for transfer of the effector binding signal to the NB-LRR regulatory unit (consisting of a central nucleotide binding and C-terminal leucine-rich repeats).	[Saur, Isabel Marie-Luise; Conlan, Brendon Francis; Rathjen, John Paul] Australian Natl Univ, Res Sch Biol, Acton, ACT 2601, Australia	Australian National University	Rathjen, JP (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Acton, ACT 2601, Australia.	john.rathjen@anu.edu.au	rathjen, john p/C-9327-2009; Conlan, Brendon F/A-7013-2012	rathjen, john p/0000-0003-4073-8088; Conlan, Brendon F/0000-0002-0934-3865	Australian Research Council [FT0992129, DP110103322]; Australian National University	Australian Research Council(Australian Research Council); Australian National University(Australian National University)	This work was supported by Grants FT0992129 and DP110103322 from the Australian Research Council (to J. P. R.). This work was also supported by a Tuition Fee Exemption Sponsorship from the Australian National University (to I. M. L. S.).	Balmuth A, 2007, PLANT J, V51, P978, DOI 10.1111/j.1365-313X.2007.03199.x; Banerjee D, 2001, GENETICS, V158, P439; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong J, 2009, PLANT CELL, V21, P1846, DOI 10.1105/tpc.109.066878; Du XR, 2012, MOL PLANT, V5, P1058, DOI 10.1093/mp/sss014; Gutierrez JR, 2010, PLANT J, V61, P507, DOI 10.1111/j.1365-313X.2009.04078.x; Hao W, 2013, J BIOL CHEM, V288, P35868, DOI 10.1074/jbc.M113.517417; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Linhoff MW, 2001, MOL CELL BIOL, V21, P3001, DOI 10.1128/MCB.21.9.3001-3011.2001; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mucyn TS, 2009, MOL PLANT MICROBE IN, V22, P391, DOI 10.1094/MPMI-22-4-0391; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Ntoukakis V, 2014, CURR OPIN PLANT BIOL, V20, P69, DOI 10.1016/j.pbi.2014.04.002; Ntoukakis V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003123; Ntoukakis V, 2009, SCIENCE, V324, P784, DOI 10.1126/science.1169430; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; Slootweg EJ, 2013, PLANT PHYSIOL, V162, P1510, DOI 10.1104/pp.113.218842; Staskawicz BJ, 2001, PLANT PHYSIOL, V125, P73, DOI 10.1104/pp.125.1.73; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P117, DOI 10.1016/j.tplants.2005.01.006; van Ooijen G, 2008, MOL PLANT, V1, P401, DOI 10.1093/mp/ssn009; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109	37	18	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11258	11267		10.1074/jbc.M114.616532	http://dx.doi.org/10.1074/jbc.M114.616532			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792750	Green Published, hybrid			2022-12-26	WOS:000353719400005
J	Kreiseder, B; Holper-Schichl, YM; Muellauer, B; Jacobi, N; Pretsch, A; Schmid, JA; de Martin, R; Hundsberger, H; Eger, A; Wiesner, C				Kreiseder, Birgit; Holper-Schichl, Yvonne M.; Muellauer, Barbara; Jacobi, Nico; Pretsch, Alexander; Schmid, Johannes A.; de Martin, Rainer; Hundsberger, Harald; Eger, Andreas; Wiesner, Christoph			Alpha-Catulin Contributes to Drug-Resistance of Melanoma by Activating NF-kappa B and AP-1	PLOS ONE			English	Article							CISPLATIN-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; DOUBLE-EDGED-SWORD; E-CADHERIN; MESENCHYMAL TRANSITION; SNAIL TRANSCRIPTION; CELL-PROLIFERATION; MALIGNANT-MELANOMA; EPITHELIAL-CELLS; ERK ACTIVATION	Melanoma is the most dangerous type of skin cancer accounting for 48,000 deaths worldwide each year and an average survival rate of about 6-10 months with conventional treatment. Tumor metastasis and chemoresistance of melanoma cells are reported as the main reasons for the insufficiency of currently available treatments for late stage melanoma. The cytoskeletal linker protein alpha-catulin (CTNNAL1) has been shown to be important in inflammation, apoptosis and cytoskeletal reorganization. Recently, we found an elevated expression of alpha-catulin in melanoma cells. Ectopic expression of alpha-catulin promoted melanoma progression and occurred concomitantly with the downregulation of E-cadherin and the upregulation of mesenchymal genes such as N-cadherin, Snail/Slug and the matrix metalloproteinases 2 and 9. In the current study we showed that alpha-catulin knockdown reduced NF-kappa B and AP-1 activity in malignant melanoma cells. Further, downregulation of alpha-catulin diminished ERK phosphorylation in malignant melanoma cells and sensitized them to treatment with chemotherapeutic drugs. In particular, cisplatin treatment led to decreased ERK-, JNK- and c-Jun phosphorylation in alpha-catulin knockdown melanoma cells, which was accompanied by enhanced apoptosis compared to control cells. Altogether, these results suggest that targeted inhibition of alpha-catulin may be used as a viable therapeutic strategy to chemosensitize melanoma cells to cisplatin by down-regulation of NF-kappa B and MAPK pathways.	[Kreiseder, Birgit; Muellauer, Barbara; Pretsch, Alexander; Wiesner, Christoph] SeaLife Pharma GmbH, Tulln, Austria; [Holper-Schichl, Yvonne M.; Schmid, Johannes A.; de Martin, Rainer] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria; [Jacobi, Nico; Hundsberger, Harald; Eger, Andreas; Wiesner, Christoph] Univ Appl Sci, Med & Pharmaceut Biotechnol, Krems, Austria	Medical University of Vienna	Wiesner, C (corresponding author), SeaLife Pharma GmbH, Tulln, Austria.	wiesner@sealifepharma.com	Schmid, Johannes A./C-7659-2009	Schmid, Johannes A./0000-0002-6586-3507; hundsberger, harald/0000-0002-8479-1633; Wiesner, Christoph/0000-0002-3281-0695	Austrian FFG (Forschungs Forderungs Gesellschaft); Project COIN, FFG-Project [821021]; Niederosterreichischen Forschungs-und Bildungsgesellschaft NFB Project [LS-11.013]	Austrian FFG (Forschungs Forderungs Gesellschaft); Project COIN, FFG-Project; Niederosterreichischen Forschungs-und Bildungsgesellschaft NFB Project	This work was supported by the Austrian FFG (Forschungs Forderungs Gesellschaft); Project COIN, FFG-Project Nr.: 821021 to CW and AE and by the Niederosterreichischen Forschungs-und Bildungsgesellschaft NFB Project Nr. LS-11.013 to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Amatschek S, 2011, BRIT J CANCER, V104, P469, DOI 10.1038/sj.bjc.6606056; Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Balch CM, 2001, TUMORI, V87, pS64; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; BOURS V, 1994, BIOCHEM PHARMACOL, V47, P145, DOI 10.1016/0006-2952(94)90448-0; Cao C, 2012, MOL CANCER RES, V10, P892, DOI 10.1158/1541-7786.MCR-12-0169; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Colpi GM, 2004, EUR J OBSTET GYN R B, V113, pS2, DOI 10.1016/j.ejogrb.2003.11.002; Costantini P, 2000, J NATL CANCER I, V92, P1042, DOI 10.1093/jnci/92.13.1042; Dent P, 2001, CLIN CANCER RES, V7, P775; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elsum IA, 2013, J CELL SCI, V126, P3990, DOI 10.1242/jcs.129387; Fan LC, 2011, ONCOGENE, V30, P2610, DOI 10.1038/onc.2010.637; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Howell S J, 2005, J Natl Cancer Inst Monogr, P12; Hurst EA, 2003, ARCH DERMATOL, V139, P1067, DOI 10.1001/archderm.139.8.1067; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Karin M, 2001, BIOFACTORS, V15, P87, DOI 10.1002/biof.5520150207; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kojima H, 1998, J BIOL CHEM, V273, P16647, DOI 10.1074/jbc.273.27.16647; Kreiseder B, 2013, INT J CANCER, V132, P521, DOI 10.1002/ijc.27698; Kuphal S, 2004, ONCOGENE, V23, P8509, DOI 10.1038/sj.onc.1207831; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liang CH, 2013, CANCER RES, V73, P428, DOI 10.1158/0008-5472.CAN-12-2095; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Mandic A, 2001, MELANOMA RES, V11, P11, DOI 10.1097/00008390-200102000-00002; Merdek KD, 2004, MOL CELL BIOL, V24, P2410, DOI 10.1128/MCB.24.6.2410-2422.2004; Mirmohammadsadegh A, 2007, J INVEST DERMATOL, V127, P2207, DOI 10.1038/sj.jid.5700870; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Paul I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.186; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Spangler B, 2011, PIGM CELL MELANOMA R, V24, P148, DOI 10.1111/j.1755-148X.2010.00787.x; Sun W, 2001, CURR TREAT OPTION ON, V2, P139; Ueda Y, 2006, PIGM CELL RES, V19, P112, DOI 10.1111/j.1600-0749.2006.00304.x; Venkatraman M, 2005, MOL CARCINOGEN, V44, P51, DOI 10.1002/mc.20116; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	53	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119402	10.1371/journal.pone.0119402	http://dx.doi.org/10.1371/journal.pone.0119402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793618	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200080
J	Liu, YC; Liu, ZB; Sun, GX; Wang, Y; Ling, JH; Gao, JY; Huang, JH				Liu, Yingchun; Liu, Zhongbo; Sun, Guoxiang; Wang, Yan; Ling, Junhong; Gao, Jiayue; Huang, Jiahao			Monitoring and Evaluating the Quality Consistency of Compound Bismuth Aluminate Tablets by a Simple Quantified Ratio Fingerprint Method Combined with Simultaneous Determination of Five Compounds and Correlated with Antioxidant Activities	PLOS ONE			English	Article							CHINESE HERBAL MEDICINE; CHROMATOGRAPHIC FINGERPRINT; PHARMACEUTICAL PRODUCTS; LICORICE	A combination method of multi-wavelength fingerprinting and multi-component quantification by high performance liquid chromatography (HPLC) coupled with diode array detector (DAD) was developed and validated to monitor and evaluate the quality consistency of herbal medicines (HM) in the classical preparation Compound Bismuth Aluminate tablets (CBAT). The validation results demonstrated that our method met the requirements of fingerprint analysis and quantification analysis with suitable linearity, precision, accuracy, limits of detection (LOD) and limits of quantification (LOQ). In the fingerprint assessments, rather than using conventional qualitative "Similarity" as a criterion, the simple quantified ratio fingerprint method (SQRFM) was recommended, which has an important quantified fingerprint advantage over the "Similarity" approach. SQRFM qualitatively and quantitatively offers the scientific criteria for traditional Chinese medicines (TCM)/HM quality pyramid and warning gate in terms of three parameters. In order to combine the comprehensive characterization of multi-wavelength fingerprints, an integrated fingerprint assessment strategy based on information entropy was set up involving a super-information characteristic digitized parameter of fingerprints, which reveals the total entropy value and absolute information amount about the fingerprints and, thus, offers an excellent method for fingerprint integration. The correlation results between quantified fingerprints and quantitative determination of 5 marker compounds, including glycyrrhizic acid (GLY), liquiritin (LQ), isoliquiritigenin (ILG), isoliquiritin (ILQ) and isoliquiritin apioside (ILA), indicated that multi-component quantification could be replaced by quantified fingerprints. The Fenton reaction was employed to determine the antioxidant activities of CBAT samples in vitro, and they were correlated with HPLC fingerprint components using the partial least squares regression (PLSR) method. In summary, the method of multi-wavelength fingerprints combined with antioxidant activities has been proved to be a feasible and scientific procedure for monitoring and evaluating the quality consistency of CBAT.	[Liu, Yingchun; Ling, Junhong] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang, Peoples R China; [Liu, Yingchun; Liu, Zhongbo; Sun, Guoxiang; Wang, Yan; Gao, Jiayue; Huang, Jiahao] Shenyang Pharmaceut Univ, Sch Pharm, Pharmaceut Informat Lab, Shenyang, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Sun, GX (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Pharmaceut Informat Lab, Shenyang, Peoples R China.	gxswmwys@126.com	LIU, YING/GZL-7252-2022; liu, ying/GXF-4294-2022					Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Chen P, 2011, J AOAC INT, V94, P1411, DOI 10.5740/jaoacint.10-291; CHMP, 2005, GUID QUAL HERB MED P; Dan M, 2009, PHYTOCHEM ANALYSIS, V20, P68, DOI 10.1002/pca.1099; *DRUG ADM BUR CHIN, 2002, REQ STUD FING TRAD C; Feng HS, 2007, CHINA PHARM, V16, P32; Food and Drug Administration, 2004, GUID IND BOT DRUG PR; Garza-Juarez A, 2011, PLANTA MED, V77, P958, DOI 10.1055/s-0030-1250684; Gong F, 2005, ANAL LETT, V38, P2475, DOI 10.1080/00032710500318338; Gumus G, 2005, ANAL CHIM ACTA, V547, P138, DOI 10.1016/j.aca.2005.03.028; Jana S, 2010, APPL CLAY SCI, V50, P337, DOI 10.1016/j.clay.2010.08.023; Jeronimo PCA, 2004, ANAL CHIM ACTA, V504, P235, DOI 10.1016/j.aca.2003.10.049; Kondo K, 2013, PHYTOCHEM ANALYSIS, V24, P527, DOI [10.1002/pca.2427, DOI 10.1002/PCA.2427]; Kondo K, 2007, BIOL PHARM BULL, V30, P1271, DOI 10.1248/bpb.30.1271; National Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, V1, P587; Pan RJ, 2011, J PHARMACEUT BIOMED, V55, P391, DOI 10.1016/j.jpba.2011.01.016; Qiao X, 2012, J CHROMATOGR A, V1258, P84, DOI 10.1016/j.chroma.2012.08.041; Rodriguez JA, 2007, J PHARMACEUT BIOMED, V45, P47, DOI 10.1016/j.jpba.2007.05.025; SFDA. State Drug Administration of China, 2000, CHIN TRADIT PAT MED, V22, P671; Shen DADA, 2012, FOOD CHEM, V130, P1003, DOI 10.1016/j.foodchem.2011.07.121; Sun Guo-xiang, 2009, Yaoxue Xuebao, V44, P401; Sun GX, 2007, CENTRAL S PHARM, V6, P25; Sun GX, 2009, CENTRAL S PHARM, V2, P19; Syam Ari Fahrial, 2009, Acta Med Indones, V41, P95; Tzanavaras PD, 2004, ANAL CHIM ACTA, V505, P167, DOI 10.1016/S0003-2670(03)00017-5; Wang LB, 2012, BIOCHEM SYST ECOL, V40, P138, DOI 10.1016/j.bse.2011.10.014; Wichtl M, 1994, HERBAL DRUGS PHYTOPH; Wu YC, 2009, ACTA CHIN MED PHARM, V37, P56; Xie PS, 2006, J CHROMATOGR A, V1112, P171, DOI 10.1016/j.chroma.2005.12.091; Xu L, 2004, CHEMOMETRICS PRINCIP, P16; Xu LanJu, 2004, China Poultry, P14; Yun YR, 2012, LUMINESCENCE, V27, P352, DOI 10.1002/bio.1357; Zapata-Colindres JC, 2006, CAN J GASTROENTEROL, V20, P277, DOI 10.1155/2006/175217; Zhang QF, 2011, PHYTOCHEM ANALYSIS, V22, P18, DOI 10.1002/pca.1245; Zhang QY, 2009, J CHROMATOGR A, V1216, P1954, DOI 10.1016/j.chroma.2008.07.072	35	16	16	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118223	10.1371/journal.pone.0118223	http://dx.doi.org/10.1371/journal.pone.0118223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793599	Green Submitted, gold, Green Published			2022-12-26	WOS:000352084200017
J	Ramasamy, S; Velmurugan, G; Rajan, KS; Ramprasath, T; Kalpana, K				Ramasamy, Subbiah; Velmurugan, Ganesan; Rajan, K. Shanmugha; Ramprasath, Tharmarajan; Kalpana, Krishnan			MiRNAs with Apoptosis Regulating Potential Are Differentially Expressed in Chronic Exercise-Induced Physiologically Hypertrophied Hearts	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; MICRORNAS; RATS; FAILURE; DISEASE; TOOL	Physiological cardiac hypertrophy is an adaptive mechanism, induced during chronic exercise. As it is reversible and not associated with cardiomyocyte death, it is considered as a natural tactic to prevent cardiac dysfunction and failure. Though, different studies revealed the importance of microRNAs (miRNAs) in pathological hypertrophy, their role during physiological hypertrophy is largely unexplored. Hence, this study is aimed at revealing the global expression profile of miRNAs during physiological cardiac hypertrophy. Chronic swimming protocol continuously for eight weeks resulted in induction of physiological hypertrophy in rats and histopathology revealed the absence of tissue damage, apoptosis or fibrosis. Subsequently, the total RNA was isolated and small RNA sequencing was executed. Analysis of small RNA reads revealed the differential expression of a large set of miRNAs during physiological hypertrophy. The expression profile of the significantly differentially expressed miRNAs was validated by qPCR. In silico prediction of target genes by miRanda, miRdB and TargetScan and subsequent qPCR analysis unraveled that miRNAs including miR-99b, miR-100, miR-19b, miR-10, miR-208a, miR-133, miR-191a, miR-22, miR-30e and miR-181a are targeting the genes that primarily regulate cell proliferation and cell death. Gene ontology and pathway mapping showed that the differentially expressed miRNAs and their target genes were mapped to apoptosis and cell death pathways principally via PI3K/Akt/mTOR and MAPK signaling. In summary, our data indicates that regulation of these miRNAs with apoptosis regulating potential can be one of the major key factors in determining pathological or physiological hypertrophy by controlling fibrosis, apoptosis and cell death mechanisms.	[Ramasamy, Subbiah; Velmurugan, Ganesan; Rajan, K. Shanmugha] Madurai Kamaraj Univ, Sch Biol Sci, Dept Mol Biol, Cardiac Hypertrophy Lab, Madurai 625021, Tamil Nadu, India; [Ramprasath, Tharmarajan] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Kalpana, Krishnan] Tamilnadu Agr Univ, Reg Res Stn, Dept Plant Pathol, Krishangiri, Tamil Nadu, India	Madurai Kamaraj University; University of Alberta; Tamil Nadu Agricultural University	Ramasamy, S (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Dept Mol Biol, Cardiac Hypertrophy Lab, Madurai 625021, Tamil Nadu, India.	subbiahr@nrcbsmku.org	Velmurugan, Ganesan/D-2360-2010; krishnan, kalpana/AAP-1297-2020; Ramprasath, Tharmarajan/V-5186-2017	Velmurugan, Ganesan/0000-0001-7536-4472; Ramprasath, Tharmarajan/0000-0002-2115-5875	Science & Engineering Research Board (SERB), Ministry of Science & Technology, Government of India [SR/FT/LS-37/2011]	Science & Engineering Research Board (SERB), Ministry of Science & Technology, Government of India	Funding: This work was funded by the Science & Engineering Research Board (SERB), Ministry of Science & Technology, Government of India (Project Ref. No. SR/FT/LS-37/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JY, 2013, NUCLEIC ACIDS RES, V41, P727, DOI 10.1093/nar/gks1187; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Archer E, 2011, PROG CARDIOVASC DIS, V53, P387, DOI 10.1016/j.pcad.2011.02.006; Balakumar P, 2006, BASIC CLIN PHARMACOL, V99, P418, DOI 10.1111/j.1742-7843.2006.pto_569.x; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Coppola A, 2014, STEM CELL RES, V12, P323, DOI 10.1016/j.scr.2013.11.008; Da Silva ND, 2012, MED SCI SPORT EXER, V44, P1453, DOI 10.1249/MSS.0b013e31824e8a36; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fernandes T, 2011, BRAZ J MED BIOL RES, V44, P836, DOI 10.1590/S0100-879X2011000900003; Fernandes T, 2011, HYPERTENSION, V58, P182, DOI 10.1161/HYPERTENSIONAHA.110.168252; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Martinelli NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093271; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Nagpal N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00099; Pan W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053950; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Soci UPR, 2011, PHYSIOL GENOMICS, V43, P665, DOI 10.1152/physiolgenomics.00145.2010; Song DW, 2014, BIOCHEM J, V457, P151, DOI 10.1042/BJ20130833; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495	30	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121401	10.1371/journal.pone.0121401	http://dx.doi.org/10.1371/journal.pone.0121401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793527	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900131
J	Berron, D; Fruhholz, S; Herrmann, M				Berron, David; Fruehholz, Sascha; Herrmann, Manfred			Neural Control of Enhanced Filtering Demands in a Combined Flanker and Garner Conflict Task	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MEDIAL TEMPORAL-LOBE; RESPONSE-CONFLICT; HUMAN BRAIN; ELECTROPHYSIOLOGICAL EVIDENCE; INTERFERENCE RESOLUTION; CONTROL MECHANISMS; COGNITIVE CONTROL; PARIETAL CORTEX; FMRI	Several studies demonstrated that visual filtering mechanisms might underlie both conflict resolution of the Flanker conflict and the control of the Garner effect. However, it remains unclear whether the mechanisms involved in the processing of both effects depend on similar filter mechanisms, such that especially the Garner effect is able to modulate filtering needs in the Flanker conflict. In the present experiment twenty-four subjects participated in a combined Garner and Flanker task during two runs of functional magnetic resonance imaging (fMRI) recordings. Behavioral data showed a significant Flanker but no Garner effect. A run-wise analysis, however, revealed a Flanker effect in the Garner filtering condition in the first experimental run, while we found a Flanker effect in the Garner baseline condition in the second experimental run. The fMRI data revealed a fronto-parietal network involved in the processing of both types of effects. Flanker interference was associated with activity in the inferior frontal gyrus, the anterior cingulate cortex, the precuneus as well as the inferior (IPL) and superior parietal lobule (SPL). Garner interference was associated with activation in middle frontal and middle temporal gyrus, the lingual gyrus as well as the IPL and SPL. Interaction analyses between the Garner and the Flanker effect additionally revealed differences between the two experimental runs. In the first experimental run, activity specifically related to the interaction of effects was found in frontal and parietal regions, while in the second run we found activity in the hippocampus, the parahippocampal cortex and the basal ganglia. This shift in activity for the interaction effects might be associated with a taskrelated learning process to control filtering demands. Especially perceptual learning mechanisms might play a crucial role in the present Flanker and Garner task design and, therefore, increased performance in the second experimental run could be the reason for the lack of behavioral Garner interference on the level of the whole experiment.	[Berron, David; Fruehholz, Sascha; Herrmann, Manfred] Univ Bremen, Dept Neuropsychol & Behav Neurobiol, D-28359 Bremen, Germany; [Berron, David] Otto Von Guericke Univ, Inst Cognit Neurol & Dementia Res, Magdeburg, Germany; [Fruehholz, Sascha; Herrmann, Manfred] Univ Bremen, Ctr Cognit Sci ZKW, D-28359 Bremen, Germany; [Fruehholz, Sascha] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland	University of Bremen; Otto von Guericke University; University of Bremen; University of Geneva	Berron, D (corresponding author), Univ Bremen, Dept Neuropsychol & Behav Neurobiol, D-28359 Bremen, Germany.	david.berron@med.ovgu.de	Herrmann, Manfred/H-3931-2011; Berron, David/V-2886-2018	Herrmann, Manfred/0000-0003-1872-8406; Berron, David/0000-0003-1558-1883	BMBF Neuroimaging program from the Center for Advanced Imaging (CAI) 'Magdeburg/Bremen [01GO0202]; Center for Cognitive Sciences (ZKW) at Bremen University	BMBF Neuroimaging program from the Center for Advanced Imaging (CAI) 'Magdeburg/Bremen; Center for Cognitive Sciences (ZKW) at Bremen University	The study was part of the BMBF Neuroimaging program (01GO0202) from the Center for Advanced Imaging (CAI) 'Magdeburg/Bremen (MH) and supported by the Center for Cognitive Sciences (ZKW) at Bremen University (SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek EG, 2013, BIOL PSYCHOL, V93, P269, DOI 10.1016/j.biopsycho.2013.02.009; Akyurek EG, 2010, NEUROPSYCHOLOGIA, V48, P3335, DOI 10.1016/j.neuropsychologia.2010.07.019; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; BENARTZI E, 1995, PERCEPT PSYCHOPHYS, V57, P1151, DOI 10.3758/BF03208371; Boenke LT, 2009, NEUROIMAGE, V45, P1272, DOI 10.1016/j.neuroimage.2009.01.019; Caclin A, 2008, J COGNITIVE NEUROSCI, V20, P49, DOI 10.1162/jocn.2008.20001; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Desseilles M, 2011, NEUROIMAGE, V54, P1662, DOI 10.1016/j.neuroimage.2010.08.061; Dosher BA, 2010, VISION RES, V50, P402, DOI 10.1016/j.visres.2009.09.010; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Dyson BJ, 2010, ATTEN PERCEPT PSYCHO, V72, P1676, DOI 10.3758/APP.72.6.1676; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; Egner T, 2011, J COGNITIVE NEUROSCI, V23, P3903, DOI 10.1162/jocn_a_00064; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Friedman-Hill SR, 2003, P NATL ACAD SCI USA, V100, P4263, DOI 10.1073/pnas.0730772100; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; Fruhholz S, 2011, NEUROIMAGE, V54, P622, DOI 10.1016/j.neuroimage.2010.07.071; Garner W. R., 1974, PROCESSING INFORM ST; GARNER WR, 1976, COGNITIVE PSYCHOL, V8, P98, DOI 10.1016/0010-0285(76)90006-2; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kaganovich N, 2006, BRAIN RES, V1114, P161, DOI 10.1016/j.brainres.2006.07.049; Kuchinke L, 2011, NEUROIMAGE, V54, P2412, DOI 10.1016/j.neuroimage.2010.08.062; Lew H, 1997, J Am Acad Audiol, V8, P104; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; McCarley JS, 2008, ACTA PSYCHOL, V128, P102, DOI 10.1016/j.actpsy.2007.10.005; Melara RD, 2008, BRAIN RES, V1215, P147, DOI 10.1016/j.brainres.2008.03.026; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Petersen SE, 2012, NEUROIMAGE, V62, P1177, DOI 10.1016/j.neuroimage.2011.09.084; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Pomerantz J. R., 1989, OBJECT PERCEPTION ST, P53; POMERANTZ JR, 1983, J EXP PSYCHOL GEN, V112, P516, DOI 10.1037/0096-3445.112.4.516; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Verbruggen F, 2006, PSYCHON B REV, V13, P328, DOI 10.3758/BF03193852; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Wendt M, 2012, J EXP PSYCHOL HUMAN, V38, P675, DOI 10.1037/a0025902; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zhu DC, 2010, NEUROIMAGE, V50, P810, DOI 10.1016/j.neuroimage.2009.12.087	49	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120582	10.1371/journal.pone.0120582	http://dx.doi.org/10.1371/journal.pone.0120582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790026	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400164
J	Huang, JP; Dang, RH; Torigoe, D; Lei, CZ; Lan, XY; Chen, H; Sasaki, N; Wang, JX; Agui, T				Huang, Jieping; Dang, Ruihua; Torigoe, Daisuke; Lei, Chuzhao; Lan, Xianyong; Chen, Hong; Sasaki, Nobuya; Wang, Jinxi; Agui, Takashi			Identification of Genetic Loci Affecting the Severity of Symptoms of Hirschsprung Disease in Rats Carrying Ednrb(sl) Mutations by Quantitative Trait Locus Analysis	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; ENDOTHELIN RECEPTOR-B; MICE LACKING GDNF; ALBINISM TYPE-IV; MOUSE MODEL; TRANSCRIPTIONAL REGULATION; NEURON PRECURSORS; MODIFIER GENE; SOX10; RET	Hirschsprung's disease (HSCR) is a congenital disease in neonates characterized by the absence of the enteric ganglia in a variable length of the distal colon. This disease results from multiple genetic interactions that modulate the ability of enteric neural crest cells to populate developing gut. We previously reported that three rat strains with different backgrounds (susceptible AGH-Ednrb(sl/sl), resistant F344-Ednrb(sl/sl), and LEH-Ednrb(sl/sl)) but the same null mutation of Ednrb show varying severity degrees of aganglionosis. This finding suggests that strain-specific genetic factors affect the severity of HSCR. Consistent with this finding, a quantitative trait locus (QTL) for the severity of HSCR on chromosome (Chr) 2 was identified using an F-2 intercross between AGH and F344 strains. In the present study, we performed QTL analysis using an F-2 intercross between the susceptible AGH and resistant LEH strains to identify the modifier/resistant loci for HSCR in Ednrb-deficient rats. A significant locus affecting the severity of HSCR was also detected within the Chr 2 region. These findings strongly suggest that a modifier gene of aganglionosis exists on Chr 2. In addition, two potentially causative SNPs (or mutations) were detected upstream of a known HSCR susceptibility gene, Gdnf. These SNPs were possibly responsible for the varied length of gut affected by aganglionosis.	[Huang, Jieping; Dang, Ruihua; Lei, Chuzhao; Lan, Xianyong; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Torigoe, Daisuke; Wang, Jinxi; Agui, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Lab Anim Sci & Med, Sapporo, Hokkaido 060, Japan; [Sasaki, Nobuya] Kitasato Univ, Sch Vet Med, Lab Lab Anim Sci & Med, Aomori, Japan	Northwest A&F University - China; Hokkaido University; Kitasato University	Dang, RH (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	dangruihua@nwsuaf.edu.cn; leichuzhao1118@126.com			National Natural Science Foundation of China [81270439]; Fundamental Research Funds for the Central Universities [Z109021204]; Research Foundation for Advanced Talents [Z111021202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Foundation for Advanced Talents	This work was supported by the National Natural Science Foundation of China (grant 81270439), the Fundamental Research Funds for the Central Universities (grant Z109021204) and the Research Foundation for Advanced Talents (grant Z111021202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MMM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015144; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Cantrell VA, 2004, HUM MOL GENET, V13, P2289, DOI 10.1093/hmg/ddh243; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chan AYK, 2005, BRIT J DERMATOL, V153, P1072, DOI 10.1111/j.1365-2133.2005.06912.x; COHEN IT, 1982, J PEDIATR SURG, V17, P632, DOI 10.1016/S0022-3468(82)80124-3; Cozma D, 2002, GENOME RES, V12, P969, DOI 10.1101/gr.210502; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027902; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024086; Du JY, 2002, J BIOL CHEM, V277, P402, DOI 10.1074/jbc.M110229200; Fitze G, 2003, HUM MOL GENET, V12, P3207, DOI 10.1093/hmg/ddg354; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052873; Gui HS, 2013, HUM GENET, V132, P591, DOI 10.1007/s00439-013-1272-9; Hori R, 2013, AURIS NASUS LARYNX, V40, P539, DOI 10.1016/j.anl.2013.05.003; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Jiang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021219; Karaki H, 1996, BIOCHEM BIOPH RES CO, V222, P139, DOI 10.1006/bbrc.1996.0711; Konno T, 2009, AM J MED GENET A, V149A, P1773, DOI 10.1002/ajmg.a.32964; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Leon TYY, 2009, J PEDIATR SURG, V44, P1904, DOI 10.1016/j.jpedsurg.2008.11.055; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Mundt E, 2010, SEMIN PEDIATR SURG, V19, P107, DOI 10.1053/j.sempedsurg.2009.11.015; Nadeau JH, 2003, CURR OPIN GENET DEV, V13, P290, DOI 10.1016/S0959-437X(03)00061-3; Parisi MA, 2002, AM J MED GENET, V108, P51, DOI 10.1002/ajmg.10185; Pellerin D, 1992, Cir Pediatr, V5, P57; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sasongko Teguh Haryo, 2007, Kobe J Med Sci, V53, P157; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Stanchina L, 2006, DEV BIOL, V295, P232, DOI 10.1016/j.ydbio.2006.03.031; Stanchina L, 2010, DEV BIOL, V341, P416, DOI 10.1016/j.ydbio.2010.02.036; Tanaka M, 2000, BBA-GENE STRUCT EXPR, V1494, P63, DOI 10.1016/S0167-4781(00)00218-9; Wallace AS, 2011, NEUROGASTROENT MOTIL, V23, pE510, DOI 10.1111/j.1365-2982.2011.01692.x; Wallace AS, 2010, NEUROBIOL DIS, V40, P622, DOI 10.1016/j.nbd.2010.08.006; Walters LC, 2010, HUM MOL GENET, V19, P4353, DOI 10.1093/hmg/ddq357; Winkler PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092127; Woodbury D, 1998, BRAIN RES, V803, P95, DOI 10.1016/S0006-8993(98)00627-1; Xu Bei, 2012, Zhonghua Yi Xue Za Zhi, V92, P254; Zhu L, 2004, NAT GENET, V36, P732, DOI 10.1038/ng1371	43	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122068	10.1371/journal.pone.0122068	http://dx.doi.org/10.1371/journal.pone.0122068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790447	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400209
J	Martellos, S; Nimis, PL				Martellos, Stefano; Nimis, Pier Luigi			From Local Checklists to Online Identification Portals: A Case Study on Vascular Plants	PLOS ONE			English	Article							INFORMATION-SYSTEM; KEYS	Checklists, the result of time-consuming exploration and painstaking bibliographic research, can be easily converted into online databases, which have the advantage of being updatable online in real time, and of reaching a much wider audience. However, thousands of local checklists (Natural Parks, protected areas, etc.) are still available on paper only, and most of those published online appear as dry lists of latin names, which strongly reduces their outreach for a wider audience. The University of Trieste has recently started the publication of several local checklists in a way that may be more appealing for the general public, by linking species' names to archives of digital resources, and especially to digital identification tools produced by software FRIDA (FRiendly IDentificAtion). The query interfaces were developed on the basis of feedback from a wide range of users. The result is no longer a simple list of names accessible on the Web, but a veritable multimedial, interactive portal to the biodiversity of a given area. This paper provides an example of how relevant added value can be given to local lists of taxa by embedding them in a complex system of biodiversity-related resources, making them usable for a much wider audience than a restricted circle of specialists, as testified by the almost 1.000.000 unique visitors reached in 2014. A critical mass of digital resources is also put at disposal of the scientific community by releasing them under a Creative Commons license.	[Martellos, Stefano; Nimis, Pier Luigi] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Trieste	Martellos, S (corresponding author), Univ Trieste, Dept Life Sci, Via L Giorgieri 10, Trieste, Italy.	martelst@units.it		Martellos, Stefano/0000-0001-5201-8948				Attorre F, 2013, PLANT BIOSYST, V147, P1101, DOI 10.1080/11263504.2013.860054; Castello M, 2006, POLAR BIOL, V29, P604, DOI 10.1007/s00300-005-0095-0; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; Conti F, 2007, NATURA VICENTINA, V10, p[2006, 5]; Dalla Fior G, 1981, GUIDA CONOSCENZA FLO; Euro+Med PlantBase-the information resource for Euro-Mediterranean plant diversity, 2006, EUR MED PLANTBASE I; Fischer Eberhard, 2010, Journal of East African Natural History, V99, P129; Germishuizen G., 2003, STRELITZIA; Hagedorn G, 2010, TOOLS IDENTIFYING BI, P59; Lauber K, 2012, FLORA HELVETICA, P5; Llimona X., 2001, BOCCONEA, V14, P5; Martellos S, 2012, PLANT BIOSYST, V146, P764, DOI 10.1080/11263504.2012.740088; Martellos S, 2011, PLANT BIOSYST, V145, P758, DOI 10.1080/11263504.2011.620342; Martellos S., 2008, P IASK INT C TEACH L, P863; Martellos S, 2013, PLANT BIOSYST, V147, P529, DOI 10.1080/11263504.2012.760497; Martellos S, 2010, TAXON, V59, P922, DOI 10.1002/tax.593020; Nimis PL, 2012, PLANT BIOSYST, V146, P783, DOI 10.1080/11263504.2012.740089; NIMIS P. L., 2003, MUSEO REGIONALE SCI, VIV; Nimis PL, 2009, ECO MONT, V1, P61, DOI 10.1553/ecomont2s61; Nimis PL, 2002, BIBLIOTHECA LICHENOL, V82, P271; Nimis PL, 2013, GUIDA FLORA ALPI CAR; Onofri S., 2005, CHECKLIST ITALIAN FU; Pignatti S., 1982, FLORA DITALIA, VVolume I; Smith VS, 2011, ZOOKEYS, P53, DOI 10.3897/zookeys.150.2193; Tutin T.G., 1964, FLORA EUROPAEA, V1-5	25	8	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120970	10.1371/journal.pone.0120970	http://dx.doi.org/10.1371/journal.pone.0120970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790121	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400185
J	Mehta, V; Sen, R; Moshiri, H; Salavati, R				Mehta, Vaibhav; Sen, Rajashree; Moshiri, Houtan; Salavati, Reza			Mutational Analysis of Trypanosoma brucei RNA Editing Ligase Reveals Regions Critical for Interaction with KREPA2	PLOS ONE			English	Article							COMPLEX; DNA; TRANSCRIPT; PROTEINS; DELETION; ENZYME	The Trypanosoma brucei parasite causes the vector-borne disease African sleeping sickness. Mitochondrial mRNAs of T. brucei undergo posttranscriptional RNA editing to make mature, functional mRNAs. The final step of this process is catalyzed by the essential ligase, T. brucei RNA Editing Ligase 1 (TbREL1) and the closely related T. brucei RNA Editing Ligase 2 (TbREL2). While other ligases such as T7 DNA ligase have both a catalytic and an oligonucleotide/oligosaccharide-binding (OB)-fold domain, T. brucei RNA editing ligases contain only the catalytic domain. The OB-fold domain, which is required for interaction with the substrate RNA, is provided in trans by KREPA2 (for TbREL1) and KREPA1 (for TbREL2). KREPA2 enhancement of TbREL1 ligase activity is presumed to occur via an OB-fold-mediated increase in substrate specificity and catalysis. We characterized the interaction between TbREL1 and KREPA2 in vitro using full-length, truncated, and point-mutated ligases. As previously shown, our data indicate strong, specific stimulation of TbREL1 catalytic activity by KREPA2. We narrowed the region of contact to the final 59 C-terminal residues of TbREL1. Specifically, the TbREL1 C-terminal KWKE (441-444) sequence appear to coordinate the KREPA2-mediated enhancement of TbREL1 activities. N-terminal residues F206, T264 and Y275 are crucial for the overall activity of TbREL1, particularly for F206, a mutation of this residue also disrupts KREPA2 interaction. Thus, we have identified the critical TbREL1 regions and amino acids that mediate the KREPA2 interaction.	[Mehta, Vaibhav; Sen, Rajashree; Moshiri, Houtan; Salavati, Reza] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Salavati, Reza] McGill Univ, Inst Parasitol, Montreal, PQ H9X 3V9, Canada; [Salavati, Reza] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; McGill University	Salavati, R (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Bldg, Montreal, PQ H3G 1Y6, Canada.	reza.salavati@mcgill.ca			Canadian Institutes of Health Research (CIHR) [259835]; CIHR Chemical Biology Fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Chemical Biology Fellowship	This work was supported in part by the Canadian Institutes of Health Research (CIHR) grant 259835 (to R. S.). VM is supported by CIHR Chemical Biology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2008, P NATL ACAD SCI USA, V105, P17278, DOI 10.1073/pnas.0805820105; Amaro RE, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000068; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Deng JP, 2004, J MOL BIOL, V343, P601, DOI 10.1016/j.jmb.2004.08.041; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Drozdz M, 2002, EMBO J, V21, P1791, DOI 10.1093/emboj/21.7.1791; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; Gao GH, 2005, P NATL ACAD SCI USA, V102, P4712, DOI 10.1073/pnas.0500553102; Hajduk S, 2010, RNA BIOL, V7, P229, DOI 10.4161/rna.7.2.11393; Ho CK, 2002, P NATL ACAD SCI USA, V99, P12709, DOI 10.1073/pnas.192184699; Huang CE, 2002, MOL CELL BIOL, V22, P3194, DOI 10.1128/MCB.22.9.3194-3203.2002; Huang CE, 2001, EMBO J, V20, P4694, DOI 10.1093/emboj/20.17.4694; Kang XD, 2004, J BIOL CHEM, V279, P3893, DOI 10.1074/jbc.M310185200; KLEISEN CM, 1976, EUR J BIOCHEM, V64, P153, DOI 10.1111/j.1432-1033.1976.tb10283.x; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Moshiri H, 2011, J BIOL CHEM, V286, P14178, DOI 10.1074/jbc.M110.199646; Moshiri H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq333; Nandakumar J, 2004, J BIOL CHEM, V279, P31337, DOI 10.1074/jbc.M402394200; Palazzo SS, 2003, MOL BIOCHEM PARASIT, V127, P161, DOI 10.1016/S0166-6851(02)00333-X; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; RIOU G, 1969, P NATL ACAD SCI USA, V62, P210, DOI 10.1073/pnas.62.1.210; Samai P, 2012, J BIOL CHEM, V287, P28609, DOI 10.1074/jbc.M112.380428; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Shaneh A, 2010, J MOL MODEL, V16, P61, DOI 10.1007/s00894-009-0506-1; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Yin SM, 2004, VIROLOGY, V319, P141, DOI 10.1016/j.virol.2003.10.037	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120844	10.1371/journal.pone.0120844	http://dx.doi.org/10.1371/journal.pone.0120844			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790471	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400179
J	Petrzik, K; Vondrak, J; Kviderova, J; Lukavsky, J				Petrzik, Karel; Vondrak, Jan; Kviderova, Jana; Lukavsky, Jaromir			Platinum Anniversary: Virus and Lichen Alga Together More than 70 Years	PLOS ONE			English	Article							CAULIFLOWER-MOSAIC-VIRUS; CHLOROPHYLL FLUORESCENCE; VIRAL-INFECTION; BLOOM; TRANSMISSION; ABUNDANCE; SEQUENCE	Trebouxia aggregata (Archibald) Gartner (phylum Chlorophyta, family Trebouxiaceae), a lichen symbiotic alga, has been identified as host of the well-known herbaceous plant virus Cauliflower mosaic virus (CaMV, family Caulimoviridae). The alga had been isolated from Xanthoria parietina more than 70 years ago and has been maintained in a collection since that time. The CaMV detected in this collection entry has now been completely sequenced. The virus from T. aggregata is mechanically transmissible to a herbaceous host and induces disease symptoms there. Its genome differs by 173 nt from the closest European CaMV-D/H isolate from cauliflower. No site under positive selection was found on the CaMV genome from T. aggregata. We therefore assume that the virus's presence in this alga was not sufficiently long to fix any specific changes in its genome. Apart from this symbiotic alga, CaMV capsid protein sequences were amplified from many other non-symbiotic algae species maintained in a collection (e.g., Oonephris obesa, Elliptochlorissp., Microthamnion kuetzingianum, Chlorella vulgaris, Pseudococcomyxasp.). CaMV-free Chlorella vulgaris was treated with CaMV to establish virus infection. The virus was still detected there after five passages. The virus infection is morphologically symptomless on Chlorellaalgae and the photosynthesis activity is slightly decreased in comparison to CaMV-free alga culture. This is the first proof as to the natural presence of CaMV in algae and the first demonstration of algae being artificially infected with this virus.	[Petrzik, Karel] Acad Sci Czech Republ, Dept Plant Virol, Inst Plant Mol Biol, Ctr Biol, Ceske Budejovice, Czech Republic; [Vondrak, Jan] Czech Univ Life Sci Prague, Fac Environm Sci, Prague 6, Suchdol, Czech Republic; [Kviderova, Jana; Lukavsky, Jaromir] Acad Sci Czech Republ, Inst Bot, Trebon, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Petrzik, K (corresponding author), Acad Sci Czech Republ, Dept Plant Virol, Inst Plant Mol Biol, Ctr Biol, Ceske Budejovice, Czech Republic.	petrzik@umbr.cas.cz	Petrzik, Karel/B-6957-2008	Petrzik, Karel/0000-0001-9668-1223; Kviderova, Jana/0000-0002-5700-477X; Vondrak, Jan/0000-0001-7568-6711	Czech Science Foundation [P501/12/1747]; Biology Centre [RVO60077344]; Institute of Botany [RVO67985939]; Technology Agency of the Czech Republic [TE01020080]; Ministry of Education, youth and sports [LM2010009]	Czech Science Foundation(Grant Agency of the Czech Republic); Biology Centre; Institute of Botany; Technology Agency of the Czech Republic; Ministry of Education, youth and sports(Ministry of Education, Youth & Sports - Czech Republic)	P501/12/1747 Czech Science Foundation, http://www.gacr.cz/en/ KP - funded the study design, consumables, preparation of the manuscript; RVO60077344 - governmental support for Biology Centre, KP - funded personal costs of KP; RVO67985939 - governmental support for Institute of Botany, JL - funded personal costs of JV, JL, JK; TE01020080 - Technology Agency of the Czech Republic, http://www.tacr.cz JL - funded sample collection and maintaining in collection; LM2010009 - Ministry of Education, youth and sports, http://www.msmt.cz - funded FluorCam instrument and data analysis.	Ahmadjian V, 1993, THE LICHEN SYMBIOSIS; ALLEN MM, 1976, ARCH MICROBIOL, V110, P55, DOI 10.1007/BF00416969; BABICH H, 1980, WATER RES, V14, P185, DOI 10.1016/0043-1354(80)90236-5; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Blanc Stephane, 2001, P143, DOI 10.1016/B978-012327681-0/50011-X; Brown Jr RM, 1964, PUBL U TEXAS, V6417, P1; CABI, 2014, CROP PROT COMP; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Dunigan DD, 2006, VIRUS RES, V117, P119, DOI 10.1016/j.virusres.2006.01.024; Farzadfar S, 2013, VIRUS GENES, V47, P347, DOI 10.1007/s11262-013-0948-5; FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1; Friedl T, 2008, LICHEN BIOLOGY, 2ND EDITION, P9, DOI 10.1017/CBO9780511790478.003; Froissart R, 2005, PLOS BIOL, V3, P389, DOI 10.1371/journal.pbio.0030089; Galloway DJ, 2008, LICHEN BIOLOGY, 2ND EDITION, P315, DOI 10.1017/CBO9780511790478.017; Guiry MD, 2014, ALGAEBASE; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; HULL R, 1976, J GEN VIROL, V31, P93, DOI 10.1099/0022-1317-31-1-93; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Juneau P, 2003, AQUAT MICROB ECOL, V31, P9, DOI 10.3354/ame031009; Khelifa M, 2010, VIROLOGY, V396, P238, DOI 10.1016/j.virol.2009.09.032; Lawrence J., 2005, ALGAL CULTURING TECH, P365; MACKENZIE JJ, 1972, VIROLOGY, V49, P517, DOI 10.1016/0042-6822(72)90503-X; Marco S., 1985, Phytopathologia Mediterranea, V24, P211; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martinez F, 2009, J GEN VIROL, V90, P3057, DOI 10.1099/vir.0.013425-0; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MAYER JA, 1979, NATURE, V281, P299, DOI 10.1038/281299a0; Meier FA, 2002, BIOL J LINN SOC, V76, P259, DOI 10.1111/j.1095-8312.2002.tb02087.x; MEINTS RH, 1981, VIROLOGY, V113, P698, DOI 10.1016/0042-6822(81)90198-7; NAMBA R, 1981, J ECON ENTOMOL, V74, P546, DOI 10.1093/jee/74.5.546; Nedbal L, 2000, PHOTOSYNTH RES, V66, P3, DOI 10.1023/A:1010729821876; Petrzik K, 1998, VIRUS GENES, V16, P303, DOI 10.1023/A:1008039024963; Petrzik K, 2014, EUR J PLANT PATHOL, V138, P549, DOI 10.1007/s10658-013-0246-z; Pietschmann SM, 1989, COLLOIDAL GOLD PRINC, P255; PIQUE M, 1995, GENE, V155, P305, DOI 10.1016/0378-1119(94)00927-K; Polischuk V, 2007, FEMS MICROBIOL ECOL, V59, P409, DOI 10.1111/j.1574-6941.2006.00242.x; Qiu SG, 1997, VIROLOGY, V227, P180, DOI 10.1006/viro.1996.8314; Quispel A., 1943, THESIS U GRONINGEN; Rohacek K, 1999, PHOTOSYNTHETICA, V37, P339, DOI 10.1023/A:1007172424619; Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x; Shepherd RJ, 1981, CMI AAB DESCRIPTIONS; Spak J, 1989, OCHRANA ROSTLIN, V25, P177; Syngouna VI, 2010, ENVIRON SCI TECHNOL, V44, P4539, DOI 10.1021/es100107a; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarutani K, 2000, APPL ENVIRON MICROB, V66, P4916, DOI 10.1128/AEM.66.11.4916-4920.2000; Van Etten JL, 2012, TRENDS PLANT SCI, V17, P1, DOI 10.1016/j.tplants.2011.10.005; VANETTEN JL, 1983, VIROLOGY, V126, P117, DOI 10.1016/0042-6822(83)90466-X; Weber MX, 2012, ADV BOT RES, V64, P119, DOI 10.1016/B978-0-12-391499-6.00004-9; Whon TW, 2012, J VIROL, V86, P8221, DOI 10.1128/JVI.00293-12; Wilhelm SW, 2008, FRESHWATER BIOL, V53, P1076, DOI 10.1111/j.1365-2427.2008.01980.x; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; Yamada T, 2006, ADV VIRUS RES, V66, P293, DOI 10.1016/S0065-3527(06)66006-5; Yasaka R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085641; Zaady E, 2000, SOIL BIOL BIOCHEM, V32, P959, DOI 10.1016/S0038-0717(00)00004-3; Zfang X, 2011, P NATL ACAD SCI USA, V108, P14837, DOI [10.1073/pnas.1107847108, DOI 10.1073/PNAS.1107847108]	55	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120768	10.1371/journal.pone.0120768	http://dx.doi.org/10.1371/journal.pone.0120768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789995	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400174
J	Sierakowiak, A; Monnot, C; Aski, SN; Uppman, M; Li, TQ; Damberg, P; Brene, S				Sierakowiak, Adam; Monnot, Cyril; Aski, Sahar Nikkhou; Uppman, Martin; Li, Tie-Qiang; Damberg, Peter; Brene, Stefan			Default Mode Network, Motor Network, Dorsal and Ventral Basal Ganglia Networks in the Rat Brain: Comparison to Human Networks Using Resting State-fMRI	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY NETWORKS; GLOBAL SIGNAL; ANIMAL-MODELS; BOLD; PATHOPHYSIOLOGY; FLUCTUATIONS; ARCHITECTURE; DISEASE; CORTEX; MOUSE	Rodent models are developed to enhance understanding of the underlying biology of different brain disorders. However, before interpreting findings from animal models in a translational aspect to understand human disease, a fundamental step is to first have knowledge of similarities and differences of the biological systems studied. In this study, we analyzed and verified four known networks termed: default mode network, motor network, dorsal basal ganglia network, and ventral basal ganglia network using resting state functional MRI (rsfMRI) in humans and rats. Our work supports the notion that humans and rats have common robust resting state brain networks and that rsfMRI can be used as a translational tool when validating animal models of brain disorders. In the future, rsfMRI may be used, in addition to short-term interventions, to characterize longitudinal effects on functional brain networks after long-term intervention in humans and rats.	[Sierakowiak, Adam; Brene, Stefan] Karolinska Inst, Care Sci & Soc NVS, Dept Neurobiol, Stockholm, Sweden; [Monnot, Cyril] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Aski, Sahar Nikkhou; Uppman, Martin; Li, Tie-Qiang; Damberg, Peter] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Sierakowiak, A (corresponding author), Karolinska Inst, Care Sci & Soc NVS, Dept Neurobiol, Stockholm, Sweden.	adam.sierakowiak@ki.se		Li, Tie-Qiang/0000-0002-4866-5904; Sierakowiak, Adam/0000-0003-2273-2133	Swedish Research Council [3474]; Karolinska Institutet-National Institutes of Health Graduate Partnerships Program; Karolinska Experimental Research Imaging Center	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet-National Institutes of Health Graduate Partnerships Program; Karolinska Experimental Research Imaging Center	Funding from Swedish Research Council grant no 3474, Karolinska Institutet-National Institutes of Health Graduate Partnerships Program, and the Karolinska Experimental Research Imaging Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, HUM BRAIN MAPP, V32, P919, DOI 10.1002/hbm.21079; Angenstein F, 2010, NEUROIMAGE, V50, P1364, DOI 10.1016/j.neuroimage.2010.01.070; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arnberg F, 2012, STROKE, V43, P2437, DOI 10.1161/STROKEAHA.112.655126; Becerra L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025701; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Benveniste H, 2002, PROG NEUROBIOL, V67, P393, DOI 10.1016/S0301-0082(02)00020-5; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Castellanos FX, 2013, NEUROIMAGE, V80, P527, DOI 10.1016/j.neuroimage.2013.04.083; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gopinath K, 2011, NEUROIMAGE, V54, P380, DOI 10.1016/j.neuroimage.2010.07.021; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kalthoff D, 2013, NMR BIOMED, V26, P638, DOI 10.1002/nbm.2908; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Magnuson ME, 2014, NMR BIOMED, V27, P291, DOI 10.1002/nbm.3062; Majeed W, 2011, NEUROIMAGE, V54, P1140, DOI 10.1016/j.neuroimage.2010.08.030; Mehler-Wex C, 2006, NEUROTOX RES, V10, P167, DOI 10.1007/BF03033354; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Razafsha M, 2013, NEUROSCIENCE, V240, P204, DOI 10.1016/j.neuroscience.2013.02.045; Rocco-Donovan M, 2011, SOMATOSENS MOT RES, V28, P63, DOI 10.3109/08990220.2011.606660; Rubinov M, 2013, TRENDS COGN SCI, V17, P641, DOI 10.1016/j.tics.2013.10.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz AJ, 2013, NEUROSCIENCE, V228, P243, DOI 10.1016/j.neuroscience.2012.10.032; Schwarz AJ, 2013, BRAIN CONNECT, V3, P503, DOI 10.1089/brain.2013.0168; Sforazzini F, 2014, NEUROIMAGE, V87, P403, DOI 10.1016/j.neuroimage.2013.09.050; SHARP T, 1986, PHARMACOL BIOCHEM BE, V24, P1755, DOI 10.1016/0091-3057(86)90516-2; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Upadhyay J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027839; van Buuren M, 2009, HUM BRAIN MAPP, V30, P3031, DOI 10.1002/hbm.20729; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van der Marel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057780; Vogt BA, 2014, BRAIN STRUCT FUNCT, V219, P185, DOI 10.1007/s00429-012-0493-3; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	56	40	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120345	10.1371/journal.pone.0120345	http://dx.doi.org/10.1371/journal.pone.0120345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789862	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400153
J	Xiao, YD; Zhang, XQ; Ji, P				Xiao, Yundan; Zhang, Xiongqing; Ji, Ping			Modeling Forest Fire Occurrences Using Count-Data Mixed Models in Qiannan Autonomous Prefecture of Guizhou Province in China	PLOS ONE			English	Article							ZERO-INFLATED POISSON; REGRESSION-MODELS; TREE RECRUITMENT; CLIMATE	Forest fires can cause catastrophic damage on natural resources. In the meantime, it can also bring serious economic and social impacts. Meteorological factors play a critical role in establishing conditions favorable for a forest fire. Effective prediction of forest fire occurrences could prevent or minimize losses. This paper uses count data models to analyze fire occurrence data which is likely to be dispersed and frequently contain an excess of zero counts (no fire occurrence). Such data have commonly been analyzed using count data models such as a Poisson model, negative binomial model (NB), zero-inflated models, and hurdle models. Data we used in this paper is collected from Qiannan autonomous prefecture of Guizhou province in China. Using the fire occurrence data from January to April (spring fire season) for the years 1996 through 2007, we introduced random effects to the count data models. In this study, the results indicated that the prediction achieved through NB model provided a more compelling and credible inferential basis for fitting actual forest fire occurrence, and mixed-effects model performed better than corresponding fixed-effects model in forest fire forecasting. Besides, among all meteorological factors, we found that relative humidity and wind speed is highly correlated with fire occurrence.	[Xiao, Yundan; Ji, Ping] Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing, Peoples R China; [Zhang, Xiongqing] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Ji, P (corresponding author), Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing, Peoples R China.	jiping@caf.ac.cn	Zhang, Xiongqing/AAW-6171-2020	Zhang, Xiongqing/0000-0001-5592-6730	National Natural Science Foundation of China and International S&T Cooperation program of China (ISTCP) [2014DFG32140-2]	National Natural Science Foundation of China and International S&T Cooperation program of China (ISTCP)	The research was sponsored by the National Natural Science Foundation of China and International S&T Cooperation program of China (ISTCP) (No. 2014DFG32140-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck DLR, 2006, CAN J FOREST RES, V36, P2994, DOI 10.1139/X06-189; Alvarez Gonzalez Juan Gabriel, 2004, Annals of Forest Science, V61, P439, DOI 10.1051/forest:2004037; Calama R, 2005, SILVA FENN, V39, P37, DOI 10.14214/sf.394; Chuvieco E, 2008, GLOBAL CHANGE BIOL, V14, P1488, DOI 10.1111/j.1365-2486.2008.01585.x; Conedera M, 2000, ADV GLOB CHANGE RES, V3, P247; Fortin M, 2007, FOREST SCI, V53, P529; Gurmu S, 1997, J APPL ECONOMET, V12, P225; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Holsten A, 2013, EGU GEN ASS; Karazsia BT, 2008, J PEDIATR PSYCHOL, V33, P1076, DOI 10.1093/jpepsy/jsn055; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Lexerod NL, 2005, FOREST ECOL MANAG, V206, P91, DOI 10.1016/j.foreco.2004.11.001; Li L, 2012, INNER MONOLIA FOR IN, V35, P124; Li RX, 2011, CAN J FOREST RES, V41, P2077, DOI [10.1139/x11-117, 10.1139/X11-117]; Little RC, 1996, SAS SYSTEM MIXED MOD; Liu W, 2008, CIICT 2008: PROCEEDINGS OF CHINA-IRELAND INTERNATIONAL CONFERENCE ON INFORMATION AND COMMUNICATIONS TECHNOLOGIES 2008, P1; Lu A. F, 2011, J ANHUI AGR SCI, V39, P15332; MacNeil MA, 2009, ICES J MAR SCI, V66, P708, DOI 10.1093/icesjms/fsp022; Mandallaz D, 1997, CAN J FOREST RES, V27, P1685, DOI 10.1139/cjfr-27-10-1685; Min YY, 2005, STAT MODEL, V5, P1, DOI 10.1191/1471082X05st084oa; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Munns EN, 1921, MONTHLY WEATHER REV, V49, P149, DOI [DOI 10.1175/1520-0493(1921)492.0.CO;2, 10.1175/1520-0493(1921)49<149:EAFF>2.0.CO;2, DOI 10.1175/1520-0493(1921)49<149:EAFF>2.0.CO;2]; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pyne S, 1996, INTRO WILDLAND FIRE; Shonkwiler JS, 1996, J AGR RESOUR ECON, V21, P210; Skvarenina J., 2003, INT BIOCL WORKSH SLO; Tian XR, 2014, INT J WILDLAND FIRE, V23, P185, DOI 10.1071/WF13014; Wallenius TH, 2004, CAN J FOREST RES, V34, P1400, DOI [10.1139/x04-023, 10.1139/X04-023]; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wotton BM, 2003, CLIMATIC CHANGE, V60, P275, DOI 10.1023/A:1026075919710; Wykoff WR, 1986, USERS GUIDE STAND S; Xiao YunDan, 2011, Scientia Silvae Sinicae, V47, P128; Xu S, 2011, J W CHINA FOR SCI, V42, P98; Zhang XiongQing, 2012, Scientia Silvae Sinicae, V48, P54; Zhang XQ, 2012, FOREST ECOL MANAG, V270, P209, DOI 10.1016/j.foreco.2012.01.028; Zhao Feng, 2007, THESIS CHINESE ACAD; Zhu B, 2007, METEOROL DISASTER RE, V30, P65; Zumbrunnen T, 2012, REG ENVIRON CHANGE, V12, P935, DOI 10.1007/s10113-012-0307-4; [No title captured]	40	11	13	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120621	10.1371/journal.pone.0120621	http://dx.doi.org/10.1371/journal.pone.0120621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790309	Green Published, gold			2022-12-26	WOS:000351425400167
J	Zhang, Y; Zhao, PW; Feng, G; Xie, G; Wang, AQ; Yang, YH; Wang, D; Du, XB				Zhang, Yu; Zhao, Ping-Wu; Feng, Gang; Xie, Gang; Wang, An-Qun; Yang, Yong-Hong; Wang, Dong; Du, Xiao-Bo			The Expression Level and Prognostic Value of Y-Box Binding Protein-1 in Rectal Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YB-1; PREDICTIVE MARKER; POOR SURVIVAL; RISK-FACTORS; RESISTANCE; CELLS; PROLIFERATION; SENSITIVITY; CISPLATIN; DISEASE	The aims of this study were to simultaneously evaluate the expression of Y-box binding protein-1 (YB-1) in non-neoplastic rectal tissue and rectal cancer tissue, and to collect clinical follow-up data for individual patients. Additionally, we aimed to investigate the developmental functions and prognostic value of YB-1 in rectal cancer. We performed immunohistochemical studies to examine YB-1 expression in tissue samples from 80 patients with rectal cancer, 30 patients with rectal tubular adenoma, and 30 patients with rectitis. The mean YB-1 histological scores for rectal cancer, rectal tubular adenoma, and rectitis tissue specimens were 205.5, 164.3, and 137.7, respectively. Shorter disease-free and overall survival times were found in patients with rectal cancer who had higher YB-1 expression than in those with lower expression (38.2 months vs. 52.4 months, P = 0.013; and 44.4 months vs. 57.3 months, P = 0.008, respectively). Our results indicate that YB-1 expression is higher in rectal cancer tissue than in rectal tubular adenoma and rectitis tissue and that it may be an independent prognostic factor for rectal cancer.	[Zhang, Yu; Feng, Gang; Du, Xiao-Bo] MianYang Cent Hosp, Dept Oncol, Mianyang, Peoples R China; [Zhang, Yu; Wang, Dong] LuZhou Med Coll, Dept Surg, Luzhou, Peoples R China; [Zhao, Ping-Wu; Wang, Dong] MianYang Cent Hosp, Dept Surg, Mianyang, Peoples R China; [Xie, Gang; Wang, An-Qun; Yang, Yong-Hong] MianYang Cent Hosp, Dept Pathol, Mianyang, Peoples R China	Southwest Medical University	Wang, D (corresponding author), LuZhou Med Coll, Dept Surg, Luzhou, Peoples R China.	1572612023@qq.com; duxiaobo2005@126.com						Astanehe A, 2009, ONCOGENE, V28, P2406, DOI 10.1038/onc.2009.81; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Basaki Y, 2010, EUR J CANCER, V46, P954, DOI 10.1016/j.ejca.2009.12.024; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Chen ZH, 2012, WORLD J GASTROENTERO, V18, P64, DOI 10.3748/wjg.v18.i1.64; den Dulk M, 2007, ANN SURG, V246, P83, DOI 10.1097/01.sla.0000259432.29056.9d; Dhillon J, 2010, ONCOGENE, V29, P6294, DOI 10.1038/onc.2010.365; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Fujiwara-Okada Y, 2013, BRIT J CANCER, V108, P836, DOI 10.1038/bjc.2012.579; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; Ito T, 2012, BREAST CANCER RES TR, V133, P145, DOI 10.1007/s10549-011-1731-8; Karlson D, 2002, J BIOL CHEM, V277, P35248, DOI 10.1074/jbc.M205774200; Kashihara M, 2009, J THORAC ONCOL, V4, P1066, DOI 10.1097/JTO.0b013e3181ae2828; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kolk A, 2011, BRIT J CANCER, V105, P1864, DOI 10.1038/bjc.2011.491; Lasham A, 2003, J BIOL CHEM, V278, P35516, DOI 10.1074/jbc.M303920200; Lasham A, 2000, GENE, V252, P1, DOI 10.1016/S0378-1119(00)00220-1; Li XJ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0781-7; Li Y, 2011, ANN SURG ONCOL, V18, P3370, DOI 10.1245/s10434-011-1725-0; Maciejczyk A, 2012, ANTICANCER RES, V32, P3177; MCCARTY KS, 1986, CANCER RES, V46, P4244; Mertens PR, 2002, J BIOL CHEM, V277, P24875, DOI 10.1074/jbc.M200445200; Ohga T, 1998, J BIOL CHEM, V273, P5997, DOI 10.1074/jbc.273.11.5997; Ohga T, 1996, CANCER RES, V56, P4224; Schittek B, 2007, INT J CANCER, V120, P2110, DOI 10.1002/ijc.22512; Shibahara K, 2004, CANCER SCI, V95, P348, DOI 10.1111/j.1349-7006.2004.tb03214.x; Stein U, 2005, ONCOGENE, V24, P3606, DOI 10.1038/sj.onc.1208386; Stein U, 2001, J BIOL CHEM, V276, P28562, DOI 10.1074/jbc.M100311200; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Szczuraszek K, 2011, ANTICANCER RES, V31, P2963; Tabung FK, 2014, CANC CAUSES IN PRESS; Tay WL, 2009, MODERN PATHOL, V22, P282, DOI 10.1038/modpathol.2008.181; Toulany M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2845; Valadao AF, 2002, MOL BIOCHEM PARASIT, V125, P47, DOI 10.1016/S0166-6851(02)00210-4; Wu Y, 2012, J SURG ONCOL, V105, P724, DOI 10.1002/jso.23030; Yan YC, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0816-0; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119385	10.1371/journal.pone.0119385	http://dx.doi.org/10.1371/journal.pone.0119385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790262	Green Submitted, gold, Green Published			2022-12-26	WOS:000351425400077
J	Cheng, B; Annamalai, T; Sandhaus, S; Bansod, P; Tse-Dinh, YC				Cheng, Bokun; Annamalai, Thirunavukkarasu; Sandhaus, Shayna; Bansod, Priyanka; Tse-Dinh, Yuk-Ching			Inhibition of Zn(II) Binding Type IA Topoisomerases by Organomercury Compounds and Hg(II)	PLOS ONE			English	Article							ESCHERICHIA-COLI DNA; CLEAVAGE; DOMAINS; TOP3-BETA; PROTEIN	Type IA topoisomerase activities are essential for resolving DNA topological barriers via an enzyme-mediated transient single strand DNA break. Accumulation of topoisomerase DNA cleavage product can lead to cell death or genomic rearrangement. Many antibacterial and anticancer drugs act as topoisomerase poison inhibitors that form stabilized ternary complexes with the topoisomerase covalent intermediate, so it is desirable to identify such inhibitors for type IA topoisomerases. Here we report that organomercury compounds were identified during a fluorescence based screening of the NIH diversity set of small molecules for topoisomerase inhibitors that can increase the DNA cleavage product of Yersinia pestis topoisomerase I. Inhibition of relaxation activity and accumulation of DNA cleavage product were confirmed for these organomercury compounds in gel based assays of Escherichia coli topoisomerase I. Hg(II), but not As(III), could also target the cysteines that form the multiple Zn(II) binding tetra-cysteine motifs found in the C-terminal domains of these bacterial topoisomerase I for relaxation activity inhibition. Mycobacterium tuberculosis topoisomerase I activity is not sensitive to Hg(II) or the organomercury compounds due to the absence of the Zn(II) binding cysteines. It is significant that the type IA topoisomerases with Zn(II) binding domains can still cleave DNA when interfered by Hg(II) or organomercury compounds. The Zn(II) binding domains found in human Top3 alpha and Top3 beta may be potential targets of toxic metals and organometallic complexes, with potential consequence on genomic stability and development.	[Cheng, Bokun] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Annamalai, Thirunavukkarasu; Sandhaus, Shayna; Bansod, Priyanka; Tse-Dinh, Yuk-Ching] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Tse-Dinh, Yuk-Ching] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA	New York Medical College; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Tse-Dinh, YC (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.	ytsedinh@fiu.edu			National Institute of Health [R21 NS067592, R01 AI069313, R01 GM054226]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067592] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This research was supported by National Institute of Health grants R21 NS067592 and R01 AI069313, R01 GM054226 to YT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aedo S, 2012, ANTIMICROB AGENTS CH, V56, P5458, DOI 10.1128/AAC.01182-12; Ahmed W, 2013, NUCLEIC ACIDS RES, V41, P7462, DOI 10.1093/nar/gkt506; Ahumada A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-13; Annamalai T, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-18; Bhaduri T, 1998, J BIOL CHEM, V273, P13925, DOI 10.1074/jbc.273.22.13925; Chen SH, 2012, J BIOL CHEM, V287, P19346, DOI 10.1074/jbc.M112.363044; Cheng B, 2005, J BIOL CHEM, V280, P38489, DOI 10.1074/jbc.M509722200; Cheng BK, 2003, J BIOL CHEM, V278, P30705, DOI 10.1074/jbc.M303403200; Cheng B, 2008, NUCLEIC ACIDS RES, V36, P1017, DOI 10.1093/nar/gkm1126; Cheng BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060770; Cheng BK, 2009, J MOL BIOL, V385, P558, DOI 10.1016/j.jmb.2008.10.073; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Grishin NV, 2000, J MOL BIOL, V299, P1165, DOI 10.1006/jmbi.2000.3841; Jaxel C, 1999, EUR J BIOCHEM, V260, P103, DOI 10.1046/j.1432-1327.1999.00128.x; KARLOVSKY P, 1986, BIOCHEM BIOPH RES CO, V138, P778, DOI 10.1016/S0006-291X(86)80564-2; Kitchin KT, 2008, J INORG BIOCHEM, V102, P532, DOI 10.1016/j.jinorgbio.2007.10.021; Lu JX, 2011, BIOMETALS, V24, P729, DOI 10.1007/s10534-011-9425-6; Narula G, 2012, NUCLEIC ACIDS RES, V40, P9233, DOI 10.1093/nar/gks688; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Sorokin EP, 2008, NUCLEIC ACIDS RES, V36, P4788, DOI 10.1093/nar/gkn460; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Tse-Dinh YC, 2009, NUCLEIC ACIDS RES, V37, P731, DOI 10.1093/nar/gkn936; TSEDINH YC, 1988, J BIOL CHEM, V263, P15857; TSEDINH YC, 1991, J BIOL CHEM, V266, P14317; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Xu DY, 2013, NAT NEUROSCI, V16, P1238, DOI 10.1038/nn.3479; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216; Zhou XX, 2011, J BIOL CHEM, V286, P22855, DOI 10.1074/jbc.M111.232926; Zhu CX, 2000, J BIOL CHEM, V275, P5318, DOI 10.1074/jbc.275.8.5318; Zhu CX, 1995, J MOL BIOL, V50, P609; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120022	10.1371/journal.pone.0120022	http://dx.doi.org/10.1371/journal.pone.0120022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798600	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300103
J	Cesqui, B; Mezzetti, M; Lacquaniti, F; d'Avella, A				Cesqui, Benedetta; Mezzetti, Maura; Lacquaniti, Francesco; d'Avella, Andrea			Gaze Behavior in One-Handed Catching and Its Relation with Interceptive Performance: What the Eyes Can't Tell	PLOS ONE			English	Article							VISUAL-SEARCH; TEMPORAL CONSTRAINTS; TARGET MOTION; REACTION-TIME; MOVEMENTS; BALL; PURSUIT; COORDINATION; INFORMATION; SMOOTH	In ball sports, it is usually acknowledged that expert athletes track the ball more accurately than novices. However, there is also evidence that keeping the eyes on the ball is not always necessary for interception. Here we aimed at gaining new insights on the extent to which ocular pursuit performance is related to catching performance. To this end, we analyzed eye and head movements of nine subjects catching a ball projected by an actuated launching apparatus. Four different ball flight durations and two different ball arrival heights were tested and the quality of ocular pursuit was characterized by means of several timing and accuracy parameters. Catching performance differed across subjects and depended on ball flight characteristics. All subjects showed a similar sequence of eye movement events and a similar modulation of the timing of these events in relation to the characteristics of the ball trajectory. On a trial-by-trial basis there was a significant relationship only between pursuit duration and catching performance, confirming that keeping the eyes on the ball longer increases catching success probability. Ocular pursuit parameters values and their dependence on flight conditions as well as the eye and head contributions to gaze shift differed across subjects. However, the observed average individual ocular behavior and the eye-head coordination patterns were not directly related to the individual catching performance. These results suggest that several oculomotor strategies may be used to gather information on ball motion, and that factors unrelated to eye movements may underlie the observed differences in interceptive performance.	[Cesqui, Benedetta; Lacquaniti, Francesco; d'Avella, Andrea] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Cesqui, Benedetta; Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [Mezzetti, Maura] Univ Roma Tor Vergata, Dept Econ & Finance, Rome, Italy; [Lacquaniti, Francesco] Univ Rome, Neurosci Sect, Dept Syst Med, Rome, Italy; [d'Avella, Andrea] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata; Sapienza University Rome; University of Messina	Cesqui, B (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	b.cesqui@hsantalucia.it	d'Avella, Andrea/K-6856-2018; Lacquaniti, Francesco/J-9842-2016	d'Avella, Andrea/0000-0002-3393-4956; Lacquaniti, Francesco/0000-0003-0896-7315; MEZZETTI, MAURA/0000-0002-8214-7000	European Union [248311]; Italian University Ministry (PRIN project) [2010MEFNF7 002]; Italian Space Agency (CRUSOE grant); Italian Space Agency (COREA grant)	European Union(European Commission); Italian University Ministry (PRIN project); Italian Space Agency (CRUSOE grant)(Agenzia Spaziale Italiana (ASI)); Italian Space Agency (COREA grant)(Agenzia Spaziale Italiana (ASI))	Research was supported by grants from the European Union FP7-ICT program (Adaptive Modular Architectures for Rich Motor skills, AMARSI, Grant 248311), the Italian University Ministry (PRIN project grant 2010MEFNF7 002), and Italian Space Agency (CRUSOE and COREA grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1987, HUM MOVEMENT SCI, V6, P283, DOI 10.1016/0167-9457(87)90001-7; ABERNETHY B, 1990, PERCEPTION, V19, P63, DOI 10.1068/p190063; Abernethy B, 1990, J SPORT SCI, V8, P17, DOI 10.1080/02640419008732128; ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Amazeen EL, 2001, ECOL PSYCHOL, V13, P71, DOI 10.1207/S15326969ECO1302_1; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BAHILL AT, 1983, IEEE T BIO-MED ENG, V30, P781, DOI 10.1109/TBME.1983.325078; BAHILL AT, 1984, AM SCI, V72, P249; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Barr DJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00328; Bates DM, 2010, LMER4 MIXED EFFECTS; Bennett SJ, 2003, J NEUROPHYSIOL, V90, P2504, DOI 10.1152/jn.01145.2002; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bosco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049381; Brenner E, 2011, HUM MOVEMENT SCI, V30, P475, DOI 10.1016/j.humov.2010.12.007; Brouwer AM, 2003, EXP BRAIN RES, V152, P368, DOI 10.1007/s00221-003-1556-8; Cesqui B, 2013, J VIS, V13, DOI [10.1167/13.14.13, DOI 10.1167/13.14.13]; Cesqui B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031770; Croft JL, 2010, HUM MOVEMENT SCI, V29, P751, DOI 10.1016/j.humov.2009.10.004; D'Andola M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00107; d'Avella A, 2011, J NEUROSCI METH, V196, P264, DOI 10.1016/j.jneumeth.2011.01.013; Daye PM, 2014, J VIS, V14, DOI [10.1167/14.14.14, DOI 10.1167/14.14.14]; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; de Brouwer S, 2001, J NEUROPHYSIOL, V86, P550, DOI 10.1152/jn.2001.86.2.550; de Xivry JJO, 2007, J PHYSIOL-LONDON, V584, P11, DOI 10.1113/jphysiol.2007.139881; Delle Monache S, 2015, EXP BRAIN RES, V233, P359, DOI 10.1007/s00221-014-4120-9; deSperati C, 1997, J NEUROSCI, V17, P3932; Dessing JC, 2012, EXP BRAIN RES, V216, P635, DOI 10.1007/s00221-011-2967-6; Dessing JC, 2009, EXP BRAIN RES, V192, P669, DOI 10.1007/s00221-008-1588-1; Diaz G, 2013, J VIS, P13; Diaz G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0064; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Hayhoe MM, 2012, EXP BRAIN RES, V217, P125, DOI 10.1007/s00221-011-2979-2; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; Huys R, 2002, J SPORT SCI, V20, P171, DOI 10.1080/026404102317284745; Katsumata H, 2012, EXP BRAIN RES, V216, P499, DOI 10.1007/s00221-011-2954-y; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 2000, PHILOS T ROY SOC B, V355, P1147, DOI 10.1098/rstb.2000.0656; LAURENT M, 1994, EXP BRAIN RES, V101, P314, DOI 10.1007/BF00228752; Locker L, 2007, BEHAV RES METHODS, V39, P723, DOI 10.3758/BF03192962; Lopez-Moliner J, 2010, EXP BRAIN RES, V206, P409, DOI 10.1007/s00221-010-2421-1; Mann DL, 2007, HUM MOVEMENT SCI, V26, P343, DOI 10.1016/j.humov.2006.12.003; Mann DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058289; Marinovic W, 2009, EXP PSYCHOL, V56, P265, DOI 10.1027/1618-3169.56.4.265; Mazyn LIN, 2007, ACTA PSYCHOL, V126, P59, DOI 10.1016/j.actpsy.2006.10.001; Mazyn LIN, 2006, MOTOR CONTROL, V10, P143, DOI 10.1123/mcj.10.2.143; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; Moscatelli A, 2012, J VIS, P12; Mrotek LA, 2007, J NEUROSCI, V27, P7297, DOI 10.1523/JNEUROSCI.2046-07.2007; Mrotek LA, 2006, EXP BRAIN RES, V172, P175, DOI 10.1007/s00221-005-0326-1; Mrotek LA, 2013, EXP BRAIN RES, V227, P161, DOI 10.1007/s00221-013-3496-2; Oudejans RRD, 1999, J EXP PSYCHOL HUMAN, V25, P531, DOI 10.1037/0096-1523.25.2.531; Panchuk D, 2013, ACTA PSYCHOL, V142, P394, DOI 10.1016/j.actpsy.2013.01.014; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; Regan D, 2012, OPHTHAL PHYSL OPT, V32, P257, DOI 10.1111/j.1475-1313.2012.00909.x; RIPOLL H, 1988, ERGONOMICS, V31, P1647, DOI 10.1080/00140138808966814; Rodrigues ST, 2002, J SPORT SCI, V20, P187, DOI 10.1080/026404102317284754; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; SCHALEN L, 1980, ACTA OTO-LARYNGOL, V90, P404, DOI 10.3109/00016488009131742; Schenk T, 2004, EXP BRAIN RES, V154, P85, DOI 10.1007/s00221-003-1642-y; Shapiro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013296; Sharp R., 1975, J HUMAN MOVEMENT STU, V1, P124; Singer RN, 1998, RES Q EXERCISE SPORT, V69, P290, DOI 10.1080/02701367.1998.10607696; Spering M, 2011, J NEUROPHYSIOL, V105, P1756, DOI 10.1152/jn.00344.2010; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; Tijtgat P, 2010, EXP BRAIN RES, V201, P875, DOI 10.1007/s00221-009-2102-0; Tresilian JR, 2005, PERCEPT PSYCHOPHYS, V67, P129, DOI 10.3758/BF03195017; TYNAN PD, 1982, VISION RES, V22, P61, DOI 10.1016/0042-6989(82)90167-5; Vickers JN., 1997, INT J SPORTS VIS, V4, P18; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wilmut K, 2006, EXP BRAIN RES, V175, P654, DOI 10.1007/s00221-006-0580-x; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3	76	33	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119445	10.1371/journal.pone.0119445	http://dx.doi.org/10.1371/journal.pone.0119445			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793989	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200083
J	Danaviah, S; de Oliveira, T; Bland, R; Viljoen, J; Pillay, S; Tuaillon, E; Van de Perre, P; Newell, ML				Danaviah, Sivapragashini; de Oliveira, Tulio; Bland, Ruth; Viljoen, Johannes; Pillay, Sureshnee; Tuaillon, Edouard; Van de Perre, Philippe; Newell, Marie-Louise			Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission	PLOS ONE			English	Article							BREAST-MILK; CELL-FREE; SEQUENCES; PERFORMANCE; INFECTION; AFRICA; WOMEN; RNA; DNA	Exposure of the infant's gut to cell-associated and cell-free HIV-1 trafficking in breast milk (BM) remains a primary cause of mother-to-child transmission (MTCT). The mammary gland represents a unique environment for HIV-1 replication and host-virus interplay. We aimed to explore the origin of the virus transmitted during breastfeeding, and the link with quasi-species found in acellular and cellular fractions of breast-milk (BM) and in maternal plasma. The C2-V5 region of the env gene was amplified, cloned and sequenced from the RNA and DNA of BM, the RNA from the mother's plasma (PLA) and the DNA from infant's dried blood spot (DBS) in 11 post-natal mother-infant pairs. Sequences were assembled in Geneious, aligned in ClustalX, manually edited in SeAL and phylogenetic reconstruction was undertaken in PhyML and MrBayes. We estimated the timing of transmission (ETT) and reconstructed the time for the most recent common ancestor (TMRCA) of the infant in BEAST. Transmission of single quasi-species was observed in 9 of 11 cases. Phylogenetic analysis illustrated a BM transmission event by cell-free virus in 4 cases, and by cell-associated virus in 2 cases but could not be identified in the remaining 5 cases. Molecular clock estimates, of the infant ETT and TMRCA, corresponded well with the timing of transmission estimated by sequential infant DNA PCR in 10 of 11 children. The TMRCA of BM variants were estimated to emerge during gestation in 8 cases. We hypothesize that in the remaining cases, the breast was seeded with a long-lived lineage latently infecting resting T-cells. Our analysis illustrated the role of DNA and RNA virus in MTCT. We postulate that DNA archived viruses stem from latently infected quiescent T-cells within breast tissue and MTCT can be expected to continue, albeit at low levels, should interventions not effectively target these cells.	[Danaviah, Sivapragashini; de Oliveira, Tulio; Bland, Ruth; Viljoen, Johannes; Pillay, Sureshnee; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Viljoen, Johannes; Tuaillon, Edouard; Van de Perre, Philippe] Univ Montpellier I, F-34090 Montpellier, France; [Bland, Ruth] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; [Tuaillon, Edouard; Van de Perre, Philippe] CHU Montpellier, Dept Bacteriol Virol, Inst Rech Biotherapie, F-34295 Montpellier, France; [Tuaillon, Edouard; Van de Perre, Philippe] CHU Montpellier, Dept Med Informat, F-34295 Montpellier, France; [Newell, Marie-Louise] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	University of Kwazulu Natal; Universite de Montpellier; University of Glasgow; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Southampton	Danaviah, S (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.	sdanaviah@africacentre.ac.za	Van de Perre, Philippe/B-9692-2008; Newell, Marie-Louise/AAE-8222-2019	Van de Perre, Philippe/0000-0002-3912-0427; Newell, Marie-Louise/0000-0002-1074-7699; Bland, Ruth/0000-0003-1675-9268; Tuaillon, Edouard/0000-0001-5866-9530	Wellcome Trust; Africa Centre; Africa Centre Laboratory; French Agence Nationale de Recherches sur le Sida et les hepatitis virales (ANRS) [1271]	Wellcome Trust(Wellcome TrustEuropean Commission); Africa Centre; Africa Centre Laboratory; French Agence Nationale de Recherches sur le Sida et les hepatitis virales (ANRS)(ANRS)	The Wellcome Trust funds the Africa Centre and Africa Centre Laboratory and provided funding for the VTS Study. Additional funding for this investigation was provided by the French Agence Nationale de Recherches sur le Sida et les hepatitis virales (ANRS Grant#1271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Becquart P, 2007, VIROLOGY, V363, P256, DOI 10.1016/j.virol.2007.02.003; Bland RM, 2007, CLIN INFECT DIS, V45, P1502, DOI 10.1086/523320; Bland RM, 2010, INT J EPIDEMIOL, V39, P351, DOI 10.1093/ije/dyp165; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Chaillon A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090421; Chevenet F, 2013, BIOINFORMATICS, V29, P561, DOI 10.1093/bioinformatics/btt010; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Drummond A., 2011, GENEIOUS V5 5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duri K, 2012, AIDS RES HUM RETROV, V28, P885, DOI [10.1089/AID.2011.0217, 10.1089/aid.2011.0217]; Engstrom JL, 2007, BREASTFEED MED, V2, P83, DOI 10.1089/bfm.2006.0019; Gantt S, 2010, J VIROL, V84, P10812, DOI 10.1128/JVI.00543-10; Gordon M, 2003, J VIROL, V77, P2587, DOI 10.1128/JVI.77.4.2587-2599.2003; Gray RR, 2011, AIDS, V25, P143, DOI 10.1097/QAD.0b013e328340fdaf; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Koulinska IN, 2006, JAIDS-J ACQ IMM DEF, V41, P93, DOI 10.1097/01.qai.0000179424.19413.24; Manasa J, 2014, JOVE-J VIS EXP, DOI 10.3791/51242; Masharsky AE, 2010, J INFECT DIS, V201, P1697, DOI 10.1086/652702; National Department of Health, 2004, NAT ANT TREATM GUID; Ndirangu J, 2012, PLOS ONE IN PRESS; Ndirangu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051493; Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203; Pillay S, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-3; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rademeyer C, 2004, AIDS, V18, P2096, DOI 10.1097/00002030-200410210-00019; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Salazar-Gonzalez JF, 2011, J VIROL, V85, P2751, DOI 10.1128/JVI.02316-10; Shapiro RL, 2005, J INFECT DIS, V192, P713, DOI 10.1086/432489; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Valea D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-34; Van de Perre P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003327	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120389	10.1371/journal.pone.0120389	http://dx.doi.org/10.1371/journal.pone.0120389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793402	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900022
J	El Hachmane, MF; Komai, AM; Olofsson, CS				El Hachmane, Mickael F.; Komai, Ali M.; Olofsson, Charlotta S.			Cooling Reduces cAMP-Stimulated Exocytosis and Adiponectin Secretion at a Ca2+-Dependent Step in 3T3-L1 Adipocytes	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN; CELLS; CA2+; EXPRESSION; FUSION; ACRP30	We investigated the effects of temperature on white adipocyte exocytosis (measured as increase in membrane capacitance) and short-term adiponectin secretion with the aim to elucidate mechanisms important in regulation of white adipocyte stimulus-secretion coupling. Exocytosis stimulated by cAMP (included in the pipette solution together with 3 mM ATP) in the absence of Ca2+ (10 mM intracellular EGTA) was equal at all investigated temperatures (23 degrees C, 27 degrees C, 32 degrees C and 37 degrees C). However, the augmentation of exocytosis induced by an elevation of the free cytosolic [Ca2+] to similar to 1.5 mu M (9mMCa(2+) + 10 mM EGTA) was potent at 32 degrees C or 37 degrees C but less distinct at 27 degrees C and abolished at 23 degrees C. Adiponectin secretion stimulated by 30 min incubations with the membrane permeable cAMP analogue 8-Br-cAMP (1 mM) or a combination of 10 mu M forskolin and 200 mu M IBMX was unaffected by a reduction of temperature from 32 degrees C to 23 degrees C. At 32 degrees C, cAMP-stimulated secretion was 2-fold amplified by inclusion of the Ca2+ ionophore ionomycin (1 mu M), an effect that was not observed at 23 degrees C. We suggest that cooling affects adipocyte exocytosis/adiponectin secretion at a Ca2+-dependent step, likely involving ATP-dependent processes, important for augmentation of cAMP-stimulated adiponectin release.	[El Hachmane, Mickael F.; Komai, Ali M.; Olofsson, Charlotta S.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Metab Physiol, Gothenburg, Sweden	University of Gothenburg	Olofsson, CS (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Metab Physiol, Gothenburg, Sweden.	charlotta.olofsson@physiol.gu.se		Olofsson, Charlotta/0000-0001-8824-3151	Jeanssons Stiftelse; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse; Diabetesfonden [DIA-2011-073, DIA2012-050, DIA2013-070]; Novonordiskfonden; Knut och Alice Wallenbergs Stiftelse [KAW2012.0263]; IngaBritt och Arne Lundbergs Stiftelse [401]; Swedish Medical Research Council [521-2012-2994, 522-2010-2656]	Jeanssons Stiftelse; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse; Diabetesfonden; Novonordiskfonden(Novo Nordisk Foundation); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); IngaBritt och Arne Lundbergs Stiftelse; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	Funding provided by Jeanssons Stiftelse, http://www.jeanssonsstiftelser.se/, Ake Wibergs Stiftelse, http://ake-wiberg.se/, Magnus Bergvalls Stiftelse, http://www.magnbergvallsstiftelse.nu/, Diabetesfonden (DIA-2011-073, DIA2012-050 and DIA2013-070), http://diabetesfonden.se/, Novonordiskfonden, http://www.novonordiskfonden.dk/en, Knut och Alice Wallenbergs Stiftelse (Dnr KAW2012.0263), https://www.wallenberg.com/kaw/, IngaBritt och Arne Lundbergs Stiftelse (Grant ID: 401), http://www.lundbergsstiftelsen.se/ and Swedish Medical Research Council (Grant IDs: 521-2012-2994 and 522-2010-2656), http://vr.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenstrom P, 2004, BBA-MOL CELL RES, V1742, P51, DOI 10.1016/j.bbamcr.2004.09.029; Astrom-Olsson K, 2012, BIOCHEM BIOPH RES CO, V422, P732, DOI 10.1016/j.bbrc.2012.05.071; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; Blumer RME, 2008, METABOLISM, V57, P1655, DOI 10.1016/j.metabol.2008.07.020; Bogan JS, 1999, J CELL BIOL, V146, P609, DOI 10.1083/jcb.146.3.609; Bose A, 2005, J BIOL CHEM, V280, P36946, DOI 10.1074/jbc.M508317200; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Elmendorf JS, 1999, J BIOL CHEM, V274, P37357, DOI 10.1074/jbc.274.52.37357; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Komai AM, 2014, J PHYSIOL-LONDON, V592, P5169, DOI 10.1113/jphysiol.2014.280388; Lihn AS, 2004, MOL CELL ENDOCRINOL, V219, P9, DOI 10.1016/j.mce.2004.03.002; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Meyer LK, 2013, ADIPOCYTE, V2, P217, DOI 10.4161/adip.24953; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; OKANO K, 1993, NEURON, V11, P165, DOI 10.1016/0896-6273(93)90280-5; Proks P, 1996, J PHYSIOL-LONDON, V496, P255, DOI 10.1113/jphysiol.1996.sp021682; Renstrom E, 1996, J PHYSIOL-LONDON, V494, P41, DOI 10.1113/jphysiol.1996.sp021474; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Tse A, 2000, J PHYSIOL-LONDON, V528, P79, DOI 10.1111/j.1469-7793.2000.00079.x; Zhang Z, 2008, J GEN PHYSIOL, V131, P117, DOI 10.1085/jgp.200709891	24	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119530	10.1371/journal.pone.0119530	http://dx.doi.org/10.1371/journal.pone.0119530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793888	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200092
J	Garg, KM; Chattopadhyay, B; Doss, DPS; Kumar, AKV; Kandula, S; Ramakrishnan, U				Garg, Kritika M.; Chattopadhyay, Balaji; Doss, D. P. Swami; Kumar, A. K. Vinoth; Kandula, Sripathi; Ramakrishnan, Uma			Males and Females Gain Differentially from Sociality in a Promiscuous Fruit Bat Cynopterus sphinx	PLOS ONE			English	Article							KIN SELECTION; CONSEQUENCES; POPULATIONS; COOPERATION; EVOLUTION; PATERNITY; PROGRAM; ECOLOGY; RELATEDNESS; CHIMPANZEES	Sociality emerges when the benefits of group living outweigh its costs. While both males and females are capable of strong social ties, the evolutionary drivers for sociality and the benefits accrued maybe different for each sex. In this study, we investigate the differential reproductive success benefits of group membership that males and females might obtain in the promiscuous fruit bat Cynopterus sphinx. Individuals of this species live in flexible social groups called colonies. These colonies are labile and there is high turnover of individuals. However, colony males sire more offspring within the colony suggesting that being part of a colony may result in reproductive benefits for males. This also raises the possibility that long-term loyalty towards the colony may confer additional advantage in terms of higher reproductive success. We used ten seasons of genetic parentage data to estimate reproductive success and relatedness of individuals in the colony. We used recapture data to identify long and short-term residents in the colony as well as to obtain rates of recapture for males and females. Our results reveal that males have a significantly higher chance of becoming long-term residents (than females), and these long-term resident males gain twice the reproductive success compared to short-term resident males. We also observed that long-term resident females are related to each other and also achieve higher reproductive success than short-term resident females. In contrast, long-term resident males do not differ from short-term resident males in their levels of relatedness. Our results re-iterate the benefits of sociality even in species that are promiscuous and socially labile and possible benefits of maintaining a colony.	[Garg, Kritika M.; Chattopadhyay, Balaji; Ramakrishnan, Uma] TIFR, Natl Ctr Biol Sci, Ecol & Evolut, Bangalore 560065, Karnataka, India; [Chattopadhyay, Balaji; Doss, D. P. Swami; Kumar, A. K. Vinoth; Kandula, Sripathi] Madurai Kamaraj Univ, Sch Biol Sci, Madurai 625021, Tamil Nadu, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Madurai Kamaraj University	Garg, KM (corresponding author), TIFR, Natl Ctr Biol Sci, Ecol & Evolut, Bellary Rd, Bangalore 560065, Karnataka, India.	kritika.m.garg@gmail.com		Devaraj, Paramanantha Swami Doss/0000-0001-8602-6612; Chattopadhyay, Balaji/0000-0002-4423-3127; Garg, Kritika M./0000-0003-3510-3408; Ramakrishnan, Uma/0000-0002-5370-5966	Department of Science and Technology; National Centre for Biological Science-Tata Institute of Fundamental Research; Department of Science and Technology Young Scientist grant; Ramanujan fellowship (Department of Science and Technology, Government of India)	Department of Science and Technology(Department of Science & Technology (India)); National Centre for Biological Science-Tata Institute of Fundamental Research; Department of Science and Technology Young Scientist grant; Ramanujan fellowship (Department of Science and Technology, Government of India)	This work was supported by Department of Science and Technology grant to UR, National Centre for Biological Science-Tata Institute of Fundamental Research funding to KMG and UR, and Department of Science and Technology Young Scientist grant to DPS. UR was supported by the Ramanujan fellowship (Department of Science and Technology, Government of India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard C.J., 2004, ANIMAL BEHAV MECH DE; Black JM, 2001, BEHAV ECOL, V12, P640, DOI 10.1093/beheco/12.5.640; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Campbell P, 2008, J MAMMAL, V89, P1351, DOI 10.1644/08-MAMM-S-059.1; Chattopadhyay B, 2011, MAMM BIOL, V76, P290, DOI 10.1016/j.mambio.2010.08.003; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Garg KM, 2012, MOL ECOL, V21, P4093, DOI 10.1111/j.1365-294X.2012.05665.x; Hatchwell BJ, 2010, ETHOLOGY, V116, P203, DOI 10.1111/j.1439-0310.2009.01732.x; Hua PY, 2011, MOL ECOL, V20, P3669, DOI 10.1111/j.1365-294X.2011.05192.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; Kerth G, 2012, MOL ECOL, V21, P633, DOI 10.1111/j.1365-294X.2011.05233.x; Kerth G, 2008, BIOSCIENCE, V58, P737, DOI 10.1641/B580810; Krause J, 2002, LIVING GROUPS; Krause J, 2009, BEHAV ECOL SOCIOBIOL, V63, P967, DOI 10.1007/s00265-009-0747-0; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Ortega J, 2003, MOL ECOL, V12, P2409, DOI 10.1046/j.1365-294X.2003.01924.x; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; SANDHU S, 1984, Journal of the Bombay Natural History Society, V81, P600; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Storz Jay F., 1999, Mammalian Species, V613, P1; Storz JF, 2001, EVOLUTION, V55, P1215; Storz JF, 2000, J ZOOL, V251, P151; Voigt CC, 2003, ANIM BEHAV, V65, P149, DOI 10.1006/anbe.2002.2031; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wiszniewski J, 2010, ANIM BEHAV, V80, P895, DOI 10.1016/j.anbehav.2010.08.013	39	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122180	10.1371/journal.pone.0122180	http://dx.doi.org/10.1371/journal.pone.0122180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794185	Green Submitted, gold, Green Published			2022-12-26	WOS:000352083900173
J	McCleery, RA; Holdorf, AR; Hubbard, LL; Peer, BD				McCleery, Robert A.; Holdorf, Allison R.; Hubbard, Laura L.; Peer, Brian D.			Maximizing the Wildlife Conservation Value of Road Right-of-Ways in an Agriculturally Dominated Landscape	PLOS ONE			English	Article							LAND-USE CHANGE; SMALL MAMMALS; SPECIES RICHNESS; COMMUNITY STRUCTURE; BIRD COMMUNITIES; GRASSLAND BIRDS; HABITAT; MANAGEMENT; POPULATIONS; VERGES	There has been a growing recognition that the narrow linear strips of uncultivated vegetation that lie between roads and agricultural crops, referred to as roadside right-of-ways or verges, can serve as areas for the conservation of wildlife. The features of right-of-ways that should influence the composition of wildlife communities vary considerably. Our goal was to determine what features of right-of-ways increased the conservation potential of right-of-ways for wildlife in a grassland system dominated by agricultural production. We sampled 100 right-of-ways for birds and 92 right-of-ways for small mammals in McDonough and Warren Counties in west-central Illinois. We found that the sizes of right-of-ways and the amount of traffic on the adjacent roads synergistically worked to influence wildlife communities. On roads with low traffic, avian species richness increased rapidly with increased right-of-way width, while on roads with high traffic, avian richness increased only slightly with increasing right-of-way widths. We found that wider roadside right-of-ways (preferably across the road from equally wide right-of-ways) with thicker and taller vegetation had the greatest conservation value for birds and small mammals. The features that enhanced the conservation value of right-of-ways in our study area were uncommon. Efforts to create or enhance these features for the benefit of wildlife would likely face numerous obstacles. Nonetheless, from a grassland conservation perspective, working with stakeholders to implement specific strategies to enhance these often neglected areas may be an effective complement to purchasing and restoring conservation lands away from roads.	[McCleery, Robert A.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Holdorf, Allison R.; Hubbard, Laura L.; Peer, Brian D.] Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA	State University System of Florida; University of Florida; Western Illinois University	McCleery, RA (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	ramccleery@ufl.edu		McCleery, Robert/0000-0001-7018-005X; Holdorf, Allison/0000-0001-9629-6106	Illinois Institute for Rural Affairs at Western Illinois University	Illinois Institute for Rural Affairs at Western Illinois University	This project was funding through non-grant funding from the Illinois Institute for Rural Affairs at Western Illinois University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LW, 1983, J APPL ECOL, V20, P403, DOI 10.2307/2403516; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Andrews Kimberly M., 2008, P121; ARNOLD GW, 1990, BIOL CONSERV, V53, P295, DOI 10.1016/0006-3207(90)90098-A; Avenant N, 2011, WILDLIFE RES, V38, P626, DOI 10.1071/WR10223; Avenant NL, 2007, INTEGR ZOOL, V2, P212, DOI 10.1111/j.1749-4877.2007.00064.x; Bellamy PE, 2000, MAMMAL REV, V30, P131, DOI 10.1046/j.1365-2907.2000.00061.x; BENNETT AF, 1990, LANDSCAPE ECOL, V4, P109, DOI 10.1007/BF00132855; Berger RL., 2005, NCHRP SYNTHESIS HIGH; Bergin TM, 1997, WILSON BULL, V109, P437; Bissonette JA, 2009, ECOL SOC, V14; BOLLINGER EK, 1990, WILDLIFE SOC B, V18, P142; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Buckingham DL, 2006, AGR ECOSYST ENVIRON, V112, P21, DOI 10.1016/j.agee.2005.06.019; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Butcher GS, 2007, COMBINING DATA CHRIS; Campbell HW, 1082, HERPETOLOGICAL COMMU, V13, P193; Canterbury GE, 2000, CONSERV BIOL, V14, P544, DOI 10.1046/j.1523-1739.2000.98235.x; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; de Molenaar Johannes G., 2006, P114; DeVault TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087944; Fleishman E, 2002, OECOLOGIA, V133, P78, DOI 10.1007/s00442-002-1003-8; Fleishman E, 2005, CONSERV BIOL, V19, P1125, DOI 10.1111/j.1523-1739.2005.00168.x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2002, ENVIRON MANAGE, V29, P782, DOI 10.1007/s00267-001-0065-4; Gannon W, 2009, J MAMMAL, V88, P809; Garden JG, 2007, AUSTRAL ECOL, V32, P669, DOI 10.1111/j.1442-9993.2007.01750.x; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goldewijk KK, 2001, GLOBAL BIOGEOCHEM CY, V15, P417, DOI 10.1029/1999GB001232; Govindan BN, 2012, OIKOS, V121, P623, DOI 10.1111/j.1600-0706.2011.19747.x; Hinsley SA, 2000, J ENVIRON MANAGE, V60, P33, DOI 10.1006/jema.2000.0360; Hofmann JE., 2008, FIELD MANUAL ILLINOI; Hopwood JL, 2008, BIOL CONSERV, V141, P2632, DOI 10.1016/j.biocon.2008.07.026; HOWE HF, 1994, CONSERV BIOL, V8, P691, DOI 10.1046/j.1523-1739.1994.08030691.x; Hurst ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074520; Iverson LR, 1988, LANDSCAPE ECOL, V2, P45, DOI 10.1007/BF00138907; Jaster L.A., 2012, BIRDS N AM ONLINE; Kamp J, 2011, BIOL CONSERV, V144, P2607, DOI 10.1016/j.biocon.2011.07.010; Keesing F, 2000, BIOSCIENCE, V50, P205, DOI 10.1641/0006-3568(2000)050[0205:CCATEO]2.3.CO;2; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M., 2010, INTRO WINBUGS ECOLOG; Kociolek AV, 2011, CONSERV BIOL, V25, P241, DOI 10.1111/j.1523-1739.2010.01635.x; Koford RR, 1999, STUD AVIAN BIOL-SER, P187; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Legagneux P, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0417; LEIGHTON MM, 1948, J GEOL, V56, P16, DOI 10.1086/625474; Lucey A, 2011, TRANSPORT RES REC, P164, DOI 10.3141/2262-16; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MAC ARTHUR ROBERT H., 1967; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manson RH, 2001, ECOLOGY, V82, P3320, DOI 10.2307/2680155; McClure CJW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2290; McGregor RL, 2008, J APPL ECOL, V45, P117, DOI 10.1111/j.1365-2664.2007.01403.x; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Meunier FD, 1999, CAN J ZOOL, V77, P108, DOI 10.1139/cjz-77-1-108; Meunier FD, 2000, BIOL CONSERV, V92, P291, DOI 10.1016/S0006-3207(99)00094-4; Millar RB, 2009, BIOMETRICS, V65, P962, DOI 10.1111/j.1541-0420.2008.01162.x; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; Monadjem A, 2003, AFR ZOOL, V38, P127; Nakarmi B, 2009, ILLINOIS ROADSIDE RI; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; OXLEY DJ, 1974, J APPL ECOL, V11, P51, DOI 10.2307/2402004; PARISH T, 1994, J APPL ECOL, V31, P764, DOI 10.2307/2404166; Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049; POWELL GVN, 1986, BIOL CONSERV, V36, P101, DOI 10.1016/0006-3207(86)90001-7; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Reijnen R, 2006, ENVIRONM POLLUT SER, V10, P255, DOI 10.1007/1-4020-4504-2_12; Benayas JMR, 2012, ECOSYSTEMS, V15, P883, DOI 10.1007/s10021-012-9552-0; Rich SM, 1996, J MAMMAL, V77, P985, DOI 10.2307/1382779; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Ries L, 2001, CONSERV BIOL, V15, P401, DOI 10.1046/j.1523-1739.2001.015002401.x; Roach GL, 1985, TRANSPORT RES REC, V1016, P11; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Saarinen K, 2005, BIOL CONSERV, V123, P403, DOI 10.1016/j.biocon.2004.12.012; Salek M, 2009, AGR ECOSYST ENVIRON, V134, P8, DOI 10.1016/j.agee.2009.06.018; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Temple Stanley A., 2002, Birds of North America, V703, P1; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Underhill J. E., 2000, Environmental Reviews, V8, P21, DOI 10.1139/er-8-1-21; United States Census Bureau, 2014, AM FACTF PROF GEN PO; United States Department of Agriculture, LAND VAL 2013 SUMM; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Walther BA, 2001, IBIS, V143, P413, DOI 10.1111/j.1474-919X.2001.tb04942.x; WARNER RE, 1992, WILDLIFE SOC B, V20, P279; WAY J M, 1977, Biological Conservation, V12, P65, DOI 10.1016/0006-3207(77)90058-1; Weaver JE, 1932, BOT GAZ, V93, P0113, DOI 10.1086/334244; Webster W.D., 1982, Mammalian Species, P1; With KA, 2008, BIOL CONSERV, V141, P3152, DOI 10.1016/j.biocon.2008.09.025	98	7	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120375	10.1371/journal.pone.0120375	http://dx.doi.org/10.1371/journal.pone.0120375			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794180	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900020
J	Meng, QB; Kang, WM; Yu, JC; Liu, YQ; Ma, ZQ; Zhou, L; Cui, QC; Zhou, WX				Meng, Qing-Bin; Kang, Wei-Ming; Yu, Jian-Chun; Liu, Yu-Qin; Ma, Zhi-Qiang; Zhou, Li; Cui, Quan-Cai; Zhou, Wei-Xun			Overexpression of Eukaryotic Translation Initiation Factor 5A2 (EIF5A2) Correlates with Cell Aggressiveness and Poor Survival in Gastric Cancer	PLOS ONE			English	Article							CARCINOMAS CORRELATION; INDEPENDENT PREDICTOR; C-MYC; PROMOTES; METASTASIS; MTA1; PROGRESSION; EXPRESSION; INVASION; EIF-5A2	Eukaryotic translation initiation factor 5A2 (EIF5A2) plays an important role in tumor progression and prognosis evaluation. However, little information is available about its potential role in gastric cancer. This study aimed to investigate the function of EIF5A2 in tumor progression and its potential mechanisms. EIF5A2 expression was measured in human gastric cancer cell lines, the immortalized gastric mucosal epithelial cell line (GES-1) and human gastric cancer tissues and knocked down by RNA interference or upregulated by EIF5A2 plasmid transfection. Cell proliferation, migration and invasion were assessed in vitro. The downstream targets of EIF5A2 were examined by western blotting. EIF5A2 and its potential target metastasis-associated protein 1 (MTA1) expression were examined in 160 pairs of human gastric cancer and adjacent non-tumor specimens using immunohistochemistry (IHC) staining, and its correlation with clinicopathological features and survival was investigated. Knockdown of EIF5A2 or MTA1 caused an apparent suppression of HGC27 cell proliferation, migration and invasion. After knockdown of EIF5A2 in HGC27 cells, E-cadherin levels were upregulated and vimentin, cyclin D1, cyclin D3, C-MYC and MTA1 levels were downregulated. Upregulation of EIF5A2 in MKN45 cells resulted in the converse. IHC results showed a positive correlation between EIF5A2 and MTA1 expression in gastric cancers (P< 0.001). Both EIF5A2 and MTA1 overexpression were correlated with pT stage (P= 0.018 and P= 0.042), pN stage (P= 0.037 and P= 0.020) and lymphovascular invasion (P= 0.016 and P= 0.044). EIF5A2 or MTA1 overexpression was significantly associated with poor overall survival and disease-free survival (All P< 0.05). Multivariate analyses identified EIF5A2 as an independent predictor for both overall survival (P= 0.012) and disease-free survival (P= 0.008) in gastric cancer patients. Our findings indicate that EIF5A2 upregulation plays an important oncogenic role in gastric cancer. EIF5A2 may represent a new predictor for poor survival and is a potential therapeutic target for gastric cancer.	[Meng, Qing-Bin; Kang, Wei-Ming; Yu, Jian-Chun; Ma, Zhi-Qiang; Zhou, Li] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China; [Meng, Qing-Bin; Kang, Wei-Ming; Yu, Jian-Chun; Ma, Zhi-Qiang; Zhou, Li; Cui, Quan-Cai; Zhou, Wei-Xun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Meng, Qing-Bin] First Hosp, Dept Gastrointestinal Surg, Wuhan, Hubei Provence, Peoples R China; [Liu, Yu-Qin] Chinese Acad Med Sci, Inst Basic Med Sci, Cell Ctr, Wuhan, Hubei Provence, Peoples R China; [Cui, Quan-Cai; Zhou, Wei-Xun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Yu, JC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	yujch001@163.com	Zhou, Li/GSE-4531-2022	Kang, Weiming/0000-0002-6736-4728	Beijing Municipal Natural Science Foundation [7132209]; Hubei Province health and family planning scientific research project [WJ2015MB137]; Major science and technology projects in Beijing City [D141100000414004]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Hubei Province health and family planning scientific research project; Major science and technology projects in Beijing City	This work was supported by grants from the Beijing Municipal Natural Science Foundation (No. 7132209), Hubei Province health and family planning scientific research project (No. WJ2015MB137) and Major science and technology projects in Beijing City (No. D141100000414004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Cao DF, 2004, CANCER BIOL THER, V3, P1081, DOI 10.4161/cbt.3.11.1175; CHEN W, 2009, CHIN J CANCER RES, V25, P10, DOI DOI 10.3978/J.ISSN.1000-9604.2012.12.04; Chen W, 2009, CANCER EPIDEM BIOMAR, V18, P400, DOI 10.1158/1055-9965.EPI-08-0754; Deng XM, 2013, WORLD J SURG, V37, P792, DOI 10.1007/s00268-012-1898-0; Guan XY, 2000, CANCER GENET CYTOGEN, V123, P27, DOI 10.1016/S0165-4608(00)00306-X; He LR, 2011, INT J CANCER, V129, P143, DOI 10.1002/ijc.25669; He QJ, 2003, CANCER GENET CYTOGEN, V144, P112, DOI 10.1016/S0165-4608(02)00959-7; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Hyung WJ, 2002, ANN SURG ONCOL, V9, P562; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jenkins ZA, 2001, GENOMICS, V71, P101, DOI 10.1006/geno.2000.6418; Kawasaki G, 2008, INT J ORAL MAX SURG, V37, P1039, DOI 10.1016/j.ijom.2008.05.020; Khosravi S, 2014, BRIT J CANCER, V110, P399, DOI 10.1038/bjc.2013.688; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Marchet A, 2007, ANN SURG ONCOL, V14, P1058, DOI 10.1245/s10434-006-9090-0; Schaefer IM, 2011, MED ONCOL, V28, P1023, DOI 10.1007/s12032-010-9604-2; Song YA, 2012, PATHOL INT, V62, P127, DOI 10.1111/j.1440-1827.2011.02765.x; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.3.CO;2-H; Wang FW, 2013, INT J BIOL SCI, V9, P1013, DOI 10.7150/ijbs.7191; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wei Ying-xin, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P634, DOI 10.3881/j.issn.1000-503X.2013.06.009; Yang F, 2013, J CANCER RES CLIN, V139, P437, DOI 10.1007/s00432-012-1324-x; Yang GF, 2009, GYNECOL ONCOL, V112, P314, DOI 10.1016/j.ygyno.2008.10.024; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zheng LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055719; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207	30	44	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119229	10.1371/journal.pone.0119229	http://dx.doi.org/10.1371/journal.pone.0119229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793713	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200063
J	Nazar, FN; Barrios, BE; Kaiser, P; Marin, RH; Correa, SG				Nicolas Nazar, F.; Barrios, Bibiana E.; Kaiser, Pete; Marin, Raul H.; Correa, Silvia G.			Immune Neuroendocrine Phenotypes in Coturnix coturnix: Do Avian Species Show LEWIS/FISCHER-Like Profiles?	PLOS ONE			English	Article							SOCIAL REINSTATEMENT BEHAVIOR; PITUITARY-ADRENAL AXIS; REAL-TIME PCR; JAPANESE-QUAIL; MESSENGER-RNA; ADRENOCORTICAL RESPONSIVENESS; CORTICOSTERONE RESPONSE; TONIC IMMOBILITY; CHRONIC STRESS; LEWIS RATS	Immunoneuroendocrinology studies have identified conserved communicational paths in birds and mammals, e. g. the Hypothalamus-Pituitary-Adrenal axis with anti-inflammatory activity mediated by glucocorticoids. Immune neuroendocrine phenotypes (INPs) have been proposed for mammals implying the categorization of a population in subgroups underlying divergent immune-neuroendocrine interactions. These phenotypes were studied in the context of the LEWIS/FISCHER paradigm (rats expressing high or low pro-inflammatory profiles, respectively). Although avian species have some common immunological mechanisms with mammals, they have also evolved some distinct strategies and, until now, it has not been studied whether birds may also share with mammals similar INPs. Based on corticosterone levels we determined the existence of two divergent groups in Coturnix coturnix that also differed in other immune-neuroendocrine responses. Quail with lowest corticosterone showed higher lymphoproliferative and antibody responses, interferon-gamma and interleukin-1 beta mRNA expression levels and lower frequencies of leukocyte subpopulations distribution and interleukin-13 levels, than their higher corticosterone counterparts. Results suggest the existence of INPs in birds, comparable to mammalian LEWIS/FISCHER profiles, where basal corticosterone also underlies responses of comparable variables associated to the phenotypes. Concluding, INP may not be a mammalian distinct feature, leading to discuss whether these profiles represent a parallel phenomenon evolved in birds and mammals, or a common feature inherited from a reptilian ancestor millions of years ago.	[Nicolas Nazar, F.; Marin, Raul H.] Natl Sci & Tech Res Council CONICET, Biol & Technol Invest Inst IIByT, Cordoba, Argentina; [Nicolas Nazar, F.; Barrios, Bibiana E.; Marin, Raul H.; Correa, Silvia G.] Natl Univ Cordoba, Cordoba, Argentina; [Kaiser, Pete] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Barrios, Bibiana E.; Correa, Silvia G.] Natl Sci & Tech Res Council CONICET, Clin Biochem & Immunol Res Ctr CIBICI, Cordoba, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Correa, SG (corresponding author), Natl Sci & Tech Res Council CONICET, Clin Biochem & Immunol Res Ctr CIBICI, Cordoba, Argentina.	scorrea@fcq.unc.edu.ar	Nazar, Franco Nicolas/I-5464-2019	Nazar, Franco Nicolas/0000-0002-5282-5931; Marin, Raul/0000-0001-8161-4044	Secretaria de Ciencia y Tecnologia (SECyT) de la Universidad Nacional de Cordoba (UNC); CONICET-FONCyT-PICT ANPCyT [1216 2012]	Secretaria de Ciencia y Tecnologia (SECyT) de la Universidad Nacional de Cordoba (UNC); CONICET-FONCyT-PICT ANPCyT	This work was supported by Secretaria de Ciencia y Tecnologia (SECyT) de la Universidad Nacional de Cordoba (UNC); and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET-Fondo para la Investigacion Cientifica y Tecnologica (FONCyT)-Proyecto de Investigacion Cientifica y Tecnologica (PICT) 1216 2012 de la Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheim K, 1997, P NATL ACAD SCI USA, V94, P2681, DOI 10.1073/pnas.94.6.2681; BAUMGARTNER J, 1994, WORLD POULTRY SCI J, V50, P227; Bilcik B, 1999, BRIT POULTRY SCI, V40, P444, DOI 10.1080/00071669987188; Butts CL, 2008, CELL IMMUNOL, V252, P7, DOI 10.1016/j.cellimm.2007.09.009; Carmichael NL, 1998, APPL ANIM BEHAV SCI, V58, P353, DOI 10.1016/S0168-1591(97)00151-2; Cockrem JF, 2005, HORM BEHAV, V48, P492, DOI 10.1016/j.yhbeh.2005.03.008; Correa SG, 2007, CYTOKINE GROWTH F R, V18, P125, DOI 10.1016/j.cytogfr.2007.01.011; Davison F, 2011, AVIAN IMMUNOLOGY; Dhabhar Firdaus S, 2008, Allergy Asthma Clin Immunol, V4, P2, DOI 10.1186/1710-1492-4-1-2; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Di Rienzo J., 2013, INFOSTAT VERSION 201; Downing JEG, 2000, IMMUNOL TODAY, V21, P281, DOI 10.1016/S0167-5699(00)01635-2; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Elenkov IJ, 2008, J IMMUNOL, V181, P1737, DOI 10.4049/jimmunol.181.3.1737; Francois N, 2000, BEHAV PROCESS, V48, P171, DOI 10.1016/S0376-6357(99)00081-9; Hazard D, 2008, GEN COMP ENDOCR, V155, P288, DOI 10.1016/j.ygcen.2007.05.009; Heijnen CJ, 2007, BRAIN BEHAV IMMUN, V21, P1, DOI 10.1016/j.bbi.2006.08.008; Huss D, 2008, LAB ANIMAL, V37, P513, DOI 10.1038/laban1108-513; Jafarian-Tehrani M, 2000, ANN NY ACAD SCI, V917, P819; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; Kaiser P, 2009, GEN COMP ENDOCR, V163, P83, DOI 10.1016/j.ygcen.2008.09.013; Kuenzel WJ, 2010, POULTRY SCI, V89, P832, DOI 10.3382/ps.2009-00376; Labaque MC, 2008, BRIT POULTRY SCI, V49, P409, DOI 10.1080/00071660802262050; Laurence A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047475; Lay DC, 2011, POULTRY SCI, V90, P278, DOI 10.3382/ps.2010-00962; Marin RH, 2002, POULTRY SCI, V81, P261, DOI 10.1093/ps/81.2.261; Martin LB, 2005, GEN COMP ENDOCR, V140, P126, DOI 10.1016/j.ygcen.2004.10.010; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Monfort SL, 2002, REPROD SCI INTEGRATE, DOI [10.1017/CBO9780511615016, DOI 10.1017/CBO9780511615016]; Nazar FN, 2011, STRESS, V14, P166, DOI 10.3109/10253890.2010.523093; Nilsson PB, 2008, COMP BIOCHEM PHYS A, V149, P275, DOI 10.1016/j.cbpa.2008.01.002; Puvadolpirod S, 2000, POULTRY SCI, V79, P363, DOI 10.1093/ps/79.3.363; Raisman G, 1997, ANNU REV NEUROSCI, V20, P533, DOI 10.1146/annurev.neuro.20.1.533; REESE EP, 1962, J EXP ANAL BEHAV, V5, P265, DOI 10.1901/jeab.1962.5-265; Roberts ML, 2009, J EXP BIOL, V212, P3125, DOI 10.1242/jeb.030726; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Rubolini D, 2005, HORM BEHAV, V47, P592, DOI 10.1016/j.yhbeh.2005.01.006; Satterlee DG, 2004, POULTRY SCI, V83, P1003, DOI 10.1093/ps/83.6.1003; Satterlee DG, 2002, POULTRY SCI, V81, P1071, DOI 10.1093/ps/81.7.1071; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sever J, 1962, J IMMUNOL; Shini S, 2009, Stress, V12, P388, DOI 10.1080/10253890802526894; Shini S, 2010, POULTRY SCI, V89, P841, DOI 10.3382/ps.2009-00483; Shini S, 2010, STRESS, V13, P185, DOI 10.3109/10253890903144639; Smits JEG, 2005, DEV COMP IMMUNOL, V29, P161, DOI 10.1016/j.dci.2004.06.007; STADECKER MJ, 1977, J IMMUNOL, V118, P1564; Sternberg EM, 2001, J ENDOCRINOL, V169, P429, DOI 10.1677/joe.0.1690429; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P2374, DOI 10.1073/pnas.86.7.2374; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P4771, DOI 10.1073/pnas.86.12.4771; Tella JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003295; Thomas DG, 2004, NEW ZEAL VET J, V52, P76, DOI 10.1080/00480169.2004.36408; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Uchiyama R, 2005, J VET MED SCI, V67, P441, DOI 10.1292/jvms.67.441; Uno Y, 2012, POULTRY SCI, V91, P2496, DOI 10.3382/ps.2012-02283; Washburn BE, 2002, CONDOR, V104, P558, DOI 10.1650/0010-5422(2002)104[0558:UACART]2.0.CO;2; Wei RT, 2003, J NEUROIMMUNOL, V135, P10, DOI 10.1016/S0165-5728(02)00429-0; Zalcman SS, 2006, BRAIN BEHAV IMMUN, V20, P507, DOI 10.1016/j.bbi.2006.05.002	59	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120712	10.1371/journal.pone.0120712	http://dx.doi.org/10.1371/journal.pone.0120712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793369	Green Published, gold, Green Submitted			2022-12-26	WOS:000352083900067
J	Smejkal, M; Ricard, D; Prchalova, M; Riha, M; Muska, M; Blabolil, P; Cech, M; Vasek, M; Juza, T; Herreras, AM; Encina, L; Peterka, J; Kubecka, J				Smejkal, Marek; Ricard, Daniel; Prchalova, Marie; Riha, Milan; Muska, Milan; Blabolil, Petr; Cech, Martin; Vasek, Mojmir; Juza, Tomas; Herreras, Agustin Monteoliva; Encina, Lourdes; Peterka, Jiri; Kubecka, Jan			Biomass and Abundance Biases in European Standard Gillnet Sampling	PLOS ONE			English	Article							LAKE FISH ASSEMBLAGES; SIZE-SELECTIVITY; WATER; CATCHABILITY; TRAWL; COMMUNITIES; POPULATIONS; GRADIENTS; DENSITY; CATCHES	The European Standard EN 14757 recommends gillnet mesh sizes that range from 5 to 55mm (knot-to-knot) for the standard monitoring of fish assemblages and suggests adding gillnets with larger mesh sizes if necessary. Our research showed that the recommended range of mesh sizes did not provide a representative picture of fish sizes for larger species that commonly occur in continental Europe. We developed a novel, large mesh gillnet which consists of mesh sizes 70, 90, 110 and 135mm (knot to knot, 10m panels) and assessed its added value for monitoring purposes. From selectivity curves obtained by sampling with single mesh size gillnets (11 mesh sizes 6 - 55mm) and large mesh gillnets, we identified the threshold length of bream (Abramis brama) above which this widespread large species was underestimated by European standard gillnet catches. We tested the European Standard gillnet by comparing its size composition with that obtained during concurrent pelagic trawling and purse seining in a cyprinid-dominated reservoir and found that the European Standard underestimated fish larger than 292mm by 26 times. The inclusion of large mesh gillnets in the sampling design removed this underestimation. We analysed the length-age relationship of bream in the Rimov Reservoir, and concluded that catches of bream larger than 292mm and older than five years were seriously underrepresented in European Standard gillnet catches. The Rimov Reservoir is a typical cyprinid-dominated water body where the biomass of bream > 292mm formed 70% of the pelagic trawl and purse seine catch. The species-specific relationships between the large mesh gillnet catch and European Standard catch suggested that the presence of carp (Cyprinus carpio), European catfish (Silurus glanis), tench (Tinca tinca) or bream warrants the use of both gillnet types. We suggest extending the gillnet series in the European Standard to avoid misinterpretation of fish community biomass estimates.	[Smejkal, Marek; Ricard, Daniel; Prchalova, Marie; Riha, Milan; Muska, Milan; Blabolil, Petr; Cech, Martin; Vasek, Mojmir; Juza, Tomas; Peterka, Jiri; Kubecka, Jan] Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic; [Smejkal, Marek; Blabolil, Petr] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Herreras, Agustin Monteoliva] Ecohydros SL, Poligono Ind Cros, Maliano, Cantabria, Spain; [Encina, Lourdes] Univ Seville, Fac Biol, Dept Plant Biol & Ecol, Seville, Spain	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Sevilla	Kubecka, J (corresponding author), Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic.	kubecka@hbu.cas.cz	Peterka, Jiří/C-7218-2014; Ricard, Daniel/G-1814-2014; Vasek, Mojmir/C-5839-2014; Čech, Martin/C-5797-2014; Prchalová, Marie/F-8664-2014; Blabolil, Petr/K-9548-2015; Riha, Milan/AAF-9819-2019; Blabolil, Petr/N-8719-2019; Riha, Milan/G-1065-2014; Juza, Tomas/G-3159-2014; Šmejkal, Marek/E-1269-2017; Muska, Milan/AAC-8744-2019; Muska, Milan/A-7978-2014; Kubecka, Jan/A-8230-2011	Vasek, Mojmir/0000-0001-6386-4015; Čech, Martin/0000-0003-1350-4286; Prchalová, Marie/0000-0001-5000-2918; Blabolil, Petr/0000-0003-1344-9627; Riha, Milan/0000-0002-3930-420X; Šmejkal, Marek/0000-0002-7887-6411; Muska, Milan/0000-0001-6659-986X; Kubecka, Jan/0000-0001-9203-4854	Ecohydros S.L.	Ecohydros S.L.	Ecohydros S.L. provided support in the form of salaries for authors [AMH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Achleitner D, 2012, FISHERIES MANAG ECOL, V19, P352, DOI 10.1111/j.1365-2400.2012.00851.x; [Anonymous], 2014, R LANG ENV STAT COMP; Appelberg M, 1995, WATER AIR SOIL POLL, V85, P401, DOI 10.1007/BF00476862; Argillier C, 2013, HYDROBIOLOGIA, V704, P193, DOI 10.1007/s10750-012-1282-y; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Begon M, 2009, ECOLOGY INDIVIDUALS, P89; Bonar SA, 2009, STANDARD METHODS FOR SAMPLING NORTH AMERICAN FRESHWATER FISHES, P1; Brucet S, 2013, FRESHWATER BIOL, V58, P1779, DOI 10.1111/fwb.12167; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Carol J, 2007, J APPL ICHTHYOL, V23, P654, DOI 10.1111/j.1439-0426.2007.00871.x; CEN, 2005, 147572013 CEN PREN; D & L Software Pty Ltd Australia, 2011, DES NEWM OZIEXPLORER; Emmrich M, 2014, J BIOGEOGR, V41, P2221, DOI 10.1111/jbi.12366; Emmrich M, 2011, FRESHWATER BIOL, V56, P2316, DOI 10.1111/j.1365-2427.2011.02658.x; EU, 2000, OFFICIAL J L, V327, P1; Finstad AG, 2000, CAN J FISH AQUAT SCI, V57, P1718, DOI 10.1139/cjfas-57-8-1718; Garcia XF, 2006, J FISH BIOL, V68, P1144, DOI 10.1111/j.0022-1112.2006.01009.x; Gassner H, 2005, INT REV HYDROBIOL, V90, P422, DOI 10.1002/iroh.200510798; GODO OR, 1990, FISH RES, V9, P165, DOI 10.1016/0165-7836(90)90062-Z; HAMLEY JM, 1975, J FISH RES BOARD CAN, V32, P1943, DOI 10.1139/f75-233; Hansen Michael J., 1998, North American Journal of Fisheries Management, V18, P847, DOI 10.1577/1548-8675(1998)018<0847:GNSBLT>2.0.CO;2; HANSSON S, 1995, CAN J FISH AQUAT SCI, V52, P75, DOI 10.1139/f95-007; Hjellvik V, 2002, CAN J FISH AQUAT SCI, V59, P33, DOI 10.1139/F01-193; Holmgren K, 2000, J FISH BIOL, V57, P1312, DOI 10.1006/jfbi.2000.1395; Garcia-Asorey MI, 2011, CAN J FISH AQUAT SCI, V68, P1892, DOI 10.1139/F2011-108; JENSEN JW, 1986, J FISH BIOL, V28, P637, DOI 10.1111/j.1095-8649.1986.tb05198.x; Jurvelius J, 2011, HYDROBIOLOGIA, V660, P29, DOI 10.1007/s10750-010-0385-6; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Kurkilahti M, 2002, FISH RES, V54, P153, DOI 10.1016/S0165-7836(00)00301-5; Kurkilahti M, 1996, FISH RES, V27, P243, DOI 10.1016/0165-7836(95)00463-7; LAMMENS EHRR, 1992, ENVIRON BIOL FISH, V33, P195, DOI 10.1007/BF00002564; Maury O, 2013, J THEOR BIOL, V324, P52, DOI 10.1016/j.jtbi.2013.01.018; Mehner T, 2007, FRESHWATER BIOL, V52, P2285, DOI 10.1111/j.1365-2427.2007.01836.x; Mehner T, 2010, LIMNOL OCEANOGR, V55, P203, DOI 10.4319/lo.2010.55.1.0203; Muska M, 2013, HYDROBIOLOGIA, V707, P17, DOI 10.1007/s10750-012-1401-9; Olin M, 2003, HYDROBIOLOGIA, V506, P443, DOI 10.1023/B:HYDR.0000008545.33035.c4; Olin M, 2004, FISH RES, V68, P135, DOI 10.1016/j.fishres.2004.01.005; Olin M, 2009, FISH RES, V96, P88, DOI 10.1016/j.fishres.2008.09.007; Pope KL, 2005, FISH RES, V76, P117, DOI 10.1016/j.fishres.2005.05.013; Prchalova M, 2011, FISH RES, V107, P201, DOI 10.1016/j.fishres.2010.10.021; Prchalova M, 2010, FISH RES, V102, P291, DOI 10.1016/j.fishres.2009.12.011; Prchalova M, 2009, FISH RES, V96, P51, DOI 10.1016/j.fishres.2008.09.017; Psuty I, 1997, FISH RES, V32, P249, DOI 10.1016/S0165-7836(97)00056-8; Reis EG, 1999, FISH RES, V39, P263, DOI 10.1016/S0165-7836(98)00199-4; Riha M, 2009, FISHERIES MANAG ECOL, V16, P121, DOI 10.1111/j.1365-2400.2008.00650.x; Riha M, 2012, FISH RES, V127, P56, DOI 10.1016/j.fishres.2012.04.012; RUDSTAM LG, 1984, CAN J FISH AQUAT SCI, V41, P1252, DOI 10.1139/f84-151; Sondergaard M, 2005, J APPL ECOL, V42, P616, DOI 10.1111/j.1365-2664.2005.01040.x; Turunen T, 1998, ERGEB LIMNOL, V50, P429; Vasek M, 2004, INT REV HYDROBIOL, V89, P352, DOI 10.1002/iroh.200410734; Vasek M, 2013, ECOL ENG, V52, P104, DOI 10.1016/j.ecoleng.2012.12.100	51	33	35	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122437	10.1371/journal.pone.0122437	http://dx.doi.org/10.1371/journal.pone.0122437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793776	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900179
J	Wang, F; Yang, T; Burlyaeva, M; Li, L; Jiang, JY; Fang, L; Redden, R; Zong, XX				Wang, Fang; Yang, Tao; Burlyaeva, Marina; Li, Ling; Jiang, Junye; Fang, Li; Redden, Robert; Zong, Xuxiao			Genetic Diversity of Grasspea and Its Relative Species Revealed by SSR Markers	PLOS ONE			English	Article							LATHYRUS-SATIVUS L.; INFERENCE; NUMBER; WILD; EST	The study of genetic diversity between Lathyrus sativus L. and its relative species may yield fundamental insights into evolutionary history and provide options to meet the challenge of climate changes. 30 SSR loci were employed to assess the genetic diversity and population structure of 283 individuals from wild and domesticated populations from Africa, Europe, Asia and ICARDA. The allele number per loci ranged from 3 to 14. The average gene diversity index and average polymorphism information content (PIC) was 0.5340 and 0.4817, respectively. A model based population structure analysis divided the germplasm resources into three subgroups: the relative species, the grasspea from Asia, and the grasspea from Europe and Africa. The UPGMA dendrogram and PCA cluster also demonstrated that Asian group was convincingly separated from the other group. The AMOVA result showed that the cultivated species was quite distinct from its relative species, however a low level of differentiation was revealed among their geographic origins. In all, these results provided a molecular basis for understanding genetic diversity of L. sativus and its relatives.	[Wang, Fang; Yang, Tao; Jiang, Junye; Fang, Li; Zong, Xuxiao] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100081, Peoples R China; [Burlyaeva, Marina] NI Vavilov Res Inst Plant Ind, Dept Leguminous Crops Genet Resources, St Petersburg 190000, Russia; [Li, Ling] Liaoning Acad Agr Sci, Inst Cash Crops, Liaoyang 111000, Peoples R China; [Redden, Robert] Australian Temperate Field Crops Collect, Dept Primary Ind, Horsham, Vic 3401, Australia	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Vavilov All-Russian Institute of Plant Genetic Resources	Redden, R (corresponding author), Australian Temperate Field Crops Collect, Dept Primary Ind, Horsham, Vic 3401, Australia.	bob.redden@depi.vic.gov.au; zongxuxiao@caas.cn	Burlyaeva, Marina Olegovna/I-1283-2017	Burlyaeva, Marina Olegovna/0000-0002-3708-2594	Agricultural Science and Technology Innovation Program (ASTIP) in CAAS; Ministry of Agriculture of China [2014NWB030-09, CARS-09]; National Infrastructure for Crop Germplasm Resources project from the Ministry of Science and Technology of China [2005DKA21001-006]; National Key Technology R&D Program of China from the Ministry of Science and Technology of China [2013BAD01B05-2]	Agricultural Science and Technology Innovation Program (ASTIP) in CAAS; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Infrastructure for Crop Germplasm Resources project from the Ministry of Science and Technology of China; National Key Technology R&D Program of China from the Ministry of Science and Technology of China	This study was funded by the Agricultural Science and Technology Innovation Program (ASTIP) in CAAS, grants from the Ministry of Agriculture of China (2014NWB030-09, CARS-09), National Infrastructure for Crop Germplasm Resources project from the Ministry of Science and Technology of China (2005DKA21001-006), supported by the National Key Technology R&D Program of China from the Ministry of Science and Technology of China (2013BAD01B05-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allkin R, 1986, NAMES SYNONYMS SPECI, V7, P1; [Anonymous], 2001, LATHYRUS LATHYRISM N; Asmussen CB, 1998, AM J BOT, V85, P387, DOI 10.2307/2446332; Barik DP, 2007, Z NATURFORSCH C, V62, P869; Belaid Y, 2006, GENET RESOUR CROP EV, V53, P1413, DOI 10.1007/s10722-005-5680-0; Blair MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049488; Ceccarelli M, 2010, CYTOGENET GENOME RES, V128, P237, DOI 10.1159/000298852; Chabane K, 2005, GENET RESOUR CROP EV, V52, P903, DOI 10.1007/s10722-003-6112-7; Croft AM, 1999, EUPHYTICA, V107, P167, DOI 10.1023/A:1003520721375; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Hopf M., 1986, ARCHAEOLOGICAL EVIDE, P35; JACKSON MT, 1984, EUPHYTICA, V33, P549, DOI 10.1007/BF00021156; Kumar S, 2011, FOOD CHEM TOXICOL, V49, P589, DOI 10.1016/j.fct.2010.06.051; KUPICHA F K, 1983, Notes from the Royal Botanic Garden Edinburgh, V41, P209; Lioi L, 2011, GENET RESOUR CROP EV, V58, P425, DOI 10.1007/s10722-010-9589-x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rohlf F, 2006, NTSYSPC NUMERICAL TA; Shehadeh A, 2013, GENET RESOUR CROP EV, V60, P2101, DOI 10.1007/s10722-013-9977-0; Shiferaw E, 2012, MOL BREEDING, V30, P789, DOI 10.1007/s11032-011-9662-y; Singh M., 2013, GRASS PEA, P269; Sthapit B., 2010, INDIAN J PLANT GENET, V23, P145; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavoletti S, 2007, PLANT BREEDING, V126, P607, DOI 10.1111/j.1439-0523.2007.01407.x; Vavilov, 1951, CHRON BOT, V13, P13; Weir BS, 1996, SINAUER ASS SUNDERL; Yang T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-65; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Zalkind FL., 1937, GRASS PEA, P171; Zhang XY, 2008, THEOR APPL GENET, V117, P629, DOI 10.1007/s00122-008-0807-2	37	23	27	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118542	10.1371/journal.pone.0118542	http://dx.doi.org/10.1371/journal.pone.0118542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793712	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200027
J	Wu, Z; Wang, L; Guo, ZG; Wang, K; Zhang, Y; Tian, KB; Zhang, JT; Sun, W; Yu, CJ				Wu, Zhen; Wang, Liang; Guo, Zhengguang; Wang, Ke; Zhang, Yang; Tian, Kaibing; Zhang, Junting; Sun, Wei; Yu, Chunjiang			Experimental Study on Differences in Clivus Chordoma Bone Invasion: An iTRAQ-Based Quantitative Proteomic Analysis	PLOS ONE			English	Article							SKULL BASE; EXPRESSION; PTEN	Although a bone tumor, significant differences in the extent of bone invasion exist in skull base chordoma, which directly affect the extent of surgical resection, and have an impact on its prognosis. However, the underlying mechanism of the phenomenon is not clearly understood. Therefore, we used an iTRAQ-based quantitative proteomics strategy to identify potential molecular signatures, and to find predictive markers of discrepancy in bone invasion of clivus chordoma. According to bone invasive classification criteria, 35 specimens of clivus chordoma were calssified to be either endophytic type (Type I) or exophytic type (Type II). An initial screening of six specimens of endophytic type and six of exophytic was performed, and 250 differentially expressed proteins were identified. Through the GO and IPA analysis, we found evidence that the expression of inflammatory activity-associated proteins up-regulated in endophytic type, whereas the expression of cell motility-associated proteins up-regulated in exophytic ones. Moreover, TGF beta 1 and mTOR signal pathway seemed to be related with bone invasion. Thus, TGF beta 1, PI3K, Akt, mTOR, and PTEN were validated in the following 23 samples by immune histochemistry and Western blot. The expression levels of TGF beta 1 and PTEN were significantly lower in the endophytic type than in the exophytic ones. It was found that TGF beta 1 may play an important role in its bone invasion. The mechanisms may be related with conducting an increased inflammatory cell response and a decline in cytoskeletal protein expression. PTEN is confirmed to be associated with the degree of bone invasion. The PI3K/AKT/mTOR signaling pathway might be associated with the bone invasion, but still needs a larger sample size to be verified These results, for the first time, not only demonstrate the biological changes that occur in different growth patterns from the perspective of proteomics, but also provide novel markers that may help to reveal the mechanisms behind clivus chordomas.	[Wu, Zhen; Wang, Liang; Wang, Ke; Zhang, Yang; Tian, Kaibing; Zhang, Junting] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Guo, Zhengguang; Sun, Wei] Chinese Acad Med Sci, Sch Basic Med, Core Facil Instruments, Inst Basic Med Sci,Peking Union Med Coll, Beijing 100730, Peoples R China; [Yu, Chunjiang] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Capital Medical University	Yu, CJ (corresponding author), Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China.	sunwei1018@hotmail.com; ttyyliguilin@126.com			National Nature Science Foundation of China [81101910]; Natural Science Foundation of Beijing [7122062]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This study was supported by the National Nature Science Foundation of China (No. 81101910) and the Natural Science Foundation of Beijing (No. 7122062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bydon M, 2012, EXPERT OPIN THER TAR, V16, P1139, DOI 10.1517/14728222.2012.714772; Chen KW, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0886-7; Hopkins BD, 2014, TRENDS BIOCHEM SCI, V39, P183, DOI 10.1016/j.tibs.2014.02.006; Kim S, 2008, CELLULAR SIGNALING, V20, P1212; Kitamura Y, 2013, J NEUROPATH EXP NEUR, V72, P816, DOI 10.1097/NEN.0b013e3182a065d0; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; McMaster ML, 2001, CANCER CAUSE CONTROL, V12, P1, DOI 10.1023/A:1008947301735; Naka T, 2008, HUM PATHOL, V39, P217, DOI 10.1016/j.humpath.2007.06.005; Presneau N, 2009, BRIT J CANCER, V100, P1406, DOI 10.1038/sj.bjc.6605019; Samii A, 2007, J NEUROSURG, V107, P319, DOI 10.3171/JNS-07/08/0319; Song K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061896; Sun W, 2006, MOL CELL PROTEOMICS, V5, P769, DOI 10.1074/mcp.T500022-MCP200; Thodou E, 2000, J NEUROSURG, V92, P976, DOI 10.3171/jns.2000.92.6.0976; Triana A, 2005, AM J SURG PATHOL, V29, P1422, DOI 10.1097/01.pas.0000180447.25141.a4; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu Z, 2010, NEUROSURG REV, V33, P451, DOI 10.1007/s10143-010-0273-6; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465; Zhou H, 2010, J SURG ONCOL, V102, P720, DOI 10.1002/jso.21674	18	15	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119523	10.1371/journal.pone.0119523	http://dx.doi.org/10.1371/journal.pone.0119523			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793716	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200090
J	Pan, YH; Zhang, HL; Zhang, DL; Li, JJ; Xiong, HY; Yu, JP; Li, JL; Rashid, MAR; Li, GL; Ma, XD; Cao, GL; Han, LZ; Li, ZC				Pan, Yinghua; Zhang, Hongliang; Zhang, Dongling; Li, Jinjie; Xiong, Haiyan; Yu, Jianping; Li, Jilong; Rashid, Muhammad Abdul Rehman; Li, Gangling; Ma, Xiaoding; Cao, Guilan; Han, Longzhi; Li, Zichao			Genetic Analysis of Cold Tolerance at the Germination and Booting Stages in Rice by Association Mapping	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LOW-TEMPERATURE GERMINABILITY; GENOME-WIDE ASSOCIATION; SSR-MARKERS; IDENTIFICATION	Low temperature affects the rice plants at all stages of growth. It can cause severe seedling injury and male sterility resulting in severe yield losses. Using a mini core collection of 174 Chinese rice accessions and 273 SSR markers we investigated cold tolerance at the germination and booting stages, as well as the underlying genetic bases, by association mapping. Two distinct populations, corresponding to subspecies indica and japonica showed evident differences in cold tolerance and its genetic basis. Both subspecies were sensitive to cold stress at both growth stages. However, japonica was more tolerant than indica at all stages as measured by seedling survival and seed setting. There was a low correlation in cold tolerance between the germination and booting stages. Fifty one quantitative trait loci (QTLs) for cold tolerance were dispersed across all 12 chromosomes; 22 detected at the germination stage and 33 at the booting stage. Eight QTLs were identified by at least two of four measures. About 46% of the QTLs represented new loci. The only QTL shared between indica and japonica for the same measure was qLTSSvR6-2 for SSvR. This implied a complicated mechanism of old tolerance between the two subspecies. According to the relative genotypic effect (RGE) of each genotype for each QTL, we detected 18 positive genotypes and 21 negative genotypes in indica, and 19 positive genotypes and 24 negative genotypes in japonica. In general, the negative effects were much stronger than the positive effects in both subspecies. Markers for QTL with positive effects in one subspecies were shown to be effective for selection of cold tolerance in that subspecies, but not in the other subspecies. QTL with strong negative effects on cold tolerance should be avoided during MAS breeding so as to not cancel the effect of favorable QTL at other loci.	[Pan, Yinghua; Zhang, Hongliang; Li, Jinjie; Xiong, Haiyan; Yu, Jianping; Li, Jilong; Rashid, Muhammad Abdul Rehman; Li, Gangling; Li, Zichao] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Heterosis & Utilizat, Minist Educ, Beijing 100193, Peoples R China; [Zhang, Dongling; Ma, Xiaoding; Cao, Guilan; Han, Longzhi] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Germplasm Resources & Biotechnol,Min, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Ma, Xiaoding] Guangxi Acad Agr Sci, Rice Res Inst, Nanning 530005, Guangxi, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Guangxi Academy of Agricultural Sciences	Han, LZ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Germplasm Resources & Biotechnol,Min, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China.	hanlongzhi@caas.cn; lizichao@cau.edu.cn	Xiong, Haiyan/AAL-9383-2021; Li, Zichao/AAS-8954-2021; Rashid, Muhammad Abdul Rehman/R-5982-2018	Xiong, Haiyan/0000-0003-4145-2719; Li, Zichao/0000-0002-3186-1132; Rashid, Muhammad Abdul Rehman/0000-0002-4941-3469	National Natural Science Foundation of China [31471456, 31371584]; 973 Project [2010CB125904]; China National Key Technologies RD Program [2013BAD01B02-15, 2015BAD02B01]; 948 Project of MOA [2011-G2B and 2011-G1(2)-25]; Project of National Species Resources Protection [2014NWB015]; Guangxi Natural Science Foundation Program [0991053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); China National Key Technologies RD Program(National Key Technology R&D Program); 948 Project of MOA; Project of National Species Resources Protection; Guangxi Natural Science Foundation Program(National Natural Science Foundation of Guangxi Province)	This work was funded by the National Natural Science Foundation of China(31471456 and 31371584), the 973 Project (2010CB125904), China National Key Technologies R&D Program (2013BAD01B02-15 and 2015BAD02B01), the 948 Project of MOA(2011-G2B and 2011-G1(2)-25), Project of National Species Resources Protection (2014NWB015), and Guangxi Natural Science Foundation Program (0991053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Chang T T, 1976, P S CLIM RIC, P87; Cui D, 2013, EUPHYTICA, V193, P369, DOI 10.1007/s10681-013-0935-x; Dai LY, 2004, BREEDING SCI, V54, P253, DOI 10.1270/jsbbs.54.253; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fujino K, 2004, THEOR APPL GENET, V108, P794, DOI 10.1007/s00122-003-1509-4; Fujino K, 2008, P NATL ACAD SCI USA, V105, P12623, DOI 10.1073/pnas.0805303105; Guirguis K, 2011, GEOPHYS RES LETT, DOI [10.1029/2011GL0487622, DOI 10.1029/2011GL0487622]; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Iwata H, 2007, THEOR APPL GENET, V114, P1437, DOI 10.1007/s00122-007-0529-x; Ji SuLan, 2008, Acta Agronomica Sinica, V34, P551, DOI 10.3724/SP.J.1006.2008.00551; Jia LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032703; KATO SHIGEMOTO, 1928, BULT SCI FAK TERK KJUSU IMP UNIV, V3, P132; Kodra E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047103; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029350, 10.1371/journal.pone.0051199]; Liu XF, 2010, ACTA GEOGRAPHICA SIN, V67, P1223; Meuwissen THE, 2001, GENETICS, V157, P1819; Narayanan NN, 2004, MOL BREEDING, V14, P61, DOI 10.1023/B:MOLB.0000037995.63856.2d; NISHIYAMA I, 1982, JPN J CROP SCI, V51, P462, DOI 10.1626/jcs.51.462; Saito K, 2010, PLANT SCI, V179, P97, DOI 10.1016/j.plantsci.2010.04.004; Sthapit BR, 1998, CROP SCI, V38, P660, DOI 10.2135/cropsci1998.0011183X003800030007x; Sun W, 2011, AGR FOREST METEOROL, V151, P1193, DOI 10.1016/j.agrformet.2011.04.009; Tai LM, 2006, SW CHINA J AGARIC SC, V19, P49; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Xu LM, 2008, PLANT SCI, V174, P340, DOI 10.1016/j.plantsci.2007.12.003; Ye C, 2009, CROP PASTURE SCI, V60, P328, DOI 10.1071/CP09006; Zeng Y., 2001, ACTA AGRON SIN, V27, P15; Zhang DL, 2009, THEOR APPL GENET, V119, P1105, DOI 10.1007/s00122-009-1112-4; Zhang Yan-mei, 2012, Chinese Journal of Rice Science, V26, P423, DOI 10.3969/j.issn.1001-7216.2012.04.006; Zhou L, 2010, THEOR APPL GENET, V121, P895, DOI 10.1007/s00122-010-1358-x	37	60	66	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120590	10.1371/journal.pone.0120590	http://dx.doi.org/10.1371/journal.pone.0120590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790128	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400165
J	Scherer, A; Kuhl, S; Wessels, D; Lusche, DF; Hanson, B; Ambrose, J; Voss, E; Fletcher, E; Goldman, C; Soll, DR				Scherer, Amanda; Kuhl, Spencer; Wessels, Deborah; Lusche, Daniel F.; Hanson, Brett; Ambrose, Joseph; Voss, Edward; Fletcher, Emily; Goldman, Charles; Soll, David R.			A Computer-Assisted 3D Model for Analyzing the Aggregation of Tumorigenic Cells Reveals Specialized Behaviors and Unique Cell Types that Facilitate Aggregate Coalescence	PLOS ONE			English	Article							BREAST-CANCER; MOTION ANALYSIS; 3-DIMENSIONAL RECONSTRUCTION; FLUORESCENCE MICROSCOPY; EXTRACELLULAR-MATRIX; LIVE CELLS; TUMOR; CULTURE; INVADOPODIA; PHENOTYPE	We have developed a 4D computer-assisted reconstruction and motion analysis system, J3D-DIAS 4.1, and applied it to the reconstruction and motion analysis of tumorigenic cells in a 3D matrix. The system is unique in that it is fast, high-resolution, acquires optical sections using DIC microscopy (hence there is no associated photoxicity), and is capable of long-term 4D reconstruction. Specifically, a z-series at 5 mu m increments can be acquired in less than a minute on tissue samples embedded in a 1.5 mm thick 3D Matrigel matrix. Reconstruction can be repeated at intervals as short as every minute and continued for 30 days or longer. Images are converted to mathematical representations from which quantitative parameters can be derived. Application of this system to cancer cells from established lines and fresh tumor tissue has revealed unique behaviors and cell types not present in non-tumorigenic lines. We report here that cells from tumorigenic lines and tumors undergo rapid coalescence in 3D, mediated by specific cell types that we have named "facilitators" and "probes." A third cell type, the "dervish", is capable of rapid movement through the gel and does not adhere to it. These cell types have never before been described. Our data suggest that tumorigenesis in vitro is a developmental process involving coalescence facilitated by specialized cells that culminates in large hollow spheres with complex architecture. The unique effects of select monoclonal antibodies on these processes demonstrate the usefulness of the model for analyzing the mechanisms of anticancer drugs.	[Scherer, Amanda; Kuhl, Spencer; Wessels, Deborah; Lusche, Daniel F.; Hanson, Brett; Ambrose, Joseph; Voss, Edward; Soll, David R.] Univ Iowa, Dept Biol, Monoclonal Antibody Res Inst, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA; [Fletcher, Emily; Goldman, Charles] Mercy Hosp Syst Des Moines, Des Moines, IA USA	University of Iowa	Soll, DR (corresponding author), Univ Iowa, Dept Biol, Monoclonal Antibody Res Inst, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA.	david-soll@uiowa.edu		Lusche, Daniel Felix/0000-0002-8848-4198	Monoclonal Antibody Research Institute; Developmental Studies Hybridoma Bank	Monoclonal Antibody Research Institute; Developmental Studies Hybridoma Bank	This work was supported by the Monoclonal Antibody Research Institute and the Developmental Studies Hybridoma Bank, the latter a National Resource created by the National Institutes of Health (NIH) and housed at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Beaty BT, 2014, J CELL BIOL, V205, P737, DOI 10.1083/jcb.201312046; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Dobrucki JW, 2007, BIOPHYS J, V93, P1778, DOI 10.1529/biophysj.106.096636; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Freshney R. I., 2005, CULTURE ANIMAL CELLS, V5th; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; George SP, 2013, J CELL SCI, V126, P312, DOI 10.1242/jcs.116244; Godugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053708; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Heid PJ, 2005, J CELL SCI, V118, P2225, DOI 10.1242/jcs.02342; Heid PJ, 2002, DEV BIOL, V245, P329, DOI 10.1006/dbio.2002.0631; HOWLETT AR, 1995, J CELL SCI, V108, P1945; Jaiswal R, 2013, CURR BIOL, V23, P1373, DOI 10.1016/j.cub.2013.06.013; Jensen EC, 2012, ANAT REC, V295, P2031, DOI 10.1002/ar.22602; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; KELLY T, 1994, J CELL PHYSIOL, V158, P299, DOI 10.1002/jcp.1041580212; Kharaishvili G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-41; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Laplantine E, 2000, J CELL SCI, V113, P1167; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li LY, 2011, J CANCER, V2, P458, DOI 10.7150/jca.2.458; Lusche DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108495; Martin MD, 2008, CLIN EXP METASTAS, V25, P877, DOI 10.1007/s10585-008-9206-y; Moin K, 2012, METHOD ENZYMOL, V506, P175, DOI 10.1016/B978-0-12-391856-7.00034-2; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Pampaloni F, 2014, INTEGR BIOL-UK, V6, P988, DOI 10.1039/c4ib00121d; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Poston T, 1998, COMPUT GRAPH FORUM, V17, pC137, DOI 10.1111/1467-8659.00261; PRICE JE, 1990, CANCER RES, V50, P717; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Riabov V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00075; Rohan TE, 2014, JNCI-J NATL CANCER I, P106; Sameni M, 2012, JOVE-J VIS EXP, DOI 10.3791/3661; SATYASWAROOP PG, 1991, CANCER RES, V51, P5661; Scales TME, 2013, ONCOGENE, V32, P3965, DOI 10.1038/onc.2012.415; Scherer A, 2010, J CELL SCI, V123, P3756, DOI 10.1242/jcs.068619; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Sharma Ved P, 2012, Intravital, V1, P77; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Sionov RV, 2015, CANCER MICROENVIRON, V8, P125, DOI 10.1007/s12307-014-0147-5; Soll DR, 2009, EUKARYOT CELL, V8, P1381, DOI 10.1128/EC.00121-09; Soll David R, 2003, ScientificWorldJournal, V3, P827; Soll David R., 2007, P365, DOI 10.1007/978-3-540-71331-9_13; Soll DR, 1999, COMPUT MED IMAG GRAP, V23, P3, DOI 10.1016/S0895-6111(98)00058-5; Soll DR, 1995, INT REV CYTOL, V163, P43; Soll DR, 2000, SCANNING, V22, P249, DOI 10.1002/sca.4950220404; Soll DR, 2001, METH MOL B, V161, P45; Soll DR, 1998, TECH MOD B, P25; SOULE HD, 1990, CANCER RES, V50, P6075; Sung Myong-Hee, 2013, Cells, V2, P284, DOI 10.3390/cells2020284; Varzavand A, 2013, CLIN EXP METASTAS, V30, P541, DOI 10.1007/s10585-012-9558-1; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; Wessels Deborah, 2006, V346, P261; Wessels D, 2009, METHODS MOL BIOL, V586, P315, DOI 10.1007/978-1-60761-376-3_18	67	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118628	10.1371/journal.pone.0118628	http://dx.doi.org/10.1371/journal.pone.0118628			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790299	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400037
J	Yanagi, T; Shi, RX; Aza-Blanc, P; Reed, JC; Matsuzawa, S				Yanagi, Teruki; Shi, Ranxin; Aza-Blanc, Pedro; Reed, John C.; Matsuzawa, Shu-ichi			PCTAIRE1-Knockdown Sensitizes Cancer Cells to TNF Family Cytokines	PLOS ONE			English	Article							PROTEIN-KINASE; CYCLIN Y; PHOSPHORYLATION; APOPTOSIS; CASPASE-8; SURVIVAL; TRAIL; DEATH; FADD; DEGRADATION	While PCTAIRE1/PCTK1/Cdk16 is overexpressed in malignant cells and is crucial in tumorigenesis, its function in apoptosis remains unclear. Here we investigated the role of PCTAIRE1 in apoptosis, especially in the extrinsic cell death pathway. Gene-knockdown of PCTAIRE1 sensitized prostate cancer PPC1 and Du145 cells, and breast cancer MDA-MB-468 cells to TNF-family cytokines, including TNF-related apoptosis-inducing ligand ( TRAIL). Meanwhile, PCTAIRE1-knockdown did not sensitize non-malignant cells, including diploid fibroblasts IMR-90 and the immortalized prostate epithelial cell line 267B1. PCTAIRE1-knockdown did not up-regulate death receptor expression on the cell surface or affect caspase-8, FADD and FLIP expression levels. PCTAIRE1-knockdown did promote caspase-8 cleavage and RIPK1 degradation, while RIPK1 mRNA knockdown sensitized PPC1 cells to TNF-family cytokines. Furthermore, the kinase inhibitor SNS-032, which inhibits PCTAIRE1 kinase activity, sensitized PPC1 cells to TRAIL-induced apoptosis. Together these results suggest that PCTAIRE1 contributes to the resistance of cancer cell lines to apoptosis induced by TNF-family cytokines, which implies that PCTAIRE1 inhibitors could have synergistic effects with TNF-family cytokines for cytodestruction of cancer cells.	[Yanagi, Teruki; Shi, Ranxin; Aza-Blanc, Pedro; Reed, John C.; Matsuzawa, Shu-ichi] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@sanfordburnham.org; smatsuzawa@sanfordburnham.org	Yanagi, Teruki/D-4222-2017	Yanagi, Teruki/0000-0003-2196-7600	JSPS fellowships; Kanae foundation; Sumitomo life social welfare service foundation; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	JSPS fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae foundation; Sumitomo life social welfare service foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Teruki Yanagi is supported by JSPS fellowships for research abroad, Kanae foundation, and Sumitomo life social welfare service foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304; Cole AR, 2009, NEUROSIGNALS, V17, P288, DOI 10.1159/000231895; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Finnberg N, 2008, CELL CYCLE, V7, P1525, DOI 10.4161/cc.7.11.5975; Garcia-Garcia C, 2010, BIOCHEM PHARMACOL, V79, P853, DOI 10.1016/j.bcp.2009.10.022; Graeser R, 2002, J CELL SCI, V115, P3479; Jia SH, 2008, J BIOL CHEM, V283, P5402, DOI 10.1074/jbc.M706462200; Kennedy NJ, 1998, J IMMUNOL, V160, P4881; Le Bouffant F, 2000, MOL CELL NEUROSCI, V16, P388, DOI 10.1006/mcne.2000.0881; Lemke J, 2014, CELL DEATH DIFFER, V21, P491, DOI 10.1038/cdd.2013.179; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Matthess Y, 2010, MOL CELL BIOL, V30, P5726, DOI 10.1128/MCB.00731-10; Mikolcevic P, 2012, CELL CYCLE, V11, P3758, DOI 10.4161/cc.21592; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Palacios C, 2010, CANCER LETT, V287, P207, DOI 10.1016/j.canlet.2009.06.012; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; PARDA DS, 1993, PROSTATE, V23, P91, DOI 10.1002/pros.2990230202; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Scatena CD, 1998, J BIOL CHEM, V273, P30777, DOI 10.1074/jbc.273.46.30777; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shimada K, 2004, CARCINOGENESIS, V25, P1089, DOI 10.1093/carcin/bgh130; Shirley S, 2013, CANCER LETT, V332, P141, DOI 10.1016/j.canlet.2010.10.009; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Yanagi Teruki, 2014, Oncoscience, V1, P624; Yanagi T, 2014, CANCER RES, V74, P5795, DOI 10.1158/0008-5472.CAN-14-0872	35	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119404	10.1371/journal.pone.0119404	http://dx.doi.org/10.1371/journal.pone.0119404			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790448	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400079
J	Wong, ET; Maretzky, T; Peleg, Y; Blobel, CP; Sagi, I				Wong, Eitan; Maretzky, Thorsten; Peleg, Yoav; Blobel, Carl P.; Sagi, Irit			The Functional Maturation of A Disintegrin and Metalloproteinase (ADAM) 9, 10, and 17 Requires Processing at a Newly Identified Proprotein Convertase (PC) Cleavage Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; Epidermal Growth Factor Receptor (EGFR); Furin; Metalloprotease; Shedding; Proenzyme Processing; Proprotein Convertase	ALPHA-SECRETASE ADAM10; GROWTH-FACTOR-ALPHA; 12 MELTRIN ALPHA; INTRACELLULAR MATURATION; CYSTEINE SWITCH; FURIN CLEAVAGE; PROTEIN; ACTIVATION; ECTODOMAIN; CLONING	Background: Proprotein convertases (PCs) control the maturation of several A Disintegrin and Metalloprotease (ADAM) proteases. Results: Mutating a newly identified upstream PC site interferes with activation of ADAMs 9, 10, and 17. Conclusion: Processing at the upstream PC site is important for the activation of these ADAMs. Significance: The upstream PC site in several ADAMs suggests a novel general mechanism for their maturation. Proenzyme maturation is a general mechanism to control the activation of enzymes. Catalytically active members of the A Disintegrin And Metalloprotease (ADAM) family of membrane-anchored metalloproteases are synthesized as proenzymes, in which the latency is maintained by their autoinhibitory pro-domains. A proteolytic processing then transforms the proenzyme into a catalytically active form. The removal of the pro-domain of ADAMs is currently thought to depend on processing at a canonical consensus site for the proprotein convertase Furin (RXXR) between the pro- and the catalytic domain. Here, we demonstrate that this previously described canonical site is a secondary cleavage site to a prerequisite cleavage in a newly characterized upstream PC site embedded within the pro-domain sequence. The novel upstream regulatory site is important for the maturation of several ADAM proenzymes. Mutations in the upstream regulatory site of ADAM17, ADAM10, and ADAM9 do not prevent pro-domain processing between the pro- and metalloprotease domain, but nevertheless, cause significantly reduced catalytic activity. Thus, our results have uncovered a novel functionally relevant PC processing site in the N-terminal part of the pro-domain that is important for the activation of these ADAMs. These results suggest that the novel PC site is part of a general mechanism underlying proenzyme maturation of ADAMs that is independent of processing at the previously identified canonical Furin cleavage site.	[Wong, Eitan; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-7610001 Rehovot, Israel; [Peleg, Yoav] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-7610001 Rehovot, Israel; [Maretzky, Thorsten; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Blobel, Carl P.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Blobel, Carl P.] Weill Cornell Med Coll, Dept Physiol Biophys & Syst Biol, New York, NY 10021 USA	Weizmann Institute of Science; Weizmann Institute of Science; Cornell University; Cornell University	Sagi, I (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-7610001 Rehovot, Israel.	Irit.Sagi@weizmann.ac.il	Regan, Clinton/E-6250-2012; Maretzky, Thorsten/GSN-2981-2022; Maretzky, Thorsten/AEN-1915-2022; Wong, Eitan/AHB-8360-2022; Wong, Eitan/GRN-9218-2022	Maretzky, Thorsten/0000-0003-1282-6080; 	SaveMe FP7, ISF; National Institutes of Health [GM64750]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	SaveMe FP7, ISF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by SaveMe FP7, ISF and by National Institutes of Health Grant GM64750 to C. P. B.	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Buckley CA, 2005, AM J PHYSIOL-LUNG C, V288, pL1132, DOI 10.1152/ajplung.00429.2004; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; Golubkov VS, 2010, J BIOL CHEM, V285, P27726, DOI 10.1074/jbc.M110.135442; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Hall T, 2009, BIOSCIENCE REP, V29, P217, DOI 10.1042/BSR20080145; Hooper NM, 2002, CURR MED CHEM, V9, P1107, DOI 10.2174/0929867023370121; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Howard L, 2000, BIOCHEM J, V348, P21, DOI 10.1042/0264-6021:3480021; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Kang TB, 2002, J BIOL CHEM, V277, P25583, DOI 10.1074/jbc.M203532200; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Rosenblum G, 2007, J AM CHEM SOC, V129, P13566, DOI 10.1021/ja073941l; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schwarz J, 2013, BBA-MOL CELL RES, V1833, P3355, DOI 10.1016/j.bbamcr.2013.10.005; Solomon A, 2007, P NATL ACAD SCI USA, V104, P4931, DOI 10.1073/pnas.0700066104; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Wiley HS, 1998, J CELL BIOL, V143, P1317, DOI 10.1083/jcb.143.5.1317; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	50	49	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12135	12146		10.1074/jbc.M114.624072	http://dx.doi.org/10.1074/jbc.M114.624072			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25795784	Green Published, hybrid			2022-12-26	WOS:000354388600027
J	Jiang, BJ; Shen, H; Chen, Z; Yin, L; Zan, LS; Rui, LY				Jiang, Bijie; Shen, Hong; Chen, Zheng; Yin, Lei; Zan, Linsen; Rui, Liangyou			Carboxyl Terminus of HSC70-interacting Protein (CHIP) Down-regulates NF-kappa B-inducing Kinase (NIK) and Suppresses NIK-induced Liver Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; C-TERMINUS; TUMOR-SUPPRESSOR; DEGRADATION; IMMUNODEFICIENCY; OVEREXPRESSION; IDENTIFICATION; ACTIVATION; SURVIVAL; MUTATION	Ser/Thr kinase NIK (NF-kappa B-inducing kinase) mediates the activation of the noncanonical NF-kappa B2 pathway, and it plays an important role in regulating immune cell development and liver homeostasis. NIK levels are extremely low in quiescent cells due to ubiquitin/proteasome-mediated degradation, and cytokines stimulate NIK activation through increasing NIK stability; however, regulation of NIK stability is not fully understood. Here we identified CHIP (carboxyl terminus of HSC70-interacting protein) as a new negative regulator of NIK. CHIP contains three N-terminal tetratricopeptide repeats (TPRs), a middle dimerization domain, and a C-terminal U-box. The U-box domain contains ubiquitin E3 ligase activity that promotes ubiquitination of CHIP-bound partners. We observed that CHIP bound to NIK via its TPR domain. In both HEK293 and primary hepatocytes, overexpression of CHIP markedly decreased NIK levels at least in part through increasing ubiquitination and degradation of NIK. Accordingly, CHIP suppressed NIK-induced activation of the noncanonical NF-kappa B2 pathway. CHIP also bound to TRAF3, and CHIP and TRAF3 acted coordinately to efficiently promote NIK degradation. The TPR but not the U-box domain was required for CHIP to promote NIK degradation. In mice, hepatocyte-specific overexpression of NIK resulted in liver inflammation and injury, leading to death, and liver-specific expression of CHIP reversed the detrimental effects of hepatic NIK. Our data suggest that CHIP/TRAF3/NIK interactions recruit NIK to E3 ligase complexes for ubiquitination and degradation, thus maintaining NIK at low levels. Defects in CHIP regulation of NIK may result in aberrant NIK activation in the liver, contributing to live injury, inflammation, and disease.	[Jiang, Bijie; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Natl Beef Cattle Improvement Ctr, Yangling 712100, Shaanxi, Peoples R China; [Jiang, Bijie; Shen, Hong; Chen, Zheng; Yin, Lei; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Rui, Liangyou] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	Northwest A&F University - China; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Natl Beef Cattle Improvement Ctr, Yangling 712100, Shaanxi, Peoples R China.	zanlinsen@163.com; ruily@umich.edu	shen, hong/I-6179-2016	SHEN, HONG/0000-0002-1559-3633	Michigan Diabetes Research and Training Center (National Institutes of Health) [DK020572]; Michigan Metabolomics and Obesity Center (National Institutes of Health) [DK089503]; University of Michigan Comprehensive Cancer Center (National Institutes of Health) [CA46592]; University of Michigan Nathan Shock Center (National Institutes of Health) [P30AG013283]; University of Michigan Gut Peptide Research Center (National Institutes of Health) [DK34933]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK091591, P30DK089503, R01DK094014, P30DK034933, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	Michigan Diabetes Research and Training Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Metabolomics and Obesity Center (National Institutes of Health); University of Michigan Comprehensive Cancer Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Nathan Shock Center (National Institutes of Health); University of Michigan Gut Peptide Research Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Liang Sheng, Lin Jiang, and Zheng Chen and Nish Patel for assistance and discussion. We thank Dr. Klaus Rajewsky (Immune Disease Institute, Harvard Medical School, Boston, MA) for providing STOP-NIK mice, and we thank Drs. Patterson (University of North Carolina, Chapel Hill) and Yoichi Osawa (University of Michigan) for providing CHIP and HSC70 cDNAs. This work utilized the cores supported by the Michigan Diabetes Research and Training Center (National Institutes of Health Grant DK020572), Michigan Metabolomics and Obesity Center (National Institutes of Health Grant DK089503), the University of Michigan Comprehensive Cancer Center (National Institutes of Health Grant CA46592), the University of Michigan Nathan Shock Center (National Institutes of Health Grant P30AG013283), and the University of Michigan Gut Peptide Research Center (National Institutes of Health Grant DK34933).	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Blessing NA, 2014, MOL CELL BIOL, V34, P3132, DOI 10.1128/MCB.00296-14; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Gaude H, 2012, ONCOGENE, V31, P1582, DOI 10.1038/onc.2011.342; Hacker H, 2012, J IMMUNOL, V188, P4602, DOI 10.4049/jimmunol.1200021; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Koike R, 1996, EUR J IMMUNOL, V26, P669, DOI 10.1002/eji.1830260324; Li F, 2009, J BIOL CHEM, V284, P20090, DOI 10.1074/jbc.M109.017046; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Shang Y, 2014, BIOCHEM BIOPH RES CO, V446, P387, DOI 10.1016/j.bbrc.2014.02.124; Shen H, 2014, HEPATOLOGY, V60, P2065, DOI 10.1002/hep.27348; Sheng L, 2012, NAT MED, V18, P943, DOI 10.1038/nm.2756; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Su CH, 2011, CELL SIGNAL, V23, P1824, DOI 10.1016/j.cellsig.2011.06.018; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang TX, 2014, ONCOTARGET, V5, P1969, DOI 10.18632/oncotarget.1890; Wang YQ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010132; Willmann KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6360; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	38	29	30	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11704	11714		10.1074/jbc.M114.635086	http://dx.doi.org/10.1074/jbc.M114.635086			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792747	hybrid, Green Published			2022-12-26	WOS:000353719400043
J	Amaral, FE; Parker, D; Randis, TM; Kulkarni, R; Prince, AS; Shirasu-Hiza, MM; Ratner, AJ				Amaral, Fabio E.; Parker, Dane; Randis, Tara M.; Kulkarni, Ritwij; Prince, Alice S.; Shirasu-Hiza, Mimi M.; Ratner, Adam J.			Rational Manipulation of mRNA Folding Free Energy Allows Rheostat Control of Pneumolysin Production by Streptococcus pneumoniae	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; TRANSLATION EFFICIENCY; BIAS; EXPRESSION; SELECTION; ASSOCIATION; VAGINOLYSIN; ADAPTATION; VIRULENCE	The contribution of specific factors to bacterial virulence is generally investigated through creation of genetic "knockouts" that are then compared to wild-type strains or complemented mutants. This paradigm is useful to understand the effect of presence vs. absence of a specific gene product but cannot account for concentration-dependent effects, such as may occur with some bacterial toxins. In order to assess threshold and dose-response effects of virulence factors, robust systems for tunable expression are required. Recent evidence suggests that the folding free energy (Delta G) of the 5' end of mRNA transcripts can have a significant effect on translation efficiency and overall protein abundance. Here we demonstrate that rational alteration of 5' mRNA folding free energy by introduction of synonymous mutations allows for predictable changes in pneumolysin (PLY) expression by Streptococcus pneumoniae without the need for chemical inducers or heterologous promoters. We created a panel of isogenic S. pneumoniae strains, differing only in synonymous (silent) mutations at the 5' end of the PLY mRNA that are predicted to alter Delta G. Such manipulation allows rheostat-like control of PLY production and alters the cytotoxicity of whole S. pneumoniae on primary and immortalized human cells. These studies provide proof-of-principle for further investigation of mRNA Delta G manipulation as a tool in studies of bacterial pathogenesis.	[Amaral, Fabio E.; Parker, Dane; Randis, Tara M.; Kulkarni, Ritwij; Prince, Alice S.; Ratner, Adam J.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Prince, Alice S.] Columbia Univ, Dept Pharmacol, New York, NY USA; [Shirasu-Hiza, Mimi M.] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Amaral, Fabio E.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Amaral, Fabio E.] ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal	Columbia University; Columbia University; Columbia University; Universidade do Minho	Ratner, AJ (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	ar127@columbia.edu	Parker, Dane/AAX-7001-2021	Parker, Dane/0000-0001-7304-3392; Randis, Tara/0000-0003-0348-6766; Amaral, Fabio/0000-0002-1547-8213; Ratner, Adam/0000-0003-1761-794X	National Institutes of Health [R01 AI092743, R21 AI111020]; Portuguese Foundation for Science and Technology [SFRH/BD/33901/2009]; Luso-American Development Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111020, R01AI092743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Luso-American Development Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	`This work was supported by the National Institutes of Health (www.nih.gov) (R01 AI092743 and R21 AI111020 to A.J.R.). F.E.A. was supported by the Portuguese Foundation for Science and Technology (www.fct.pt) SFRH/BD/33901/2009 and the Luso-American Development Foundation (www.flad.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008076; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Coleman JR, 2011, J INFECT DIS, V203, P1264, DOI 10.1093/infdis/jir010; Crook J, 1998, CLIN DIAGN LAB IMMUN, V5, P205, DOI 10.1128/CDLI.5.2.205-210.1998; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Johansson N, 2008, DIAGN MICR INFEC DIS, V60, P255, DOI 10.1016/j.diagmicrobio.2007.10.011; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lee SF, 2009, MICROBIOL-SGM, V155, P3581, DOI 10.1099/mic.0.030064-0; Los FCO, 2013, MICROBIOL MOL BIOL R, V77, P173, DOI 10.1128/MMBR.00052-12; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Rampersaud R, 2011, J BACTERIOL, V193, P1034, DOI 10.1128/JB.00694-10; Randis TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005207; Roller M, 2013, NUCLEIC ACIDS RES, V41, P8842, DOI 10.1093/nar/gkt673; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shockett PE, 1996, P NATL ACAD SCI USA, V93, P5173, DOI 10.1073/pnas.93.11.5173; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Supek F, 2010, GENETICS, V185, P1129, DOI 10.1534/genetics.110.115477; Tuller T, 2011, NUCLEIC ACIDS RES, V39, P4743, DOI 10.1093/nar/gkr054; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Zur H, 2012, EMBO REP, V13, P272, DOI 10.1038/embor.2011.262	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119823	10.1371/journal.pone.0119823	http://dx.doi.org/10.1371/journal.pone.0119823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798590	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300083
J	Alao, JP; Weber, AM; Shabro, A; Sunnerhagen, P				Alao, John P.; Weber, Andrea M.; Shabro, Aidin; Sunnerhagen, Per			Suppression of Sensitivity to Drugs and Antibiotics by High External Cation Concentrations in Fission Yeast	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; ANTIFUNGAL RESISTANCE; POTASSIUM-TRANSPORT; PROTEIN-PHOSPHATASE; PH HOMEOSTASIS; SALT TOLERANCE; KILLER TOXINS	Background Potassium ion homeostasis plays an important role in regulating membrane potential and therefore resistance to cations, antibiotics and chemotherapeutic agents in Schizosaccharomyces pombe and other yeasts. However, the precise relationship between drug resistance in S. pombe and external potassium concentrations (particularly in its natural habitats) remains unclear. S. pombe can tolerate a wide range of external potassium concentrations which in turn affect plasma membrane polarization. We thus hypothesized that high external potassium concentrations suppress the sensitivity of this yeast to various drugs. Methods We have investigated the effect of external KCl concentrations on the sensitivity of S. pombe cells to a wide range of antibiotics, antimicrobial agents and chemotherapeutic drugs. We employed survival assays, immunoblotting and microscopy for these studies. Results We demonstrate that KCl, and to a lesser extent NaCl and RbCl can suppress the sensitivity of S. pombe to a wide range of antibiotics. Ammonium chloride and potassium hydrogen sulphate also suppressed drug sensitivity. This effect appears to depend in part on changes to membrane polarization and membrane transport proteins. Interestingly, we have found little relationship between the suppressive effect of KCl on sensitivity and the structure, polarity or solubility of the various compounds investigated. Conclusions High concentrations of external potassium and other cations suppress sensitivity to a wide range of drugs in S. pombe. Potassium-rich environments may thus provide S. pombe a competitive advantage in nature. Modulating potassium ion homeostasis may sensitize pathogenic fungi to antifungal agents.	[Alao, John P.; Weber, Andrea M.; Shabro, Aidin; Sunnerhagen, Per] Univ Gothenburg, Dept Chem & Mol Biol, SE-40530 Gothenburg, Sweden	University of Gothenburg	Alao, JP (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Box 462, SE-40530 Gothenburg, Sweden.	john.p.alao@cmb.gu.se	Sunnerhagen, Per/G-1696-2012; Alao, John-Patrick/AAY-8645-2021	Sunnerhagen, Per/0000-0002-0967-8729; 	Swedish Research Council [2010 4645]; Chemical Biology Platform at the University of Gothenburg	Swedish Research Council(Swedish Research CouncilEuropean Commission); Chemical Biology Platform at the University of Gothenburg	This work was financially supported by the Swedish Research Council (2010 4645) and the Chemical Biology Platform at the University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2012, MICROBIOL-SGM, V158, P1258, DOI 10.1099/mic.0.057075-0; AHMED S, 1983, BIOCHEM J, V212, P105, DOI 10.1042/bj2120105; Alao JP, 2008, MOL MICROBIOL, V68, P246, DOI 10.1111/j.1365-2958.2008.06147.x; Alao JP, 2010, MOL MICROBIOL, V77, P143, DOI 10.1111/j.1365-2958.2010.07193.x; Alcazar-Fuoli L, 2014, BRIT J HAEMATOL, V166, P471, DOI 10.1111/bjh.12896; Aouida M, 2004, BIOCHEM J, V384, P47, DOI 10.1042/BJ20040392; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Aouida M, 2004, CURR GENET, V45, P265, DOI 10.1007/s00294-004-0492-x; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Asher V, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-113; Balcells L, 1997, EUR J BIOCHEM, V250, P476, DOI 10.1111/j.1432-1033.1997.0476a.x; Bianchi L, 1998, CANCER RES, V58, P815; Brown WRA, 2011, G3-GENES GENOM GENET, V1, P615, DOI 10.1534/g3.111.001123; Calero F, 2003, FEMS YEAST RES, V4, P1, DOI 10.1016/S1567-1356(03)00111-9; Calero F, 2000, J BACTERIOL, V182, P394, DOI 10.1128/JB.182.2.394-399.2000; Canovas D, 2007, FEMS MICROBIOL ECOL, V61, P258, DOI 10.1111/j.1574-6941.2007.00344.x; Castaneda-Garcia A, 2011, J ANTIMICROB CHEMOTH, V66, P1489, DOI 10.1093/jac/dkr165; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080; FAPARUSI SI, 1972, APPL MICROBIOL, V24, P853, DOI 10.1128/AEM.24.6.853-856.1972; Forsburg SL, 2003, GROWTH MANIPULATION, pChapter 13; Georgopapadakou NH, 1996, ANTIMICROB AGENTS CH, V40, P279, DOI 10.1128/AAC.40.2.279; GRAVEN SN, 1966, P NATL ACAD SCI USA, V56, P654, DOI 10.1073/pnas.56.2.654; GUFFANTI AA, 1979, J GEN MICROBIOL, V114, P201, DOI 10.1099/00221287-114-1-201; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; KAGAN BL, 1983, NATURE, V302, P709, DOI 10.1038/302709a0; Konings WN, 2000, CURR OPIN MICROBIOL, V3, P276, DOI 10.1016/S1369-5274(00)00089-8; LAFONLAFOURCADE S, 1983, A VAN LEEUW J MICROB, V49, P349, DOI 10.1007/BF00399509; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Miceli MH, 2011, MYCOSES, V54, pE666, DOI 10.1111/j.1439-0507.2011.02032.x; Navarro L, 2000, J APPL MICROBIOL, V88, P44, DOI 10.1046/j.1365-2672.2000.00865.x; NKANGA EJ, 1978, ANTIMICROB AGENTS CH, V14, P51, DOI 10.1128/AAC.14.1.51; PERLIN DS, 1988, J BIOL CHEM, V263, P18118; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Sheehan DJ, 1999, CLIN MICROBIOL REV, V12, P40, DOI 10.1128/CMR.12.1.40; Stella CA, 2001, ANTIMICROB AGENTS CH, V45, P1589, DOI 10.1128/AAC.45.5.1589-1590.2001; Teixeira MC, 2011, MICROBIOL-SGM, V157, P945, DOI 10.1099/mic.0.043661-0; Tenreiro S, 2005, BIOCHEM BIOPH RES CO, V327, P952, DOI 10.1016/j.bbrc.2004.12.097; Thornton G, 2005, GENES CELLS, V10, P941, DOI 10.1111/j.1365-2443.2005.00891.x; Vanden B.H., 1989, FOCUS AZOLE ANTIF S1, V32, P35, DOI DOI 10.1111/j.1439-0507.1989.tb02293.x; Vargas RC, 2007, EUKARYOT CELL, V6, P134, DOI 10.1128/EC.00290-06; VERTUTDOI A, 1988, BIOCHEM BIOPH RES CO, V157, P692, DOI 10.1016/S0006-291X(88)80305-X; VILLALOBO A, 1982, J BIOL CHEM, V257, P1824; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wang LY, 2005, MOL CELL BIOL, V25, P3945, DOI 10.1128/MCB.25.10.3945-3955.2005; Wright MB, 1997, J BIOL CHEM, V272, P13647, DOI 10.1074/jbc.272.21.13647; Yang XX, 2006, FEMS YEAST RES, V6, P195, DOI 10.1111/j.1567-1364.2006.00026.x; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939	53	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119297	10.1371/journal.pone.0119297	http://dx.doi.org/10.1371/journal.pone.0119297			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793410	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200069
J	Bukontaite, R; Ranarilalatiana, T; Randriamihaja, JH; Bergsten, J				Bukontaite, Rasa; Ranarilalatiana, Tolotra; Randriamihaja, Jacquelin Herisahala; Bergsten, Johannes			In or Out-of-Madagascar?-Colonization Patterns for Large-Bodied Diving Beetles (Coleoptera: Dytiscidae)	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; EXONEURINE ALLODAPINE BEES; MOLECULAR PHYLOGENY; SINGLE-ORIGIN; EVOLUTIONARY HISTORY; ENDEMIC CLADES; DIVERSIFICATION; BIOGEOGRAPHY; RADIATION; INFERENCE	High species diversity and endemism within Madagascar is mainly the result of species radiations following colonization from nearby continents or islands. Most of the endemic taxa are thought to be descendants of a single or small number of colonizers that arrived from Africa sometime during the Cenozoic and gave rise to highly diverse groups. This pattern is largely based on vertebrates and a small number of invertebrate groups. Knowledge of the evolutionary history of aquatic beetles on Madagascar is lacking, even though this species-rich group is often a dominant part of invertebrate freshwater communities in both standing and running water. Here we focus on large bodied diving beetles of the tribes Hydaticini and Cybistrini. Our aims with this study were to answer the following questions 1) How many colonization events does the present Malagasy fauna originate from? 2) Did any colonization event lead to a species radiation? 3) Where did the colonizers come from-Africa or Asia- and has there been any out-of-Madagascar event? 4) When did these events occur and were they concentrated to any particular time interval? Our results suggest that neither in Hydaticini nor in Cybistrini was there a single case of two or more endemic species forming a monophyletic group. The biogeographical analysis indicated different colonization histories for the two tribes. Cybistrini required at least eight separate colonization events, including the non-endemic species, all comparatively recent except the only lotic (running water) living Cybister operosus with an inferred colonization at 29 Ma. In Hydaticini the Madagascan endemics were spread out across the tree, often occupying basal positions in different species groups. The biogeographical analyses therefore postulated the very bold hypothesis of a Madagascan origin at a very deep basal node within Hydaticus and multiple out-of-Madagascar dispersal events. This hypothesis needs to be tested with equally intense taxon sampling of mainland Africa as for Madagascar.	[Bukontaite, Rasa; Bergsten, Johannes] Swedish Museum Nat Hist, Dept Zool, Box 50007, S-10405 Stockholm, Sweden; [Bukontaite, Rasa] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Ranarilalatiana, Tolotra; Randriamihaja, Jacquelin Herisahala] Univ Antananarivo, Fac Sci, Dept Entomol, Antananarivo, Madagascar; [Ranarilalatiana, Tolotra; Randriamihaja, Jacquelin Herisahala] Programme Natl Lutte Paludisme Madagascar, Antananarivo 101, Madagascar	Swedish Museum of Natural History; Stockholm University; University Antananarivo	Bukontaite, R (corresponding author), Swedish Museum Nat Hist, Dept Zool, Box 50007, S-10405 Stockholm, Sweden.	rasa.bukontaite@nrm.se			Swedish Research Council [2009-3744]; Royal Swedish Academy of Sciences [FOA09H-024]; Riksmusei Vanner (Rene och Ebba Malaises stiftelse); Entomological Society in Stockholm	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Riksmusei Vanner (Rene och Ebba Malaises stiftelse); Entomological Society in Stockholm	This work was supported by the Swedish Research Council (Grant No: 2009-3744) to JB, the Royal Swedish Academy of Sciences (Grant No: FOA09H-024) to JB, Riksmusei Vanner (Rene och Ebba Malaises stiftelse) to JB and from the Entomological Society in Stockholm to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2012, CURRENT TOPICS IN PHYLOGENETICS AND PHYLOGEOGRAPHY OF TERRESTRIAL AND AQUATIC SYSTEMS, P33; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Almeida EAB, 2012, J BIOGEOGR, V39, P526, DOI 10.1111/j.1365-2699.2011.02624.x; [Anonymous], 2015, PHYTOPATHOLOGY, DOI DOI 10.1094/PHYTO-04-15-0101-RVW; [Anonymous], 2003, P BIOL SCI; Balke M., 1993, Koleopterologische Rundschau, V63, P39; Balke M, 2010, DYTISCIDAE GENUS RHA, P129; Balke M, 2007, ZOOL SCR, V36, P173, DOI 10.1111/j.1463-6409.2006.00265.x; Balke M, 2009, P ROY SOC B-BIOL SCI, V276, P2359, DOI 10.1098/rspb.2009.0015; Benstead JP, 2003, BIOSCIENCE, V53, P1101, DOI 10.1641/0006-3568(2003)053[1101:CMFB]2.0.CO;2; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Buerki S, 2013, BOT J LINN SOC, V171, P304, DOI 10.1111/boj.12008; Buerki S, 2011, J BIOGEOGR, V38, P531, DOI 10.1111/j.1365-2699.2010.02432.x; Bukontaite R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-5; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Chenoweth LB, 2011, J BIOGEOGR, V38, P1471, DOI 10.1111/j.1365-2699.2011.02488.x; Crandall KA, 2008, HYDROBIOLOGIA, V595, P295, DOI 10.1007/s10750-007-9120-3; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Daniels SR, 2006, MOL PHYLOGENET EVOL, V40, P227, DOI 10.1016/j.ympev.2006.02.022; Dijkstra KDB, 2014, ANNU REV ENTOMOL, V59, P143, DOI 10.1146/annurev-ento-011613-161958; Douady CJ, 2002, MOL PHYLOGENET EVOL, V22, P357, DOI 10.1006/mpev.2001.1055; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duncan R.A., 1990, P ODP SCI RESULTS, V115, P43, DOI DOI 10.2973/ODP.PROC.SR.115.141.1990; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filardi CE, 2005, NATURE, V438, P216, DOI 10.1038/nature04057; Gioria Margherita, 2014, P307; Goodman SM, 2005, UPDATED ESTIMATES BI, P39; Goswami A, 2010, ZOOL SCR, V39, P406, DOI 10.1111/j.1463-6409.2010.00433.x; Griffith MB, 1998, ANN ENTOMOL SOC AM, V91, P195, DOI 10.1093/aesa/91.2.195; Hanski I, 2007, BIOLOGY LETT, V3, P344, DOI 10.1098/rsbl.2007.0043; Harmon LJ, 2008, SYST BIOL, V57, P562, DOI 10.1080/10635150802304779; Harris AJ, 2009, J SYST EVOL, V47, P349, DOI 10.1111/j.1759-6831.2009.00044.x; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Heads M, 2011, SYST BIOL, V60, P204, DOI 10.1093/sysbio/syq075; Hjalmarsson AE, 2014, ECOGRAPHY; Hjalmarsson AE, 2013, ZOOKEYS, P21, DOI 10.3897/zookeys.350.6127; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Isambert B, 2011, BIOL CONSERV, V144, P1902, DOI 10.1016/j.biocon.2011.04.016; Jackson D. J., 1956, Journal of the Linnean Society London, V43, P18; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; Kodandaramaiah U, 2010, J BIOGEOGR, V37, P3, DOI 10.1111/j.1365-2699.2009.02221.x; Kruger A, 2012, TAXON, V61, P629, DOI 10.1002/tax.613011; Kuntner M, 2011, MOL PHYLOGENET EVOL, V59, P477, DOI 10.1016/j.ympev.2011.02.002; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; LOBL I., 2003, ARCHOSTEMATA MYXOPHA, V1, P1, DOI DOI 10.1673/031.013.12601; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; Matzke N, 2013, PROBABILISTIC HIST B, P1; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Miller KB, 2003, BIOL J LINN SOC, V79, P359, DOI 10.1046/j.1095-8312.2003.00195.x; Miller KB, ECOLOGY SYSTEM UNPUB; Miller KB, 2007, ZOOL SCR, V36, P41, DOI 10.1111/j.1463-6409.2006.00254.x; Miller KB, 2009, ZOOL SCR, V38, P591, DOI 10.1111/j.1463-6409.2009.00393.x; Miraldo Andreia, 2011, Insects, V2, P112, DOI 10.3390/insects2020112; Monaghan MT, 2005, P ROY SOC B-BIOL SCI, V272, P1829, DOI 10.1098/rspb.2005.3139; Moriniere J, 2014, CLADISTICS, P1; Nazari V, 2011, J ZOOL SYST EVOL RES, V49, P204, DOI 10.1111/j.1439-0469.2011.00620.x; Nilsson AN, 2001, DYTISCIDAE COLEOPTER, P1; Nobre T, 2010, P ROY SOC B-BIOL SCI, V277, P359, DOI 10.1098/rspb.2009.1373; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; Orsini L, 2007, CLADISTICS, V23, P145, DOI 10.1111/j.1096-0031.2006.00139.x; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; PECK SB, 1993, CAN ENTOMOL, V125, P259, DOI 10.4039/Ent125259-2; Pena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039071; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Raxworthy CJ, 2008, J ZOOL, V275, P423, DOI 10.1111/j.1469-7998.2008.00460.x; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rehan SM, 2010, MOL PHYLOGENET EVOL, V55, P1042, DOI 10.1016/j.ympev.2010.01.011; Ribera I, 2008, CLADISTICS, V24, P563, DOI 10.1111/j.1096-0031.2007.00192.x; Rocchi S., 1991, Frustula Entomologica, V14, P71; Rocha S, 2007, MOL PHYLOGENET EVOL, V43, P685, DOI 10.1016/j.ympev.2006.07.010; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Sandwell DT, 2014, SCIENCE, V346, P65, DOI 10.1126/science.1258213; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schwarz MP, 2006, SYST BIOL, V55, P31, DOI 10.1080/10635150500431148; Sole CL, 2011, INSECT SYST EVOL, V42, P29, DOI 10.1163/187631211X552800; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toon A, 2010, J BIOGEOGR, V37, P2275, DOI 10.1111/j.1365-2699.2010.02374.x; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; van den Bogaard P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02107; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Vuataz L, 2013, MOL PHYLOGENET EVOL, V66, P979, DOI 10.1016/j.ympev.2012.12.003; Warren BH, 2003, MOL PHYLOGENET EVOL, V29, P67, DOI 10.1016/S1055-7903(03)00063-0; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; Wells NA, 2003, SOME HYPOTHESES MESO; Wikstrom N, 2010, J BIOGEOGR, V37, P1094, DOI 10.1111/j.1365-2699.2009.02258.x; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wirta H, 2010, MOL PHYLOGENET EVOL, V57, P710, DOI 10.1016/j.ympev.2010.08.013; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zakharov EV, 2004, EVOLUTION, V58, P2763	106	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120777	10.1371/journal.pone.0120777	http://dx.doi.org/10.1371/journal.pone.0120777			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794184	Green Submitted, Green Published, gold			2022-12-26	WOS:000352083900074
J	Dicay, MS; Hirota, CL; Ronaghan, NJ; Peplowski, MA; Zaheer, RS; Carati, CA; MacNaughton, WK				Dicay, Michael S.; Hirota, Christina L.; Ronaghan, Natalie J.; Peplowski, Michael A.; Zaheer, Raza S.; Carati, Colin A.; MacNaughton, Wallace K.			Interferon-gamma Suppresses Intestinal Epithelial Aquaporin-1 Expression via Janus Kinase and STAT3 Activation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; RECEPTOR; IRF-1; TRANSLOCATION; MACROPHAGES; MODEL	Inflammatory bowel diseases are associated with dysregulated electrolyte and water transport and resultant diarrhea. Aquaporins are transmembrane proteins that function as water channels in intestinal epithelial cells. We investigated the effect of the inflammatory cytokine, interferon-gamma, which is a major player in inflammatory bowel diseases, on aquaporin-1 expression in a mouse colonic epithelial cell line, CMT93. CMT93 monolayers were exposed to 10 ng/mL interferon-gamma and aquaporin-1 mRNA and protein expressions were measured by real-time PCR and western blot, respectively. In other experiments, CMT93 cells were pretreated with inhibitors or were transfected with siRNA to block the effects of Janus kinases, STATs 1 and 3, or interferon regulatory factor 2, prior to treatment with interferon-gamma. Interferon-gamma decreased aquaporin-1 expression in mouse intestinal epithelial cells in a manner that did not depend on the classical STAT1/JAK2/IRF-1 pathway, but rather, on an alternate Janus kinase (likely JAK1) as well as on STAT3. The pro-inflammatory cytokine, interferon-gamma may contribute to diarrhea associated with intestinal inflammation in part through regulation of the epithelial aquaporin-1 water channel via a non-classical JAK/STAT receptor signalling pathway.	[Dicay, Michael S.; Hirota, Christina L.; Ronaghan, Natalie J.; Peplowski, Michael A.; Zaheer, Raza S.; MacNaughton, Wallace K.] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada; [Dicay, Michael S.; Hirota, Christina L.; Ronaghan, Natalie J.; Peplowski, Michael A.; Zaheer, Raza S.; MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Carati, Colin A.] Flinders Univ S Australia, Dept Anat & Histol, Bedford Pk, SA 5042, Australia	University of Calgary; University of Calgary; Flinders University South Australia	MacNaughton, WK (corresponding author), Univ Calgary, Inflammat Res Network, Calgary, AB, Canada.	wmacnaug@ucalgary.ca	Hirota, Christina/AAS-8585-2020	Hirota, Christina/0000-0003-0799-2041	Crohn's and Colitis Foundation of Canada	Crohn's and Colitis Foundation of Canada	Funding was provided by Crohn's and Colitis Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ani B, 1999, BRIT J PHARMACOL, V128, P1105, DOI 10.1038/sj.bjp.0702834; Asfaha S, 2001, AM J PHYSIOL-GASTR L, V281, pG635, DOI 10.1152/ajpgi.2001.281.3.G635; Blanco JCG, 2000, J EXP MED, V191, P2131, DOI 10.1084/jem.191.12.2131; Caldenhoven E, 1999, J LEUKOCYTE BIOL, V65, P391, DOI 10.1002/jlb.65.3.391; Duan ZF, 2006, CLIN CANCER RES, V12, P6844, DOI 10.1158/1078-0432.CCR-06-1330; Finley MJ, 2011, J LEUKOCYTE BIOL, V90, P111, DOI 10.1189/jlb.1010546; FRANKS LM, 1978, J PATHOL, V124, P35, DOI 10.1002/path.1711240108; Glover LE, 2011, J IMMUNOL, V186, P1790, DOI 10.4049/jimmunol.1001442; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; Hardin JA, 2004, CELL TISSUE RES, V318, P313, DOI 10.1007/s00441-004-0932-4; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Laforenza U, 2012, MOL ASPECTS MED, V33, P642, DOI 10.1016/j.mam.2012.03.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKay DM, 1996, AM J PHYSIOL-CELL PH, V270, pC418, DOI 10.1152/ajpcell.1996.270.2.C418; Ng IHW, 2012, BIOCHEM J, V447, P125, DOI 10.1042/BJ20120941; Paul G, 2012, J BIOL CHEM, V287, P2144, DOI 10.1074/jbc.M111.318139; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Sakai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054788; Salkowski CA, 1999, J IMMUNOL, V163, P1529; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Thiagarajah JR, 2007, GUT, V56, P1529, DOI 10.1136/gut.2006.104620; Zahn A, 2007, WORLD J GASTROENTERO, V13, P1687, DOI 10.3748/wjg.v13.i11.1687	24	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118713	10.1371/journal.pone.0118713	http://dx.doi.org/10.1371/journal.pone.0118713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793528	gold, Green Published, Green Submitted			2022-12-26	WOS:000352084200034
J	Kang, SH; Jung, DJ; Cho, KH; Park, JW; Yoon, KW; Do, JY				Kang, Seok Hui; Jung, Da Jung; Cho, Kyu Hyang; Park, Jong Won; Yoon, Kyung Woo; Do, Jun Young			The Association between Metabolic Syndrome or Chronic Kidney Disease and Hearing Thresholds in Koreans: The Korean National Health and Nutrition Examination Survey 2009-2012	PLOS ONE			English	Article							RISK-FACTORS; US ADULTS; RENAL-FAILURE; UNITED-STATES; INNER-EAR; POPULATION; IMPAIRMENT; PREVALENCE; HYPERFILTRATION; WOMEN	Background The aim of this study was to determine whether metabolic syndrome (MetS) or chronic kidney disease (CKD) is associated with hearing thresholds in the general Korean population. Patients and Methods A total of 16,554 participants were included in this study. MetS was defined using the National Cholesterol Education Program Adult Treatment Panel III guidelines, and CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2) or a dipstick protein-uria result of >= 1+. The hearing thresholds were measured at 0.5, 1, 2, 3, 4, and 6 kHz. Low-frequency (Freq) was defined as pure-tone averages at 0.5 and 1 kHz, while Mid-Freq and High-Freq were defined as the average thresholds at mid-frequency (2 and 3 kHz) and high frequency (4 and 6 kHz), respectively. Results In men, the hearing thresholds were 15.1 +/- 14.5 dB, 22.2 +/- 21.3 dB, and 37.3 +/- 26.5 dB for Low-, Mid-, and High-Freq, respectively. In women, the hearing thresholds were 14.9 +/- 15.3 dB, 16.6 +/- 18.0 dB, and 26.1 +/- 21.5 dB for Low-, Mid-, and High-Freq, respectively. The hearing thresholds for men were significantly higher than the hearing thresholds for women in all 3 threshold categories. Male and female subjects with MetS or CKD had higher hearing thresholds than the subjects that did not have these disorders. In the multivariate analysis, MetS was associated with increased hearing thresholds in women, and CKD was associated with increased hearing thresholds in men and women. Conclusion MetS is associated with hearing thresholds in women, and CKD is associated with hearing thresholds in men and women. Therefore, patients with MetS or CKD should be closely monitored for hearing impairment.	[Kang, Seok Hui; Cho, Kyu Hyang; Park, Jong Won; Yoon, Kyung Woo; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea; [Jung, Da Jung] Kyungpook Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Daegu, South Korea	Yeungnam University; Yeungnam University Hospital; Kyungpook National University; Kyungpook National University Hospital	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.	jydo@med.yu.ac.kr						ADLER D, 1980, ACTA OTO-LARYNGOL, V90, P55, DOI 10.3109/00016488009131697; Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Agrawal Y, 2009, OTOL NEUROTOL, V30, P139, DOI 10.1097/MAO.0b013e318192483c; Akiyama K, 2010, J HISTOCHEM CYTOCHEM, V58, P759, DOI 10.1369/jhc.2010.956045; [Anonymous], 2010, AUDIOL MED; Antonelli A R, 1990, Acta Otolaryngol Suppl, V476, P54; ARNOLD W, 1984, ANN OTO RHINOL LARYN, V93, P119, DOI 10.1177/00034894840930S420; Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231; Bainbridge KE, 2011, DIABETES CARE, V34, P1540, DOI 10.2337/dc10-2161; Bainbridge KE, 2010, DIABETES CARE, V33, P811, DOI 10.2337/dc09-1193; BAZZI C, 1995, NEPHROL DIAL TRANSPL, V10, P1865; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Cao X, 2014, INT UROL NEPHROL, V46, P2183, DOI 10.1007/s11255-014-0805-z; DEFRONZO RA, 1981, J CLIN INVEST, V67, P563, DOI 10.1172/JCI110067; Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Flamme GA, 2011, INT J AUDIOL, V50, pS11, DOI 10.3109/14992027.2010.540582; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Frisina ST, 2006, HEARING RES, V211, P103, DOI 10.1016/j.heares.2005.09.002; GATLAND D, 1991, J ROY SOC MED, V84, P587; Gohh R., 2013, R I MED J, V104, P14; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Hederstierna C, 2007, ACTA OTO-LARYNGOL, V127, P149, DOI 10.1080/00016480600794446; Hwang JH, 2011, CLIN ENDOCRINOL, V75, P614, DOI 10.1111/j.1365-2265.2011.04090.x; Kang HT, 2013, NEPHROL DIAL TRANSPL, V28, P927, DOI 10.1093/ndt/gfs535; Kang JW, 2014, AM J CLIN NUTR, V99, P1407, DOI 10.3945/ajcn.113.072793; Kang YU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093795; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT SUPPL, V2, P337; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; Miller RK, 2010, DEV DYNAM, V239, P77, DOI 10.1002/dvdy.22059; MORTON LP, 1992, ADV PERIT D, V8, P150; Odagiri K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088873; Oh SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094120; Ohashi T, 1999, ANN OTO RHINOL LARYN, V108, P955, DOI 10.1177/000348949910801006; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Schaeffner ES, 2008, NEPHROL DIAL TRANSPL, V23, P1246, DOI 10.1093/ndt/gfm757; Shargorodsky J, 2010, LARYNGOSCOPE, V120, P1887, DOI 10.1002/lary.21039; Thodi C, 2006, NEPHROL DIAL TRANSPL, V21, P3023, DOI 10.1093/ndt/gfl472; Tsuruya K, 2014, ATHEROSCLEROSIS, V233, P260, DOI 10.1016/j.atherosclerosis.2013.12.037; Vilayur E, 2010, AM J KIDNEY DIS, V56, P661, DOI 10.1053/j.ajkd.2010.05.015; Woodcock K, 2008, INT J REHABIL RES, V31, P297, DOI 10.1097/MRR.0b013e3282fb7d4d; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021	48	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120372	10.1371/journal.pone.0120372	http://dx.doi.org/10.1371/journal.pone.0120372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794036	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900019
J	Liu, X; Hinney, A; Scholz, M; Scherag, A; Tonjes, A; Stumvoll, M; Stadler, PF; Hebebrand, J; Bottcher, Y				Liu, Xuanshi; Hinney, Anke; Scholz, Markus; Scherag, Andre; Toenjes, Anke; Stumvoll, Michael; Stadler, Peter F.; Hebebrand, Johannes; Boettcher, Yvonne			Indications for Potential Parent-of-Origin Effects within the FTO Gene	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; COMMON VARIANTS; FAT MASS; MISSING HERITABILITY; SEQUENCE VARIANTS; EARLY-ONSET; LOCI; OBESITY; POPULATION	Genome-Wide Association Studies (GWAS) were successfully applied to discover associations with obesity. However, the GWAS design is usually based on unrelated individuals and inheritance information on the parental origin of the alleles is missing. Taking into account parent-of-origin may provide further insights into the genetic mechanisms contributing to obesity. We hypothesized that there may be variants within the robustly replicated fat mass and obesity associated (FTO) gene that may confer different risk for obesity depending on transmission from mother or father. Genome-wide genotypes and pedigree information from the Sorbs population were used. Phased genotypes among 525 individuals were generated by AlphaImpute. Subsequently, 22 SNPs within FTO introns 1 to 3 were selected and parent-of-origin specific association analyses were performed using PLINK. Interestingly, we identified several SNPs conferring different genetic effects (P <= 0.05) depending on parental origin-among them, rs1861868, rs1121980 and rs9939973 (all in intron 1). To confirm our findings, we investigated the selected variants in 705 German trios comprising an (extremely) obese child or adolescent and both parents. Again, we observed evidence for POE effects in intron 2 and 3 (P <= 0.05) as indicated by the parental asymmetry test. Our results suggest that the obesity risk transmitted by several FTO variants may depend on the parental origin of the allele. Larger family-based studies are warranted to replicate our findings.	[Liu, Xuanshi; Stumvoll, Michael; Boettcher, Yvonne] Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany; [Liu, Xuanshi] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Hinney, Anke; Hebebrand, Johannes] Univ Duisburg Essen, Psychosomat & Psychotherapy Uni Klinkum Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Scherag, Andre] Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr IFB, Clin Epidemiol, Jena, Germany; [Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Stadler, Peter F.] AG RNom, Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Stadler, Peter F.] Sante Fe Inst, Santa Fe, NM USA	Leipzig University; Leipzig University; University of Duisburg Essen; Leipzig University; Friedrich Schiller University of Jena; Leipzig University; Fraunhofer Gesellschaft; Leipzig University; University of Vienna; The Santa Fe Institute	Bottcher, Y (corresponding author), Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany.	yvonne.boettcher@medizin.uni-leipzig.de	Hinney, Anke/D-6953-2011; Stumvoll, Michael/ABE-1121-2021; Stadler, Peter F. F/L-7857-2015	Hinney, Anke/0000-0001-5659-0706; Stumvoll, Michael/0000-0001-6225-8240; Stadler, Peter F. F/0000-0002-5016-5191	German Research Foundation [BO 3147/4-1, DFG - SFB 1052 C01, SPP 1629 TO 718/2-1]; German Diabetes Association; DDS Foundation; IFB AdiposityDiseases [ADI-K50D, K7-45, ADI-K7-39, ADI-K-7-38]; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001, FKZ: 01EO1002, 01GI1120A, 01GI1120B]; Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank) [FKZ 01GI1128]; Deutsche Forschungsgemeinschaft [SFB 1052/1, HI1865/2-1]; LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony; European Union [262055 ESGI]; BMBF (NGFN-Plus) [01GS0820]	German Research Foundation(German Research Foundation (DFG)); German Diabetes Association; DDS Foundation; IFB AdiposityDiseases; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony; European Union(European Commission); BMBF (NGFN-Plus)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (BO 3147/4-1 to Y.B and DFG - SFB 1052 C01, SPP 1629 TO 718/2-1 to A.T.). This work was further supported by grants from the German Diabetes Association (to Y.B.) and from the DDS Foundation to Y.B. Y.B was further supported by a research grant from the IFB AdiposityDiseases ADI-K50D; K7-45; and ADI-K7-39, ADI-K-7-38. IFB AdiposityDiseases is supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. This work was further supported by the Kompetenznetz Adipositas (Competence network for Obesity) funded by the Federal Ministry of Education and Research (German Obesity Biomaterial Bank; FKZ 01GI1128), a grant from Deutsche Forschungsgemeinschaft the SFB 1052/1: "Obesity mechanisms" (project A01) (to M. S.). This work is supported by LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. The work of A.H. was supported by grants from the European Union (FP7 no262055 ESGI), the BMBF (NGFN-Plus; 01GS0820) and the Deutsche Forschungsgemeinschaft (HI1865/2-1). A. S. who performed the PAT analyses is supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1002, 01GI1120A, and 01GI1120B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gong J, 2013, AM J HUM GENET, V93, P661, DOI 10.1016/j.ajhg.2013.08.012; Gorkin DU, 2014, NATURE, V507, P309, DOI 10.1038/nature13212; Gross A, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-67; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Hebebrand J, 1994, AKTUELLE ERNAHRUNGSM; Hickey JM, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-9; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hoggart CJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004508; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Knoll N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055884; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Paterson AD, 1999, HUM HERED, V49, P197, DOI 10.1159/000022875; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tonjes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107; Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	40	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119206	10.1371/journal.pone.0119206	http://dx.doi.org/10.1371/journal.pone.0119206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793382	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084200060
J	McCarty, G; Loeb, DM				McCarty, Gregory; Loeb, David M.			Hypoxia-Sensitive Epigenetic Regulation of an Antisense-Oriented lncRNA Controls WT1 Expression in Myeloid Leukemia Cells	PLOS ONE			English	Article							TUMOR SUPPRESSOR WT1; MINIMAL RESIDUAL DISEASE; DNA METHYLATION; MESSENGER-RNA; PEDIATRIC AML; GENE WT1; DIFFERENTIATION; DIAGNOSIS; SURVIVAL; ROLES	WT1 is a transcription factor expressed in hematopoietic stem cells and in most cases of myeloid leukemia. We investigated the roles of hypoxia and epigenetics in the regulation of WT1 expression in myeloid leukemia cells. WT1 expression correlates with hypomethylation of the CpG island in Intron 1, and pharmacologic demethylation of this CpG island induces WT1 mRNA expression. Hypoxia causes decreases in DNMT expression and activity and increased expression and activity of TET2 and TET3, resulting in demethylation of this CpG island and expression of WT1 mRNA. Demethylation of the CpG island, either from pharmacologic treatment or induction of hypoxia, results in transcription of an antisense-oriented lncRNA, and inhibiting lncRNA expression with shRNA blocks WT1 mRNA expression. These results reveal a novel model of hypoxia-mediated epigenetic gene regulation. In addition, this is the first report that TET2 and TET3, increasingly recognized as important epigenetic regulators of gene expression in stem cells and in cancer cells, can be regulated by hypoxia, providing a solid mechanistic link between hypoxia and epigenetic regulation of gene expression with important implications for the role of hypoxia in stem cell function.	[McCarty, Gregory; Loeb, David M.] Johns Hopkins Univ, Dept Oncol, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Loeb, DM (corresponding author), Johns Hopkins Univ, Dept Oncol, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	loebda@jhmi.edu			Children's Cancer Foundation; Heather Brooke Foundation; Giant Food Children's Cancer Research Fund	Children's Cancer Foundation; Heather Brooke Foundation; Giant Food Children's Cancer Research Fund	This work was funded by the Children's Cancer Foundation, The Heather Brooke Foundation, Giant Food Children's Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Chawla RK, 1996, J CELL BIOCHEM, V61, P72; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Cilloni D, 2009, J CLIN ONCOL, V27, P5195, DOI 10.1200/JCO.2009.22.4865; Dallosso AR, 2007, RNA, V13, P2287, DOI 10.1261/rna.562907; Dallosso AR, 2004, HUM MOL GENET, V13, P405, DOI 10.1093/hmg/ddh038; Dao T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005661; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Ellisen LW, 2001, EMBO J, V20, P1897, DOI 10.1093/emboj/20.8.1897; Fatemi M, 2014, CANCER-AM CANCER SOC, V120, P172, DOI 10.1002/cncr.28316; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Ho PA, 2014, PEDIATR BLOOD CANCER, V61, P81, DOI 10.1002/pbc.24700; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; Loeb DM, 2001, CANCER RES, V61, P921; Malik K, 2000, CANCER RES, V60, P2356; Maurer U, 1997, EXP HEMATOL, V25, P945; McCarty G, 2011, J BIOL CHEM, V286, P43634, DOI 10.1074/jbc.M111.310128; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; Miglino M, 2011, LEUKEMIA LYMPHOMA, V52, P1961, DOI 10.3109/10428194.2011.585673; MIWA H, 1992, LEUKEMIA, V6, P405; Moorwood K, 1998, J PATHOL, V185, P352, DOI 10.1002/(SICI)1096-9896(199808)185:4<352::AID-PATH119>3.0.CO;2-#; Noronha SA, 2009, PEDIATR BLOOD CANCER, V53, P1136, DOI 10.1002/pbc.22142; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Shide K, 2012, LEUKEMIA, V26, P2216, DOI 10.1038/leu.2012.94; Skowronski K, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12400; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Wagner KD, 2003, FASEB J, V17, P1364, DOI 10.1096/fj.02-1065fje; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Ward A, 1998, J PATHOL, V185, P342, DOI 10.1002/(SICI)1096-9896(199808)185:4<342::AID-PATH136>3.0.CO;2-9; Willasch AM, 2009, LEUKEMIA, V23, P1472, DOI 10.1038/leu.2009.51; Yang WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088827	37	47	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119837	10.1371/journal.pone.0119837	http://dx.doi.org/10.1371/journal.pone.0119837			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794157	Green Published, gold, Green Submitted			2022-12-26	WOS:000352084200121
J	Moser, CB; Gupta, M; Archer, BN; White, LF				Moser, Carlee B.; Gupta, Mayetri; Archer, Brett N.; White, Laura F.			The Impact of Prior Information on Estimates of Disease Transmissibility Using Bayesian Tools	PLOS ONE			English	Article							INFLUENZA-A H1N1; SERIAL INTERVAL; REPRODUCTION NUMBER; GENERATION INTERVAL; PARAMETERS	The basic reproductive number (R-0) and the distribution of the serial interval (SI) are often used to quantify transmission during an infectious disease outbreak. In this paper, we present estimates of R-0 and SI from the 2003 SARS outbreak in Hong Kong and Singapore, and the 2009 pandemic influenza A(H1N1) outbreak in South Africa using methods that expand upon an existing Bayesian framework. This expanded framework allows for the incorporation of additional information, such as contact tracing or household data, through prior distributions. The results for the R-0 and the SI from the influenza outbreak in South Africa were similar regardless of the prior information ((R-0) over cap = 1.36-1.46, (mu) over cap = 2.0-2.7, (mu) over cap = mean of the SI). The estimates of R-0 and mu for the SARS outbreak ranged from 2.0-4.4 and 7.4-11.3, respectively, and were shown to vary depending on the use of contact tracing data. The impact of the contact tracing data was likely due to the small number of SARS cases relative to the size of the contact tracing sample.	[Moser, Carlee B.; Gupta, Mayetri; White, Laura F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Archer, Brett N.] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa	Boston University; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Moser, CB (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	cmoser@sdac.harvard.edu	Archer, Brett Nicholas/A-5610-2012	Archer, Brett Nicholas/0000-0002-4144-1094; White, Laura F/0000-0002-0588-8235	National Institute of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LFW was supported by the National Institute of General Medical Sciences (Grant U54GM088558). CBM, MG, and BNA received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], INFECT DIS HUMANS DY; Archer BN, 2009, EUROSURVEILLANCE, V14, P11; Archer BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049482; Archer BN, 2012, J INFECT DIS, V206, pS148, DOI 10.1093/infdis/jis583; Becker NG, 2010, EURO SURVEILL, V14; Benavoli A., 2011, IJCAI 2011 P INT JOI, P2107; Bernardo JM, 1998, J ROY STAT SOC D-STA, V47, P101; Black AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073420; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Chowell G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-214; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Griffin JT, 2011, BIOSTATISTICS, V12, P303, DOI 10.1093/biostatistics/kxq058; Hens N, 2012, AM J EPIDEMIOL, V176, P196, DOI 10.1093/aje/kws006; Kelly D, 2011, RELIAB ENG SYST SAFE, V96, P398, DOI 10.1016/j.ress.2010.11.008; Kenah E, 2008, MATH BIOSCI, V213, P71, DOI 10.1016/j.mbs.2008.02.007; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; McBryde E, 2009, EURO SURVEILL, V14; McDonald SA, 2014, INFLUENZA OTHER RESP, V8, P33, DOI 10.1111/irv.12201; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Shubin M, 2014, EPIDEMIOL INFECT, V142, P964, DOI 10.1017/S0950268813002537; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010; te Beest DE, 2013, EPIDEMIOLOGY, V24, P244, DOI 10.1097/EDE.0b013e31827f50e8; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang F, 2013, ANN EPIDEMIOL, V23, P301, DOI 10.1016/j.annepidem.2013.04.005; Zhu M, 2004, J STAT ED, V12, P1	35	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118762	10.1371/journal.pone.0118762	http://dx.doi.org/10.1371/journal.pone.0118762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793993	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000352084200038
J	Peng, DH; Shi, F; Li, G; Fralick, D; Shen, T; Qiu, MH; Liu, J; Jiang, KD; Shen, DG; Fang, YR				Peng, Daihui; Shi, Feng; Li, Gang; Fralick, Drew; Shen, Ting; Qiu, Meihui; Liu, Jun; Jiang, Kaida; Shen, Dinggang; Fang, Yiru			Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; DIRECT-CURRENT STIMULATION; WHITE-MATTER INTEGRITY; CORTICAL THICKNESS; PSYCHOMOTOR RETARDATION; FUNCTIONAL CONNECTIVITY; COGNITIVE DEFICITS; SUBCORTICAL VOLUME; WORKING-MEMORY; ABNORMALITIES	Major depressive disorder (MDD) is accompanied by atypical brain structure. This study first presents the alterations in the cortical surface of patients with MDD using multidimensional structural patterns that reflect different neurodevelopment. Sixteen first-episode, untreated patients with MDD and 16 matched healthy controls underwent a magnetic resonance imaging (MRI) scan. The cortical maps of thickness, surface area, and gyrification were examined using the surface-based morphometry (SBM) approach. Increase of cortical thickness was observed in the right posterior cingulate region and the parietal cortex involving the bilateral inferior, left superior parietal and right paracentral regions, while decreased thickness was noted in the parietal cortex including bilateral pars opercularis and left precentral region, as well as the left rostral-middle frontal regions in patients with MDD. Likewise, increased or decreased surface area was found in five sub-regions of the cingulate gyrus, parietal and frontal cortices (e. g., bilateral inferior parietal and superior frontal regions). In addition, MDD patients exhibited a significant hypergyrification in the right precentral and supramarginal region. This integrated structural assessment of cortical surface suggests that MDD patients have cortical alterations of the frontal, parietal and cingulate regions, indicating a vulnerability to MDD during earlier neurodevelopmental process.	[Peng, Daihui; Shen, Ting; Qiu, Meihui; Fang, Yiru] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China; [Peng, Daihui; Shi, Feng; Li, Gang; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Peng, Daihui; Shi, Feng; Li, Gang; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Fralick, Drew] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Suicide Res & Prevent Ctr, Shanghai 200030, Peoples R China; [Fralick, Drew] Palo Alto Univ, Palo Alto, CA USA; [Liu, Jun] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai 200433, Peoples R China; [Jiang, Kaida] Fudan Univ, Huashan Hosp, Shanghai 200433, Peoples R China; Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Shanghai Jiao Tong University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Shanghai Jiao Tong University; Fudan University; Fudan University; Korea University	Peng, DH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China.	pdhsh@126.com; dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020	Shen, Dinggang/0000-0002-7934-5698; Li, Gang/0000-0001-9585-1382	Shanghai Jiao Tong University [11XJ21006, YG2012MS11]; Science and Technology Commission of Shanghai Municipality [134119a6200]; Shanghai health bureau [GWHW201208]; "12th Five-year Plan" of National Key Technologies RD Program [2012BAI01B04]; National Natural Science Foundation of China [91232719]; National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH) [2011-873]; National Institutes of Health (NIH) [EB006733, EB008374, EB009634, AG041721, MH100217, AG042599]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006733, R01EB009634, R01EB008374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041721, R01AG042599] Funding Source: NIH RePORTER	Shanghai Jiao Tong University; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai health bureau; "12th Five-year Plan" of National Key Technologies RD Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Science Fund of Shanghai Jiao Tong University (Grant #11XJ21006 and Grant #YG2012MS11), Fund of Science and Technology Commission of Shanghai Municipality (Grant #134119a6200), Overseas Talent Project of Shanghai health bureau (Grant #GWHW201208), the "12th Five-year Plan" of National Key Technologies R&D Program (Grant #2012BAI01B04), National Natural Science Foundation of China (Grant #91232719), The National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH, 2011-873). In addition, this grant is also partially supported by National Institutes of Health (NIH) grants (Grant #EB006733, EB008374, EB009634, AG041721, MH100217, and AG042599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DJ, 2013, J COGNITIVE NEUROSCI, V25, P1664, DOI 10.1162/jocn_a_00430; Aghajani M, 2014, PSYCHOL MED, V44, P2287, DOI 10.1017/S0033291713003000; Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Bracht T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052238; Brunoni AR, 2014, J AFFECT DISORDERS, V162, P43, DOI 10.1016/j.jad.2014.03.026; Canbeyli R, 2010, BEHAV BRAIN RES, V207, P249, DOI 10.1016/j.bbr.2009.11.002; Casanova MF, 2008, NEUROSCIENTIST, V14, P101, DOI 10.1177/1073858407309091; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Dinh L, 2009, NEUROCHEM RES, V34, P1896, DOI 10.1007/s11064-009-9966-z; DUM RP, 1991, J NEUROSCI, V11, P667; El Mansari M, 2010, CNS NEUROSCI THER, V16, pe1, DOI 10.1111/j.1755-5949.2010.00146.x; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Furey ML, 2013, JAMA PSYCHIAT, V70, P280, DOI 10.1001/2013.jamapsychiatry.60; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goddard AW, 2010, DEPRESS ANXIETY, V27, P339, DOI 10.1002/da.20642; Goldman-Rakic P S, 1980, Prog Brain Res, V53, P1; GRAZIANO M, 2009, THE INTELLIGENT MOVE; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Grimm S, 2009, NEUROPSYCHOPHARMACOL, V34, P932, DOI 10.1038/npp.2008.81; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Han KM, 2014, J AFFECT DISORDERS, V155, P42, DOI 10.1016/j.jad.2013.10.021; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Hulvershorn LA, 2011, BRAIN IMAGING BEHAV, V5, P307, DOI 10.1007/s11682-011-9134-3; Hwang JP, 2010, J GERIATR PSYCH NEUR, V23, P171, DOI 10.1177/0891988710363713; Ilamkar KR, 2014, J CLIN DIAGN RES, V8, P124, DOI 10.7860/JCDR/2014/7221.4026; Jarnum H, 2011, ACTA PSYCHIAT SCAND, V124, P435, DOI 10.1111/j.1600-0447.2011.01766.x; Kelly PA, 2013, BIOL PSYCHIAT, V74, P845, DOI 10.1016/j.biopsych.2013.06.020; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klein M., 2014, CEREB CORTEX; Koolschijn PCMP, 2010, EUR NEUROPSYCHOPHARM, V20, P398, DOI 10.1016/j.euroneuro.2010.02.010; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Kumar A, 2012, AM J GERIATR PSYCHIA; la Fougere C, 2011, NEUROIMAGE, V56, P951, DOI 10.1016/j.neuroimage.2010.11.015; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; LAUTER JL, 1985, HEARING RES, V20, P199, DOI 10.1016/0378-5955(85)90024-3; Leung KK, 2009, PSYCHOL MED, V39, P1097, DOI 10.1017/S0033291708004546; Li CT, 2010, NEUROIMAGE, V50, P347, DOI 10.1016/j.neuroimage.2009.11.021; Li G, 2014, J NEUROSCI, V34, P4228, DOI 10.1523/JNEUROSCI.3976-13.2014; Li G, 2013, CEREB CORTEX, V23, P2724, DOI 10.1093/cercor/bhs265; Lim HK, 2012, NEUROPSYCHOPHARMACOL, V37, P838, DOI 10.1038/npp.2011.264; Lim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033767; Lyall A.E., 2014, CEREB CORTEX; Mackin RS, 2013, AM J GERIAT PSYCHIAT, V21, P794, DOI 10.1016/j.jagp.2013.01.013; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mitchell JP, 2009, PHILOS T R SOC B, V364, P1309, DOI 10.1098/rstb.2008.0318; Nejad AB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00666; Nixon NL, 2014, BRIT J PSYCHIAT, V204, P283, DOI 10.1192/bjp.bp.113.129965; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Qiu L, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.18; Qiu LH, 2014, J PSYCHIATR NEUROSCI, V39, P78, DOI 10.1503/jpn.130034; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Reynolds S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-83; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; Rimes KA, 2005, BEHAV RES THER, V43, P1673, DOI 10.1016/j.brat.2004.12.002; Sakurai Y, 2008, BEHAV NEUROL, V19, P93, DOI 10.1155/2008/393912; Salvadore G, 2011, NEUROIMAGE, V54, P2643, DOI 10.1016/j.neuroimage.2010.11.011; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Silani G, 2013, J NEUROSCI, V33, P15466, DOI 10.1523/JNEUROSCI.1488-13.2013; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sumner JA, 2010, BEHAV RES THER, V48, P614, DOI 10.1016/j.brat.2010.03.013; Sweeney JA, 2000, BIOL PSYCHIAT, V48, P674, DOI 10.1016/S0006-3223(00)00910-0; Taschereau-Dumouchel V, 2012, J NEUROSCI, V32, P759, DOI 10.1523/JNEUROSCI.5357-11.2012; Thomsen M, 2011, EXP CLIN PSYCHOPHARM, V19, P342, DOI 10.1037/a0024053; Tu PC, 2012, PSYCHIAT RES-NEUROIM, V202, P206, DOI 10.1016/j.pscychresns.2011.07.011; Urs NM, 2011, NEUROPSYCHOPHARMACOL, V36, P551, DOI 10.1038/npp.2010.186; van Eijndhoven P, 2013, AM J PSYCHIAT, V170, P1477, DOI 10.1176/appi.ajp.2013.12121504; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Wagner G, 2012, J PSYCHIATR RES, V46, P1449, DOI 10.1016/j.jpsychires.2012.07.013; Walther S, 2012, NEUROBIOL DIS, V47, P13, DOI 10.1016/j.nbd.2012.03.019; Whittle S, 2014, AM J PSYCHIATRY; Ye T, 2012, EUR J RADIOL, V81, P4035, DOI 10.1016/j.ejrad.2011.04.058; Yoon KL, 2014, J BEHAV THER EXP PSY, V45, P368, DOI 10.1016/j.jbtep.2014.03.004; Yuan YG, 2008, BIOL PSYCHIAT, V64, P541, DOI 10.1016/j.biopsych.2008.04.032; Zhang Mingyuan, 1998, RATING SCALES MANUAL; Zhang YC, 2009, NEUROREPORT, V20, P378, DOI 10.1097/WNR.0b013e3283249b34; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	87	58	62	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120704	10.1371/journal.pone.0120704	http://dx.doi.org/10.1371/journal.pone.0120704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793287	gold, Green Submitted, Green Published			2022-12-26	WOS:000352083900066
J	Talley, DM; Talley, TS; Blanco, A				Talley, Drew M.; Talley, Theresa Sinicrope; Blanco, Alexander			Insights into the Establishment of the Manila Clam on a Tidal Flat at the Southern End of an Introduced Range in Southern California, USA	PLOS ONE			English	Article							SALT-MARSH; RUDITAPES-PHILIPPINARUM; ENVIRONMENTAL-STRESS; BRITISH-COLUMBIA; INVASION; RECRUITMENT; SETTLEMENT; ORGANISMS; DIVERSITY; ESTUARIES	Coastal ecosystem modifications have contributed to the spread of introduced species through alterations of historic disturbance regimes and resource availability, and increased propagule pressure. Frequency of occurrence of the Manila clam (Venerupis phillipinarum, Veneridae) in Southern California estuaries has increased from absent or sparse to common since the mid-1990s. Potential invasion vectors include seafood sales and aquaculture, and spread from established northern populations over decades. The clam's post-settlement habitat preferences are, however, uncertain in this region. Our project aimed to identify factors associated with established patches of the clam within a bay toward the southern end of this introduced range. During summer 2013, we sampled 10 tidal flat sites in Mission Bay, San Diego; each containing an area with and without hard structure (e. g., riprap, boulders). We measured likely environmental influences (e. g., sediment variables, distance to ocean). Manila clam densities across the bay were most strongly associated with site, where highest densities were located in the northern and/or back halves of the bay; and weakly correlated with lower porewater salinities. Within sites, Manila clam density was enhanced in the presence of hard structure in most sites. Prevailing currents and salinity regimes likely contribute to bay wide distributions, while hard structures may provide suitable microhabitats (refuge from predators and physical stress) and larval entrapment within sites. Results provide insights into decisions about future shoreline management efforts. Finally, we identify directions for future study to better understand and therefore predict patterns of establishment of the Manila clam in the southern portion of its introduced range.	[Talley, Drew M.; Blanco, Alexander] Univ San Diego, Dept Marine Sci & Environm Studies, San Diego, CA 92110 USA; [Talley, Theresa Sinicrope] Univ Calif San Diego, Scripps Inst Oceanog, Calif Sea Grant Extens Program, La Jolla, CA 92093 USA	University of San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Talley, DM (corresponding author), Univ San Diego, Dept Marine Sci & Environm Studies, San Diego, CA 92110 USA.	dtalley@sandiego.edu	Talley, Drew/M-7872-2019		University of San Diego TRiO McNair Scholars Post274 baccalaureate Achievement Program	University of San Diego TRiO McNair Scholars Post274 baccalaureate Achievement Program	This project was funded in part by the University of San Diego TRiO McNair Scholars Post274 baccalaureate Achievement Program in which AB participated during summer 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abelson A, 1997, ANNU REV ECOL SYST, V28, P317, DOI 10.1146/annurev.ecolsys.28.1.317; Barros F, 2001, ESTUAR COAST SHELF S, V52, P191, DOI 10.1006/ecss.2000.0734; BAYNE BL, 1979, PHILOS T ROY SOC B, V286, P563, DOI 10.1098/rstb.1979.0046; Bendell LI, 2014, ESTUAR COAST, V37, P369, DOI 10.1007/s12237-013-9677-1; Bonsall MB, 2004, J ANIM ECOL, V73, P1043, DOI 10.1111/j.0021-8790.2004.00874.x; BOURNE N, 1982, Journal of Shellfish Research, V2, P47; Burnaford JL, 2011, MAR BIOL, V158, P1915, DOI 10.1007/s00227-011-1703-x; Caldow RWG, 2007, P ROY SOC B-BIOL SCI, V274, P1449, DOI 10.1098/rspb.2007.0072; Carlton James T., 1992, Journal of Shellfish Research, V11, P489; Chew K, 1989, DEV AQUACULTURE FISH, P243; Cohen A.N, 2011, EXOTICS GUIDE NONNAT; Cooper M, 2013, SAN DIEGO BAY NATIVE; Crooks Jeffrey A., 2001, Biological Invasions, V3, P23, DOI 10.1023/A:1011404914338; Davis JLD, 2002, MAR BIOL, V140, P1249, DOI 10.1007/s00227-002-0779-8; DAVIS N, 1982, MAR BIOL, V70, P295, DOI 10.1007/BF00396848; Dudas SE, 2005, J EXP MAR BIOL ECOL, V325, P8, DOI 10.1016/j.jembe.2005.04.015; Dugan JE, 2008, MAR ECOL-EVOL PERSP, V29, P160, DOI 10.1111/j.1439-0485.2008.00231.x; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; Fimrite P, 2013, SFGATE          1115; Fimrite P, 2012, SFGATE          0706; Fisheries and Aquaculture Department, 2011, DAT INTR AQ SPEC DIA; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; GREEN BF, 1960, PSYCHOMETRIKA, V25, P127, DOI 10.1007/BF02288577; Grosholz ED, 2012, AQUATIC INVASIVE SPE; Herbert RJH, 2012, J BIOGEOGR, V39, P585, DOI 10.1111/j.1365-2699.2011.02626.x; Johnson K, 2008, STATUS FISHERIES REP; Jones G.G., 1993, MANILA CLAMS HATCHER; Largier JL, 1997, ESTUAR COAST SHELF S, V45, P789, DOI 10.1006/ecss.1997.0279; Levin LA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P661; LEVIN LA, 1983, ESTUARIES, V6, P364, DOI 10.2307/1351395; LINDBERG SE, 1973, LIMNOL OCEANOGR, V18, P788, DOI 10.4319/lo.1973.18.5.0788; Lockwood JL, 2007, INVASION ECOLOGY; MACDONALD KB, 1969, ECOL MONOGR, V39, P33, DOI 10.2307/1948564; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; NORDBY CS, 1991, ESTUARIES, V14, P80, DOI 10.2307/1351985; Novoa A, 2013, P 2013 SACNAS NAT C; Paul-Pont I, 2010, ENVIRON SCI POLLUT R, V17, P987, DOI 10.1007/s11356-009-0283-5; Pellizzato M, 2011, AQUACULT INT, V19, P541, DOI 10.1007/s10499-010-9370-3; Peterson CH, 2004, MAR ECOL PROG SER, V268, P81, DOI 10.3354/meps268081; Ponurovsky S. K., 1992, Journal of Shellfish Research, V11, P265; Pranovi F, 2006, BIOL INVASIONS, V8, P595, DOI 10.1007/s10530-005-1602-5; Queiros AD, 2011, BIOL INVASIONS, V13, P1059, DOI 10.1007/s10530-011-9948-3; Reilly PN, 2001, CALIFORNIAS LIVING M; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Souza W, 1979, ECOLOGY, V60, P1225; Steel R., 1997, PRINCIPLES PROCEDURE; Tezuka N, 2013, J EXP MAR BIOL ECOL, V439, P108, DOI 10.1016/j.jembe.2012.10.020; THOMPSON DS, 1995, ESTUARIES, V18, P91, DOI 10.2307/1352285; Thrush SF, 1996, MAR ECOL PROG SER, V132, P83, DOI 10.3354/meps132083; Tuskes Paul M., 2012, Festivus, V44, P13; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; Wetzel MA, 2014, MAR ENVIRON RES, V99, P125, DOI 10.1016/j.marenvres.2014.04.008	53	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118891	10.1371/journal.pone.0118891	http://dx.doi.org/10.1371/journal.pone.0118891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793603	Green Published, Green Submitted, gold			2022-12-26	WOS:000352084200044
J	Wang, T; Huang, KK; Wang, Z; Zheng, XP				Wang, Tao; Huang, Keke; Wang, Zhen; Zheng, Xiaoping			Impact of Small Groups with Heterogeneous Preference on Behavioral Evolution in Population Evacuation	PLOS ONE			English	Article							TIT-FOR-TAT; PRISONERS-DILEMMA; COOPERATION; RECIPROCITY; GAMES; NEIGHBORHOOD	Up to now, there have been a great number of mechanisms to explain the individual behavior and population traits, which seem of particular significance in evolutionary biology and social behavior analysis. Among them, small groups and heterogeneity are two useful frameworks to the above issue. However, vast majority of existing works separately consider both scenarios, which is inconsistent with realistic cases in our life. Here we propose the evolutionary games of heterogeneous small groups (namely, different small groups possess different preferences to dilemma) to study the collective behavior in population evacuation. Importantly, players usually face completely different dilemmas inside and outside the small groups. By means of numerous computation simulations, it is unveiled that the ratio of players in one certain small group directly decides the final behavior of the whole population. Moreover, it can also be concluded that heterogeneous degree of preference for different small groups plays a key role in the behavior traits of the system, which may validate some realistic social observations. The proposed framework is thus universally applicable and may shed new light into the solution of social dilemmas.	[Wang, Tao; Huang, Keke; Wang, Zhen; Zheng, Xiaoping] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Wang, Zhen] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Tsinghua University; Kyushu University	Zheng, XP (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	asean@mail.tsinghua.edu.cn			973 Program [2011CB706900]; National Natural Science Foundation of China [71225007]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported in part by the 973 Program under Grant 2011CB706900, and by the National Natural Science Foundation of China under Grants 71225007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; AVENI AF, 1977, SOCIOMETRY, V40, P96, DOI 10.2307/3033551; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Chadefaux T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013471; Chazelle B, 2015, J STAT PHYS, V158, P514, DOI 10.1007/s10955-014-1140-6; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Ge WN, 2012, IEEE T PATTERN ANAL, V34, P1003, DOI 10.1109/TPAMI.2011.176; Helbing D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012530; Helbing D, 2008, ADV COMPLEX SYST, V11, P641, DOI 10.1142/S0219525908001866; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jin Q, 2014, SCIENTIFIC REPORTS, V4; JOHNSON NR, 1987, SOC PROBL, V34, P362, DOI 10.1525/sp.1987.34.4.03a00040; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; Macal CM, 2005, PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, P2, DOI 10.1109/WSC.2005.1574234; Maynard Smith J., 1982, pi; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2009, NATURE, V457, P79, DOI 10.1038/nature07601; Paternotte C, 2012, BRIT J PHILOS SCI; Pennisi E, 2005, SCIENCE, V309, P93, DOI 10.1126/science.309.5731.93; Perc M, 2013, CHAOS SOLITON FRACT, V56, P1, DOI 10.1016/j.chaos.2013.06.002; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2010, INT J BIFURCAT CHAOS, V20, P849, DOI 10.1142/S0218127410026137; Poundstone W., 1992, PRISONERS DILEMMA J; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Smelser N.J., 2011, THEORY COLLECTIVE BE; Sysi-Aho M, 2005, EUR PHYS J B, V44, P129, DOI 10.1140/epjb/e2005-00108-5; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Uguz S, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413501010; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; Wang Z, 2013, SCI REPORTS, V3; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Weibull J W, 1997, EVOLUTIONARY GAME TH; Xia CY, 2013, CHAOS SOLITON FRACT, V51, P22, DOI 10.1016/j.chaos.2013.03.002; Yuan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091012; Zhang GQ, 2013, CHAOS SOLITON FRACT, V51, P31, DOI 10.1016/j.chaos.2013.03.003; Zheng XP, 2011, COMPUT MATH APPL, V62, P4627, DOI 10.1016/j.camwa.2011.10.048	52	19	19	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121949	10.1371/journal.pone.0121949	http://dx.doi.org/10.1371/journal.pone.0121949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793637	gold, Green Published, Green Submitted			2022-12-26	WOS:000352083900159
J	Wolfson, LJ; Walker, A; Hettle, R; Lu, XY; Kambili, C; Murungi, A; Knerer, G				Wolfson, Lara J.; Walker, Anna; Hettle, Robert; Lu, Xiaoyan; Kambili, Chrispin; Murungi, Andrew; Knerer, Gerhart			Cost-Effectiveness of Adding Bedaquiline to Drug Regimens for the Treatment of Multidrug-Resistant Tuberculosis in the UK	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HOUSEHOLD CONTACTS; TRANSMISSION; FITNESS; RISK; LIFE	Objective To evaluate the cost-effectiveness of adding bedaquiline to a background regimen (BR) of drugs for multidrug-resistant tuberculosis (MDR-TB) in the United Kingdom (UK). Methods A cohort-based Markov model was developed to estimate the incremental cost-effectiveness ratio of bedaquiline plus BR (BBR) versus BR alone (BR) in the treatment of MDR-TB, over a 10-year time horizon. A National Health Service (NHS) and personal social services perspective was considered. Cost-effectiveness was evaluated in terms of Quality-Adjusted Life Years (QALYs) and Disability-Adjusted Life Years (DALYs). Data were sourced from a phase II, placebo-controlled trial, NHS reference costs, and the literature; the US list price of bedaquiline was used and converted to pounds ( pound 18,800). Costs and effectiveness were discounted at a rate of 3.5% per annum. Probabilistic and deterministic sensitivity analysis was conducted. Results The total discounted cost per patient (pp) on BBR was pound 106,487, compared with pound 117,922 for BR. The total discounted QALYs pp were 5.16 for BBR and 4.01 for BR. The addition of bedaquiline to a BR resulted in a cost-saving of pound 11,434 and an additional 1.14 QALYs pp over a 10-year period, and is therefore considered to be the dominant (less costly and more effective) strategy over BR. BBR remained dominant in the majority of sensitivity analyses, with a 81% probability of being dominant versus BR in the probabilistic analysis. Conclusions In the UK, bedaquiline is likely to be cost-effective and cost-saving, compared with the current MDR-TB standard of care under a range of scenarios. Cost-savings over a 10-year period were realized from reductions in length of hospitalization, which offset the bedaquiline drug costs. The cost-benefit conclusions held after several sensitivity analyses, thus validating assumptions made, and suggesting that the results would hold even if the actual price of bedaquiline in the UK were higher than in the US.	[Wolfson, Lara J.; Lu, Xiaoyan] Janssen Pharmaceut NV, Beerse, Belgium; [Walker, Anna; Hettle, Robert] HERON Commercializat, London, England; [Kambili, Chrispin] Janssen Global Serv LLC, Raritan, NJ USA; [Murungi, Andrew; Knerer, Gerhart] Janssen Janssen Cilag, High Wycombe, Bucks, England	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals	Wolfson, LJ (corresponding author), Janssen Pharmaceut NV, Beerse, Belgium.	LWolfson@its.jnj.com	Wolfson, Lara/AAC-1400-2019	Wolfson, Lara/0000-0002-6454-3368	Janssen Pharmaceutical Companies of Johnson and Johnson; Janssen Pharmaceutica N.V.; Janssen Global Services LLC; Janssen-Cilag; HERON(TM) Commercialization	Janssen Pharmaceutical Companies of Johnson and Johnson; Janssen Pharmaceutica N.V.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Janssen Global Services LLC; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); HERON(TM) Commercialization	The study was commissioned and funded by Janssen Pharmaceutical Companies of Johnson and Johnson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LJW and XL were employed by Janssen Pharmaceutica N.V. at the time of writing this manuscript; CK was employed by Janssen Global Services LLC; and GK and AM were employed by Janssen-Cilag. Janssen Pharmaceutica N.V., Janssen Global Services LLC, Janssen-Cilag and AW and RH are employed by HERON (TM) Commercialization. Janssen Pharmaceutica N.V., Janssen Global Services LLC, Janssen-Cilag and HERON (TM) Commercialization provided support in the form of salaries for authors LJW, XL, CK, GK, AM, AW and RH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	[Anonymous], 2008, GUID PROGR MAN DRUG; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Brigden G, 2014, B WORLD HEALTH ORGAN, V92, P68, DOI 10.2471/BLT.13.122028; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Curry International TB Center, 2008, CITC CURR INT TUB CT; Day M, 2012, EURO SURVEILL, V17; Denholm JT, 2012, INT J TUBERC LUNG D, V16, P1320, DOI 10.5588/ijtld.12.0092; Department of Health, 2013, BRIT NATL FORMULARY; Department of Health, 2012, NHS REF COSTS 2011 2; Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865; Diel R., 2013, EUR RESP J; Drummond MF, 2007, INT J TECHNOL ASSESS, V23, P36, DOI 10.1017/S0266462307051550; ECDC, 2013, TUB SURV MON EUR; EMA, 2014, ORPH DES; European Commission, 2015, COMM REG MED PROD HU; European Medicines Agency, 2013, EMACHMP7713242013; FDA, 2012, ANT DRUGS ADV COMM M; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Grandjean L, 2011, INT J TUBERC LUNG D, V15, P1164, DOI 10.5588/ijtld.11.0030; Guglielmetti L, 2015, CLIN INFECT DIS, V60, P188, DOI 10.1093/cid/ciu786; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Health Protection Agency, 2013, TUB UK ANN REP TUB S; HPA, 2014, TUB UK 2013 REP; Janssen, 2013, SIRTURO HIGHLIGHTS U; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5376; Kind P., 1999, 172 U YORK YORK HLTH; Kurbatova E, 2013, EVALUATION SPUTUM CU; Liao CM, 2012, RISK ANAL, V32, P1420, DOI 10.1111/j.1539-6924.2011.01750.x; Liu CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019399; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Murphy BM, 2002, MATH BIOSCI, V180, P161, DOI 10.1016/S0025-5564(02)00133-5; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; National Institute for Health & Care Excellence (NICE), 2010, MEAS EFF COST EFF QA; Ndjeka N, 2014, S AFR MED J, V104, P164; Neely F, 2010, J PUBLIC HEALTH-UK, V32, P44, DOI 10.1093/pubmed/fdp056; NICE, 2011, CG117 NICE; NICE, 2009, METH DEV NICE PUBL H; ONS, 2013, OFF NAT STAT LIF TAB; Ormerod P, 1998, THORAX, V53, P536; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Siebert U, 2012, VALUE HEALTH, V15, P812, DOI 10.1016/j.jval.2012.06.014; Single N, 2011, INT J TUBERC LUNG D, V15, P1326, DOI 10.5588/ijtld.10.0564; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; US CDC, 2007, MULT RES TUB MDR TB; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Vassell A, 2013, COST EFFECTIVENESS I; White VLC, 2000, THORAX, V55, P962, DOI 10.1136/thorax.55.11.962; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; *WHO, 2011, GLOB PLAN STOP TB 20; World Health Organization, 2013, USE BEDAQUILINE TREA; World Health Organization, DEF REP FRAM TUB 201	54	31	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120763	10.1371/journal.pone.0120763	http://dx.doi.org/10.1371/journal.pone.0120763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794045	Green Published, Green Submitted, gold			2022-12-26	WOS:000352083900073
J	Bo, M; Bavestrello, G; Angiolillo, M; Calcagnile, L; Canese, S; Cannas, R; Cau, A; D'Elia, M; D'Oriano, F; Follesa, MC; Quarta, G; Cau, A				Bo, Marzia; Bavestrello, Giorgio; Angiolillo, Michela; Calcagnile, Lucio; Canese, Simonepietro; Cannas, Rita; Cau, Alessandro; D'Elia, Marisa; D'Oriano, Filippo; Follesa, Maria Cristina; Quarta, Gianluca; Cau, Angelo			Persistence of Pristine Deep-Sea Coral Gardens in the Mediterranean Sea (SW Sardinia)	PLOS ONE			English	Article							BLACK CORAL; ANTHOZOA HEXACORALLIA; WATER ANTIPATHARIANS; ISIDELLA-ELONGATA; GROWTH-RATES; BIODIVERSITY; GORGONIANS; HABITAT; ASSEMBLAGES; DISTURBANCE	Leiopathes glaberrima is a tall arborescent black coral species structuring important facies of the deep-sea rocky bottoms of the Mediterranean Sea that are severely stifled by fishing activities. At present, however, no morphological in vivo description, ecological characterization, age dating and evaluation of the possible conservation actions have ever been made for any population of this species in the basin. A dense coral population was reported during two Remotely Operated Vehicle (ROV) surveys conducted on a rocky bank off the SW coasts of Sardinia (Western Mediterranean Sea). L. glaberrima forms up to 2 m-tall colonies with a maximal observed basal diameter of nearly 7 cm. The radiocarbon dating carried out on a colony from this site with a 4 cm basal diameter revealed an approximately age of 2000 years. Considering the size-frequency distribution of the colonies in the area it is possible to hypothesize the existence of other millennial specimens occupying a supposedly very stable ecosystem. The persistence of this ecosystem is likely guaranteed by the heterogeneous rocky substrate hosting the black coral population that represents a physical barrier against the mechanical impacts acted on the surrounding muddy areas, heavily exploited as trawling fishing grounds. This favorable condition, together with the existence of a nursery area for catsharks within the coral ramifications and the occurrence of a meadow of the now rare soft bottom alcyonacean Isidella elongata in small surviving muddy enclaves, indicates that this ecosystem have to be considered a pristine Mediterranean deep-sea coral sanctuary that would deserve special protection.	[Bo, Marzia; Bavestrello, Giorgio] Univ Genoa, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy; [Angiolillo, Michela; Canese, Simonepietro] Ist Super Protez & Ric Ambientale, Rome, Italy; [Calcagnile, Lucio; D'Elia, Marisa; Quarta, Gianluca] Univ Salento, Ctr Dataz & Diagnost, Dipartimento Ingn Innovaz, Lecce, Italy; [Cannas, Rita; Cau, Alessandro; Follesa, Maria Cristina; Cau, Angelo] Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [D'Oriano, Filippo] Geophi Srl, CNR, Res Area, Bologna, Italy	University of Genoa; Italian Institute for Environmental Protection & Research (ISPRA); University of Salento; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR)	Bavestrello, G (corresponding author), Univ Genoa, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy.	giorgio.bavestrello@unige.it	Canese, Simonepietro/AAA-5499-2019; Cau, Alessandro/G-9537-2014; Angiolillo, Michela/L-2274-2015	Canese, Simonepietro/0000-0001-6049-4506; Cau, Alessandro/0000-0003-4082-7531; Angiolillo, Michela/0000-0001-5420-8868; Cannas, Rita/0000-0001-6627-4053; Bo, Marzia/0000-0001-8400-6722; d'Oriano, Filippo/0000-0003-4573-8909	Autonomous Region of Sardinia [3189/DecA/108 del 19.12.2008]	Autonomous Region of Sardinia(Regione Sardegna)	This work was financed by the Autonomous Region of Sardinia within the framework of the following scientific projects: 1) "Struttura spaziale, di popolazione e genetica dei banchi di Corallium rubrum del Mediterraneo centro occidentale. L.R. 7 Agosto 2007, n. 7 (AC). 2) "Misure gestionali volte al ripopolamento degli stock di corallo rosso (Corallium rubrum L., 1758). Decr Ass. Agricoltura n. 3189/DecA/108 del 19.12.2008 (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiliar R., 2013, MEDITERRANEAN DEEP S; Andrews AH, 2009, MAR ECOL PROG SER, V397, P173, DOI 10.3354/meps08193; Angeletti L, 2014, MEDITERR MAR SCI, V15, P263, DOI 10.12681/mms.558; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bo M, 2008, ITAL J ZOOL, V75, P185, DOI 10.1080/11250000701882908; Bo M, 2014, ITAL J ZOOL, V81, P112, DOI 10.1080/11250003.2013.859750; Bo M, 2011, ITAL J ZOOL, V78, P231, DOI 10.1080/11250001003652619; Bo M, 2009, MAR ECOL PROG SER, V397, P53, DOI 10.3354/meps08185; Bo M, 2009, ITAL J ZOOL, V76, P392, DOI 10.1080/11250000802684104; Bo M, 2014, BIOL CONSERV, V171, P167, DOI 10.1016/j.biocon.2014.01.011; Bo M, 2014, MAR ECOL-EVOL PERSP, V35, P332, DOI 10.1111/maec.12089; Bo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049870; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; Bongiorni L, 2010, BIOL CONSERV, V143, P1687, DOI 10.1016/j.biocon.2010.04.009; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Calcagnile L, 2004, NUCL INSTRUM METH B, V223, P16, DOI 10.1016/j.nimb.2004.04.007; Canepa Antonio, 2014, P237; Cannas Rita, 2011, Studi Trentini di Scienze Naturali, V89, P9; Carpine C, 1973, B I OCEANOGR MONACO, V71, P1; Carreiro-Silva M, 2013, MAR ECOL PROG SER, V473, P189, DOI 10.3354/meps10052; Cartes JE, 2013, DEEP-SEA RES PT I, V76, P52, DOI 10.1016/j.dsr.2013.01.006; Cau A, 2014, LEIOPATHES GLABERRIM, P40; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; D'Elia M, 2004, NUCL INSTRUM METH B, V223, P278, DOI 10.1016/j.nimb.2004.04.056; D'Onghia G., 2003, Journal of Northwest Atlantic Fishery Science, V31, P263; D'Onghia G, 2010, DEEP-SEA RES PT II, V57, P397, DOI 10.1016/j.dsr2.2009.08.022; Damalas D, 2011, FISH RES, V108, P142, DOI 10.1016/j.fishres.2010.12.012; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Deidun A., 2010, Marine Biodiversity Records, V3, pe90; DRUFFEL ERM, 1995, GEOCHIM COSMOCHIM AC, V59, P5031, DOI 10.1016/0016-7037(95)00373-8; Etnoyer P, 2007, B MAR SCI, V81, P553; Fabri MC, 2014, DEEP-SEA RES PT II, V104, P184, DOI 10.1016/j.dsr2.2013.06.016; Fabri MC, 2012, SRM MO INITIAL ASSES; Follesa MC, 2013, MAR FRESHWATER RES, V64, P706, DOI 10.1071/MF12235; Food and Agriculture Organization (FAO), 2006, 147 FAO, V147; Food and Agriculture Organization (FAO), 2009, INT GUID MAN DEEP SE, P73; Gianfrate G, 2007, NUCL INSTRUM METH B, V259, P316, DOI 10.1016/j.nimb.2007.01.309; Gori A, 2011, MAR BIOL, V158, P1721, DOI 10.1007/s00227-011-1686-7; Gori A, 2011, MAR BIOL, V158, P143, DOI 10.1007/s00227-010-1548-8; GRASSLE JF, 1977, NATURE, V265, P618, DOI 10.1038/265618a0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Maynou F, 2012, J MAR BIOL ASSOC UK, V92, P1501, DOI 10.1017/S0025315411001603; Maynou F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021818; Miller KJ, 1998, MAR ECOL PROG SER, V163, P225, DOI 10.3354/meps163225; Molodtsova TN, 2011, ZOOTAXA, P52; Mytilineou C, 2014, DEEP-SEA RES PT II, V99, P146, DOI 10.1016/j.dsr2.2013.07.007; Ocaû£a O., 2004, REV ACAD CANARIA CIE, V15, P159; Olita A, 2013, CONT SHELF RES, V71, P95, DOI 10.1016/j.csr.2013.10.011; Opresko Dennis M., 2001, Senckenbergiana Biologica, V81, P1; Opresko Dennis M., 1998, Records of the South Australian Museum (Adelaide), V31, P99; OPRESKO DM, 2004, MAR MEDITERRANEO FAU, V2, P506; Pardo E., 2011, CHRONICA NATURAE, V1, P20; Parker NR, 1997, MAR BIOL, V130, P11, DOI 10.1007/s002270050220; Ponti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102782; Prouty NG, 2011, MAR ECOL PROG SER, V423, P101, DOI 10.3354/meps08953; Raimundo J, 2013, DEEP-SEA RES PT II, V98, P129, DOI 10.1016/j.dsr2.2013.01.012; Ramsey CB, 2001, RADIOCARBON, V43, P355; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Reimer PJ, 2002, RADIOCARBON, V44, P159, DOI 10.1017/S0033822200064766; Relini G., 1988, Bollettino dei Musei e degli Istituti Biologici dell'Universita di Genova, V52, P139; Risk MJ, 2009, MAR ECOL PROG SER, V397, P219, DOI 10.3354/meps08414; Roark EB, 2006, MAR ECOL PROG SER, V327, P1, DOI 10.3354/meps327001; Roark EB, 2009, P NATL ACAD SCI USA, V106, P5204, DOI 10.1073/pnas.0810875106; Sampaio I, 2012, J MAR BIOL ASSOC UK, V92, P1547, DOI 10.1017/S0025315412000045; Sherwood OA, 2009, MAR ECOL PROG SER, V397, P209, DOI 10.3354/meps08166; Sinniger F, 2009, J COR REEF STU, V11, P21, DOI DOI 10.3755/GALAXEA.11.21; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Tsounis G, 2010, OCEANOGR MAR BIOL, V48, P161, DOI 10.1201/EBK1439821169-c3; Vafidis D, 2006, P 10 ICZEGAR PATR GR; Vertino A, 2010, DEEP-SEA RES PT II, V57, P380, DOI 10.1016/j.dsr2.2009.08.023; Vogel S., 1994, LIFE MOVING FLUIDS P; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; WEINBERG S, 1978, MAR BIOL, V49, P41, DOI 10.1007/BF00390729; Williams B, 2007, B MAR SCI, V81, P437; Williams B, 2006, GEOLOGY, V34, P773, DOI 10.1130/G22685.1	80	82	82	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119393	10.1371/journal.pone.0119393	http://dx.doi.org/10.1371/journal.pone.0119393			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790333	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400078
J	Lopes, AM; Machado, JAT				Lopes, Antonio M.; Machado, J. A. Tenreiro			Dynamical Analysis and Visualization of Tornadoes Time Series	PLOS ONE			English	Article							POWER LAWS; INTENSITY; DISTRIBUTIONS; STATISTICS; COMPLEXITY; DAMAGE	In this paper we analyze the behavior of tornado time-series in the U.S. from the perspective of dynamical systems. A tornado is a violently rotating column of air extending from a cumulonimbus cloud down to the ground. Such phenomena reveal features that are well described by power law functions and unveil characteristics found in systems with long range memory effects. Tornado time series are viewed as the output of a complex system and are interpreted as a manifestation of its dynamics. Tornadoes are modeled as sequences of Dirac impulses with amplitude proportional to the events size. First, a collection of time series involving 64 years is analyzed in the frequency domain by means of the Fourier transform. The amplitude spectra are approximated by power law functions and their parameters are read as an underlying signature of the system dynamics. Second, it is adopted the concept of circular time and the collective behavior of tornadoes analyzed. Clustering techniques are then adopted to identify and visualize the emerging patterns.	[Lopes, Antonio M.] Univ Porto, Fac Engn, Inst Engn Mech, P-4100 Oporto, Portugal; [Machado, J. A. Tenreiro] Polytech Porto, Inst Engn, Oporto, Portugal	Universidade do Porto; Polytechnic Institute of Porto	Lopes, AM (corresponding author), Univ Porto, Fac Engn, Inst Engn Mech, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aml@fe.up.pt	Lopes, António M./A-2740-2016; Machado, J. A. Tenreiro/M-2173-2013	Lopes, António M./0000-0001-7359-4370; Machado, J. A. Tenreiro/0000-0003-4274-4879				BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Beran J., 1994, STAT LONG MEMORY PRO; BERRY MV, 1979, J PHYS A-MATH GEN, V12, P781, DOI 10.1088/0305-4470/12/6/008; Brooks H, 2001, ATMOS RES, V56, P191, DOI 10.1016/S0169-8095(00)00098-3; Brooks HE, 2004, WEATHER FORECAST, V19, P310, DOI 10.1175/1520-0434(2004)019<0310:OTROTP>2.0.CO;2; Carlson JM, 1999, PHYS REV E, V60, P1412, DOI 10.1103/PhysRevE.60.1412; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cox T. F., 2000, MULTIDIMENSIONAL SCA; Doswell CA, 2006, WEATHER FORECAST, V21, P939, DOI 10.1175/WAF959.1; Dotzec N, 2003, ATMOS RES, V67-8, P163, DOI 10.1016/S0169-8095(03)00050-4; Dotzek N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024583; Dotzek N, 2009, ATMOS RES, V93, P564, DOI 10.1016/j.atmosres.2008.10.015; Edwards R, 2013, B AM METEOROL SOC, V94, P641, DOI 10.1175/BAMS-D-11-00006.1; Feuerstein B, 2011, ATMOS RES, V100, P547, DOI 10.1016/j.atmosres.2010.12.026; Fisher N., 1995, STAT ANAL CIRCULAR D; Fujita T, 1973, 8 C SEV LOC STORMS D, P142; Fujita T.T., 1971, 91 SMRP; FUJITA TT, 1981, J ATMOS SCI, V38, P1511, DOI 10.1175/1520-0469(1981)038<1511:TADITC>2.0.CO;2; Jain AK., 1988, TECHNOMETRICS; Kurgansky M. V., 2000, DOKL EARTH SCI, V371, P408; Machado JAT, 2012, COMMUN NONLINEAR SCI, V17, P2237, DOI 10.1016/j.cnsns.2011.09.041; Malamud BD, 2012, ATMOS CHEM PHYS, V12, P8459, DOI 10.5194/acp-12-8459-2012; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pinto CMA, 2012, COMMUN NONLINEAR SCI, V17, P3558, DOI 10.1016/j.cnsns.2012.01.013; Potter S., 2007, WEATHERWISE, V62, P64; Schielicke L, 2013, NONLINEAR PROC GEOPH, V20, P47, DOI 10.5194/npg-20-47-2013; Schielicke L, 2011, ATMOS RES, V100, P357, DOI 10.1016/j.atmosres.2010.08.027; Schroeder M, 1991, FRACTALS CHAOS POWER; Simmons KM, 2013, ENVIRON HAZARDS-UK, V12, P132, DOI 10.1080/17477891.2012.738642; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Sornette D, 2003, GEOPHYS RES LETT, V30; Machado JAT, 2015, NONLINEAR DYNAM, V79, P63, DOI 10.1007/s11071-014-1645-1; Machado JAT, 2012, NONLINEAR DYNAM, V70, P789, DOI 10.1007/s11071-012-0495-y; Tenreiro Machado JA, 2013, MATH PHYS; Turcotte D. L., 2002, INT GEOPHYS SER, V81, P209; Verbout SM, 2006, WEATHER FORECAST, V21, P86, DOI 10.1175/WAF910.1; Vuong QH, 1989, ECONOMETRICA J ECONO, P307; West BJ, 2014, REV MOD PHYS, V86, P1169, DOI 10.1103/RevModPhys.86.1169; West BJ, 2012, FRACT CALC APPL ANAL, V15, P70, DOI 10.2478/s13540-012-0006-3	40	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120260	10.1371/journal.pone.0120260	http://dx.doi.org/10.1371/journal.pone.0120260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790281	gold, Green Published			2022-12-26	WOS:000351425400147
J	Motawi, TK; Shaker, OG; El-Maraghy, SA; Senousy, MA				Motawi, Tarek Kamal; Shaker, Olfat Gamil; El-Maraghy, Shohda Assem; Senousy, Mahmoud Ahmed			Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4	PLOS ONE			English	Article							CIRCULATING MICRORNAS; HCV REPLICATION; VIRUS-INFECTION; EXPRESSION; GENE; EFFICACY; POLYMORPHISM; TELAPREVIR; INDUCTION; PROFILES	MicroRNAs are messengers during interferon-virus interplay and are involved in antiviral immunity, however, little is known about interferon-related microRNAs regarding their detection in serum and their potential use as non-invasive diagnostic and prognostic biomarkers in chronic hepatitis C (CHC). To elucidate some of the molecular aspects underlying failure of pegylated interferon-alpha/ribavirin therapy, we investigated pretreatment expression profiles of seven selected interferon-related microRNAs (miR-146a, miR-34a, miR-130a, miR-19a, miR-192, miR-195, and miR-296) by quantitative RT-PCR custom array technology in serum of Egyptian CHC genotype 4 patients and whether their pretreatment levels would predict patient response to the combination therapy. One hundred and six CHC patients and forty matched healthy controls were included. Patients were divided into sustained virological response (SVR) and non-responder (NR) groups. Serum miR-34a, miR-130a, miR-19a, miR-192, miR-195, and miR-296 were upregulated, whereas serum miR-146a was downregulated in CHC compared to controls. Significant correlations were found between expression levels of studied microRNAs and also with clinical data. Pretreatment levels of miR-34a, miR-130a, and miR-195 were significantly higher, whereas miR-192 and miR-296 levels were significantly lower in SVR than NR patients. miR-19a and miR-146a levels were not significantly different between the two groups. miR-34a was superior to differentiate CHC from controls, whereas miR-296 was superior to discriminate SVR from NR patients by receiver operating characteristic analysis. Multivariate logistic analysis revealed miR-34a and miR-195 as independent predictors for SVR and miR-192 as an independent variable for non-response. In conclusion, pretreatment expression profiles of five interferon-related microRNAs are associated with treatment outcome in CHC. Of these, miR-34a, miR-195, and miR-192 could predict treatment response. The profiling results could be used as novel non-invasive diagnostic and prognostic pharmacogenetic biomarkers for treatment personalization in CHC and could help to identify new microRNA-based antivirals.	[Motawi, Tarek Kamal; El-Maraghy, Shohda Assem; Senousy, Mahmoud Ahmed] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Shaker, Olfat Gamil] Cairo Univ, Fac Sci, Dept Med Biochem & Mol Biol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Senousy, MA (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	mohmoud.ali@pharma.cu.edu.eg	Shaker, Olfat G/S-2010-2017; O, Shaker/Y-6125-2019; Issa, Randa @M.T/E-7144-2019; Senousy, Mahmoud Ahmed/AAB-6410-2022	O, Shaker/0000-0002-3031-3599; Issa, Randa @M.T/0000-0003-0619-1234; Motawi, Tarek/0000-0001-8925-9702				Abouheif MM, 2010, RHEUMATOLOGY, V49, P2054, DOI 10.1093/rheumatology/keq247; Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bala S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-151; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bellecave Pantxika, 2008, Hepatology, V48, P1330, DOI 10.1002/hep.22571; Bruni R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-485; Burska AN, 2014, PHARMACOGENOMICS J, V14, P93, DOI 10.1038/tpj.2013.48; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Collins AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069090; Andrade LJD, 2009, J GLOB INFECT DIS, V1, P33, DOI 10.4103/0974-777X.52979; El-Ekiaby N, 2012, FEBS OPEN BIO, V2, P179, DOI 10.1016/j.fob.2012.07.005; Hatzakis A, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12120; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Ishida H, 2011, BIOCHEM BIOPH RES CO, V412, P92, DOI 10.1016/j.bbrc.2011.07.049; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Kamal SM, 2011, LIVER INT, V31, P45, DOI 10.1111/j.1478-3231.2010.02385.x; Kim Y, 2014, J CLIN ONCOL, V32, P121, DOI 10.1200/JCO.2013.50.8556; Kurbanov F, 2011, J INFECT DIS, V204, P1391, DOI 10.1093/infdis/jir536; Li S, 2014, J VIRAL HEPATITIS, V21, P121, DOI 10.1111/jvh.12131; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Mabrouk M, 2013, HEPATO-GASTROENTEROL, V60, P1731, DOI 10.5754/hge12745; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Mu Y, 2013, EXP MOL PATHOL, V95, P206, DOI 10.1016/j.yexmp.2013.07.005; Murakami Y, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-48; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Pol S, 2011, HEPATOLOGY, V54, p374A; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Reinsbach SE, 2012, RNA BIOL, V9, P978, DOI 10.4161/rna.20494; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Scagnolari C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-311; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009; Sekiya Y, 2011, J CELL PHYSIOL, V226, P2535, DOI 10.1002/jcp.22598; Shaker OG, 2012, HUM IMMUNOL, V73, P1039, DOI 10.1016/j.humimm.2012.07.329; Shehab H, 2014, J INTERF CYTOK RES, V34, P727, DOI 10.1089/jir.2013.0127; Shwetha S, 2013, SCI REPORTS, V3, P1; Siegrist F, 2009, BIOL PROCED ONLINE, V11, P113, DOI 10.1007/s12575-009-9012-1; Sperveslage J, 2014, ENDOCRINE, V46, P226, DOI 10.1007/s12020-014-0202-5; Steuerwald NM, 2010, LIVER INT, V30, P1490, DOI 10.1111/j.1478-3231.2010.02321.x; Su TH, 2013, P NATL ACAD SCI USA, V110, P7844, DOI 10.1073/pnas.1306138110; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang LG, 2012, CANCER EPIDEMIOL, V36, pE61, DOI 10.1016/j.canep.2011.05.002; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733	54	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120794	10.1371/journal.pone.0120794	http://dx.doi.org/10.1371/journal.pone.0120794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790297	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400177
J	Zhang, JP; Wu, Y; Li, DQ; Wang, GQ; Li, X; Xia, YP				Zhang, Jiaping; Wu, Yun; Li, Danqing; Wang, Guanqun; Li, Xin; Xia, Yiping			Transcriptomic Analysis of the Underground Renewal Buds during Dormancy Transition and Release in 'Hangbaishao' Peony (Paeonia lactiflora)	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; PEROXIDASE-ACTIVITY; GENE-EXPRESSION; LOW-TEMPERATURES; TREE PEONY; CHILLING REQUIREMENT; ECTOPIC EXPRESSION; FLORAL DEVELOPMENT; STRESS TOLERANCE; RESPIRATION RATE	Paeonia lactiflora is one of the most famous species of herbaceous peonies with gorgeous flowers. Bud dormancy is a crucial developmental process that allows P. lactiflora to survive unfavorable environmental conditions. However, little information is available on the molecular mechanism of the bud dormancy in P. lactiflora. We performed de novo transcriptome sequencing using the Illumina RNA sequencing platform for the underground renewal buds of P. lactiflora 'Hangbaishao' to study the molecular mechanism underlying its bud dormancy transition (the period from endodormancy to ecodormancy) and release (the period from ecodormancy to bud elongation and sprouting). Approximately 300 million high-quality clean reads were generated and assembled into 207,827 (mean length = 828 bp) and 51,481 (mean length = 1250 bp) unigenes using two assembly methods named "Trinity" and "Trinity+PRICE", respectively. Based on the data obtained by the latter method, 32,316 unigenes were annotated by BLAST against various databases. Approximately 1,251 putative transcription factors were obtained, of which the largest number of unique transcripts belonged to the basic helix-loop-helix protein (bHLH) transcription factor family, and five of the top ten highly expressed transcripts were annotated as dehydrin (DHN). A total of 17,705 simple sequence repeat (SSR) motifs distributed in 13,797 sequences were obtained. The budbreak morphology, levels of indole-3-acetic acid (IAA) and abscisic acid (ABA), and activities of guaiacol peroxidase (POD) and catalase (CAT) were observed. The expression of 20 interested unigenes, which annotated as DHN, heat shock protein (HSP), histone, late elongated hypocotyl (LHY), and phytochrome (PHY), and so on, were also analyzed. These studies were based on morphological, physiological, biochemical, and molecular levels and provide comprehensive insight into the mechanism of dormancy transition and release in P. lactiflora. Transcriptome dataset can be highly valuable for future investigation on gene expression networks in P. lactiflora as well as research on dormancy in other non-model perennial horticultural crops of commercial significance.	[Zhang, Jiaping; Wu, Yun; Li, Danqing; Wang, Guanqun; Xia, Yiping] Zhejiang Univ, Coll Agr & Biotechnol, Inst Landscape Architecture, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Xin] Nanjing Agr Univ, Dept Biochem & Mol Biol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Nanjing Agricultural University	Xia, YP (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Landscape Architecture, Hangzhou 310003, Zhejiang, Peoples R China.	ypxia@zju.edu.cn	Li, Xin/AAT-3305-2021	Li, Danqing/0000-0002-1914-857X	Science Technology Department of Zhejiang Province, China [2012C12909]	Science Technology Department of Zhejiang Province, China	YX received the funding for creation of germplasm and breeding of the cultivar in herbaceous perennials (2012C12909) in Science Technology Department of Zhejiang Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Anderson JV, 2005, PLANT CELL ENVIRON, V28, P1567, DOI 10.1111/j.1365-3040.2005.01393.x; Arguello JA, 2001, BIOCELL, V25, P1; Bai SL, 2013, PLANT CELL PHYSIOL, V54, P1132, DOI 10.1093/pcp/pct067; Barzilay A, 2002, HORTSCIENCE, V37, P300, DOI 10.21273/HORTSCI.37.2.300; Ben Mohamed H, 2012, ACTA PHYSIOL PLANT, V34, P429, DOI 10.1007/s11738-011-0839-0; Benkeblia N, 2004, SCI AGR, V61, P281, DOI 10.1590/S0103-90162004000300007; Benkeblia N, 2003, ACTA AGR SCAND B-S P, V53, P16, DOI 10.1080/09064710310003358; Benkeblia N, 1999, ACTA AGR SCAND B-S P, V49, P98, DOI 10.1080/09064719950135605; Bi YD, 2011, MOL BIOL REP, V38, P721, DOI 10.1007/s11033-010-0159-2; Cantwell MI, 2003, POSTHARVEST BIOL TEC, V30, P57, DOI 10.1016/S0925-5214(03)00060-7; Castelain M, 2012, PHYSIOL PLANTARUM, V145, P450, DOI 10.1111/j.1399-3054.2012.01600.x; Chang L, 2011, INDIAN J HORTIC, V68, P522; Cheng FY, 2009, ISR J PLANT SCI, V57, P357, DOI 10.1560/IJPS.57.4.357; Cheng FY, 2001, J JPN SOC HORTIC SCI, V70, P46, DOI 10.2503/jjshs.70.46; Dogramaci M, 2010, PLANT MOL BIOL, V73, P207, DOI 10.1007/s11103-010-9621-8; Dube MP, 2013, THEOR APPL GENET, V126, P823, DOI 10.1007/s00122-012-2020-6; EVANS MR, 1990, HORTSCIENCE, V25, P923, DOI 10.21273/HORTSCI.25.8.923; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Feng XM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-22; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fulton TA, 2001, SCI HORTIC-AMSTERDAM, V89, P237, DOI 10.1016/S0304-4238(00)00237-5; Furuno M, 2003, GENOME RES, V13, P1478, DOI 10.1101/gr.1060303; Gai SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055297; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; Gonzalez RE, 2013, J FOOD BIOCHEM, V37, P449, DOI 10.1111/j.1745-4514.2011.00647.x; Habu T, 2012, J JPN SOC HORTIC SCI, V81, P239, DOI 10.2503/jjshs1.81.239; Habul T, 2014, J JPN SOC HORTIC SCI, V83, P1, DOI 10.2503/jjshs1.CH-077; Halaly T, 2008, PLANTA, V228, P79, DOI 10.1007/s00425-008-0720-6; Halevy AH, 2002, HORTSCIENCE, V37, P885, DOI 10.21273/HORTSCI.37.6.885; Hall AJ, 2007, SCI HORTIC-AMSTERDAM, V113, P188, DOI 10.1016/j.scienta.2007.03.001; Hemavathi, 2011, MOL BREEDING, V28, P105, DOI 10.1007/s11032-010-9465-6; Hong SI, 2001, J SCI FOOD AGR, V81, P397, DOI 10.1002/1097-0010(200103)81:4&lt;397::AID-JSFA831&gt;3.0.CO;2-R; Horvath DP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-536; Horvath DP, 2002, PLANT PHYSIOL, V128, P1439, DOI 10.1104/pp.010885; HOSOKI T, 1992, J JPN SOC HORTIC SCI, V61, P121, DOI 10.2503/jjshs.61.121; Huang X, 2008, ACTA PHYSIOL PLANT, V30, P797, DOI 10.1007/s11738-008-0184-0; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Ibanez C, 2010, PLANT PHYSIOL, V153, P1823, DOI 10.1104/pp.110.158220; Imamura T, 2013, PLANT SCI, V213, P55, DOI 10.1016/j.plantsci.2013.08.012; Kamenetsky R, 2013, ORNAMENTAL GEOPHYTES: FROM BASIC SCIENCE TO SUSTAINABLE PRODUCTION, P1; Kamenetsky R, 2004, J AM SOC HORTIC SCI, V129, P144, DOI 10.21273/JASHS.129.2.0144; Kamenetsky R, 2003, NEW PHYTOL, V158, P109, DOI 10.1046/j.1469-8137.2003.00719.x; Kamenetsky R, 2003, SCI HORTIC-AMSTERDAM, V97, P309, DOI 10.1016/S0304-4238(02)00153-X; Kasraoui MF, 2014, J APPL BOT FOOD QUAL, V87, P1, DOI 10.5073/JABFQ.2014.087.001; Kim JY, 2003, EMBO J, V22, P935, DOI 10.1093/emboj/cdg075; Kumar G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-107; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Law RD, 2004, PHYSIOL PLANTARUM, V120, P642, DOI 10.1111/j.0031-9317.2004.0273.x; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Li L, 2011, AM J BOT, V98, pE16, DOI 10.3732/ajb.1000410; Li T, 2013, TURK J AGRIC FOR, V37, P517, DOI 10.3906/tar-1209-4; Liu B, 2004, THESIS SHANDONG AGR; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Lomax J, 2005, BRIEF BIOINFORM, V6, P298, DOI 10.1093/bib/6.3.298; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Marafon AC, 2009, REV BRAS FRUTIC, V31, P938, DOI 10.1590/S0100-29452009000400004; Mathiason K, 2009, FUNCT INTEGR GENOMIC, V9, P81, DOI 10.1007/s10142-008-0090-y; May MJ, 1998, J EXP BOT, V49, P649, DOI 10.1093/jexbot/49.321.649; Mornya PMP, 2011, HORTIC SCI, V38, P104, DOI 10.17221/11/2011-HORTSCI; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Noriega X, 2007, PHYTOCHEMISTRY, V68, P1376, DOI 10.1016/j.phytochem.2007.02.003; Ofir M, 2007, ANN BOT-LONDON, V99, P293, DOI 10.1093/aob/mcl257; Page M., 2005, GARDENERS PEONY HERB; Peng HH, 2013, PLANTA, V238, P937, DOI 10.1007/s00425-013-1944-7; Pnueli L, 2002, PLANT J, V31, P319, DOI 10.1046/j.1365-313X.2002.01364.x; Provart NJ, 2003, PLANT PHYSIOL, V132, P893, DOI 10.1104/pp.103.021261; Rhie YH, 2012, HORTIC ENVIRON BIOTE, V53, P277, DOI 10.1007/s13580-012-0002-x; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Schaart JG, 2013, NEW PHYTOL, V197, P454, DOI 10.1111/nph.12017; Seo JS, 2012, MOL BREEDING, V29, P601, DOI 10.1007/s11032-011-9576-8; Shahin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-640; Shu QY, 2009, PHYSIOL PLANTARUM, V135, P436, DOI 10.1111/j.1399-3054.2009.01206.x; Singh RK, 2011, PROTOPLASMA, V248, P839, DOI 10.1007/s00709-010-0249-y; Sun XD, 2013, THESIS SHANDONG AGR; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Suttle JC, 2004, J PLANT PHYSIOL, V161, P157, DOI 10.1078/0176-1617-01222; SUTTLE JC, 1995, PHYSIOL PLANTARUM, V95, P233, DOI 10.1111/j.1399-3054.1995.tb00832.x; Takahashi M, 2006, BREEDING SCI, V56, P39, DOI 10.1270/jsbbs.56.39; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; van der Schoot C, 2011, PLANT SCI, V180, P120, DOI 10.1016/j.plantsci.2010.08.009; Vazquez-Barrios ME, 2006, SCI HORTIC-AMSTERDAM, V108, P127, DOI 10.1016/j.scienta.2006.01.013; Wang Q, 2005, CHROMATOGRAPHIA, V62, P581, DOI 10.1365/s10337-005-0660-2; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087575; Xu J, 2008, MOL BREEDING, V21, P431, DOI 10.1007/s11032-007-9143-5; Yamagishi M, 2011, MOL BREEDING, V28, P381, DOI 10.1007/s11032-010-9490-5; Yamazaki H, 2002, PLANT GROWTH REGUL, V36, P223, DOI 10.1023/A:1016577529378; Yang L, 2009, J LIQ CHROMATOGR R T, V32, P2893, DOI 10.1080/10826070903297376; Yang YM, 2001, PLANT GROWTH REGUL, V35, P233; Yano R, 2013, PLANT J, V74, P815, DOI 10.1111/tpj.12167; Yeo SM, 2012, HORTIC ENVIRON BIOTE, V53, P263, DOI 10.1007/s13580-012-0037-z; Yuan YanBo, 2014, Acta Agriculturae Zhejiangensis, V26, P54; Yun KY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-16; Zha LP, 2011, J CHINESE MED MAT, V7, P1037; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290; Zheng GuoSheng, 2009, Scientia Silvae Sinicae, V45, P48; Zhong MT, 2013, BIOCHEM BIOPH RES CO, V431, P111, DOI 10.1016/j.bbrc.2012.12.065; Zhou YL, 2012, THESIS BEIJING FORES; Zhou ZC, 2014, MOL ECOL RESOUR, V14, P127, DOI 10.1111/1755-0998.12147; Zhu ZJ, 2004, PLANT SCI, V167, P527, DOI 10.1016/j.plantsci.2004.04.020; Zolfaghari R, 2005, ACTA BIOL HUNG, V56, P305, DOI 10.1556/ABiol.56.2005.3-4.13	104	16	21	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119118	10.1371/journal.pone.0119118	http://dx.doi.org/10.1371/journal.pone.0119118			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790307	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400067
